{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 96,
   "metadata": {},
   "outputs": [],
   "source": [
    "import aspect_based_sentiment_analysis as absa\n",
    "import json\n",
    "import pandas as pd\n",
    "from textblob import TextBlob\n",
    "import re"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 97,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open(\"C:/Users/Chitra Bhat/Desktop/tweets.json\") as jfile:\n",
    "    d = json.load(jfile)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 98,
   "metadata": {},
   "outputs": [],
   "source": [
    "data = []\n",
    "for keys in d.keys():\n",
    "    data.append(d[keys])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 99,
   "metadata": {},
   "outputs": [],
   "source": [
    "df = pd.DataFrame.from_dict(data)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 100,
   "metadata": {},
   "outputs": [],
   "source": [
    "def clean_tweet(tweet):\n",
    "    return ' '.join(re.sub(\"(@[A-Za-z0-9]+)|([^0-9A-Za-z \\t])|(\\w+:\\/\\/\\S+)\", \" \", tweet).lower().split())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 101,
   "metadata": {},
   "outputs": [],
   "source": [
    "df['tweet_text'] = df['tweet_text'].apply(clean_tweet)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "metadata": {},
   "outputs": [],
   "source": [
    "list_of_entities = []\n",
    "for tweet in df['tweet_text']:\n",
    "    blob = TextBlob(tweet)\n",
    "    list_of_entities.extend(blob.noun_phrases)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 86,
   "metadata": {},
   "outputs": [],
   "source": [
    "from collections import Counter\n",
    "c = Counter(list_of_entities)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['phase ii study', 'refractory cll', 'ibrutinib intolerant', 'overall response rate']\n",
      "['acalabrutinib venetoclax av trial', 'recruitment phase', 'mcl patients', 'non respondent', 'initial therapy']\n",
      "['nice backs astrazenecas calquence']\n",
      "['valuable option', 'pts intolerant', 'valuable data', 'decision making', 'view haematologica']\n",
      "['treatment na ve chronic lymphocytic leukemia', 'lymsm lymphoma']\n",
      "['nice backs astrazeneca s calquence']\n",
      "[]\n",
      "['astrazeneca s calquence acalabrutinib', 'free monotherapy', 'chronic lymphocytic leukaemia oncology drugapprovals pharma healthnews']\n",
      "['excellent news', 'nice approval', 'frontline cll', 'fcr br', 'unsuitable patients']\n",
      "['cll patients', 'drug ibrutinib', 'uk acalabrutinib', 'new drug pirtobrutinib', 'big impact', 'recent clinicaltrials ie ni']\n",
      "['optimal management', 'high risk cll', 'pm speaker', 'dr p g subramanian mumbai speaker', 'group captain dr harshit khurana pune chair dr s h advani mumbai moderator dr m b agarwal mumbai link']\n",
      "['ready randd']\n",
      "['national institute', 'care excellence', 'treatment option', 'certain groups', 'chronic lymphocytic leukaemia cll patients']\n",
      "['monotherapy option', '17p deletion', 'tp53 mutation', '17p deletion', 'tp53 mutation', 'rituximab fcr', 'rituximab br']\n",
      "['new oral treatment acalabrutinib', 'blood cancer chronic lymphocytic leukaemia']\n",
      "['nice backs astrazeneca s calquence']\n",
      "['nice backs astrazeneca s calquence']\n",
      "['nice backs astrazeneca s calquence']\n",
      "['nice backs astrazeneca s calquence']\n",
      "['nice backs astrazeneca s calquence']\n",
      "['nice backs astrazeneca s calquence', 'cll pharma lifesciences']\n",
      "['new article phase', 'ibrutinib intolerant patients', 'refractory chronic lymphocytic leukemia cll leusm hematology']\n",
      "['oral monotherapy calquence acalabrutinib', 'chronic lymphocytic leukaemia cll pharmanews clinicalresearchnews biotechnews lifesciencesnews medicalnews healthcarenews pharmiwebnews']\n",
      "['new treatments', 'available ireland', 'patients need']\n",
      "['backs nhs', 's calquence', 'new leukaemia indication', 's cholesterol', 'drugs nilemdo', 'nustendi heor']\n",
      "['1l cll', 'pts tp53 mut del', 'trustees marc auckland', 'sky news', 'great news', 'cll pts uk']\n",
      "['antitumor activity', 'refractory b cell malignancies', 'japanese phase i study lymphoma lymsm']\n",
      "['new article safety', 'antitumor activity', 'refractory b cell malignancies', 'japanese phase i study cll leusm hematology']\n",
      "['congress ebmt21', 'r r mantel cell lymphoma', 'btki exposure', 'clinical benefit', 'kte x19 treatment lymsm']\n",
      "['new2trip acalabrutinib calquence', 'chronic lymphocytic leukaemia cll']\n",
      "['calquence commercial', 'pretty lady', 'nurse i']\n",
      "['new clinical trial acalabrutinib umbralisib', 'mantle cell lymphoma mcl lymsm hematology']\n",
      "['astra zeneca', 'cancer drug acalabrutinib', 'immune system investigators', 'treatment protocols']\n",
      "['ash20 tip poster presentation', 'new study', 'mdm2i acalabrutinib', 'r r b cell malignancies', 'lymsm cll dlbcl']\n",
      "['iqvia rds argentina s r l representa', 'janssen vaccines amp prevention b v', 'pharma b v', 'astrazeneca ab', 'amgen inc acalabrutinib apremilast lanadelumab abatacept remdesivir infliximab mesilato', 'cenicriviroc cc']\n",
      "['fda inspections', 'ibrutinib fda approval', 'acalabrutinib fda approval', 'brexucarbatagene autoleucel fda approval', 'wonderful team']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['new article', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['chronic lymphocytic leukemia']\n",
      "['new article', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['btk inhibitors', 'obinutuzumab benefit', '17p tgtherapeutics']\n",
      "['new clinical trial acalabrutinib', 'mantle cell lymphoma mcl lymsm hematology']\n",
      "['acalabrutinib alcanza el objetivo primario', 'comparaci n', 'con ibrutinib']\n",
      "['astrazeneca s calquence azn']\n",
      "['icymi overall', 'elevate rr trial', 'tolerability profile', 'broader acalabrutinib clinical development program']\n",
      "['cll research acalabrutinib', 'cardiovascular events']\n",
      "['standard treatments', 'chronic lymphocytic l']\n",
      "['mcl survival', 'acalabrutinib discontinuation']\n",
      "['mantle cell lymphoma survival', 'acalabrutinib discontinuation']\n",
      "['calquence beneficial', 'cll study shows calquence cll chroniclymphocyticleukemia rarecancer treatment']\n",
      "['new clinical trial alicia acalabrutinib', 'cll therapy cll leusm hematology']\n",
      "[]\n",
      "['tctm21 gvhdsm chronicgvhd number', 'cgvhd drugs', 'itinib oral acalabrutinib']\n",
      "['mantle cell lymphoma treatment market', 'product type acalabrutinib jcar', 'end users application hospital clinic market share', 'depth analysis']\n",
      "['situate acalabrutinib', 'treatment options', 'treatment naive', 'rel ref cll']\n",
      "['acalabrutinib calquence hta id', 'national centre']\n",
      "['news von lesen sie jetzt den vollst ndigen beitrag unter arzt schmerz cll immunchemotherapie leuk mie immuntherapie neutropenie mutation acalabrutinib patient therapie unvertr glichkeiten zulassung studie']\n",
      "['video dr danilov discusses', 'treatment option', 'cll sll', 'medtwitter healthcare']\n",
      "['video interview dr graff discusses', 'treatment landscape', 'recent years', 'acalabrutinib calquence astrazeneca']\n",
      "['trial investigators', 'pfs benefit', 'acalabrutinib versus ibrutinib', 'high risk cll leusm']\n",
      "['standard treatments', 'chronic lymphocytic']\n",
      "['astrazeneca s calquence', 'primary efficacy endpoint', 'chronic lymphocytic leukemia hematology oncology acalabrutinib cll pfs n']\n",
      "['new2trip acalabrutinib']\n",
      "['refractory chronic lymphocytic leukaemia chronicillness digitalhealth lyfebulb']\n",
      "['noninferior progression', 'free survival', 'atrial fibrillation versus ibrutinib', 'high risk chronic lymphocytic leukemia leusm']\n",
      "['new data claims', 'leukemia drug']\n",
      "['elevate rr trial', 'tolerability profile', 'broader acalabrutinib clinical development program']\n",
      "['new data claims', 'leukemia drug']\n",
      "['new data claims', 'leukemia drug']\n",
      "['new data claims', 'leukemia drug']\n",
      "['new data claims', 'leukemia drug']\n",
      "['new data claims', 'leukemia drug']\n",
      "['news acalabrutinib', 'primary endpoint', 'inferior pfs vs ibrutinib', 'phase iii elevate rr trial', 'r r cll']\n",
      "['ammh mato l acalabrutinib un nouveau traitement chez les patients adultes atteints d', 'leuc mie lympho', 'chronique retrouvez tous les d tails', 'cette mol cule sur notre findrugs cancer innovation informationpatient h matologie traitement']\n",
      "['leukemia drugs', 'cardiac issues cardiology cancer stroke']\n",
      "['cart therapy', 'mantle cell lymphoma', 'acalabrutinib failure']\n",
      "['acalabrutinib monotherapy', 'chronic lymphocytic leukemia', 'ibrutinib cll']\n",
      "['new data claims', 'leukemia drug']\n",
      "['acalabrutinib shows noninferior pfs', 'atrial fibrillation versus ibrutinib', 'high risk cll']\n",
      "['acalabrutinib shows noninferior pfs versus ibrutinib', 'high risk cll leusm']\n",
      "['high risk chronic lymphocytic leukemia treatment', 'free survival leusm']\n",
      "['pharma marketers', 'tuesday january', 'roundup mm amp m', 'media covid19 calquence tx']\n",
      "['atrial fibrillation cases', 'johnson amp johnson', 'abbvie s', 'rival btk inhibitor imbruvica', 'chronic lymphocytic leukemia trial azn jnj abbv leukemia pharma']\n",
      "['atrial fibrillation cases', 'johnson amp johnson', 'abbvie s', 'rival btk inhibitor imbruvica', 'chronic lymphocytic leukemia trial azn jnj abbv leukemia pharma']\n",
      "['primary efficacy endpoint', 'chronic lymphocytic leukemia astrazeneca calquence lymphoma mantle cell lymphoma pfs cll acalabrutinib']\n",
      "['safer drug']\n",
      "['mantle cell lymphoma patients']\n",
      "['new article', 'european medicines agency review', 'adult patients', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['refractory chronic lymphocytic leukaemia']\n",
      "['primary efficacy endpoint']\n",
      "['refractory chroniclymphocyticleukaemia']\n",
      "['calquence tops imbruvica', 'chronic lymphocytic leukaemia study']\n",
      "['primary efficacy endpoint']\n",
      "['raggiunto l endpoint primario di efficacia nello studio testa', 'testa contro ibrutinib nella leucemia linfocitica cronica']\n",
      "['jp acalabrutinib calquence cll cardioonc']\n",
      "['astrazeneca touts calquence safety', 'leukemia trial showdown']\n",
      "['monday s', 'comirnaty s', 'provisional approval', 'hong kong', 'priority reviews', 'phase iii cll trial']\n",
      "['generation btk inhibitor astrazeneca', 'new data', 'j amp j', 'abbvie s', 'generation blockbuster imbruvica']\n",
      "['new data claims', 'leukemia drug', 'imbruvica biopharma dive pharmatopnews oncologytopnews oncology']\n",
      "['refractory cll leusm']\n",
      "['astrazeneca touts calquence safety', 'leukemia trial showdown']\n",
      "['mantle cell lymphoma patients', 'acalabrutinib jain american journal', 'hematology wiley online library']\n",
      "['refractory chronic lymphocytic leukaemia']\n",
      "['raggiunto l endpoint primario di efficacia nello studio testa', 'testa contro ibrutinib nella leucemia linfocitica cronica']\n",
      "['topline results', 'elevate rr trial show', 'acalabrutinib exhibits', 'comparable efficacy', 'superior safety', 'chronic lymphocytic leukemia cll']\n",
      "['primary efficacy endpoint', 'chronic lymphocytic leukemia neuro']\n",
      "['astrazeneca touts calquence safety', 'leukemia trial showdown strategy competitiveintelligence', 'pharmaceutical healthcare biotech']\n",
      "['astrazeneca touts calquence safety', 'leukemia trial showdown']\n",
      "['new data claims', 'leukemia drug', 'azn abbv jnj']\n",
      "['astrazeneca s calquence', 'johnson amp johnson s imbruvica', 'blood cancer', 'late stage study azn jnj']\n",
      "['new data claims', 'leukemia drug', 'imbruvica azn abbv jnj mrk']\n",
      "['astrazeneca touts calquence safety', 'leukemia trial showdown']\n",
      "['astrazeneca touts calquence safety', 'leukemia trial showdown']\n",
      "['safer drug']\n",
      "[]\n",
      "['generation btk inhibitor astrazeneca', 'new data', 'j amp j', 'abbvie s', 'generation blockbuster imbruvica']\n",
      "['calquence tops imbruvica', 'chronic lymphocytic leukaemia study']\n",
      "['azn astrazeneca reports', 'positive phase']\n",
      "['astrazeneca s calquence nabs', 'heels strategy competitiveintelligence', 'pharma biotech pharmaceutical healthcare']\n",
      "['azn calquence', 'primary efficacy endpoint', 'chronic lymphocytic leukemia']\n",
      "['astrazeneca s calquence nabs']\n",
      "['new clinical trial', 'treatment time', 'sll cll leusm hematology']\n",
      "['reports calquence', 'primary efficacy endpoint', 'refractory chronic lymphocytic leukemia']\n",
      "['brief astrazeneca']\n",
      "['primary efficacy endpoint', 'chronic lymphocytic leukaemia']\n",
      "['azn astrazeneca s calquence', 'lymphocytic leukaemia study']\n",
      "['awesomecapital astrazeneca calquence safer']\n",
      "['azn astrazeneca reports calquence', 'primary efficacy endpoint', 'ibrutinib recieves']\n",
      "['astrazeneca s calquence', 'primary efficacy endpoint', 'tickers azn']\n",
      "['calquence tops imbruvica', 'chronic lymphocytic leukaemia study pharmanews pharma']\n",
      "['azn calquence', 'primary efficacy endpoint', 'chronic lymphocytic leukemia']\n",
      "['primary efficacy endpoint', 'chronic lymphocytic leukemia']\n",
      "['primary efficacy endpoint', 'chronic lymphocytic leukemia']\n",
      "['primary efficacy endpoint', 'chronic lymphocytic leukemia']\n",
      "['high level results', 'elevate rr phase iii trial', 'high risk chronic lymphocytic leukemia']\n",
      "['azn calquence', 'primary efficacy endpoint', 'chronic lymphocytic leukemia']\n",
      "['astrazeneca s calquence', 'lymphocytic leukaemia study']\n",
      "['astrazeneca s calquence', 'lymphocytic leukaemia study azn']\n",
      "['astrazeneca s calquence', 'lymphocytic leukaemia study']\n",
      "['azn astrazeneca s calquence', 'lymphocytic leukaemia study']\n",
      "['azn astrazeneca s calquence', 'primary endpoint', 'trial vs ibrutinib', 'company states', 'positive high level results', 'elevate rr phase iii trial', 'astrazeneca s calquence']\n",
      "['atrial fibrillation', 'j amp j', 'abbvie s market', 'btk inhibitor imbruvica', 'chronic lymphocytic leukaemia pharma oncology']\n",
      "['astrazeneca s calquence', 'cll treatment azn']\n",
      "['azn calquence head', 'study vs imbruvica', '2l cll non', 'inferior pfs', 'significant reduction', 'atrial fibrillation']\n",
      "['astrazeneca s calquence', 'primary endpoint', 'trial vs ibrutinib azn']\n",
      "['goldman bel sst astrazeneca auf', 'new york dpa afx analyser', 'investmentbank goldman sachs hat', 'einstufung f r astrazeneca angesichts positiver studiendaten mit dem medikament calquence zur behandlung aktiencheck']\n",
      "['dpa afx goldman bel sst astrazeneca auf', 'new york dpa afx analyser', 'investmentbank goldman sachs hat', 'einstufung f r astrazeneca angesichts positiver studiendaten mit dem medikament calquence zur finanztreff']\n",
      "['calquence tops imbruvica', 'chronic lymphocytic leukaemia study']\n",
      "['refractory chronic lymphocytic leukaemia']\n",
      "['brief astraxeneca']\n",
      "['astrazeneca s leukaemia treatment', 'japan calquence', 'primary goal']\n",
      "[]\n",
      "[]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['azn calquence', 'refractory chronic lymphocytic leukaemia']\n",
      "['primary endpoint']\n",
      "[]\n",
      "['azn calquence', 'primary endpoint', 'primary efficacy endpoint', 'chronic lymphocytic leukaemia', 'superior safety', 'secondary endpoint', 'atrial fibrillation']\n",
      "['astrazeneca reports', 'positive test results', 'new approval']\n",
      "['astrazeneca s leukaemia treatment', 'japan calquence', 'primary goal']\n",
      "['livesquawk azn astrazeneca plc calquence', 'primary endpoint', 'ibrutinib calquence', 'primary efficacy endpoint', 'chronic lymphocytic leukaemia']\n",
      "['brief astraxeneca']\n",
      "['brief astrazeneca', 'primary endpoint']\n",
      "['azn astrazeneca plc calquence', 'primary endpoint', 'ibrutinib calquence', 'primary efficacy endpoint', 'chronic lymphocytic leukaemia']\n",
      "['refractory chronic lymphocytic leukaemia']\n",
      "[]\n",
      "['refractory chronic lymphocytic leukaemia']\n",
      "['primary efficacy endpoint', 'chronic lymphocytic leukaemia']\n",
      "['primary endpoint']\n",
      "['azn astrazeneca plc calquence', 'primary endpoint', 'ibrutinib calquence', 'primary efficacy endpoint', 'chronic lymphocytic leukaemia']\n",
      "['european medicines agency review', 'adult patients', 'chronic lymphocytic leukemia']\n",
      "['new clinical trial acalabrutinib', 'mcl patients', 'allogeneic hematopoietic stem cell transplantation allosct mcl lymsm hematology']\n",
      "['new clinical trial acalabrutinib', 'mcl patients', 'allogeneic hematopoietic stem cell transplantation allosct cll leusm hematology']\n",
      "['astrazeneca s', 'new calquence data', 'mantle cell lymphoma mcl', 'calquence ash2020 mantlecelllymphoma']\n",
      "['standard treatments']\n",
      "['oncologists design trials', 'viral infection', 'covid19 trials ruxolitinib etoposide ibrutinib selinexor lenalidomide acalabrutinib baricitinib zanabrutinib chest radiation']\n",
      "['final recommendation', 'acalabrutinib calquence', 'clinical criteria', 'chronic lymphocytic leukemia', 'full recommendation']\n",
      "['1l trial', 'richters transformation rchop vs rchop acalabrutinib', 'lymsm cll research']\n",
      "['potent bruton tyrosine kinase inhibitor', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['new article acalabrutinib', 'potent bruton tyrosine kinase inhibitor', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['standard treatments', 'chroni leukemia']\n",
      "['new post acalabrutinib market report size key players']\n",
      "['mit acalabrutinib kam im dezember ein neuer bruton tyrosinkinase btk hemmer auf den markt der', 'wird wie das seit', 'verf gbare ibrutinib peroral bei patienten mit chronisch lymphatischer leuk mie eingesetzt']\n",
      "[]\n",
      "['global acalabrutinib market', 'depth analysis report']\n",
      "['acalabrutinib market report till', 'global manufacturers analysis']\n",
      "['acalabrutinib arms', 'elevate cll tn trial', 'obinutuzumab chlorambucil', 'significant difference dr seymour', 'virtual meeting leukemia']\n",
      "['leucemia linfatica cronica acalabrutinib approvato', 'dimostrato un beneficio significativo', 'termini di efficacia e tollerabilit', 'lungo termine tanto nel trattamento', 'prima linea quanto nella malattia recidivante o refrattaria']\n",
      "['oral treatment option', 'adult patients', 'chronic lymphocytic leukemia cll']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil']\n",
      "['oral treatment option', 'adult patients', 'chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil']\n",
      "['oral treatment option', 'adult patients', 'chronic lymphocytic leukemia cll']\n",
      "['rai iii dx bm bx tx venetoclax obinutuzumab', 'acalabrutinib obinu fcr', 'aiha dx dat t bili ldh hapto retic tx roids', 'prca retics tx ist cioc edu']\n",
      "['clinicaltrial rituximab acalabrutinib', 'durvalumab rad', 'primary cns lymphoma']\n",
      "['ibrutinib acalabrutinib intolerant r r b cell malignancies w ian flinn', 'ash20 hematology hemonc leusm leukemia cllsm ctsm']\n",
      "['rituximab acalabrutinib', 'durvalumab rad', 'primary cns lymphoma status', 'condition summary primary', 'central nervous system lymphoma pcnsl']\n",
      "['james discusses', 'chronic lymphocytic leukemia cll']\n",
      "['acalabrutinib arms', 'elevate cll tn trial', 'obinutuzumab chlorambucil', 'significant difference dr seymour', 'virtual meeting cll leusm']\n",
      "['standard treatments', 'chronic lymphocy']\n",
      "['calquence product monograph', 'info health technology assessments', 'access drug documents']\n",
      "['agent acalabrutinib', 'low incidence', 'cardiac toxicities', 'clinical trials']\n",
      "['ash20 nuove importanti conferme sull utilizzo di acalabrutinib', 'combinazione nel trattamento della leucemia linfatica cronica', 'con risultati significativi', 'termini di risposta completa e mrd negativit', 'parole di francesca romana mauro']\n",
      "['agent acalabrutinib', 'low incidence', 'cardiac toxicities', 'clinical trials']\n",
      "['standard treatments', 'chronic lym']\n",
      "['generation btk inhibitor', 'cardiac toxicity', 'months hematology ash20']\n",
      "['astrazeneca s phase', 'multiple cell lymphoma patients', 'astrazeneca s cancerdrug calquence']\n",
      "[]\n",
      "[]\n",
      "[]\n",
      "['calquence r']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['cll medication', 'day capsule', 'prescription calquence', 'adult patients', 'cll bloodcancerawareness']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['azn lr op', 'class oncology portfolio', 'premium oncology portfolio', 'class assets', 'tagrisso lynparza calquence enhertu']\n",
      "['cancer drug', 'solidarity trials']\n",
      "['investigaci n los datos', 'ensayos cl nicos refuerzan su perfil', 'seguridad cardiovascular', 'con leucemia linfoc tica cr nica']\n",
      "['los datos', 'ensayos cl nicos refuerzan su perfil', 'seguridad cardiovascular', 'con leucemia linfoc tica cr nica']\n",
      "['agent acalabrutinib', 'low incidence', 'cardiac toxicities', 'treatment discontinuation hematology ash20']\n",
      "['new2trip acalabrutinib calquence chronic lymphocytic leukaemia cll']\n",
      "['kinumpirma ng department', 'health na hindi na gagamitin sa world health organization solidarity trial ng therapeutics o mga gamot ang acalabrutinib']\n",
      "['patient population', 'calquence monotherapy', 'cardiac toxicity', 'treatment discontinuation']\n",
      "['acalabrutinib hindi na gagamitin sa', 'solidarity trial ng therapeutic']\n",
      "['bad news', 'astrazeneca s blood cancer drug calquence acalabrutinib']\n",
      "['acalabrutinib hindi na gagamitin sa', 'solidarity trial ng therapeutics doh']\n",
      "['pasyente nakumpleto na ang clinical trial ng avigan bilang gamot sa covid', 'sa pilipinas clinical trial ng cancer drug na acalabrutinib sa paghanap ng gamot kontra covid', 'hindi na itinuloy ng superbalitasahapon']\n",
      "['cancer drug na acalabrutinib inalis na sa mga gamot na kasama sa', 'solidarity trial']\n",
      "['nagbigay na ng recommendation ang', 'solidarity trial', 'doh spokesperson maria rosario vergeire']\n",
      "['paggamit ng cancer drug na acalabrutinib bilang bahagi ng solidarity trial sa paghanap ng gamot para sa covid', 'hindi na itinuloy ng world health organization o']\n",
      "['standard treatments', 'chronic lymphocy']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['mantlecell lymphoma calquence']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['los datos', 'ensayos cl nicos refuerzan su perfil', 'seguridad cardiovascular', 'con llc']\n",
      "['cll medication', 'day capsule', 'prescription calquence', 'adult patients bloodcancerawareness']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['caregiver resources calquence', 'oral 2x', 'day prescription medication', 'adult patients']\n",
      "['new2trip 17p deletion', 'patients w', 'refractory chronic lymphocytic leukaemia']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['tolerability profile']\n",
      "['tolerability profile']\n",
      "['don t', 'astrazeneca s', 'calquence patient data', 'year s virtual conference']\n",
      "['tolerability profile']\n",
      "['don t', 'astrazeneca s', 'calquence patient data', 'year s virtual conference']\n",
      "['tolerability profile']\n",
      "['don t', 'astrazeneca s', 'calquence patient data', 'year s virtual conference']\n",
      "['year s', 'virtual ash', 'clinical data', 'treatment option']\n",
      "['tolerability profile']\n",
      "['tolerability profile']\n",
      "['tolerability profile']\n",
      "['tolerability profile']\n",
      "['tolerability profile']\n",
      "['tolerability profile']\n",
      "['don t', 'astrazeneca s', 'calquence patient data', 'year s virtual conference']\n",
      "['tolerability profile']\n",
      "['don t', 'astrazeneca s', 'calquence patient data', 'year s virtual conference']\n",
      "['tolerability profile']\n",
      "['don t', 'dr michael wang', 'present astrazeneca s clinical data', 'year s virtual conference']\n",
      "['don t', 'astrazeneca s', 'calquence patient data', 'year s virtual conference']\n",
      "['tolerability profile']\n",
      "['cll medication', 'day capsule', 'prescription calquence', 'adult patients', 'cll bloodcancerawareness']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['ash20 leucemia linfatica cronica il trattamento', 'con acalabrutinib', 'monoterapia si caratterizza', 'l ottimo profilo di safety elemento assolutamente decisivo nell ambito di questa patologia l intervista', 'paolo ghia']\n",
      "['acalabrutinib r chop', 'nd dlbcl ash20']\n",
      "['r r mcl ash20']\n",
      "['acalabrutinib cost effectiveness ash20']\n",
      "['acalabrutinib cardiovascular events ash20']\n",
      "['avo acalabrutinib venettoclax r o', 'r r cll ash20']\n",
      "['new clinical trial', 'high risk cll cll leusm hematology']\n",
      "['acalabrutinib demonstrates', 'low cardiac risk', 'chronic lymphocytic leukemia']\n",
      "['nhs england', 'immediate access', 'cancer drug calquence', 'certain patients', 'chronic lymphocytic leukaemia cll', 'recommendations cancer pharma']\n",
      "['certain adults', 'chronic lymphocytic leukaemia', 'draft guidance']\n",
      "['acalabrutinib demonstrates', 'low cardiac risk', 'chronic lymphocytic leukemia']\n",
      "['astrazeneca s calquence beigene s brukinsa', 'new data', 'term efficacy']\n",
      "['cll medication', 'day capsule', 'prescription calquence', 'adult patients', 'cll bloodcancerawareness']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['nice backs az calquence', 'chronic lymphocytic leukaemia']\n",
      "['waldenstr m macroglobulinemia', 'zanubrutinib ash20']\n",
      "['nice backs astrazeneca calquence', 'chronic lymphocytic leukaemia cll']\n",
      "['nice recommendation', 'astrazeneca s calquence', 'chronic lymphocytic leukaemia populations']\n",
      "['backs calquence', 'chronic lymphocytic leukaemia regulatory']\n",
      "['brown discusses', 'cardiovascular events', 'generation btk inhibitor acalabrutinib monotherapy', 'chronic lymphocytic leukemia leusm ash20']\n",
      "['eligible patients', 'chronic lymphocytic leukaemia cll', 'immediate access', 'calquence acalabrutinib', 'positive nice recommendation news pharma clinicalresearch biotech lifesciences', 'medical healthcare pharmiweb']\n",
      "['calquence data', 'trials reinforces cardiovascular safety profile', 'chronic lymphocytic leukaemia news pharma clinicalresearch biotech lifesciences', 'medical healthcare pharmiweb']\n",
      "['nice recommendation', 'astrazeneca s calquence', 'chronic lymphocytic leukaemia populations pharmaceutical']\n",
      "['clinical trials reflects', 'low cardiac risk']\n",
      "['prescient coverage', 'ash2020 day', 'chronic lymphocytic leukemia cll ror1inhibitor mdm2inhibitor ibrutinib acalabrutinib zanubritinib ublituximab loxo305']\n",
      "['clinical trials reflects', 'low cardiac risk', 'cll hematology ash20 leusm']\n",
      "['new clinical trial acalabrutinib', 'refractory autoimmune hemolytic anemia', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['aprobaci n', 'acalabrutinib contra leucemia linfoc tica cr nica', 'uni n europea']\n",
      "['nice backs az calquence', 'chronic lymphocytic leukaemia']\n",
      "['nice backs az calquence', 'chronic lymphocytic leukaemia pharmanews pharma']\n",
      "['calquence data', 'trials reinforces cardiovascular safety profile']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['calquence data', 'trials reinforces cardiovascular safety profile']\n",
      "['new calquence clinical data']\n",
      "['new calquence clinical data']\n",
      "['new calquence clinical data']\n",
      "['new calquence clinical data']\n",
      "['year s', 'virtual ash', 'clinical data', 'treatment option', 'cll ash20']\n",
      "['ash astrazeneca s calquence beigene s brukinsa', 'new data']\n",
      "['front line tx', 'venetoclax obinatuzumab', 'acalabrutinib w', 'w o cd20 moab ash2020']\n",
      "['astrazeneca reports', 'long term efficacy', 'calquence acalabrutinib', 'p ll ace']\n",
      "['uk partners caramel pilot trial', '1l acalabrutinib rituximab', 'elderly pts unfit', 'standard immunochemotherapy', 'ibrutinib r phase ii data']\n",
      "['awesomecapital ash astrazeneca s calquence beigene s brukinsa t']\n",
      "['calquence data', 'trials reinforces cardiovascular safety profile', 'chronic lymphocytic leukemia azn']\n",
      "['calquence shows', 'long term efficacy', 'refractory mantle cell lymphoma neuro']\n",
      "['brown discusses', 'cardiovascular events', 'generation btk inhibitor acalabrutinib monotherapy', 'chronic lymphocytic leukemia ash20 leusm']\n",
      "['astrazeneca s calquence beigene s brukinsa', 'new data', 'notice fiercepharma pharmatopnews oncology oncologytopnews']\n",
      "['calquence shows', 'long term efficacy']\n",
      "['ash20 poster session', 'md mph', 'refractory b cell malignancies intolerant', 'ibrutinib acalabrutinib hematology']\n",
      "['calquence data', 'trials reinforces cardiovascular safety profile', 'chronic lymphocytic leukemia']\n",
      "['azn calquence data', 'trials reinforces cardiovascular safety profile', 'chronic lymphocytic leukemia business wire']\n",
      "['amp nbsp calquence shows', 'long term efficacy']\n",
      "['calquence data', 'trials reinforces cardiovascular safety profile', 'chronic lymphocytic']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'mantle cell lymphoma mcl', 'convenient oral 2x', 'day capsule']\n",
      "['az s calquence shows', 'long term efficacy']\n",
      "['calquence shows', 'long term efficacy', 'refractory mantle cell lymphoma']\n",
      "['analysis hematology', 'cardiovascular safety data', 'calquence acalabrutinib monotherapy', 'chronic lymphocytic leukaemia cll', 'common adult leukaemia', 'low incidence', 'cardiac adverse events']\n",
      "['brief astrazeneca', 'cardiac adverse events']\n",
      "['calquence shows', 'long term efficacy', 'refractory mantle cell lymphoma']\n",
      "['calquence shows', 'long term efficacy', 'refractory mantle cell lymphoma']\n",
      "['calquence shows', 'long term efficacy', 'refractory mantle azn']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['azn calquence data', 'trials reinforces cardiovascular safety profile', 'chronic lymphocytic leukemia']\n",
      "['calquence trials reinforces cv safety', 'cll azn']\n",
      "['calquence data', 'trials reinforces cardiovascular safety profile', 'chronic lymphocytic leukaemia']\n",
      "['cardiovascular cv', 'adverse events', 'key consideration', 'chronic lymphocytic leukemia cll treatment decisions', 'cv safety data']\n",
      "['azn calquence data', 'trials reinforces cardiovascular safety profile', 'chronic lymphocytic leukemia']\n",
      "['azn bgne ash astrazeneca s calquence beigene s brukinsa', 'new data']\n",
      "['calquence shows', 'long term efficacy']\n",
      "['phase ii trial results substantiate', 'safety profile']\n",
      "['prescient coverage', 'ash2020 day', 'chronic lymphocytic leukemia cll acalabrutinib venetoclax obinutuzumab']\n",
      "['azn astrazeneca s calquence shows', 'long term efficacy', 'blood cancer']\n",
      "['astrazeneca s calquence shows', 'long term efficacy', 'blood cancer vi wic p i fin nci l re ds']\n",
      "['astrazeneca s calquence shows', 'long term efficacy', 'blood cancer']\n",
      "['astrazeneca s calquence shows', 'long term efficacy', 'blood cancer azn']\n",
      "['azn astrazeneca s calquence shows', 'long term efficacy', 'blood cancer']\n",
      "['calquence shows', 'long term efficacy', 'mcl pharmanews pharma']\n",
      "['calquence shows', 'long term efficacy']\n",
      "['astrazeneca reports', 'long term efficacy', 'calquence acalabrutinib', 'p ll ace']\n",
      "['long term', 'positive ace', 'phase ii trial', 'refractory mantle cell lymphoma mcl', 'calquence acalabrutinib', 'latestpharmanewsdec7 latestastrazenecanewsdec7']\n",
      "['calquence shows', 'long term efficacy', 'refractory mantlecelllymphoma azn']\n",
      "['tolerability profile', 'virtual conversation']\n",
      "['tolerability profile', 'virtual conversation']\n",
      "['tolerability profile', 'virtual conversation']\n",
      "['tolerability profile', 'virtual conversation']\n",
      "['tolerability profile', 'virtual conversation']\n",
      "['tolerability profile', 'virtual conversation']\n",
      "['tolerability profile', 'virtual conversation']\n",
      "['tolerability profile', 'virtual conversation']\n",
      "['tolerability profile', 'virtual conversation']\n",
      "['tolerability profile', 'virtual conversation']\n",
      "['tolerability profile', 'virtual conversation']\n",
      "['ash astrazeneca s calquence beigene s brukinsa', 'new data']\n",
      "['calquence shows', 'long term efficacy tolerability', 'r r mcl azn']\n",
      "['ash astrazeneca s calquence beigene s brukinsa', 'new data']\n",
      "['cytokine storms', 'high levels', 'pro inflammatory tnf', 'patients suffer', 'cytokine storms', 'immune systems end']\n",
      "['ash astrazeneca s calquence', 'beigene s brukinsa', 'turning heads', 'new data']\n",
      "['ash astrazeneca s calquence beigene s brukinsa', 'new data', 'notice strategy competitiveintelligence', 'pharma pharmaceutical', 'healthcare biotech']\n",
      "['alert astrazeneca', 'calquence shows', 'long term efficacy', 'refractory mantle cell lymphoma', 'time date']\n",
      "['ash astrazeneca s calquence beigene s brukinsa', 'new data']\n",
      "['new article johnson amp johnson ash astrazeneca s calquence beigene s brukinsa', 'new data', 'fintech zoom fintech blockchain crypto cryptocurrency ico']\n",
      "['ash astrazeneca s calquence beigene s brukinsa', 'new data']\n",
      "['ash astrazeneca s calquence beigene s brukinsa', 'new data']\n",
      "['ash astrazeneca s calquence beigene s brukinsa', 'new data']\n",
      "['ash astrazeneca s calquence beigene s brukinsa', 'new data']\n",
      "['calquence shows', 'long term efficacy', 'refractory mantle']\n",
      "['calquence shows', 'long term efficacy', 'refractory mantle cell lymphoma neuro']\n",
      "['question clive zent', 'cd antibody', 'btk inhibitor acalabrutinib']\n",
      "['calquence shows', 'long term efficacy', 'refractory mantle cell lymphoma']\n",
      "['calquence shows', 'long term efficacy', 'refractory mantle cell lymphoma stockmarket']\n",
      "['azn reveals findings', 'mid stage trial', 'refractory mantle cell lymphoma astrazeneca mcl mantlecelllymphoma lymphoma']\n",
      "['azn calquence shows', 'long term efficacy', 'refractory mantle cell lymphoma']\n",
      "['azn calquence shows', 'long term efficacy', 'refractory mantle cell lymphoma']\n",
      "['calquence shows', 'long term efficacy', 'refractory mantle cell lymphoma']\n",
      "['calquence shows', 'long term efficacy', 'refractory mantle cell lymphoma azn']\n",
      "['calquence shows', 'long term efficacy', 'refractory mantle c']\n",
      "['calquence shows', 'long term efficacy', 'refractory mantle cell lymphoma']\n",
      "['long term', 'refractory mantle cell lymphoma mcl']\n",
      "['calquence shows', 'long term efficacy', 'refractory mantle cell lymphoma']\n",
      "['azn calquence shows', 'long term efficacy', 'refractory mantle cell lymphoma']\n",
      "['new2trip acalabrutinib calquence chronic lymphocytic leukaemia cll']\n",
      "['don t', 'dr michael wang', 'present astrazeneca s clinical data', 'year s virtual ash20 conference']\n",
      "['mantle cell lymphoma', 'beneficial toxicity profile']\n",
      "['team member register', 'year s conference', 'loxo305 vls101 ibrutinib acalabrutinib zuma', 'car t ashfromhome']\n",
      "['thorough overview', 'safety data', 'nicola lamanna rct', 'acalabrutinib vs ibrutinib monotherapy', 'high risk r r cll', 'great interest cll ash20']\n",
      "['new calquence clinical data', 'oncologists hematologists']\n",
      "['selective inhibition', 'btk inhibitors inc', 'label administration']\n",
      "['new calquence clinical data', 'oncologists hematologists']\n",
      "['new calquence clinical data', 'oncologists hematologists']\n",
      "['new calquence clinical data', 'oncologists hematologists']\n",
      "['new calquence clinical data', 'oncologists hematologists']\n",
      "['cancer immunotherapy drugs', 'new cars', 's calquence']\n",
      "['aprobaci n', 'acalabrutinib contra leucemia linfoc tica cr nica', 'uni n europea', 'trav s']\n",
      "['agencia europea', 'medicamentos ema acaba', 'aprobar acalabrutinib para el tratamiento', 'leucemia linfoc tica cr nica una', 'las leucemias m s comunes', 'terapia deber ser aplicada por un especialista', 'f rmacos neopl sicos']\n",
      "['ema approval', 'calquence bibrands calquence', 'prescription medicine', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll emaapproval', 'cll sll']\n",
      "['aprobaci n', 'acalabrutinib contra leucemia linfoc tica cr nica', 'uni n europea']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['cll medication', 'day capsule', 'prescription calquence', 'adult patients', 'cll bloodcancerawareness']\n",
      "['cll medication', 'day capsule', 'prescription calquence', 'adult patients', 'cll bloodcancerawareness']\n",
      "['year s', 'virtual ash', 'clinical data', 'treatment option', 'cll ash20']\n",
      "['year s', 'virtual ash', 'clinical data', 'treatment option', 'cll ash20']\n",
      "['attention ash20 attendees tune', 'dr paolo ghia', 'final analysis', 'pivotal calquence trial', 'refractory cll']\n",
      "['year s', 'virtual ash', 'clinical data', 'treatment option', 'cll ash20']\n",
      "['attention ash20 attendees tune', 'dr paolo ghia', 'final analysis', 'pivotal calquence trial', 'refractory cll']\n",
      "['attention ash20 attendees tune', 'dr paolo ghia', 'final analysis', 'pivotal calquence trial', 'refractory cll']\n",
      "['attention ash20 attendees tune', 'dr paolo ghia', 'final analysis', 'pivotal calquence trial', 'refractory cll']\n",
      "['year s', 'virtual ash', 'clinical data', 'treatment option', 'cll ash20']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['q1 acalabrutinib', 'condition abim']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['cll medication', 'day capsule', 'prescription calquence', 'adult patients bloodcancerawareness']\n",
      "['acalabrutinib arm', 's solidarity trial', 'astrazeneca s trial', 'significant improvement', 'treatment outcomes']\n",
      "['acalabrutinib arm', 'solidarity therapeutics trial', 'astrazeneca s study', 'anticancer drug']\n",
      "['acalabrutinib arm', 'solidarity therapeutics trial', 'astrazeneca s study', 'anticancer drug']\n",
      "['cll medication', 'day capsule', 'prescription calquence', 'adult patients', 'cll bloodcancerawareness']\n",
      "['cll medication', 'day capsule', 'adult patients bloodcancerawareness']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['solidarity trial', 'treatments condition covid19 interventions drug remdesivir drug acalabrutinib drug interferon beta 1a', 'care sponsor covid19 sarscov2 coronavirus']\n",
      "['standard treatments', 'chronic lymphocyt leukemia']\n",
      "['standard treatments', 'chronic lymphocytic']\n",
      "['cll medication', 'day capsule', 'prescription calquence', 'adult patients bloodcancerawareness']\n",
      "['caregiver resources calquence', 'oral 2x', 'day prescription medication', 'adult patients']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['cll medication', 'day capsule', 'prescription calquence', 'adult patients bloodcancerawareness']\n",
      "['don t', 'astrazeneca s', 'calquence patient data', 'year s virtual ash20 conference']\n",
      "['don t', 'astrazeneca s', 'calquence patient data', 'year s virtual ash20 conference']\n",
      "['don t', 'astrazeneca s', 'calquence patient data', 'year s virtual ash20 conference']\n",
      "['don t', 'astrazeneca s', 'calquence patient data', 'year s virtual ash20 conference']\n",
      "['cll medication', 'day capsule', 'prescription calquence', 'adult patients', 'cll bloodcancerawareness']\n",
      "['kommt das arzneimittel calquence acalabrutinib auf den deutschen markt es handelt sich um eine neue behandlungsoption bei chronisch lymphatischer leuk mie cll']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['cll medication', 'day capsule', 'prescription calquence', 'adult patients', 'cll bloodcancerawareness']\n",
      "['caregiver resources calquence', 'oral 2x', 'day prescription medication', 'adult patients']\n",
      "['cll medication', 'day capsule', 'prescription calquence', 'adult patients bloodcancerawareness']\n",
      "['top story acalabrutinib', 'refractory chronic lymphocytic leukemia medivizor']\n",
      "['top story acalabrutinib', 'refractory chronic lymphocytic leukemia medivizor']\n",
      "['refractory chronic lymphocytic leukemia']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['azn astrazeneca', 'early stage data', 'drug acalabrutinib', 'blood cancers', 'solid tumours', 'covid vaccine']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['headline news steals amp deals', 'caregiver resources calquence', 'oral 2x', 'day prescription medication', 'adult patients wit']\n",
      "['caregiver resources calquence', 'oral 2x', 'day prescription medication', 'adult patients']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['cll medication', 'day capsule', 'prescription calquence', 'adult patients bloodcancerawareness']\n",
      "['cll medication', 'day capsule', 'prescription calquence', 'adult patients bloodcancerawareness']\n",
      "['calavi calquence calavi']\n",
      "['contribuez nous valuons', 'nouveau m dicament calquence acalabrutinib dans', 'traitement des patients atteints', 'leuc mie lympho', 'chronique llc non pr c demment trait e']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['cll medication', 'day capsule', 'prescription calquence', 'adult patients bloodcancerawareness']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['cll medication', 'day capsule', 'prescription calquence', 'adult patients bloodcancerawareness']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['cll medication', 'day capsule', 'prescription calquence', 'adult patients bloodcancerawareness']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['cll medication', 'day capsule', 'prescription calquence', 'adult patients bloodcancerawareness']\n",
      "['cll medication', 'day capsule', 'prescription calquence', 'adult patients bloodcancerawareness']\n",
      "['cll medication', 'day capsule', 'prescription calquence', 'adult patients bloodcancerawareness']\n",
      "['cll medication', 'day capsule', 'prescription calquence', 'adult patients bloodcancerawareness']\n",
      "['astrazeneca cancer drug']\n",
      "['astrazeneca s calquence', 'phase ii covid']\n",
      "['leucemia linfocitica acalabrutinib approvato', 'ue leucemia linfocitica acalabrutinib']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['calquence calavi']\n",
      "['comprehensive rw', 'danilov amp acalabrutinib', 'mcl cll amp wm', 'generation btk inhibitor', 'clinical practice', 'haematological malignancies']\n",
      "['great news']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['day course', 'treatment covid']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['generation bruton tyrosine kinase inhibitor', 'clinical practice', 'haematological malignancies lymphoma lymsm']\n",
      "['new2trip acalabrutinib calquence chronic lymphocytic leukaemia cll']\n",
      "['cll treatment paradigm', 'combination leusm']\n",
      "['resistant metastatic urothelial carcinoma esmo20 interview']\n",
      "['supportive care', 'respiratory symptoms', 'respiratory failure']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['new article', 'generation bruton tyrosine kinase inhibitor', 'clinical practice', 'haematological malignancies mcl lymsm hematology']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['europ ische kommission hat calquence mit dem wirkstoff acalabrutinib', 'zulassung f r', 'behandlung von chronisch lymphatischer leuk mie cll erteilt']\n",
      "['calquence calavi']\n",
      "['calquence calavi']\n",
      "['calquence calavi']\n",
      "['calquence calavi ai ai coronavirus']\n",
      "['calquence calavi']\n",
      "['calquence calavi ii']\n",
      "['top story treatment', 'cll sll', 'mcl calquence acalabrutinib']\n",
      "['caregiver resources calquence', 'oral 2x', 'day prescription medication', 'adult patients']\n",
      "['astrazeneca cancer drug']\n",
      "['acalabrutinib calquence', 'clinical criteria', 'chronic lymphocytic leukemia', 'full recommendation']\n",
      "['astrazeneca s calquence', 'phase ii covid']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['blood cancer cll sll', 'treatment options', 'convenient oral 2x', 'day capsule']\n",
      "['astrazeneca cancer drug']\n",
      "['astrazeneca s calquence', 'phase ii covid']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['presentations support calquence efficacy', 'long term', 'mantle cell lymphoma', 'safety data', 'chronic lymphocytic leukaemia', 'tickers azn']\n",
      "['astrazeneca cancer drug']\n",
      "['calavi phase ii trials', 'respiratory symptoms']\n",
      "['astrazeneca s calquence', 'phase ii covid']\n",
      "['cure amp astrazeneca', 'calquence connections', 'doctor patient', 'care team discusses', 'chronic lymphocytic leukemia', 'answers audience questions']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['respiratory symptoms']\n",
      "[]\n",
      "['btk acalabrutinib eu']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['cll treatment research', 'final ascend study data acalabrutinib', 'r r cll cll chroniclymphocyticleukemia ascendstudy acalabrutinib btkinhibitor']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['caregiver resources calquence', 'oral 2x', 'day prescription medication', 'adult patients']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['caregiver resources calquence', 'oral 2x', 'day prescription medication', 'adult patients']\n",
      "['calquence acalabrutinib']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['calavi phase ii trials results']\n",
      "['calquence r eu pr times']\n",
      "['oncology news update acalabrutinib', 'superior progression', 'free survival', 'r r chronic lymphocytic leukaemia patients', 'oncology news australia oncnews']\n",
      "['calquence eu']\n",
      "['calquence eu']\n",
      "['calquence eu']\n",
      "['calquence eu']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['calquence eu']\n",
      "['calquence r eu']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['cll medication', 'oral 2x', 'day capsule', 'prescription treatment option', 'adult patients', 'cll bloodcancerawareness']\n",
      "['caregiver resources calquence', 'oral 2x', 'day prescription medication', 'adult patients']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'prescription oral 2x', 'day capsule']\n",
      "['new2trip 17p deletion', 'patients w', 'refractory chronic lymphocytic leukaemia']\n",
      "['astrazeneca s calquence', 'phase ii covid', 'trials biospace jobs']\n",
      "['az btk calquence btk il', 'regeneron az covid19']\n",
      "['astrazeneca cancer drug']\n",
      "['astrazeneca s calquence', 'phase ii covid']\n",
      "['regulatory decision', 'clinical chronic lymphocytic leukemia trials elevate tn', 'ascend news leusc']\n",
      "['astrazeneca s calquence']\n",
      "['novita nel trattamento della leucemia linfatica cronica approvato calquence acalabrutinib di astrazeneca iscrizione gratuita alle newsletter xagena di medicina ematologia medicina oncoematologia xagena farmacia']\n",
      "['cure amp astrazeneca', 'calquence connections dr jeff sharman joins jim', 'chronic lymphocytic leukemia jim s wife becky', 'amp register']\n",
      "[]\n",
      "['respiratory failure', 'patients medlancr']\n",
      "['calavi phase ii trials calquence acalabrutinib', 'respiratory failure']\n",
      "['recomendaci n', 'comisi n europea', 'aprobado tambi n este tratamiento un inhibidor selectivo', 'tirosina kinasa']\n",
      "['astrazeneca press release', 'acalabrutinib phase', 'covid research', 'high quality trials', 'press release registrations']\n",
      "['astrazeneca cancer drug', 'biopharma dive pharmatopnews']\n",
      "['new article costco astrazeneca s azn calquence', 'coronavirus study', 'fintech zoom fintech blockchain crypto cryptocurrency ico']\n",
      "['solo hay avances', 'aprobado el tratamiento contra', 'leucemia linfoc tica cr nica', 'leucemia m s com n', 'pacientes adultos']\n",
      "['acalabrutinib demostr una supervivencia sin progresi n', 'superior para los pacientes', 'con leucemia linfoc tica cr nica r r ecancer oncoreporte']\n",
      "['front line treatments', 'acalabrutinib leusm jnccn360']\n",
      "['astrazenaca reveals calquence acalabrutinib', 'covid19 patients', 'respiratory failure clinicaltrials pharma therapeutics']\n",
      "['astrazeneca s calquence', 'respiratory symptoms']\n",
      "['new clinical trial', 'vr cap', 'line therapy', 'eligible patients', 'mantle cell lymphoma mcl lymsm hematology']\n",
      "['ue aprueba calquence astrazeneca para leucemia linfoc tica cr nica']\n",
      "['calquence un traitement efficace contre les chocs cytokiniques']\n",
      "['calquence un traitement efficace contre les chocs cytokiniques']\n",
      "['astrazeneca cancer drug']\n",
      "['astrazeneca s calquence', 'phase ii covid']\n",
      "['promising drug', 'calquence acalabrutinib cc']\n",
      "['astrazeneca cancer drug', 'covid19 pharmanews elonmusk healthcare']\n",
      "['astrazeneca s calquence', 'respiratory symptoms acalabrutinib est aprobado para el tratamiento', 'con leucemia linfoc tica cr nica y adultos', 'con linfoma', 'c lulas del manto']\n",
      "['astrazeneca n n umut olan ilac koronavir s tedavisinde etkisiz kald reuters n haberine g re koronavir s hastalar n n ba kl k sisteminde olu', 'sorunlar bask lamas ama lanan kan kanseri ilac calquence', 'sonu lar ba ar s z oldu']\n",
      "['adici n del inhibidor btk acalabrutinib', 'pacientes hospitalizados', 'con s ntomas respiratorios', 'proporci n', 'pacientes vivos sin insuficiencia respiratoria']\n",
      "['james discusses', 'chronic lymphocytic leukemia cll']\n",
      "['astrazeneca s calquence', 'phase ii covid']\n",
      "['azn s calquence', 'short agnpf s', 'covid patients', 'promising company', 'interim results']\n",
      "['calavi phase ii trials', 'respiratory symptoms']\n",
      "['astrazeneca s azn calquence', 'coronavirus study']\n",
      "[]\n",
      "['een nieuw', 'door eu gekeurd medicijn calquence astrazenica voor bloedkankersoorten', 'een trial geweest ook onder ziekenhuis opname pati nten covid zowel opname c19 zonder', 'ic ventilatie pati nten hoe dan']\n",
      "['european union', 'generation btk inhibitor acalabrutinib', 'adult patients', 'chronic lymphocytic leukemia news']\n",
      "['az s btk inhibitor calquence']\n",
      "['astrazenca s calquence acalabrutinib', 'primary endpoint', 'p ii studies']\n",
      "[]\n",
      "['astrazeneca s calquence']\n",
      "['astrazeneca s azn calquence', 'coronavirus study']\n",
      "['azn astrazeneca s calquence', 'phase ii covid', 'trials biospace jobs']\n",
      "['mid stage trial', 'calquence acalabrutinib', 'supportive care', 'respiratory symptoms', 'didn t meet', 'primary endpoint']\n",
      "['astrazeneca s calquence', 'short fiercepharma']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['clinical trial', 'bad news', 'leukemia amp', 'lymphoma drug calquence acalabrutinib']\n",
      "['astrazeneca s calquence']\n",
      "['s covid19 roundup', 'presidential election', 'white house', 'government health officials']\n",
      "['calavi phase ii trials', 'respiratory symptoms']\n",
      "['otro anticuerpo monoclonal que', 'evitar empeoramiento', 'con covid19 ac el posicionamiento', 'astrazeneca sobre acalabrutinib']\n",
      "['acalabrutinib covid']\n",
      "['ngiltere sve ortakl olan nl ila irketi astrazeneca taraf ndan kan kanseri tedavisi i', 'kullan lan calquence ilac n n korona vir s tedavisinde ba ar s z oldu u']\n",
      "['blood cancer medicine calquence', 'respiratory symptoms']\n",
      "['astrazeneca n n umut olan ilac koronavir s tedavisinde etkisiz kald reuters n haberine g re koronavir s hastalar n n ba kl k sisteminde olu', 'sorunlar bask lamas ama lanan kan kanseri ilac calquence', 'sonu lar ba ar s z oldu covid haber sondakika']\n",
      "['astrazeneca s calquence', 'phase ii covid', 'trials biospace jobs']\n",
      "['astrazeneca s calquence', 'short gt gt gt strategy competitiveintelligence', 'biotech healthcare', 'pharma pharmaceutical']\n",
      "['astrazeneca s calquence']\n",
      "['azn astrazeneca reports calavi phase ii trials', 'respiratory symptoms']\n",
      "['tracker moderna hits phase', 'vaccine review astrazeneca s calquence', 'covid trial fiercepharma']\n",
      "['ue aprueba calquence astrazeneca para leucemia linfoc tica cr nica']\n",
      "['ue aprueba calquence para', 'leucemia linfoc tica cr nica']\n",
      "['astrazeneca cancer drug', 'kristin jensen azn rhhby nvs sny regn']\n",
      "['primary endpoint', 'ventilator cytokine storm hypothesis']\n",
      "['astrazeneca s calquence']\n",
      "['astrazeneca s calquence']\n",
      "['stage covid', 'disappointing result', 'selective btk inhibitor']\n",
      "['nl ila reticisi astrazeneca n n kan kanseri ilac calquence n koronavir s tedavisinde etkisiz oldu u belirlendi']\n",
      "['political pressures', 'post election medicago', 'gsk adjuvant', 'phii iii']\n",
      "['awesomecapital astrazeneca s calquence flunks mid stage covid']\n",
      "['kanser ilac calquence n koronavir s tedavisinde etkisiz oldu u ortaya kt kovid19']\n",
      "['political pressures', 'post election astrazeneca s attempt', 'repurpose calquence gt gt gt strategy competitiveintelligence', 'biotech pharmaceutical healthcare']\n",
      "['leukaemia drug calquence']\n",
      "[]\n",
      "['faith i', 'lord news astrazeneca s blood cancer treatment calquence', 'survival rates', 'lung failure']\n",
      "['patients need', 'sick approach']\n",
      "['pharmaceuticals news fprx', 'preclinical data', 'cancer treatment azn', 'key goal', 'covid19 patients']\n",
      "['astrazeneca calquence']\n",
      "['calavi phase ii trials', 'respiratory symptoms', 'small molecules']\n",
      "['astrazeneca s calquence', 'survival rates', 'coronavirus patients pharmaceutical']\n",
      "['reports calavi phase ii trials', 'respiratory symptoms', 'primary endpoint']\n",
      "['acalabrutinib covid']\n",
      "['astrazeneca s cancer drug calquence', 'main goal']\n",
      "['calavi phase ii trials', 'respiratory symptoms']\n",
      "['astrazenca s calquence acalabrutinib', 'primary endpoint', 'p ii studies']\n",
      "['coronav rus medicamento contra o c ncer da astrazeneca tem resultado decepcionante', 'tratamento da covid']\n",
      "['azn astrazeneca reports calavi phase ii trials', 'respiratory symptoms']\n",
      "['giant astrazeneca rushes', 'blood cancer drug calquence', 'coronavirus trials', 'intensive care']\n",
      "['azn astrazeneca nasdaq azn reports phase ii results', 'calavi trials', 'btk inhibitor calquence acalabrutinib', 'supportive care bsc versus bsc']\n",
      "['sfbn feed covid', 'roundup astrazeneca s attempt', 'repurpose calquence flops', 'potential covid', 'treatments astrazeneca s bayarea biotech']\n",
      "['btk covid19 update', 'calavi phase ii trials', 'respiratory symptoms']\n",
      "['roundup astrazeneca s attempt', 'repurpose calquence flops']\n",
      "['roundup astrazeneca s attempt', 'repurpose calquence flops']\n",
      "['azn astrazeneca s calquence flunks mid stage covid']\n",
      "['calavi phase ii trials', 'respiratory symptoms']\n",
      "['astrazeneca s calquence flunks mid stage covid']\n",
      "['azn astrazeneca s calquence flunks mid stage covid']\n",
      "['astrazeneca s cancer drug calquence disappoints', 'mid stage covid', 'trials azn covid19 clinicaltrials']\n",
      "['apr s novartis', 'son canakinumab', 'semaine derni re c est d sormais acalabrutinib d astrazeneca qui choue sur les formes s v res du covid19']\n",
      "['calavi phase ii trials', 'respiratory symptoms', 'primary endpoint']\n",
      "['calavi phase ii trials', 'respiratory symptoms', 'primary endpoint', 'tickers azn']\n",
      "['astrazeneca s calquence', 'covid19 respiratory symptoms azn']\n",
      "['astrazeneca s blood cancer treatment calquence', 'survival rates', 'lung failure', 'mid stage trials']\n",
      "['blood cancer medicine calquence', 'respiratory symptoms']\n",
      "['el f rmaco contra', 'leucemia calquence desarrollado por astrazeneca', 'los ensayos que estudiaban su eficacia', 'con coronavirus']\n",
      "['blood cancer medicine calquence', 'respiratory symptoms']\n",
      "['primary endpoint', 'respiratory failure azn']\n",
      "['biotoday astrazeneca btk calquence covid']\n",
      "['astrazeneca s cancer drug', 'main goal', 'trials astrazeneca plc', 'blood cancer treatment calquence', 'main goal', 'mid stage trials']\n",
      "['azn acalabrutinib', 'covid trial']\n",
      "['astrazeneca btk calquence covid']\n",
      "['calavi phase ii trials', 'respiratory symptoms']\n",
      "['leucemia linfatica cronica acalabrutinib approvato', 'dimostrato un beneficio significativo', 'termini di efficacia e tollerabilit', 'lungo termine']\n",
      "['european commission', 's calquence acalabrutinib', 'adult patients', 'chronic lymphocytic leukaemia cll', 'full article visit cancernews cancerdata']\n",
      "['tumori rari leucemia linfatica cronica llc', 'commissione europea', 'approvato acalabrutinib comitatoimalatiinvisibili imalatiinvisibili comitatoimi comitatoimionlus malattierare']\n",
      "['chroniclymphocyticleukaemia azn']\n",
      "['eu ok', 'az s calquence']\n",
      "['ce aprob el inhibidor selectivo btk acalabrutinib para', 'leucemia linfoc tica cr nica', 'como el linfoma linfoc tico peque o combinado', 'con obinutuzumab y', 'monoterapia reducir', 'el riesgo', 'progresi n', 'enfermedad o muerte']\n",
      "['cll leusm']\n",
      "['eu ok', 'az s calquence']\n",
      "['chronic lymphocytic leukemia leusm']\n",
      "['btk inhibitors', 'cll courtesy', 'calquence acalabrutinib']\n",
      "['astrazeneca eu approves calquence', 'chronic lymphocytic leukaemia']\n",
      "['leucemia linfatica cronica acalabrutinib ottiene l approvazione']\n",
      "['el medicamento acalabrutinib', 'situaci n', 'secci n salud']\n",
      "['pembrolizumab vs pembrolizumab amp acalabrutinib', 'resistant muc beyondtheabstract', 'urotoday gt j george']\n",
      "['nice acalabrutinib', 'fcr chemotherapy']\n",
      "['zdravilo calquence je v eu odobreno za zdravljenje kroni ne limfocitne levkemije']\n",
      "['chronic lymphocytic leukaemia']\n",
      "['leucemia linfatica cronica approvata', 'europa una nuova terapia mirata', 'libera dalla commissione europea', 'acalabrutinib un farmaco target di nuova generazione', 'il trattamento dei pazienti adulti sia', 'prima linea sia dopo ricaduta o']\n",
      "['chronic lymphocytic leukaemia']\n",
      "['eu ok', 'az s calquence']\n",
      "['eu ok', 'az s calquence']\n",
      "['eu ok', 'az s calquence']\n",
      "['eu ok', 'az s calquence']\n",
      "['amm europ enne', 'calquence acalabrutinib dans', 'leuc mie lympho', 'chronique llc']\n",
      "['eu ok', 'az s calquence']\n",
      "['terapia leucemia linfatica cronica acalabrutinib approvato']\n",
      "['terapia leucemia linfatica cronica acalabrutinib approvato']\n",
      "['terapia leucemia linfatica cronica acalabrutinib approvato']\n",
      "['terapia leucemia linfatica cronica acalabrutinib approvato']\n",
      "['leucemia linfatica cronica acalabrutinib approvato', 'beneficio significativo', 'termini di efficacia e tollerabilit', 'lungo termine nel trattamento', 'prima linea e nella malattia recidivante o refrattaria']\n",
      "['generation btki acalabrutinib', 'adult patients', 'cll acalabrutinib', 'promising clinical efficacy', 'clinical studies']\n",
      "['astrazeneca s calquence acalabrutinib', 'eu s approval', 'chronic lymphocytic leukaemia']\n",
      "['astrazeneca s calquence acalabrutinib', 'eu s approval', 'chronic lymphocytic leukaemia']\n",
      "['l month', 'pap support', 'ibrutinib generic', 'available i']\n",
      "['small lymphocytic lymphoma', 'countries worldwide latestpharmanewsnov9 latestastrazenecanewsnov9 treatmentforchroniclymphocyticleukaemia treatmentforcll']\n",
      "['chronic lymphocytic leukaemia']\n",
      "['s solidarity trial covaxin', 'acalabrutinib arm', 'remdesivir needs', 'icmr nari chief dr samiran panda']\n",
      "['astrazeneca s calquence acalabrutinib', 'european union eu', 'adult patients', 'chronic lymphocytic leukaemia healthcare leukaemia bloodcancer cancer']\n",
      "['chronic lymphocytic leukaemia']\n",
      "['chronic lymphocytic leukaemia explore', 'predictive biomarker data', 'full news article visit cancernews cancerdata']\n",
      "['azn astrazeneca', 'eu approval']\n",
      "['astrazeneca s calquence ok d']\n",
      "['astrazeneca s btk inhibitor calquence', 'cll azn']\n",
      "['chronic lymphocytic leukaemia']\n",
      "['european approval']\n",
      "['astrazeneca eu approves calquence', 'chronic lymphocytic leukaemia', 'market news source nasdaq news']\n",
      "['chronic lymphocytic leukaemia', 'tickers azn']\n",
      "['chronic lymphocytic leukaemia azn']\n",
      "['astrazeneca s', 'drug calquence', 'european union approval', 'adult patients', 'chronic lymphocytic leukaemia ccl', 'countries worldwide']\n",
      "['azn calquence', 'chronic lymphocytic leukaemia']\n",
      "['astrazeneca s calquence acalabrutinib', 'adult patients', 'chronic lymphocytic leukaemia cll', 'common type', 'adults oncology haematology pharma azn singlestocketps']\n",
      "['brief astrazeneca']\n",
      "['chronic lymphocytic leukaemia']\n",
      "['pembrolizumab vs pembrolizumab', 'resistant metastatic urothelial cancer bladdercancer blcsm']\n",
      "['resistant metastatic urothelial carcinoma oncology']\n",
      "['chronic lymphocytic leukemia research', 'don t', 'safety study supports acalabrutinib', 'member richard furman m d precisionmedicine']\n",
      "['economic evaluation', 'ibrutinib versus acalabrutinib versus zanubrutinib', 'refractory mantle cell lymphoma blood american society']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['treatment option', 'mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['treatment option', 'mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['treatment option', 'mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['treatment option', 'mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['treatment option', 'mantle cell lymphoma mcl', 'adult patients']\n",
      "['treatment option', 'mantle cell lymphoma mcl', 'adult patients']\n",
      "['treatment option', 'mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['long term fup', 'r r mantle cell lymphoma median', 'lines d c', 'aes mdor', '6m mpfs', '0m ki67', 'pfs estim', '36m lymsm ash2020']\n",
      "['berotralstat az s acalabrutinib', 'clear pafsc review orphanpacific s sakigake', 'hereditary angioedema hae treatment berotralstat']\n",
      "['james discusses', 'chronic lymphocytic leukemia cll']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['cll patients', 'btk inhibitors', 'dr richard furman cll ibrutinib acalabrutinib btkinhibitor']\n",
      "['pembrolizumab vs pembrolizumab', 'resistant metastatic urothelial cancer oncology']\n",
      "['resistant metastatic urothelial carcinoma bladdercancer blcsm']\n",
      "['ci andy davies trial design', 'hd mtx prophylaxis', 'r chop acalabrutinib', 'additional cns prophylaxis data', 'phase i ii', 'promising ash', 'correlative translational work lymsm dlbcl']\n",
      "['gen btk inhibitor', 'free survival', 'care regimens', 'refractory cll', 'final results', 'ascend study']\n",
      "['dr richard furman', 'bruton s tyrosine kinase btk inhibitors', 'ibrutinib acalabrutinib', 'people w chroniclymphocyticleukemia cll', 'leusm lymsm']\n",
      "['global trial', 'drugs pivots', 'new ones remdesivir btk inhibitor acalabrutinib']\n",
      "['rituximab cyclophosphamide doxorubicin vincristine', 'prednisolone r chop', 'large b cell lymphoma dlbcl study protocol', 'phase ib ii', 'open label non', 'clinical trial lymphoma lymsm']\n",
      "['cancer drug acalabrutinib', 'solidarity trial reports theprinthealth']\n",
      "['cancer drug acalabrutinib', 'solidarity trial reports theprinthealth']\n",
      "['cancer drug acalabrutinib', 'solidarity trial reports theprinthealth']\n",
      "['cancer drug acalabrutinib', 'solidarity trial reports theprinthealth']\n",
      "['acalabrutinib allein oder', 'kombination mit obinutuzumab zeigt im vergleich zu anderen frontline behandlungen bei patienten mit chronisch lymphatischer leuk mie cll', 'f r fludarabin nicht geeignet sind ein g nstiges pfs und os']\n",
      "['monoterapia o', 'con obinutuzumab ottiene una sopravvivenza libera da progressione progression', 'free survival pfs e una sopravvivenza complessiva overall survival os favorevoli rispetto', 'altri trattamenti di prima']\n",
      "['james discusses', 'chronic lymphocytic leukemia', 'elevate tn trial leusm cll']\n",
      "['white cells']\n",
      "['world health organization eyes cancer drug']\n",
      "['cancer drug', 'covid solidarity trial cdsco panel', 'clarification icmr', 'covid19 acalabrutinib cdsco astrazeneca nari cancer remdesivir dexamethasone calquence']\n",
      "['berotralstat az s acalabrutinib', 'pafsc review', 'key health ministry panel', 'orphanpacific s sakigake d']\n",
      "['current standard', 'care treatments', 'r r cll lymsm lymphoma']\n",
      "['cancer drug acalabrutinib', 'solidarity trial', 'world health organization', 'coronavirus disease']\n",
      "['new agent']\n",
      "['mt oct', 'amp partner', 'clinical trial', 'blood cancer amp covid19', 'interview w burd amp byrd james cllsm leusm covid19 covid19ncancer ccc19']\n",
      "['acalabrutinib covid19ncancer']\n",
      "['astrazeneca pharma india', 'launch calquence', 'stock trades flat']\n",
      "[]\n",
      "['new drugs', 'solidarity trial acalabrutinib capsule btk inhibitor lymphoma drug potential candidates medi3506 iv inj', 'monoclonal antibody bemcentinib capsule axl inhibitor', 'uk accord mega trial covid19']\n",
      "['launch oncology drug calquence', 'india pharma pharmanews']\n",
      "['btk inhibitor', 'mantle cell lymphoma', 'ex b cell person i', 'natural abs']\n",
      "['major findings', 's piece', 'solidarity trial', 'negative results', 'test acalabrutinib i e cancer drug']\n",
      "['astrazeneca pharma india', 'launch calquence', 'stock trades flat']\n",
      "['health experts', 'cancer patients', 'possible cure']\n",
      "['astrazeneca pharma india', 'launch calquence', 'stock trades flat']\n",
      "['astrazeneca pharma india', 'launch calquence', 'stock trades flat']\n",
      "['health undersecretary maria rosario vergeire', 'world health organization', 'clinical trial', 'treatments doktornews']\n",
      "['cancer drug acalabrutinib', 'solidarity trial', 'world health organization', 'coronavirus disease']\n",
      "['world health organization eyes cancer drug']\n",
      "['world health organization eyes cancer drug']\n",
      "['astrazeneca pharma india', 'launch calquence', 'india news', 'website facebook youtube instagram india astrazenecapharma daycosecurities']\n",
      "['launch cancer drug acalabrutinib', 'brand name calquence astrazeneca astrazenecanews acalabrutinibcapsules bloodcancer calquence']\n",
      "['hero moto pleasure', 'mantle cell lymphoma calquence', 'persistent systems capiot']\n",
      "['astrazeneca pharma', 'launch calquence', 'stockmarket stockmarketnews', 'finreach india']\n",
      "['astrazeneca pharma company', 'launch calquence']\n",
      "['good morning', 'exclusive morning market news amp update astrazeneca pharma', 'launch calquence', 'market permission', 'drugs controller general']\n",
      "['astrazeneca pharma company', 'launch calquence']\n",
      "['astrazeneca pharma india', 'launch cancer drug', 'brand name calquence', 'cancerdrug calquence']\n",
      "['astrazeneca pharma drug firm astrazeneca pharma india', 'mg capsules', 'various types', 'blood cancers', 'name calquence']\n",
      "['s trade', 'capiot software', 'm amp astrazeneca', 'launch calquence', 'lymphoma treatment frontpage app']\n",
      "['s trade', 'capiot software', 'm amp astrazeneca', 'launch calquence', 'lymphoma treatment']\n",
      "['astrazeneca pharma', 'launch calquence', 'upl s material arm', 'mauritius upl corporation']\n",
      "['favorable pfs', 'cll cllsm']\n",
      "['astrazeneca pharma', 'launch calquence']\n",
      "['astrazeneca astrazeneca pharma india', 'launch calquence', 'alert calquence medicine', 'mantle cell lymphoma awaaz']\n",
      "['astrazeneca pharma', 'milligram capsules', 'various types', 'blood cancers']\n",
      "['astrazeneca pharma co', 'launch calquence', 'mantle cell lymphoma']\n",
      "['astrazeneca pharma india', 'launch calquence', 'mantle cell lymphoma pharmaceutical pharmanews']\n",
      "['new2trip acalabrutinib calquence', 'chronic lymphocytic leukaemia cll']\n",
      "['astrazen launch', 'acalabrutinib 100mg capsules calquence']\n",
      "['covid19 cancer coronavirus coronaupdates letsbeatcorona indiafightscorona india coronavirusindia']\n",
      "['etindustrynews icmr approaches experts panel', 'cancer drug acalabrutinib', 'covid treatment etindustrynews yosoyjabali']\n",
      "['govt s panel', 'cancer drug acalabrutinib', 'solidarity trial', 'effective treatment']\n",
      "['chronic lymphocytic leukemia leusm cll']\n",
      "['icmr approaches experts panel', 'cancer drug acalabrutinib', 'covid treatment']\n",
      "[]\n",
      "['btk acalabrutinib cll sll mcl']\n",
      "['icmr approaches experts panel', 'cancer drug acalabrutinib', 'covid treatment']\n",
      "['india s health research body indian council', 'medical research icmr', 'government s panel', 'cancer drug', 'world heath organization s', 'global solidarity trial']\n",
      "['btk acalabrutinib cll sll mcl', 'cll sll mcl']\n",
      "['govt s panel', 'cancer drug', 'effective treatment', 'icmr astrazeneca acalabrutinib nari worldheathorganization', 'coronavirus covid19 mangonews']\n",
      "['icmr approaches experts panel', 'cancer drug acalabrutinib', 'covid treatment']\n",
      "['btk acalabrutinib cll sll mcl']\n",
      "['btk acalabrutinib cll sll mcl']\n",
      "['icmr approaches experts panel', 'cancer drug acalabrutinib', 'covid treatment']\n",
      "['icmr approaches experts panel', 'cancer drug acalabrutinib', 'covid treatment etindustrynews']\n",
      "['ethealthworld icmr approaches experts panel', 'cancer drug acalabrutinib', 'covid treatment icmr dexamethasone clinicaltrial covid thewho solidarity remdesivir acalabrutinib']\n",
      "['medscape acalabrutinib', 'favorable pfs', 'cll cllsm']\n",
      "['icmr approaches experts panel', 'cancer drug acalabrutinib', 'covid treatment']\n",
      "['icmr approaches experts panel', 'cancer drug acalabrutinib', 'covid treatment']\n",
      "['mantlecell lymphoma calquence']\n",
      "['pembrolizumab vs pembrolizumab amp acalabrutinib', 'resistant muc beyondtheabstract', 'urotoday gt j george']\n",
      "['govt panel approval', 'cancer drug acalabrutinib', 's solidarity trial']\n",
      "['govt panel approval', 'cancer drug acalabrutinib', 's solidarity trial theprint s reports']\n",
      "['favorable pfs', 'cll cllsm']\n",
      "['govt panel approval', 'cancer drug acalabrutinib', 's solidarity trial panel', 'clarification amp', 'solidarity trial']\n",
      "['govt panel approval', 'cancer drug acalabrutinib', 's solidarity trial theprint s reports']\n",
      "['acalabrutinib btk btk']\n",
      "['acalabrutinib btk btk']\n",
      "['acalabrutinib btk btk']\n",
      "['acalabrutinib use', 'obinutuzumab shows', 'positive results', 'cll lymphomahub']\n",
      "['naj t innou l bu medikamenty', 'pro onemocn n covid', 'pomohou i e t odborn ci solidaritytrial', 'europe cz czecrin lecbacovidu sukl remdesivir acalabrutinib interferon']\n",
      "['medscape hematology oncology headlines gt gt acalabrutinib bests', 'frontline cll therapies']\n",
      "['favorable pfs', 'cll cllsm']\n",
      "['acalabrutinib use', 'obinutuzumab shows', 'positive results', 'cll lymphomahub']\n",
      "['new article comparative efficacy', 'frontline treatment', 'chronic lymphocytic leukemia', 'systematic review', 'network meta analysis cll leusm hematology']\n",
      "['nccnhem20 cll', 'phase iii rcts 1st line', 'amp e1912 show os benefit elevate tn', 'acalabrutinib acalabrutinib vs ibrutinib', 'fatigue rash venetoclax consolidation u mrd bcl2 btk cd20']\n",
      "['azn phase', 'acalabrutinib study', 'supportive care versus', 'supportive care', 'primary completion date']\n",
      "['azn phase', 'acalabrutinib study', 'supportive care versus', 'supportive care', 'primary completion date']\n",
      "['azn phase', 'relative bioavailability proton pump inhibitor ppi rabeprazole effect food effect', 'particle size effect', 'new acalabrutinib tablet', 'healthy subjects nct04488016', 'primary completion date']\n",
      "['btk acalabrutinib cll sll btk acalabrutinib cll sll']\n",
      "['btk acalabrutinib cll sll cll']\n",
      "['btk acalabrutinib cll sll']\n",
      "['btk acalabrutinib cll sll']\n",
      "['el instituto nacional del c ncer analiz que tratamiento', 'con acalabrutinib puede ser efectivo para ayudar', 'combatir el covid', 'covid19 salud informaci n sobre el estudio']\n",
      "['amp partner', 'clinical trial', 'blood cancer', 'amy burd phd amp john c byrd md james']\n",
      "['blood cancer covid']\n",
      "['blood cancer covid']\n",
      "['blood cancer covid']\n",
      "['btk acalabrutinib cll sll']\n",
      "['btk acalabrutinib cll sll']\n",
      "['calquence drug profile']\n",
      "['comparative efficacy', 'frontline treatment', 'chronic lymphocytic leukemia', 'systematic review', 'network meta analysis clinicaltherapeutics physicians']\n",
      "['comparative efficacy', 'frontline treatment', 'chronic lymphocytic leukemia', 'systematic review', 'network meta analysis']\n",
      "['acalabrutinib drug', 'btk briton tyrosine kinase protein', 'severe cases', 'cancer drug p']\n",
      "['welovetrump acalabrutinib calquence']\n",
      "['hydroxychloroquine remdesivir calquence jakafi olumiant kineret ilaris mavrilimumab', 'possible covid', 'definite decepticon school dropouts']\n",
      "['pembrolizumab vs pembrolizumab amp acalabrutinib', 'resistant muc beyondtheabstract', 'urotoday gt j george']\n",
      "['refractory chronic lymphocytic l']\n",
      "['phase iii ascend', 'acalabrutinib paolo ghia md ph d rrcll cll link', 'full video']\n",
      "['q2 astrazeneca', 'caluquence s', 'campaign astrazeneca calwuence acalabrutinib', 'newcampagintheme calendar oncology leukemia antineoplastics', 'q2 q22020 leukemiamarket dtwmarkethighlight']\n",
      "['lymphoma awarenessmonth icymi acalabrutinib', 'treatment na ve', 'refractory chronic lymphocytic leukemia cll clinicaltrial']\n",
      "['new clinical trial acalabrutinib', 'r chop', 'mantle cell lymphoma mcl lymsm hematology']\n",
      "['new2trip acalabrutinib calquence', 'chronic lymphocytic leukaemia cll']\n",
      "['pembrolizumab vs pembrolizumab acalabrutinib', 'metastatic bladddercancer', 'peterodonnell j george']\n",
      "['free survival benefit', 'chronic lymphocytic leukemia leusm']\n",
      "['new clinical trial', 'healthy subjects', 'assess bioavailability proportion', 'active effect', 'acalabrutinib tablet', 'protonpump inhibitor effect members', 'mcl lymsm hematology']\n",
      "['clinical trial', 'oral oncolytic agents', 'such acalabrutinib']\n",
      "['paolo ghia md ph d rrcll cll ascend phase iii']\n",
      "[]\n",
      "['stellar update', 'chop r', 'recruitment bham']\n",
      "['phase i ii clinical trial', 'economic evaluation', 'chronic lymphocytic leukaemia']\n",
      "['therapeutic potential', 'chronic lymphocytic leukemia', 'short review']\n",
      "['michael wang md', 'durable response', 'agent acalabrutinib', 'refractory mantle cell lymphoma']\n",
      "['new2trip acalabrutinib calquence', 'chronic lymphocytic leukaemia cll']\n",
      "['stellar update congratulations bi', '1st patient', 'chop r', 'anna nicole dr rafferty']\n",
      "['simultaneous measurement', 'acalabrutinib ibrutinib', 'beagle dog plasma', 'uplc ms ms', 'pharmacokinetic study jpba']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll bloodcancerawarenessmonth']\n",
      "['jennifer woyach md', 'james discusses', 'safety profile', 'chronic lymphocytic leukemia leusm']\n",
      "['prescription medicine', 'mantle cell lymphoma mcl']\n",
      "['prescription medicine', 'mantle cell lymphoma mcl']\n",
      "['free survival', 'tolerable safety profile', 'refractory chronic lymphocytic leukemia', 'high risk']\n",
      "['clinicaltrial lccc1841', 'refractory primary', 'secondary cns lymphomas']\n",
      "['refractory primary', 'secondary cns lymphomas status', 'condition summary lymphoma']\n",
      "['new clinical trial acalabrutinib', 'r chop', 'large b cell lymphoma dlbcl dlbcl lymsm hematology']\n",
      "['free survival', 'favorable safety profile', 'refractory chronic lymphocytic leukemia leusm']\n",
      "['promising btk inhibitor', 'pre clinical studies acalabrutinib lacks os benefit', 'cll trial relevant', 'apto gc', 'similar study']\n",
      "['paolo ghia md phd', 'discusses overall survival data', 'refractory chronic lymphocytic leukemia', 'ascend trial leusm']\n",
      "['paolo ghia md phd', 'safety profile', 'cll leusm']\n",
      "['acalabrutinib demonstrates', 'superior pfs', 'standard 0f care', 'refractory cll']\n",
      "['nice quick editorial']\n",
      "['acalabrutinib demonstrates', 'superior pfs', 'standard 0f care', 'refractory cll']\n",
      "['acalabrutinib shows', 'care regimens']\n",
      "['dr woyach']\n",
      "['soho2020 calquence']\n",
      "['jennifer woyach md', 'james discusses', 'chronic lymphocytic leukemia leusm']\n",
      "['acalabrutinib shows', 'care regimens', 'refractory cll leusm']\n",
      "['congress soho2020', 'therapy options', 'wm bortezomib', 'deep responses acalabrutinib', 'high response rates', 'low risk']\n",
      "['soho2020 patients', 'free survival', 'standard regimens data', 'paolo ghia md phd']\n",
      "['debate cll', 'agent btki', 'cll17 study']\n",
      "['recurrent headaches', 'advise teamhaem']\n",
      "['ascend trial', 'p ghia', 'positive opinion']\n",
      "['blocker tocilizumab trials', 'blocker anakinra', 'u s', 'blocker acalabrutinib', 'positive outcomes']\n",
      "['mantle cell lymphoma m', 'y o', 'bulky mediastinum', '4x6cm amp abdomen', 'spectacular response', 'rchop rdhap pet ct', 'negative deauville', 'residual pathology p53', 'fish p53 ve', 'step asct vs allo maintenance rituximab vs acalabrutinib']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['dr woyach discusses', 'chronic lymphocytic leukemia leukemia leusm']\n",
      "['sci member steve coutre', 'free survival', 'treatment naive chronic lymphocytic leukemia cll']\n",
      "['phase iii', 'acalabrutinib vs idelalisib', 'refractory cll acalabrutinib', 'i r', 'b r amp', 'acceptable safety profile', 'r r cll']\n",
      "['dr woyach discusses', 'chronic lymphocytic leukemia cllsm leusm']\n",
      "['new clinicaltrial', 'acalabrutinib obinutuzumab', 'tx naive cll pi jan burger m d ph d', 'leukemia nct04505254 endcancer leusm']\n",
      "['acalabrutinib improves progression', 'free survival vs idelalisib', 'refractory cll leusm hematology']\n",
      "['dr woyach discusses', 'chronic lymphocytic leukemia leusm leukemia']\n",
      "['drs seema bhat amp jennifer woyach', 'final ascend results', 'cll leusm hematology james']\n",
      "['blood cancer', 'financial relief', 's pbs', 'chronic leukaemia 7news']\n",
      "['cancer patients', 'new drug treatment', 'pharmaceutical benefits scheme calquence', 'chronic leukaemia 7news']\n",
      "['federal health minister', 'refractory pmbcl amp calquence acalabrutinib', 'cll amp sll', 'great news', 'lymphoma patients lime4lymphoma lymphomaawarenessmonth aus']\n",
      "['mark world lymphoma awareness month calquence', 'certain australian patients', 'chronic lymphocytic leukaemia cll', 'small lymphocytic lymphoma sll bloodcancerawarenessmonth lymphoma leukemia']\n",
      "['acalabrutinib pbs', 'p2y12 inhibitors', 'australian comparitive study pre operative anaemia']\n",
      "['cancer drugs', 'dampen cytokinestorm', 'severe covid19 calquence btkinhibitors']\n",
      "['generation btki']\n",
      "['brilliant news', 'w bloodcancer', 'treatments amp']\n",
      "['btk inhibitors', 'severe covid19 idse online llsusa sloan', 'danafarber leedshospitals calquence btkinhibitors']\n",
      "['btk inhibitors', 'severe covid19 online', 'calquence btkinhibitors']\n",
      "['early data', 'clinical study', 'bruton tyrosine kinase btk protein', 'cancer drug acalabrutinib', 'clinical benefit', 'small group', 'severe covid']\n",
      "['refractory chronic lymphocytic']\n",
      "['chronic lymphocytic leukaemia', 'small lymphocytic lymphoma video']\n",
      "['ascend phase iii', 'acalabrutinib versus idelalisib', 'refractory chronic lymphocytic leukemia']\n",
      "['btk inhibitors', 'severe covid19 idse online llsusa sloan', 'danafarber leedshospitals calquence btkinhibitors']\n",
      "['btk inhibitors', 'severe covid19 online', 'calquence btkinhibitors']\n",
      "['new clinical trial', 'r chop', 'non gcb subtype dlbcl ace', 'dlbcl lymsm hematology']\n",
      "['ace cl', 'pivotal phase', 'ascend trial', 'long term efficacy', 'chronic lymphocytic leukemia']\n",
      "['brukinsa ads', 'office hours i d']\n",
      "['cancer drugs', 'dampen cytokinestorm', 'severe covid19', 'calquence btkinhibitors']\n",
      "['pembrolizumab vs pembrolizumab', 'resistant metastatic urothelialcancer']\n",
      "['pembrolizumab versus pembrolizumab']\n",
      "['fda approval', 'btk inhibitor acalabrutinib', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'trial design', 'drug approvals', 'btk inhibitors']\n",
      "['metastatic urothelialcancer', 'j george']\n",
      "['refractory chronic lymphocytic leukemia']\n",
      "['ace cl', 'pivotal phase', 'ascend trial', 'long term efficacy', 'chronic lymphocytic leukemia']\n",
      "['clinicaltrial retreatment']\n",
      "['condition summary cll sll']\n",
      "['objective response rate progression', 'free survival', 'overall survival os', 'resistant metastatic urothelial cancer']\n",
      "['long terme d', 'th rapie cibl e', 'les patients atteints', 'leuc mie lympho', 'chronique pr s', 'r ponse apr s', 'traitement acalabrutinib llc']\n",
      "['new clinical trial retreatment', 'cll leusm hematology']\n",
      "[]\n",
      "['patient adherence', 'refractory mcl', 'clinical journal', 'treatment adherence']\n",
      "['patient adherence', 'refractory mantle cell lymphoma mcl', 'new report', 'clinical journal']\n",
      "['b cell antigen receptor pathway', 'line treatment', 'long term responses']\n",
      "[]\n",
      "['new report', 'facilitate ae management', 'medication adherence', 'mantle cell lymphoma lymphoma']\n",
      "['new report', 'facilitate ae management', 'medication adherence', 'mcl lymphoma']\n",
      "['patienten mit platinrefrakt rem metastasiertem urothelkarzinom wurden randomisiert pembrolizumab mit oder ohne acalabrutinib zugeteilt']\n",
      "['ian flinn md', 'tycel jovelle phillips md', 'bijal shah md', 'javier munoz md facp', 'r r mantle cell lymphoma lymsm']\n",
      "['metastatic urothelial cancer cancer']\n",
      "['estudio revela que el medicamento acalabrutinib aprobado por', 'fda puede calmar', 'con coronavirus']\n",
      "['new2trip ascend phase iii', 'acalabrutinib versus idelalisib', 'refractory chronic lymphocytic leukemia']\n",
      "['refractory chronic lymphocytic leukemia']\n",
      "['cancer drug', 'unknown effectiveness', 'wasn t']\n",
      "['ensayos cl nicos', 'covid los tratamientos', 'prueba son plasma', 'ivermectina mavrilimumab ruxolitinib acalabrutinib hidroxicloroquina tocilzumab solidaridad oms', 'f rmacos resultados habr reci n', 'unos meses']\n",
      "['new clinical trial acalabrutinib', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['cancer drugs', 'dampen cytokinestorm', 'severe covid19', 'calquence btkinhibitors']\n",
      "['ace cl', 'pivotal phase', 'ascend trial', 'long term efficacy', 'chronic lymphocytic leukemia']\n",
      "['name game', 'fake edition', 'bruton tyrosine kinase btk inhibitors', 'ibrutinib b zanubrutinib c oceabrutinib d acalabrutinib']\n",
      "['refractory chronic lymphocy leukemia']\n",
      "['pembrolizumab versus pembrolizumab', 'resistant metastatic urothelial cancer']\n",
      "['mcl patients']\n",
      "['calquence versus', 'care regimens', 'refractory chronic lymphocytic leukemia']\n",
      "['pembrolizumab versus pembrolizumab', 'resistant metastatic urothelial cancer']\n",
      "[]\n",
      "['acalabrutinib btk inhibitors deplete mdscs pembro', 'outcomes vs pembro', 'phase ii trial', 'post platinum metastatic urothelialcarcinoma need', 'patient selection', 'clinical data']\n",
      "['new2trip ascend phase iii', 'acalabrutinib versus idelalisib', 'refractory chronic lymphocytic leukemia']\n",
      "['phase i acalabrutinib calquence', 'nasogastric co', 'covid19 calquence', 'selective btk inhibitor', 'certain haematological malignancies']\n",
      "['rapid check phase', 'broader io trial landscape']\n",
      "['pembrolizumab versus pembrolizumab', 'resistant metastatic urothelial cancer']\n",
      "['study emergency', 'meuri guidelines idatwitter']\n",
      "['european medicines agency', 'new drug', 'chronic lymphocytic leukaemia cll', 'gt news lymphoma lymphomamatters']\n",
      "['ritable avanc e', 'leuc mie lympho', 'rechute ou r fractaire actushemato par', 'c cile tomowiak']\n",
      "['calquence jp']\n",
      "['calquence jp']\n",
      "['new clinicaltrial', 'phase ii study', 'acalabrutinib aca venetoclax ven', 'obinutuzumab obin', 'pts w chronic lymphocytic leukemia cll pi', 'leukemia nct04169737 endcancer leusm']\n",
      "[]\n",
      "['calquence jp']\n",
      "[]\n",
      "[]\n",
      "[]\n",
      "['calquence pr times']\n",
      "[]\n",
      "[]\n",
      "['cancer drugs', 'dampen cytokinestorm', 'severe covid', 'calquence btkinhibitors']\n",
      "['cancer drugs', 'dampen cytokinestorm', 'severe covid', 'calquence btkinhibitors']\n",
      "['myriad trials', 'blood cancer agents', 'cytokine storm', 'severe covid', 'covid19 calquence btkinhibitors']\n",
      "['cancer drugs', 'dampen cytokinestorm', 'severe covid', 'calquence btkinhibitors']\n",
      "['btk inhibitors amp', 'blood cancer drugs', 'btk inhibitor acalabrutinib', 'small uncontrolled case series', 'severe covid']\n",
      "['cnntownhall acalabrutinib', 'percent improvement', 'percent improvement', 'label study', 'small studies']\n",
      "['cancer drugs', 'dampen cytokinestorm', 'severe covid', 'calquence btkinhibitors']\n",
      "['bruton tyrosinekinaseinhibitor', 'chronic lymphocytic leukaemia leusm']\n",
      "['acalabrutinib zur zulassung als cll arznei empfohlen ein wesentlicher treiber der chronisch lymphatischen leuk mie ist der b zell rezeptor signalweg', 'bruton tyrosinkinase btk eine zentrale position einnimmt acalabrutinib hemmt']\n",
      "['refractory chronic lymphocytic leukemia leukemia']\n",
      "['medscape hematology oncology headlines gt gt green', 'gist acalabrutinib']\n",
      "['astrazeneca s acalabrutinib', 'janssen pharmacyclic s ibrutinib', 'cancer drugs', 'mid stage covid', 'separate clinical trials']\n",
      "['myriad trials', 'blood cancer agents', 'cytokine storm', 'severe covid', 'covid19 calquence btkinhibitors']\n",
      "['news chmp adopts', 'positive opinion', 'cll lymsm']\n",
      "['new small study acalabrutinib', 'hyperinflammatory cytokinestorm', 'severe covid19 patients', 'supplemental oxygen', 'serious acalabrutinib']\n",
      "['medscape hematology oncology headlines gt gt green', 'gist acalabrutinib']\n",
      "['eu approval', 'chronic lymphocytic leukaemia']\n",
      "['proton pump inhibitor', 'acalabrutinib capsule', 'coca cola', 'healthy participants status', 'condition summary infectious disease']\n",
      "['proton pump inhibitor', 'acalabrutinib capsule', 'coca cola', 'healthy participants']\n",
      "['cancer drugs', 'dampen cytokinestorm', 'severe covid', 'calquence btkinhibitors']\n",
      "['percent improvement', 'percent improvement', 'label study fda needs', 'small studies', 'country fda']\n",
      "['chroniclymphocyticleukaemia azn']\n",
      "['astrazeneca kann sich hoffnung auf', 'zulassung von zwei krebsmedikamenten', 'der europ ischen union machen', 'europ ische arzneimittelagentur habe', 'zulassung von calquence acalabrutinib sowie von imfinzi durvalumab empfohlen pharmazie']\n",
      "['btk acalabrutinib cll cll']\n",
      "['btk acalabrutinib cll']\n",
      "['relative bioavailability proton pump inhibitor ppi rabeprazole effect food effect', 'particle size effect', 'new acalabrutinib tablet', 'healthy subjects status', 'condition summary bioavailability b cell lymphoid']\n",
      "['relative bioavailability proton pump inhibitor ppi rabeprazole effect food effect', 'particle size effect', 'new acalabrutinib tablet', 'healthy subjects']\n",
      "['cancer drugs', 'dampen cytokinestorm', 'severe covid', 'calquence btkinhibitors']\n",
      "['btk acalabrutinib cll']\n",
      "['acalabrutinib cll', 'elevate tn cll']\n",
      "['cancer drugs', 'dampen cytokinestorm', 'severe covid', 'calquence btkinhibitors']\n",
      "['ema green', 'gist acalabrutinib']\n",
      "['cancer drugs', 'dampen cytokinestorm', 'severe covid', 'calquence btkinhibitors']\n",
      "['btk acalabrutinib cll ascend cll acalabrutinib idelalisib']\n",
      "['btk acalabrutinib cll']\n",
      "['btk acalabrutinib cll']\n",
      "['chmp recommendations', 'astrazeneca imfinzi', 'line lung cancer calquence', 'chronic lymphocytic leukaemia pharmaceutical']\n",
      "['chmp recommendations', 'astrazeneca imfinzi', 'line lung cancer calquence', 'chronic lymphocytic leukaemia pharma']\n",
      "['chronic lymphocytic leukaemia']\n",
      "['astra zenecas calquence f r godk nnanderekommendation i eu']\n",
      "['astrazeneca s calquence', 'positive chmp opinion', 'chronic blood cancer']\n",
      "['azn calquence acalabrutinib', 'adult patients', 'chronic lymphocytic leukaemia cll haematology pharma stocks astrazeneca singlestocketps']\n",
      "['astrazeneca calquence', 'eu azn']\n",
      "['astrazeneca calquence', 'eu azn', 'shares stocks ratings']\n",
      "['chronic lymphocytic leukaemia']\n",
      "['azn astrazeneca plc calquence', 'positive chmp opinion']\n",
      "['ace cl', 'pivotal phase', 'ascend trial', 'long term efficacy', 'chronic lymphocytic leukemia']\n",
      "['selective btk inhibitor', 'severe covid']\n",
      "['rare leucemia linfocitica cronica parere positivo del chmp dell ema', 'acalabrutinib comitatoimalatiinvisibili imalatiinvisibili comitatoimi comitatoimionlus malattierare']\n",
      "[]\n",
      "['covid19 aifa ufficiale autorizza tre nuovi studi su acalabrutinib ifn 1a e', 'molecola abx464']\n",
      "['european advisory group backs astrazeneca s calquence', 'leukemia treatment azn']\n",
      "['european advisory group', 's astrazeneca s calquence', 'cll azn']\n",
      "['european advisory group', 's astrazeneca s calquence']\n",
      "['azn european advisory group', 's astrazeneca s calquence']\n",
      "['mantle cell lymphoma lymphoma endcancer']\n",
      "['new article', 'adverse events amp', 'mantle cell lymphoma cjon']\n",
      "['new clinical trial', 'immune cells cd19 car t cells', 'refractory mantle cell lymphoma mcl lymsm hematology']\n",
      "['new clinical trial', 'immune cells cd19 car t cells', 'refractory mantle cell lymphoma tcl lymsm hematology']\n",
      "['neoplasie delle cellule b profilo di sicurezza favorevole', 'l inibitore di btk di nuova generazione acalabrutinib comitatoimalatiinvisibili imalatiinvisibili comitatoimi comitatoimionlus malattierare']\n",
      "['dr richard furman', 'btk inhibitors ibrutinib 1st generation acalabrutinib amp zanubrutinib', 'patients w b cell malignancies']\n",
      "['study suggests lymphoma drug acalabrutinib', 'potential therapeutic approach', 'severe covid']\n",
      "['drug acalabrutinib', 'severe covid']\n",
      "['rapid improvement', 'symptoms amp oxygenation', 'inflammatory markers', 'serious toxicity', 'short course', 'acalabrutinib sounds', 'promising aacrcovid']\n",
      "['label use', 'severe covid']\n",
      "['louis staudt', 'different types', 'therapies work', 'different stages', 'covid19 lymphoma btk inhibitor acalabrutinib', 'cytokine storm aacrcovid']\n",
      "['louis staudt acalabrutinib calquence', 'inflammation amp', 'severe covid19', 'small study clinical improvement', 'inflammatory markers', 'monocytes amp macrophages', 'hyperinflammation aacrcovid']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['label use', 'cancer drug acalabrutinib', 'btk inhibitor', 'respiratory distress amp', 'overactive immune response aacrcovid louis m staudt']\n",
      "['louis staudt', 'infectious disease discusses study', 'lymphoma drug acalabrutinib calquence', 'covid19 aacrcovid']\n",
      "[]\n",
      "['paolo ghia md phd', 'final results', 'ascend trial', 'acalabrutinib monotherapy', 'refractory cll asco20 leusm']\n",
      "['btk inhibitors', 'important drug class', 'b cell malignancies', 'generation inhibitor zanubrutinib', 'alternative option', 'acalabrutinib asco20 lymsm']\n",
      "['final results', 'ascend trial', 'favorable safety', 'care regimens', 'refractory cll asco20 leusm']\n",
      "['adverse events', 'mantle cell lymphoma lymphoma lymsm']\n",
      "['mantle cell lymphoma chronic lymphocytic leukaemia lymphoma lymsm']\n",
      "['eha25 virtual congress calquence trial results', 'chronic lymphocytic leukemia', 'eha25 calquence chroniclymphocyticleukemia']\n",
      "['biological implications', 'target occupancy', 'btk inhibitor acalabrutinib bid', 'btk occupancy', 'potent pathway inhibition']\n",
      "['el medicamento acalabrutinib inhibe', 'prote na tirosina quinasa', 'bruton btk y se asocio', 'con una reducci n', 'las dificultades respiratorias y', 'respuesta inmune hiperactiva que causa', 'los enfermos criticos por el covid fuente infoabe']\n",
      "['new article acalabrutinib', 'adverse events', 'mantle cell lymphoma mcl lymsm hematology']\n",
      "['new article acalabrutinib', 'mantle cell lymphoma chronic lymphocytic leukaemia mcl lymsm hematology']\n",
      "['acute respiratory distress syndrome']\n",
      "['final ascend data', 'safety efficacy', 'r r cll asco20 leusm']\n",
      "['hematologylife llc acalabrutinib itk hospitalespa oldebuenosaires']\n",
      "['clinical trial', 'cancer drug acalabrutinib']\n",
      "['clinical trial', 'cancer drug acalabrutinib', 'covid reports theprintexclusive']\n",
      "[]\n",
      "[]\n",
      "['clinical trial', 'cancer drug acalabrutinib']\n",
      "['btk inhibitor acalabrutinib', 'severe covid']\n",
      "['clinical trial', 'negatives india', 'guinea pigs', 'clinical trial', 'calquence acalabrutinib']\n",
      "['clinical outcomes', 'severe covid']\n",
      "['clinical trial', 'cancer drug btk inhibitor acalabrutinib calquence', 'severe covid19 patients', 'respiratory failure', 'global trial']\n",
      "['india joins', 'global trial', 'astrazeneca s blood cancer drug acalabrutinib', 'severe covid19 patients', 'total sample size']\n",
      "['cancer drug', 'inflammation amp', 'clinical outcomes', 'severe covid', 'astrazenica india', 'clinical trial', 'cancer drug acalabrutinib']\n",
      "['clinical trial', 'cancer drug acalabrutinib']\n",
      "['clinical trial', 'cancer drug acalabrutinib', 'covid reports theprintexclusive']\n",
      "['btk inhibitor acalabrutinib', 'severe covid', 'new research']\n",
      "['calquence cll mcl']\n",
      "['recent observation', 'lymphoma drug acalabrutinib', 'potential therapeutic approach', 'severe covid', 'visit whitecoats bedreffective covid19 covid corona coronavirus']\n",
      "[]\n",
      "[]\n",
      "['early data', 'early data']\n",
      "['study suggests lymphoma drug acalabrutinib', 'potential therapeutic approach', 'severe covid', 'infection news wise']\n",
      "['con k', 'queso dijo mi jefe']\n",
      "['azn astrazeneca acalabrutinib']\n",
      "['astrazeneca lymphoma drug acalabrutinib', 'potential therapy', 'severe covid', 'scam mrna', 'scam run', 'daily basis', 'action spy']\n",
      "['azn plc astrazeneca lymphoma drug acalabrutinib', 'potential therapy', 'severe covid']\n",
      "['astrazeneca lymphoma drug acalabrutinib', 'potential therapy', 'severe covid']\n",
      "['astrazeneca lymphoma drug acalabrutinib', 'potential therapy', 'severe covid']\n",
      "['astrazeneca lymphoma drug acalabrutinib', 'potential therapy', 'severe covid']\n",
      "['early data', 'sharman oncology']\n",
      "['new study', 'covid19 patients suggests lymphoma drug', 'potential therapeutic approach', 'severe infection']\n",
      "['lymphoma drug acalabrutinib', 'potential therapy', 'severe covid']\n",
      "['lymphoma drug acalabrutinib', 'potential therapy', 'severe covid', 'lymphomadrug acalabrutinib covid19 covid']\n",
      "['study suggests lymphoma drug acalabrutinib', 'potential therapeutic approach', 'severe covid']\n",
      "['cll sll', 'calquence astrazeneca acalabrutinib leukemia chroniclympoidleukemia cll lymphoma smalllymphocyticlymphoma sll oncology q1 q12020 lymphomamarket dtwmarkethighlights']\n",
      "['bruton tyrosine kinase', 'severe covid', 'covid19 ccc19 covid19ncancer acalabrutinib', 'severe covid']\n",
      "['baml azn top', 'class growth', '24e sales cagr', 'c15 ebit cagr', 'impressive launch portfolio', 'cll enhertu', 'post kadcyla breast cancer roxadustat china', 'end 20e farxiga heart failure', 'mid 20e key product']\n",
      "[]\n",
      "['new paper', 'sunny kim heme onc fellow', 'cancer journal', 'cll cancer regulatory trials deprive control arm pts', 'current standard', 'gt evidence gt clinical use']\n",
      "['announces calavi trial ace id', 'matthew fowler caxtx ccc19 2019ncov covid19clinicaltrials nct04346199 az press release']\n",
      "['bruton tyrosine kinase', 'severe covid', 'covid19 ccc19 covid19ncancer acalabrutinib', 'severe covid19']\n",
      "['rare leucemia linfatica cronica ricaduta refrattaria acalabrutinib conferma', 'sua alta efficienza', 'lungo termine comitatoimalatiinvisibili imalatiinvisibili comitatoimi comitatoimionlus malattierare']\n",
      "['cancer research', 'pandemics highlights', 'insightful use', 'bruton s tyrosine kinase btk', 'racial injustices']\n",
      "['john c byrd md', 'cll sll acalabrutinib', 'treatment naive patients eha25virtual eha25 leusm lymsm james']\n",
      "['such incredible coworkers amp mentors nhlbi']\n",
      "['biological implications', 'target occupancy', 'btk inhibitor acalabrutinib']\n",
      "['obinutuzumab versus chlorambucil', 'treatment naive chronic lymphocytic leukaemia elevate tn']\n",
      "['calquence drug profile']\n",
      "['eha25 prof paolo ghia', 'final results', 'ascend trial', 'acalabrutinib vs idelalisib rituximab', 'bendamustine rituximab', 'r r chronic lymphocytic leukaemia', 'oncology eha25virtual eha2020 cll']\n",
      "['dr richard furman speaks', 'acalabrutinib monotherapy', 'patients w chronic lymphocytic leukemia myeloma', 'aggressive lymphoma', 'different clinicaltrials']\n",
      "[]\n",
      "['different kinds', 'virus coronavirusdrug']\n",
      "['occupy btk', 'cll gt gt gt clinical', 'biological implications', 'target occupancy', 'btk inhibitor acalabrutinib blood american society']\n",
      "['remarkable paper', 'important findings', 'btk resynthesis', 'amazing clinical', 'biological implications', 'target occupancy', 'btk inhibitor acalabrutinib blood american society']\n",
      "['results support acalabrutinib use', 'upfront cll', 'dr john c byrd']\n",
      "['stellar update recruitment', 'chop r', 'richterssyndrome churchillhospital']\n",
      "['oncoalert clinical', 'biological implications', 'target occupancy', 'btk inhibitor acalabrutinib american society', 'hematology leusm cllsm lymsm']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil']\n",
      "['oral treatment option', 'adult patients', 'chronic lymphocytic leukemia cll']\n",
      "['oral treatment option', 'adult patients', 'chronic lymphocytic leukemia cll']\n",
      "['oral treatment option', 'adult patients', 'chronic lymphocytic leukemia cll']\n",
      "['oral treatment option', 'adult patients', 'chronic lymphocytic leukemia cll']\n",
      "['oral treatment option', 'adult patients', 'chronic lymphocytic leukemia cll']\n",
      "['obinutuzumab vs chlorambucil obinutuzumab', 'cll leusm hematology']\n",
      "['pulse calquence']\n",
      "['new drug']\n",
      "['calquence pulsebeatnews']\n",
      "['final results', 'ascend trial', 'resistant cll']\n",
      "['btk acalabrutinib cll2 carenet']\n",
      "['cancer drug', 'supplemental oxygen', 'large drop']\n",
      "['refractory chronic lymphocytic leukemia']\n",
      "['industriafarmac utica acalabrutinib', 'muestra eficacia', 'leucemia linfoc tica los resultados se presentaron durante el congreso anual', 'asociaci n europea']\n",
      "['calavi btk acalabrutinib covid']\n",
      "['new acalabrutinib', 'refractory chronic lymphocytic leukemia']\n",
      "['dra adriana scheliga', 'target therapy', 'acalabrutinib cll acalabrutinib leukemia']\n",
      "['astrazeneca muestra eficacia', 'leucemia linfoc tica']\n",
      "['small case study', 'btk inhibitor', 'macrophage activation', 'severe covid', 'favorable results note side']\n",
      "['astrazeneca muestra eficacia', 'leucemia linfoc tica']\n",
      "['blood samples', 'covid19 pts', 'major cytokine', 'hyper inflammation', 'acalabrutinib counts', 'low lymphocyte counts']\n",
      "[]\n",
      "['abbv catalysts', 'data focus', 'additional rinvoq phase', 'atopic derm', 'skyrizi phase', 'motivate data', 'cd induction', 'bi voltaire x interchangeability study', 'biosimilar humira head', 'calquence imbruvica data', 'r r cll']\n",
      "['novel reversible btk inhibitor', 'likely attacks', 'protein epitome', 'irreversible btk inhibitors', 'ibrutinib acalabrutinib', 'btk inhibitor', 'resistant lymphoma']\n",
      "['ruxolitinib boosts sars cov', 'jak stat e g baricitinib amp btk inhibitor', 'acalabrutinib timing', 'remdesivir dexamethason baricitinib combo', 'don t']\n",
      "[]\n",
      "['new acalabrutinib', 'refractory chronic lymphocytic leukemia']\n",
      "['eha25virtual ace cl', 'alessandra tedeschi']\n",
      "['dr alan skarbnik', 'ascend trail', 'cll rr ehavirtual eha25 leukemia']\n",
      "['cancer drug', 'supplemental oxygen', 'large drop']\n",
      "[]\n",
      "['acalabrutinib aumenta', 'supervivencia libre', 'progresi n recidivante o leucemia linfoc tica cr nica refractaria ecancer']\n",
      "['inhibitor apg', 'vs r r cll sll', 'collab w acertapharma ph1b', 'combo w acerta s btk inhibitor acalabrutinib oncology leukemia lymphoma']\n",
      "['long term management treatment option']\n",
      "['con acalabrutinib rapido miglioramento dei sintomi di covid', 'grave secondo i dati di uno studio pubblicato su science immunology']\n",
      "[]\n",
      "[]\n",
      "[]\n",
      "[]\n",
      "['ascentage acerta', 'calquence combo', 'r r cll sll']\n",
      "['el acalabrutinib usado', 'el tratamiento contra', 'leucemia bloquear', 'prote na btk que provoca', 'propagaci n', 'descartan que se aplique para los casos graves']\n",
      "['refractory disease', 'disease progression', 'months versus', 'physician s choice']\n",
      "['cell signal blocker', 'effective new chemo', 'free treatment option', 'chronic lymphocytic leukaemia cll', 'gt sundayread']\n",
      "['acalabrutinib monotherapy', 'mature b cell malignancies', 'eha25virtual hematology lymsm leusm eha25 hemonc']\n",
      "[]\n",
      "['cancer drug', 'supplemental oxygen', 'large drop']\n",
      "['favorable efficacy', 'tolerable safety profile', 'refractory chronic lymphocytic leukemia leusm']\n",
      "['dr dr thomas witzig eha library jun']\n",
      "['dr john byrd', 'treatment naive cll comparisons', 'btk inhibitors', 'years patients']\n",
      "['q amp', 'eha25virtual paolo ghia', 'final data', 'ascend trial', 'acalabrutinib vs idelalisib rituximab', 'bendamustine rituximab', 'r r cll pfs', 'acalabrutinib vs idr br overall amp', 'del 17p tp53 mutations lymsm']\n",
      "['centros comerciales buscar impulsar econom', 'oit advierte', 'un posible incremento del trabajo infantil el acalabrutinib usado', 'el tratamiento contra', 'leucemia bloquear', 'prote na btk que provoca', 'propagaci n']\n",
      "['acalabrutinib carenet carenet']\n",
      "['el acalabrutinib usado', 'el tratamiento contra', 'leucemia bloquear', 'prote na btk que provoca', 'propagaci n', 'descartan que se aplique para los casos graves']\n",
      "['centros comerciales buscar impulsar econom', 'oit advierte', 'un posible incremento del trabajo infantil el acalabrutinib usado', 'el tratamiento contra', 'leucemia bloquear', 'prote na btk que provoca', 'propagaci n']\n",
      "['acalabrutinib treatment', 'r r mantle cell lymphoma patients', 'high rate', 'durable responses', 'overall response', 'complete response', 'favorable safety profile']\n",
      "['gli update presentati', 'eha25virtual confermano l efficacia di acalabrutinib nel trattamento della leucemia linfatica cronica rendendolo un interessante opzione terapeutica anche prima linea', 'parole di alessandra tedeschi']\n",
      "['effectivement ce ne sont pas les r sultats pr liminaires', 'forcetrial mais ceux d un essai exploratoire', 'l inhibiteur', 'btk acalabrutinib chez les patients atteints d', 'forme s v re', 'covid19 nous jugeons cette information int ressante donc nous']\n",
      "['congress eha25virtual john byrd james', 'ace cl', 'acalabrutinib monotherapy', 'treatment na ve cll patients results', 'durable remissions', 'long term tolerability lymsm']\n",
      "['allergic reactions acalabrutinib', 'bruton s kinase inhibitor', 'mouse model', 'severe anaphylaxis']\n",
      "['azitromicina el ritonavir y', 'ivermectina son usados para tratar casos graves', 'los ltimos d', 'se les suma el acalabrutinib usado para el tratamiento']\n",
      "['acalabrutinib demonstrates', 'term efficacy', 'cll hematology leusm eha25virtual']\n",
      "['acalabrutinib calquence']\n",
      "['rapid improvements', 'cancer drug acalabrutinib']\n",
      "['atenci n el acalabrutinib usado', 'el tratamiento contra', 'leucemia bloquear', 'prote na btk que provoca', 'propagaci n', 'descartan que se aplique para los casos graves']\n",
      "['btkinhibitor acalabrutinib', 'encouraging preliminary data supplemental oxygen group oxygenation', 'room air', 'mechanical ventilation group']\n",
      "['medical news bulletin']\n",
      "['covid19 coronavirus pandemic coronavirustreatment']\n",
      "['acalabrutinib pharmacodynamics', 'chronic lymphocytic leukemia cl']\n",
      "['member richard r furman md', 'hematologic malignancies precisionmedicine']\n",
      "['astrazeneca s calquence', 'chronic lymphocytic leukemia patients', 'separate study']\n",
      "['los m dicos han publicado sus conclusiones', 'revista science immunology consideran que', 'clave est', 'prote na btk y que este f rmaco inhibe covid19 salud acalabrutinib']\n",
      "['demiurge ai', 'covid19 clinicaltrials outcome predictions', 'public test', 'acalabrutinib nct04380688', 'acerta pharma b v']\n",
      "['da paolo ghia un focus sui dati dell analisi finale dello studio ascend presentato', 'con ulteriori evidenze', 'acalabrutinib nella leucemia linfatica cronica']\n",
      "['ma ana', 'caretas el pa s avanza', 'reactivaci n econ mica e impulsa', 'los comercios', 'oit advierte', 'un dr stico incremento del trabajo infantil el acalabrutinib bloquear', 'prote na que provoca', 'propagaci n', 'esto y m s']\n",
      "['cancer reduces inflammation', 'supplemental oxygen', 'patients researchers']\n",
      "['dr sharman shares', 'expert insights amp discusses', 'new exploratory dataset', 'infection amp', 'severe acute respiratory distress syndrome ards']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['ace cl', 'pivotal phase', 'ascend trial', 'long term efficacy', 'chronic lymphocytic leukemia']\n",
      "['blood cancer', 'oncology research physicians']\n",
      "['eha25virtual ascend trial', 'clinical benefit', 'acalabrutinib monotherapy', 'refractory chronic lymphocytic leukemia', 'paolo ghia']\n",
      "['bruton tyrosine kinase', 'severe covid19 meaning scientists', 'drug acalabrutinib', 'clinical trial']\n",
      "['new phase ii data', 'truxima biosimilar rituximab lenalidomide', 'acalabrutinib r2a', 'aggressive b cell lymphoma news pharma pharmiweb']\n",
      "['new phase ii data', 'truxima biosimilar rituximab lenalidomide', 'acalabrutinib r2a', 'aggressive b cell lymphoma news pharma pharmiweb']\n",
      "[]\n",
      "['pharmacodynamic analysis', 'btk inhibition', 'chronic lymphocytic leukemia']\n",
      "['anticancer drug', 'promising results', 'treatment acalabrutinib bruton tyrosine kinase btk inhibitor', 'chronic lymphocytic']\n",
      "['acalabrutinib versus investigator s choice', 'refractory cll', 'r r cll rct']\n",
      "['cancer drug', 'severe covid']\n",
      "['btk inhibitor acalabrutinib']\n",
      "['m dicos del hospital walter', 'maryland estados unidos han descubierto que el medicamento acalabrutinib utilizado', 'algunos c nceres puede ser una soluci n covid19']\n",
      "['btk inhibitors']\n",
      "['cheap ish', 'similar concept', 'acalabrutinib i', 'week reduction', 'outcomes response']\n",
      "['acalabrutinib vs idelalisib rituximab', 'bendamustine rituximab', 'refractory cll ascend trial leusm hematology']\n",
      "['zonder obinutuzumab vs chloorambucil', 'obinutuzmab als', 'voor cll']\n",
      "['cancer drug', 'supplemental oxygen', 'large drop']\n",
      "['jefferies analysts', 'pharma companies', 'european union', 'new drug launches', 'novo nordisk s rybelsus', 'astrazeneca s calquence']\n",
      "['calquence acalabrutinib oncology trials astrazeneca leukemia oncology clinicaltrials calquencetrials biopharmaceutical biotechnology pharmaceutical drugdevelopment drugdiscovery ddw drugdiscoveryworld']\n",
      "['acalabrutinib inhibe btk mejorando cuadro hipoxia covid19 estos datos nos hacen pensar que el momento', 'ideal para administrar el tratamiento es cuando empieza', 'citoquinas antes', 'que se hayan producido da os muy graves se ala baselga']\n",
      "['covid19 hypoxia inhibitor btk gene acalabrutinib ibrutinib', 'wm patients', 'full dose ibrutinib ibrutinib', 'mg d', 'rapid improvement']\n",
      "['cytokine storm acalabrutinib assists', 'study ont']\n",
      "['early data show potential benefit', 'severe covid']\n",
      "['healthday reports acalabrutinib', 'severe covid', 'physician s']\n",
      "['medscape acalabrutinib calquence astrazeneca', 'bruton tyrosine kinase btk inhibitor', 'early signs', 'severe covid', 'case study']\n",
      "['que administra acalabrutinib iniciar ensayos cl nicos', 'los pa ses m s afectados por', 'epidemia entre ellos chile qu dateencasa qu dateenradio']\n",
      "['long term efficacy', 'chronic lymphocytic leukaemia']\n",
      "['new phase ii data', 'truxima biosimilar rituximab lenalidomide', 'acalabrutinib r2a', 'aggressive bcelllymphoma eha20']\n",
      "['nuovi dati di fase ii indicano che un regime combinato di truxima lenalidomide e acalabrutinib pu essere ben tollerato', 'efficace nella terapia del linfoma', 'cellule b aggressivo refrattario recidivato']\n",
      "['astrazeneca s blood cancer drug calquence']\n",
      "['nuovi dati di fase ii indicano che un regime combinato di truxima lenalidomide e acalabrutinib pu essere ben tollerato', 'efficace nella terapia del linfoma', 'cellule b aggressivo refrattario recidivato']\n",
      "['astrazeneca s blood cancer drug calquence']\n",
      "['astrazeneca s blood cancer drug calquence']\n",
      "['new phase ii data', 'truxima lenalidomide', 'aggressive b']\n",
      "['astrazeneca s blood cancer drug calquence']\n",
      "['acalabrutinib carenet']\n",
      "['new phase ii data', 'truxima biosimilar rituximab lenalidomide', 'acalabrutinib r2a', 'aggressive b cell lymphoma']\n",
      "['new phase ii data', 'truxima biosimilar rituximab lenalidomide', 'acalabrutinib r2a']\n",
      "[]\n",
      "['nouvelles donn es', 'phase ii indiquent qu un traitement combinant truxima rituximab biosimilaire l nalidomide', 'acalabrutinib r2a pourrait tre efficace', 'bien tol r par les patients atteints d un lymphome cellules b agressif']\n",
      "['nieuwe fase ii gegevens geven aan dat regime van truxima biosimilar rituximab lenalidomide', 'acalabrutinib r2a wellicht', 'wordt verdragen', 'bij recidief refractair agressief b cellymfoom']\n",
      "['neue phase ii daten deuten auf gute vertr glichkeit und wirksamkeit des therapieschemas mit truxima rituximab biosimilar lenalidomid und acalabrutinib r2a bei rezidivierten refrakt ren aggressiven b zell lymphomen hin']\n",
      "['los nuevos datos', 'fase ii indican que el r gimen', 'truxima biosimilar', 'rituximab lenalidomida y acalabrutinib r2a puede ser bien tolerado y efectivo', 'el linfoma', 'c lulas b agresivo recidivante refractario']\n",
      "['new phase ii data', 'truxima biosimilar rituximab lenalidomide', 'acalabrutinib r2a', 'aggressive b cell lymphoma']\n",
      "['nuovi dati di fase ii indicano che un regime combinato di truxima rituximab biosimilare lenalidomide e acalabrutinib r2a pu essere ben tollerato', 'efficace nella terapia del linfoma', 'cellule b aggressivo refrattario recidivato']\n",
      "['ser calmada', 'con acalabrutinib seg n publicaci n', 'un estudio observacional', 'pacientes pero se precisa un ensayo cl nico aleatorizado prospectivo para establecer su posible papel terap utico coronavirus']\n",
      "[]\n",
      "[]\n",
      "['kanser ilac acalabrutinib', 'r covid', 'vakalar nda potansiyel bir tedavi stratejisi olabilir']\n",
      "['kanser ilac acalabrutinib', 'r covid', 'vakalar nda potansiyel bir tedavi stratejisi olabilir']\n",
      "['majority acalabrutinib', 'selective btk inhibitor', 'severe covid', 'day treatment course acalabrutinib']\n",
      "['lungs dr staudt', 'drug acalabrutinib', 'inflammatory fire', 'macrophages covid19 talkingheads']\n",
      "['buena noticia para pacientes', 'coronavirus graves prueban', 'con xito f rmaco acalabrutinib']\n",
      "['leucemia linfatica cronica dimostrata l efficacia e', 'lungo termine di acalabrutinib i risultati di', 'studi presentati', 'congresso eha european hematology association']\n",
      "['kanser ilac acalabrutinib', 'r covid', 'vakalar nda potansiyel bir tedavi stratejisi olabilir']\n",
      "['leucemia linfatica cronica dimostrata affidabilit e tollerabilit di acalabrutinib']\n",
      "['label observational study', 'covid19 immunomodulatory treatment', 'supplemental oxygen patients', 'room air amp', 'mechanical ventilation patients', 'room air']\n",
      "['kanser ilac acalabrutinib', 'r covid', 'vakalar nda potansiyel bir tedavi stratejisi olabilir']\n",
      "['jco ascend phase iii', 'acalabrutinib vs idelalisib rituximab', 'bendamustine rituximab', 'refractory cll btk pi3k syk bcl']\n",
      "['final results', 'dr paolo ghia', 'eha25virtual lymsm oncology']\n",
      "['early data', 'clinical study', 'bruton tyrosine kinase btk protein', 'clinical benefit', 'small group', 'severe covid']\n",
      "['lgbtqa pride month']\n",
      "['coronavirus bloodcancer policenama']\n",
      "['lancet acalabrutinib w', 'w o obinutuzumab vs chlorambucil', 'treatment naive cll elevate tn']\n",
      "['astrazeneca s blood cancer drug calquence', 'patients biospace jobs']\n",
      "['buena noticia para pacientes', 'coronavirus graves prueban', 'con xito f rmaco acalabrutinib']\n",
      "['buena noticia para pacientes', 'coronavirus graves prueban', 'con xito f rmaco acalabrutinib']\n",
      "['label observational study suggests', 'drug acalabrutinib', 'b cell cancers', 'hyperinflammatory cytokinestorm immune response', 'severe cases']\n",
      "['label observational study suggests', 'drug acalabrutinib', 'b cell cancers', 'hyperinflammatory cytokinestorm immune response', 'severe cases']\n",
      "['han dicho acalabrutinib', 'lasexta noche covid19']\n",
      "['1l cll phase ii trial n', '53m median fup', 'd c', 'pd tox profile', 'g3 htn', 'headache orr', '48m dor', '48m efs', 'non trial data', 'uk eams scheme', 'time eha25virtual cll lymsm']\n",
      "['small study', 'btk inhibitor', 'lymphoma drug', 'promising results covid19 infectiousdisease pharmacyandpharmacology researchanddevelopment']\n",
      "['btk inhibitor acalabrutinib inhibition', 'bruton tyrosine kinase', 'severe covid']\n",
      "['cytokine storm', 'tocilizumab actemra blocks il', 'remdesivir acalabrutinib calquence', 'btk inhibitor cytosorb blood filter']\n",
      "['ee uu dieron', 'con un f rmaco capaz', 'vencer las formas m s graves', 'covid19 el hallazgo se produjo gracias', 'prote na que podr', 'ser clave', 'reacci n hiperinflamatoria que', 'prote na btk']\n",
      "['buena noticia para pacientes', 'coronavirus graves prueban', 'con xito f rmaco acalabrutinib']\n",
      "['buena noticia para pacientes', 'coronavirus graves prueban', 'con xito f rmaco acalabrutinib']\n",
      "['long term efficacy', 'trials azn eha20']\n",
      "['f rmaco acalabrutinib para frenar', 'respuesta inmune hiperinflamatoria mediada por citoquinas que se', 'pacientes graves']\n",
      "['acalabrutinib g un cll eha2020']\n",
      "['new drug', 'covid19 hyperinflammatory immune response don t']\n",
      "['azn calquence', 'long term efficacy', 'chronic lymphocytic leukaemia', 'trials astrazeneca oncology singlestocketps']\n",
      "['phase ii ace cl', 'pivotal phase iii ascend trial', 'long term efficacy', 'chronic lymphocytic leukaemia chronicdiseases astrazeneca']\n",
      "['cancer drug', 'supplemental oxygen', 'large drop']\n",
      "['label observational study suggests', 'drug acalabrutinib', 'b cell cancers', 'hyperinflammatory cytokinestorm immune response', 'severe cases']\n",
      "[]\n",
      "['label observational study suggests', 'drug acalabrutinib', 'b cell cancers', 'hyperinflammatory cytokinestorm immune response', 'severe cases']\n",
      "['estados unidos dio', 'con un f rmaco que vence las formas m s graves', 'covid19 el hallazgo se produjo gracias', 'prote na que podr', 'ser clave', 'reacci n hiperinflamatoria que', 'prote na btk']\n",
      "['cancer drug', 'small group', 'covid19 patients']\n",
      "['acalabrutinib como medicamento para tratar', 'hiperinflamaci n', 'pacientes covid']\n",
      "[]\n",
      "['acalabrutinib como medicamento para tratar', 'hiperinflamaci n', 'pacientes covid']\n",
      "['se encuentra una prote na letal btk', 'el coronavirus y su posible f rmaco acalabrutinib', 'trav s']\n",
      "['parece que ya', 'se necesitan las vacunas contra covid', 'nuevo estudio', 'ee uu muestran que el acalabrutinib medicamento contra el c ncer mata', 'virus incluso estando', 'uci te recuperas']\n",
      "['buena noticia para pacientes', 'coronavirus graves prueban', 'con xito f rmaco acalabrutinib']\n",
      "['cytokine storm', 'tocilizumab anakinra acalabrutinib covid19 coronavirus']\n",
      "['buena noticia para pacientes', 'coronavirus graves prueban', 'con xito f rmaco acalabrutinib']\n",
      "['new drug']\n",
      "['dr richard furman details asco20 research', 'wide range', 'b cell malignancies', 'chronic lymphocytic leukemia cll amp waldenstroms']\n",
      "['leucemia terapia', 'con acalabrutinib efficace e tollerata']\n",
      "['bruton tyrosine kinase', 'severe covid', 'science immunology acalabrutinib']\n",
      "['coronavirus pruebanf rmaco coronavirus probaron un f rmaco usado contra el c ncer se trata del acalabrutinib v']\n",
      "['covid19 news', 'week s pod antibody test accuracy treatments', 'children potential benefit', 'states lodge record hospitalizations']\n",
      "['stellar update patient recruitment', 'acalabrutinib monotherapy tc bec', 'research nurses sian', 'jess pi dr fox', 'research team']\n",
      "['cytokine storm', 'cancer drug calquence']\n",
      "['encontraron f rmaco que vence las formas m s graves']\n",
      "['buena noticia para pacientes', 'coronavirus graves prueban', 'con xito f rmaco acalabrutinib']\n",
      "['buena noticia para pacientes', 'coronavirus graves prueban', 'con xito f rmaco acalabrutinib']\n",
      "['healthday reports acalabrutinib', 'severe covid']\n",
      "['azn astrazeneca calquence', 'long term efficacy amp tolerability', 'chronic lymphocytic leukaemia', 'trials ace cl', 'overall response rate', 'safety profile']\n",
      "['pivotal ascend trial', 'refractory disease', 'months vs', 'comparators leukaemia calquence acalabrutinib eha25virtual']\n",
      "['ace cl', 'overall response rate', 'safety profile', 'years leukaemia calquence acalabrutinib eha25virtual']\n",
      "['phase ii ace cl', 'pivotal phase iii ascend trials', 'long term efficacy amp tolerability', 'calquence acalabrutinib', 'chronic lymphocytic leukaemia']\n",
      "['leucemia linfatica cronica dimostrata l efficacia e', 'lungo termine di acalabrutinib leucemia linfatica cronica']\n",
      "['btk inhibitor acalabrutinib shows', 'supplemental oxygen group', 'steep drop']\n",
      "['un estudio', 'con covid', 'que requirieron hospitalizaci n por bajos niveles', 'ox geno y un cuadro', 'inflamaci n demostr que el medicamento acalabrutinib es ben fico sobre todo si se administra']\n",
      "['resultat fr n tv nya studier pekar p att l ngtidseffekten r mycket god vid', 'calquence till patienter', 'kronisk lymfatisk leukemi leukemi astrazeneca lifesciencesweden pharma']\n",
      "['nello studio ace cl', 'acalabrutinib dimostra un tasso di risposta globale del', 'e un profilo di sicurezza prolungato nel trattamento di pazienti', 'con leucemia linfatica cronica non pretrattati oncology']\n",
      "['acalabrutinib efficace e tollerato', 'lungo termine nel trattamento della leucemia linfatica cronica llc', 'forma pi comune di leucemia dell adulto salute']\n",
      "['long term efficacy', 'chronic lymphocytic leukaemia']\n",
      "['tras los xitos', 'nuestras salas', 'tocilizumab lopinavir rendesivir hidroxicloro y dem s vedettes llega', 'muestras pantallas', 'nueva promesa', 'impronunciable acalabrutinib']\n",
      "[]\n",
      "['encuentran prote na clave que causa', 'inflamaci n', 'mortal del coronavirus']\n",
      "['medscape btk inhibitor acalabrutinib', 'severe covid', 'case study', 'patients suggests']\n",
      "['ee uu dieron', 'con un f rmaco capaz', 'vencer las formas m s graves', 'ser clave', 'reacci n hiperinflamatoria que', 'el virus', 'prote na btk el descubrimiento da esperanza', 'consecuci n', 'un tratamiento']\n",
      "['long term efficacy', 'chronic lymphocytic leukaemia']\n",
      "['new drug', 'coca cola', 'cure coronavirus patients']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['severe covid', 'hyperinflammatory immune response suggestive', 'macrophage activation bruton tyrosine kinase btk regulates macrophage', 'activation acalabrutinib selective btk inhibitor traduc']\n",
      "['new drug', 'coca cola', 'cure coronavirus patients']\n",
      "['drugs amp devices', 'purify blood', 'cytokine storm scientists', 'cancer drug calquence acalabrutinib', 'source ind india']\n",
      "['parece que ya', 'se necesitan las vacunas contra covid', 'nuevo estudio', 'ee uu muestran que el acalabrutinib medicamento contra el c ncer mata', 'virus incluso estando', 'uci te recuperas']\n",
      "['una esperanza para los pacientes', 'estado cr tico probaron', 'con xito el acalabrutinib un f rmaco ya existente']\n",
      "['estadosunidos investigadores observaron que el uso del medicamento acalabrutinib un f rmaco usado', 'el tratamiento', 'varios tipos', 'c ncer', 'sangre proporcion beneficios cl nicos', 'los pacientes cr ticos por covid19']\n",
      "['el acalabrutinib inhibidor', 'tirosina quinasa', 'bruton btk podria ser til', 'el tratamiento', 'casos severos', 'covid19 publica estudio', 'con su administraci n', 'pacientes ahora toca hacer un ensayo clinico']\n",
      "['leyendo sobre', 'inflamacion provocada por el covid haran estudios', 'con pacientes', 'paises mas afectados y', 'aparece panam triste', 'con un medicamento q bloquea', 'prote na btk llamado acalabrutinib y aqu x q', 'supongo q', 'aprobado tal cosa susalaaabaaoo']\n",
      "[]\n",
      "['buena noticia para pacientes', 'coronavirus graves prueban', 'con xito f rmaco acalabrutinib']\n",
      "['exciting news', 'dr monticelli', 'medical oncologist', 'rocky mountain cancer centers', 'penrose amp dr roshon chief', 'medical staff', 'penrose st francis', 'cancer drug']\n",
      "['acalabrutinib un f rmaco', 'astrazeneca que trata', 'inflamaci n', 'cancer se', 'probado efectivo', 'con neumonia hallada', 'prote na clave que causa una inflamaci n', 'covid barricadanews']\n",
      "['hidroxicloroquina ivermectina remdesivir etc y ahora el acalabrutinib aparecen', 'escena pero el numero', 'muertos se incrementa dia']\n",
      "['el acalabrutinib fue probado', 'y logr combatir', 'con xito', 'estados avanzados']\n",
      "['encontraron f rmaco que vence las formas m s graves']\n",
      "['encuentran prote na clave que causa', 'inflamaci n', 'mortal del coronavirus covid19']\n",
      "['evan kirstel remotework', 'twitter i', 'u amp gt', 'new drug', 'coca cola', 'cure coronavirus patients twitter']\n",
      "['btk inhibitor acalabrutinib', 'severe covid', 'case study', 'patients suggests']\n",
      "['estudio cl nico se ala acalabrutinib medicamento para combatir el c ncer inhibe reacci n inflamatoria descontrolada y mejora niveles', 'oxigenaci n', 'con covid', 'grave inhibition', 'bruton tyrosine kinase', 'severe covid']\n",
      "['con xito el acalabrutinib para pacientes', 'con coronavirus']\n",
      "['buena noticia para pacientes', 'coronavirus graves prueban', 'con xito f rmaco acalabrutinib']\n",
      "['buena noticia para pacientes', 'coronavirus graves prueban', 'con xito un f rmaco acalabrutinib']\n",
      "['buena noticia para pacientes', 'coronavirus graves prueban', 'con xito un f rmaco acalabrutinib']\n",
      "['encuentran prote na clave que causa', 'inflamaci n', 'mortal del coronavirus news suite']\n",
      "['si se salva alguna vida bienvenida sea', 'news aun hoy sigo creyendo', 'comunidad cientifica medica', 'acalabrutinib este y', 'sea otro fake para amasar money']\n",
      "['acalabrutinib covid']\n",
      "[]\n",
      "['case study', 'patients suggests', 'btk inhibitor acalabrutinib', 'severe covid19 medicine science coronavirus pandemic publichealth']\n",
      "['acalabrutinib ald ktan sonraki', 'g n i inde tamamlay c oksijen grubundaki hastalar n o unda iltihaplanmada belirgin bir d vard ve nefes almada d zelme oldu']\n",
      "['news i']\n",
      "['btk inhibitor acalabrutinib', 'severe covid', 'case study', 'patients suggests']\n",
      "['small study', 'btk inhibitor', 'lymphoma drug', 'promising results covid19 infectiousdisease pharmacyandpharmacology researchanddevelopment']\n",
      "['calquence calavi']\n",
      "['encuentran prote na clave que causa', 'inflamaci n', 'mortal del coronavirus']\n",
      "['m dicos', 'estados unidos dieron', 'con un f rmaco capaz', 'combatir y vencer las formas m s graves', 'covid19 covid19']\n",
      "['con xito el acalabrutinib para pacientes', 'con coronavirus']\n",
      "['con xito el acalabrutinib para pacientes', 'con coronavirus']\n",
      "['buena noticia para pacientes', 'coronavirus graves prueban', 'con xito un f rmaco ya existente el acalabrutinib']\n",
      "['con xito el acalabrutinib para pacientes', 'con coronavirus']\n",
      "['con xito el acalabrutinib para pacientes', 'con coronavirus']\n",
      "['buena noticia para pacientes', 'coronavirus graves prueban', 'con xito un f rmaco ya existente el acalabrutinib']\n",
      "['buena noticia para pacientes', 'coronavirus graves prueban', 'con xito un f rmaco ya existente el acalabrutinib']\n",
      "['buena noticia para pacientes', 'coronavirus graves prueban', 'con xito un f rmaco ya existente el acalabrutinib']\n",
      "['el estudio fue desarrollado para probar si el bloqueo', 'prote na btk', 'con acalabrutinib reducir', 'inflamaci n y mejorar', 'el resultado cl nico para pacientes hospitalizados', 'con covid', 'estado cr tico']\n",
      "['un medicamento que se usa actualmente para tratar pacientes', 'con linfoma c ncer', 'las c lulas sangu neas puede ser efectivo para ayudar', 'los pacientes', 'con covid', 'con formas m s agudas', 'enfermedad calquence producido por astrazeneca']\n",
      "['acalabrutinib el nuevo medicamento que salvar', 'personas contagiadas']\n",
      "['resultados inesperados', 'experimentaci n el producto es bienvenido benjam n n ez vega', 'administraron acalabrutinib un f rmaco', 'astrazeneca especialmente dise ado para bloquear', 'btk y aprobado para el tratamiento', 'algunos c nceres']\n",
      "['cytokine storm btk inhibitor acalabrutinib shows']\n",
      "['new drug', 'coca cola', 'cure coronavirus patients']\n",
      "['acalabrutinib f rmaco para bloquear', 'btk tirosina kinasa', 'bruton y aprobado para el tratamiento', 'algunos c nceres y aplicado', 'pacientes covid19', 'con buenos resultados', 'ellos disminuyendo', 'citoquinas ocasionada']\n",
      "['una esperanza para los pacientes', 'estado cr tico probaron', 'con xito un f rmaco ya existenteel uso del acalabrutinib usado contra el c ncer logr combatir', 'con xito', 'estados avanzados noticias710']\n",
      "['eeuu investigadores observaron que el uso del medicamento acalabrutinib un f rmaco usado', 'el tratamiento', 'varios tipos', 'c ncer', 'sangre proporcion beneficios cl nicos', 'los pacientes cr ticos por covid19']\n",
      "['eeuu investigadores observaron que el uso del medicamento acalabrutinib un f rmaco usado', 'el tratamiento', 'varios tipos', 'c ncer', 'sangre proporcion beneficios cl nicos', 'los pacientes cr ticos por covid19']\n",
      "['eeuu investigadores observaron que el uso del medicamento acalabrutinib un f rmaco usado', 'el tratamiento', 'varios tipos', 'c ncer', 'sangre proporcion beneficios cl nicos', 'los pacientes cr ticos por covid19']\n",
      "['estadosunidos investigadores observaron que el uso del medicamento acalabrutinib un f rmaco usado', 'el tratamiento', 'varios tipos', 'c ncer', 'sangre proporcion beneficios cl nicos', 'los pacientes cr ticos por covid19 n4v']\n",
      "['el uso del acalabrutinib usado contra el c ncer logr combatir', 'con xito', 'estados avanzados el remedio inhibe una prote na covid']\n",
      "['una esperanza para los pacientes', 'estado cr tico probaron', 'con xito un f rmaco ya existente acalabrutinib']\n",
      "['que administra acalabrutinib iniciar ensayos cl nicos', 'los pa ses m s afectados por', 'epidemia entre ellos chile qu dateencasa qu dateenradio']\n",
      "['f rmaco acalabrutinib']\n",
      "['favorite soft drink', 'chemical solvent', 'promising preliminary findings', 'critical covid19 patients']\n",
      "['una noticia referente', 'este medicamento acalabrutinib', 'se si lo', 'comentado o sabes algo gracias y un saludo']\n",
      "['reduces inflammation', 'oxidation article btk inhibitor acalabrutinib shows']\n",
      "[]\n",
      "[]\n",
      "['ese nombre por si acaso']\n",
      "['new drug', 'coca cola', 'cure coronavirus patients smartnews']\n",
      "[]\n",
      "['el f rmaco acalabrutinib un inhibidor que controla', 'inflamaci n mejora', 'oxigenaci n', 'los pacientes', 'un plazo', 'sin toxicidad perceptible']\n",
      "['cancer drug acalabrutinib shows potential', 'respiratory distress phillyvoice']\n",
      "['calquence acalabrutinib un f rmaco anticanceroso', 'especialmente dise ado para bloquear', 'proteinabtk interruptor', 'central que regula toda', 'citoquinas que provoca el coronavirus']\n",
      "[]\n",
      "[]\n",
      "['el acalabrutinib un inhibidor', 'enzima tirosina quinasa', 'con covid19', 'grave mejora su capacidad', 'oxigenaci n y', 'inflamaci n sin mostrar efectos t xicos', 'un hilo un']\n",
      "['prote na clave que causa una inflamaci n', 'covid19 y primeros resultados', 'con acalabrutinib para luchar contra']\n",
      "[]\n",
      "[]\n",
      "['new drug', 'coca cola', 'cure coronavirus patients bgr covid19']\n",
      "[]\n",
      "[]\n",
      "['new drug', 'coca cola', 'cure coronavirus patients']\n",
      "['estudios observacionales', 'acalabrutinib contra covid19 nota', 'para clar n sociedad', 'opini n']\n",
      "['new drug', 'cure coronavirus patients beverages']\n",
      "['early data show potential benefit', 'severe covid']\n",
      "['wow calquence', 'moderate non', 'ok i wonder', 'new drug', 'coca cola', 'cure coronavirus patients']\n",
      "['u gt', 'new drug', 'coca cola', 'cure coronavirus patients']\n",
      "['astrazeneca s blood cancer drug calquence']\n",
      "['astrazeneca s blood cancer drug calquence']\n",
      "['btk inhibitor acalabrutinib shows']\n",
      "['astrazeneca s blood cancer drug calquence']\n",
      "['new drug', 'coca cola', 'cure coronavirus patients bgr']\n",
      "['new drug', 'coca cola', 'cure coronavirus patients']\n",
      "['present data', 'label use btk inhib acalabrutinib', 'sarscov2 covid19', 'great story', 'amazing oxygen response', 'cytokines crp amp lymphocyte']\n",
      "['coca cola', 'cure coronavirus patients', 's awesome']\n",
      "[]\n",
      "['parody article', 'new drug', 'coca cola', 'cure coronavirus patients bgr']\n",
      "['new drug', 'coca cola', 'cure coronavirus patients']\n",
      "['r r cll', 'btki naive']\n",
      "['dr nicole lamanna dr jan burger dr javier', 'pinilla ibarz discusses', 'ascend acalabrutinib trial', 'r r cll']\n",
      "['new drug', 'coca cola', 'cure coronavirus patients']\n",
      "['new drug', 'coca cola', 'cure coronavirus patients']\n",
      "['new drug', 'coca cola', 'cure coronavirus patients']\n",
      "['new drug', 'coca cola', 'cure coronavirus patients']\n",
      "['acalabrutinib versus investigator s choice therapy', 'chronic lymphocytic leukemia', 'ascend trial cll leusm jco']\n",
      "['possible treatment calquence', 'research needs', 'blood cancer']\n",
      "['el f rmaco acalabrutinib aprobado por', 'fda para el tratamiento', 'varios tipos', 'c ncer', 'linfocitos b mejor los niveles', 'oxigenaci n y disminuy los marcadores moleculares', 'inflamaci n', 'mayor parte', 'una muestra']\n",
      "['btk inhibitor acalabrutinib shows']\n",
      "['l anticanc reux acalabrutinib semble d int r t dans', 's v re donn es non randomis es inhibiteur', 'tyrosine kinase', 'bruton btk science immunology']\n",
      "['se trata del medicamento calquence aprobado para tratar el linfoma y que pertenece', 'una clase conocida como inhibidores', 'btk comenta y rt']\n",
      "['btk inhibitor acalabrutinib shows']\n",
      "['astrazeneca s calquence shows', 'promising clinical improvement']\n",
      "['calquence acalabrutinib', 'bruton s tyrosine kinase btk inhibitor', 'clinical outcomes', 'coronavirus patients', 'severe covid19 disease', 'new study', 'science immunology']\n",
      "['btk inhibitor acalabrutinib shows']\n",
      "['btk inhibitor acalabrutinib shows']\n",
      "['acalabrutinib showcases', 'long term tolerability', 'b cell malignancies']\n",
      "['se trata del medicamento calquence aprobado para tratar el linfoma y que pertenece', 'una clase conocida como inhibidores']\n",
      "['btk inhibitor acalabrutinib shows', 'trav s']\n",
      "['blood cancers', 'respiratory distress', 'small group', 'national cancer institute']\n",
      "['btk inhibitor acalabrutinib shows']\n",
      "['acalabrutinib showcases', 'long term tolerability', 'b cell malignancies']\n",
      "['btk inhibitor acalabrutinib shows']\n",
      "[]\n",
      "['cancer drug', 'rapid improvements', 'cancer drug acalabrutinib calquence']\n",
      "['long term data', 'acalabrutinib calquence', 'treatment na ve chronic lymphocytic leukemia']\n",
      "['rapid improvements', 'cancer drug acalabrutinib calquence', 'oncology network', 'network results', 'exploratory research']\n",
      "['acalabrutinib showcases', 'long term tolerability', 'b cell malignancies']\n",
      "['early data', 'clinical study', 'bruton tyrosine kinase btk protein', 'cancer drug acalabrutinib', 'clinical benefit', 'small group', 'severe covid']\n",
      "['small study', 'btk inhibitor', 'lymphoma drug', 'promising results covid19 infectiousdisease pharmacyandpharmacology researchanddevelopment']\n",
      "['promising clinical improvement', 'covid 19patients mednews']\n",
      "['l acalabrutinib serait b n fique', 'les patients gravement atteints un m dicament contre', 'aider des malades', 'covid jdq']\n",
      "['recent study', 'clinical outcomes', 'severe covid', 'selective btk inhibitor']\n",
      "['astrazeneca s blood cancer drug calquence', 'patients epidemiology medtwitter']\n",
      "['astrazeneca s calquence shows']\n",
      "['new analysis shows', 'bruton s tyrosine kinase btk inhibitor calquence acalabrutinib', 'clinical outcomes', 'severe covid', 'disease astrazeneca covi']\n",
      "['marketwatch astrazeneca s calquence shows', 'oxygen requirements', 'patients covid19 covid19vaccine vaccines']\n",
      "['acalabrutinib blocks', 'bruton tyrosine kinase btk protein', 'blood cancers', 'comments kawasaki']\n",
      "['jco acalabrutinib']\n",
      "['clinical improvement']\n",
      "['cancer drug shows potential', 'respiratory distress']\n",
      "['recent study', 'preliminary basis']\n",
      "['various drugs', 'symptomatic relief', 'cancer drug acalabrutinib', 'british swedish pharmaceutical company astrazeneca']\n",
      "['scrabble du jour acalabrutinib elle d sactive', 'tyrosine kinase', 'bruton btk qui fait des siennes avec', 'cytokine j esp re qu il vous reste des lettres']\n",
      "['astrazeneca s cancer drug acalabrutinib', 'inflammation firstpost']\n",
      "[]\n",
      "['big pharma', 'impressive slate', 'new drugs', 'strong high single', 'low double digit product sales growth', 'new launches tagrisso imfinzi lynparza fasenra faxiga calquence roxadustat', 'big pharma imho chart']\n",
      "['acalabrutinib targets', 'clinical improvement']\n",
      "['label use', 'cancer drug acalabrutinib', 'btk inhibitor', 'blood cancers', 'respiratory distress', 'overactive immune response']\n",
      "['astrazeneca s calquence shows', 'positive effect', 'covid patients']\n",
      "['selective btk inhibitor', 'severe covid', 'supplemental oxygen', 'mechanical ventilation', 'oxygen requirements']\n",
      "['l acalabrutinib serait b n fique', 'les patients gravement atteints']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['l acalabrutinib serait b n fique', 'les patients gravement atteints']\n",
      "['bruton tyrosine kinase btk protein', 'cancer drug acalabrutinib', 'clinical benefit', 'small group', 'severe covid']\n",
      "['favipiravir acalabrutinib', 'gente que busca tratamiento para el covid', 'escuch demasiado', 'las ketchup']\n",
      "['astrazeneca s calquence shows', 'coronavirus treatment']\n",
      "['el acalabrutinib muestra una mejora r pida', 'un peque o grupo', 'con covid', 'grave estudio seg n los hallazgos del estudio publicados', 'science immunology referencia fuente science immunology']\n",
      "['results support acalabrutinib calquence use', 'upfront cll', 'dr john c byrd']\n",
      "['btk inhibitor', 'covid19 patients acalabrutinib wikipedia']\n",
      "['un tratamiento contra el c ncer podr', 'ser til', 'casos severos', 'coronavirus el acalabrutinib fue probado', 'con buenos resultados', 'pacientes advierten que faltan estudios m s completos y que es muy caro']\n",
      "['acalabrutinib shows', 'rapid improvement', 'small group', 'severe covid']\n",
      "['acalabrutinib shows', 'rapid improvement', 'small group', 'severe covid']\n",
      "['stages drugs', 'cost considerations i', 'venture agents', 'curcumin andrographis']\n",
      "['acalabrutinib shows', 'rapid improvement', 'small group', 'severe covid', 'btkinhibitor covid19 btk inhib fenebrutinib didnt work']\n",
      "['astrazeneca s blood cancer drug calquence']\n",
      "['acalabrutinib shows', 'rapid improvement', 'small group', 'severe covid']\n",
      "['acalabrutinib shows', 'rapid improvement', 'small group', 'severe covid']\n",
      "['potential cytokine storm treatment', 'severe covid', 'respiratory distress', 'bruton tyrosine kinase btk inhibitor']\n",
      "['astrazeneca reports results', 'calquence acalabrutinib', 'calavi study', 'patients shots', 'calavi program involves', 'calquence bsc vs bsc']\n",
      "['blood cancers', 'respiratory distress', 'small group', 'national cancer institute']\n",
      "['astrazeneca s blood cancer drug calquence']\n",
      "['astrazeneca s cancer drug acalabrutinib']\n",
      "['study reports', 'promising covid', 'az s calquence']\n",
      "['az calquence shows']\n",
      "['bruton tyrosine kinase', 'severe covid19 acalabrutinib', 'severe covid', 'majority amp', 'discernable toxicity']\n",
      "['vidaysalud investigaciones recientes sugieren que el tratamiento', 'con acalabrutinib puede ser efectivo porque su objetivo del btk es hiperactivo', 'las c lulas inmunes graves covid19 conoce m s']\n",
      "['cancer drug shows potential', 'respiratory distress']\n",
      "['az calquence shows', 'pharmanews news']\n",
      "['azn calquence covid19']\n",
      "['con acalabrutinib rapido miglioramento dei sintomi di covid', 'grave studio su science immunology']\n",
      "['blood cancers', 'respiratory distress', 'small group', 'national cancer institute']\n",
      "['s blood cancer drug calquence shows potiential', 'stage covid19 patients']\n",
      "['public health cytokine storm acalabrutinib assists', 'study ont']\n",
      "['az calquence shows']\n",
      "['astrazeneca s calquence', 'small group']\n",
      "['coronavirus treatment covid19']\n",
      "['media availability', 'clinical study', 'small number', 'overactive immune response', 'respiratory distress', 'label cancerresearch']\n",
      "['positive data', 'case series', 'blood cancer drug calquence acalabrutinib', 'severe covid', 'laboratory markers', 'inflammation amp', 'clinical outcomes']\n",
      "['promising clinical improvement']\n",
      "['new study', 'cancer drug calquence acalabrutinib suggests', 'cytokine storm', 'patients w covid19', 'cocacola slurry']\n",
      "['astrazeneca s calquence', 'small group']\n",
      "['cancer drug acalabrutinib', 'severe forms', 'article image cc']\n",
      "['cytokine storm acalabrutinib assists']\n",
      "['astrazeneca s cancer drug acalabrutinib']\n",
      "['early rct data suggests', 'bruton tyrosine kinase', 'cancer drug acalabrutinib', 'severe covid', 'apparent toxicity coronavirus medicine hplovecraft newhaven']\n",
      "['promising clinical improvement']\n",
      "['immunomodulatory oncologic drugs', 'positive impact', 'severe infectious disease syndromes']\n",
      "['coronavirus astra pharm drug potential repurpose drug calquence', 'study calquence', 'supp oxygen', 'severe cases', 'forbes amp science immunology']\n",
      "['label use', 'cancer drug acalabrutinib', 'btk inhibitor', 'blood cancers', 'respiratory distress', 'overactive immune response']\n",
      "['cytokine storm acalabrutinib assists', 'study outbreak news']\n",
      "['respiratory distress', 'bruton tyrosine kinase btk inhibitor', 'days covid19cytokinestorm infectiousdiseases drugd']\n",
      "['az calquence shows']\n",
      "['awesomecapital astrazeneca s calquence shows', 'positive effect']\n",
      "['astrazeneca s cancer drug acalabrutinib']\n",
      "['astrazeneca azn calquence']\n",
      "['cytokine storm acalabrutinib assists']\n",
      "['astrazeneca reports results', 'calquence acalabrutinib', 'calavi study']\n",
      "['astrazeneca s btk inhibitor calquence shows', 'severe covid', 'patients pharmaceutical']\n",
      "['az calquence shows']\n",
      "['az calquence shows']\n",
      "['astrazeneca s calquence shows', 'positive effect', 'covid patients azn coronavirus covid2019']\n",
      "['covid19 patients']\n",
      "['azn astrazeneca s calquence shows', 'positive effect', 'covid patients']\n",
      "['complex event analysis', 'pst top news focus germany troops trump republican trump calquence covid']\n",
      "['covid19 patients', 'respiratory distress', 'bruton tyrosine kinase btk inhibitor', 'days clinicaltrials inflammation healthnews cv19']\n",
      "['forbestech astrazeneca s calquence', 'small group']\n",
      "['astrazeneca s btk inhibitor calquence shows', 'severe covid19 patients']\n",
      "['small study cytokine storm acalabrutinib assists']\n",
      "['researchhighlight acalabrutinib', 'cancer drug', 'inflammatory responses', 'details click']\n",
      "['complex event analysis', 'pst top news focus calquence covid', 'drug calquence covid', 'national cancer institute calquence covid']\n",
      "['der bruton kinase btk inhibitor acalabrutinib der zur behandlung bestimmter lymphome entwickelt wurde hat', 'einer offenen studie', 'science immunology den zytokinsturm bei patienten abgeschw cht', 'erkrankt waren']\n",
      "['astrazeneca s calquence', 'small group']\n",
      "['btk inhibitor zeigt klinische wirkung bei covid', 'bethesda der bruton kinase btk inhibitor acalabrutinib der zur behandlung bestimmter lymphome entwickelt wurde hat', 'einer offenen studie', 'studie covid19 biologika btkinhibitor']\n",
      "['az calquence shows']\n",
      "['jobs az calquence shows']\n",
      "['n calquence acalabrutinib']\n",
      "['cytokine storm', 'oxygenation levels', 'molecular markers']\n",
      "['astrazeneca s calquence improves outcomes']\n",
      "['bloodcancer acalabrutinib scienceimmunologyjournal corona coronavirus coronacure marathinews sakal sakalnews']\n",
      "['cll bloomberg calquence']\n",
      "['astrazeneca s calquence improves outcomes', 'trials arena']\n",
      "['study identifies potential approach', 'severe covid19', 'clinical study', 'bruton tyrosine kinase btk protein', 'cancer drug acalabrutinib', 'clinical benefit', 'small group']\n",
      "['ascend phase iii', 'acalabrutinib versus idelalisib', 'refractory chronic lymphocytic leukemia oncology']\n",
      "['el estudio aplic el medicamento contra el c ncer acalabrutinib', 'un grupo', 'con covid', 'grave obteniendo buenos resultados']\n",
      "[]\n",
      "['covid19 btk acalabrutinib', 'crp il6 nci']\n",
      "['massive immune response', 'severe covid', 'drug acalabrutinib fda', 'b cell cancers', 'oxygenation levels cytokine']\n",
      "['covid19 azn data', 'acalabrutinib calquence btk inhibitor usage', 'severe patients discharge rates', 'supplemental oxygen cohort amp', 'mech vent cohort', 'mech vents']\n",
      "['protein bruton tyrosine kinase btk', 'bruton protein patient']\n",
      "['btk inhibitor', 'blood cancers', 'respiratory distress', 'overactive immune response', 'btk journal blood']\n",
      "[]\n",
      "[]\n",
      "['uk hospitals', 'new drugs', 'coronavirus treatment', 'global medi3506']\n",
      "['cytokine storm acalabrutinib assists', 'study outbreak news']\n",
      "['cytokine storm acalabrutinib']\n",
      "['cytokine storm acalabrutinib assists']\n",
      "['drug acalabrutinib', 'oral drug', 'cytokine storm', 'macrophage activation']\n",
      "['cytokine storm', 'severe covid', 'patients study', 'drug acalabrutinib fda', 'b cell cancers', 'oxygenation levels']\n",
      "['antineoplastic drug acalabrutinib', 'covid 19with respiratory distress', 'potential approach', 'severe covid']\n",
      "['acalabrutinib zdravilo ki se uporablja za zdravljenje b celi nih limfomov je pokazalo dobre rezultate pri zdravljenju pacientov z resnim covid19 zdravilo inibira encim ki igra pomembno vlogo pri vnetju tako da je zmanj alo vnetje', 'potrebo po dodatnem kisiku za paciente']\n",
      "['astrazeneca s calquence', 'small group', 'coronavirus impact economy', 'market news source forbes']\n",
      "['inflamaci n excesiva', 'con un inhibidor', 'tirosina quinasa', 'bruton como el acalabrutinib puede ser una estrategia terap utica eficaz', 'con covid']\n",
      "['blood cancer drug calquence', 'astrazenca shows', 'positive signs', 'treatments health tips']\n",
      "['este medicamento puede calmar', 'con coronavirus estudio revela que el medicamento acalabrutinib aprobado por', 'fda puede calmar', 'con coronavirus']\n",
      "['chemotherapy pct', 'cancer stem cells', 'immune inhibitory receptors', 'metastatic cancers', 'pharmaceutical mixture', 'probiotic lactobacillus rhamnosus']\n",
      "['astrazeneca s calquence', 'small group']\n",
      "['astrazeneca s calquence', 'small group']\n",
      "['astrazeneca s blood cancer drug shows', 'covid19 calquence fe']\n",
      "['early data', 'clinical study', 'bruton tyrosine kinase btk protein', 'cancer drug acalabrutinib', 'clinical benefit', 'small group', 'severe covid']\n",
      "['astrazeneca s calquence', 'small group']\n",
      "['study shows', 'bruton tyrosine kinase btk inhibitor', 'severe respiratory distress']\n",
      "['interesting study', 'science immunology acalabrutinib selective btk inh', 'patients n', 'severe covid19', 'favorable results']\n",
      "['new drug', 'severe covid', 's hyperinflammatory immune response suggests macrophage activation acalabrutinib', 'bruton tyrosine kinase btk inhibitor decreases inflammation', 'improves oxygen levels', 'severe covid19']\n",
      "['acalabrutinib treatment', 'supplemental oxygen cohort', 'room air', 'mechanical ventilation cohort', 'room air']\n",
      "['cacncermedicinen acalabrutinib ser v ldigt lovande ut liten studie ingen kontrollgrupp men bra resultat amp', 'st rre studie ska nu g ras acalabrutinib modulerar immunf rsvaret']\n",
      "['acalabrutinib fda', 'cytokine storm']\n",
      "['mcl markets', 'interesting idea', 'certain moas', 'different disease areas', 'shouldn t', 'drug ideas', 'good data', 'cancer drug']\n",
      "['cancer drug tests nat l cancer institute', 'covid patients w', 'severe disease drug blocks', 'cell surface bruton tyrosine kinase btk', 'hyperinflammatory response cytokine storm']\n",
      "['study identifies potential approach', 'severe respiratory distress', 'covid19 inhibition', 'bruton tyrosinekinase', 'severe covid', 'btk acalabrutinib cytokinestorm']\n",
      "['astrazeneca s calquence', 'small group']\n",
      "['astrazeneca s calquence', 'small group']\n",
      "['reuters foto', 'archivo del logo', 'nueva york por ludwig burger fr ncfort', 'jun reuters el medicamento contra el c ncer calquence', 'astrazeneca lon']\n",
      "['calquence medicamento contra el c ncer', 'mostrado indicios', 'que puede ayudar', 'los pacientes hospitalizados por covid']\n",
      "['trial design', 'calavi acalabrutinib', 'clinical trial', 'severe covid19']\n",
      "['el medicamento contra el c ncer leucemia calquence', 'empresa farmac utica astrazeneca', 'mostrado indicios', 'que puede ayudar', 'los pacientes hospitalizados', 'con covid', 'superar lo peor', 'para m s informaci n visitanos']\n",
      "['l acalabrutinib inhibiteur s lectif', 'btk donne des r sultats spectaculaires sur des patients covid', 'sous oxyg ne']\n",
      "['nuevo estudio sugiere que el medicamento acalabrutinib aprobado por fda se usa para tratar varios tipos', 'c ncer', 'c lulas b puede ayudar', 'disminuir el proceso inflamatorio mejor conocido como tormenta', 'cotocinas producido', 'con cuadros severos por sarscov2']\n",
      "['early data', 'brutontyrosinekinase btk protein', 'small group', 'severecovid19 covid19 acalabrutinib covid19treatment acuterespiratorydistresssyndrome ards']\n",
      "['agent acalabrutinib', 'chronic lymphocytic leukemia leusm cancer saturdaythoughts']\n",
      "['astrazeneca s cancer drug calquence', 'initial signs', 'day funops funopspakistan coronavirus pakistan']\n",
      "['small number', 'covid19 patients', 'cancer drug', 'respiratory distress', 'overactive immune response', 'patients thanks']\n",
      "['sick covid', 'supplemental oxygen', 'blood cancer drug']\n",
      "['covid19 i btk inhibitors', 'target pathological monocyte macrophage activation amp dampen cytokinestorm', 'sars cov', 'infection acalabrutinib ibrutinib lymphoma cll']\n",
      "['study identifies potential approach', 'severe respiratory distress', 'covid19 covid19research coronavirusresponse covid19treatment coronavirustreatment']\n",
      "['oral medication', 'immunological storm']\n",
      "['target btk', 'severe covid', 'immune cells']\n",
      "['treatment option', 'severe covid', 'cancer drug acalabrutinib btk inhibitor', 'blood cancers']\n",
      "['cancer drug acalabrutinib', 'respiratory distress', 'covid19 patients', 'health healthcare healthylifestyle healthylife covid', 'coronavirus coronavid19 covid19pandemic coronavirusoutbreak coronalockdown covid2019']\n",
      "['early events', 'label use', 'acalabrutinib btk inhibitor drug', 'covid19 pneumonia']\n",
      "['astrazeneca blood cancer drug shows signs', 'patients health news', 'healthworld reuters stefan wermuth file photo', 'ludwig burger frankfurt astrazeneca s cancer drug calquence']\n",
      "['estudio revela que el medicamento acalabrutinib aprobado por', 'fda puede calmar', 'con coronavirus noticias tendenciastech']\n",
      "['day treatment course acalabrutinib', 'discernable toxicity']\n",
      "['cancer drug acalabrutinib', 'protein bruton tyrosine kinase btk', 'covid19 patients', 'clinical benefit']\n",
      "['astrazeneca s blood cancer drug calquence shows', 'initial signs', 'patients business journal']\n",
      "['coronavirus astrazeneca s blood cancer drug calquence shows', 'initial signs']\n",
      "['acalabrutinib efficace', 'il trattamento di gravi difficolt respiratorie']\n",
      "['severe covid', 'btk protein', 'target btk', 'severe covid', 'immune cells']\n",
      "['covid19 use', 'btk inhibitor ca drug acalabrutinib', 'blood ca', 'respiratory distress amp', 'overactive immune response', 'supplemental oxygen']\n",
      "['acalabrutinib dosis', 'mg por v', 'oral dos veces', 'con ox geno suplementario y', 'con ventilaci n mec nica']\n",
      "['calquence medicamento contra el c ncer puede ayudar', 'con covid']\n",
      "['calquence medicamento contra el c ncer puede ayudar', 'con covid']\n",
      "['promising clinical improvement', 'patients results', 'science immunology', 'calquence acalabrutinib', 'bruton s tyrosine kinase btk inhibitor']\n",
      "['btk acalabrutinib az nf b il il']\n",
      "['promising clinical improvement']\n",
      "['calquence medicamento contra el c ncer puede ayudar', 'con covid']\n",
      "['el medicamento contra el c ncer calquence', 'mostrado indicios', 'que puede ayudar', 'los pacientes hospitalizados', 'con covid', 'superar lo peor']\n",
      "['astrazeneca s calquence', 'small group', 'patients gt gt gt strategy competitiveintelligence', 'biotech pharma pharmaceutical']\n",
      "['bruton tyrosine kinase btk inhibitor acalabrutinib']\n",
      "['farmac utica brit nica tienen el respaldo', 'institutos nacionales', 'estados unidos']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['interesting hypothesis', 'interest disagree', 'abstract acalabrutinib', 'control group', 'w support']\n",
      "[]\n",
      "['astrazeneca s calquence', 'small group']\n",
      "['btk inhibitor reduces cytokine storm']\n",
      "['cov19 researchers', 'label use', 'cancer drug acalabrutinib', 'btk inhibitor', 'blood cancers', 'respiratory distress amp', 'overactive immune response']\n",
      "['promising clinical improvement']\n",
      "[]\n",
      "['promising clinical improvement']\n",
      "['acalabrutinib kan vara v rd att l gga p minnet nu n r det blir tydligare att den kritiska sjukdomen r kardiovaskul r s kommer flera nya approacher till l kemedel bra']\n",
      "['el medicamento contra el c ncer calquence', 'mostr indicios', 'que puede ayudar', 'pacientes hospitalizados', 'con covid19', 'superar lo peor']\n",
      "['promising clinical improvement']\n",
      "['science inhibition', 'bruton tyrosine kinase', 'severe covid', 'day treatment course acalabrutinib']\n",
      "['prospective study', 'severe covid19 highlights', 'potential benefit', 'btk inhibitor acalabrutinib', 'clinical trial']\n",
      "['acalabrutinib selective bruton tyrosine kinase']\n",
      "['internacional el medicamento contra el c ncer calquence', 'mostrado indicios', 'que puede ayudar', 'los pacientes hospitalizados', 'con covid', 'superar lo peor', 'que los investigadores se esfuerzan por readaptar los tratamientos']\n",
      "['astrazeneca s calquence', 'small group']\n",
      "['astrazeneca s calquence', 'small group', 'patients health pharma']\n",
      "['estudio revela que el medicamento acalabrutinib aprobado por', 'fda puede calmar', 'con coronavirus']\n",
      "['toma eso coronavirus el medicamento calquence', 'mostrado indicios', 'que puede ayudar', 'los pacientes hospitalizados', 'con covid19', 'superar lo peor']\n",
      "['edninforma el medicamento contra el c ncer calquence', 'mostrado indicios', 'que puede ayudar', 'los pacientes hospitalizados', 'con covid', 'superar lo peor', 'enfermedad edntv medicamento astrazeneca pacientes hospitalizados covid19 enfermedad']\n",
      "['science immunology bruton tyrosine kinase btk acalabrutinib il']\n",
      "['astrazeneca s calquence', 'small group']\n",
      "['astrazeneca s calquence', 'small group']\n",
      "['astrazeneca s calquence', 'small group']\n",
      "['acalabrutinib scheint bei schweren pulmonalen covid', 'erkrankungen hilfreich inhibition', 'bruton tyrosine kinase', 'severe covid']\n",
      "['study identifies potential approach', 'severe respiratory distress', 'covid19 coronavirus']\n",
      "['study identifies potential approach', 'severe respiratory distress']\n",
      "['promising clinical improvement']\n",
      "['astrazeneca s calquence shows', 'rapid improvement', 'small group', 'severe covid']\n",
      "['late covid', 'actemra tocilizumab']\n",
      "['major cytokine', 'severe covid', 'btk inhibitor counts']\n",
      "['azn news calquence', 'promising clinical improvement', 'covid19 patients', 'global trials aim', 'findings btkinhibitor inflammation singlestocketps']\n",
      "['cytokine storm', 'drug acalabrutinib fda', 'b cell cancers', 'oxygenation levels', 'molecular markers health']\n",
      "['astra zeneca uppger sig', 'uppn tt lovande kliniska f rb ttringar f r flertalet av', 'patienter som behandlats', 'blodcancerl kemedlet calquence']\n",
      "['astra zenecas kliniska studie', 'l kemedlet calquence hos', 'stycken covid', 'patienter visade lovande resultat enligt ett pressmeddelande']\n",
      "['early data', 'potential approach', 'severe covid']\n",
      "['calquence acalabrutinib', 'btk inhibitor deoxygenation', 'hyperinflammatory immune responses', 'covid19 patients covid coronavirus covid', 'pandemic quarantine quaratinelife covid', 'covid2019 coronavirusfacts']\n",
      "['early data', 'potential approach', 'severe covid']\n",
      "['new option', 'cytokine storm', 'severe covid', 'cytokinestorm acalabrutinib covid19 coronavirus covid19 corona']\n",
      "['label observational study suggests', 'drug acalabrutinib', 'b cell cancers', 'hyperinflammatory cytokinestorm immune response', 'severe cases']\n",
      "['s cancer drug calquence', 'initial signs', 'covid19 patients']\n",
      "['blood cancer drug', 'small study', 'good news']\n",
      "['covid patients', 'azn results', 'science immunology', 'clinical outcomes', 'severe covid']\n",
      "['promising clinical improvement']\n",
      "['acalabrutinib fda', 'b cell cancers', 'oxygenation levels', 'molecular markers', 'severe covid19']\n",
      "['clinical advice', 'public health response', 'early data', 'potential approach', 'severe covid']\n",
      "['blood cancer drug shows', 'severe cases']\n",
      "['astrazeneca anuncia que calquence un medicamento para tratar el c ncer muestra signos', 'covid19 hospitalizados reuters azn']\n",
      "['astrazeneca s cancer drug calquence shows', 'initial signs']\n",
      "['initial signs']\n",
      "['azn june', 'reuters astrazeneca s azn l cancer drug calquence', 'initial signs']\n",
      "['astrazeneca s calquence', 'small group']\n",
      "[]\n",
      "['label observational study suggests', 'drug acalabrutinib', 'b cell cancers', 'hyperinflammatory cytokinestorm immune response', 'severe cases']\n",
      "['astrazeneca s cancer drug calquence', 'initial signs', 'patients rtrs']\n",
      "['astrazeneca s calquence shows signs', 'patients reuters', 'azn show', 'items gt gt']\n",
      "['astrazeneca s calquence', 'small group']\n",
      "['astrazeneca s cancer drug calquence', 'initial signs', 'patients rtrs pump', 'spy qqq']\n",
      "['astrazeneca s cancer drug calquence', 'initial signs', 'patients rtrs']\n",
      "['astrazeneca s cancer drug calquence shows', 'initial signs', 'patients azn']\n",
      "['astrazeneca s cancer drug calquence', 'initial signs', 'patients rtrs']\n",
      "['astrazeneca s cancer drug calquence', 'initial signs', 'patients rtrs']\n",
      "['astrazeneca s cancer drug calquence', 'initial signs', 'patients rtrs']\n",
      "['astrazeneca s cancer drug calquence', 'initial signs', 'patients rtrs']\n",
      "['un nuevo estudio', 'observaci n', 'etiqueta sugiere que el medicamento acalabrutinib aprobado por', 'fda puede ayudar', 'respuesta inmunitaria', 'citocinas hiperinflamatorias asociada', 'con casos graves']\n",
      "['friday lymphoma lunch', 'richters transformation', 'new data', 'vr epoch data', 'acalabrutinib study lymsm cllsm']\n",
      "['acalabrutinib calquence mantlecelllymphona chronic lymphocytic leukaemia']\n",
      "['visita el post', 'facebook el acalabrutinib se usa para tratar linfoma', 'c lulas del manto mcl un c ncer', 'crecimiento r pido que empieza', 'las c lulas del sistema inmune que ya', 'sido tratado', 'menos otro medicamento', 'quimioterapia el aca']\n",
      "['asco20 study', 'agent acalabrutinib', 'chronic lymphocytic leukemia leusm cancer ascendstudy']\n",
      "['leukemia reports', 'acalabrutinib monotherapy', 'refractory mantle cell lymphoma mcl']\n",
      "['phase iii ascend trial', 'acceptable safety profile', 'r r cll leusm hemeonc']\n",
      "['acerta pharma maker', 'btk inhibitors', 'allergen anaphylaxis']\n",
      "['phase iii', 'acalabrutinib versus idelalisib', 'r r chronic lymphocytic leukemia cll']\n",
      "['generation bruton tyrosine kinase btk inhibitor', 'cll patients']\n",
      "['uk hospitals', 'sarscov2 treatment trial', 'heparin bemcentinib medi3506 acalabrutinib zilucoplan']\n",
      "['uk hospitals', 'new drugs', 'coronavirus treatment', 'heparin bemcentinib medi3506 acalabrutinib zilucoplan covid19 accord2']\n",
      "['new drugs', 'severe covid19', 'heparin i', 'calquence bemcentinib medi3506 zilucoplan']\n",
      "['new drugs', 'heparin bemcentinib medi3506 calquence zilucoplan safety']\n",
      "['asco20 study', 'agent acalabrutinib', 'chronic lymphocytic leukemia leusm cancer ascendstudy']\n",
      "['co19 remdesivir hydroxychloroquin chloroquine azithromycin convalescent plasma actemra tocilizumab calquence acalabrutinib xeljanz tofacitinib jakafi ruxolitinib olumiant baricitinib kineret']\n",
      "['dr richard furman', 'asco20 safety', 'acalabrutinib monotherapy', 'hematologic malignancies', 'clinical trials abstract']\n",
      "['poster safety', 'acalabrutinib monotherapy', 'hematologic malignancies', 'clinical trials virtual asco20 runs']\n",
      "['poster acalabrutinib', 'treatment na ve cll', 'mature results', 'phii study', 'durable remissions amp', 'long term tolerability virtual asco20 runs']\n",
      "['ascend phase iii', 'acalabrutinib versus idelalisib', 'refractory chronic lymphocytic leukemia thewiderwiserview']\n",
      "['cll update ibrutinib', 'refractory cll median f u', 'remissions acalabrutinib w', 'side effect profile', 'unknown pathophys asco20 cll']\n",
      "['congress asco20 ascend trial', 'final results', 'paolo ghia', 'r r cll lymsm']\n",
      "['ascend phase iii', 'acalabrutinib versus idelalisib', 'refractory chronic lymphocytic leukemia cll']\n",
      "['novel vs novel agent trial', 'clear pfs benefit', 'idela r', 'r r cll lymsm ascend phase iii', 'acalabrutinib vs idelalisib r', 'r r cll']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll asco20']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll asco20']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll asco20']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll asco20']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll asco20']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil asco20']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil asco20']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil asco20']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil asco20']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil asco20']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil asco20']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil asco20']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil asco20']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil asco20']\n",
      "['chronic lymphocytic leukemia cll patients 1l calquence obinutuzumab', 'relative risk reduction hr', 'p lt', 'disease progression', 'death vs gcib obinutuzumab chlorambucil asco20']\n",
      "['oral treatment option', 'adult patients', 'chronic lymphocytic leukemia cll asco20']\n",
      "['oral treatment option', 'adult patients', 'chronic lymphocytic leukemia cll asco20']\n",
      "['oral treatment option', 'adult patients', 'chronic lymphocytic leukemia cll asco20']\n",
      "['oral treatment option', 'adult patients', 'chronic lymphocytic leukemia cll asco20']\n",
      "['oral treatment option', 'adult patients', 'chronic lymphocytic leukemia cll asco20']\n",
      "['ascend phase iii', 'acalabrutinib versus idelalisib', 'refractory chronic lymphocytic leukemia']\n",
      "['new article ascend phase iii', 'acalabrutinib versus idelalisib', 'refractory chronic lymphocytic leukemia cll leusm hematology']\n",
      "[]\n",
      "['ascend phase iii', 'acalabrutinib versus idelalisib', 'refractory chronic lymphocytic leukemia']\n",
      "['new clinical trial acalabrutinib lenalidomide', 'positive stage iii iv grade', '3a follicular lymphoma fl lymsm hematology']\n",
      "['acalabrutinib post blood', 'marrow transplantation', 'mantle cell lymphoma status', 'condition summary mantle cell lymphoma']\n",
      "['clinicaltrial treatment', 'acalabrutinib post blood', 'marrow transplantation', 'mantle cell lymphoma']\n",
      "['new clinical trial treatment', 'acalabrutinib post blood', 'marrow transplantation', 'mantle cell lymphoma mcl lymsm hematology']\n",
      "[]\n",
      "['chronic lymphocytic leukaemia cll', 'd gain access', 'therapy bloodcancer targetedtherapy']\n",
      "['expert review', 'clinical pharmacology', 'dr jurczak', 'novel btk inhibitor acalabrutinib', 'clinical applications', 'refractory mantle cell lymphoma']\n",
      "['oral treatment option', 'adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll asco20']\n",
      "['calquence un traitement efficace contre les chocs cytokiniques']\n",
      "['mantle cell lymphoma mcl', 'adult patients', 'therapy asco20']\n",
      "['mantle cell lymphoma mcl', 'adult patients', 'therapy asco20']\n",
      "['mantle cell lymphoma mcl', 'adult patients', 'therapy asco20']\n",
      "['mantle cell lymphoma mcl', 'adult patients', 'therapy asco20']\n",
      "['mantle cell lymphoma mcl', 'adult patients', 'therapy asco20']\n",
      "['mantle cell lymphoma mcl', 'adult patients', 'therapy asco20']\n",
      "['mantle cell lymphoma mcl', 'adult patients', 'therapy asco20']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['mantle cell lymphoma mcl', 'adult patients', 'therapy asco20']\n",
      "['mantle cell lymphoma mcl', 'adult patients', 'therapy asco20']\n",
      "['mantle cell lymphoma mcl', 'adult patients', 'therapy asco20']\n",
      "['mantle cell lymphoma mcl', 'adult patients', 'therapy asco20']\n",
      "['mantle cell lymphoma mcl', 'adult patients', 'therapy asco20']\n",
      "['mantle cell lymphoma mcl', 'adult patients', 'therapy asco20']\n",
      "['mantle cell lymphoma mcl', 'adult patients', 'therapy asco20']\n",
      "['mantle cell lymphoma mcl', 'adult patients', 'therapy asco20']\n",
      "['treatment option', 'mantle cell lymphoma mcl', 'adult patients', 'therapy asco20']\n",
      "['treatment option', 'mantle cell lymphoma mcl', 'adult patients', 'therapy asco20']\n",
      "['treatment option', 'mantle cell lymphoma mcl', 'adult patients', 'therapy asco20']\n",
      "['treatment option', 'mantle cell lymphoma mcl', 'adult patients', 'therapy asco20']\n",
      "['treatment option', 'mantle cell lymphoma mcl', 'adult patients', 'therapy asco20']\n",
      "['calquence un traitement efficace contre les chocs cytokiniques']\n",
      "['elevate tn interim analysis acalabrutinib', 'effective chemo', 'free option', 'chronic lymphocytic leukemia cll sharman lymsm']\n",
      "['acalabrutinib study', 'supportive care versus', 'supportive care', 'condition covid', 'intervention drug acalabrutinib sponsors coronavirus sars cov']\n",
      "['depth evaluation', 'mantle cell lymphoma']\n",
      "['phase ii trial', 'r r cll', 'sll results', 'long term', 'promising lymsm']\n",
      "['acalabrutinib study', 'supportive care versus', 'supportive care', 'calavi calquence', 'virus condition covid', 'intervention coronavirus sars cov']\n",
      "[]\n",
      "['announces calavi trial ace id', 'matthew fowler caxtx ccc19 2019ncov covid19clinicaltrials nct04346199 az press release']\n",
      "['marisol urbieta astrazeneca nous allons tester acalabrutinib dans', 'd tresse respiratoire covid']\n",
      "['cll cllsm']\n",
      "['acalabrutinib trial', 'severe covid19', 'btk inhibitors increase', 'fungal infection', 'immunosuppressive effect', 'jak il6']\n",
      "['ce soir marisol urbieta directrice m dicale oncologie france chez astrazeneca nous explique que l acalabrutinib va tre test', 'traitement des temp tes', 'cytokines dans', 'lutte contre', 'sras cov', 'pharma nicolas viudez astrazeneca']\n",
      "['frenchnewtech covid', 'nous allons tester acalabrutinib dans', 'd tresse respiratoire industrie pharma actus']\n",
      "['effective treatment option', 'refractory chronic lymphocytic leukemia']\n",
      "['baml azn oncology feedback po', 'kingdom tagrisso adjuvant dfs', 'solid debates os amp safety', 'sizeable op', 'bullish lynparza', '1l ovarian', 'imminent calquence uptake', 'outstanding safety']\n",
      "['effective treatment option', 'refractory chronic lymphocytic leukemia']\n",
      "[]\n",
      "['cll1 acalabrutinib iii lancet carenet']\n",
      "['treatment outcomes', 'real world patients', 'clinical trials', 'community setting leukemias']\n",
      "['dr leslie', 'treatment outcomes', 'real world patients', 'clinical trials', 'community setting cllsm leusm']\n",
      "['real world data', 'treatment landscape leukemias']\n",
      "['announces calavi trial ace id', 'matthew fowler caxtx ccc19 2019ncov covid19clinicaltrials nct04346199 az press release']\n",
      "['obinutuzumab vs chlorambucil obinutuzumab', 'asco post']\n",
      "['new article acalabrutinib', 'new option', 'cll cll leusm hematology']\n",
      "['novedad glosario', 'ver nica saladrigas menda lerenda y g polledo m s', 'ab abg abnormal taste', 'absolute ethanol y acalabrutinib', 'zero patient zinc ionophore zingerol y zoonosis consulta', 'l nea']\n",
      "['calquence 88m']\n",
      "['btk inhibitors', 'cll skills challenge', 'clinical pearls', 'acalabrutinib drug drug interactions']\n",
      "['btk inhibitors', 'cll skills challenge', 'clinical pearls', 'ibrutinib vs acalabrutinib']\n",
      "['new option']\n",
      "['calquence chroniclymphocyticleukaemia mantlecelllymphoma acalabrutinib']\n",
      "['cd20 antibody ie', 'free survival', 'acalabrutinib obinutuzumab', 'acalabrutinib monotherapy', 'analysis cll lymsm']\n",
      "['einer gro', 'vergleichsstudie verl ngerte der bruton kinase inhibitor acalabrutinib das progressionsfreie berleben von erstmals behandelten patienten mit chronisch lymphatischer leuk mie cll erheblich nach', 'jahren betrug der anteil']\n",
      "['calquence calavi']\n",
      "['treatment medications', 'galaxy remdesivir favipiravir tocilizumab baricitinib acalabrutinib']\n",
      "['acalabrutinib calquence']\n",
      "['basic covid bros', 'chloroquine people', 'i m', 'tocilizumab acalabrutinib favipiravir']\n",
      "['baml azn ln astrazeneca 1q', 'class growth', 'cons calquence 1l enhertu roxa china', 'farxiga hf']\n",
      "['calquence study', 'coronavirus treatment']\n",
      "['con o sin obinutuzumab mejor', 'supervivencia libre', 'progresi n sobre', 'con obinutuzumab clorambucilo lo cual brinda una opci n', 'tratamiento libre', 'con un perfil', 'efectos secundarios']\n",
      "['free survival', 'obinutuzumab chlorambucil chemoimmunotherapy', 'free therapy option', 'acceptable side effect profile', 'symptomatic chroniclymphocyticleukemia']\n",
      "['mantlecelllymphoma calquence ceftazidime acalabrutinib']\n",
      "[]\n",
      "['burton kinase inhibitor', 'covid19 burton kinase plays', 'b cell develoment clinicaltrial maga2020 coronavirus']\n",
      "['mainstream pub politico', 'clinical trials database', 'trials note', 'remdesivir acalabrutinib baricitinib amp favipiravir', 'tablets tocilizumab']\n",
      "[]\n",
      "['astrazeneca announces calavi trial']\n",
      "['cancer drug calquence', 'coronavirus patients power']\n",
      "['calquence calavi']\n",
      "['calquence acalabrutinib mantlecelllymphoma chroniclymphocyticleukaemia']\n",
      "['i m', 'lab alum speakers', 'zoom lab meetings', 'ms student', 'covid drug']\n",
      "['clinical trial', 'blood cancer drug calquence', 'patients businessnews cambridge coronavirus health lifescience']\n",
      "['elevate tn acalabrutinib', 'obinutuzumab vs chlorambucil obinutuzumab', 'cll leusm hematology']\n",
      "['cll btk acalabrutinib elevate tn']\n",
      "['leukemia patients', 'previous drugs', 'blood cancers']\n",
      "['new drug calquence chroniclymphocyticleukaemia mantlecelllymphoma acalabrutinib']\n",
      "['obinutuzumab vs chlorambucil obinutuzumab', 'asco post']\n",
      "['promising results', 'stage covid19 patients']\n",
      "['study acalabrutinib', 'obinutuzumab chlorambucil therapy', 'treatment na ve cll patients', 'free treatment option', 'acceptable side effect profile']\n",
      "['blood cancer drug calquence', 'clinical benefit']\n",
      "['btk tki acalabrutinib covid19 sarscov2']\n",
      "['btk calquence acalabrutinib']\n",
      "['blood cancer drug calquence', 'clinical benefit pharma covidtreatments covid19']\n",
      "['calquence calavi']\n",
      "['calquence calavi']\n",
      "['calquence acalabrutinib', 'effective treatment option', 'refractory chronic lymphocytic leukemia']\n",
      "['major trial', 'cytokine storms']\n",
      "['calquence calavi pr times']\n",
      "['calquence calavi']\n",
      "['calquence calavi']\n",
      "['calquence calavi']\n",
      "['calquence acalbrutinib', 'cancer drug', 'possibility covid19 coronavirus']\n",
      "['obinutuzumab versus chlorambucil']\n",
      "['acalabrutinib calquence', 'btk inhibitor', 'certain types', 'cytokine storm']\n",
      "['clinical trial', 'calquence acalabrutinib', 'immune response', 'calavi trial', 'luminasllc covid19 coronavirus covidclinicaltrial']\n",
      "['interesting comment', 'nih director francis collins', 'azn s calquence company', 'patients background']\n",
      "['chronic lymphocytic leukemia calquence', 'formulary status', 'step therapy']\n",
      "['covidncancer updates trial', 'covid19 patients clinical trial accruals', 'increase society']\n",
      "['astrazeneca s acalabrutinib']\n",
      "['obinutuzumab versus chlorambucil', 'treatment naive chronic lymphocytic leukaemia elevate tn']\n",
      "['nurse times nurse times coronavirus allo studio farmaco', 'tempesta di citochine associata', 'infezione si tratta di acalabrutinib inibitore della tirosina chinasi di bruton lo informazione sanit serio', 'affidabile nursetimes']\n",
      "['obinutuzumab versus chlorambucil', 'treatment naive chronic lymphocytic leukaemia elevate tn']\n",
      "['lancet acalabrutinib', 'treatment naive cll covid19', 'u s fda sars cov', 'tests pnn journalwatch']\n",
      "['global clinical trial', 'blood cancer drug', 'sickest covid19 patients']\n",
      "['selektif bruton s tyrosine kinase inhibit r acalabrutinib calquence covid19 sitokin f rt nas nda etkinli ini ara t racak faziii', 'ma tasarland announces calavi trial']\n",
      "['astrazeneca s calquence btk inhibitor shows']\n",
      "['exclusive astrazeneca s calquence shows', 'patients healthcare transformation']\n",
      "['potential support', 'azn s calquence btk inhibitor efficacy', 'respiratory symptoms', 'apto s cg', 'pan btk flt3 inhibitor']\n",
      "['acalabrutinib btk btk btk']\n",
      "['protein btk', 'clinical benefit', 'lung disease']\n",
      "['articles acalabrutinib', 'obinutuzumab versus chlorambucil', 'treatment naive chronic lymphocytic leukaemia elevate tn', 'trial thewiderwiserview']\n",
      "['long term', 'phase i ii ace cl', 'median values', 'dor efs', 'agent acalabrutinib', 'refractory chronic lymphocytic leukemia cll lylsm']\n",
      "['btk inhibitor', 'clinical trial', 'immune response', 'cytokine storm', 'covid19 btk']\n",
      "['astrazeneca acerta pharma b v']\n",
      "['tap stellar clinicaltrial', 'phase ii', 'chop r', 'chop r']\n",
      "['oncoalert acalabrutinib', 'obinutuzumab versus chlorambucil', 'treatment naive chronic lymphocytic leukaemia cll elevate tn', 'trial cllsm leusm lymsm']\n",
      "['new article', 'phase iii rct', 'free treatment option']\n",
      "['acalabrutinib btk inhibitor', 'cytokine storm atanas rna uni']\n",
      "['phase i ii study', 'agent acalabrutinib', 'treatment initiation', 'refractory chronic lymphocytic leukemia cll lylsm']\n",
      "['btk inhibitor', 'chronic lymphocytic leukemia', 'mantle cell lymphoma']\n",
      "['astrazeneca announces calavi trial', 'cancer network']\n",
      "['global clinical trial calavi', 'supportive care']\n",
      "['initial treatment', 'chronic lymphocytic leukaemia', 'insightful editorial']\n",
      "['acalabrutinib study', 'supportive care versus', 'supportive care', 'calavi calquence', 'virus condition covid', 'intervention coronavirus sars cov']\n",
      "['important study', 'frontline acalabrutinib', 'cll patients congrats']\n",
      "['news stories', 'week article', 'roundup thisweek pharmaforecast']\n",
      "['astrazeneca initiates calavi clinical trial', 'pandemic covid', 'clinicaltrial clinicalresearch vaccine research pharmaceutical lungs']\n",
      "['bloodcancer drugs', 'coronavirus myeloma leukemia calquence selinexor clinicaltrials']\n",
      "['overheden kunnen nu alleen maar doemdenken mbt coronavirus binnekort testen van meerdere kansrijke therapie n beschikbaar o', 'remdesivir calquence', 'firazyr dit kunnen stuk voor stuk gamechangers zijn', 'ic capaciteit niet meer', 'beperkende factor maken thinkpositive']\n",
      "['astrazeneca history']\n",
      "['az bkt acalabrutinib covid']\n",
      "['clinical trial']\n",
      "['elevate tn', 'big pfs adv', 'acalabrutinib obin vs obin chl', 'great news', 'cll patients', 'front line acalabrutinib', 'use cll lymsm congrats sharman', 'co authors']\n",
      "['obinutuzumab versus chlorambucil', 'treatment naive chronic lymphocytic leukaemia elevate tn']\n",
      "['initial treatment', 'chronic lymphocytic leukaemia']\n",
      "['comment acalabrutinib', 'initial treatment', 'chronic lymphocytic leukaemia thewiderwiserview']\n",
      "['elevate tn', 'dr sharman', 'great data', 'pfs benefit', 'obinutuzmab cllsm']\n",
      "['obinutuzumab versus chlorambucil', 'treatment naive chronic lymphocytic leukaemia elevate tn']\n",
      "['long term benefit']\n",
      "['obinutuzumab versus chlorambucil', 'treatment naive chronic lymphocytic leukaemia elevate tn', 'lancet link']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "['clinical trial', 'calquence acalabrutinib', 'cytokine storm overreaction', 'immune system calquence', 'btk inhibitor']\n",
      "['long term benefit']\n",
      "['icymi s calquence shows', 'covid19 patients']\n",
      "['study results', 'fda approval', 'cll good evidence']\n",
      "['long term benefit']\n",
      "['long term benefit', 'data lylsm']\n",
      "['long term benefit']\n",
      "['blood cancer drug calquence', 'clinical benefit pharma covidtreatments covid19']\n",
      "['calavi trial', 'supportive care', 'ventilation biopharma pharmaceuticals pharma covid19']\n",
      "['covid19 play', 'safety tolerability profile', 'clinical data', 'btk inhibitors reduces', 'respiratory distress']\n",
      "['strong scientific evidence supports', 'btk inhibition', 'inflammatory cytokines', 'respiratory complications', 'covid19 coronavirus']\n",
      "['new trial lead', 'leukemia drug']\n",
      "['covid19 trial', 'p3 study', 'acalabrutinib btk inhibitor']\n",
      "['medicamento calquence da astrazeneca obt m resultados promissores contra covid']\n",
      "['global clinical trial', 'calquence acalabrutinib', 'immune response cytokine storm']\n",
      "['interesting astrazeneca announces calavi trial']\n",
      "['great news', 'treatment naive patients', 'covid19 ie']\n",
      "['cytokine storm', 'severe immune overreaction', 'respiratory complications']\n",
      "['astrazeneca initiates calquence clinical trial']\n",
      "['blood cancer drug calquence', 'clinical benefit']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['astrazeneca announces calavi trial']\n",
      "['calavi clinical trial', 'immune response', 'cytokine storm']\n",
      "['giant astrazeneca rushes', 'blood cancer drug calquence', 'coronavirus trials']\n",
      "['blood cancer drugs lead', 'severe covid19 treatment clinical trials']\n",
      "['new post astrazeneca s cancer drug calquence']\n",
      "['calquence acalabrutinib btk inhibitor covid19']\n",
      "['cll specialists', 'novel agents acalabrutinib obinutuzumab']\n",
      "['acalabrutinib covid']\n",
      "['covid19 clinicaltrial', 'lymphoma drug', 'inhibits burton s tyrosine kinase i wonder', 'patient trial', 'pharma astrazeneca']\n",
      "['acalabrutinib monotherapy', 'refractory chronic lymphocytic leukemia', 'results blood american society']\n",
      "['btk inhibitor calquence', 'chronic lymphocytic leukemia', 'mantle cell lymphoma', 'respiratory complications']\n",
      "['cancer drug', 'clinical trial', 'cancer drug calquence', 'excessive immune response covid']\n",
      "['pharma biotech clinicaltrial coronavirus']\n",
      "['astrazeneca initiates calavi clinical trial']\n",
      "['cancer medicine', 'astrazeneca plc', 'new cancer medicine calquence', 'respiratory distress', 'supportive care']\n",
      "[]\n",
      "['daily briefings', 'cancer drug', 'calquence amp', 'patients paywall']\n",
      "['forbesbr medicamento calquence da astrazeneca obt m resultados promissores contra covid', 'forbesbrasil forbes']\n",
      "['global clinical trial', 'infection astrazeneca cambridgeshire']\n",
      "['calquence calquence']\n",
      "['leukemia drug', 'treatment biopharma dive']\n",
      "['leukemia drug', 'treatment biopharma dive']\n",
      "['lethal immune response', 'patients experience']\n",
      "['chronic lymphocytic leukemia', 'btk inhibitors', 'acalabrutinib impact', 'cll webinar']\n",
      "['immune response']\n",
      "['blood cancer drug calquence', 'clinical benefit covid19']\n",
      "[]\n",
      "[]\n",
      "['blood cancer drug calquence', 'clinical benefit']\n",
      "['calquence study', 'coronavirus treatment']\n",
      "['cancer drug calquence', 'coronavirus patients']\n",
      "[]\n",
      "['astrazeneca initiates calavi clinical trial']\n",
      "['astrazeneca initiates calavi study', 'calquence acalabrutinib', 'pharmashots astrazeneca calquence acalabrutinib covid19']\n",
      "['btk inhibitor calquence acalabrutinib', 'immune response', 'patients coronavirus covid19 coronapandemic coronaoutbreak']\n",
      "['btk inhibitor calquence acalabrutinib', 'immune response', 'patients coronavirus covid19 coronapandemic coronaoutbreak']\n",
      "['btk inhibitor calquence', 'cytokine storm', 'infection el dise o calavi se basa', 'evidencia cient fica s lida que respalda el papel', 'producci n', 'citocinas inflamatorias']\n",
      "['acalabrutinib covid']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "['acalabrutinib covid19 trial']\n",
      "['calquence astrazeneca']\n",
      "['cancer drug calquence', 'coronavirus patients']\n",
      "['coronavirus astrazeneca']\n",
      "['astrazeneca btk calquence insights4 pharma']\n",
      "[]\n",
      "['global clinical trial', 'blood cancers', 'respiratory harm', 'deaths amp']\n",
      "['coronavirus astrazeneca rushes', 'potential treatment', 'encouraging trial']\n",
      "['blood cancer drug shows', 'blood cancer', 'fight coronavirus', 'forbes researchers', 'national cancer institute', 'small group', 'late stage']\n",
      "['british drug company launches trial', 'potential covid']\n",
      "['blodkreftlegemidlet calquence skal testes p sv rt syke covid', 'pasienter i', 'global klinisk studie rsaken er', 'legemidlet har vist lovende resultater p covid', 'pasienter som er p', 'og i respirator covid19 korona']\n",
      "['cytokinstorm handlar det om v der nej det r den verreaktion fr n immunf rsvaret som vissa covid', 'patienter r kar ut f r och som ger sv ra lungskador nu testar ett l kemedel se']\n",
      "['calquence world covid']\n",
      "['astrazeneca initiates calavi study', 'calquence acalabrutinib']\n",
      "['calquence astrazeneca']\n",
      "['covid19 battle', 'potential medicine']\n",
      "[]\n",
      "['encouraging news coronavirus astrazeneca rushes', 'potential treatment', 'encouraging trial covid19']\n",
      "[]\n",
      "['calquence astrazeneca']\n",
      "['british drug company launches trial', 'potential covid']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "['cancer drug calquence', 'coronavirus patients article amp reuters']\n",
      "['btk inhibitor', 'calavi trial', 'cytokine storm']\n",
      "['blood cancer drug calquence', 'clinical benefit']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "['coronavirus astrazeneca rushes', 'potential treatment', 'encouraging trial smartnews']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "['astrazeneca initiates calavi clinical trial']\n",
      "['astrazeneca initiates calavi clinical trial']\n",
      "['astrazeneca initiates calavi clinical trial']\n",
      "['astrazeneca anunciou o', 'estudo calavi para avaliar', 'efic cia', 'btk acalabrutinibe', 'tto da hipercitocinemia associada infec o por covid', 'o medicamento indicado para o tto da llc e mcl em segunda linha onconews']\n",
      "['pharmacodynamic analysis', 'btk inhibition', 'chronic lymphocytic leukemia']\n",
      "['calquence un medicamento contra', 'leucemia podr', 'soluci n pr xima contra el coronaviru googlealerts']\n",
      "['bruton tki inhibition', 'covid19 cytokine storm haem haematology']\n",
      "['astrazeneca btk calquence']\n",
      "[]\n",
      "['clinical trial', 'cancer drug calquence', 'immune system response']\n",
      "['british drug company launches trial', 'potential covid', 'signs newsintweets worldnewsintweets newsintweetscom']\n",
      "['british drug company launches trial', 'potential covid']\n",
      "['acalabrutinib covid']\n",
      "['exclusive astrazeneca s calquence shows', 'btk inhibition', 'target activities covid']\n",
      "['cancer drug calquence', 'coronavirus patients']\n",
      "[]\n",
      "['trial astrazeneca', 'anecdotal evidence', 'intensive care patients']\n",
      "['pharmascrip astrazeneca s covid', 'calquence trial pharmascrip']\n",
      "['astrazeneca testet', 'wirkung des krebsmedikaments calquence auf twittersmash']\n",
      "['giant astrazeneca rushes', 'blood cancer drug calquence', 'coronavirus trials']\n",
      "['coronavirus astrazeneca rushes', 'potential treatment', 'encouraging trial']\n",
      "['stage human tests', 'experimental vaccines', 'tuesday british firm astrazeneca', 'global clinical trial', 'treatment calquence', 'blood cancers covid19']\n",
      "['interesting idea']\n",
      "['acalabrutinib covid19 trial']\n",
      "['acalabrutinib covid19 trial', 'covid19pandemic coronavirus']\n",
      "['cancer drug calquence', 'coronavirus patients']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "['astrazeneca launches drug calquence trial', 'coronavirus treatment']\n",
      "['cancer drug calquence', 'coronavirus patients']\n",
      "['astrazeneca initiates clinical trial']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "[]\n",
      "['membercompany making', 'big moves', 'clinical trial']\n",
      "['btk inhibitor', 'sickest patients experts', 'ohio state', 'md anderson', 'cll webinar cllsm covid19']\n",
      "['astrazeneca s covid', 'calquence trial pharmascrip']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "['blood cancer drug calquence', 'clinical benefit']\n",
      "['positive news', 'coronavirus front', 'pharmaceutical company astrazeneca', 'medical trials', 'late term symptoms']\n",
      "[]\n",
      "['acalabrutinib monotherapy', 'refractory chronic lymphocytic leukemia', 'results leusm cll']\n",
      "[]\n",
      "['exclusive astrazeneca s calquence shows', 'promising science']\n",
      "['blood cancer drug calquence', 'clinical benefit']\n",
      "['astra zenecas l kemedel mot blodcancer calquence har anv nts p allvarligt virussjuka i usa och vissa patienter blev avsev rt hj lpta svpol coronavirussverige covid19']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "['possible therapy', 'clinical trials underway', 'global pandemic']\n",
      "['cancer treatment', 'blood cancer drug calquence']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "[]\n",
      "['british drug company launches trial', 'potential covid']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "['global clinicaltrial', 'calquence acalabrutinib', 'immune response cytokine storm']\n",
      "['covid19 azn astrazeneca', 'global clinical trial calavi', 'assess calquence btki', 'immune response', 'patients cytokinestorm']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "['blood cancer drug calquence', 'certain patients', 'cytokine storm', 'global trial azn coronavirus']\n",
      "['supportive care bsc', 'symptoms covid19 calquence calavi']\n",
      "['early clinical data', 'btk inhibition', 'respiratory distress covid19 calquence calavi']\n",
      "['global clinical trial', 'calquence acalabrutinib', 'immune response cytokine storm', 'covid19 infection', 'patients calavi']\n",
      "['clinical trial', 'assess calquence potential', 'patients covid19 calquence calavi']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "['btk inhibitor', 'extreme immune responses', 'cytokine storms']\n",
      "['calquence covid19']\n",
      "['trial gl']\n",
      "['tweetuk 87rt fda cocacola ukhashtags']\n",
      "['calquence un medicamento contra', 'leucemia podr', 'soluci n pr xima contra el coronavirus']\n",
      "[]\n",
      "['blood cancer drug calquence', 'patients news']\n",
      "['new study', 'chronic lymphocytic leukemia cll', 'initial treatment', 'drug combination therapy']\n",
      "['azn astrazeneca initiates calavi clinical trial', 'global clinical trial', 'calquence acalabrutinib', 'immune response cytokine storm']\n",
      "['azn astrazeneca initiates calavi clinical trial', 'global clinical trial', 'calquence acalabrutinib', 'immune response cytokine storm']\n",
      "['astrazeneca initiates calavi clinical trial']\n",
      "['astra zenica vedsko britanska farmaceutska kompanija po inje globalno klini ko testiranje lijeka calquence za suzbijanje smrtnosti od covid', 'ovaj lijek se koristi protiv nekih tipova leukemije cancera krvi']\n",
      "['lifesciences pharma']\n",
      "['cancer drug calquence', 'coronavirus patients']\n",
      "[]\n",
      "['important issue', 'covid victims astrazeneca', 'btk inhibitor calquence', 'cytokine storm']\n",
      "['cancer drug calquence', 'coronavirus patients']\n",
      "['new news', 'exclusive astrazeneca s calquence shows']\n",
      "['label use', 'small number', 'severe covid']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "[]\n",
      "['pre astrazeneca', 'trial reuters']\n",
      "['cancer drug calquence', 'coronavirus patients pharma pharmanews coronavirus covid19india indiaincfightscovid19']\n",
      "['c e elaboreaza 1plan', 'relansare ec', 'mld euro acalabrutinib vandut', 'astrazeneca sub numele', 'aratat semne pozitive', 'o serie', 'subiecti cu covid', 'acest medicament e folosit', 'tratament vs leucemie franta dr didier raoult criticat dur']\n",
      "['azn inicia el ensayo cl nico calavi', 'con calquence contra covid19']\n",
      "['astrazeneca initiates calavi clinical trial']\n",
      "['trial lifeatbj barringtonjames drugtrial clinicaltrial']\n",
      "['azn astrazeneca initiates calavi clinical trial']\n",
      "['exclusive astrazeneca calquence shows', 'coronavirus patients']\n",
      "['cancer drug fight covid', 'lymphoma treatment calquence']\n",
      "['astrazeneca s calquence shows', 'covid19 patients']\n",
      "['astrazeneca initiates calavi clinical trial']\n",
      "['astrazeneca soars', 'giant announces', 'clinical trial', 'cancer drug calquence', 'immune response', 'mortality amp', 'severe cases']\n",
      "['giant astrazeneca rushes', 'blood cancer drug calquence', 'coronavirus trials']\n",
      "['astrazeneca initiates calavi clinical trial']\n",
      "['pit blood cancer drug calquence', 'company s', 'trial launch pharmaceutical']\n",
      "['clinical trial', 'calquence drug', 'coronavirus coronavirus']\n",
      "['giant astrazeneca surge', 'clinical trial', 'calquence drug', 'coronavirus dan grote investment markets']\n",
      "['cancer drug calquence', 'coronavirus patients']\n",
      "[]\n",
      "['azn initiates calavi clinical trial']\n",
      "['pit blood cancer drug calquence', 'company s', 'trial launch']\n",
      "['cv update', 'blood cancers', 'respiratory system']\n",
      "['cv update', 'blood cancers', 'respiratory system']\n",
      "['cv update', 'blood cancers', 'respiratory system']\n",
      "['cancer drug calquence', 'coronavirus patients']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['azn s leukemia treatment calquence', 'coronavirus symptoms']\n",
      "['giant astrazeneca', 'coronavirus patients calquence', 'blood cancers cambridgeshire heartnews']\n",
      "['astrazeneca shares', 'calquence drug', 'patients covid19']\n",
      "[]\n",
      "[]\n",
      "['clinical trials', 'calquence drug s effectiveness', 'severe coronavirus patients', 'giant s shares shot', 'clinical trial']\n",
      "['astrazeneca initiates clinical trial']\n",
      "['jobs az', 'biotechnews pharmanews']\n",
      "['marketwatch az', 'strong scientific evidence', 'btk pathway', 'inflammatory cytokines']\n",
      "['trial calquence']\n",
      "['cv19 trial yeah i', 'pharmaceutical giants', 'huge payday', 'different expensive drugs']\n",
      "[]\n",
      "['btk inhibitor calquence', 'cytokine storm', 'covid19 infection azn']\n",
      "['azn astrazeneca', 'cancer drug calquence', 'coronavirus patients']\n",
      "['astrazeneca startar klinisk pr', 'av substans som verkar kunna lugna den inflammatoriska reaktionen som skapar stora problem i covid']\n",
      "['astra s', 'new tests', 'calquence drug', 'severe coronavirus', 'clinical trial']\n",
      "['healthcare covid']\n",
      "['update shares', 'clinical trial', 'calquence drug']\n",
      "['giant astrazeneca rushes', 'blood cancer drug calquence', 'coronavirus trials', 'intensive care']\n",
      "[]\n",
      "[]\n",
      "[]\n",
      "['cancer drug calquence', 'coronavirus patients']\n",
      "['covid19 coronavirus', 'global clinicaltrial immuneresponse scientificevidence clinicaldata respiratory drug mortality ventilation clinicalbenefit patients clinicaltrial icu itu ventilators']\n",
      "['early days', 'hiv treatment', 'chemo drugs']\n",
      "['giant astrazeneca rushes', 'blood cancer drug calquence', 'coronavirus trials', 'intensive care']\n",
      "['clinical trials', 'cancer drug calquence', 'covid19 coronavirusupdates']\n",
      "['cancer drug calquence', 'coronavirus patients']\n",
      "['cancer drug calquence', 'coronavirus patients', 'vigorbot medicine']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "['new drug calquence', 'tyrosine kinase inhibitor tki', 'pivotal point', 'immune response cascade', 'fatal cytokine storm', 'egcg epigallocatechin gallate', 'green tea']\n",
      "['dangerous amp', 'cynical astrazeneca']\n",
      "['cancer drug calquence', 'coronavirus patients']\n",
      "['astrazeneca initiates calavi clinical trial']\n",
      "[]\n",
      "['astrazeneca testar cancerl kemedel mot covid', 'covid19 l kemedel', 'kemedelsv rlden']\n",
      "['giant astrazeneca', 'cancer drug calquence', 'coronavirus patients']\n",
      "['giant astrazeneca rushes', 'blood cancer drug calquence', 'coronavirus trials', 'intensive care']\n",
      "['azn coronavirus']\n",
      "['astra zenecas l kemedel calquence som r det senaste hoppet f r att behandla coronaviruset har visat lovande resultat bland intensivv rdspatienter', 'det skriver forbes']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "[]\n",
      "['cancer drug calquence', 'coronavirus patients azn gsk coronavirus covid2019']\n",
      "['cancer drug calquence', 'coronavirus patients']\n",
      "['good news', 'exclusive astrazeneca s calquence shows']\n",
      "['brief astrazeneca initiates trial', 'article amp reuters']\n",
      "['calquence trial', 'europe covid2019']\n",
      "['uk astra zeneca obtient l autorisation', 'tester un m dicament', 'leuc mie sur des malades', 'il coute', 'comprim s']\n",
      "['cancer drug calquence', 'coronavirus patients']\n",
      "[]\n",
      "['astrazeneca btk calquence']\n",
      "['astrazeneca initiates calavi clinical trial']\n",
      "['trial article amp reuters']\n",
      "['giant astrazeneca rushes', 'blood cancer drug calquence', 'coronavirus trials']\n",
      "['astrazeneca initiates calavi clinical trial']\n",
      "['encouraging small molecule inhibitor', 'inhibits btk', 'dependent cytokines', 'lung pathology manufacture', 'eg biologics trials', 'way anecdotal reports patients']\n",
      "['vigorbot medicine']\n",
      "['immunomodulatory drug jumps', 'covid19 bandwagon']\n",
      "['azn initiates calavi clinical trial']\n",
      "['astrazeneca initiates calavi clinical trial', 'btk astrazeneca btk calquence covid']\n",
      "['astrazeneca initiates calavi clinical trial', 'good results']\n",
      "['astrazeneca initiates calavi clinical trial']\n",
      "[]\n",
      "['medicin astra zeneca inleder tester av l kemedlet calquence mot covid', 'l kemedlet har potential att hj lpa sv rt sjuka coronapatienter']\n",
      "['trial azn']\n",
      "['corona tunnel astrazeneca initiates calavi clinical trial', 'covid19 covid19sweden']\n",
      "[]\n",
      "[]\n",
      "[]\n",
      "['astra zeneca inleder tester av l kemedlet calquence mot covid', 'l kemedlet har potential att hj lpa sv rt sjuka coronapatienter']\n",
      "['astrazeneca rozpoczyna testy leku przeciwko covid']\n",
      "['bra nyheter fr n astra']\n",
      "['l t oss hoppas att det lyckas']\n",
      "['astrazeneca initiates calavi clinical trial']\n",
      "['early clinical data', 'btk inhibition', 'respiratory distress']\n",
      "['astrazeneca initiates calavi clinical trial']\n",
      "['interesting azn', 'btk calquence', 'cytokine storm', 'patients bgne novn']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "[]\n",
      "['astrazeneca initiates calavi clinical trial']\n",
      "['blood cancer drug', 'small number', 'sick u s patients', 'massive clinical trials']\n",
      "['inflammatory effect', 'cytokine storm', 'late covid19 covid ards covid']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "['btk inhibitors', 'inflammatory benefit', 'cytokine storm astrazeneca s calquence shows']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "['clinical trial amp', 'year career astrazeneca s calquence shows']\n",
      "['btk inhibitors attenuate cytokine storm', 'exclusive astrazeneca s calquence shows']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "['exclusive astrazeneca s calquence shows', 'amazing discovery acalabrutinib amp ibrutinib', 'cll drug', 'cytokine storm', 'covid19 patients']\n",
      "['astrazeneca s calquence shows']\n",
      "['astrazeneca s calquence shows']\n",
      "['coca cola', 'powder acalabrutinib', 'coca cola', 'covid19 covid2019']\n",
      "['patient education']\n",
      "['awesomecapital astrazeneca s calquence shows']\n",
      "['btk inhibitors', 'covid hmmm']\n",
      "['wow btk inhibitors', 'late stage', 'severe coronavirus infections astrazeneca s calquence shows']\n",
      "['astrazeneca s calquence shows', 'covid19 patients']\n",
      "['50m mcap company', 'cancer drug i', 'calquence amp imbruvica', 'astrazeneca s calquence shows']\n",
      "['exclusive astrazeneca s calquence shows', 'patients analytics googleads facebookads']\n",
      "['interesting discussion', 'btk inhibitors', 'covid patients', 'exclusive astrazeneca s calquence shows']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "['exclusive astrazeneca s calquence shows', 'patients forbes']\n",
      "['cytokine storm astrazeneca s calquence shows']\n",
      "['exclusive astrazeneca s calquence shows', 'patients gt gt gt strategy competitiveintelligence', 'pharmaceutical healthcare biotech']\n",
      "[]\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "['british drug', 'giant astrazeneca', 'big clinical trial', 'blood cancer drug calquence', 'promising results', 'stage covid', 'intensive care units']\n",
      "['tyrosine kinase inhibitors suffix tinib imatinib cml', 'erlotinib non', 'small cell lung cancer sunitinib renal cell carcinoma acalabrutinib mantle cell lymphoma lapatinib breast cancer dasatinib ph cml', 'nilotinib cml bosutinib cml']\n",
      "['coronavirus breakthrough', 'leukemia drug']\n",
      "[]\n",
      "['british drug', 'big clinical trial', 'blood cancer drug calquence', 'promising results', 'stage covid', 'intensive care units']\n",
      "['british drug', 'giant astrazeneca', 'big clinical trial', 'blood cancer drug calquence', 'promising results', 'stage covid', 'intensive care units']\n",
      "['interesting approach', 'btk inhibitors']\n",
      "['class growth', '24e sales cagr', 'mid teens ebit cagr', 'impressive launch portfolio key launches', 'post kadcyla']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "['exclusive astrazeneca s calquence shows', 'patients health pharma']\n",
      "['patient trial', 'exclusive story']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "['exclusive astrazeneca s calquence shows']\n",
      "['btk inhibitors', 'treatment landscape']\n",
      "['oncoalert acalabrutinib monotherapy', 'refractory chronic lymphocytic leukemia cll', 'results american society', 'hematology hematology cllsm leusm lymsm']\n",
      "['acalabrutinib monotherapy', 'refractory chronic lymphocytic leukemia', 'results blood american society', 'hematology cll leusm']\n",
      "['antitumor potency', 'cd19 chimeric antigen receptor t cell therapy lisocabtagene maraleucel']\n",
      "['acalabrutinib monotherapy', 'refractory chronic lymphocytic leukemia', 'results blood american society']\n",
      "['jefferies analysts', 'pharma companies', 'european union', 'new drug launches', 'novo nordisk s rybelsus', 'astrazeneca s calquence', 'new medicine', 'free new launch guid']\n",
      "['jefferies analysts', 'pharma companies', 'european union', 'new drug launches', 'novo nordisk s rybelsus', 'astrazeneca s calquence', 'new medicine']\n",
      "['durable responses', 'time leukemia']\n",
      "['abbv catalysts', 'agn acquisition', 'rinvoq ph', 'atopic derm', 'skyrizi ph3 motivate data', 'cd induction', 'bi voltaire x interchangeability study', 'biosimilar humira head', 'calquence imbruvica data', 'r r cll']\n",
      "['generation btk inhibitors', 'fungal response', 'cll patients acalabrutinib', 'potential risk', 'innate immune response']\n",
      "['new article acalabrutinib', 'therapeutic potential', 'chronic lymphocytic leukemia', 'short review', 'data cll leusm hematology']\n",
      "['benjamin l lampson md phd', 'primary efficacy', 'safety findings', 'phase ii trial', 'acalabrutinib venetoclax', 'frontline cll leukemia']\n",
      "['acalabrutinib triplet impresses', 'frontline cll advances', 'phase iii study']\n",
      "['acalabrutinib triplet impresses', 'frontline cll advances', 'phase iii study leukemia']\n",
      "['new study', 'chronic lymphocytic leukemia cll', 'initial treatment', 'drug combination therapy', 'calquence gazyva']\n",
      "['dr sharman', 'secondary end points', 'phase iii elevate tn trial', 'treatment naive chronic lymphocytic leukemia leusm leukemias']\n",
      "['icymi lori leslie md', 'john theurer cancer center', 'real world data', 'different toxicity profiles', 'btk inhibitors']\n",
      "['tyrosine kinase inhibitors prefix inib imatinib cml', 'erlotinib non', 'small cell lung cancer sunitinib renal cell carcinoma acalabrutinib mantle cell lymphoma lapatinib breast cancer dasatinib ph cml', 'nilotinib cml bosutinib cml']\n",
      "['access programme', 'irish patients', 'line options']\n",
      "['overall dr sharman', 'alert patients', 'adverse event', 'findings cllsm leusm']\n",
      "['chronic lymphocytic leukemia leusm']\n",
      "['para cu les condiciones o enfermedades se prescribe el acalabrutinib']\n",
      "['great news', 'cll pts', 'frontline patients', 'covid19 era', 'early access programme', 'industry supportive', 'challenging times cll lymsm covid19']\n",
      "[]\n",
      "['video acalabrutinib venetoclax', 'obinutuzumab upfront', 'cll w', 'leusm immunoonc ash19 hematology']\n",
      "['phase ii trial', 'r r cll', 'btk inhibitor acalabrutinib', 'month pfs']\n",
      "['biological implications', 'target occupancy', 'btk inhibitor acalabrutinib blood american society']\n",
      "['acalabrutinib monotherapy', 'refractory cll']\n",
      "['biological implications', 'target occupancy', 'btk inhibitor acalabrutinib haematology thewiderwiserview']\n",
      "['new iwmf acalabrutinib', 'rituximab fact sheets']\n",
      "['new article clinical', 'biological implications', 'target occupancy', 'btk inhibitor acalabrutinib cll leusm hematology']\n",
      "['treatment naive', 'refractory chronic lymphocytic leukemia']\n",
      "['leukemia patients', 'previous drugs', 'blood cancers']\n",
      "['student krista isaac', 'excellent review acalabrutinib', 'therapeutic potential', 'chroni cmar']\n",
      "['elevate tn study', 'cll chaitra ujjani md', 'associate professor university', 'hutchinson cancer research center', 'elevate tn study']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['front line treatment', 'cll leusm hematology ash19']\n",
      "['march issue acalabrutinib', 'treatment na ve', 'refractory chronic lymphocytic leukemia cll clinicaltrial']\n",
      "['front line treatment', 'cll leusm hematology']\n",
      "['market permission paves way', 'acalabrutinib 100mg capsules calquence', 'india subject', 'statutory approvals', 'licenses momarketupdates']\n",
      "['astrazeneca pharma india', 'dcgi nod', 'calquence acalabrutinib 100mg capsules astrazeneca pharma india drugs controller general', 'india acalabrutinib capsules lymphocytic leukaemia dcgi astrazeneca']\n",
      "['exciting data', 'chronic lymphocytic leukemia leusm']\n",
      "['overman m', 'j immunother cancer', 'phase ii study', 'bruton tyrosine kinase inhibitor acalabrutinib', 'pancreatic cancer']\n",
      "['astrazeneca pharma', 'market permission']\n",
      "['overman m', 'j immunother cancer', 'phase ii study', 'bruton tyrosine kinase inhibitor acalabrutinib', 'pancreatic cancer']\n",
      "['overman m', 'j immunother cancer', 'phase ii study', 'bruton tyrosine kinase inhibitor acalabrutinib', 'pancreatic cancer']\n",
      "['overman m', 'j immunother cancer', 'phase ii study', 'bruton tyrosine kinase inhibitor acalabrutinib', 'pancreatic cancer']\n",
      "['overman m', 'j immunother cancer', 'phase ii study', 'bruton tyrosine kinase inhibitor acalabrutinib', 'pancreatic cancer']\n",
      "['overman m', 'j immunother cancer', 'phase ii study', 'bruton tyrosine kinase inhibitor acalabrutinib', 'pancreatic cancer']\n",
      "['new overman m', 'j immunother cancer', 'phase ii study', 'bruton tyrosine kinase inhibitor acalabrutinib', 'pancreatic cancer']\n",
      "['astrazeneca pharma india ltd', 'dcgi equity bulls gt gt gt strategy competitiveintelligence', 'pharma healthcare biotech pharmaceutical']\n",
      "['astrazeneca pharma india ltd', 'dcgi astrazenecapharmaindia permission calquence dcgi']\n",
      "['hi dr', 'mcl i', 'acala si']\n",
      "['tc bec', 'phase ii', 'chop r', 'chop r']\n",
      "['overman m', 'j immunother cancer', 'phase ii study', 'bruton tyrosine kinase inhibitor acalabrutinib', 'pancreatic cancer']\n",
      "['overman m', 'j immunother cancer', 'phase ii study', 'bruton tyrosine kinase inhibitor acalabrutinib', 'pancreatic cancer']\n",
      "['overman m', 'j immunother cancer', 'phase ii study', 'bruton tyrosine kinase inhibitor acalabrutinib', 'pancreatic cancer']\n",
      "['overman m', 'j immunother cancer', 'phase ii study', 'bruton tyrosine kinase inhibitor acalabrutinib', 'pancreatic cancer']\n",
      "['overman m', 'j immunother cancer', 'phase ii study', 'bruton tyrosine kinase inhibitor acalabrutinib', 'pancreatic cancer']\n",
      "['new overman m', 'j immunother cancer', 'phase ii study', 'bruton tyrosine kinase inhibitor acalabrutinib', 'pancreatic cancer']\n",
      "['new overman m', 'j immunother cancer', 'phase ii study', 'bruton tyrosine kinase inhibitor acalabrutinib', 'pancreatic cancer']\n",
      "['new overman m', 'j immunother cancer', 'phase ii study', 'bruton tyrosine kinase inhibitor acalabrutinib', 'pancreatic cancer']\n",
      "['new article rumpel leede phenomenon', 'chronic lymphocytic leukemia', 'acalabrutinib cll leusm hematology']\n",
      "['tag auspar acalabrutinib']\n",
      "['new auspar', 'calquence acalabrutinib', 'chronic lymphocytic leukaemia cll', 'small lymphocytic lymphoma sll']\n",
      "['new overman m', 'j immunother cancer', 'phase ii study', 'bruton tyrosine kinase inhibitor acalabrutinib', 'pancreatic cancer']\n",
      "['dr awan', 'cll leukemia']\n",
      "['cll leusm']\n",
      "['dr ryan', 'mantle cell lymphoma', 'real world setting bloodcancer']\n",
      "['acalabrutinib shows', 'refractory mantle cell lymphoma rd360 raredisease mantlecelllymphoma']\n",
      "['project orbis fda approves acalabrutinib']\n",
      "['new overman m', 'j immunother cancer', 'phase ii study', 'bruton tyrosine kinase inhibitor acalabrutinib', 'pancreatic cancer']\n",
      "[]\n",
      "['trial coordinator bec', 'bi beatson', 'stellar clinicaltrial', 'phase ii', 'chop r', 'chop r', 'richterssyndrome cltap']\n",
      "['new jitc article', 'phase ii study', 'bruton tyrosine kinase inhibitor acalabrutinib', 'pancreatic cancer overman']\n",
      "['phase ii study', 'bruton tyrosine kinase inhibitor acalabrutinib', 'pancreatic cancer lymphoma lymsm']\n",
      "['new auspar', 'calquence acalabrutinib', 'mantle cell lymphoma']\n",
      "['tag auspar acalabrutinib']\n",
      "['overman amp colleagues', 'btk inhibitor acalabrutinib v combo', 'preclinical data']\n",
      "['therapeutic options', 'frontline setting', 'generation btk inhibitor acalabrutinib leukemia gotohem james']\n",
      "['calquence acalabrutinib 100mg mcl calquence mcl']\n",
      "['jennifer woyach md', 'james discusses', 'frontline setting', 'space leukemia gotohem']\n",
      "['phase ii study', 'bruton tyrosine kinase inhibitor acalabrutinib', 'pancreatic cancer']\n",
      "['jeff sharman md sharman discusses results', 'elevate tn trial', 'fda approval', 'treatment na ve cll']\n",
      "['ash19 acalabrutinib', 'free survival', 'treatment na ve chronic lymphocytic leukemia cll']\n",
      "['real world analysis explores', 'current role', 'mcl mantle cell lymphoma lymsm rwd rwe']\n",
      "['interview dr ryan', 'mantle cell lymphoma', 'real world setting mclsm lymsm']\n",
      "['new2trip acalabrutinib calquence mantle cell lymphoma mcl']\n",
      "['stellar site initiation', 'hosp stellar', 'phase ii', 'chop r', 'chop r', 'richterssyndrome clinicaltrials cltap']\n",
      "['promising responses', 'refractory mcl', 'real world setting mantlecelllymphoma lymphoma']\n",
      "['dr ryan', 'real world setting lymsm mclsm']\n",
      "['btk inhibitors', 'cll acalabrutinib', 'acalabrutinib patients experience', 'agents leusm']\n",
      "['dr sharman', 'differentiates acalabrutinib', 'btk inhibitors', 'chronic lymphocytic leukemia leusm']\n",
      "['acalabrutinib bij macroglobulinemie van waldenstr m']\n",
      "['triplet therapy', 'acalabrutinib venetoclax', 'treatment na ve chronic lymphocytic leukemia value', 'cancer care']\n",
      "['dr richard furman speaks', 'chronic lymphocytic leukemia cll']\n",
      "['dr sharman', 'differentiates acalabrutinib', 'btk inhibitors', 'chronic lymphocytic leukemia leusm']\n",
      "['acalabrutinib monotherapy', 'waldenstr m macroglobulinemia oncology learning network']\n",
      "['new2trip acalabrutinib calquence mantle cell lymphoma mcl']\n",
      "['btk btk tirosina quinasa', 'bruton desempe', 'un papel', 'maduraci n', 'las c lulas b ejemplos acalabrutinib calquence indicaci n linfoma', 'c lulas del manto efectos secundarios trombocitopenia leucopenia anemia fatiga dolor']\n",
      "['btk inhibitors btk bruton s tyrosine kinase', 'core role', 'b cell maturation examples acalabrutinib calquence indication mantle cell lymphoma side', 'thrombocytopenia leucopenia anemia fatigue headache']\n",
      "['btk inhibitors btk bruton s tyrosine kinase', 'core role', 'b cell maturation examples acalabrutinib calquence indication mantle cell lymphoma side', 'thrombocytopenia leucopenia anemia fatigue headache']\n",
      "['acalabrutinib monotherapy', 'waldenstr m macroglobulinemia mmsm']\n",
      "['new article pharmacodynamic analysis', 'btk inhibition', 'chronic lymphocytic leukemia', 'acalabrutinib cll leusm hematology']\n",
      "['acalabrutinib monotherapy', 'waldenstr m macroglobulinemia', 'arm multicentre phase', 'study lymphoma lymsm']\n",
      "['pharmacodynamic analysis', 'btk inhibition', 'chronic lymphocytic leukemia']\n",
      "['btk inhibitor', 'approval zanubrutinib joins ibrutinib', 'therapy lymphoma']\n",
      "['retrospective analysis', 'real world patients', 'chronic lymphocytic leukemia', 'acalabrutinib calquence leusm']\n",
      "['triplet regimen', 'acalabrutinib venetoclax', 'frontline therapy', 'chronic lymphocytic leukemia']\n",
      "['leukemia patients', 'blood cancers']\n",
      "['dr davids', 'exciting data', 'cll leukemia']\n",
      "['yo pt', 'htn paroxysmal af savr gt', 'hematological malignancy', 'good response', 'mg apixiban', 'mg bid']\n",
      "['anticd19 car tcell therapy', 'bcell lymphoma', 'phase iii trial studies', 'axicabtagene ciloleucel', 'bcell lymphoma acalabrutinib', 'renalcell kidneycancer']\n",
      "['new clinical trial acalabrutinib', 'cd19 car t cell therapy', 'b cell lymphoma fl lymsm hematology']\n",
      "['new clinical trial acalabrutinib', 'cd19 car t cell therapy', 'b cell lymphoma dlbcl lymsm hematology']\n",
      "['new clinical trial acalabrutinib', 'cd19 car t cell therapy', 'b cell lymphoma tcl lymsm hematology']\n",
      "['video resistance', 'btk mutations w jennifer woyach', 'leusm hemeonc ash19 hematology']\n",
      "['dr davids', 'exciting data', 'cll leukemia']\n",
      "['video elevate tn approval', 'adult cll w sharman', 'leusm lymsm hemeonc ash19 hematology']\n",
      "['btk inhibitors novel combinations', 'agents leukemia']\n",
      "['treatment naive', 'refractory cll']\n",
      "['discusses elevate tn results']\n",
      "[]\n",
      "['exciting times', 'james elevate tn']\n",
      "['frontline therapy', 'acalabrutinib venetoclax', 'encouraging rates', 'complete remission', 'high rates', 'undetectable measurable residual disease', 'chronic lymphocytic leukemia cll']\n",
      "['overall response rate', 'agent acalabrutinib', 'waldenstrom s macroglobulinemia', 'years lymsm']\n",
      "['month s', 'possible new treatment', 'waldenstr m s macroglobulinaemia', 'bloodcancer lymsm']\n",
      "['trial acalabrutinib rchop', '1l dlbcl phi ii', 'southampton amp oxford', 'top recruiter ston', 'good oxford effort', 'great study', 'results lymsm research']\n",
      "['real world study defines acalabrutinib users']\n",
      "['fda nod']\n",
      "['acalabrutinib monotherapy', 'refractory cll']\n",
      "['phase iii elevate tn trial ash19 ash jeff sharman md', 'phase iii elevate tn trial']\n",
      "['american society', 'hematology ash', 'dr george', 'elevate clinical trial', 'ash shows', 'effective treatment option', 'cll patients']\n",
      "['new cases', 'u s', 's approval', 'new hope', 'common types', 'adult leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leu']\n",
      "['chronic lympho']\n",
      "['chronic lymphocytic l leukemia']\n",
      "['chronic lymphocytic leu']\n",
      "['chronic lymphocytic']\n",
      "['acalabrutinib monotherapy', 'waldenstr m macroglobulinemia', 'arm multicentre phase', 'lancet haematology']\n",
      "['time patients', 'disease progression', 'chronic lymphocytic leukemia', 'full results', 'phase iii elevate tn trial']\n",
      "['fuck outta', 'leukemia okay i ve', 'lukanol lu ka nol']\n",
      "['antitumor potency', 'cd19 chimeric antigen receptor t cell therapy lisocabtagene maraleucel', 'digest gt']\n",
      "['supplemental approval', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['waldenstr m monoterapia', 'con acalabrutinib es activa', 'con un perfil', 'pacientes sin tratamiento previo reca da o enfermedad refractaria lancet haematol']\n",
      "['subsequent therapy', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['phase ib ii study', 'cll orrs', 'treatment na ve', 'r r disease', 'months pfs', 'toxicities leusm hemeonc']\n",
      "['leukemia patients', 'blood cancers']\n",
      "['wm high orr', 'r r pts median time', '6m 24m pfs', 'r r pts', 'great uk presence', 'contribution lymsm lymphoma']\n",
      "['great results', 'roger owen', 'orr rate', 'rel ref pts', 'common g3', 'aes neutropenia amp pneumonia lymsm']\n",
      "['uk cll forum paper', 'month acalabrutinib', 'forum cll blooducation']\n",
      "['1st study', 'waldenstr m macroglobulinemia', 'treatment na ve', 'r r patients', 'treatment naive patients', 'r r pts']\n",
      "['cll btk acalabrutinib pfs']\n",
      "['dr leslie', 'chronic lymphocytic leukemia', 'real word clinics leusm']\n",
      "['gen btk inhibitors acalabrutinib', 'clinical trials']\n",
      "['phase iii elevate tn study', 'acalabrutinib calquence', 'w obinutuzumab gazyva', 'w acalabrutinib', 'obinutuzumab chlorambucil leukeran ash19']\n",
      "['update analysis', 'phase ii trial', 'r r cll', 'median dor', 'month pfs', 'leusm hemeonc']\n",
      "['new article acalabrutinib', 'treatment naive', 'refractory chronic lymphocytic leukemia cll leusm hematology']\n",
      "['treatment na ve', 'refractory chronic lymphocytic leukemia cll clinicaltrial']\n",
      "['perc e contre', 'leuc mie', 'r pandu astrazeneca canada', 'annonc aujourd hui que sant canada avait homologu l utilisation orale', 'calquence ac actualit s']\n",
      "['treatment na ve', 'refractory chronic lymphocytic leukemia cll clinicaltrial']\n",
      "['clinic acalabrutinib', 'adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma lymsm leusm hematology']\n",
      "['preclinical studies', 'cd19 car t cell function', 'bruton tyrosine kinase inhibitors ibrutinib', 't helper cell phenotype immunoonc hemeonc']\n",
      "['dr leslie', 'chronic lymphocytic leukemia', 'real word clinics leusm']\n",
      "[]\n",
      "['antitumor potency', 'cd19 car t chimeric antigen receptor t cell therapy lisocabtagene maraleucel']\n",
      "['select patients', 'jennifer woyach md']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['leucemia linfatica cronica maggiore efficacia di calquence', 'monoterapia rispetto alla chemioimmunoterapia']\n",
      "['antitumor potency', 'cd19 chimeric antigen receptor t cell therapy lisocabtagene maraleucel']\n",
      "['antitumor potency', 'cd19 chimeric antigen receptor t cell therapy lisocabtagene maraleucel', 'acalabrutinib lymphoma lymsm']\n",
      "['icymi acalabrutinib', 'free survival', 'treatment na ve patients', 'chronic lymphocytic leukemia']\n",
      "['antitumor potency', 'cd19 chimeric antigen receptor t cell therapy lisocabtagene maraleucel']\n",
      "['new article antitumor potency', 'cd19 chimeric antigen receptor t cell therapy lisocabtagene maraleucel', 'acalabrutinib cll leusm hematology']\n",
      "['kinaseinhibitors cll', 'cellae veritas realcellsmatter importance', 'covalent inhibitors', 'real cells journal ibrutinib acalabrutinib', 'nice work']\n",
      "['combination improves pfs', 'frontline cll leukemia']\n",
      "['acalabrutinib triplet', 'frontline cll leukemia']\n",
      "['dr mato', 'ibrutinib versus acalabrutinib']\n",
      "['immuno oncology', 'fda approval', 'researchers donors', 'new therapies']\n",
      "['acalabrutinib benefit', 'long term']\n",
      "['sharman showcases frontline acalabrutinib activity', 'cll leukemia']\n",
      "['selective btk inhibitor', 'inc ombinatoin', 'effective treatment', 'treatment naive chronic lymphocytic leukemia', 'dr sharman cllsm']\n",
      "['kasim aralik', 'fda onaylari acalabrutinib atezolizumab crizanlizumab enfortumabvedotin enzalutamid fda givosiran hematoloji hematolojiistanbul kansertedavisi luspatercept memorialata ehirhematoloji onkoloji profdrhisari trastuzumabde']\n",
      "['dr sharman', 'elevate tn data', 'optimal role', 'annual meeting cllsm']\n",
      "['obinutuzumab versus obinutuzumab', 'treatment na ve chronic lymphocytic leukemia leusm']\n",
      "['dr lampson', 'acalabrutinib venetoclax', 'cll leukemia ash2019 ash19']\n",
      "['acalabrutinib monotherapy', 'r r cll leusm']\n",
      "['combination improves pfs', 'frontline cll leukemia ash2019 ash19']\n",
      "['phenomenal timeline', 'rtor projectorbis approval', 'additional indications cll sll']\n",
      "['acalabrutinib monotherapy', 'refractory chronic lymphocytic leukemia', 'results lymphoma lymsm']\n",
      "['agent acalabrutinib', 'treatment na ve', 'refractory waldenstrom macroglobulinemia wm']\n",
      "['cll leukemia onclivecountsdown2019']\n",
      "['new article acalabrutinib monotherapy', 'refractory chronic lymphocytic leukemia', 'results cll leusm hematology']\n",
      "['strong pfs data', 'hand astrazeneca s calquence']\n",
      "['acalabrutinib phase ii r r cll n', 'lines af', '45m pfs', 'headache diarrhoea fatigue', 'common self', 'del17p ck pfs', 'similar pfs', 'lines pre ibrutinib rct', 'safety diff']\n",
      "[]\n",
      "['new drug', 'steps chemical synthesis', 'target identification toxicology patent application clinical trial phase', 'fda approval majority']\n",
      "['cancer therapies', 'patient ads', 'lymphoma calquence experience', 'open water swim', 'kayak trip']\n",
      "['new article', 'relative selectivity', 'covalent inhibitors', 'inactivation kinetics', 'cellular occupancy', 'case study', 'acalabrutinib cll leusm hematology']\n",
      "['acalabrutinib monotherapy', 'waldenstr m macroglobulinemia', 'arm multicentre phase', 'study lymphoma lymsm']\n",
      "['i wonder']\n",
      "['ibrutinib sounds', 'btk inhibitors']\n",
      "['acalabrutinib triplet', 'frontline cll leukemia']\n",
      "['acalabrutinib benefit', 'long term']\n",
      "['sharman showcases frontline acalabrutinib activity', 'cll leukemia']\n",
      "['astrazenica booth', 'pivotal trial', 'acalabrutinib i', 'drug ibrutinib', 'scientific data']\n",
      "['selective btk inhibitor', 'inc ombinatoin', 'effective treatment', 'treatment naive chronic lymphocytic leukemia', 'dr sharman cllsm']\n",
      "['new research', 'roger owen', 'colleagues shows', 'single agent therapy', 'manageable safety profile', 'waldenstr m macroglobulinemia wmsm']\n",
      "['acalabrutinib monotherapy', 'waldenstr m macroglobulinemia mmsm']\n",
      "['phase iii elevate tn study', 'ash19 meeting', 'acalabrutinib obinutuzumab vs acalabrutinib', 'vs obinutuzumab chlorambucil', 'treatment naive cll']\n",
      "['thelancethaematology waldentr m acalabrutinib acalabrutinib', 'monoth rapie', 'patients atteints', 'macroglobulin mie', 'waldenstr m tude', 'simple bras multicentrique']\n",
      "['time patients', 'disease progression', 'chronic lymphocytic leukemia']\n",
      "[]\n",
      "['calquence btk']\n",
      "['astrazeneca co ltd', 'chronic lymphocytic leukemia', 'astrazeneca s acalabrutinib calquence']\n",
      "[]\n",
      "[]\n",
      "['dr richard furman s', 'speedy summary', 'long term', 'r r cll patients', 'acalabrutinib monotherapy']\n",
      "['jeff sharman md leukemia wednesdaywisdom hematology oncology oncologist physician cancer clinicaltrial elevatetn obinutuzumab ash19']\n",
      "['james n gerson md discusses', 'ibrutinib acalabrutinib', 'r r mcl']\n",
      "['selective btk inhibitor acalabrutinib', 'effective treatment option', 'cll leukemia sharman']\n",
      "['dr sharman', 'safety profile', 'phase iii elevate tn trial', 'treatment na ve chronic lymphocytic leukemia leusm']\n",
      "['leucemialinfaticacronica acalabrutinib', 'prima linea da solo o', 'combinazione allontana', 'progressione ash19 ecm']\n",
      "['leucemialinfaticacronica acalabrutinib', 'prima linea da solo o', 'combinazione allontana', 'progressione ash19 ecm']\n",
      "['newindicationnotification calquence acalabrutinib', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll']\n",
      "['new indication', 'chronic lymphocytic leukemia cll']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll']\n",
      "['new indication', 'chronic lymphocytic leukemia cll']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll']\n",
      "['new indication', 'chronic lymphocytic leukemia cll']\n",
      "['i3 health sharman', 'chronic lymphocytic leukemia ash19 cll hematology oncology leusm cancernews']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['leucemia linfatica cronica acalabrutinib migliora significativamente il tempo libero da progressione o morte nei pazienti non precedentemente trattati tumore salute']\n",
      "['i risultati di tollerabilit e sicurezza fattori fondamentali', 'questa popolazione di pazienti si sono inoltre rivelati incoraggianti nei', 'bracci di trattamento', 'con acalabrutinib tumore leucemia']\n",
      "['avec un suivi', 'important que donne l acalabrutinib dans', 'lymphome cellules du manteau', 'rechute ou']\n",
      "['jeff sharman md discusses acalabrutinib', 'chronic lymphocytic leukemia ash19']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['mantle cell lymphoma mcl', 'adult patients']\n",
      "['treatment option', 'mantle cell lymphoma mcl', 'adult patients']\n",
      "['treatment option', 'mantle cell lymphoma mcl', 'adult patients']\n",
      "['treatment option', 'mantle cell lymphoma mcl', 'adult patients']\n",
      "['treatment option', 'mantle cell lymphoma mcl', 'adult patients']\n",
      "['treatment option', 'mantle cell lymphoma mcl', 'adult patients']\n",
      "['jeff p sharman md', 'cll trial results', 'acalabrutinib obinutuzumab', 'chlorambucil leusm hematology ash19 ash2019 sharman']\n",
      "['sharman showcases frontline acalabrutinib activity']\n",
      "['sharman showcases frontline acalabrutinib activity', 'cll leukemia sharman']\n",
      "['sharman showcases frontline acalabrutinib activity']\n",
      "['leucemia linfatica cronica acalabrutinib migliora significativamente il tempo libero da progressione o morte nei pazienti non precedentemente trattati']\n",
      "['tumori rari leucemia linfatica cronica l inibitore di btk di nuova generazione acalabrutinib allontana', 'progressione sia da solo che', 'combinazione comitatoimalatiinvisibili imalatiinvisibili comitatoimi comitatoimionlus']\n",
      "['zanubrutinib ash data', 'v v good', 'head2head trial tho need', 'ibrutinib s weak spot']\n",
      "['i ve', 'favourite btki', 'phase i']\n",
      "['acalabrutinib calquence nuevas indicaciones aprobadas para adultos', 'con leucemia linfoc tica cr nica cll o linfoma linfoc tico peque o sll']\n",
      "['leucemia linfatica cronica acalabrutinib migliora significativamente il tempo libero da progressione o morte nei pazienti non precedentemente trattati']\n",
      "['cll sll calquence product approvals drug']\n",
      "['chronic graft versus host disease', 'phase ii trial studies', 'chronic graft versus host disease acalabrutinib', 'effective treatment']\n",
      "['leucemia linfatica cronica acalabrutinib migliora significativamente salutedomani podcast']\n",
      "['ash astrazeneca s calquence posts sky high survival numbers']\n",
      "['abbvie s imbruvica', 'az s']\n",
      "['leucemia linfatica cronica acalabrutinib migliora significativamente il tempo libero da progressione o mo']\n",
      "['leucemia linfatica cronica acalabrutinib migliora significativamente il tempo libero da progressione o mo']\n",
      "['leucemia linfatica cronica acalabrutinib migliora significativamente il tempo libero da progressione o mo']\n",
      "['leucemia linfatica cronica acalabrutinib migliora significativamente il tempo libero da progressione o mo']\n",
      "['leucemia linfatica cronica acalabrutinib migliora significativamente il tempo libero da']\n",
      "['leucemia linfatica cronica acalabrutinib migliora significativamente il tempo libero da progressione o morte leucemia linfatica cronica']\n",
      "['chemist s blog', 'calquence vascepa', 'oxbryta amongst', 'subjects chemistry', 'chem pharma']\n",
      "['strong pfs data', 'hand astrazeneca s calquence']\n",
      "['astrazeneca s calquence', 'fda approval', 'chronic lymphocytic leukemia']\n",
      "['triplet regimen', 'acalabrutinib venetoclax', 'frontline therapy', 'chronic lymphocytic leukemia']\n",
      "['dr furman', 'acalabrutinib monotherapy', 'refractory chronic lymphocytic leukemia leusm cllsm']\n",
      "['astrazeneca s calquence', 'adult patients', 'chronic lymphocytic leukaemia']\n",
      "['calquence acalabrutinib mejora', 'supervivencia libre', 'progresi n', 'leucemia linfoc tica cr nica']\n",
      "['astrazeneca prueba que calquence prolonga', 'con leucemia']\n",
      "['calquence acalabrutinib mejora', 'supervivencia libre', 'progresi n', 'leucemia linfoc tica cr nica']\n",
      "['free survival', 'treatment na ve patients', 'chronic lymphocytic leukemia']\n",
      "['objective responses', 'cll leukemia ash2019 ash19']\n",
      "['astrazeneca s calquence steps', 'line cll pharma regulatory']\n",
      "['calquence acalabrutinib mejora', 'supervivencia libre', 'progresi n', 'con leucemia linfoc tica cr nica seg n los resultados completos del ensayo fase iii elevate tn presentados por']\n",
      "['pharmascrip astrazeneca s calquence steps', 'line cll pharmascrip']\n",
      "['dr lampson', 'acalabrutinib venetoclax', 'cll leukemia ash2019 ash19']\n",
      "['merck s surprise buyout', 'cancer drugs', 'j amp j s imbruvica', 'astrazeneca s calquence']\n",
      "['astrazeneca s calquence steps', 'line cll pharmascrip']\n",
      "['astrazeneca demuestra que calquence prolonga', 'con leucemia linfoc tica cr nica']\n",
      "['presentaci n', 'sobre datos', 'leucemia linfoc tica cr nica']\n",
      "['leukemia rivals', 'chase merck amp', 's surprise buyout', 'cancer drugs', 'j amp amp j amp', 's imbruvica', 'astrazeneca amp', 's calquence']\n",
      "['acalabrutinib calquence', 'time patients', 'disease progression', 'chronic lymphocytic leukaemia news pharma pharmiweb']\n",
      "['calquence acalabrutinib', 'prolonga significativamente el tiempo que los pacientes', 'con leucemia linfoc tica cr nica', 'tratada previamente viven sin progresi n']\n",
      "['astrazeneca s calquence boosts pfs', 'cll patients acalabrutinib']\n",
      "['az calquence boosts pfs', 'cll patients']\n",
      "['ash astrazeneca s calquence posts sky high survival numbers', 'cll fiercepharma cancer clinicalresearch oncology clinicaltrials leukemia drugdevelopment']\n",
      "['dr furman', 'long term data', 'acalabrutinib monotherapy', 'refractory cll cllsm ash19']\n",
      "['l acalabrutinib inhibiteur', 'kinase fait ses preuves', 'premi re ligne dans', 'leuc mie lympho', 'chronique seul ou associ l obinutuzumab pr vention secondaire']\n",
      "['az calquence boosts pfs', 'cll patients news pharmatimes clinicalresearch research phaseiii haematology leukaemia cll randd']\n",
      "['acalabrutinib un inibitore della tirosin kinasi di bruton', 'designazione di terapia fortemente innovativa nel linfoma mantellare']\n",
      "['refractory cll', 'btk inhibitor acalabrutinib leukemia ash2019 ash19']\n",
      "['acalabrutinib monotherapy', 'r r cll']\n",
      "['jeff sharman sharman', 'oncology network', 'elevate tn trial treatment na ve chronic lymphocytic leukaemia cll patients', 'acalabrutinib versus chlorambucil']\n",
      "['strong pfs data', 'hand s calquence']\n",
      "['ash19 dr furman', 'acalabrutinib monotherapy', 'refractory chronic lymphocytic leukemia leukemias']\n",
      "['strong pfs data', 'hand astrazeneca s calquence', 'imbruvica biospace']\n",
      "['chronic lymphocytic leukemia', 'retrospective analysis', 'real world patients ash19 hematology org']\n",
      "['strong pfs data', 'hand astrazeneca s calquence', 'imbruvica biospace jobs ash2019 astrazeneca']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['acalabrutinib benefit', 'long term', 'leukemia ash2019 ash19']\n",
      "['full results', 'phase iii elevate tn trial', 'obinutuzumab vs', 'disease progression']\n",
      "['astrazeneca s calquence', 'fda approval', 'chronic lymphocytic leukemia']\n",
      "['strong pfs data', 'hand astrazeneca s calquence']\n",
      "['astrazeneca s calquence impresses', 'cll pmlive']\n",
      "['astrazeneca s trial', 'leukaemia drug calquence yields', 'positive results']\n",
      "['phase ii study', 'undetectable minimal residual disease', 'bone marrow', 'monthly cycles', 'cll leukemia ash2019 ash19']\n",
      "['astrazeneca s calquence', 'fda approval', 'chronic lymphocytic leukemia']\n",
      "['az calquence boosts pfs']\n",
      "['calquence boosts survival', 'cll patients astrazeneca data shows']\n",
      "['astrazeneca s calquence posts sky high survival numbers']\n",
      "['az calquence boosts pfs', 'cll patients']\n",
      "['tripartite review', 'cll sll', 'project orbis ash19 azn']\n",
      "['dr nicholas richardson', 'new initiative', 'concurrent submission', 'new drug applications', 'regulatory agencies']\n",
      "['congratulations sharman md', 'oral presentation', 'elevate tn']\n",
      "['ash19 az s calquence']\n",
      "['ash19 az s calquence']\n",
      "['az calquence boosts pfs', 'cll patients']\n",
      "['az calquence boosts pfs', 'cll patients']\n",
      "['az calquence boosts pfs', 'cll patients']\n",
      "['astrazeneca reports results', 'calquence acalabrutinib', 'p iii elevate tn study', 'chronic lymphocytic leukemia']\n",
      "['hems oncs', 'acalabrutinib acalabrutinib venetoclax obinutuzumab ibrutinib rituximab ibrutinib venetoclax zanubrutinib ibrutinib', 'data ash19 cll', 'rapid impact report']\n",
      "[]\n",
      "['azn astrazeneca calquence', 'time patients', 'disease progression']\n",
      "['acalabrutinib regimens', 'treatment na ve patients']\n",
      "['astrazeneca s trial', 'leukaemia drug calquence yields', 'positive results pharmaceutical']\n",
      "['astrazeneca s trial', 'leukaemia drug calquence yields', 'positive results']\n",
      "['ash19 az s calquence']\n",
      "['az calquence boosts pfs', 'cll patients healthcare pharma']\n",
      "['btk inhibitor', 'disease progression', 'obinutuzumab chlorambucil cll ash2019 ash19 sharman']\n",
      "['jobs calquence', 'time patients', 'disease progression']\n",
      "['time patients', 'disease progression', 'cll pharma regulatory']\n",
      "['time patients', 'disease progression', 'chroniclymphocyticleukaemia azn']\n",
      "[]\n",
      "['elevate tn ascend ascend calquence calquence65289 cll cll65289']\n",
      "['calquence cll oncologytribune']\n",
      "['calquence cll']\n",
      "['calquence acalarutinib adalah obat baru untuk kanker leukemia yaitu mantle cell lymphoma mcl dan chronic lymphocytic leukimia cll pada', 'drug administration u s government fda telah menyetujui calquence s']\n",
      "['calquence acalarutinib adalah obat baru untuk kanker leukemia yaitu mantle cell lymphoma mcl dan chronic lymphocytic leukimia cll pada', 'drug administration u s government']\n",
      "['calquence cll']\n",
      "['calquence cll']\n",
      "['calquence cll']\n",
      "['calquence cll']\n",
      "['dr richard furman reports results', 'long term', 'r r cll patients', 'w acalabrutinib ash19']\n",
      "['excellent summary', 'dr woyach', 'btki intolerance female sex', 'therapies ldh amp del17p assoc w incr risk', 'acalabrutinib d c', 'univariate analysis', 'pts w progression', 'btk mutations ash19']\n",
      "['congress ash19 jennifer woyach', 'james discusses mechanisms', 'cll lymsm']\n",
      "['dr woyach', 'w cll progression', 'btk mutations', 'btk c481s median time', 'mutation detection', 'mon ash19 cllsm']\n",
      "['dr woyach btk c481 mutations', 'resistant cll', 'clinical relapse', 'months cllsm ash19']\n",
      "['acalabrutinib treatment', 'treatment na ve cll usoncology wvci']\n",
      "['nice coverage', 'ph2 avo study', '1l cll', 'ash2019 triplet therapy', 'chronic lymphocytic leukemia']\n",
      "['updates calquence data', 'line chronic lymphocytic leukaemia', 'rival imbruvica']\n",
      "['acalabrutinib venetoclax', 'frontline therapy', 'cll leukemia ash2019 ash19']\n",
      "['con o sin obinutuzumab mejora', 'llc sciencelink']\n",
      "['complete response', 'undetectable mrd', 'bone marrow', 'dr lampson leusm leukemia']\n",
      "['free survival', 'obinutuzumab chlorambucil', 'treatment na ve chronic lymphocytic leukemia cll']\n",
      "['astrazeneca s btk inhibitor calquence', 'delays disease progression death', 'cll azn ash19']\n",
      "['acalabrutinib triplet', 'frontline cll ash19']\n",
      "['fda approves acalabrutinib', 'cll sll', 'project orbis leusm lymsm hematology']\n",
      "['front line acalabrutinib regimen', 'safe induces', 'complete response', 'chronic lymphocytic leukemia healio front line acalabrutinib regimen', 'safe induces', 'complete response', 'chronic lymphocytic leukemia healio']\n",
      "['ash astrazeneca s calquence posts sky high survival numbers']\n",
      "['acalabrutinib data', 'cll gt acalabrutinib', 'combination improves pfs', 'frontline cll']\n",
      "['amp astrazeneca btk calquence cll ph3']\n",
      "['astrazeneca btk calquence cll ph3']\n",
      "['ash astrazeneca s calquence posts sky high survival numbers']\n",
      "['clinicaltrial acalabrutinib', 'r ice', 'refractory lymphoma']\n",
      "['r ice', 'refractory lymphoma status', 'condition summary diffuse', 'large b cell lymphoma chronic lymphocytic leukemia', 'small lymphocytic leukemia', 'marginal zone lymphoma']\n",
      "['ash astrazeneca s calquence posts sky high survival numbers']\n",
      "['ash astrazeneca s calquence posts sky high survival numbers', 'cll gt gt gt strategy competitiveintelligence', 'pharmaceutical pharma biotech']\n",
      "['ash astrazeneca s calquence posts sky high survival numbers']\n",
      "['ash astrazeneca s calquence posts sky high survival numbers']\n",
      "[]\n",
      "['acalabrutinib treatment', 'treatment na ve cll', 'clinical news']\n",
      "['novel agents', 'triplet acalabrutinib venetoclax obinutuzumab avo ash2019 oncopharm']\n",
      "['positive updates', 'cll patients', 'new treatment options ibrutinib', 'complete remission', 'treatment acalabrutinib']\n",
      "['significant improvement', 'treatment na ve patients', 'cll ash2019 ash19 sharman']\n",
      "['significant improvement', 'treatment na ve cll', 'phase iii elevate tn trial', 'ash19 leusm']\n",
      "['dr lampson lead author', 'phase ii study', 'frontline avo triplet', 'acalabrutinib venetoclax']\n",
      "['acalabrutinib triplet', 'frontline cll ash2019 ash19 lylsm']\n",
      "['location coverage', 'chronic lymphocytic leukemia leusm']\n",
      "['ash19 front line acalabrutinib regimen', 'safe induces', 'complete responses', 'chronic lymphocytic leukemia', 'patients overall response rate', 'complete responses study', 'ben lampson']\n",
      "['huge calquence booth', 'ash19 i']\n",
      "['combination improves pfs', 'frontline cll ash2019 ash19 cll lylsm']\n",
      "['s time', 'spl ash19 brands', 'questions qollor answers', 'gazya check']\n",
      "['headache responds', 'clinic experience', 'dr bruce cheson', 'such thing', 'coffee ash19 acalabrutinib cll']\n",
      "['selective btk inhibitor', 'selective ibrutinib ash19 cll lymsm']\n",
      "['top brands', 'venclexta imbruvica calquence qollor knownow']\n",
      "['ash2019 flight', 'video ads', 'calquence imbruvica novartis', 'baggage claim ash19 nvs gild azn jnj abbv']\n",
      "['triple therapy', 'cll acalabrutinib venetoclax', 'obinutuzumab ash19']\n",
      "['treatment naive chronic lymphocytic leukemia ash19']\n",
      "['ash19 fyi', 'patients d c ibrutinib', 'slow uptake', 'calquence analyst', 'overl y', 'optimistic view', '1l cll gt ramp uptake', 'slow likely peak', 'yrs imho lymsm']\n",
      "['time patients', 'disease progression', 'chronic lymphocytic leukemia', 'full results', 'phase iii elevate tn trial']\n",
      "['astrazeneca calquence', 'time patients', 'disease progression', 'chronic lymphocytic leukemia', 'full results', 'phase iii elevate tn trial']\n",
      "['calquence combination', 'leukemia patients', 'financial news', 'market intelligence', 'fly s', 'real time streami']\n",
      "['acalabrutinib venetoclax', 'w acala x1 month', 'infusion rxn', 'c4 decreases risk', 'tls cll ash19']\n",
      "['acalabrutinib obinutuzumab venetoclax', 'interesting outcome', 'bm mrd neg']\n",
      "['congress ash19 benjamin lampson', 'phase ii data', 'acalabrutinib venetoclax', 'frontline cll therapy', 'high proportion', 'bm umrd amp cr', 'triplet combo', 'disease lymsm']\n",
      "['venetoclax ramp', 'avo w duration', 'active time', 'approach w ven timing', 'low risk', 'w umrd', 'c8 v', 'pts w tp53 loss']\n",
      "['time patients', 'disease progression', 'chronic lymphocytic leukemia']\n",
      "['new research', 'ash19 check', 'press release', 'elevate tn trial', 'chronic lymphocytic leukemia cll']\n",
      "['acalabrutinib obinutuzumab beats chlorambucil obinutuzumab', 'ibrutinib role', 'obinutuzumab unclear', 'frontline btki', 'options ash19 cllsm']\n",
      "['time patients', 'disease progression', 'chronic lymphocy azn']\n",
      "['elevate tn study', 'jeff sharman']\n",
      "['elevate tn phase', 'acalabrutinib combo w obinutuzumab', 'vs o chlorambucil', 'treatment naive cll session', '30am hall d level', 'orange co conv ctr ash19 ash2019']\n",
      "['elevate tn curves', 'detect benefit', 'cll ash19']\n",
      "['ash19 acalabrutinib']\n",
      "['elevate study', 'cll acalabrutinib obinotuzumab vs acala', 'vs chlorambucil obinotuzumab', 'unfit patients', 'invasive aspergillosis', 'acalabrutinib arm', 'selective btk inhibitor']\n",
      "['jeff sharman', 'cll morning session results', 'elevate tn phase', 'trial acalabrutinib obinutuzumab', 'acalabrutinib monotherapy', 'pfs vs obinutuzumab chrorambucil trial', 'pfs comparison', 'combination tx cll leusm ash19']\n",
      "['elevate study g acala vs g chl']\n",
      "['time patients', 'disease progression', 'chronic lymphocytic leukaemia']\n",
      "['acalabrutinib obinutuzumab', 'tn cll opening ash19', 'exciting presentation']\n",
      "['acalabrutinib obinutuzumab', 'acala monotherapy', 'ofs benefit', 'real benefit', 'pts food']\n",
      "['clinicaltrial acalabrutinib', 'ibrutinib intolerant mantle cell lymphoma']\n",
      "['ibrutinib intolerant mantle cell lymphoma status', 'condition summary mantle cell lymphoma']\n",
      "['ibrutinibintolerant mantle cell lymphoma', 'phase ii trial studies', 'mantle cell lymphoma', 'tolerate ibrutinib acalabrutinib']\n",
      "['chronic lymphocytic leukemia cll treatment calquence', 'canadian cancer patients', 'treatment options projectorbis drugandmeddevice']\n",
      "['l homologation acc l r e', 'calquence qui sert traiter', 'leuc mie lympho', 'chronique llc offre d autres options', 'traitement aux canadiens atteints du cancer projetorbis m dicamentsetinstrumentsm dicaux']\n",
      "['ash19 wonder', 'long term outcome curves w calquence', 'mcl lymsm azn bgne']\n",
      "['new clinical trial acalabrutinib', 'ibrutinib intolerant mantle cell lymphoma mcl lymsm hematology']\n",
      "['new clinical trial acalabrutinib', 'r ice', 'refractory lymphoma dlbcl lymsm hematology']\n",
      "['new clinical trial acalabrutinib', 'r ice', 'refractory lymphoma cll leusm hematology']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll']\n",
      "['new indication', 'chronic lymphocytic leukemia cll']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll']\n",
      "['new indication', 'chronic lymphocytic leukemia cll']\n",
      "['open label phase iii elevante tn ace cl', 'trial researchers', 'safety amp efficacy', 'combination w obinutuzumab gazyva vs chlorambucil obinutuzumab', 'treatment na ve patients w cll']\n",
      "['refractory setting', 'deletion 17p']\n",
      "['fda therapy', 'cll scl']\n",
      "['iycmi calquence', 'fda approval', 'cll leukemia cancer chroniclymphocyticleukemia cll']\n",
      "['dr mato', 'ibrutinib versus acalabrutinib', 'cll leusm']\n",
      "['jeezus i m', 'calquence advertisements']\n",
      "['drug administration s approval', 'calquence acalabrutinib', 'adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'exciting treatment option', 'dr john c byrd']\n",
      "['astrazeneca s calquence', 'fda approval', 'chronic lymphocytic leukemia']\n",
      "['acalabrutinib calquence astrazeneca', 'adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['astrazeneca presenta datos', 'calquence para leucemia linfoc tica cr nica']\n",
      "['presentar los datos del ensayo fase iii elevate tn', 'calquence acalabrutinib', 'leucemia linfoc tica cr nica', 'primera l nea', 'como otros avances', 'c nceres hematol gicos']\n",
      "['astrazeneca s calquence', 'fda approval', 'chronic lymphocytic leukemia']\n",
      "['ash19 oncoalert ash19rc top10 abstracts', 'preliminary safety', 'efficacy results', 'acalabrutinib venetoclax', 'chronic lymphocytic leukemia cll lymsm']\n",
      "['ash19 oncoalert ash19rc top10 abstracts elevate tn phase', 'obinutuzumab o', 'vs o', 'chlorambucil clb', 'patients pts', 'treatment naive chronic lymphocytic leukemia cll lymsm']\n",
      "['supplemental approval', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['astrazeneca presentar', 'diciembre los primeros datos', 'leucemia linfoc tica cr nica']\n",
      "['industria presenta datos', 'calquence para leucemia linfoc tica cr nica']\n",
      "['s fridayfact', 'recent fda approval', 'cll amp sll dyk leukemia lymphoma chroniclymphocyticleukemia smalllymphocyticlymphoma fdaapproval oncology hematology hematologist oncologist']\n",
      "['industriafarmac utica astrazeneca presenta datos', 'calquence para leucemia linfoc tica cr nica']\n",
      "['astrazeneca presenta nuevos datos', 'leucemia linfoc tica cr nica esalud marketingparamedicos saluddigital']\n",
      "['nuevos datos', 'sobre calquence', 'leucemia linfoc tica cr nica']\n",
      "['tag calquence']\n",
      "['drug administration drug approvals updates', 'thursday november', 'calquence nda', 'deferasirox anda', 'givlaari nda']\n",
      "['fda approves acalabrutinib', 'sll evidence', 'elevate tn', 'ascend studies lymsm leusm']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll lymsm']\n",
      "['cognitrexcancerdigest fda approves astrazeneca s calquence']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['weekly drug news', 'fda drug approval news', 'week oxbryta', 'novel agent', 'sickle cell disease', 'ok d', 'partial onset seizures', 'calquence gains', 'new cancer use']\n",
      "['international collaboration approves', 'new treatment option', 'chroniclymphocyticleukemia calquence ddnewsusfda viglya4growth']\n",
      "['title calquence', 'cll sllcategory health', 'amlast editorial review']\n",
      "[]\n",
      "['astrazeneca s calquence', 'fda approval', 'chronic lymphocytic leukemia biospace jobs']\n",
      "['leukemia astrazeneca fda']\n",
      "['cll sll']\n",
      "['cll sll ven calquence', 'fda approval', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll acalabrutinib']\n",
      "['cll sll']\n",
      "['clinicaltrial study', 'chronic lymphocytic leukemia']\n",
      "['fda approves acalabrutinib', 'sll evidence', 'elevate tn', 'ascend studies lylcl lymphoma']\n",
      "['fda approves calquence']\n",
      "['fda approves calquence', 'treatment option']\n",
      "['astrazeneca s calquence', 'fda approval', 'chronic lymphocytic leukemia']\n",
      "['astrazeneca s calquence', 'fda approval', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia status', 'condition summary chronic lymphocytic leukemia binet']\n",
      "['astrazeneca s calquence', 'fda approval', 'chronic lymphocytic leukemia']\n",
      "['cll sll']\n",
      "['astrazeneca s calquence', 'fda approval', 'chronic lymphocytic leukemia']\n",
      "['leucemialinfatica cronica fda approva acalabrutinib ecm']\n",
      "['leucemialinfatica cronica fda approva acalabrutinib ecm']\n",
      "['new clinical trial study', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "[]\n",
      "['leucemia linfatica cronica fda approva acalabrutinib informatori news isf pharma farmaci informatoriscientifici']\n",
      "['calquence cll sll']\n",
      "['calquence cll']\n",
      "['cll sll']\n",
      "['cll sll title calquence', 'cll sll category health news', 'editorial review']\n",
      "['cll sll']\n",
      "['fda approves astrazeneca s calquence', 'chronic lymphoma pharmafile']\n",
      "['fda approves astrazeneca s calquence', 'chronic lymphoma pharmafile']\n",
      "['cll sll']\n",
      "[]\n",
      "['media release acalabrutinib', 'tga approval', 'sll cancers', 'acalabrutinib calquence', 'chronic lymphocytic leukaemia', 'small lymphocytic leukaemia']\n",
      "['mantle cell lymphoma mcl', 'open lymsm']\n",
      "['fda approves calquence', 'chronic lymphocytic leukemia']\n",
      "['fda approves calquence', 'chronic lymphocytic leukemia']\n",
      "['cll sll']\n",
      "['trial results']\n",
      "['astrazeneca scores', 'btk race heats']\n",
      "['fda acalabrutinib']\n",
      "['calquence uses side', 'interactions amp']\n",
      "['acalabrutinib uses side', 'interactions amp']\n",
      "['fda nod']\n",
      "[]\n",
      "['fda approves astrazeneca s calquence', 'chronic lymphoma']\n",
      "['fda approves astrazeneca s calquence', 'chronic lymphoma pharmaceutical']\n",
      "['astrazeneca s calquence', 'fda approval', 'chronic lymphocytic leukemia pharma regulatory']\n",
      "['astrazeneca s calquence catches', 'imbruvica s cll claim pharma regulatory']\n",
      "['astrazeneca s calquence', 'fda approval', 'chronic lymphocytic leukemia']\n",
      "['novel drugs givlaari', 'project orbis collaboration calquence', 'humira biosimilar']\n",
      "['dr mato', 'ibrutinib versus acalabrutinib', 'cll cllsm leukemia']\n",
      "['new treatment option', 'fda approval', 'james improves outcomes', 'cancer cells']\n",
      "['astrazeneca s calquence', 'fda approval', 'chronic lymphocytic leukemia']\n",
      "['astrazeneca s calquence', 'fda approval', 'chronic lymphocytic leukemia']\n",
      "['fda nod']\n",
      "[]\n",
      "['astrazeneca s calquence', 'fda approval', 'chronic lymphocytic leukemia']\n",
      "['astrazeneca s calquence', 'fda approval', 'chronic lymphocytic leukemia']\n",
      "['treatments f nonhodgkinslymphoma']\n",
      "['cll sll digestive']\n",
      "['label expansion', 'btk inhibitor calquence', 'rhhby azn biib gild']\n",
      "['tag acalabrutinib', 'tga approval', 'sll cancers']\n",
      "['project orbis', 'adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['mantle cell lymphoma medivizor']\n",
      "[]\n",
      "[]\n",
      "[]\n",
      "['project orbis', 'simultaneous approval', 'calquence acalabrutinib', 'australia shows', 'oncology breakthroughs', 'cll fda']\n",
      "['astrazeneca s calquence steps', 'challenge imbruvica', 'big cll green']\n",
      "['fda approves acalabrutinib', 'cll sll']\n",
      "['calquence cll sll calquence acalabrutinib cll sll']\n",
      "['fda acalabrutinib']\n",
      "['pharmascrip astrazeneca s calquence catches', 'imbruvica s cll claim pharmascrip']\n",
      "['canada bloodcancers']\n",
      "['astrazeneca s calquence catches', 'imbruvica s cll claim pharmascrip']\n",
      "['fda approves acalabrutinib', 'cll sll']\n",
      "['cll sll']\n",
      "['drug administration fda', 'astrazeneca s calquence acalabrutinib', 'chronic lymphocytic leukaemia cll', 'small lymphocytic lymphoma sll']\n",
      "[]\n",
      "['cll sll']\n",
      "['adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic']\n",
      "['fda s project orbis initiative', 'phase iii', 'trials elevate tn', 'ascend leukemia lymphoma']\n",
      "['chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'subsequent therapy', 'cancer ps hematologyconferences cancerconferences hematology cancer']\n",
      "['drs john byrd', 'jen woyach james hematology', 'fda approval', 'generation btk inhibitor acalabrutinib']\n",
      "['astrazeneca scores', 'btk race heats']\n",
      "['long term f u study', 'cross trial comparisons ibrutinib', 'cr rate vs', 'long term']\n",
      "['cll sll']\n",
      "['astrazeneca s calquence steps', 'challenge imbruvica', 'big cll green', 'market share', 'imbruvica azn oncology pharma']\n",
      "['friday s company news roundup', 'label expansion', 'astrazeneca s calquence', 'project orbis', 'fda canada', 'viiv neon horizon sk bio', 'wuxi vaccines azn ntgn']\n",
      "['cll sll mednews']\n",
      "['fda approves acalabrutinib', 'cll indication']\n",
      "['calquence cll sll']\n",
      "['calquence cll']\n",
      "['astrazeneca scores', 'btk race heats']\n",
      "['fda approval', 'chronic lymphoma pmlive']\n",
      "['calquence acalabrutinib efficacy', 'btk inhibitor', 'adult patients', 'mantle cell lymphoma location', 's date dec', 'pm rsvp jason mcdonald', 'jason mcdonald2 com']\n",
      "['cll sll']\n",
      "[]\n",
      "[]\n",
      "[]\n",
      "[]\n",
      "[]\n",
      "[]\n",
      "[]\n",
      "[]\n",
      "[]\n",
      "[]\n",
      "[]\n",
      "[]\n",
      "['u s fda', 'calquence acalabrutinib capsules', 'adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['astrazeneca s calquence', 'fda approval', 'chronic lymphocytic leukemia biospace']\n",
      "['cll sll']\n",
      "['project orbis fda approves acalabrutinib']\n",
      "['fda approves calquence', 'chronic lymphocytic leukemia']\n",
      "['cll sll']\n",
      "['fda approves acalabrutinib']\n",
      "['fda approves acalabrutinib']\n",
      "['key fda approval expands', 'common chronic lymphocytic leukemia']\n",
      "['fda nod']\n",
      "['new treatment option', 'fda approval', 'james improves outcomes', 'cancer cells']\n",
      "['acalabrutinib fda', 'surrogate endpoint', 'btki metoodrug thebarislowforfdaapproval cllsm']\n",
      "['calquence ok boosts astrazeneca s challenge', 'new fda approval expands calquence amp', 'common blood cancer']\n",
      "['calquence ok boosts astrazeneca s challenge', 'new fda approval expands calquence amp', 'common blood cancer']\n",
      "['fda nod', 'calquence line']\n",
      "['fda nod', 'cll pharmanews healthcare']\n",
      "['acalabrutinib occurs', 'superior safety profile', 'ibrutinib lymphoma']\n",
      "['international collaboration project orbis approves', 'new treatment option', 'chronic lymphocytic leukemia calquence acalabrutinib']\n",
      "['drug administration fda', 'astrazeneca s calquence acalabrutinib', 'chronic lymphocytic leukaemia cll', 'small lymphocytic lymphoma sll']\n",
      "['fda nod']\n",
      "['astrazeneca scores', 'btk race heats', 'gt gt gt strategy competitiveintelligence', 'biotech pharmaceutical', 'healthcare pharma']\n",
      "[]\n",
      "['astrazeneca scores', 'btk race heats']\n",
      "['astrazeneca s calquence steps', 'challenge imbruvica', 'big cll green']\n",
      "['adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'subsequent therapy leusm']\n",
      "['fda nod', 'az s calquence', 'new imbruvica showdown']\n",
      "['astrazeneca s calquence garners fda approval', 'chronic lymphocytic leukaemia', 'small lymphocytic lymphoma']\n",
      "['fda nod', 'az s calquence', 'new imbruvica showdown']\n",
      "['amazing grand rounds', 'upfront therapy', 'young fit pts', 'good risk disease', 'real potential', 'cure ibrutinib va acalabrutinib vs obinutuzumab venetoclax']\n",
      "['supplemental approval', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['fda approval', 's calquence', 'chronic lymphocytic leukaemia', 'j amp j s imbruvica']\n",
      "['phase iii data astrazeneca', 'fda approval', 'btk inhibitor calquence', 'common adult blood cancers chronic lymphocytic']\n",
      "['astrazeneca scores', 'btk race heats']\n",
      "['jobs fda nod', 'cll pharmatimes']\n",
      "['fda nod', 'cll pharma regulatory']\n",
      "['broader label', 'usa pharma']\n",
      "['international collaboration', 'astrazeneca s', 'new treatment option', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukaemia']\n",
      "['fda approves acalabrutinib', 'cll sll', 'w amp projectorbis', 'singapore healthsciencesauthority amp switzerland hematology lymsm']\n",
      "['fda approval', 'chronic lymphoma pharma regulatory']\n",
      "['adult patients']\n",
      "['pharma industry news november', 'roche launches atezolizumab', 'india laurus labs vidakhapatnam units usfda inspection', 'astrazeneca s calquence', 'usfda pharmaindustrynews roche laurus zydus calquence novo merz']\n",
      "['azn baml astrazeneca calquence cll approval', 'strong label']\n",
      "['astrazeneca s calquence garners fda approval', 'chronic lymphocytic leukaemia', 'small lymphocytic lymphoma azn']\n",
      "['fda approves acalabrutinib']\n",
      "['azn astrazeneca astrazeneca calquence', 'record time', 'neutral 7950p vs 7700p', 'neutral 7950p vs 7700p', 'record time', 'cll calquence', 'equity stocks']\n",
      "['international project orbis collaboration', 'sll leusm lymsm hemeonc']\n",
      "['fda approves acalabrutinib']\n",
      "['supplemental approval', 'sll leukemia haszn lat val']\n",
      "['astrazeneca s calquence acalabrutinib', 'fda s approval', 'chronic lymphocytic leukemia', 'project orbis']\n",
      "['jobs fda approves astrazeneca s calquence', 'lymphocytic cancers drugdiscovery']\n",
      "['international collaboration approves', 'new treatment option calquence acalabrutinib astrazeneca', 'chronic lymphocytic leukemia fda']\n",
      "['irreversible selective btki', 'cll sll']\n",
      "['cll sll acalabrutinib fda fda oncologytribune']\n",
      "['generation btk inhibitor acalabrutinib']\n",
      "['fda approves azn s calquence glyc s data', 'enlv withdraws offering nasdaq']\n",
      "['fda approves azn s calquence glyc s data', 'enlv withdraws offering news']\n",
      "['fda approves azn s calquence glyc s data', 'enlv withdraws offering']\n",
      "['calquence acalabrutinib', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll calquence']\n",
      "['fda tga', 'canadian regulatory authorities', 'new treatment', 'cll acalabrutinib', 'generation btk', 'usual treatments']\n",
      "['fda approves calquence', 'chronic lymphocytic leukemia']\n",
      "['project orbis fda approves acalabrutinib', 'sll orbis fda acalabrutinib cll sll']\n",
      "['astrazeneca s calquence steps', 'challenge imbruvica', 'big cll green']\n",
      "['adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma leukemia lymphoma']\n",
      "['fda approves calquence', 'chronic lymphocytic leukemia']\n",
      "['regulatory news', 'food amp drug administration drug approvals updates', 'thursday november', 'calquence nda', 'deferasirox anda', 'givlaari nda', 'others fda']\n",
      "['biotech updates', 'glyc data delay', 'azn calquence fda approval intra day offerings ontx', 'enlv withdraws offering pipeline updates biib enta entx imrn iova sny tnxp xers']\n",
      "['fda approves acalabrutinib']\n",
      "['astrazeneca s calquence steps', 'challenge imbruvica', 'big cll green']\n",
      "['fda approves acalabrutinib']\n",
      "['fda approves acalabrutinib']\n",
      "['fda approves acalabrutinib', 'cll sll', 'project orbis', 'asco post', 'tremendous initiative orbis', 'reg agencies']\n",
      "['certain patients', 'chronic lymphocytic leukemia cll']\n",
      "['australia canada', 'new drug', 'blood cancers']\n",
      "['astrazeneca s calquence acalabrutinib', 'adult patients', 'chronic lymphocytic leukaemia cll', 'small lymphocytic lymphoma sll']\n",
      "['fda approves calquence', 'chronic lymphocytic leukemia', 'international collaboration']\n",
      "['project orbis fda approves acalabrutinib', 'sll oncology newsburst']\n",
      "['fda update', 'u s food', 'drug administration fda', 'acalabrutinib calquence astrazeneca', 'adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['fda approves acalabrutinib', 'cll sll', 'project orbis hematology lymsm']\n",
      "['fda approves acalabrutinib', 'cll indication']\n",
      "['additional option', 'cll sll patients head', 'acalabrutinib vs ibrutinib', 'fda approves', 'new treatment option']\n",
      "['fda aprueba acalabrutinib', 'el tratamiento', 'llc sciencelink']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['acalabrutinib calquence astrazeneca', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'drug label']\n",
      "['project orbis fda approves acalabrutinib']\n",
      "['new drug', 'btk inhibitor acalabrutinib', 'treatment options', 'patients targetedtherapy']\n",
      "['adult patients', 'chronic lymphocytic leukemia']\n",
      "['project orbis fda approves acalabrutinib']\n",
      "['adult patients', 'chronic lymphocytic leukemia', 'phase iii calquence trials', 'superior progressionfree survival', 'multiple settings', 'favorable tolerabilitycalquence']\n",
      "['astrazeneca s calquence steps', 'challenge imbruvica', 'big cll green']\n",
      "['awesomecapital fda', 'astrazeneca s calquence']\n",
      "['azn calquence', 'adult patients', 'chronic lymphocytic leukemia']\n",
      "['elevate tn', 'ascend trials', 'tx regimens acalabrutinib', 'meaningful improvement', 'multiple settings', 'favorable tolerability', 'safety profile']\n",
      "['drug name drugnames pharmacists oncologypharmacists']\n",
      "['calquence acalabrutinib', 'adult patients', 'chronic lymphocytic leukaemia']\n",
      "['astrazeneca s calquence', 'lymphocytic leukemia azn']\n",
      "['azn fda', 'astrazeneca s calquence', 'lymphocytic leukemia']\n",
      "['week s pod', 'acalabrutinib s cll sll approval']\n",
      "['fda approves acalabrutinib']\n",
      "['fda approves acalabrutinib', 'cll sll']\n",
      "[]\n",
      "[]\n",
      "['exciting ash fda approves acalabrutinib']\n",
      "['new drug approval copy paste error', 'grade aes', 'gr3 aes']\n",
      "['astrazeneca s calquence steps', 'challenge imbruvica', 'big cll green', 'light gt gt gt strategy competitiveintelligence', 'pharma pharmaceutical healthcare biotech']\n",
      "['astrazeneca s calquence steps', 'challenge imbruvica', 'big cll green', 'light azn abbv jnj pharma']\n",
      "['adult patients', 'chronic lymphocytic leukaemia']\n",
      "['fda approves acalabrutinib']\n",
      "['generation btk inhibitor', 'fda s project orbis gt fda approves acalabrutinib']\n",
      "['astrazeneca s calquence steps', 'challenge imbruvica', 'big cll green']\n",
      "['fda grants supplemental approval', 'calquence acalabrutinib', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['great news approves acalabrutinib']\n",
      "['excellent news', 'effective treatment option', 'ibrutinib fda approves acalabrutinib', 'cll sll']\n",
      "['astrazeneca s calquence steps', 'challenge imbruvica', 'big cll green', 'light pharma regulatory']\n",
      "['acalabrutinib calquence', 'adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['secondary malignancy', 'imbruvica s']\n",
      "['oncopharm news', 'projectorbis acalabrutinib', 'sll leukemia lymphoma lymsm leuksm']\n",
      "['fda approves acalabrutinib']\n",
      "['cll sll', 'therapeutic options']\n",
      "['international collaboration approves', 'new treatment option', 'chronic lymphocytic leukemia fda acalabrutinib leusm cllsm']\n",
      "['fda approves calquence', 'chronic lymphocytic leukemia', 'international collaboration']\n",
      "['supplemental approval', 'calquence acalabrutinib', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['cll fda approves acalabrutinib']\n",
      "['fda approves acalabrutinib']\n",
      "['proud ro', 'frontline phase iii trial', 'ash cllsm']\n",
      "['projectorbis action acalabrutinib']\n",
      "['fda approves acalabrutinib', 'cll lymsm']\n",
      "['fda approves acalabrutinib']\n",
      "['fda approves acalabrutinib', 'cll lylsm']\n",
      "['fda approves calquence', 'chronic lymphocytic leukemia', 'international collaboration']\n",
      "['fda approves calquence', 'chronic lymphocytic leukemia', 'international collaboration']\n",
      "['fda highlights', 'project orbis success azn s calquence']\n",
      "[]\n",
      "[]\n",
      "[]\n",
      "['early obinutuzumab', 'high risk recurrent', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'phase ii trial studies']\n",
      "['new clinical trial acalabrutinib', 'early obinutuzumab', 'high risk recurrent', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll leusm hematology']\n",
      "['ash newsletter', 'elevate tn study', 'acalabrutinib obinutuzumab vs obinutuzumab chlorambucil', 'cll lymsm oncology']\n",
      "['indepth evaluation', 'mantlecell lymphoma regimens', 'intensive immunochemotherapy', 'highdose therapy', 'autologous stem cell transplant', 'standard treatment renalcell kidneycancer']\n",
      "['chronic lymphocytic leukemia cll acalabrutinib improves progression', 'free survival']\n",
      "['new article', 'depth evaluation', 'mantle cell lymphoma mcl lymsm hematology']\n",
      "['depth evaluation', 'mantle cell lymphoma lymphoma lymsm']\n",
      "['pascal soriot', 'chine est', 'astrazeneca aussi', 'profitable que l europe usa pharma biotech china fda health calquence brukinsa china drugs oncology imbruvica mantlecelllymphoma']\n",
      "['globe acalabrutinib', 'western populations', 'new fda approval', 'positive step']\n",
      "['beigene fda cancer drug nod', 'chinese biopharma', 'j amp amp j', 'abbvie amp', 's imbruvica', 'astrazeneca amp', 's calquence']\n",
      "['j amp j', 'abbvie s imbruvica', 'astrazeneca s calquence']\n",
      "['new article elevate tn phase', 'obinutuzumab o', 'vs o', 'chlorambucil clb', 'patients pts', 'treatment naive chronic lymphocytic leukemia cll cll leusm hematology']\n",
      "['new article', 'preliminary safety', 'efficacy results', 'acalabrutinib venetoclax', 'chronic lymphocytic leukemia cll cll leusm hematology']\n",
      "['great honor', 'irreversible btk inhibitors ibrutinib acalabrutinib', 'great benefits', 'whole new class', 'reversible btk inhibitors']\n",
      "['chronic lymphocytic leukemia cll acalabrutinib improves pfs', 'obinutuzumab interim results', 'elevate tn trial', 'ash19 hematology cancernews']\n",
      "['interesting discussion', 'elevate tn trial', 'acalabrutinib obinutuzumab vs obinutuzumab chlorambucil', 'cll data', 'ash19 oncology']\n",
      "['experience acalabrutinib', 'cll trials n', 'r r', 'r r', 'intol pts median fup 5m dc', 'short fup', 'ibr intol population', 'nice wk yazdy ash19']\n",
      "['indirect comparisons', 'acalabrutinib versus', 'refractory mantle cell lymphoma lymphoma lymsm']\n",
      "['new article', 'indirect comparisons', 'acalabrutinib versus', 'refractory mantle cell lymphoma mcl lymsm hematology']\n",
      "['btk inhibition', 'btk occupancy', 'ultimate mechanism', 'pts pre clinical relapse', 'ibrutinib acalabrutinib ash19']\n",
      "['btk mut key mech resistance', 'cll btk c481', 'c481r c481y', 'pt btk c481s co', 'plcg2 mut', 'pt mut detect', 'initiation time', 'mut gt relapse 12m ash19']\n",
      "['aonn2019 conference', 'adverse events', 'r r mcl', 'acalabrutinib clinical experience', 'dr mcl']\n",
      "['chlorambucil obinutuzumab control arm', 'significant diff']\n",
      "['leucemia linfatica cronica maggiore efficacia di calquence', 'monoterapia rispetto alla chemioimmunoterapia']\n",
      "['elevate tn trial', 'acalabrutinib obinutuzumab', 'vs obinutuzumab chlorambucil', 'treatment naive cll lymsm']\n",
      "['btk acalabrutinib elevate tn ash']\n",
      "['new article', 'mantle cell lymphoma design development', 'therapy mcl lymphoma hematology']\n",
      "['new advancements', 'robust hematology portfolio', 'breakthrough phase iii data', 'elevate tn study', 'chronic lymphocytic leukemia cll']\n",
      "['calquence data', 'free survival', 'phase iii front line chroniclymphocyticleukaemia trial']\n",
      "['calquence data', 'free survival', 'phase iii front line chronic lymphocytic leukemia', 'annual meeting']\n",
      "['calquence data', 'free survival', 'phase iii front line chronic lymphocytic leukemia', 'annual meeting business wire']\n",
      "['calquence data', 'free survival', 'phase iii front line chronic lymphocytic leukemia']\n",
      "['calquence data', 'progressionfree survival', 'phase iii frontline chronic lymphocytic leukemia', 'annual meeting robust earlystage pipeline advancements', 'multiple scientific platforms']\n",
      "['combination acalabrutinib', 'free survival']\n",
      "[]\n",
      "['ash abstracts', 'online elevate tn trial', 'treatment naive cll', 'mos pfs', 'acala o', 'acala mono food', 'co author', 'study sharman']\n",
      "['calquence data']\n",
      "['calquence data', 'free survival', 'phase iii front line chronic lymphocytic leukaemia trial', 'annual meeting']\n",
      "['dr wang', 'bendamustine rituximab', 'mcl mclsm lymphoma']\n",
      "['baml azn', 'busy year end', 'pipeline newsflow focus', 'calquence 1l cll data ash abstract', 'nov roxadustat anaemia piii cv data asn', 'pivotal destiny breast01']\n",
      "['jonathon cohen', 'obinutizumab acalabrutinib', 'science summit']\n",
      "['indirect comparisons', 'acalabrutinib versus', 'refractory mantle cell lymphoma']\n",
      "['health canada', 'calquence acalabrutinib', 'mantle cell lymphoma mcl', 'therapy drugandmeddevice cancer']\n",
      "['sant canada', 'homologu calquence acalabrutinib', 'les adultes atteints', 'lymphome cellules du manteau lcm ayant essay au moins un traitement m dicamentsetinstrumentsm dicaux cancer']\n",
      "['abbvie s imbruvica', 'az s']\n",
      "['abbvie s imbruvica', 'az s']\n",
      "['abbvie s imbruvica', 'az s']\n",
      "['abbvie s imbruvica', 'az s', 'gt gt gt strategy competitiveintelligence', 'pharma biotech healthcare']\n",
      "['abbvie s imbruvica', 'az s', 'health blog']\n",
      "['abbvie s imbruvica', 'az s', 'pharma regulatory']\n",
      "['prediction calquence', '1l cll', 'approval max peak market share', 'imbruvica data', '1l risk status subtypes', 'nccn language']\n",
      "['stellar trial', 'richters transformation', 'treatment pathway', 'important partners study', 'awful disease', 'desperate need', 'treatment advances lymsm']\n",
      "['dr siddiqi', 'treatment landscape', 'chronic lymphocytic leukemia', 'phase iii ascend trial leukemia leusm']\n",
      "['primary reason patients', 'lead study author dr rogers leukemia']\n",
      "['competitive data', 'calquence leukemia study', 'oncology sales']\n",
      "['btk inhibitor acalabrutinib', 'high rate', 'high tolerability', 'chronic lymphocytic leukemia', 'ibrutinib leusm leukemia']\n",
      "['b cell lymphoma', 'colleague julie durocher']\n",
      "['grand round', 'lymphoma therapy', 'mcgill university acalabrutinib', 'eric kader', 'beautiful montr']\n",
      "['b cell lymphoma thanks', 'colleague paul vardanis']\n",
      "['year outcomes', 's1106 study', 'r hyper cvad vs r bendamustine', 'mantle cell lymphoma pre asct', 'favorable outcomes', 'r b supports study', 'r b', 'acalabrutinib cytarabine']\n",
      "['svb leerink s porges', 'biopharma deals', 'decade value', 'plough keytruda bmy medarex opdivo gild vrus sovaldi sny genzyme azn acerta calquence']\n",
      "['btk inhibitor acalabrutinib', 'high rate', 'high tolerability', 'chronic lymphocytic leukemia', 'ibrutinib bloodcancer']\n",
      "['agents ibrutinib acalabrutinib', 'refractory space', 'upfront setting', 'cll cllsm mclsm lymphoma leukemia']\n",
      "['acalabrutinib breakthrough designation', 'cllsm leukemia']\n",
      "['acalabrutinib shows benefit', 'refractory cll cllsm leukemia']\n",
      "['dr wang', 'toxicity profiles', 'ibrutinib acalabrutinib', 'mcl mclsm lymphoma']\n",
      "['durable response', 'agent acalabrutinib', 'refractory mantle cell lymphoma lymsm']\n",
      "['michael wang m d', 'lymphoma amp myeloma discusses', 'toxicity profiles', 'btk inhibitors ibrutinib acalabrutinib', 'mantle cell lymphoma mcl endcancer lymsm']\n",
      "['astrazeneca canada s calquence acalabrutinib', 'health canada approval', 'mantle cell lymphoma mcl']\n",
      "['health canada approves calquence acalabrutinib', 'adult patients', 'mantle cell lymphoma']\n",
      "['health canada approves calquence acalabrutinib', 'adult patients', 'mantle cell lymphoma mcl']\n",
      "['azn astrazeneca s calquence ok d']\n",
      "['dr eradat discusses data', 'cll cllsm leukemia']\n",
      "['regulatory approval', 'alternative agent', 'tolerate ibrutinib', 'eradat md leusm']\n",
      "['initial trials', 'promising activity', 'generation inhibitor ibrutinib', 'eradat md']\n",
      "['durable response', 'agent acalabrutinib', 'refractory mantle cell lymphoma']\n",
      "['dr eradat discusses data']\n",
      "['chemotherapy regimens', 'mantle cell lymphoma', 'phase ii trial compares', 'chemotherapy regimens', 'bendamustine rituximab high dose cytarabine']\n",
      "['paolo ghia', 'excellent summary', 'novel btk inhibitors', 'resistance eshlymphoid2019']\n",
      "['arm phase ii study', 'bendamustine rituximab highdose cytarabine bendamustine rituximab highdose cytarabine acalabrutinib bendamustine rituximab acalabrutinib']\n",
      "['bruton s tyrosine kinase btk', 'bio targets irreversible inhibitors ibrutinib', 'reversible inhibitors', 'chimera protac', 'target btk']\n",
      "['time efforts']\n",
      "['wang rule', 'long term results ace', 'fup 26m acalabrutinib r r mcl orr', 'pet mdor 26m mpfs 20m headache', 'diarrhoea fatigue aes', 'af rx d c pd', 'ki67 option', 'acala vs', 'mcl lymsm']\n",
      "['durable response', 'agent acalabrutinib', 'refractory mantle cell lymphoma lymphoma lymsm']\n",
      "['durable response', 'agent acalabrutinib', 'refractory mantle cell lymphoma lymsm lymphoma']\n",
      "['acalabrutinib macht ibrutinib', 'der therapie der cll konkurrenz']\n",
      "['ascend study results', 'superior tolerability', 'acalabrutinib vs rituximab', 'r r cll', 'high risk']\n",
      "['access articles', 'benda r', 'mcl trials', 'molecular pathogenesis', 't cell lymphoma lymsm']\n",
      "['fda otorga', 'designaci n', 'terapia innovadora', 'acalabrutinib para', 'leucemia linfoc tica cr nica ecancer']\n",
      "['relapsedrefractory bcell nonhodgkin lymphoma nccn guidelines', 'b cell lymphoma', 'aggressive nhl', 'highdose renalcell kidneycancer']\n",
      "['dr siddiqi acalabrutinib', 'fda acalabrutinib', 'toxicity profile', 'ibrutinib leusm leukemia']\n",
      "['clinicaltrial acalabrutinib', 'refractory b cell non hodgkin lymphoma']\n",
      "['refractory b cell non hodgkin lymphoma status', 'condition summary non hodgkin lymphoma b cell']\n",
      "['dr siddiqi acalabrutinib', 'fda cllsm hematology']\n",
      "['fda calquence fda', 'breakthrough therapy designation']\n",
      "['dr siddiqi', 'treatment landscape', 'chronic lymphocytic leukemia', 'phase iii ascend trial cllsm leusm']\n",
      "['jp azn ceo', 'takeaways bullish', 'strong topline growth ceo pascal soriot ps', 'astra s', 'strong topline growth outlook', 'numerous recent positive clinical trial datapoints', 'new launch products tagrisso imfinzi lynparza farxiga calquence']\n",
      "['congress soho2019', 'jennifer woyach', 'rr pfs nr', 'tp53 loss lymphoma lymsm']\n",
      "['congress soho2019', 'exciting data', 'acalabrutinib benda rituximab', 'rr patients', 'mcl orr', 'rr cr', 'lymsm lymphoma']\n",
      "['baml azn top', 'class growth', 'sales cagr', 'pipeline catalysts', 'delta vs cons roxa', 'busy 2h', 'lynparza roxa', 'calquence data fy20', 'assets inc tezepelumab epanova']\n",
      "['calquence api', 'brexit raps']\n",
      "['acalabrutinib monotherapy', 'chronic lymphocytic leukemia']\n",
      "['zanubrutinib acalabrutinib venetoclax', 'ofatumumab rmelivewm soho2019houston']\n",
      "['calquence acalabrutinib', 'breakthrough therapy designation btd', 'chronic lymphocytic leukemia']\n",
      "['commercial impact', 'top non hodgkin lymphoma data', 'asco oncologists analyze lenalidomide rituximab polatuzumab vedotin obinutuzumab lenalidomide acalabrutinib pembrolizumab', 'sample report']\n",
      "['regulatory news astrazeneca', 'calquence api', 'brexit raps']\n",
      "['acalabrutinib versus chlorambucil', 'adult subjects', 'chronic lymphocytic leukemia status', 'condition summary', 'chronic lymphocytic leukemia']\n",
      "['clinicaltrial study', 'acalabrutinib versus chlorambucil', 'adult subjects', 'chronic lymphocytic leukemia']\n",
      "['az s calquence']\n",
      "['eu regulatory roundup astrazeneca', 'calquence api', 'brexit raps']\n",
      "['eu regulatory roundup astrazeneca', 'calquence api']\n",
      "['eu regulatory roundup astrazeneca', 'calquence api', 'brexit pharma regulatory']\n",
      "['eu regulatory roundup astrazeneca', 'calquence api', 'brexit regulatory focus']\n",
      "['disease models', 'b cell malignancies', 'novel agents', 'lymphomas examples', 'bortexomib lenalidomide ibrutinib']\n",
      "['rogers md', 'chronic lymphocytic leukemia acalabrutinib', 'treatment naive', 'refractory disease hematology leusm']\n",
      "['primary malignancy cllsm leusm']\n",
      "['az calquence', 'breakthrough therapy designation']\n",
      "['acalabrutinib monotherapy']\n",
      "['fda grants breakthrough designation', 'acalabrutinib monotherapy', 'chronic lymphocytic leukemia cll']\n",
      "['astrazeneca fda calquence acalabrutinib btd cll cll']\n",
      "['kerry rogers md', 'james discusses', 'ibrutinib intolerant patients', 'refractory cll']\n",
      "['high orrs', 'survival benefits', 'good tolerability', 'refractory cll', 'phase ii trial']\n",
      "['acalabrutinib shows benefit', 'refractory cll']\n",
      "['acalabrutinib shows benefit', 'refractory cll']\n",
      "['acalabrutinib shows benefit', 'refractory cll']\n",
      "['acalabrutinib shows benefit', 'refractory cll']\n",
      "['acalabrutinib trial']\n",
      "['acalabrutinib trial']\n",
      "['acalabrutinib key clinical data']\n",
      "['fda grants breakthrough therapy designation']\n",
      "['excellent news', 'cll patients cllsm calquence']\n",
      "['acalabrutinib key clinical data']\n",
      "['breakthrough therapy designation', 'chronic lymphocytic leukaemia cll']\n",
      "['astrazeneca s juggernaut parp player lynparza scoops']\n",
      "['astrazeneca s calquence', 'breakthrough therapy designation', 'chronic lymphocyticleukemia', 'site news', 'designation healthcare']\n",
      "['astrazeneca calquence', 'fda s breakthrough status']\n",
      "['azn priority medicines', 'oncology need', 'tagrisso calquence lynparza imfinzi', 'respiratory fasenra', 'cvrm farxiga lokelma brilinta', 'roxadustat fgen']\n",
      "['phase iii elevate tn', 'ascend studies', 'disease progression', 'standard regimens leukemia']\n",
      "['az calquence', 'breakthrough therapy designation astrazeneca calquence']\n",
      "['breakthrough therapy designation']\n",
      "['bruton tki cm fda grants breakthrough therapy designation']\n",
      "['drug administration fda', 'breakthrough therapy designation btd', 'monotherapy treatment', 'adult patients', 'chronic lymphocytic leukaemia cll lymphoma lymsm']\n",
      "['astrazeneca announces breakthrough therapy status']\n",
      "['breakthrough therapy designation', 'astrazeneca s leukaemia treatment calquence']\n",
      "['astrazeneca announces breakthrough therapy status', 'breakthrough therapy designation', 'calquence acalabrutinib', 'adult patients']\n",
      "['fda grants breakthrough therapy designation']\n",
      "[]\n",
      "['breakthrough therapy designation', 'acalabrutinib monotherapy', 'adult patients', 'chronic lymphocytic leukemia cllsm leusm']\n",
      "['breakthroughtherapy designation', 'chroniclymphocyticleukaemia astrazeneca azn']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['astrazeneca s calquence', 'breakthroughtherapy designation acalabrutinib leukaemia']\n",
      "['breakthrough designation']\n",
      "['breakthrough therapy designation', 'cll leukemia']\n",
      "['astrazeneca s juggernaut parp player lynparza scoops']\n",
      "['new designation', 'calquence marks', 'such designation']\n",
      "['astrazeneca s juggernaut parp player lynparza scoops', 'calquence azn']\n",
      "['az calquence', 'breakthrough therapy designation pharmanews pharma']\n",
      "['calquence acalabrutinib', 'breakthrough therapy designation', 'chronic lymphocytic leukemia']\n",
      "['fda calquence']\n",
      "['fda grants acalabrutinib breakthrough designation', 'breakthrough therapy designation', 'acalabrutinib calquence', 'chronic lymphocytic leukemia']\n",
      "['press acalabrutinib', 'breakthrough designation', 'elevate tn', 'btk inhibitor']\n",
      "['breakthrough therapy designation', 'agent acalabrutinib cllsm leusm']\n",
      "['az calquence', 'breakthrough therapy designation']\n",
      "['fda grants acalabrutinib breakthrough designation', 'cll leukemia']\n",
      "['astrazeneca calquence', 'breakthrough therapy designation']\n",
      "['breakthrough status', 'chronic lymphocytic leukemia biotech']\n",
      "['phase iii', 'breakthrough therapy designation']\n",
      "['az calquence', 'breakthrough therapy designation']\n",
      "['fda grants acalabrutinib breakthrough designation']\n",
      "['fda grants acalabrutinib breakthrough designation']\n",
      "['astrazeneca s juggernaut parp player lynparza scoops', 'calquence endpoints news']\n",
      "['astrazeneca s juggernaut parp player lynparza scoops']\n",
      "['breakthrough therapy designation', 'chronic lymphocytic leukaemia']\n",
      "['azn calquence', 'breakthrough therapy designation', 'chronic lymphocytic leukaemia']\n",
      "['az calquence', 'breakthrough therapy designation pharma regulatory']\n",
      "['astrazeneca onco team', 'new ceo pascal soriot', 'medical text books', 'new treatment paths thanks', 'collective team']\n",
      "['breakthrough therapy designation btd', 'new bloodcancer treatment option', 'chronic lymphocytic leukemia cll']\n",
      "['fda grants breakthrough therapy designation', 'chronic lymphocytic leukemia cll acalabrutinib']\n",
      "['calquence acalabrutinib', 'breakthrough therapy designation', 'chronic lymphocytic leukemia']\n",
      "['calquence acalabrutinib', 'breakthrough therapy designation', 'chronic lymphocytic leukemia']\n",
      "['calquence acalabrutinib', 'breakthrough therapy designation', 'chronic lymphocytic leukemia designation', 'positive results', 'phase iii trialsastrazeneca', 'drug administration fda']\n",
      "['astrazeneca s juggernaut parp player lynparza scoops', 'calquence gt gt gt strategy competitiveintelligence', 'healthcare pharma biotech pharmaceutical ci']\n",
      "[]\n",
      "['astrazeneca s juggernaut parp player lynparza scoops']\n",
      "['azn oncology', 'phiiis astrazeneca s juggernaut parp player lynparza scoops']\n",
      "['fda calquence']\n",
      "['azn calquence', 'breakthrough therapy designation', 'chronic lymphocytic leukaemia']\n",
      "['azn calquence', 'breakthrough therapy designation', 'chronic lymphocytic leukaemia']\n",
      "['astrazeneca s calquence acalabrutinib', 'fda s breakthrough therapy designation', 'chronic lymphocytic leukemia']\n",
      "['breakthrough therapy designation', 'chronic lymphocytic leukaemia', 'positive results', 'phase iii trials']\n",
      "['astrazeneca upbeat']\n",
      "['azn calquence breakthrough therapy designation', 'lymphocytic leukaemia']\n",
      "['breakthrough therapy designation', 'chronic lymphocytic leukaemia']\n",
      "['awesomecapital astrazeneca calquence', 'breakthrough ther']\n",
      "['astrazeneca plc calquence', 'breakthrough therapy designation azn']\n",
      "['breakthrough therapy designation', 'chronic lymphocytic leukaemia']\n",
      "['breakthrough therapy designation']\n",
      "['acalabrutinib trial']\n",
      "[]\n",
      "['dr sharman', 'potential future', 'cll leukemia']\n",
      "['dr sharman', 'potential future', 'cll cllsm']\n",
      "['acalabrutinib trial']\n",
      "['acalabrutinib therapy infection rate amp headaches']\n",
      "['baml azn', 'strong 2q results amp ve roxa news', 'fgen pre nda', 'statistical analyses', 'poseidon 1l nsclc', 'farxiga heart failure amp', 'calquence cll', 'fy20 23e eps cagr']\n",
      "['checkout study', 'generation btk', 'bioavailable btk inhibitor', 'safety amp efficacy', 'generation btk inhibitors', 'chroniclymphocyticleukemia cll']\n",
      "['video impact', 'ascend trial', 'cll w barbara eichhorst', 'leusm cllsm icml2019']\n",
      "['rogers md', 'chronic lymphocytic leukemia acalabrutinib', 'treatment naive', 'refractory disease leusm hematology']\n",
      "['btk inhibition', 'risky proposition', 'sameem abedin md']\n",
      "['sameem abedin md', 'favorable agent']\n",
      "['dr kipps', 'btk inhibitors ibrutinib', 'real bright spots', 'toxicity management']\n",
      "['dr abedin discusses differences']\n",
      "['certain type', 'cancer mantle cell lymphoma mcl acalabrutinib', 'cancer cells', 'kinase inhibitors pharmaceuticalmedicine rsp']\n",
      "['pi3k inhibition', 'pre clinical models', 'aggressive lymphomas lymphoma lymsm']\n",
      "['bjh single', 'pi3k inhibition', 'aggressive lymphoma models spriano university']\n",
      "['pi3k inhibition', 'pre clinical models', 'aggressive lymphomas spriano british journal', 'haematology wiley online library lymphoma lymsm']\n",
      "['baml azn', 'low double digit', 'high sd', 'small upside', 'poseidon 1l nsclc', 'farxiga heart failure amp', 'calquence cll']\n",
      "['r r cll nhl btk occupancy', 'b d', 'cll cohort', 'subcut g3', 'tox orr', 'short fup', 'vs acalabrutinib matter lymsm']\n",
      "['zanubrutinib inhibiteur', 'bruton tk ach ve sa phase', 'leuc mie lympho', 'chronique avec l acalabrutinib dans', 'lymphome du manteau des alternatives l ibrutinib dans']\n",
      "['bendamustine rituximab', 'refractory chronic lymphocytic leukemia', 'paolo ghia']\n",
      "['phase i ii clinical trial', 'economic evaluation', 'chronic lymphocytic leukaemia springerlink']\n",
      "['eha congress', 'refractory cll monotherapy', 'bruton tyrosine kinase btk inhibitor', 'tolerable safety profile']\n",
      "['dr karmali', 'recent advances', 'btk inhibitors', 'profound activity', 'mcl mcl lymphoma']\n",
      "['promising developments', 'refractory cll', 'interim results', 'ascend trial hematology ehacongress', 'month eha24 lymphomanews trialslink haematology clinicaltrial lymsm']\n",
      "['btk inhibitors ibrutinib', 'major subsets']\n",
      "['new acalabrutinib', 'chronic lymphocytic leukemia']\n",
      "['acalabrutinib treatment', 'preclinical model', 'chronic lymphocytic leukemia', 'itk inhibition', 'cell population']\n",
      "['healtheconja phase i ii clinical trial', 'economic evaluation', 'chronic lymphocytic leukaemia']\n",
      "['vitro dissolution', 'vivo exposure', 'acalabrutinib part i mechanistic', 'drug product dissolution', 'pbpk model input drug product dissolution', 'mg capsules pharmacy']\n",
      "['dr woyach', 'acalabrutinib obinutuzumab combo', 'cll leukemia']\n",
      "['large bcell lymphoma background diffuse', 'large bcell lymphoma', 'common type', 'nonhodgkin lymphoma', 'renalcell kidneycancer']\n",
      "['calquence acalabrutinib astrazeneca acerta', 'global drug overview']\n",
      "['dynamic duo', 'leukemia treatments', 'innovative cll treatment']\n",
      "['calquence acalabrutinib astrazenecaacerta overview', 'product profile report', 'dublin amp', 'business wire amp', 'calquence amp', 'offering calquence']\n",
      "['calquence acalabrutinib astrazeneca acerta overview', 'product profile report']\n",
      "['acalabrutinib nel linfoma', 'cellule del mantello recidivato o refrattario studio ace']\n",
      "['cll shows', 'good tolerability cllsm eha2019']\n",
      "['btk inhibitor trials', 'gem abraxane ibrutinib b ibrutinib durvalumab c acalabrutinib keytruda i hope']\n",
      "['ecancer eha']\n",
      "['chronic lymphocytic leukemia']\n",
      "['large bcell lymphoma background diffuse', 'large bcell lymphoma', 'common type', 'nonhodgkin lymphoma', 'renalcell kidneycancer']\n",
      "['el ensayo ascend compar acalabrutinib', 'con rituximab', 'combinaci n', 'con idelalisib o bendamustina', 'funci n del criterio del m dico seom es acalabrutinib leucemialinfociticacronica']\n",
      "['astrazeneca anuncia los resultados detallados del', 'lisis intermedio del ensayo llamado fase iii ascend seom es acalabrutinib leucemialinfociticacronica']\n",
      "['astrazeneca anuncia resultados positivos', 'acalabrutinib para', 'leucemia linfoc tica cr nica recurrente seom es acalabrutinib leucemialinfociticacronica']\n",
      "['cll shows', 'good tolerability cllsm eha2019']\n",
      "['leucemia linfatica cronica acalabrutinib prolunga significativamente il tempo di vita senza progressione', 'i pazienti affetti da forma recidivante o refrattaria l', 'dei pazienti trattati dopo', 'mesi di trattamento non presenta segni di progressione']\n",
      "['astrazeneca anuncia resultados positivos', 'acalabrutinib para', 'leucemia linfoc tica cr nica recurrente acalabrutinib leucemialinfociticarecurrente']\n",
      "['cll shows', 'good tolerability cllsm eha2019']\n",
      "['chronic lymphocytic leukemia']\n",
      "['long term acalabrutinib obinutuzumab trial', 'overall response rate', 'treatment lylal']\n",
      "['chronic lymphocytic leukemia leukemia']\n",
      "['el ensayo ascend compar acalabrutinib', 'con rituximab', 'combinaci n', 'con idelalisib o bendamustina', 'funci n del criterio del m dico los pacientes', 'llc recurrente o refractaria acalabrutinib leucemialinfociticarecurrente']\n",
      "['cll shows', 'good tolerability', 'science news']\n",
      "['cll shows', 'good tolerability amsterdam', 'new drug']\n",
      "['cll shows', 'good tolerability']\n",
      "['biopharmaceutic tools', 'calquence drugdiscovery']\n",
      "['durable responses', 'disease progression', 'line option', 'visit hematologyconferences leukemia oncology cancer']\n",
      "['calquence astrazeneca aumenta', 'con leucemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['astrazeneca anuncia resultados positivos', 'acalabrutinib para', 'leucemia linfoc tica cr nica recurrente acalabrutinib leucemialinfociticarecurrente']\n",
      "['calquence astrazeneca prolonga', 'leucemia linfoc tica cr nica recurrente o refractaria']\n",
      "['video acalabrutinib obinutuzumab', 'kerry rogers', 'icml19 hemeonc']\n",
      "['astrazeneca calquence cll data', 'regulatory submissions']\n",
      "['prof paolo ghia speaks', 'ascend study', 'full video', 'gt gt bloodcancer eha2019']\n",
      "['long term data', 'obinutuzumab showcase', 'treatment na ve', 'refractory chronic cll lylcl']\n",
      "['baml azn', 'positive data imfinzi s caspian', 'extensive stage', 'small cell lung meeting os endpoint', 'interim analysis', 'addressable market', 'cons catalyst', 'poseidon 1l nsclc', 'farxiga heart failure', 'calquence cll']\n",
      "['azn abbv jnj biotech analysis', 'central astrazeneca calquence cll data', 'regulatory submissions']\n",
      "['astrazeneca calquence cll data', 'regulatory submissions']\n",
      "['azn astrazeneca calquence cll data', 'regulatory submissions']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['woyach highlights', 'long term acalabrutinib obinutuzumab data', 'cll lylcl']\n",
      "['woyach highlights', 'long term acalabrutinib obinutuzumab data']\n",
      "['woyach highlights', 'long term acalabrutinib obinutuzumab data', 'cll onclive', 'long term data', 'acalabrutinib calquence', 'obinutuzumab gazyva showcase', 'bo artificialintelligence privacy toronto']\n",
      "['nice presentation', 'dr byrd', 'data field', 'acalabrutinib trials']\n",
      "[]\n",
      "['video astrazeneca executive highlights', 'extensive development program', 'cll asco2019 leukemia lymphoma']\n",
      "[]\n",
      "['durable responses', 'disease progression', 'line option', 'visit hematologyconferences leukemia']\n",
      "[]\n",
      "['astrazeneca acarabultinib calquence', 'free survival', 'refractory chronic lymphocytic leukemia']\n",
      "[]\n",
      "['opinion decision', 'paediatric investigation plan pip acalabrutinib decision type therapeutic area pip number p', 'pharma regulatory']\n",
      "['cll patient', 'generic ibrutinib icml15 icml2019 valuebasedcare icml19']\n",
      "['mantle cell lymphoma program', 'md anderson', 'fda approvals']\n",
      "['viable option', 'ibrutinib intolerant', 'refractory cll acalabrutinib', 'high rates', 'chronic lymphocytic leukemia']\n",
      "['rare leucemia linfatica cronica nei pazienti recidivanti o refrattari acalabrutinib migliora il tempo libero da progressione comitatoimalatiinvisibili imalatiinvisibili comitatoimi comitatoimionlus malattierare']\n",
      "['viable option', 'ibrutinib intolerant', 'refractory cll james leusm']\n",
      "['leucemia linfatica cronica acalabrutinib migliora significativamente il tempo libero da progressione nei pazienti recidivanti o refrattari']\n",
      "['fibrillation atriale avec les anticanc reux acalabrutinib ibrutinib', 'sonid gib sfpt']\n",
      "['eha2019 insights gt gt gt', 'asco post', 'twitter ascend trial compares acalabrutinib vs investigator s choice', 'refractory cll eha24 lucidquest followthepatient myeloma lymphoma bloodcancers leusm mmsm']\n",
      "['leucemia linfatica cronica acalabrutinib migliora significativamente il tempo libero da progressione dei pazienti recidivanti o refrattari']\n",
      "['leucemia linfatica cronica acalabrutinib migliora significativamente il tempo libero da progressione dei pazienti recidivanti o refrattari']\n",
      "['ascend trial compares acalabrutinib vs investigator s choice', 'refractory cll leusm hematology eha2019']\n",
      "['leucemia linfatica cronica acalabrutinib migliora significativamente il tempo libero da progressione nei pazienti recidivanti o refrattari']\n",
      "['leucemia linfatica cronica acalabrutinib migliora significativamente il tempo libero da progressione nei pazienti recidivanti o refrattari salute']\n",
      "['un importante nuova arma terapeutica', 'i pazienti affetti da leucemia linfatica cronica un opzione di trattamento che non prevede l uso della chemioterapia e presenta un profilo di sicurezza favorevole', 'una patologia tanto pericolosa']\n",
      "['video acalabrutinib', 'ibrutinib intolerant cll patients', 'new doors', 'kerry roger', 'icml19 cllsm']\n",
      "['leucemia linfatica cronica acalabrutinib migliora il tempo libero da progressione nei pazienti recidivanti o refrattari eha19']\n",
      "['cll question', 'safety data vs ibrutinib study', 'r r setting icml2019 icml19 yazdy']\n",
      "['leucemia linfatica cronica acalabrutinib migliora significativamente il tempo libero da progressione nei']\n",
      "['leucemia linfatica cronica acalabrutinib migliora significativamente il tempo libero da progressione nei']\n",
      "['leucemia linfatica cronica acalabrutinib migliora significativamente il tempo libero da progressione nei']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['leucemia linfatica cronica acalabrutinib migliora significativamente il tempo libero da progressione nei']\n",
      "['congress 15icml p ghia', 'phase iii ascend study', 'significant amp', 'acalabrutinib monotherapy', 'combination regimen', 'bendamustine lymsm']\n",
      "['ascend study acalabrutinib monotherapy vs idela r', 'br btki', 'superior pfs', 'group high discontinuations', 'os benefit']\n",
      "['leucemia linfatica cronica acalabrutinib migliora il tempo di vita senza progressione leucemia linfatica cronica']\n",
      "['leucemia linfatica cronica acalabrutinib migliora il tempo di vita senza progressione leucemia linfatica cronica']\n",
      "['dr vose', 'acalabrutinib pembrolizumab combo', 'dlbcl icml lymsm']\n",
      "['btkis simon use', 'instance headaches', 'caffeine icml2019']\n",
      "['brown highlights', 'cll treatment icml19 leusm']\n",
      "['congress 15icml kerry', 'phase ii study', 'r r cll', 'ibrutinib lymsm patients intolerant', 'ibrutinib tolerate acalabrutinib', 'show good responses']\n",
      "['free treatment', 'agent acalabrutinib', 'meaningful improvement', 'free survival']\n",
      "['press release']\n",
      "['new post eha', 'acalabrutinib shows', 'remarkable benefit', 'refractory chronic lymphocytic leukaemia', 'oncology news australia']\n",
      "['new post forty', 'acerta collaborate', 'triple combo therapy', 'dlbcl patients']\n",
      "['astrazeneca s calquence', 'big cll survival numbers', 'cll patients azn']\n",
      "['az calquence shows pfs benefit', 'cll patients healthcare pharmanews']\n",
      "['calquence cll data', 'submissions biotech drugtrial hematology oncology research uk']\n",
      "['acalabrutinib verbetert pfs bij rr cll eha2019 eha24']\n",
      "['astrazeneca s calquence', 'big cll survival numbers']\n",
      "['astrazeneca s calquence', 'big cll survival numbers']\n",
      "[]\n",
      "['astrazeneca s calquence', 'big cll survival numbers']\n",
      "['az s calquence threatens imbruvica', 'new leukaemia data']\n",
      "['astrazeneca s calquence', 'big cll survival numbers gt gt gt strategy competitiveintelligence', 'healthcare pharma pharmaceutical biotech ci']\n",
      "['agent acalabrutinib showcases potential practice', 'refractory cll']\n",
      "['agent acalabrutinib showcases potential practice', 'refractory cll leusm']\n",
      "['study results', 'eha congress', 'phase iii ascend trial', 'acalabrutinib monotherapy', 'cll eha19']\n",
      "['agent acalabrutinib showcases potential practice', 'refractory cll']\n",
      "['acalabrutinib incrementa', 'leucemia linfoc tica cr nica refractaria sciencelink']\n",
      "['astrazeneca plc lon azn drug', 'chronic lymphocytic leukaemia', 'time patients', 'interim analysis', 'business businessnews']\n",
      "['astrazeneca s calquence', 'big cll survival numbers']\n",
      "['astrazeneca s calquence', 'big cll survival numbers']\n",
      "['astrazeneca s calquence', 'big cll survival numbers pharma regulatory']\n",
      "['az calquence shows pfs benefit', 'cll patients']\n",
      "['astrazeneca reports results', 'calquence acalabrutinib', 'p iii ascend study', 'r r chronic lymphocytic leukemia eha2019']\n",
      "['az calquence shows pfs benefit', 'cll patients']\n",
      "['az calquence shows pfs benefit', 'cll patients']\n",
      "['az calquence shows pfs benefit', 'cll patients']\n",
      "['astrazenica s calquence threatens abbvie johnson amp johnson s imbruvica', 'new leukaemia data cancer leukaemia']\n",
      "['azn astrazeneca reports calquence', 'time patients', 'disease progression']\n",
      "['calquence phase iii clinical trials']\n",
      "['azn astrazeneca calquence', 'time patients', 'disease progression']\n",
      "['az s calquence threatens imbruvica', 'new leukaemia data pharma regulatory']\n",
      "['az calquence shows pfs benefit', 'cll patients']\n",
      "['cancer drug calquence', 'standard care', 'chronic lymphocytic leukaemia', 'uk pharma', 'abbvie j amp j s blockbuster imbruvica']\n",
      "['az calquence shows pfs benefit', 'cll patients pharma regulatory']\n",
      "['time patients', 'disease progression', 'refractory chroniclymphocyticleukaemia eha19 azn']\n",
      "['astrazeneca s calquence cuts risk', 'disease progression death', 'chronic lymphocytic leukaemia study azn eha24']\n",
      "['eha24 nuove prospettive', 'il trattamento della cll r r grazie allo studio ascend acalabrutinib dimostra maggiori efficacia e sicurezza rispetto ai trattamenti tradizionali ne abbiamo parlato', 'con paolo ghia leusm']\n",
      "['azn astrazeneca', 'encouraging effects', 'leukaemia treatment calquence', 'uk azn brighterir andrewscotttv capitalnetwork1']\n",
      "['acalabrutinib cll']\n",
      "['astrazeneca upbeat', 'calquence trial data']\n",
      "['month survival', 'disease progression', 'refractory chronic lymphocytic leukaemia']\n",
      "['babcock rejects takeover approach', 'serco astrazeneca upbeat', 'calquence data']\n",
      "['astrazeneca plc calquence', 'time patient', 'disease progression azn']\n",
      "['com astra zeneca f r positiva resultat fr n leukemistudie']\n",
      "['astra zeneca f r positiva resultat fr n leukemistudie']\n",
      "['acalabrutinib cll']\n",
      "['time patient']\n",
      "['acalabrutinib cll']\n",
      "['leuc mie lympho', 'chronique r cidivante r fractaire l acalabrutinib allonge', 'survie sans progression']\n",
      "['acalabrutinib monotherapy', 'improves pfs', 'refractory cll eha19 leusm']\n",
      "['high response rates', 'treatment na ve patients', 'dr woyach leusm hematology']\n",
      "['target activity arql', 'target safety', 'ibrutinib arql']\n",
      "['btki vs pi3ki amp cit', 'btki ibrutinib acalabrutinib']\n",
      "['disease pathways', 'critical unmet', 'medical need', 'phase iii data', 'chronic lymphocytic leukemia cll']\n",
      "['congress eha24 paolo ghia', 'universit vita salute san raffaele', 'abstract session', 'ascend phase iii study', 'acalabrutinib vs idr', 'r r cll lymsm lymphoma eha2019']\n",
      "['eha24 cll ascend acalabrutinib']\n",
      "['r r cll regardless', 'pfs nr vs 16mo orr']\n",
      "['acalabrutinib key clinical data']\n",
      "['acalabrutinib calquence', 'pembrolizumab keytruda', 'overall response rate', 'refractory dlbcl', 'phase i ii keynote', 'study hematology eha24']\n",
      "['awesomecapital astrazeneca calquence', 'leukemia survival']\n",
      "['fda approval', 'major advance', 'effective agents', 'acalabrutinib venetoclax', 'bispecific antibodies', 'future lymsm']\n",
      "['time patients', 'disease progression', 'refractory chronic lymphocytic leukaemia']\n",
      "['congress eha24 k maddocks', 'phase i ii study results', 'acalabrutinib pembrolizumab', 'r r dlbcl lymsm eha2019']\n",
      "['mcl research efforts', 'free induction therapy', 'refractory disease', 'btk inhibitors ibrutinib', 'acalabrutinib lymsm']\n",
      "['astrazeneca s phase', 'elevate tn trial', 'chronic lymphocyticleukemia', 'primary endpoint', 'interim analysis', 'site news clinicaltrial healthcare']\n",
      "['calquence acalabrutinib', 'time patients', 'disease progression', 'refractory chronic lymphocytic leukemia']\n",
      "['calquence acalabrutinib', 'time patients', 'disease progression']\n",
      "['acalabrutinib trial']\n",
      "['pm cest', 'new phase iii data', 'chronic lymphocytic leukemia cll']\n",
      "['calquence acalabrutinib', 'time patients', 'disease progression', 'refractory chronic lymphocytic leukemia']\n",
      "['ibrutinib intolerant r r cll patients', 'hematology eha24 cc']\n",
      "['ich habe gerade paolo ghia acalabrutinib', 'prolongs time patients']\n",
      "['acalabrutinib nuova opzione terapeutica', 'cll ascend eha24 fama83']\n",
      "['cll potential alternatives', 'ibrutinib susan o brien', 'discusses eha24 hematology cllsm leusm']\n",
      "['ghia p ascend study demonstrates acalabrutinib', 'prolongs pfs', 'cll lb2601 eha24']\n",
      "['time patients', 'disease progression', 'refractory chronic lymphocytic leukaemia']\n",
      "['month progression', 'free survival', 'month pfs', 'annual meeting asco19 cll leukemia']\n",
      "['blood spotlight acalabrutinib', 'mantle cell lymphoma']\n",
      "['true arql', 'p2 trial', 'richter s', 'ibrutinib calquence mutational failures', 'doesn t']\n",
      "['astrazeneca co ltd astrazeneca s acarabultinib calquence', 'key endpoint', 'interim analysis', 'phase iii elevate tn trial', 'chronic lymphocytic leukemia', 'treatment history']\n",
      "['calquence iii elevate tn']\n",
      "['calquence elevate tn']\n",
      "['calquence elevate tn']\n",
      "['cancer vigilance au congr s sfpt2019 sfpt risque', 'fibrillation atriale avec les anticanc reux acalabrutinib ibrutinib', 'sonid gib']\n",
      "['pharmacovigilance congr s sfpt risque', 'fibrillation atriale avec les anticanc reux acalabrutinib ibrutinib', 'sonid gib']\n",
      "['icymi astrazeneca s calquence treads', 'imbruvica s turf', 'azn jnj abbv pharma']\n",
      "['high response rates', 'treatment na ve patients', 'dr woyach cllsm leusm']\n",
      "['l tude', 'elevate tn atteint l objectif principal', 'survie sans progression avec acalabrutinib calquence astrazeneca', '1l dans', 'leuc mie lympho', 'l adulte']\n",
      "['amp astrazeneca btk calquence']\n",
      "['astrazeneca suma otro xito', 'ensayo cl nico']\n",
      "['combination therapy']\n",
      "['trial acalabrutinib', 'high rates', 'refractory cll', 'ps hematologyconferences hematologyconferences2019']\n",
      "['calquence hits endpoints', 'late stage leukemia trial pharma']\n",
      "['preclinical paper']\n",
      "['az calquence hits endpoints', 'late stage leukemia trial']\n",
      "['calquence trial']\n",
      "['calquence phase iii elevate tn trial', 'primary endpoint', 'interim analysis', 'chronic lymphocytic leukaemia']\n",
      "['astrazeneca s calquence treads', 'imbruvica s turf']\n",
      "['combination therapy']\n",
      "['new btk inhibitor', 'great potential', 'wm iwmf iwmfef2019']\n",
      "['acalabrutinib obinutuzumab combo improves pfs', 'frontline cll']\n",
      "['astrazeneca s calquence', 'cll study']\n",
      "['az report', 'positive results', 'phase iii cll trial']\n",
      "['leucemia linfatica cronica llc', 'acalabrutinib centra l end point comitatoimalatiinvisibili imalatiinvisibili comitatoimi comitatoimionlus malattierare']\n",
      "['astrazeneca ends', 'calquence trial']\n",
      "['astrazeneca s calquence treads', 'imbruvica s turf', 'gazyva play', 'cll azn']\n",
      "['rogers md', 'chronic lymphocytic leukemia acalabrutinib', 'treatment naive', 'refractory disease leusm hematology asco19 james']\n",
      "['astrazeneca calquence hits endpoints', 'late stage leukemia trial acalabrutinib cll']\n",
      "['astrazeneca s calquence shows superiority']\n",
      "['astrazeneca s calquence shows superiority', 'cll calquence bcellbloodcancers leukaemiadrugs']\n",
      "['calquence hits goals', 'chronic lymphocytic leukemia trial pharma']\n",
      "['leucemia linfatica cronica acalabrutinib centra l end point', 'fase iii']\n",
      "['leucemia linfatica cronica acalabrutinib centra l end point', 'fase iii']\n",
      "['astrazeneca stocks', 'calquence ammunition', 'big btk', 'j amp j abbvie azn jnj abbv']\n",
      "['overall response rate', 'refractory cll', 'obinutuzumab cllsm asco19']\n",
      "['leucemia linfoc tica cr nica acalabrutinib incrementa', 'pacientes sin tratamiento previo sciencelink']\n",
      "['obinutuzumab induces', 'durable responses', 'chronic lymphocytic leukemia']\n",
      "['astrazeneca s calquence treads', 'imbruvica s turf']\n",
      "['astrazeneca s calquence', 'phase iii chronic lymphocytic leukemia study']\n",
      "['acalabrutinib obinutuzumab combo improves pfs', 'frontline cll']\n",
      "['acalabrutinib obinutuzumab combo improves pfs', 'frontline cll']\n",
      "['refractory cll', 'obinutuzumab asco19 leusm']\n",
      "['astrazeneca s calquence treads', 'imbruvica s turf']\n",
      "['az s calquence hits endpoint', 'cll phase iii study pharmascrip']\n",
      "['astrazeneca stocks', 'calquence ammunition', 'big btk', 'j amp j abbvie']\n",
      "['astrazeneca ends', 'calquence trial']\n",
      "['astrazeneca s calquence shows strength', 'common adult leukaemia pharma cancer leukemia']\n",
      "['good news', 'approvals cll cllsm']\n",
      "['az calquence hits endpoints', 'late stage leukemia trial lifesciences pharmanews']\n",
      "['astrazeneca ends cll study', 'biospace jobs biotech pharma oncology hematology']\n",
      "['obinutuzumab induces', 'durable responses', 'chronic lymphocytic leukemia leusm ssbmt']\n",
      "['astrazeneca plc lon azn drug', 'chronic lymphocytic leukaemia', 'phase iii clinical trial az s calquence', 'business businessnews']\n",
      "['astrazeneca ends', 'calquence trial']\n",
      "['astrazeneca ends', 'calquence trial']\n",
      "['astrazeneca ends cll study']\n",
      "['obinutuzumab induces', 'durable responses', 'chronic lymphocytic leukemia leukemia oncology']\n",
      "['astrazeneca reports results', 'calquence acalabrutinib', 'p iii elevate tn trial', 'chronic lymphocytic leukemia pharmashots']\n",
      "['astrazeneca stocks', 'calquence ammunition', 'big btk', 'j amp j abbvie gt gt gt strategy competitiveintelligence', 'pharma biotech ci healthcare pharmaceutical']\n",
      "['chronic lymphocytic leukemia cll']\n",
      "['astrazeneca stocks', 'calquence ammunition', 'big btk', 'j amp j abbvie']\n",
      "['astrazeneca stocks', 'calquence ammunition', 'big btk', 'j amp j abbvie']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['astrazeneca stocks', 'calquence ammunition', 'big btk', 'j amp j abbvie']\n",
      "['calquence phase iii elevatetn trial', 'primary endpoint', 'interim analysis']\n",
      "['high response rates', 'treatment na ve patients', 'dr woyach', 'james hematology bloodcancer']\n",
      "['az calquence hits endpoints', 'late stage leukemia trial']\n",
      "['astrazeneca s calquence', 'pivotal cll study shares']\n",
      "['azn rhhby astrazeneca s calquence', 'pivotal cll study shares']\n",
      "['az calquence hits endpoints', 'late stage leukemia trial pharma regulatory']\n",
      "['com astra zeneca n dde prim rm l i elevate tn studie f r calquence']\n",
      "['astra zeneca n dde prim rm l i elevate tn studie f r calquence']\n",
      "['astrazeneca s calquence shows strength', 'common adult leukaemia pharma cancer leukemia']\n",
      "['chronic lymphocytic leukaemia drug calquence', 'positive results pharma']\n",
      "['astrazeneca s calquence shows strength', 'common adult leukaemia pharmaceutical']\n",
      "['astrazeneca s btk inhibitor calquence hits', 'main goal', 'late stage study', 'chronic lymphocytic leukaemia azn']\n",
      "['successful trials', 'astrazeneca s blood cancer drug', 'astrazeneca bloodcancer calquence lymphocyticleukaemia']\n",
      "['azn acalabrutinib obinutuzumab', 'pfs endpoint', 'chemo obi', '1l cll data', 'eha ibrutinib p3', 'vs chemo']\n",
      "['azn calquence', 'life expectancy result', 'elevate tn trial', 'particular form']\n",
      "['acalabrutinib calquence', 'refractory mantle cell lymphoma']\n",
      "['acalabrutinib c entra l end pont']\n",
      "['astrazeneca s calquence phase iii elevate tn trial', 'primary end point', 'interim analysis', 'chronic lymphocytic leukaemia']\n",
      "['azn uk calquence phase iii elevate tn trial', 'primary endpoint astrazeneca plc']\n",
      "['astrazeneca calquence phase iii elevate tn trial', 'primary endpoint azn']\n",
      "['calquence phase iii elevate tn trial', 'primary endpoint', 'interim analysis', 'chronic lymphocytic leukaemia']\n",
      "['calquence phase iii elevate tn trial']\n",
      "['high response rates', 'various settings', 'small preliminary trial', 'leusm asco19']\n",
      "['acalabrutinib combo induces', 'cll james asco19 leusm']\n",
      "['visita el post', 'facebook el acalabrutinib se usa para tratar linfoma', 'c lulas del manto mcl un c ncer', 'crecimiento r pido que empieza', 'las c lulas del sistema inmune que ya', 'sido tratado', 'menos otro medicamento', 'quimioterapia el aca']\n",
      "['rogers md', 'chronic lymphocytic leukem asco2019 asco2019 oncologytribune']\n",
      "['treatment combination', 'high response rates', 'treatment naive patients', 'tp53 status']\n",
      "['asco19 lymsm leusm cllsm tues', 'chairs bartlett amp davids', 'r r cll acalabrutinib amp obinutuzumab woyach']\n",
      "['asco19 lymsm leusm cllsm tues', 'chairs bartlett amp davids', 'r r cll acalabrutinib amp obinutuzumab woyach']\n",
      "['asco19 lymsm leusm cllsm tues', 'chairs bartlett amp davids', 'r r cll acalabrutinib amp obinutuzumab woyach responses']\n",
      "['asco19 woyach 3yr followup', 'acalabrutinib obinutuzumab', '1st line n']\n",
      "['asco19 lymsm leusm cllsm tues', 'chairs bartlett amp davids', 'r r cll acalabrutinib amp obinutuzumab woyach']\n",
      "['asco19 lymsm leusm cllsm tues', 'chairs bartlett amp davids', 'r r cll acalabrutinib amp obinutuzumab woyach']\n",
      "['asco19 lymsm leusm cllsm tues', 'chairs bartlett amp davids', 'r r cll acalabrutinib amp obinutuzumab woyach']\n",
      "['cancer cll ibrutinib acalabrutinib']\n",
      "['acerta astrazeneca', 'ibrutinib intolerant r r chronic lymphocytic leukemia', 'site news']\n",
      "['ibrutinib acalabrutinib', 'chronic lymphocytic leukemia', 'cancers melanoma skincancer lungcancer prostatecancer leukemia asco2019']\n",
      "['long term', 'r r mantle cell lymphoma w simon', 'ash18 hematology lymsm lymphoma trialupdate hemonc']\n",
      "['new patent', 'astrazeneca drug calquence']\n",
      "['new patent', 'astrazeneca drug calquence']\n",
      "['huge efforts', 'fda indication']\n",
      "['acalabrutinib calquence', 'refractory mantle cell lymphoma']\n",
      "['severe hepatic impairment']\n",
      "['severe hepatic impairment', 'metabolite status', 'condition summary hepatic impairment hepatic insufficiency healthy subjects']\n",
      "['bloodwise uk', 'stellar trial protocol', 'prospective multicentre trial', 'richter s syndrome', 'trial investigation chop r', 'arm platform study']\n",
      "['acalabrutinib obinutuzumab', 'r r cll', 'r r pts', 'common g3', 'low anc', 'low plts', 'g3 af high', 'durable orr 36m pfs', 'rr pts blooducation cll asco2019']\n",
      "['long term outcome']\n",
      "['acalabrutinib trial']\n",
      "['fda approval', 'major advance', 'effective agents', 'acalabrutinib venetoclax', 'bispecific antibodies', 'future lymsm']\n",
      "['cll btk acalabrutinib', 'ascend pfs acalabrutinib']\n",
      "['high response rate', 'refractory cll', 'ibrutinib clinicaltrials observations lymphoidneoplasia']\n",
      "[]\n",
      "['asco data', 'az s calquence', 'rival imbruvica', 'cll analyst fiercepharma']\n",
      "['cll p3 az qlifepro btk']\n",
      "['cll p3 az qlifepro']\n",
      "['acalabrutinib monotherapy', 'chronic lymphocytic leukemia']\n",
      "['asco data', 'az s calquence', 'rival imbruvica', 'cll analyst']\n",
      "['asco data', 'az s calquence', 'rival imbruvica', 'cll analyst']\n",
      "['awesomecapital asco data', 'az s calquence', 'rival imbruvic']\n",
      "['asco data', 'az s calquence', 'rival imbruvica', 'cll analyst']\n",
      "['asco data', 'az s calquence', 'rival imbruvica', 'cll analyst']\n",
      "['asco data', 'az s calquence', 'cll analyst azn pharma']\n",
      "['asco data', 'az s calquence', 'rival imbruvica', 'cll analyst gt gt gt strategy competitiveintelligence', 'ci healthcare biotech pharma pharmaceutical']\n",
      "['asco data', 'az s calquence', 'rival imbruvica', 'cll analyst pharma regulatory']\n",
      "['asco data', 'az s calquence', 'rival imbruvica', 'cll analyst']\n",
      "['acalabrutinib monotherapy', 'chronic lymphocytic leukemia', 'ibrutinib blood advances']\n",
      "['current issue', 'cryptococcal infection', 'chronic lymphocytic leukemia']\n",
      "['astrazeneca s hematology center', 'clinical trial', 'new triple therapy combination', 'monoclonal antibody']\n",
      "['long term outcome']\n",
      "['astrazeneca s calquence preps', 'imbruvica showdown']\n",
      "['az calquence ascend jp']\n",
      "['calquence iii ascend']\n",
      "['calquence ascend']\n",
      "[]\n",
      "['calquence ascend']\n",
      "['acalabrutinib trial']\n",
      "['acala dose reductions orr', '1y pfs', 'ibrutinib intolerant pts', 'important data acalabrutinib monotherapy', 'chronic lymphocytic leukemia']\n",
      "['astrazeneca fortyseven', 'triple immunotherapy combo', 'lymphoma rituximab calquence acalabrutinib nonhodgkins']\n",
      "['oncoalert lymsm acalabrutinib monotherapy', 'chronic lymphocytic leukemia cll', 'ibrutinib advances']\n",
      "['astrazeneca ascend calquence cll astrazeneca', 'positive results', 'phase iii ascend trial', 'cll patients']\n",
      "['refractory mantle cell lymphoma', 'phase ii trial studies', 'acalabrutinib work', 'mantle cell lymphoma']\n",
      "['b nefices', 'survie sans progression', 'l acalabrutinib calquence astrazeneca dans', 'leuc mie lympho', 'chronique montr s']\n",
      "['acalabrutinib trial']\n",
      "[]\n",
      "['acalabrutinib study', 'early pfs vs comparator', 'r benda idelalisib', 'isn t chlorambucil advantage', 'btk selectivity', 'target ae']\n",
      "['calquence phase iii ascend trial', 'primary endpoint', 'interim analysis', 'refractory cll', 'side note', 'time jose baselga', 'cll trial']\n",
      "['dr brian koffman comments', 'exciting acalabrutinib news cll cllsm leukemia']\n",
      "['chronic lymphocytic leukemia', 'meaningful improvement', 'free survival', 'acalabrutinib monotherapy cllsm leusm']\n",
      "['cancer cll cllsm acalabrutinib ibrutinib']\n",
      "['important news', 'acalabrutinib cll cllsm acalabrutinib']\n",
      "['acalabrutinib increases progression', 'free survival', 'refractory chronic lymphocytic leukaemia ecancer']\n",
      "['acertapharma amp fortyseven', 'initiate clinicaltrials', 'rituximab acalabrutinib vs dlbcl', 'cd47 antibody', 'attack tumor cells', 'don t', 'signal immunooncology lymphoma cancer']\n",
      "['agent acalabrutinib', 'primary end point', 'r r cll leukemia cancer']\n",
      "['weekly news roundup az imbruvica', 'rival reports', 'positive trial results patents', 'scrutiny fda', 'rare disease drug pharma calquence drugpatents drugapproval raredisease']\n",
      "['acalabrutinib increases progression', 'free survival', 'refractory chronic lymphocytic leukaemia', 'targetedtherapy clinicaltrials cll']\n",
      "['acalabrutinib improves pfs', 'refractory cll', 'cll patients']\n",
      "['chronic lymphocytic leukemia', 'meaningful improvement', 'free survival', 'acalabrutinib monotherapy treatment']\n",
      "['az calquence trial', 'endpoints pharmanews lifesciences']\n",
      "['positive results astrazeneca', 'phase iii ascend trial', 'chronic lymphocytic leukaemia', 'time patients', 'disease progression']\n",
      "['frontline role', 'cll paradigm', 'patients venetoclax duvelisib', 'btk inhibitor leusm']\n",
      "['marketwatch az s trial', 'increase patients', 'time patients', 'disease progression lymphocyticleukaemia drugtrials thepmi19']\n",
      "['astrazeneca s calquence preps', 'imbruvica showdown', 'calquence challenge imbruvica s stronghold', 'cll azn']\n",
      "['astrazeneca ends calquence trial', 'chronic lymphocytic leukaemia pharma']\n",
      "['j amp j astrazeneca', 'star cancer drug franchises calquence acalabrutinib']\n",
      "['primary endpoint', 'meaningful improvement', 'acalabrutinib single agent leusm leukemia']\n",
      "['az calquence trial']\n",
      "['az calquence trial']\n",
      "['az calquence trial']\n",
      "['az calquence trial', 'endpoints pharma regulatory']\n",
      "['az calquence trial']\n",
      "['az ends calquence trial', 'chronic lymphocytic leukaemia']\n",
      "['az ends calquence trial', 'chronic lymphocytic leukaemia']\n",
      "['az ends calquence trial', 'chronic lymphocytic leukaemia pharmaceutical']\n",
      "['astrazeneca ends calquence trial', 'chronic lymphocytic leukaemia pharma']\n",
      "['calquence phase iii trial', 'good results biotech drugtrial hematology oncology research uk']\n",
      "['jobs astrazeneca s blood cancer drug calquence improves pfs', 'phase iii ascend trial']\n",
      "['acalabrutinib improves pfs', 'refractory cll']\n",
      "['astrazeneca reports results', 'calquence acalabrutinib', 'p iii ascend study', 'r r chronic lymphocytic leukaemia']\n",
      "['acalabrutinib monotherapy', 'meaningful improvement', 'cll leusm']\n",
      "['astrazeneca s calquence preps', 'imbruvica showdown', 'gt gt gt strategy competitiveintelligence', 'pharma biotech healthcare pharmaceutical ci']\n",
      "['cll btk acalabrutinib pfs']\n",
      "['azn s majority', 'abbv s imbruvica', 'tall order']\n",
      "['acalabrutinib improves pfs', 'refractory cll leusm']\n",
      "['acalabrutinib improves pfs', 'refractory cll']\n",
      "['acalabrutinib improves pfs', 'refractory cll']\n",
      "['astrazeneca s calquence preps', 'imbruvica showdown']\n",
      "['astrazeneca blood cancer drug hits study goal', 'astrazeneca amp', 's majority', 'tall order']\n",
      "['exciting day']\n",
      "['astrazeneca s calquence preps', 'imbruvica showdown']\n",
      "['calquence phase iii ascend trial', 'primary endpoint', 'interim analysis', 'refractory chronic lymphocytic leukaemia']\n",
      "['calquence monotherapy', 'free survival', 'chronic lymphocytic leukemia', 'ascend trial']\n",
      "['astrazeneca s calquence preps', 'imbruvica showdown']\n",
      "['astrazeneca s calquence preps', 'imbruvica showdown', 'pharma regulatory']\n",
      "['astrazeneca s calquence preps', 'imbruvica showdown']\n",
      "['leucemia linfoc tica cr nica refractaria estudio fase iii ascend evaluando acalabrutinib alcanza objetivo primario', 'lisis interino y cerrara anticipadamente sciencelink']\n",
      "['calquence phase iii ascend trial', 'primary endpoint', 'interim analysis', 'refractory chroniclymphocyticleukaemia']\n",
      "['cll btk acalabrutinib pfs']\n",
      "['ubs bel sst astrazeneca auf', 'pence z', 'rich dpa afx analyser', 'schweizer gro bank ubs hat', 'einstufung f r astrazeneca nach neuen daten einer leuk mie studie mit calquence auf', 'mit einem kursziel von', 'onvista dpa']\n",
      "['azn gild rhhby astrazeneca s calquence', 'late stage leukemia study']\n",
      "['dpa afx goldman bel sst astrazeneca auf', 'new york dpa afx analyser', 'investmentbank goldman sachs hat', 'einstufung f r astrazeneca nach positiven daten aus einer leuk mie studie mit calquence auf']\n",
      "['goldman bel sst astrazeneca auf', 'new york dpa afx analyser', 'investmentbank goldman sachs hat', 'einstufung f r astrazeneca nach positiven daten aus einer leuk mie studie mit calquence auf', 'mit onvista dpa']\n",
      "['stops phase iii trial', 'chronic lymphocytic leukaemia drug calquence', 'promising results']\n",
      "['calquence phase iii ascend trial', 'primary endpoint', 'interim analysis', 'refractory chronic lymphocytic leukaemia']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['calquence vs imbruvica', 'irrelevant jnj abbv rhhby']\n",
      "['cll btk acalabrutinib pfs']\n",
      "['astrazeneca s calquence phase', 'trial shows', 'positive results', 'chronic lymphocytic leukaemia']\n",
      "['astrazeneca s calquence hits', 'main goal', 'late stage study', 'chronic lymphocytic leukaemia azn']\n",
      "['cll btk acalabrutinib pfs bp']\n",
      "['astrazeneca s calquence phase iii ascend trial', 'primary endpoint', 'chronic lymphocytic leukaemia', 'phase iii cll trial results']\n",
      "['astrazeneca company', 'positive results', 'phase iii ascend trial', 'calquence azn pharma']\n",
      "['astrazeneca plc calquence phase iii ascend trial', 'primary endpoint azn']\n",
      "['rt astra calquence p3 monotherapy', 'r r cll', 'astra calquence p3 monotherapy', 'r r cll']\n",
      "['astra calquence p3 monotherapy', 'r r cll']\n",
      "['calquence phase iii ascend trial', 'primary endpoint', 'interim analysis', 'refractory chronic lymphocytic leukaemia']\n",
      "['calquence phiii ascend trial', 'primary endpoint']\n",
      "['azn astrazeneca announces', 'positive results', 'phase iii ascend trial']\n",
      "['awesomecapital astrazeneca calquence', 'primary endpoint']\n",
      "['astrazeneca reports calquence', 'primary endpoint', 'ascend trial azn']\n",
      "['nsfw radio', 'da f ck', 'playin wit', 'courtesy calquence']\n",
      "['frontline trials', 'danielle brander md', 'acalabrutinib stateofscience hemonc']\n",
      "['clinicaltrial study', 'chinese adult subjects', 'refractory mantle cell lymphoma', 'b cell malignancies']\n",
      "['chinese adult subjects', 'refractory mantle cell lymphoma', 'bcell malignancies', 'openlabel twopart study', 'safety tolerability pharmacokinetics', 'clinical renalcell kidneycancer']\n",
      "['chinese adult subjects', 'refractory mantle cell lymphoma', 'b cell malignancies status', 'condition summary phase i', 'refractory b cell malignancies phase ii']\n",
      "['calquence mcl fda']\n",
      "['acalabrutinib monotherapy']\n",
      "['pivotal study', 'adverse events', 'infection rash fatigue']\n",
      "['acalabrutinib therapy infection rate amp headache michael wang m d lymphoma']\n",
      "['acalabrutinib key clinical data']\n",
      "['r r mcl', 'standard practice', 'bijal d shah md']\n",
      "['bijal shah md moffitt cancer center discusses', 'btk inhibitors', 'btk inhibitors ibrutinib', 'acalabrutinib treatment', 'response assessment']\n",
      "['bijal shah md hematologist oncologist', 'moffitt cancer center compares', 'btk inhibitors ibrutinib', 'mantle cell lymphoma mcl treatment', 'response assessment']\n",
      "['chronic lymphocytic leukemia amp need', 'initial treatment', 'new study', 'acalabrutinib venetoclax obinutuzumab', 'info cllsm']\n",
      "['society congress', 'conference acalabrutinib calquence mantlecelllymphoma lymphoma']\n",
      "['dr matthew davids', 'discusses data', 'frontline treatment', 'cll stateofscience']\n",
      "['ons congress', 'mcl patients', 'acalabrutinib onscongress acalabrutinib calquence']\n",
      "['mantle cell lymphoma lymphoma lymsm']\n",
      "['society congress', 'anaheim i m', 'adverse events', 'r r mcl pts', 'overall pi', 'study mantlecelllymphoma']\n",
      "['chopr therapy', 'richter s syndrome', 'stellar trial']\n",
      "['phoenix trial rchop ibrutinib', '1l dlbcl overall efs', 'diff btwn arms', 'efs advantage', 'lt 60y', 'tox discontinuations gt 60yr helpful data', 'phase ii', 'richters transformation cll rchop acalabrutinib blooducation lymsm']\n",
      "['cs azn', 'recent japan investor bus tours ds', 'main point', 'discussion ds', 'azn s oncology footprint amp leverage', 'global oncology infrastructure', 'tagrisso imfinzi lynparza calquence']\n",
      "['acalabrutinib key clinical data ash2018 hematology ash hematology cancer cancerfree oncology cancerresearch endcancer beatcancer fightcancer solvecancer healthcare', 'acalabrutinib cll leukemia']\n",
      "['whitewash radio tilt', 'ty calquence']\n",
      "['acalabrutinib therapy infection rate amp headaches mdanderson ash2018 hematology ash acalabrutinib lymphoma cancer cancerfree oncology cancerresearch endcancer']\n",
      "['xagena acalabrutinib aggiornamenti', 'xagena ematologiaoncologica farmaciematologici web amp amp database', 'ematologia amp oncoematologia']\n",
      "['acalabrutinib monotherapy', 'cll ash2018 hematology ash hematology cancer cancerfree oncology cancerresearch endcancer beatcancer fightcancer solvecancer healthcare', 'acalabrutinib cll leukemia']\n",
      "['acalabrutinib trial', 'mdanderson ash2018 hematology ash acalabrutinib lymphoma cancer cancerfree oncology cancerresearch endcancer beatcancer']\n",
      "['phase iii trials', 'high risk patients', 'mature ibrutinib leukemia leusm']\n",
      "['dr barrientos ibrutinib bloodcancer hematology']\n",
      "['venetoclax treatment', 'high risk', 'early treatment', 'immune system']\n",
      "['xagena acalabrutinib aggiornamenti', 'xagena web']\n",
      "['dr barrientos', 'viable option', 'patients cllsm leukemia bloodcancer']\n",
      "['acalabrutinib venetoclax', 'obinutuzumab cd20 mab versus chemoimmunotherapy fcr', 'bendamustine r lymsm']\n",
      "['dr goy', 'promising data']\n",
      "['clinical trial', 'women age', 'mantle cell lymphoma mcl', 'acalabrutinib renalcell kidneycancer']\n",
      "['dr byrd', 'exciting results']\n",
      "['great option', 'cll patients', 'r r patients bloodcancer leukemia']\n",
      "['treatment landscape', 'mantle cell lymphoma space', 'refractory disease', 'promising regimen']\n",
      "['dr goy', 'promising data', 'mcl lymsm']\n",
      "['dr wang', 'agent acalabrutinib', 'mcl lymsm']\n",
      "['informative interview', 'dr byrd', 'frontline setting', 'ash2018 cancer bloodcancer leukemia ash2018 calquence']\n",
      "['dr wang', 'agent acalabrutinib', 'mcl lymsm']\n",
      "['p2 study pembro acalabrutinib w pbmcs', 'potentiate pd l1 monocytes amp cd8 t cells', 'activ periph tregs', 'cr pr pts', 'tregs j george gu19 bladdercancer']\n",
      "['novel agents bortezomib lenalidomide', 'ibrutinib acalabrutinib', 'frontline phase', 'trials shine echo trials', 'trial sympatico', 'kite zuma', 'juno celgene car t trial', 'entire history']\n",
      "['refractory cll', 'objective response rates', 'btk inhibitor acalabrutinib leusm']\n",
      "['shine study', 'massive international phase', 'mantle cell lymphoma', 'frontline bendamustine rituximab acalabrutinib vs bendamustine rituximab placebo']\n",
      "['long term', 'cll w john byrd', 'hematology ash18 leukemia cllsm hemeonc leusm']\n",
      "['bioavailability metabolism', '14c acalabrutinib']\n",
      "['cancer drug', 'mantle cell lymphoma share', 'above topic', 'issue 20th february']\n",
      "['novel agents', 'b cell lymphomas lenalidomide ibrutininb acalabrutinib idelalisib copanlisib duvelisib venetoclax']\n",
      "['new patent', 'astrazeneca drug calquence']\n",
      "['new patent', 'astrazeneca drug calquence', 'annual drug patent expirations', 'calquence calquence', 'patents protectingthe post', 'new pharmacy']\n",
      "['new patent', 'astrazeneca drug calquence']\n",
      "['new patent', 'astrazeneca drug calquence']\n",
      "['acalabrutinib key clinical data hematology']\n",
      "['anvisa aprovou o registro', 'calquence acalabrutinibe indicado para o tratamento', 'pacientes adultos com lcm que tenham recebido pelo menos um tratamento pr vio para', 'confira gt oncologia anvisa aprova o cancer oncologiabrasil sa']\n",
      "['phase iii study nct02477696 acalabrutinib', 'suitable frontline option', 'tolerate ibrutinib', 'shagun arora md']\n",
      "['acalabrutinib fda']\n",
      "['acalabrutinib trial']\n",
      "['long term', 'btk inhibitors acalabrutinib', 'refractory mcl lymsm']\n",
      "['tycel phillips interview']\n",
      "['mantle cell lymphoma lymphoma lymsm']\n",
      "['dr patel discusses', 'mcl lymsm']\n",
      "['acalabrutinib monotherapy', 'durable response', 'mantle cell lymphoma lymsm']\n",
      "['lead researcher discusses acalabrutinib', 'mcl lymsm']\n",
      "['acalabrutinib demonstrates', 'promising response rates', 'cll di']\n",
      "['long term outcome']\n",
      "['lead researcher highlights', 'acalabrutinib mcl data oncology']\n",
      "['dr tycel phillips discusses', 'non hodgkin lymphoma']\n",
      "['dr phillips', 'bendamustine rituximab', 'mcl lymsm']\n",
      "['acalabrutinib monotherapy', 'cll hematology ash18']\n",
      "['acalabrutinib trial', 'hematology ash18']\n",
      "['responses pfs', 'agent acalabrutinib', 'long term', 'refractory mcl lymsm']\n",
      "['lead researcher highlights', 'acalabrutinib mcl data']\n",
      "['dr wang discusses', 'agent acalabrutinib', 'mcl lymsm']\n",
      "['lead researcher highlights', 'acalabrutinib mcl data']\n",
      "['robert dean md']\n",
      "['new post calquence shows', 'durable responses', 'cll sll patients']\n",
      "['calquence shows', 'durable responses', 'cll sll patients']\n",
      "['novel btk inhibitor acalabrutinib shows']\n",
      "['positive results', 'waldenstr m s macroglobulinemia']\n",
      "['acalabrutinib therapy infection rate amp headaches hematology']\n",
      "['acalabrutinib therapy infection rate amp headaches']\n",
      "['acalabrutinib calquence', 'refractory mantle cell lymphoma']\n",
      "['acalabrutinib key clinical data hematology']\n",
      "[]\n",
      "['novel agents', 'ibrutinib venetoclax idelalisib', 'treatment landscape', 'neil e kay md leusm']\n",
      "['dr goy', 'acalabrutinib versus ibrutinib', 'mcl lymsm']\n",
      "['refractory mcl', 'btk inhibitor', 'mcl lymphoma']\n",
      "['aprovado novo tratamento para tipo agressivo', 'linfoma o produto o calquence acalabrutinibe indicado para pacientes adultos que j tenham recebido tratamento pr vio', 'c lulas', 'manto lcm confira mais informa es', 'portal da anvisa']\n",
      "['efficacia di acalabrutinib un inibitore btk nel linfoma mantellare resistente o recidivante']\n",
      "['positive results', 'waldenstr m s macroglobulinemia']\n",
      "['anvisa aprova novo tratamento para tipo agressivo', 'linfoma medicamento indicado para pacientes adultos que j tenham recebido tratamento pr vio', 'c lulas', 'manto revistamedicinasa linfoma anvisa medicamento calquence']\n",
      "['promising response rates', 'mantlecelllymphoma mcl cancertreatment']\n",
      "['aprovado novo tratamento para tipo agressivo', 'linfoma o produto o calquence acalabrutinibe indicado para pacientes adultos que j tenham recebido tratamento pr vio', 'c lulas', 'manto lcm confira mais informa es', 'portal da anvisa']\n",
      "['mantle cell lymphoma eurekamag']\n",
      "['dr phillips mcl', 'rare subset', 'non hodgkin lymphoma', 'standard treatment', 'patients cancer bloodcancer']\n",
      "['positive results', 'waldenstr m s macroglobulinemia']\n",
      "['lead researcher discusses acalabrutinib', 'mcl oncology']\n",
      "['acalabrutinib monotherapy', 'cll hematology']\n",
      "['acalabrutinib trial']\n",
      "['acalabrutinib monotherapy']\n",
      "['acalabrutinib key clinical data']\n",
      "['small study', 'effective dr phillips', 'mantle cell lymphoma lymphoma lymsm']\n",
      "['lead researcher discusses acalabrutinib', 'mcl lymsm']\n",
      "['quick clip', 'dr phillips', 'mantle cell lymphoma mcl lymphomas lymsm']\n",
      "['acalabrutinib trial']\n",
      "['acalabrutinib therapy infection rate amp headaches']\n",
      "['lead researcher discusses acalabrutinib']\n",
      "['rare subset', 'non hodgkin lymphoma', 'patients dr phillips', 'interview check', 'short clip', 'mcl lymsm oncology']\n",
      "['population pharmacokinetics', 'btk inhibitor acalabrutinib', 'active metabolite', 'healthy volunteers', 'b cell malignancies lymphoma lymsm']\n",
      "['durable responses', 'mantle cell lymphoma', 'toxicity profiles stand', 'findings lymphoma hematology']\n",
      "['calquence shows', 'durable responses', 'refractory mantle cell lymphoma phase', 'trial shows']\n",
      "['new post calquence shows', 'durable responses', 'refractory mantle cell lymphoma phase', 'trial shows']\n",
      "['rare subset', 'non hodgkin lymphoma', 'patients dr phillips', 'patients mantlecell lymphoma lymsm']\n",
      "['safety profile', 'safety profiles', 'dr phillips', 'ash18 lymphomas lymsm']\n",
      "['synergistic mechanism dr phillips', 'acalabrutinib combo', 'mantle cell lymphoma lymphoma lymsm mcl']\n",
      "['dr sun', 'results support', 'high risk treatment na ve cll', 'mg bid dose', 'acalabrutinib cllsm leukemia']\n",
      "['year s ash', 'btk inhibitors', 'treatment course', 'mantle cell lymphoma dr phillips', 'mcl data', 'year s meeting lymphoma hematology']\n",
      "['dr phillips discusses', 'bendamustine rituximab', 'treatment naive', 'refractory mantle cell lymphoma mantlecell lymphoma lymsm']\n",
      "['btk inhibitor acalabrutinib', 'high orrs', 'treatment na ve', 'refractory patients', 'phase ib trial', 'annual meeting']\n",
      "['acalabrutinib regimen', 'mcl oncology']\n",
      "['refractory cll', 'objective response rates', 'btk inhibitor acalabrutinib results', 'open label phase ii trial']\n",
      "['drug development', 'bruton s tyrosine kinase', 'competitive ibrutinib']\n",
      "['acalabrutinib regimen', 'mcl lymsm']\n",
      "['acalabrutinib regimen']\n",
      "['combination therapy', 'overall response rate', 'treatment na ve mantle cell lymphoma mcl lymphoma lymsm']\n",
      "['high response rates', 'cll leusm']\n",
      "['high response rates']\n",
      "['reversible inhibitors', 'bruton s tyrosine kinase btk', 'acalabrutinib resistance', 'promising clinical trial', 'md anderson cancer center']\n",
      "['good friend jackie barrientos', 'cll highlights', 'acalabrutinib abstract', 'umbralisib pembrolizumab abstract', 'car t cells ibrutinib abstract lba']\n",
      "['long term', 'acalabrutinib monotherapy', 'refractory mantle cell lymphoma shows', 'new safety signals', 'ash18 lymsm']\n",
      "['dr phillips', 'bendamustine rituximab', 'mcl ash18']\n",
      "['astrazeneca s calquence', 'azn pharma']\n",
      "['ph3 h2h', 'new drugs nvs 5b', 'jnj tremfya beats cosentyx', 'psoriasis azn acalabrutinib vs abbv ibrutinib cll mrk', 'pd l1 tgf vs keytruda 1l nsclc pfe oral jaki vs regn dupi']\n",
      "['ash18 acalabrutinib', 'mcl confirms efficacy amp tolerability', 'lymsm cancertreatment']\n",
      "['long term', 'mantle cell lymphoma cr rate']\n",
      "[]\n",
      "[]\n",
      "['pr times']\n",
      "[]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['astrazeneca s calquence', 'gt gt gt strategy competitiveintelligence', 'biotech healthcare pharma pharmaceutical ci']\n",
      "['az s calquence']\n",
      "['long term', 'chronic lymphocytic leukaemia patients', 'meaningful response']\n",
      "['long term', 'acalabrutinib monotherapy', 'refractory mcl shows', 'new safety signals']\n",
      "['dr wang', 'mantle cell lymphoma ash18 mcl lymsm']\n",
      "['term data', 'ash18 astrazeneca acertapharma']\n",
      "['positive data']\n",
      "['long term', 'acalabrutinib monotherapy', 'refractory mcl shows', 'new safety signals']\n",
      "['ash18 doubts', 'patients gt', 'r minichop ibrutinib r chop acalabrutinib']\n",
      "['term data']\n",
      "['tycel phillips', 'treatment naive', 'refractory mantle cell lymphoma mcl ash18']\n",
      "['tycel j phillips m d s poster', 'ash18 safety', 'treatment naive', 'refractory mantle cell lymphoma']\n",
      "['term data']\n",
      "['acalabrutinib monotherapy', 'durable response', 'mantle cell lymphoma ash18']\n",
      "['ash18 john byrd', 'acalabrutinib monotherapy', 'high response rates', 'acceptable safety profile', 'treatment na ve cll lymsm lymphoma']\n",
      "['bruce cheson', 'key question', 'john byrd front', 'ibrutinib vs acalabrutinib hematology']\n",
      "['efs front line']\n",
      "['btk inhibitors', 'acalabrutinib frontline data']\n",
      "['long term data', 'mantle cell lymphoma mcl registrational trial', 'new data', 'chronic lymphocytic leukemia cll']\n",
      "['ae profile', 'months median']\n",
      "['term data']\n",
      "['tycel j phillips md discusses safety', 'efficacy findings', 'treatment naive', 'refractory mcl']\n",
      "['dr ujjani', 'don t', 'day patient compliance', 'lymphoma mantlecelllymphoma']\n",
      "['term calquence data', 'mantle cell lymphoma mcl haematology biologics blood cancer lymphoma leukaemia']\n",
      "['chronic lymphocytic leukaemia cll haematology biologics blood cancer lymphoma leukaemia']\n",
      "['american society', 'annual meeting', 'scientific presentations', 'long term data frm calquence', 'mantle cell lymphoma amp', 'phase trial results', 'chronic lymphocytic leukaemia haematology blood cancer']\n",
      "['positive results', 'waldenstr m s macroglobulinemia']\n",
      "['btk inhibitors ibrutinib amp acalabrutinib', 'recent data', 'brian t hill md phd', 'lylsm lylcl']\n",
      "['acalabrutinib calquence', 'refractory mantle cell lymphoma']\n",
      "['liveyourlife conference dr iyengar', 'dramatic responses', 'novel agents e g btk inhibitors', 'ibrutinib acalabrutinib', 'nice approval', 'mcl amp']\n",
      "['novel bruton tyrosine kinase inhibitor acalabrutinib quantification', 'lc ms ms method', 'pharmacokinetic study', 'sprague dawley rats lymphoma lymsm']\n",
      "['bioavailability biotransformation', 'covalent btk inhibitor acalabrutinib', 'rats dogs', 'humans drug metab dispos metabolomics']\n",
      "[]\n",
      "['bioavailability biotransformation', 'covalent btk inhibitor acalabrutinib', 'rats dogs', 'humans massspec dmd']\n",
      "['novel bruton tyrosine kinase inhibitor acalabrutinib quantification', 'lc ms ms method', 'pharmacokinetic study', 'sprague dawley rats jpba']\n",
      "['acalabrutinib un inibitore della tirosin kinasi di bruton', 'designazione di terapia fortemente innovativa nel linfoma mantellare']\n",
      "['con acalabrutinib pu essere efficace nel trattamento della macroglobulinemia di waldenstr m']\n",
      "['acalabrutinib calquence', 'mantle cell lymphoma']\n",
      "['afib acalabrutinib', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['high risk cll', 'clear benefit', '200mg b d dose', '100mg b d high orr', 'doses aspergillosis hep b reactivation', 'reminder re', 'btk inhibitors cll ash18']\n",
      "['cll ash18 acalabrutinib induces', 'platelet function defect']\n",
      "['rituximab br', 'acalabrutinib btk inhibitor', 'mantle cell lymphoma lymsm']\n",
      "['pt show', 'price transparency', 'shameful drug']\n",
      "['big i vj']\n",
      "[]\n",
      "['btk inhibitor', 'active drug', 'waldenstrom macroglobulinemia']\n",
      "['btk inhibitor', 'active drug', 'waldenstrom macroglobulinemia']\n",
      "['san diego', 'velosbio raises 58m', 'round co', 'dave johnson ex ceo', 'w azn story']\n",
      "['acalabrutinib calquence', 'refractory mantle cell lymphoma']\n",
      "['bruton kinase btk inhibitors', 'acalabrutinib increase', 'atrial fibrillation infection']\n",
      "['btk inhibitors', 'iwnhl18 lymsm hematology']\n",
      "['cefalea es un efecto adverso frecuente del acalabrutinib y suele remitir tras el primer mes']\n",
      "['absorci n', 'acalabrutinib opci n', 'linfoma del manto', 'reca da se ve mermada por el uso']\n",
      "[]\n",
      "[]\n",
      "['btk inhibitor', 'active drug', 'waldenstrom macroglobulinemia']\n",
      "['bijal d shah md', 'toxicity profiles']\n",
      "['main factor', 'acalabrutinib bijal d shah md']\n",
      "['dr shah compares toxicity profiles']\n",
      "['dr shah compares toxicity profiles']\n",
      "['bijal shah md hematologist oncologist', 'moffitt cancer center compares', 'btk inhibitors ibrutinib', 'mantle cell lymphoma']\n",
      "['acalabrutinib calquence', 'refractory mantle cell lymphoma']\n",
      "['video simon', 'positive results', 'waldenstr m s macroglobulinemia eha23 lymsm nonhodgkin ctsm hcsm combinationtherapy elderlypatients hemoglobin']\n",
      "['new medication', 'treats lymphoma']\n",
      "['ibrutinib acalabrutinib bruton s tyrosine kinase']\n",
      "['follicular lymphoma thursdaythoughts cancertreatment']\n",
      "['christopher r flowers md ms considers safety', 'long term data amp patient preferences', 'btk inhibitors']\n",
      "['mantle cell lymphoma', 'data dr bijal shah', 'discussss safety differences stateofscience hemonc mcl']\n",
      "['mantle cell lymphoma mcl updates', 'tampa community', 'dr shah', 'chair ibrutinib', 'acalabrutinib updates stateofscience hematology acabrutinib']\n",
      "['positive results', 'waldenstr m s macroglobulinemia']\n",
      "['xagena acalabrutinib']\n",
      "['1igr ok c8r ufo tdhebdkwowc8x']\n",
      "['new oel fastrac monograph', 'acalabrutinib oelfastrac']\n",
      "[]\n",
      "['positive results', 'waldenstrm s macroglobulinemia']\n",
      "['btk inhibitor', 'active drug', 'waldenstrom macroglobulinemia']\n",
      "['dr pip nicolson prof steve watson', 'colleagues inhibition', 'specific concentrations', 'acalabrutinib delays', 'block platelet aggregation']\n",
      "['btk inhibitor', 'active drug', 'waldenstrom macroglobulinemia']\n",
      "[]\n",
      "['novel btk inhibitor acalabrutinib shows']\n",
      "['specific concentrations', 'acalabrutinib delays', 'block platelet aggregation']\n",
      "['astrazeneca outlook calquence', 'mantle cell myloma']\n",
      "['dr jacobs', 'mcl lymsm']\n",
      "['acalabrutinib calquence', 'refractory mantle cell lymphoma']\n",
      "['azn astrazeneca astrazeneca', 'calquence astrazeneca']\n",
      "['new btk inhibitor acalabrutinib', 'minimal treatment', 'acalabrutinib ibrutinib']\n",
      "['acalabrutinib recibe aprobaci n', 'fda para linfomas', 'c lulas del manto']\n",
      "['dr wang', 'unmet need', 'mantle cell lymphoma', 'btk inhibitors patients', 'incurable lymphoma lymsm']\n",
      "['novel btk inhibitor acalabrutinib shows']\n",
      "['key findings', 'acalabrutinib study', 'simon rule', 'eha23 lymphoma lymsm']\n",
      "['acalabrutinib monotherapy', 'effective treatment', 'durable responses', 'treatment naive', 'refractory patients', 'waldenstr m s macroglobulinemia roger owen md lymsm hematology asco18']\n",
      "[]\n",
      "[]\n",
      "['astrazeneca outlook calquence', 'mantle cell myloma']\n",
      "['clinicaltrials uk', 'phase ib ii combination', 'r chop', 'patient diffuse', 'large b cell lymphoma dlbcl']\n",
      "['lol companies', 'gen btki s', 'vitro data', 'acalabrutinib zanubrutinib arql snss apto tgtx loxo bgne']\n",
      "['btk inhibitor', 'active drug', 'waldenstrom macroglobulinemia']\n",
      "['atlanta dr john byrd acalabrutinib', 'cll chronic lymphocytic leukemia']\n",
      "[]\n",
      "['agent acalabrutinib', 'wm waldenstromsmacroglobulinemia asco18 asco2018']\n",
      "['key findings', 'acalabrutinib study', 'wm lymphoma lymsm']\n",
      "[]\n",
      "['cd19 car t cell trial', 'mantle cell lymphoma patients']\n",
      "['clinical unmet need', 'mantle cell lymphoma', 'btk inhibitors', 'incurable lymsm mcl']\n",
      "['acalabrutinib monotherapy', 'waldenstrom macroglobulinemia']\n",
      "['simon updates', 'novel therapies', 'interview hematology lymsm lymphoma wmsm hemonc ctsm caxtx']\n",
      "['astrazeneca s acalabrutinib', 'overall response rate', 'dlbcl patients', 'phase i data']\n",
      "['combination study', 'btki presentation', 'acalabrutinib data', 'low toxicity', 'fast kinetics', 'igm r duction', 'ibrutinib eha23']\n",
      "['combination treatment', 'acalabrutinib acp', 'high response rate', 'non germinal center b cell']\n",
      "['key findings', 'acalabrutinib study', 'lymsm eh23 hematology']\n",
      "['astrazeneca outlook calquence', 'mantle cell myloma']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['acalabrutinib na terapia', 'macroglobulinemia waldenstr m fase ii', 'inibidor bruton tirosino kinase resposta duradoura novas perspectivas']\n",
      "['oncolinesprofiler compares ic50 s', 'anticancer drugs', 'cell lines ntrc', 'compound database', 'different agents incl herceptin trastuzumab adc kadcyla sumoylation inh ml', 'btk inhibitor acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['acalabrutinib blinatumomab', 'inotuzumab ozogamicin']\n",
      "['acalabrutinib calquence', 'refractory mantle cell lymphoma']\n",
      "['abbv abbvie inc calquence', '5bn drug calquence', 'eu pharma', 'elevate rr study calquence vs imbruvica', 'r r cll', 'azn catalyst', 'available datasets']\n",
      "['dr jia ruan w', 'asco18 research', 'acalabrutinib monotherapy', 'r r dlbcl patients lymsm']\n",
      "[]\n",
      "['btk inhibitor', 'active drug', 'waldenstrom macroglobulinemia']\n",
      "['dr peter martin re acalabrutinib clinicaltrial', 'promising response rates', 'follicular lymphoma asco18']\n",
      "['generic name', 'certain cancer type mcl', 'mantle cell lymphoma diabetic medicine treatment cancer treatment']\n",
      "['acalabrutinib monotherapy', 'waldenstrom macroglobulinemia cancer asco18']\n",
      "['host site', 'effective amp', 'people w waldenstrom s macroglobulinemia trial data']\n",
      "[]\n",
      "['patients pts', 'waldenstr m macroglobulinemia wm dr r owen', 'promising results', 'btk inhibitor monotherapy asc018 bopa']\n",
      "['dr richard furman', 'clinicaltrial data', 'waldenstrom s macroglobulinemia pts asco18 lymsm']\n",
      "['mantle cell lymphoma patient', 'couldn t', 'ibrutinib acalabrutinib', 'situation amp', 'free regimens', 'cases amp', 'good option']\n",
      "['asc018 abst', 'durable responses', 'reasonable toxicity profile']\n",
      "[]\n",
      "['proton pump inhibitors', 'exclusion criteria', 'acalabrutinib trial', 'waldenstrom macroglobulinemia', 'ibrutinib asco18']\n",
      "['asco18 lymsm leusm wmsm oral abstracts hematologic malignancies lymphoma', 'cll abstract', 'waldenstroms macroglobulinemia']\n",
      "['new treatment option']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['e eso', 'weekly poll', 's session', 'usual check', 'refractory mcl']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['i block']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['azn drugs']\n",
      "['acalabrutinib monotherapy', 'refractory dlbcl asco18', 'patients orr', 'surprising handful', 'cr lymsm btk inhibitor monotherapy']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['twtr i guess azn', 'market share', 'imbruvica abbv']\n",
      "['astrazeneca outlook calquence', 'mantle cell myloma']\n",
      "['pharmacy forum', 'lymphoma tbt']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['acalabrutinib monotherapy', 'dlbcl pts', 'ref pts', 'dlbcl asco18']\n",
      "['promising response rates', 'fl asco18']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['didn t', 'md anderson']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['rel ref dlbcl', 'true sense', 'activity asco2018 lymphoma']\n",
      "['ryan w jacobs md', 'mantle cell lymphoma']\n",
      "['mcl paradigm acalabrutinib', 'ryan jacobs md']\n",
      "['severe platelet dysfunction', 'nhl patients']\n",
      "['dr jacobs']\n",
      "['mantle cell lymphoma btk']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia nejm']\n",
      "['dr jacobs']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['astrazeneca outlook calquence', 'mantle cell myloma']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['earlystage chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'phase ii trials studies']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['clinicaltrial acalabrutinib', 'early stage chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['early stage chronic lymphocytic leukemia', 'small lymphocytic lymphoma status', 'condition summary ccnd1', 'negative chronic lymphocytic leukemia', 'small lymphocyt']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['pharmacy forum', 'acalabrutinib lymphoma bloodcancer']\n",
      "['nationalcancerresearchmonth check', 'john theurer cancer center researchsaveslives ncrm18']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['goy shares insights', 'ibrutinib data', 'mcl thanks', 'questions mantlecelllymphoma mcl lymphomas']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['certain patients', 'aggressive type', 'non hodgkin lymphoma', 'mantle cell lymphoma']\n",
      "['pharmacy forum', 'lymphoma bloodcancer']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['acalabrutinib treatment', 'high rate', 'durable responses', 'favourable safety profile', 'refractory mantle cell lymphoma michael wang md', 'colleagues lymsm hematology']\n",
      "['trial explores', 'standard dlbcl treatment']\n",
      "['new post phase', 'trial explores', 'standard dlbcl treatment']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['mantlecelllymphoma mcl lymphoma']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['recent approval', 'treatment landscape', 'mantle cell lymphoma', 'q amp', 'field click', 'mantlecelllymphoma hematology oncology']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['astrazeneca outlook calquence', 'mantle cell myloma']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['fda s approval', 'mantle cell lymphoma', 'interview mantlecelllymphoma lymphoma lymsm']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['weekly va heme clinic']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['recent fda approval', 'acalabrutinib calquence', 'treatment landscape', 'adverse events', 'mantlecelllymphoma mcl lymsm']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['interesting loxo', 'c481 mutants', '1l btki treatments', 'jnj s ibrutinib wonder', 'azn s acalabrutinib potency', 'vs c481 muts', 'potency number slide']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['bcl2 cdk9 acalabrutinib btk']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['astrazeneca outlook calquence', 'mantle cell myloma']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['setting zanubrutinb bgb3111 results', 'rational pricing lymsm']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['recent phase ii study', 'support approval', 'refractory mantle cell lymphoma lymsm endcancer']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "[]\n",
      "['dr barrientos discusses acalabrutinib', 'cll leusm']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['bmo abbv', 'neutral mavyret trends', 'term imbruvica', 'modest downside calquence impact focus', 'humira biosimilar threat', 'rova t setback']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['new post acalabrutinib', 'fda approval', 'mantle cell lymphoma', 'colorectal cancer charity']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "['luciacalabru calquence acalabrutinib']\n",
      "[]\n",
      "['dr barrientos', 'discusses acalabrutinib', 'cll leusm']\n",
      "['acalabrutinib bij gerecidiveerd', 'refractair mantelcellymfoom']\n",
      "['acalabrutinib market launch insights']\n",
      "['new treatment option']\n",
      "['common adverse event', 'dangerous etiologies', 'headache eg hemorrhage hopa18']\n",
      "['acalabrutinib monotherapy', 'refractory mantle cell lymphoma', 'cr hopa18']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['dose escalation study', 'rapid absorption', 'acalabrutinib hopa18']\n",
      "['astrazeneca outlook calquence', 'mantle cell myloma']\n",
      "['goy lends insight', 'mcl oncology']\n",
      "['andre goy md discusses', 'ibrutinib combination strategies', 'mantle cell lymphoma lymsm']\n",
      "['goy lends insight']\n",
      "['goy lends insight', 'mcl lymsm']\n",
      "['acalabrutinib launch insight', 'delveinsight s acalabrutinib launch insight', 'comprehensive insight', 'acalabrutinib s launch']\n",
      "['dr logan', 'discusses acalabrutinib', 'cll leusm']\n",
      "['dr neil kay', 'discusses acalabrutinib role', 'cll dr kay', 'good alternative', 'chronic side', 'e g arthralgia diarrhea hypertension amp rash']\n",
      "['acalabrutinib shows', 'target activity', 'mantle cell lymphoma']\n",
      "['dr neil kay', 'tv cll leukemia']\n",
      "['new treatment option']\n",
      "['dr kay discusses', 'cll leusm']\n",
      "['astrazeneca outlook calquence', 'mantle cell myloma']\n",
      "['btk inhibitors', 'j george talk']\n",
      "['acalabrutinib therapy', 'mantle cell lymphoma']\n",
      "['atlanta dr richard furman']\n",
      "[]\n",
      "['new new treatment option']\n",
      "[]\n",
      "['top treatment option', 'clinical trial', 'oral chemotherapy acalabrutinib i trust']\n",
      "['novel btk inhibitor acalabrutinib shows']\n",
      "['astrazeneca outlook calquence', 'mantle cell myloma']\n",
      "['acalabrutinib btk inh', 'mantle cell lymphoma q', 'long term tox', 'setting bruton']\n",
      "['brian t hill md phd shares', 'ibrutinib s efficacy', 'novel strategies', 'treatment landscape lymsm']\n",
      "['efficacy amp safety', 'acalabrutinib acp', 'subjects w', 'refractory cll amp intolerant', 'ibrutinib therapy cllsm leusm nct02717611 n']\n",
      "['acalabrutinib versus ibrutinib', 'mcl lymsm']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia', 'cllsm leusm nct02029443']\n",
      "['mantle cell lymphoma comment']\n",
      "['phase ii results', 'r r mcl patients lymphoma lymsm']\n",
      "['infos traitement lymphome du manteau l acalabrutinib un inhibiteur hautement s lectif', 'bruton tyrosine']\n",
      "['refractory mantle cell lymphoma ace', 'arm multicentre phase', 'week s issue']\n",
      "['study reports', 'bruton tyrosine kinase inhibitor', 'mantle cell lymphoma patients', 'standard drugs', 'bone marrow transplantation']\n",
      "['acalabrutinib es efectivo', 'linfoma del manto reca', 'refractario resultados', 'sin rama control poco seguimiento plaquetas mejor que ibrutinib']\n",
      "['refractory mantle cell lymphoma ace', 'arm multicentre phase']\n",
      "['mantle cell lymphoma patients', 'mantle cell lymphoma patients benefit', 'calquence astrazeneca reports']\n",
      "['acalabrutinib recibe aprobaci n', 'fda para linfomas', 'c lulas del manto']\n",
      "['biotech page', 'life sciences industry oss']\n",
      "['acalabrutinib acp']\n",
      "['mantle cell lymphoma patients benefit', 'calquence astrazeneca reports', 'gt gt']\n",
      "['mantle cell lymphoma patients benefit', 'calquence astrazeneca reports', 'gt gt']\n",
      "['mantle cell lymphoma patients benefit', 'calquence astrazeneca reports', 'gt gt']\n",
      "['astrazeneca reports', 'cancer drug sales newsastrazeneca', 'product sales', 'new drugs', 'bladder cancer treatment imfinzi', 'lymphoma medication calquence']\n",
      "['astrazeneca reports', 'cancer drug sales newsastrazeneca', 'product sales', 'new drugs', 'bladder cancer treatment imfinzi', 'lymphoma medication calquence']\n",
      "['cancer astrazeneca reports', 'cancer drug sales newsastrazeneca', 'product sales', 'new drugs', 'bladder cancer treatment imfinzi', 'lymphoma medication calquence']\n",
      "['mantle cell lymphoma patients benefit', 'calquence astrazeneca reports', 'gt gt']\n",
      "['acalabrutinib acp']\n",
      "['acalabrutinib acp']\n",
      "['acalabrutinib acp']\n",
      "['acalabrutinib acp']\n",
      "['new treatment', 'mantle cell lymphoma']\n",
      "['mantle cell lymphoma patients benefit', 'calquence astrazeneca reports', 'gt gt']\n",
      "['mantle cell lymphoma patients benefit', 'calquence astrazeneca reports', 'gt gt']\n",
      "['dr barrientos', 'cll leusm']\n",
      "['early green light', 'btk blockbuster']\n",
      "['early green light', 'btk blockbuster']\n",
      "['early green light', 'btk blockbuster']\n",
      "['novel btk inhibitor acalabrutinib shows', 'cll leukemia cll ash17']\n",
      "['new treatment option', 'certain patients', 'aggressive blood cancer lymsm endcancer']\n",
      "['new treatment option']\n",
      "['mantle cell lymphoma patients benefit', 'calquence astrazeneca reports']\n",
      "['new post', 'mantle cell lymphoma patients benefit', 'calquence astrazeneca reports']\n",
      "['b cell receptor', 'article discusses btk inhibitors', 'pancreaticcancer amp preclinical data', 'clinical trials', 'ibrutinib amp acalabrutinib']\n",
      "['new treatment option']\n",
      "['non hodgkin lymphoma']\n",
      "['new2trip acalabrutinib calquence', 'adults w mantle cell lymphoma']\n",
      "['drug acalabrutinib', 'mantlecelllymphoma mcl', 'ibrutinib dr owen o connor']\n",
      "['fda grants', 'mantle cell lymphoma']\n",
      "['drug acalabrutinib calquence', 'mantle cell lymphoma']\n",
      "['kinase inhibitor acalabrutinib', 'mantle cell lymphoma mcl']\n",
      "['fda aprob acalabrutinib para el tratamiento', 'con linfoma', 'c lulas del manto aprenda m s sobre', 'aprobaci n']\n",
      "['therapeutic acalabrutinib', 'aggressive form', 'non hodgkin lymphoma']\n",
      "['novel btk inhibitor acalabrutinib shows']\n",
      "['novel btk inhibitor acalabrutinib shows']\n",
      "['new2trip acalabrutinib calquence', 'adults w mantle cell lymphoma']\n",
      "['lymphoma snapshot']\n",
      "['early acalabrutinib obinutuzumab combo data', 'high response rates', 'r r', 'tn patients ash', 'oral abstract', 'agingdata nacda']\n",
      "['acalabrutinib treatment', 'high rate', 'durable responses', 'favorable safety profile', 'refractory mantle cell lymphoma study co']\n",
      "['acalabrutinib recibe aprobaci n', 'fda para linfomas', 'c lulas del manto']\n",
      "['new2trip acalabrutinib calquence', 'adults w mantle cell lymphoma']\n",
      "['acalabrutinib monotherapy shows', 'durable remission results', 'r r', 'high risk disease', 'mid stage cll trial ash17 oral abstract', 'lymsm cll']\n",
      "['early acalabrutinib obinutuzumab combo data', 'high response rates', 'r r', 'tn patients ash17 oral abstract', 'lymsm cll']\n",
      "['recent clinicaltrial shows', 'promising results', 'refractory mcl patients', 'hematology oncogenomics precisiononcology precisionmedicine lymphoma']\n",
      "['acalabrutinib amp', 'cure mantlecelllymphoma mcl fingerscrossedagain']\n",
      "['acalabrutinib amp', 'cure mantlecelllymphoma mcl fingercrossedagain']\n",
      "['dr o connor', 'acalabrutinib versus ibrutinib', 'mcl lymsm']\n",
      "['dysfunctional thrombus formation', 'aggregation response', 'lymsm lymphoma cll']\n",
      "['acalabrutinib shows', 'high risk cll leukemia cancer']\n",
      "['cellule mantellari nei pazienti refrattari acalabrutinib risulta molto efficace']\n",
      "['new2trip acalabrutinib calquence', 'adults w mantle cell lymphoma']\n",
      "['acerta az s acalabrutinib', 'hgh response rates', 'durable remissions', 'cll amp sll', 'patient trial', 'overall response rate', 'partial response w lymphocytosis']\n",
      "['drug administration', 'acalabrutinib calquence', 'mantle cell lymphoma']\n",
      "['dr zelenetz']\n",
      "['brown discusses acalabrutinib']\n",
      "['new2trip acalabrutinib calquence', 'adults w mantle cell lymphoma']\n",
      "['calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma trial']\n",
      "['new2trip acalabrutinib calquence', 'adults w mantle cell lymphoma']\n",
      "['nice paper', 'mechanistic ex vivo differences', 'platelet function', 'ibrutinib vs acalabrutinib lymsm leusm']\n",
      "['therapeutic acalabrutinib calquence', 'certain patients', 'aggressive type', 'non hodgkin lymphoma', 'mantle cell lymphoma']\n",
      "['severe platelet dysfunction', 'nhl patients']\n",
      "['refractory mantle cell lymphoma ace', 'arm multicentre phase']\n",
      "['mantle cell lymphoma']\n",
      "['ash17 acalabrutinib monotherapy shows potential', 'refractory mantle cell lymphoma']\n",
      "['mcl phase ii', 'different response criteria', 'crr 12mo pfs', 'common ae headache', 'ibrutinib lymsm lymphoma']\n",
      "['astrazeneca s calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma trial']\n",
      "['fda update acalabrutinib', 'mantle cell lymphoma cancertreatment healthcare']\n",
      "['expert reflects', 'acalabrutinib approval']\n",
      "['protocol amendment']\n",
      "['mantle cell lymphoma space', 'lawrence kaplan md']\n",
      "['acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma']\n",
      "['phase ii results', 'r r mcl patients', 'ash17 oral abstract', 'lymsm lymphoma']\n",
      "['refractory mantle cell lymphoma ace']\n",
      "['refractory mantle cell lymphoma ace']\n",
      "['mcl chemo', 'free therapy', 'toxicity profile', 'wang lymsm']\n",
      "['acalabrutinib calquence', 'mantle cell lymphoma']\n",
      "['clinic acalabrutinib', 'mantle cell lymphoma lymsm']\n",
      "['severe platelet dysfunction', 'nhl patients']\n",
      "['acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma lymsm ash17 hematology']\n",
      "['fda approval', 'mantle cell lymphoma cancernews']\n",
      "['new kid', 'town acalabrutinib', 'refractory mantle cell lymphoma ace', 'arm multicentre phase', 'trial es pethema hematology']\n",
      "['didyouknow acalabrutinib', 'mantle cell lymphoma']\n",
      "['severe platelet dysfunction', 'non hodgkin lymphoma', 'generation btk inhibitor acalabrutinib']\n",
      "['acalabrutinib approval', 'mcl lymsm']\n",
      "['generation btk inhibitor acalabrutinib calquence astrazeneca impresses', 'cll leukemia oncology cancer chroniclymphocyticleukemia']\n",
      "['astra zeneca pins', 'rare blood cancer drug calquence business', 'times amp', 'sunday times']\n",
      "['severe platelet dysfunction', 'nhl patients']\n",
      "['refractory mantle cell lymphoma ace', 'arm multicentre phase']\n",
      "['acalabrutinib approval']\n",
      "['mantle cell lymphoma']\n",
      "['kinase inhibitor', 'mantle cell lymphoma']\n",
      "['mantle cell lymphoma']\n",
      "['mantle cell lymphoma']\n",
      "['refractory mantle cell lymphoma ace', 'arm multicentre phase']\n",
      "['drug acalabrutinib calquence', 'mantle cell lymphoma']\n",
      "['astrazeneca s calquence acalabrutinib shows potential', 'chronic lymphocytic leukaemia trials']\n",
      "['astrazeneca s calquence acalabrutinib shows potential', 'chronic lymphocytic leukaemia trials']\n",
      "['bioimpact news btk acalabrutinib']\n",
      "['lancet article acalabrutinib', 'refractory mantle cell lymphoma ace', 'arm multicentre phase']\n",
      "['new post acalabrutinib', 'fda approval', 'mantle cell lymphoma']\n",
      "['mantle cell lymphoma']\n",
      "['refractory mantle cell lymphoma ace', 'arm multicentre phase']\n",
      "['certain patients', 'aggressive type', 'non hodgkin lymphoma', 'mantle cell lymphoma']\n",
      "['dr wang', 'acalabrutinib activity', 'mantle cell lymphoma']\n",
      "['acalabrutinib treatment', 'high rate', 'durable responses', 'favourable safety profile', 'refractory mantle cell lymphoma lymsm caxtx hemeonc']\n",
      "['acalabrutinib calquence', 'global approval', 'approach dams', 'tumour survival']\n",
      "['refractory mantle cell lymphoma ace', 'arm multicentre phase']\n",
      "['refractory mantle cell lymphoma ace', 'arm multicentre phase']\n",
      "['thelancet lymphomedumanteau acalabrutinib acalabrutinib dans', 'lymphome du manteau', 'rechute ou r fractaire ace', 'simple bras']\n",
      "['phase ii study', 'ash17 shows', 'safety profile', 'refractory mantle cell lymphoma']\n",
      "['hematology milestones', 'weeks mcl medicine', 'full data']\n",
      "['novel btk inhibitor acalabrutinib', 'cr rate', 'refractory mantle cell lymphoma', 'phase ii ace', 'trial ash17']\n",
      "[]\n",
      "['astrazeneca s acalabrutinib shows treatment effect', 'cll studies shares', 'azn sitifatimah malaysia']\n",
      "['astrazeneca s acalabrutinib shows treatment effect', 'cll studies shares']\n",
      "['astrazeneca s calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma trial']\n",
      "['fda update acalabrutinib', 'mantle cell lymphoma cancertreatment healthcare']\n",
      "['astrazeneca s calquence acalabrutinib shows potential']\n",
      "['refractory mcl ash17']\n",
      "['pre astrazeneca s calquence acalabrutinib shows potential', 'chronic lymphocytic leukaemia trials']\n",
      "['pre astrazeneca s calquence acalabrutinib shows potential', 'chronic lymphocytic leukaemia trials']\n",
      "['azn astrazeneca reports phase i ii data', 'chronic lymphocytic leukemia trials']\n",
      "['azn astrazeneca reports data', 'overall response rate', 'complete response rate']\n",
      "['azn reports phase i ii data', 'chronic lymphocytic leukemia trials']\n",
      "['azn reports data', 'overall response rate', 'complete response rate']\n",
      "['astrazeneca s calquence acalabrutinib shows potential', 'chronic lymphocytic leukaemia trials business wire']\n",
      "['astrazenecas calquence visar potential']\n",
      "['astrazeneca s calquence acalabrutinib shows potential', 'chronic news pharma']\n",
      "['astrazeneca s calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma trial syria']\n",
      "['refractory mcl']\n",
      "['refractory mcl']\n",
      "['refractory mcl']\n",
      "['refractory mcl']\n",
      "['astrazeneca s calquence acalabrutinib shows potential', 'chronic lymphocytic leukemia trials']\n",
      "['astrazeneca s calquence acalabrutinib shows potential', 'chronic lymphocytic leukaemia trials']\n",
      "['astrazeneca amp rsquo s calquence acalabrutinib shows potential', 'chronic lymphocytic leukaemia trials']\n",
      "[]\n",
      "['astra zeneca pins', 'rare blood cancer drug calquence googlealerts']\n",
      "['astrazeneca s calquence acalabrutinib shows potential', 'chronic lymphocytic leukaemia trials']\n",
      "['astrazeneca s calquence acalabrutinib shows potential', 'chronic lymphocytic leukaemia trials']\n",
      "['astrazeneca s calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma trial']\n",
      "['astrazeneca s calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma trial']\n",
      "['astrazeneca s calquence acalabrutinib shows potential', 'chronic lymphocytic leukemia trials drug medicinal pharmaceutical']\n",
      "['astrazeneca s calquence acalabrutinib shows potential', 'chronic lymphocytic leukemia trials']\n",
      "['astrazeneca s calquence acalabrutinib shows potential', 'chronic lymphocytic leukemia trials wilmington del business wire astrazeneca', 'acerta pharma', 'hematology research', 'development center']\n",
      "['astrazeneca s calquence acalabrutinib shows potential', 'chronic lymphocytic leukaemia trials cambridge england business wire astrazeneca', 'acerta pharma', 'haematology research', 'development centre']\n",
      "['astrazeneca s calquence acalabrutinib shows potential', 'chronic lymphocytic leukemia trials']\n",
      "['astrazeneca s calquence acalabrutinib shows potential', 'chronic lymphocytic leukaemia trials']\n",
      "['astrazeneca s calquence acalabrutinib shows potential', 'chronic lymphocytic leukemia trials']\n",
      "['astrazeneca s calquence acalabrutinib shows potential', 'chronic lymphocytic leukemia trials']\n",
      "['astrazeneca s calquence acalabrutinib shows potential', 'chronic lymphocytic leukaemia trials']\n",
      "['acalabrutinib data', 'r r cll', 'dr byrd ash17']\n",
      "['new data']\n",
      "['azn astrazeneca s calquence acalabrutinib shows potential', 'chronic lymphocytic leukemia trials']\n",
      "['astrazeneca s calquence acalabrutinib shows potential', 'chronic lymphocytic leukemia trials']\n",
      "['astrazeneca s calquence acalabrutinib shows potential', 'chronic lymphocytic leukaemia trials']\n",
      "['acalabrutinib obinotuzumab', '1stl amp rr cll', 'table 18m dor', 'ibrutinib r', 'ir vs i mono', 'rr obino']\n",
      "['astrazeneca s calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma trial business wire press release']\n",
      "['dr neil berinstein', 'r r mcl ab', 'ash17 lymsm']\n",
      "['astra zeneca pins', 'rare blood cancer drug calquence acalabrutinib', 'encouraging results', 'early trials', 'chronic lymphocytic leukaemia cll']\n",
      "['astra zeneca pins', 'rare blood cancer drug calquence']\n",
      "['acalabrutinib yields', 'promising response rates', 'refractory mantle cell lymphoma cancer therapy advisor treatment tcsc']\n",
      "['astrazeneca s calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma t']\n",
      "['astrazeneca s calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma']\n",
      "['acalabrutinib yields', 'promising response rates', 'refractory mantle cell lymphoma ash17 hematology']\n",
      "['azn ash17 astrazeneca announces calquence demonstrates activity', 'refractory mantle cell lymphoma trial']\n",
      "['mg bid demonstrates', 'promising efficacy', 'phase ii ace', 'r r mcl orr', 'amp cr rate']\n",
      "['top story drugs amp pharma cos news astrazeneca s calquence acalabrutinib dem']\n",
      "['astrazeneca amp rsquo s calquence acalabrutinib demonstrates activity', 'refractory mantle']\n",
      "['astrazenecas calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma trial', 'overall response rate', 'complete response rate', 'investigator assessment', 'consistent results']\n",
      "['astrazenecas calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma trial', 'overall response rate', 'complete response rate', 'investigator assessment', 'consistent results']\n",
      "['azn reveals findings', 'refractory mantle cell lymphoma']\n",
      "['azn calquence acalabrutinib demonstrates activity', 'r r mantle cell lymphoma trial ash17']\n",
      "['astrazenecas calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma trial', 'overall response rate', 'complete response rate', 'investigator assessment', 'consistent results']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['astrazenecas calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma trial', 'overall response rate', 'complete response rate', 'investigator assessment', 'consistent results']\n",
      "['astrazeneca s calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma trial laboratoire laboratory biotech']\n",
      "['ash17 acalabrutinib data', 'mantle cell lymphoma']\n",
      "['lungcancer news astrazenecas calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma trial', 'overall response rate', 'complete response rate', 'investigator assessment', 'consistent results']\n",
      "['lungcancer news astrazenecas calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma trial', 'overall response rate', 'complete response rate', 'investigator assessment', 'consistent results']\n",
      "['mantle cell lymphoma', 'pivotal trial']\n",
      "['astrazeneca s calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma tri']\n",
      "['astrazeneca s calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma trial wilmington del business wire astrazeneca', 'acerta pharma', 'hematology research', 'development center']\n",
      "['astrazeneca s calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma trial']\n",
      "['astrazeneca s calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma trial cambridge england business wire astrazeneca', 'acerta pharma', 'haematology research', 'development centre']\n",
      "['astrazeneca s calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma trial']\n",
      "['astrazeneca s calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma trial']\n",
      "['calquence oral presentation']\n",
      "['cancer astrazenecas calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma trial', 'overall response rate', 'complete response rate', 'investigator assessment', 'consistent results']\n",
      "['cancer astrazenecas calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma trial', 'overall response rate', 'complete response rate', 'investigator assessment', 'consistent results']\n",
      "['michael wang', 'exciting acalabrutinib data', 'r r mcl ash17']\n",
      "['mcl ash2017']\n",
      "['acalabrutinib talk']\n",
      "['high response rates', 'durable responses', 'mcl wang', 'btk inhib naive pts', 'headache lymsm ash17']\n",
      "['astrazeneca s calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma trial']\n",
      "['astrazeneca s calquence acalabrutinib demonstrates activity', 'refractory mantle cell lymphoma trial']\n",
      "['mcl orr', 'ibrutinib ash2017 lymsm']\n",
      "['azn astrazeneca s calquence acalabrutinib demonstrates activity', 'refractory mantle c']\n",
      "['azn calquence acalabrutinib demonstrates activity', 'r r mantle cell lymphoma trial ash17']\n",
      "['ash17 acalabrutinib', 'safety profile']\n",
      "['nice waterfall', 'r r mcl']\n",
      "['mcl study dr wang ash17 orr', 'amp cr']\n",
      "['rr mcl', 'pts median prev lines', 'median time', 'resp 2m grade']\n",
      "['mcl ace', 'good btk', 'itk inh n', 'btki naive', 'ugib ulcer zero afib', 'gr3 headache']\n",
      "['r r mcl lymphoma ash17']\n",
      "['dr wang', 'r r mcl', 'btk inhibitor', 'ibrutinib ash17']\n",
      "['acalabrutinib obat baru untuk terapi lymphoma sel mantel']\n",
      "['therapeutic acalabrutinib calquence', 'mantle cell lymphoma']\n",
      "['dr o connor', 'discusses acalabrutinib', 'mcl lymsm']\n",
      "['acalabrutinib calquence', 'mantlecelllymphoma mcl', 'owen o connor md phd discusses']\n",
      "['acalabrutinib monotherapy', 'refractory mantle cell lymphoma', 'study lymsm ash17']\n",
      "['blood cancers', 'american society', 'annual meeting', 'data presentation', 'calquence acalabrutinib', 'mantle cell lympho']\n",
      "['blood cancers', 'american society', 'annual meeting', 'data presentation', 'calquence acalabrutinib', 'mantle cell lympho']\n",
      "['cancer astrazeneca', 'blood cancers', 'american society', 'annual meeting', 'data presentation', 'calquence acalabrutinib', 'mantle cell']\n",
      "['therapeutic acalabrutinib', 'mantle cell lymphoma']\n",
      "['exciting options', 'chronic lymphocytic leukemia']\n",
      "['hearty calquence', 'mantle cell lymphoma']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['exciting options']\n",
      "['hearty calquence', 'mantle cell lymphoma']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['key efficacy', 'acalabrutinib monotherapy', 'refractory mantle cell lymphoma']\n",
      "['fda astrazeneca calquence acalabrutinib mantle cell lymphoma']\n",
      "['newmonographmonday calquence acalabrutinib', 'refractory mantle cell lymphoma']\n",
      "['acalabrutinib mcl approval raises', 'questions oncology']\n",
      "['exciting options', 'cll oncology']\n",
      "['fda approves acalabrutinib calquence', 'mantle cell lymphoma thehindupatrika']\n",
      "['lymphoma rx']\n",
      "['acalabrutinib mcl approval raises', 'angelica welch lymsm']\n",
      "['dr o connor', 'tgtx clinical trials amp']\n",
      "['btk inhibitor']\n",
      "['phase ii data', 'r r mantle cell lymphoma lymsm median', 'lines orr', '12mo dor']\n",
      "['acalabrutinib mcl approval raises']\n",
      "['acalabrutinib mcl approval raises', 'questions lymsm']\n",
      "['delaney clause', 'acalabrutinib adoptivecelltransfer alvinjsitemancancercenter']\n",
      "['ngs genomics analysis acalabrutinib mcl approval raises']\n",
      "['acalabrutinib mono', '12mo pfs', 'r r mantle cell major improvement', 'ibrutinib ash17 lymsm']\n",
      "['acalabrutinib mcl approval raises']\n",
      "['genomics ngs', 'acalabrutinib mcl approval raises']\n",
      "['hearty calquence', 'mantle cell lymphoma']\n",
      "['fda approves astrazeneca s calquence acalabrutinib', 'adult patients', 'mantle cell lymphoma']\n",
      "['fda approves astrazeneca s calquence']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['exciting options', 'cll leusm']\n",
      "['exciting options']\n",
      "['exciting options']\n",
      "['fda grants', 'mantle cell lymphoma', 'gt gt']\n",
      "['cll pts', 'richter hematology']\n",
      "['acalabrutinib efficace nel linfoma mantellare resistente o recidivante']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer']\n",
      "['fda grants', 'mantle cell lymphoma', 'gt gt']\n",
      "['fda approves s calquence', 'adult patients w', 'mantle cell lymphoma']\n",
      "['fda approves btk inhibitor calquence', 'mantle cell lymphoma']\n",
      "['fda approves', 'new treatment', 'mantle cell lymphoma']\n",
      "['fda grants', 'mantle cell lymphoma', 'gt gt']\n",
      "['recent study shows', 'certain mantle cell lymphoma patients oncogenomics']\n",
      "['fda grants', 'mantle cell lymphoma', 'gt gt']\n",
      "['fda approves', 'new treatment', 'mantle cell lymphoma']\n",
      "['mantle cell lymphoma']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['fda grants approval', 'mantle cell lymphoma']\n",
      "['fda grants', 'mantle cell lymphoma', 'gt gt']\n",
      "['bmo azn calquence acalabrutinib mcl label', '5bn franchise']\n",
      "['fda approves astrazeneca s calquence', 'mantle cell lymphoma raredisease orphandrug']\n",
      "['fda approves', 'new treatment', 'mantle cell lymphoma']\n",
      "[]\n",
      "['early green light', 'btk blockbuster', 'calquence azn smallcap']\n",
      "['u s fda', 'mantle cell lymphoma']\n",
      "['fda grants', 'mantle cell lymphoma', 'gt gt']\n",
      "['c lulas', 'manto calquence']\n",
      "['fda approves calquence', 'mantle cell lymphoma']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['cbc test', 'office use calquence', 'mantle cell lymphoma g csf']\n",
      "['fda mcl fda', 'mcl calquence']\n",
      "['fda mcl fda', 'mcl calquence']\n",
      "['fda approves calquence treatment', 'mantle cell lymphoma']\n",
      "['calquence mcl fda']\n",
      "['calquence mcl fda']\n",
      "['fda grants', 'mantle cell lymphoma', 'gt gt']\n",
      "['linfoma mantellare acalabrutinib di astrazeneca approvato dall fda', 'i pazienti adulti']\n",
      "['fda approves astrazeneca s calquence', 'adult patients']\n",
      "['fda grants', 'mantle cell lymphoma ecancer news']\n",
      "['fda approves calquence acalabrutinib', 'mantle cell lymphoma']\n",
      "['fda drug approvals changes', 'tuesday october', 'calquence prexxartan zegerid otc']\n",
      "['early green light', 'btk blockbuster', 'calquence azn smallcap']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'adults rxwiki']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'adults rxwiki']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'adults rxwiki']\n",
      "['new lymphoma rx', 'drug administration fda']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'adults rxwiki']\n",
      "['new lymphoma rx', 'drug administration fda']\n",
      "['new lymphoma rx', 'drug administration fda']\n",
      "['new lymphoma rx', 'drug administration fda']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'adults rxwiki']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'adults rxwiki']\n",
      "['calquence mcl fda']\n",
      "['calquence mcl fda']\n",
      "['calquence mcl fda']\n",
      "['calquence mcl fda']\n",
      "['early green light', 'btk blockbuster', 'calquence azn smallcap']\n",
      "['fda grants', 'mantle cell lymphoma', 'gt gt']\n",
      "['linfoma mantellare acalabrutinib di astrazeneca approvato dall fda salutedomani podcast']\n",
      "['early green light', 'btk blockbuster', 'calquence azn smallcap']\n",
      "['fda approves astrazeneca s calquence acalabrutinib', 'adult patients', 'mantle cell lymph']\n",
      "['early green light', 'btk blockbuster', 'calquence azn smallcap']\n",
      "['linfoma mantellare acalabrutinib di astrazeneca approvato dall fda', 'i pazienti']\n",
      "['linfoma mantellare acalabrutinib di astrazeneca approvato dall fda', 'i pazienti adulti']\n",
      "['linfoma mantellare acalabrutinib di astrazeneca approvato dall fda', 'i pazienti adulti']\n",
      "['linfoma mantellare acalabrutinib di astrazeneca approvato dall fda', 'i pazienti adulti']\n",
      "['linfoma mantellare acalabrutinib di astrazeneca approvato dall fda', 'i pazienti adulti']\n",
      "['early green light', 'btk blockbuster', 'calquence azn smallcap']\n",
      "['retweet apotheker huisarts nieuws uit pw fda geeft voorrang aan acalabrutinib']\n",
      "['rt nieuws uit pw apothekersassistent apotheker apotheek huisarts fda geeft voorrang aan acalabrutinib']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma amp']\n",
      "['fda geeft voorrang aan acalabrutinib']\n",
      "['new lymphoma rx', 'drug administration fda']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'adults rxwiki']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'adults rxwiki']\n",
      "['calquence mcl fda']\n",
      "['new lymphoma rx', 'drug administration fda']\n",
      "['fda grants', 'mantle cell lymphoma lymphoma']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'adults rxwiki']\n",
      "['calquence mcl']\n",
      "['calquence mcl']\n",
      "['calquence mcl fda pr times']\n",
      "['calquence mcl']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['new lymphoma rx', 'drug administration fda']\n",
      "['new lymphoma rx', 'drug administration fda']\n",
      "['new lymphoma rx', 'drug administration fda']\n",
      "['new lymphoma rx', 'drug administration fda']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'adults rxwiki']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'adults rxwiki']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'adults rxwiki']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'adults rxwiki']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'adults rxwiki']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'adults rxwiki']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'adults rxwiki']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'adults rxwiki']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'adults rxwiki']\n",
      "['new lymphoma rx', 'drug administration fda']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'adults rxwiki']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'adults rxwiki']\n",
      "['new lymphoma rx', 'drug administration fda']\n",
      "['fda approval', 'adult patients', 'mantle cell lymphoma mcl']\n",
      "['gen btk inhibitor', 'r r mcl']\n",
      "['fda approval', 'acalabrutinib calquence', 'gt 2l mantle cell lymphoma lymsm']\n",
      "['approvalswatch news acalabrutinib', 'fda approval', 'mantle cell lymphoma']\n",
      "['pharma news', 'fda approval', 's calquence']\n",
      "['acalabrutinib mantle cell lymphoma']\n",
      "['precisionmedicine congratulations', 'organon kinase', 'immunology team members', 'calquence alcalabrutinib gene expression analysis', 'genenominator confirms']\n",
      "['fda otorg', 'aprobaci n acelerada', 'acalabrutinib calquence para linfoma', 'c lulas del manto']\n",
      "['fda approves acalabrutinib calquence', 'mantle cell lymphoma']\n",
      "['acalabrutinib erh lt fda zulassung f r', 'behandlung von mantelzellenlymphomen bei erwachsenen']\n",
      "['btk acalabrutinib']\n",
      "['btk acalabrutinib fda']\n",
      "['abbvie st mmer astrazeneca vill', 'royalties f r calquence bn']\n",
      "['breakthrough therapy designation', 'mantle cell lymphoma']\n",
      "['fda otorg', 'aprobaci n acelerada', 'acalabrutinib calquence para linfoma', 'c lulas del manto']\n",
      "['fda approval']\n",
      "['fda acalabrutinib']\n",
      "['fda grants', 'mantle cell lymphoma lymphoma']\n",
      "['fda calquence astrazeneca']\n",
      "['mantle cell lymphoma']\n",
      "['adult patients']\n",
      "['acalabrutinib azn vs ibruvica jnj']\n",
      "['fda approves acalabrutinib', 'mantle cell lymphoma']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['cytokine research pharmacodynamics', 'proteomic analysis', 'acalabrutinib therapy similarity', 'ontarget eff']\n",
      "['astrazeneca s calquence secures fda approval', 'mantle cell lymphoma']\n",
      "['fda approves acalabrutinib', 'mantle cell lymphoma oncology']\n",
      "['astrazeneca s calquence siphon share', 'j amp j s imbruvica mantlecelllymphoma']\n",
      "['fda grants', 'mantle cell lymphoma lymphoma']\n",
      "['fda approves astrazeneca s drug calquence', 'mantle cell lymphoma fda astrazeneca cancer']\n",
      "['early green light', 'btk blockbuster', 'calquence azn smallcap']\n",
      "['breakthrough therapy designation', 'mantle cell lymphoma']\n",
      "['fda grants', 'mantle cell lymphoma source esmo']\n",
      "['mantle cell lymphoma']\n",
      "[]\n",
      "['proteomic analysis', 'acalabrutinib therapy similarity']\n",
      "['breakthrough therapy designation', 'mantle cell lymphoma']\n",
      "['breakthrough therapy designation', 'mantle cell lymphoma']\n",
      "[]\n",
      "['early green light', 'btk blockbuster', 'calquence azn smallcap']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['abbv sues', 'patent royalties', 'new drug calquence claims', 'invention bloomberg']\n",
      "['early green light', 'btk blockbuster', 'calquence azn smallcap']\n",
      "['fda approves astrazeneca s calquence', 'mantle cell lymphoma']\n",
      "['cienciasmedicasnews calquence', 'mantle cell lymphoma medli']\n",
      "['azn calquence', 'adult patients']\n",
      "['early green light', 'btk blockbuster', 'calquence azn smallcap']\n",
      "['early green light', 'btk blockbuster', 'calquence azn smallcap']\n",
      "['early green light', 'btk blockbuster', 'calquence azn smallcap']\n",
      "['acalabrutinib gains fda approval']\n",
      "['mantle cell lymphoma']\n",
      "['astrazeneca s calquence', 'adult patients w', 'mantle cell lymphoma cll']\n",
      "['fda nod', 'calquence drug store news']\n",
      "['fda approves calquence', 'mantlecelllymphoma fda rt']\n",
      "['mantle cell lymphoma']\n",
      "['fda aprova acalabrutinib para linfoma folicular']\n",
      "['fda grants', 'mantle cell lymphoma lymphoma']\n",
      "['azn approval', 'mantle zone lymphoma drug acalabrutinib', 'lymphoma w', 'poor prog']\n",
      "['fda grants', 'mantle cell lymphoma lymphoma']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['mantle h creli lenfoma tedavisi i', 'acalabrutinib fda onay ald']\n",
      "['s article fda', 'mantle cell lymphoma cancer targetedtherapy']\n",
      "['mantle cell lymphoma wellness health']\n",
      "['fda nod', 'calquence david salazarthe mantle cell lymphoma treatment']\n",
      "['lungcancer news astrazeneca', 'fda nod', 'calquence david salazarthe mantle cell lymphoma treatment']\n",
      "['fda calquence astrazeneca']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['kanser onkolog onkoloji hematolog hematoloji fda lenfoma sa l khaber']\n",
      "['fda approves calquence acalabrutinib', 'mantle cell lymphoma mcl 2017accp']\n",
      "['fda approves acalabrutinib calquence', 'new treatment', 'mantle cell lymphoma']\n",
      "['dispense calquence', 'mantlecelllymphoma dplo']\n",
      "['cancer calquence acalabrutinib fda approves', 'new treatment', 'mantle cell lymphoma']\n",
      "['fda approves acalabrutinib', 'mantle cell lymphoma cancer fda']\n",
      "['fda approves calquence acalabrutinib', 'adult patients', 'mantle cell lymphoma']\n",
      "['fda approves az s calquence acalabrutinib', 'adult patients']\n",
      "['fda approves astrazeneca s calquence acalabrutinib', 'adult patients', 'mantle cell lymphoma']\n",
      "['usa s fda medger p skyndat godk nnande f r cancerl kemedlet acalabrutinib']\n",
      "['fda aprob un nuevo oncol gico', 'astrazeneca fda aprobaci n astrazeneca oncol gico linfoma pharmabiz']\n",
      "['fda aprob un nuevo oncol gico', 'astrazeneca fda aprobaci n astrazeneca oncol gico linfoma pharmabiz']\n",
      "['fda calquence astrazeneca']\n",
      "['fda calquence astrazeneca']\n",
      "['adult patients']\n",
      "['calquence gegen mcl astrazeneca bekommt', 'zulassung f r calquence']\n",
      "['fda calquence astrazeneca']\n",
      "['calquence acalabrutinib', 'www biospectrumasia com']\n",
      "['fda grants', 'mantle cell lymphoma drug info mei ecm']\n",
      "['fda grants', 'mantle cell lymphoma']\n",
      "['mantle cell lymphoma']\n",
      "['az nets ultrafast approval', 'rival calquence']\n",
      "['mantle cell lymphoma']\n",
      "['mantle cell lymphoma']\n",
      "['mantle cell lymphoma']\n",
      "['health calquence', 'mantle cell lymphoma title calquence', 'mantle cell lymphoma category']\n",
      "['mantle cell rhythmhealth drbotha']\n",
      "['astrazeneca snags', 'quick fda ok', 'potential lymphoma blockbuster calquence']\n",
      "['dispense calquence', 'mantle cell lymphoma']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['fda approves astrazeneca s calquence']\n",
      "['dplo diplomat pharmacy', 'pharmacy panel', 'dispense astrazeneca s azn calquence']\n",
      "['fda approves acalabrutinib calquence', 'mantle cell lymphoma']\n",
      "['mantle cell lymphoma']\n",
      "['azn s', 'abbv s imbruvica franchise']\n",
      "['azn s', 'abbv s imbruvica franchise']\n",
      "['fda approves acalabrutinib', 'mantle cell lymphoma']\n",
      "['fda approves astrazeneca s calquence acalabrutinib', 'adult patients', 'mantle cell lymphoma']\n",
      "[]\n",
      "['fda approves acalabrutinib calquence', 'mantle cell lymphoma']\n",
      "['fda approves btk inhibitor calquence', 'mantle cell lymphoma']\n",
      "['fda grants', 'mantle cell lymphoma']\n",
      "['early green light', 'btk blockbuster', 'calquence azn']\n",
      "['dispense calquence', 'mantle cell lymphoma']\n",
      "['fda approves btk inhibitor calquence', 'mantle cel']\n",
      "['fda grants', 'mantle cell lymphoma']\n",
      "['fda grants', 'mantle cell lymphoma']\n",
      "['good oncopharm podcast', 'own 1st episode acalabrutinib']\n",
      "[]\n",
      "['fda grants calquence acalabrutinib', 'r r mcl']\n",
      "['fda approves drug', 'rel ref mcl lymphoma acalabrutinib calquence']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'biologics i']\n",
      "['sdbn feed astrazeneca snags', 'quick fda ok', 'potential lymphoma blockbuster calquence']\n",
      "['lungcancer news calquence acalabrutinib', 'mantle cell lymphoma']\n",
      "['astrazeneca s calquence', 'mantle cell lymphoma']\n",
      "['fda approves astrazeneca s calquence acalabrutinib', 'adult patients']\n",
      "['acalabrutinib approval', 'important development', 'lymphoma patients', 'lymsm endcancer']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['fda approves calquence regulatory']\n",
      "['cro calquence acalabrutinib', 'mantle cell lymphoma']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'biologics i']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'biologics i']\n",
      "['cancer calquence acalabrutinib', 'mantle cell lymphoma']\n",
      "['calquence acalabrutinib']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma', 'biologics inc']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['fda approves astrazeneca s calquence acalabrutinib', 'adult patients', 'mantle cell lympho']\n",
      "['astrazeneca s mantle cell lymphoma drug calquence', 'siphon share', 'j amp j s imbruvica']\n",
      "['mantle cell lymphomasource healthday', 'medlineplus pages lymphoma']\n",
      "['astrazeneca s calquence', 'siphon share', 'j amp j s imbruvica azn jnj abbv pharma']\n",
      "['fda approves', 'new bloodcancer medicine', 'critical unmet', 'medical need', 'certain mantle cell lymphoma']\n",
      "['astrazeneca s calquence', 'siphon share', 'j amp j s imbruvica']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma']\n",
      "['fda approves astrazeneca s calquence acalabrutinib', 'adult patients']\n",
      "['fda approves astrazeneca s calquence acalabrutinib', 'adult patients', 'mantle cell lymphoma']\n",
      "['mantle cell lymphoma health']\n",
      "['fda approves astrazeneca s calquence acalabrutinib', 'adult patients']\n",
      "['blood cancer drug']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer']\n",
      "['calquence approval azn strikes lesser tone', 'tralokinumab ph']\n",
      "['astrazeneca snags', 'quick fda ok', 'potential lymphoma blockbuster calquence']\n",
      "['fda approves astrazeneca s calquence']\n",
      "['fda approves acalabrutinib', 'mantle cell lymphoma']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['astrazeneca nets', 'lymphoma nod', 'rival calquence']\n",
      "['adults w mantle cell lymphoma lymsm']\n",
      "['astrazeneca snags', 'quick fda ok', 'potential lymphoma blockbuster calquence']\n",
      "['astrazeneca snags', 'quick fda ok', 'potential lymphoma blockbuster calquence']\n",
      "['astrazeneca snags', 'quick fda ok', 'potential lymphoma blockbuster calquence']\n",
      "['astrazeneca snags', 'quick fda ok', 'potential lymphoma blockbuster calquence']\n",
      "['fda approval', 'mantle cell lymphoma treatment cancer pharmacy']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['fda approves acalabrutinib', 'mantlecell lymphoma', 'therapy ssbmt lymsm']\n",
      "['mantle cell lymphoma']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['fda approves acalabrutinib', 'line treatment']\n",
      "['adult patients', 'mantle cell lymphoma']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['votre argent astrazeneca profite d', 'calquence astrazeneca avance']\n",
      "['fda grants', 'mantle cell lymphoma']\n",
      "['fda grants', 'mantle cell lymphoma lymphoma']\n",
      "['mantlecell lymphoma', 'didn t']\n",
      "['americancancer news', 'fda approves calquence', 'mantle cell lymphoma']\n",
      "['hot news fda grants acc approval', 'calquence acalabrutinib', 'mantle cell lymphoma cancer']\n",
      "['news fda approves calquence', 'mantle cell lymphoma']\n",
      "['peninsula company', '1st cancer drug']\n",
      "['excellent umbralisib pi3 k delta inhibitor safety data', 'w acalabrutinib label']\n",
      "['acalabrutinib data', 'mcl azn']\n",
      "['fda approves acalabrutinib btk inhibitor', 'mantle cell lymphoma']\n",
      "['astrazeneca snags', 'quick fda ok', 'btk inhibitor amp potential lymphoma blockbuster calquence biospace jobs']\n",
      "['mantle cell lymphoma']\n",
      "['astrazeneca snags', 'quick fda ok', 'potential lymphoma blockbuster calquence']\n",
      "['fda acalabrutinib']\n",
      "['fda approves astrazeneca s calquence astrazeneca s calquence', 'speedy green light']\n",
      "['astrazeneca snags', 'quick fda ok', 'potential lymphoma blockbuster calquence']\n",
      "['astrazeneca profite d', 'calquence investingfrance']\n",
      "['astrazeneca profite d']\n",
      "['hematology teams', 'new medicine', 'certain bloodcancer patients']\n",
      "['azn s calquence enters hematology market', 'imbruvica footsteps', '5b payout', 'acerta shareholders']\n",
      "['early green light', 'btk blockbuster']\n",
      "['early green light', 'btk blockbuster', 'calquence endpoints news']\n",
      "['mantle cell lymphoma']\n",
      "['mantle cell lymphoma haleplushearty']\n",
      "['fda approves astrazeneca s calquence']\n",
      "['fda approves astrazeneca s calquence']\n",
      "['fda approves astrazeneca s calquence pharma biotech bigpharma medtech']\n",
      "['fda approves astrazeneca s calquence pharma health']\n",
      "['fda approves astrazeneca s calquence']\n",
      "['early green light', 'btk blockbuster', 'calquence biopharma drugdevelopment']\n",
      "['calquence approval', 'oncology lymphoma']\n",
      "['calquence approval']\n",
      "['calquence approval']\n",
      "['astrazeneca nets mantlecell lymphoma nod', 'rival calquence raredisease orphandrug regulatoryaffairs']\n",
      "['astrazeneca nets mantlecell lymphoma nod', 'rival calquence raredisease orphandrug regulatoryaffairs']\n",
      "['fda grants calquence acalabrutinib', 'r r mcl lymsm']\n",
      "['linfoma mantellare approvazione fda accelerata', 'acalabrutinib comitatoimalatiinvisibili imalatiinvisibili']\n",
      "['fda approves acalabrutinib calquence', 'mantle cell lymphoma medscape']\n",
      "['fda approves calquence', 'mantlecelllymphoma fda']\n",
      "['fda approves acalabrutinib calquence', 'mantle cell lymphoma']\n",
      "['u s approval', 'blood cancer drug reuters reuters', 'black swan', 'intelligent insight']\n",
      "['fda approves', 'new treatment acalabrutinib', 'mantle cell lymphoma']\n",
      "['efficacy profile', 'similar drugs fingers']\n",
      "['good news', 'bad news']\n",
      "['u s approval', 'blood cancer drug article amp reuters']\n",
      "['astrazeneca s calquence secures fda approval', 'mantle cell lymphoma']\n",
      "['astrazeneca s calquence secures fda approval', 'mantle cell lymphoma']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer']\n",
      "['fda approves acalabrutinib calquence', 'mantle cell lymphoma']\n",
      "['fda approves acalabrutinib calquence', 'mantle cell lymphoma health news newsassistant']\n",
      "[]\n",
      "['new post calquence', 'mantle cell lymphoma']\n",
      "['line mantle cell lymphoma']\n",
      "['good cr rate', 'remission fda approves acalabrutinib', 'mantle cell lymphoma']\n",
      "['btk acalabrutinib approval']\n",
      "['early green light', 'btk blockbuster', 'calquence biotech drugdevelopment']\n",
      "['astrazeneca nets', 'lymphoma nod', 'rival calquence']\n",
      "['fda approval', 'alert acalabrutinib', 'mantle cell lymphoma']\n",
      "['asx partner', 'fantastic news', 'fda approval']\n",
      "['mantle cell lymphoma tuesday oct', 'healthday news calquence']\n",
      "[]\n",
      "['mantle cell lymphoma nutrition']\n",
      "['regulatory news fda drug approvals changes', 'tuesday october', 'calquence prexxartan zegerid']\n",
      "[]\n",
      "['r r mcl', 'velcade revlimid', 'amp acalabrutinib', 'comparison study', 'acal rr']\n",
      "['biotech updates', 'azn calquence approval stml data', 'acor cprx incy mrns']\n",
      "['astrazeneca nets', 'lymphoma nod', 'rival calquence']\n",
      "['mantle cell lymphoma']\n",
      "['fda approves', 'new treatment acalabrutinib', 'generation btk inhibitor', 'mantle cell lymphoma']\n",
      "['u s approval', 'blood cancer drug']\n",
      "['fda approves calquence acalabrutinib', 'mantle cell lymphoma']\n",
      "['fast fda approval']\n",
      "['fda approves calquence acalabrutinib', 'mantle cell lymphoma']\n",
      "['fda approves calquence acalabrutinib', 'mantle cell lymphoma']\n",
      "['acalabrutinib calquence', 'mantle cell lymphoma']\n",
      "['mantle cell lymphoma', 'therapy treatment']\n",
      "['new treatment option', 'mantle cell lymphoma', 'certain patients bloodcancer']\n",
      "['calquence acalabrutinib']\n",
      "['mantle cell lymphoma']\n",
      "['mantle cell lymphoma']\n",
      "[]\n",
      "['azn s calquence acalabrutinib', 'new treatment', 'mantle cell lymphoma']\n",
      "['u s approval', 'blood cancer drug']\n",
      "['blood cancer drug reuters', 'black swan', 'intelligent insight']\n",
      "['calquence acalabrutinib']\n",
      "['fda approves astrazeneca s calquence acalabrutinib', 'adult patients']\n",
      "['astrazeneca plc', 'fda approves astrazeneca s calquence acalabrutinib', 'adult patients']\n",
      "['acalabrutinib gains fda approval']\n",
      "['fda approves acalabrutinib calquence', 'mantle cell lymphoma']\n",
      "['breakingnews spx ndx avella', 'calquence acalabrutinib']\n",
      "['mantle cell lymphoma fda hematology']\n",
      "['fda approves calquence acalabrutinib', 'mantle cell lymphoma']\n",
      "['patients w mantle cell lymphoma']\n",
      "['astrazeneca nets', 'lymphoma nod', 'rival calquence']\n",
      "['fda approves calquence acalabrutinib', 'mantle cell lymphoma']\n",
      "['fda approves calquence acalabrutinib', 'mantle cell lymphoma']\n",
      "['mantle cell lymphoma']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['reuters astrazeneca', 'u s approval', 'blood cancer drug']\n",
      "['u s approval', 'blood cancer drug reuters']\n",
      "['event rate', 'acalabrutinb calquence']\n",
      "['reuters astrazeneca', 'u s approval', 'blood cancer drug']\n",
      "['u s approval', 'blood cancer drug reuters']\n",
      "['fda grants az s treatment', 'certain patients', 'mantle cell lymphoma']\n",
      "['fda approves astrazeneca s calquence acalabrutinib', 'adult patients']\n",
      "['reuters astrazeneca', 'u s approval', 'blood cancer drug']\n",
      "['reuters astrazeneca', 'u s approval', 'blood cancer drug']\n",
      "['reuters astrazeneca', 'u s approval', 'blood cancer drug']\n",
      "['reuters astrazeneca', 'u s approval', 'blood cancer drug']\n",
      "['u s approval', 'blood cancer drug']\n",
      "['u s approval', 'blood cancer drug']\n",
      "['reuters astrazeneca', 'u s approval', 'blood cancer drug']\n",
      "['rt reuters astrazeneca', 'u s approval', 'blood cancer drug']\n",
      "['u s approval', 'blood cancer drug']\n",
      "['acalabrutinib btk fda approves', 'new treatment', 'mantle cell lymphoma']\n",
      "['mantle cell lymphoma']\n",
      "['early green light', 'btk blockbuster']\n",
      "['monthly average price']\n",
      "['astrazeneca nets', 'lymphoma nod', 'rival calquence']\n",
      "['fda approves astrazeneca s calquence acalabrutinib', 'new treatment', 'mantle cell lymphoma']\n",
      "['fda approves astrazeneca s calquence acalabrutinib', 'new treatment', 'mantle cell lymphoma']\n",
      "['early green light', 'btk blockbuster']\n",
      "['mantle cell lymphoma']\n",
      "['fda approves astrazeneca s calquence acalabrutinib', 'adult patients']\n",
      "['calquence approval grace guthrie jane huang brian lannutti amy peterson patientimpact']\n",
      "['linfoma mantellare approvazione fda accelerata']\n",
      "['fda approval', 'alert acalabrutinib', 'mantle cell lymphoma']\n",
      "['astrazeneca nets', 'lymphoma nod', 'rival calquence']\n",
      "['astrazeneca nets', 'lymphoma nod', 'rival calquence fiercepharma']\n",
      "['fda approves acalabrutinib calquence', 'mantle cell lymphoma']\n",
      "['fda approves calquence', 'mantle cell lymphoma']\n",
      "['fda approves acalabrutinib', 'mantle cell lymphoma']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer']\n",
      "['blood cancer drug reuters', 'black swan', 'intelligent insight']\n",
      "['fda approves astrazeneca s calquence acalabrutinib', 'adult patients']\n",
      "['astrazeneca nets', 'lymphoma nod', 'rival calquence az oncology cancer']\n",
      "['pharmacy fda approves acalabrutinib calquence', 'mantle cell lymphoma']\n",
      "['fda approves acalabrutinib calquence', 'mantle cell lymphoma']\n",
      "['certain patients', 'mantle cell lymphoma bloodcancer']\n",
      "['fda grants', 'mantle cell lymphoma oncology cancer']\n",
      "['fda approves acalabrutinib', 'good news']\n",
      "['calquence acalabrutinib', 'mantle cell lymphoma lymsm']\n",
      "['fda approves az s calquence acalabrutinib', 'adult patients', 'mantle cell lymphoma']\n",
      "['fda approves acalabrutinib calquence', 'new treatment', 'adults salutedomani podcast']\n",
      "['fda approves acalabrutinib calquence', 'new treatment', 'adults salutedomani podcast']\n",
      "['fda approves acalabrutinib', 'mantle cell lymphoma']\n",
      "['fda approves acalabrutinib', 'mantle cell lymphoma', 'full post']\n",
      "['aggressive mantle cell lymphoma', 'new treatment option acalabrutinib matlecell lymphoma bcell btk']\n",
      "['fda approves acalabrutinib calquence', 'mantle cell lymphoma medscape']\n",
      "['fda approves acalabrutinib calquence', 'mantle cell lymphoma pharmacy health']\n",
      "['blood cancer drug reuters', 'black swan', 'intelligent insight']\n",
      "['aggressive mantle cell lymphoma', 'new therapy option mantlecell btk inhibitor']\n",
      "['btk inhibitor acalabrutinib', 'mcl patients']\n",
      "['aggressive mantle cell lymphoma', 'new treatment option acalabrutinib mantlecell lymphoma', 'new threapy btk']\n",
      "['fda approves acalabrutinib calquence', 'mantle cell lymphoma']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer reuters health news london reuters astrazenec']\n",
      "['astrazeneca nets', 'lymphoma nod', 'rival calquence']\n",
      "['astrazeneca s calquence', 'food amp drug administration interactive investor', 'black swan intelligen']\n",
      "['u s approval', 'blood cancer drug']\n",
      "['halloween lede', 'azn jnj abbv pharma']\n",
      "['astrazeneca nets', 'lymphoma nod', 'rival calquence']\n",
      "['astrazeneca nets', 'lymphoma nod', 'rival calquence']\n",
      "['fda grants', 'mantle cell lymphoma']\n",
      "['astrazeneca s acalabrutinib', 'mantle cell lymphoma shares']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer reuters', 'u s food', 'drug administration']\n",
      "['astrazeneca s acalabrutinib', 'mantle cell lymphoma shares']\n",
      "['fda approves calquence acalabrutinib', 'adult patients']\n",
      "['astrazeneca s acalabrutinib', 'mantle cell lymphoma shares', 'azn sitifatimah malaysia financialp']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer']\n",
      "['astrazeneca nets', 'lymphoma nod', 'rival calquence']\n",
      "['astrazeneca s acalabrutinib', 'mantle cell lymphoma shares']\n",
      "['great news', 'r r mantle cell lymphoma']\n",
      "['fast fda approval']\n",
      "['fda approves astrazeneca s calquence acalabrutinib', 'adult patients', 'mantle cell lymph']\n",
      "[]\n",
      "['proc dure acc l r e par', 'l acalabrutinib dans', 'lymphome cellules du manteau']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer']\n",
      "['fda godk nner astrazenecas calquence acalabrutinib f r vuxna patienter', 'tidigare behandlad mantelcellslymfom']\n",
      "['new drug', 'mantle cell lymphoma lymphoma calquence cancer']\n",
      "['news fda grants', 'mantle cell lymphoma lymphoma']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer reuters', 'u s food', 'drug administration fda']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer reuters', 'u s food', 'drug administration']\n",
      "['healthnews fda approves astrazeneca s calquence', 'rare blood cancer']\n",
      "['new post fda approves astrazeneca s calquence', 'rare blood cancer']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer']\n",
      "['fda approves acalabrutinib', 'mantle cell lymphoma lymsm']\n",
      "['fda approves acalabrutinib calquence', 'new treatment', 'mantle cell']\n",
      "['azn btk inhibitor acalabrutinib', 'mantle cell lymphoma']\n",
      "[]\n",
      "['fda grants', 'mantle cell lymphoma lymsm']\n",
      "['fda grants', 'mantle cell lymphoma lymsm']\n",
      "['fda approves', 'new treatment', 'mantle cell lymphoma calquence acalabrutinib azn']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer']\n",
      "['fda approves acalabrutinib calquence', 'new treatment', 'mantle cell lymphoma']\n",
      "['fda approves acalabrutinib calquence', 'new treatment', 'mantle cell lymphoma']\n",
      "['fda approves acalabrutinib calquence', 'new treatment', 'mantle cell lymphoma']\n",
      "['fda approves acalabrutinib calquence', 'new treatment', 'mantle cell lymphoma']\n",
      "['breakingnews fda approves calquence', 'mantle cell lymphoma']\n",
      "['astrazeneca s calquence garners fda approval', 'mantle cell lymphoma azn']\n",
      "['early green light', 'btk blockbuster', 'calquence pharma cancer']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer']\n",
      "['median duration', 'median time', 'months acalabrutinib mantlecelllymphoma lymphoma lymsm']\n",
      "['fda approves acalabrutinib', 'mantle cell lymphoma v']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer']\n",
      "['health news', 'entire community', 'reliable source']\n",
      "['early green light', 'btk blockbuster']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer reuters health news reuters', 'u s food']\n",
      "['fda grants acc approval', 'calquence acalabrutinib', 'mantle cell lymphoma']\n",
      "['mantle cell lymphoma treatment']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer']\n",
      "['q1 astrazeneca', 'early green light', 'btk blockbuster']\n",
      "[]\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer']\n",
      "['fda approves astrazeneca s calquence', 'rare blood cancer']\n",
      "['fda approves acalabrutinib', 'mantle cell lymphoma lymsm']\n",
      "['wow acalabrutinib']\n",
      "['astrazeneca pharmaceuticals', 'new treatment', 'mantle cell lymphoma']\n",
      "['fda approves', 'new treatment acalabrutinib calquence', 'mantle cell lymphoma oncology mcl']\n",
      "['fda approves azn calquence acalabrutinib', 'mantle cell lymphoma']\n",
      "['btk inhibitor space', 'august acalabrutinib', 'approval azn']\n",
      "['calquence label']\n",
      "['fda pr', 'azn calquence acalabrutinib pharma biotech']\n",
      "['azn fda approves calquence acalabrutinib', 'adult patients', 'mantle cell lymphoma']\n",
      "['calquence approval details fda azn pharma biotech']\n",
      "['azn fda approves astrazeneca s mantle cell lymphoma treatment calquence']\n",
      "['fda approves azn acalabrutinib', 'patients w mantle cell lymphoma brand name calquence recall', 'imbruvica killer abbv']\n",
      "['azn s', 'new mantle cell lymphoma therapy calquence', 'btk inhibitor', 'fda approval']\n",
      "['acalabrutinib acerta pharma', 'cancer research']\n",
      "['astrazeneca retracts preclinical paper admits', 'acalabrutinib cancer network']\n",
      "['acalabrutinib btki', 'breakthrough therapy designation']\n",
      "['cancer drugs acalabrutinib mcl alectibib nsclc ato apl bosutinib cml brentuximab ctcl']\n",
      "['video side', 'btk inhibitors', 'peter hillmen']\n",
      "['astrazeneca retracts preclinical paper admits']\n",
      "[]\n",
      "[]\n",
      "['astra zeneca retracts acalabrutinib', 'pre clinical data paper astrazeneca', 'preclinical data']\n",
      "['astra zeneca retracts', 'preclinical data', 'acalabrutinib az accalabrutinib btk inhibitor']\n",
      "['industria astrazeneca retracts preclinical paper admits']\n",
      "['astrazeneca retracts preclinical paper admits']\n",
      "['astrazeneca retracts preclinical paper admits']\n",
      "['astrazeneca retracts preclinical paper admits', 'preclinical data', 'developmental agent acalabrutinib']\n",
      "['astrazeneca retracts preclinical paper admits', 'acalabrutinib cancer cancerdrugs']\n",
      "['fda acalabrutinib', 'acerta pharma']\n",
      "[]\n",
      "['acerta pharma', 'acerta pharma55 acalabrutinib']\n",
      "['pharmafile acerta pharma acalabrutinib']\n",
      "['cancer drug acalabrutinib study data']\n",
      "['early data', 'ca drug acalabrutinib', 'human trials']\n",
      "['btk amp pi3k inhibition', 'acalabrutinib amp acp', 'improves survival amp tumor control', 'cll mouse model']\n",
      "['poor form', 'ascerta amp']\n",
      "['pi3k delta inhibition', 'improves survival', 'tumor control']\n",
      "['acalabrutinib lymphoma lymsm']\n",
      "['acalabrutinib breakthrough designation']\n",
      "['fda revis o da prioridade']\n",
      "['fda awards acalabrutinib priority review']\n",
      "['mantle cell lymphoma']\n",
      "['great talk dr susan o brien review novel tx', 'nice slide', 'clinical trials']\n",
      "['dlbcl r chop', 'checkpoint inhibitor']\n",
      "['fda news', 'august oncology', 'priority review']\n",
      "['esmo17 i o combo', 'n mrk', 'pd1 azn btki acalabrutinib combo', 'os vs mono', 'bladder cancer', 'fatal aes']\n",
      "['breakthrough therapy designation', 'fda astrazeneca lymphoma']\n",
      "['new combo treatment', 'dlbcl r chop', 'gt gt']\n",
      "['new combo treatment', 'dlbcl r chop', 'gt gt']\n",
      "['new combo treatment', 'dlbcl r chop', 'gt gt']\n",
      "['new cancer clinical trial combination', 'refractory b cel']\n",
      "['new cancer clinical trial combination', 'refractory b cel']\n",
      "['new combo treatment', 'dlbcl r chop', 'gt gt']\n",
      "['new combo treatment', 'dlbcl r chop', 'gt gt']\n",
      "['trial rchop acalabrutinib lymsm']\n",
      "['astrazeneca nda', 'mantle cell lymphoma', 'gt gt']\n",
      "['salute domani linfoma mantellare fda breakthrough therapy designation e priority review']\n",
      "['astrazeneca s acalabrutinib', 'fda breakthrough therapy designation pharma health']\n",
      "['astrazeneca nda', 'mantle cell lymphoma', 'gt gt']\n",
      "['astrazeneca nda', 'mantle cell lymphoma', 'gt gt']\n",
      "['astrazeneca nda', 'mantle cell lymphoma', 'gt gt']\n",
      "['astrazeneca nda', 'mantle cell lymphoma', 'gt gt']\n",
      "['phiii breakdown azn cruises', 'fda decision', 'btk blockbuster']\n",
      "['new combo treatment', 'dlbcl r chop']\n",
      "['new combo treatment', 'dlbcl r chop']\n",
      "['astrazeneca s acalabrutinib', 'fda breakthrough therapy designation pharma health']\n",
      "['astrazeneca nda', 'mantle cell lymphoma', 'gt gt']\n",
      "['astrazeneca s acalabrutinib', 'fda breakthrough therapy designation pharma health']\n",
      "['fda breakthrough therapy designation', 'mantle cell lymphoma cancer']\n",
      "['astrazeneca nda', 'mantle cell lymphoma', 'gt gt']\n",
      "['lymphoma treatment acalabrutinib', 'breakthrough therapy status']\n",
      "['fda grants breakthrough therapy designation', 'mantle cell lymphoma', 'gt gt']\n",
      "['fda grants breakthrough therapy designation', 'mantle cell lymphoma', 'gt gt']\n",
      "['fda grants breakthrough therapy designation', 'mantle cell lymphoma', 'gt gt']\n",
      "['fda grants breakthrough therapy designation status']\n",
      "['fda grants breakthrough therapy designation', 'mantle cell lymphoma', 'gt gt']\n",
      "['fda considera acalabrutinib uma terap utica inovadora para o tratamento']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['linfoma mantellare negli usa acalabrutinib ottiene', 'breakthrough therapy designation']\n",
      "['potential mantle cell lymphoma therapy acalabrutinib', 'fda priority review status']\n",
      "['fda grants breakthrough therapy designation', 'mantle cell lymphoma', 'gt gt']\n",
      "['fda accepts regulatory submission', 'grants priority review']\n",
      "['breakthrough therapy designation', 'mantle cell lymphoma']\n",
      "['fda grants breakthrough therapy designation', 'mantle cell lymphoma', 'gt gt']\n",
      "['fda accepts regulatory submission', 'grants priority review']\n",
      "['astrazeneca nda']\n",
      "['astrazeneca nda']\n",
      "['fda grants breakthrough therapy designation', 'mantle cell lymphoma', 'gt gt']\n",
      "['clinical trials acalabrutinib', 'breakthrough therapy designation']\n",
      "['breakthrough therapy designation']\n",
      "[]\n",
      "['fda grants breakthrough therapy designation', 'mantle cell lymphoma', 'gt gt']\n",
      "['priority review', 'acalabrutinib inhibitor']\n",
      "['astrazeneca s acalabrutinib', 'fda breakthrough therapy designation pharma health']\n",
      "['fda accepts regulatory submission', 'grants priority review']\n",
      "['fda accepts regulatory submission', 'grants priority review']\n",
      "['fda accepts regulatory submission', 'grants priority review']\n",
      "['clinicaltrials salehstevens acalabrutinib', 'breakthrough therapy designation']\n",
      "['fda accepts regulatory submission', 'grants priority review']\n",
      "['breakthrough therapy designation']\n",
      "['breakthrough therapy designation']\n",
      "['breakthrough therapy designation', 'mantle cell lymphoma']\n",
      "['fda accepts regulatory submission', 'grants priority review']\n",
      "['fda awards acalabrutinib priority review', 'mcl oncology']\n",
      "['fda grants acalabrutinib breakthrough designation', 'mcl oncology']\n",
      "['fda grants acalabrutinib breakthrough therapy designation', 'refractory mantle cell lymphoma lymsm']\n",
      "['generation btk inhibitors']\n",
      "['breakthrough therapy designation', 'mantle cell lymphoma']\n",
      "['linfoma mantellare fda breakthrough therapy designation e priority review']\n",
      "['vistusertib mtori acalabrutinib btki trial ace ly110', 'interesting combo lymsm']\n",
      "['acalabrutinib fda']\n",
      "['fda grants acalabrutinib nda priority review', 'r r mcl', 'lymsm lymphoma']\n",
      "['fda accepts regulatory submission', 'grants priorityreview']\n",
      "[]\n",
      "['priority review', 'new drug application']\n",
      "['priority review']\n",
      "['fda accepts regulatory submission', 'grants priority review']\n",
      "['fda accepts regulatory submission', 'grants priority review']\n",
      "['fda accepts regulatory submission', 'grants priority review pharma biotech medtech']\n",
      "['fda accepts regulatory submission', 'grants priority review']\n",
      "['priority review', 'breakthrough status', 'az acalabrutinib regulatory']\n",
      "['fda accepts regulatory submission', 'grants priority review', 'blog wx']\n",
      "['fda accepts regulatory submission', 'grants priority review', 'blog wx']\n",
      "['linfoma mantellare negli usa acalabrutinib ottiene', 'breakthrough therapy designation']\n",
      "['acalabrutinib fda']\n",
      "['acalabrutinib fda']\n",
      "['priority review', 'breakthrough status', 'acalabrutinib pharma biotech']\n",
      "['acalabrutinib fda']\n",
      "['acalabrutinib fda']\n",
      "['acalabrutinib fda pr times']\n",
      "['acalabrutinib fda prtimes news']\n",
      "['acalabrutinib fda']\n",
      "['acalabrutinib fda']\n",
      "['acalabrutinib fda']\n",
      "['acalabrutinib fda']\n",
      "['acalabrutinib fda']\n",
      "['acalabrutinib fda']\n",
      "['acalabrutinib fda']\n",
      "['acalabrutinib fda']\n",
      "['acalabrutinib fda pr times']\n",
      "['acalabrutinib fda prtimes news']\n",
      "['acalabrutinib fda']\n",
      "['fda grants priorityreview', 'btk inhibitor drug acalabrutinib', 'r r mcl bloodcancer']\n",
      "['priority review']\n",
      "['acalabrutinib breakthrough status', 'pts w mantle cell lymphoma lymsm']\n",
      "['priority review']\n",
      "['fda grants acalabrutinib breakthroughdesignation mantlecelllymphoma mcl']\n",
      "['fda breakthrough therapy designation']\n",
      "['great news', 'mcl patients', 'conduct clinical trials', 'great new drugs']\n",
      "['fda awards acalabrutinib priority review']\n",
      "['breakthrough therapy designation']\n",
      "['priority review', 'breakthrough status', 'az acalabrutinib']\n",
      "['astrazeneca s acalabrutinib', 'priority review', 'mantle cell lymphoma']\n",
      "['fda grants acalabrutinib breakthrough therapy designation', 'r r mcl', 'lymsm lymphoma']\n",
      "['astrazeneca s acalabrutinib', 'priority review', 'mantle cell lymphoma']\n",
      "['astrazeneca s acalabrutinib', 'priority review', 'mantle cell lymphoma']\n",
      "['fda astrazeneca fda grants priority review', 'astrazeneca s', 'btk inhibitor acalabrutinib', 'mantle cell']\n",
      "['astrazeneca s acalabrutinib', 'priority review', 'mantle cell lymphoma']\n",
      "['astrazeneca s acalabrutinib', 'priority review', 'mantle cell lymphoma']\n",
      "['astrazeneca s', 'good news', 'fda priority review', 'reprieve pharma']\n",
      "['fda grants breakthrough therapy designation', 'mantle cel googlealerts']\n",
      "['fda awards acalabrutinib priority review']\n",
      "['linfoma mantellare dall fda doppio riconoscimento', 'acalabrutinib di astrazeneca']\n",
      "['priority review', 'new drug application nda']\n",
      "['fda grants breakthrough therapy designation status', 'acalabrutinib rt']\n",
      "['breakthrough therapy designation']\n",
      "['breakthrough status', 'blood cancer drug bloodcancer']\n",
      "['priority review']\n",
      "['priority review']\n",
      "['phiii breakdown astrazeneca cruises', 'fda decision', 'btk blockbuster']\n",
      "['fda awards acalabrutinib priority review']\n",
      "['fda awards acalabrutinib priority review', 'mcl lymsm']\n",
      "['fda awards acalabrutinib priority review']\n",
      "['pharma biotech fda approval oncology priority review', 'breakthrough status', 'az acalabrutinib']\n",
      "['az s acalabrutinib', 'priority review']\n",
      "['fda grants breakthrough therapy designation', 'mantle cell lymphoma']\n",
      "['astrazeneca s acalabrutinib', 'fda breakthrough therapy designation pharma health']\n",
      "['linfoma mantellare fda breakthrough therapy designation e priority salutedomani podcast']\n",
      "['linfoma mantellare fda breakthrough therapy designation e priority salutedomani podcast']\n",
      "['linfoma mantellare dall fda doppio riconoscimento', 'acalabrutinib di astrazeneca']\n",
      "['phiii breakdown astrazeneca cruises', 'fda decision', 'btk blockbuster']\n",
      "['astrazeneca s', 'good news', 'fda priority review', 'reprieve pharma']\n",
      "['az advances hematology program', 'fda priority review']\n",
      "['fda grants', 'fast review', 'az cancer drug pharmaphorum', 'black swan', 'intelligent insight']\n",
      "['linfoma mantellare dall fda doppio riconoscimento', 'acalabrutinib comitatoimalatiinvisibili']\n",
      "['linfoma mantellare fda breakthrough therapy designation e priority review']\n",
      "['linfoma mantellare fda breakthrough therapy designation e priority review']\n",
      "['linfoma mantellare fda breakthrough therapy designation e priority review']\n",
      "['linfoma mantellare fda breakthrough therapy designation e priority review']\n",
      "['linfoma mantellare fda breakthrough therapy designation e priority review']\n",
      "['linfoma mantellare fda breakthrough therapy designation e priority review']\n",
      "['fda grants breakthrough therapy designation', 'mantle cell lymphoma']\n",
      "['breakthrough therapy designation', 'mantle cell']\n",
      "['fda grants priority review', 'mantle cell lymphoma lymsm']\n",
      "['fda grants priority review', 'mantle cell lymphoma lymsm']\n",
      "['phiii breakdown astrazeneca cruises', 'fda decision', 'btk blockbuster']\n",
      "['fda grants breakthrough therapy designation', 'acalabrutinib company news azn']\n",
      "['priority review', 'breakthrough status', 'az acalabrutinib']\n",
      "['astrazeneca s', 'good news', 'fda priority review', 'reprieve pharma']\n",
      "['az announces fda acceptance', 'priority review status']\n",
      "['fda grants acalabrutinib breakthrough designation', 'mcl fda lymsm']\n",
      "['breakthrough therapy designation']\n",
      "['priority review', 'breakthrough status', 'az acalabrutinib']\n",
      "['wuxiapptec acalabrutinib', 'breakthrough therapy designation', 'blog wx']\n",
      "['wuxiapptec acalabrutinib', 'breakthrough therapy designation', 'blog wx']\n",
      "['phiii breakdown azn cruises', 'fda decision', 'btk blockbuster', 'biotech pharma']\n",
      "['acertapharma priority review', 'breakthrough status', 'az acalabrutinib']\n",
      "['astrazeneca revue prioritaire', 'acalabrutinib investingfrance']\n",
      "['astrazeneca revue prioritaire']\n",
      "['acalabrutinib acp', 'generation btk inhibitor journal', 'hematology amp oncology', 'full text']\n",
      "['breakthrough status', 'blood cancer drug radiology']\n",
      "['breakthrough status', 'blood cancer drug pediatrics']\n",
      "['breakthrough status', 'blood cancer drug neurology']\n",
      "['astrazeneca fda accepts acalabrutinib', 'amp grants priority review', 'uk news']\n",
      "['fda breakthrough designation', 'acalabrutinib acp196']\n",
      "['fda review', 's acalabrutinib pharma']\n",
      "['phiii breakdown astrazeneca cruises', 'fda decision', 'btk blockbuster']\n",
      "['breakthrough status', 'blood cancer drug']\n",
      "['phiii breakdown astrazeneca cruises', 'fda decision', 'btk blockbuster']\n",
      "['phiii breakdown astrazeneca cruises', 'fda decision', 'btk blockbuster']\n",
      "['fda accepts regulatory submission', 'grants priority review']\n",
      "['fda review', 's acalabrutinib pharma']\n",
      "['fda grants', 'fast review', 'az cancer drug']\n",
      "['fda grants', 'fast review', 'az blood cancer drug']\n",
      "['fda grants', 'fast review', 'az cancer drug']\n",
      "['fda grants', 'fast review', 'az cancer drug']\n",
      "['priority review', 'breakthrough status', 'az acalabrutinib pharmatimes']\n",
      "['priority review']\n",
      "['fda review', 'az s acalabrutinib']\n",
      "['fda review', 'az s acalabrutinib']\n",
      "['fda beviljar astra zenecas acalabrutinib prioriterad']\n",
      "['fda accepts regulatory submission', 'grants priority review']\n",
      "['azn astrazeneca', 'priority review']\n",
      "['astrazeneca az acalabrutinib submission']\n",
      "['priority review', 'breakthrough status', 'az acalabrutinib']\n",
      "['fda grants priority review', 'astrazeneca s', 'btk inhibitor acalabrutinib', 'mantle cell lymphoma azn']\n",
      "['mantle cell lymphoma fda grants breakthrough therapy designation']\n",
      "['priority review', 'breakthrough status', 'az acalabrutinib']\n",
      "['priority review', 'breakthrough status', 'az acalabrutinib pharma health']\n",
      "['priority review', 'breakthrough status', 'az acalabrutinib']\n",
      "['priority review', 'breakthrough status', 'az acalabrutinib']\n",
      "['priority review', 'breakthrough status', 'az acalabrutinib pharma biotech bigpharma medtech']\n",
      "['priority review', 'breakthrough status', 'az acalabrutinib']\n",
      "['azn acalabrutinib fda', 'priority review', 'drip drip', 'pipeline rnss']\n",
      "['btk announcement acerta owners']\n",
      "['astrazeneca priority review']\n",
      "['breakthrough status', 'blood cancer drug cardiology']\n",
      "['fda grants acalabrutinib breakthrough therapy designation', 'mantle cell lymphoma']\n",
      "['astrazeneca plc az acalabrutinib submission']\n",
      "['fda accepts regulatory submission', 'grants priority review']\n",
      "['azn pdufa', 'mantle cell lymphoma', 'didn t', 'specific date']\n",
      "['az acalabrutinib submission']\n",
      "['nuevas terapias para pacientes', 'con linfoma fda grants acalabrutinib breakthrough therapy designation']\n",
      "['astrazeneca s acalabrutinib', 'breakthrough therapy', 'mantle cell lymphoma']\n",
      "['astrazeneca s acalabrutinib', 'breakthrough therapy', 'mantle cell lymphoma']\n",
      "['fda grants acalabrutinib breakthrough designation']\n",
      "['astrazeneca s acalabrutinib', 'breakthrough therapy', 'mantle cell lymphoma azn mcl', 'good news']\n",
      "['fda grants acalabrutinib breakthrough designation', 'mcl lymsm']\n",
      "['breakthrough designation', 'refractory mantle cell']\n",
      "['fda grants acalabrutinib breakthrough therapy designation', 'mantle cell lymphoma lymsm']\n",
      "['mystic disappointment', 'breakthrough designations', 'days durvalumab']\n",
      "['azn astrazeneca s acalabrutinib', 'breakthrough therapy', 'mantle cell lymphoma']\n",
      "['mantle cell lymphoma fda grants breakthrough therapy designation', 'acalabrutinib hematology lymphoma']\n",
      "['mantle cell lymphoma fda grants breakthrough therapy designation', 'acalabrutinib cancer therapy advisor']\n",
      "['breakthrough therapy designation', 'mantle cell lymp']\n",
      "['astrazeneca s acalabrutinib', 'breakthrough therapy', 'mantle cell lymphoma']\n",
      "['astrazeneca s acalabrutinib', 'breakthrough therapy', 'mantle cell lymphoma azn sitifatimah malaysia']\n",
      "['astrazeneca s acalabrutinib', 'breakthrough therapy', 'mantle cell lymphoma azn']\n",
      "['astrazeneca plc release acalabrutinib', 'breakthrough therapy designation', 'u s fda']\n",
      "['acalabrutinib breakthrough therapy', 'mantle cell lymphoma mcl']\n",
      "['fda grants breakthrough therapy designation', 'az s acalabrutinib acp196']\n",
      "['fda grants breakthrough therapy designation status', 'acalabrutinib astrazeneca acertapharma']\n",
      "['fda grants breakthrough therapy designation', 'mantle cell lymphoma lymsm']\n",
      "['fda grants breakthrough therapy designation', 'mantle cell lymphoma lymsm']\n",
      "['astrazeneca azn', 'breakthroughtherapy designation', 'acalabrutinib treatment', 'mantle cell lymphoma mcl']\n",
      "['fda grants breakthrough therapy designation status']\n",
      "['fda grants breakthrough therapy designation status']\n",
      "['fda grants acalabrutinib btd', 'mantle cell lymphoma', 'exciting times', 'market forecasts askdrgexperts']\n",
      "['giant astrazeneca plc scores']\n",
      "['giant astrazeneca plc scores']\n",
      "['giant astrazeneca plc scores']\n",
      "['giant astrazeneca plc scores']\n",
      "['breakthrough therapy designation', 'mantle cell']\n",
      "['breakthrough therapy designation', 'patients business wire']\n",
      "['breakthrough therapy designation', 'mantle cell']\n",
      "['breakthrough therapy designation', 'mantle cell']\n",
      "['breakthrough therapy designation', 'mantle cell']\n",
      "['azn acalabrutinib', 'breakthrough therapy designation']\n",
      "['breakthrough therapy designation', 'mantle cell']\n",
      "['cancer cancer acalabrutinib', 'breakthrough therapy designation']\n",
      "['breakthrough therapy designation', 'mantle cell']\n",
      "['loxo amp redx', 'btk inhibitor', 'azn stresses']\n",
      "['acalabrutinib d signation', 'traitement novateur dans', 'traitement du lymphome cellules du manteau']\n",
      "['breakthrough therapy designation']\n",
      "['azn astrazeneca', 'breakthrough therapy designation']\n",
      "['astra zenecas acalabrutinib har erh llit genombrottsstatus hos fda']\n",
      "['fda breakthrough therapy designation', 'fast track', 'mantle cell lymphoma azn']\n",
      "['azn fda grants acalabrutinib breakthrough designation', 'mantle cell lymphoma']\n",
      "['n chster fda breakthrough therapy status f r astrazeneca', 'negative mystic studiendaten belasten aktie weiter']\n",
      "['fda grants breakthrough therapy designation']\n",
      "['astrazeneca plc btd', 'az s acalabrutinib', 'mantle cell lymphoma']\n",
      "['astrazeneca s acalabrutinib', 'breakthrough therapy designation', 'mantle cell lymphoma']\n",
      "['breakthrough therapy designation', 'mantle cell']\n",
      "['breakthrough designation', 'acerta btk', 'mantle cell lymphoma']\n",
      "['ensayo cl nico para pacientes', 'con leucemia linfocitica cronica refractaria m s informaci n']\n",
      "['azn acalabrutinib btk submission', 'efficacy endpt', '7b drug zs9']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['acalabrutinib team jobs', 'gaithersburg md gaithersburg md jobs jobsearch']\n",
      "['ensayo cl nico para pacientes', 'con leucemia linfocitica cronica refractaria m s informaci n']\n",
      "['ensayo cl nico para pacientes', 'con leucemia linfocitica cronica refractaria m s informaci n']\n",
      "['selective bruton tyrosine kinase inhibitor', 'chronic lymphocytic l']\n",
      "['ensayo cl nico para pacientes', 'con leucemia linfocitica cronica refractaria m s informaci n']\n",
      "['ensayo cl nico para pacientes', 'con leucemia linfocitica cronica refractaria m s informaci n']\n",
      "['refractory bcellmalignancies']\n",
      "['ensayo cl nico para pacientes', 'con leucemia linfocitica cronica refractaria m s informaci n']\n",
      "['japanese adult patients', 'bcell malignancies']\n",
      "['busy final week', 'june aldr ph3 cara ph2b gemp hofh pbyi ph3 pti cf rarx pnh azn acalabrutinib gt abbv bgne']\n",
      "['pi3k inhibition', 'improves survival', 'tumor control tumorimmuno']\n",
      "['pi3k inhibition', 'improves survival', 'tumor control', 'cll mouse mo']\n",
      "['ensayo cl nico para pacientes', 'con leucemia linfocitica cronica refractaria m s informaci n']\n",
      "['dlbcl r chop', 'checkpoint inhibitor']\n",
      "['ensayo cl nico para pacientes', 'con leucemia linfocitica cronica refractaria m s informaci n']\n",
      "['astrazeneca pharmaceuticals lp', 'global brand manager acala']\n",
      "['leucemia linf tica cr nica b', 'reca da']\n",
      "['leucemia linf tica cr nica', 'reca da']\n",
      "['ensayo cl nico para pacientes', 'con leucemia linfocitica cronica refractaria m s informaci n']\n",
      "['bruton tyrosine kinase btk inhibitor acalabrutinib demonstrates']\n",
      "['ensayo cl nico para pacientes', 'con leucemia linfocitica cronica refractaria m s informaci n']\n",
      "['dlbcl r chop', 'checkpoint inhibitor']\n",
      "[]\n",
      "['dlbcl r chop', 'checkpoint inhibitor']\n",
      "['ensayo cl nico para pacientes', 'con leucemia linfocitica cronica refractaria m s informaci n']\n",
      "['ensayo cl nico para pacientes', 'con leucemia linfocitica cronica refractaria m s informaci n']\n",
      "['nuevo ensayo cl nico para pacientes', 'con leucemia linfocitica cronica refractaria m s informaci n']\n",
      "[]\n",
      "['andrew zelenetz md phd', 'discusses potential', 'acalabrutinib bgb']\n",
      "['dr zelenetz']\n",
      "['dr zelenetz', 'cll onconotes lylcl']\n",
      "['dlbcl r chop', 'checkpoint inhibitor']\n",
      "['dlbcl r chop', 'checkpoint inhibitor']\n",
      "['astrazeneca pharmaceuticals lp', 'global medical aff']\n",
      "['brown discusses acalabrutinib']\n",
      "['brown discusses acalabrutinib']\n",
      "['brown discusses acalabrutinib']\n",
      "['video acalabrutinib', 'richter s transformation amp cll pts', 'ibrutinib intolerance', 'p hillmen']\n",
      "['dlbcl r chop', 'checkpoint inhibitor']\n",
      "['acalabrutinib ono', 'novel btk inhibitors']\n",
      "['ph3 head', 'trial vs ibrutinib bgne bgb', 'wm 1st', 'azn acalabrutinib']\n",
      "['early data', 'clinical activity', 'difficult lymphoma leukemia']\n",
      "['generation btk inhibitor acalabrutinib', 'cll leusm']\n",
      "['acalabrutinib ono', 'novel btk inhibitors']\n",
      "['acalabrutinib ono', 'novel btk inhibitors']\n",
      "['common side', 'btk inhibitors ibrutinib']\n",
      "['common side', 'btk inhibitors ibrutinib', 'cll treatment leukemia']\n",
      "['common side', 'btk inhibitors ibrutinib amp acalabrutinib', 'cll treatment leukemia']\n",
      "['vitro efficacy', 'src kinases', 'healthy t lymphocyte cll leusm']\n",
      "['selective btk inhibitor', 'chronic lymphocytic leukemia cells cll']\n",
      "['video p hillmen', 'richter s transformation amp cll pts', 'ibrutinib intolerance']\n",
      "['video j woyach', 'potential pi3k', 'btk inhibitors', 'cll duvelisib acalabrutinib']\n",
      "['video peter hillmen discusses', 'use acalabrutinib', 'cll cllsm']\n",
      "['dlbcl r chop', 'checkpoint inhibitor']\n",
      "['selective bruton tyrosine kinase inhibitor', 'chronic tumorimmuno']\n",
      "['selective bruton tyrosine kinase inhibitor', 'chronic lymphocytic']\n",
      "['dlbcl r chop', 'checkpoint inhibitor']\n",
      "['acalabrutinib shows', 'ibrutinib intolerant cll sll oncology immunooncology']\n",
      "['acalabrutinib ono', 'novel btk inhibitors']\n",
      "['richter transformation oncology immunooncology']\n",
      "['acalabrutinib ono', 'novel btk inhibitors']\n",
      "['richter transformation oncology immunooncology']\n",
      "['video p hillmen', 'richter s transformation', 'cll pts', 'ibrutinib intolerance']\n",
      "['acalabrutinib shows', 'ibrutinib intolerant cll sll leusm']\n",
      "['early data', 'clinical activity', 'chronic lymphocytic leukemia']\n",
      "['early data', 'clinical activity', 'chronic lymphocytic leukemia']\n",
      "['acalabrutinib shows', 'ibrutinib intolerant cll sll']\n",
      "['acalabrutinib shows', 'ibrutinib intolerant cll sll leusm']\n",
      "['acalabrutinib shows', 'ibrutinib intolerant cll sll oncology immunooncology']\n",
      "['exciting isn t']\n",
      "['richter transformation']\n",
      "['ibrutinib intolerant cll sll']\n",
      "['richter transformation']\n",
      "['preliminary findings', 'promising activity']\n",
      "['findings support', 'phase ii trial', 'ibrutinib intolerant patients leusm']\n",
      "['cll ibrutinib acalabrutinib ash2016 ash16']\n",
      "['clinical activity']\n",
      "['clinical activity']\n",
      "['clinical activity', 'difficulttotreat c']\n",
      "['clinical activity']\n",
      "['new data', 'btk inhibitors imbruvica acalabrutinib']\n",
      "['early data', 'clinical activity', 'chronic business wire']\n",
      "['astrazeneca plc release', 'clinical activity']\n",
      "['early data', 'clinical activity', 'chronic lymphocytic']\n",
      "['early data', 'clinical activity', 'chronic lymphocytic leukaemia']\n",
      "['ibrutinib intolerant cll sll']\n",
      "['early data', 'clinical activity', 'chronic lymphocytic leukaemia']\n",
      "['early data', 'clinical activity', 'chronic lymphocytic leukaemia']\n",
      "['copd news', 'clinical activity', 'difficulttotreat chronic lymphocytic l']\n",
      "['ibrutinib intolerant cll sll ash16']\n",
      "['rt acalabrutinib', 'ibrutinib intolerant cll sll']\n",
      "['ash16 ibrutinib', 'acalabrutinib blocks', 't cell itk pathway relevant', 'combo therapies', 'car t']\n",
      "['early data', 'clinical activity', 'chronic lymphocytic leukemia']\n",
      "['early data', 'clinical activity', 'chronic business wire']\n",
      "['astrazeneca plc release', 'clinical activity']\n",
      "['diagnostics news', 'clinical activity', 'difficulttotreat chronic lympho']\n",
      "['early data', 'clinical activity', 'difficulttotreat chronic lymphocytic leukemia']\n",
      "['early data', 'clinical activity', 'chronic lymphocytic leukemia']\n",
      "['early data', 'clinical activity', 'chronic lymphocytic leukemia']\n",
      "['early data', 'clinical activity', 'chronic lymphocytic leukaemia']\n",
      "['early data', 'clinical activity', 'cambridge england business']\n",
      "['early data', 'clinical activity', 'wilmington del business wi']\n",
      "['azn astrazeneca plc', 'clinical activity', 'acalabrutinib news']\n",
      "['early data', 'clinical activity', 'chronic business wire']\n",
      "['clinical activity', 'chronic lymphocytic']\n",
      "['acerta pharma', 'new phase i ii trial data', 'cll ash16']\n",
      "['early data', 'clinical activity']\n",
      "['dr awan acalabrutinib', 'imbruvica intolerant ph i cll cohort ash16 azn abbv']\n",
      "['early data', 'clinical activity', 'chronic lymphocytic leukaemia']\n",
      "['ae profile', 'ibrutinib intolerant patients']\n",
      "['early data', 'clinical activity', 'chronic lymphocytic leukaemia']\n",
      "['ash16 words', 'inspire skepticism grade', 'fungal infection']\n",
      "['richter transformation ash16']\n",
      "['acalabrutinib monotherapy', 'richter transformation ash16']\n",
      "['acalabrutinib monotherapy', 'richter transformation ash16']\n",
      "['ash16 dr hillman acalabrutinib 200bid', 'richter orr', 'median dor', '5m tho', 'combo rx']\n",
      "['common side', 'btk inhibitors ibrutinib']\n",
      "['bruton s tyrosine kinase btk inhibitor acalabrutinib demonstrates']\n",
      "['phase i study', 'acalabrutinib acp']\n",
      "['dlbcl r chop acalabrutinib amp obinutuzumab amp checkpointinhibitor']\n",
      "['acalabrutinib team jobs', 'gaithersburg md gaithersburg md jobs jobsearch']\n",
      "[]\n",
      "['phase i study', 'acalabrutinib acp']\n",
      "['common side', 'btk inhibitors ibrutinib']\n",
      "['azn q3 setbacks acalabrutinib', 'durva hnscc', 'plan durva trem']\n",
      "['azn q3 setbacks acalabrutinib', 'durva hnscc', 'plan durva treme hnscc clinical hold']\n",
      "['abbv btk', 'azn latters btk acalabrutinib']\n",
      "['video andrew davies', 'dlbcl r chop', 'acalabrutinib amp']\n",
      "['cll richter hematology']\n",
      "['phase i study', 'acalabrutinib acp']\n",
      "['gen btki bgne bgb', 'azn acerta acalabrutinib']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia nejm']\n",
      "['story acalabrutinib', 'effective medicine', 'astrazaneca story', 'dutch pharma hcsmeu']\n",
      "['vijf jaar van', 'naar miljardenbedrijf msd oss farmacie acalabrutinib fd']\n",
      "['dlbcl r chop w acalabrutinib amp']\n",
      "['btk inhibitor', 'exhibits activity', 'b cell lymphoma vcs2016']\n",
      "['r chop', 'acalabrutinib amp obinutuzumab', 'checkpoint inhibitor lymphoma iwnhl16']\n",
      "['dlbcl r chop', 'acalabrutinib amp']\n",
      "['dlbcl r chop', 'checkpoint inhibitor']\n",
      "['phase i study', 'acalabrutinib acp']\n",
      "['phase i study', 'acalabrutinib acp']\n",
      "['common side', 'btk inhibitors ibrutinib', 'acalabrutinib medicboard']\n",
      "['common side', 'btk inhibitors ibrutinib']\n",
      "['phase i study', 'acalabrutinib acp']\n",
      "['acalabrutinib ono', 'btk inhibitors', 'cll leukemia']\n",
      "['acalabrutinib ono', 'novel btk inhibitors']\n",
      "['astrazeneca pone foco', 'con lanzamiento', 'nuevos f rmacos hasta', 'para hematolog']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia cll', 'full text nejm']\n",
      "['bruton s tyrosine kinase btk inhibitors', 'clinical trials cancer acalabrutinib spebrutinib cc']\n",
      "['preclinical evaluation', 'novel btk inhibitor acalabrutinib', 'canine models', 'b cell non hodgkin lymphoma']\n",
      "['new agents', 'uk temsirolimus lenalidomide venetoclax idelalisib acalabrutinib lymphomaexpert']\n",
      "['phase i study', 'acalabrutinib acp']\n",
      "['acalabrutinib acp', 'bruton tyrosine kinase btk inhibitor acerta pharma']\n",
      "['hematology overview', 'phase i study', 'acalabrutinib acp', 'cll medicboard']\n",
      "['phase i study', 'acalabrutinib acp']\n",
      "['common side', 'btk inhibitors ibrutinib']\n",
      "['leucemia linfatica cronica acalabrutinib promettente nei pazienti na ve']\n",
      "['leucemia linfatica cronica acalabrutinib promettente nei pazienti na ve comitatoimalatiinvisibili']\n",
      "['hematology news acalabrutinib shows efficacy', 'cll medicboard']\n",
      "['acalabrutinib shows efficacy', 'asco16 poster hematology hematologynews']\n",
      "['pembro acalabrutinib', 'durva ibrutinib', 'azn asset']\n",
      "['phase i study', 'acalabrutinib acp']\n",
      "['asco16 acalabrutinib', 'chronic lymphocytic leukemia cll']\n",
      "['phase i study', 'acalabrutinib acp']\n",
      "['likely safer btk', '1l cll asco16']\n",
      "['acalabrutinib shows efficacy']\n",
      "['acalabrutinib posible opci n', 'primera l nea para tratar lcc']\n",
      "['acerta pharmas acalabrutinib', 'orphan drug status', 'ema bidness etc']\n",
      "['dr richard furman', 'cll asco16']\n",
      "['ema committee', 'orphan drug status', 'indications pharma']\n",
      "['nice review', 'gen cll therapies tgr', 'pi3k amp acalabrutinib btk lead', 'respective classes tgtx']\n",
      "[]\n",
      "['aclue people azn', 'acerta pharma', 'aka acalabrutinib']\n",
      "['high risk cll trial']\n",
      "['r amp d']\n",
      "['high risk cll trial']\n",
      "['high risk cll trial', 'great choices ibrutinib']\n",
      "['high risk cll trial']\n",
      "['oncology links acalabrutinib', 'high risk cll trial patients', 'chronic lymp']\n",
      "['high risk cll trial', 'simi cml leukemia']\n",
      "['high risk cll trial']\n",
      "['high risk cll trial agingdata leukemia']\n",
      "['high risk cll trial', 'simi cml leukemia']\n",
      "['high risk cll trial']\n",
      "['high risk cll trial oncology']\n",
      "['high risk cll trial oncology']\n",
      "['acalabrutinib team jobs', 'gaithersburg md gaithersburg md jobs jobsearch']\n",
      "['phase i study', 'acalabrutinib acp']\n",
      "['usan cancer drug name', 'acalabrutinib acp', 'cll mcl wm btk inhibitor acerta']\n",
      "['common side', 'btk inhibitors ibrutinib']\n",
      "['acalabrutinib team jobs jobs jobsearch']\n",
      "['common side', 'btk inhibitors', 'cll ibrutinib acalabrutinib']\n",
      "['refractory cll']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['common side', 'btk inhibitors ibrutinib']\n",
      "['gaithersburgjobs director', 'acalabrutinib team gaithersburg md', 'director gaithersburg jobs']\n",
      "['common side', 'btk inhibitors ibrutinib']\n",
      "['clinical trial', 'refractory cll clinicaltrials gov ct2 show nct02717611']\n",
      "['common side', 'btk inhibitors ibrutinib']\n",
      "['ema recomienda acalabrutinib como medicamento hu rfano', 'tres tipos', 'tumores raros']\n",
      "['ue designa medicamento hu rfano', 'acalabrutinib para tres tipos', 'c ncer']\n",
      "['endlymphoma lymphoma endcancer acalabrutinib acp', 'generation btk inhibitor']\n",
      "['ue designa medicamento hu rfano', 'acalabrutinib para tres tipos', 'c ncer']\n",
      "['ema recomienda acalabrutinib para su designaci n como medicamento hu rfano', 'c ncer']\n",
      "['astrazeneca recomendado', 'europa como medicamento hu rfano lee m s']\n",
      "['acalabrutinib medicamento hu rfano', 'c ncer']\n",
      "['acalabrutinib medicamento hu rfano', 'c ncer', 'europa lee m s']\n",
      "['europa como medicamento hu rfano v']\n",
      "['herenciageneticayenfermedad acalabrutinib recomendado', 'europa para su desig']\n",
      "['ema recomend acalabrutinib como medicamento hu rfano', 'tres tipos', 'tumores raros']\n",
      "['ue designa medicamento hu rfano', 'acalabrutinib para tres tipos', 'c ncer farmacia']\n",
      "['ema recomend acalabrutinib como medicamento hu rfano', 'tres tipos', 'tumores raros farmacia']\n",
      "['ema recomend acalabrutinib como medicamento hu rfano', 'mirada newscancer']\n",
      "['ema recomienda acalabrutinib para su designaci n como medicamento hu rfano', 'c ncer salud']\n",
      "['ema recomend acalabrutinib como medicamento hu rfano', 'mirada newscancer']\n",
      "['ema recomienda acalabrutinib para su designaci n como medicamento hu rfano', 'c ncer']\n",
      "['news recomienda como medicamento hu rfano', 'acalabrutinib para tres tumores']\n",
      "['ema recomienda acalabrutinib astrazeneca como medicamento hu rfano', 'tres tipos', 'tumores raros']\n",
      "['ema recomienda acalabrutinib para su designaci']\n",
      "['orphan drug designation', 'indications lymphoma leukemia']\n",
      "['acalabrutinib medicamento hu rfano', 'c ncer']\n",
      "['acalabrutinib medicamento hu rfano', 'c ncer', 'europa onmedic ehealth esalud']\n",
      "['ema recomienda acalabrutinib para su designaci n como medicamento hu rfano', 'c ncer v']\n",
      "['ema recomienda como medicamento hu rfano', 'acalabrutinib para tres tumores']\n",
      "['ema recomienda acalabrutinib como medicamento hu rfano', 'tres tipos', 'c ncer farmacia']\n",
      "['ema recomienda acalabrutinib astrazeneca como medicamento hu rfano', 'tres tipos']\n",
      "['europa como medicamento hu rfano v']\n",
      "['ema recomienda acalabrutinib astrazeneca como medicamento hu rfano', 'tres tipos', 'tumores raros']\n",
      "['astrazeneca recomendado', 'europa como medicamento hu rfano']\n",
      "['ema recomienda acalabrutinib para su designaci n como medicamento hu rfano']\n",
      "['clashofclans news', 'ema recomienda acalabrutinib astrazeneca como medicamento hu rfano', 'tres tipos']\n",
      "['ema recomienda acalabrutinib astrazeneca como medicamento hu rfano', 'tres tipos', 'tumores newssalud']\n",
      "['ema recomienda acalabrutinib astrazeneca como medicamento hu rfano', 'tres tipos', 'tumores newscancer']\n",
      "['ema recomienda acalabrutinib astrazeneca como medicamento hu rfano', 'tres tipos', 'tumores raros v']\n",
      "['ema recomienda acalabrutinib astrazeneca como medicamento hu rfano', 'tres tipos', 'tumores raros']\n",
      "['ema recomienda acalabrutinib astrazeneca como medicamento hu rfano', 'tumores raros v']\n",
      "['acalabrutinib ono', 'novel btk inhibitors']\n",
      "['orphan drug designation', 'indications regulatory']\n",
      "['astrazeneca s acalabrutinib', 'eu orphan drug designation']\n",
      "['esperti ema raccomandano', 'designazione di farmaco orfano', 'acalabrutinib comitatoimalatiinvisibili']\n",
      "['acerta acalabrutinib leaps', 'eu orphan status']\n",
      "['acalabrutinib drug pharma clinicaltrials astrazeneca']\n",
      "['orphan drug designation']\n",
      "['orphan drug designation', 'eu rt']\n",
      "['acerta s acalabrutinib leaps', 'eu orphan status']\n",
      "[]\n",
      "['orphan drug designation']\n",
      "['orphan drug designation', 'eu prt']\n",
      "['ema committee', 'orphan drug status']\n",
      "['ya est n aqu los btk', 'segunda generaci n acalabrutinib hu rfano ema']\n",
      "['acerta s acalabrutinib leaps', 'eu orphan status']\n",
      "['astrazeneca azn', 'acerta pharma s acalabrutinib', 'orphan drug status']\n",
      "['acerta pharmas acalabrutinib', 'orphan drug status', 'ema bidness etc']\n",
      "['orphan drug designation', 'indications pharma']\n",
      "['orphan drug designation', 'indications pharma biotech medtech p']\n",
      "['orphan drug designation']\n",
      "['orphan drug designation', 'indications pharma biotech medtech']\n",
      "['orphan drug designation']\n",
      "['orphan drug designation']\n",
      "['orphan drug designation', 'indications astrazeneca']\n",
      "['orphan drug designation', 'indications astrazeneca']\n",
      "['orphan drug designation', 'indications astrazeneca']\n",
      "['orphan drug designation', 'indications ast mymexicandrugstore']\n",
      "['orphan drug designation']\n",
      "['orphan drug designation', 'indications astrazeneca']\n",
      "['dtn pharma news acalabrutinib', 'orphan drug designation', 'indications astraz']\n",
      "['btk inhibitor leukemia lymphoma acalabrutinib']\n",
      "['ema committee', 'orphan drug status']\n",
      "['ema committee', 'orphan drug status', 'european medicines ag']\n",
      "['pharma news ema committee', 'orphan drug status']\n",
      "['acerta cancer drug acalabrutinib', 'eu orphan status', 'international business times india edition vi']\n",
      "['orphan drug designation']\n",
      "['acerta cancer drug acalabrutinib', 'eu orphan status']\n",
      "['acerta cancer drug acalabrutinib', 'eu orphan status']\n",
      "['acerta pharma s acalabrutinib', 'orphan drug']\n",
      "[]\n",
      "['orpan drug recommendations', 'haem malignancy indications']\n",
      "['pretty impressive line', 'haem malignancies astrazeneca acalabrutinib']\n",
      "['orphan drug designation', 'haem malignancies astrazeneca']\n",
      "['article gt acerta s acalabrutinib leaps', 'eu orphan status']\n",
      "['acerta s acalabrutinib leaps', 'eu orphan status']\n",
      "['orphandrug designation', 'cancer indications']\n",
      "['acerta pharma s acalabrutinib', 'orphan drug', 'indications azn']\n",
      "['orphan drug designation']\n",
      "['acalabrutinib ema']\n",
      "['acalabrutinib cll scl mcl', 'earnings eyes']\n",
      "['acerta s acalabrutinib leaps', 'eu orphan status']\n",
      "['acerta s acalabrutinib leaps', 'eu orphan status']\n",
      "['acerta s acalabrutinib leaps', 'eu orphan status acerta s acalabrutinib leaps', 'eu orphan status']\n",
      "['acerta s acalabrutinib leaps', 'eu orphan status acerta s acalabrutinib leaps', 'eu orphan status']\n",
      "['acerta s acalabrutinib leaps', 'eu orphan status acerta s acalabrutinib leaps', 'eu orphan status']\n",
      "['acerta s acalabrutinib leaps', 'eu orphan status acerta s acalabrutinib leaps', 'eu orphan status']\n",
      "['acerta s acalabrutinib leaps', 'eu orphan status']\n",
      "['orphan drug designation pharma astrazeneca orphandrugs']\n",
      "['acerta acalabrutinib acp196', 'orphan drug status', 'europe pancreaticcancer trials']\n",
      "['acerta s acalabrutinib leaps', 'eu orphan status']\n",
      "['acerta s acalabrutinib leaps', 'eu orphan status pharma biotech bigpharma medtech']\n",
      "['acerta s acalabrutinib leaps', 'eu orphan status pharma health']\n",
      "['acerta s acalabrutinib leaps', 'eu orphan status']\n",
      "['orphan drug designation', 'indications pharma industry']\n",
      "['orphan drug designation']\n",
      "['acertapharma astrazeneca', 'acerta s acalabrutinib']\n",
      "['astrazeneca azn', 'acerta s acalabrutinib']\n",
      "['astrazeneca azn plc acalabrutinib orphan drug designation']\n",
      "['brief astrazeneca azn', 'orphan drug designation']\n",
      "['orphan drug designation']\n",
      "['orphan drug designation', 'europe acalabrutinib']\n",
      "['acalabrutinib orphan drug designation']\n",
      "['cmlhope acalabrutinib', 'orphan drug designation', 'indications cml leukemia']\n",
      "['cmlhope acalabrutinib orphan drug designation', 'i chronic lymphocytic leukemia leuk cml leukemia']\n",
      "['ftse100 acalabrutinib orphan drug designation', 'market news', 'alert astrazeneca plc']\n",
      "['brief astrazeneca', 'orphan drug designation', 'europe acalabrutinib recomm']\n",
      "['orphan drug designation']\n",
      "['ema comp', 'orphan designations', 'astrazeneca s acalabrutinib', 'cll sll mcl']\n",
      "['astrazeneca azn', 'orphan drug designation']\n",
      "['brief astrazeneca', 'orphan drug designation']\n",
      "['brief astrazeneca', 'orphan drug designation']\n",
      "['brief astrazeneca', 'orphan drug designation', 'europe acalabrutinib recomm']\n",
      "['astrazeneca acalabrutinib', 'eu orphan designation']\n",
      "['astrazeneca azn acalabrutinib orphan drug designation']\n",
      "['news nasdaq omx globenewswire acalabrutinib orphan drug designation']\n",
      "['astrazeneca azn acalabrutinib orphan drug designation']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia']\n",
      "['nejm acalabrutinib acp', 'chronic lymphocytic leukemia']\n",
      "['risultati promettenti dall inibitore btk di seconda generazione acalabrutinib nel t pharmakon feb']\n",
      "['new leukemia drug']\n",
      "['acalabrutinib gan cancer']\n",
      "[]\n",
      "['phase i study', 'acalabrutinib acp']\n",
      "['leucemia linfatica cronica arriva il nuovo e promettente inibitore acalabrutinib comitatoimalatiinvisibili']\n",
      "['original article acalabrutinib acp', 'chronic lymphocytic leukemia']\n",
      "['news acalabrutinib', 'chronic lymphocytic leukaemia']\n",
      "['acalabrutinib acp', 'generation selective irreversible inhibitor']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia nejm']\n",
      "['tu bruton', 'bruton kinase inhibitor acalabrutinib']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia nejm']\n",
      "['reviews venetoclax acalabrutinib mitral choices vitd', 'wheeze dialysis decisions genomism']\n",
      "['endlymphoma lymphoma cll acalabrutinib acp', 'chronic lymphocytic leukemia']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia nejm']\n",
      "['nejm acalabrutinib acp', 'chronic lymphocytic leukemia']\n",
      "['acalabrutinib yields', 'overall response']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia nejm']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia nejm', 'class drug']\n",
      "['common side', 'btk inhibitors ibrutinib']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia']\n",
      "['leukemia cll acalabrutinib', 'selective btk inhibitor venetoclax bcl2 protein inhibitor', 'strong responses']\n",
      "['acalabrutinib acp', 'leucemia linfoc tica cr nica']\n",
      "[]\n",
      "['john c byrd']\n",
      "['dr jacqueline barrientos', 'acalabrutinib acp', 'cll ash2015']\n",
      "['common side', 'btk inhibitors ibrutinib']\n",
      "['selective btk inhibitor acalabrutinib shows', 'promising safety amp efficacy profiles', 'chronic lymphocytic leukemia']\n",
      "['acalabrutinib acp']\n",
      "['phase i study', 'acalabrutinib acp']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia nejm']\n",
      "['ser comercializado ibrutinib', 'y ya tenemos', 'puertas otro inh 2a generaci n acalabrutinib']\n",
      "['new btk inhibitor', 'high r']\n",
      "[]\n",
      "[]\n",
      "['cll oncology hcsm']\n",
      "['unique properties', 'generation btk inhibitor']\n",
      "[]\n",
      "['john byrd md', 'james discusses', 'alacabrutinib compares']\n",
      "['john c byrd md']\n",
      "['dr byrd']\n",
      "[]\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia nejm']\n",
      "['pal query', 'acalabrutinib acp', 'btk pathway']\n",
      "[]\n",
      "[]\n",
      "['cll oncology']\n",
      "['cll oncology']\n",
      "['ash15 venetoclax acalabrutinib', 'cll hematology']\n",
      "['acalabrutinib posible nuevo f rmaco', 'con una pinta excelente ojal revolucione']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia nejm']\n",
      "['acerta pharma btk acalabrutinib']\n",
      "['acalabrutinib acp', 'shows efficacy safety', 'adult cll v']\n",
      "[]\n",
      "['news acalabrutinib', 'pts w', 'chronic lymphocytic leukaemia lylcl']\n",
      "['imbruvica 1st', 'class time', 'mkt advantage', 'r r cll orr', 'imbruvica abbv azn']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia nejm']\n",
      "['wm astarazeneca', 'acerta pharma p3 btk acalabrutinib']\n",
      "['leukemia cells drop', 'cll acalabrutinib']\n",
      "['hematology venetoclax acalabrutinib', 'cll ash15']\n",
      "['acalabrutinib selective irreversible btk inhibitor', 'mo median followup orr']\n",
      "['acalabrutinib acp', 'shows efficacy safety', 'adult cll']\n",
      "['astrazeneca bets', 'acerta pharma phase iii btk inhibitor acalabrutinib']\n",
      "['astrazeneca comprar fatia majorit ria na acerta por', 'bi transa o visa o medicamento acalabrutinib cont']\n",
      "['astrazeneca comprar fatia majorit ria na acerta por', 'bi transa o visa o medicamento acalabrutinib cont']\n",
      "['astrazeneca comprar fatia majorit ria na acerta por', 'bi transa o visa o medicamento acalabrutinib cont']\n",
      "['cancer drug']\n",
      "['cancer drug']\n",
      "['cancer drug']\n",
      "['cancer drug']\n",
      "['cancer drug']\n",
      "['imbruvia challenger acalabrutinib s development plan']\n",
      "['cancer drug astrazeneca', 'acalabrutinib sales']\n",
      "['4b cancer bloodcancer acalabrutinib']\n",
      "['acalabrutinib wasn t', 'harry potter']\n",
      "['cancer drug astrazeneca', 'acalabrutinib sales']\n",
      "['cancer drug astrazeneca', 'acalabrutinib sales']\n",
      "['cancer drug astrazeneca', 'acalabrutinib sales']\n",
      "['cll oncology hcsm']\n",
      "[]\n",
      "['new study', 'exciting result']\n",
      "['generation btk inhibitor']\n",
      "['acalabrutinib acp', 'shows efficacy safety', 'adult cll']\n",
      "['acerta pharma', 'gain rights', 'promising blood cancer compound acalabrutinib']\n",
      "['astrazeneca confirms acquisition', 'acerta pharma', 'blood cancer compound acalabrutinib']\n",
      "['copd news acalabrutinib acp196 shows efficacy safety', 'adult cll']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['stemcells news acalabrutinib acp196 shows efficacy safety', 'adult cll']\n",
      "['research news acalabrutinib acp', 'chronic lymphocytic leukemia nejm']\n",
      "[]\n",
      "['amy johnson phd', 'new treatment', 'chronic lymphocytic leukemia cll']\n",
      "['acerta pharma btk inhibitor acalabrutinib acp']\n",
      "['cll patients', 'acerta drug acalabrutinib dutch biotech']\n",
      "['new post acerta pharma announces study', 'new england journal', 'medicine demonstrates acalabrutinib']\n",
      "['r r cll ibrutinib', 'similar study', 'nejm orr', 'lymphocytosis abbv jnj']\n",
      "['acalabrutinib good drug smart']\n",
      "['amy johnson phd', 'new treatment', 'chronic lymphocytic leukemia']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia nejm']\n",
      "['5bn acquisition', 'gen imbruvica competitor acalabrutinib ash15 data', 'r r cll']\n",
      "['acerta pharma announces study', 'new england journal', 'medicine demonstrates acalabrutinib acp']\n",
      "['gen btkinhibitor', 'safer team', 'acalabrutinib cll ash15']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia nejm']\n",
      "['selective btk inhibitor', 'cll onc']\n",
      "['excellent activity', 'acalabrutinib acp', 'chronic lymphocytic leukemia nejm']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia nejm']\n",
      "['new btk inhibitor', 'refractory cll cme ce medpage']\n",
      "['drug acalabrutinib shows potential', 'prevalent form', 'adult leukemia']\n",
      "['generation btk inhibitor acalabrutinib', 'phase iii cll study ash15']\n",
      "['response rate', 'durable remissions', 'favorable safety profile', 'cll ash15']\n",
      "['ash venetoclax acalabrutinib']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia']\n",
      "['drug shows potential', 'prevalent form', 'adult leukemia', 'new drug acalabrutinib']\n",
      "['ash venetoclax acalabrutinib', 'cll health medicine']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia nejm']\n",
      "['acerta pharma announces study', 'new england journal', 'medicine demonstrates acalabrutinib acp']\n",
      "['ash15 acalabrutinib acp', 'chronic lymphocytic leukemia']\n",
      "[]\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia nejm']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia']\n",
      "['drug shows potential', 'prevalent form', 'adult leukemia', 'new drug acalabrutinib acp']\n",
      "['drug shows potential', 'prevalent form', 'adult leukemia', 'new drug acalabrutinib']\n",
      "['organic gmofree', 'new drug acalabrutinib acp', 'response rates']\n",
      "['cacao coffee', 'new drug acalabrutinib acp', 'response rates']\n",
      "['nutrition diet', 'new drug acalabrutinib acp', 'response rates']\n",
      "['new drug acalabrutinib acp', 'response rates', 'patie health glutenfree']\n",
      "['health longevity', 'new drug acalabrutinib acp', 'response rates']\n",
      "['drug shows potential', 'prevalent form', 'adult leukemia', 'new drug acalabrutinib']\n",
      "['drug shows potential', 'prevalent form', 'adult leukemia', 'new drug acalabrutinib']\n",
      "['drug shows potential', 'prevalent form', 'adult leukemia', 'new drug acalabrutinib']\n",
      "['drug shows potential', 'prevalent form', 'adult leukemia', 'new drug acalabrutinib']\n",
      "['nutrition gmofree', 'new drug acalabrutinib acp', 'response rates']\n",
      "['drug shows potential', 'prevalent form', 'adult leukemia', 'new drug acalabrutinib']\n",
      "['drug shows potential', 'prevalent form', 'adult leukemia', 'new drug acalabrutinib']\n",
      "['drug shows potential', 'prevalent form', 'adult leukemia', 'new drug acalabrutinib']\n",
      "['drug shows potential', 'prevalent form', 'adult leukemia', 'new drug acalabrutinib']\n",
      "['drug shows potential', 'prevalent form', 'adult leukemia', 'new drug acalabrutinib']\n",
      "['new drug acalabrutinib acp', 'response rates']\n",
      "['new drug acalabrutinib acp', 'response rates']\n",
      "['science health', 'new drug acalabrutinib acp', 'response rates']\n",
      "['drug shows potential', 'prevalent form', 'adult leukemia', 'new drug acalabrutinib']\n",
      "['drug shows potential', 'prevalent form', 'adult leukemia', 'new drug acalabrutinib']\n",
      "['drug shows potential', 'prevalent form', 'adult leukemia', 'new drug acalabrutinib']\n",
      "['drug shows potential', 'prevalent form', 'adult leukemia', 'new drug acalabrutinib']\n",
      "['uncontrolled phase', 'acalabrutinib shows activity', 'chronic lymphocytic leukemia']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia nejm']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia pharmacy health']\n",
      "['btk inhibitor acalabrutinib', 'promising safety', 'patients w', 'chronic lymphocytic leukemia cll']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia nejm']\n",
      "['acerta pharma announces study', 'new england journal', 'medicine demonstrates acalabrutinib acp196 s']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia']\n",
      "['acalabrutinib acp196', 'atrial fibrillation', 'overall response rate ash15 leusm nejm']\n",
      "['news acerta pharma announces study', 'new england journal', 'medicine demonstrates acalabrutinib acp']\n",
      "['news acerta pharma announces study', 'new england journal', 'medicine demonstrates acalabrutinib acp']\n",
      "['acerta pharma announces study', 'new england journal', 'medicine demonstrates acalabrutinib acp']\n",
      "['substantial antitumor', 'phase i ii study', 'patients w', 'poor prognosis cll ash15']\n",
      "['acalabrutinib acp', 'chronic lymphocytic leukemia']\n",
      "['great news', 'cll research team']\n",
      "['new article', 'prognostic significance', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['jacqueline claudia barrientos md ms', 'frontline setting', 'chronic lymphocytic leukemia', 'research efforts', 'interest leusm']\n",
      "['chronic lymphocytic leukemia cll', 'asymptomatic elevation', 'white cells', 'routine evaluation']\n",
      "['chronic lymphocytic leukemia cll', 'massive overproduction', 'leukemic lymphocytes', 'monoclonal production', 'b lymphocytes etiology']\n",
      "['hemonc cme cllsm']\n",
      "['new article', 'common genetic polymorphisms contribute', 'chronic lymphocytic leukaemia', 'non melanoma skin cancer cll leusm hematology']\n",
      "['new article concurrent chronic lymphocytic leukemia', 'comprehensive review', 'epidemiological diagnostic', 'cll leusm hematology']\n",
      "['new article stat3 induces', 'chronic lymphocytic leukemia cells cll leusm hematology']\n",
      "['new article monoclonal b cell lymphocytosis', 'prednisolone therapy', 'dermatomyositis cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'scleral nodule']\n",
      "['cll projects']\n",
      "['top questions', 'covidvaccine amp', 'cll bloodcancer']\n",
      "['research projects', 'big data', 'research cancer myeloma cll lymsm mds aml leukaemia']\n",
      "['treatment paradigm', 'chronic lymphocytic leukemia', 'continuous treatment', 'btk inhibitors']\n",
      "['mrna vaccine', 'future reference', 'chronic lymphocytic leukemia', 'lymph nodes', 'night sweats']\n",
      "['new clinical trial', 'tq b3525', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll leusm hematology']\n",
      "['new clinical trial', 'safety pk', 'refractory non hodgkin lymphoma r r nhl', 'chronic lymphocytic leukemia cll cll leusm hematology']\n",
      "['ibrutinib vs ibrutinib', 'refractory high risk cll comment', 'isabel cunningham md']\n",
      "['oncology case', 'roundtable event daniel o persky md', 'old patient', 'chronic lymphocytic leukemia leusm']\n",
      "['final call', '16icml submissions', 'cet submit', 'lymphoma lymsm cll myeloma']\n",
      "['early venetoclax treatment', 'patients wi']\n",
      "['chronic lymphocytic leukemia market research report insights']\n",
      "['weeks til i shot', 'leukemia patient cll', 'others immune']\n",
      "['phase iii rct results', 'powerful results', 'ibrutinib intolerant patients', 'cll patients']\n",
      "['cd markers', 'chronic lymphocytic leukemia cll abim usmle medstudent']\n",
      "['human pluripotent stem cell model', 'targetable features', 'chronic lymphocytic leukemia', 'patient samples']\n",
      "['rectal cancer', 'chronic lymphocytic leukemia']\n",
      "['shares treatment considerations', 'chronic lymphocytic leukemia leusm']\n",
      "['overall response rate', 'previous safety profile', 'refractory high risk chronic lymphocytic leukemia leusm']\n",
      "['cllsociety covid', 'interim recommendations', 'people drs brian koffman', 'neil kay', 'cll patients']\n",
      "['cll town hall address', 'own advocate experts', 'patient guests', 'care partners', 'care stay']\n",
      "['s shuo ma md phd amp jennifer boyer msn aprn np c s deborah stephens', 's virtual town hall', 'patients amp families', 'chronic lymphocytic leukemia cll']\n",
      "['treatment landscape', 'current cll treatment landscape', 'research state', 'cll town hall']\n",
      "['facebook cll', 'resume treatment', 'facebook page', 'cll town hall']\n",
      "['ibrutinib efficacy', 'factor prognostic model', 'cll lymsm cll']\n",
      "['town hall', 'current cll treatment landscape amp', 're kicking', 'cll amp questions', 'doctor tune', 'facebook page']\n",
      "['new cll town hall', 'research state']\n",
      "['chronic lymphocytic leukemia cells contributes', 'apoptosis resistance', 'jak src stat3 mcl']\n",
      "['angioimmunoblastic t cell lymphoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'novel form', 'composite lymphoma', 'richter syndrome']\n",
      "['angioimmunoblastic t cell lymphoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'novel form', 'composite lymphoma', 'richter syndrome lymphoma lymsm']\n",
      "['disease state cll tgtx']\n",
      "['oncology eternal oncternal therapeutics', 'clinical stage pharma company', 'rare cancers', 'chronic lymphocytic leukemia cll', 'mantle cell lymphoma mcl', 'small molecule', 'sarcoma raredisease']\n",
      "['treatment strategies', 'chronic lymphocytic leukemia', 'cost efficiency convenience', 'minimal toxicity james leusm']\n",
      "['new article idiopathic perniosis', 'acral purpuric lesions', 'literature cll leusm hematology']\n",
      "['new article angioimmunoblastic t cell lymphoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'novel form', 'composite lymphoma', 'richter syndrome cll leusm hematology']\n",
      "['new article angioimmunoblastic t cell lymphoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'novel form', 'composite lymphoma', 'richter syndrome aml leusm hematology']\n",
      "['new article angioimmunoblastic t cell lymphoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'novel form', 'composite lymphoma', 'richter syndrome dlbcl lymsm hematology']\n",
      "['monday shows', 'antibodies i']\n",
      "['t cell dysfunction', 'chronic lymphocytic leukemia', 'epigenetic perspective haematology thewiderwiserview']\n",
      "['chronic lymphoc']\n",
      "['chronic lymphocytic leukemia aug', 'rai sawitsky cronkite chanana levy pasternack cllsm leusm']\n",
      "['james discusses updates', 'key studies', 'novel pi3k inhibitors', 'chronic lymphocytic leukemia leusm']\n",
      "['new article efficacy', 'refractory chronic lymphocytic leukemia', 'clinical trials', 'group cll leusm hematology']\n",
      "['march 23rd', 'cet don t', 'international event', 'lymphoma submit', 'lymsm cll myeloma']\n",
      "['easiest way', 'train color recognition motor skills grip control', 'patience edtech education homeschool cll click', 'child gt']\n",
      "['cll blood cancer community', 'family members']\n",
      "['year progression', 'free survival rate', 'year os', 'tp53 aberrant cll leusm cll ibrutinib']\n",
      "['cll patients leusm cllsm']\n",
      "['disease flare', 'temporary interruption', 'ibrutinib therapy', 'chronic lymphocytic leukemia leukemia cll ibrutinib drugtherapy flareup']\n",
      "['doctor s office', 'i don t', 'chronic lymphocytic leukemia']\n",
      "['cll leukaemia patients haematology bloodcancer bloodcancerawareness']\n",
      "['friendly friday reminder', 'iwcll2021 visit', 'full list', 'guidelines deadline', 'amp registration', 'oral poster presentation cll']\n",
      "['amp impact', 'cll patients', 'amp cll leukaemia haematology bloodcancer bloodcancerawareness']\n",
      "['ibrunat 140mg 30s capsules', 'mantle cell lymphoma', 'blood cancer chronic lymphocytic leukemia', 'ibrunat 140mg 30s']\n",
      "['ibrunat 140mg 30s capsules', 'mantle cell lymphoma', 'blood cancer chronic lymphocytic leukemia', 'incepta ibrunat 140mg 30s incepta']\n",
      "['chronic lymphocytic leukemia cll', 'blood cancer', 'inactivate tumor', 'cancer growth']\n",
      "['new clinical trial study', 'b cell lymphoma', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new clinical trial phase ib clinical study', 'keynatinib cll leusm hematology']\n",
      "['new clinical trial study', 'b cell lymphoma', 'chronic lymphocytic leukemia fl lymsm hematology']\n",
      "['new treatment options', 'cll patients', 'time pirtobrutinib', 'btk inhibitor']\n",
      "['antigen expression reflects ighv mutational status', 'prognostic categories', 'chronic lymphocytic leukemia monoclonal b cell lymphocytosis', 'small lymphocytic lymphoma lymphoma lymsm']\n",
      "['new article marcks affects cell motility', 'btk inhibitors', 'cll cll leusm hematology']\n",
      "['chronic lymphocytic leukemia causes picture symptoms treatment']\n",
      "['new mrna cancer drivers', 'chronic lymphocytic leukemia genomeweb']\n",
      "['study tracks covid vaccine response', 'blood cancers cll patients']\n",
      "['new article overall survival', 'adverse events', 'economic burden', 'chronic lymphocytic leukemia', 'systemic therapy', 'real world evidence', 'medicare population cll leusm hematology']\n",
      "['new article intensity', 'antigen expression reflects ighv mutational status', 'prognostic categories', 'chronic lymphocytic leukemia monoclonal b cell lymphocytosis', 'small lymphocytic lymphoma cll leusm hematology']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['r gregory bociek md', 'minimal residual disease', 'chronic lymphocytic leukemia leusm']\n",
      "['cll patients', 'long time', 'susan o brien cll patientpower']\n",
      "['global bridges core lecture series heme malignancies block', 'informative talk', 'chronic lymphocytic leukemia']\n",
      "['new article', 'vivo ex vivo', 'vitro dasatinib activity', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article eomes', 'antitumor activity', 'cd8 t cells', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article interleukin', 'suppression enhances t cell antitumor immunity', 'checkpoint blockade', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['astrazeneca leukaemia treatment', 'cll leukaemia']\n",
      "['chronic myeloid leukemia', 'tyrosine kinase inhibitors clinicaltrial ea9171 blast mrd cml', 'leusm cll']\n",
      "['chronic lymphocytic leukemia cll patients', 'pluripotent stem cells', 'cll share', 'similar transcriptional perturbations']\n",
      "['active role', 'cll treatment decisions webinar tuesday', '10am pt', 'cll expert', 'leusm cllsm']\n",
      "['chronic lymphocytic leukemia', 'mantle cell lymphoma', 'recent years dr james gerson reviews', 'blood amp cancer']\n",
      "['ibrutinib interferes', 'innate immunity', 'chronic lymphocytic leukemia patients', 'infection haematology thewiderwiserview']\n",
      "['r gregory bociek md', 'prognostic factors', 'chronic lymphocytic leukemia leusm']\n",
      "['good friends', 'uk cllsa', 'great webinar', 'prof hillmen', 'cll clinicaltrial', 'great interest', 'community ni ie']\n",
      "['new article', 'kinase inhibitors', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article integrative prognostic models', 'term survival', 'chronic lymphocytic leukemia patients cll leusm hematology']\n",
      "['new clinical trial study', 'adverse events', 'disease activity movement', 'oral abbv', 'adult participants', 'b cell cancers cll leusm hematology']\n",
      "[]\n",
      "['global market', 'chronic lymphocytic leukemia cll', 'new therapies', 'cll patients', 'high unmet needs']\n",
      "['good news', 'oral drugs', 'uk cll leukaemia bloodcancer bloodcancerawareness haematology']\n",
      "['astrazeneca leukaemia treatment', 'cll leukaemia']\n",
      "['human pluripotent stem cells identify molecular targets', 'chronic lymphocytic leukemia patients']\n",
      "['new article human pluripotent stem cells identify molecular targets', 'chronic lymphocytic leukemia patients cll leusm hematology']\n",
      "['r gregory bociek md', 'reserve allogeneic stem cell transplant', 'certain patients', 'chronic lymphocytic leukemia leusm']\n",
      "['cll blood cancer i', 'az jab', 'antibody test', 'astra zeneca s fault']\n",
      "['free virtual town hall', 'chronic lymphocytic leukemia cll patients', 'family members', 'saturday march', 'details leusm']\n",
      "['saturday s', 'hour town hall', 'cll patients thanks', 'drs shuo ma', 'debbie stephens', 'cll leusm patientpower']\n",
      "['busy day learning', 'sct amp bonemarrowfailures', 'cll therapy', 'asovasna friends', 'normal life virtual meetings', 'good points']\n",
      "['virtual cme opportunities host', 'grand rounds activity', 'full details', 'book cc sharman mm cll myelofibrosis']\n",
      "['medicine approach', 'cll focus', 'genomic instability', 'clonal evolution leusm cllsm jnccn360']\n",
      "['esh john goldman', 'international research award fund', 'research project', 'tfr mrd', 'long term remission', 'cure cml cll aml', 'myeloma leukemia lymphoma eshjga']\n",
      "['new article self', 'cancer survivors results', 'profiles registry cll leusm hematology']\n",
      "['new article safety', 'rituximab biosimilars', 'onco hematology cll leusm hematology']\n",
      "['productive patient education council meeting', 'group aplasticanemia mds pnh aml cll bmt hematology']\n",
      "['review amsterdam scientists', 'epigenetic dys regulation', 't cells', 'chronic lymphocytic leukemia patients', 'neoplastic b cells']\n",
      "['new drug combination', 'exciting new chronic lymphocytic leukemia cll treatment option', 'promising new combination therapy', 'ublituximab leusm']\n",
      "['new article human adipose', 'mesenchymal stem cells', 'lymphocyte apoptosis', 'alleviate atherosclerosis', 'mir 125b', '3p bcl11b signal axis cll leusm hematology']\n",
      "['ehacampus eha', 'cml cll mm leukemia leukaemia hsct']\n",
      "['congress ebmt21 antonio jos cabrera serrano pts', 'wide association study', 'chronic lymphocytic leukemia risk lymsm lymphoma']\n",
      "['ch leukemia']\n",
      "['new article interphase fluorescence', 'situ hybridization analysis', 'cells utility', 'post therapy samples', 'b cell neoplasms cll leusm hematology']\n",
      "['cancer health', 'great cll story', 'heidi yates', 'cll heidiyates']\n",
      "[]\n",
      "['neoantigen vaccines', 'wu lab trial']\n",
      "['vaccination schedule', 'cancer patients', 'cll patients', 'clear statement']\n",
      "['stem cll humanities', 'arts ambassadors', 'ideas personaldevelopment']\n",
      "['new btk inhibitor pirtobrutinib shows']\n",
      "['james discusses updates', 'key studies', 'novel pi3k inhibitors', 'chronic lymphocytic leukemia leusm']\n",
      "['human pluripotent stem cells identify molecular targets', 'chronic lymphocytic leukemia patients']\n",
      "['treatment options', 'treatment research', 'chronic lymphocytic leukemia cll', 'ash2020 leusm bloodcancer']\n",
      "['anthony mato md', 'memorial sloan', 'cancer center', 'chronic lymphocytic leukemia', 'discusses findings', 'informcll registry']\n",
      "['unknown chromosomal aberration', 'chronic lymphocytic leukemia', 'extra isochromosome 4q']\n",
      "['new article', 'unknown chromosomal aberration', 'chronic lymphocytic leukemia', 'extra isochromosome 4q cll leusm hematology']\n",
      "['new article oxidative stress', 'cancer cll leusm hematology']\n",
      "['nombreux succ s cliniques nox e36', 'phase 2a dans', 'diabetic nephropathy nox a12', 'phase 2a dans', 'multiple myeloma nox a12', 'phase 2a dans', 'chronic lymphocytic leukemia nox a12', 'phase 2a dans', 'nox a12', 'phase 2a dans']\n",
      "['cancer charities', 'cancer services onecancervoice charitytuesday bloodcancer cll leukaemia']\n",
      "['chronic lymphocytic leukemia', 'bone marrow', 'lymphocytes chronic lymphocytic leukemia', 'bone marrow']\n",
      "['chronic lymphocytic leukemia', 'recent clinical advances', 'inhibitors lymphoma lymsm']\n",
      "['oncology case', 'roundtable event daniel o persky md', 'old patient', 'chronic lymphocytic leukemia leusm']\n",
      "['challenge i', 'myheartisyellow cll nextmove ilovechallenges tmobile proudemployee happyemployees', 'happycustomers loyaltymatters ilovewhatido']\n",
      "['new article', 'tissue counterpart', 'monoclonal b cell lymphocytosis cll leusm hematology']\n",
      "['clonal evolution', 'chronic lymphocytic leukemia', 'refractory cases', 'chemo immune therapy haematology thewiderwiserview']\n",
      "['genomic microarrays', 'equivalent methods', 'genomic complexity risk stratification', 'chronic lymphocytic leukemia patients haematology thewiderwiserview']\n",
      "['important paper', 'richter transformation', 'cll gt gt gt', 'richter transformation', 'novel cll agents leusm']\n",
      "['new article', 'chronic lymphocytic leukemia', 'recent clinical advances', 'inhibitors cll leusm hematology']\n",
      "['order connections', 'subsets implications', 'patient classification', 'cll cll']\n",
      "['mksap pearl intravenous immunoglobulin g replacement therapy reduces', 'chronic lymphocytic leukemia']\n",
      "['review paper', 't cell dysfunction', 'chronic lymphocytic leukemia', 'epigenetic perspective', 'main points']\n",
      "['abstracts closes', 'new deadline', 'march 23rd', 'info lymsm cll myeloma']\n",
      "['chronic lymphocytic leukaemia cll', 'watch amp', 'phone interview', 'research study', 'email c dunnion']\n",
      "['new clinical trial cord blood', 'cd19 car', 'nk cells', 'b lymphoid malignancies cll leusm hematology']\n",
      "['new clinical trial', 'universal chimeric antigen receptor', 'at19 cells', 'refractory hematological malignancies cll leusm hematology']\n",
      "['sad news', 'professor jim dornan', 'actor jamie dornan prof dornan', 'patient advocate', 'own diagnosis']\n",
      "['novel agent', 'free survival', 'chronic lymphocytic leukemia cll', 'leusm bloodcancer']\n",
      "['multi kinase inhibitor tg02 induces apoptosis', 'blocks b cell receptor', 'chronic lymphocytic leukemia', 'dual mechanisms', 'action cll']\n",
      "['bloodcancer conference', 'mid atlantic region', 'cll expert register']\n",
      "['r gregory bociek md', 'minimal residual disease', 'chronic lymphocytic leukemia leusm']\n",
      "['new paper', 'tanja stankovic s lab', 'tlr9 expression determines', 'xenograft models', 'chronic lymphocytic leukaemia bloodcancer']\n",
      "['mrna shots', 'large numbers', 'blood cancer chronic lymphocytic leukemia', 'interesting cll', 'self devaluation program']\n",
      "['multi kinase inhibitor tg02 induces apoptosis', 'blocks b cell receptor', 'chronic lymphocytic leukemia', 'dual mechanisms']\n",
      "['language underpins learning amp literacy amp', 'year s languagedevelopment slcn cll']\n",
      "['new article', 'multi kinase inhibitor tg02 induces apoptosis', 'blocks b cell receptor', 'chronic lymphocytic leukemia', 'dual mechanisms', 'action cll leusm hematology']\n",
      "['sawaf md discusses', 'minimal residual disease', 'chronic lymphocytic leukemia', 'cll14 leusm']\n",
      "['amazing work', 'novel therapies', 'patients cll noveltherapies medicine innovation']\n",
      "['pirtobrutinib loxo', 'r r cll', 'nhl lymphomas oncoalert oncology lymsm leusm']\n",
      "['chronic lymphocytic leukemia']\n",
      "['r gregory bociek md', 'prognostic factors', 'chronic lymphocytic leukemia leusm']\n",
      "['overall response rate orr', 'previous safety profile', 'refractory high risk chronic lymphocytic leukemia leusm']\n",
      "['clinical trials', 'chronic lymphocytic leukaemia', 'uk london leukemia lymsm leusm cll cancer']\n",
      "['r gregory bociek md', 'reserve allogeneic stem cell transplant', 'certain patients', 'chronic lymphocytic leukemia leusm']\n",
      "['frontline treatment', 'year progression', 'overall survival rates', 'chronic lymphocytic leukemia', 'tp53 aberrations leusm']\n",
      "['sure cll', 'cll community blood cancer patients survivors hesitate']\n",
      "['desk walls', 'amp harbor', 'i ve', 'team i', 'glad i', 'new role', 'cll planning', 'reediculous lastdayvibes ram', 'cll subtlegoodbye']\n",
      "['review sequence therapies', 'r r cll', 'cllsm hemonc']\n",
      "['conjugate pneumococcal vaccine', 'chronic lymphocytic leukemia leusm hematology']\n",
      "['amazing work', 'pepper2 amp', 'leukeamia cll aml']\n",
      "['sawaf md discusses', 'minimal residual disease', 'chronic lymphocytic leukemia', 'cll14 leusm']\n",
      "['heme cancers', 'dose pre print highlights', 'cancer pts', 'cll pts']\n",
      "['march 17th', 'virtual cme ce cpe', 'clinical data', 'therapeutic options', 'chronic lymphocytic leukemia grubhub gift cards']\n",
      "['chronic lymphocytic leukemia cll healthline']\n",
      "['bispecific single domain antibody boosts autologous v gamma 9v delta', 't cell responses', 'chronic lymphocytic leukemia']\n",
      "['bispecific single domain antibody boosts autologous v gamma 9v delta', 't cell responses', 'chronic lymphocytic leukemia']\n",
      "['new article', 'monoclonal gammopathy', 'renal significance', 'monoclonal gammopathy', 'neurological significance cll leusm hematology']\n",
      "['new article ustekinumab', 'chronic lymphocytic leukemia', 'psoriatic arthritis cll leusm hematology']\n",
      "['new article content validity', 'psychometric evaluation', 'functional assessment', 'chronic illness therapy fatigue scale', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'world data', 'eric cll database', 'illustrative example cll leusm hematology']\n",
      "['r gregory bociek md', 'minimal residual disease', 'chronic lymphocytic leukemia leusm']\n",
      "['important webinar', 'cll patients', 'leukemia research foundation', 'webinar partner', 'program conquerbloodcancers']\n",
      "['cllsm leusm']\n",
      "['q amp', 'renowned experts', 'common questions', 'current state', 'cll research', 'new treatment options covid19 vaccine updates amp', 'bloodcancer experts']\n",
      "['genomic microarrays', 'equivalent methods', 'genomic complexity risk stratification', 'chronic lymphocytic leukemia patients hvhebron hemat text complet']\n",
      "['vit d insufficiency amp prognosis', 'chronic lymphocytic leukemia cll nov', 'shanafelt drake', 'cllsm leusm supponc geriheme']\n",
      "['hun ju lee md discusses', 'mantle cell lymphoma', 'chronic lymphocytic leukemia leusm']\n",
      "['content validity', 'psychometric evaluation', 'functional assessment', 'chronic illness therapy fatigue scale', 'chronic lymphocytic leukemia']\n",
      "['content validity', 'psychometric evaluation', 'functional assessment', 'chronic illness therapy fatigue scale', 'chronic lymphocytic leukemia']\n",
      "['new article orelabrutinib', 'approval cll leusm hematology']\n",
      "['new article highlights', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article bruton tyrosine kinase inhibitors', 'frontline treatment', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['cll cll', 'patientreporter leukemia']\n",
      "['mapk pathway mediates resistance', 'pi3k inhibitors', 'chronic lymphocytic leukemia cll haematology thewiderwiserview']\n",
      "['cll team', 'treatment decisions register', 'leusm cllsm']\n",
      "['chronic lymphocytic leukemia cll', 'aggressive lymphoma richter syndrome', 'large b cell lymphoma', 'cll patient blood journal', 'disabilityinfo zusia']\n",
      "['cme ce curriculum', 'mcl pt care', 'dynamic hands', 'oncology clinicians', 'therapeutic strategies', 'challenging malignancies lymsm mclsm cllsm']\n",
      "['amp dr steven coutre md', 'switch medicines', 'lifestyle changes', 'life amp']\n",
      "['ash20 loxo', 'promising response', 'efficacy rates', 'poor prognosis chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['con y garciavidal', 'llc y covid', 'implicaci n del sistema inmune', 'las infecciones del paciente onco hematol gico llc cll infectiousdiseases hematorules']\n",
      "['pm mt', 'medical use applications', 'medical cannabis bill sb', 'conditions list', 'residency requirements ms cll']\n",
      "['virtual meet', 'professor series', 'chronic lymphocytic leukemia', 'dr steven courtre', 'stanford university school', 'medicine register']\n",
      "['yeahhhhh gebeld door het amc ik krijg', 'er wordt onderzocht', 'ik na', 'stoffen ga aanmaken zooooo blij covid', 'namelijk geen fijne combi']\n",
      "['cll chronic lymphocytic leukemia', 'days i', 't function', 'leukemia amp fatigue']\n",
      "['new article ibrutinib interferes', 'innate immunity', 'chronic lymphocytic leukemia patients', 'infection cll leusm hematology']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['new article t cell dysfunction', 'chronic lymphocytic leukemia', 'epigenetic perspective cll leusm hematology']\n",
      "['new article clonal evolution', 'chronic lymphocytic leukemia', 'refractory cases', 'chemo immune therapy cll leusm hematology']\n",
      "['new article chromosome', 'genomic microarrays', 'equivalent methods', 'genomic complexity risk stratification', 'chronic lymphocytic leukemia patients cll leusm hematology']\n",
      "['t cell dysfunction', 'chronic lymphocytic leukemia', 'epigenetic perspective lymphoma lymsm']\n",
      "['new article t cell dysfunction', 'chronic lymphocytic leukemia', 'epigenetic perspective mmsm multiplemyeloma hematology']\n",
      "['jacqueline claudia barrientos md ms', 'frontline setting', 'chronic lymphocytic leukemia', 'research efforts', 'interest leusm']\n",
      "['zanubrutinib bgb', 'generation selective covalent inhibitor', 'bruton s tyrosine kinase', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['allin cll thatnewnew weloveourcustomers']\n",
      "['new article', 'hotspot mutation', 'transcription factor ikzf3', 'b cell neoplasia', 'transcriptional dysregulation cll leusm hematology']\n",
      "['rogers md james discusses', 'phase 1b study', 'chronic lymphocytic leukemia', 'research leusm']\n",
      "['zanubrutinib bgb', 'generation selective covalent inhibitor', 'bruton s tyrosine kinase', 'chronic lymphocytic leukemia']\n",
      "['treatment paradigm', 'chronic lymphocytic leukemia', 'continuous treatment', 'btk inhibitors']\n",
      "['early venetoclax treatment']\n",
      "['prayer warriors', 'chronic lymphocytic leukemia', 'proper treatment']\n",
      "[]\n",
      "['esther schorr', 'patient power march', 'matt davids', 'susan obrien cll']\n",
      "['new article zanubrutinib bgb', 'generation selective covalent inhibitor', 'bruton s tyrosine kinase', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['zanubrutinib bgb', 'generation selective covalent inhibitor', 'bruton s tyrosine kinase', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['cancerpatients cll patient amp advocate carol preston shares']\n",
      "['new opportunity role cll']\n",
      "['b cells rituximab', 'non hodgkin lymphoma rheumatoid arthritis chronic lymphocytic leukemia immune thrombocytopenic purpura pemphigus vulgaris']\n",
      "['murali i', 'brown jr blood activation', 'mapk pathway mediates resistance', 'pi3k inhibitors', 'chronic lymphocytic leukemia cll']\n",
      "['dr jennifer', 'mapk erk activation plays', 'key role', 'pi3k i', 'chronic lymphocytic leukemia cll']\n",
      "['year life', 'masks covid19 vaccines amp', 'cll expert dr nicole lamanna answers questions']\n",
      "['william wierda md phd', 'md anderson cancer center discusses results', 'captivate trial', 'chronic lymphocytic leukemia cll', 'leukemia amp lymphoma society']\n",
      "['brilliant work', 'alan ramsey', 'tumour activity']\n",
      "['alexander egle shows', 'interesting data', 'bcl2 correlation', 'cll loss', 'del 11q associates']\n",
      "['new clinical trial lymph node microenvironment modifications', 'regimens cll leusm hematology']\n",
      "['cll proliferation cell cycle arresnt', 'promising new target', 'cll therapy congratulation', 'allison michie', 'team form', 'scientific work']\n",
      "['uk cll forum', 'annual scientific day i aki martin subero', 'exciting science']\n",
      "['help whilst', 'cll download', 'small things', 'big difference booklet', 'cll community']\n",
      "['great event cll']\n",
      "['centret f r livsl ngt l rande ser ett kande intresse f r samarbete i norden cll']\n",
      "['overall response rate orr', 'previous safety profile', 'refractory high risk chronic lymphocytic leukemia leusm']\n",
      "['shares treatment considerations', 'chronic lymphocytic leukemia leusm']\n",
      "['active role', 'cll treatment decisions register', 'leusm cllsm register']\n",
      "['car t cell therapy lisocabtagene maraleucel liso cel', 'mantle cell lymphoma', 'refractory chronic lymphocytic leukemia data cannabis marijuana']\n",
      "['great session', 'early language', 'expert speakers languagedevelopment phonicsprep neli wordaware eyfs cll']\n",
      "['cll patients', 'btk inhibitor treatment considerations', 'advancedpractitioners webinar', 'march 11th', 'ap s role', 'btk inhibitor therapy']\n",
      "['active ingredient', 'medicine gleevec', 'chronic myelogenous leukemia', 'acute lymphocytic leukemia dermatofibrosarcoma protuberans gastrointestinal stromal tumors gist imatinib', 'bcr abl tyrosine kinase']\n",
      "['fish ighv', '17p deletion', 'cll care danielle roberts', 'leusm cllsm']\n",
      "['negative effects', 'solid logistics plan check']\n",
      "['chronic lymphocytic leukemia', 'common type', 'blood cancer']\n",
      "['chronic lymphocytic leukemia', 'common type', 'blood cancer']\n",
      "['chronic lymphocytic leukemia', 'common type', 'blood cancer']\n",
      "['chronic lymphocytic leukemia', 'common type', 'blood cancer']\n",
      "['cool paper', 'cathy wu s group', 'ikzf3 hotspot mutation', 'cll cll bloodcancer']\n",
      "['available hemonc cme cllsm']\n",
      "['cell dr catherine wu', 'chronic lymphocytic leukemia', 'b cell', 'conditional knockin mouse model']\n",
      "['new researchers', 'chronic lymphocytic leukemia cll', 'progressive forms', 'bloodcancer leusm']\n",
      "['new cll drug cll leusm lymsm']\n",
      "['00pm gmt prof hillmen', 'flair trial amp', 'new static trial', 'patient s cll experience', 'email webinar org uk bloodcancer']\n",
      "['chronic lymphocytic leukemia']\n",
      "['hematologic malignancies', 'blood bone marrow', 'lymph nodes', 'various types', 'acute lymphocytic chronic lymphocytic', 'acute myeloid chronic myeloid myeloma', 'lymphoma hodgkin s', 'non hodgkin s']\n",
      "['mapk pathway mediates resistance', 'pi3k inhibitors', 'chronic lymphocytic leukemia cll']\n",
      "['recent joint paper', 'uniteglioblastoma consortium', 'major aryl hydrocarbon receptor ahr', 'cll tumor']\n",
      "['new article activation', 'mapk pathway mediates resistance', 'pi3k inhibitors', 'chronic lymphocytic leukemia cll cll leusm hematology']\n",
      "['international interest', 'cll tumor control', 'autophagy induction nct04626843']\n",
      "['new article', 'phase ib', 'open label dose escalation trial', 'cd37 monoclonal antibody bi', 'refractory chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article development', 'venetoclax nanocrystals', 'oral bioavailability enhancement cll leusm hematology']\n",
      "['treatment paradigm', 'chronic lymphocytic leukemia', 'continuous treatment', 'btk inhibitors', 'obinutuzumab leusm']\n",
      "['i m', 'advocate stories', 'way mark', 'family healthevoiceslive cllwomenstrong cll']\n",
      "['new article', 'circular rnas', 'acute myeloid leukemia cll leusm hematology']\n",
      "['paper xueyan cui', 'lab shows', 'tfpi enhances cxcl12', 'transendothelial migration', 'chronic lymphocytic leukemia cells', 'cxcl12 receptor cxcr7', 'organ infiltration']\n",
      "['serious adverse reactions', 'covid19 mrna vaccines prostate cancer breast cancer', 'multiple myeloma non hodgkins lymphoma chronic lymphocytic leukemia mantle cell lymphoma hairy cell leukemia bladder cancer colorectal cancer kidney cancer']\n",
      "['john hayslip md executive', 'medical director', 'abbvie pharmaceuticals discusses', 'murano study', 'leukemia amp lymphoma society']\n",
      "['new article', 'chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['new article vs38', 'flow cytometry', 'small b cell lymphoma', 'lymphoplasmacytic lymphoma waldenstr m macroglobulinemia cll leusm hematology']\n",
      "['interesting case', 'yo male', 'month history', 'tender perilimbal nodule', 'nodular scleritis', 'small b cell lymphoma', 'cd5 consistent', 'chronic lymphocytic leukemia']\n",
      "['new clinical trial', 'vivo metabolic', 'cll chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'lef1 protein expression', 'differential diagnosis', 'lymphoblastic lymphoma', 'acute lymphoblastic leukemia cll leusm hematology']\n",
      "['new article', 'bruton tyrosine kinase', 'non covalent inhibitors', 'b cell malignancies cll leusm hematology']\n",
      "['new article quantification', 'hematological tyrosine kinase inhibitors', 'whole blood', 'lc ms ms method cll leusm hematology']\n",
      "['new article pirtobrutinib', 'refractory b cell malignancies bruin', 'study cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'psoriatic arthritis']\n",
      "['zeldzame non hodgkinlymfomen', 'aandacht voor', 's te herbekijken', 'onderwerp webinar zeldzame non hodgkinlymfomen', 'chronische lymfatische leukemie']\n",
      "['laser tspl', 'scalable fabrication', '1d amp', 'biomedical applications']\n",
      "['question stem', 'old man', 'diffuse lymphadenopathy boards', 'chronic lymphocytic leukemia', 'mc leukemia']\n",
      "['new mrna cancer drivers', 'chronic lymphocytic leukemia news science wakeupyoufuckingdopes']\n",
      "['car t', 'standard risk dz', 'outstanding safety profile', 'high risk dz', 'critical itisjustanstart']\n",
      "['educational saturday morning']\n",
      "['treatment algorithm', 'cll dr carlo moreno cll']\n",
      "['cll comparison', 'therapy side', 'dr carlo moreno cll ashc21']\n",
      "['green trial', 'obinutuzumab monotherapy', 'refractory chronic lymphocytic leukemia']\n",
      "['treatment options', 'cll dr carlo moreno ssbd ashc21 cll']\n",
      "['new article rgds', 'hydroxyethyl methacrylate', 'vitro leukemia model cll leusm hematology']\n",
      "['new article car t therapy', 'cll leusm hematology']\n",
      "['new article non', 'dark side matter', 'cll universe cll leusm hematology']\n",
      "['new article aberrant expression', 'tlr2 tlr7 tlr9', 'chronic lymphocytic leukemia patients cll leusm hematology']\n",
      "['new article', 'acute myeloid leukemia cll leusm hematology']\n",
      "['new article activation', 'chronic lymphocytic leukemia cells contributes', 'apoptosis resistance', 'jak src stat3 mcl', 'pathway cll leusm hematology']\n",
      "['new article apoptotic blocks', 'primary non hodgkin b cell lymphomas', 'cll leusm hematology']\n",
      "['monica d mead md', 'line setting', 'chronic lymphocytic leukemia leusm']\n",
      "[]\n",
      "['ibrutinib venetoclax rationale']\n",
      "['line therapy']\n",
      "['line trials']\n",
      "['cll therapy evolution']\n",
      "['cll leusm']\n",
      "['research paper stat3 induces', 'chronic lymphocytic leukemia cells']\n",
      "['prof daan dierickx', 'zeer zeldzame nonhodgkin lymfomen raredisease amp wildgroei nonhodgkin amp cll', 'speciale voor jonge patienten']\n",
      "['amp wildgroei organiseren vandaag een webinar nonhodgkin amp cll', 'speciale voor jonge patienten', 'kijken alvast uit naar']\n",
      "['abstracts closes deadline', 'cet abstracts', 'info 16icml lymphoma lymsm cll myeloma']\n",
      "['tube multiplex method', 'bruton tyrosine kinase btk gene', 'chronic lymphocytic leukemia patients', 'ibrutinib lymphoma lymsm']\n",
      "['hoy felicitamos', 'nuestra higienista raquel que cumple', 'con nosotros por muchos', 'os m s', 'el equipo cll lacasalitner cienciaentusonrisa ortodoncia valdemoro']\n",
      "['severe disease', 'high risk patients', 'available everywhere']\n",
      "['natural prevention', 'chronic lymphocytic leukemia']\n",
      "['memorial sloan', 'dr alvaro alencar', 'cll team leusm lymsm']\n",
      "['overall response rate']\n",
      "['important data', 'rr cll congrats', 'team thanks', 'impressive new drug']\n",
      "['entire program', 'demand recordings', 'year access', 'e posters access', 'virtual exhibition area lymphoma lymsm cll myeloma']\n",
      "['new research paper', 'scf equipment dr andrea pepper', 'sussex cancer fund', 'bloodcancer leukaemia cll cancerresearch']\n",
      "['promising data', 'resistant cll', 'mcl congrats', 'loxo team']\n",
      "['long term survivorship tool', 'cll patients cllsm leusm']\n",
      "['b cell receptor pathway', 'chronic lymphocytic leukemia review']\n",
      "['digital advocacy', 'health equity', 'cll patients cllsm leusm']\n",
      "['memorial sloan', 'dr alvaro alencar', 'cll team leusm lymsm']\n",
      "['sawaf md', 'universit t zu k ln discusses', 'cll14 trial', 'term treatment', 'chronic lymphocytic leukemia patients', 'standard treatment']\n",
      "['bone marrow', 'cll diagnosis', 'treatment leusm']\n",
      "['important study amp paper', 'outstanding efficacy amp safety', 'r r cll amp mcl incl', 'covalent btki']\n",
      "['cll research ublituximab', 'ibrutinib vs ibrutinib', 'chronic lymphocytic leukemia cll']\n",
      "['tissue factor pathway inhibitor upregulates cxcr7 expression', 'enhances cxcl12', 'chronic lymphocytic leukemia', 'chronic lymphocytic leukemia cll cells', 'lymphoid organs correlates', 'disease severity']\n",
      "['new article therapeutic', 'carbon pathway perspectives pitfalls', 'potential cll leusm hematology']\n",
      "['new article tissue factor pathway inhibitor upregulates cxcr7 expression', 'enhances cxcl12', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'tube multiplex method', 'bruton tyrosine kinase btk gene', 'chronic lymphocytic leukemia patients', 'ibrutinib cll leusm hematology']\n",
      "['il cll e', 'fondazione hanno sottoscritto una convenzione', 'con l obiettivo di realizzare il progetto residenza', 'traduttori un soggiorno mensile presso il vittoriale', 'tre traduttori di lingua madre tedesca info e bando']\n",
      "['others pirtobrutinib', 'refractory b cell malignancies bruin', 'study cll leusm lymsm']\n",
      "['tube multiplex method', 'bruton tyrosine kinase btk gene', 'chronic lymphocytic leukemia patients', 'ibrutinib lymphoma lymsm']\n",
      "['r gregory bociek md', 'reserve allogeneic stem cell transplant', 'certain patients', 'chronic lymphocytic leukemia leusm']\n",
      "['renowned expert', 'recent advances', 'chroniclymphocyticleukemia diffuse', 'large b cell lymphoma amp follicularlymphoma', 'interview article oncology amp hematology review']\n",
      "['multiple r r b cell malignancies cll mcl sll', 'covalent btk inhibitors phase', 'bruin trial lymsm']\n",
      "['key data', 'efficacy amp safety profile', 'r r cll mcl lymsm']\n",
      "['i ve', 'fantastic trial', 'pandemic cll mcl loxo305']\n",
      "['big news day', 'mcl patients', 'fantastic results', 'international study congrats', 'others pirtobrutinib', 'refractory b cell malignancies bruin']\n",
      "['chronic lymphocytic leukemia']\n",
      "['substantial amount', 'blood cancer', 'chronic lymphocytic leukemia cll', 'exact inactivation', 'tumor suppressor genes', 'mrna level']\n",
      "['encouraging data', 'covalent btki resistance catchy name', 'colleagues lymsm cll']\n",
      "['lymphoma pts']\n",
      "['new article validation', 'alternative international prognostic score e aips e analysis', 'binet stage', 'chronic lymphocytic patients', 'o cll1 gisl protocol cll leusm hematology']\n",
      "['new article subcutaneous immunoglobulins replacement therapy', 'secondary antibody deficiencies', 'real life evidence', 'primary antibody deficiencies cll leusm hematology']\n",
      "['new article tumor lysis syndrome risk', 'outpatient versus inpatient administration', 'acute myeloid leukemia cll leusm hematology']\n",
      "['new article eukaryotic protein us19', 'human diseases cll leusm hematology']\n",
      "['b cell malignancy', 'daily dose', 'mg loxo', 'covalent btki therapy', 'btk c481s mutation']\n",
      "['novel combination regimens', 'refractory chronic lymphocytic leukemia']\n",
      "['medical use cannabis', 'medical use applications', 'pm mt', 'ms cll']\n",
      "['lrf sabmember christopher flowers md ms', 'cll patients', 'btk inhibitors', 'covid19 vaccines click']\n",
      "['lurie cancer center oncologist dr shuo ma', 'nurse practitioner jennifer boyer', 'virtual town hall meeting', 'chronic lymphocytic leukemia patients', 'family members register']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['blood eosinophil', 'cll leusm jnccn360']\n",
      "['measurable residual disease']\n",
      "['trna leuaag', 'trna leutag', 'poor prognosis', 'b cell chronic lymphocytic leukemia', 'classical prognostic factors']\n",
      "['clinicalcaseseries webinar', 'btk inhibitor therapy', 'ap role']\n",
      "['new article', 'trna leuaag', 'trna leutag', 'poor prognosis', 'b cell chronic lymphocytic leukemia', 'classical prognostic factors cll leusm hematology']\n",
      "['new article quercetin', 'resistant b', 'expression cll leusm hematology']\n",
      "['new article risk', 'b cell malignancies', 'systematic review', 'meta analysis', 'trials cll leusm hematology']\n",
      "['new article ocular toxoplasmosis', 'distinction cll leusm hematology']\n",
      "['unmet needs', 'chronic lymphocytic leukemia cll', 'national alliance', 'nac amp stay']\n",
      "['new clinical trial ipilimumab ibrutinib', 'chronic lymphocytic leukemia', 'richter transformation cll leusm hematology']\n",
      "['jacqueline claudia barrientos md ms', 'frontline setting', 'chronic lymphocytic leukemia', 'research efforts', 'interest leusm']\n",
      "['treatment na ve chronic lymphocytic leukemia', 'study lymphoma lymsm']\n",
      "['treatment naive chronic lymphocytic leukemia']\n",
      "['encouraging clinical activity', 'acceptable safety profile', 'chronic lymphocytic leukemia', 'ibrutinib therapy leusm']\n",
      "['maintien d', 'agence emploi', 'centre ville', 'toulouse gr ve ce jour l appel du snu cgt fo cll snap sud oc lemerle emploi annick']\n",
      "['week rsvp', 'friday march 5th']\n",
      "['cll clinical nurse specialist advisory panel', 'leukaemia care nurse education initiatives', 'empower haematology nurses', 'specific knowledge']\n",
      "['free patient webinar', 'chronic lymphocytic leukemia cll']\n",
      "['grand rounds presentations i', 'pgr podcast shout', 'amazing mentors mccullough', 'cll oncopharm']\n",
      "['march hemasphere issue', 'ngs myeloidmaligancies dlbcl genetherapy covid19 vwf cll scd cart']\n",
      "['cll reveals', 'functional defects', 'bacterial infections cll']\n",
      "['free chronic lymphocytic leukemia', 'patients amp families', 'own advocate', 'treatment decisions amp supportive care covid19 risks amp safety', 'vaccines register']\n",
      "['cll patient sandy peterson shares', 'care cllsm leusm']\n",
      "['active role', 'cll treatment decisions webinar', '10am pt', 'cll expert', 'leusm cllsm']\n",
      "['new mrna cancer drivers', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll patients', 'patients hematology experts', 'rocky mountain cancer centers address', 'questions amp']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['sister charities', 'cll leukaemia']\n",
      "['treatment na ve chronic lymphocytic leukemia']\n",
      "['new article blood cancer driver musashi', 'therapeutic target', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'novel models', 'richter transformation diffuse', 'large b cell lymphoma cll leusm hematology']\n",
      "['new article risk', 'treatment naive chronic lymphocytic leukemia', 'study cll leusm hematology']\n",
      "['mikhaila rice pharmd bcps', 'therapies advancements', 'chronic lymphocytic leukemia pharmacology ce', 'pharmacists physicians physician assistants', 'nurse practitioners twitterx']\n",
      "['treatment na ve chronic lymphocytic leukemia', 'study lymphoma lymsm']\n",
      "['recent interview', 'dr amjad hayat', 'university hospital galway', 'shares insightful information', 'cll covid19 vaccine', 'clinicaltrials thanks', 'shane coleman']\n",
      "['genomic tools', 'precision medicine', 'chronic lymphocytic leukemia eric', 'adrian wiestner vol', 'illustration science phd sciencecommunication publication']\n",
      "[]\n",
      "['apps sklz amrs dkng tsla zm plug sq roku cmbm crwd u mgni vips fcx cll']\n",
      "['oncologist dr shuo ma', 'nurse practitioner jennifer boyer', 's virtual town hall meeting', 'chronic lymphocytic leukemia patients', 'family members register']\n",
      "['new article aid overexpression', 'aggressive murine cll', 'non ig mutations', 'mirror human neoplasms cll leusm hematology']\n",
      "['new article pre', 'treatment emergent autoimmune cytopenias', 'drugs cll leusm hematology']\n",
      "['new article association', 'case control study cll leusm hematology']\n",
      "['shares treatment considerations', 'chronic lymphocytic leukemia leusm']\n",
      "['new article proteomic', 'cll reveals', 'functional defects', 'bacterial infections cll leusm hematology']\n",
      "['novel agents', 'allogeneic stem cell transplant o']\n",
      "['montana cannabis legalization amp', 'webinar don t', 'instant access', 'essential information', 'mt applications', 'cll cannabis']\n",
      "['physical fitness regulates', 'vitro tumor cell growth', 'treatment naive chronic lymphocytic leukemia cll medrxiv']\n",
      "['car t cell therapy lisocabtagene maraleucel liso cel', 'mantle cell lymphoma', 'refractory chronic lymphocytic leukemia data cannabis marijuana']\n",
      "['cd94 nkg2c nk cells', 'chronic lymphocytic leukemia', 'monoclonal b cell lymphocytosis', 'human cytomegalovirus seronegativity', 'nkg2c deletions hvhebron hemat']\n",
      "['cll patient panel', 'patient information input']\n",
      "['prof hillmen', 'march registrations', 'cll haematology leukaemia bloodcancer bloodcancerawareness charitytuesday']\n",
      "['chronic lymphocytic leukemia cll patients', 'secondary cancers cll experts address', 'important topic', 'secondary cancers', 'hand advice', 'bloodcancers leusm patientpower']\n",
      "['new article impact', 'treatment institution type', 'chronic lymphocytic leukemia', 'british columbia canada cll leusm hematology']\n",
      "[]\n",
      "['sawaf md', 'universit t zu k ln', 'chronic lymphocytic leukemia cll', 'leukemia amp lymphoma society']\n",
      "['available venetoclax10mg venetoclax50mg', 'india t', 'chronic lymphocytic leukemia cll', 'acute myeloid leukemia aml', 'small lymphocytic lymphoma sll']\n",
      "['chronic lymph leukemia']\n",
      "['high risk variations fun times', 'cll progression amp genetics']\n",
      "['important study', 'cll patients']\n",
      "['chimeric antigen receptor t cell treatment', 'chronic lymphocytic leukemia leukemia']\n",
      "['cll experts', 'rocky mountain cancer centers don t', 'key takeaways', 'secondary cancers', 'clinical trials', 'leusm chroniclymphocyticleukemia']\n",
      "['cll patients', 'btk inhibitor treatment considerations', 'advancedpractitioners webinar', 'march 11th', 'ap s role', 'btk inhibitor therapy']\n",
      "['new article', 'genomic tools', 'precision medicine', 'chronic lymphocytic leukemia eric', 'way cll leusm hematology']\n",
      "['new article venetoclax', 'therapeutic option', 'chronic lymphocytic leukemia', 'cll leusm hematology']\n",
      "['chronic lymphocytic leukemia cll', 'common form', 'u s adults']\n",
      "['chronic lymphocytic leukemia cll patients', 'clinical trials experts', 'rocky mountain cancer centers', 'clinicaltrials amp', 'blood cancer patients leusm']\n",
      "['new article', 'igg aggregation', 'chronic activation', 'complement system', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'patients knowledge', 'chronic lymphocytic leukemia validation', 'eric cll knowledge questionnaire', 'greece cll leusm hematology']\n",
      "['new clinical trial effect', 'digital health', 'self efficacy', 'acute myeloid leukemia', 'chronic lymphocytic leukemia aml leusm hematology']\n",
      "['new clinical trial effect', 'digital health', 'self efficacy', 'acute myeloid leukemia', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['committee lymsm']\n",
      "['early venetoclax treatment', 'patients w']\n",
      "['new article', 'kr nikus lymphoid leukaemia mai kezel s nek interdiszciplin ris k rd sei cll leusm hematology']\n",
      "['idelalisib rituximab combination']\n",
      "['jacqueline claudia barrientos md ms', 'frontline setting', 'chronic lymphocytic leukemia', 'research efforts', 'interest leusm']\n",
      "['murano trial duvelisib', 'r r cll sll', 'richter s syndrome w', 'ash20 hematology hemonc leukemia leusm cllsm ctsm trialupdate']\n",
      "['long term ibrutinib treatment', 'immune cells', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['cancer cll', 'brad adams', 'decade amp', 'others navigate', 'disease patientstories leusm patientpower']\n",
      "['great work', 'collaborator damian kovalovsky', 'car t cells', 'chronic lymphocytic leukemia cll siglec']\n",
      "['damian kovalovsky', 'chronic lymphocytic leukemia cll', 'novel car t cell treatment']\n",
      "['pourquoi les relations', 'nos jours ne tiens', 'longtemps cll']\n",
      "['idelalisib rituximab combination', 'chronic lymphocytic leukemia']\n",
      "['idelalisib rituximab combination']\n",
      "['pm eastern time', 'special covid19', 'hematologic malignancies session leusm lymphoma mds cll aml']\n",
      "['regulates gene expression', 'protein synthesis', 'chronic lymphocytic leukemia thewiderwiserview']\n",
      "[]\n",
      "['critical study gcllsg', 'clinical trial']\n",
      "['new article', 'case nephrotic syndrome', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['ali abutalib md', 'jennifer r', 'brown md phd', 'novel approaches', 'chronic lymphocytic leukemia leusm hematology abutalibmd']\n",
      "['cll therapies', 'new molecules', 'winter hematology conference', 'great crossfire section', 'drs goy', 'brown chanan khan']\n",
      "['great day', 'gcllsg team', 'hard work', 'important trial']\n",
      "['cll patients']\n",
      "['good news', 'cll patients cll17', 'european study ireland', 'trial locations']\n",
      "['iowa mayo clinic lymphoma spore conducts innovative interactive translational research', 'lymphoma chronic lymphocytic leukemia', 'small lymphocytic lymphoma lymsm']\n",
      "['j aime', 'pens e je d teste', 'l humiliation mon ennemi c est', 'pauvret ma richesse c est ma cll']\n",
      "['great lectures', 'cll cll', 'own cmo dr koffman']\n",
      "['brown cochair cortes winterheme']\n",
      "['bad news', 'chronic lymphocytic leukemia', 'good news', 'hematology oncologist']\n",
      "['jaarlijks krijgen', 'diagnose van cll sll n', 'v zeldzame ziektendag wil evy haar lotgenoten een hart onder', 'riem steken notaunicorn getuigenis chronische lymfatische leukemie cll']\n",
      "['pense n gativement', 'trouve des probl mes partout cll']\n",
      "['rentr e', 'soir sain', 'sauf est', 'gr ce que dieux t accorde alors dit lui merci cll']\n",
      "['beaut mais', 'comportement cll']\n",
      "['new article', 'tp53 alterations', 'del 11q chronic lymphocytic leukemia cll leusm hematology']\n",
      "['tp53 alterations', 'del 11q chronic lymphocytic leukemia']\n",
      "['measurable residual disease', 'filo trial cll']\n",
      "['y o man w chronic lymphocytic leukemia', 'day history', 'melena chest discomfort amp lightheadedness', 'manage stroke risk w', 'history vote cardioonc']\n",
      "['novel targets', 'cancers cll synthetic biology diagnostics vaccines celltherapy cellulartherapeutics celltherapyrx crisprcas9 crispr immunotherapy immunooncology io cellulartherapy']\n",
      "['iwcll2021 abstracts meeting registration', 'oral poster presentation visit', 'full list', 'submission guidelines deadline', 'cc medicalconference cll']\n",
      "['leukaemia mpn cll hcl mf', 'pv leukemia']\n",
      "['chimeric antigen receptor t cell treatment', 'chronic lymphocytic leukemia']\n",
      "['frontiers phosphoinositide', 'tumor microenvironment', 'chronic lymphocytic leukemia', 'pi3k inhibitors immunology']\n",
      "['new article siglec', 'chimeric antigen receptor t cell treatment', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['ash20 click', 'cll lymsm']\n",
      "['great summary', 'cll cancer treatment']\n",
      "['regulates gene expression', 'protein synthesis', 'chronic lymphocytic leukemia haematology thewiderwiserview']\n",
      "['cll ireland', 'good friend shane coleman', 'dr gerard crotty consultant haematologist', 'behalf dr crotty', 'cll vaccine covid19 clinicaltrials']\n",
      "['immune dysfunction', 'chronic lymphocytic leukemia', 'covid19 pandemic acta haematol abstract']\n",
      "['cd94 nkg2c nk cells', 'chronic lymphocytic leukemia', 'monoclonal b cell lymphocytosis', 'human cytomegalovirus seronegativity', 'nkg2c deletions']\n",
      "['free books', 'great care', 'free books', 'medifocus guidebook', 'chronic lymphocytic leukemia', 'medifocus com inc']\n",
      "['new article immune dysfunction', 'chronic lymphocytic leukemia', 'pandemic cll leusm hematology']\n",
      "['new article ublituximab', 'ibrutinib versus ibrutinib', 'refractory high risk chronic lymphocytic leukaemia', 'open label', 'trial cll leusm hematology']\n",
      "['new article immune dysfunction', 'chronic lymphocytic leukemia', 'pandemic coronavirus covid19 2019ncov']\n",
      "['usa ny', 'new york', 'practice provider nurse practitioner', 'physician assistant chronic lymphocytic leukemia cll clinical research ability jobs']\n",
      "['frontline setting', 'dr william wierda cll endcancer']\n",
      "['host immune cells', 'chronic lymphocytic leukemia']\n",
      "['tct2021 update', 'transplant outcomes', 'australasia leusm jnccn360']\n",
      "['jacqueline claudia barrientos md ms', 'frontline setting', 'chronic lymphocytic leukemia', 'research efforts', 'interest leusm']\n",
      "['comprehensive review', 'cll phosphoinositide', 'tumor microenvironment', 'chronic lymphocytic leukemia', 'pi3k inhibitors']\n",
      "['tct2021 case', 'phase cll', 'transplantation leusm jnccn360']\n",
      "['y o man w chronic lymphocytic leukemia', 'hematology clinic', 'cardiology w', 'new onset palpitations amp dyspnea', 'rate control', 'amp vote cardioonc']\n",
      "['new article lymphoreticular malignancies', 'serous effusions cytomorphologic flow cytometric', 'immunocytochemical analysis cll leusm hematology']\n",
      "['s chronic lymphocytic leukemia program florida cll patients don t', 'exciting opportunity', 'oncologists hematologists']\n",
      "['personal news husband 54yo', 'progressive multifocal leukoencephalopathy', 'chronic lymphocytic leukemia miraculous cll pml leusm lymphoma']\n",
      "['cart t cell therapy', 'recurrent cll treatment', 'hodgkin lymphoma', 'gduhem2021 education lymphoma cll hematologicmalignancies']\n",
      "['anthony mato md msce discusses', 'observational registry study', 'real world prognostic biomarker', 'treatment patterns', 'chronic lymphocytic leukemia leusm']\n",
      "['new article prolymphocytic', 'richter s transformation', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article preclinical evaluation', 'hsp90 inhibitor snx', 'resistant cll cll leusm hematology']\n",
      "['new article adenoid cystic carcinoma', 'chronic lymphocytic leukaemia synchronous presentations', 'lung cll leusm hematology']\n",
      "['new clinical trial', 'pilot study', 'intermittent ibrutinib', 'phase chronic lymphocytic leukemia cll cll leusm hematology']\n",
      "['12p est advances', 'available hemonc cme cllsm']\n",
      "['tgtx tg therapeutics', 'big month', 'fda approval', 'ukoniq umbralisib', 'promising final results', 'ublituximab ibrutinib', 'rr chronic lymphocytic leukemia']\n",
      "['late 1960s', 'sicker post tx', 'chronic lymphocytic leukemia cll']\n",
      "['publication population pk pd', 'lymphocyte dynamics', 'chronic lymphocytic leukemia patients', 'ibrutinib treatment clinpharm']\n",
      "['study dr rossana maffei', 'univ scientists', 'irf4 levels', 'chronic lymphocytic leukemia cells', 'irf4 vector']\n",
      "['irf4 modulates', 'bcr activation', 'chronic lymphocytic leukemia']\n",
      "['ap s role', 'btk inhibitor therapy']\n",
      "['y o woman w chronic lymphocytic leukemia', 'asymptomatic afib', 'routine ekg', 'clinical trial participation', 'anticoagulation vote cardioonc']\n",
      "['novel mitochondrial', 'internal trna', 'rna fragment possesses clinical utility', 'molecular prognostic biomarker', 'chronic lymphocytic leukemia']\n",
      "['new article outcomes', 'cll patients', 'notch1 regulatory pathway mutations cll leusm hematology']\n",
      "['epigenetic trajectories', 'malignant transition', 'chronic lymphocytic leukemia blood cancer discovery leusm cll']\n",
      "['rural settings', 'cll patient', 'cme webinar february 27th strategies', 'address barriers', 'care treatment adherence', 'cms measures']\n",
      "['doctor specialist', 'chronic lymphocytic leukemia']\n",
      "['overt myeloma', 'chronic lymphocytic leukemia', 'ibrutinib therapy']\n",
      "['5pm est', 'informative discussion', 'new treatment options', 'florida cancer specialists amp research institute amp']\n",
      "['sars cov', 'future infection cll cllreporter']\n",
      "['smudge cells', 'chronic lymphocytic leukemia pathophysiology laboratory considerations', 'clinical significance']\n",
      "['new article il', 'early stage chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article irf4 modulates', 'bcr activation', 'chronic lymphocytic leukemia', 'syk cll leusm hematology']\n",
      "['cll derivates', 'technologyoffer lifesciences pharma wemarketinnovation nrwhip']\n",
      "['covidvaccine priority list', 'additional groups', 'blood cancer', 'severe risk', 'severe covid19 disease glynn']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['cll community', 'divisive amongst', 'patient community', 'need vaccination', 'minimise risk', 'severe disease']\n",
      "['cd94 nkg2c nk cells', 'chronic lymphocytic leukemia', 'monoclonal b cell lymphocytosis', 'human cytomegalovirus seronegativity', 'nkg2c deletions', 'anna puiggros']\n",
      "['lymphoma australia ambassadors', 'australia lymphoma cll']\n",
      "['new article statins', 'potassium channels kv1', 'cancer cells cll leusm hematology']\n",
      "['mazyar shadman md shares treatment considerations', 'chronic lymphocytic leukemia leusm']\n",
      "['don t', 'sci member steven coutre', 'lifelong journey', 'treatment options', 'pm chroniclymphocyticleukemia']\n",
      "['immunoglobulin gene analysis', 'chronic lymphocytic leukemia']\n",
      "['somatic hypermutation status', 'chronic lymphocytic leukemia cll']\n",
      "['comparative analysis', 'gene mutations', 'chronic lymphocytic leukemia', 'eric multi center study']\n",
      "['new article zap', 'regulates gene expression', 'protein synthesis', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'low dose fludarabine', 'line treatment', 'elderly comorbid patients', 'chronic lymphocytic leukaemia', 'small lymphocytic lymphoma cll sll', 'long term results', 'cll leusm hematology']\n",
      "['new article', 'phase i dose escalation study', 'antibody drug conjugate', 'c type lectin', 'acute myeloid leukemia cll leusm hematology']\n",
      "['new article minimal residual disease', 'chronic lymphocytic leukemia highlights', 'cll leusm hematology']\n",
      "['informative amp', 'exciting evening', 'docs cll series', 'amp experts', 'florida cancer specialists amp research institute', 'fl residents', 'events amp', 'gift card']\n",
      "['new article eosinophilic folliculitis eosinophilic dermatosis', 'hematologic malignancy', 'acneiform follicular mucinosis', 'case reports', 'histopathology cll leusm hematology']\n",
      "['new article', 'cd94 nkg2c nk cells', 'chronic lymphocytic leukemia', 'monoclonal b cell lymphocytosis', 'human cytomegalovirus seronegativity', 'nkg2c deletions cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia', 'scleral nodule cll leusm hematology']\n",
      "['new article', 'low dose', 'duration lenalidomide maintenance versus observation', 'frontline chemo immunotherapy', 'cll cll leusm hematology']\n",
      "['new article erythrodermic psoriasis', 'b cell chronic lymphocytic leukemia cll leusm hematology']\n",
      "['chance register']\n",
      "['paper thanks', 'constructive review process']\n",
      "['esh john goldman', 'international research award', 'research project', 'tfr mrd', 'long term remission', 'cure deadline', 'applications april', 'cml cll aml', 'myeloma leukemia lymphoma eshjga']\n",
      "['r gregory bociek md', 'chronic lymphocytic leukemia leusm']\n",
      "['tgtx tg therapeutics announces publication', 'final results', 'genuine trial', 'refractory high risk chronic lymphocytic leukemia']\n",
      "['tgtx tg therapeutics announces publication', 'final results', 'genuine trial', 'refractory high risk chronic lymphocytic leukemia', 'lancet haematology biospace jobs']\n",
      "['tg therapeutics announces publication', 'final results', 'genuine trial', 'refractory high risk chronic lymphocytic leukemia', 'lancet haematology tg therapeutics inc tgtx']\n",
      "['tgtx tg therapeutics announces publication', 'final results', 'genuine trial', 'refractory high risk chronic lymphocytic leukemia']\n",
      "['tgtx tg therapeutics announces publication', 'final results', 'genuine trial', 'refractory high risk chronic lymphocytic leukemia']\n",
      "['tgtx tg therapeutics announces publication', 'final results', 'genuine trial', 'refractory high risk chronic lymphocytic leukemia', 'lancet haematology']\n",
      "['tg therapeutics announces publication', 'final results', 'genuine trial']\n",
      "['tgtx tg therapeutics announces publication', 'final results', 'genuine trial', 'refractory high risk chronic lymphocytic leukemia', 'lancet haematology']\n",
      "['new clinical trial safety', 'ct125a cells', 'refractory cd5 hematopoietic malignancies cll leusm hematology']\n",
      "['se discutir n las nuevas gu', 'cll para el diagn stico tratamiento y seguimiento paolo ghia lydia scarf barbara eichhorst moritz f rstenau hematology eha']\n",
      "['new article', 'low dose fludarabine', 'line treatment', 'elderly comorbid patients', 'chronic lymphocytic leukaemia', 'small lymphocytic lymphoma cll sll', 'long term results', 'cll leusm hematology']\n",
      "['new article eosinophilic folliculitis eosinophilic dermatosis', 'hematologic malignancy', 'acneiform follicular mucinosis', 'case reports', 'histopathology cll leusm hematology']\n",
      "['new article', 'cd94 nkg2c nk cells', 'chronic lymphocytic leukemia', 'monoclonal b cell lymphocytosis', 'human cytomegalovirus seronegativity', 'nkg2c deletions cll leusm hematology']\n",
      "['new article minimal residual disease', 'chronic lymphocytic leukemia highlights', 'cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia', 'scleral nodule cll leusm hematology']\n",
      "['new article', 'low dose', 'duration lenalidomide maintenance versus observation', 'frontline chemo immunotherapy', 'cll cll leusm hematology']\n",
      "['new article erythrodermic psoriasis', 'b cell chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article impact', 'long term ibrutinib treatment', 'immune cells', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['long term ibrutinib treatment', 'immune cells', 'chronic lymphocytic leukemia']\n",
      "['long term ibrutinib treatment', 'immune cells', 'chronic lymphocytic leukemia']\n",
      "['long term ibrutinib treatment', 'immune cells', 'chronic lymphocytic leukemia', 'solman ig blum lk burger ja kipps tj dean jp james df mongan']\n",
      "['new results', 'genuine trial show', 'ibrutinib improves overall response', 'safety profile', 'ibrutinib monotherapy', 'patients w r r high risk chronic lymphocytic leukaemia cll leusm']\n",
      "['long term ibrutinib treatment', 'immune cells', 'chronic lymphocytic leukemia']\n",
      "['long term ibrutinib treatment', 'immune cells', 'chronic lymphocytic leukemia']\n",
      "['dr william wierda shares', 'captivate clinical trial', 'patient subgroups', 'treatment response cll endcancer']\n",
      "['ohc s cancer expert dr james essell', 'healthcare professionals amp survivors', 'w blood cancer', 'zoom dr essell', 'lymphoma amp cll register']\n",
      "['anthony mato md msce discusses', 'observational registry study', 'real world prognostic biomarker', 'treatment patterns', 'chronic lymphocytic leukemia leusm']\n",
      "['king s researchers', 'new therapies', 'chronic lymphocytic leukemia foreverkings']\n",
      "['ehaguidelines workshop', 'eha endorsement', 'clinical practice guidelines', 'diagnosis treatment']\n",
      "['cll click', 'information lymsm']\n",
      "['available hemonc cme cllsm']\n",
      "['elevate rr elevate rr']\n",
      "['final charge']\n",
      "['excelente herramienta', 'international prognostic score', 'stage chronic lymphocytic leukemia']\n",
      "[]\n",
      "['car t cell therapy', 'high risk chronic lymphocytic leukemia leusm']\n",
      "['stable somatic mutations', 'transcription factors pax5', 'epigenetic regulator lrif1', 'atypical b cell chronic lymphocytic leukemia', 'q32 q21']\n",
      "['new clinical trial', 'human study', 'chronic lymphocytic leukaemia', 'mantle cell lymphoma cll leusm hematology']\n",
      "['new article identification', 'stable somatic mutations', 'transcription factors pax5', 'epigenetic regulator lrif1', 'atypical b cell chronic lymphocytic leukemia', 'cll leusm hematology']\n",
      "['1er art culo del nuevo m dulo', 'online cll ips', 'stage cll comentado por tycho baumann score basado', 'estado mutighv linfocitosis y adenopat', 'para predecir tiempo hasta tto', 'asintom ticos es sig art']\n",
      "['chronic lymphocytic leukemia market research report insights']\n",
      "['chronic lymphocytic leukemia market research report insights']\n",
      "['chronic lymphocytic leukemia market research report insights']\n",
      "['chronic lymphocytic leukemia market research report insights']\n",
      "['chronic lymphocytic leukemia market research report insights']\n",
      "['chronic lymphocytic leukemia market research report insights pharmaceuticalsbiotech professionalservices science uk']\n",
      "['huge honor', 'cll management']\n",
      "['chronic lymphocytic leukemia', 'purpuric rash']\n",
      "['i m', 'trip calgary banff cll jasper']\n",
      "['jacqueline claudia barrientos md ms', 'frontline setting', 'chronic lymphocytic leukemia', 'research efforts', 'interest leusm']\n",
      "['chronic lymphocytic leukemia cells', 'bone marrow stroma cells', 'drug resistance']\n",
      "['new article', 'diagnostic accuracy', 'matutes score', 'chronic lymphocytic leukemia', 'resources laboratories cll leusm hematology']\n",
      "['new article', 'flexible integration', 'variant characteristics', 'rare variant association studies', 'laplace approximation cll leusm hematology']\n",
      "['new article sunlight exposure', 'lymphoid malignancy', 'meta analysis', 'observational studies cll leusm hematology']\n",
      "['new article safety', 'refractory chronic lymphocytic leukaemia patients', 'final analysis', 'phase iiib green study cll leusm hematology']\n",
      "['new article preneoplastic alterations', 'cll dna methylome', 'disease progression', 'therapy cll leusm hematology']\n",
      "['new article therapeutic options', 'tp53 deficient chronic lymphocytic leukemia narrative review cll leusm hematology']\n",
      "['new article', 'chronic lymphocytic leukemia impact', 'individual comorbidities', 'treatment mortality', 'death cll leusm hematology']\n",
      "['new article ibrutinib', 'venetoclax target distinct subpopulations', 'cll cells implication', 'residual disease eradication cll leusm hematology']\n",
      "['new article syngeneic leukemia models', 'lentiviral transgenics cll leusm hematology']\n",
      "['new article upregulation', 'chronic lymphocytic leukemia cells', 'bone marrow stroma cells', 'drug resistance cll leusm hematology']\n",
      "[]\n",
      "['bispecific single domain antibody boosts autologous v 9v', 't cell responses', 'chronic lymphocytic leukemia']\n",
      "['potential utility', 'chronic lymphocytic leukemia leusm']\n",
      "['new treatment options', 'cll leukemia bloodcancerawareness']\n",
      "['chronic lymphocytic leukemia cll patients', 'common form', 'u s adults']\n",
      "['chronic lymphocytic leukemia cll patients', 'common form', 'u s adults']\n",
      "['heme malignancies virtual meeting', 'dr john allan', 'different agents', 'refractory chronic lymphocytic leukemia cll']\n",
      "['q amp']\n",
      "['william g wierda md phd discusses', 'captivate trial', 'chronic lymphocytic leukemia leusm']\n",
      "['early intervention', 'asymptomatic chronic lymphocytic leukemia', 'eli muchtar md neil e kay md', 'parikh md chroniclymphocyticleukemia cll']\n",
      "['nordic cll meeting', 'free registration', 'excellent speakers', 'richard rosenquist brandell', 'matthew davids ncllsg2021']\n",
      "['cll chronic lymphocytic leukemia patients', 'tp53 gene', 'poorer treatment outcomes', 'new trial', 'drug apr', 'leukemia lymphoma medicine science']\n",
      "['mr david ozor', 'chronic lymphocytic leukemia blood cancer amp needs', 'care amp chemotherapy pls click', 'noire doctor']\n",
      "['great debates amp updates', 'hematologic malignancies', 'exceptional education', 'multiple myeloma', 'chronic lymphocytic', 'myeloid leukemia', 'lymphoma gduhem2021']\n",
      "['new article', 'real world healthcare resource utilization', 'chronic lymphocytic leukemia differences', 'line ibrutinib', 'bendamustine rituximab']\n",
      "['social media channels', 'linkedin facebook lymphoma lymsm cll myeloma']\n",
      "[]\n",
      "['md mmsc discusses', 'year analysis', 'murano study', 'refractory chronic lymphocytic leukemia leusm']\n",
      "['patient power advocates', 'chronic lymphocytic leukemia patients', 'journeys pharmacyclics inc pharmacyclics', 'abbvie company']\n",
      "['chronic lymphocytic leukemia cll2 bio primary endpoint analysis', 'open label phase ii trial haematologica']\n",
      "['combinig venetoclax', 'cll gt gt gt ibrutinib', 'venetoclax target distinct subpopulations', 'cll cells implication', 'residual disease eradication']\n",
      "['don t', 's dr richard furman', 'chronic lymphocytic leukemia cll updates', 'free meeting', 'healthcare professionals cc cme lymsm leusm']\n",
      "['scca s dr mazyar shadman', 'treatment considerations', 'chronic lymphocytic leukemia', 'leusm cancertreatment cll']\n",
      "['navigate clltreatment decisions', 'cll patients']\n",
      "['long term strategy', 'cll patients', 'dr steven coutre', 'week leukemia patientpower leusm']\n",
      "['cll patients leusm']\n",
      "['cll program']\n",
      "[]\n",
      "['informative discussion feb', 'new treatment options', 'patient advocate', 'florida cancer specialists amp research institute']\n",
      "['simple observation', 'cll patients', 'package insert', 'package insert']\n",
      "['leukemia therapeutics market', 'leukemia therapeutics market categories', 'global market', 'type cll', 'cml aml treatment type chemotherapy amp']\n",
      "['chronic lymphocytic leukemia', 'ibrutinib development', 'factor prognostic model journal', 'clinical oncology']\n",
      "['factor score', 'ibrutinib treatment', 'chronic lymphocytic leukemia prognostic model', 'risk group definition journal', 'clinical oncology']\n",
      "['chronic lymphocytic leukemia impact', 'individual comorbidities', 'treatment mortality']\n",
      "['new article', 'asymptomatic chronic lymphocytic leukemia cll leusm hematology']\n",
      "['clinicaltrial venetoclax rituximab', 'tn patients', 'undetectable minimal residual disease umrd', 'treatment na ve patients', 'chronic lymphocytic leukemia cll']\n",
      "['venetoclax rituximab', 'tn patients', 'undetectable minimal residual disease umrd', 'treatment na ve patients', 'chronic lymphocytic leukemia cll status', 'condition summary chronic lymphocytic leukemia cl']\n",
      "['ophthopedia update chronic lymphocytic leukemia', 'scleral nodule ophthalmology ophthotwitter eyecare']\n",
      "['chimeric antigen receptor t cell production', 'chronic lymphocytic leukemia patients fan', 'international journal']\n",
      "['car t cell therapy lisocabtagene maraleucel liso cel', 'mantle cell lymphoma', 'refractory chronic lymphocytic leukemia data cannabis marijuana']\n",
      "['covid19 cancer cll james joins']\n",
      "['coronavirus vaccines', 'cancer covidvaccine cll cllreporter']\n",
      "['chronic lymphocytic leukemia']\n",
      "['shares treatment considerations', 'chronic lymphocytic leukemia leusm']\n",
      "['stephan stilgenbauer md', 'official paolo ghia md phd', 'brown md phd', 'frontline treatment options', 'chronic lymphocytic leukemia leusm']\n",
      "['previous events', 'online events', 'cll amp myeloma experts']\n",
      "['mein mann zur risikogruppe geh rend aufgrund von chronischlymphatischerleuk mie cll wartet noch mit mir zusammen ich asthmatikerin u seine ehefrau auf', 'impfung er kann nicht mal homeoffice machen']\n",
      "['cart cell generation', 'ibrutinib results', 'cell viability', 'cll patient', 'cart cells gt gt gt ibrutinib', 'chimeric antigen receptor t cell production', 'cll patients leusm']\n",
      "['friday feb', '30pm est', 'lls facebook', 'geoff grubbs', 'chronic lymphocytic leukemia journey', 'support groups', 'cll society', 'free resources', 'lls livingwithcll']\n",
      "['chronic lymphocytic leukemia', 'cold agglutination hemepath pathtwitter medtwitter']\n",
      "['imbruvica s cardiotoxicity claims', 'recent chronic lymphocytic leukemia study']\n",
      "['chronic lymphocytic leukemia', 'practical tasks', 'diagnosis bloodcancer cancer']\n",
      "['cll experts', 'new webinar', 'cll patients', 'switch meds', 'lifestyle changes']\n",
      "['sure resources', 'tamug cll']\n",
      "['30pm est', 'chronic lymphocytic leukemia cll patients', 'common form', 'u s adults']\n",
      "['whole landscape', 'small things', 'big difference booklet', 'emotional ups']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['invite applications', 'tumourimmunology unit', 'omics bioinformatics', 'b cells', 'general eha']\n",
      "['new clinical trial venetoclax rituximab', 'tn patients', 'undetectable minimal residual disease umrd', 'treatment na ve patients', 'chronic lymphocytic leukemia cll cll leusm hematology']\n",
      "['new clinical trial', 'access program', 'cerdulatinib cll leusm hematology']\n",
      "['chronic lymphocytic leukemia']\n",
      "['new clinical trial ds 1594b', 'azacitidine venetoclax', 'mini hcvd', 'acute myeloid leukemia', 'acute lymphoblastic leukemia cll leusm hematology']\n",
      "['30am pst', 'chronic lymphocytic leukemia cll patients', 'common form', 'u s adults']\n",
      "['re updates', 'cll head', 'friday registration', 'cme credits', 'ash20 chroniclymphocyticleukemia hematology']\n",
      "['car t cell therapy lisocabtagene maraleucel liso cel', 'mantle cell lymphoma', 'refractory chronic lymphocytic leukemia data cannabis marijuana']\n",
      "['new series', 'renowned cll experts cll patient advocate', 'florida cancer specialists', 'free dinner giftcard', 'florida residents', 'only sign']\n",
      "['sneak peak', 'professor jim allen', 'chronic lymphocytic leukemia cll thanks', 'hard work']\n",
      "['anthony mato md', 'memorial sloan', 'cancer center', 'chronic lymphocytic leukemia', 'discusses findings', 'informcll registry']\n",
      "['chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'line therapy']\n",
      "['sawaf md', 'universit t zu k ln', 'chronic lymphocytic leukemia cll', 'leukemia amp lymphoma society']\n",
      "['good news chemo drug', 's job hemoglobin', 'white cell', 'cll chroniclymphocyticleukemia']\n",
      "['hark hhd2021 virtual thursday', 'week opening 8am cet', 'prof j gribben president hematology registration', 'hematology covid19 cll aml', 'leusm bigdata']\n",
      "['inhibitor venetoclax abt', 'chronic lymphocytic leukemia', 'acute myeloid leukemia', 'hiv reservoir size', 'vitro latency model hivcure']\n",
      "['joint webinar', 'facebook page', 'support people', 'chronic lymphocytic leukaemia cll', 'diagnosis gt']\n",
      "['chronic lymphocytic leukemia']\n",
      "['safe 16icml', 'virtual event', 'significant data', 'virtual setting lymsm cll myeloma']\n",
      "['chronic lymphocytic leukemia bendamustinedose', 'bendamustine100mg kigali durban douala bangui nairobi mombasa embakasi lagos maputo nacala georgia idaho hawaii illinois uae']\n",
      "['new clinical trial clinical study', 'refractory chronic lymphocytic leukemia cll leusm hematology']\n",
      "['available hemonc cme cllsm']\n",
      "['joint webinar', 'support people', 'chronic lymphocytic leukaemia cll', 'diagnosis register', 'gt bloodcancerawareness']\n",
      "['sirp suppresses response', 'therapeutic antibodies', 'chronic lymphocytic leukemia patients']\n",
      "['double remission', 'chronic lymphocytic leukemia', 'secondary acute myeloid leukemia', 'venetoclax monotherapy', 'case report lymphoma lymsm']\n",
      "['tlr9 expression', 'chronic lymphocytic leukemia identifies', 'pro migratory subpopulation', 'novel therapeutic target idra mgnk adro xcur phio checkmatepharma cpg tlr9 sbph']\n",
      "['new article structure', 'pyrimidine cdk9 inhibitors', 'cancer agents cll leusm hematology']\n",
      "['new article assessment', 'factor score retrospective analysis', 'cll patients', 'campus cll study cll leusm hematology']\n",
      "['new article', 'unexpected hematologic malignancies', 'prostatectomy case report', 'literature review cll leusm hematology']\n",
      "['new article double remission', 'chronic lymphocytic leukemia', 'secondary acute myeloid leukemia', 'venetoclax monotherapy', 'case report cll leusm hematology']\n",
      "['tuesday hemonc cme nursetwitter']\n",
      "['chronic lymphocytic leukemia']\n",
      "['factor score retrospective analysis', 'cll patients', 'ibrutinib morabito american journal', 'hematology leusm']\n",
      "['spike protein', 'sars cov', 'endoplasmic reticulum stress impairs trf2', 'telomere fusion', 'mimic diseases', 'telomere fusion', 'chronic lymphocytic leukemia', 'cancer patients']\n",
      "['simay dolaner shares', 'research project', 'therapeutic targets', 'chronic lymphocytic leukemia', 'researchfellowship researchproject citizenscientist learnwithpine']\n",
      "['public healthcare fc chlorambucil rituximab', 'rare alentuzumab int access program', 'private healthcare ibrutinib acala venetoclax obinutuzumab bendamustine', 'different thecancergap cllsm']\n",
      "['joint webinar', 'support people', 'chronic lymphocytic leukaemia cll', 'diagnosis register', 'gt bloodcancerawareness']\n",
      "['car t', 'clinical trial', 'cll patients']\n",
      "['chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['chronic lymphocytic leukemia patients', 'novel agents', 'veterans health administration system lymphoma lymsm']\n",
      "['important study', 'intervention trial', 'high risk cll', 'right endpoint os']\n",
      "['reminder spotlightonhematology webinar', 'great opportunity', 'hematology experts', 'mpn mm mds aml cll', 'free webinar', 'moasc org']\n",
      "['clinical trial manuscript', 'syk inhibition', 'safe molecule', 'resistance cll', 'view haematologica']\n",
      "['cll ers register', 'q amp', 'cll specialists', 'cll leukemia']\n",
      "['february 23rd', 'q amp']\n",
      "['idelalisib rituximab combination']\n",
      "['new research paper', 'scf equipment dr andrea pepper', 'sussex cancer fund', 'bloodcancer leukaemia cll cancerresearch']\n",
      "['exciting audience', 'q amp', 'cll experts dr nicole lamanna md', 'cll research treatment amp']\n",
      "['genomic instability', 'clonal evolution', 'chronic lymphocytic leukemia clinical relevance cagenome cllsm leusm cll']\n",
      "['master thesis', 'crispr gene editing', 'cll cells', 'pezzella warmest congratulations laura tumourimmunology']\n",
      "['small things', 'big difference booklet', 'support people']\n",
      "['main ones', 'acute lymphocytic anemia', 'chronic lymphocytic leukemia cll', 'chronic myelogenous leukemia cml', 'common form', 'childhood leukemia']\n",
      "['new article', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article notch activation', 'dlbcl implications', 'b cell tumors cll leusm hematology']\n",
      "['new article risk', 'new malignancies', 'chemotherapy results', 'danish population', 'study cll leusm hematology']\n",
      "['new article outcomes', 'chronic lymphocytic leukemia patients', 'novel agents', 'veterans health administration system cll leusm hematology']\n",
      "['new article ibrutinib', 'acute kidney injury', 'interstitial nephritis cll leusm hematology']\n",
      "['new article cerebral invasive aspergillosis', 'chronic lymphocytic leukemia', 'bruton tyrosine kinase inhibitor cll leusm hematology']\n",
      "['incurable blood cancer', 'ireland needs', 'great work', 'ie needs']\n",
      "['car t', 'clinical trial', 'cll patients', 'patients need']\n",
      "['cerebral invasive aspergillosis', 'chronic lymphocytic leukemia', 'bruton tyrosine kinase inhibitor']\n",
      "['hematologic malignancies', 'blood bone marrow', 'lymph nodes', 'various types', 'acute lymphocytic chronic lymphocytic', 'acute myeloid chronic myeloid myeloma', 'lymphoma hodgkin s', 'non hodgkin s nhl']\n",
      "['cold damp houston night leusm cll clinicaltrials immunotherapy readinglist pubs']\n",
      "['cardiologist couldn t diagnose', 'chronic lymphocytic leukemia', 'cancer diagnosis']\n",
      "['layer covid19', 'll fire', 'dr lamanna', 'leukemia leusm patientpower']\n",
      "['rural settings', 'cme event', 'multiple sessions february']\n",
      "['great research article chronic lymphocytic leukemia patients', 'novel agents', 'veterans health administration system']\n",
      "['cll patients', 'cllsm leusm']\n",
      "['patient involvement research delphi projects', 'bigdataforbloodcancer contact', 'hematology cancer bloodcancer acuteleukemia myeloma cll multiplemyeloma childhoodcancer']\n",
      "['chronic lymphocytic leukemia patients', 'novel agents', 'veterans health administration system']\n",
      "[]\n",
      "['real world healthcare resource utilization', 'chronic lymphocytic leukemia differences', 'line ibrutinib', 'bendamustine rituximab lymphoma lymsm']\n",
      "['good afternoon doctor', 'chronic lymphocytic leukemia']\n",
      "['new article', 'intercellular interaction', 'extracellular vesicle exchange', 'co culture model', 'chronic lymphocytic leukemia', 'stromal cells', 'light sheet fluorescence microscopy cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia', 'aortic valve', 'case report cll leusm hematology']\n",
      "['new article risk', 'hematological malignancies', 'nodular lymphocyte predominant hodgkin lymphoma cll leusm hematology']\n",
      "['new article', 'real world healthcare resource utilization', 'chronic lymphocytic leukemia differences', 'line ibrutinib', 'bendamustine rituximab cll leusm hematology']\n",
      "['chronic lymphocytic leukemia']\n",
      "['cll evolution', 'richter s syndrome', 'andrea visentin', 'ash20 hematology hemonc leukemia leusm cllsm']\n",
      "['year s winter hematology update', 'optimal selection', 'new molecules', 'frontline amp r r disease', 'friday feb']\n",
      "['chronic lymphocytic leukemia cll symptoms', 'lymph nodes', 'various types']\n",
      "['bcr stereotypy', 'chronic lymphocytic leukemia']\n",
      "[]\n",
      "['prognostic role']\n",
      "['new cll', 'dr nicole lamanna md', 'cll questions']\n",
      "['william wierda md phd', 'md anderson cancer center discusses results', 'captivate trial', 'chronic lymphocytic leukemia cll', 'leukemia amp lymphoma society']\n",
      "['review management considerations', 'pandemic claim', 'seat oncology clinicalxchange']\n",
      "['new clinical trial immunogenicity', 'available vaccines', 'sars cov', 'hematologic malignancies cll leusm hematology']\n",
      "['new clinical trial', 't cell', 'nk cells', 'b cell malignancies cll leusm hematology']\n",
      "['new article', 'remission induction', 'von willebrand syndrome', 'chronic lymphocytic leukemia', 'case report cll leusm hematology']\n",
      "['hematology endorsement', 'esmo guidelines', 'chronic lymphocytic leukemia authors', 'guidelines amp', 'clinical scenarios', 'cet leusm']\n",
      "['chronic lymphocytic leukemia', 'shiyu wang', 'scientificchallenge project', 'run medchem compchem drugdesign drugdiscovery']\n",
      "['florida cll ers i m', 'host patientpower nights', 'local hematologists feb', 'floridacancerspecialists leukemia cll cllflorida']\n",
      "['chronic lymphocytic leukemia']\n",
      "['successful treatment', 'silver nitrate chemical cauterization', 'chronic lymphocytic leukemia', 'ibrutinib therapy']\n",
      "['lymphoma research foundation webinar update', 'oral therapies', 'dr jonathon cohen', 'emory university lymphoma cll helpline']\n",
      "['chronic lymphocytic leukemia', 'common blood cancer']\n",
      "['eric certification', 'ig mutations', 'cll thanks', 'dr maria teresa bochicchio', 'dr daniele calistri cancerresearch oncology']\n",
      "['new article', 'practice perspectives', 'tumor lysis syndrome', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article impact', 'clinical outcomes', 'real world patients', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'chronic lymphocytic leukaemia', 'extensive chronic graft versus host disease', 'allogeneic haematopoietic stem cell transplantation', 'oral venetoclax cll leusm hematology']\n",
      "['new article t cells', 'chronic lymphocytic leukemia', 'sword cll leusm hematology']\n",
      "['new article sirp suppresses response', 'therapeutic antibodies', 'chronic lymphocytic leukemia patients cll leusm hematology']\n",
      "['new article phosphoinositide', 'tumor microenvironment', 'chronic lymphocytic leukemia', 'pi3k inhibitors cll leusm hematology']\n",
      "['new article', 'successful treatment', 'silver nitrate chemical cauterization', 'chronic lymphocytic leukemia', 'ibrutinib therapy cll leusm hematology']\n",
      "['car t cell therapy lisocabtagene maraleucel liso cel', 'mantle cell lymphoma', 'refractory chronic lymphocytic leukemia data cannabis marijuana']\n",
      "['joint webinar', 'support people', 'chronic lymphocytic leukaemia cll', 'diagnosis register', 'gt bloodcancerawareness']\n",
      "['community perspectives', 'refractory chronic lymphocytic leukemia']\n",
      "['management considerations', 'review cll therapies amp', 'cancer amp covid']\n",
      "['practical strategies', 'cll cllsm leusm jnccn360']\n",
      "['interesting data', 'constitutive activation', 'high risk cll', 'murine cll model', 'b cells']\n",
      "['congress tctm21 michael bishop uc bmt', 'transcend cll', 'liso cel', 'r r cll sll', 'future use', 'car t therapy', 'cll lymsm']\n",
      "['video shares findings', 'phase i ii trial', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma ash20 leusm']\n",
      "['michael bishop', 'cart therapies', 'cll catch', 'cll coverage', 'bmtsm gvhd immunoonc cellulartherapy leusm lymsm chroniclymphocyticleukemia']\n",
      "['active akt', 'triggers cll', 'richter transformation']\n",
      "['current cll treatment approaches cllsm leusm']\n",
      "['excellence program', 'relevant computational project', 'cll precisionmedicine massspectrometry', 'bioinformatics networkbiology center', 'health data science']\n",
      "['rare translocation', 'chromosomes cllsm leusm jnccn36']\n",
      "['clean hotel', 'free continental breakfast book', 'daysinnbryancollegestation daysinn wyndham collegestationtx hospitality cll']\n",
      "['uk cll forum', 'annual scientific day', 'march registration', 'cll cllforum']\n",
      "['john hayslip md executive', 'medical director', 'abbvie pharmaceuticals discusses', 'murano study', 'leukemia amp lymphoma society']\n",
      "[]\n",
      "['new study uses', 'bim antibody', 'chronic lymphocytic leukemia cll']\n",
      "['secondary prophylaxis', 'febrile neutropenia', 'rituximab regimens', 'chronic lymphocytic leukemia', 'real world single center experience lymphoma lymsm']\n",
      "['week s learningmondays', 'prof gunnar larfors sweden', 'cll access', 'full question']\n",
      "['mercaptopurine indications prevents organ transplant rejection chronic lymphocytic leukemia chronic myeloid leukemia crohn s disease ulcerative colitis', 'antimetabolite class', 'purine nucleotide synthesis']\n",
      "['bone marrow', 'acute lymphoblastic leukemia', 'acute myeloid leukemia', 'chronic lymphocytic leukemia']\n",
      "['cd200 expression', 'chronic lymphocytic leukemia', 'mature b cell neoplasms']\n",
      "['virtual event', 'hemonc cme cllsm']\n",
      "[]\n",
      "['tiny regulators', 'gene expression', 'pivotal roles', 'normal b cell development', 'b cell chronic lymphocytic leukemia']\n",
      "['common types', 'chronic lymphocytic leukemia cll', 'middle age']\n",
      "['author correction determinants', 'cd19 chimeric antigen receptor car t cell therapy', 'chronic lymphocytic leukemia']\n",
      "['cancer patients cll lungcancer vaccines']\n",
      "['tiny regulators', 'gene expression', 'pivotal roles', 'normal b cell development', 'b cell chronic lymphocytic leukemia']\n",
      "['cllsociety s dr brian koffman', 'cancer patients', 'additional statements', 'drs chaitra ujjani amp elad sharon', 'cancer cll patients', 'sars cov']\n",
      "['new article outcomes', 'secondary prophylaxis', 'febrile neutropenia', 'rituximab regimens', 'chronic lymphocytic leukemia', 'real world cll leusm hematology']\n",
      "['new article author correction determinants', 'cd19 chimeric antigen receptor car t cell therapy', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article micrornas', 'tiny regulators', 'gene expression', 'pivotal roles', 'normal b cell development', 'b cell chronic lymphocytic leukemia cll leusm hematology']\n",
      "['lymphoma research foundation webinar update', 'oral therapies', 'dr jonathon cohen', 'emory university lymphoma cll helpline']\n",
      "['cure panel', 'new patient', 'caregiver research', 'cll chroniclymphocyticleukemia', 'info com', 'reference facp cll']\n",
      "['new article chilblain', 'outbreak cll leusm hematology']\n",
      "['new article nfat5', 'stub1 facilitates malignant cell survival', 'p38 mapk activation', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article lymphocyte', 'chronic lymphocytic leukemia', 'modern era', 'real life study', 'patients cll leusm hematology']\n",
      "['new article myeloid neoplasms', 'chronic lymphocytic leukaemia chronic lymphocytic leukaemia', 'clinicopathological study', 'cll leusm hematology']\n",
      "['new article high expression', 'bcl6 inhibits', 'hematopoietic stem cells', 'chickens cll leusm hematology']\n",
      "['new article', 'low expression', 'zhx2 impacts', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['long term ibrutinib treatment', 'immune cells', 'chronic lymphocytic leukemia']\n",
      "['boy outta chelsea', 'boy cll']\n",
      "['current treatment', 'chronic lymphocytic leukemia', 'novel drugs fulltext acta haematologica karger publishers']\n",
      "['joint webinar', 'support people', 'chronic lymphocytic leukaemia cll', 'diagnosis register', 'gt bloodcancerawareness']\n",
      "['ibrutinib aes', 'life threat', 'infections diarrhea cvs aes', 'real world data', 'trials cll']\n",
      "['different types', 'main ones', 'acute lymphocytic anemia', 'chronic lymphocytic leukemia cll', 'chronic myelogenous leukemia cml']\n",
      "['chronic lymphocytic leukemia cll robert figlin md', 'mazyar shadman md mph', 'clinical highlights', 'obr peer spectives']\n",
      "['population pk pd', 'lymphocyte dynamics', 'chronic lymphocytic leukemia patients', 'ibrutinib treatment']\n",
      "['susan o brien md', 'fantastic cll community panel', 'aditi choudhry md pleasant hill ca robert galamaga', 'phoenix az', 'stephen goldfarb', 'sierra vista az beyondash21 virtualmeetings ash20']\n",
      "['covid19 vaccine']\n",
      "['justin scca s', 'covid19 vaccinations', 'blood cancers', 'cll check']\n",
      "['cancer patients']\n",
      "['sawaf md', 'universit t zu k ln discusses', 'cll14 trial', 'term treatment', 'chronic lymphocytic leukemia patients', 'standard treatment']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['cell line model', 'pro survival effect', 'chronic lymphocytic leukemia']\n",
      "['non hodgkins lymphoma', 'chronic lymphocytic leukemia', 'roundup deserve justice']\n",
      "['measurable residual disease', 'chronic lymphocytic leukemia']\n",
      "['new article recurrent uveitis', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article protein kinase c', 'dependent changes', 'glucose metabolism', 'bone marrow stromal cells', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article population pk pd', 'lymphocyte dynamics', 'chronic lymphocytic leukemia patients', 'ibrutinib treatment cll leusm hematology']\n",
      "['new article', 'biological variation', 'swath ms', 'proteomic analysis', 'chronic lymphocytic leukaemia cells cll leusm hematology']\n",
      "['chronic lymphocytic leukemia therapeutics market growth demand', 'applications market research report']\n",
      "['stub1 facilitates malignant cell survival', 'p38 mapk activation', 'chronic lymphocytic leukemia']\n",
      "['life hemonc cme nursetwitter']\n",
      "['donate blood', 'stem cell donor', 'option iamandiwill cll stemcelldonor donateblood donateplasma']\n",
      "['tara graff', 'active areas', 'chronic lymphocytic leukemia leusm']\n",
      "['telemedicine impact time', 'cll cllsm leusm']\n",
      "['cme curriculum', 'cll mcl patient care', 'interactive activities check', 'lymsm mclsm cllsm']\n",
      "['chronic lymphocytic leukemia time flies']\n",
      "['ofatumumab arzerra kesimpta ofatumumab', 'cll chronic lymphocytic leukemia', 'multiple sclerosis', 'cd20 side', 'rtis rash anemia neutropenia infusion site reactions']\n",
      "['op wereldkankerdag lanceren', 'onze webinar nonhodgkin', 'cll van', 'maart inschrijven']\n",
      "['long term survivorship tool', 'cll patients cllsm leusm']\n",
      "['medical treatments', 'chronic lymphocytic leukemia', 'worldcancerday worldcancerday2021 openscience']\n",
      "['worldcancer day i', 'chronic lymphocytic leukemia i m', 'lucky people', 'day research']\n",
      "['cancer patients', 'treatment journey patient leaders', 'cll community', 'impact jeff']\n",
      "['chronic lymphocytic leukemia', 'indolent non hodgkin lymphoma hematology']\n",
      "['roundup lawsuit', 'non hodgkins lymphoma', 'chronic lymphocytic leukemia']\n",
      "['melanoma cll leukaemia']\n",
      "['cllsociety worldcancerday']\n",
      "['vi k mper', 'blodkr ft patienter og', 'blodcancer fri verden worldcancerday verdenscancerdag iamandiwill', 'aml cll cml cmml lymfekr ft mds wcd2021 lav din egen poster']\n",
      "['dr mato dr wierda', 'presentations worldcancerday cll']\n",
      "['joint webinar', 'support people', 'chronic lymphocytic leukaemia cll', 'diagnosis register', 'gt bloodcancerawareness']\n",
      "['important new study', 'vaccine email haematologyengagement bham ac uk']\n",
      "['cll patient', 'answers iamandiwill']\n",
      "['james gerson md', 'navigates treatment selection', 'chronic lymphocytic leukemia', 'exciting developments', 'pipeline leusm']\n",
      "['uk cll patients', 'important study', 'immune response', 'covid19 vaccination email haematologyengagement bham ac uk', 'uk helen']\n",
      "['harmony unites', 'bloodcancer worldcancerday iamandiwill bigdataforbloodcancer cancer acuteleukemia myeloma cll lymsm mmsm multiplemyeloma childhoodcancer mds aml leukaemia leukemia mpnsm cml']\n",
      "['cll delphi survey launces', 'core outcome', 'meaningful measures', 'treatment research']\n",
      "['new article structural determinants', 'irf4 dna homodimeric', 'complex cll leusm hematology']\n",
      "['new article', 'unusual case', 'prolymphocytic leukemia transformation', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['dr mato', 'triple combo pill', 'richter s dr wierda', 'transcend car t study liso cel ibrutinib', 'captivate worldcancerday']\n",
      "['cll community', 'cancer community', 'collective voice', 'personal action']\n",
      "['worldcancerday cll blood cancer patients', 'high risk', 'high risk']\n",
      "['worldcancerday2021 iamandiwill', 'cll blood cancer patients']\n",
      "['invite uk patients', 'cll leukaemia', 'immune response', 'covid19 vaccination email haematologyengagement bham ac uk', 'study haematology bloodcancer']\n",
      "['cll blood cancer', 'global network', 'families iamandiwill']\n",
      "['b cell receptor stereotypy', 'chronic lymphocytic leukemia']\n",
      "['mayoclinicetf kudos', 'crazy cll', 'research ideas']\n",
      "['nice example', 'progressive cll hemepath pathology cll hematology']\n",
      "['live virus', 't replicate', 'cellular damage cll expert dr philip thompson', 'covid vaccine', 'immune systems']\n",
      "['agricultural workers', 'roundup herbicide', 'non hodgkins lymphoma', 'chronic lymphocytic leukemia deserve justice']\n",
      "['org a041702 ph3 rct ibrutinib obinutuzumab venetoclax', 'patients gt 70yo', 'chronic lymphocytic leukemia cll pi woyach nct03737981 leusm cllsm geriheme']\n",
      "['ash20 cll practice aids']\n",
      "['cll patient sandy peterson shares', 'care cllsm leusm']\n",
      "['bispecific single domain antibody boosts autologous v 9v', 't cell responses', 'chronic lymphocytic leukemia cll']\n",
      "['cll support membership', 'members means', 'cll community leukaemia haematology bloodcancer bloodcancerawareness']\n",
      "['bispecific single domain antibody boosts autologous v 9v', 't cell responses', 'chronic lymphocytic leukemia']\n",
      "['antitumor activity', 't regulatory type', 'cd4 t cells', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['pathological rank', 'b cells', 'chronic lymphocytic leukemia journal', 'experimental medicine rockefeller university press']\n",
      "['new article smudge cells', 'chronic lymphocytic leukemia pathophysiology laboratory considerations', 'clinical significance cll leusm hematology']\n",
      "['new article eomes', 'antitumor activity', 't regulatory type', 'cd4 t cells', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article pdq cancer information summaries cll leusm hematology']\n",
      "['cll patients', 'clinical trials']\n",
      "['available btk inhibitors']\n",
      "['natural history', 'monoclonal b cell lymphocytosis mbl', 'chronic lymphocytic leukemia cll families haematology thewiderwiserview']\n",
      "['b cell', 'acute lymphoblastic leukemia', 'chronic lymphocytic leukemia', 'lenalidomide haematology thewiderwiserview']\n",
      "['new study', 'spanish hospitals', 'mortality rates', 'cll coronavirus leusm covid19ncancer jnccn360']\n",
      "['cll blood cancer', 'cancer patients everywhere iamandiwill']\n",
      "['btki gt gt gt bendamustine', 'chronic lymphocytic leukemia cll2 bio primary endpoint analysis', 'open label phase ii trial haematologica cll leusm']\n",
      "['krakow poland', 'email updates', 'way cll bioascend']\n",
      "['telemedicine activate', 'remote tools', 'manage cll cllsm leusm']\n",
      "['actions props', 'creativity links', 'cache eye unit', 'eyp unit', 'stories books literacy reading language cll communication eytagteam eytwittertagteam']\n",
      "['cll genetic', 'cllsm leusm']\n",
      "['interview dr matthew davids', 'dana farber cancer institute discusses', 'car t cell therapy', 'chronic lymphocytic leukemia']\n",
      "['nyt tv', 'i l reruddannelsen tv', 'styrker sprogindl ringen sprog tv', 'sprogdidaktik centerforsprogogl ring cll', 'cfg syddanskuniversitet sdu detnationalecenterforfremmedsprog ncff']\n",
      "['patient recruitment']\n",
      "['uk cll forum guidance', 'covid19 pandemic']\n",
      "['joint webinar', 'support chronic lymphocytic leukaemia cll patients', 'diagnosis register', 'gt bloodcancerawareness']\n",
      "['new article convalescent plasma', 'humoral immunodeficiency cll leusm hematology']\n",
      "['new article telomere dysfunction', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article oncologist', 'patient preferences', 'novel agents', 'line treatment', 'chronic lymphocytic leukemia commonalities', 'disconnects cll leusm hematology']\n",
      "['sawaf md', 'universit t zu k ln', 'chronic lymphocytic leukemia cll', 'leukemia amp lymphoma society universit t zu k ln', 'leukemia amp lymphoma society']\n",
      "['pathological rank protein', 'bcells triggers autoimmunediseases', 'chroniclymphocyticleukemia cll lupuserythematosus leukemia lymphoma']\n",
      "['new article retrospective analysis', 'adverse event', 'idelalisib interruption', 'dose reduction', 'clinical outcomes', 'refractory b cell malignancies cll leusm hematology']\n",
      "['new article noncatalytic bruton s tyrosine kinase activates plc', 'ibrutinib resistance', 'human chronic lymphocytic leukemia cells cll leusm hematology']\n",
      "['life register', 'virtual event', 'hemonc cme cllsm']\n",
      "['evidence supports btk inhibition', 'chronic lymphocytic leukemia', 'oncology evidence supports btk inhibition', 'chronic lymphocytic leukemia']\n",
      "['human anticd19 chimeric antigen receptor t cells', 'refractory lymphoid malignancies status', 'condition summary non hodgkin lymphoma', 'acute lymphoblastic leukemia chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll']\n",
      "['dr john pagel s', 'top tips', 'cll telemedicine visit cllsm leusm']\n",
      "['low lymphocytes', 'cll expert', 'low means', 'lymphocyte numbers', 'leusm patientpower']\n",
      "['transform care', 'blood cancer patients worldwide', 'bloodcancer treatments', 'critical unmet', 'medical needs']\n",
      "['bispecific single domain antibody boosts autologous v 9v', 't cell responses', 'chronic lymphocytic leukemia', 'summary click']\n",
      "['james gerson md', 'navigates treatment selection', 'chronic lymphocytic leukemia', 'exciting developments', 'pipeline leusm']\n",
      "['new clinical trial human anticd19 chimeric antigen receptor t cells', 'refractory lymphoid malignancies cll leusm hematology']\n",
      "['incredible achievement amp', 'wonderful mondaymotivation', 'grateful charity', 'cll leukaemia haematology bloodcancer bloodcancerawareness']\n",
      "['b cell receptor stereotypy', 'chronic lymphocytic leukemia']\n",
      "['b cell', 'acute lymphoblastic leukemia', 'chronic lymphocytic leukemia', 'lenalidomide hvhebron onco text complet']\n",
      "['small molecule medicine', 'protein bruton s tyrosine kinase', 'b cells', 'b cell cancers', 'mantlecell lymphoma chronic lymphocytic leukemia', 'waldenstr m s macroglobulinemia']\n",
      "['syndrome richter s syndrome', 'aggressive type', 'acute adult leukemia', 'chronic lymphocytic leukemia', 'large cell lymphoma']\n",
      "['nouvelle mascotte loot sur castrum finalfantasyxiv ce qui monte mon score', 'oui je vient', 'm assoir sur', 'mascotte ultra moche ff14 cll castrum finalfantasy14 ffxiv']\n",
      "['learning challenge', 'cll maths']\n",
      "['sequoia zanubrutinib', 'del 17p', 'constantine tam', 'ash20 hematology hemonc leukemia leusm cllsm ctsm trialupdate']\n",
      "['cancer dr barrientos', 'professional fulfillment', 'chronic lymphocytic leukemia cll alumnus', 'womeninmedicine medtwitter']\n",
      "['car t cell therapy lisocabtagene maraleucel liso cel', 'mantle cell lymphoma', 'refractory chronic lymphocytic leukemia data cannabis marijuana']\n",
      "['idelalisib rituximab combination']\n",
      "['md phd', 'captivate findings', 'chronic lymphocytic leukemia leusm']\n",
      "['wide association study identifies risk loci', 'progressive chronic lymphocytic leukemia']\n",
      "['wide association study identifies risk loci', 'progressive chronic lymphocytic leukemia']\n",
      "['stern s memoir', 'chronic lymphocytic leukemia']\n",
      "['idelalisib rituximab combination']\n",
      "['new article b cell', 'acute lymphoblastic leukemia', 'chronic lymphocytic leukemia', 'lenalidomide cll leusm hematology']\n",
      "['new article', 'natural history', 'monoclonal b cell lymphocytosis mbl', 'chronic lymphocytic leukemia cll families cll leusm hematology']\n",
      "['new article ror1', 'antibody drug conjugate vls', 'richter syndrome patient', 'xenograft mouse models cll leusm hematology']\n",
      "['new article tlr9 expression', 'chronic lymphocytic leukemia identifies', 'pro migratory subpopulation', 'novel therapeutic target cll leusm hematology']\n",
      "['new article notch', 'promotes disease initiation', 'murine chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article genome', 'wide association study identifies risk loci', 'progressive chronic lymphocytic leukemia cll leusm hematology']\n",
      "['idelalisib rituximab combination', 'chronic lymp']\n",
      "['chronic lymphocytic leukemia', 'tp53 gene alterations', 'clinicopathologic analysis']\n",
      "['important questions', 'cll field']\n",
      "['support cll patient mark silverstein amp carepartner nelia pacheco share lessons', 'healthy relationship ways', 'communication amp']\n",
      "['scca cll expert', 'current perspectives', 'chronic lymphocytic leukemia', 'information leusm']\n",
      "['informative talk', 'haematology team', 'recent trials', 'current treatment options']\n",
      "['oncoalert ibrutinib', '1l therapy sustains efficacy safety', 'tp53 chronic lymphocytic leukemia cll leusm']\n",
      "['podcast developments', 'cll mrd loxo', 'ash20 don t', 'new podcast', 'hemonc cllsm leusm caxtx ctsm trialupdate']\n",
      "['dr john allan', 'efficacy amp safety', 'frontline therapy', 'chronic lymphocytic leukemia cll patients', 'tp53 aberrations']\n",
      "['great pnh', 'cll minds', 'time i m']\n",
      "['non neurosurg journal i ve', 'lancet s seminar series', 'chronic lymphocytic leukaemia', 'i wonder', 'isn t', 'imatinib cll']\n",
      "['extraordinary clinician', 'happy retirement cll']\n",
      "['new clinical trial', 'bempegaldesleukin bempeg nktr', 'children adolescents', 'young adults', 'resistant cancer cll leusm hematology']\n",
      "['new article diagnostic value', 'plasma mir', 'april oncogene', 'b cell chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article aberrant methylation', 'tumour suppressor gene adam12', 'chronic lympocytic leukemia patients application', 'specific pcr technique cll leusm hematology']\n",
      "['new article musashi', 'influences chronic lymphocytic leukemia cell survival', 'growth making', 'potential therapeutic target cll leusm hematology']\n",
      "['new article optimal panel', 'b cell non hodgkin lymphoma', 'bone marrow biopsy', 'tertiary care center study cll leusm hematology']\n",
      "['new article entospletinib', 'refractory chronic lymphocytic leukemia', 'b cell malignancies cll leusm hematology']\n",
      "['venetoclax therapy', 'ian flinn hematology ash20 hemonc leukemia leusm cllsm ctsm trialupdate']\n",
      "['dasatinib tx', 'characterizes geneexpressionprofiles', 'sensitive amp', 'resistant cll cells', 'rnaseq defines', 'geneexpressionsignature assoc']\n",
      "['authors prof eichhorst amp prof ghia', 'eha endorsement', 'esmo clinical practice guidelines', 'diagnosis treatment amp', 'chronic lymphocytic leukemia']\n",
      "['current perspectives', 'chronic lymphocytic leukemia cll']\n",
      "['serum monoclonal component', 'chronic lymphocytic leukemia hematology']\n",
      "['comparison idph', 'strong ph3 efficacy', 'cll fl', 'nvax shows', 'excellent vaccine efficacy', 'nvax multivalent approach caveat']\n",
      "['great alternative', 'cll therapy']\n",
      "['ash20 rapidimpactreports', 'hemonc analyses', 'therapeutic agents', 'chroniclymphocyticleukemia order', 'cll report']\n",
      "['rhapsody music', 'haukuish cll']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['md anderson cancer center', 'ash20 takeaways', 'beyondthecongress cme conference', 'cc cprtp']\n",
      "['cme curriculum', 'cll mantlecelllymphoma patient care', 'interactive activities check']\n",
      "['novel agents', 'allogeneic stem cell transplant ou']\n",
      "['new article duvelisib copiktra', 'refractory chronic lymphocytic leukemia safety', 'efficacy cll leusm hematology']\n",
      "['new article nurse', 'chronic lymphocytic leukemia b cells', 'mutualistic crosstalk', 'tissue microenvironments cll leusm hematology']\n",
      "['new article proteomics', 'regression model', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['important cll news look', 'full results']\n",
      "['feb 11th', 're resilient', 'real resilience', 'patient advocates', 'cll patientexperience patientengagement']\n",
      "['full text', 'bio link', 'pulmonary cryptococcosis', 'chronic lymphocytic leukemia']\n",
      "['novel therapeutics', 'cme video activity']\n",
      "['dana farber patient', 'week cll cancerpatients']\n",
      "['safety data', 'cancerpatients cll']\n",
      "['cll patients']\n",
      "['beautiful picture', 'own interests', 'eymatters maths literacy ead cll learningthroughplay']\n",
      "['top story', 'idelalisib rituximab combination', 'chronic lymphocytic leukemia medivizor']\n",
      "['top story', 'idelalisib rituximab combination', 'chronic lymphocytic leukemia medivizor']\n",
      "['idelalisib rituximab combination', 'chronic leukemia']\n",
      "['new article', 'real world outcomes', 'venetoclax therapy', 'chronic lymphocytic leukemia', 'richter syndrome', 'filo study', 'compassionate use cohort cll leusm hematology']\n",
      "['new article regulation', 'bcl xl', 'non canonical nf b', 'drug resistance', 'cll cll leusm hematology']\n",
      "['available btk inhibitors']\n",
      "['busy mark making fingers', 'pattern cards', 'own marks', 'physicaldevelopment cll']\n",
      "['dr john allan comments', 'chronic lymphocytic leukemia cll', 'covid19 pandemic cc leusm lymsm']\n",
      "['lisocabtagene maraleucel', 'viable treatment option', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'high risk disease']\n",
      "['old woman', 'doctor dr randall davis', 'convalescent blood plasma', 'remarkable recovery']\n",
      "['top es llc cll']\n",
      "['r r b cell malignancies dor']\n",
      "['fda approves rituximab biosimilar', 'cll treatment leusm jnccn360']\n",
      "['measurable residual disease mrd impact treatment decisions', 'practice patterns', 'demand webinar']\n",
      "['high risk disease', 'richter s', 'amp others', 'genetic markers', 'patient s disease risk amp', 'cll leusm']\n",
      "['interesting debate lymsm lymphoma cll']\n",
      "['hot seat', 'experts address', 'challenging topics', 'mantlecelllymphoma patient care', 'prognosis frontline chemoimmunotherapy', 'novel agents']\n",
      "['car t cell therapy lisocabtagene maraleucel liso cel', 'mantle cell lymphoma', 'refractory chronic lymphocytic leukemia data cannabis marijuana']\n",
      "['attn ya chronic lymphocytic leukemia survivors check', 'cll coach', 'survivors track', 'manage symptoms manage stress gain', 'contact matthew leblanc edu ayacancer']\n",
      "['rhhbf phase', 'zanubrutinib obinutuzumab', 'chronic lymphocytic leukemia cll', 'small lymphocytic leukemia sll nct03824483', 'primary completion date']\n",
      "['idelalisib rituximab combination']\n",
      "['new article identification', 'novel resistance mechanism', 'venetoclax treatment', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'msc communication', 'leukemic bone marrow niche cll leusm hematology']\n",
      "['new article', 'biophysical parameters', 'chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['new article helq', 'egr3 expression correlate', 'ighv mutation status', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['mind strength', 'words zeal', 's salute', 'republicday republicdayindia republicday2021 cll mmsm endcancer leusm', 'hccwebinar lymsm mmsm realworldevidence collaborativeresearch hematology']\n",
      "['james gerson md', 'navigates treatment selection', 'chronic lymphocytic leukemia', 'exciting developments', 'pipeline leusm']\n",
      "['cll pt 17p', 'nma allo pre allo s p', 'current options', 'new planet', 'great performance', 'amazing progress']\n",
      "['promising efficacy data', 'cll sll', 'potential benefit', 'liso cel combination', 'ibrutinib willliam wierda md phd', 'leusm leukemia']\n",
      "['cll pfs cll']\n",
      "['cll cll']\n",
      "['treatments people', 'chronic lymphocytic leukemia', 'common form']\n",
      "['chronic lymphocytic leukemia cll', 'u s', 'deaths cll', 'common leukemia', 'age memorial sloan', 'cancer center zusia']\n",
      "['calcitriol vitamin d receptor system regulates key immune', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia prognostic factors', 'center leusm jcogo']\n",
      "['video shares findings', 'phase i ii trial', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma ash20 leusm']\n",
      "['new article expression profiles', 'b cll', 'leukocytes contribute', 'relapse cll leusm hematology']\n",
      "['new article high incidence', 'kmt2d mutations', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['car t cell therapy lisocabtagene maraleucel liso cel', 'mantle cell lymphoma', 'refractory chronic lymphocytic leukemia data cannabis marijuana']\n",
      "['new strategies', 'rural practice', 'quality improvement measures', 'webinar january 27th']\n",
      "['patie nonhodgkinslymphoma']\n",
      "['cancer cancer humor cancersurvivor cll']\n",
      "['s dr marc hoffman', 'low grade lymphoma', 'chronic lymphocytic leukemia cll', 'kuashreview kubloodcancer']\n",
      "['chronic lymphocytic leukemia']\n",
      "['new article ex vivo mitochondrial respiration parallels biochemical response', 'cll cells cll leusm hematology']\n",
      "['treatment strategies', 'fish p53', 'ighv mutation ipc']\n",
      "['cll mgmt', 'cme activity', 'selection duration', 'treatment management', 'disease outcomes', 'different lines', 'therapy lymsm']\n",
      "['year dfs rates', 'ibrutinib venetoclax', 'cll william wierda md phd', 'leusm leukemia']\n",
      "['interview dr matthew davids', 'dana farber cancer institute discusses', 'car t cell therapy', 'chronic lymphocytic leukemia']\n",
      "['new guidance', 'covid19 vaccination', 'cancer patients recommendation']\n",
      "['measurable residual disease mrd impact treatment decisions', 'practice patterns', 'demand webinar']\n",
      "['stories links', 'cache eye units', 'eyp unit', 'btec cpld unit', 'emergent literacy reading literacy books cll readingforpleasure']\n",
      "['books reading stories cll readingforpleasure literacy']\n",
      "['study amp', 'molecular diagnostics', 'early stages email webinar org uk']\n",
      "['dr guillaume cartron', 'refractory lymphoma', 'cll patients', 'cd19 car t cells']\n",
      "['chronic lymphocytic leukemia', 'year results', 'genomic complexity', 'gene mutations', 'murano phase iii study journal', 'clinical oncology']\n",
      "['chronic lymphocytic leukemia', 'precursor stage', 'amp others check']\n",
      "['noxxonpharma medlmmune llc novartis march', 'leuc mie lymphocytaire chronique', 'tude compl te explore l norme croissance', 'future noxxonpharma medimmune llc novartis jumbo news']\n",
      "['drg epidemiology extrapolatedworldwidecoverage forecasts', 'new cases', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'nhl lymphoma nonhodgkinslymphoma']\n",
      "['hematologic experts', 'community questions ipc', 'chair drs verstovsek', 'neelapu mechanisms', 'car t therapy myelofibrosis dlbcl cll discontinue maintenance']\n",
      "['treatment strategies', 'fish p53', 'ighv mutation ipc']\n",
      "['don t', 'review series', 'jennifer woyach', 'recent advances', 'chronic lymphocytic leukemia']\n",
      "['immunodeficient patient', 'convalescent plasma', 'old patient', 'own immune defense', 'sars cov', 'chronic lymphocytic leukemia']\n",
      "['key presentations', 'cll treatment', 'unity cll captivate', 'bruin trials hematology ash20 hemonc leukemia leusm cllsm immunoonc caxtx trialupdate ctsm']\n",
      "['md mmsc', 'unity trials', 'refractory chronic lymphocytic leukemia', 'mantle cell lymphoma lymsm']\n",
      "['cll cllsm leusm']\n",
      "['new article comorbidities', 'diagnosis survival', 'chronic lymphocytic leukemia', 'study cll leusm hematology']\n",
      "['new article', 'respiratory complications', 'sars cov', 'clinical experience', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'pivotal role', 'chronic lymphocytic leukemia monoclonal type', 'igg k cryoglobulinemia', 'chronic lymphocytic leukemia diagnosis', 'human metapneumovirus infection cll leusm hematology']\n",
      "['new article', 'calcitriol vitamin d receptor system regulates key immune', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article hematopoietic versus', 'solid cancers', 't cell dysfunction', 'distinctions cll leusm hematology']\n",
      "['mr david ozor', 'chronic lymphocytic leukemia blood cancer amp needs', 'care amp chemotherapy pls click', 'noire doctor']\n",
      "['drg epidemiology extrapolatedworldwidecoverage estimates', 'new cases', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['kerry rogers md discusses', 'phase 1b study', 'chronic lymphocytic leukemia', 'ibrutinib therapy leusm']\n",
      "['cancer patients', 'md anderson cll leukemia']\n",
      "['cll i doubt', 'intensity affects resistance']\n",
      "['big thanks', 'funders immunotherapy immunoonc cll lymphoma']\n",
      "['measurable residual disease mrd impact treatment decisions', 'practice patterns', 'demand webinar']\n",
      "['obinutuzumab ibrutinib', 'chronic lym']\n",
      "['cll clue project', 'newsletter cll precisionmedicine']\n",
      "['pre neoplastic alterations', 'cll dna methylome', 'disease progression', 'therapy commentary epigenetic trajectories', 'malignant transition', 'chronic lymphocytic leukemia']\n",
      "['cll patients', 'telemedicine dr john pagel', 'cllsm leusm']\n",
      "['t cell activity']\n",
      "['new article non overt', 'intravascular coagulopathy', 'obinutuzumab administration', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'humoral immune response', 'high dose influenza vaccine', 'monoclonal b cell lymphocytosis mbl', 'chronic lymphocytic leukemia cll cll leusm hematology']\n",
      "['new article progressive multifocal leukoencephalopathy', 'chronic lymphocytic leukemia', 'ibrutinib cll leusm hematology']\n",
      "['new article cytokine adsorption therapy', 'hemophagocytic lymphohistiocytosis', 'allogeneic stem cell transplantation cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia b cell', 'tnf impairs bone marrow myelopoiesis cll leusm hematology']\n",
      "['new article adapter chimeric antigen receptor adcar', 'shelf cellular therapeutic', 'universal tumor', 'cll leusm hematology']\n",
      "['new article management', 'buccal space mass', 'clinical case report cll leusm hematology']\n",
      "['new article', 'late epstein barr virus', 'post transplant lymphoproliferative disorder', 'intestinal involvement', 'chronic graft versus host disease', 'allogeneic hematopoietic stem cell transplantation cll leusm hematology']\n",
      "['new article comparison', 'nontransplant high risk chronic lymphocytic leukemia patients', 'therapy era cll leusm hematology']\n",
      "['chronisch lymphatische leuk mie ist', 'h ufigste leuk mieerkrankung bei erwachsenen', 'zwar meist langsam verl uft jedoch bisher nicht heilbar ist forscher des testen neuen impfstoff gegen cll']\n",
      "['chemotherapy drug bendamustine100mg', 'chronic lymphocytic leukemia cll rituximab bendamustine100mg dose uses bendamustine mauritius zimbabwe seychelles camroon southafrica congo nigeria angola liberia niger']\n",
      "['drg epidemiology extrapolatedworldwidecoverage forecasts', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'nhl lymphoma nonhodgkinslymphoma']\n",
      "['hematology ipc covid', 'treatment approach', 'young patients need']\n",
      "['patients car t cell therapy', 'cll treatment cartcr tcell celltherapy']\n",
      "['small molecule agents', 'cll understanding', 'individual mechanisms', 'critical foundation', 'jadpro review article apcaresafecare']\n",
      "['cllsm leusm']\n",
      "['great fun', 'nursery making gruffalo food', 'words sticky slimy yakky', 'mushy cll']\n",
      "['cll treatment landscape', 'expert panel', 'patient perspective', 'novel therapeutics', 'treatment options', 'cme video']\n",
      "['chronic lymphocytic leukemia cll specialist dr kerry rogers', 'james shares advice', 'new amp', 'current patients', 'right times', 'treatment amp']\n",
      "['anthony mato md', 'memorial sloan', 'cancer center', 'chronic lymphocytic leukemia', 'discusses findings', 'informcll registry', 'leukemia amp lymphoma society']\n",
      "['humoral immune response', 'high dose influenza vaccine', 'monoclonal b cell lymphocytosis mbl', 'chronic lymphocytic leukemia cll']\n",
      "['mr david ozor', 'chronic lymphocytic leukemia blood cancer amp needs', 'care amp chemotherapy pls click']\n",
      "['sawaf md', 'universit t zu k ln', 'chronic lymphocytic leukemia cll', 'leukemia amp lymphoma society universit t zu k ln', 'leukemia amp lymphoma society']\n",
      "['drg epidemiology extrapolatedworldwidecoverage', 'worldwide estimates', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'nhl lymphoma nonhodgkinslymphoma']\n",
      "['james gerson md discusses', 'navigates treatment selection', 'chronic lymphocytic leukemia', 'exciting developments', 'pipeline leusm']\n",
      "['cll treatment cancer chroniclymphocyticleukemia cll']\n",
      "['mr david ozor', 'chronic lymphocytic leukemia blood cancer amp needs', 'care amp chemotherapy pls click']\n",
      "['different ways', 'own words', 'new words cll']\n",
      "['cll treatment decisions cllsm leusm']\n",
      "['rural practice gain knowledge', 'cancer care', 'cme event january 27th register']\n",
      "['cll terms', 'cllsm leusm']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['year s ash20 meeting access hemonc insights impressions amp changes', 'clinicaltrial data', 'aml nhl cll multiplemyeloma amp myelodysplasticsyndrome']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['available btk inhibitors']\n",
      "['recurrent xpo1 mutations', 'chronic lymphocytic leukemia cll']\n",
      "['bgne phase', 'zanubrutinib obinutuzumab', 'chronic lymphocytic leukemia cll', 'small lymphocytic leukemia sll nct03824483', 'primary completion date']\n",
      "['superb program', 'hhd2021 virtual', 'amp contribute', 'free registration hematology hematology uutisoi covid19 cll aml', 'leusm bigdata']\n",
      "['clinkloyalty chez sonae un groupe tr s', 'mati re d animation commerciale', 'fid lisation que nous sommes fiers d accompagner depuis', 'ans cll animationcommerciale fid lisation']\n",
      "['james gerson md', 'navigates treatment selection', 'chronic lymphocytic leukemia', 'exciting developments']\n",
      "['cllsociety s', 'official covid', 'triage statement']\n",
      "['cll society s', 'official covid', 'triage statement']\n",
      "['bispecific single domain antibody boosts autologous v 9v', 't cell responses', 'chronic lymphocytic leukemia gdtcells aacr']\n",
      "['recurrent xpo1 mutations', 'chronic lymphocytic leukemia']\n",
      "['new article', 'bispecific single domain antibody boosts autologous v 9v', 't cell responses', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article guidance document validation', 'high performance liquid chromatography tandem mass spectrometry immunopeptidomics assay', 'hla class i ligands', 'pharmaceutical therapies cll leusm hematology']\n",
      "['new article recurrent xpo1 mutations', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['diagnosis survival', 'chronic lymphocytic leukemia', 'trav s']\n",
      "['covid19 era btk', 'immune state', 'specific therapies']\n",
      "['bad news', 'cll patients covid19 vaccinestrategy']\n",
      "['james gerson md', 'navigates treatment selection', 'chronic lymphocytic leukemia', 'exciting developments', 'pipeline leusm']\n",
      "['afternoon learning', 'small molecule inhibitors', 'chronic lymphocytic leukemia treatment', 'silliest name idelalisib']\n",
      "['pharmacyphunquiz quickie', 'tremfya guselkumab', 'inhibitor mab b igg1', 'cd52 mab', 'ms b cell chronic lymphocytic leukemia', 'psoriasis psoriatic arthritis']\n",
      "['transplant cart therapy']\n",
      "['treatment considerations', 'chronic lymphocytic leukemia', 'historic parameters leusm']\n",
      "['post ash cll sessions w', 'john gribben alessandra tedeschi amp click', 'ash20 hemonc leusm leukemia ctsm cllsm immunoonc']\n",
      "['new article bird', 'bh4 domain', 'provokes bax bak', 'independent cell death', 'b cell cancers', 'mitochondrial ca2', 'dependent mptp opening cll leusm hematology']\n",
      "['new article decreases', 'different dnmt3b activities drive distinct development', 'hematologic malignancies', 'mice cll leusm hematology']\n",
      "['new article radon', 'cancer mortality', 'underground uranium miners', 'p bram region', 'czech republic cll leusm hematology']\n",
      "['new article multi cytogenetic changes', 'cll progresses cll leusm hematology']\n",
      "['new article', 'mir 181b', 'b cells', 'cll improves', 'tumor cytotoxic t cell response cll leusm hematology']\n",
      "['health canada', 'treatment na ve chronic lymphocytic leukemia leusm']\n",
      "['factor score', 'ibrutinib treatment', 'chronic lymphocytic leukemia prognostic model', 'risk group definition oncology']\n",
      "['chronic lymphocytic leukemia', 'ibrutinib development', 'factor prognostic model oncology']\n",
      "['chronic lymphocytic leukemia blood advances american society']\n",
      "['bispecific single domain antibody boosts autologous v 9v', 't cell responses', 'chronic lymphocytic leukemia']\n",
      "['wonderful time', 'covid19 vaccine work']\n",
      "['practical advice', 'cll diagnosis', 'cllsm leusm']\n",
      "['blog gep fellow niamh appleby', 'whole genome', 'potential targets', 'richter s syndrome genomics wgs cll richters']\n",
      "['tandem cd19 cd20 car t cells', 'cd19 loss relapses', 'dlbcl mcl cll', 'fl cartcell lymsm']\n",
      "['great new publication', 'clinical cancer research', 'v 9v', 't cells', 'cso hans van der vliet md phd aacr cancerresearch bispecifics tcells cll cd1d oncology immunooncology']\n",
      "['chronic lymphocytic leukemia cll']\n",
      "['new article vaccinations', 'cll implications', 'cll leusm hematology']\n",
      "['new article', 't cell activity', 'cll cll leusm hematology']\n",
      "['cll nnnnntknnnnsla o g olimpodebe bk nnnn nn nn np n un n n nnnnph las g nn k9gnv lasnvb nnn n nn nnl koko unn n nn nnnnmm nnnmnnjnnn nn nnn nn nntnnn', 'ni jtnn']\n",
      "['cll lymsm hematology']\n",
      "['cll implications', 'covid19 gt gt gt effect', 'bruton tyrosine kinase inhibitor', 'recombinant hepatitis b', 'zoster vaccines leusm']\n",
      "['line treatment', 'chronic lymphocytic leukemia', 'strategies dr brander', 'select treatment', 'event hemonc leukemia']\n",
      "['james gerson md', 'navigates treatment selection', 'chronic lymphocytic leukemia', 'exciting developments', 'pipeline leusm']\n",
      "['american society', 'hematology nov', 'chronic lymphocytic leukemia lymphoma', 'sars cov']\n",
      "['natural molecule', 'destroys drug', 'resistant chronic lymphocytic', 'chronic myeloid leukemia cells dr steve martin']\n",
      "['cll b cell chroniclymphocyticleukemia']\n",
      "['cll pts', 'novel agents']\n",
      "['oncoalert vaccinations', 'cll implications', 'covid19 american society', 'hematology leusm cllsm covid19vaccination']\n",
      "['interesting report raises imp s timing', 'covid vaccine pre cll rx indolent b cell malig', 'viral pandemic s influ seq timing', 'cll rx', 'cll lymphoma patients co habitants deserve', 'vaccine results', 'req lymsm']\n",
      "['haematology experts dr james d rozario', 'professor john seymour', 'refractory chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll', 'james amp dr susan leclair phd', 'radiation ct scans mris mrd biopsies']\n",
      "['human disease', 'chronic lymphocytic leukemia']\n",
      "['cll treatments impact', 'care cllsm leusm']\n",
      "['news health canada', 'ibrutinib rituximab', 'chronic lymphocytic leukemia', 'phase iii e1912 study', 'fda amp ema', 'lymphoma lymsm']\n",
      "['members library highlight reading construction plans cll pwxathome']\n",
      "['onct ash2020']\n",
      "['phase i clinicaltrial', 'peptide vaccine', 'chronic lymphocytic leukemia cll', 'minimal residual disease', 'line therapy']\n",
      "['b cell receptor stereotypy', 'chronic lymphocytic leukemia cll']\n",
      "['available btk inhibitors']\n",
      "['b cell receptor pathway inhibition', 'preparation uk']\n",
      "['new article pharmacovigilance evaluation', 'skin disorders', 'adverse drug event report database cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia prognostic models', 'real life', 'long way', 'cll leusm hematology']\n",
      "['new article transformation', 'monoclonal b lymphocytosis', 'epstein barr virus', 'positive large b cell lymphoma', 'large b cell lymphoma', 'classic hodgkin lymphoma cll leusm hematology']\n",
      "['new article statins', 'potassium channels kv1', 'cancer cells cll leusm hematology']\n",
      "['new article', 'long non', 'rna linc00665 promotes gemcitabine resistance', 'cholangiocarcinoma cells', 'stemness properties', '5p bcl9l axis cll leusm hematology']\n",
      "['new article impact', 'economic burden', 'chronic lymphocytic leukemia', 'canada cll leusm hematology']\n",
      "['news von lesen sie jetzt den vollst ndigen beitrag unter zulassung leuk mie chemotherapie iqwig arzneimittel zusatznutzen mutation studie immuntherapie cll wirkstoff kombination']\n",
      "['chronic lymphocytic leukemia increases peripheral blood hematopoietic stem cells']\n",
      "['dr brander', 'select treatment', 'chronic lymphocytic leukemia', 'oncology case', 'peer perspectives event leusm leukemia']\n",
      "['acute leukemia', 'chronic lymphocytic leukemia']\n",
      "['cll clinical trials', 'cllsm leusm clinicaltrials']\n",
      "['tlr9 expression', 'agonist cell', 'free dna correlate', 'leukaemia cell migration', 'poor prognosis', 'cll dual', 'tlr9 amp btk', 'inhibits cll cell migration', 'preclinical models leusm']\n",
      "['health canada approves imbruvica ibrutinib', 'chronic lymphocytic leukemia cll']\n",
      "['long term survivorship tool', 'cll patients cllsm leusm']\n",
      "['post ash cll sessions w john gribben alessandra tedeschi amp', 'demand ash20 hemonc leusm leukemia ctsm cllsm immunoonc']\n",
      "['simay dolaner shares', 'research project', 'therapeutic targets', 'chronic lymphocytic leukemia', 'researchfellowship researchproject citizenscientist learnwithpine']\n",
      "['bloodcancer diagnosis', 'common type', 'chronic lymphocytic leukemia']\n",
      "['icliniq chronic lymphocytic leukemia stages symptoms risk factors']\n",
      "['cll diagnosis', 'full cll faq', 'patient amp expert advice patientpower leusm']\n",
      "['william wierda md phd', 'md anderson cancer center discusses results', 'captivate trial', 'chronic lymphocytic leukemia cll', 'leukemia amp lymphoma society md anderson cancer center']\n",
      "[]\n",
      "['early discontinuation dose modification', 'refractory chronic lymphocytic leukemia oncology']\n",
      "['don t', 'details endcancer leusm', 'leukemia cll ash20']\n",
      "['concomittant occurence', 'thyroid carcinoma metastasis', 'chronic lymphocytic leukemia', 'lymph node', 'internal jugular vein thrombus', 'case report lymphoma lymsm']\n",
      "['new article chronic lymphocytic leukemia prognostic factors', 'center cll leusm hematology']\n",
      "['new article concomittant occurence', 'thyroid carcinoma metastasis', 'chronic lymphocytic leukemia', 'lymph node', 'internal jugular vein thrombus', 'case report cll leusm hematology']\n",
      "['new article', 'immune cell microenvironment', 'chronic lymphocytic leukaemia', 'patient similarity networks cll leusm hematology']\n",
      "['new article corrigendum', 'stat5 pathway underlies', 'novel inhibitory role', 'chronic lymphocytic leukemia exp cell res', 'cll leusm hematology']\n",
      "['new article evaluation', 'microrna 125a expression association', 'bcl2 genes', 'blood leukocytes', 'cll patients', 'case control study cll leusm hematology']\n",
      "['new article antitumor', 'prima 1met apr246', 'hematological malignancies', 'mutant p53', 'dependent affair cll leusm hematology']\n",
      "['chronic lymphocytic leukemia cll', 'patientexperience lymsm cll fatigue research blood']\n",
      "['newarticle impact', 'economic burden', 'chronic lymphocytic leukemia', 'jean lachaine catherine beauchemin', 'chroniclymphocyticleukemia oraltargetedtherapy economicburden markovmodel']\n",
      "['james discusses', 'elevate tn trial', 'treatment na ve cll cll']\n",
      "['chronic lymphocytic leukemia blood advances american society']\n",
      "['b cell receptor stereotypy', 'chronic lymphocytic leukemia']\n",
      "['cancer experts', 'treatment options', 'chronic lymphocytic leukemia', 'dr mazyar shadman']\n",
      "['frontline ibrutinib', 'chronic lymphocytic leukemia', 'tp53 aberrations']\n",
      "['stephan stilgenbauer md', 'official paolo ghia md phd', 'brown md phd', 'cll leusm']\n",
      "['cll treatment approach', 'cllsm leusm']\n",
      "[]\n",
      "['100th issue', 'blood advances', 'review i', 'anthony mato', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll american society', 'hematology leusm lymsm']\n",
      "['digital advocacy', 'health equity', 'cll patients']\n",
      "['increase risk', 'cll indolent nhl', 'anticoagulation antiplatelet therapy cancer therapy advisor oncology medtwitter']\n",
      "['dr jennifer woyach', 'james shares', 'expert perspective leusm cllsm']\n",
      "['mksap pearl immune thrombocytopenic purpura', 'sle chronic lymphocytic leukemia lymphoma hiv hepatitis c', 'h pylori infection']\n",
      "['ash20 chronic lymphocytic leukemia web broadcast', 'expert panel', 'world cases', 'novel therapeutics']\n",
      "['esmo cll clinicalpracticeguidelines', 'patient stratification amp choice']\n",
      "['don t', 'post ash20 cll session w john gribben alessandra tedeschi amp', 'ash20 hemonc leusm leukemia ctsm cllsm']\n",
      "['dr blanca espinet', 'dr anna puiggros', 'barcelona spain', 'chronic lymphocytic leukemia cll', 'saphyr results', 'complex cll samples', 'cytoscan hd amp karyotype bngo bionanosymposium']\n",
      "['bu ak', 'kroniklenfositiklosemi konu aca z lgi duyan ve vakti olanlar bekleriz losemi kll immunoterapi kokhucre cll cancer']\n",
      "['esmo clinical practice guidelines', 'diagnosis treatment', 'cll european research initiative', 'cll eric']\n",
      "['emil j freireich hematology', 'grand rounds cll ash20 update', 'william wierda md phd', 'cst endcancer leusm']\n",
      "['post ash20', 'roundtable discussion w cll experts', 'ash20 hemonc leusm leukemia ctsm cllsm']\n",
      "['chronic lymphocytic leukaemia', 'useful guidance', 'esmo clinical practice guidelines', 'diagnosis treatment', 'cll hematology leusm oncology']\n",
      "['new article', 'endocrinological side', 'ibrutinib cll leusm hematology']\n",
      "['new article', 'current status', 'gpcr drugs', 'different cancers cll leusm hematology']\n",
      "['new article cutaneous manifestation', 'possible implications cll leusm hematology']\n",
      "['new article evidence', 'b cell clonality', 'schnitzler syndrome cll leusm hematology']\n",
      "['tndailynews berlin researchers', 'new approach', 'car t cell therapy', 'follicular lymphomas', 'chronic lymphocytic leukemia', 'common type', 'blood cancer']\n",
      "['dr nguyen', 'beautiful lecture', 'b cell receptor', 'chronic lymphocytic leukemia cancerbiology']\n",
      "['clinical utility', 'genomic arrays', 'copy number alterations assessment', 'cll diagnostics', 'retrospective analysis']\n",
      "['great night', 'cll data']\n",
      "['i ve', 'wasn t', 'blood tests i', 'wouldn t']\n",
      "['growth factor', 'cancer cells', 'breast cancer chronic lymphocytic leukemia', 'acute myeloid leukemia', 'leukemia cells', 'vegf receptors dr steve martin']\n",
      "['comprehensive review', 'ibrutinib cll hememalignancies crst']\n",
      "['cme activity don t', 'field john m burke md amp manuel', 'santiago md gt gt']\n",
      "['super day', 'nursery kicking', 'new book', 'woodland bird song', 'woods cll']\n",
      "['jan burger md phd', 'ash20 endcancer leukemia', 'line ibrutinib', 'cll sll', 'mutational risk']\n",
      "['refractory chronic lymphocytic leukemia status', 'condition summary lymphocytic leukemia chronic sll']\n",
      "['john hayslip md executive', 'medical director', 'abbvie pharmaceuticals discusses', 'murano study', 'leukemia amp lymphoma society abbvie', 'leukemia amp lymphoma society']\n",
      "['bloodcancer understanding', 'early test', 'common type', 'chronic lymphocytic leukemia']\n",
      "['clinicaltrial cap', 'refractory chronic lymphocytic leukemia']\n",
      "['new clinical trial cap', 'refractory chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article intracranial hemorrhage', 'chronic lymphocytic leukemia', 'ibrutinib cll leusm hematology']\n",
      "['new2trip venetoclax', 'chronic lymphocytic leukemia', 'yr results amp evaluation', 'genomic complexity amp gene mutations', 'murano phase iii study']\n",
      "['wonderful free event', 'eyfs practitioners earlylanguage cll']\n",
      "['cll w lydia scarf', 'ash20 hemonc leusm leukemia mrd immunoonc ctsm trialupdate hematology cllsm']\n",
      "['cancer stat facts sheet']\n",
      "['tanya siddiqi md', 'car t cell therapy', 'chronic lymphocytic leukemia leusm']\n",
      "['rituximab arrx', 'rituximab biosimilar', 'non hodgkin lymphoma', 'chronic lymphocytic leukemia', 'lymsm lymphoma']\n",
      "['new article cll', 'monoclonal b cell lymphocytosis displays', 'inflammatory signature', 'early stage chronic lymphocytic leukemia cll leusm hematology']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['new article molecular weight', 'dependent flexible phase behaviors', 'amphiphilic block copolymer additive complexes', 'aqueous solution cll leusm hematology']\n",
      "['new article corticosteroids contribute', 'serious adverse events', 'varicella vaccination', 'zoster vaccination cll leusm hematology']\n",
      "['cll pts']\n",
      "['hairy cell leukemia coexistent', 'chronic lymphocytic leukemia cll']\n",
      "['line ibrutinib vs chemoimmunotherapy', 'cll w', 'ash20 hemonc leusm leukemia realworlddata immunoonc hematology cllsm']\n",
      "['cme activity don t', 'field john m burke md amp manuel', 'santiago md gt gt']\n",
      "['cll advocates network covid statement', 'english german spanish', 'vaccnations covid cll bloodcancer']\n",
      "['primary cutaneous lymphomas', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll', 'cases lymphoma lymsm']\n",
      "['new article myeloid disease', 'csf3r t618i mutation', 'cll cll leusm hematology']\n",
      "['new article birc3', 'birc5 multi', 'cancer cll leusm hematology']\n",
      "['rip tr s engag', 'langue fran aise au luxembourg l crivain', 'r sistant luxembourgeois emile hemmen dispara t', 'ans den emile hemmen ass dout bettel bachelot fice cll livre edition']\n",
      "['gc follicular colonization', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma comment', 'small lymphocytic lymphoma', 'primary cutaneous', 'marginal zone lymphoma', 'germinal center follicles']\n",
      "['colorado cll patients', 'new dinner', 'docs series', 'rocky mountain cancer centers registration', 'free dinner gift card']\n",
      "['mbl immune environment', 'exp hematol cll mbl vhebron cll', 'monoclonal b cell lymphocytosis displays']\n",
      "['followfriday check', 'global education platform', 'clinical updates', 'lymphoma subtypes', 'chronic lymphocytic leukemia cll lymsm']\n",
      "['sawaf md', 'universit t zu k ln discusses', 'cll14 trial', 'term treatment', 'chronic lymphocytic leukemia patients', 'standard treatment']\n",
      "['follicular colonization', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma comment', 'small lymphocytic lymphoma', 'primary cutaneous', 'marginal zone lymphoma', 'germinal center follicles lymphoma lymsm']\n",
      "['molecular biomarkers', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['new article ibrutinib', 'orbital metastasis', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article characteristics', 'non aids patients', 'acute respiratory failure', 'pneumocystis pneumonia cll leusm hematology']\n",
      "['new article follicular colonization', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma comment', 'small lymphocytic lymphoma', 'primary cutaneous', 'marginal zone lymphoma', 'germinal center cll leusm hematology']\n",
      "['new article', 'molecular biomarkers', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article building', 'reference centers', 'red53 initiative cll leusm hematology']\n",
      "['new article', 'prognostic marker', 'clinical heterogeneity', '13q deletion cll leusm hematology']\n",
      "['new paper', 'chronic lymphocytic leukaemia cll', 'new therapeutic drug target']\n",
      "[]\n",
      "['tlr9 expression', 'chronic lymphocytic leukemia identifies', 'pro migratory subpopulation', 'novel therapeutic target blood american society']\n",
      "['team effort', 'lockdown collaborators', 'amazing funders uk', 'michael chowen research fund']\n",
      "['2ne1 cll bom parkbom dara sandarapark minzy']\n",
      "[]\n",
      "['chronic lymphocytic leukemia', 'american journal', 'forensic medicine']\n",
      "['current cll treatment approaches cllsm']\n",
      "['international workshop', 'chronic lymphocytic leukemia iwcll head', 'current meeting information amp register', 'iwcll2021 cll hematology oncology cc']\n",
      "['medicare beneficiary george', 'chronic lymphocytic leukemia medication']\n",
      "['cll patients']\n",
      "['prognostic indices', 'chronic lymphocytic leukemia cll']\n",
      "['cll patients access', 'clinical trials cllsm leusm']\n",
      "['icymi experts', 'cll patients', 'chronic lymphocytic leukemia', 'difficult year experts reflect', 'amp address', 'covid19 vaccine', 'things re', 'open amp']\n",
      "['new article', 'novel agents', 'cll cll leusm hematology']\n",
      "['new article eha endorsement', 'esmo clinical practice guidelines', 'diagnosis treatment', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article concurrent bk polyomavirus adenovirus', 'cytomegalovirus infections', 'chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['sars cov', 'antibody response', 'chronic lymphocytic leukemia aug', 'leukemia covid19ncancer covid19 cllsm leusm ccc19 ht md']\n",
      "['cll covid19', 'statement liz']\n",
      "['new members', 'patient organisations']\n",
      "['tp53 network', 'hematology thanks', 'ighv mutational analysis', 'whole country thanks', 'successful initiative cll']\n",
      "['refractory cll', 'hematology ash20 hemonc leukemia leusm ctsm trialupdate cllsm']\n",
      "['checkpoint blockade', 'melanoma patients', 'chronic lymphocytic leukemia']\n",
      "['crbiotech paper', 'pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line', 'autophagic flux']\n",
      "['line therapy', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['new study uses', 'bim antibody', 'chronic lymphocytic leukemia cll']\n",
      "['print pre neoplastic alterations', 'cll dna methylome', 'disease progression', 'therapy molgen leusm']\n",
      "['cll expert dr john pagel', 'long term survivorship care', 'patients cllsm leusm cll']\n",
      "['winship hematologist jonathon cohen md ms discusses therapeutic options', 'old patients', 'chronic lymphocytic leukemia', 'genomic aberration']\n",
      "['chronic lymphocytic leukemia', 'bone marrow', 'white blood cell']\n",
      "['current situation', 'new levels', 'stress amp anxiety', 'cll bloodcancer leukaemia', 'help amp advice']\n",
      "['kerry rogers md', 'james discusses', 'minimal residual disease assessment component', 'obinutuzumab ibrutinib', 'chronic lymphocytic leukemia leusm']\n",
      "['patient advocate jay blatt', 'dr nicole lamanna', 'questions amp', 'hand perspectives leusm patientpower']\n",
      "['iwcll2021 visit', 'biennial international meeting', 'september cc cll hematology oncology']\n",
      "['vaccines work', 'blood cancer patients', 'chronic lymphocytic leukemia cll']\n",
      "['sawaf md', 'germany discusses', 'cll14 trial', 'chronic lymphocytic leukemia leusm']\n",
      "['regional differences', 'chronic lymphocytic leukemia cll patients purchase', 'insight report']\n",
      "['natural history', 'monoclonal b cell lymphocytosis mbl', 'chronic lymphocytic leukemia cll families']\n",
      "['telemedicine impact time', 'cll cllsm']\n",
      "['novel therapeutics', 'cme video activity']\n",
      "['hemasphere s', 'monthly issue', 'available january s articles', 'hematopoeisis biosimilars genetherapy mpns doac cll mantlecelllymphoma allohct']\n",
      "['anthony mato md', 'memorial sloan', 'cancer center', 'chronic lymphocytic leukemia', 'discusses findings', 'informcll registry', 'leukemia amp lymphoma society']\n",
      "['svar fra dk p mange sp rgsm l om vaccination mod covid19 hvordan og hvorn r kontakt egen l ge', 'blodkr ft blodcancer lymfekr ft leuk mi mds', 'aml apl cll cml sundpol sundhedsstyrelsen dksund']\n",
      "['new clinical trial', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll leusm hematology']\n",
      "['new article attachment', 'chronic lymphocytic leukaemia cells', 'autologous polymorphonuclear neutrophils', 'cd19 cd64 antibody cll leusm hematology']\n",
      "['new article', 'leukemia microenviroment', 'vitro cll leusm hematology']\n",
      "['new article flow cytometric analysis', 'protein expression', 'b cell chronic lymphocytic leukemia prognostication usefulness', 'limitations cll leusm hematology']\n",
      "['new article trna', 'fragments mechanisms', 'gene expression', 'potential applications', 'therapeutic targets', 'virus infections cll leusm hematology']\n",
      "['sawaf md', 'universit t zu k ln', 'chronic lymphocytic leukemia cll', 'leukemia amp lymphoma society universit t zu k ln', 'leukemia amp lymphoma society']\n",
      "['liso cel', 'refractory cll', 'hematology ash20 hemonc leukemia leusm mrd immunoonc tcellrx ctsm trialupdate cllsm']\n",
      "['cartcelltherapy market size']\n",
      "['cll society s', 'official statement', 'sars cov', 'cll patients chronic lymphocytic leukemia physician', 'official statement']\n",
      "['global chronic lymphocytic leukemia treatment market production capacity revenue price']\n",
      "['iqwig ibrutinib', 'rituximab bei nicht vorbehandelter cll hinweis auf zusatznutzen f r patienten mit gutem allgemeinzustand', 'kombination verl ngert das gesamt berleben f r andere patientengruppen liegen keine studiendaten vor']\n",
      "['key studies', 'generation btk inhibitors combo treatments', 'car t therapies']\n",
      "['key studies', 'generation btk inhibitors combo treatments amp car t therapies']\n",
      "['telemedicine activate', 'remote tools', 'manage cll cllsm']\n",
      "['new cll activity', 'ash20 cme']\n",
      "['novant health cancer institute', 'frontline therapy', 'chronic lymphocytic leukemia leusm']\n",
      "['leukemic extracellular vesicles', 'chimeric antigen receptor t cell dysfunction', 'chronic lymphocytic leukemia sciencedirect']\n",
      "['leukemic extracellular vesicles', 'chimeric antigen receptor t cell dysfunction', 'chronic lymphocytic leukemia']\n",
      "['great collaboration', 'neil kay', 'immunosuppressive tumor evs', 'car t cell function extracellularvesicles cart cll']\n",
      "['leukemic extracellular vesicles', 'chimeric antigen receptor t cell dysfunction', 'chronic lymphocytic leukemia']\n",
      "['cll indication', 'good general health', 'combination prolongs overall survival', 'study data', 'patient groups']\n",
      "['rituximab bei nicht vorbehandelter cll hinweis auf zusatznutzen f r patienten mit gutem allgemeinzustand', 'kombination verl ngert das gesamt berleben f r andere patientengruppen liegen keine studiendaten vor']\n",
      "['standard treatment protocols', 'chronic lymphocytic leukemia experts', 'pandemic cll covid']\n",
      "['new article leukemic extracellular vesicles', 'chimeric antigen receptor t cell dysfunction', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['startling case study', 'asymptomatic covid', 'immune system', 'cll chronic lymphocytic leukemia', 'cll amp', 'immuno suppressive treatment']\n",
      "['18f fdg pet ct role', 'richter transformation', 'chronic lymphocytic leukemia', 'overall survival']\n",
      "['venetoclax chronic lymphocytic leukemia cll phase']\n",
      "['cll saglife']\n",
      "['chronic lymphocytic leukemia', 'small lymphocytic lymphoma space venetoclax', 'positive reports', 'clinical trials', 'acute myeloid leukemia', 'multiple myeloma leusm mmsm']\n",
      "['vaccines work', 'blood cancer patients', 'chronic lymphocytic leukemia cll']\n",
      "['genomic arrays', 'high risk chronic lymphocytic leukemia', 'prime time']\n",
      "['18f fdg pet ct role', 'richter transformation', 'chronic lymphocytic leukemia', 'overall survival lymphoma lymsm']\n",
      "['new article genomic arrays', 'high risk chronic lymphocytic leukemia', 'prime time cll leusm hematology']\n",
      "['new article', '18f fdg pet ct role', 'richter transformation', 'chronic lymphocytic leukemia', 'overall survival mmsm multiplemyeloma hematology']\n",
      "['paul m barr md', 'novel therapies', 'chronic lymphocytic leukemia leusm']\n",
      "['md mmsc', 'year analysis', 'murano study', 'refractory chronic lymphocytic leukemia leusm']\n",
      "['tanya siddiqi md', 'car t cell therapy', 'chronic lymphocytic leukemia cll']\n",
      "['large granular lymphocytic leukemia lgl tweetorial goodman heme', 't cell lgl', 'chronic lymphoproliferative disorder', 'nk cells', 'aggressive nk cell leukemia lgl cells', 'large lymphs', 'moderate copious cytoplasm', 'prominent azurophilic granules reniform nucleus']\n",
      "['rare case presentation', 'chronic lymphocytic leukemia', 'chronic myeloid leukemia', 'patkar salil panchal harsha asha anand patel apurva', 'parikh sonia', 'full text article']\n",
      "['epigenetic regulation', 'steroidogenic enzymes', 'peripheral blood mononuclear cells', 'healthy individuals', 'chronic lymphocytic leukemia']\n",
      "['bruton tyrosine kinase inhibitors', 'frontline treatment', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['new article genomic instability', 'clonal evolution', 'chronic lymphocytic leukemia clinical relevance cll leusm hematology']\n",
      "['new article microenvironment', 'subsequent clinical implications', 'large b cell histologic variant', 'richter syndrome cll leusm hematology']\n",
      "['new article bruton tyrosine kinase inhibitors', 'frontline treatment', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article refractory chronic lymphocytic leukemia', 'central nervous system involvement', 'case report', 'literature review cll leusm hematology']\n",
      "['new article', 'refractory chronic lymphocytic leukaemia', 'unusual course cll leusm hematology']\n",
      "['happy new year', 'cll pts']\n",
      "['62nd ash', 'annual meeting amp exposition focus']\n",
      "['ash2020 update', 'adolescents amp', 'young adults', 'chronic lymphocytic leukemia medtwitter cancer']\n",
      "['cll patients', 'dr nicole lamanna', 'amp dr jennifer', 'new year leusm patientpower']\n",
      "['strong support', '1st resistance line', 'aml indication', 'potential data', 'eha2021 cll 750mg', 'pts amp']\n",
      "['molecular remission', 'low dose immunotherapy', 'minimal toxicities', 'poor prognosis ighv', 'chronic lymphocytic leukemia', 'maharaj d srinivasan g abreu mm ko mw jewett', 'gouvea j']\n",
      "['chronic lymphocytic leukemia increases peripheral blood hematopoietic stem cells chronic lymphocytic leukemia']\n",
      "['new clinical trial anakinra', 'chronic lymphocytic leukemia patients cll leusm hematology']\n",
      "['difficult case', 'refractory cipd cll', 'amp company']\n",
      "['preliminary results', 'phase i trial', 'liso cel', 'r r cll w', 'ash20 hematology hemonc leusm leukemia cllsm tcellrx immunoonc ctsm']\n",
      "['john n allan md', 'safety profile', 'high risk chronic lymphocytic leukemia leusm']\n",
      "['paul m barr md', 'novel therapies', 'chronic lymphocytic leukemia leusm']\n",
      "['biosimilar riabni', 'non hodgkin s lymphoma chronic lymphocytic leukemia granulomatosis', 'microscopic polyangiitis']\n",
      "['cll patients', 'utilize telemedicine']\n",
      "['patients w']\n",
      "['expert expands', 'treatment choices', 'genomic aberrations']\n",
      "['william wierda md phd', 'md anderson cancer center discusses results', 'captivate trial', 'chronic lymphocytic leukemia cll', 'leukemia amp lymphoma society md anderson cancer center']\n",
      "['new clinical trial', 'multi peptide vaccination', 'cll patients cll leusm hematology']\n",
      "['new article', 'active stat3', 'chronic lymphocytic leukemia', 'clinical trial', 'stat3 inhibitor pyrimethamine', 'pharmacodynamic analyses cll leusm hematology']\n",
      "['new article thrombin generation profile', 'various lymphoma sub groups', 'andexanet alfa cll leusm hematology']\n",
      "['new article tumor lysis syndrome', 'chronic lymphocytic leukemia', 'conventional treatment versus novel agents', 'systematic review', 'meta analysis cll leusm hematology']\n",
      "['new article relationship', 'chronic lymphocytic leukaemia', 'causation cll leusm hematology']\n",
      "['standard treatment protocols']\n",
      "['pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line', 'autophagic flux']\n",
      "['practical tips', 'chronic lymphocytic leukemia cll cll leukemia cancer']\n",
      "['cd3xcd19 dart molecule treatment induces non apoptotic', 'high risk chemotherapy', 'resistant cll cells']\n",
      "['car t cells', 'concurrent ibrutinib', 'ibrutinib failure']\n",
      "['acute promyelocytic leukemia', 'chronic lymphocytic leukemia leusm']\n",
      "['pi3k inhibitor inhibits ros', 'human monocytes', 'treatment promotes nkcell', 'malignant bcells', 'akt nox2 cll']\n",
      "['new article', 'annual meeting highlights', 'practitioner hematologic malignancies cll leusm hematology']\n",
      "['new article', 'stable improvement', 'classical b cell chronic lymphocytic leukemia', 'dietary interventions', 'personal experience cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia skin infiltrates', 'eyebrow alopecia', 'erythematous pruritic papules refractory', 'topical steroids cll leusm hematology']\n",
      "['new article expression', 'lipoprotein lipase', 'c myc oncogene', 'chronic lymphocytic leukemia', 'chornobyl accident cll leusm hematology']\n",
      "['new article study', 'chromosome instability', 'human somatic cells', 'bystander effect cll leusm hematology']\n",
      "['new article c3 glomerulopathy', 'b cell chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article autoimmune cytopenia', 'chronic lymphocytic leukemia diagnosis', 'treatment cll leusm hematology']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['gene expression', 'predicts sensitivity', 'chronic lymphocytic leukemia cells']\n",
      "['new article gene expression', 'predicts sensitivity', 'chronic lymphocytic leukemia cells', 'dasatinib cll leusm hematology']\n",
      "['new article correction hdac7', 'actionable driver', 'therapeutic antibody resistance', 'cll patients cll leusm hematology']\n",
      "['cryptoliveleak show', 'livestream package', 'cll cll cryptoliveleaktoken', 'io view offering']\n",
      "['telemedicine impact time']\n",
      "['innocare announces', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'refractory mantle cell lymphoma biospace']\n",
      "['vie est un don', 'dieu quand nous avons', 'chance d tre heureux se ne te prive pas', 'il faut l tre au', 'maximum cll bon d', 'semaine tous']\n",
      "['crbiotech paper', 'pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line', 'autophagic flux']\n",
      "['john hayslip md executive', 'medical director', 'abbvie pharmaceuticals discusses', 'murano study', 'leukemia amp lymphoma society abbvie', 'leukemia amp lymphoma society']\n",
      "['chronic lymphocytic leukemia market size epidemiology', 'companies drugs', 'competitive analysis']\n",
      "['new clinical trial copanlisib', 'r r cll cll leusm hematology']\n",
      "['transcend cll', 'monotherapy cohort w tanya siddiqi', 'ash20 hematology hemonc leusm leukemia cllsm tcellrx']\n",
      "['duration treatment venclexta venclyxto venetoclax', 'chronic lymphocytic leukemia cll']\n",
      "['tanya siddiqi md', 'car t cell therapy', 'chronic lymphocytic leukemia leusm']\n",
      "['innocare announces', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'refractory mantle cell lymphoma business wire']\n",
      "['innocare announces', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'refractory mantle cell lymphoma stockmarket']\n",
      "['innocare announces', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'refractory mantle cell lymphoma']\n",
      "['innocare announces', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'refractory mantle cell lymphoma business wire innocare announces']\n",
      "['innocare announces', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'refractory mantle cell lymphoma']\n",
      "['paul m barr md', 'novel therapies', 'chronic lymphocytic leukemia']\n",
      "['innocare announces', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'refractory mantle cell lymphoma']\n",
      "['innocare announces', 'refractory chronic lymphocytic']\n",
      "['standard treatment protocols']\n",
      "['tanya siddiqi md', 'car t cell therapy', 'chronic lymphocytic leukemia leusm']\n",
      "['real world patients', 'chronic lymphocytic leukemia bloodcancer medtwitter']\n",
      "['duration venetoclax obinutuzumab therapy', 'effective mrd eradication', 'chronic lymphocytic leukemia ash2020 bloodcancer medtwitter']\n",
      "['duration ibrutinib venetoclax', 'line option', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma oncology']\n",
      "['duration ibrutinib venetoclax', 'line option', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma hematology']\n",
      "['post ash20', 'roundtable discussion w cll experts', 'incredible opportunity', 'exciting updates', 'ash tue jan', 'pm cet', 'est ash20 hemonc leusm leukemia ctsm cllsm']\n",
      "['interesting clinical trial', 'impact amp potential benefits', 'cancer progression', 'patients w cll chronic lymphocytic leukemia', 'months health diet']\n",
      "['data highlights venetoclax treatment', 'chronic lymphocytic leukemia ash2020 leusm cancer']\n",
      "['chronic lymphocytic leukemia b cell', 'tnf impairs bone marrow myelopoiesis']\n",
      "['rare case presentation', 'chronic lymphocytic leukemia', 'chronic myeloid leukemia', 'patkar salil panchal harsha asha anand patel apurva', 'parikh sonia', 'full text article']\n",
      "['long term outcomes', 'chronic lymph']\n",
      "['adolescents amp', 'young adults', 'chronic lymphocytic leukemia medtwitter cancer ash2020']\n",
      "['sawaf md', 'universit t zu k ln discusses', 'cll14 trial', 'term treatment', 'chronic lymphocytic leukemia patients', 'standard treatment']\n",
      "['hucart19 il18', 'nhl cll patients status', 'condition summary chronic lymphocytic leukemia non hodgkin lymphoma']\n",
      "['fda approves riabni rituximab arrx', 'amgen riabni rituximab arrx', 'cytolytic antibody biosimilar', 'rituxan 50b sales', 'adult patients', 'non hodgkin s lymphoma chronic lymphocytic leukemia', 'wegener s pharma']\n",
      "['duration ibrutinib venetoclax', 'line option', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma hematology']\n",
      "['combination therapies w john allan', 'ash20 hematology hemonc leusm leukemia cllsm immunoonc']\n",
      "['interesting cll']\n",
      "['duration imbruvica venclexta combo benefits people', 'chronic lymphocytic leukemia']\n",
      "['new clinical trial hucart19 il18', 'nhl cll patients cll leusm hematology']\n",
      "['new clinical trial', 'chronic cll sll cll leusm hematology']\n",
      "['dr danilov', 'old patient', 'chronic lymphocytic leukemia leusm leukemia']\n",
      "['absent response', 'sars cov', 'chronic lymphocytic leukemia lymphoma']\n",
      "['md mmsc', 'year analysis', 'murano study', 'refractory chronic lymphocytic leukemia leusm']\n",
      "['duration imbruvica venclexta combo benefits people', 'chronic lymphocytic leukemia ash20']\n",
      "['btk inhibitor ibrutinib', 'cll cells', 'lymph nodes dampens cd40', 'alternative prosurvival proteins bclxl', 'biological rationale']\n",
      "['ash2020 update', 'chronic lymphocytic leukemia', 'bruin clinical trial', 'cll sll cancer medtwitter']\n",
      "['venetoclax uncover', 'functional hierarchy']\n",
      "['molecular remission', 'low dose immunotherapy', 'minimal toxicities', 'poor prognosis ighv', 'chronic lymphocytic leukemia', 'full text']\n",
      "['liver intrahepatic bile duct cancer', 'chronic lymphocytic leukemia', 'mantle cell lymphoma']\n",
      "['cll drug trial news dr anthony mato loxo', 'demonstrates efficacy', 'cll sll loxo25']\n",
      "['season s greetings', 'scientific cooperations', 'clinical protocols', 'future generations', 'cll gcllsg']\n",
      "['new article chronic lymphocytic leukemia increases', 'peripheral blood hematopoietic stem cells', 'skews differentiation cll leusm hematology']\n",
      "['new article cll dedifferentiation', 'myeloid cells cll leusm hematology']\n",
      "['new article constitutive activation', 'lyn kinase enhances bcr responsiveness', 'e tcl1 mice cll leusm hematology']\n",
      "['pubsaludmurcia clinical characteristics', 'sars cov', 'chronic lymphocytic leukemia', 'european country']\n",
      "['restriction requirements', 'england scotland', 'wales covid cll']\n",
      "['ash astct covid', 'questions cll ash s faqs', 'blood cancer patients', 'cll dr wiestner']\n",
      "['generation non covalent bruton tyrosine kinase inhibitors', 'chimeric antigen receptor t cell therapy', 'chronic lymphocytic leukemia leusm']\n",
      "['chronic lymphocytic leukemia', 'fast dosent']\n",
      "['duration imbruvica venclexta combo benefits people', 'chronic lymphocytic leukemia ash20']\n",
      "['umbralisib ublituximab improves progression', 'free survival', 'chronic lymphocytic leukemia cll leukemia hematology hematologist accme oncology oncologist cll tuesdaynewsday']\n",
      "['wonderwoman strength', 'powerful enemies empowers', 'cll movie', 'leukemia cancer bloodcancer quote tweet']\n",
      "['car t cell therapy lisocabtagene maraleucel liso cel', 'mantle cell lymphoma', 'refractory chronic lymphocytic leukemia data cannabis marijuana']\n",
      "['cll dedifferentiation', 'myeloid cells cll']\n",
      "['anthony mato md', 'memorial sloan', 'cancer center', 'chronic lymphocytic leukemia', 'discusses findings', 'informcll registry', 'leukemia amp lymphoma society']\n",
      "['chronic lymphocytic leukemia cll', 'multiple sclerosis']\n",
      "['new clinical trial polatuzumab vedotin', 'richter s transformation cll leusm hematology']\n",
      "['cll stories', 'cll diagnosis']\n",
      "['clinical characteristics', 'sars cov', 'chronic lymphocytic leukemia', 'european country publicht']\n",
      "['clinical characteristics', 'sars cov', 'chronic lymphocytic leukemia', 'european country hvhebron onco hemat text complet oncology']\n",
      "['new article chronic lymphocytic leukemia', 'coronary arteries', 'incidental autopsy', 'cll leusm hematology']\n",
      "['new article', 'accurate assessment', 'minimal residual disease', 'chronic lymphocytic leukemia', 'novel cd160 ror1 assay cll leusm hematology']\n",
      "['important survey', 'cll patients', 'duration treatments']\n",
      "['cll amp covid', 'expert answers', 'cll patients', 'cll treatments', 'pandemic btk amp pi3k inhibition']\n",
      "['btk elevate tn asend']\n",
      "['btk inhibitors', 'dr jacqueline barrientos shares', 'vaccine approvals']\n",
      "['mmmmm i', 'chinese hamster ovary cell proteins', 'subcutaneous rituximab injection', 'nanaimo cancer clinic', 'holiday season', 'cheery friendly vibe']\n",
      "['ash20 highlight video', 'aps sara tinsley phd aprn aocn', 'moffitt cancer center discusses', 'murano study findings', 'r r cll', 'rituximab abstract']\n",
      "['cll clinical trial', 'doctor cllsm leusm']\n",
      "['duration imbruvica venclexta combo benefits people', 'chronic lymphocytic leukemia ash20']\n",
      "['common side', 'therapies dr jennifer woyach', 'leusm cllsm']\n",
      "['adult patients', 'non hodgkin lymphoma chronic lymphocytic leukemia granulomatosis', 'microscopic polyangiitis hematology biosimilars']\n",
      "['fda expands indications', 'drugs covid', 'cll sll dapagliflozin']\n",
      "['69yo w', 'recent gleason', 'pca psa', 'ct pelvic', 'lns pt', 'chronic lymphocytic leukemia cll', 'such findings']\n",
      "['cll meeting', 'particular iwcll2021 savethedate cme']\n",
      "['chronic lymphocytic leukemia increases', 'peripheral blood hematopoietic stem cells', 'skews differentiation cll']\n",
      "['monday blues', 'umbralisib ublituximab', 'mondaymotivation mm nurse physician oncology oncologist leukemia hematology hematologist ash2020 ash20']\n",
      "['important questions', 'radiation ct scans mris mrd bloodwork biopsies', 'leusm patientpower']\n",
      "['great discussion', 'mpn hodgkinlymphoma myeloma']\n",
      "['cll stories reminds', 'small things', 'big difference', 'cll download']\n",
      "['early discontinuation dose modification', 'refractory chronic lymphocytic leukemia post', 'phase iii murano study haematology thewiderwiserview']\n",
      "['sars cov', 'antibody response', 'chronic lymphocytic leukemia']\n",
      "['sars cov', 'antibody response', 'chronic lymphocytic leukemia aug', 'leukemia covid19ncancer covid19 cllsm leusm ccc19 covid19vaccine n', 'onconotes cfr']\n",
      "['sars cov', 'antibody response', 'chronic lymphocytic leukemia aug', 'leukemia covid19ncancer covid19 cllsm leusm ccc19 ht md']\n",
      "['new article ab initio spillover compensation', 'cytof data cll leusm hematology']\n",
      "['chronic lymphocytic leukemia oncology']\n",
      "['1c category', 'vaccine distribution', 'fellow patients', 'risky immuno', 'mpnsm i']\n",
      "['cll patients', 'long term antibody response', 'covid infection']\n",
      "['phase 1b', 'fcr dfcr', 'frontline therapy', 'cll patients leukemia']\n",
      "[]\n",
      "['u s', 'national institutes', 'pesticide dicamba', 'numerous cancers', 'intrahepatic bile duct cancers', 'chronic lymphocytic leukemia', 'mantle cell lymphoma']\n",
      "['duration venetoclax obinutuzumab therapy', 'effective mrd eradication', 'chronic lymphocytic leukemia ash2020 bloodcancer medtwitter']\n",
      "['sars cov', 'antibody response', 'chronic lymphocytic leukemia leukemia']\n",
      "['chronic lymphocytic leukemia cll leusm']\n",
      "['world experts']\n",
      "['inspirational tweeps', 'lymsm cll']\n",
      "[]\n",
      "['cll specifikt nyhedsbrev hvor lyle udtaler sig udgivet af netdoktor dk det er vigtig', 'f den rigtig', 'og bedre livskvalitet resten af livet blodkr ft blodcancer network lymphoma coalition']\n",
      "['new article clinical characteristics', 'sars cov', 'chronic lymphocytic leukemia', 'european country cll leusm hematology']\n",
      "['rescue dog', 'great support', '5th star', 'cll stories', 'support people', 'short walk']\n",
      "['obinutuzumab ibrutinib', 'cll w kerry rogers', 'ash20 hematology hemonc leukemia leusm cllsm cll ctsm immunoonc']\n",
      "['systems biology drug', 'identifies statins', 'current therapies', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['erlene seymour md', 'discusses investigational btk inhibitors', 'chronic lymphocytic leukemia cll']\n",
      "['ash20 cll review register', 'post ash20', 'roundtable discussion w tue jan', 'pm cet', 'est ash20 hemonc leusm leukemia ctsm cllsm']\n",
      "['free survival', 'low rates', 'chronic lymphocytic leukemia']\n",
      "['manage life', 'cll management']\n",
      "['important murano tox ax sharman', 'premature d c vr lt 2y pfs', 'prem d c ven', 'reason pd', 'p lt', 'pfs os tox mx', 'venr pfs outcome cll lymsm']\n",
      "['cll speakers', 'md anderson tx pgimer chandigarh', 'new delhi', 'zoom link', 'pm leusm hememalignancies']\n",
      "['ash20 updates', 'cll leusm']\n",
      "['exciting session', 'webinar webinar id', 'cll mmsm ash20 endcancer leusm', 'hccwebinar lymsm mmsm']\n",
      "['special thanks', 'antonella santoro amp elisa laurenti', 'bone marrow failure', 'cll patients lymsm american society']\n",
      "['new article association', 'tp53 polymorphisms', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article systems biology drug', 'identifies statins', 'current therapies', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article cd37', 'b cell', 'monoclonal antibodies cll leusm hematology']\n",
      "['free treatments', 'treatment na ve chronic leukemia']\n",
      "['tgtx umbralisib ublituximab cll']\n",
      "['cll chroniclymphaticleukemia leukemia cancersucks pleaseshare']\n",
      "['gofundme pleasehelp cll chroniclymphatic chroniclymphaticleukemia pleaseshare']\n",
      "['imbruvica ibrutinib', 'venclexta venclyxto venetoclax combination shows', 'free survival', 'year post treatment', 'chronic lymphocytic leukemia cll']\n",
      "['tumor lysis syndrome', 'chronic lymphocytic leukemia medicine']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['tumor lysis syndrome', 'chronic lymphocytic leukemia medicine']\n",
      "['telemedicine impact time', 'cll cllsm leusm']\n",
      "['rituximab arrx', 'adult patients', 'non hodgkin lymphoma chronic lymphocytic leukemia granulomatosis', 'microscopic polyangiitis']\n",
      "['real world patients', 'chronic lymphocytic leukemia bloodcancer medtwitter']\n",
      "['covidvaccine cll doc cll']\n",
      "['systems biology drug', 'identifies statins', 'current therapies', 'chronic lymphocytic leukemia']\n",
      "['cll patient', 'treatment decisions dr jennifer woyach', 'james shares advice leusm cllsm']\n",
      "['u s', 'front line therapy', 'chronic lymphocytic leukemia cll dr richard furman expands']\n",
      "['new cll survivor', 'cll specialists', 'treatment pathway', 'life goals leusm patientpower']\n",
      "['rituximab arrx riabni', 'non hodgkin lymphoma chronic lymphocytic leukemia granulomatosis', 'microscopic polyangiitis']\n",
      "['case report chronic lymphocytic leukemia', 'rare translocation t', 'q32 q13', 'igh bcl3 rearrangements', 'chinese cases', 'literature review']\n",
      "['free treatments', 'treatment na ve chronic lymp']\n",
      "['mabtas ra 500mg injection', 'chronic lymphocytic leukemia requirement visit', 'information contact', 'hiv medicines pharmaceutical wholesaler genericmedicines exporter']\n",
      "['new article case report chronic lymphocytic leukemia', 'rare translocation t', 'q32 q13', 'igh bcl3 rearrangements', 'chinese cases', 'literature review cll leusm hematology']\n",
      "['new article hdac6 inhibition alleviates cll', 't cell dysfunction', 'enhances immune checkpoint blockade efficacy', 'e tcl1 model cll leusm hematology']\n",
      "['new article', 'complement system status', 'b cell malignancies', 'rituximab cll leusm hematology']\n",
      "['new article highlights b chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article expression', 'alternative proteins', 'cll patients', 'venetoclax cll leusm hematology']\n",
      "['new article', 'early discontinuation dose modification', 'refractory chronic lymphocytic leukemia post', 'phase iii murano study cll leusm hematology']\n",
      "['cll stories', 'nick norah john']\n",
      "[]\n",
      "['w alzheimer s i', 'slow decay', 'new cll diagnosis']\n",
      "['rituxan biosimilar riabni', 'non hodgkin lymphoma chronic lymphocytic leukemia', 'blood vessel disorders']\n",
      "['rituximab arrx', 'adult patients', 'non hodgkin lymphoma chronic lymphocytic leukemia granulomatosis', 'microscopic polyangiitis']\n",
      "['frontiers cd200', 'chronic lymphocytic leukemia biological', 'clinical relevance oncology leusm cll']\n",
      "['data highlights venetoclax treatment', 'chronic lymphocytic leukemia ash2020 leusm cancer']\n",
      "['oncoalert changes', 'venetoclax uncover', 'functional hierarchy', 'cll american society', 'hematology lymsm leusm cllsm']\n",
      "['hey guys', 'father s bday', 'dr appt', 'w cll chronic lymphocytic leukemia', 'good vibes', 'car accident']\n",
      "['fish ighv', '17p deletion', 'cll care danielle roberts', 'leusm cllsm']\n",
      "['cll experts dr stacey', 'flu season', 'cll patient leusm patientpower']\n",
      "['ash20 phase ii captivate study update', 'cll leusm jnccn360']\n",
      "['ash20 umbralisib ublituximab combo', 'free survival', 'chronic lymphocytic leukemia hematology cll data', 'john g gribben md']\n",
      "[]\n",
      "['chronic lymphocytic leukemia biological', 'clinical relevance lymphoma lymsm']\n",
      "['biosimilar rituximab zytuxtm', 'non hodgkin lymphoma', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['new article', 'genes atm sf3b1 notch1 birc3 xpo1 myd88 tnfaip3', 'tumor mutational burden', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article efficacy', 'biosimilar rituximab zytuxtm', 'non hodgkin lymphoma', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article cd200', 'chronic lymphocytic leukemia biological', 'clinical relevance mcl lymsm hematology']\n",
      "['chronic lymphoc']\n",
      "[]\n",
      "[]\n",
      "['real world patients', 'chronic lymphocytic leukemia bloodcancer medtwitter']\n",
      "['new ash2020 research', 'chronic lymphocytic leukemia cancer medtwitter']\n",
      "['chronic lymphocytic leukemia causes picture symptoms treatment']\n",
      "['healthcare providers', 'chronic lymphocytic leukemia cll', 'common form', 'u s']\n",
      "['soccer ball chromatin', 'chronic lymphocytic leukemia']\n",
      "['pen chronic lymphocytic leukemia cll network manager volleen', 'white shares', 'cll patient']\n",
      "['don t', 'new cll', 'free webinar', 'experts dr lamanna', 'amp dr']\n",
      "['murano trial', 'retreat patients', 'refractory chronic lymphocytic leukemia', 'treatment benefit']\n",
      "['hour reminder', 'practical strategies', 'cll registration']\n",
      "['vaccine covid19', 'cll webinar', 'great interest', 'community top uk experts', 'questions thanks']\n",
      "['post ash20', 'roundtable discussion w cll experts john gribben alessandra tedeschi meghan thompson amp matthew davids register', 'tue jan', 'pm cet', 'est ash20 hemonc leusm leukemia ctsm cllsm']\n",
      "['post ash20', 'roundtable discussion w cll experts john gribben alessandra tedeschi meghan thompson amp matthew davids tue jan', 'pm cet', 'est ash20 hemonc leusm leukemia ctsm cllsm']\n",
      "['cll clinicaltrials telemedicine']\n",
      "['cll experts dr allan dr barrientos amp', 'new research', 'cll care disparities covid19']\n",
      "['umbralisib ublituximab', 'cll wednesdaywisdom ww leukemia hematology hematologist oncology oncologist cll']\n",
      "['s1925 nct04269902', 'evolve cll sll study', 'asymptomatic high risk patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'ctsu members website']\n",
      "['william wierda md phd', 'md anderson cancer center discusses results', 'captivate trial', 'chronic lymphocytic leukemia cll', 'leukemia amp lymphoma society md anderson cancer center']\n",
      "['selective non covalent btk inhibitor', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma hematology ash20']\n",
      "['lymphoid enhancer', 'flow cytometry', 'chronic lymphocytic leukemia', 'atypical immunophenotypic', 'soliman ds', 'kuwari e siveen ks']\n",
      "['chronic lymphocyt']\n",
      "['allison winter md', 'chronic lymphocytic leukemia cll']\n",
      "['adolescents amp', 'young adults', 'chronic lymphocytic leukemia medtwitter cancer ash2020']\n",
      "['novel insights', 'cll14 trial john pagel md ash20 chroniclymphocyticleukemia cll cancer research link', 'full video']\n",
      "['cll patients access', 'clinical trials cll leusm']\n",
      "['encouraging rate', 'refractory chronic lymphocytic leukemia', 'recent research']\n",
      "['cll forum uk guidelines', 'cll management', 'covid19 pandemic cll']\n",
      "['unity cll clinical trial', 'synergistic activity', 'treatment leusm']\n",
      "['cll diagnosis physician assistant danielle roberts', 'practical advice', 'patients leusm cllsm']\n",
      "['new article', 'specific immune effector signatures', 'whole blood loop assay', 'cll patients cll leusm hematology']\n",
      "['new article response assessment', 'refractory chronic lymphocytic leukemia', 'ultrasonography cll leusm hematology']\n",
      "['new article abnormal eosinophil', 'cll diagnosis correlates', 'shorter treatment', 'free survival cll leusm hematology']\n",
      "['new article downregulation', 'lymphoid enhancer', 'flow cytometry', 'chronic lymphocytic leukemia', 'atypical immunophenotypic', 'cll leusm hematology']\n",
      "['new article', 'new skin manifestation', 'wolf s isotopic response cll leusm hematology']\n",
      "['new article immune dysfunctions', 'therapeutic interventions', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['ash highlights', '62nd ash', 'annual meeting hematology', 'cll cartcells lymphome']\n",
      "['handy covid19 vaccine q amp', 'cll leukaemia bloodcancer bloodcancerawareness haematology']\n",
      "['der cll immunchemotherapie wird zunehmend verdr ngt welche ist', 'effektivste kombination mit dem g nstigsten nebenwirkungsprofil wie intensiv muss', 'therapie fortgef hrt werden', 'highlight studien zusammengefasst ash20 leuk mie']\n",
      "['chronic lymphocytic leukemia treatment market', 'outstanding growth']\n",
      "['ash20 updates']\n",
      "['dr barrientos', 'new group', 'btk resistance', 'manage ipc chair duration', 'treatment shows']\n",
      "['ublituximab doublet bests chemoimmunotherapy', 'chronic lymphocytic leukemia', 'oncology ublituximab doublet bests chemoimmunotherapy', 'chronic lymphocytic leukemia']\n",
      "['john hayslip md executive', 'medical director', 'abbvie pharmaceuticals discusses', 'murano study', 'leukemia amp lymphoma society abbvie', 'leukemia amp lymphoma society']\n",
      "['youtubedown cryptoliveleak', 'cryptoliveleak cll']\n",
      "['cll cryptoliveleaktoken', 'website check']\n",
      "[]\n",
      "['measurable residual disease mrd impact treatment decisions', 'practice patterns']\n",
      "['ash2020 update', 'adolescents amp', 'young adults', 'chronic lymphocytic leukemia medtwitter cancer']\n",
      "['nitin jain md', 'cll ash20 updates hemecancer leusm leukemia']\n",
      "['liso cel', 'r r cll sll william wierda md phd', 'endcancer ash20 leusm leukemia']\n",
      "['cll therapies impact patient care dr jennifer woyach', 'james shares', 'perspective leusm cllsm']\n",
      "['cll clinical trials', 'cll leusm cllsm clinicaltrials']\n",
      "['new ai ecg tools', 'identify signs', 'atrial fibrillation', 'chronic lymphocytic leukemia', 'recent clinicaltrial', 'clinicalresearch cardiology healthtech']\n",
      "['current cll treatment approaches cll leusm cllsm']\n",
      "['cll patients', 'leusm cllsm']\n",
      "['umbralisib ublituximab improves progression', 'free survival', 'chronic lymphocytic leukemia cll']\n",
      "['lymphoma canada s', 'canadian cll community', 'current information', 'treatment options december', '30pm est register', 'lymphomaawareness cll']\n",
      "['new clinical trial study', 'versus investigator s choice idelar', 'sll cll leusm hematology']\n",
      "['new clinical trial sars cov', 'donor recipient immunity', 'cll leusm hematology']\n",
      "['30pm ist', 'chronic lymphocytic leukemia', 'popular demand experts', 'cll information']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['long term outcomes', 'chronic lympho']\n",
      "['imbruvica treatment', 'chronic lymphocytic leukemia', 'certain mutation']\n",
      "['chronic lymphocytic leukemia market', 'new business experts ideas', 'ono pharmaceuticals']\n",
      "['epidemiology longitudinal treatment patterns', 'chronic lymphocytic leukemia', 'israel lymphoma lymsm']\n",
      "['congratulations dr yvonne gomez titanstaff cll', 'titanpride psjaproud']\n",
      "['ash20 experts', 'combination therapy', 'cll questions', 'covid19 vaccine']\n",
      "['potential market share', 'big money guess', 'new soc']\n",
      "[]\n",
      "['s dr paul barr', 'refratctory chronic lymphocytic leukemia']\n",
      "['novel agents', 'chronic lymphocytic leukemia']\n",
      "['download kindle medifocus guidebook', 'chronic lymphocytic leukemia gt']\n",
      "['new article', 'purplish skin nodules', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article bcl7c suppresses ovarian cancer growth', 'mutant p53 cll leusm hematology']\n",
      "['new article epidemiology longitudinal treatment patterns', 'chronic lymphocytic leukemia', 'israel cll leusm hematology']\n",
      "['amazing experience ash20', 'cll post ash20', 'roundtable discussion w tue jan', 'pm cet', 'est ash20 hemonc leusm leukemia ctsm cllsm']\n",
      "['important real world data', 'treatment naive patients', 'baseline fish', 'cit treatment failure cll']\n",
      "['line treatments', 'chronic lymphocytic leukemia analysis', 'survival time']\n",
      "['chronic lymphocytic leukemia market size epidemiology', 'companies drugs', 'competitive analysis']\n",
      "['chronic lymphocytic leukemia market size epidemiology', 'companies drugs', 'competitive analysis']\n",
      "['chronic lymphocytic leukemia market size epidemiology', 'companies drugs', 'competitive analysis']\n",
      "['burger md phd', 'influential research', '62nd american society', 'annual meeting', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma hematology']\n",
      "['longitudinal cite seq', 'chronic lymphocytic leukemia', 'ibrutinib treatment e']\n",
      "['chronic lymphocytic leukemia market size epidemiology', 'companies drugs', 'competitive analysis']\n",
      "['chronic lymphocytic leukemia market size epidemiology', 'companies drugs', 'competitive analysis']\n",
      "['chronic lymphocytic leukemia market size epidemiology', 'companies drugs', 'competitive analysis', 'delveinsight business healthmedicine marketingsales pharmaceuticalsbiotech']\n",
      "['hour cme ce cpe', 'optimal management', 'treatment naive', 'r r cll use password']\n",
      "['new article', 'line treatments', 'chronic lymphocytic leukemia analysis', 'survival time cll leusm hematology']\n",
      "['new article aniline', 'parthenolide synthesis', 'chronic lymphocytic leukaemia activity cll leusm hematology']\n",
      "['new article longitudinal cite seq', 'chronic lymphocytic leukemia', 'ibrutinib treatment evolution', 'immune cells', 'relapse cll leusm hematology']\n",
      "['new article', 'chronic lymphocytic leukemia', 'indolent non hodgkin lymphoma', 'idelalisib cll leusm hematology']\n",
      "['sawaf md', 'universit t zu k ln discusses', 'cll14 trial', 'term treatment', 'chronic lymphocytic leukemia patients', 'standard treatment']\n",
      "['cll symptoms', 'cll expert dr john pagel discusses', 'optimal care', 'cll symptom type cllsm leusm']\n",
      "['new clinical trial ibrutinib', 'b cell malignancies', 'coronavirus disease', 'cll leusm hematology']\n",
      "['treatment response', 'refractory chronic lymphocytic leukemia cll', 'mrd negativity']\n",
      "['treatment duration', 'year disease', 'free survival', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma hematology']\n",
      "['chronic lymphocytic leukemia']\n",
      "['webinar streamline', 'cll analysis', 'multiple assays', 'cll sureseq ngs ogt']\n",
      "[]\n",
      "['oral adherence', 'hematological oncology agents', 'comorbid therapy adherence status', 'condition summary chronic myeloid leukemia chronic lymphocytic leukemia', 'multiple myeloma', 'multiple chronic conditions']\n",
      "['chronic lymphocytic leukemia']\n",
      "['checkpoint blockade', 'melanoma patients', 'chronic lymphocytic leukemia']\n",
      "['ash2020 meeting', 'new treatments', 'new car t treatment', 'cll patients', 'complete remissions', 'cll cell', 'cityof hope']\n",
      "['live discussion', '62nd ash', 'annual meeting amp exposition don t', 'replays amp transcripts', 'cll mpn amp myeloma experts']\n",
      "['new data', 'pivotal phase', 'studies support', 'duration chemotherapy', 'free venetoclax', 'certain people', 'chronic lymphocytic leukemia']\n",
      "['incorporate assessment', 'measurable residual disease mrd', 'routine clinical practice']\n",
      "['cll myeloma', 'mpn patients', 'docs amp nurses', 'mmsm leusm mpnsm patientpower']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "[]\n",
      "['data highlights venetoclax treatment', 'chronic lymphocytic leukemia ash2020 leusm cancer']\n",
      "['free remission', 'cll william wierda md phd', 'endcancer ash20 leusm leukemia']\n",
      "['bcr responsiveness', 'cll pathogenesis', 'great part', 'viktoria s master thesis', 'amazing job']\n",
      "['new blog btk therapies', 'site implications', 'chronic lymphocytic leukemia']\n",
      "['serious inpatient bacterial infections', 'chronic lymphocytic leukemia', 'survival abstract hematolog']\n",
      "['new ash2020 research', 'chronic lymphocytic leukemia cancer medtwitter']\n",
      "['new clinical trial oral adherence', 'hematological oncology agents', 'comorbid therapy adherence cll leusm hematology']\n",
      "['rare case presentation', 'chronic lymphocytic leukemia', 'chronic myeloid leukemia visit']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['bntx phase', 'pilot study', 'neoantigen cancer vaccine', 'low dose cyclophosphamide', 'treatment naive asymptomatic patients', 'chronic lymphocytic leukemia nct03219450', 'primary completion date']\n",
      "['chronic lymphocytic leukaemia', 'vulnerable adults opt', 'cll bloodcancer haematology covid19']\n",
      "['real game changer', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['new article venetoclax', 'real game changer', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article c myc amplification', 'chronic lymphocytic leukemia', 'case report', 'literature cll leusm hematology']\n",
      "['new article combination strategies', 'bcl2 inhibitor venetoclax', 'hematologic malignancies cll leusm hematology']\n",
      "['cll society ash day', 'cd19 car t cells', 'richter s transformation car t oral presentations', 'liso cel loxo', 'umbralisib ublituximab', 'real world prognostic biomarker', 'cll society s test']\n",
      "['ascentage pharma announces updates', 'clinical development']\n",
      "['ascentage pharma announces updates', 'clinical development', 'refractory chronic lymphocytic leukemia news pharma clinicalresearch biotech lifesciences', 'medical healthcare pharmiweb']\n",
      "['year s hematology virtual expo', 'aml data', 'posters amp', 'oral presentations']\n",
      "['free investigational combination', 'disease progression', 'chronic lymphocytic leukemia', 'john gribben md dsc', 'hematology leuksm']\n",
      "['john n allan md', '62nd american society', 'annual meeting', 'chronic lymphocytic leukemia cll hematology']\n",
      "['drs john m burke amp manuel', 'line vs', 'refractory settings', 'cme credits gt gt']\n",
      "['cll treatment decision leusm cllsm']\n",
      "['ash20 cll expert answers questions', 'covid vaccine amp', 'cancer news dr philip thompson', 'shares news', 'dr fauci', 'patients amp', 'covid19 vaccine advances', 'cll treatments amp']\n",
      "['pi3k inhibitor inhibits ros', 'human monocytes', 'treatment promotes nkcell', 'malignant bcells', 'akt nox2 cll']\n",
      "['cll clinical trials', 'bloodcancer research']\n",
      "['car t cell therapy', 'lisocabtagene maraleucel', 'durable responses', 'high risk', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma cartcells ash20']\n",
      "['inh btk loxo', 'leucemia linfoc tica cr nica y linfoma linfoc tico peque o lograr', '6m aumentando', '10m eventos adversos m s comunes ser', 'fatiga diarrea y confusi n arritmias auriculares y hemorragia']\n",
      "['decodingcancer podcast', 'own shares', 'incurable blood cancer cll', 'covid ni utv']\n",
      "['jacqueline barrientos feinstein institutes', 'medical research', 'frontline treatment']\n",
      "['duration venclexta combos gain steam', 'pharmaceutical pharma leukemia cancer']\n",
      "['genomic experts', 'case studies', 'chronic lymphocytic leukemia cll', 'key messages', 'cll click', 'applications hematology']\n",
      "['new clinical trial polatuzumab vedotin venetoclax', 'hyaluronidase human', 'refractory mantle cell lymphoma cll leusm hematology']\n",
      "['chronic lymphocytic leukemia cll', 'catch symptoms', 'swollen lymph nodes', 'fatigue leukemiaawareness beatingcancertogether hematology bloodcancer treatment options']\n",
      "['parexel informatics ash2020 poster clinical relevance', 'persistent amp', 'longest diameter', 'chronic lymphocytic leukemia', 'complete remission clinicaltrials']\n",
      "['ihrem satellitensymposium geben einblick', 'neuen ash20 daten zur cll und', 'diese f r eine neue leitlinie bedeuten insbesondere f r zielgerichtete und rezidiv therapien von', '00h ashtoday hematology leusm']\n",
      "['new article checkpoint blockade', 'melanoma patients', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'rare case', 'pleural localization', 'metastatic merkel cell carcinoma', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['kml videoberichte vom ash20 h matologen von uniklinikum universit tsmedizin g ttingen und dem universit tsklinikum hamburgeppendorf berichten ber cll nhl multiplesmyelom hodgkinlymphom lymsm moderation']\n",
      "['btk inhibitors', 'cll review', 'special thanks']\n",
      "['der letzte tag des ashtoday startet ab', 'uhr mit den tracks aml nhl mit schwerpunkt fl und mcl sowie cll', 'aktuellsten ash20 studien zusammengefasst von unseren top experten machen sie gleich mit auf hematology lymsm leusm ashfromhome']\n",
      "['j clin', 'driver mutations', 'copy number abnormalities identify binet stage', 'chronic lymphocytic leukemia', 'aggressive progression']\n",
      "['cll dr wierda s presentation', 'transcend cll', 'bestofash ash20 lymsm']\n",
      "['crbiotech paper', 'pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line', 'autophagic flux']\n",
      "['multiple phase', 'imbruvica ibrutinib show efficacy', 'high risk', 'chronic lymphocytic leukemia cll', 'real world data', 'low biomarker']\n",
      "['researchers amp hcw making', 'drug venetoclax', 'game changer', 'chronic lymphocytic leukemia cll', 'aml precision medicine', 'combination therapies ash20']\n",
      "['new thing', 'phd cll haematology leukaemiaresearch', 'biclonal case', 'chronic lymphocytic leukaemia', 'discordant mutational status', 'heavy chain', 'variable region', 'bimodal cd49d expression']\n",
      "['abstracts ashkudos cll lymsm']\n",
      "['abbvie roche s', 'duration venclexta combos gain steam', 'new ph']\n",
      "['constantine tam md mbbs fracp frcpa', 'cll treatment']\n",
      "['clinical science danelle james md m', 's reflects', 'cll research affects', 'patients caregivers']\n",
      "['clinical science danelle james md m', 's reflects', 'cll research affects', 'patients caregivers']\n",
      "['technical advance', 'month s jlb heitmann muller', 'team describe', 'novel flow cytometry', 'b cell receptor', 'prognostic factor', 'chronic lymphocytic leukemia bcell cll']\n",
      "['government facilities leaders']\n",
      "['ash20 cll', 'important research', 'duration therapy']\n",
      "['subcutaneous masses', 'unusual manifestation', 'atypical chronic lymphocytic leukemia', 'prolymphocytoid transformation', 'complex karyotype', 'diagnostic dilemma']\n",
      "['high risk cll', 'dr jennifer woyach', 'leusm cllsm']\n",
      "['measurable residual disease mrd impact treatment decisions', 'practice patterns']\n",
      "['monitor symptoms patient advocate jay blatt', 'dr nicole lamanna', 'common questions amp', 'leusm patientpower']\n",
      "['cll patients', 'immune system', 'international data ash20 highlights', 'high risk', 'contract covid', 'high morbidity', 'uk blood cancer', 'priority list']\n",
      "['cll patients', 'families patients deserve access', 'new issue', 'priority list', 'covid vaccine', 'clzl patients']\n",
      "['blood cancer']\n",
      "['amazing experience', 'don t blame', 'recap register', 'cll post ash20', 'roundtable discussion w ash20 ashfromhome hemonc leusm leukemia ctsm']\n",
      "['free survival data', 'captivate study', 'imbruvica ibrutinib']\n",
      "['exciting news', 'term outcomes', 'chronic lymphocytic leukemia cll patients', 'ibrutinib dr john allan', 'research study']\n",
      "['spot cll ashfromhome']\n",
      "['promising new drug combination', 'exciting new chronic lymphocytic leukemia cll treatment option leusm patientpower']\n",
      "['chronic lymphocytic leukemia', 'routine wellness', 'health amidst', 'cll ash20']\n",
      "['ash20 genetic mutation predicts', 'poor outcomes', 'chronic lymphocytic leukemia hematology cll data', 'ferran nadeu']\n",
      "['cll treatment', 'treatment response leusm cllsm']\n",
      "['seer medicare data analysis', 'high comorbid burden nci comorbidity index', 'frail medicare claims', 'prognosis assoc w t', 'dx geriheme']\n",
      "['convalescent plasma', 'chronic lymphocytic leukemia']\n",
      "['ash20 tgtx umbralisib ublituximab cll']\n",
      "['ash20 tgtx umbralisib ublituximab u2 cll']\n",
      "['ash20 tgtx umbralisib ublituximab u2 ven cll leusm']\n",
      "['loxo oncology', 'bruin clinical trial', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'american society', 'annual meeting news pharma clinicalresearch biotech']\n",
      "['field s', 'research clinical trials', 'current events', 'cancer patients', 'exciting cll news', '4pm pt 7pm']\n",
      "['cll hematology cancerresearch realworldevidence']\n",
      "['great news', 'cll patients', 'free treatment irish patients need', 'similar access ncpe']\n",
      "['new clinical trial', 'non hodgkin lymphoma', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['excellent summary', 'cll trial data whilst reminder', 'real world evidence', 'rx decisions', 'cll patients caveats', 'trial data', 'poor arena re', 'rx influ sequen plans dep', 'novel agents rec']\n",
      "['person convalescent plasma', 'humoral immunodeficiency', 'valuable lessons learnt cll antibodies']\n",
      "['new article microrna', 'prevents traits', 'cutaneous squamous cell carcinoma', 'cll leusm hematology']\n",
      "['carla s dad', 'chronic lymphocytic leukaemia cll', 'blog head']\n",
      "['nonhodgkinslymphoma nhl', 'chronic lymphocytic leukemia cll', 'roundup weedkiller', 'minute eligibility survey gt']\n",
      "['good news', 'cll patients', 'scottish medicines consortium smc', 'certain people', 'chronic lymphocytic leukaemia', 'free treatment option haematology bloodcancer nhsscotland']\n",
      "['cornishlithium lepidico lpd cll']\n",
      "['new data', 'imbruvica ibrutinib', 'venclexta venclyxto venetoclax combination shows', 'free survival', 'year post treatment', 'chroniclymphocyticleukemia cll abbv']\n",
      "['loxo oncology', 'bruin clinical trial', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'american society', 'annual meeting']\n",
      "['imbruvica ibrutinib', 'venclexta venclyxto venetoclax combination shows', 'free survival', 'year post treatment', 'chroniclymphocyticleukemia cll']\n",
      "['multiple phase', 'imbruvica ibrutinib show efficacy', 'high risk', 'chroniclymphocyticleukemia cll abbv']\n",
      "['crbiotech paper', 'pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line', 'autophagic flux']\n",
      "['abbvie reports results', 'imbruvica ibrutinib', 'p iii studies', '1l treatment', 'chronic lymphocytic leukemia']\n",
      "['abbvie reports results', 'imbruvica ibrutinib', 'p iii studies', '1l treatment', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia treatment market']\n",
      "['encouraging efficacy', 'refractory chronic lymphocytic leukemia', 'btk inhibitor ash20 leusm']\n",
      "['sdgr malt1 mucosa', 'lymphoid tissue lymphoma translocation protein', 'potential therapeutic target', 'non hodgkin s b cell lymphomas', 'chronic lymphocytic leukemia cll']\n",
      "['tgtx ash20', 'umbralisib ublituximab', 'refractory chronic lymphocytic leukemia cll']\n",
      "['som discusses', 'decision making', 'chronic lymphocytic leukemia leusm']\n",
      "['btk inhibitor loxo', 'chronic lymphocytic leukemia']\n",
      "['free medifocus guidebook', 'chronic lymphocytic leukemia gt gt']\n",
      "['icymi tg therapeutics inc', 'umbralisib tgr', 'chronic lymphocytic leukemia']\n",
      "['common type', 'bloodcancer innovation', 'accurate diagnosis', 'treatment options', 'cll patients']\n",
      "['novel therapies', 'large range', 'blood cancers', 'bloodcancer care']\n",
      "['wonderful results', 'indolent nodal lymphoma', 'thoughts ash20 lymsm leusm']\n",
      "['inbox bi', 'monthly sign', 'cll newsletter']\n",
      "['constantine tam md mbbs fracp frcpa', 'cll treatment']\n",
      "['cll ash20']\n",
      "['ash20 tgtx umbralisib ublituximab cll']\n",
      "['new data', 'term benefit', 'imbruvica ibrutinib', 'line treatment', 'high risk chronic']\n",
      "['congress ash20', 'comprehensive genomic classification identifies distinct m cll', 'u cll driver landscapes', 'rna expression subtypes goal', 'cll leusm']\n",
      "['year data', 'murano study show', 'venetoclax rituximab', 'chronic lymphocytic leukemia hematology data', 'arnon p kater md phd']\n",
      "['rituximab sustains survival benefit', 'cll ash20']\n",
      "['loxo oncology', 'bruin clinical trial', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['dr richard furman shares insights', 'multicenter retrospective study', 'chronic lymphocytic leukemia cll patients', 'venetoclax ash20']\n",
      "['vital tests', 'cll patients', 'dr jennifer woyach', 'leusm cllsm']\n",
      "['ash20 news patients', 'refractory chronic lymphocytic leukemia', 'venclexta amp rituxan', 'free survival', 'overall survival benefit', 'bendamustine amp rituxan']\n",
      "['15pm bo', 'oral presentation', 'murine model', 'penetrant cll ash20 hematology cll']\n",
      "['bruton kinase inhibitor', 'line treatment', 'cll ash20']\n",
      "['present updates', 'd v', 'r r cll']\n",
      "['key cll treatment decision making factors cllsm leusm']\n",
      "['ash2020 update', 'adolescents amp', 'young adults', 'chronic lymphocytic leukemia medtwitter cancer']\n",
      "['unity cll', 'hematology ash20 cll leukemia leusm']\n",
      "['hodgkin variant', 'richter s transformation hvrt', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll patients', 'british columbia bc canada american society']\n",
      "[]\n",
      "['ash20 tgtx umbralisib ublituximab u2 cll']\n",
      "['cll treatments', 'leusm cllsm']\n",
      "['free survival', 'cll patients ash2020']\n",
      "['pts intolerant', 'ash20 sharman cll mcl mzl wm lymphoma']\n",
      "['great summary', 'informcll data', 'cll patients', 'del 17p tp53mut', 'igvh ash20']\n",
      "['cll ash20 news', 'cll docs cll register']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['great talks', 'don t', 'online loxo', 'outcomes cll amp zrsr2', 'mds rna seq identifies lztr1 leusm lymsm ash20']\n",
      "['ash20 stefano molica comments', 'yrs update', 'murano study', 'finite duration treatment', 'refractory relapse chronic lymphocytic leukemia leusm']\n",
      "['client presentations', 'ash20 ashkudos', 'dr gribben', 'dr zinzani', 'pivotal data presentations tgtx']\n",
      "['congress ash20', 'shows data', 'informcll registry', 'prognostic marker', 'sub optimal treatment', 'high risk cll patients lymsm cll']\n",
      "['ash20 presentation', 'cll leusm lymsm']\n",
      "['line treatment', 'cll ash20']\n",
      "['nice work anthony', 'important work', 'cll leusm ash20']\n",
      "['great presentation', 'dr tanya siddiqi', 'favorable responses', 'liso cel', 'high risk cll patients', 'patients ash20']\n",
      "['congress ash20 tanya siddiqi', 'transcend cll', 'liso cel monotherapy', 'cr cri responses', 'mrd negativity lymsm cll']\n",
      "['cll amp sll data']\n",
      "['umbralisib ublituximab shows', 'superior outcomes', 'care chemoimmunotherapy', 'interview w john gribben', 'ash20 hematology oncoalert hemonc leusm leukemia cllsm ctsm trialupdate immunoonc']\n",
      "['congress ash20 ohad benjamini', 'cd19 cart product', 'complete responses', 'ne neutropenia', 'common lymsm cll']\n",
      "['congress ash20 shows', 'transcend cll', 'liso cel', 'hr cll patients', 'r r', 'ibrutinib orr', 'flow cytometry crs', 'low mtd', 'lymsm cll']\n",
      "['dr gribben', 'ph3 unity cll data', 'tn amp r r cll dr zinzani', 'unity nhl ph2 data', 'r r inhl tgtx press release presentations']\n",
      "['cll web broadcast', 'claim credit']\n",
      "['ublituximab umbralisib r r 1l cll vs o chl rct n', 'u2 arm', 'novel rx naive', 'vs 18m pfs diff mpfs', '5m 1l', 'r r u2', 'g3 diarrhoea', 'ven o', 'data post na', 'place ash20']\n",
      "['congress ash20', 'phase iii unity cll trial', 'dual pi3k', 'ck1 inhibitor umbralisib', 'mos vs', 'obi orr', 'r r cll aes', 'pi3ki lymsm cll']\n",
      "['william wierda md phd transcend cll', 'lisocabtagene maraleucel liso cel', 'refractory r r chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll ash20 leusm']\n",
      "['excellent presentation', 'new btk inhibitor']\n",
      "['loxo oncology', 'bruin clinical trial', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'american society']\n",
      "['new clinical trial study', 'oral venetoclax tablets', 'intravenous obinutuzumab injection', 'assess achievement', 'adult participants', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['loxo oncology', 'bruin study']\n",
      "['congress ash20', 'shows results', 'bruin study withbtki loxo', 'cll sll orr', 'time fatigue', 'common teaes mtd', 'lymsm cll']\n",
      "['r r cll pts phase i ii non covalent reversible btki', 'btki v high risk cohort', 'selective minimal tox af lt', 'resistant c481 btki intol orr deepen', 'time game']\n",
      "['bruin clinical trial', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['loxo oncology', 'bruin clinical trial', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'american society', 'annual meeting clinicaltrial']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['jennifer crombie md', 'preliminary efficacy', 'duvelisib venetoclax', 'cll sll', 'richter s syndrome patients ash20 abstract link']\n",
      "['ella thompson', 'great work', 'molecular haematology', 'complex resistance mechanisms', 'ash2020 ash20 cllsm lymsm']\n",
      "['mantle cell lymphoma', 'refractory chronic lymphocytic leukemia']\n",
      "['venetoclax obinutuzumab']\n",
      "[]\n",
      "['don t', 's presentation transcend cll', 'lisocabtagene maraleucel liso cel', 'refractory r r chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll ash20 leusm']\n",
      "['das n chste ashtoday satellitensymposium mit meet amp', 'ist von presse von', 'uhr gibt es hier eine expertendiskussion ber cll auf cll leusm ash20 medtalksgermany']\n",
      "['chronic lymphocytic leukemia market', 'global analysis amp', 'market research report']\n",
      "['abbvie s venclexta venclyxto combination bebeficial', 'chronic lymphocytic leukemia abbv']\n",
      "['convalescent plasma', 'covid19 patient', 'chronic lymphocytic leukemia']\n",
      "['abbvie s venclexta venclyxto combination bebeficial', 'chronic lymphocytic leukemia vi wic p i fin nci l re ds']\n",
      "['abbvie s venclexta venclyxto combination bebeficial', 'chronic lymphocytic leukemia abbv']\n",
      "['abbvie s venclexta venclyxto combination bebeficial', 'chronic lymphocytic leukemia']\n",
      "['abbvie s venclexta venclyxto combination bebeficial', 'chronic lymphocytic leukemia']\n",
      "['abbv rhhby abbvie s venclexta venclyxto combination bebeficial', 'chronic lymphocytic leukemia']\n",
      "['new article external validation', 'international prognostic score', 'stage chronic lymphocytic leukaemia', 'alternative score cll leusm hematology']\n",
      "['new article bacterial triacylglycerol lipase', 'potential cholesterol esterase identification', 'key determinant', 'specificity cll leusm hematology']\n",
      "['letzten ashtoday tracks f r heute von', 'uhr umfasst', 'neusten ash20 daten zu cll nhl mit schwerpunkt dlbcl und ptcl und mpn machen sie mit auf leusm mpnsm hematology ashfromhome medtalksgermany nonhodgkinslymphoma']\n",
      "[]\n",
      "['abbvie s imbruvica shows treatment benefit', 'chronic lymphocytic leukemia vi wic p i fin nci l re ds']\n",
      "['abbvie s imbruvica shows treatment benefit', 'chronic lymphocytic leukemia']\n",
      "['abbvie s imbruvica shows treatment benefit', 'chronic lymphocytic leukemia abbv']\n",
      "['abbv abbvie s imbruvica shows treatment benefit', 'chronic lymphocytic leukemia']\n",
      "['erlene seymour md', 'discusses investigational btk inhibitors', 'chronic lymphocytic leukemia leusm']\n",
      "['venetoclax obinutuzumab', 'improves chronic lymphocytic leukemia survival md magazine']\n",
      "['roche reports', 'long term benefits', 'venclexta venclyxto', 'r r chronic lymphocytic leukemia']\n",
      "['roche reports', 'long term benefits', 'venclexta venclyxto', 'r r chronic lymphocytic leukemia']\n",
      "['duration treatment venclexta venclyxto venetoclax', 'chroniclymphocyticleukemia cll abbv']\n",
      "['ep4 receptor agonist l', 'augments cytotoxic activities', 'ibrutinib idelalisib', 'chronic lymphocytic leukemia cells lymphoma lymsm']\n",
      "['clonal dynamics', 'composite chronic lymphocytic leukemia', 'hairy cell leukemia variant lymphoma lymsm']\n",
      "['clonal dynamics', 'composite chronic lymphocytic leukemia', 'hairy cell leukemia variant']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['multiple phase', 'imbruvica ibrutinib show efficacy', 'high risk', 'chronic lymphocytic leukemia cll', 'real world data', 'low biomarker']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['janssen reports', 'long term benefits', 'imbruvica ibrutinib', '1l treatment', 'high risk chronic lymphocytic leukemia']\n",
      "['janssen reports', 'long term benefits', 'imbruvica ibrutinib', '1l treatment', 'high risk chronic lymphocytic leukemia']\n",
      "['cll gt', 'complex disease gt ven r vs br', 'right shows', 'chromosomal anomalies doi pubs']\n",
      "['ash20 tgtx umbralisib ublituximab u2 cll']\n",
      "['ash20 tgtx umbralisib ublituximab cll']\n",
      "['mutations genomics', 'gon na']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['multiple phase', 'imbruvica ibrutinib show efficacy', 'high risk', 'chronic lymphocytic leukemia cll', 'real world data', 'low biomarker']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['apto history', 'non covalent btk inhibitors', 'cll patients', 'threshold plasma exposure', 'btk inhibition', 'target lymphocytosis', 'modest nodal reduction lt', 'pr s']\n",
      "['ash20 cll leusm']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['cll session', 'exciting session', 'u2 cart', 'rwe ash20 drs gribben benjamini']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['cll society ash', 'update dr anthony fauci shares', 'blood cancer', 'dr koffman sums', 'captivate clarity murano amp cll14 clinical trials']\n",
      "['minimum residual disease', 'treatment plans', 'practical implementation strategies']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['brilliant presentation amp', 'interesting results', 'duration venetoclax obinutuzumab rx', 'cll mrd ash2020 ash20 lymsm']\n",
      "['chronic lymphocytic leukemia cll leusm']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['free survival data', 'captivate study', 'imbruvica ibrutinib', 'line treatment', 'chronic lymphocytic leukemia clinical trials', 'medical discoveries']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['cll114 data', 'ash2020 show', 'significant progression', 'free survival rate', 'venetoclax obinutuzumab']\n",
      "['abbv abbvie', 'duration treatment venclexta venclyxto venetoclax', 'chronic lymphocytic leukemia cll clinical trials', 'medical discoveries']\n",
      "['multiple phase', 'imbruvica show efficacy', 'high risk', 'chronic lymphocytic leukemia', 'real world data', 'low biomar', 'tickers abbv']\n",
      "['multiple phase', 'imbruvica ibrutinib show efficacy', 'high risk']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['beigene announces data', 'brukinsa zanubrutinib', 'marginal zone lymphoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', '62nd ash', 'annual meeting']\n",
      "['mrd concordance', 'cll patients peripheral blood', 'bone marrow ash20']\n",
      "['erlene seymour md', 'discusses investigational btk inhibitors', 'chronic lymphocytic leukemia cll btk']\n",
      "['evaluates mrd', 'cll ash20 clonoseq', 'assess mrd', 'cll mm', 'important info incl sample types amp test limitations']\n",
      "['bgne beigene announces data', 'brukinsa zanubrutinib', 'marginal zone lymphoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', '62nd ash', 'annual meeting business wire']\n",
      "['new data', 'term benefit', 'imbruvica ibrutinib', 'line treatment', 'high risk chronic lymphocytic leukemia']\n",
      "['amazing session', 'cll biology treatment resistance', 'ash20 check', 'thanks hematology', 'amazing ashfromhome']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['long term', 'line treatment', 'high risk chronic lymphocytic leukemia cll']\n",
      "['new data', 'term benefit', 'imbruvica ibrutinib', 'line treatment', 'high risk chronic lymphocytic leukemia']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['new data', 'term benefit', 'imbruvica ibrutinib', 'line treatment', 'high risk chronic lymphocytic leukemia stockmarket']\n",
      "['high risk chronic lymphocytic leukemia cll data', 'pivotal studies']\n",
      "['new data', 'term benefit', 'imbruvica ibrutinib', 'line treatment', 'high risk chronic lymphocytic leukemia']\n",
      "['leusm leukemia cllsm hematology hemonc ash20']\n",
      "['new data', 'term benefit', 'imbruvica ibrutinib', 'line treatment', 'high risk chronic lymphocytic leukemia']\n",
      "['kind reminder', 'poster presentation', 'cll ash20 cll']\n",
      "['multiple phase', 'imbruvica ibrutinib show efficacy', 'high risk', 'chronic lymphocytic leukemia cll', 'real world data']\n",
      "['bgne beigene announces data', 'brukinsa zanubrutinib', 'marginal zone lymphoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', '62nd ash', 'annual m']\n",
      "['multiple phase', 'imbruvica ibrutinib show efficacy', 'high risk', 'chronic lymphocytic leukemia cll', 'real world data', 'low biomarker']\n",
      "['great compile', 'cll ashtogether leukemia bloodcancer']\n",
      "['multiple phase', 'imbruvica ibrutinib show efficacy', 'high risk', 'chronic lymphocytic leukemia cll', 'real world data', 'low biomarker', 'patients stockmarket']\n",
      "['great work ash20 subclonal c481mut assoc', 'btki resis', 'drive overall resistance', 'mut amp wt subclones', 'diff survival strategies incl mut subclone', 'subclonal tp53 mut lymsm']\n",
      "['asia news beigene announces data', 'brukinsa zanubrutinib', 'marginal zone lymphoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', '62nd ash', 'annual meeting']\n",
      "['ash20 data', 'real world studies', 'high risk cll']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['multiple phase', 'imbruvica ibrutinib show efficacy', 'high risk previo']\n",
      "['multiple phase', 'imbruvica ibrutinib show efficacy', 'high risk', 'chronic lymphocytic leukemia cll', 'real world data', 'low biomarker']\n",
      "['beautiful work', 'dr lipsky', 'transcriptome analysis', 'c481 mut vs wt cll cells ash20']\n",
      "['bgne beigene announces data', 'brukinsa zanubrutinib', 'marginal zone lymphoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', '62nd ash', 'annual meeting']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['beigene announces data', 'brukinsa zanubrutinib', 'marginal zone lymphoma', 'trial i']\n",
      "['bgne announces data', 'marginal zone lymphoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['beigene announces data', 'brukinsa zanubrutinib', 'marginal zone lymphoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', '62nd ash', 'annual meeting']\n",
      "['bgne beigene announces data', 'brukinsa zanubrutinib', 'marginal zone lymphoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', '62nd ash', 'annual meeting']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['ash20 kerry rogers', 'phase ib trial', 'hematology oncoalert hemonc leukemia leusm cllsm immunoonc trialupdate ctsm']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['ash20 venetoclax ibrutinib', 'free remission', 'chronic lymphocytic leukemia hematology', 'william g wierda md phd']\n",
      "['senior medical director jim dean md phd discusses', 'scientific progress', 'cll treatment', 'hematology virtual meeting']\n",
      "['senior medical director jim dean md phd discusses', 'scientific progress', 'cll treatment', 'hematology virtual meeting']\n",
      "['oral presentation', 'group prajish', 'collaborative work', 'richter s transformation ash20 cll lymphoma']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['ash abbvie roche s', 'duration venclexta combos gain steam', 'cll abbvie', 'cll patients abbv rhhby pharma cll']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['day people', 'cancer manage', 'bloodcancer patient terry shares', 'chronic lymphocytic leukemia cll ash20']\n",
      "['real world data', 'address questions', 'clinical trials']\n",
      "['poster session', 'leukemogenesis ash20 cll']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['prescient coverage', 'ash2020 day', 'chronic lymphocytic leukemia cll zanubrutinib venetoclax obinutuzumab lanalumab mrd']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['cll covid']\n",
      "['cll ash20']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['ash20 oral presentation', 'william wierda phd md', 'cll leusm leukemia']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['big data project']\n",
      "['great cll education session', 'manage toxicities', 'female panel', 'lymsm ash20']\n",
      "['excellent work', 'others i', 'authors ash20 cll lymsm covid19']\n",
      "['ash20 worldwide examination', 'global collaborative study']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['practical guidance', 'drug toxicities', 'cll helpful', 'lymphoma drs cns pharmacists', 'btki venetoclax', 'excellent pre', 'videos amp q amp', 'great summary pre discussion kirsten fischer nicole lamanna']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['new article', 'biclonal case', 'chronic lymphocytic leukaemia', 'discordant mutational status', 'heavy chain', 'variable region', 'bimodal cd49d expression cll leusm hematology']\n",
      "['new article ep4 receptor agonist l', 'augments cytotoxic activities', 'ibrutinib idelalisib', 'chronic lymphocytic leukemia cells cll leusm hematology']\n",
      "['new article clonal dynamics', 'composite chronic lymphocytic leukemia', 'hairy cell leukemia variant cll leusm hematology']\n",
      "['ash20 ham wasserman lecture', 'dr andrew roberts', 'therapeutic develepment', 'current uses', 'knowledge learnt', 'promising future', 'hematology apoptosis venetoclax lymsm leusm mmsm cll cllsm']\n",
      "['duration treatment venclexta venclyxto venetoclax', 'chronic lymphocytic leukemia cll']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['survival benefit', 'refractory cll persists', 'years onclive december', 'refractory chronic lymphocytic leukemia']\n",
      "['duration treatment venclexta venclyxto venetoclax', 'chronic lymphocytic leukemia cll']\n",
      "['free survival data', 'captivate study', 'imbruvica ibrutinib', 'line treatment', 'chronic lymphocytic leukemia']\n",
      "['imbruvica ibrutinib', 'venclexta venclyxto venetoclax combination shows', 'free survival', 'year post treatment', 'chronic lymphocytic leukemia cll']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['chronic lymp']\n",
      "['abbv abbvie', 'duration treatment venclexta venclyxto', 'chronic lymphocytic leukemia dec', 'reuters abbvie inc abbvie abbvie']\n",
      "['control arm', 'cll trial zero reason', 'imho ash20']\n",
      "['cll ash20']\n",
      "['abbv abbvie', 'duration treatment venclextavenclyxto venetoclax']\n",
      "['line cll', 'traditional btki failure', 'important ash20 lymsm']\n",
      "[]\n",
      "['measurable residual disease', 'chronic lymphocytic leukemia oncology']\n",
      "['great session', 'switch altogether', 'considerations w covid19', 'special kudos']\n",
      "['subclonal btk resistance']\n",
      "['great presentation', 'captivate study', 'ash20 janssen ibrutinib cll']\n",
      "['captivate data', 'itt marrow mrd neg', 'assess benefit', 'mrd randomization', 'mrd neg', 'ven ibr', 'ibr monotherapy']\n",
      "['excellent presentation', 'cll hematology']\n",
      "['congress ash20 kirsten fischer nicole lamanna', 'cll patients', 'venetoclax btki', 'lymsm cll']\n",
      "['year dfs data', 'captivate study', '1st line ibrutinib venetoclax', 'cll sll', 'therapy lymsm ash20']\n",
      "['imbruvica ibrutinib', 'venclexta venclyxto venetoclax combination shows', 'free survival', 'year post treatment', 'chronic lymphocytic leukemia cll']\n",
      "['free survival data', 'captivate study', 'imbruvica ibrutinib', 'line treatment', 'chronic lymphocytic leukemia']\n",
      "['promising efficacy data', 'tablet therapy btki mtori imid', 'r r dlbcl', 'richters transformation ash20 cll richters']\n",
      "['genentech announces', 'new data', 'long term benefit', 'refractory chronic lymphocytic leukemia']\n",
      "['free survival data', 'captivate study', 'imbruvica ibrutinib', 'line treatment', 'chronic lymphocytic leukemia']\n",
      "['right chroniclymphocyticleukemia treatment', 'needs dr nicole lamanna md hematologist', 'cll treatment', 'leusm patientpower']\n",
      "['del 17p tp53 mut cll']\n",
      "['gene mutations', 'btki resistance', 'cll ash20']\n",
      "['del 17p tp53 mut cll']\n",
      "['care treatment', 'chronic lymphocytic leukemia cll', 'line treatment', 'cll ash20']\n",
      "['captivate mrd', 'rct 1y dfs', 'umrd cohort', 'ibr vs observation post 3m ibr gt', 'cycles iv umrd pb', 'umrd cohort', 'diff 1y dfs ibr vs obs risk', 'ash20 cll']\n",
      "['trt vs', 'cd20 mabs', 'r r cll ash20']\n",
      "['ash20 cll']\n",
      "['important topics', 'free front line trt', 'cll ash20']\n",
      "['fun way', 'ash20 ash2020', 'excellent cll oral abstract session']\n",
      "['line chemo', 'free cll trt ash20']\n",
      "['ash20 lrfgrantee jacob d soumerai', 'chronic lymphocytic leukemia ashtogether']\n",
      "['identify development', 'clonal hematopoiesis', 'cll patients', 'pm pt don t', 'oral presentation', 'piers blombery', 'ash20 apoptosis cll leukemia']\n",
      "['yr f u cll14', 'sawaf ash20 4yr pfs', 'chlor obi', 'yrs time', 'therapy freedom', 'chlor obi', 'os diff', 'absolute diff', 'yr time', 'duration therapy', 'important endpoint cll']\n",
      "['ro genentech announces', 'new data', 'long term benefit', 'refractory chronic lymphocytic leukemia']\n",
      "['algorithm treatment', 'front line venetoclax obinutuzumab progression', 'cll ash2020']\n",
      "['algorithm treatment', 'front line btki progression', 'cll ash2020']\n",
      "['abbvie abbv', 'duration treatment venclexta venclyxto venetoclax', 'chronic lymphocytic leukemia cll stockmarket']\n",
      "['yr murano f u', 'kater ash20 median', 'mths umrd', 'mrd median', 'mths mrd', 'clinical pd retreatment', 'high risk tp53 abnl ck ighv', '5yr pfs', 'yr os', 'r r cll', 'r benda cll']\n",
      "['elegant presentation', 'obin ven cll14', 'growth clonal rate', 'therapy cll ash20 ashfromhome']\n",
      "['year pfs', 'os update', 'gcllsg dr', 'sawaf ash20 congratulations', 'important dataset', 'cll field']\n",
      "['free management ash20']\n",
      "['murano f u', 'mrd reappearance', 'clinical progression gt', 'don t', 'mrd post ven benchmark', 'setting cll ash20']\n",
      "['cll management ash20']\n",
      "['phase i trial', 'novel combination therapy', 'hematologygy oncoalert hemonc cll cllsm leukemia ctsm trialupdate lymphoma lymsm']\n",
      "['map fot', 'cll ash20']\n",
      "['duration treatment venclexta venclyxto venetoclax', 'chronic l']\n",
      "['abbv reveals', 'new findings', 'clinical trials', 'venclexta venclyxto', 'chronic lymphocytic leukemia abbvie cll chroniclymphocyticleukemia leukemia']\n",
      "['excellent presentation', 'richter hematology ash20 ashfromhome']\n",
      "['childsafety genentech announces', 'new data', 'long term benefit', 'refractory chronic lymphocytic leukemia']\n",
      "['childsafety genentech announces', 'new data', 'long term benefit', 'refractory chronic lymphocytic leukemia']\n",
      "['captivate study', 'line treatment', 'chronic lymphocytic leukemia cll']\n",
      "['genentech announces', 'new data', 'long term benefit']\n",
      "['duration treatment venclexta venclyxto venetoclax']\n",
      "['cll hematology ash20']\n",
      "['abbv abbvie', 'duration treatment venclexta venclyxto venetoclax', 'chronic lymphocytic leukemia cll']\n",
      "['rhhby genentech announces', 'new data', 'long term benefit', 'refractory chronic lymphocytic leukemia']\n",
      "['ash20 cll leusm']\n",
      "['new data', 'novel endpoints', 'treatment combinations', 'chronic lymphocytic leukemia', 'ash20 rhhby rog media rocheinnovation hematology']\n",
      "['genentech announces', 'new data', 'long term benefit', 'refractory chronic lymphocytic leukemia stockmarket']\n",
      "['free survival data', 'captivate study', 'imbruvica ibrutinib', 'line treatment', 'chronic lymphocytic leukemia stockmarket']\n",
      "['ibrutinib ven', 'cll 1st line captivate', 'rr setting tap clarity', 'long term remissions', 'therapy ash20 ashfromhome']\n",
      "['year update', 'murano trial', 'cll ash20 hematology']\n",
      "['abbv 15s', 'press release', 'duration treatment venclexta venclyxto venetoclax', 'chronic lymphocytic leukemia cll']\n",
      "['rhhby genentech announces', 'new data', 'long term benefit', 'refractory chronic lymphocytic leukemia business wire']\n",
      "['free survival data', 'captivate study', 'imbruvica ibrutinib', 'line treatment', 'chronic lymphocytic leukemia']\n",
      "['clarity trial', 'treatment discontinuation', 'cll aid mrd', 'hematology ash20']\n",
      "['new future', 'cll cll ash20']\n",
      "['duration treatment venclexta venclyxto venetoclax', 'chronic lymphocytic leukemia cll abbv abbv']\n",
      "['ash20 cll leusm']\n",
      "['ash20 cll ashkudos']\n",
      "['rhhby 15s', 'press release', 'genentech announces', 'new data', 'long term benefit', 'refractory chronic lymphocytic leukemia']\n",
      "['clarity trial schedule', 'clinical trials ash20 hematology']\n",
      "['genentech announces', 'new data', 'long term benefit', 'refractory chronic lymphocytic leukemia']\n",
      "['cll wm mcl patients ash20 lymsm']\n",
      "['pivotal studies', 'duration chemotherapy', 'free regimens', 'chronic lymphocytic leukemia']\n",
      "['year disease', 'free survival results', 'mrd cohort', 'captivate study hematology oncoalert hemonc cll cllsm leukemia ctsm trialupdate']\n",
      "['duration treatment venclexta venclyxto', 'chronic lymphocytic leukemia abbv']\n",
      "['abbv abbvie', 'duration treatment venclexta venclyxto venetoclax', 'chronic lymphocytic leukemia cll']\n",
      "['excellent data amp presentation i ll', 'big fan', 'treatment discontinuation concept', 'cll ashkudos', 'abstract hematology ash20']\n",
      "['new data', 'captivate clinical trial', 'line treatment', 'cll ash20']\n",
      "['free survival data', 'captivate study', 'imbruvica ibrutinib', 'line treatment', 'chronic lymphocytic leukemia']\n",
      "['impressive mrd negativity cll', 'captivate trial hematology ash20']\n",
      "['captivate trial', 'treatment discontinuation', 'negative cll', 'color flow', 'important question hematology ash20']\n",
      "['captivate study', 'hematology ash20 cll']\n",
      "['helios study ibrutinib rb', 'r r cll', 'del 17p patients', 'pfs i br', 'mo br', 'mo hr', 'i br', 'os benefit hr', 'ash20 cll']\n",
      "['abbv imbruvica ibrutinib', 'venclexta venclyxto venetoclax combination shows', 'free survival', 'year post treatment', 'chronic lymphocytic leukemia cll']\n",
      "['schedule cll hematology ash20 ashfromhome', 'ready wonder']\n",
      "['chronic lymphocytic leukemia cll', 'oral presentation']\n",
      "['don t', 'ash20 oral presentation', 'william wierda md phd', 'hematology session', 'cll leusm leukemia']\n",
      "['doesn t', 'dr mato', 'amp don t', 'novel therapies', 'ash20 drs barrientos moreno amp mato', 'great q amp']\n",
      "['oral session']\n",
      "['don t', 'ash20 education session w', 'identification amp mgmt', 'pi3k inhibitors', '2pm pt lymsm leusm']\n",
      "['ash20 coverage', 'pm pst', 'pm est', 'dr thompson', 'register amp', 'full rundown']\n",
      "['t t ash20 check', 'karyotypic complexity predicts outcomes']\n",
      "['arm c', 'sequoia trial', 'btk inhibitor', 'chronic lymphocytic leukemia', 'small cell lymphocytic lymphoma', 'hematology lymsm cllsm ash20']\n",
      "['erlene seymour md', 'discusses investigational btk inhibitors', 'chronic lymphocytic leukemia cll btk']\n",
      "['club success mantra', 'student activities', 'leadership sub committee sal', 'language learning', 'utmost pleasure', 'inter university aptitude quiz competition register', 'ncu sal cll skills communication']\n",
      "['fantastic overview', 'cll toxicity management', 'critical part', 'notable durable clinical benefit', 'excellent talk ash20']\n",
      "['common type', 'blood cancer', 'chronic lymphocytic leukemia', 'small cell lymphocytic lymphoma', 'beigene s', 'blood cancer ash2020 lymsm cllsm']\n",
      "['kirsten fischer s slides', 'great work', 'practical overview', 'tls prevention', 'risk management strategies', 'venetoclax v', 'nice overview', 'education book', 'cll tls']\n",
      "['s ash20 ash2020 cll cll session', 'excellent presentations']\n",
      "['new article treatment', 'chronic lymphocytic leukemia', 'venetoclax cll leusm hematology']\n",
      "['new article', 'tumor lysis syndrome', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article approaches', 'free frontline regimens cll leusm hematology']\n",
      "['new article', 'kinase pi3k inhibitors cll leusm hematology']\n",
      "['new article', 'bruton tyrosine kinase inhibitors cll leusm hematology']\n",
      "['new article', 'standard treatment approaches', 'refractory chronic lymphocytic leukemia', 'frontline chemoimmunotherapy cll leusm hematology']\n",
      "['new article car t cells', 'pediatric non b cell hematologic malignancies cll leusm hematology']\n",
      "['new article chemotherapy', 'free frontline therapy', 'cll leusm hematology']\n",
      "['new article clinical characteristics', 'hematologic malignancies', 'systematic review cll leusm hematology']\n",
      "['oncoalert approaches', 'free frontline regimens hematology american society', 'hematology leusm cllsm lymsm chemofree']\n",
      "['present data', 'free frontline regimens', 'ash20 education session']\n",
      "['free pathways', 'topic algorithms', 'free frontline regimens']\n",
      "['new publication', 'venetoclax algorithm', 'evidence gaps']\n",
      "['tgtx tg therapeutics initiates', 'biologics license application', 'u s food', 'drug administration', 'chronic lymphocytic leukemia gt gt rfp bd com']\n",
      "['important results', 'novel combination', 'ibrutinib venetoclax']\n",
      "['excellent session', 'cll susan m o brien john pagel ian flinn ash20 cll education']\n",
      "['symposium w', 'great discussion', 'mrd status', 'cll therapy disease state landscape', 'interactive workshop', 'clinical advances', 'chronic lymphocytic leukemia ash2020 ash20 greatfulforavirtualash']\n",
      "['ash20 don t', 'chronic lymphocytic leukemia cll session', 'term data', 'combination treatment options']\n",
      "['patient advocate', 'inspire others', 'active role', 'treatment journey ash20']\n",
      "['leukemia cll cancerlivesmatter cancerawareness']\n",
      "['dr richard furman', 'clinical advances', 'chronic lymphocytic leukemia cll s ash20', 'refractory settings access', 'live webcast']\n",
      "['congress ash20', 'mrd status', 'traditional response criteria', 'definite validation', 'mrd assessment', 'excellent overview']\n",
      "['chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'american journal', 'surgical pathology']\n",
      "['years novel agents', 'treatment landscape', 'chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukemia', 'routine wellness', 'people prioritize health amidst']\n",
      "['pre covid era', 'legend ash cll']\n",
      "['patient advocate', 'inspire others', 'active role', 'treatment journey ash20']\n",
      "['ash20 attendees', 'insights newsletter', 'leukemia research', 'available treatments', 'available leusm', 'cml cmml aml mds bpdcn cll cart']\n",
      "['fantastic discussion', '1st line cll']\n",
      "['ash20 oral presentation', 'william wierda md phd', 'hematology session', 'cll leusm leukemia']\n",
      "['rare blood cancers', 'chronic lymphocytic leukemia', 'b cell malignancies', 'social media ash20 lymsm cllsm']\n",
      "['frontline options', 'patients cllsm cll']\n",
      "['chronic lymphocytic leukemia cll', 'active observation', 'spleen dr nicole lamanna md hematologist']\n",
      "['cll patients', 'oncology ash20']\n",
      "['frontline therapy', 'chronic lymphocytic leukemia leusm']\n",
      "['chronic lymphocytic leukemia leusm cll']\n",
      "['blood cancers', 'follicularlymphoma amp chronic lymphocytic leukemia', 'new effective therapies', 'b cell malignancies amp']\n",
      "['refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['cll richter transformation', 'dr weirda lymsm leusm']\n",
      "['telemedicine impacts patients', 'cll time', 'therapy cllsm leusm']\n",
      "['flashback friday', 'twitter versary', 'amazing cll leader', 'ash20 highlights']\n",
      "['blood cancers', 'cancer cell survival']\n",
      "['frontline therapy', 'novel therapies', 'insurance doesn t', 'healthcare system needs', 'makeover ash2020 hematology']\n",
      "['i didn t', 'cll jeremy abramson', 'right lymsm ash20']\n",
      "['good friend', 'colleague jeremy abramson', 'cll ash20 ashfromhome']\n",
      "['cll web broadcast', 'visit ash20']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['cll web broadcast', 'visit ash20']\n",
      "['dr pinilla ibarz', 'panel discussion', 'pi3k inhibitors treatment', 'chronic lymphocytic leukemia follicular lymphoma', 'marginal zone lymphoma']\n",
      "['dr john gribben panelists', 'cllsociety peerivew joint', 'pre ash', 'event practice', 'real world patient case scenarios register', 'ash20 cllsociety cll']\n",
      "['pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line', 'autophagic flux']\n",
      "['new article antibody peptides', 'cancer vaccine turning weapons', 'targets cll leusm hematology']\n",
      "['symptoms victoriesovercancer ash20']\n",
      "['pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line', 'autophagic flux']\n",
      "['excitement amp', 'cll community bloodcancerawareness haematology']\n",
      "['virtual town hall', '00p est gain', 'expert insight']\n",
      "['excellent ash20', 'educational preview', 'dr lamanna', 'clinical pearls', 'btk inhibitor toxicities', 'hematology2020 education', 'digital format']\n",
      "['aa patients', 'cll nhl', 'similar access review hematology ash20 ashfromhome']\n",
      "['dlbcl fl', 'cll hematology ash20']\n",
      "['patient power', 'programs saturday s', 'details cll ash2020 ash20']\n",
      "['uk cll pilot lead', 'dr part', 'genomics england', 'genomes project', 'cll patients genomes', 'confirms wgs', 'comprehensive analysis', 'different types', 'genetic alterations']\n",
      "['top cll experts', 'new era', 'cll management']\n",
      "['chronic lymphocytic leukemia', 'quarantine symptoms', 'extreme lethargy', 'severe headaches i m', 'smdh s']\n",
      "['minimum residual disease', 'treatment plans', 'practical implementation strategies']\n",
      "['onlinefirst pre neoplastic alterations', 'cll dna methylome', 'disease progression', 'therapy molgen leusm']\n",
      "['biological factors', 'cutaneous squamous cell carcinoma', 'chronic lymphocytic leukemia']\n",
      "['saturday s', 'special edition webinar', 'fire questions', 'md anderson cll specialist dr phil thompson cll leusm cancerpatients mdanderson ash20 patientpower mdanews']\n",
      "['pst ash20', 'new era', 'cll management precision medicine', 'patient perspectives', 'treatment na ve', 'disease f philip', 'thompson mb ms', 'leusm leukemia']\n",
      "['pst ash20 application', 'cll sll novel agents combinations', 'therapy william g wierda md phd', 'leusm leukemia']\n",
      "['mantle cell lymphoma', 'refractory chronic lymphocytic leukemia']\n",
      "['mantle cell lymphoma', 'refractory chronic lymphocytic leukemia']\n",
      "['mantle cell lymphoma', 'refractory chronic lymphocytic leukemia']\n",
      "['cme opportunities ash20 peerview leusm']\n",
      "['tg therapeutics inc', 'umbralisib tgr', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'precursor stage', 'new aacr paper ash20']\n",
      "['dr danielle brander', 'prestigious ash20 education program session', 'toxicities w', '2pm pacific don t']\n",
      "['important cll work', 'virtual world']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['future cll expert', 'twitter community', 'date comments']\n",
      "['re treatment']\n",
      "['re treatment']\n",
      "['cll worlddisabilityday']\n",
      "['leukemia cells', 'lymph nodes', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['long term outcomes', 'chronic lymphocytic leukemia']\n",
      "['dec 4dr john gribben panelists', 'cllsociety peerivew joint', 'pre ash', 'event practice', 'real world patient case scenarios register', 'ash20 cllsociety cll']\n",
      "['tgtherapeutics announces publication', 'pi3k inhibitortherapy', 'blood tgtx']\n",
      "['immune response dysfunction', 'chronic lymphocytic leukemia', 'molecular mechanisms', 'microenvironmental conditions']\n",
      "['thompson mb ms', 'cll experts endcancer leusm ash20']\n",
      "['web broadcast', 'new era', 'cll management precision medicine', 'patient perspectives', 'treatment na ve', 'disease ash20']\n",
      "['chronic lymphocytic leukemia cll i ll', 'hospital bed', 'san bernardino terror attack unfold']\n",
      "['cll genetic', 'dr jennifer woyach', 'james shares details leusm cllsm']\n",
      "['peerview s expert tumor board', 'new cme activity', 'll gain insight', 'cll care']\n",
      "['chronic lymphocytic leukemia cll leusm']\n",
      "['peerview s expert tumor board', 'new cme activity', 'll gain insight', 'cll care']\n",
      "['cll treatment', 'cllsm leusm']\n",
      "['r r cll ash20 ash2020']\n",
      "['top cll advances', 'monday dec 7th', '7am pst', 'novel non covalent btk inhibitor', 'cll loxo']\n",
      "['cll care', 'remote tools', 'patient care', 'dr pagel']\n",
      "['announces publication', 'chronic lymphocytic leukemia', 'pi3k inhibitor therapy']\n",
      "['tg therapeutics announces publication', 'chronic lymphocytic leukemia', 'pi3k inhibitor tgtx biotech leukemia cll']\n",
      "['8m people', 'u s', 'chronic lymphocytic leukemia', 'critical role caregivers', 'caregivers nfcmonth']\n",
      "['tgtx tg therapeutics announces publication', 'chronic lymphocytic leukemia', 'pi3k inhibitor therapy']\n",
      "['new article effect', 'bruton tyrosine kinase inhibitor', 'recombinant hepatitis b', 'zoster vaccines cll leusm hematology']\n",
      "['new article phase', 'pi3k inhibitor therapy cll leusm hematology']\n",
      "['new article pdq cancer information summaries cll leusm hematology']\n",
      "['tg therapeutics initiates', 'biologics license application', 'u s food', 'drug administration', 'chronic lymphocytic leukemia']\n",
      "['tg therapeutics announces publication', 'chronic lymphocytic leukemia', 'pi3k inhibitor therapy']\n",
      "['announces publication', 'chronic lymphocytic leukemia', 'pi3k inhibitor therapy']\n",
      "['tgtx tg therapeutics announces publication', 'chronic lymphocytic leukemia', 'pi3k inhibitor therapy']\n",
      "['tgtx tg therapeutics announces publication', 'chronic lymphocytic leukemia', 'pi3k inhibitor therapy']\n",
      "['tg therapeutics announces publication', 'chronic lymphocytic leukemia', 'pi3k inhibitor therapy']\n",
      "['tg therapeutics announces publication', 'chronic lymphocytic leukemia', 'pi3k inhibitor therapy', 'blood tgtx ash20']\n",
      "['tg therapeutics announces publication', 'chronic lymphocytic leukemia', 'pi3k inhibitor therapy', 'blood stockmarket']\n",
      "['tg therapeutics announces publication', 'chronic lymphocytic leu']\n",
      "['tg therapeutics announces publication', 'chronic lymphocytic leukemia', 'pi3k inhibi tgtx']\n",
      "['tgtx tg therapeutics announces publication', 'chronic lymphocytic leukemia', 'pi3k inhibitor therapy']\n",
      "['new clinical trial cd19', 'car t cell therapy', 'refractory b cell leukemia', 'lymphoma cll leusm hematology']\n",
      "['blood cancers', 'cancer cell survival']\n",
      "['blood cancers', 'cancer cell survival']\n",
      "['live tweets']\n",
      "['diskussion der kml videoberichte jetzt anmelden f r aktuelle lymphom news vom ash20 mit den themen cll myelom inhl anhl hodgkinlymphom moderiert von infos amp anmeldung ber']\n",
      "['rule changes', 'comprehensive information', 'website cll leukaemia bloodcancer bloodcancerawareness haematology patients uk']\n",
      "['germline atm tumor suppressor gene contribute', 'cll dr jennifer', 'cll patients', 'variance mutation', 'atm gene']\n",
      "['data clinical trial', 'pi3k inhibitor intolerant cll', 'great collaborative effort']\n",
      "['term outcomes', 'chronic lymphocytic']\n",
      "['medical oncologist cleveland clinic discusses', 'chronic lymphocytic leukemia leusm cll']\n",
      "['biologics license application', 'food amp drug administration', 'chronic lymphocytic leukemia', 'common type', 'adult leukemia']\n",
      "['bcri intol', 'pi3k i intol', 'tp53 dx reasons', 'd c rash', 'umbra gt', 'd c umbra', 'important prospective data', 'active ix space']\n",
      "['cll expert dr john pagel shares', 'cllsm leusm']\n",
      "['drs flinn o brien', '3pm pt', 'medical need', 'btk inhibitors', 'outcomes friday satellite symposium', '62nd ash', 'annual meeting', 'exposition hematology cco cll ash2020']\n",
      "['common cll treatment side', 'cllsm leusm']\n",
      "['chronic lymphocytic leukemia education', 'key component', 'treatment paradigms']\n",
      "['cll treatment approach', 'cllsm leusm']\n",
      "['u2 combination', 'chronic lymphocytic leukemia leusm leukemia']\n",
      "['cll mrd immunotherapy', 'hsct webinar cll saudiblood']\n",
      "['tgtx tg therapeutics initiates', 'biologics license application', 'u s food', 'drug administration', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['tgtx initiates', 'biologics license application', 'chronic lymphocytic leukemia']\n",
      "['exciting sessions check', 'top abstract list']\n",
      "['tg therapeutics initiates', 'biologics license application', 'u s food', 'drug administration', 'chronic lymphocytic leukemia']\n",
      "['online training courses', 'development browse', 'full portfolio cll']\n",
      "['tgtx tg therapeutics initiates', 'biologics license application', 'u s food', 'drug administration', 'chronic lymphocytic leukemia']\n",
      "['tgtx tg therapeutics initiates', 'biologics license application', 'u s food', 'drug administration', 'chronic lymphocytic leukemia tg therapeutics inc']\n",
      "['tgtx initiates', 'chronic lymphocytic leukemia completion']\n",
      "['tgtx tg therapeutics initiates', 'biologics license application', 'u s food', 'drug administration', 'chronic lymphocytic leukemia']\n",
      "['new clinical trial safety', 'car t therapy', 'refractory b cell leukemia', 'lymphoma cll leusm hematology']\n",
      "['new article obinutuzumab', 'adverse events', 'systematic review', 'meta analysis cll leusm hematology']\n",
      "['new article', 'b cell', 'lymphomas cll leusm hematology']\n",
      "['new article cd43', 'malignant flow cytometry laboratory', 'cll leusm hematology']\n",
      "['new article collision tumor', 'spinal schwannoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma case report', 'literature cll leusm hematology']\n",
      "['video updates', 'german cll study group', 'soho2020 oncoalert leusm leukemia cllsm']\n",
      "['early intervention', 'high risk chronic lymphocytic leukemia']\n",
      "['cll community need', 'high risk', 'covid access', 'novel treatments ncpe', 'remote learning', 'high risk families ire', 'specific advice']\n",
      "['chronic lymphocytic leukemia leusm']\n",
      "['i fight', 'good fight', 'cll chronic lymphocytic leukemia check', 'story god']\n",
      "['covid vaccines amp cll patients', 'mind brian koffman', 'good job', 'amp don t', 'effectiveness amp safety', 'new covid vaccines', 'chronic lymphocytic leukemia']\n",
      "['genomic experts', 'case studies', 'chronic lymphocytic leukemia cll', 'key messages', 'cll click', 'applications hematology']\n",
      "[]\n",
      "['ash2020 beigene', 'new data', 'btk inhibitor', 'chronic lymphocytic leukemia waldenstrom macroglobulinemia', 'classical hodgkin lymphoma hematology']\n",
      "['drs john m burke amp manuel', 'line vs', 'refractory settings', 'cme credits gt gt']\n",
      "['chronic lymphocytic leukemia cll', 'own unique set', 'unmet needs nfcmonth']\n",
      "['chronic lymphocytic leukemia cll patients', 'care partners', 'telemedicine cll patient', 'care partner bob', 'thoughts cll']\n",
      "['modern era', 'cll treatment management register', 'web broadcast', 'friday december', 'drs gribben jacobs tedeschi']\n",
      "['nicole lamanna md', 'comprehensive cancer center discusses potential frontline treatment options', 'chronic lymphocytic leukemia']\n",
      "['peerview s expert tumor board', 'new cme activity', 'll gain insight', 'cll care']\n",
      "['cll patients', 'utilize telemedicine cllsm leusm']\n",
      "['cll treatment cllsm leusm']\n",
      "['agent zanubrutinib', 'high risk treatment na ve patients', 'del 17p cll sll cll lymsm']\n",
      "['november webinar', 'huge thanks', 'speakers cll leukaemia bloodcancer bloodcancerawareness haematology']\n",
      "['new article case study', 'infectious sars cov', 'cancer cll leusm hematology']\n",
      "['new study uses', 'bim antibody', 'chronic lymphocytic leukemia cll']\n",
      "['demand activity', 'decision making', 'cll solutions', 'decision making', 'cll care cme cll']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['refractory cll']\n",
      "['refractory cll w', 'soho2020 hemonc leusm cllsm leukemia oncoalert']\n",
      "['wide spread vaccine use', 's pull', 'sars cov', 'share app']\n",
      "['important hematology ash20 data', 'year updates murano trial', 'point imo', 'don t']\n",
      "['interesting oral cll ash20 abstract', 'sharman amp others observational study shows', 'prognostic risk factors', 'ashfromhome hematology']\n",
      "['co mutations', 'clinical implications cc ash20 hematology ashfromhome']\n",
      "['63yo m w', 'chronic lymphocytic leukemia', 'venetoclax r', 'extensive covid', 'complete response', 'normal lung wo', 'such thing']\n",
      "['community top cll experts', 'agents pre ash']\n",
      "['multicenter gibb study', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['risk factors', 'keratinocyte carcinomas', 'pigment traits', 'sun sensitivity']\n",
      "['good news', 'australia drug combination approval deborah sims cll patient shares', 'amazing story', 'australian news foreningen']\n",
      "['cytoplasmic crystal inclusions', 'chronic lymphocytic leukemia villuendas v zquez', 'ejhaem wiley online library']\n",
      "['great news', 'cll patients', 'australian govt focus attention', 'blood cancer']\n",
      "['routine diagnosis']\n",
      "['dr davids discusses', 'mantle cell lymphoma', 'chronic lymphocytic leukemia', 'refractory population lymphoma hematology']\n",
      "['video cart19', 'cd19 malignancies w', 'cart immunotherapy regenerativemedicine hemonc', 'cll leusm lymsm']\n",
      "['f r den ashtoday werden prof barbara eichhorst vom dr eugen tausch von der und prof clemens wendtner von der', 'den track der cll vertreten', 'wichtigsten daten des ash20 pr sentieren auf leusm']\n",
      "['new article serine', 'prevents oxidative stress', 'dna damage', 'mitochondrial redox metabolism cll leusm hematology']\n",
      "['new article', 'phase ii japanese trial', 'fludarabine cyclophosphamide', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article phase', 'multicenter gibb study', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['research project', 'cll utilizes bigdata', 'specific biomarkers', 'chroniclymphocyticleukemia leusm']\n",
      "['john allan md john m burke md rocky mountain cancer centers amp nicole lamanna md', 'chronic lymphocytic leukemia']\n",
      "['disease flare', 'common reason', 'elective procedures cc']\n",
      "['multicenter gibb study', 'cll leusm']\n",
      "['novel agents', 'allogeneic stem cell transplant outcomes leukemia']\n",
      "['cll care cllsm']\n",
      "['experts navigate', 'cll therapeutics', 'web broadcast', 'pst leusm']\n",
      "['cll data', 'ash20 w john gribben', 'full video', 'hematology oncoalert hemonc leusm leukemia ctsm cllsm ibrutinib venetoclax loxo305 vay736']\n",
      "['lacrimal gland', 'mantle cell lymphoma', 'chronic lymphocytic leukemia cll', 'day hemepath collisiontumor']\n",
      "['kinase selectivity', 'btk inhibitors', 'chronic lymphocytic leukemia leusm btk']\n",
      "['recent article', 'p66shc deficient cll cells modulates', 'chemokine landscape', 'stromal microenvironment cll']\n",
      "['new research method', 'tumor microenvironment', 'mass cytometry application', 'chronic lymphocytic leukemia', 'tumor microenvironment tme']\n",
      "['long life invest', 'long life', 'cll society', 'cll society', 'platinum seal']\n",
      "['chronic lymphocytic leukemia treatment market size industry analysis key findings', 'technologies revenue', 'key findings']\n",
      "['stress amp anxiety', 'cll leukaemia', 'charity bloodcancer']\n",
      "['new article', 'current treatment', 'chronic lymphocytic leukemia', 'novel drugs cll leusm hematology']\n",
      "['new article pnp inhibitors', 'cancer cells', 'samhd1 cll leusm hematology']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['new article', 'whole exome', 'mutational profile', 't cell chronic lymphocytic leukemia cll leusm hematology']\n",
      "['long way', 'conference place', 'cll leukaemia bloodcancer bloodcancerawareness charity']\n",
      "['email bulletin', 'events amp', 'cll leukaemia bloodcancer charity']\n",
      "['hour helpline', 'pandemic calls', 'cll leukaemia bloodcancer']\n",
      "['information pack', 'new cll support member cll leukaemia bloodcancer bloodcancerawareness charity']\n",
      "['global chronic lymphocytic leukemia treatment market', 'experience immense growth']\n",
      "['frontline therapies', 'chronic lymphocytic leukemia', 'dr neil', 'dr john pagel', 'swedish cancer institute joins']\n",
      "['cll discussion', 'dr paul barr', 'year data']\n",
      "['ibrutinib dr brian koffman', 'dr paul barr']\n",
      "['chronic lymphocytic leukemia therapeutics market', 'future cheshire media gt gt gt strategy competitiveintelligence', 'pharma biotech', 'healthcare pharmaceutical']\n",
      "[]\n",
      "['s fl', 'chronic lymphocytic leukemia patient', 'rm bcuz', 'cancer patient', 'open lobby']\n",
      "['dr davids discusses', 'mantle cell lymphoma', 'chronic lymphocytic leukemia', 'refractory population lymphomas lymsm']\n",
      "['genomic experts', 'case studies', 'chronic lymphocytic leukemia cll', 'key messages', 'cll click', 'applications hematology']\n",
      "['bone marrow dendritic cells support', 'chronic lymphocytic leukemia cells', 'dependent manner']\n",
      "['macrophage polarization', 'chronic lymphocytic leukemia nurse', 'leukemic cells']\n",
      "['year f u', 'murano trial', 'important concept', 'duration therapy', 'undetectable mrd predicts']\n",
      "['new article intra abdominal hypertension', 'acute kidney injury', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article macrophage polarization', 'chronic lymphocytic leukemia nurse', 'leukemic cells cll leusm hematology']\n",
      "['ascentage pharma announces', 'phase ib ii study', 'inhibitor apg', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma gt gt rfp bd com']\n",
      "['ascentage pharma announces', 'phase ib ii study', 'inhibitor apg', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma businessnews']\n",
      "['ascentage pharma announces', 'phase ib ii study', 'inhibitor apg', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['ascentage pharma announces', 'phase ib ii study', 'inhibitor apg', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma suzhou ch']\n",
      "['ascentage pharma announces', 'phase ib ii study', 'inhibitor apg', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['prognostic model', 'pubs identifies patients', 'chronic lymphocytic leukemia', 'poorer survival outcomes', 'ibrutinib study', 'inhye e ahn md nhlbi', 'lindsey e roeker md']\n",
      "['btk inhibitor ibrutinib', 'refractory chronic lymphocytic leukemia', 'mantle cell lymphoma', 'bit dr davids', 'interview lymsm lymphomas']\n",
      "['fannie mae freddie mac', 'loan limits increase', 'maximum loan limits', 'ma fanniemae freddiemac cll']\n",
      "['chroniclymphocyticleukemia cll treatment', 'dr paolo caimi', 'amp dr brian hill', 'new cll treatments', 'combination therapies amp classes', 'btk inhibitors']\n",
      "['drs gribben jacobs tedeschi', 'live web broadcast', 'cll treatment advances', 'btk pi3k', 'inhibitor options', 'novel antibodies ash20 cme']\n",
      "['wednesday s webinar cll']\n",
      "['future chronic lymphocytic leukemia cll care cll expert dr john pagel shares', 'long term survivorship care', 'patients cll telemedicine']\n",
      "['full remission', 'test i', 'cancer cell amongst', 'blood cells', 'negative cll', 'years decades', 'i ll', 'good news']\n",
      "['uk cll forum guidance', 'covid19 pandemic', 'uk lymsm cll covid19']\n",
      "['treatment naive cll leusm coronavirus covid19ncancer jnccn360']\n",
      "[]\n",
      "['front line treatments', 'chronic lymphocytic leuke leukemia']\n",
      "['new article frequency', 'tp53 gene mutation', 'chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['new article prognostic role', 'lymphocyte monocyte ratio', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'protective net', 'infective vaccine strategies', 'hematologic malignancy', 'marrow transplantation cll leusm hematology']\n",
      "['new article', 'severe treatment', 'resistant autoimmune haemolytic anaemia', 'metastatic melanoma', 'cll cll leusm hematology']\n",
      "['new article chronic lymphoproliferative disorders', 'secondary cancers', 'purine analogues', 'cll leusm hematology']\n",
      "['dr seymour', 'frontline treatment options', 'chronic lymphocytic leukemia leusm leukemia']\n",
      "['macrophage polarization', 'chronic lymphocytic leukemia nurse', 'leukemic cells']\n",
      "['global chronic lymphocytic leukemia treatment market research report']\n",
      "['lymphoid aggregates', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma stains cd5 cd20 lef1', 'cll sll', 'renal disease', 'mgrs i e conditions']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['happy week', 'holidays ucdavis ucd aggies leadershipdevelopment leadership cll']\n",
      "['amazing story cll i', 'daniel catovsky estela matutes', 'stories insights', 'biology patient', 'patient outcome']\n",
      "['complex chronic lymphocytic leukemia armamentarium', 'btk inhibitors leumsm']\n",
      "['dr jennifer woyach', 'leusm cllsm']\n",
      "['globe w robin fo', 'eric2020 hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['long term outcomes', 'chronic lymphocytic']\n",
      "['amp discusses', 'chronic lymphocytic leukemia leusm']\n",
      "['test results', 'cll patients', 'live webinar', 'susan leclair phd', 'leusm cll patientpower']\n",
      "['dhpsp inpst', 'oxidative stress', 'infectious complications', 'chroni leukemia hematology blood antioxidants oxidativestress reactiveoxygenspecies infectiousdiseases infections cll']\n",
      "['richter s transformation', 'cll experts', 'amp address', 'questions amp', 'leusm patientpower']\n",
      "['ash20 breakingdata s panel', 'analyze clinicaldata', 'aml nhl cll multiplemyeloma myelodysplasticsyndrome amp', 'adoptive celltherapies']\n",
      "['new clinical trial impact', 'car t cells', 'cll patients cll leusm hematology']\n",
      "['congratulations cll']\n",
      "['r110 defines', 'aggressive biological subtype', 'risk stratification']\n",
      "['pigmentary traits sun exposure', 'non hodgkin s lymphoma chronic lymphocytic leukemia', 'french e3n', 'prospective cohort lymphoma lymsm']\n",
      "['driver mutations', 'copy number abnormalities identify binet stage', 'chronic lymphocytic leukemia', 'aggressive progression asturias publihuca ispa', 'full text']\n",
      "['amazing person i', 'trap lopez', 'chronic lymphocytic leukemia']\n",
      "['line treatment', 'chronic lymphocytic leukemia cll focus', 'mrd results', 'amp leusm']\n",
      "['critical cll', 'questions dr susan leclair', 'james register']\n",
      "['amazing work', 'uk friends', 'transcriptomic correlates', 'richters transformation', 'cll data show', 'new potential therapeutic targets']\n",
      "['new article pigmentary traits sun exposure', 'non hodgkin s lymphoma chronic lymphocytic leukemia', 'french e3n', 'prospective cohort cll leusm hematology']\n",
      "['new treatment']\n",
      "['novel agents', 'allogeneic stem cell transplant outcomes']\n",
      "['cll treatment resistance', 'kinase inhibitors w dimitar efremov eric2020 hemonc oncoalert leusm leukemia cllsm cll']\n",
      "[]\n",
      "['complex chronic lymphocytic leukemia armamentarium', 'btk inhibitors leusm']\n",
      "['new article', 'cd20 antibodies', 'kinase inhibitors', 'b cell receptor', 'chronic lymphocytic leukaemia cells cll leusm hematology']\n",
      "['new article', 'clinical trials', 'chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['new article driver mutations', 'copy number abnormalities identify binet stage', 'chronic lymphocytic leukemia', 'aggressive progression cll leusm hematology']\n",
      "['nationwide study', 'inpatient opportunistic infections', 'chronic lymphocytic leukemia', 'pre ibrutinib era']\n",
      "['aggressive biological subtype', 'chronic lymphocytic leukemia', 'intermediate epigenetics']\n",
      "['natural history', 'noninfectious ibrutinib', 'attributable adverse events', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['cll society covid', 'case study', 'asymptomatic cll patient sheds virus', 'chronic lymphocytic leukemia', 'sars cov', 'dr brian koffman comments']\n",
      "['yr analysis', 'murano study demonstrates', 'undetectable minimal residual disease umrd', 'non 17p del', 'r r cll pts', 'duration venetoclax rituximab venr therapy tx']\n",
      "['venetoclax venclexta', 'clinical criteria', 'chronic lymphocytic leukemia', 'full recommendation']\n",
      "['jan burger md phd', 'leusm cll endcancer leukemia']\n",
      "['video resonate', 'w jan burger', 'eric2020 hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['cll clinical trial', 'doctor cllsm']\n",
      "['phase ii trial focuses', 'short course fludarabine', 'continuous ibrutinib', 'cll leusm jnccn360']\n",
      "['drs gribben jacobs tedeschi', 'friday december', 'web broadcast', 'cll ash20']\n",
      "['promising cll treatments dr', 'leusm cllsm']\n",
      "['monday nov', 'radiation ct scans mri bloodwork amp', 'dr susan leclair', 'critical cll', 'james register']\n",
      "['genomic experts', 'case studies', 'chronic lymphocytic leukemia cll', 'key messages', 'cll click', 'applications hematology']\n",
      "['negative regulation', 't cells', 'chronic lymphocytic leukemia']\n",
      "['new article iglv3', 'aggressive biological subtype', 'chronic lymphocytic leukemia', 'intermediate epigenetics cll leusm hematology']\n",
      "['new article', 'nationwide study', 'inpatient opportunistic infections', 'chronic lymphocytic leukemia', 'pre ibrutinib era cll leusm hematology']\n",
      "['new article tim', 'negative regulation', 't cells', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'natural history', 'noninfectious ibrutinib', 'attributable adverse events', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'human intelligence', 'flow cytometry', 'hematologic malignancies cll leusm hematology']\n",
      "['cll cancersupportandreaserch']\n",
      "['transcriptomic correlates', 'richter s transformation', 'chronic lymphocytic leukemia']\n",
      "['transcriptomic correlates', 'richter s transformation', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['new article genomic', 'transcriptomic correlates', 'richter s transformation', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['william wierda md', 'md anderson leusm leukemia cll soho2020']\n",
      "['otilt chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll', 'aggressive large b cell lymphoma', 'rare process', 'richter s transformation', 'progressive course', 'patients w cll sll']\n",
      "['telemedicine impact time']\n",
      "['cancer muggles cll oncology cancertalk illness health bestofintentions forms']\n",
      "['lymphoma program dr raghuveer ranganathan', 'patients questions', 'car t cell therapy', 'dr ranganathan s', 'full response check']\n",
      "['course treatment', 'obinutuzumab ibrutinib', 'treatment na ve cll cancer leukemia']\n",
      "['select treatment', 'multiple myeloma', 'clinical evidence', 'individual patient amp disease characteristics', 'cme credits']\n",
      "['cll treatment choices', 'webinar lineberger john allan', 'patientpower leusm']\n",
      "['sound right', 'jeff folloder', 'cll shares advice', 'positive impact']\n",
      "['cll care', 'cll expert dr john pagel details', 'high cost', 'care cllsm leusm']\n",
      "['eshcll2020 bill wierda', 'elegant conceptual talk', 'endless possibilities', 'cll therapies']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['esh e conference', 'programme session ix', 'therapeutic concepts chairs jennifer', 'brown boston michael hallek cologne', 'cet access', 'live eshcll2020 eshconferences']\n",
      "['session viii clonal heterogeneity clonal evolution amp mechanisms', 'drug resistance chairs davide rossi john seymour', 'discussion access', 'live register eshconferences cll']\n",
      "['dr hoffman', 'old woman', 'chronic lymphocytic leukemia', 'treatment considerations', 'patient case', 'btk inhibitors leukemia hematology']\n",
      "['cll patients']\n",
      "['btk inhibitors', 'ash20 medscape', 'town hall physicians']\n",
      "['present dr moles', 'phd thesis', 'lrc thanks', 'examiners elaine willmore amp maggie harnett congratulations mike']\n",
      "['esh e conference', 'expert sessions seats', 'available register', 'live eshconferences']\n",
      "['dr hoffman', 'old woman', 'chronic lymphocytic leukemia', 'oncology case', 'peer perspective event leusm leukemias']\n",
      "['chronic lymphocytic leukemia', 'new treatments', 'remissions leusm hematology']\n",
      "['wgs analysis uk chop ofat richters trial pts', 'poor risk cll drivers amp genes', 'dna damage response pathway mapk pathway', 'important great work oxford team jenny k amp']\n",
      "['great discussion', 'safety amp organ toxicity', 'new drugs', 'cll panel', 'interdisciplinary structures', 'cancer agents oncotoxicity good experience']\n",
      "['mithralog ec', 'induces chronic lymphocytic leukemia cell death', 'tonic b cell receptor', 'asturias publihuca ispa', 'full text']\n",
      "['giggle cll', 'diwali2020 matters']\n",
      "['cll expert dr john pagel', 'routine management', 'cll cllsm chroniclymphocyticleukemia']\n",
      "['cll genetic', 'dr jennifer woyach', 'james shares details leusm cllsm']\n",
      "['risk stratification', 'chronic lymphocytic leukemia cll']\n",
      "['initial workup', 'chronic lymphocytic leukemia leusm']\n",
      "['esh e conference', 'session vii efficacy', 'safety chairs barbara eichhorst cologne javid moslehi nashville', 'discussion access', 'live register eshcll2020 eshconferences']\n",
      "['live discussion', 'cellular amp non cellular immunotherapies', 'cll chairs matthew davids peter dreger discussants peter hillmen alexey danilov eric', 'stephen schuster access', 'live eshcll2020 eshconferences']\n",
      "['live webinar', 'novel agents combinations amp', 'cll patients friday satellite symposium', '62nd ash', 'annual meeting', 'exposition cco cll ash2020']\n",
      "['web broadcast', 'new era', 'cll management precision medicine', 'patient perspectives', 'treatment na ve', 'disease ash20 leusm']\n",
      "['esh e conference', 'session vi therapeutic options', 'cellular amp non cellular immunotherapies', 'cll chairs m davids p dreger access', 'live register eshcll2020 eshconferences']\n",
      "['cost side', 'multiple treatment options', 'cll patients', 'expert advice', 'dr john allan', 'amp register']\n",
      "['november newsletter', 'flu jabs details', 'webinar news', 'cll treatments tips', 'mental health member perspectives', 'lockdown amp']\n",
      "['cll management', 'ksa time', 'gmt health care professionals', 'free registration cll saudiblood']\n",
      "['eshcll2020 arnon kater sums', 'cll therapy', 'lymphoid malignancies', 'cart cell therapy']\n",
      "['important role', 'immunomodulatory interactions', 'cll microenvironment hypoxia']\n",
      "['esh e conference', 'cll session v', 'leukaemic microenvironment chairs silvia deaglio adrian wiestner', 'discussion access', 'live register eshcll2020 eshconferences']\n",
      "['article title', 'bilateral chylous effusions', 'chronic lymphocytic leukemia edoriumjournals chroniclymphocyticleukemia chylothorax chylouseffusion article url']\n",
      "['new article cll', 'focus news', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article venetoclax', 'chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['new article comparison', 'bruton tyrosine kinase inhibitor', 'upfront treatment', 'chronic lymphocytic leukemia cll', 'systematic review', 'network meta analysis cll leusm hematology']\n",
      "['new article bh3 mimetics', 'b cell malignancies insights', 'clinic cll leusm hematology']\n",
      "[]\n",
      "['esh translational research e conference', 'cll eshcll2020 access', 'live register', 'information amp', 'full programme eshconferences']\n",
      "['norwegian scabies', 'leukemia cutis', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['tumor microenvironment', 'mass cytometry application', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['immune system', 'cll patients', 'novel immunotherapeutic strategies check', 'new review', 'immunotherapy immune dysfunctions', 'therapeutic interventions', 'chronic lymphocytic leukemia']\n",
      "['ian w flinn md', '30pm ct', 'optimal management', 'treatment naive', 'r r cll use password']\n",
      "['month drug habit', 'hit i don t', 'doesn t']\n",
      "['bone marrows', 'blood films', 'bathroom floor', 'x10 hemepath haempath cll haematology clinicalscientist']\n",
      "['new article zap', 'immune microenvironment', 'b cell malignancies cll leusm hematology']\n",
      "['new article heterogeneity', 'tp53 mutations', 'p53 protein residual function', 'matter cll leusm hematology']\n",
      "['new article evolution', 'chronic lymphoid leukemia', 'cell transcriptomics', 'case report cll leusm hematology']\n",
      "['new article', 'norwegian scabies', 'leukemia cutis', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'leukocyte telomere length', 'cancer risk mortality', 'uk biobank', 'tcga datasets', 'genetic risk score', 'mendelian randomization approaches cll leusm hematology']\n",
      "['new article method', 'tumor microenvironment', 'mass cytometry application', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article research', 'pd l1 overexpression', 'car t', 'acute myeloid leukemia cll leusm hematology']\n",
      "['rush pgy', 'chronic lymphocytic leukemia treatments', 'excellent grand rounds presentation']\n",
      "['dr david spaner cll diagnosis', 'minute video', 'chronic lymphocytic leukemia', 'toronto cll specialist dr david spaner health medicine leukemia lymphoma']\n",
      "['telemedicine play', 'cll patients', 'hospital stays', 'optimize care', 'car t patients']\n",
      "['esh e conference', 'live programme', 'demand programme register', 'eshcll2020 eshconferences']\n",
      "['chronic lymphocytic leukemia cll', 'common form', 'u s']\n",
      "['poster walk', 'flow cytometry', 'fluorescent cell', 'cll cells']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['chronic lymphocytic leukemia cll', 'common form', 'u s']\n",
      "['esh e conference', 'poster walk leaders alexey danilov amp davide rossi access', 'live agenda', 'register eshcll2020 eshconferences']\n",
      "['lindsey roeker', 'new york', 'cll therapies btki', 'reasonable option']\n",
      "['esh e conference', 'long term', 'clinical trials versus', 'real world data', 'clinical trials data oct chair j woyach access', 'live register eshcll2020 eshconferences']\n",
      "['real world data show temporal trends', 'serious bacterial infections']\n",
      "['eric2020 presentations', 'demand sessions', 'depth discussion', 'cll frontline treatment', 'r r disease', 'hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['cll bloodcancer']\n",
      "['bad news sars cov', 'cancer patients', 'female patient', 'chronic lymphocytic leukemia cll', 'infectious virus', 'viral rna']\n",
      "['telemedicine play', 'car t', 'cll patients', 'hospital stays cll telemedicine']\n",
      "['new article prognostic models', 'chronic lymphocytic leukemia patients', 'ibrutinib therapy results', 'comparative performance analysis cll leusm hematology']\n",
      "['new article predictive significance', 'gene mutations', 'refractory chronic lymphocytic leukemia patients', 'ibrutinib cll leusm hematology']\n",
      "['new article', 'clinical trials', 'chronic lymphocytic leukaemia', 'uk cll leusm hematology']\n",
      "['new article', 'md anderson cancer center', 'leukemic non nodal mantle cell lymphoma', 'pleomorphic variant mantle cell lymphoma', 'cll leusm hematology']\n",
      "['new article', 'stat5 pathway underlies', 'novel inhibitory role', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article malignant solitary fibrous tumor', 'case report cll leusm hematology']\n",
      "['new article oncostatin m', 'mysterious cytokine', 'cancers cll leusm hematology']\n",
      "['telemedicine mitigate', 'financial toxicity', 'cll patients dr john pagel details', 'high cost', 'cll care cll']\n",
      "['mophmolmon lymphocytosis adult flow cd5 cd19 cd20 dim cd23 partial kappa dim', 'typical cll fish shows 2r ccnd1', '3g igh', 'normal 6q cen12', '13q 17p', 'ddx addn l tests', 'dx prognosis hemepath ampath molpath cll']\n",
      "['cll cancer']\n",
      "['1st translational conference', 'cll summarizes data', 'btk inhibitors ibrutinib', 'zanubrutinib lymphoma leukemia leusm']\n",
      "['cll patients', 'cll expert sharman', 'different approaches', 'treatment amp shares advice', 'decision making']\n",
      "['esh e conference', 'session iii therapeutic options', 'cll chairs alain delmer reims michael hallek cologne access', 'live register', 'eshcll2020 eshconferences']\n",
      "['e res salud hematology', 'vbhc program', 'hematological malignancies lymphoma cll myeloma', 'proms amp prems questionnaires', 'medicine hrqol ehealth digitalhealth']\n",
      "['therapeutic targets', 'chronic lymphocytic leukemia dimitar efremov amp team']\n",
      "['lunch amp', 'discusses optimal management', 'treatment naive', 'r r cll use password']\n",
      "['esh e conference', 'poster walk leaders matthew davids amp alessandra tedeschi agenda', 'live register eshcll2020 eshconferences']\n",
      "['live discussion', 'bcr activation amp', 'cll paolo ghia kostas stamatopoulos hassan jumaa andrew steele anthony mato amp pablo oppezzo', 'questions access', 'eshcll2020 eshconferences']\n",
      "['chronic lymphocytic leukaemia cll eqas', 'tp53 analysis', 'ighv analysis login', 'genqa account', 'details tp53 ighv cll']\n",
      "['1st translational conference', 'excellent speakers content', 'lively discussion', 'perfect start', 'leukemia leusm']\n",
      "['esh e conference', 'cet session ii', 'bcr activation amp', 'cll chairs paolo ghia kostas stamatopoulos access', 'live register', 'eshcll2020 eshconferences']\n",
      "['interactive discussion', 'esh e conference', 'epigenomic landscape', 'clinical consequences', 'live register', 'eshcll2020 eshconferences']\n",
      "['new chemotherapy', 'free treatment', 'cll patients front line trial data', 'standard treatments', 'uk ncpe']\n",
      "['new chemotherapy', 'free treatment', 'chronic lymphocytic leukaemia cll']\n",
      "['esh e conference', 'session i', 'genomic amp epigenomic landscape', 'cll amp clinical consequences chairs j', 'brown c oakes access', 'live register', 'eshcll2020 eshconferences']\n",
      "['new clinical trial ft819', 'b cell malignancies cll leusm hematology']\n",
      "['chronic lymphocytic leukaemia cll impacts', 'emotional hurdles', 'support cll patients']\n",
      "['new member hellenic group', 'chronic lymphocytic leukemia greece', 'cll advocates network']\n",
      "['place wednesday', 'nov 1pm', 'new cll treatment opportunities speakers incl prof adrian bloor haematologist manchester dominic pivonka amp rob coster register', 'webinar org uk']\n",
      "['good news', 'england venetoclax obinutuzumab combo', 'adults w leukaemia', 'cll patients', 'don t', '17p deletion', 'tp53 mutation']\n",
      "['chroniclymphocyticleukemia i', 'clinical interest', 'medical student', 'chronic lymphocytic leukemia']\n",
      "['cll i', 'clinical interest', 'medical student', 'chronic lymphocytic leukemia']\n",
      "['major cll experts leukemia leusm']\n",
      "['chairpersons j', 'brown p ghia', 'live interactive discussions', 'cet register', 'translational research e conference', 'cll eshcll2020', 'welcome video eshconferences']\n",
      "['generation btk inhibitors', '1st translational research conference chronic lymphocytic leukemia']\n",
      "['long term outcomes', 'chronic l leukemia']\n",
      "['long term outcomes', 'chronic lymphocytic leuk']\n",
      "['btk inhibitors', 'cll register', 'town hall dec']\n",
      "['real world outcomes', 'chronic lymphocytic leukemia']\n",
      "['grande juan cll buen d', 'juan francisco idiarte se toma un caf', 'con federico paz v']\n",
      "['week s blog link', 'bio nonhodgkinslymphoma sll cll', 'strong findacure']\n",
      "['free combination venclyxto venetoclax', 'front line patients', 'chronic lymphocytic leukaemia cll']\n",
      "['live programme register', 'translational research e conference', 'cll nov', 'eshcll2020 chairs j', 'brown p ghia m hallek information eshconferences']\n",
      "['leukaemia care', 'cll patients', 'family members', 'cll survey']\n",
      "['long term outcomes', 'chronic lymphocytic leukemia medivizor']\n",
      "['term outcomes', 'chronic lymphocytic']\n",
      "[]\n",
      "['chronic lymphocytic leukemia']\n",
      "['btk inhibitors', 'cll register', 'town hall dec']\n",
      "['dr pleyer discusses', 'course fludarabine', 'chronic lymphocytic leukemia leusm leukemia']\n",
      "['ennio s doctor', 'medical team s', 'chronic lymphocytic leukemia', 'log hours']\n",
      "['telemedicine tools', 'communities patientchat']\n",
      "['chronic lymphocytic leukemia', 'respiratory failure', 'severe covid', 'infection case report', 'literature review sep', 'ejhaem covid19ncancer covid19 cllsm leusm caxtx']\n",
      "['chronic lymphocytic leukaemia cll impacts', 'emotional hurdles', 'support cll patients']\n",
      "['cll clinical trials leusm cllsm']\n",
      "['primary efficacy analysis', 'complete remission', 'course fludarabine', 'chronic lymphocytic leukemia leusm']\n",
      "['leukaemia care', 'cll patients', 'family members', 'cll survey']\n",
      "['serious inpatient bacterial infections', 'chronic lymphocytic leukemia', 'survival abtract hematolog']\n",
      "['interesting i m', 'unity trial', 'debate re', 'ash20 cll']\n",
      "['news fda grants ublituximab umbralisib', 'fast track designation', 'adult patients', 'cll lymsm']\n",
      "['nice leukaemia drugapprovals oncology healthnews cll chroniclymphocyticleukaemia']\n",
      "['novel agents', 'allogeneic stem cell transplant outcome']\n",
      "['virtual visit', 'e conference platform translational research e conference', 'cll register', 'eshcll2020 chairs paolo ghia eshconferences']\n",
      "['new clinical trial intermittent', 'cll sll cll leusm hematology']\n",
      "['cll patients', 'cll amp sll patients leukaemia haematology bloodcancer bloodcancerawareness']\n",
      "['new article', 'p66shc deficient cll cells modulates', 'chemokine landscape', 'stromal microenvironment cll leusm hematology']\n",
      "['new article acral ulcers', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article epileptic seizure', 'bone metastasis', 'chronic lymphoid leukemia', 'merkel cell carcinoma cll leusm hematology']\n",
      "['chronic lymphocytic leukemia']\n",
      "['treatment paradigm', 'chronic lymphocytic leukemia', 'mumbai hematology group details', 'treatment paradigm']\n",
      "['chronic lymphocytic leukemia', 'molecular pathogenesis', 'novel therapeutic strategies haematologica', 'julio delgado ferran nadeu dolors colomer', 'elias campo']\n",
      "['dr pleyer discusses', 'course fludarabine', 'chronic lymphocytic leukemia cllsm leusm']\n",
      "['manitoba primary care providers', 'p m', 'session cases', 'cancer chronic lymphocytic leukemia', 'guest expert banerji', 'facilitator dr mark kristjanson register']\n",
      "['hour chairs', 'leukemia lymphoma ipc', 'chronic lymphocytic leukemia jack', 'allison winter md oncliveipc']\n",
      "['remote visit checklist', 'cll telemeducation empowerment resource center']\n",
      "['cartcell therapy amp secondarycancer risk', 'cll patients cll expert dr richard furman', 'car t cell therapy', 'treatment option', 'btk inhibitors']\n",
      "['modern era', 'cll treatment management register', 'web broadcast', 'drs gribben jacobs tedeschi', 'thompson ash20']\n",
      "['experts navigate', 'cll therapeutics', 'cme web broadcast', 'annual meeting']\n",
      "['cll treatment advances', 'btk pi3k', 'inhibitor options', 'novel antibodies ash20']\n",
      "['explainer video', 'cll treatment decisions']\n",
      "['cll treatment approach', 'individual disease', 'important factors physicians']\n",
      "['new article apoptotic effect', 'b chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'allogeneic nk cells', 'b chronic lymphocytic leukemia b cll cells', 'sporadic cases', 'resistance cll leusm hematology']\n",
      "['recordatorio algoritmo', '1ra l nea para leucemia linf tica cr nica es cll llc gellc']\n",
      "['recordar el algoritmo', 'llc es cll llc gellc']\n",
      "['con el dr marco gonz lez jefe', 'servicio presenta gu', 'sclhh una aproximaci n cr tica llc cll']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['cll patients']\n",
      "['new clinical trial au2', 'cll cll leusm hematology']\n",
      "['nitib capsule', 'chronic lymphocytic leukemia requirement visit', 'information contact', 'hiv medicines pharmaceutical wholesaler genericmedicines exporter']\n",
      "['alexey v danilov md phd', 'discusses btk inhibitors', 'chronic lymphocytic leukemia']\n",
      "['mornings work', 'supersquirrels independentplay pse utw maths cll eymatters']\n",
      "['uk s', 'venclyxto gazyva', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'respiratory failure', 'severe covid', 'infection case report', 'literature review sep', 'ejhaem covid19ncancer covid19 cllsm leusm caxtx']\n",
      "['chronic lymphocytic leukemia', 'b c']\n",
      "['virtual sessions', 'top experts', 'field leukemia cll leusm']\n",
      "['free combination', 'venetoclax obinutuzumab', 'frontline treatment']\n",
      "['modulates cd40', 'chronic lymphocytic leukemia', 'bcr inhibitors']\n",
      "['translational research e conference', 'cll meet', 'expert sessions', 'experts register', 'eshcll2020 chairs j', 'brown p ghia m hallek information eshconferences']\n",
      "['apto cc', 'nodal reductions', 'early indicator', 'pr s', 'huge milestone aml']\n",
      "['modulates cd40', 'chronic lymphocytic leukemia', 'bcr inhibitors']\n",
      "['paper blood mir', 'modulates cd40', 'chronic lymphocytic leukemia', 'bcr inhibitors blood american society']\n",
      "['new article mir', 'modulates cd40', 'chronic lymphocytic leukemia', 'bcr inhibitors cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia', 'primary nonlymphoid malignancies cytopathologic study', 'cases cll leusm hematology']\n",
      "['new article', 'survival time', 'chronic lymphocytic leukemia', 'free regimens', 'line cll leusm hematology']\n",
      "['new article', 'measurable residual disease', 'filo trial cll leusm hematology']\n",
      "['good news', 'new chemotherapy', 'free treatment option', 'year leukemia haematology bloodcancerawareness']\n",
      "['great news', 'cll patients', 'venetoclax obinutuzumab', 'front line', 'lymsm hematology oncology']\n",
      "['apto loxo', 'announces details', 'ash2020 loxo305', 'effective non covalent btkin', 'mcl amp', 'oral poster presentations']\n",
      "['flu season', 'sinus infections', 'extra precaution tune', 'dr stacey', 'sinus center']\n",
      "['apto nodal reduction cll', 'chronic lymphocytic leukemia high numbers', 'abnormal lymphocytes', 'blood lymph nodes amp bone marrow', 'abnormal cells', 'normal lymphocytes', 'lymph nodes amp']\n",
      "['true breakthrough', 'great news cll']\n",
      "['excellent news', 'cll patients', 'free combination venclyxto venetoclax', 'front line patients', 'chronic lymphocytic leukaemia cll']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['brilliant news', 'english cll sll patients', 'venetoclax amp ibrutinib obinutuzumab', 'choice amp opportunity', 'fcr chemotherapy']\n",
      "['cll treatment', 'btk inhibitors', 'minimal residual disease mrd', 'dr brian hill', 'taussig cancer center', 'questions amp']\n",
      "['new article treatment strategies', 'chronic lymphocytic leukemia', 'therapies cll leusm hematology']\n",
      "['new article', 'acute kidney injury', 'leukemic infiltration', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article ibrutinib', 'cardiac tamponade', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article therapeutic targets', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article genetic', 'non genetic mechanisms', 'b cell malignancies cll leusm hematology']\n",
      "['times i', 'inner wonderwoman cll', 'warrior hooah']\n",
      "['great news', 'wales cll patients', 'nice approves', 'duration treatment option', 'patients ni']\n",
      "['irish cll patients', 'treatment option front line']\n",
      "['great news', 'cll patients', 'free combination treatment venetoclax', 'front line patients ncpe']\n",
      "['new epcoritamab trial', 'genmab amp abbvie safety', 'efficacy study', 'refractory chronic lymphocytic leukemia gmab abbv duobody cd3xcd20 gen3013 cll']\n",
      "['chronic lymphocytic leukemia', 'sarscov2 virus']\n",
      "['new clinical trial safety', 'efficacy study', 'refractory chronic lymphocytic leukemia cll leusm hematology']\n",
      "['perdeu les xerrades genetic', 'epigenetic disruption', 'rna modifications', 'human cancer', 'laia coll cancer epigenetics group i potential use', 'chronic lymphocytic leukemia', 'l ngel bistu', 'functional cytomics group']\n",
      "['treatment paradigm', 'cll friday', 'pm guest faculty dr versha benerji canada']\n",
      "['chroniclymphocyticleukemia cll', 'cll risk factors', 'cll visit', 'comprehensive look leusm patientpower']\n",
      "[]\n",
      "['cancer leukemia cll oncology scanxiety kornacki khakis']\n",
      "['chronic lymp']\n",
      "['cll page', 'family members', 'stages thanks', 'dr kerry rogers']\n",
      "['coronavirus pandemic', 'founders amp', 'cll amp covid', 'share tips', 'communication virtual support groups amp']\n",
      "['case study', 'infectious sars cov', 'cancer patient covid19 cll']\n",
      "['health crisis telemedicine', 'routine healthcare', 'cll care cll cllpatients cllawareness', 'expert dr john pagel']\n",
      "['flu season', 'extra precautions', 'cll patients', 'amp dr stacey', 'important tips', 'safe amp', 'host register']\n",
      "['week s blog life', 'bio nonhodgkinslymphoma sll cll lifewithcancerisstilllife findacure']\n",
      "['zur anmeldung bei der chronischen lymphatischen leuk mie cll gibt es fundamentale nderungen nun schon ab der erstlinientherapie spannende diskussion morgen beim webinar cll alles neu schon wieder medizin krebs cll']\n",
      "['cll patients', 'risk patients', 'person cll cllawareness cllpatients']\n",
      "['dia s', 'own robin weinick svp', 'clinical leader', 'patient diversity problem registration', 'free cll']\n",
      "['cd20 function', 'human b cells', 'great work unifr rituximab cll lymphoma immunotherapy']\n",
      "['cases rise', 'cancer leaders', 'essential cancer tests amp treatments cll leukaemia bloodcancerawareness charity patients']\n",
      "['free treatments', 'treatment na leukemia']\n",
      "['cll cll']\n",
      "['chronic lymphocytic leukemia', 'follicular lymphoma oncology']\n",
      "['chronic lymphocytic leukemia']\n",
      "['video treatment approaches', 'cll w freda stevenson', 'eric2020 hemonc oncoalert leusm leukemia cllsm']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['good work cll aml ash20']\n",
      "[]\n",
      "['methodology cll', 'practicum students', 'community partners attiah hossameldin zoom room', 'psualr2020 communityservice languagecourses linguistics']\n",
      "['chronic lymphocytic leukemia visit', '3meds 3medsonlinemedicine 3medsonlinepharmacy health medicine fitness']\n",
      "['front line treatments', 'chronic lymphocytic leuk']\n",
      "['video covid19', 'gaia cll13 trial w barbara eichhorst', 'eric2020 hemonc oncoalert leusm leukemia cllsm ctsm cll']\n",
      "['mmit reality check', 'chronic lymphocytic leukemia nov']\n",
      "['provocative analysis', 'cost effectiveness']\n",
      "['aml b cml c chronic lymphocytic leukemia cll']\n",
      "['cost effectiveness', 'cll thoughtful editorial']\n",
      "['key cll treatment decision making factors leusm cllsm']\n",
      "['giacopelli brian', 'global dna methylation analysis', 'chronic epigenetics cll']\n",
      "['new article efficacy', 'late relapse chronic lymphocytic leukemia', 'allogeneic hematopoietic stem cell transplantation cll leusm hematology']\n",
      "['new article pathogenesis', 'chronic lymphocytic leukemia', 'novel therapeutic strategies cll leusm hematology']\n",
      "['new article', 'measurable residual disease', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'lipoic acid', 'functional state', 'peripheral nerve fibers', 'chronic hemoblastosis cll leusm hematology']\n",
      "['new article serum monoclonal component', 'chronic lymphocytic leukemia baseline correlations', 'prognostic impact cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia', 'humoral immunosuppression', 'systematic review cll leusm hematology']\n",
      "['genereviews pot1 tumor predisposition pot1 tpd', 'lifetime risk', 'multiple cutaneous melanomas chronic lymphocytic leukemia angiosarcoma']\n",
      "['monthly blood cancer virtual support group', 'pm pt aml multiplemyeloma leukemia lymphoma cll']\n",
      "['discusses factors', 'chronic lymphocytic leukemia leusm']\n",
      "['experts navigate', 'cll therapeutics', 'web broadcast', 'pst ash20 leusm']\n",
      "['late relapse cll', 'allogeneic hematopoietic stem cell transplantation leusm']\n",
      "['cll treatment', 'leusm cllsm']\n",
      "['cll diagnosis nathan tirey', 'u s', 'inspirational story']\n",
      "['dr jessica marini pgy2 oncology resident', 'ce lecture', 'chronic lymphocytic leukemia novel', 'pharmacist expertise', 'new adverse events amp drug interactions']\n",
      "['select treatment', 'multiple myeloma', 'clinical evidence', 'individual patient amp disease characteristics', 'cme credits']\n",
      "['cll aml', 'blood cancers']\n",
      "['cll aml', 'blood cancers']\n",
      "['european society', 'medical oncology', 'new clinical practice guidelines', 'chronic lymphocytic leukaemia', 'gt cll lymphomamatters']\n",
      "['new lockdown rules', 'november newsletter cll leukaemia haematology bloodcancerawareness covid']\n",
      "['chronic lymphocytic leukemia', 'follicular lymphoma']\n",
      "['clinicaltrial pharmacokinetics', 'chronic lymphocytic leukemia']\n",
      "['effective treatments foreningen']\n",
      "['cll w', 'eric2020 hemonc oncoalert leusm leukemia cllsm']\n",
      "['chronic lymphocytic leukemia status', 'condition summary chronic lymphocytic leukemia']\n",
      "['novel selective inhi bitor', 'pi3k demonstrates', 'promising preclinical antitumor activity', 'b cell lymphomas', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['christmas pyjamas', 'meme memes letstalk', 'ferma comedia paratiiiiii tvshow dontrun cll mascara quarintena quarantaine']\n",
      "['btk inhibitors', 'chronic lymphocytic leukemia', 'cme video', 'recent web broadcast']\n",
      "['cll treatment approach', 'important factors physicians', 'cllsm leusm']\n",
      "['drug combo induces', 'treatment naive', 'refractory chronic lymphocytic leukemia', 'rogers md']\n",
      "['onct ash paper cirmtuzumab', 'ror1 antibody', 'ibrutinib clinical activity', 'mantle cell lymphoma mcl', 'chronic lymphocytic leukemia cll']\n",
      "['bo zhang', 'oral presentation', 'sf3b1 k700e accelerates', 'chronic lymphocytic leukemia', 'del 13q murine model ash20 hematology cll']\n",
      "['poster presentation', 'integrative transcriptome', 'quantitative proteome analyses identify mettl3', 'key regulator', 'aberrant rna processing', 'chronic lymphocytic leukemia ash20 hematology cll']\n",
      "['r r cll pts', 'y median', 'anticd20 chemo btki orr', 'tox profile', 'similar orr', 'c481s mut', 'impressive non covalent btki', 'big update']\n",
      "['telemedicine impact time', 'cll leusm']\n",
      "['epidemiological data', 'urban residence', 'large b cell lymphoma', 'chronic lymphocytic leukemia', 'non hispanic', 'black americans cancer therapy adviser']\n",
      "['ash20 abstract', 'umbralisib ublituximab', 'venetoclax u2 ven', 'refractory chronic lymphocytic leukemia cll tgtx']\n",
      "['ash20 tgtx abstract', 'ublituximab u2', 'chlorambucil o chl', 'treatment na ve amp', 'refractory r r chronic lymphocytic leukemia cll results', 'unity cll study']\n",
      "['front line treatments', 'chronic lymphocytic leukemia']\n",
      "['available treatment paths', 'health factors dr hill', 'combination therapies', 'cll amp']\n",
      "['classic cll patients', 'target lymphocytosis', 'phospho btk', 'whole blood', 'plasma inhibitor activity pia assay', 'reporter cells']\n",
      "['new clinical trial pharmacokinetics', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['early treatment', 'fcr versus', 'stage binet', 'high risk chronic lymphocytic leukemia cll']\n",
      "['new article shc014748m', 'novel selective inhi bitor', 'pi3k demonstrates', 'promising preclinical antitumor activity', 'b cell lymphomas', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'active akt', 'triggers cll', 'richter s transformation', 'notch1 cll leusm hematology']\n",
      "['new article', 'b cell malignancies', 'therapeutic resistance cll leusm hematology']\n",
      "['new article', 'secondary itp', 'adults cll leusm hematology']\n",
      "['video relapse', 'stem cell transplant differences', 'leukemic cells w catherine wu', 'eric2020 hemonc oncoalert leusm leukemia cllsm cll bmtsm']\n",
      "['worldwide chronic lymphocytic leukemia treatment market', 'remarkable growth']\n",
      "['ibrutinib resistance', 'chronic lymphocytic leukemia']\n",
      "['18f fdg pet', 'richter s transformation', 'b cell receptor inhibitor haematologica leusm']\n",
      "['dia s', 'own robin weinick svp', 'clinical leader', 'patient diversity problem registration', 'free cll']\n",
      "['common cll treatment side']\n",
      "['stress relief', 'blood cancer video', 'virtual meeting', 'free safe drop', 'aml multiplemyeloma leukemia lymphoma cll cancers']\n",
      "['ublituximab umbralisib combo', 'fast track designation cll chroniclymphocyticleukemia cancer treatment raredisease']\n",
      "['pallasch lab', 'university hospital', 'wunderlich lab', 'metabolism research', 'active akt', 'triggers cll', 'richter s transformation', 'notch1 cll']\n",
      "['serious question', 'medical professionals', 'great network', 'miami area', 'i m', 'i m', 'great oncologist hematologist', 'chronic lymphocytic leukemia']\n",
      "['forthcoming lockdown rules', 'general population cll patients amp', 'own level', 'own vulnerability leukaemia haematology']\n",
      "['proliferative signals', 'chronic lymphocytic leukemia', 'lymphoma lymsm']\n",
      "['curso chronic lymphocytic leukemia']\n",
      "['new article osteonecrosis', 'late complication', 'herpes zoster infection', 'case report cll leusm hematology']\n",
      "['new article proliferative signals', 'chronic lymphocytic leukemia', 'cll leusm hematology']\n",
      "['new article clinical radiological', 'hematopoietic stem cell transplantation cll leusm hematology']\n",
      "['new article atypical presentation', 'cutaneous herpes simplex virus', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', '18f fdg pet', 'richter s transformation', 'chronic lymphocytic leukemia', 'b cell receptor inhibitor cll leusm hematology']\n",
      "['new article high rate', 'mrd responses', 'fit patients', 'chronic lymphocytic leukemia', 'front line fludarabine cyclophosphamide', 'ofatumumab fco2 cll leusm hematology']\n",
      "['new article prognostic impact', 'prevalent chronic lymphocytic leukemia', 'subsets analysis', 'prospective clinical trials', 'german cll study group gcllsg cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['cll patient care', 'cne cme credit', 'smartphone play']\n",
      "['cll treatment options leusm cllsm']\n",
      "['chroniclymphocyticleukemia expert dr richard furman speaks', 'patients risk', 'people w cll leusm lymsm']\n",
      "['class biologic drugs', 'laryngeal cancer', 'clinical trials', 'chronic lymphocytic leukemia']\n",
      "['b cell receptor stereotypy', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['resistance mechanisms', 'chronic lymphocytic leukemia']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['new article', 'short term results', 'recombinant varicella zoster glycoprotein e', 'initial btk inhibitor therapy', 'lymphoplasmacytic lymphoma cll leusm hematology']\n",
      "['new article', 'nucleotide polymorphisms', 'leukaemia evidence', 'case control studies cll leusm hematology']\n",
      "['important point clinical judgement', 'patients plt lt', 'trigger treatment', 'stable fluctuate', 'long period', 'time cll leusm']\n",
      "['interesting analysis', 'large proportion', 'cll cases', 'non cytotoxic novel agents', 'cytotoxic chemotherapy covid19']\n",
      "['chronic lymphocytic leukaemia esmo clinical practice guidelines', 'diagnosis treatment', 'cll leusm']\n",
      "['erlene seymour md', 'ibrutinib versus chemoimmunotherapy', 'chronic lymphocytic leukemia leusm cll']\n",
      "['cost effectiveness', 'chronic lymphocytic leukemia']\n",
      "['oncology case', 'peer perspectives event', 'dr brander', 'old female patient', 'chronic lymphocytic leukemia leukemia']\n",
      "['year results', 'phase iii murano study', 'refractory cll', 'arnon kater', 'lymsm cll']\n",
      "['s holiday i', 'thoughts cancer halloween cll bloodcancer']\n",
      "['encore presentation', 'key factors', 'patients w cll', 'ap role', 'prevention mitigation', 'adverse events jadprolive']\n",
      "['encore presentation', 'identify key factors', 'patients w cll', 'aps role', 'prevention mitigation', 'adverse events jadprolive']\n",
      "['new article sf3b1', 'chronic lymphocytic leukemia shows evidence', 'notch1 pathway activation', 'cd20 downregulation cll leusm hematology']\n",
      "['new article venetoclax', 'bendamustine rituximab', 'bendamustine obinutuzumab', 'chronic lymphocytic leukemia', 'final results', 'phase 1b study go28440 cll leusm hematology']\n",
      "['free treatments', 'treatment na ve chronic']\n",
      "['cll patients', 'risk patients', 'person cllsm']\n",
      "['farrukh awan m d discusses', 'novel therapies', 'clinical trials', 'chronic lymphocytic leukemia cll']\n",
      "[]\n",
      "['scale bail', 'b cell lymphoma edition', 'online ancc', 'cll patient care don t']\n",
      "['ross salvaris', 'chronic lymphocytic leukemia cll', 'chronic lymphocytic leukemia']\n",
      "['corner fate s car nk therapeutic approach poses excitement', 'address gaps', 'target car t therapies', 'b cell malignancies']\n",
      "['new article diagnostic', 'therapeutic potential', 'extracellular vesicles', 'b cell malignancies cll leusm hematology']\n",
      "['new article covid', 'fortuitous discovery', 'chronic lymphocytic leukemia biological findings', 'cll leusm hematology']\n",
      "['new article', 'platelet volume', 'prognostic value', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article time', 'p53 dysfunction', 'chronic lymphocytic leukaemia results', 'o cll1 study', 'early stage patients cll leusm hematology']\n",
      "['new article ascorbic acid vitamin c', 'therapeutic effect', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article resistance mechanisms', 'treatment strategies', 'chronic lymphocytic leukemia cll leusm hematology']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['new article abnormal expression', 'chronic lymphocytic leukemia', 'clinical significance cll leusm hematology']\n",
      "['new article genereviews cll leusm hematology']\n",
      "['factor prognostic model', 'identify patients', 'chronic lymphocytic leukemia', 'ibrutinib failure', 'recent research']\n",
      "['dia s', 'own robin weinick svp', 'clinical leader', 'patient diversity problem registration', 'free cll']\n",
      "['oncology case', 'peer perspectives event dr brander', 'old female patients', 'chronic lymphocytic leukemia leusm leukemia']\n",
      "['drs gribben jacbos tedeschi', 'live web broadcast', 'cll treatment advances', 'btk pi3k', 'inhibitor options', 'novel antibodies ash20 leusm']\n",
      "['cll treatment']\n",
      "['novel agents', 'allogeneic stem cell transplant outcomes f']\n",
      "['llc evoluci n constante es hemato2020 cll llc']\n",
      "['free treatments', 'treatment na ve chronic']\n",
      "['vitamin c', 'chronic lymphocytic leukemia cll b cells', 'synergistic interaction', 'full text']\n",
      "['new clinical trial ibrutinib monotherapy versus', 'duration venetoclax', 'obinutuzumab versus', 'duration ibrutinib', 'chronic lymphocytic leukaemia cll cll leusm hematology']\n",
      "['obinutuzumab ibrutinib']\n",
      "['new article concurrence', 'chronic lymphocytic leukaemia', 'small lymphocytic lymphoma', 'acute myeloid leukaemia', 'bone marrow biopsy cll leusm hematology']\n",
      "['new article cofilin', 'chronic lymphocytic leukemia cells cll leusm hematology']\n",
      "['bruton tyrosine kinase inhibitors', 'upfront treatment', 'chronic lymphocytic leukemia cll', 'systematic review', 'network meta analysis']\n",
      "['ibrutinib treatment', 'alternative administration', 'chronic lymphocytic leukemia', 'dysphagia lymphoma lymsm']\n",
      "['dual pd1 lag3 immune checkpoint blockade limits tumor development', 'murine model', 'chronic lymphocytic leukemia blood american society', 'hematology cytofpub']\n",
      "['frontiers method', 'tumor microenvironment', 'mass cytometry application', 'chronic lymphocytic leukemia immunology cytofpub']\n",
      "['cll care']\n",
      "['treatment paradigm', 'chronic lymphocytic leukemia', 'continuous therapeutic agents leukemia leusm']\n",
      "['cll clinical trial', 'doctor cllsm']\n",
      "['rank rankl', 'important survival axis', 'chronic lymphocytic leukemia cll cells', 'beg m alankus veronika ecker j rgen ruland muenchen', 'colleagues leukemia lymphoma']\n",
      "['certain times', 'structure slab leaks', 'concrete slab springs', 'concrete cll slableakages waterproof']\n",
      "['research changes patients', 'haematological diseases', 'interview hematology wednesdaywisdom myeloma cll lymphomas', 'acute adult leukemias genetherapy']\n",
      "['day terry m', 'connait captain leader legend cll']\n",
      "['monthly newsletter', 'october edition lymsm']\n",
      "['new article dleu2', 'oncogenesis cll leusm hematology']\n",
      "['rituximab biosimilars market nonhodgkins lymphoma nhl cll mpa leukemia rheumatoidarthritis pfizer mylan amgen teva celltrion sandoz reliance bioxpress intas covid19 tbrc globalmarketmodel']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['7th cohort 65mg', '1st pr', 'cll patient', 'drug apto', 'therapeutic dose butt need time', 'pr s', 'post ash i don t care', 'pr s']\n",
      "['soo jin seung', 'world data', 'health system costs', 'chronic lymphocytic leukemia', 'treatment patterns survival outcomes', 'resource utilization', 'cll patients capt actp2020']\n",
      "['cll treatment', 'dr jennifer woyach', 'james cllsm']\n",
      "['cost effectiveness']\n",
      "['cll treatment', 'dr jennifer woyach']\n",
      "['cost effectiveness', 'line vs', 'line ibrutinib', 'chronic lymphocytic leukemia']\n",
      "['professor webinar', 'chronic lymphocytic leukemia', 'mrd btk versus bcl', 'front therapy', 'btk inhibitor side']\n",
      "['don t', 'patient groups', 'clinical groups', 'patient outcomes', 'september cll cml patientadvocacy']\n",
      "['high risk', 'recent international studies', 'cll patients']\n",
      "['remote learning plan', 'high risk family member', 'difficult choice', 'children ire']\n",
      "['agentorangeawareness month', 'health issues', 'service vietnamvets']\n",
      "['seasonal influenza flu shot', 'late october', 'chroniclymphocyticleukemia cll', 'immune system']\n",
      "['essential genetic tests']\n",
      "['common practice', 'coronavirus crisis', 'cll expert dr pagel']\n",
      "['virtual ash20', 'dr alexey danilov', 'full video', 'educational slide deck', 'oncology hematology lymsm']\n",
      "['interactive cme moc webinars', 'dr neil', 'faculty members', 'complimentary activities', 'chronic lymphocytic leukemia lung cancer', 'gynecologic cancers register solange']\n",
      "['tg therapeutics', 'fast track designation', 'cll chronic lymphocytic leukemia oncology cancer']\n",
      "['cll treatment', 'leusm cllsm']\n",
      "['chroniclymphocyticleukemia cll', 'different stages', 'physician assistant', 'cll expert chris d andrea']\n",
      "['recent publication', 'refractory chronic lymphocytic leukemia', 'hovon data center colleagues', 'erasmus mc']\n",
      "['old man', 'gastrointestinal involvement', 'chronic lymphocytic leukemia']\n",
      "['free treatments', 'treatment na ve chronic']\n",
      "['wnt5a enhances proliferation', 'chronic lymphocytic leukemia', 'ror1 dock2', 'dependent mechanism']\n",
      "['video retrospective analysis', 'covid19 infection', 'cll patients w lydia scarfo', 'eric2020 hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['chronic lymphocytic leukemia', 'richter transformation skin involvement', 'herpes virus infection lymphoma lymsm']\n",
      "['tgtx lymphoma cll']\n",
      "['worldwide chronic lymphocytic leukemia treatment market', 'outstanding growth']\n",
      "['cost effectiveness', 'line vs', 'line ibrutinib', 'monthly cost', 'line ibrutinib', 'effective blood american society']\n",
      "['dr davids discusses', 'current treatment landscape', 'chronic lymphocytic leukemia', 'chemoimmunotherapy leusm leukemia']\n",
      "['early intervention', 'high risk chronic lymphocytic leukemia cll']\n",
      "['cll patients', 'certain types', 'myelodysplastic syndromes mds']\n",
      "['new article human cxcr5 pd', 'cd8 t cells', 'healthy individuals', 'hematologic malignanciesvan bruggen cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia concomitant', 'case report cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia', 'richter transformation skin involvement', 'herpes virus infection cll leusm hematology']\n",
      "['new article wnt5a enhances proliferation', 'chronic lymphocytic leukemia', 'ror1 dock2', 'dependent mechanism cll leusm hematology']\n",
      "['tg therapeutics announces', 'fast track designation', 'adult patients', 'chronic lymphocytic leukemia tcell']\n",
      "['atrial fib', 'arrhythmias inhibition', 'target effect', 'cardioonc cllsm mclsm lysm lymphoma cll']\n",
      "['editor questions cll patient bob levis smart patients', 'smart care magazine educatedpatientsummit']\n",
      "['free treatments', 'treatment na ve chronic lymphocytic leukemia medivizor']\n",
      "['year survival', 'dr bryan magazine educatedpatientsummit leukemia lymphoma leusm', 'adverse cytogenetics']\n",
      "['new study uses', 'bim antibody', 'chronic lymphocytic leukemia cll']\n",
      "['multiple myeloma', 'cme lecture', 'john m burke md amp manuel', 'santiago md gt gt']\n",
      "['molecular diagnostics', 'supports patients', 'common fusion transcripts', 'acute myeloid leukemia aml', 'acute lymphocytic leukemia', 'chronic myeloid leukemia cml']\n",
      "['japanese patients', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma lymphoma lymsm']\n",
      "['new article obinutuzumab', 'autoimmune haemolytic anaemia', 'immune thrombocytopenia', 'chronic lymphocytic leukaemia', 'small lymphocytic lymphoma cll leusm hematology']\n",
      "['new article', 'real world analysis', 'treatment patterns', 'clinical outcomes', 'chronic lymphocytic leukemia', 'latin american countries cll leusm hematology']\n",
      "['new article phase', 'japanese patients', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll leusm hematology']\n",
      "['new article circadian clock gene period2 suppresses human chronic myeloid leukemia cell proliferation cll leusm hematology']\n",
      "['new article invasive fungal infections', 'bruton s tyrosine kinase inhibitors cll leusm hematology']\n",
      "['new article immune checkpoint inhibition therapy', 'skin cancer', 'concomitant hematological malignancy', 'retrospective multicenter decog study', 'patients cll leusm hematology']\n",
      "['frontline fcr', 'high risk mutations', 'r idelalisib r venetocalx', 'symptomatic relapse']\n",
      "['virtueel symposium lymmcare', 's cll mm lymfoom letscurethis leukemia cllsm']\n",
      "['novel agents', 'allogeneic stem cell transplant outcome']\n",
      "['big shoes', 'awesome fnce', 'i m', 'sure fnce', 'good hands', 'entire cll team']\n",
      "['car nk cell therapy', 'car t cell therapy dr katy rezvani', 'car nk therapy', 'nhl patients']\n",
      "['secondary itp', 'viral infections', 'chickenpox parvovirus hepatitis c epstein barr hiv covid systemic lupus erythematosus sle chronic lymphocytic leukemia cll drug', 'immune thrombocytopenia sepsis']\n",
      "['i m vhr', 'absolute troopers', 'piecemeal support']\n",
      "['results impact', 'cll treatment options register', 'dr jennifer woyach', 'james leusm cllsm register']\n",
      "['chronic lymphocytic leukemia cll patients', 'notch mutations need', 'aggressive treatments', 'aggressive treatments', 'richter s transformation dr barr', 'questions amp']\n",
      "['chronic lymphocytic leukemia cll patients', 'cancer care centers', 'overall survival os']\n",
      "['matthew s davids md mmsc director', 'clinical research', 'lymphoma program', 'medical oncologist', 'dana farber cancer institute discusses investigational doublets', 'chronic lymphocytic leukemia cll chroniclymphocyticleukemia']\n",
      "['chimeric antigen receptor t cells', 'chronic lymphocytic leukemia']\n",
      "['decisions w', 'patients i don t', 'dr john allan highlights', 'patient input', 'chroniclymphocyticleukemia cll']\n",
      "['flu shot', 'cll patients cll leukemia flushot']\n",
      "['results impact cll treatment options register', 'dr jennifer woyach', 'james leusm cllsm']\n",
      "['peggy s life', 'w chronic lymphocytic leukemia cll', 'common cancers']\n",
      "['lab scientist', 'yrs i', 'poor circulation', 'blood thinners', 'don t use coumadin warfarin', 'quality thrombin inhibitors i', 'bone marrow issues']\n",
      "['squaric acid', 'parthenolide amp', 'cll activity', 'special edition', 'tetrahedron mds unibham openaccess']\n",
      "['epigenetic changes', 'report gene', 'specific changes', 'patient treatment work', 'jgw patterson foundation cancer medresearch']\n",
      "['cost effectiveness', 'line vs', 'line ibrutinib', 'chronic lymphocytic leukemia blood american society', 'hematology 1rst line ibrutinib', 'current pricing']\n",
      "['global experts', 'esh translational research e conference', 'chronic lymphocytic leukemia cll eshcll2020']\n",
      "['inflection biosciences', 'positive pre clinical data', 'pim pi3k inhibitor', 'chronic lymphocytic leukemia']\n",
      "['gc cxcl13 plasma levels function', 'disease activity', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'dr richard r furman']\n",
      "['leadership footsteps', 'cll vice chair', 'awesome fnce']\n",
      "['new clinical trial venetoclax', 'magrolimab venom', 'refractory indolent b cell malignancies cll leusm hematology']\n",
      "['novel somatic plcg2 variant', 'syk inhibition', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['new article cost effectiveness', 'cll cll leusm hematology']\n",
      "['new article', 'novel somatic plcg2 variant', 'syk inhibition', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article clinical considerations', 'chronic lymphocytic leukemia', 'rare clinical scenarios', 'case series', 'literature cll leusm hematology']\n",
      "['new article cxcl13 plasma levels function', 'disease activity', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article fc', 'fc effector function', 'b cell malignancies cll leusm hematology']\n",
      "['chronic cancer', 'delay cancellation', 'active surveillance appointments', 'disease progression', 'clinical trials', 'enable access', 'novel agents', 'frontline chemo']\n",
      "['cll community', 'bright star', 'big hugs', 'dublin deb']\n",
      "['cll chronic lymphocytic leukemia patient power']\n",
      "['dap kinase', 'protein kinase', 'key regulator', 'molecular marker', 'chronic lymphocytic leukemia co', 'zhou amp']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['oncoalert prognostic score', 'categorizes patients', 'risk groups', 'variables tp53 aberration', 'refractory disease', 'mg l ldh gt', 'u l cllsm leusm lymsm']\n",
      "['free treatments', 'treatment na ve c']\n",
      "['fast track designation', 'umbralisib u2', 'adult patients', 'chronic lymphocytic leukemia']\n",
      "['prof john seymour amp prof andrew roberts', 'joint winners', 'ramaciotti medal', 'cancer drug venetoclax', 'cll patients']\n",
      "['ggal cll sigue sin mostrar debilidad']\n",
      "['cost effectiveness', 'line vs', 'line ibrutinib', 'cll blood american society', 'hematology leusm']\n",
      "['apto cg', 'new class', 'only agent', 'inhibit btk', 'cll andflt3']\n",
      "['tg therapeutics', 'fast track designation', 'chronic lymphocytic leukemia cll', 'oncology regulatoryaffairs drugdevelopment biotech']\n",
      "['cost effectiveness', 'line vs', 'line ibrutinib', 'chronic lymphocytic leukemia blood american society']\n",
      "['vitro conditions', 'tumor microenvironment blood advances american society', 'bcl2 cll venetoclax']\n",
      "['vitro conditions', 'tumor microenvironment']\n",
      "['sandra kurtin phd anp c aocn', 'education sessions', 'jadprolive virtual', 'chronic lymphocytic leukemia cll']\n",
      "['interactive virtual meeting', 'cll leukemia fightcancer']\n",
      "['open translational research e conference', 'cll register', 'eshcll2020 chairs jennifer', 'brown paolo ghia michael hallek visit', 'e conference platform eshconferences']\n",
      "['tg therapeutics', 'fast track designation', 'chronic lymphocytic leukemia cll tgtx']\n",
      "['tg therapeutics announces', 'fast track designation', 'adult patients', 'chronic lymphocytic leukemia tgtx tcell biotech leukemia cll']\n",
      "['ibrutinib 140mg', 'mantle cell lymphoma chronic lymphocytic leukemia', 'small lymphocytic lymphoma waldenstrom macroglobulinemia', 'marginal zone lymphoma treatment visit', 'website wechat amp whatsapp']\n",
      "['cll patient care', 'cme cne opportunities', 'aren t']\n",
      "['project cll clue', 'tero aittokallio barbara eichhorst carsten niemann thorsten zenz laszlo zsombor commission']\n",
      "['new clinical trial pharmacists', 'care oncology model pcom', 'cancer medications cll leusm hematology']\n",
      "['clinical trials', 'cll patients', 'major advances', 'new treatments', 'cross border access', 'important discussion']\n",
      "['new article ibl', 'vitro conditions', 'tumor microenvironment cll leusm hematology']\n",
      "['new article cancer duplicity', 'chronic lymphocytic leukemia', 'metastatic melanoma', 'ipilimumab cll leusm hematology']\n",
      "['new article epigenome', 'wide analysis reveals', 'functional modulators', 'drug sensitivity', 'post treatment survival', 'chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['new article high throughput single cell detection', 'multiplex crispr', 'gene modifications cll leusm hematology']\n",
      "['new article dap kinase', 'protein kinase', 'key regulator', 'molecular marker', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['kinase selectivity', 'btk inhibitors', 'chronic lymphocytic leukemia leusm btk']\n",
      "['cllsociety dr john pagel s ash', 'dr sameer parikh monoclonal b cell lymphocytosis mbl']\n",
      "['virtualhem2020 view', 'hematology virtual blood targetedtherapy chemotherapy clinicalperspectives bioevents medicalconference exhibitions cml aml']\n",
      "['btk inhibitors', 'frontline treatment', 'chronic lymphocytic leukemia leusm']\n",
      "['early intervention', 'high risk chronic lymphocytic leukemia']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['zanubrutinib bgb', 'chronic lymphocytic leukemia', 'follicular lymphoma zanubrutinib', 'cll sll', 'deep responses']\n",
      "['cdc birx', 'power heartland covid crush medpage']\n",
      "['fda grants', 'fast track designation', 'ublituximab umbralisib combo', 'chronic lymphocytic leukemia']\n",
      "['novel agents', 'chronic lymphocytic leukemia']\n",
      "['fda grants ublituximab umbralisib combo', 'fast track status']\n",
      "['tg therapeutics announces', 'fast track designation', 'adult patients', 'chronic lymphocytic leukemia']\n",
      "['fast track designation', 'adult patients', 'chronic lymphocytic leukemia leukemia leusm']\n",
      "['dr susan o brien', 'cll clinical trial options', 'physician leusm']\n",
      "['tg therapeutics announces', 'fast track designation', 'adult patients', 'chronic lymphocytic leukemia']\n",
      "['tgtx tg therapeutics announces', 'fast track designation', 'adult patients', 'chronic lymphocytic leukemia', 'tgtx ampcard', 'tgtx cll']\n",
      "['wide analysis reveals', 'functional modulators', 'drug sensitivity', 'post treatment survival', 'chronic lymphocytic leukaemia cll']\n",
      "['chronic lymphocytic leukemia i m fortunate', 'canada amp', 'month meds', 'amp i']\n",
      "['line chronic lymphocytic leukemia']\n",
      "['time itschemotime leukemia cll bloodcancer wearadamnmasktoprotectpeoplelikeus']\n",
      "['ross salvaris', 'chronic lymphocytic leukemia cll', 'chronic lymphocytic leukemia']\n",
      "['clinical collaborators', 'belfast city hospital cll']\n",
      "['free treatments', 'treatment na ve ch']\n",
      "['tgtx tg therapeutics announces', 'fast track designation', 'adult patients', 'chronic lymphocytic leukemia']\n",
      "['pathological rank', 'b cells', 'chronic lymphocytic leukemia', 'beg m alankus veronika ecker j rgen ruland muenchen', 'colleagues leukemia lymphoma']\n",
      "['notch1 mutation leusm jnccn360']\n",
      "['tg therapeutics reports fda', 'fast track designation', 'chronic lymphocytic leukemia', 'tickers tgtx']\n",
      "['artikel om hvordan h matologisk patienter klarer sig i covid19 tiden', 'kr ftensbek mpelse har st ttet dk blodkr ft blodcancer lyle dk sundpol dksund', 'aml apl cll cml cmml lymfekr ft mds']\n",
      "['fast track designation', 'combo w umbralisib', 'fast track', 'unity cll phase', 'study details tgtx']\n",
      "['tg therapeutics announces', 'fast track designation', 'umbralisib fo']\n",
      "['headline nasdaq tgtx protagonist tg therapeutics announces', 'fast track designation', 'adult patients', 'chronic lymphocytic leukemia stockstowatch premarket']\n",
      "['fast track designation', 'adult patients', 'chronic lymphocytic leukemia cll']\n",
      "['tgtx tg therapeutics announces', 'fast track designation', 'adult patients', 'chronic lymphocytic leukemia tg therapeutics inc']\n",
      "['tgtx 15s', 'press release', 'tg therapeutics announces', 'fast track designation', 'adult patients', 'chronic lymphocytic leukemia']\n",
      "['tgtx announces', 'fast track designation', 'adult patients', 'chronic lymphocytic leukemia']\n",
      "['tgtx tg therapeutics announces', 'fast track designation', 'adult patients', 'chronic lymphocytic leukemia']\n",
      "['catherine holliday chief exec', 'global speaks', 'peek study', 'patient advocate neil mathews uk aust patients amp family talk', 'cll chronic lymphocytic leukemia thanks prof peter hillman']\n",
      "['sharon winton ceo discusses improvements', 'treatment options', 'pbs amp', 'survival rates', 'vital tests', 'chronic lymphocytic leukemia cll uk aus webinar', 'co host']\n",
      "['mc webinar', 'uk amp australian patients amp families', 'cll chronic lymphocytic leukemia haematologist prof peter hillman', 'current treatment amp research thanks']\n",
      "['new article clinical trial risk', 'leukemia biomarkers', 'trial design cll leusm hematology']\n",
      "['new article', 'geographic diversity', 'chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['new article pathological rank', 'b cells', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['covid19 infection', 'hematological patients', 'danishcancersociety dk blodkr ft blodcancer', 'aml apl cll cml mds lymfekr ft lyle dk']\n",
      "['leukemia treatment breakthroughs', 'chronic lymphocytic leukemia']\n",
      "['pathological rank', 'b cells', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['novel agents', 'allogeneic stem cell transplant outcomes f']\n",
      "['icliniq q i', 'high white blood', 'hematology chroniclymphocyticleukemia']\n",
      "['treatment naive del17 cll', 'frontline del17p cll btkinhibitor']\n",
      "['recent research suggests', 'aggressive chronic lymphocytic leukemia', 'independent prognostic genetic factor', 'tp53 mutations', 'cases haematologica journal ferrata storti foundation']\n",
      "['obinutuzumab ibrutinib']\n",
      "['chroniclymphocyticleukemia patients', 'cll diagnosis host amp cll patient', 'social worker robin katz', 'share communication tips']\n",
      "['don t', 'i suffer', 'chronic lymphocytic leukemia', 'doesn t', 'i don t suffer', 'cancer research']\n",
      "['novel agents', 'allogeneic stem cell transpla leukemia']\n",
      "['onc visit cll']\n",
      "['mind blog', 'hard cider', 'drug products trademarks registrability cll']\n",
      "['names venex', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'acute myeloid leukemia aml']\n",
      "['new article', 'alert chronic lymphocytic leukemia', 'primary non lymphoid malignanc cytopath cyto']\n",
      "['shuo ma md phd', 'btk inhibitors', 'refractory chronic lymphocytic leukemia']\n",
      "['hematology virtual blood targetedtherapy chemotherapy clinicalperspectives bioevents medicalconference exhibitions cml aml']\n",
      "['results validate ngs', 'mutation analysis', 'multicenter trial', 'prognostic workup']\n",
      "['predictive role', 'gene mutations', 'chronic lymphocytic leukemia results', 'pivotal phase iii study complement1']\n",
      "['new article biclonal lymphoproliferative disorders', 'chronic lymphocytic leukaemias cll leusm hematology']\n",
      "['new article fluorescence', 'situ hybridization', 'molecular cytogenetic abnormalities', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article effect', 'ifn response', 'chronic lymphocytic leukemia cells cll leusm hematology']\n",
      "['new article enterobius vermicularis infection', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article obinutuzumab use', 'progressive multifocal leukoencephalopathy', 'chronic lymphocytic leukemia', 'case report cll leusm hematology']\n",
      "['new article diagnosis', 'chronic lymphocytic leukemia recommendations', 'french cll study group filo cll leusm hematology']\n",
      "['new article application', 'chimeric antigen receptor t cells', 'hematological malignancies cll leusm hematology']\n",
      "['new article', 'apoptotic role', 'ebv lmp1', 'lymphoma cells cll leusm hematology']\n",
      "['new article lights', 'generation pi3k inhibitors', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['duration venetoclax', 'rituximab venr', 'free survival pfs', 'refractory chronic lymphocytic leukemia cll']\n",
      "['cll genetic markers checkout michele', 'cll tests amp mutations']\n",
      "['free treatments', 'treatment na ve chronic']\n",
      "['chronic lymphocytic leukemia cll landscape', 'novel therapeutics', 'treatment plans check', 'cme video']\n",
      "['novel biomarkers', 'classification system', 'cll w andreas agathangelidis', 'eric2020 hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['dr richard furman', 'common reasons', 'chroniclymphocyticleukemia cll therapy', 'prognostic markers', 'treatment planning cc leusm lymsm']\n",
      "['covid impact cll patients cllsm']\n",
      "['clinical practice guidelines', 'chronic lymphocytic leukemia cll']\n",
      "['clinical practice guidelines', 'diagnosis treatment', 'chronic lymphocytic leukemia cll']\n",
      "['husk vi har', 'p fredag kun', 'medlemmer meld dig til', 'vi snakker om blodkr ft blodcancer lymfekr ft leuk mi mds', 'patienter og p r rende i lyle dk v r', 'bestemme lyle s fremtid aml apl', 'cll cml']\n",
      "['webinar friday', 'special guest speaker', 'dr samir agrawal senior lecturer', 'haematology amp consultant haemo oncologist', 'london register', 'webinar org uk cll bloodcancer']\n",
      "['chronic lymphocytic leukemia']\n",
      "['matthew s davids md mmsc', 'mantlecelllymphoma leusm lymsm cllsm mclsm hemeonc jnccn360']\n",
      "['top concern cll patient cll patient amp advocate leslie powell', 'robin katz', 'share tips amp advice']\n",
      "['current clinical practice', 'cll w lydia scarfo', 'eric2020 hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['i m', 'nathan s', 'increase awareness', 'support research', 'treatment options', 'nathan s']\n",
      "['chronic lymphocytic leukemia questions', 'amp cll expert dr nicole lamanna', 'questions leusm', 'questions amp register']\n",
      "['whelp i guess', 'cll fallball bluemountain']\n",
      "['erlene seymour md', 'ibrutinib versus chemoimmunotherapy', 'chronic lymphocytic leukemia leusm cll']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['novel agents', 'chronic lymphocytic leukemia', 'oncology novel agents', 'chronic lymphocytic leukemia']\n",
      "['video genomic aberrations', 'cll w', 'eric2020 hemonc oncoalert leusm leukemia cllsm cll']\n",
      "[]\n",
      "['novel agents', 'chronic lymphocyticleukemia']\n",
      "['ibrutix ibrutinib lymphoma chronic lymphocytic leukemia b nh b ch c u m n t nh ibrutinib mcl cll sll wm mzl']\n",
      "['video cll cell treatment resistance', 'microenvironmental interactions w dimitar efremov eric2020 hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['pulmonary arterial hypertension', 'chronic lymphocytic leukemia patient']\n",
      "['insightful report', 'professor tatjana stankovic', 'european research initiative', 'cll eric', 'international meeting']\n",
      "['anticancer compounds', 'b cell cancer therapy', 'cellular stress response anticancer compounds', 'endoplasmic reticulum er stress response', 'multiple myeloma mm chronic lymphocytic leukemia cll']\n",
      "['cll cell proliferation clinical overview w jan burger', 'eric2020 hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['chronic lymphocytic leukemia']\n",
      "['shuo ma md', 'novel agents', 'btk inhibitor', 'resistant cll']\n",
      "['duration venetoclax', 'durable response', 'chronic lymphocytic leukemia']\n",
      "['predictive role', 'gene mutations', 'chronic lymphocytic leukemia results', 'pivotal phase iii study complement1 haematologica']\n",
      "['bhat md', 'james discusses', 'combination regimens', 'chronic lymphocytic leukemia leusm cll']\n",
      "['factor prediction model shows', 'chronic lymphocytic leukemia', 'nhlbi clinicaltrial', 'pubs hematology']\n",
      "['genetic tests', 'cll treatment options']\n",
      "['dap kinase', 'protein kinase', 'key regulator', 'molecular marker', 'chronic lymphocytic leukemia']\n",
      "['anticancer compounds', 'endoplasmic reticulum stress response', 'multiple myeloma mm chronic lymphocytic leukemia cll']\n",
      "['zanubrutinib monotherapy', 'treatment na ve cll', '17p deletion leusm lymsm']\n",
      "['autumnal patterns', 'offering emergent maths language', 'communication possibilities galore links', 'cache eye units', 'eyp units', 'maths cll eytagteam forestschool outdoorclassroom']\n",
      "['immunoglobulin genes', 'cll w andreas agathangelidis', 'certh eric2020 hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['real world evidence', 'chronic lymphocytic leukemia']\n",
      "['great baseball', 'worldseries berth', 'present chest2015', 'leukemiclungdisease bronchopulmonaryleukemicinfiltrates cll pulmcc']\n",
      "['bhat md', 'btk inhibitors', 'cll shares', 'btk leusm']\n",
      "['webinar cll treatment', 'tues oct 27th 10am pt 1pm']\n",
      "['weeks blog sort', 'plan link', 'bio nonhodgkinslymphoma cll sll findacure watchandwait']\n",
      "['predictive model', 'ibrutinib treatment', 'chronic lymphocytic leukemia leusm hematology']\n",
      "['7pm i', 'yr survivor', 'chronic lymphocytic leukemia cll i', 'cancer mike giannamore s light', 'night walk fund raising page']\n",
      "['copyright developments denial', 'certiorari leaves', 'banc decision', 'heaven skidmorevledzeppelin stairwaytoheaven cowanliebowitz cll']\n",
      "['don t', 'annual national patient conference', 'lymphoma amp cll']\n",
      "['chronic lymphocytic leukemia']\n",
      "['proliferative signals', 'chronic lymphocytic leukemia', 'scholaralerts cll cd40l']\n",
      "['right choice', 'essential leakages', 'buildings lead', 'eventual collapse', 'admixture visit cll construction']\n",
      "[]\n",
      "['dr john allan s', 'treatment paradigm', 'combination therapies', 'people w chroniclymphocyticleukemia cll', 'peer exchange lymsm leusm']\n",
      "['patienten webinar zur cll des cio k ln referentin ist prof dr barbara eichhorst ober rztin der klinik i innere medizin anmeldung unter']\n",
      "['politics making', 'cll w ulrich j ger', 'wien eric2020 hemonc oncoalert leusm leukemia cllsm cll hematology']\n",
      "['chronic lymphocytic leukemia']\n",
      "['ibrutix ibrutinib 140mg', 'mantle cell lymphoma chronic lymphocytic leukemia', 'small lymphocytic lymphoma waldenstrom macroglobulinemia', 'marginal zone lymphoma treatment visit', 'website wechat amp whatsapp']\n",
      "['monitor manage', 'clonoseq mrd', 'cll clonoseq', 'assess mrd', 'cll mm', 'important info incl sample types amp test limitations']\n",
      "['monitor manage', 'clonoseq mrd', 'cll clonoseq', 'assess mrd', 'cll mm', 'important info incl sample types amp test limitations']\n",
      "['cne activity cme activity gameshow', 'important advances', 'cll patient care', 'idea play', 'ce credit']\n",
      "['video cll', 'genomic level w catherine wu', 'eric2020 hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['factor score', 'ibrutinib treatment', 'chronic lymphocytic leukemia prognostic model', 'risk group definition']\n",
      "['new article', 'factor score', 'ibrutinib treatment', 'chronic lymphocytic leukemia prognostic model', 'risk group definition cll leusm hematology']\n",
      "['new article pdq cancer information summaries cll leusm hematology']\n",
      "['b cell receptor stereotypy', 'chronic lymphocytic leukemia cll']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['alankus ruland muenchen amp colleagues', 'chronic lymphocytic leukemia cll cells', 'microenvironmental rankl', 'rankl rank', 'kills murine', 'human cll cells']\n",
      "['beg m alankus j rgen ruland muenchen', 'chronic lymphocytic leukemia cll cells', 'microenvironmental rankl', 'rankl rank', 'kills murine', 'human cll cells']\n",
      "['discusses factors', 'chronic lymphocytic leukemia leusm']\n",
      "['interactive discussion', 'dr neil', 'dr john pagel', 'swedish cancer institute', 'chronic lymphocytic leukemia register']\n",
      "['predictive model', 'cll patients', 'important step', 'excellent editorial']\n",
      "['high beta', 'high ldh', 'tp53 aberration', 'inferior pfs amp os', 'cll patients', 'ibrutinib high risk pts', 'richter transformation', 'w clinicaltrials implications']\n",
      "['chronic lymphocytic leukemia', 'ibrutinib development', 'factor prognostic model journal', 'clinical oncology']\n",
      "['healthcare resource utilization', 'line ibrutinib', 'chemoimmunotherapy treatment', 'medicare beneficiaries', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['b cell receptor stereotypy', 'chronic lymphocytic leukemia']\n",
      "['outcomes pfs amp os', 'cll pts', 'initiation tp53 abn', 'rx b2m gt', 'mg l ldh gt', 'u l 3y pfs', 'applicable lymsm cll']\n",
      "['rare case', 'pseudohypoxemia coronavirus covid19ncancer leusm jnccn360']\n",
      "['new article healthcare resource utilization', 'line ibrutinib', 'chemoimmunotherapy treatment', 'medicare beneficiaries', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article ibrutinib', 'chronic lymphocytic leukemia', 'respiratory failure', 'severe covid', 'infection case report', 'literature review cll leusm hematology']\n",
      "['new article', 'mutational landscape', 'bystander cells drug', 'blood cancer', 'high prevalence pre neoplasias', 'braf inhibitors cll leusm hematology']\n",
      "['chronic lymphocytic leukemia cll']\n",
      "['cll w freda stevenson', 'eric2020 hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['key cll treatment decision making factors']\n",
      "['treatment health care resource utilization', 'ibrutinib use', 'u s veterans', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'real world retrospective analysis heor lymphoma']\n",
      "['chronic lymphocytic leukemia chronic lymphocytic leukemia', 'common type', 'white blood cells', 'bone marrow', 'chronic lymphocytic']\n",
      "['interesting initial combination ven ibr data', 'r r cll nb', 'af rate look', 'final data n', 'observation vs ibrutinib', 'umrd pts post 15m combo rx', 'future ven ibrutinib', 'r r cll blood ash']\n",
      "['obinutuzumab ibrutinib', 'venetoclax i leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['sureseq cll cnv panel', 'key genes', 'chromosomal regions', 'cll progression', 'cll cnv ngs']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['kinase selectivity', 'btk inhibitors', 'chronic lymphocytic leukemia leusm btk']\n",
      "['dr sandoval sus', 'treatment options', 'old patient', 'chronic lymphocytic leukemia', 'oncology case', 'peer perspective event leukemia']\n",
      "['chronic lymphocytic leukemia causes picture symptoms treatment']\n",
      "['jacob d soumerai md', 'live discussion', 'optimal care', 'cll patients', 'q amp', 'challenging cases', 'advance cll covid']\n",
      "['ips e', 'new international prognostic score', 'early stage chronic lymphocytic leukemia', 'leusm cllsm']\n",
      "['stephan stilgenbauer', 's susan o brien', 'upfront treatment', 'chronic lymphocytic leukemia cll leusm']\n",
      "['early stage chronic lymphocytic leukemia', 'ighv genes', 'absolute lymphocyte', 'palpable lymph nodes leusm cllsm']\n",
      "['ips e', 'new international prognostic score', 'early stage chronic lymphocytic leukemia', 'leusm cllsm']\n",
      "['chronic lymphocytic leukemia', 'new drugs', 'years patients']\n",
      "['small study patients', 'rel ref chronic lymphocytic leukemia', 'free survival', 'btki therapy leusm cllsm']\n",
      "['cll facebook support groups', 'guidance hope', 'show community finalist']\n",
      "['dr khan', 'old patient', 'bone marrow biopsy', 'chronic lymphocytic leukemia', 'oncology case', 'peer perspectives event leusm leukemia']\n",
      "['share cll treatment', 'webinar tuesday', '1pmet cll leusm cllsm register']\n",
      "['btk inhibitors', 'chronic lymphocytic leukemia', 'expert panel', 'cme video']\n",
      "['scientific rationale', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll', 'blood cancer', 'affects blood', 'bone marrow', 'chronicillness healthcare health']\n",
      "['soho state', 'art updates', 'questions clonal evolution', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['new article soho state', 'art updates', 'questions clonal evolution', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'treatment naive cll', 'cll leusm hematology']\n",
      "['cll patients', 'richter transformation w barbara eichhorst', 'eric2020 hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['dr matthew davids', 'grand rounds', 'week cll bcl']\n",
      "['patients hodgkin transformation', 'cll patients', 'patient population thanks', 'great collaborative effort']\n",
      "['long life invest', 'long life', 'cll society cll society', 'platinum seal']\n",
      "['cll collaboration']\n",
      "['ti ara', 'bicrollcall ti ara', 'chronic lymphocytic leukemia', 'transcriptome network analysis', 'identify novel treatments', 'don t']\n",
      "['good debate', 'cll treatment', 'chronic lymphocytic leukemia', 'asco post']\n",
      "['patient experiences disease progression', 'trigger suspicion', 'richter s transformation susan m o brien md']\n",
      "['valuable data', 'amp colleagues suggests abvd', 'hodgkin transformation', 'cll context', 'transformation amp richters risk score', 'prognostic cll naive pts', 'lymsm lymphoma']\n",
      "['new article covid', 'cancer patients', 'setting cll leusm hematology']\n",
      "['new article', 'brain lesions', 'chronic lymphocytic leukaemia', 'regimen cll leusm hematology']\n",
      "['new article association', 'common variants', 'tnfrsf13b genes', 'cll risk', 'clinical picture', 'products april', 'taci molecules cll leusm hematology']\n",
      "['hodgkin lymphoma']\n",
      "['cll disease management w robin fo', 'eric2020 hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['clonal dynamics', 'chronic lymphocytic leukemia']\n",
      "['multiple myeloma', 'cme lecture', 'john m burke md amp manuel', 'santiago md gt gt']\n",
      "['bhat md', 'james discusses', 'chronic lymphocytic leukemia leusm']\n",
      "['chronic lymphocytic leukemia', 'year results', 'genomic complexity', 'gene mutations', 'murano phase iii study awesome paper i', 'del 13q']\n",
      "['new article', 'order immunoglobulin repertoire restrictions', 'illustrative case', 'cll leusm hematology']\n",
      "['new article increase', 'ibrutinib therapy reduces infection rate', 'chronic lymphocytic leukemia cll patients cll leusm hematology']\n",
      "['new article changes', 'proteomic profile', 'blood serum', 'coronary atherosclerosis cll leusm hematology']\n",
      "['cll society s', 'global virtual patient amp caregiver', 'educational forum saturday october', 'important event', 'cll patients', 'great benefit', 'good friend dr brian koffman']\n",
      "['good advice', 'weeks limit', 'contacts cll patients']\n",
      "['chronic lymphocytic leukemia', 'ibrutinib development', 'factor prognostic model haematology thewiderwiserview']\n",
      "['ibrutinib therapy reduces infection rate', 'chronic lymphocytic leukemia cll patients cassin hematological oncology wiley online library']\n",
      "['covid19 coronavirus leusm covid19cancer jnccn360']\n",
      "['cll treatment']\n",
      "['chronic lymphocytic leukemia', 'ibrutinib development', 'factor prognostic model']\n",
      "['car t cell therapy', 'specific types', 'blood cancers clinical trials', 'car t cell therapies', 'chronic lymphocytic leukemia', 'multiple myeloma']\n",
      "['chroniclymphocyticleukemia cll treatment', 'dr richard furman sheds light', 'minimal residual disease mrd', 'expert clip', 'leusm lymsm']\n",
      "['old man', 'chronic lymphocytic leukemia cll', 'abdominal cramps', 'radiology case']\n",
      "['concurrent cutaneous localization', 'langerhans cell sarcoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['physician decision making', 'novel agents', 'chronic lymphocytic leukemia cll', 'preferences oncology']\n",
      "['new article safety', 'rapid dose escalation', 'cll patients', 'b cell receptor', 'antagonists cll leusm hematology']\n",
      "['important survey', 'cll patients', 'duration treatments']\n",
      "[]\n",
      "['john allan md', 'john m burke md', 'nicole lamanna md', 'predictive factors']\n",
      "['new research genetic loss', 'lck kinase', 'chronic lymphocytic leukemia', 'chronic lymphocytic leukemia cll exhibit', 'indolent disease course', 'unresponsive b cell receptors bcrs']\n",
      "[]\n",
      "['pin cushion i', 'findacure nonhodgkinslymphoma cll sll fight']\n",
      "['chronic lymphocytic leukemia', 'ibrutinib development', 'factor prognostic model revistes']\n",
      "['clinical tls', 'standard approach cll lymsm']\n",
      "['cancer treatments drugs amp trials worldwide includ icp', 'gt versus chlorambucil', 'cll sll visit cll chroniclymphocyticleukemia leukemia']\n",
      "['rapid dose escalation', 'cll patients', 'b cell receptor']\n",
      "['common cll treatment side', 'cllsm leusm']\n",
      "['cll patients', 'ct scans', 'treatment cll expert dr richard furman', 'leusm chronicmyeloidleukemia']\n",
      "['cll webinar cll treatment', 'oct 27th', '10am pt']\n",
      "['200ma breakout', 'new leg', '135m cash apto', 'pr partial responses', '52w high']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['new article venetoclax', 'refractory chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article prediction', 'chronic lymphocytic leukemia', 'ibrutinib development', 'factor prognostic model cll leusm hematology']\n",
      "['new article association', 'rs3751143 polymorphism', 'p2rx7 gene', 'chronic lymphocytic leukemia', 'meta analysis cll leusm hematology']\n",
      "['new article', 'curious chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 't cells', 'avadomide sensitizes cll', 'pd l1 pd', 'immunotherapy cll leusm hematology']\n",
      "['eric2020 meeting', 'medical content', 'fresh cll updates hemonc oncoalert leusm leukemia']\n",
      "['s meeting', 'fantastic set', 'cll lymsm']\n",
      "['schongewusst bestimmte risikofaktoren beeinflussen den krankheitsverlauf den therapieerfolg und', 'lebenserwartung von menschen mit chronischer lymphatischer leuk mie kurz cll mehr dazu hier']\n",
      "['versus chlorambucil', 'cll sll status', 'condition summary chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['zanubrutinib bgb', 'chronic lymphocytic leukemia', 'follicular lymphoma lymphoma lymsm']\n",
      "['john allan md', 'john m burke md', 'nicole lamanna md']\n",
      "['chronic lymphocytic leukemia cll', 'richter transformation rt molecular evolution risk factors', 'molecular heterogeneity', 'rt treatment', 'immune evolution', 'biomarkers clinical advances', 'hematology amp oncology']\n",
      "['ibrutinib development', 'factor prognostic model journal', 'clinical oncology leusm']\n",
      "['cll society q', 'dear abby', 'cll society', 'lab scientist', 'hospice doctor']\n",
      "['dr john allan', 'people w chroniclymphocyticleukemia cll', 'peer exchange lymsm leusm']\n",
      "['patient classification', 'chronic lymphocytic leukemia news cmm']\n",
      "['ibrucent ibrutinib mantle cell lymphoma chronic lymphocytic leukemia generic medicine cancermedicine cancersupport lymphomasupport www atoz drugs com']\n",
      "['terrible troll', 'isn t', 'eyfs characters cll diggingdeep matters']\n",
      "['tumor mutational load predicts time', 'chronic lymphocytic leukemia cll', 'monoclonal b cell lymphocytosis', 'international prognostic index hematolog']\n",
      "['bloodcancer diagnosis pete', 'treatment options', 'pete s', 'active role', 'chronic lymphocytic leukemia']\n",
      "['new ejh case report ibrutinib', 'chronic lymphocytic leukemia', 'respiratory failure', 'severe covid', 'infection case report', 'literature review']\n",
      "['new clinical trial icp', 'versus chlorambucil', 'cll sll cll leusm hematology']\n",
      "['new clinical trial cc', 'refractory cd20', 'positive b cell lymphoma cll leusm hematology']\n",
      "['new article rcd chemoimmunotherapy', 'chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['new article zanubrutinib bgb', 'chronic lymphocytic leukemia', 'follicular lymphoma cll leusm hematology']\n",
      "['new article bispecific', 'cd19 car t cells', 'b cell malignancies', 'dose escalation', 'expansion trial cll leusm hematology']\n",
      "['new article berberine affects mitochondrial activity', 'cell growth', 'leukemic cells', 'chronic lymphocytic leukemia patients cll leusm hematology']\n",
      "['fludarabine cyclophosphamide', 'young patients', 'treatment na ve cll lymsm cll']\n",
      "['cll patients']\n",
      "['update 4year murano study']\n",
      "['new chronic lymphocytic leukemia cll toolkit highlights', 'decision making download tools', 'current treatment options cme clltoolkit']\n",
      "['zanubrutinib bgb', 'chronic lymphocytic leukemia', 'follicular lymphoma']\n",
      "['year findings', 'murano trial venetoclax', 'chronic lymphocytic leukemia leusm hematology']\n",
      "['cll patient story cancer leukemia cll raredisease']\n",
      "['zanubrutinib bgb', 'chronic cll', 'follicular lymphoma blood advances lymsm']\n",
      "['obinutuzumab venetoclax', 'good responses', 'chronic lymphocytic leukemia']\n",
      "['cll treatment']\n",
      "['chronic lymphocytic leukemia leusm']\n",
      "['novel bispecific cartcell product', 'cd20 cd19 antigens demonstrates', 'excellent safety profile amp high clinical efficacy', 'b cell non hodgkin lymphoma', 'chronic lymphocytic leukemia nmedclinical immunotherapy clinicaltrials']\n",
      "['new treatment approaches', 'cll expert']\n",
      "['clinical trials']\n",
      "['dr mato', 'cll treatment']\n",
      "['promising cll research']\n",
      "['cll treatment options webinar']\n",
      "['new2trip rituximab riximyo non hodgkin s lymphoma chronic lymphocytic leukemia', 'rheumatoid arthritis']\n",
      "['dr susan o brien', 'key steps factors', 'cll treatment choices leusm']\n",
      "['cll treatment approaches', 'important decision making considerations', 'clinical trials', '10am pt cllsm leusm']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['hoy queremos felicitar', 'nuestra higienista m s veterana que acaba', 'con nosotros felicidades blanca por muchos', 'os m s', 'el equipo cll lacasalitner cienciaentusonrisa']\n",
      "['chronic lymphocytic leukemia cll pete', 'disease shares']\n",
      "['betty s journey', 'chronic lymphocytic leukemia', 'common type', 'u s']\n",
      "['new article', 'risk factor', 'review cll leusm hematology']\n",
      "['new article', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['year findings', 'murano trial venetoclax', 'chronic lymphocytic leukemia', 'asco post']\n",
      "['chronic lymphocytic leukemia cll', 'doctor shares']\n",
      "['cll treatment', 's webinar oct', 'leusm cllsm']\n",
      "['new bispecific car t cell product', 'cd19 antigens demonstrates', 'excellent safety profile', 'high clinical efficacy', 'b cell non hodgkin lymphoma', 'chronic lymphocytic leukemia']\n",
      "['cll care cllsm leusm']\n",
      "['national patient conference', 'lymphoma amp cll', 'lymphoma research', 'own home']\n",
      "['chroniclymphocyticleukemia patients', 'notch mutations need', 'aggressive treatments', 'aggressive treatments', 'richter s transformation host amp cll patient amp dr paul barr']\n",
      "['tous nos coll gues professeurs du cll les conseillers p dagogiques du spdp vous souhaitent', 'excellente journ e mondiale des enseignantes', 'des enseignants']\n",
      "['project orbis', 'breast lung liver', 'endometrial cancer', 'chronic lymphocytic leukemia', 'exceptional circs']\n",
      "['certh splenic', 'marginal zone lymphoma chronic lymphocytic leukemia']\n",
      "['abbv phase', 'chronic lymphocytic leukemia', '17p deletion nct01889186', 'primary completion date']\n",
      "['btk inhibitors', 'chronic lymphocytic leukemia', 'cme video', 'recent web broadcast']\n",
      "['epigenetic regulation', 'steroidogenic enzymes', 'peripheral blood mononuclear cells', 'healthy individuals', 'chronic lymphocytic leukemia']\n",
      "['epigenetic regulation', 'steroidogenic enzymes', 'peripheral blood mononuclear cells', 'healthy individuals', 'chronic lymphocytic leukemia']\n",
      "['new article alk', 'positive histiocytosis', 'chronic lymphocytic leukaemia', 'small lymphocytic lymphoma', 'multitarget response', 'ibrutinib cll leusm hematology']\n",
      "['new article epigenetic regulation', 'steroidogenic enzymes', 'peripheral blood mononuclear cells', 'healthy individuals', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['vitamin d deficit link', 'considerable i', 'hi dose vit d', 'certain blood cancer patients', 'mmsm cll nhl']\n",
      "['sheds light', 'kinase selectivity', 'btk inhibitors', 'chronic lymphocytic leukemia leusm']\n",
      "['dr khan', 'old patient', 'bone marrow biopsy', 'chronic lymphocytic leukemia', 'oncology case', 'peer perspectives event leusm leukemia']\n",
      "['corona risky', 'cll patients cll covid corona']\n",
      "['obinutuzumab ibrutinib', 'chronic lymph']\n",
      "['full text', 'bio link catheter', 'acromioclavicular damage', 'trichosporon asahii infection', 'chronic lymphocytic leukemia case report']\n",
      "['new article cart19', 'multicenter trial', 'cell therapy', 'refractory malignancies cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "[]\n",
      "['hosts amp guests', 's cll town hall mdphd', 'articles amp video segments', 's town hall']\n",
      "['cll treatments', 'town hall cll', 'cll treatment', 'fda approvals clinical trials', 'richter s transformation']\n",
      "['cll treatments', 'town hall', 'current cll landscape', 'treatment options side', 'minimal residual disease mrd']\n",
      "['cll treatments', 'town hall cll', 'resume treatment', 'coronavirus pandemic', 'cll patients tune', 'facebook page']\n",
      "['ulrich j ger discusses eha links', 'eu initiatives', 'hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['certh discusses', 'eric cll database', 'eric2020 content click', 'hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['good discussion', 'various aspects', '1l therapy', 'cll leukemia']\n",
      "['collaborative efforts', 'real world evidence', 'cll explore', 'hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['final day', 'amazing experience', 'hemonc oncoalert leusm leukemia cll']\n",
      "['routable discussion', 'refractory disease check', 'eric2020 coverage', 'hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['live town hall', 'things cll', 'helpful info', 'treatment register']\n",
      "['new chronic lymphocytic leukemia activity', 'soho2020 cme']\n",
      "['roundtable time', 'eric2020 frontline treatment w john seymour florence cymbalista kirsten fischer george', 'alessandra tedeschi amp jennifer woyach hemonc leusm leukemia cllsm cll']\n",
      "['global chronic lymphocytic leukemia treatment market', 'recent trends growth opportunities']\n",
      "['new article', 'curious case', 'hyperkalemia cll leusm hematology']\n",
      "['new article idelalisib treatment', 'allogeneic stem cell transplantation', 'chronic lymphocytic leukemia', 'ebmt chronic malignancies', 'party cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia', 'paraneoplastic pemphigus potential', 'therapeutic strategies cll leusm hematology']\n",
      "['chronic lymphocytic leukemia leusm']\n",
      "['nice conclusion', 'cll management']\n",
      "['new potential targets']\n",
      "['m canismes', 'ibrutinib cll']\n",
      "['r r cll']\n",
      "['acala prolongs pfs', 'cll patients']\n",
      "[]\n",
      "['young patients cll']\n",
      "[]\n",
      "['cll event', 'treatments covid']\n",
      "['covid online event']\n",
      "['cll town hall', 'amp register', 'cll leukemia']\n",
      "['complete remission', 'short course fludarabine', 'chronic lymphocytic leukemia leusm']\n",
      "['good responses']\n",
      "['s cll town hall']\n",
      "['cll patient story cancer leukemia chroniclymphocyticleukemia cll']\n",
      "['i m', 'afyer ven r combination', 'therapy clinicaltrials lymsm cll']\n",
      "['case report ibrutinib', 'acute lung injury', 'cll covid19']\n",
      "['treatment advances', 'stemcell transplant', 'car t cell therapy', 'chronic lymphocytic leukemia patients', 'cll experts', 'cure dr paul barr']\n",
      "['friday october', 'saturday october', 'annual national patient conference', 'year s lymphoma', 'cll conference']\n",
      "['hematological malignancies', 'supportive treatment', 'chronic lymphocytic leukemia']\n",
      "['i m nervous', 'trial i m', 'i need']\n",
      "['co pi colleagues', 'support research', 'chronic lymphocytic leukemia']\n",
      "['andreas agathangelidis', 'full interview', 'eric2020 hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['discusses genomic aberrations', 'great interview w', 'hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['chronic lymphocytic leukemia', 'diagnosis prognosis']\n",
      "['monoclonal b lymphocytosis chronic lymphocytic leukemia', 's non agressive form', 'major symptoms', 'good cancer']\n",
      "['hematology case study', 'lablogatory lymphocytic inclusions']\n",
      "['cll cell proliferation w jan burger', 'interview w', 'hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['eric2020 meeting', 'hemonc oncoalert leusm leukemia cll']\n",
      "['real world outcomes', 'chronic lymphocytic leukemia']\n",
      "['venetoclax obinutuzumab vs chlorambucil obinutuzumab', 'chronic lymphocytic leukemia oncology medtwitter']\n",
      "['eric2020 adrian wiestner', 'discusses cll', 'microenvironmental addictions check', 'eric2020 coverage', 'eric2020 hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['new partnership', 'social media network', 'social media accounts cll lacrosse newpartnership']\n",
      "['stephan stilgenbauer', 'apoptotic phenotype explore', 'eric2020 coverage', 'hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['interactive discussion', 'drs neil', 'william wierda', 'md anderson', 'chronic lymphocytic leukemia register']\n",
      "['chronic lymphocytic leukemia cll treatment market', 'financial information developments swot analysis']\n",
      "['new article outdoor', 'artificial light', 'non hodgkin lymphoma', 'california teachers study cohort cll leusm hematology']\n",
      "['new article', 'regulates bcr', 'malignant b cells cll leusm hematology']\n",
      "['chronic lymphoid leukemia cll threatens', 'tp53 gene affects treatments effectiveness', 'mutation detection', 'prof rka posp ilov', 'dr jitka mal kov brno cz cancer womeninscience scicomm']\n",
      "['molecular genetics', 'high risk chronic lymphocytic leukemia']\n",
      "[]\n",
      "['idelalisib treatment', 'allogeneic stem cell transplantation', 'chronic lymphocytic leukemia', 'ebmt chronic malignancies', 'party oncology medtwitter']\n",
      "['dr reddy goodtoseeyouagain updates', 'cll abrutinib', 'front line']\n",
      "['cowan liebowitz amp latman alumna shira perlmutter', 'copyrights copyrights copyrightlaw cll']\n",
      "['free drop', 'blood cancers video', 'support group', 'pm eastern', 'tom henry aml multiplemyeloma leukemia lymphoma cll']\n",
      "['4y murano', 'pfs hr', 'os hr', 'genomic complexity', 'strong prognostic mrd predicts gt pfs', 'duration option', 'r r cll', 'data re btki n', 'ven n', 're rx data post ven r lymsm']\n",
      "['chronic lymphocytic leukemia nejm']\n",
      "['dr susan o brien', 'common cll treatment side', 'clltreatment plan leusm']\n",
      "['new article analysis', 'heavy variable chain rearrangement', 'chronic lymphocytic leukemia patients', 'workers cll leusm hematology']\n",
      "['new article leukaemia', 'ano cll leusm hematology']\n",
      "['new article transformation', 'plasmablastic lymphoma', 'ibrutinib treatment cll leusm hematology']\n",
      "['eric2020 panagiotis baliakas', 'university discusses chip', 'primary myeloid malignancies explore', 'eric2020 coverage', 'hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['eric2020 davide rossi', 'richter transformation check', 'eric2020 coverage', 'hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['new partnership', 'canadian lacrosse league', 'social media network', 'social media accounts cll lacrosse']\n",
      "['eric2020 catherine wu', 'clonal evolution', 'genome check', 'eric2020 coverage', 'hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['robin fo', 'globe check', 'eric2020 hemonc oncoalert leusm leukemia cllsm']\n",
      "['venetoclax therapy', 'cll leusm jnccn360']\n",
      "['andrew rawstron', 'eric2020 coverage', 'eric2020 hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['way ticket', 'cll lydia scarfo', 'eric2020 check', 'exclusive eric2020 content', 'eric2020 hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['eric2020 meeting', 'experts catch', 'hemonc oncoalert leusm leukemia cll']\n",
      "['w freda stevenson', 'cll catch', 'exclusive interview', 'hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['paolo ghia opening', 'eric2020 catch', 'eric2020 hemonc oncoalert leusm leukemia cllsm cll']\n",
      "['support children s cll development', 'brainer ntrust']\n",
      "['line training', 'sencos managers', 'communicationandlanguage cll']\n",
      "['human chronic lymphocytic leukemia', 'current researchpaper biotech']\n",
      "['researchers unravel', 'new mechanism', 'cell survival', 'chronic lymphocytic leukemia']\n",
      "['obinutuzumab ibrutinib', 'chronic l leukemia']\n",
      "['peer perspectives event dr hill', 'old patients', 'chronic lymphocytic leukemia leukemia leusm']\n",
      "['chronic lymphocytic leukemia', 'year results', 'genomic complexity', 'gene mutations', 'murano phase iii study haematology thewiderwiserview']\n",
      "['patient nathan tirey', 'year bloodcancerawarenessmonth']\n",
      "['cll bloodcancer ongoingstory']\n",
      "['cd19 car t treatment', 'rs cr']\n",
      "['chronic lymphocytic leukemia', 'year results', 'genomic complexity', 'gene mutations', 'murano phase iii study journal', 'clinical oncology']\n",
      "['cll patient story cancer leukemia chroniclymphocyticleukemia cll']\n",
      "['chronic lymphocytic leukemia', 'year results', 'genomic complexity', 'gene mutations', 'murano phase iii study']\n",
      "['dr khan', 'old patient', 'bone marrow biopsy', 'chronic lymphocytic leukemia', 'oncology case', 'peer perspectives event leusm leukemia']\n",
      "['chronic lymphocytic leukemia', 'year results', 'genomic complexity', 'gene mutations', 'murano phase iii study']\n",
      "['clinical activity', 'axicabtagene ciloleucel', 'adult patients', 'richter syndrome blood advances american society', 'hematology cll leusm']\n",
      "['date ancan', 'bones blood cancers video', 'virtual support group oct', 'pm eastern aml multiplemyeloma leukemia lymphoma cll']\n",
      "['small lymphocytic leukemia sll', 'chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukemia chronic lymphocytic leukemia', 'common cancer', 'u s', 'doesn t', 'obvious symptoms', 'urgent treatment']\n",
      "['new mechanism', 'cell survival', 'chronic lymphocytic leukemia']\n",
      "['new mechanism', 'cell survival', 'chronic lymphocytic leukemia']\n",
      "['virtual meeting', 'cll eric2020 hemonc oncoalert leusm leukemia']\n",
      "['chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukemia', 'year results', 'genomic complexity', 'gene mutations', 'murano phase iii study thewiderwiserview']\n",
      "['new article dbs assay', 'lc ms ms', 'selective pi3k inhibitor', 'mice blood', 'pharmacokinetic study cll leusm hematology']\n",
      "['new article', 'order connections', 'subsets implications', 'patient classification', 'cll cll leusm hematology']\n",
      "['new article mucosal side', 'topical imiquimod', 'literature cll leusm hematology']\n",
      "['oncology case', 'peer perspective event jose sandoval sus md', 'treatment options', 'old patient', 'chronic lymphocytic leukemia leusm leukemias']\n",
      "['chronic lymphocytic leukemia', 'year results', 'genomic complexity', 'gene mutations', 'murano phase iii study']\n",
      "['virtualhem2020 view', 'hematology virtual blood targetedtherapy chemotherapy clinicalperspectives bioevents medicalconference exhibitions cml aml']\n",
      "['cll research', 'scans treatments', '17p deletion']\n",
      "['venr vs br', 'r r cll gt gt gt venetoclax', 'chronic lymphocytic leukemia', 'year results', 'genomic complexity', 'gene mutations', 'murano phase iii study journal', 'clinical oncology']\n",
      "['noah s ark', 'cll patient story cancer leukemia chroniclymphocyticleukemia cll']\n",
      "['chronic lymphocytic leukemia', 'year results', 'genomic complexity', 'gene mutations', 'murano phase iii study']\n",
      "['cll advocate michele nadeem', 'ibrutinib side', 'cll ibrutinib imbruvica clltreatment clinicaltrial cllpatientinfluencer']\n",
      "['dr susan o brien', 'cll treatment leusm']\n",
      "['virtual fashion law institute', 'friday september', 'great success cll fashionlaw']\n",
      "['soho2020 chemotherapy', 'free combination therapy', 'phase iii trial leusm jnccn360']\n",
      "['chronic lymphocytic leukemia market', 'double digit cagr till']\n",
      "['chronic lymphocytic leukemia cll']\n",
      "['overt myeloma', 'chronic lymphocytic leukemia', 'ibrutinib therapy lymphoma lymsm']\n",
      "['new article venetoclax', 'chronic lymphocytic leukemia', 'year results', 'genomic complexity', 'gene mutations', 'murano phase iii study cll leusm hematology']\n",
      "['new article expression analysis', 'bat3 signal transduction molecules', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article emergence', 'overt myeloma', 'chronic lymphocytic leukemia', 'ibrutinib therapy cll leusm hematology']\n",
      "['new article btk inhibition impairs', 'innate response', 'fungal infection', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article genetic loss', 'lck kinase', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['virtual meeting', 'eric2020 hemonc oncoalert leusm leukemia cll']\n",
      "['chronic lymphocytic leukemia', 'year results', 'genomic complexity', 'gene mutations', 'murano phase iii study oncology']\n",
      "['phase ii study', 'combination obinutuzumab ibrutinib', 'treatment na ve', 'refractory chronic lymphocytic leukemia oncology']\n",
      "['cll patient story cancer leukemia chroniclymphocyticleukemia cll']\n",
      "['tuesday s oct', 'cll webinar register', 'cll treatment options leusm cllsm']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['dr susan o brien', 'useful tools', 'cll care leusm']\n",
      "['chronic lymphocytic leukemia cll', 'certain white blood cells', 'lymphocytes don t function', 'cll myths', 'separate fact']\n",
      "['hem oncs don t', 'cme activity', 'cll pt care', 'patient prognosis', 'available vs', 'therapeutic agents']\n",
      "['chronic lymphocytic leukaemia cll eqas', 'tp53 mutation analysis', 'ighv mutation status', 'joint collaboration']\n",
      "['car t studies', 'essential improvements amp', 'high amp', 'low grade lymphoma', 'chronic lymphocytic leukaemia cll']\n",
      "['new article', 'hepatitis b virus reactivation', 'ibrutinib therapy', 'hepatitis b surface antigens', 'clinical course cll leusm hematology']\n",
      "['new article neutralization', 'b cell', 'factor baff', 'belimumab reinforces', 'small molecule inhibitor treatment', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'dr bhargava director', 'blood disorders', 'bone marrow transplant', 'fortis hospital gurugram leukemia']\n",
      "['cll rec hemasphere leusm']\n",
      "['pharmaceutical care program', 'chronic lymphocyti']\n",
      "['chronic lymphocytic leukemia treatment market worldwide top key players profile analysis']\n",
      "['news hemonc oncoalert leusm leukemia cll']\n",
      "['pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line', 'autophagic flux openaccess crbiotech']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['wife jan', 'incurable blood cancer cll', 'sick years', 'clinical trial', 'new drug', 'bone marrow']\n",
      "['registration deadline ends', 'cll news click', 'register eric2020 hemonc oncoalert leusm leukemia']\n",
      "['prognostic significance', 'pet ct', 'chronic lymphocytic leukemia cll', 'frontline leusm chemoimmunotherapy']\n",
      "['thankscoach cll coquitlamreds tcyba cmfsc sd43', 'i parent', 'favourite athlete', 'good human', 'great things']\n",
      "['chronic lymphocytic leukemia']\n",
      "['peer perspectives event dr hill', 'old patients', 'chronic lymphocytic leukemia leusm']\n",
      "['b cell receptor immunome', 'chronic lymphocytic leukemia revelations']\n",
      "['chronic lymphocytic leukemia cells', 'stromal microenvironment', 'direct contact soluble factors', 'extracellular vesicles']\n",
      "['heavy variable chain rearrangement', 'chronic lymphocytic leukemia patients', 'experimental oncology']\n",
      "['long term outcomes', 'car t cells treatment', 'unresponsive chronic lymphocytic leukemia']\n",
      "['term outcomes', 'car t cells treatment', 'unresponsive chroni']\n",
      "['new article lymphoid enhancer', 'lef1 expression', 'hodgkin lymphoma', 'richter syndrome', 'classic hodgkin lymphoma cll leusm hematology']\n",
      "['new article reading', 'b cell receptor immunome', 'chronic lymphocytic leukemia revelations', 'applications cll leusm hematology']\n",
      "['new article novel genotype definition', 'epidemiological investigation', 'canine adenovirus type', 'central china cll leusm hematology']\n",
      "['new article importance', 'chronic lymphocytic leukemia cells', 'stromal microenvironment', 'direct contact soluble factors', 'extracellular vesicles cll leusm hematology']\n",
      "['lecture du jour bonjour hematologie chroniclymphocyticleukemia cll interne hematology jle']\n",
      "['ibrutinib rituximab vs', 'classic chemoimmunotherapy', 'chronic lymphocytic leukemia']\n",
      "['dr graeme fraser', 'juravinski cancer centre', 'cll session', 'current review', 'frontline cll']\n",
      "['tuesday september', 'chronic lymphocytic leukemia cll', 'common form', 'u s']\n",
      "['cll patient story raredisease leukemia chroniclymphocyticleukemia cll']\n",
      "['review eq5d', 'health state utility values', 'haematological malignancies', 'multiple myeloma cll cml aml non hodgkin s lymphoma nhl', 'mantle cell lymphoma']\n",
      "['chronic lymphocytic leukemia medication', 'pocket costs', 'george s', 'full story']\n",
      "['essential genetic tests', 'cll cllsm leusm bcam']\n",
      "['cll chronic lymphocytic leukemia lymphoma clll']\n",
      "['dual inhibitor', 'chronic lymphocytic leukemia patients leusm cancer fbf']\n",
      "['undetectable mrd', 'right treatment goal', 'assess mrd', 'cll mm', 'important info incl sample types amp test limitations']\n",
      "['tuesday september', 'chronic lymphocytic leukemia cll', 'common form', 'u s']\n",
      "['hawaii society', 'clinical oncology', 'webinar series', 'hours don t', 'informative discussion', 'takeaway tools', 'effective care delivery']\n",
      "['cll treatment', 'panel discussion', 'david macdonald', 'jonathan stevens']\n",
      "['cll forum', 'great meeting registration', 'cll lymsm']\n",
      "['chronic lymphocytic leukemia', 'eortc qlq c30', 'qlq cll17 questionnaire abstract hematolog']\n",
      "['eric2020 arnon kater', 'new cll research', 'full interview', 'eric2020 hemonc oncoalert leusm leukemia cllsm']\n",
      "['new article efficacy', 'unfit patients', 'chronic lymphocytic leukemia', 'indirect comparison', 'real world setting', 'gimema eric', 'study cll leusm hematology']\n",
      "['new article occupational radiation', 'haematopoietic malignancy mortality', 'retrospective cohort study', 'radiologic technologists', 'cll leusm hematology']\n",
      "['new article idelalisib rescues', 'natural killer cells', 'reactive oxygen species cll leusm hematology']\n",
      "['review eq5d', 'health state utility values', 'haematological malignancies', 'multiple myeloma cll cml aml non hodgkin s lymphoma nhl', 'mantle cell lymphoma']\n",
      "['chronic lymphocytic leukaemia recommendations', 'french cll study group filo cll chroniclymphocyticleukemia']\n",
      "['oxidative stress', 'cytogenetic abnormalities']\n",
      "['coronavirus pandemic', 'dr laurie sehn bc cancer', 'bccancer coronavirus cll']\n",
      "['disease flare', 'temporary interruption', 'ibrutinib therapy', 'chronic lymphocytic leukemia', 'interesting findings', 'fellow p']\n",
      "['cll patient story raredisease leukemia chroniclymphocyticleukemia cll']\n",
      "['bcma vs blood cancers', 'initial efforts', 'biomarker assay', 'multiplemyeloma amp cll haemonc oncology diagnostics hematology']\n",
      "['cll treatment options register', 'leusm cllsm']\n",
      "['cll treatment options register', 'leusm cllsm bcam']\n",
      "['mind blog', 'famous slogan', 'don t', 'trademark cll']\n",
      "['chronic lymphocytic leukemia', 'time duration treatment']\n",
      "['real world study assesses', 'cll leusm jnccn360']\n",
      "['new article factors', 'car t cell infusion', 'refractory b cell malignancies cll leusm hematology']\n",
      "['virtual meeting', 'link eric2020 hemonc oncoalert leusm leukemia']\n",
      "['aniversario del colegio pap tbt ni o primaria cll huarazperu uniforme bendecido']\n",
      "['spindle cell melanoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'rare collision tumor', 'multiple sites']\n",
      "['bloodcancerawareness month', 'episode video series', 'understanding chronic lymphocytic leukemia', 'uci health s susan m o brien m d']\n",
      "['und acomohoy degustacion cll']\n",
      "['dr clive zent amp team', 'patients cll urochesterresearch']\n",
      "['new 3i investigator article', 'alert atrial fibrillation', 'chronic lymphocytic leukemia', 'veterans health administration sciencetwitter academictwitter researchmatters']\n",
      "['chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll', 'myd88 l265p mutation', 'cohort study']\n",
      "['eye opening', 'year journey', 'chroniclymphocyticleukemia cll bloodcancer bloodcancerawarenessmonth']\n",
      "['aml cll multiplemyeloma']\n",
      "['sheds light', 'kinase selectivity', 'btk inhibitors', 'chronic lymphocytic leukemia leusm']\n",
      "['major types', 'bloodcancers leukemia lymphoma amp myeloma', 'new therapies', 'b cell malignancies', 'chronic lymphocytic leukemia', 'blood cancers']\n",
      "['gain expert opinion', 'optimal care', 'cll patients', 'cco cll cme covid19']\n",
      "['drs neil', 'chronic lymphocytic leukemia click', 'zoom link']\n",
      "[]\n",
      "['collega denise sprak verpleegkundig specialist carolien van het het', 'belangrijk om zelf regie te nemen', 'het behandelproces aldus carolien lees', 'een cll pati nt aflegt bloodcancerawarenessmonth']\n",
      "['new clinical trial venetoclax obinutuzumab ibrut', 'r r cll cll leusm hematology']\n",
      "['alessandra ferrajoli', 'treatment approaches', 'cll check', 'leukemia leusm oncoalert']\n",
      "['cll field don t', 'registration deadline monday', 'register eric2020 hemonc oncoalert leusm leukemia']\n",
      "['spindle cell melanoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'rare collision tumor', 'multiple sites lymphoma lymsm']\n",
      "['new article rate differences', 'primary cancers', 'immune dysfunction', 'key risk factor cll leusm hematology']\n",
      "['new article', 'high risk chronic lymphocytic leukemia cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['exciting collaborative effort', 'important phenomenon', 'clinicians cll lymsm']\n",
      "['new treatments', 'chronic lymphocytic leukemia cll', 'helpful advice']\n",
      "['early intervention', 'high risk chronic lymphocytic leukemia cll']\n",
      "['covid19 cll']\n",
      "[]\n",
      "['leukemia therapeutics market', 'marketsandmarkets leukemia therapeutics market categories', 'global market', 'type cll', 'cml aml treatment type chemo']\n",
      "['uncommon mutation']\n",
      "['social media accounts']\n",
      "['variant sll', 'common type', 'bone marrow', 'combination therapy', 'deep remissions', 'cll leukemiaawareness']\n",
      "['new article monosomic loss', 'mir15a mir16', 'multiple myeloma proliferation', 'disease progression cll leusm hematology']\n",
      "['new article relationship', 'chromosomal aberrations', 'gene expressions', 'p53 pathway', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'true hyperkalemia', 'chronic lymphocytic leukemia', 'diverticulitis cll leusm hematology']\n",
      "['new article atrial fibrillation', 'chronic lymphocytic leukemia', 'veterans health administration cll leusm hematology']\n",
      "['chroniclymphocyticleukemia chroniclymphocytictreatment chroniclymphocyticmedication leukemia leukemiaawareness leukemiawarrior leukemiafighter', 'info visit']\n",
      "['full text', 'bio link', 'monoclonal antibody encephalitis', 'chronic lymphocytic leukemia']\n",
      "['incidental richter transformation', 'chronic lymphocytic leukemia patients', 'temporary interruption', 'ibrutinib blood advances american society', 'hematology p']\n",
      "['early intervention', 'high risk chronic lymphocytic leukemia']\n",
      "['hawaii society', 'clinical oncology', 'various treatment options', 'novel therapies']\n",
      "['imbruvica ibrutinib', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma register']\n",
      "['chronic lymphocytic leukemia', 'rituximab br', 'similar efficacy']\n",
      "['new indication', 'imbruvica imbruvica janssen pharmacyclics ibrutinib oncology leukemia cll smm newindication leadingtheway waveofevidence leukemiamarket q2 q22020']\n",
      "['chronic lymphocytic leukemia', 'common leukemia', 'u s adult patients', 'new cases', 'states memorial sloan', 'cancer center zusia bless r b g']\n",
      "['cancer activity', 'obinutuzumab ibrutinib', 'cll leusm jnccn360']\n",
      "['celg phase', 'maintenance therapy', 'b cell chronic lymphocytic leukemia cll', 'line therapy nct00774345', 'primary completion date']\n",
      "['advocacy doesn t', 'i m', 'saturday november', 'family healthevoiceslive cll patientadvocate bloodcancerawarenessmonth bloodcancer leukemia chroniclymphocyticleukemia']\n",
      "['cll patients', 'ct scans', 'cll expert', 'patientpower leusm']\n",
      "['incidental richter transformation', 'chronic lymphocytic leukemia patients', 'temporary interruption']\n",
      "['dr phillip thompson', 'covid19 affects cll patients', 'cll treatment cllsm leusm bcam cancelbloodcancer']\n",
      "[]\n",
      "['chronic lymphocytic leukemia cll', 'scientific advancement bloodcancerawareness ourexpresssions']\n",
      "['positive predictive value', 'cd200 positivity', 'differential diagnosis', 'chronic lymphocytic leukemia sorigue', 'cytometry part b clinical cytometry']\n",
      "['janssen research amp development llc s jnj', 'human phase', 'non hodgkin lymphoma', 'chronic lymphocytic leukemia', 'bispecifics clinical development']\n",
      "['positive predictive value', 'cd200 positivity', 'differential diagnosis', 'chronic lymphocytic leukemia cd200 cll', 'cll vs mcl']\n",
      "['pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line', 'autophagic flux openaccess crbiotech']\n",
      "['chronic lymphocytic leukemia', 'options bloodcancer bloodcancerawarenessmonth cll bloodcancerawareness']\n",
      "['new article inducible secretion', 'tumor activity', 'chimeric antigen receptor t cells cll leusm hematology']\n",
      "['new article', 'prognostic value', 'ligand april serum levels', 'treatment naive patients', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['week s broadresearchroundup', 'new covid19 diagnostics relapse roots']\n",
      "['evolutionary paths', 'chronic lymphocytic leukemia', 'graft versus leukemia effect']\n",
      "['partner schools', 'virtual sessions', 'ssp programmes', 'yr phonics cll repeatedstories']\n",
      "['chronic lymphocytic leukemia']\n",
      "['ibrutinib treatment', 'refractory chronic lymphocytic leukemia', 'final analysis', 'pivotal phase ib ii pcyc', 'study esmo20']\n",
      "['incidental richter transformation', 'chronic lymphocytic leukemia patients', 'temporary interruption', 'ibrutinib blood advances american society']\n",
      "['prognostic value', 'ligand april serum levels', 'treatment naive patients', 'chronic lymphocytic leukemia chronic lymphocytic leukemia april prognosis chemotherapy']\n",
      "[]\n",
      "['multicenter phase', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['new article incidental richter transformation', 'chronic lymphocytic leukemia patients', 'temporary interruption', 'ibrutinib cll leusm hematology']\n",
      "['new article skin', 'cll leusm hematology']\n",
      "['new article', 'cll patients', 'initial therapy cll leusm hematology']\n",
      "['monoclonal antibodies', 'chronic lymphocytic leukemia']\n",
      "['collaborative effort', 'cll amp covid19']\n",
      "['cll treatments', 'town hall event', 'cll amp covid19', 'patient advocates amp experts', 'amp register']\n",
      "['chronic lymphocytic leukemia']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['control tamponade isurus oxyrhincus chronic lymphocytic leukemia theater warfare fox grape']\n",
      "['natural prevention', 'chronic lymphocytic leukemia']\n",
      "['wildflower biopharma inc', 'project efficacy', 'novel small molecule', 'chronic lymphocytic leukemia', 'stage molecular biologist']\n",
      "['international study treatment', 'bruton tyrosine kinase inhibitors btki']\n",
      "['week s broadresearchroundup', 'new covid19 diagnostics relapse roots']\n",
      "['case report', 'breast involvement', 'male patient', 'cll leusm jnccn360']\n",
      "['educational activity', 'btk inhibitors', 'chronic lymphocytic leukemia cll', 'expert insight', 'btk inhibitors', 'patient treatment plans']\n",
      "['educational activity', 'btk inhibitors', 'chronic lymphocytic leukemia cll', 'expert insight', 'btk inhibitors', 'patient treatment plans']\n",
      "['incidental richter transformation', 'chronic lymphocytic leukemia patients', 'temporary interruption', 'ibrutinib blood advances american society']\n",
      "['recent commentary', 'drs amp myung sun kim', 'fda approvals', 'bruton tyrosine kinase inhibitors', 'chronic lymphocytic leukemia potential inefficiencies', 'trial design', 'evidence generation']\n",
      "[]\n",
      "[]\n",
      "[]\n",
      "['covid impact cll patients bcam cllsm leusm']\n",
      "['jojo cll']\n",
      "['cancer hallmarks', 'chronic lymphocytic leukemia']\n",
      "['recent progress', 'prognostic biomarkers', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['new article diffuse', 'painful plaques', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'recent progress', 'prognostic biomarkers', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article validation', 'survival risk score srs', 'refractory cll patients', 'idelalisib rituximab cll leusm hematology']\n",
      "['new article distinct', 'evolutionary paths', 'chronic lymphocytic leukemia', 'graft versus leukemia effect cll leusm hematology']\n",
      "['new article role', 'chronic lymphocytic leukemia cll', 'tumor progression', 'survival cll leusm hematology']\n",
      "['new article non', 'cancer hallmarks', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article high m mdsc percentage', 'negative prognostic factor', 'chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'l265p myd88 mutation', 'lymphoma leukemia hematology oncology']\n",
      "['international study treatment', 'bruton tyrosine kinase inhibitors btki']\n",
      "['imbruvica presentation', 'imbruvica ibrutinib', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['front line treatments', 'chronic lympho leukemia']\n",
      "['drs carolina amp miguel pavlovsky buenos aires', 'latin america', 'excellent technical quality amp', 'interesting discussions e g', 'good response', 'ibrutinib therapy', 'atrial fibrillation leusm leukemia']\n",
      "['chronic lymphocytic leukaemia', 'non hodgkin s lymphoma', 'cd37 radioimmunoconjugate 212pb nnv003 usa nordicnanovector tat cll nhl biotech radioimmunotherapy']\n",
      "['obinutuzumab ibrutinib', 'chronic lym']\n",
      "['virtual meeting', 'updates eric2020 hemonc oncoalert leusm leukemia']\n",
      "['c481s mutation', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'level r1 resistance mutations', 'ibrutinib overall', 'tumor types']\n",
      "['obinutuzumab ibrutinib']\n",
      "['chronic lymphocytic leukemia', 'common type', 'cll visit', 'bloodcancerawareness month']\n",
      "['new study uses', 'bim antibody', 'chronic lymphocytic leukemia cll']\n",
      "[]\n",
      "[]\n",
      "['mr zatta amp', 'local oncologist w', 'complex cll case', 'opinion telemedicine program', 'pandemic goal', 'expert opinion amp', 'home letsbeatcancertogether']\n",
      "['good information']\n",
      "['genetic tests', 'cll treatment options bcam leusm cllsm']\n",
      "['jeffrey zatta s', 'chronic lymphocytic leukemia', 'expert opinion s dr andrew evens amp community', 'medical center s dr chirag shah']\n",
      "['obinutuzumab ibrutinib', 'chronic lymphocytic leukemia']\n",
      "['weeks register', 'cll eric2020 hemonc oncoalert leusm leukemia']\n",
      "['dr ivanova', 'opinion leader', 'resistant chronic lymphocytic leukemia', 'saint petersburg']\n",
      "['new article metastatic lung adenocarcinoma', 'richter transformation', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article prognostic value', 'high sensitivity', 'measurable residual disease assessment', 'front line chemoimmunotherapy', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'monoclonal b lymphocyte expansion', 'chinese population', 'observational cohort study cll leusm hematology']\n",
      "['new article', 'cd20 treatment', 'b cell malignancies', 'current status', 'future directions cll leusm hematology']\n",
      "['cancer drug', 'chronic lymphocytic leukemia cll mantle cell lymphoma mcl', 'marginal zone lymphoma mzl', 'waldenstrom s macroglobulinemia']\n",
      "['prognostic value', 'high sensitivity', 'measurable residual disease assessment', 'front line chemoimmunotherapy', 'chronic lymphocytic leukemia']\n",
      "['cancer drug', 'chronic lymphocytic leukemia cll mantle cell lymphoma mcl', 'marginal zone lymphoma mzl', 'waldenstrom s macroglobulinemia']\n",
      "['chroniclymphocyticleukemia market']\n",
      "['oncology nurses don t', 'onsbridge btk cne registration info']\n",
      "['interesting paper', 'cathy wu s lab congrats', 'evolutionary paths', 'chronic lymphocytic leukemia', 'graft versus leukemia effect']\n",
      "['chronic lymphocytic leukemia', 'similar efficacy', 'patients leukemia cll hematology oncology']\n",
      "['cll relapse post bone marrow transplant']\n",
      "['cll treatment decisions cllsm leusm bcam']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['long term outcomes', 'cd19 car t', 'r r cll w david l porter', 'soho2020 oncoalert hemonc immunoonc cartcells tcellrx leukemia leusm']\n",
      "['party s', 'cancer leukemia lymphoma oncology phlegm pain liverspots']\n",
      "['cll treatment options webinar tuesday', '1pmet 10am pt leusm cllsm']\n",
      "['cll diagnosis', 'i ll', 'northwestern s oncology lcsw amp fellow patient advocate lesliepowell northwesternmedical luriecenter cll']\n",
      "['acute lymphoblastic leukemia', 'acute myeloid leukemia aml', 'chronic lymphocytic leukemia cll', 'lab sciencemajor sciencemajors biology chemistry microbiology']\n",
      "['30pm ct', 'leukemia diagnosis', 'social worker robin katz', 'challenging conversation register', 'free program cll']\n",
      "['cll treatment options webinar tuesday', '1pmet 10am pt leusm cllsm bcam cancelbloodcancer']\n",
      "['exciting announcement', 'lymphoma cll lymsm']\n",
      "['long term results support efficacy', 'ublituximab ibrutinib', 'high risk chronic lymphocytic leukemia cancer medtwitter wbw']\n",
      "['year i', 'chronic lymphocytic leukemia', 'cll cll', 'common blood cancer', 'entire lives', 'signs wld20']\n",
      "['t cell dynamics', 'chronic lymphocytic leukemia', 'different treatment modalities']\n",
      "['cll ireland deborah sims patient', 'australia shares', 'cll trial']\n",
      "['dr brian koffman cll society', 'treatment options', 'cll journey patients need', 'possible care']\n",
      "['new2trip rituximab ruxience non hodgkin s lymphoma nhl chronic lymphocytic leukemia cll rheumatoid arthritis ra']\n",
      "['chronic lymphocytic leukemia', 'joint study', 'european research initiative', 'cll campus']\n",
      "['bloodcancerawareness month', 'episode video series', 'understanding chronic lymphocytic leukemia', 'uci health s susan m o brien m d']\n",
      "['cll webinar', 'clltreatment options']\n",
      "['disease flare', 'ibrutinib therapy pauses']\n",
      "['don t', 'emil j freireich hematology', 'grand rounds', 'cst leusm', 'leukemia cll']\n",
      "['registration sohoitaly20 hematology oncology ematologia oncologia leukemya myeloma', 'aml mm myeloma lymphoma cll cml ms mpn therapy research cura paziente terapiasallimite']\n",
      "['cll patients', 'standard therapies', 'aggressive treatment', 'dr barr']\n",
      "['brewery industry insight', 'different parties', 'identical mark', 'restaurant services trademark breweries breweryindustry cll']\n",
      "['cll diagnosis', 'social worker robin katz', 'condition register']\n",
      "['novel agents', 'important part', 'chronic lymphocytic leukemia landscape']\n",
      "['cll leukemia cancer']\n",
      "['new article development', 'address clinical limitations', 'kinase inhibitors cll leusm hematology']\n",
      "['new article', 'mrna translation initiation factors', 'novel therapeutic strategy', 'mature b cell neoplasms cll leusm hematology']\n",
      "['new article', 'large bowel obstruction', 'small lymphocytic lymphoma cll leusm hematology']\n",
      "['pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line', 'autophagic flux openaccess crbiotech']\n",
      "['campath alemtuzumab', 'animal dna', 'chronic lymphocytic leukemia']\n",
      "['campath alemtuzumab', 'animal dna', 'chronic lymphocytic leukemia']\n",
      "['remission rates', 'combination therapies cll patientpower']\n",
      "['world lymphoma awareness day wlad2020', 'patient advocacy communities', 'patient outcomes']\n",
      "['world lymphoma awareness day wlad2020', 'cll ni uk']\n",
      "['promising advances', 'therapy options', 'new treatments']\n",
      "['liverpool uk', 'chronic lymphocytic leukaemia research cll oncologyresearch']\n",
      "['great morning learning', 'eyfs cll npps']\n",
      "['drug therapies', 'clinical trial amp', 'stem cell transplant', 'free leusm']\n",
      "['apto ceo', 'level 750mg', 'classic cll patients']\n",
      "['september 9pm ksa time', 'ssbmt webinar series', 'chronic lymphocytic leukemia w prof arnon kater', 'amsterdam amp prof john gribben', 'barts cancer institute ssbmt saudihematology', 'registration click']\n",
      "['obinutuzumab ibrutinib']\n",
      "['independent predictor', 'free survival', 'overall survival', 'cll patients', 'chemo immunotherapy neogenomics', 'biomarker cll mrd flow panel', 'detect mrd', 'level cll lymphoma']\n",
      "[]\n",
      "['cll web broadcast', 'claim credit']\n",
      "['avoidable deaths', 'current model', 'cll ibrutinib']\n",
      "['btki therapy', 'dual goals']\n",
      "['cll society s oct', 'virtual patient', 'educational forum dr john byrd', 'clinical trials', 'clinical trial']\n",
      "['venetoclax amp obinutuzumab ven obi vs chlorambucil amp obinutuzumab', 'cll cll14', 'open label', 'trial results', 'ven obi', 'pfs amp umrd', 'overall survival']\n",
      "['cll14 fup', 'venetoclax amp obintuzumab vs o chl pfs hr', 'tox profile', 'ven o', 'line btki data', 'date ck amp tp53 cll gt mrd ve mrd status predicts pfs', '2y pfs', 'tp53 cll17 v', 'important iv vs o v vs i cll lymsm']\n",
      "['oncology product', 'available contact', 'order wechat emon54 whatsapp', 'ibrutix140mg ibrutinib mantle cell lymphoma chronic lymphocytic', 'small lymphocytic lymphoma leukemia leukemiatreatment ibrutix ibrutinib140mg']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['chronic lymphocytic leukemia', 'oncology patient access program leusm']\n",
      "['pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line', 'autophagic flux openaccess crbiotech']\n",
      "['american cancer society cancer action network', 'hope home', 'bismarck nd', 'lung cancer amp', 'kidney amp prostrate cancer amp', 'chronic lymphocytic leukemia lightsofhope']\n",
      "['good alternatives', 'survival rates', 'dr jan burger', 'treatment advances', 'chronic lymphocytic leukemia cll leukemia endcancer']\n",
      "['couple days', 'nice walk', 'zoom friends', 'final day']\n",
      "['cytogenetic abnormalities', 'oxidative stress']\n",
      "['important biomarker', 'clinical trials', 'cll william wierda md phd', 'news soho2020 leusm']\n",
      "['cytogenetic abnormalities', 'oxidative stress']\n",
      "['new article changes', 'family protein profile', 'idelalisib therapy mimic', 'duvelisib therapy', 'chronic lymphocytic leukemia lymphocytes cll leusm hematology']\n",
      "['video value', 'mrd measurement', 'cll w', 'soho2020 oncoalert hemonc leukemia leusm']\n",
      "['ibrutinib restores immune cell numbers', 'refractory chronic lymphocytic leukemia', 'solman ig blum lk hoh hy kipps tj burger ja barrientos jc o brien s mulligan sp kay ne hillmen p byrd jc lal id dean j']\n",
      "['new article', 'b cell receptors', 'diverse brazilian series', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article ibrutinib restores immune cell numbers', 'refractory chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article hur affects proliferation', 'chronic lymphocytic leukemia cells', 'nf b pathway cll leusm hematology']\n",
      "['new article', 'fatal mucormycosis', 'atypical host', 'invasive mold infections cll leusm hematology']\n",
      "['new article', 'ibrutinib rituximab vs', 'classic chemoimmunotherapy', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'chloro adenosine inhibits proliferation', 'mda mb', 'sk br', 'breast cancer cells', 'adar1 p53', 'pathway cll leusm hematology']\n",
      "['wonder women front line healthcare pros fabulous', 'relatable icon', 'leukemia patient wonderwoman empowers', 'survival wonderwoman84 cll bloodcancerawarenessmonth leukemia']\n",
      "['congress soho2020', 'elizabeth shpall takeaways', 'car therapy', 'current approaches', 'results leusm']\n",
      "['assess minimal residual disease mrd', 'bone marrow', 'chronic lymphocytic leukemia cll']\n",
      "['fantastic talks', 'amazing opportunity', 'phd project', 'cll epigenetics qub']\n",
      "['brian koffman md cll society inc discusses adaptive biotechnologies', 'fda clearance']\n",
      "['john pagel md swedish cancer institute discusses adaptive biotechnologies', 'fda clearance']\n",
      "['nature vs nurture', 'burger iwnhl20 nonhodgkinlymphoma lymsm oncoalert nhlsm hodgkinlymphoma leusm cllsm']\n",
      "['swedish study', 'fold risk', 'bacterial infections', 'early mortality', 'infection leusm jnccn360']\n",
      "['ashmhm20 amp recommendations', 'cll leusm']\n",
      "['committee member astrid pavlovsky', 'lymsm eha25virtual']\n",
      "['yes tina i', 'patients leukemia cll']\n",
      "['independent satellite symposium iv', 'cll care', 'btk inhibitors selection safety', 'disease continuum william wierda md phd', 'thompson mb ms leusm']\n",
      "['soho2020 session vi cll', 'residual disease clinical implications william wierda md phd leusm']\n",
      "['new clinical trial', 'registry cll leusm hematology']\n",
      "['new clinical trial', 'cd19 chimeric antigen receptor t cells', 'refractory non hodgkin lymphoma cll leusm hematology']\n",
      "['congress soho2020 william wierda', 'philip thompson', 'btk inhibitors', 'cll lymsm']\n",
      "['cll web broadcast']\n",
      "['cll web broadcast']\n",
      "['nilanjan ghosh md phd', 'btk inhibitors', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma leusm lymsm']\n",
      "['chronic lymphocytic leukemia', 'molecular pathogenesis', 'novel therapeutic strategies']\n",
      "['ibrutix ibrutinib ibrucent mantle cell lymphoma chronic lymphocytic leukemia generic medicine cancermedicine cancersupport lymphomasupport cancer treatment doctor medicine oncology contact', 'orders wechat nituchy whatsapp']\n",
      "['cll cll']\n",
      "['decades thanks', 'novel anticancer medications']\n",
      "['real world outcomes', 'chronic lymphocytic leukemia']\n",
      "['common types', 'acute lymphocytic leukemia', 'acute myeloid leukemia aml chronic lymphocytic leukemia cll chronic myeloid leukemia cml']\n",
      "['congress soho2020', 'interesting debate', 'john byrd', 'michael hallek', 'frontline therapy', 'cll thread']\n",
      "['nitin look', 'cure cll cll17 leukemia']\n",
      "['cme opportunities soho2020']\n",
      "['science ppl', 'yes i need', 'cll sll', 'context n', 'chronic lymphocytic leukemia', 'small cell lymphocytic lymphoma']\n",
      "['emil j freireich hematology', 'grand rounds treatment', 'nitin jain md', 'cst endcancer leusm']\n",
      "['congress soho2020', 'btk inhibitors', 'paolo ghia']\n",
      "['moleculartumorboard session', 'dr chaudhry check']\n",
      "['predictive molecular biomarkers', 'chronic lymphocytic leukemia', 'new review article', 'member dr y lynn wang', 'jimmy lee', 'free online']\n",
      "['chronic lymphocytic leukemia', 'joseph flynn d o mph facp chief', 'administrative officer norton', 'medical group amp physician', 'chief norton cancer institute']\n",
      "['leukemia cll', 'hospitalization amp', 'icu admission', 'study amp']\n",
      "['william wierda md phd', 'residual disease clinical implications sept', 'pm cst soho2020 session vi cll endcancer leusm']\n",
      "['cll treatment', 'leusm cllsm register']\n",
      "['chronic lymphocytic leukemia', 'multiple myeloma', 'clinical advances', 'john m burke md amp manuel', 'santiago md', 'cme credits']\n",
      "['happy september leukemiaandlymphomaawarenessmonth', 'secondary disease', 'chronic lymphocytic leukemia cll click']\n",
      "['cll14 trial', 'chronic lymphocytic leukemia leusm hematology']\n",
      "['fact cll stands', 'chronic lymphocytic leukemia bloodcancerawarenessmonth']\n",
      "['jojo cll cll']\n",
      "['katrine melvold', 'master s degree', 'vitro sensitivity', 'mantle cell lymphoma', 'chronic lymphocytic leukemia']\n",
      "['janssen s imbruvica', 'european commission s approval', 'chronic lymphocytic leukemia']\n",
      "['new article highlights', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article highlights', 'chronic lymphocytic leukemia', 'american society', 'clinical oncology', 'annual meeting cll leusm hematology']\n",
      "['new article eosinophilic panniculitis', 'arthropod bites', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article immune impacts', 'bruton tyrosine kinase inhibitors', 'chronic lymphocytic leukemia patients', 'grail cll leusm hematology']\n",
      "['new article relevant cytokines', 'b cell lymphoma micro environment cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia cll leusm hematology']\n",
      "['clonal dynamics', 'chronic lymphocytic leukemia']\n",
      "['virtual meeting', 'cll updates', 'news eric2020 hemonc oncoalert leusm leukemia']\n",
      "['world lymphomaawarenessday magazine', 'dr susan o brien', 'chronic lymphocytic leukemia', 'alltrials demanddiversity diversitymatters']\n",
      "['new study', 'claudia p rez carretero', 'hern ndez s nchez teresa gonz lez', 'hematology chroniclymphocyticleukemia cll ngs rv iis']\n",
      "['moleculartumorboard session', 'great success', 'colorectalcancer p register']\n",
      "['bloodcancer folks', 'peer video', 'cll pharmacist tom henry', 'aml multiplemyeloma leukemia lymphoma cll']\n",
      "['cll german study group catch', 'soho2020 oncoalert leukemia leusm']\n",
      "['stephan stilgenbauer', 's susan o brien', 'upfront treatment', 'chronic lymphocytic leukemia cll leusm']\n",
      "['chronic lymphocytic leukemia', 'new drugs', 'years patients']\n",
      "['ips e', 'new international prognostic score', 'early stage chronic lymphocytic leukemia cll']\n",
      "['early stage chronic lymphocytic leukemia cll', 'ighv genes', 'absolute lymphocyte', 'palpable lymph nodes leusm']\n",
      "['small study patients', 'rel ref chronic lymphocytic leukemia cll', 'free survival', 'btki therapy leusm']\n",
      "['free bloodcancer video', 'peer support', 'pm edt info bloodcancerawarenessmonth aml multiplemyeloma leukemia lymphoma cll']\n",
      "['allogeneic stem cell transplantation', 'archaic intervention']\n",
      "['worldlymphomaawarenessday magazine', 'dr susan o brien', 'chronic lymphocytic leukemia check', 'video series cll bloodcancers']\n",
      "['litigation law', 'alert tiffany s', 'summary judgement', 'trademark infringement', 'appeal litigation trademark trademarkinfringement cll']\n",
      "['clonal dynamics', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia amp', 'small lymphocytic lymphoma', 'dr parameswaran venugopal', 'wednesday sept', 'blood cancers virtual series register']\n",
      "['soho2020 mtp session xix cll seymour park ferrajoli leusm']\n",
      "['janssen announces europeancommission decision', 'imbruvica ibrutinib', 'chronic lymphocytic leukaemia cll']\n",
      "['stellar update', 'september hospital leicesterroyalinfirmary', 'stellar thanks', 'pi dr ben kennedy', 'hard work bham richterssyndrome cll']\n",
      "['soho2020 mtp session ix cll moreno thompson jain', 'webinar leusm']\n",
      "[]\n",
      "['don t', 'key cll updates click', 'register eric2020 hemonc oncoalert leusm leukemia']\n",
      "['new clinical trial trial', 'japanese subjects', 'r r b nhl cll leusm hematology']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['new article glucocorticoid', 'lipid profiles disorders amongst lymphoid malignancy survivors cll leusm hematology']\n",
      "['new article roles', 'hepatic macrophage polarization', 'liver parenchymal cell', 'specific nemo deletion cll leusm hematology']\n",
      "['new article pdq cancer information summaries cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'molecular pathogenesis', 'novel therapeutic strategies']\n",
      "['atrial fibrillation', 'side effect', 'ibrutinib treatment']\n",
      "['pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line', 'autophagic flux openaccess crbiotech']\n",
      "['cll good outcomes', 'vo arm othman', 'sawaf md', 'venetoclax obinutuzumab']\n",
      "['non hodgkin lymphoma nhl', 'chronic lymphocytic leukemia cll']\n",
      "['ascentage pharma s bcl', 'inhibitor apg', 'orphan drug designation', 'chronic lymphocytic leukaemia ascentage fda cll']\n",
      "['alessandra ferrajoli md', 'btk inhibitor toxicities sept', 'soho2020 mtp session xix cll register', 'endcancer leusm']\n",
      "['oncoalert allogeneic hematopoietic cell transplantation', 'high risk chronic lymphocytic leukemia cll american society', 'hematology cllsm leusm lymsm bmtsm']\n",
      "['nitin jain md', 'bcl2 sept', 'soho2020 mtp session ix cll register', 'endcancer leusm']\n",
      "['thompson mb bs', 'cit sept', 'soho2020 mtp session ix cll register', 'endcancer leusm']\n",
      "['cll eyfs phonics teamearlychildhood inf']\n",
      "['cll webinar', 'cll treatment approaches', 'important decision making considerations', 'clinical trials leusm cllsm']\n",
      "['non melanoma skincancer', 'human papillomavirus hpv implication support', 'innate immune system', 'viral support']\n",
      "['janssen s imbruvica ibrutinib rituximab', 'ec s', 'chronic lymphocytic leukemia']\n",
      "['eu expands scope', 'cll patients cll oncology haematology marketingauthorisation ibrutinib patients chroniclymphocyticleukaemia cll drug pharma pharmaceutical chemoimmunotherapy fludarabine efficacy safety']\n",
      "['experts william g wierda md phd amp philip', 'thompson mb ms', 'chronic lymphocytic leukemia', 'cme web broadcast', 'friday september', 'cdt soho2020']\n",
      "['fda grants orphan drug designation', 'novel bcl']\n",
      "['orphan drug designation', 'chronic lymphocytic leukemia leusm']\n",
      "[]\n",
      "['priti patel', 's heroes', 'invaluable work', 'clinical development', 'multiple blood cancers', 'chronic lymphocytic leukemia cll bloodcancerawarenessmonth']\n",
      "['janssen s imbruvica ibrutinib rituximab', 'ec s', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic lymphoma cll', 'acute myeloid leukemia aml', 'common blood cancers pen', 'bloodcancerawarenessmonth bcam']\n",
      "['non hodgkin lymphoma nhl', 'chronic lymphocytic leukemia cll status', 'condition summary lymphoma non hodgkin leukemia lymphocytic chronic b cell']\n",
      "['bruton s tyrosine kinase btk', 'important therapeutic target', 'b cell cancers', 'chronic lymphocytic leukemia ghoshdastidar', 'describe zybt1', 'novel irreversible inhibitor']\n",
      "['janssen s imbruvica', 'treatment na ve patients', 'chronic lymphocytic leukaemia cll', 'leukaemia healthcare']\n",
      "['name prescription drug', 's fda', 'chronic lymphocytic leukemia cll cll', 'white blood cells']\n",
      "['name prescription drug', 's fda', 'chronic lymphocytic leukemia cll cll', 'white blood cells']\n",
      "['chronic lymphocytic leukemia', 'mrd negativity', 'goal lymphoma lymsm']\n",
      "['new clinical trial', 'non hodgkin lymphoma nhl', 'chronic lymphocytic leukemia cll cll leusm hematology']\n",
      "['janssen announces europeancommission decision', 'imbruvica ibrutinib', 'chroniclymphocyticleukaemia cll jnj']\n",
      "['biological knowledge']\n",
      "['research project', 'cll utilizes bigdata', 'specific biomarkers', 'chroniclymphocyticleukemia leusm']\n",
      "['ascentage pharma s bcl', 'inhibitor apg', 'orphan drug designation', 'chronic lymphocytic leukemia']\n",
      "['ec approval', 'imbruvica ibrutinib', 'cll pharma pharmanews']\n",
      "['blood cancer patients need', 'ear answers', 'support group', 'richard farmer amp', 'bloodcancerawarenessmonth cll bloodcancer mml aml nhl mpn leukemia']\n",
      "['cll patients clonoseq', 'assess mrd', 'cll mm', 'important info incl sample types amp test limitations']\n",
      "['ascentage pharma s bcl', 'inhibitor apg', 'orphan drug designation', 'chronic lymphocytic leukemia ascentage rockvillemd bethesdamd rockville potomacmd dmv maryland leukemia cancer hepatitisb orphandrug']\n",
      "['ascentage pharma s bcl', 'inhibitor apg', 'orphan drug designation', 'chronic lymphocytic leukemia ascentage rockvillemd bethesdamd rockville potomacmd dmv maryland leukemia cancer hepatitisb orphandrug']\n",
      "['michele kenny amp richard ancan', 'bones blood cancers video', 'virtual support group sep', 'pm eastern aml multiplemyeloma leukemia lymphoma cll']\n",
      "['september leukemia awareness month leukemia abnormal blood cells', 'bone marrow', 'main types', 'acute lymphoblastic', 'chronic lymphocytic cll', 'acute myelocytic aml', 'chronic myelocytic cml leukemia']\n",
      "['ascentage pharma s bcl', 'inhibitor apg', 'orphan drug designation', 'chronic lymphocytic leukemia biospace jobs cancerresearch clinicaltrials leukemia bloodcancer orphandiseases']\n",
      "['european commission approves s imbruvica', 's mabthera', 'line combination therapy', 'chronic lymphocytic leukemia jnj rog']\n",
      "['ascentage pharma s bcl', 'inhibitor apg', 'orphan drug designation', 'chronic lymphocytic leukemia']\n",
      "['new post ascentage pharma s bcl', 'inhibitor apg', 'orphan drug designation']\n",
      "['ascentage pharma s bcl', 'inhibitor apg', 'orphan drug designation']\n",
      "['ascentage pharma s bcl', 'inhibitor apg', 'orphan drug designation', 'chronic lymphocytic leukemia news pharma pharmiweb']\n",
      "['ascentage pharma s bcl', 'inhibitor apg', 'orphan drug designation', 'chronic lymphocytic leukemia news pharma pharmiweb']\n",
      "['ascentage pharma s bcl', 'inhibitor apg', 'orphan drug designation', 'chronic lymphocytic leukemia']\n",
      "['ascentage pharma s bcl', 'inhibitor apg', 'orphan drug designation', 'chronic lymphocytic leukemia']\n",
      "['oxygen treatment', 'prostate cancer', 'chronic lymphocytic leukemia', 'cancer cells', 'aerobic cellfood']\n",
      "['main types', 'details visit']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['specific relationship', 'developmental skills', 'literacy readiness', 'phonics amp others aspects', 'literacy preparation', 'prep diet', 'cll eyfs phonics']\n",
      "['cutaneous manifestations', 'b cell chronic lymphocytic leukemia']\n",
      "['new2trip rituximab ruxience non hodgkin s lymphoma nhl chronic lymphocytic leukemia cll rheumatoid arthritis ra']\n",
      "['strong bloodcancerawarenessmonth cll fuckcancer bloodcancer']\n",
      "['real world outcomes', 'chronic lymphocytic leukemia leukemia']\n",
      "['renowned speakers', 'virtual congress', 'hematology virtualhem2020', 'pia raanani website hematology blood targetedtherapy chemotherapy clinicalperspectives cml aml']\n",
      "['medical oncologist', 'clinical research interests', 'moleculartumorboard session', 'morning register']\n",
      "['combination obinutuzumab ibrutinib', 'chronic lymphocytic leukemia oncology']\n",
      "['novel drugs allogeneic hematopoietic cell transplantation', 'high risk chronic lymphocytic leukemia blood advances american society']\n",
      "['dr paul hampel p', 's molecular tumor board', 'pm nepal', 'excellent educational opportunity', 'cll management', 'free admission register']\n",
      "['video cll', 'green study w v ronique leblond', 'ebmt20virtual oncoalert hemonc leukemia leusm immunoonc ctsm']\n",
      "['reca da o refractario']\n",
      "['combination obinutuzumab ibrutinib', 'chronic lymphocytic leukemia cll', 'deep remissions leusm jco']\n",
      "['long term outcomes', 'dose optimization study', 'chimeric antigen receptor', 't cells', 'chronic lymphocytic leukemia tmc']\n",
      "['new podcast series', 'dr roger strair chief', 'blood disorders', 'amp dr seth cohen', 'new insights', 'cll treatments clinical trials amp', 'full podcast']\n",
      "['tratamiento cll']\n",
      "[]\n",
      "['algoritmo diagn stico']\n",
      "['ibrutix ibrutinib mantle cell lymphoma chronic lymphocytic leukemia', 'small lymphocytic lymphoma waldenstrom macroglobulinemia', 'marginal zone lymphoma cancer treatment contact', 'orders wechat amp whatsapp']\n",
      "['allosct post novel agents', 'r r cll lymsm allogeneic hematopoietic cell transplantation', 'high risk chronic lymphocytic leukemia blood advances american society']\n",
      "['worldleukemiaday wld2020 wld20 leuk mi aml', 'apl cll cml']\n",
      "['new article disease flare', 'temporary interruption', 'ibrutinib therapy', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article population', 'epidemiological data', 'follicular lymphoma', 'observation cll leusm hematology']\n",
      "['new article evaluation', 'immunophenotypic markers', 'clinico hematological profile', 'chronic lymphocytic leukemia implications', 'prognosis cll leusm hematology']\n",
      "['new article', 'cll leusm hematology']\n",
      "['new article allogeneic hematopoietic cell transplantation', 'high risk chronic lymphocytic leukemia cll leusm hematology']\n",
      "['disease flare', 'temporary interruption', 'ibrutinib therapy', 'chronic lymphocytic leukemia oncologist cancer epidemiology']\n",
      "['cll patients', 'high mortality rates', 'covid19 diagnosis', 'case fatality rate', 'full article']\n",
      "['faculty p', 'year oncology fellow', 'moleculartumorboard session', 'cll dr hampel', 'research interests', 'cll register']\n",
      "['cme credit', 'medscapelive symposium', 'btk inhibitors', 'treatment na ve chronic lymphocytic leukemia w amp', 'experts register']\n",
      "['spot leukemia wld20 cll spotleukemia fatigue', 'lymph nodes', 'routine blood work discovers cll thanks']\n",
      "['week s fragilenucleosome seminars', 'giacomo corleone', 'effie kostareli', 'multiple myeloma', 'chronic lymphocytic leukaemia cll leukemia cancer']\n",
      "['leukaemia cll thanks']\n",
      "['btk inhibitor therapy']\n",
      "['long term outcomes', 'dose optimization study', 'car t chimeric antigen receptor', 't cells', 'chronic lymphocytic leukemia pubs']\n",
      "['cll society highlights', 'cll patients need', 'high risk']\n",
      "['irish politician', 'school forgottenfamilies']\n",
      "['dyk lymphoma', 'common blood cancer', 'new treatment options', 'cll mcl', 'r amp d efforts lymsm bcam']\n",
      "[]\n",
      "['car t shortfalls', 't cells', 'cll patients leukemia oncology hematology']\n",
      "['blood cancers', 'cll aml', 'blood cancer', 'family member', 'mpn leukemias mpn']\n",
      "['years patients', 'chroniclymphocyticleukemia llc', 'venclexta venetoclax']\n",
      "['front line treatments', 'chronic lymphocytic leukemia']\n",
      "['international experience']\n",
      "['chronic lymphocytic leukaemia cll', 'body s immune system', 'lymphoma incl cll', 'family physicians', 'pivotal role', 'cll wlad2020']\n",
      "['chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'bumper sticker dm', 'worldleukemiaday leukemia cll']\n",
      "['cll need', 'herd immunity', 'full discussion', 'covid19 vaccines', 'cll patients', 'dr anthony mato']\n",
      "['dr neil', 'dr kerry rogers', 'ohio state university', 'chronic lymphocytic leukemia register', 'free cme webinar']\n",
      "['blood cancer chronic myeloid leukaemia', 'acute lymphocytic leukemia', 'gastrointestinal stromal tumor']\n",
      "['durham team', 'support schools', 'identify gaps amp', 'good practice', 'eyfs cll eyfs']\n",
      "['blood cancer awareness month cll']\n",
      "['blood cancer chronic myeloid leukaemia', 'acute lymphocytic leukemia', 'gastrointestinal stromal tumor']\n",
      "['ben je opmerkelijk vaak verkouden vaak moe heb je opgezette lymfeklieren ga naar je huisarts', 'laat je controleren op leukemie cll 12jaar maarikbenernog enblijfooknogeven wld20 worldleukaemiaday']\n",
      "['chroniclymphocytic leukemia patients contract covid19 heidi yates cll patient']\n",
      "['awareness amp', 'hemasphere publications aml cll pv', 'cmml wld20 bloodcancerawarenessmonth']\n",
      "['chronic lymphocytic leukemia treatment market', 'size share', 'growth drivers', 'audience segments industry analysis']\n",
      "['couldn t', 'matt s gp', 'symptoms amp', 'chronic lymphocytic leukaemia wld20 worldleukaemiaday worldleukemiaday cll']\n",
      "['concise editorial', 'remarkable effort', 'colleagues i', 'cll patients']\n",
      "['chronic lymphocytic leukemia', 'molecular pathogenesis', 'novel therapeutic strategies haematologica cll']\n",
      "['cll treatment paradigm', 'carsten niemann', 'copenhagen hematology eha25 hemonc oncoalert', 'eha25virtual leusm leukemia']\n",
      "['wld2020 leukemia', 'common cancer eha partners', 'basic translational amp clinical research', 'aml amp cll', 'europe amp work', 'patient outcomes']\n",
      "['world leukaemia day wld20 deb sims', 'cll patient', 'treatment option']\n",
      "['chronic lymphocytic leukemia cll', 'massive overproduction', 'leukemic lymphocytes', 'monoclonal production', 'b lymphocytes etiology']\n",
      "['steven treon md phd', 'pulmonary failure', 'ibrutinib cll leusm covid19ncancer']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['mattsson m', 'chronic lymphocytic leukemia', 'future rise', 'nationwide population']\n",
      "['covid19 american society', 'hematology cllsm leusm lymsm']\n",
      "['oncoalert outcomes', 'international experience american society', 'hematology cllsm leusm lymsm cc']\n",
      "['emili montserrat', 'editorial commentary', 'covid19 cll series', 'blood american society']\n",
      "['novel agents', 'retrospective study', 'blood advances']\n",
      "['phillip thompson m d', 'leukemia leusm cll soho2020']\n",
      "['video md discusses research', 'high risk', 'refractory chronic lymphocytic leukemia', 'asco20 leuksm']\n",
      "['pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line', 'autophagic flux openaccess crbiotech']\n",
      "['new article synergistic effect', 'cd19 car t cells', 'raji cells', 'vitro cll leusm hematology']\n",
      "['cme web broadcast', 'experts william g wierda md phd amp philip', 'thompson mb ms soho2020']\n",
      "['tumor mutational load predicts time', 'chronic lymphocytic leukemia cll', 'monoclonal b cell lymphocytosis', 'international prognostic index hematolog']\n",
      "['cll patient', 'extreme high risk', 'similar situations']\n",
      "['differential methylation', 'chronic lymphocytic leukaemia', 'evolutionary heritage', 'modulates expression', 'proximal genes retrotransposon cll methylation dnamethylation', 'view haematologica']\n",
      "['real time tutor', 'virtual classroom', 'complimentary taster session don t']\n",
      "['chronic lymphocytic leukemia', 'molecular pathogenesis', 'novel therapeutic strategies haematologica']\n",
      "['p tide det nationale genom forskningscenter starter arbejdet', 'sj ldnesygdomme som ex cll og lymfekr ft blodkr ft blodcancer sundpol dksund kr ftdagen2020']\n",
      "['degree relatives', 'indolent lymphoid malignancies', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['optic neuropathy', 'chronic lymphocytic leukemia case report chroniclymphocyticleukemia americanjournalofophthalmologycasereports opticneuropathy']\n",
      "['cll amp p', 'amp dr chaudhry']\n",
      "['case report', 'viral co infection', 'parainfluenza leusm jnccn360']\n",
      "[]\n",
      "['recurrent gly101val mutation', 'bcl2 confers resistance', 'progressive chronic lymphocytic leukemia cytofpub']\n",
      "['i m', 'wegohealthawards finalist', 'amongst top patients', 'patients patientadvocate cll leukemia patientinfluencer bloodcancerawarenessmonth']\n",
      "['clinical guidelines', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll', 'massive overproduction', 'leukemic lymphocytes', 'monoclonal production', 'b lymphocytes etiology']\n",
      "['adaptive biotechnologies', 'fda clearance', 'clonoseq assay', 'assess minimal residual disease mrd', 'chronic lymphocytic leukemia']\n",
      "['adaptive biotechnologies', 'fda clearance', 'clonoseq assay', 'assess minimal residual disease mrd', 'chronic lymphocytic leukemia', 'common questions']\n",
      "['adaptive biotechnologies', 'fda clearance', 'clonoseq assay', 'assess minimal residual disease mrd', 'chronic lymphocytic leukemia john pagel md s']\n",
      "['adaptive biotechnologies', 'fda clearance', 'clonoseq assay', 'assess mrd', 'chronic lymphocytic leukemia']\n",
      "['adaptive biotechnologies', 'fda clearance', 'clonoseq assay', 'assess mrd', 'chronic lymphocytic leukemia fda clearance', 'cll brian k']\n",
      "['adaptive biotechnologies', 'fda clearance', 'clonoseq assay', 'assess mrd', 'chronic lymphocytic leukemia brian koffman md cll society inc']\n",
      "['line therapy', 'chronic lymphocytic leukemia', 'mazyar shadman md mph', 'deborah m stephens', 'nccn2020 virtual', 'annual conference cll leusm']\n",
      "['nicole lamanna md', 'john allan md', 'john burke md', 'rocky mountain cancer centers', 'cll leusm']\n",
      "['dr barr', 'old woman', 'chronic lymphocytic leukemia', 'btk inhibitors', 'frontline setting leusm leukemias']\n",
      "['btk inhibitor', 'treatment chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['major lack', 'big risk']\n",
      "['new article concordance', 'degree relatives', 'indolent lymphoid malignancies', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article microrna 148a 3p', 'extracellular vesicles', 'bone marrow mesenchymal stem cells suppresses smurf1', 'femoral head cll leusm hematology']\n",
      "['new article kappa', 'lambda immunohistochemistry', 'situ hybridization', 'atypical cutaneous lymphoid infiltrates cll leusm hematology']\n",
      "['new article', 'btk inhibitor', 'treatment chronic lymphocytic leukemia cll leusm hematology']\n",
      "['20th anniversary issue', 'headandneck cancer biliarytract cancer breast cancer cll mesothelioma neuroendocrine tumours amp']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['vitamin d levels', 'non hodgkin lymphoma diffuse', 'large b cell lymphoma chronic lymphocytic leukemia', 'multiple myeloma']\n",
      "['minimal residual disease mrd', 'small number', 'cancer cells', 'minimal residual disease mrd', 'cll patients dr furman']\n",
      "['pharmaceutical care program', 'chronic lymphocytic l']\n",
      "['drug combination therapy', 'complete remission', 'high risk chronic lymphocytic leukemia cll']\n",
      "['live ce credit', 'chronic lymphocytic leukemia', 'common leukemia', 'western countries', 'cll cecredit pharmacy']\n",
      "['chronic lymphocytic leukemia cll diagnosis', 'patient resource chronic lymphocytic leukemia', 'order yours']\n",
      "['web broadcast', 'cll care', 'btk inhibitors selection safety', 'disease continuum soho2020']\n",
      "['novel agents', 'allohct outcomes', 'cll cancer leukemia']\n",
      "['oncology patient access program', 'patient access novartis oncology']\n",
      "['blood cancer awareness month mb', 'clinicians scientists', 'leukaemia patients', 'world cll hcl aml']\n",
      "['food industry insight', 'trademark genericism', 'd ingenuity', 'creativity trademarks genericwords languages registrability cll']\n",
      "['starter fokus blodkr ft i sep stor', 'i behandlinger flere overlever blodcancer end tidligere bloodcancerawarenessmonth letstalkaboutbloodcancer makebloodcancervisible lyle dk aml', 'cll cml apl lymfekr ft leuk mi og mds lymphoma leukemia']\n",
      "['cll society s asco', 'conference coverage end', 'dr koffman s asco top', 'dr koffman highlights results', 'duration venetoclax obinutuzumab']\n",
      "['cll society s', 'big global virtual', 'educational forum', 'live local meeting', 'top cll experts wise patients amp', 'cll education']\n",
      "['september blood cancer awareness month', 'cme activities', 'mantlecelllymphoma patient care lymsm']\n",
      "['clinical guidelines', 'chronic lymphocytic leukemia patients', 'partnership w']\n",
      "['ebmt20virtual olivier tournilhac', 'ebmt database', 'idelalisib lymsm']\n",
      "['chronic lymphocytic leukemia', 'new treatment options']\n",
      "['new article changes', 'secondary hemostasis', 'ibrutinib cll leusm hematology']\n",
      "['real world outcomes', 'chronic lymphocytic leukemia']\n",
      "['generation techniques w richard rosenquist', 'hematology eha25 hemonc oncoalert', 'eha25virtual leusm leukemia']\n",
      "['combination therapies', 'single agents', 'cll patients', 'term remission', 'dr nitin jain cll leukemia endcancer']\n",
      "['cll society', 'patient survey', 'cll patients', 'duration therapies', 'input smarter patients', 'smarter care thanks']\n",
      "['car t cells', 'cll cancer leukemia']\n",
      "['dual inhibitor', 'chronic lymphocytic leukemia patients bloodcancer leusm cancer health medtwitter']\n",
      "['leusm patientpower']\n",
      "['new2trip rituximab ruxience non hodgkin s lymphoma nhl chronic lymphocytic leukemia cll rheumatoid arthritis ra']\n",
      "['white blood cells', 'chronic lymphocytic leukaemia', 'elderly credit steve gschmeissner science photo library anatomy biology cancer leukemia oncology science microscopy']\n",
      "['cancer therapy', 'pgx info', 'breastcancer colorectalcancer', 'chronic lymphocytic leukemia cll', 'prognostic amp predictive purposes amp pt', 'tumor xenograft models']\n",
      "['exciting week', 'dr neil', 'multiple myeloma gynecologic cancers', 'chronic lymphocytic leukemia', 'clinical investigators register', 'free webinars']\n",
      "['s chronic lymphocytic leukemia', 'social security amp medicare i', 'medical coverage period i', 'medical coverage donald trump doesn t care', 'poor amp', 'american citizens']\n",
      "['chronic lymphocytic leukemia', 'complete remission', 'green tea extract', 'durable molecular remission', 'chronic lymphocytic leukemia', 'green tea']\n",
      "['series cure speaks', 'dr susan o brien', 'chronic lymphocytic leukemia']\n",
      "['real world outcomes', 'chronic lymphocytic leukemia leukemia']\n",
      "['dr barr', 'old woman', 'chronic lymphocytic leukemia', 'btk inhibitors', 'frontline setting leusm']\n",
      "['new real world outcomes', 'chronic lymphocytic leukemia']\n",
      "['allogeneic stem cell transplantation', 'chronic lymphocytic leukemia', 'novel agents blood advances american society']\n",
      "['s chronic lymphocytic leukemia', 'social security amp medicare i', 'medical coverage period i', 'medical coverage donald trump doesn t care', 'poor amp', 'american citizens']\n",
      "['allogeneic stem cell transplantation', 'chronic lymphocytic leukemia', 'novel agents blood advances american society']\n",
      "['new article', 'predictive model', 'cancer patients disease outcome', 'co expression networks cll leusm hematology']\n",
      "['new article', 'cd4 t cell recovery kinetics', 'large cohort', 'b cell lymphoproliferative disease', 'rituximab bendamustine cll leusm hematology']\n",
      "['oncoalert longitudinal health', 'life hrqol', 'chronic lymphocytic leukemia cll results', 'cll registry sharman', 'ejhaem cllsm leusm lymsm']\n",
      "['real world data cll w peter hillmen', 'hematology eha25 hemonc oncoalert', 'eha25virtual leusm leukemia realworlddata']\n",
      "['cll treatments', 'chroniclymphocyticleukemia expert dr furman', 'patient questions', 'full article']\n",
      "['fantastic talk', 'current landscape']\n",
      "['s chronic lymphocytic leukemia', 'social security amp medicare i', 'medical coverage period i', 'medical coverage donald trump doesn t care', 'poor amp', 'american citizens']\n",
      "['phase 1b study', 'japanese patients', 'refractory follicular lymphoma', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['sars cov', 'antibody response', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['new article development', 'cell line model', 'pro survival effect', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article ofatumumab', 'complement replacement', 'refractory chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article outcomes', 'chronic lymphocytic leukemia patients', 'partial remission', 'pilot study cll leusm hematology']\n",
      "['new article epigenetic', 'long non', 'rna bm742401', 'multiple myeloma impact', 'myeloma dissemination cll leusm hematology']\n",
      "['new article', 'sars cov', 'antibody response', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article chidamide', 'histone deacetylase inhibitor inhibits autophagy', 'exhibits therapeutic implication', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia cells', 'osteoclastogenesis role', 'tnf il', 'cytokines cll leusm hematology']\n",
      "['dr portell', 'patient case', 'chronic lymphocytic leukemia cllsm leusm']\n",
      "['immune system', 'own highlights', 'covid numbers', 'rise glynn']\n",
      "['high risk', 'cll covid19']\n",
      "['blood diseases', 'myelodysplastic syndrome', 'dr courtney dinardo leukemia mds endcancer']\n",
      "['scott s battle', 'chronic lymphocytic leukemia']\n",
      "['whew sigh', 'self thread', 'slight chance amp', 'slight chance', 'cll chronic lymphocytic leukemia']\n",
      "['long term outcomes', 'dose optimization study', 'chimeric antigen receptor', 't cells', 'chronic lymphocytic leukemia']\n",
      "['blood cancers', 'cll aml', 'families dr courtney d dinardo discusses', 'family genetic predisposition', 'blood cancer']\n",
      "['cll lymsm']\n",
      "['international ultman chicago lymphoma symposium', 'remarkable advances', 'cll lymphoma bloodcancer hematology']\n",
      "['real percentage', 'blood cancers', 'important piece', 'dr courtney dinardo', 'hereditary blood cancers leukemia mpn endcancer']\n",
      "['bloodcancers hereditary founder amp courtney dinardo md hereditary hematologic malignancy clinic leader', 'family genetic predisposition', 'heme cancer amp', 'available treatments endcancer leusm']\n",
      "['t cell immunosuppressive therapy', 'squamous cell carcinoma', 'chronic lymphocytic leukemia']\n",
      "['pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line', 'autophagic flux openaccess crbiotech']\n",
      "['sars cov', 'antibody response', 'chronic lymphocytic leukemia leukemia covid']\n",
      "['verb vocab', 'sentences describe activity', 'recount amp', 'stories verbs', 'tip amp splash', 'water area', 'good practice cll eyfs']\n",
      "['real world outcomes', 'chronic lymphocytic leukemia']\n",
      "['wcrf aicr cancer prevention guidelines', 'chronic lymphocytic leukemia', 'mcc spain study']\n",
      "['new article clinicopathological characterization', 'chronic lymphocytic leukemia', 'myd88 mutations l265p', 'non l265p mutations', 'different features cll leusm hematology']\n",
      "['new article development', 'cd32b antibodies', 'fc function', 'plasma cell malignancies cll leusm hematology']\n",
      "['new article evaluation', 'hbv hcv', 'hiv seroprevalence', 'plasma cell disorders cll leusm hematology']\n",
      "['new article', 'serological evidences', 'sars cov', 'literature cll leusm hematology']\n",
      "['new article refractory', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['husband s uk mask', 'large cranium', 'perfect coverage', 'quality material', 'cool wearamask bloodcancer leukaemia cll']\n",
      "['tumor lysis syndrome', 'chronic lymphocytic leukemia', 'rare case report']\n",
      "['great virtual meeting', 'pam profusek', 'nursetwitter leukemia']\n",
      "['chronic lymphocytic leukemia', 'fortunate i don t need treatment']\n",
      "['allogeneic stem cell transplantation', 'chronic lymphocytic leukemia', 'novel agents cll']\n",
      "['don t', 's cll answers', 'pm pst', 'pm est', 'dr barr', 'aggressive treatment options', 'leusm patientpower']\n",
      "['oral loxo', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'non hodgkin s lymphoma']\n",
      "['real world outcomes', 'chronic lymphocytic leukemia']\n",
      "['clinicopathological characterization', 'chronic lymphocytic leukemia', 'myd88 mutations l265p', 'non l265p mutations', 'different features']\n",
      "['red flag', 'cll cancer oncology']\n",
      "['cll patients delay treatment', 'dr mato', 'patient s', 'unique situation']\n",
      "['new real world outcomes', 'chronic lymphocytic leukemia']\n",
      "['oncology experts reflect', 'chronic lymphocytic leukemia cll']\n",
      "['cll society', 'cll patients', 'limit contact', 'others download', 'official statement', 'hr co workers hcps e']\n",
      "['obinutuzumab ibrutinib', 'treatment naive', 'refractory chronic lymphocytic leukemia hematology leusm']\n",
      "['professional insight', 'chronic lymphocytic leukemia', 's educatedpatient webinar', 'lymphoma experts']\n",
      "['allogeneic stem cell transplantation', 'chronic lymphocytic leukemia', 'novel agents blood advances american society']\n",
      "['online training', 'complimentary taster session', 'expertise book']\n",
      "['video eha', 'cll highlights w paolo ghia', 'hematology eha25 hemonc oncoalert', 'eha25virtual cll leukemia leusm']\n",
      "[]\n",
      "['clinicopathological characterization', 'chronic lymphocytic leukemia', 'myd88 mutations l265p', 'non l265p mutations', 'different features']\n",
      "['soho2020 cll session speakers', 'session chairs jennifer', 'brown amp florence cymbalista', 'soho2020houston lymphoma leukemia hemonc oncopharm leusm lymsm mmsm bmtsm mdssm']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['exciting data', 'dr rogers team', 'james mrd', 'negative pts', 'tx naive', 'r r disease obinutuzumab ibrutinib', 'treatment naive', 'refractory cll', 'asco post']\n",
      "['allogeneic stem cell transplantation', 'chronic lymphocytic leukemia', 'novel agents blood advances american society']\n",
      "['dr wei wang', 'md anderson cancer center scientists', 'cll cases', 'l265p mutation', 'myd88 gene', 'distinctive clinical immunophenotypic cytogenetic', 'full article']\n",
      "['burger md phd', 'leukemia reviews btk inhibitors', 'cll endcancer leusm']\n",
      "['positive results', 'combination therapy']\n",
      "['essential genetictests', 'cll dr steven coutre', 'overview leusm fishtest ighv cllms']\n",
      "['william g wierda md phd amp philip', 'thompson mb ms', 'live web broadcast', 'cll treatment soho2020']\n",
      "['mind blog', 'non u s trademark applicant establishes', 'bona fide intent', 'u s commerce trademark intenttouse itu cll']\n",
      "['treatment landscape', 'common form']\n",
      "['asco20 don t', 'chronic lymphocytic leukemia', 'virtual meeting cancer leusm medtwitter']\n",
      "['oral therapy', 'cll treatments', 'car t therapy amp clinical trials', 'aug 27th', 'pm pt', 'live webinar', 's dr paul barr', 'options amp']\n",
      "['cll market report ftse lacks direction', 'investors await', 'big market mover', 'uk cll']\n",
      "['erlene seymour m d', 'chronic lymphocytic leukemia webinar', 'patients caregivers amp advocates participants', 'submit questions']\n",
      "['allogeneic stem cell transplantation', 'chronic lymphocytic leukemia', 'novel agents']\n",
      "['new article exosomal clic1', 'cll promotes huvecs angiogenesis', 'mapk erk axis cll leusm hematology']\n",
      "['new article allogeneic stem cell transplantation', 'chronic lymphocytic leukemia', 'novel agents cll leusm hematology']\n",
      "[]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['elevate tn']\n",
      "['virtual case', 'peer perspectives event dr burger', 'treatment options', 'chronic lymphocytic leukemia', 'old female patient cllsm leusm']\n",
      "['allo transplant', 'novel agents', 'great collaboration', 'y nrm', 'novel agents', 'impact survival cll bmt']\n",
      "['rr cll', 'novel agent na era', 'nas pre allo amp na', 'pre allo', 'impact survival hct comorb index predicts pfs', 'risk cll factors', 'great collaboration']\n",
      "['live ce credit', 'chronic lymphocytic leukemia cll', 'common leukemia', 'western countries', 'cll cecredit pharmacy']\n",
      "['oncoalert allogeneic stem cell transplantation', 'chronic lymphocytic leukemia cll', 'novel agents american society', 'hematology lymsm leusm cllsm bmtsm']\n",
      "['allogeneic stem cell transplantation', 'chronic lymphocytic leukemia', 'novel agents blood advances american society']\n",
      "['cll patients', 'telemedicine cllsm']\n",
      "['dr richard furman', 'common questions', 'cll patients', 'long term', 'oral agents leukemia leusm']\n",
      "['holistic approaches', 'manage cll w kostas stamatopoulos hematology eha25 hemonc oncoalert', 'eha25virtual leusm leukemia']\n",
      "['dr paul barr', 'patients thursday', 'webinar patientpower leusm']\n",
      "['vitro diagnostic mrd assay', 'cll clonoseq', 'cancer cell', 'healthy cells', 'oncoalert hemeonc leukemia leusm cllsm']\n",
      "['new2trip rituximab ruxience non hodgkin s lymphoma nhl chronic lymphocytic leukemia cll rheumatoid arthritis ra']\n",
      "['new article high percentage', 'smudge cells', 'utility cll leusm hematology']\n",
      "['new article morphologic diversity', 'merkel cell carcinoma cll leusm hematology']\n",
      "['new article lpl deletion', 'poorer response', 'overall survival', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article colonic adenoma', 'chronic lymphocytic leukemia infiltration cll leusm hematology']\n",
      "['cll society registration', 'global virtual patient amp caregiver', 'educational forum cll experts', 'frontline therapy test', 'clinical trials car t vaccines richter s expert access']\n",
      "['week dr neil', 'discusses chronic lymphocytic leukemia lung cancer', 'gynecologic cancers', 'clinical investigators register', 'free cme moc webinars']\n",
      "['new paper', 'slamf receptor', 'great job']\n",
      "['multidisciplinary diagnostics', 'chronic lymphocytic leukemia european research initiative', 'cll eric recommendations']\n",
      "['cll patient needs', 'aggressive treatments', 'cll answers', 's dr paul barr thursday aug', 'pm pst', 'pm est register']\n",
      "['chronic lymphocytic leukemia']\n",
      "['dr phillip thompson', 'key test results', 'impact cll treatment timing', 'approaches ighv fishtest btkinhitors leusm']\n",
      "['malignant melanoma', 'clinical response', 'chronic lymphocytic leukemia', 'case series']\n",
      "['raman spectroscopy', 'fingerprint characteristics', 'chronic lymphocytic leukemia', 'large b cell lymphoma lymphoma lymsm']\n",
      "['cll patients', 'initial therapy cllsm leusm lymsm gerionc geriheme']\n",
      "['slamf receptors', 'b cell receptor', 'chronic lymphocytic leukemia']\n",
      "['dr davids discusses', 'unity cll clinical trial', 'chronic lymphocytic leukemia leusm hematology']\n",
      "['triplet regimen', 'deep remissions', 'treatment na ve', 'refractory chronic lymphocytic leukemia leukemias leusm']\n",
      "['chronic lymphocytic leukemia nejm']\n",
      "['cll chronic lymphocytic leukemia i', 'positive amp healthy i', 'silence prayer rest meditation healthy food amp yoga', 'dear friends']\n",
      "['rwd researchers', 'inpatient bacterial infection trends', 'chronic lymphocytic leukemia findings', 'effective treatments', 'long term']\n",
      "['susan o brien university', 'california irvine']\n",
      "['slamf receptors', 'b cell receptor', 'chronic lymphocytic leukemia', 'von wenserski l schulthei c bolz s schliffke s simnica d willscher e gerull h wolters eisfeld g riecken k fehse b']\n",
      "['reminder age', 'study participants matters', 'lymphoma lymsm idelalisib', 'follicular lymphoma', 'chronic lymphocytic leukemia', 'treatment outcomes', 'clinical trial participants vs medicare beneficiaries']\n",
      "['new article slamf receptors', 'b cell receptor', 'chronic lymphocytic leukemia', 'cll leusm hematology']\n",
      "['new article noninvasive evaluation', 'cd20 expression', 'f ab', 'lymphoma cll leusm hematology']\n",
      "['phase ii study', 'combination obinutuzumab ibrutinib', 'treatment na ve', 'refractory chronic lymphocytic leukemia']\n",
      "['obinutuzumab ibrutinib', 'primary goal', 'deep remissions', 'duration combination', 'agents leukemia bloodcancer']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['new article', 't cell', 'venetoclax elicits synergistic cytotoxicity', 'b cell lines', 'vitro cll leusm hematology']\n",
      "['new article demographic pattern', 'chronic lymphocytic leukemia', 'tertiary hospital', 'nigeria cll leusm hematology']\n",
      "['video front line', 'r r updates', 'w peter hillmen', 'hematology eha25 hemonc oncoalert', 'eha25virtual leusm leukemia']\n",
      "['genmab announces plan', 'transition arzerra ofatumumab', 'oncology access program', 'chroniclymphocyticleukemia patients', 'u s gmab']\n",
      "['und acomohoy degustacion cll']\n",
      "['novel agents fcr', 'btki candidates', 'long term', 'important study']\n",
      "['moleculartumorboard faculty spotlight', 'precision oncology alliance', 'medical oncologist', 'cll session', 'amp register']\n",
      "['discussion topics', 'panel faculty', 'cure s educatedpatient webinar', 'chronic lymphocytic leukemia']\n",
      "['dr paul barr', 'live webinar', 'week cll patientpower leukemia leusm']\n",
      "['wonderful resource', 'great questions', 'asynchronous learning', 'meaningful way', 'cll maha']\n",
      "['new article il4i1', 'metabolic immune checkpoint', 'promotes tumor progression cll leusm hematology']\n",
      "['new article', 'new nomenclature', 'eosinophilic dermatosis', 'hematologic malignancy edhm hematologic', 'eosinophilic dermatosis', 'cll leusm hematology']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['triplet regimen', 'deep remissions', 'treatment na ve', 'refractory chronic lymphocytic leukemia leusm leukemias']\n",
      "['new series', 'chronic lymphocytic leukemia', 'moderator dr neil', 'dr brad kahl', 'siteman cancer center register', 'free cme webinar']\n",
      "['genmab announces plan', 'transition arzerra ofatumumab', 'oncology access program', 'chronic lymphocytic leukemia patients', 'u s news pharma pharmiweb']\n",
      "['deutsche gesellschaft f r h matologie und medizinische onkologie e v dgho empfiehlt', 'ihrer onkopedia leitlinie zur cll genetische untersuchungen auf bestimmte risikofaktoren vor einleitung einer therapie mehr dazu hier']\n",
      "['mrd assay', 'chronic lymphocytic leukemia']\n",
      "['genmab announces plan', 'transition arzerra ofatumumab', 'oncology access program', 'chronic lymphocytic leukemia patients', 'u s']\n",
      "['overview role', 'current treatments clinical trials amp', 'patient experience', 'associate professor dr jason butler', 'sims cll lymphoma']\n",
      "['news genmab announces plan', 'transition arzerra ofatumumab', 'oncology access program', 'chronic lymphocytic leukemia patients', 'u s gmab']\n",
      "['gmab nvs genmab announces plan', 'transition arzerra ofatumumab', 'oncology access program', 'chronic lymphocytic leukemia patients', 'u s']\n",
      "['new article genmab announces plan', 'transition arzerra ofatumumab', 'oncology access program', 'chronic lymphocytic leukemia patients', 'u s']\n",
      "['genmab announces plan', 'transition arzerra ofatumumab', 'oncology access program', 'chronic lymphocytic leukemia patients', 'u s']\n",
      "['genmab announces plan', 'transition arzerra ofatumumab', 'oncology access program', 'chronic lymphocytic leukemia patients', 'u s']\n",
      "['gmab genmab announces plan', 'transition arzerra ofatumumab', 'oncology access program', 'chronic lymphocytic leukemia patients', 'u s']\n",
      "['genmab announces plan', 'transition arzerra ofatumumab', 'oncology access program', 'chronic lymphocytic leu']\n",
      "['genmab gmab announces plan', 'transition arzerra ofatumumab', 'oncology access program', 'chronic lymphocytic leukemia patients', 'u s']\n",
      "['gmab novartis', 'transition availability', 'oncology access program', 'chronic lymphocytic leukemia patients', 'u s genmab', 'potential royalties']\n",
      "['pr genmab announces plan', 'transition arzerra ofatumumab', 'oncology access program', 'chronic lymphocytic leukemia patients', 'u s gmab']\n",
      "['obinutuzumab ibrutinib', 'primary goal', 'deep remissions', 'duration combination', 'agents cllsm leukemia']\n",
      "['chronic lymphocytic leukemia', 'multiple myeloma', 'clinical advances', 'john m burke md amp manuel', 'santiago md', 'cme credits']\n",
      "['fro u t', 'chronic lymphocytic leukemia', 's energy amp general health', 'couldn t manage u t', 'unity ticket']\n",
      "['recent lte researchers', 'cll patients']\n",
      "['s time', 'webinar replay', 'dr susan o brien cllsm leusm']\n",
      "['mind blog look', 'local connotations', 'trademark don t', 'consumers trademarks connotation cll']\n",
      "['exciting results', 'combo ivo', 'long term', 'bcl2 cll']\n",
      "['susan o brien md', 'chao family', 'comprehensive cancer center', 'chronic lymphocytic leukemia cll', 'national blood cancer conference', 'gt gt']\n",
      "['1st september 1pm key speakers', 'dr satarupa choudhuri consultant haematologist', 'royal oldham hospital', 'cll patient s experience', 'chair marc auckland register', 'webinar org uk']\n",
      "['sunday september', 'dr chaudhry']\n",
      "['chronic lymphocytic leukemia b', 'multiple myeloma clonoseq', 'assess mrd', 'cll mm', 'important info incl sample types amp test limitations']\n",
      "['long term results support efficacy', 'ublituximab ibrutinib', 'high risk chronic lymphocytic leukemia cancer leusm medtwitter']\n",
      "['new series', 'chronic lymphocytic leukemia', 'moderator dr neil', 'dr brad kahl register', 'free cme webinar']\n",
      "['chronic lymphocytic leukemia oncology']\n",
      "['career development award cda', 'postdoctoral fellowship grantees', 'chronic lymphocytic leukemia cll', 'specific research projects']\n",
      "['chronic lymphocytic leukemia', 'william g wierda md phd amp philip', 'thompson mb ms', 'cme web broadcast']\n",
      "['dr coutre', 'old woman', 'white blood cell', 'chronic lymphocytic leukemia cllsm leusm']\n",
      "['phase ii study', 'course fludarabine', 'chronic lymphocytic leukemia']\n",
      "['dual inhibitor', 'chronic lymphocytic leukemia patients leusm cancer wednesdaythoughts']\n",
      "['new2trip rituximab ruxience non hodgkin s lymphoma nhl chronic lymphocytic leukemia cll rheumatoid arthritis ra']\n",
      "['new article', 'phase ii study', 'course fludarabine', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article development', 'conceptual model', 'chronic lymphocytic leukemia', 'patient experience cll leusm hematology']\n",
      "['new article statpearls cll leusm hematology']\n",
      "['allogeneic hematopoietic cell transplantation', 'tp53 mutant', 'chronic lymphocytic leukemia results', 'prospective observational study amchelsinki tutkimus']\n",
      "['high numbers', 'fcr chlorambucil phase ii study', 'combination obinutuzumab ibrutinib', 'treatment na ve', 'refractory chronic lymphocytic leukemia']\n",
      "['haben bezeichnungen wie ighv 17p und tp53 mit der chronischen lymphatischen leuk mie kurz cll zu tun dieser artikel erkl rt s gemeinsamgrenzenverschieben onkologie krebs']\n",
      "['chronic lymphocytic leukemia nejm resident', 'lt meta property twitter image content gt lt meta property og image content gt']\n",
      "['llni cll epigenetics']\n",
      "['video significance', 'eric study', 'p53 mutants', 'cll w kostas stamatopoulos', 'hematology eha25 hemonc oncoalert', 'eha25virtual leusm ctsm leukemia']\n",
      "['new study', 'dominant issue', 'chronic lymphocytic leukemia openaccess']\n",
      "['btk inhibitors', 'chronic lymphocytic leukemia', 'william g wierda md phd amp philip', 'thompson mb ms', 'cme web broadcast']\n",
      "['william g wierda md phd amp philip', 'thompson mb ms', 'btk inhibitors', 'chronic lymphocytic leukemia', 'cme web broadcast']\n",
      "['covid19 increases', 'chronic lymphocytic leukemia', 'impact death', 'international study']\n",
      "['background leukemia', 'blood cancer', 'major subtypes', 'acute leukemia', 'rapid intervention', 'acute myelogenous aml', 'acute lymphocytic leukemia']\n",
      "['expert opinion', 'chronic lymphocytic leukemia', 'sarscov2 pandemic cll covid19']\n",
      "['important symptom', 'lymsm cll development', 'conceptual model', 'chronic lymphocytic leukemia', 'patient experience']\n",
      "['nicole lamanna md', 'john allan md', 'john burke md', 'cll leusm']\n",
      "['chronic lymphocytic leukemia cll', 'common leukemia', 'financial assistance', 'treatment amp management', 'fund page']\n",
      "['dr o brien tune']\n",
      "['patient plays', 'key role dr susan o brien', 'cll treatment plan', 'cllsm leusm']\n",
      "['cll patients', 'need treatment', 'dr susan o brien']\n",
      "['dr susan o brien reviews key decision making factors', 'current cll treatments', 'research cllsm leusm']\n",
      "['cllsm leusm']\n",
      "['cll webinar', '10am pt cllsm leusm']\n",
      "['chronic lymphocytic leukemia cll', 'treatment decisions', 'story amongst others']\n",
      "['phase ii study', 'combination obinutuzumab ibrutinib', 'treatment na ve', 'refractory cll journal', 'clinical oncology']\n",
      "['covid impact cll patients dr phillip thompson', 'view leusm']\n",
      "['large cohort study', 'serious bacterial infections']\n",
      "['don t', 'cll therapy']\n",
      "['complex karyotype', 'chronic lymphocytic leukemia cll', 'comprehensive review']\n",
      "['grand rounds presentation', 'pgy2 oncology resident', 'chronic lymphocytic leukemia']\n",
      "['new clinical trial', 'cd19 allo car t cells', 'b cell malignancies', 'hsct cll leusm hematology']\n",
      "['chronic lymphocytic leukemia']\n",
      "['new article', 'manage patients', 'chronic lymphocytic leukemia', 'sars cov', 'pandemic cll leusm hematology']\n",
      "['new article high cxcr3', 'leukemic cells distinguishes ighv mut', 'ighv unmut', 'chronic lymphocytic leukemia evidence', 'cd5low clones cll leusm hematology']\n",
      "['new article itga4 gene methylation status', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article crystal structure', 'spry domain', 'unique structural', 'cll leusm hematology']\n",
      "['new article', 'whole exome', 'whole genome', 'chronic lymphocytic leukemia', 'new biomarkers', 'target cll leusm hematology']\n",
      "['fact sheet', 'cll case study i', 'healthcarescience community traineebms ibms haematology cll']\n",
      "['cancer caregiver leukemia']\n",
      "['manage patients', 'chronic lymphocytic leukemia hemasphere']\n",
      "['free moleculartumorboard', 'top institutions', 'dr chaudhry', 'ubereats gift card']\n",
      "['leukemia research', 'brighton amp sussex', 'medical school', 'cell interactions', 'chronic lymphocytic leukemia cll cells', 'vascular endothelium', 'shear flow cancer microfluidics']\n",
      "['chronic lymphocytic leukemia']\n",
      "['cll lymphoma']\n",
      "['dr davids discusses', 'unity cll clinical trial', 'chronic lymphocytic leukemia leusm cllsm']\n",
      "['allogeneic cart cell therapy', 'pluripotent stem cells ipscs', 'nhl cll', 'flexible expression', 't cell receptor alpha receptor trac hematology hematology']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['cll treatment', 'dr steven coutre', 'cll specialist reviews', 'current approaches', 'options cllsm leusm']\n",
      "['dr paolo ghia', 'dr peter anglin', 'regional health centre', 'covid19 era']\n",
      "[]\n",
      "['combination obinutuzumab ibrutinib', 'treatment na ve', 'refractory chronic lymphocytic leukemia cll']\n",
      "['season btw cll foreverblue jt26']\n",
      "['allogeneic hematopoietic cell transplantation', 'tp53 mutant', 'chronic lymphocytic leukemia results', 'prospective observational study bone marrow transplantation cll leusm']\n",
      "['erlene seymour m d', 'chronic lymphocytic leukemia webinar', 'cll information', 'patients caregivers amp advocates participants', 'submit questions', 'expert panel register']\n",
      "['new clinical trial sequential regimen', 'obinutuzumab ga101 zanubrutinib bgb', 'venetoclax abt', 'refractory cll cll leusm hematology']\n",
      "['principia biopharma pharma pharmaceuticals drugdevelopment immunology acquisition randd researchanddevelopment btkinhibitors immunemediateddiseases brutontyrosinekinaseinhibitors cll follicularlymphoma mantlecelllymphoma sle']\n",
      "['new article phase ii study', 'combination obinutuzumab ibrutinib', 'treatment na ve', 'refractory chronic lymphocytic leukemia cll leusm hematology']\n",
      "['das vorliegen bzw nichtvorhandensein von bestimmten genetischen merkmalen bei einer cll beeinflusst nicht nur das tempo', 'dem der krebs fortschreitet es hat auch einfluss auf', 'wahl einer wirksamen therapie hier wird es erkl rt leuk mie']\n",
      "['lymphoma cll experts', 'don t']\n",
      "['cll society announces lymphoma australia virtual conference', 'own dr brian koffman joins dr matt davids dr jason butler', 'patient deb sims', 'pm pt', 'melbourne australia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['allogeneic hematopoietic cell transplantation', 'tp53 mutant', 'chronic lymphocytic leukemia results', 'prospective observational study']\n",
      "['allogeneic hematopoietic cell transplantation', 'tp53 mutant', 'chronic lymphocytic leukemia results', 'prospective observational study']\n",
      "['number blocs', 'september ncetm numberblocs mathsmastery smallworld eyfs cll talk4maths']\n",
      "['chronic lymphocytic leukemia patients', 'richter s syndrome', 'large b cell lymphoma', 'poor prognosis', 'population cll society', 'zusia bless r b g']\n",
      "['triplet regimen', 'exciting responses', 'treatment na ve chronic lymphocytic leukemia leukemia leusm']\n",
      "['video umbralisib', 'r r cll', 'mcl w', 'hematology eha25 hemonc oncoalert', 'eha25virtual leusm ctsm leukemia']\n",
      "['free range', 'role play', 'traditional question', 'worksheets cll']\n",
      "['merkel cell carcinoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['2do dia perroo cll hs']\n",
      "['chronic lymphocytic leukemia cll']\n",
      "['front line treatments', 'chronic lymphocytic leukemia']\n",
      "['new article crossing', 'reactive oxygen species', 'b cell malignancies cll leusm hematology']\n",
      "['new article', 'drug sensitivity', 'resistance test', 'droplet microarray cll leusm hematology']\n",
      "['study explores', 'cll mcl']\n",
      "['chronic lymphocytic leukaemia cll', 'time systematic review', 'evidence cancer']\n",
      "['webinar register', 'cll expert dr susan o brien']\n",
      "['phone interview', 'chronic lyphocytic leukemia cll patients']\n",
      "['dr sharman reviews', 'old man', 'chronic lymphocytic leukemia leusm']\n",
      "['cll society', 'mrd status', 'big player', 'certain treatments', 'cll don t', 'cll society', 'webinar mrd']\n",
      "['t cell dynamics', 'chronic lymphocytic leukemia', 'different treatment modalities cll']\n",
      "['eyfs team', 'eyfs training', 'language development', 'eyfs cll eyfssquad']\n",
      "['recent advances', 'chronic lymphocytic leukemia diffuse', 'large b cell lymphoma amp follicularlymphoma ian w flinn oncology amp hematology review', 'access article']\n",
      "['new article', 'current diagnosis', 'chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['new article prevalence distribution', 'predictive value', 'xpo1 mutation', 'real life chronic lymphocytic leukaemia cohort cll leusm hematology']\n",
      "['new article toso interacts', 'enhances bcr pathway activation', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['cll society', 'mrd status', 'big player', 'certain treatments', 'cll don t', 'cll society', 'webinar mrd', 'drs anthony mato']\n",
      "[]\n",
      "['chronic lymphocytic leukemia risk', 'early mortality', 'serious inpatient bacterial infection', 'study data leukemia']\n",
      "['dual inhibitor', 'chronic lymphocytic leukemia patients bloodcancer leusm cancer health medtwitter']\n",
      "['experts william g wierda md phd amp philip', 'thompson mb ms', 'chronic lymphocytic leukemia', 'cme web broadcast', 'cdt soho2020']\n",
      "['flt3 inhibitor cg', 'aml amp', 'acute disease amp', '1st month amp', 'bone marrow']\n",
      "['arql drug', 'btk amp dose escalation investors']\n",
      "['chronic lymphocytic leukemia risk', 'early mortality', 'serious inpatient bacterial infection', 'study data']\n",
      "['treatment naive cll']\n",
      "['complete cll society s test', 'critical tests', 'certain medications test', 'knowledge share', 'experience request', 'free test']\n",
      "['chronic lymphocytic leukaemia cll', 'time systematic review', 'evidence cancer']\n",
      "['triplet combination', 'encouraging response rates', 'treatment na ve chronic lymphocytic leukemia leukemia leusm']\n",
      "['apto cg', 'clinical development plan', 'lymphoid cll nhl', 'myeloid aml malignancies']\n",
      "['new clinical trial pitavastatin', 'chronic lymphocytic leukemia', 'acute myeloid leukemia aml leusm hematology']\n",
      "['new clinical trial pitavastatin', 'chronic lymphocytic leukemia', 'acute myeloid leukemia cll leusm hematology']\n",
      "['clarity update', 'clarity abstract', 'venetoclax combination treatment', 'refractory cll patients']\n",
      "['cll society announces lymphoma australia virtual conference', 'own dr brian koffman joins dr matt davids dr jason butler', 'patient deb sims', 'pm pt', 'melbourne australia']\n",
      "['schongewusst ighv steht f r einen genabschnitt der bei der cll mutiert sein kann patienten mit unmutiertem ighv status haben im vergleich zu denen mit mutation eine ung nstigere prognose mehr dazu hier leuk mie onkologie krebs']\n",
      "['proteomic markers', 'prognostic impact', 'chronic lymphocytic leukemia patients', 'chemo immunotherapy results']\n",
      "['t cell dynamics', 'chronic lymphocytic leukemia', 'different treatment modalities']\n",
      "['icaho20 lymphoid malignancies session', 'dr william bensinger', 'dr venugopal', 'cll lymphoma amp multiplemyeloma register']\n",
      "['pm eastern', 'videochat blood cancer virtual support group', 'free drop', 'info aml multiplemyeloma leukemia lymphoma cll']\n",
      "['cell mtdna mutations', 'dissect subclones', 'solid tumors']\n",
      "['asco20 don t', 'conference highlights', 'chronic lymphocytic leukemia cancer leusm medtwitter']\n",
      "['tanya siddiqi m d', 'international expert', 'chronic lymphocytic leukemia', 'cancer research', 'special message']\n",
      "['chronic lymphocytic leukemia management', 'campus cll report covid19']\n",
      "['pharmacy experts', 'treatment considerations', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'tp53 alterations nejm']\n",
      "['panel discusses', 'patient education', 'different treatment regimens', 'chronic lymphocytic leukemia']\n",
      "['video transcend cll', 'lisocabtagene maraleucel', 'cll w tanya siddiqi', 'hematology eha25 hemonc oncoalert', 'eha25virtual leukemia leusm immunoonc tcellrx']\n",
      "['george thorogood', 'delaware rocker', 'lymphoma society', 'canada i', 'cll chronic lymphocytic leukemia', 'george thorogood']\n",
      "['dr jonathon b cohen', 'year woman', 'chronic lymphocytic leukemia', 'virtual case', 'peer perspectives series hemonc oncology']\n",
      "['dual inhibitor', 'chronic lymphocytic leukemia patients leusm cancer wednesdaythoughts']\n",
      "['chronic lymphocytic leukemia', 'co founder', 'questions register', 'leusm patientpower']\n",
      "['international experience cll multicenter sars cov', 'covid19 btki healthbook']\n",
      "['iciclle update', 'long term mrd response', 'obinutuzumab cll']\n",
      "['online training', 'quality management', 't amp c s']\n",
      "['leukemia leukemia', 'involves blood cells', 'acute lymphocytic leukemia', 'acute myelogenous leukemia aml chronic lymphocytic leucemia cll chronic myelogenous leukemia cml']\n",
      "['cll society dr nitin jain defines mrd', 'patients attain', 'low level']\n",
      "['complex karyotype', 'chronic lymphocytic leukemia', 'literature haematology thewiderwiserview']\n",
      "['new article risk', 'bendamustine rituximab', 'tolerable treatment', 'elderly patients', 'chronic lymphocytic leukaemia', 'regional real world report', 'consecutive swedish patients cll leusm hematology']\n",
      "['new article proteomic markers', 'prognostic impact', 'chronic lymphocytic leukemia patients', 'chemo immunotherapy results', 'study mmsm multiplemyeloma hematology']\n",
      "['schongewusst bei der chronischen lymphatischen leuk mie kurz cll beeinflussen bestimmte risikofaktoren den krankheitsverlauf den therapieerfolg und', 'lebenserwartung von patienten mehr dazu hier gemeinsamgrenzenverschieben onkologie']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['chinese technology huawei', '5g network cll huawei']\n",
      "['chinese technology huawei', '5g network cll huawei']\n",
      "['moleculartumorboard faculty spotlight dr arvind chaudhry', 'summit cancer centers', 'medical oncologist', 'cll session', 'amp register']\n",
      "['autoimmune conditions', 'immunoglobulin g lgg', 'primary immune deficiency disease', 'chronic b cell lymphocytic leukemia kroger specialty pharmacy', 'journey specialtypharmacy']\n",
      "['tuesday s aug', 'review key decision making factors', 'current cll treatments', 'research cllsm']\n",
      "['sweet girl', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma', 'katy i', 'offering mini sessions', 'august 22nd']\n",
      "['chronic lymphocytic leukemia', 'molecular pathogenesis', 'novel therapeutic strategies']\n",
      "['chronic lymphocytic leukemia', 'molecular pathogenesis', 'novel therapeutic strategies', 'excellent summer review', 'cll good', 'new softer confination covid', 'period congrats elias julio ferran amp dolors']\n",
      "['new article ibrutinib', 'bruton s tyrosine kinase inhibitor', 'new risk factor', 'cryptococcosis cll leusm hematology']\n",
      "['new article abnormal expression', 'immune checkpoint molecules', 'chronic lymphocytic leukemia patients cll leusm hematology']\n",
      "['new article identification', 'potential biomarker', 'skin cutaneous melanoma', 'bioinformatics analysis cll leusm hematology']\n",
      "['new article', 'autophagy protein lc3', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article card9 mediates t cell inflammatory response', 'coxsackievirus b3', 'acute myocarditis cll leusm hematology']\n",
      "['rns aim cll cello health plc scheme']\n",
      "['ptcma virtual cpd', 'chronic lymphocytic leukemia']\n",
      "['atrial fibrillation', 'side effect', 'ibrutinib treatment']\n",
      "['new post chronic lymphocytic leukemia therapeutics market research report']\n",
      "['moleculartumorboard faculty spotlight', 'cll session', 'section head', 'hematology oncology']\n",
      "['kenny s', 'moderate ancan', 'free drop', 'bloodcancers videochat virtual support group aug', 'pm eastern aml multiplemyeloma leukemia lymphoma cll']\n",
      "['cll society dr nitin jain defines mrd', 'low level']\n",
      "['brain fog', 'wednesday rang doctor', 'mecfs i', 'only mecfs', 'small mercies']\n",
      "['current state', 'chronic lymphocytic leukemia']\n",
      "['cart celltherapy', 'clinical trial', 'refractory chronic lymphocytic leukemia', 'acute lymphoblastic leukemia', 'non hodgkin s lymphoma']\n",
      "['giftanorgan youngindiansgao cll yibhopal organdonation']\n",
      "['cll society adaptive biotechnologies', 'fda clearance', 'clonoseq assay', 'monitor minimal', 'measurable residual disease mrd']\n",
      "['hot seat', 'experts address', 'challenging topics', 'mantlecelllymphoma patient care', 'prognosis frontline chemoimmunotherapy', 'novel agents', 'cme lymsm']\n",
      "['rt massivebio leuekemia patients', 'treatment options', 'chronic lymphocytic leukemia clinical trials', 'approval process', 'ai leukemiaawareness cll cl']\n",
      "['leuekemia patients', 'treatment options', 'chronic lymphocytic leukemia clinical trials', 'approval process', 'ai leukemiaawareness cll clinical trials']\n",
      "['rns aim cll cello health plc relevant securities']\n",
      "['different frontline treatment combinations', 'chronic lymphocytic leu leukemia']\n",
      "['new article exosomes', 'chronic lymphocytic leukaemia cells', 'mir 146a', 'mesenchymal stromal cells', 'fibroblasts cll leusm hematology']\n",
      "['clonoseq assay', 'monitor mrd', 'bone marrow', 'chronic lymphocytic leukemia leusm']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['clonoseq assay', 'monitor mrd', 'bone marrow', 'chronic lymphocytic leukemia fda leusm']\n",
      "['zanubrutinib treatment', 'unresponsive chronic lymphocytic']\n",
      "['rns aim cll cello health plc']\n",
      "['new cancer', 'cognitive impairment', 'chronic lymphocytic leukemia']\n",
      "['richter s transformation', 'case cll', 'purple population cd19 loss cd20 cd5 cd10', 'sig lcl', 'orange population cd19 cd20 cd5 het cd10 lambda restriction', 'nice cytological picture hemepath cytopath flowcytometry']\n",
      "['virtual moleculartumorboard', 'top tier institutions']\n",
      "['new article biomarkers', 'cryoglobulinemia patients withnon hodgkin lymphoma cll leusm hematology']\n",
      "['new article suppression', 'restore necroptotic pathway', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'therapeutic option', 'melanoma cll leusm hematology']\n",
      "['new article eq 5d', 'health state utility values', 'hematologic malignancies', 'systematic review cll leusm hematology']\n",
      "['new article', 'year findings', 'helios study', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll leusm hematology']\n",
      "['brian coffman mdcm fcfp dabfm ms', 'fda clearing', 'clonoseq assay', 'monitor mrd', 'bone marrow', 'cll leusm']\n",
      "['triplet combination', 'encouraging response rates', 'treatment na ve chronic lymphocytic leukemia leukemia leusm']\n",
      "['cll sessions', 'key cll updates', 'asco amp eha', 'demand w john gribben susan o brien amp barbara eichhorst click', 'hematology leukemia leusm oncoalert']\n",
      "['chronic lymphocytic leukemia']\n",
      "['year findings', 'helios study', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll leusm']\n",
      "['clonoseq assay', 'monitor minimal residual disease', 'bone marrow', 'chronic lymphocytic leukemia']\n",
      "['cll therapy', 'finite amp combination oral therapy faculty dr nitin jain usa']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['dose escalation', 'dose expansion study', 'zx 101a', 'hematologic malignancies status', 'condition summary non hodgkin lymphoma chronic lymphocytic leukemia', 'small lymphocytic']\n",
      "['concurrent chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'hairy cell leukemia clinical pathologic', 'lymphoma lymsm']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['cll oncology covid19 covid']\n",
      "['educational talk', 'dr arvind chaudhry', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['t shirt', 'wearamask bloodcancer leukaemia cll']\n",
      "['chronic lymphocytic leukemia', 'family clonoseq', 'assess mrd', 'cll mm', 'important info incl sample types amp test limitations']\n",
      "['chronic lymphocytic leukemia cll jul', 'burger cllsm leusm']\n",
      "['rns aim cll cello health plc court sanction']\n",
      "['clonoseq assay', 'monitor minimal residual disease', 'bone marrow', 'chronic lymphocytic leukemia leusm']\n",
      "['recent study', 'venetoclax monotherapy', 'refractory chronic lymphocytic leukemia']\n",
      "['rns aim cll cello health plc', 'additional block', 'ordinary shares']\n",
      "['adaptive biotechnologies', 'fda clearance', 'clonoseq assay', 'assess minimal residual disease mrd', 'chronic lymphocytic leukemia', 'media snippet']\n",
      "['new clinical trial dose escalation', 'dose expansion study', 'zx 101a', 'hematologic malignancies cll leusm hematology']\n",
      "['wide range', 'online training courses', 'common business', 'august t amp c s']\n",
      "['new article concurrent chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'hairy cell leukemia clinical pathologic', 'cll leusm hematology']\n",
      "['ptcma virtual cpd', 'chronic lymphocytic leukemia']\n",
      "['point mutations', 'chronic lymphocytic leukemia patients cll', 'timely detection', 'clinical outcomes', 'prevalent disease cancers biotech']\n",
      "['cell line model', 'pro survival effect', 'chronic lymphocytic leukemia']\n",
      "['hoy es el primer dia que comenze', 'mi marca que emocion cll']\n",
      "['mrd cll', 'mrd assessment', 'manage cll therapy', 'clinical trials']\n",
      "['new issue dual inhibitor', 'chronic lymphocytic leukemia patients leusm cancer thursdaythoughts']\n",
      "['mrd assay', 'chronic lymphocytic leukemia cll']\n",
      "['mrd assay', 'chronic lymphocytic leukemia fda leusm']\n",
      "['education credit', 'chronic lymphocytic leukemia patient management simulator']\n",
      "['triplet combination', 'encouraging response rates', 'treatment na ve chronic lymphocytic leukemia cllsm leusm']\n",
      "['scan results stochastic', 'ful resi ars gbp tifs anii fcrm maje mhpc cll cyan dsg rps nwt uvel sigc']\n",
      "['offering mrd', 'chronic lymphocytic leukemia cll pts', 'assess mrd', 'cll mm', 'important info incl sample types amp test limitations']\n",
      "['chronic lymphocytic leukemia', 'co founder', 'leusm patientpower ama']\n",
      "['video examples', 'treatment decisions', 'cll w kostas stamatopoulos', 'hematology eha25 hemonc oncoalert', 'eha25virtual leusm leukemia']\n",
      "['i m', 'work adaptive', 'clonoseq chronic lymphocytic leukemia cll clonoseq', 'indications cll b', 'multiple myeloma got2adapt']\n",
      "['own chronic lymphocytic leukemia cll expert dr richard furman', 'patient faqs', 'free webinar', 'register lymsm']\n",
      "['clonoseq assay', 'important advance', 'community got2adapt']\n",
      "['adaptive biotechnologies', 'fda clearance', 'clonoseq assay', 'assess minimal residual disease mrd', 'chronic lymphocytic leukemia']\n",
      "['line treatment', 'cll leukemia endcancer leusm']\n",
      "['covid19 pandemic']\n",
      "['network manager', 'cll network manager', 'cancer patients', 'email job org cllsm bcsm']\n",
      "['ptcma virtual cpd', 'chronic lymphocytic leukemia']\n",
      "['i m', 'fundamentals amp', 'cll amp', 'chart entry point look', 'macd crossover', '1st time']\n",
      "['chronic lymphocytic leukemia cll', 'clonoseq clonoseq', 'assess mrd', 'cll mm', 'important info incl sample types amp test limitations']\n",
      "['adaptive biotechnologies', 'fda clearance', 'clonoseq assay', 'assess minimal residual disease', 'chronic lymphocytic leukemia adpt']\n",
      "['adaptive biotechnologies', 'fda clearance', 'clonoseq assay', 'assess minimal residual disease mrd', 'chronic lymphocytic leukemia']\n",
      "['adpt adaptive biotechnologies', 'fda clearance', 'clonoseq assay', 'assess minimal residual disease', 'chronic lymphocytic leukemia']\n",
      "['cll society ash', 'dr paul barr', 'duration venetoclax ibrutinib', 'response rate', 'important indicator']\n",
      "['adpt adaptive biotechnologies', 'fda clearance', 'clonoseq assay', 'assess minimal residual disease mrd', 'chronic lymphocytic leukemia', 'huge news']\n",
      "['adpt adaptive biotechnologies', 'fda clearance', 'clonoseq assay', 'assess minimal residual disease mrd', 'chronic lymphocytic leukemia']\n",
      "['adaptive biotechnologies', 'fda clearance', 'clonoseq assay', 'assess minimal residual disease mrd', 'chronic lymphocytic leukemia']\n",
      "['adpt adaptive biotechnologies', 'fda clearance', 'clonoseq assay', 'assess minimal residual disease mrd', 'chronic lymphocytic leukemia']\n",
      "['adpt adaptive biotechnologies', 'fda clearance', 'clonoseq assay', 'assess minimal residual disease mrd', 'chronic lymphocytic leukemia']\n",
      "['manage patients', 'chronic lymphocytic leukemia dur hemasphere', 'excellent cooperation', 'world leukemia cll covid']\n",
      "['new clinical trial double', 'prospective phase iii study', 'primary infection prophylaxis', 'chronic lymphocytic leukemia', 'pro sid study cll leusm hematology']\n",
      "['new clinical trial cirmtuzumab consolidation', 'detectable cll', 'venetoclax cll leusm hematology']\n",
      "['clonal igh rearrangement', 'cll cll pitfalls', 'precise pathobiology', 'rational choice', 'mrd techniques', 'major importante hemepath']\n",
      "['new article', 'clonal igh rearrangement', 'cll pitfalls', 'cll leusm hematology']\n",
      "['new article hematological malignancies', 'abo blood group', 'teaching hospital varanasi india cll leusm hematology']\n",
      "['new article psychological distress', 'pandemic cll leusm hematology']\n",
      "['new article reply', 'hospital clinic', 'interim report analysis', 'hematological centers', 'cll commission', 'lombardy hematology network rel cll leusm hematology']\n",
      "['new article relation', 'neutrophil gelatinase', 'lipocalin overexpression', 'tumor b cells', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['chronic lymphocytic leukemia nejm']\n",
      "['manage patients', 'chronic lymphocytic leukemia cll', 'sars cov', 'covid19 pandemic eha cllsm leusm']\n",
      "['ibrutinib treatment', 'refractory chronic lymphocytic leukemia', 'final analysis', 'pivotal phase ib ii pcyc']\n",
      "['chronic lymphocytic leukemia nejm', 'excellent review', 'era novel therapies', 'jan burger']\n",
      "['great educational event', 'pts cll accessible online', 'august virtual seattle lymphoma workshop', 'lymphoma research foundation']\n",
      "[]\n",
      "['bullish list', 'pdz pnl cns mte grl eye rcn cll']\n",
      "['research endeavors', 'ni qub']\n",
      "['chronic lymphocytic leukemia nejm cll treatment nejm link']\n",
      "['new chronic lymphocytic leukemia btk inhibition program', 'great audience questions', 'don t', 'monday 11am est', 'virtual seat']\n",
      "['webinar tuesday', '1pmet cll cllsm register']\n",
      "['definitive review', 'important advances', 'common leukemia hematology treatment', 'chronic lymphocytic leukemia nejm']\n",
      "['august 5th', 'singer keyboardist george duke', 'frank zappa collaborator', 'clarke duke project', 'chronic lymphocytic leukemia', 'los angeles california', 'pop funk amp soul music']\n",
      "['george duke', 'chronic lymphocytic leukemia']\n",
      "['imo apto', 'right direction amp', 'therapeutic dose', '1st month amp']\n",
      "['george duke', 'chronic lymphocytic leukemia']\n",
      "['kinase inhibitors', 'b cell receptor', 'bcl2 b cell lymphoma', 'antagonist venetoclax', 'chronic lymphocytic leukemia cll treatment landscape hematologyoncology medstudenttwitter']\n",
      "['classic cll patients']\n",
      "['male breast involvement', 'chronic lymphocytic leukemia', 'case report', 'literature lymphoma lymsm']\n",
      "['new article', 'mechanistic model', 'minimal residual disease kinetics', 'venetoclax therapy', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article tumor lysis syndrome', 'achilles heel', 'cll cll leusm hematology']\n",
      "['new article quality', 'chronic lymphocytic leukemia', 'eortc qlq c30', 'qlq cll17 questionnaire cll leusm hematology']\n",
      "['new article male breast involvement', 'chronic lymphocytic leukemia', 'case report', 'literature cll leusm hematology']\n",
      "['new article genomic alterations', 'chronic lymphocytic leukemia', 'clinico hematological parameters', 'disease progression cll leusm hematology']\n",
      "['meld dig til temadag om h matologisk sygdom i aalborg hotelhvidehus d', 'se sp ndende program og vi gl der os til', 'se jer', 'aml apl cll cml cmml lymfekr ft f svarp sp rgsm l aalborguh blodkr ft blodcancer']\n",
      "['don t', 'cll sessions w john gribben susan o brien amp barbara eichhorst', 'demand hematology leukemia leusm oncoalert']\n",
      "['interesting data supports', 'own observation', 'continuous therapy', 'del 17p tp53', 'cll patients', 'leukemic cells', 'various agents btki venetoclax', 'cd20 antibodies lenalidomide', 'long term remissions']\n",
      "['good comprehensive review', 'jan burger', 'md anderson cancer center', 'cll leukemia leusm']\n",
      "['novel mitochondrial', 'internal trna', 'rna fragment possesses clinical utility', 'molecular prognostic biomarker', 'chronic lymphocytic leukemia']\n",
      "['health forum', 'i d', 'active member', 'universal worldview', 'members worldwide', 'chronic lymphocytic leukemia cll amp']\n",
      "['full text', 'bio link aspergillus fumigatus association', 'chronic lymphocytic leukemia increases leishmaniasis susceptibility']\n",
      "['chronic lymphocytic leukemia cll risk', 'multiple enhancer variants', 'cll risk loci']\n",
      "['macrophage inhibition', 'invasive fungal infection']\n",
      "['chronic lymphocytic leukemia article']\n",
      "['dr fl ch re fortin s presentation genomic evaluation', 'chronic lymphocytic leukemia', 'acgh snp platform', 'ngs cnv detection approach']\n",
      "['review article chronic lymphocytic leukemia']\n",
      "['novel mitochondrial', 'internal trna', 'rna fragment possesses clinical utility', 'molecular prognostic biomarker', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll jul', 'burger cllsm leusm']\n",
      "['trustee norah grant', 's programme', 'august cll leukaemia bloodcancerawareness charity']\n",
      "['chronic lymphocytic leukemia evidence expectations', 'future prospects lymphoma lymsm']\n",
      "['new article', 'novel mitochondrial', 'internal trna', 'rna fragment possesses clinical utility', 'molecular prognostic biomarker', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'undetectable sars cov', 'antibodies cll leusm hematology']\n",
      "['new article', 'clinical phenotype oncological associations', 'immunopathologic insights', 'paraneoplastic kelch', 'encephalitis cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia cll risk', 'multiple enhancer variants', 'cll risk loci cll leusm hematology']\n",
      "['new article venetoclax', 'chronic lymphocytic leukemia evidence expectations', 'future prospects cll leusm hematology']\n",
      "['new article microrna', 'inhibits proliferation', 'chronic lymphocytic leukaemia cells', 'bruton s tyrosine kinase phospholipase c', 'pathway cll leusm hematology']\n",
      "['pharmaceutical care program', 'chronic lymp']\n",
      "['cll sessions don t fret', 'entire event', 'john gribben susan o brien amp barbara eichhorst click', 'hematology leukemia leusm oncoalert']\n",
      "['highlight cll', 'school nervous time', 'vulnerable parents', 'covid risk']\n",
      "['online training courses', 'interactive tutor', 'august t amp c s', 'bsi cll']\n",
      "['patient groups', 'leukemia leukaemia aml', 'cll cml foreningen']\n",
      "['chronic lymphocytic leukemia nejm']\n",
      "['wld20 worldleukemiaday', 'patient groups', 'leukemia leukaemia aml', 'cll cml']\n",
      "['new special issue', 'chronic lymphocytic leukaemia guest', 'professor stephen opat lymphoma lymphocytic leukemia']\n",
      "['new zanubrutinib treatment', 'unresponsive chronic lymphocytic leukemia']\n",
      "['dr yan', 'chronic lymphocytic leukemia', 'couldn t']\n",
      "['optimal treatment options', 'chronic lymphocytic leukemia leukemia']\n",
      "['case study', 'humoral immunity therapy', 'covid19 coronavirus leusm jnccn360']\n",
      "['bruce g raphael md', 'chronic lymphocytic leukemia leusm']\n",
      "['primer d', 'el institut pasteur', 'con feliz ansiosa emocionada todas son correctas lovescience cll phd']\n",
      "['long term results support efficacy', 'ublituximab ibrutinib', 'high risk chronic lymphocytic leukemia cancer leusm medtwitter']\n",
      "['great review', 'nejm hematology lymphoma cll']\n",
      "['phone interview opportunity', 'chronic lymphocytic leukemia cll link', 'email melikanixon com']\n",
      "['dr hoffman', 'old man', 'chronic lymphocytic leukemia', 'virtual case', 'peer perspectives event leusm leukemias']\n",
      "['cll therapy', 'dr susan o brien', 'leusm cllsm register']\n",
      "['hdac1 regulates', 'chromatin landscape', 'transcriptional dependencies', 'chronic lymphocytic leukemia biorxiv']\n",
      "['great podcast discussion', 'amp dr richard furman re bruton s tyrosine kinase btk inhibitors', 'pts w chronic lymphocytic leukemia cll']\n",
      "['matthew davids md mmsc', 'anthony mato md msce', 'btk inhibitors', 'chronic lymphocytic leukemia register questions']\n",
      "['cll sessions webinar don t', 'exclusive broadcast w john gribben susan o brien amp barbara eichhorst', 'cll updates', 'asco amp eha register', 'hematology leusm']\n",
      "['rns aim cll cello health plc results', 'court meeting', 'general meeting']\n",
      "['course i m awake', 'thanks night sweats cll']\n",
      "['new article results', 'wide cohort study', 'term outcomes', 'immunotactoid glomerulopathy cll leusm hematology']\n",
      "['front line treatments', 'chronic lymphocytic leuk']\n",
      "['btk inhibitors', 'cll w florence cymbalista', 'hematology eha25 hemonc oncoalert', 'eha25virtual leusm leukemia']\n",
      "['chronic lymphocytic leukemia cll patients cll society']\n",
      "[]\n",
      "['goodbye boston', 'brilliant years', 'good friends', 'future collaborations', 'cll lymphoma amp immunotherapy research']\n",
      "['optimal treatment options', 'chronic lymphocytic leukemia leukemia']\n",
      "['chronic lymphocytic leukemia', 'such alterations', 'study patients', 'continuous ibrutinib', 'durable response']\n",
      "['chronic lymphocytic leukemia', 'tp53 alterations nejm']\n",
      "['rna editing contributes', 'epitranscriptome diversity', 'chronic lymphocytic leukemia']\n",
      "['optimal treatment options', 'chronic lymphocytic leukemia']\n",
      "['new article', 'reveals molecular heterogeneity', 'non cll clonal b cell lymphocytosis cll leusm hematology']\n",
      "['systematic review', 'meta analysis protocol treatment', 'tumor lysis syndrome', 'chronic lymphocytic leukemia protocol', 'systematic review', 'meta analysis']\n",
      "['recent publications']\n",
      "['cll sessions webinar', 'asco amp eha', 'don t', 'exclusive broadcast w john gribben susan o brien amp barbara eichhorst register', 'hematology leusm']\n",
      "['new england journal', 'medicine search results', 'hematology oncology gt gt', 'chronic lymphocytic leukemia', 'tp53 alterations']\n",
      "['interesting case examples', 'somatic hypermutation patterns', 'cll patients ngs cll hemepath molpath']\n",
      "['healthcare professionals', 'dr jennifer woyach', 'cll treatment innovation', 'webinar monday', 'noon click', 'free virtual event']\n",
      "['chronic lymphocytic leukemia cll patients cll society']\n",
      "['cllsociety covid', 'significant threat', 'cll community dr koffman', 'cll researchers', 'cll patients']\n",
      "['dr koffman s', 'long term', 'cd19 car t cell therapy', 'b cell lymphoma chronic lymphocytic leukemia cll']\n",
      "['james researchers', 'incredible breakthroughs', 'chronic lymphocytic leukemia life', 'free world']\n",
      "['new research resistance', 'chronic lymphocytic leukemia patients', 'novel agents inhibitors', 'b cell receptor', 'antagonist venetoclax']\n",
      "['cll i', 'frontline use', 'management strategies', 'unique ade profiles oncpharm']\n",
      "['undiacomohoy cll']\n",
      "['chronic lymphocytic leukemia cll']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['new article', 'real world outcomes', 'chronic lymphocytic leukemia', 'ibrutinib cll leusm hematology']\n",
      "['new article prognostic models', 'chronic lymphocytic leukaemia', 'systematic review', 'meta analysis cll leusm hematology']\n",
      "['new article 3d co culture model', 'chronic lymphocytic leukemia bone marrow microenvironment predicts patient', 'specific response', 'agents cll leusm hematology']\n",
      "['new article', 'nodal shrinkage', 'independent adverse outcome', 'ibrutinib therapy', 'chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['cochrane prognostic model systematic review shows', 'model development', 'external validation studies', 'prognostic models', 'cll cochrane prognostic model cll']\n",
      "['chronic lymphocytic leukemia cll ppt video online download']\n",
      "['cll sessions webinar don t', 'exclusive broadcast w john gribben susan o brien amp barbara eichhorst', 'cll updates', 'asco amp eha register', 'hematology leusm']\n",
      "['oncoalert chronic lymphocytic leukemia patients', 'igh translocations', 'distinct genetic landscape', 'prognostic implications p rez carretero', 'international journal', 'cancer lymsm cllsm leusm']\n",
      "['tatpremiers lead', 'foxmemorial whanau cll glenora rugby league football club est']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['thread chronic lymphocytic leukemia', 'cll patients', 'psuedo richter transformation']\n",
      "['cll sessions webinar', 'key cll updates', 'asco amp eha', 'don t', 'exclusive broadcast w john gribben susan o brien amp barbara eichhorst register', 'hematology leukemia leusm']\n",
      "['tuesday aug', '10am pt 1pm']\n",
      "['chronic lymphocytic leukemia therapeutics market analysis amp technological innovation', 'key players hoffmann', 'roche ltd abbvie inc teva pharmaceutical industries ltd johnson amp johnson services medic report']\n",
      "['clinical pearls amp morning reports chronic lymphocytic leukemia hematologyoncology medstudenttwitter']\n",
      "['chronic lymphocytic leukemia therapeutics market analysis amp technological innovation', 'key players hoffmann', 'roche ltd abbvie inc teva pharmaceutical industries ltd johnson amp johnson services medic report']\n",
      "['chronic lymphocytic leukemia', 'cll patients need', 'covid19 insights', 'leusm patientpower cancernews']\n",
      "['new longitudinal study shows treatment', 'patient s risk level']\n",
      "['pi3ki treatment', 'chronic lymphocytic leukemia cll nejm']\n",
      "['important milestone', 'cancer leukemia lymphoma cll']\n",
      "['new clinical trial study', 'apg2575 single agent', 'combination therapy', 'refractory cll sll cll leusm hematology']\n",
      "['new article rna editing contributes', 'epitranscriptome diversity', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['chronic lymphocytic leukemia patients', 'igh translocations', 'distinct genetic landscape', 'prognostic implications asturias publihuca hematology']\n",
      "['technical alerts boomer', 'setup pocket pivot non adx']\n",
      "['excellent review', 'dr burger', 'week treatment', 'chronic lymphocytic leukemia nejm md']\n",
      "['chronic lymphocytic leukemia therapeutics market analysis amp technological innovation', 'key players hoffmann', 'roche ltd abbvie inc teva pharmaceutical industries ltd johnson amp johnson services medic report']\n",
      "['scan results', 'pullback bullish', 'cll als so4 gpss fres aug ggp panr rai jan cvsg indv jesc tpou ukml cey']\n",
      "['scan results hammer candlestick', 'adam cll utlf afmc vnet zoo cpt blp sdvp oct amo', 'autg sens ukml cct']\n",
      "['risk factors', 'invasive fungal infection', 'cll patients leukemia cancer']\n",
      "['therapies w lydia scarf', 'hematology eha25 hemonc oncoalert', 'eha25virtual leusm leukemia']\n",
      "['rns aim cll cello health plc']\n",
      "['therapy efficacy post venetoclax failure', 'refractory chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia nejm']\n",
      "['chronic lymphocytic leukemia cll', 'common types', 'leukemia rt', 'cll care']\n",
      "['recent advances', 'treatments people', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'tp53 alterations nejm']\n",
      "['muscle pain', 'chronic lymphocytic leukemia treate']\n",
      "['online focus group', 'chronic lymphocytic leukemia']\n",
      "['cell secretome', 'supports survival', 'b chronic lymphocytic leukemia cells lymphoma lymsm']\n",
      "['vitamin d levels', 'non hodgkin lymphoma diffuse', 'large b cell lymphoma chronic lymphocytic leukemia', 'multiple myeloma lymphoma lymsm']\n",
      "['new article ibrutinib', 'chronic lymphocytic leukemia', 'tp53 alterations cll leusm hematology']\n",
      "['new article treatment', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article tensor decomposition', 'relational constraints', 'multiple types', 'microrna disease associations cll leusm hematology']\n",
      "['new article promoter dna methylation frequency', 'clinicopathological role', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article bdnf', 'cell secretome', 'supports survival', 'b chronic lymphocytic leukemia cells cll leusm hematology']\n",
      "['new article vitamin d levels', 'non hodgkin lymphoma diffuse', 'large b cell lymphoma chronic lymphocytic leukemia', 'multiple myeloma mmsm multiplemyeloma hematology']\n",
      "['chronic lymphocytic leukemia', 'tp53 alterations nejm']\n",
      "['chronic lymphocytic leukemia therapeutics market analysis amp technological innovation', 'key players hoffmann', 'roche ltd abbvie inc teva pharmaceutical industries ltd johnson amp johnson services medic report']\n",
      "['online training courses', 'interactive tutor', 'expertise browse', 't amp c s']\n",
      "['tatpremiers v glenorabears', 'home ground saturday foxmemorial bethere tatproud whanau cll harold moody park']\n",
      "['chronic lymphocytic leukemia nejm', 'drug exposure']\n",
      "['chronic lymphocytic leukemia nejm']\n",
      "['review article', 'chronic lymphocytic leukemia', 'cll leusm oncology oncopharm']\n",
      "['comprehensive piece', 'zainal nzr j14']\n",
      "['chronic lymphocytic leukemia nejm']\n",
      "['chronic lymphocytic leukemia', 'cll patients need', 'covid19 insights', 'leusm patientpower']\n",
      "['patient age', 'transaminase elevation', 'cll patients', 'idelalisib lymsm cll']\n",
      "['s educatedpatient webinar', 'chronic lymphocytic leukemia', 'dr kerry rogers', 'dr danielle brander', 'jill vershel ms pa c']\n",
      "['line treatment setting', 'cll results', 'significant cost savings', 'line regimens']\n",
      "['new atrial fibrillation', 'side effect', 'ibrutinib treatment']\n",
      "['chronic lymphocytic leukemia']\n",
      "['titanic cancer cll leukemia mask', 'super spreaders socialdistance']\n",
      "['open clinicaltrial', 'dose escalation', 'cohort expansion study', 'hematological malignancies pi philip thompson', 'leukemia nct03833180 endcancer leusm aml']\n",
      "['gt duvelisib', 'resistant chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll']\n",
      "['rns aim cll cello health plc']\n",
      "['chronic lymphocytic leukemia patients', 'igh translocations', 'distinct genetic landscape', 'prognostic implications']\n",
      "['new article highlights', 'chronic lymphocytic leukemia', 'american society', 'clinical oncology', 'annual meeting commentary cll leusm hematology']\n",
      "['new article highlights', 'chronic lymphocytic leukemia', 'american society', 'clinical oncology', 'annual meeting cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia patients', 'igh translocations', 'distinct genetic landscape', 'prognostic implications cll leusm hematology']\n",
      "['new article', 'low humoral immune response', 'ineffective clearance', 'sars cov', 'cll leusm hematology']\n",
      "['new article correction epidemiology', 'bloodstream infections', 'chronic lymphocytic leukemia', 'longitudinal nation', 'wide cohort study cll leusm hematology']\n",
      "['new article', 'recent advances', 'chronic lymphocytic leukemia therapy cll leusm hematology']\n",
      "['cll management webinar', 'youtube channel cll']\n",
      "['cll sessions expert discussions', 'cll updates', 'asco amp eha', 'exclusive broadcast w john gribben susan o brien amp barbara eichhorst', 'august 5pm cest don t', 'hematology leukemia leusm']\n",
      "['effective vaccine strategies', 'high risk', 'infection jul', 'leusm cllsm idonc']\n",
      "['improvement immunization', 'pts w monoclonal b cell lymphocytosis', 'cll jul', 'leusm cllsm idonc']\n",
      "['hematology abstract blitz months', 'final week cll james']\n",
      "['interesting paper', 'potential role', 'endogenous retrovirus sequences', 'ugt2b17 overexpression', 'b cells ty', 'lab s work', 'group s work']\n",
      "['atypical morphology', 'dr haitham khogeer cll']\n",
      "['dr haitham khogeer cll ssbd']\n",
      "['real world', 'challenging cll cases', 'dr riad el fakih cll']\n",
      "['ibrutinib dr mervet mattar cll']\n",
      "['challenging cll cases session dr mervat mattar cll']\n",
      "['uk cll treatment algorithm', 'dr peter hillmen cll']\n",
      "['cll management', 'dr hillmen cll ssbd']\n",
      "['dr hillmen talk cll']\n",
      "['cll ssbd']\n",
      "['cll patient s risk', 'questions friday', 'expert researcher', 'cll patient', 'cllsm cll covid19']\n",
      "['cll webinar', 'pm eastern', 'pm ct']\n",
      "['btk inhibitor treatment', 'chronic lymphocytic leukemia', 'expert panel', 'identify key factors', 'cll register']\n",
      "['mind blog certification mark protectability certificationmark ttab trademark cll distillingindustry spiritsindustry']\n",
      "['chronic lymphocytic leukemia']\n",
      "['rns aim cll cello health plc notification', 'major holdings']\n",
      "['don t', 'p m', 'lymphoma experts', 'relevant information', 'chronic lymphocytic leukemia register']\n",
      "['new clinical trial', 'long term', 'clbr001 car t cll leusm hematology']\n",
      "['new article determination', 'cd200 surface expression improves accuracy', 'b cell lymphoma', 'cll leusm hematology']\n",
      "['new article development', 'analytical method', 'aqbd principles cll leusm hematology']\n",
      "['new article monoclonal gammopathy', 'serum immunoglobulin levels', 'prognostic factors', 'chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['new article antihistamines', 'bruton s tyrosine kinase inhibiter ibrutinib', 'lysosome disruption', 'chronic lymphocytic leukemia cll cells cll leusm hematology']\n",
      "['new article clinical course', 'risk factors', 'haematological malignancies cll leusm hematology']\n",
      "['new article blockade', 'immune checkpoints', 'cd8 t cells', 'early clinical stages', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article hdac7', 'actionable driver', 'therapeutic antibody resistance', 'cll patients cll leusm hematology']\n",
      "['new article occupational exposure', 'chronic lymphocytic leukaemia', 'mcc spain study cll leusm hematology']\n",
      "['new article enhancement', 'lignin extraction', 'deep eutectic solvent', 'low halogen content cll leusm hematology']\n",
      "['new article chemokine receptors ccr1', 'peripheral blood mononuclear cells', 'positive chronic lymphocytic leukemia cll leusm hematology']\n",
      "['chronic lymphocytic leukemia market']\n",
      "['video prevalence', 'ibrutinib w paolo ghia', 'hematology eha25 hemonc oncoalert', 'eha25virtual leusm leukemia ctsm']\n",
      "['dr danilov', 'old woman', 'refractory chronic lymphocytic leukemia', 'virtual case', 'peer perspectives event leukemia']\n",
      "['clinical updates', 'chronic lymphocytic leukemia', 'mitigation strategies', 'minimize aes', 'novel therapies amp']\n",
      "['summer cll']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['dr hoffman', 'old ma', 'chronic lymphocytic leukemia', 'virtual case', 'peer perspectives event leusm']\n",
      "['dna methylation profiles', 'chronic lymphocytic leukemia patients']\n",
      "['new article differential roles', 'mir 15a', 'immune cell development', 'homeostasis cll leusm hematology']\n",
      "['new article', 'cancer incidence', 'cll patients', 'btk inhibitors cll leusm hematology']\n",
      "['cll patients']\n",
      "['partner genentech allege', 'dr reddy s', 'new drug application', 'generic version', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma drug venclexta violates']\n",
      "['rns aim cll cello health plc']\n",
      "['mdpijcm specialissue advances', 'chronic lymphocytic leukemia submit']\n",
      "['ace cl']\n",
      "['long term outcomes', 'car t cells treatment', 'unresponsive chronic lymphocytic leukemia medivizor']\n",
      "['john gribben md dsc', 'treatment na ve patients', 'chronic lymphocytic leukemia leusm']\n",
      "['minute medscapeedu video', 'data amp recommendations', 'bruton tyrosine kinase btk inhibitors', 'patients w chronic lymphocytic leukemia', 'w drs jeff sharman']\n",
      "['survey cll society', 'critical tests', 'certain medications']\n",
      "['dr sharman reviews', 'old man', 'chronic lymphocytic leukemia leukemia leusm']\n",
      "['atrial fibrillation', 'side effect', 'ibrutinib treatment', 'patients wi']\n",
      "['patient influencer amp cll', 'i need', 'patientadvocate leukemia']\n",
      "['video cll14 trial obinutuzumab venetoclax vs obinutuzumab chlorambucil w othman', 'hematology eha25 hemonc leusm oncoalert', 'eha25virtual cll immunoonc luekemia ctsm']\n",
      "['interesting study', 'cll patient', 'cartcell products', 't cell differentiation', 't cells', 'cart cell expansion']\n",
      "['positive opinion', 'imbruvica ibrutinib', 'chroniclymphocyticleukaemia cll jnj']\n",
      "['full time', 'jackcolvinpark oats', 'foxmemorial tatproud tatpremiers otahuhuleopards whanau veisarikid cll jack colvin park']\n",
      "['front line treatments', 'chronic lymphocytic']\n",
      "['leukemia treatment breakthroughs', 'chronic lymphocytic leukemia']\n",
      "['discussion topics', 'panel faculty', 'cure s', 'patient webinar', 'chronic lymphocytic leukemia']\n",
      "['otahuhuleopards visitors', 'facilities whanau veisarikid cll te atatu roosters']\n",
      "['high throughput analysis', 't cell receptor gene repertoire', 'monoclonal b cell lymphocytosis mbl reveals', 'distinct profile', 'chronic lymphocytic leukemia cll jan', 'leusm cllsm lymsm']\n",
      "['monoclonal b cell lymphocytosis mbl', 'early stage chronic lymphocytic cll leukemia diagnosis', 'natural history', 'risk stratification jun', 'strati amp shanafelt leusm cllsm lymsm']\n",
      "['tireless work', 'patient advocacy groups', 'critical information', 'lymphoma patients', 'ceo lorna warwick']\n",
      "['american society', 'annual meeting practice', 'treatment na ve chronic lymphocytic leukemia hematology']\n",
      "['anthony mato md msce', 'brian koffman mdcm dcfp fcfp dabfp', 'cll management register']\n",
      "['ema chmp', 'positive opinion', 'imbruvica ibrutinib', 'chronic lymphocytic leukemia imbruvica worldwide sales']\n",
      "['video jenn shares', 'chronic lymphocytic leukemia']\n",
      "['car chimeric antigen receptor t cell production', 'chronic lymphocytic leukemia patients']\n",
      "['uk cll forum guidance', 'post lockdown period', 'uk covid19 cll']\n",
      "['clinical trial data', 'small molecule therapies', 'chronic lymphocytic leukemia cll review activty medscapeedu w dr jennifer']\n",
      "['new article', 'persistent covid', 'remdesivir therapy cll leusm hematology']\n",
      "['new article', 'lrp2 nephropathy', 'concurrent kidney infiltration', 'lymphoma cll leusm hematology']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['new article', 'recurrent chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article meta analysis reveals', 'significant sex differences', 'chronic lymphocytic leukemia progression', 'e tcl1 transgenic mouse model cll leusm hematology']\n",
      "['day i ll', 'acute lymphoblastic leukaemia', 'acute myeloid leukemia chronic lymphocytic leukaemia amp chronic myeloid leukaemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['otahuhuleopards saturday', '45pm bethere tatproud whanau veisarikid cll foxmemorial jack colvin']\n",
      "['pre zoom', 'amazing mentor']\n",
      "['bendamustine ofatumumab', 'ibrutinib treatment', 'chronic lymphocytic leukemia w']\n",
      "['new article cryolipolysis cll', 'fat review', 'analysis cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia', 'pituitary stalk', 'cll leusm hematology']\n",
      "['new research', 'autophagy protein lc3', 'chronic lymphocytic leukemia chronic lymphocytic leukemia cll', 'common type', 'adult leukemia', 'western hemisphere', 'endocrinology endo']\n",
      "['cannabis industry insight u s trademark registrations', 'dietary supplements', 'cbd trademark cannabisindustry cbd cll']\n",
      "['risk factors', 'transaminase elevation', 'chronic lymphocytic leukemia', 'idelalisib leukemia']\n",
      "['pleural empyema', 'rare infection', 'cll jnccn360 leusm']\n",
      "['drug treatment', 'complete responses', 'high risk chronic lymphocytic leukemia']\n",
      "['zanubrutinib treatment', 'unresponsive chronic lymphocytic leukemia']\n",
      "['basic lands', 'base prizes', 'mtgcll mtgo mtglegacy cll']\n",
      "['novel drugs', 'chronic lymphocytic leukemia', 'states lymphoma lymsm']\n",
      "['bsi s', 'bsiph cll']\n",
      "['treatment response', 'cll leusm jnccn360']\n",
      "['dr dressler', 'blood cancer', 'dog cancer answers chronic lymphocytic leukemia', 'favorite podcast app']\n",
      "['international group', 'covid19 pts']\n",
      "['cll management webinar', 'free registration cll']\n",
      "['video btk', 'plcg2 mutations', 'cll patients', 'ibrutinib w lydia scarf', 'hematology eha25 hemonc leusm oncoalert', 'eha25virtual leukemia']\n",
      "['chronic lymphocytic leukemia cll need', 'coronavirus cll expert dr coutre', 'current global pandemic']\n",
      "['est buscando un curso', 'capacitaci n online', 'est ndares iso conozca y descargue', 'para elegir', 'mejor opci n', 'cursos online que bsi como experto', 'elaborado solicite m s informaci n cll', 'bsim xico']\n",
      "['chronic lymphocytic leukemia shares', 'colleague marie', 'personal passion', 'new ways', 'fit right']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['novel drugs', 'chronic lymphocytic leukemia']\n",
      "['global coronavirus pandemic', 'bsiuk cll']\n",
      "['new article comparison', 'novel drugs', 'chronic lymphocytic leukemia', 'states mmsm multiplemyeloma hematology']\n",
      "['herbal drugs', 'cancer patient cells saarumsciences herbalmedicines cancer biotech pharmaceuticals nutraceuticals patientprimarycells 3dculture', 'plantextracts neurosphere mammosphere aml cll']\n",
      "['special cll event', 'international guests', 'prof matt davids dana farber cancer institute usa amp dr brian koffman founder cll society usa cll patient doctor register']\n",
      "['weekend v otahuhuleopards', 'foxmemorial game saturday', 'ways cll veisarikid whanau']\n",
      "['i don t', 'leukaemia bloodcancer cll royalmarsden cancercarer']\n",
      "['excellent collaborative', 'international effort', 'covid19 pts cfr', 'pts tx w btki', 'drug interruption epub', 'glad 2b part']\n",
      "['ibrutinib resistance', 'chronic lymphocytic leukemia', 'alternative treatment strategies expert review', 'hematology vol', 'ja leusm cll']\n",
      "['cll patients', 'reports mrd s importance', 'cll treatment cll mrd chroniclymphocyticleukemia']\n",
      "['international multicenter study', 'cll pts']\n",
      "['ibrutinib ublituximab combo', 'cll cll chroniclymphocyticleukemia leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['pharmaceutical care program', 'chronic lymphocytic leukemia']\n",
      "['bus aim cll millennium partners l p form', 'cello health plc']\n",
      "['magazine webinar']\n",
      "['nicole lamanna md', 'cll hematology hemonc cme ce']\n",
      "['patient webinar', 'chronic lymphocytic leukemia', 'p m']\n",
      "['rns aim cll cello health plc block', 'update amp total']\n",
      "['new article maltotriose', 'propylene imine glycodendrimers', 'potential novel platform', 'chronic lymphocytic leukemia', 'concept pilot study', 'animal model', 'cll cll leusm hematology']\n",
      "['new article incidence', 'prognostic significance', 'serum immunoglobulins', 'chronic lymphocytic leukaemia', 'valuable piece', 'cll leusm hematology']\n",
      "['new article antimicrobial use', 'chronic lymphocytic leukemia', 'retrospective cohort study cll leusm hematology']\n",
      "['new article atypical spindle cell lipomatous lesion', 'cll cll leusm hematology']\n",
      "['collaborative effort']\n",
      "['antimicrobial use', 'chronic lymphocytic leukemia', 'retrospective cohort study leukemia cancer epidemiology']\n",
      "['international series', 'cll pts', 'specific series', 'date inpt crf age cirs ckd indep rfs', 'clear protective btki effect', 'diagnosis equiv os w w vs pre rx']\n",
      "['tgtx phase', 'chronic lymphocytic leukemia', 'therapy nct02742090', 'primary completion date']\n",
      "['chimeric antigen receptor t cell production', 'chronic lymphocytic leukemia patients lymphoma lymsm']\n",
      "['rns aim cll cello health plc']\n",
      "['duration regimen', 'superior efficacy', 'deep responses', 'chronic lymphocytic leukemia', 'obinutuzumab asco20 leusm']\n",
      "['active treatment', 'w amp w', 'high mortality', 'international collaboration']\n",
      "['case report treatment emergent tumor lysis syndrome', 'pi3k inhibition', 'car t cell therapy', 'chronic lymphocytic leukemia jcoop leusm']\n",
      "['dr sharman reviews', 'old man', 'chronic lymphocytic leukemia leusm']\n",
      "['market leaders', 'new data', 'multiple venclexta combinations genentech abbvie gazyva venclexta obinutuzumab venetoclaz tablets leukemia cll oncology q1 q12020 leukemiamarket newdata dtwmarkethighlight']\n",
      "['patient chronic lymphocytic leukemia webinar', 'patients caregivers']\n",
      "['glenn sabin', 'radicalremission survivor', 'chronic lymphocytic leukemia cll', 'early age', 'own treatment', 'own words']\n",
      "['kenneth research', 'global leukemia treatment market', 'disease type chronic myelogenous leukemia chronic lymphocytic leukemia', 'acute lymphoblastic leukemia', 'acute myeloid leukemia', 'drug class', 'small molecule']\n",
      "['new clinical trial', 'acute myeloid leukemia cll leusm hematology']\n",
      "['bus aim cll millennium partners l p form', 'cello health plc']\n",
      "['cody steeves pharmd bcop', 'community physicians', 'chronic lymphocytic leukemia cll', 'panel discussion']\n",
      "['old man', 'chronic lymphocytic leukemia']\n",
      "['chimeric antigen receptor t cell production', 'chronic lymphocytic leukemia patients']\n",
      "['educatedpatient cll', 'patientresources chroniclymphocyticleukemia']\n",
      "['new article ibrutinib', 'chimeric antigen receptor t cell production', 'chronic lymphocytic leukemia patients dlbcl lymsm hematology']\n",
      "['online training', 'traditional classroom', 'virtual learning']\n",
      "['new atrial fibrillation', 'side effect', 'ibrutinib treatment']\n",
      "['pharmaceutical care program', 'chronic lymph']\n",
      "['chronic lymphocytic leukemia', 'drs john m burke amp manuel', 'santiago gt gt cme']\n",
      "['dr nancy torres tle', 'nurse sharon', 'dr clive zent s outpatient clinic', 'lymphoma hematology oncology']\n",
      "['initial findings', 'triplet therapy', 'chronic lymphocytic leukemia medtwitter sundaythoughts']\n",
      "['intracytoplasmic crystalline inclusions', 'chronic lymphocytic leukemia cll ramlal']\n",
      "['new article delineation', 'biological factors', 'cutaneous squamous cell carcinoma amongst chronic lymphocytic leukemia patients cll leusm hematology']\n",
      "['new article mnda', 'chronic lymphocytic leukemia cells cll leusm hematology']\n",
      "['new article', 'curable entity', 'chaotic covid', 'pandemic cll leusm hematology']\n",
      "['uk saveourshielders campaign', 'financial support', 'mp bloodcancerawareness cll']\n",
      "['research lab', 'future amp', 'viable treatment option', 'chronic lymphocytic leukemia amp', 'doesn t']\n",
      "['cll asco20']\n",
      "['pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line', 'autophagic flux']\n",
      "['paper studies', 'acute myelogenous leukemia aml', 'acute lymphocytic leukemia', 'chronic myelogenous leukemia cml', 'chronic lymphocytic leukemia cll']\n",
      "['car t cell therapy', 'b cell non hodgkin lymphoma', 'chronic lymphocytic leukemia clinical trials', 'real world experiences lymphoma lymsm']\n",
      "['chronic lymphocytic leukemia causes picture symptoms treatment']\n",
      "['howick score', 'full time tatreserves', 'tatproud whanau veisarikid cll graememurdoch paparoa park home', 'howick hornets']\n",
      "['heme lecture', 'smudge cells', 'basket cells chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukemia']\n",
      "['i wake', 'cll cancer night sweats i']\n",
      "['front line treatments', 'chronic lymphocyti']\n",
      "['expert pharmacists', 'community physicians', 'chronic lymphocytic leukemia cll']\n",
      "['trademark law', 'alert lady', 'interesting issues', 'trademark recordingindustry musicindustry cll']\n",
      "['early stage chronic lymphocytic leukemia', 'ighv genes', 'absolute lymphocyte', 'palpable lymph nodes leusm']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['new article mechanisms', 'ibrutinib resistance', 'chronic lymphocytic leukemia', 'alternative treatment strategies cll leusm hematology']\n",
      "['new article resistance', 'chronic lymphocytic leukemia patients', 'novel agents cll leusm hematology']\n",
      "['new article', 'successful outcomes', 'severe covid', 'chronic lymphocytic leukemia diagnostic', 'hosts cll leusm hematology']\n",
      "['new article management', 'chronic lymphocytic leukemia', 'coronavirus pandemic cll leusm hematology']\n",
      "['new article pd', 'malignant melanoma', 'clinical response', 'chronic lymphocytic leukemia', 'case series cll leusm hematology']\n",
      "['new article car t cell therapy', 'b cell non hodgkin lymphoma', 'chronic lymphocytic leukemia clinical trials', 'real world experiences mmsm multiplemyeloma hematology']\n",
      "['video patients', 'partial response', 'venetoclax obinutuzumab w othman', 'hematology eha25 hemonc oncoalert', 'eha25virtual ctsm immunoonc leusm']\n",
      "['chronic lymphocytic leukemia', 'e tcl1 transgenic mice lymphoma lymsm']\n",
      "['suppression enhances t cell antitumor immunity', 'checkpoint blockade', 'chronic lymphocytic leukemia biorxiv immuno']\n",
      "['suppression enhances t cell antitumor immunity', 'checkpoint blockade', 'chronic lymphocytic leukemia biorxiv']\n",
      "['car t cell therapy', 'b cell non hodgkin lymphoma', 'chronic lymphocytic leukemia clinical trials', 'real world experiences lympsm leusm cartcell cellrx']\n",
      "['long term outcomes', 'car t cells treatment', 'unresponsive chronic l']\n",
      "['pharmaceutical care program', 'chronic lymphocyti']\n",
      "['fda grants orphan drug designation', 'oncternal therapeutics', 'chronic lymphocytic leukemia', 'mantle cell lymphoma chroniclymphocyticleukemia cll mantlecelllymphoma mcl raredisease']\n",
      "['exclusive video video md discusses', 'ascend trials', 'chronic lymphocytic leukemia', 'virtual asco20 cll leuksm']\n",
      "['autoimmune manifestations', 'chronic lymphocytic leukemia cll', 'trav s']\n",
      "['rns aim cll cello health plc form', 'cello health plc']\n",
      "['cll treatment', 'dr steven coutre', 'treatment plan', 'leusm btkinhibitor cartcell cllsm']\n",
      "['current study', 'chroniclymphocyticleukemia cll register', 'paidresearch patientvoice joinourdatabase']\n",
      "['common type', 'year share']\n",
      "['chronic lymphocytic leukemia', 'e tcl1 transgenic mice']\n",
      "['video jacob soumerai md', 'initial findings', 'phase ii study', 'virtual asco20', 'chronic lymphocytic leukemia cll leuksm']\n",
      "['new article cd74', 'chronic lymphocytic leukemia', 'e tcl1 transgenic mice cll leusm hematology']\n",
      "['new article covid', 'chronic lymphocytic leukaemia', 'pseudohypoxemia cll leusm hematology']\n",
      "['new article aspartic aminopeptidase', 'novel biomarker', 'aggressive chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'immune checkpoint inhibitors', 'chronic lymphocytic leukemia cll', 'systematic review', 'meta analysis', 'trials cll leusm hematology']\n",
      "['atrial fibrillation', 'side effect', 'ibrutinib treatment', 'patients wit']\n",
      "['antagonist shows preclinical efficacy', 'chronic lymphocytic leukemia']\n",
      "['cousin katelyn', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'treatment costs', 'gofundme page']\n",
      "['paparoa park howick foxmemorial game bethere whanau cll veisarikid paparoa park home', 'howick hornets']\n",
      "['irish time', 'interesting online event', 'cll survivors', 'car t treatment experience']\n",
      "['husband s oncology appointment', 'exhale cll']\n",
      "['amp discusses', 'line treatments', 'chronic lymphocytic leukemia patients']\n",
      "['easy task', 'foxmemorial whanau veisarikid cll graememurdoch']\n",
      "['administration sequence', 'toxicity jnccn360 leusm']\n",
      "['cll society', 'dr brian koffman s', 'durable responses', 'pi3k inhibitor', 'intermittent schedule', 'refractory follicular lymphoma amp']\n",
      "['chronic lymphocytic leukemia', 'cll dinner', 'docs series', 'local conversation', 'cancer patients docs', 'caregivers leusm']\n",
      "['cll society', 'dr brian koffman s', 'pfs orr', 'mrd negativity', 'high risk cl']\n",
      "['rns aim cll cello health plc update re antitrust clearances']\n",
      "['susan o brien university', 'california irvine']\n",
      "['rns aim cll cello health plc']\n",
      "['new article detection', 'somatic tp53 mutations', '17p deletions', 'chronic lymphocytic leukemia', 'current methods cll leusm hematology']\n",
      "['cll jsoulbrothers']\n",
      "['chronic lymphocytic leukemia cll abnormal numbers', 'mature lymphocytes predominate', 'marrow lymph nodes', 'spleen pathology']\n",
      "['cll society', 'dr brian koffman s', 'premature venetoclax interruption', 'refractory cll p']\n",
      "['new research front line therapy', 'elderly chronic lymphocytic leukemia patients bendamustine', 'real life retrospective multicenter study', 'lazio region', 'previous studies']\n",
      "['allogeneic transplant', 'chronic lymphocytic leukemia', 'historical experience rituximab improves nonmyeloablative allogeneic hsct transplant', 'cll cbci']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['litigation law', 'alert u s', 'supreme court rules', 'u s', 'supreme court', 'scotus trademarks cll']\n",
      "['chronic lymphocytic leukemia', 'cll dinner', 'docs series', 'local conversation', 'cancer patients docs', 'caregivers leusm']\n",
      "['dual inhibitor', 'cll patients']\n",
      "['rns aim cll cello health plc form', 'cello health plc']\n",
      "['minute medscapeedu video', 'data amp recommendations', 'bruton tyrosine kinase btk inhibitors', 'patients w chronic lymphocytic leukemia', 'w drs jeff sharman']\n",
      "['new article efficacy', 'high dose corticosteroid', 'chronic lymphocytic leukemia patients', 'p53 abnormalities', 'b cell receptor inhibitors cll leusm hematology']\n",
      "['new article carbon isotope ratio', 'leaf litter correlates', 'litter production', 'mangrove ecosystem', 'china cll leusm hematology']\n",
      "['new article chromatin network markers', 'leukemia cll leusm hematology']\n",
      "['new article risk factors', 'transaminase elevation', 'chronic lymphocytic leukemia', 'idelalisib cll leusm hematology']\n",
      "['rns aim cll cello health plc']\n",
      "['rns aim cll cello health plc']\n",
      "['pharmaceutical care program', 'chronic leukemia']\n",
      "['cll society', 'dr brian koffman s', 'initial results', 'zanubrutinib obinutuzumab']\n",
      "['cll society', 'dr brian koffman s', 'clinical activity', 'ror1 antibody cirmtuzumab']\n",
      "['duvelisib pi3k g d', 'covid19 sars cov2 therapeutic', 'separate trial', 'trial cancer lymphoma leukemia cll sll fl ptcl']\n",
      "['community oncology program', 'central newjersey patient', 'educational program dinnerwiththedocs patientpower']\n",
      "['chronic lymphocytic leukemia', 'central newjersey', 'cll dinner', 'docs series', 'local conversation', 'cancer patients docs', 'caregivers leusm']\n",
      "['rise cll']\n",
      "['utilize btk inhibitors', 'cll treatment', 'cme video', 'panel discussions', 'therapy selection safety', 'treatment continuum']\n",
      "['initial findings', 'triplet therapy', 'chronic lymphocytic leukemia medtwitter mondaythoughts']\n",
      "['pharmaceutical care program', 'chronic lymphocytic leu']\n",
      "['amazing team', 'pi3k ck1 inhibitor', 'trial chronic lymphocytic leukemia cll therapy', 'preserves treg number amp function check', 'visual abstract amp paper']\n",
      "['bus aim cll millennium partners l p form', 'cello health plc']\n",
      "['invitation til temadag', 'meget sp ndende opl g og', 'efterfulgt af', 'i lyle dk i aalborguh hvidehus kom og v r', 'p lyle dk blodkr ft blodcancer h matologi aml', 'apl cml cll mds lymfekr ft']\n",
      "['cll society', 'dr brian koffman s', 'cll patients', 'veterans health administration']\n",
      "['5th case series reports', 'similar high death rate', 'bloodcancer patients covid19', 'severe covid19', 'cll leukemia lymphoma']\n",
      "['new article primary merkel cell carcinoma', 'retrospective analysis', 'poland cll leusm hematology']\n",
      "['new article refractory', 'chronic lymphocytic leukemia', 'pathway inhibitors', 'allogeneic stem cell transplantation cll leusm hematology']\n",
      "['bus aim cll barclays plc form', 'cello health plc']\n",
      "['optimal treatment options', 'chronic lymphocytic leukemia']\n",
      "['herbal drugs', 'cancer patient cells sapienbiosciences herbalmedicines cancer biotech pharmaceuticals nutraceuticals patientprimarycells 3dculture', 'plantextracts neurosphere mammosphere aml cll']\n",
      "['rns aim cll cello health plc']\n",
      "['rns aim cll cello health plc publication', 'scheme document']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['car nk', 'cll cll']\n",
      "['official result', 'tatpremiers v richmondrovers', 'saturday s foxmemorial game tatproud tatpremiers cll whanau veisarikid aquatechnics upthemightyroosters richmond bulldogs grey lynn park']\n",
      "['platelet function', 'mantle cell lymphoma patients', 'ibrutinib hematology']\n",
      "['dr davids', 'long term', 'chronic lymphocytic leukemia', 'mantle cell lymphoma lymphomas hematology']\n",
      "['richter transformation', 'recent analysis', 'fl chemotherapy', 'chemo immunotherapy os', 'rt cohort possibility apto s', 'flt3 inh']\n",
      "['interesting event', 'car t stories']\n",
      "['richter transformation', 'chronic lymphocytic leukemia', 'novel agents lymphoma lymsm']\n",
      "['plesiomonas shigelloides gastroenteritis', 'chronic lymphocytic leukemia cll leusm endcancer']\n",
      "['line treatment', 'cll amp leusm endcancer']\n",
      "['trial hla', 'cd19 car nk cells', 'cord blood', 'refractory cd19', 'positive cancers non hodgkin s lymphoma', 'chronic lymphocytic leukemia cll']\n",
      "['new scarf l', 'leukemia covid', 'chronic lymphocytic leukemia', 'joint study', 'european research initiative', 'cll campus']\n",
      "['different frontline treatment combinations', 'chronic lymp leukemia']\n",
      "['rapid emergence', 'chronic lymphocytic leukemia', 'jak2 inhibitor therapy']\n",
      "['btk inhibitors', 'monoclonal antibodies', 'chronic lymphocytic leukemia leusm']\n",
      "['new article richter transformation', 'chronic lymphocytic leukemia', 'novel agents cll leusm hematology']\n",
      "['new article', 'rapid emergence', 'chronic lymphocytic leukemia', 'jak2 inhibitor therapy', 'myelofibrosis cll leusm hematology']\n",
      "['new article covid', 'chronic lymphocytic leukemia', 'joint study', 'european research initiative', 'cll campus cll leusm hematology']\n",
      "['new article', 'degradation pathways', 'stress conditions cll leusm hematology']\n",
      "['drug administration approvals', 'bruton tyrosine kinase inhibitors', 'chronic lymphocytic leukemia potential inefficiencies', 'trial design', 'evidence generation lymphoma lymsm']\n",
      "['foxmemorial game tatproud tatpremiers cll', 'western leader richmond bulldogs grey lynn park']\n",
      "['nj cll patients', 'exclusive virtual dinners w amp docs', 'ubereats gift card', 'nosh amp', 'experts amp fellow patients', 'cll register powerfulpatients patientpower']\n",
      "['scan results', 'pullback bullish', 'oout mrl kwg cns tung adme aas rai cll jse miri qfi cmcx ptro ung usa']\n",
      "['scan results hammer candlestick', 'aavc tta acc iit dev smds mafl sigt cll rtn jwng nfx srb gdp autg rmdl']\n",
      "['main event', 'tatpremiers v richmondrovers', 'greylynnpark round', 'foxmemorial premiership whanau', 'proud sponsors', 'roosters cll veisarikid aquatechnics']\n",
      "['dinnerwiththedocs events w focus', 'patients amp families amp', 'collab w community oncologists dinner', 'local community']\n",
      "['year i guess i wasn t', 'cancer leukemia cll oncology covid coronavirus']\n",
      "['chronic lymphocytic leukemia therapeutics market']\n",
      "['eha swg day', 'major area', 'hemonc niemann', 'copenhagen outlines', 'cll treatment paradigm hematology eha25 hemonc leusm leukemia']\n",
      "['new commentary', 'fda approvals', 'bruton tyrosine kinase inhibitors', 'chronic lymphocytic leukemia potential inefficiencies', 'trial design', 'evidence generation leusm']\n",
      "['optimal treatment options', 'chronic lymphocytic leukemia']\n",
      "['bus aim cll barclays plc form', 'cello health plc']\n",
      "['new article nivolumab', 'progressive multifocal leukoencephalopathy', 's zary syndrome cll leusm hematology']\n",
      "['new article', 'drug administration approvals', 'bruton tyrosine kinase inhibitors', 'chronic lymphocytic leukemia potential inefficiencies', 'trial design', 'evidence generation cll leusm hematology']\n",
      "['new article', 'initial ophthalmic manifestation', 'disease importance', 'unspecific visual deterioration cll leusm hematology']\n",
      "['dr davids', 'long term', 'chronic lymphocytic leukemia', 'mantle cell lymphoma lymsm']\n",
      "['rns aim cll cello health plc']\n",
      "['rt medivizor', 'pharmaceutical care program', 'chronic lymphocytic l', 'medivizor leukemia']\n",
      "['pm tatpremiers greylynnpark upthemightyroosters cll veisarikid aquatechnics waterviewlaundromat richmond bulldogs grey lynn park']\n",
      "['cancernetwork tumor board series', 'multidisciplinary approach', 'chronic lymphocytic leukemia click']\n",
      "['month checkup', 'good numbers', 'chemo chronic lymphocytic leukemia']\n",
      "['cll campus']\n",
      "['prognostic significance', 'pet ct', 'chronic lymphocytic leukemia cll', 'frontline chemoimmunotherapy']\n",
      "['don t', 'cancernetwork tumor board series', 'multidisciplinary approach', 'chronic lymphocytic leukemia click']\n",
      "['ivig infusion day', 'usual thanks', 'great safe care cll']\n",
      "['rns aim cll cello health plc']\n",
      "['bus aim cll sand grove capital management form', 'cello health plc']\n",
      "['occupy btk']\n",
      "['immunoglobulin gene rearrangements', 'oncogenic translocations', 'lymphoid neoplasms check', 'fantastic collaboration', 'friend ferran nadeu elias campo', 'others smm nhl cll']\n",
      "['rns aim cll cello health plc']\n",
      "['chronic lymphocytic leukemia', 'treatment tammi doesn t', 'incredible story', '1pm edt register']\n",
      "['tgtherapeutics announces publication', 'blood advances', 'unique immunomodulatory', 'cll tcells', 'umbralisib tgtx']\n",
      "['new article multicenter cohort study', 'regorafenib treatment kscc1603 cll leusm hematology']\n",
      "['new article b cell', 'new targets', 'precision medicine', 'cll cll leusm hematology']\n",
      "['new article', 'chronic lymphocytic leukemia', 'concomitant breast cancer cll leusm hematology']\n",
      "['new article population pharmacokinetics', 'non asian patients', 'ulcerative colitis', 'crohn s disease cll leusm hematology']\n",
      "['new article prognostic significance', 'pet ct', 'chronic lymphocytic leukemia cll', 'frontline chemoimmunotherapy cll leusm hematology']\n",
      "['rt medivizor', 'pharmaceutical care program', 'chronic lymphocytic l', 'medivizor leukemia']\n",
      "['tatreserves whet', 'tatpremiers v richmondrovers', 'foxmemorial bethere greylynnpark', 'saturday whanau cll veisarikid']\n",
      "['combo merfolk', 'mtg cll', 'mtglegacy mtgo']\n",
      "['bruce g raphael md', 'chronic lymphocytic leukemia leusm']\n",
      "['pharmaceutical care program', 'chronic lymphocytic l']\n",
      "['tonights mtg cll event']\n",
      "['haven t', 'cancernetwork tumor board series', 'multidisciplinary approach', 'chronic lymphocytic leukemia click']\n",
      "['dr davids', 'long term', 'chronic lymphocytic leukemia', 'mantle cell lymphoma lymphomas lymsm']\n",
      "['dr davids', 'long term', 'chronic lymphocytic leukemia', 'mantle cell lymphoma lymphomas lymsm']\n",
      "['chronic lymphocytic leukemia primary analysis', 'open label', 'mable study']\n",
      "['aberrant chromatin', 'chronic lymphocytic leukemia', 'tf s networks', 'dna methylation', 'histone modifications nucleosome positions chromatin accessibility ctcf', 'b cell transcriptome']\n",
      "['dr davids discusses', 'long term', '1b trial', 'refractory chronic lymphocytic leukemia', 'mantle cell lymphoma', 'umbralisib lymsm']\n",
      "['dual pi3k ck1 inhibitor umbralisib exhibits', 'unique immunomodulatory', 'cll t cells']\n",
      "['family friend']\n",
      "['local cll discussions', 'top docs', 'patients register']\n",
      "['cll webinar']\n",
      "['s chronic lymphocytic leukemia dinner w', 'w drs andrew evens roger strair rajat bannerji kathy toomey seth cohen amp robert grossman']\n",
      "['umbralisib preserves treg cell function ex vivo amp', 'mouse model', 'cll vs idelalisib amp duvelisib suggests', 'ck1 mitigates treg impairment', 'pi3k inhibition hematology oncology leukemia']\n",
      "['bus aim cll sand grove capital management form', 'cello health plc']\n",
      "['patients ages', 'status chronic lymphocytic leukemia', 'renal transplantation', 'conditions cirrhosis hypertension']\n",
      "['cll chronic lymphocytic leukemia', 'lymph nodes', 's scary']\n",
      "['research opportunity register', 'part medicalmarketresearch takepart patientvoice fightcll cll cancer joinus cancerresearch leukemia uk']\n",
      "['new article', 'dual pi3k ck1 inhibitor umbralisib exhibits', 'unique immunomodulatory', 'cll t cells cll leusm hematology']\n",
      "['new article health', 'economic burden', 'chronic lymphocytic leukemia', 'agents cll leusm hematology']\n",
      "['virtual article chronic lymphocytic leukemia captivate mrd cohort ibrutinib', 'high rates', 'undetectable mrd', 'cll sll']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['tgtx tg therapeutics engages', 'chronic lymphocytic leukemia cll non hodgkin s lymphoma nhl', 'multiple sclerosis ms brb setup', 'weekly chart']\n",
      "['new concept', 'amazing experts', 'rutger s cinj', 'rwjbarnabas health nj cll patients', 'care teams', 'cll leukemia']\n",
      "['chronic lymphocytic leukemia cll', 'april i', 'morning i', 'update hey', 'i haven t']\n",
      "['i m', 'mile cycle', 'cancer research', 'chronic lymphocytic leukemia', 'i m', 'x donate', 'cancer research uk']\n",
      "['alert protection', 'masks trademarks covid19law counterfeits cll']\n",
      "['cancernetwork tumor board series', 'multidisciplinary approach', 'chronic lymphocytic leukemia click']\n",
      "['new chemotherapy', 'free cll treatment', 'venetoclax leusm jnccn360']\n",
      "['bus aim cll sand grove capital management form', 'cello health plc']\n",
      "['clinical implications', 'birc3 mutations', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'coronavirus pandemic covid coronavirus']\n",
      "['new clinical trial btk inhibitor zanubrutinib bgb', 'patient cll leusm hematology']\n",
      "['new article cll', 'focus cll leusm hematology']\n",
      "['new article', 'discrete choice experiment', 'question cll leusm hematology']\n",
      "['new article inhibitory', 'glycosaminoglycan placental chondroitin sulfate', 'proliferation migration', 'cancer cells cll leusm hematology']\n",
      "['bruce g raphael md', 'tumor lysis syndrome', 'chronic lymphocytic leukemia leusm']\n",
      "['chronic lymphocytic leukemia', 'real world data', 'india leusm jcogo']\n",
      "['hpv infection', 'cll leusm skcsm jnccn360']\n",
      "['days ancan', 'bones blood cancers videochat virtual support group', 'pm edt aml multiplemyeloma leukemia lymphoma cll']\n",
      "['dr davids discusses', 'long term', '1b trial', 'refractory chronic lymphocytic leukemia', 'mantle cell lymphoma', 'umbralisib lymphoma lymsm']\n",
      "['bullish list', 'hwg rmmc egl vrp xar aaz cll w7l']\n",
      "['cme video', 'expert insight', 'cll treatment continuum']\n",
      "['s cll chronic lymphocytic leukemia cll dinner', 'w drs andrew evens roger strair rajat bannerji kathleen toomey seth cohen amp robert grossman register']\n",
      "['rns aim cll cello health plc form', 'cello health plc']\n",
      "['bus aim cll sand grove capital management form', 'cello health plc']\n",
      "['intensity allogeneic stem cell transplant', 'chronic lymphocytic leukemia view']\n",
      "['chronic lymphocytic leukemia', 'human b1 cell development']\n",
      "['season eqa samples', 'acquiredarray ntrk fusions', 'rapid prenatal aneuploidy', 'laboratories cll fish prenatal quality eqa']\n",
      "['place 1pm', 'coordinator org uk cll haematology covid', 'leukaemia bloodcancerawareness']\n",
      "['new article', 'long non', 'rnas lncrnas', 'leukemia progression cll leusm hematology']\n",
      "['new article bone marrow coexistence', 'chronic lymphocytic leukemia', 'langerhans cell sarcoma cll leusm hematology']\n",
      "['new article', 'long term efficacy', 'refractory chronic lymphocytic leukemia results', 'polish adult leukemia study group observational study cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'march i haven t', 'bubble amp i m gon na squeeze']\n",
      "['b cell receptor antagonists', 'cll w', 'hematology eha25 hemonc oncoalert', 'eha25virtual leusm leukemia']\n",
      "['encouraging news']\n",
      "['don t', 'new abstracts', 'chronic lymphocytic leukemia', 'asco20 cancer leusm medtwitter sundaymotivation']\n",
      "['discusses novel approaches', 'refractory chronic lymphocytic leukemia leusm']\n",
      "['line treatment', 'astrid pavlovsky', 'pdf resource lymsm']\n",
      "['facilitate covid19 infection', 'risk factor', 'severe infection', 'cll patients dr montserrat']\n",
      "['pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line', 'autophagic flux']\n",
      "['duo clinical trial treatment', 'refractory chronic lymphocytic leukemia', 'ofatumumab leusm leukemias']\n",
      "['diagnostic test', 'chronic lymphocytic leukemia']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['chronic lymphocytic leukemia', 'eliza hall institute']\n",
      "[]\n",
      "['atrial fibrillation', 'side effect', 'ibrutinib treatment', 'chro leukemia']\n",
      "['t cell dynamics', 'chronic lymphocytic leukemia', 'different treatment modalities']\n",
      "['chronic lymphocytic leukemia', 'molecular pathogenesis', 'novel therapeutic strategies lymphoma lymsm']\n",
      "['t cell dynamics', 'chronic lymphocytic leukemia', 'different treatment modalities lymphoma lymsm']\n",
      "['new article leukostasis', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article t cell dynamics', 'chronic lymphocytic leukemia', 'different treatment modalities cll leusm hematology']\n",
      "['treatment emergent tumor lysis syndrome', 'pi3k inhibition', 'car t cell therapy', 'chronic lymphocytic leukemia']\n",
      "['moleculardiagnosticsprogram performs moleculartechniques', 'generation technology', 'detect chronic myeloid leukemia cml', 'acute myeloid leukemia aml', 'acute lymphocytic leukemia', 'solid tumors']\n",
      "['predictive molecular biomarkers', 'chronic lymphocytic leukemia pathologist hemepath moldx molpath']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['tumor board series', 'multidisciplinary approach', 'chronic lymphocytic leukemia link']\n",
      "['chronic lymphoblastic leukemia', 'new jersey cll community register', 'docs talks', 'people night', 'gift card', 'newjersey household leusm']\n",
      "['bus aim cll sand grove capital management form', 'cello health plc']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['cll webinar']\n",
      "['bruce g raphael md', 'chronic lymphocytic leukemia leusm']\n",
      "['new article prognostic', 'predictive molecular biomarkers', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article occupy btk', 'cll cll leusm hematology']\n",
      "['new article chilblain', 'serological study', 'case series cll leusm hematology']\n",
      "['new article dermatological toxicities', 'bruton s tyrosine kinase inhibitors cll leusm hematology']\n",
      "['new article response', 'refractory chronic lymphocytic leukemia', 'duration venetoclax', 'rituximab cll leusm hematology']\n",
      "['facilitate covid19 infection', 'risk factor', 'severe infection', 'cll patients dr montserrat']\n",
      "['rns aim cll cello health plc replacement form', 'opd cello health plc']\n",
      "['michael choi md', 'chronic lymphocytic leukemia leusm']\n",
      "['natural prevention', 'chronic lymphocytic leukemia']\n",
      "['t cell dynamics', 'chronic lymphocytic leukemia', 'different treatment modalities']\n",
      "['wego health awards', 'secret amp rookie', 'year cll chroniclymphocyticleukemia leukemia bloodcancer awards wego health']\n",
      "['new report', 'cll patients', 'gaia cll13 trial', 'venetoclax amp rituximab', 'obinutuzumab ibrutininb']\n",
      "['s mission', 'research julybirthday lls cll mds']\n",
      "['chronic lymphocytic leukemia cll', 'small percentage', 'new cancer cases', 'common leukemia', 'western countries']\n",
      "['pandemic poems', 'current issue', 'chronic lymphocytic leukemia pandemicpoems covid19 health medicine leukemia']\n",
      "['new article', 'print itga4 gene methylation status', 'chronic lymphocytic leukemia lylcl click']\n",
      "['chronic lymphocytic leukemia', 'cll treatment costs', 'medical experts', 'duration therapy', 'financial resources leusm chronicillness patientpower']\n",
      "['cure dr mazyar shadman', 'chronic lymphocytic leukemia']\n",
      "['atrial fibrillation', 'side effect', 'ibrutinib treatment', 'patient leukemia']\n",
      "['new article paraneoplastic pemphigus', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'rurality race', 'non hodgkin lymphoma incidence cll leusm hematology']\n",
      "['new article analytical evaluation', 'clonoseq assay', 'measurable minimal residual disease', 'acute lymphoblastic leukemia chronic lymphocytic leukemia', 'multiple myeloma cll leusm hematology']\n",
      "['new article correction', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['rns aim cll cello health plc form', 'opd cello health plc']\n",
      "['central southern', 'northern newjersey town hall virtual dinner events w', 'academic cll experts amp local community oncologists', 'patients amp families']\n",
      "['chronic lymphocytic leukemia', 'competitive landscape']\n",
      "['oncoalert patients', 'del 11q trisomy', 'atm notch1 sf3b1', 'birc3 mutations', 'chemoimmunotherapy cllsm leusm lymsm']\n",
      "['prognostic tool predicts need', 'stage chronic lymphocytic leukemia davide rossi md oncology institute', 'southern switzerland']\n",
      "['informative interactive discussion', 'chronic lymphocytic leukemia experts', 'diagnosis letsbehealthytogether']\n",
      "['scan results expansion breakout', 'hayd cll redx gmr aau jog bhmg bvc hgt mtr']\n",
      "['scan results macd bullish signal line cross', 'cll ibpo ctea wgb pvcs tstr tpt hgm bme swg pgit ssty wtg bks jog bhmg']\n",
      "['scan results', 'hayd cll redx gmr shg ergo aau ika bhmg bvc bnzl agy smt att pct igg']\n",
      "['scan results', 'cll ghe ecsc ctea nxr wgb pvcs luce tstr iit cldn sumo gsf brsc hfd ams']\n",
      "['i ll', 'daily basis', 'dow dow dia dia ba ba m m', 'main main ko ko goog goog htz htz ltc ltc bac bac aapl aapl amzn amzn tsla tsla fx fx fb fb rt rt oxlc oxlc epr epr ccl cll nclh nclh']\n",
      "['s cll chronic lymphocytic leukemia dinner', 'w drs andrew evens roger strair rajat bannerji kathy toomey seth cohen amp robert grossman register']\n",
      "['cll therapy']\n",
      "['predictive impact', 'genetic markers']\n",
      "['i note cll', 'cash bid', 'feb numbers', 'honest i']\n",
      "['pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line', 'autophagic flux']\n",
      "['cll cello health s takeover', 'health care', 'sector suggests liberum', 'uk cll']\n",
      "['new research car t cell therapy', 'b cell non hodgkin lymphoma', 'chronic lymphocytic leukemia clinical trials', 'real world experiences chimeric antigen receptor', 'car t cells']\n",
      "['cll market report ftse', 'year high', 'uk cll']\n",
      "['new article treatment emergent tumor lysis syndrome', 'pi3k inhibition', 'car t cell therapy', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article covid', 'fit patients', 'combinations cll leusm hematology']\n",
      "['new article', 'venetoclax activity', 'hematological malignancies cll leusm hematology']\n",
      "['new article', 'medical comorbidities', 'chronic lymphocytic leukaemia', 'idelalisib analysis', 'clinical trials cll leusm hematology']\n",
      "['i margen']\n",
      "['cll cello health surges', 'uk cll']\n",
      "['takeover bid', 'holders i', 'decent company']\n",
      "['feduni dr marice alcantara', 'phd thesis', 'invariant t mait cells', 'chronic lymphocytic leukemia dr alcantara', 'immuno oncology', 'hope centre', 'los angeles']\n",
      "['premium investegate arsenal capital mgmt announcements arsenal capital mgmt']\n",
      "['atrial fibrillation', 'side effect', 'ibrutinib treatment']\n",
      "['old man', 'chronic lymphocytic leukemia cll', 'abdominal cramps', 'radiology case']\n",
      "['pathologic findings', 'bronchopulmonary leukemic infiltrates', 'chronic lymphocytic leukemia']\n",
      "['orphan drug designation', 'mantle cell lymphoma', 'chronic lymphocytic leukemia', 'small lymphocytic leukemia mclsm lymsm']\n",
      "['fda grants orphan status', 's cirmtuzumab vs mantle cell lymphoma amp chronic lymphocytic leukemia', 'ror1 immunotherapy', 'vs her2 breastcancer immunooncology antibodies']\n",
      "['david lauterstein ceo', 'long time client nasty pig inc', 'notable lgbtq leader amp executive', 'crain s ny business', 'pride lgbtq cll cowanliebowitz crainsnewyork']\n",
      "['oncternal therapeutics', 'orphan drug designations odd', 'mantle cell lymphoma', 'chronic lymphocytic leukemia', 'regulatoryaffairs biotech leukemia lymphoma']\n",
      "['optimal treatment options', 'chronic lymphocytic leukemia']\n",
      "['atrial fibrillation', 'ibrutinib therapy']\n",
      "['cme activities', 'new advances', 'cll mantlecelllymphoma patient care lots', 'clinical insight', 'don t']\n",
      "['video sequence', 'r r cll patients w', 'hematology eha25 hemonc leusm oncoalert', 'eha25virtual immunoonc']\n",
      "['tumor board series', 'multidisciplinary approach', 'chronic lymphocytic leukemia link']\n",
      "['analytical evaluation', 'clonoseq assay', 'measurable minimal residual disease', 'acute lymphoblastic leukemia chronic lymphocytic leukemia', 'multiple myeloma']\n",
      "['oncternal therapeutics announces orphan drug designations', 'cirmtuzumab ror1 antibody', 'mantle cell lymphoma', 'chronic lymphocytic leukemia']\n",
      "['oncternal therapeutics announces orphan drug designations', 'cirmtuzumab ror1 antibody', 'mantle cell lymphoma', 'chronic lymphocytic leukemia oncology medtwitter']\n",
      "['onct oncternal therapeutics announces orphan drug designations', 'cirmtuzumab ror1 antibody']\n",
      "['i ve', 'positive reasons', 'public spaces', 'i ll', 'public spaces', 'unborn child']\n",
      "['oncternal therapeutics announces orphan drug designations', 'cirmtuzumab ror1 antibody', 'mantle cell']\n",
      "['optimal treatment', 'line setting', 'chronic lymphocytic leukemia', 'dr mazyar shadman']\n",
      "['onct 15s', 'press release', 'oncternal therapeutics announces orphan drug designations', 'cirmtuzumab ror1 antibody', 'mantle cell lymphoma', 'chronic lymphocytic leukemia']\n",
      "['btk inhibitors', 'monoclonal antibodies', 'chronic lymphocytic leukemia leusm']\n",
      "['chronic lymphocytic leukemia treatment market', 'global industry revenue share size status growth rate services']\n",
      "['bruce g raphael md', 'sheds light', 'chronic lymphocytic leukemia leusm']\n",
      "['ibrutinib therapy', 'chroniclymphocyticleukemia leusm cll']\n",
      "['michael choi md', 'front treatment decisions impact', 'refractory setting', 'chronic lymphocytic leukemia leusm']\n",
      "['atrial fibrillation', 'ibrutinib therapy cancer therapy advisor oncology medtwitter']\n",
      "['entre pacientes', 'con cll leucemialinfoc ticacr nica tratados', 'con combinaciones', 'venetoclax reci n publicado ch calo ya']\n",
      "['chronic lymphocytic leukemia', 'cll treatment costs', 'medical experts', 'duration therapy', 'financial resources leusm chronicillness patientpower']\n",
      "['new paper', 'group phd candidate anne martens shows', 'cd3xcd19 dart', 'venetoclax resistance']\n",
      "['s talks', 'cll treatment', 'landscape amp learning', 'clinical experts dr david allsup', 'cll cns helen knight partners']\n",
      "['cll w lydia scarf', 'hematology eha25 hemonc leusm oncoalert', 'eha25virtual leukemia immunoonc']\n",
      "['lucivenet tablets', 'active ingredient', 'lucius pharma', '10mg amp 100mg', 'oral use', 'cancer medication']\n",
      "['bioanalytical methods', 'chronic lymphocytic leukemia drugs', 'biological matrices maskotlib']\n",
      "['new jitc article cd3xcd19 dart molecule treatment induces non apoptotic', 'high risk chemotherapy', 'resistant chronic lymphocytic leukemia cells']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['nicole lamanna md', 'cll hematology hemonc cme ce']\n",
      "['chronic lymphocytic leukemia']\n",
      "['cll patients immune system']\n",
      "['don t', 'cll treatment', 'future treatments']\n",
      "['cll society ash', 'dr john pagel amp dr alexey danilov', 'dr danilov s research', 't cell function', 'cll patients']\n",
      "['new clinical trial', 'cll amp non hodgkin lymphoma patients clinicaltrials chroniclymphocyticleukemia cure s clinical trial corner june']\n",
      "['coronavirus risks', 'chronic lymphocytic leukemia cll']\n",
      "['captivate mrd', 'oral regimen', 'ibrutinib venetoclax', 'deep molecular remissions', 'bone marrow', 'peripheral blood', 'cll sll eha2020']\n",
      "['non hodgkins lymphoma b', 't cell leukemia', 'chronic lymphocytic leukemia', 'major settlement']\n",
      "['chronic lymphocytic leukemia experts host', 'important topics']\n",
      "['pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line', 'autophagic flux']\n",
      "['interesting target', 'lymsm cll ror1', 'reliable marker', 'minimal residual disease', 'chronic lymphocytic leukaemia']\n",
      "['new article time', 'triplet therapy induces', 'rapid undetectable mrd responses', 'cll cll leusm hematology']\n",
      "['new article front line therapy', 'elderly chronic lymphocytic leukemia patients bendamustine', 'real life retrospective multicenter study', 'lazio region cll leusm hematology']\n",
      "['new article', 'infrequent chronic lymphocytic leukemia', 'specific immunoglobulin stereotypes', 'monoclonal b cell lymphocytosis cll leusm hematology']\n",
      "['new article chronic lymphocytic leukaemia', 'prolymphocytic leukaemia', 'coin cll leusm hematology']\n",
      "['new article clinical relevance', 'c gt t vegfa', 'c 233c gt t bfgf polymorphisms', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['great talk', 'c niemann copenhagen', 'eha ash symp eha25virtual', 'impressive integration amp', 'hospital datalake rwd', 'cll hematology hematology ai augmentedintelligence']\n",
      "['long term outcomes', 'car t cells treatment', 'unresponsive c']\n",
      "['diabetes amp chronic lymphocytic leukemia', 'senator daines', 'dry mtsen']\n",
      "['cd3xcd19 dart molecule treatment induces non apoptotic', 'high risk chemotherapy', 'resistant cll cells journal', 'cancer leusm']\n",
      "['refractory cll', 'complex karyotypes', 'complex karyotypes', 'alternative combination therapy leusm leukemias']\n",
      "['video key opinion leaders', 'patient populations', 'chronic lymphocytic leukemia cll']\n",
      "['dr mato', 'venetoclax interruptions', 'refractory chronic lymphocytic leukemia', 'rituximab leusm leukemias']\n",
      "['final results', 'genuine trial', 'cll leusm jnccn360']\n",
      "['cll chroniclymphocyticleukemia cll', 'middle age', 'abnormal increase', 'lymphocytes cancer leukemia']\n",
      "['cd3xcd19 dart molecule treatment induces non apoptotic', 'high risk chemotherapy', 'resistant chronic lymphocytic leukemia cells lymphoma lymsm']\n",
      "['new article genetics', 'cll therapy cll leusm hematology']\n",
      "['new article ibrutinib', 'chronic lymphocytic leukemia clinical applications drug resistance', 'prospects cll leusm hematology']\n",
      "['new article cd3xcd19 dart molecule treatment induces non apoptotic', 'high risk chemotherapy', 'resistant chronic lymphocytic leukemia cells cll leusm hematology']\n",
      "['new article', 'human visualization', 'cll compartment', 'cll leusm hematology']\n",
      "['new england journal', 'therapy destroys leukemia', 'chronic lymphocytic leukemia', 'patients mercuryretrograde']\n",
      "['prognostic factors', 'chronic lymphocytic leukemia', 'current status view']\n",
      "['eha25virtual venice i findings', 'resistant cll leusm jnccn360']\n",
      "['cll sll', 'full article']\n",
      "['flow cytometry', 'special test', 'immune cells', 'cll sll flow cytometry', 'individual cells', 'cell lymphoma']\n",
      "['cll sll', 'different types']\n",
      "['time cll sll', 'aggressive type', 'lymphoma pathologists']\n",
      "['immune system', 'own cells', 'hemolytic anemia', 'red blood cells', 'lymphoma leukemia']\n",
      "['cll sll', 'routine blood test lymphoma leukemia']\n",
      "['complex karyotype', '17p deletion', 'strong predictor', 'early progression', 'chronic lymphocytic leukemia', 'btk inhibitor ibrutinib']\n",
      "['vice versa', 'name cll sll leukemia lymphoma']\n",
      "['cancer cells', 'chronic lymphocytic leukemia cll', 'cancer cells', 'lymph nodes', 'small lymphocytic lymphoma sll patientcare']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['immune system chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'lymphoma patienteducation']\n",
      "['new article', 'common type', 'different names chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['oncoalert prognostic', 'predictive impact', 'genetic markers', 'venetoclax american society', 'hematology lymsm leusm cllsm']\n",
      "['oncoalert genetics', 'cll therapy american society', 'hematology lymsm cllsm leusm']\n",
      "['captivate mrd', 'oral regimen', 'ibrutinib venetoclax', 'deep molecular remissions', 'bone marrow', 'peripheral blood', 'cll sll eha2020']\n",
      "['expert dr steven coutre', 'telemedicine options', 'chronic lymphocytic leukemia cll leusm']\n",
      "['refractory chronic lymphocytic leukemia cll']\n",
      "['quiz chronic lymphocytic leukemia cll treatment']\n",
      "['mind blog', 'trademarks trademarks infringement litigation cll']\n",
      "['bmy mmsm lysmm cll mcl dlbcl fl lymphoma myeloma']\n",
      "['cll connections dinner', 'central nj']\n",
      "['current issue systemic', 'large vessel vasculitis', 'retroperitoneal fibrosis', 't cell chronic lymphocytic leukemia', 'case report']\n",
      "['new clinical trial', 'chronic lymphocytic leukemia cll cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia', 'real world data', 'india cll leusm hematology']\n",
      "['new article', 'obinutuzumab chlorambucil regimen', 'chronic lymphocytic leukemia', 'free immunotherapy approach cll leusm hematology']\n",
      "['new article ror1', 'reliable marker', 'minimal residual disease', 'chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['new article', 'chronic lymphocytic leukaemia slamf1 deregulation', 'genomic complexity', 'outcome cll leusm hematology']\n",
      "['new article leukemia incidence trends', 'national level', 'cll leusm hematology']\n",
      "['new article autoimmune hemolytic anemia', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article pdq cancer information summaries cll leusm hematology']\n",
      "['new bjh paper', 'unexpected kinetics', 'sars cov', 'total antibodies', 'chronic lymphocytic leukemia']\n",
      "['cll co', 'gurus mary ann anderson', 'john seymour', 'exciting times', 'exciting future']\n",
      "['cognitive impairment', 'chronic lymphocytic leukemia']\n",
      "['long term', 'patients w']\n",
      "['interesting paper', 'big data mosaic chromosomal alterations', 'subjects gt', 'ethnic differences', 'genomic locations', 't cell leukemia']\n",
      "['btk inhibitor therapy']\n",
      "['covid vacation self improvement covid coronavirus cancer fauci self', 'oncology leukemia cll', 'blood television']\n",
      "['cll patients resume', 'person treatment', 'good quesyions', 'intelligen answers cllstrong patinetpower askpatientpower']\n",
      "['ways cancer', 'charlie rogers', 'long work hours']\n",
      "['sever skin toxicity', 'skin lesions', 'old male patient', 'chronic lymphocytic leukemia case report', 'literature review']\n",
      "['promising news ror1', 'dlbcl cell lines cll f ckcancer']\n",
      "['new article covid', 'parainfluenza co infection', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'nuclear notch2', 'gliotoxin recovers', 'tumor suppressor notch3 activity', 'cll cll leusm hematology']\n",
      "['new article development', 'palliative care intervention', 'cancer patients', 'participatory design approach cll leusm hematology']\n",
      "['immunophenotypic characteristics', 'monoclonal b cell lymphocytosis', 'healthy korean individuals', 'lymphocytosis ann lab', 'korean society', 'laboratory medicine chronic lymphocytic leukemia prevalence korea']\n",
      "['btk bcl2 order blood american society', 'hematology cll lymsm']\n",
      "['simple phonics activity', 'coat hangers links', 'eye units', 'phonics literacy cll eytwittertagteam eytagteam']\n",
      "['cll chronic lymphocytic leukemia']\n",
      "['different frontline treatment combinations', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll', 'line therapy thanks', 'new clinical trial results']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['bruton s tyrosine kinase inhibitor monotherapy', 'chronic lymphocytic leukemia patients', 'special consideration', 'resonate trial regimen']\n",
      "['unmet need', 'ibrutinib virtual meeting']\n",
      "['research report explores', 'chronic lymphocytic leukemia therapeutics market', 'tremendous growth']\n",
      "['multicenter phase', 'chronic lymphocytic leukemia', 'richter s syndrome', 'scientific program', 'r epoch']\n",
      "['snss resumes', 'non covalent btk inhibitor vecabrutinib', 'phase 1b', 'refractory chronic lymphocytic leukemia cll', 'b cell malignancies']\n",
      "['eha25 advances', 'high risk chronic lymphocytic leukaemia', 'eha25virtual eha2020 oncology cll leukaemia']\n",
      "['new article prognostic models', 'chronic lymphocytic leukemia cll', 'systematic review', 'meta analysis cll leusm hematology']\n",
      "['different frontline treatment combinations', 'chronic lymphocytic']\n",
      "['chronic lymphocytic leukemia cll pathogenesis', 'clinical presentation']\n",
      "['chronic lymphocytic leukemia', 'drs john m burke amp manuel', 'santiago gt gt cme']\n",
      "['btk inhibitors', 'monoclonal antibodies', 'chronic lymphocytic leukemia leusm']\n",
      "['clinic ibrutinib', 'chronic lymphocytic leukemia leusm hematology']\n",
      "['acute chronic cll chronic lymphocytic leukemia clld chronic lymphoproliferative leukemic disorders']\n",
      "['chronic lymphocytic leukemia market size overview', 'industry trends', 'growth factor']\n",
      "['chronic lymphocytic leukemia cll need', 'coronavirus cll expert dr coutre', 'current global pandemic']\n",
      "['onct oncternal therapeutics', 'fda orphan drug designation', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['restaurant industry insight', 'descriptive restaurant name restaurantindustry trademark cll']\n",
      "['optimal treatment options', 'chronic lymphocytic leukemia']\n",
      "['royal marsden', 'hasn t', 'time amp', 'strong cll']\n",
      "['t cell repertoire', 'tumor heterogeneity', 'chronic lymphocytic leukemia patients', 'allogeneic t cell therapy poster aacr20 virtual', 'annual meeting']\n",
      "['hemasphere nikos sousos reports', 'rapid emergence', 'chronic lymphocytic leukemia', 'jak2 inhibitor therapy', 'myelofibrosis hemasphere']\n",
      "['dra adriana scheliga', 'cll eha25virtual eha cll leukemia']\n",
      "['new article biomimetic nanoparticle', 'obatoclax mesylate', 'small cell lung cancer nsclc', 'cll leusm hematology']\n",
      "['prognostic models', 'chronic lymphocytic leukemia cll', 'systematic review', 'meta analysis']\n",
      "['michael choi md', 'sheds light', 'chronic lymphocytic leukemia leusm']\n",
      "['bioinformatics immunoglobulin gene analysis', 'chronic lymphocytic leukemia']\n",
      "['ngs genomics immunoglobulin gene analysis', 'chronic lymphocytic leukemia']\n",
      "['immunoglobulin gene analysis', 'chronic lymphocytic leukemia']\n",
      "['excellent wk', 'investigation high alc', 'ighv amp', 'palpable nodes u', 'predictive model', 'tp53 mutation', '17p deletion']\n",
      "['novel insights', 'cll heterogeneity', 'smart multi mics integration eha25 eha25virtual cll']\n",
      "['different frontline treatment combinations', 'chronic lymphocy']\n",
      "['new article ibrutinib', 'oral irreversible bruton s tyrosine kinase inhibitor', 'chronic lymphocytic leukemia dmitrieva', 'adp aggregation']\n",
      "['superior efficacy', 'venetoclax obinutuzumab']\n",
      "['prognostic models', 'chronic lymphocytic leukemia cll', 'systematic oncology medtwitter']\n",
      "['immunoglobulin gene analysis', 'chronic lymphocytic leukemia']\n",
      "['new article', 'ball prognostic score identifies', 'refractory cll patients', 'agent ibrutinib therapy cll leusm hematology']\n",
      "['new article immunoglobulin gene analysis', 'chronic lymphocytic leukemia', 'cll leusm hematology']\n",
      "['new article', 'circ rpl15 predicts', 'poor survival', 'gastric cancer', '3p olfm4 stat3 pathway cll leusm hematology']\n",
      "['oncology quiz', 'rheumatoid arthritis ra', 'general population', 'large b cell lymphoma dlbcl b hepatosplenic t cell lymphoma c chronic lymphocytic leukemia cll explanation']\n",
      "['chronic lymphocytic leukemia', 'b cell lymphoma', 'cd19 car t cell therapy fmc63 28z', 'axicabtagene ciloleucel', 'durable rates', 'remission leusm lymsm']\n",
      "['chronic lymphocytic leukemia', 'blood bone cancer', 'don t comment', 'god doesn t', 'proof i']\n",
      "['slide theme', 'congrats dr moreno cll eha25virtual']\n",
      "['immunoglobulin gene analysis', 'chronic lymphocytic leukemia']\n",
      "['hairy mcclary literacy cll eytwittertagteam eytagteam']\n",
      "['ngs genomics', 'eha building blocks', 'optimise treatments', 'therapies tools', 'generation diagnostics']\n",
      "['q amp', 'eha25virtual gabriela forestieri institute', 'oncology research ior', 'high risk cll', 'high risk cll lymsm']\n",
      "['q amp', 'eha25virtual sonali sharma', 'brno university hospital', 'cll lymsm']\n",
      "['q amp', 'eha25virtual fabienne meier abt', 'large scale proteomic analysis', 'trisomy12 amp ighv mutational status', 'main determinants', 'protein expression', 'cll lymsm']\n",
      "['q amp', 'eha25virtual andy rawstron', 'clarity trial', 'term responses', 'ibrutinib venetoclax treatment', 'r r cll mrd levels', 'therapy cessation lymsm']\n",
      "['q amp', 'eha25virtual anne sophie michallet', 'icll07 filo study', 'immunochemotherapy course', 'durable responses', 'term toxicity lymsm']\n",
      "['eha25virtual interview w carsten niemann', 'copenhagen hematology eha25 hemonc leusm leukemia ctsm oncoalert']\n",
      "['important eric study btk', 'plcg2 mutations', 'real world evidence']\n",
      "['chemoimmunotheraphy courses']\n",
      "['q amp', 'eha25virtual othman', 'cll14 trial', 'duration ven obinutuzumab', 'therapy cessation lymsm']\n",
      "['q amp', 'eha content gt gt hematology eha25 hemonc leusm leukemia ctsm']\n",
      "['eha25virtual venetoclax', 'r r cll arnon kater', 'eha content gt gt hematology eha25 hemonc leusm leukemia ctsm']\n",
      "['cork pathology dept', 'optimise treatments']\n",
      "['q amp', 'eha25virtual carsten niemann', 'live q amp', 'panel discussion transformation', 'indolent lymphomas', 'chronic lymphocytic leukemia cll', 'clinical trials lymsm']\n",
      "['eha building blocks', 'optimise treatments', 'therapies tools', 'generation diagnostics']\n",
      "['bruton tyrosine kinase inhibitor btki', 'refractory chronic lymphocytic leukemia', 'venetoclax leusm']\n",
      "['effective treatment option', 'chronic lymphocytic leukemia']\n",
      "['generation treatments', 'cll experts']\n",
      "['q amp', 'eha25virtual gianluca gaidano', 'eastern piedmont', 'q amp', 'panel discussion chronic lymphocytic leukemia cll', 'generation approaches lymsm']\n",
      "['q amp', 'generation diagnostic era', 'comprehensive diagnostic tests', 'information lymsm']\n",
      "['cll therapies', 'live q amp', 'important question', 'prof carol moreno foreningen']\n",
      "['q amp', 'panel discussion chronic lymphocytic leukemia cll', 'generation approaches tools', 'cll foreningen']\n",
      "['tanya siddiqi', 'cll updates', 'captivate trial', 'cll hematology eha25 hemonc leusm leukemia ctsm']\n",
      "['different frontline treatment combinations', 'chronic lymphocytic leuke']\n",
      "['leukemia news', 'eha25virtual efficacy', 'patients w r r cll primary endpoint analysis', 'venice i trial w arnon kater', 'nl hematology eha25 hemonc leusm leukemia ctsm']\n",
      "['combination treatments', 'obinutuzumab ibrutinib venetoclax', 'impressive umrd foreningen']\n",
      "['new article patterns', 'real life practice cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia management', 'campus cll report cll leusm hematology']\n",
      "['new article news', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'unexpected kinetics', 'sars cov', 'total antibodies', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article response', 'conjugate pneumococcal vaccine pcv13', 'chronic lymphocytic leukemia cll cll leusm hematology']\n",
      "['new article genomic deregulation', 'prmt5 supports growth', 'stress tolerance', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article lc facseq', 'rare clones', 'leukemia cll leusm hematology']\n",
      "['new article expression level', 'target gene prediction', 'mir 181b', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article expression level', 'target gene prediction', 'mir 181b', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article tp53 dysfunction', 'chronic lymphocytic leukemia clinical relevance', 'b cell receptors', 'inhibitors cll leusm hematology']\n",
      "['eha25virtual phase iii trial', 'duration venetoclax obinutuzumab', 'cll patients w othman', 'hematology eha25 hemonc leusm leukemia ctsm']\n",
      "['plcg2 mutations', 'ibrutinib w lydia scarf', 'hematology eha25 hemonc leusm leukemia eha25virtual ctsm']\n",
      "['s expert', 'panel discussions', 'conduct research view', 'hematology lymsm bigdataforbloodcancer']\n",
      "['s greats', 'new treatments', 'irish patients']\n",
      "['tumor lysis syndrome', 'richter s transformation', 'chronic lymphocytic leukemia treatment', 'disease progression lymphoma lymsm']\n",
      "['chronic lymphocytic leukemia advantages']\n",
      "['flowcytometry remission']\n",
      "['bad blood', 'thursday night raising', 'cll leukemia gibbons5k togetheritspossible teambadblood2020']\n",
      "['different frontline treatment combinations', 'chronic lymphocytic']\n",
      "['dr steven coutre']\n",
      "['congress eha25virtual carol moreno', 'extensive overview', 'cll therapies', 'therapies lymsm']\n",
      "['study findings', 'dose escalation study', 'refractory cll leusm jnccn360']\n",
      "['congress eha25virtual stuart blakemore', 'akt causes transformation', 'aggressive lymphoma', 'notch ligand circuit lymsm']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['high school student jakub henzl', '1st place', 'regional level', 'national level', 'secondary school research', 'mutational subtypes', 'cll ceitec municz soc jcmm']\n",
      "['chronic lymphocytic leukemia', 'progressive anemia', 'composite lymphoma']\n",
      "['own cody steeves pharmd bcop', 'video panel discussion', 'chronic lymphocytic leukemia cll']\n",
      "['cll care', 'normal cllstrong patientpower']\n",
      "['nice article', 'likely doesn t matter', 'salvage chemo auto']\n",
      "['congress eha25virtual junyan lu', 'multi omics integration data', 'independent functional biomarker cll pd', 'novel aggressive cll subgroup lymsm']\n",
      "['good outcomes cancer therapy advisor oncology medtwitter']\n",
      "['multiple options', 'frontline setting', 'chronic lymphocytic leukemia', 'therapeutic strategy', 'debate leukemias']\n",
      "['new article tumor lysis syndrome', 'richter s transformation', 'chronic lymphocytic leukemia treatment', 'disease progression dlbcl lymsm hematology']\n",
      "['provisional date', 'diary wednesday', 'dr ben kennedy', 'cll webinar', 'patient speaker']\n",
      "['chronic lymphocytic leukemia cll pathogenesis', 'clinical presentation']\n",
      "['conjugate pneumococcal vaccine pcv13', 'chronic lymphocytic leukemia cll']\n",
      "['long term outcomes', 'car t cells treatment', 'unresponsive chronic leukemia']\n",
      "['venetoclax treatment', 'cll leusm jnccn360']\n",
      "['btki therapy', 'durable disease control', 'remission duration', 'deep response', 'subsequent btki therapy cll cllsm leusm lymsm']\n",
      "['oncoalert btk inhibitor therapy', 'venetoclax cllsm leusm lymsm']\n",
      "['video seema', 'bhat md', 'hematologist discusses', 'venetoclax studies', 'virtual asco20 cll leukemia']\n",
      "['different frontline treatment combinations', 'chronic lymphocyt']\n",
      "['nccn virtual', 'annual conference drs stephens', 'optimal frontline therapy', 'chronic lymphocytic leukemia leusm lekemias']\n",
      "['scan results stochastic', 'bvic iqe cll bhgg bsd utle itek abby']\n",
      "['zanubrutinib treatment', 'unresponsive chronic lymphocyti leukemia']\n",
      "['otto d trautz', 'vermont s longest', 'public servants', 'medical center', 'chronic lymphocytic leukemia']\n",
      "['cll treatment', 'experts prof dr david allsup', 'cll cns helen knight partners']\n",
      "['i suppose i m', 'ready i', 'i m', 'leukaemia bloodcancer cll bloodcancercarer covid19']\n",
      "['congress eha25virtual lydia scarf', 'btk amp plcg2 mutations', 'eric study', 'real world evidence', 'btk p c481 mutation lymsm']\n",
      "['abdomen bowels colon rectum cancer carcinoma', 'anorexia respiratory chest bronchia lung cancer', 'large cell carcinoma constriction pain', 'cough blood leukemia chronic lymphocytic leukemia anemia', 'severe lactic acidosis germaniummetallicum']\n",
      "['cd20 mfi', 'equal performance', 'matutes score', 'fmc7 gt gt gt', 'matutes score', 'new opportunity', 'multiparameter flow cytometry cll leusm']\n",
      "['chronic lymphocytic leukemia cll pathogenesis', 'clinical presentation', 'medtwitter medstudenttwitter']\n",
      "['congress eha25virtual tanya siddiqi', 'captivate study', 'ibrutinib venetoclax combination', 'cll sll results', 'mrd remissions amp ibrutinib lead', 'tls risk lymsm']\n",
      "['chronic lymphocytic leukemia', 'cll treatment', 'dr alexy danilov', 'cll patients', 'cll answers', 'program leusm']\n",
      "['congress eha25virtual cll2', 'trial henriette huber ulm', 'obinutuzumab ibrutinib venetoclax therapy', '17p deletion tp53 mutation', 'good response', 'cr cri ci', 'p lt', 'umrd lymsm']\n",
      "['cll society s covid', 'virtual community meeting', 're entry', 'expert panel dr', 'dr susan leclair']\n",
      "['different frontline treatment combinations', 'chronic lymphocytic leuke']\n",
      "['new article coincidence', 'autoimmune hemolytic anemia', 'pure red cell aplasia', 'cll cll leusm hematology']\n",
      "['new article hsp90 overexpression potentiates', 'b cell receptor', 'fibroblast growth factor receptor survival signals', 'chronic lymphocytic leukemia cells cll leusm hematology']\n",
      "['society i', 'cautious i', 'etsy leukaemia bloodcancer cll']\n",
      "['new therapeutic advances', 'chronic lymphocytic leukemia view']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['different frontline treatment combinations', 'chronic lymphocytic leukemia']\n",
      "['s educatedpatient webinar', 'chronic lymphocytic leukemia']\n",
      "['antagonist shows preclinical efficacy', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'cll treatment', 'dr alexy danilov', 'cll patients', 'cll answers', 'program leusm']\n",
      "['cll community', 'virtual meeting', 'dr brian koffman', 's impact', 'families research']\n",
      "['cll web rebroadcast', 'claim credit']\n",
      "['old man', 'medical history', 'chronic lymphocytic leukemia', 'bilateral retinal detachment status post scleral', 'right proptosis', 'erythema acrcaseinpoint']\n",
      "['cll society s covid', 'virtual community meeting', 're entry', 'expert panel dr', 'dr susan leclair']\n",
      "['new article', 'excessive amount', 'calpain affects apoptotic machinery', 'chronic b cell leukemia cells', 'disease cll leusm hematology']\n",
      "['new article', 'glucose lipid metabolism', 'chronic lymphocytic leukemia cll cll leusm hematology']\n",
      "['new article flow cytometry', 'mature b cell lymphoproliferative disorders cll leusm hematology']\n",
      "['new article frontline therapy', 'chronic lymphocytic leukemia', 'treatment paradigm cll leusm hematology']\n",
      "['new article', 'comprehensive genomic analysis', 'noonan syndrome', 'acute myeloid leukemia', 'future directions cll leusm hematology']\n",
      "['new article selinexor', 'hematologic malignancies cll leusm hematology']\n",
      "['new article', 'resistant subpopulation', 'cll cll leusm hematology']\n",
      "['new article cryptococcal meningitis', 'case report', 'literature review cll leusm hematology']\n",
      "['phase ib study', 'chronic lymphocytic leukemia']\n",
      "['hetero healthcare launches', 'cancer drug', 'chronic lymphocytic leukaemia', 'small lymphocytic leukaemia', 'mantle cell lymphoma cll chroniclymphocyticleukaemia smalllymphocyticleukaemia mantlecelllymphoma heterohealthcare']\n",
      "['pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line', 'autophagic flux']\n",
      "['key opinion leaders', 'decision criteria', 'front line therapy', 'chronic lymphocytic leukemia cll']\n",
      "['eha2020 health congress coverage focus', 'lymphoma amp cll', 'f morschhauser', 't witzig', 't cell lymphomas', 'outstanding colleagues s ansell b eichhorst m rummel', 'pl zinzani']\n",
      "['andrew ip m d', 'susan m o brien md', 'relevant information', 'cll patients register']\n",
      "['cll web rebroadcast']\n",
      "['cll web rebroadcast']\n",
      "['scientific rationale', 'chronic lymphocytic leukemia']\n",
      "['preliminary efficacy study', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma status', 'condition summary lymphoma non hodgkin']\n",
      "['preliminary efficacy study', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['new clinical trial', 'preliminary efficacy study', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll leusm hematology']\n",
      "['cll eqas', 'cll tp53 ighv quality']\n",
      "['chronic lymphocytic leukemia therapeutics market research report', 'cumulative impact']\n",
      "['phase ib study', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia treatment market growth']\n",
      "['european hematology association eha congress', 'australia s', 'lymphoma experts', 'lymphoma cll']\n",
      "['novel bcl2 mutations', 'resistant ibrutinib', 'resistant cll patients', 'btk plcg2 mutations']\n",
      "['chronic lymphocytic leukemia']\n",
      "['video lynn', 'chronic lymphocytic leukemia patient shares', 'cll diagnosis']\n",
      "['helpful ways', 'chronic lymphocytic leukemia diagnosis']\n",
      "['video jenn', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll', 'video cll survivors steve', 'chronic lymphocytic leukemia']\n",
      "['flag day greetings flagday trademarks americanflag cll']\n",
      "['zanubrutinib obinutuzumab venetoclax triplet 2m zanuo', 'tls risk pre ven time', 'approach itki', 'gt anticd20', 'cycles post mrd bm n', 'mfup 11m g3', 'main tox', 'pb umrd', '8m rx', 'impressive eha25virtual cll']\n",
      "['web rebroadcast', 'btkinhibitors amp cll', 'week s plans register', 'pm edt']\n",
      "['chronic lymphocytic leukemia cll', 'quantitative cross sectional study', 'italian patients experiences', 'ail associazione italiana contro', 'leucemie linfomi e mielomi eha25virtual patientadvocacyvirtual leukemia qol']\n",
      "['levels i', 'feeling leukaemia bloodcancer cll']\n",
      "['new article correction', 'real world treatment patterns', 'adverse events resource use', 'chronic lymphocytic leukemia', 'retrospective cohort study cll leusm hematology']\n",
      "['optimal treatment options', 'chronic lymphocytic leukemia']\n",
      "['great treatment responses', 'cll nhs patients', 'early stages', 'clarity trial eha25virtual']\n",
      "['triplet regimen', 'ibrutinib venetoclax', 'encouraging response rates', 'acceptable safety profile', 'treatment na ve patients', 'high risk chronic lymphocytic leukemia hematology eha25virtual leusm']\n",
      "['manage patients', 'aggressive lymphoma', 'covid19 pandemic recommendations', 'gianluca gaidano', 'eastern piedmont novara', 'eha25 covid lymsm']\n",
      "['gofundme cll fuckcancer donate myelofibrosis leukemia bonemarrowcancer']\n",
      "['chronic lymphocytic leukemia', 'data covid', 'cll patient', 'cll specialist leusm']\n",
      "['ibrutinib dose modification', 'journal dr janice gabrilove', 'corresponding author']\n",
      "['great results', 'clarity trial', 'venetoclax combination', 'r r cll mrd']\n",
      "['clarity trial update', 'positive results', 'r r cll patients thanks']\n",
      "['clinical trial data', 'small molecule therapies', 'chronic lymphocytic leukemia cll review activty medscapeedu w dr jennifer']\n",
      "['mrd data', 'uk clin trials clarity trial', 'ibrutinib amp venetoclax combination', 'r r cll', 'log gt', 'months venetoclax predictive', 'mrd response', 'time amp ability', 'mrd vity cll lymsm eha25virtual']\n",
      "['lydia scarfo', 'chronic lymphocytic leukemia patients', 'full interview', 'eha25virtual hematology eha25 hemonc cll leusm']\n",
      "['btk amp plcg2 mut', 'post ibrutinib', 'full dose minimal interruptions eric initiative', 'btk mut plcg2 mut', 'btk mut', 'overall non covalent btki', 'space cll lymsm eha25virtual']\n",
      "['bm mrd ve lt', '9m post ibrutinib obinutuzumab mrd ve ibrutinib mono', 'gt 16m mrd ve fc obinx4', '1l cll pts', 'interesting concept amp', 'effective overall strategy', 'mrd ve lymsm eha25virtual']\n",
      "['zanubrutinib treatment', 'unresponsive chronic lymphocytic leu']\n",
      "['pre lysis sample preparation technique', 'flow cytometric minimal residual disease assessment', 'multiple myeloma chronic lymphocytic leukemia', 'b non hodgkin lymphoma lymphoma lymsm']\n",
      "['fungal infections', 'chronic lymphocytic leukemia patients', 'ibrutinib lymphoma lymsm']\n",
      "['selective btk inhibitor', 'generation drug', 'chronic lymphocytic leukemia', 'mantle cell lymphoma', 'trial issue time']\n",
      "['stream der kml videoberichte auf lymphome aktuelle lymphom news vom eha25 mit', 'diskussion zu covid19 cll myelom inhl anhl hodgkinlymphom aus dem k lner studio moderiert von weitere infos amp anmeldung']\n",
      "['evolutionary paths', 'chronic lymphocytic leukemia', 'graft versus leukemia', 'bachireddy p search catherine j lab apr']\n",
      "['global oncology trial management', 'clinicaltrials cll oncologytrials']\n",
      "['bilateral breast implant', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll', 'case report']\n",
      "['t n n debytoi', 's chicagolacrosseleague finlax lacrosse cll']\n",
      "[]\n",
      "['cognitive impairment', 'chronic lymphocytic leukemia leukemia']\n",
      "['new article histological findings', 'chilblain lupus', 'covid lesions', 'etiology cll leusm hematology']\n",
      "['new article fmod expression', 'whole blood aids', 'chronic lymphocytic leukemia', 'leukemic lymphoproliferative disorders', 'pilot study cll leusm hematology']\n",
      "['new article incidence', 'fungal infections', 'chronic lymphocytic leukemia patients', 'ibrutinib cll leusm hematology']\n",
      "['new article integrin', 'acute lymphoblastic leukemia cells', 'bone marrow', 'central nervous system cll leusm hematology']\n",
      "['new article epigenetic strategies synergize', 'pd l1 pd', 'cancer immunotherapies', 'enhance antitumor responses cll leusm hematology']\n",
      "['new article efficacy', 'minimal residual disease', 'immune intervention', 'allogeneic hematopoietic stem cell transplantation', 'high risk chronic lymphocytic leukemia results', 'prospective multicentric trial cll leusm hematology']\n",
      "['prognosis factors', 'chronic lymphocytic leukemia']\n",
      "['encouraging data', 'generation btkis cll eha25']\n",
      "['richter syndrome', 'spanish chronic lymphocytic leukemia study group']\n",
      "['dr lee discusses', 'clinical activity', 'ror1 antibody', 'phase 1b', 'mantle cell lymphoma', 'chronic lymphocytic leukemia leusm lymsm']\n",
      "['eha25virtual opening ceremony', 'cll expert', 'eha president prof gribben foreningen']\n",
      "['different eha', 'year s conference', 'cll expert', 'eha president prof gribben', 'open proceedings']\n",
      "['ibrutinib treatment', 'refractory chronic lymphocytic leukemia', 'final analysis', 'pivotal phase ib ii pcyc']\n",
      "['dr sharman', 'high risk', 'refractory chronic lymphocytic leukemia leukemias']\n",
      "['good boy', 'orthodox medicin', 'successful treatment', 'chronic lymphocytic leukaemia cll', 'successful treatment']\n",
      "['pf fund', 'ytd pf share', 'ytd cash', 'new rmg', 'rsg paf ule chg']\n",
      "['eha25virtual prof arnon kater', 'primary endpoint analysis', 'venice i', 'venetoclax monotherapy', 'deep responses', 'r r cll lymsm oncology']\n",
      "['chronic lymphocytic leukemia', 'expert dr sharman discusses', 'cll treatment response', 'patients chronicillness']\n",
      "['obinutuzumab chlorambucil rituximab chlorambucil', 'rituximab bendamustine', 'frontline cll treatments leukemia oncology hematology']\n",
      "['heute abend geht s los unser letzter experte den wir ihnen vor beginn des hematologytoday vorstellen ist prof dr clemens wendtner von der', 'sein thema ist', 'cll jetzt noch schnell regsitrieren hematology eha25virtual']\n",
      "['sonali sharma', 'eha congress mir', 'influences cd40', 'chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukaemia cll', 'successful treatment', 'clinical outcomes', 'patients victoriesovercancer eha25virtual cllsm']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['cll sll patient', 'dose 600mg', 'significant increase', '1st week']\n",
      "['unmet patient needs', 'hematology check', 'frontline treatment', 'chronic lymphocytic leukemia']\n",
      "['nice work', 'spanish colleagues', 'paper cll lymsm']\n",
      "['new article', 'novel t', 'igl gene deletion', 'cll patient', 'b pll', '1q gain cll leusm hematology']\n",
      "['new article venetoclax', 'chronic lymphocytic leukemia', 'immune thrombocytopenia', 'progressive multifocal leukoencephalopathy cll leusm hematology']\n",
      "['wednesday s webinar', 'peter hillmen consultant', 'clinical haematology', 'hospitals nhs trust', 'cll leukaemia bloodcancerawareness']\n",
      "['eha25virtual advances', 'high risk chronic lymphocytic leukemia']\n",
      "['european hematology association eha eha25virtual advances', 'high risk chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'new horizons', 'btk inhibitors tune', 'monday june', 'details click', 'accp continuingeducation cancer webinar']\n",
      "['datos propios', 'una leucemia linf tica cr nica llc cll', 'm s frecuente', 'el anciano', 'las leucemias', 'inmunofenotipo b', 'expresan marcadores', 'c lulas t cd5 y zap', 'cuando expresan cd38 y y zap', 'hay mal pron stico']\n",
      "['genuine clinical trial', 'significant improvement', 'objective response rate', 'btk inhibitor ibrutinib', 'high risk chronic lymphocytic leukemia leusm']\n",
      "['cognitive impairment', 'chronic lymphocytic leukemia leukemia']\n",
      "['web broadcast', 'pm edt']\n",
      "['scan results macd bullish centerline cross', 'cmcx aa4 dna3 vrs rwa ght gama cll sym']\n",
      "['oncoalert novel bcl2 mutations', 'resistant ibrutinib', 'resistant cll patients', 'btk plcg2 mutations american society', 'hematology lymsm cllsm leusm']\n",
      "['pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line']\n",
      "['matthias b ttcher mougiakakos s lab tumor microenvironment confers', 'immune privilege', 'chronic lymphocytic leukemia cll cells', 'pd l1 chronic lymphocytic leukemia', 'diffuse leukemia', 'mature t cells']\n",
      "['rns aim cll cello health plc']\n",
      "['cll management', 'cme activity', 'selection duration', 'treatment mgmt', 'disease outcomes', 'different lines', 'therapy lymsm']\n",
      "['s eha25virtual', 'new era', 'virtual meetings cll']\n",
      "['important update cll gcllsg eha2020 eha25virtual']\n",
      "['hyperviscosity syndrome', 'chronic lymphocytic leukemia', 'case report']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['clinical outcome', 'prognostic factors', 'richter syndrome', 'real world study', 'spanish chronic lymphocytic leukemia study group gellc lymphoma lymsm']\n",
      "['new article cost effectiveness', 'line ibrutinib versus', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article resveratrol enhances mrna', 'sirna lipid nanoparticles primary cll cell transfection cll leusm hematology']\n",
      "['objective responses', 'safety results', 'mantle cell lymphoma', 'chronic lymphocytic leukemia', 'phase 1b', 'trial leusm']\n",
      "['chronic lymphocytic leukemia', 'myelodysplastic syndrome']\n",
      "['cll webcast event', 'eha25virtual cme']\n",
      "['chronic lymphocytic leukemia', 'slap upside', 'deep self examination amp', 'immediate life']\n",
      "['cll group', 'awesome mentor jennifer woyach']\n",
      "['dr brander', 'treatment option', 'old man', 'chronic lymphocytic leukemia leusm leukemias']\n",
      "['long term']\n",
      "['dr jennifer woyach', 'clinical research achievement award', 'dr woyach s', 'impressive research', 'chronic lymphocytic leukemia', 'video topten james']\n",
      "['cll management', 'cme activity', 'selection duration', 'treatment management', 'disease outcomes', 'different lines']\n",
      "['clinical outcome', 'prognostic factors', 'richter syndrome', 'real world study', 'spanish chronic lymphocytic leukemia study group gellc']\n",
      "['family members carers', 'mycllife podcast']\n",
      "['chronic lymphocytic leukemia']\n",
      "['eha2020 presentation', 'reversible btk', 'flt3 inhibitor cg', 'arql loxo snss ibrutinib cll']\n",
      "['superior efficacy', 'venetoclax obinutuzumab']\n",
      "['kll14 ali masi venetoclax ob nutuzumab rej m n n uzun d nem sonu lari da olumlu g r n yor asco20 cll hematolojiistanbul kll kroniklenfositikl semi leukemia leukemiatreatment l semitedavisi memorialata ehirhematoloji obinutuzumab profdrhisari']\n",
      "['atrial fibrillation', 'chronic lymphocytic leukemia cll', 'ibrutinib risk prediction ma']\n",
      "['free drop', 'bones blood cancers virtual support group june', 'pm eastern aml multiplemyeloma leukemia lymphoma cll']\n",
      "['don t', 'new abstracts', 'chronic lymphocytic leukemia', 'asco20 cancer leusm medtwitter tuesdaymotivation']\n",
      "['mind blog', 'legal issues', 'non profits']\n",
      "['paraneoplastic pemphigus', 'chronic lymphocytic leukemia leukemia dermatology oncology medicaljournal medicalscience medicalresearch', 'medicaleducation medicine journalofmedicine research', 'medical medlife']\n",
      "['nicole lamanna md', 'cll hematology hemonc cme ce']\n",
      "['cure news', 'chronic lymphocytic leukemia']\n",
      "['available treatment', 'chronic lymphocytic leukemia cll', 'small lymphocytic leukemia sll', 'price contact', 'venclexta 10mg 50mg 100mg china cambodia indonesia canada malaysia thailand vietnam hong kong uae iraq ireland barbados estonia']\n",
      "['somatic hypermutation status', 'chronic lymphocytic leukemia cll']\n",
      "['somatic hypermutation status', 'chronic lymphocytic leukemia cll']\n",
      "['new zanubrutinib treatment', 'unresponsive chronic lymphocytic leukemia']\n",
      "['new article evaluation', 'somatic hypermutation status', 'chronic lymphocytic leukemia cll', 'cll leusm hematology']\n",
      "['new article', 'successful treatment', 'ocular chronic lymphocytic leukemia', 'ibrutinib case report', 'literature cll leusm hematology']\n",
      "['new article reconstitution', 'humoral immunity', 'chronic lymphocytic leukemia', 'bruton tyrosine kinase inhibitors cll leusm hematology']\n",
      "['new article', 'small lymphocytic lymphoma', 'primary cutaneous', 'marginal zone lymphoma', 'germinal center follicles cll leusm hematology']\n",
      "['new article platelet function', 'chronic lymphocytic leukemia', 'mantle cell lymphoma patients', 'ibrutinib mcl lymsm hematology']\n",
      "['cll patients thoughts', 'interim report', 'survey cll leukaemia haem spotleukaemia covid19uk']\n",
      "['chronic lymphocytic leukemia cll', 'common type', 'defective lymphocytes', 'abnormal lifespan', 'blood bone marrow spleen', 'lymph nodes', 'leukemic cells', 'male female ratio']\n",
      "['pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line', 'autophagic flux']\n",
      "['market access', 'cancer drug brukinsa zanubrutinib', 'adult patients', 'mantle cell lymphoma', 'adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['long term', 'untreat leukemia']\n",
      "['oxford gene technology', 'sureseq cll cnv panel', 'ngs offering', 'chronic lymphocytic leukemia']\n",
      "['great meeting', 'online i', 'long lines planes hugs friends etc eha25virtual lymsm cll']\n",
      "['cd19 car t therapy']\n",
      "['re planning', 'cme web broadcast', 'btk inhibitors', 'june 11th']\n",
      "['minutes correspondent', 'mount sinai hospital', 'chronic lymphocytic leukemia']\n",
      "['scientific rationale', 'chronic lymphocytic leukemia']\n",
      "['navigate cll covid', 'friend dr brian koffman', 'cll patient', 'virtual community meeting', 'great experts']\n",
      "['rna list story', 'pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line', 'autophagic flux']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['long term outcomes', 'dose optimization study', 'chimeric antigen receptor', 't cells', 'chronic lymphocytic leukemia oncology']\n",
      "['pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line', 'autophagic flux crbiotech phytochemicals', 'social media channels']\n",
      "['zanubrutinib treatment', 'unresponsive chronic lymphocytic leukemia']\n",
      "['clonal dynamics', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia i', 'partial remission', 'i salute', 'fellow warriors', 'others cureleukemia curecancer cancersucks nationalcancersurvivorsday']\n",
      "['dividend yield', 'net cash', 'batman ears', 'year chart']\n",
      "['positive results', 'genuine trial', 'ublituximab amp ibrutinib versus ibrutinib', 'high risk r r cll n', 'comparable ae', 'infusion reactions', 'paper cll asco20']\n",
      "['prognostic implications', 'autoimmune hemolytic anemia association', 'chronic lymphocytic leukemia b']\n",
      "['ken hill', 'year survivor', 'chronic lymphocytic leukemia ncsd2020 firsthealth cancersurvivors']\n",
      "['new article ibrutinib dose modifications', 'cll cll leusm hematology']\n",
      "['mount sinai hospital', 'chronic lymphocytic leukemia']\n",
      "['mantle cell lymphoma', 'chronic lymphocytic leukemia lymsm leusm']\n",
      "['chronic lymphocytic leukemia blood cancer', 'covid i m']\n",
      "['treatment options test']\n",
      "['new article', 'chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['new article', 'long chain', 'fatty acids', 'genetic variation', 'cancer risk cll leusm hematology']\n",
      "['recent paper', 'genetic association', 'frontline cll lymsm']\n",
      "['zanubrutinib treatment', 'unresponsive chronic lymphocytic leukemia']\n",
      "['muscle pain', 'chronic lymphocytic leukemia trea leukemia']\n",
      "['bilateral breast implant', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll', 'case report lymphoma lymsm']\n",
      "['minimal residual disease', 'minimize exposure', 'venetoclax status', 'condition summary chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma']\n",
      "['popular asco20 research', 'chronic lymphocytic leukemia visit', 'new resource center', 'leusm bloodcancer']\n",
      "['early phase trial', 'refractory mcl']\n",
      "['errorneous crosstalk', 'cll lyn kinase', 'chronic lymphocytic leukemia cll cells', 'relevant crosstalk', 'ror1 non canonical wnt']\n",
      "['new clinical trial', 'minimal residual disease', 'minimize exposure', 'venetoclax cll leusm hematology']\n",
      "['new clinical trial apr', 'venetoclax r', 'tp53 mutant r r non hodgkin lymphomas nhl cll leusm hematology']\n",
      "['stream der kml videoberichte aktuelle lymphom news vom eha25 mit', 'diskussion zu covid19 cll myelom inhl anhl hodgkinlymphom aus dem k lner studio moderiert von infos amp anmeldung']\n",
      "['new article', 'bilateral breast implant', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll', 'case report cll leusm hematology']\n",
      "['dr tait shanafelt', 'physician burnout', 'guest lecture', 'burnout amp covid19 mind blown']\n",
      "['scan results macd bullish signal line cross', 'mph elco i3e rcn hat iom gnc htcf uai pgh cll star sgi ukw hsd qq']\n",
      "['fda update ibrutinib rituximab', 'chronic lymphocytic leukemia medtwitter cancertreatment drugsafety bloodcancer']\n",
      "['chronic lymphocytic leukemia', 'cll survivor mike boston share', 'chance meeting', 'patient power founder', 'car t trial chronicleukemia chronicillness leusm']\n",
      "['chronic lymphocytic leukemia', 'cll expert', 'coronavirus leusm covid19']\n",
      "['beigene announces', 'brukinsa tm zanubrutinib', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'refractory mantle cell lymphoma stockhouse']\n",
      "['american society', 'annual meeting practice', 'treatment na ve chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['atrial fibrillation', 'chronic lymphocytic leukemia cll', 'ibrutinib risk prediction management', 'clinical outcomes lymphoma lymsm']\n",
      "['new article', 'classical hodgkin lymphoma type', 'richter transformation', 'fine needle aspiration findings', 'mimickers cll leusm hematology']\n",
      "['new article updates', 'american society', 'annual meeting practice', 'treatment na ve chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article atrial fibrillation', 'chronic lymphocytic leukemia cll', 'ibrutinib risk prediction management', 'clinical outcomes cll leusm hematology']\n",
      "['new article statpearls cll leusm hematology']\n",
      "['chronic lymphopenia', 'large granular lymphocytic leukemia']\n",
      "['chronic lymphopenia', 'large granular lymphocytic leukemia']\n",
      "['free ebook', 'therapeutic area hematology multiplemyeloma cll dlbcl aml']\n",
      "['beigene announces', 'brukinsa zanubrutinib', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'refractory mantle cell lymphoma']\n",
      "['great evidence', 'outpt oncology clinical pharmacy services', 'patient care', 'myeloma clinic', 'lymphoma cll clinic']\n",
      "['cognitive impairment', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['clinical pharmacist involvement', 'oral chemotherapy', 'outcomes oncopharm hoparx']\n",
      "['new cancer', 'cognitive impairment', 'chronic lymphocytic leukemia']\n",
      "['cognitive impairment', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'expert dr alessandra ferrajoli share guidelines', 'cll treatment', 'coronavirus leusm chronicleukemia chronicillness']\n",
      "['long term', 'resonate phase', 'ibrutinib vs ofatumumab cll']\n",
      "['chronic lymphocytic leukemia', 'delay cll treatment', 'treatment leusm covid19']\n",
      "['cll highlights', 'asco2020 abstracts evidence patients', 'expert care lots', 'new clinical trial results', 'intermediate level', 'key points']\n",
      "['richter s transformation', 'chronic lymphocytic leukaemia', 'nationwide epidemiological study leukemia amp lymphoma vol', 'c incidence', 'binet b c', 'del 17p']\n",
      "[]\n",
      "['clinical trial data', 'small molecule therapies', 'chronic lymphocytic leukemia cll review activty medscapeedu w dr jennifer']\n",
      "['beigene announces', 'brukinsa zanubrutinib', 'refractory chronic']\n",
      "['beigene announces approval', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'refractory mantle cell lymphoma', 'tickers bgne']\n",
      "['bgne beigene announces', 'brukinsa zanubrutinib', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'refractory mantle cell lymphoma']\n",
      "['new article autoimmune hemolytic anemia', 'chronic myeloid leukemia cll leusm hematology']\n",
      "['new article', 'machine learning', 'prognostic factors', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article detection', 'chronic lymphocytic leukemia subpopulations', 'peripheral blood', 'phage ligands', 'tumor immunoglobulin b cell receptors cll leusm hematology']\n",
      "['video covid19', 'cll patients w constantine tam', 'leusm hemonc oncoalert comy20']\n",
      "['chronic lymphocytic leukemia']\n",
      "['blood cancer survivor', 'current pandemic']\n",
      "['nicole lamanna md', 'cll hematology hemonc cme ce']\n",
      "['event link', 'tomorrows cll event', 'questions dm']\n",
      "['zanubrutinib treatment', 'unresponsive chronic lymphocytic leukemia leukemia']\n",
      "['new article management', 'atypical chronic lymphocytic leukemia', 'extreme leukocytosis cll leusm hematology']\n",
      "['new article', 'car t cell therapy', 'lymphoproliferative neoplasms', 'clinical practice cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'radar view']\n",
      "['btk inhibitors', 'monoclonal antibodies', 'chronic lymphocytic leukemia leusm']\n",
      "['chronic lymphocytic leukemia cll clinical update']\n",
      "['iqvia experts', 'identify patients', 'near future', 'oncology care', 'asco20 virtual', 'scientific program']\n",
      "['mind researchers', 'numerous cancers', 'intrahepatic bile duct cancers', 'chronic lymphocytic leukemia', 'mantle cell lymphoma']\n",
      "['cll cll']\n",
      "['tgtherapeutics announces', 'final results', 'genuine phase', 'high risk chroniclymphocyticleukemia']\n",
      "['blood cancer patients']\n",
      "['don t', 'new abstracts', 'chronic lymphocytic leukemia', 'asco20 cancer bloodcancer leusm medtwitter cll']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['great collection', 'asco20 lymphoma', 'cll abstracts thanks']\n",
      "['cll cells', 'ror1 chronic lymphocytic leukemia cll', 'mantle cell lymphoma mcl', 'b cell receptor bcr']\n",
      "['annual meeting', 'new articles', 'top presentations', 'cll eha25virtual']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['pumpkin delays cell proliferation', 'human chronic lymphocytic leukemia cell line', 'autophagic flux carotenoid pumpkin leukemia', 'social media channels']\n",
      "['excellent review', 'complex roles', 't cells', 'cll t cells', 'chronic lymphocytic leukemia guardians']\n",
      "['asco20 zanubrutinib obinutuzumab', 'similar rates', 'undetectable peripheral blood mrd', 'leusm lymsm']\n",
      "['chronic lymphocytic leukemia']\n",
      "['cd20 mab btki story twists', 'ublituximab benefit', 'tp53 disruption vs nil', '11q del lymsm cll']\n",
      "['congress asco20 cirmtuzumab', 'new mab', 'targets ror1 hun ju lee', 'mantle cell lymphoma', 'cll lymsm']\n",
      "['online hematology covid research agenda areas hematologists', 'blood cancer researchers', 'top priority i', 'patients patient groups', 'disease therapy', 'specific risks', 'heme malignancies cll mpnsm leusm']\n",
      "['long intergenic non', 'rna p21', 'poor prognosis', 'chronic lymphocytic leukemia']\n",
      "['congress asco20 murano phase iii trial', 'onconotes reports', 'new analysis', 'survival outcomes', 'discontinuation interruption', 'dose modification', 'r r cll']\n",
      "['congress asco20', 'genuine phase iii trial sharman', 'final results', 'cd20 ibrutinib vs ibrutinib', 'high risk r r cll', 'orr mrd neg', 'pfs lymsm']\n",
      "['new article', 'long intergenic non', 'rna p21', 'poor prognosis', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article optic neuropathy', 'chronic lymphocytic leukemia', 'disease cll leusm hematology']\n",
      "['new article cytomegalovirus proctitis', 'chronic lymphocytic leukemia', 'ibrutinib therapy', 'case report cll leusm hematology']\n",
      "['cll update car t cell therapy', 'early data', 'synergetic response', 'cr median f u', 'mos asco20 asco2020 cll']\n",
      "['nice abstract', 'r epoch vr epoch', 'richter s transformation', 'cr rate', 'arm study', 'great area', 'new therapies']\n",
      "['annual meeting', 'twittermoment asco20 lymphoma cll']\n",
      "['venetoclax venclexta w rituximab', 'superior progression', 'free survival', 'refractory chronic lymphocytic leukemia asco20']\n",
      "['hey cll colleagues', 'opinion i m', 'sure i m', 'i don t']\n",
      "['scan results stochastic', 'cll ajb riv ghh hur', 'chrt tan enog head ntbr mmx']\n",
      "['scan results bullish']\n",
      "['chronic lymphocytic leukemia', 'jak2 stat3 pathway', 'cll cell death', 'protective bone marrow microenvironment']\n",
      "['cll patients', 'financial support', 'lrf s covid', 'financial assistance grant', 'food transportation', 'utilities childcare', 'medical devices']\n",
      "['previous runs haven t', 'halvings btc bitcoin crypto cryptocurrency asset digitalassets cll crypto']\n",
      "['blood malignancies', 'non hodgkin lymphoma chronic lymphocytic leukemia', 'acute myeloid leukemia', 'multiple myeloma', 'corona carlos carrasco didn t', 'players aren t']\n",
      "['patient experience', 'cll patients', 'interim report', 'online spotleukaemia']\n",
      "['chronic lymphocytic leukemia', 'secondary hematological malignancies', 'wide cancer registry study abstract hematolog']\n",
      "['chronic lymphocytic leukemia dr', 'cll experts assess', 'patient s readiness', 'car t cell therapy', 'leusm leukemia cancertreatment']\n",
      "['long term', 'cd19 car t cell therapy', 'b cell lymphoma', 'chronic lymphocytic leukemia asco20']\n",
      "['tg therapeutics announces', 'final results', 'genuine phase', 'high risk chronic lymphocytic leukemia', '56th american society', 'clinical oncology', 'annual meeting']\n",
      "['tg therapeutics announces', 'final results', 'genuine phase', 'high risk chronic lymphocytic leukemia', '56th american society', 'clinical oncology', 'annual meeting']\n",
      "['congress asco20 reports', 'venetoclax r epoch', 'richter s syndrome leukemia lymsm']\n",
      "['patients delay chronic lymphocytic leukemia cll treatment', 'covid19 tune', '2pm est', 'own cll expert dr john allan amp others']\n",
      "['tgtx tg therapeutics announces', 'final results', 'genuine phase']\n",
      "['tgtx tg therapeutics announces', 'final results', 'genuine phase', 'high risk chronic lymphocytic leukemia', '56th american society', 'clinical oncology', 'annual meeting']\n",
      "['tg therapeutics announces', 'final results', 'genuine phase']\n",
      "['tg therapeutics announces', 'final results', 'genuine phase', 'high risk chronic lymphocytic leukemia', '56th american society', 'clinical oncology', 'annual meeting tgtx asco20']\n",
      "['tgtx tg therapeutics announces', 'final results', 'genuine phase', 'high risk chronic lymphocytic leukemia', '56th american society', 'clinical oncology', 'annual meeting']\n",
      "['tgtx tg therapeutics announces', 'final results', 'genuine phase', 'high risk chronic lymphocytic leukemia', '56th american society', 'clinical oncology', 'annual meeting']\n",
      "['tgtx tg therapeutics announces', 'final results', 'genuine phase', 'high risk chronic lymphocytic leukemia', '56th american society', 'clinical oncology', 'annual meeting']\n",
      "['tg therapeutics announces', 'final results', 'genuine phase', 'high risk chronic lymphocytic leukemia', '56th american society', 'clinical oncology', 'annual meeting tgtx']\n",
      "['tgtx tg therapeutics announces', 'final results', 'genuine phase', 'high risk chronic lymphocytic leukemia', '56th american society', 'clinical oncology', 'annual meeting']\n",
      "['car t cell therapy', 'chronic lymphocytic leukemia', 'transcend cll', 'liso cel', 'refractory disease']\n",
      "['new article differences', 'temporal changes', 'invasive pneumococcal disease', 'hematological malignancies results', 'year cohort study cll leusm hematology']\n",
      "['current perspectives', 'chronic lymphocytic leukemia american society', 'clinical oncology', 'educational book']\n",
      "['free light chain ratios', 'clinical progression', 'chronic lymphocytic leukemia view']\n",
      "['chronic lymphocytic leukemia lymphocytic lymphoma', 'waldenstrom disease', 'condition chronic lymphocytic leukemia lymphocytic lymphoma', 'coronavirus sars cov']\n",
      "['neutrophils microbicidal activity', 'chronic lymphocytic leukemia', 'early phases']\n",
      "['chronic lymphocytic leukemia cells', 'survival advantage', 'articles stat3', 'chronic lymphocytic leukemia cells', 'survival advantage j immunol', 'authors rozovski']\n",
      "['long term data support ibrutinib monotherapy', 'sll leusm jnccn360']\n",
      "['optimal treatment options', 'chronic lymphocytic leukemia']\n",
      "['cognitive impairment', 'chronic lymphocytic leukemia']\n",
      "['cll pts']\n",
      "['cognitive impairment', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['new article clinical value', 'notch1 mutations detection', 'chronic lymphocytic leukemia patients cll leusm hematology']\n",
      "['new article non aspergillus invasive mold infections', 'ibrutinib cll leusm hematology']\n",
      "['new article t cells', 'chronic lymphocytic leukemia guardians', 'disease cll leusm hematology']\n",
      "['husband goodburn', 'chronic lymphocytic leukaemia', 'cancer leukaemia cll bloodcancer']\n",
      "['wer sind', 'unerm dlichen', 'der krebsforschung ma st', 'setzen vor', 'jahren ehrten wir mit dem deutschen krebspreis f r seine cll forschung zum worldbloodcancerday empfehlen wir einen blick auf sein forscherleben']\n",
      "['smallthingsbigdifference booklet reveals heart', 'cll download', 'booklet mycllife']\n",
      "['current perspectives', 'chronic lymphocytic leukemia asco', 'educational book']\n",
      "['hasn t', 'leukaemia cll fevers headaches fatigue']\n",
      "['renal involvement', 'chronic lymphocytic leukemia clinical kidney journal oxford']\n",
      "['predictive tool', 'early stage cll']\n",
      "['international prognostic score', 'stage cll']\n",
      "['video horizon scan cll', 'car t w constantine tam', 'leusm tcellrx immunoonc hemonc oncoalert']\n",
      "['meeting library', 'long term', 'cd19 car t cell therapy', 'b cell lymphoma', 'chronic lymphocytic leukemia']\n",
      "['ibrutinib imbruvica pharmacyclics', 'primary treatment', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['mutant notch1', 'nurd corepressor', 'complex upregulates ccl17', 'chronic lymphocytic leukemia']\n",
      "['goede berichten terug uit t ziekenhuis gekomen', 'm n moeder chemokuur bij haar heeft voldoende geholpen', 'maanden terug voor controle dankbaar amp blij', 'blijven voorzichtig', 'nog steeds haar een grote vijand voor haar cll']\n",
      "['new article', 'late onset', 'acral necrosis', 'sars cov', 'infection resolution cll leusm hematology']\n",
      "['clinical presentation summary', 'tumor lysis syndrome', 'renal involvement', 'chronic lymphocytic leukemia', 'ckj openaccess onconephrology kidneycancer']\n",
      "['genomic alterations', 'high risk chronic lymphocytic leukemia', 'cell cycle key regulators', 'transcription edelmann']\n",
      "['car t', 'online cme activities']\n",
      "['scan results hammer candlestick', 'bby mini tgp pip ton mct', 'osi ggp drv csn atqt ghh cll acc web']\n",
      "['leukemia therapeutics market', 'leukemia therapeutics market categories', 'global market', 'type cll', 'cml aml treatment type chemotherapy amp']\n",
      "['data release', 'asco presentations phase', 'chronic lymphocytic leukemia', 'non hodgkin lymphomas']\n",
      "['long term', 'patients w']\n",
      "['smallthingsbigdifference booklet', 'unknown encouraging people', 'care download', 'booklet mycllife']\n",
      "['tumor lysis syndrome', 'chronic lymphocytic leukemia cll', 'routine clinical practice lymphoma lymsm']\n",
      "['new article incidence', 'tumor lysis syndrome', 'chronic lymphocytic leukemia cll', 'routine clinical practice cll leusm hematology']\n",
      "['chronic lymphocytic leukemia cll', 'white blood cell', 'lymphocyte lymphocytes', 'click chroniclymphocyticleukemia clltreatment medicaltourismindia healingtouristry']\n",
      "['long term outcomes', 'car t cells treatment', 'unresponsive chronic l']\n",
      "['transport 4wd cll wssp']\n",
      "['car t', 'online cme activities']\n",
      "['muscle pain', 'chronic lymphocytic leukemia tre']\n",
      "['international prognostic score', 'stage chronic lymphocytic leukemia blood american society']\n",
      "['natural prevention', 'chronic lymphocytic leukemia']\n",
      "['imatinib gleevec', 'chronic myelogenous leukemia cml', 'acute lymphocytic leukemia', 'philadelphia chromosome', 'positive ph', 'gastrointestinal stromal tumors gist']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['cll community', 'anonymous survey']\n",
      "['cll amp mantle cell lymphoma', 'data re cirmtuzumab monoclonal', 'r r mcl', 'rx na ve', 'r r cll pts efficacy mcl', 'cr efficacy cll', 'cr ror1 v', 'interesting novel target lymsm asco20']\n",
      "['discontinuation reason', 'short term interruption', 'w pfs', 'early discontinuation', 'w pfs optimum time length', 'venetoclax therapy', 'r r cll asco20']\n",
      "['new article infectious complications', 'tyrosine kinase inhibitors', 'hematological malignancies cll leusm hematology']\n",
      "['boven regimen', 'frontline cll high rates', 'undetectable mrd', 'great partnership']\n",
      "['skarbnik describe', 'chronic lymphocytic leukemia', 'btk inhibition', 'current trends', 'impact treatment selection leusm leukemias']\n",
      "['chronic lymphocytic leukemia', 'cancer journey', 'co founder brian koffman']\n",
      "['chronic lymphocytic leukemia', 'pancreatic involvement']\n",
      "['lovely idea', 'experience i', 'covid19 coronavirus 1percent collateraldamage wearenotinthistogether staysafe stayhome lockdown bloodcancer cll']\n",
      "['experts checkout data', 'niaid trial', 'remdesivir coronavirusrecovery covid19 cll']\n",
      "['useful tool', 'ighv status', 'predictive tool', 'early stage cll blood american society']\n",
      "['chronic lymphocytic leukemia', 'car t cell therapy', 'cll expert', 'question leusm leukemia']\n",
      "['new article development', 'quick uplc ms ms method', 'pharmacokinetic analysis', 'beagle dogs cll leusm hematology']\n",
      "['bjh article', 'protective role', 'btk inhibitors', 'chronic lymphocytic leukemia']\n",
      "['mitochondria mitochondrial genome', 'circrna mc cox2 functions', 'chronic lymphocytic leukemia']\n",
      "['cll cells', 'restores cd8 t cell responses']\n",
      "['mitochondrial genome', 'circrna mc cox2 functions', 'chronic lymphocytic leukemia']\n",
      "['term outcomes', 'car t cells treatment', 'unresponsive chroni']\n",
      "['chronic lymphocytic leukemia', 'cll patient register', 'expert discussion']\n",
      "['gene mutations', 'chromosomal aberrations', 'free survival', 'chronic lymphocytic leukemia patients', 'front line chemoimmunotherapy clinical practice experience']\n",
      "['new article mitochondrial genome', 'circrna mc cox2 functions', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'predictive tool', 'early stage cll cll leusm hematology']\n",
      "['international prognostic score', 'stage chronic lymphocytic leukemia blood american society']\n",
      "['sytuacja chorych na choroby rzadkie w czasie pandemii gov pl klrwp chorobyrzadkie sma cll tnp pandemia']\n",
      "['print online april 17th', 'btki clinical trials', 'btk inhibitor ibrutinib', 'pulmonary injury', 'patients hematology cll leusm']\n",
      "['full body fever leukaemia cll symptoms awakeandready']\n",
      "['great discussion', 'cll risks treatments management', 'prevention covid']\n",
      "['chronic lymphocytic leukemia research']\n",
      "['international prognostic score', 'stage chronic lymphocytic leukemia cll american society', 'hematology hematology cllsm leusm']\n",
      "['review data', 'high frequency', 'germline runx1 mutations', 'international prognostic score', 'predicts time', '1st treatment', 'cll patients', 'early asymptomatic disease']\n",
      "['cfc foreverblue cll jt']\n",
      "['cloud lunch', 'great speaker victor rodrigues', 'azure iot', 'pm utc', 'cll msdevirl azure']\n",
      "['chronic lymphocytic leukemia cll', 'fish ighv', 'tp53 gene']\n",
      "['chronic lymphocytic leukemia', 'cll patient register', 'expert discussion']\n",
      "['cme activities', 'new advances', 'cll mantlecelllymphoma patient care lots', 'clinical insight', 'don t']\n",
      "['sister blood cancer charities amp', 'pharmaceutical company', 'encouraging quotations', 'cll patients', 'website bloodcancerawareness']\n",
      "['new article', 'protective role', 'btk inhibitors', 'chronic lymphocytic leukemia', 'cll leusm hematology']\n",
      "['new article cll', 'hospital clinic', 'interim report cll leusm hematology']\n",
      "['new article response', 'sensorimotor neuropathy', 'atypical chronic lymphocytic leukemia', 'rituximab therapy cll leusm hematology']\n",
      "['long term outcomes', 'car t cells treatment']\n",
      "['smallthingsbigdifference booklet', 'cll download', 'mycllife materials', 'abbvieuk youtube oncology playlist']\n",
      "['t recall', 'cancer treatment series']\n",
      "['peripheral eosinophilia', 'eosinophilic bronchopneumopathy', 'chronic lymphocytic leukemia']\n",
      "['cll14 update 3y pfs', 'venetoclax g vs', 'chl g benefit', 'risk grps', 'ighv pts hr', 'pb umrd 18m post veng', 'eot predictive', 'interesting spm', 'ven vs', 'chl needs', 'duration option', '1l cll pts']\n",
      "['covid19 patients cll', 'protective role', 'btk inhibitors', 'chronic lymphocytic leukemia']\n",
      "['interactive webcast', 'pandemic register', 'expert faculty members']\n",
      "['protective role', 'btk inhibitors', 'chronic lymphocytic leukemia']\n",
      "['free webinar', 'treatment options', 'healthcare team', 'life issues register gt gt']\n",
      "['new article', 'hyperkalemia versus pseudohyperkalemia', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article crystalglobulin', 'monoclonal b cell lymphocytosis', 'case report cll leusm hematology']\n",
      "['rns aim cll cello health plc result']\n",
      "['cll cello health fair value', 'share suggests broker', 'uk cll']\n",
      "['solid net cash position', 'cash generation', 'current year', 'good cll 115p cello health rises', 'half performance', 'pandemic disruption']\n",
      "['cll cello health rises', 'half performance', 'pandemic disruption', 'uk cll']\n",
      "['cll cello health rises', 'half performance', 'pandemic disruption', 'uk cll']\n",
      "['cll update', 'anticipates cello signal', 'virus impact', 'small division', 'decent business', 'cash i don t hold']\n",
      "['cello health cll', 'overall progress']\n",
      "['rns aim cll cello health plc agm statement']\n",
      "['chronic lymphocytic leukemia lymphocytic lymphoma', 'waldenstrom disease']\n",
      "['dr dressler', 'blood cancer', 'dog cancer answers chronic lymphocytic leukemia', 'favorite podcast app']\n",
      "['prognostic significance', 'cytogenetic complexity', 'chronic lymphocytic leukemia haematology thewiderwiserview']\n",
      "['new research evaluation', 'somatic hypermutation status', 'chronic lymphocytic leukemia cll', 'somatic hypermutation shm status', 'important prognostic indicator', 'chronic lymphocytic celldevbio']\n",
      "['pa school', 'positive i', 'rural family', 'hospital hematology', 'outpatient cll', 'subject matter expert', 'disease i', 'major academic center']\n",
      "['frontiers evaluation', 'somatic hypermutation status', 'chronic lymphocytic leukemia cll', 'developmental biology']\n",
      "['richters transformation', 'spanish cll study group gellc paper', 'pau amp colleagues lymsm prognostication', 'richter syndrome context']\n",
      "['smallthingsbigdifference booklet', 'emotional needs']\n",
      "['tumor mutational load', 'strong predictor', 'chronic lymphocytic leukemia', 'monoclonal b cell lymphocytosis', 'new study leukemias cllsm']\n",
      "['international prognostic score', 'stage chronic lymphocytic leukemia oncology hematology healthbook leukemia']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'btk inhibitor zanubrutinib phase']\n",
      "['new article feasibility', 'cd19 car t cell treatment', 'b cell lymphoma relapse', 'allogeneic hematopoietic stem cell transplantation cll leusm hematology']\n",
      "['new article', 'chronic lymphocytic leukemia cells', 'restores cd8 t cell responses cll leusm hematology']\n",
      "['new article ugt2b17 modifies drug response', 'chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['openbiology study shows', 'new compound ezn', 'good candidate', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['long term outcomes', 'car t cells treatment', 'unrespons leukemia']\n",
      "['chronic lymphocytic leukemia', 'uncertain futures', 'difficult time', 'need treatment', 'new research suggests tumor mutational load', 'helpful prognostic tool leusm']\n",
      "['scan results macd bearish centerline cross', 'biln brck igp pat utlf mtu hrn i3e cnks ancr aptd sun cll rwa']\n",
      "['great cll']\n",
      "['refractory chronic lymphocytic leukemia', 'cd19 car t cells', 'complete responses', 'study results', 's journal', 'clinical oncology cart celltherapy']\n",
      "['eqa summary report', 'individual laboratory report ilr', 'eqas chronic lymphocytic leukaemia cll ighv mutation status', 'chronic lymphocytic leukaemia cll tp53', 'available login', 'results cll ighv tp53']\n",
      "['real world healthcare resource utilization', 'medicare patients', 'chronic lymphocytic leukemia', 'line ibrutinib vs chemoimmunotherapy']\n",
      "['chronic lymphocytic leukemia cll expert dr ian flinn discusses clinical trials', 'treatment tune', 'leusm chronicillness']\n",
      "['acp bekijkt', 'medicijn bij chronische lymfatische leukemie cll nationale zorggids ibrutinib imbruvica']\n",
      "['households family', 'cll patient i']\n",
      "['j rt share cll bloodcancer leukaemia uk covid19 coronavirus staysafe stayhome']\n",
      "['jennifer woyach md', 'james discusses', 'chronic lymphocytic leukemia leusm']\n",
      "['expert interview dr ian w flinn discusses', 'large b cell lymphoma chroniclymphocyticleukemia', 'full interview', 'oncology amp hematology review']\n",
      "['new clinical trial observatory', 'chronic lymphocytic leukemia lymphocytic lymphoma', 'waldenstrom disease', 'cll leusm hematology']\n",
      "['adverse events', 'novel cll treatment agents', 'cll pts']\n",
      "['chronic lymphocytic leukemia', 'basal cell carcinoma biopsy']\n",
      "['experts describe', 'chronic lymphocytic leukemia', 'btk inhibition', 'current trends', 'impact treatment selection btkinhibitor cllsm']\n",
      "['new article', 'chronic lymphocytic leukemia', 'basal cell carcinoma biopsy cll leusm hematology']\n",
      "['new article management', 'ibrutinib toxicities', 'cll leusm hematology']\n",
      "['new article prognostic significance', 'cytogenetic complexity', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'frequent mutations', 'pot1 distinguish pulmonary sarcomatoid carcinoma', 'lung cancer histologies cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'basal cell carcinoma biopsy']\n",
      "['high risk chronic lymphocytic leukemia ascodailynews asco20 leusm']\n",
      "['chronic lymphocytic leukemia cll expert dr', 'car t cell therapy', 'important role clinical trials', 'education play', 'novel therapy leusm leukemia immunotherapy']\n",
      "['long term outcomes', 'car t cells treatment', 'unresponsive chronic lym']\n",
      "['combination therapies', 'chronic lymphocytic leukemia leusm']\n",
      "['current evidence', 'future direction webinar registernow healthcare cll leukemia hematology']\n",
      "['ophthalmic involvement', 'chronic lymphocytic leukemia', 'systematic review', 'cases lymphoma lymsm']\n",
      "[]\n",
      "['pesticide dicamba', 'numerous cancers', 'intrahepatic bile duct cancers', 'chronic lymphocytic leukemia', 'mantle cell lymphoma']\n",
      "['i ve', 'cancer diagnosis', 'cll visit', 'cll heath center']\n",
      "['study findings', 'complete response', 'cd19 car t cell infusion', 'pfs regardless', 'cell dose']\n",
      "['openbiology study shows', 'new compound ezn', 'good candidate', 'chronic lymphocytic leukemia']\n",
      "['salvage therapy', 'allogeneic hct', 'chronic lymphocytic leukemia ibrutinib', 'cll relapse', 'allo hsct', 'comparable efficacy', 'high risk disease']\n",
      "['new article ophthalmic involvement', 'chronic lymphocytic leukemia', 'systematic review', 'cases cll leusm hematology']\n",
      "['new article investigational treatments', 'chronic lymphocytic leukemia', 'clinical trials cll leusm hematology']\n",
      "['new article web', 'self management', 'lymphoma assessment', 'trial cll leusm hematology']\n",
      "['new article chemical', 'semiconductor surfaces cll leusm hematology']\n",
      "['new article survey', 'ex vivo drug combination', 'chronic lymphocytic leukemia reveals synergistic drug', 'genetic dependencies cll leusm hematology']\n",
      "['new article treatment algorithm', 'japanese patients', 'chronic lymphocytic leukemia', 'therapies cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['vulnerable patients', 'patients note item', 'appendix pass', 'haematology consultants amp gps cll bloodcancerawareness leukaemia']\n",
      "['interactive cme webcast', 'drs amp sharman', 'info registration']\n",
      "['amazing partner schools links', 'cache eye unit', 'emergent literacy eytwittertagteam literacy cll']\n",
      "['cache eye unit', 'emergent literacy', 'books eytwittertagteam reading literacy books cll readingforpleasure storytime']\n",
      "['great cancer seminar', 'pathways bi']\n",
      "['world i', 'night s bloodcancers virtual support group aml multiplemyeloma leukemia lymphoma cll']\n",
      "['john m burke md amp manuel', 'santiago md', 'therapeutic approaches', 'patient management algorithms', 'cme credits']\n",
      "['dr bourne', 'chronic lymphocytic leukemia', 's teachingpoint']\n",
      "['chronic lymphocytic leukemia cll', 'treatment options']\n",
      "['mind blog trademark ownership counts', 'application trademark intenttouse trademarkapplicant trademarkownership cll']\n",
      "['thanks prof dominique bron', 'experience geriheme']\n",
      "['eurobloodnet webinar']\n",
      "['high dose', 'car t', 'low dose', 'complete response', 'excessive toxicity']\n",
      "['new ibrutinib', 'refractory chronic lymphocytic leukemia l']\n",
      "['drug synergies', 'chronic lymphocytic leukemia', 'ex vivo drug response', 'powerful tool', 'optimize combinatorial drug choice', 'precision medicine', 'marina lukas']\n",
      "['new article samhd1 limits', 'dgtp cll leusm hematology']\n",
      "['new article', 'real world data', 'chlorambucil rituximab', 'frontline treatment', 'chronic lymphocytic leukemia', 'go cllear study', 'cll leusm hematology']\n",
      "['new article', 'real world treatment patterns', 'adverse events resource use', 'chronic lymphocytic leukemia', 'retrospective cohort study cll leusm hematology']\n",
      "['new article ezn', 'treatment suppresses chronic lymphocytic leukaemia', 'environmental protection', 'increases response', 'fludarabine cll leusm hematology']\n",
      "['new article', 'monoclonal b cell lymphocytosis', 'egyptian relatives', 'cll patients cll leusm hematology']\n",
      "['grp78 hif', 'bag3 expression', 'chronic lymphocytic leukemia']\n",
      "['ex vivo drug combination', 'chronic lymphocytic leukemia', 'synergistic drug', 'genetic dependencies', 'marina lukas', 'thorsten zenz']\n",
      "['bruce g raphael md', 'tumor lysis syndrome', 'chronic lymphocytic leukemia leusm']\n",
      "['asco20 tgtx', 'final results', 'geniune phase', 'ublituximab ibrutinib', 'r r cll utx ib n', 'vs ib n', 'cr cri', 'mrd neg', 'results support maintenance therapy', 'utx abstract']\n",
      "['8pm eastern', 'free drop', 'aml multiplemyeloma leukemia lymphoma cll']\n",
      "['pfs orr', 'mrd negativity', 'high risk chronic lymphocytic leukemia', 'final results', 'genuine phase iii study tgtx asco20']\n",
      "['scan results macd bearish signal line cross', 'tri pet rdi mmit cll hyve sli ssty dddd luce digs pph reci edin bwy sclp']\n",
      "['new treatments', 'chronic lymphocytic leukemia']\n",
      "['fda approves imbruvica', 'chronic lymphocytic leukemia']\n",
      "['grace blood cancer video library dr joshua brody shares information', 'cll chronic lymphocytic leukemia', 'new generation', 'btk inhibitors cancer cancertreatment cancergrace bloodcancer cll leukemia cancerpatients btkinhibitor']\n",
      "['multiple bcl2 mutations co', 'chronic lymphocytic leukemia cll progression', 'venetoclax jan', 'cllsm leusm']\n",
      "['real world treatment patterns', 'adverse events resource use', 'chronic lymphocytic leukemia', 'retrospective cohort study']\n",
      "['s webinar', 'chroniclymphocyticleukemia register', 'rarediseases hematology erneu']\n",
      "['refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'btk inhibitor zanubrutinib phase', 'arm multicenter study lymphoma lymsm']\n",
      "['new article merkel cell carcinoma', 'chronic lymphocytic leukemia', 'successful treatment', 'pd l', 'inhibition avelumab', 'chlorambucil cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia', 'riches cll leusm hematology']\n",
      "['new article', 'dependent artifacts', 'cell genomics studies cll leusm hematology']\n",
      "['michael choi md', 'chronic lymphocytic leukemia leusm']\n",
      "['new article treatment', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'btk inhibitor zanubrutinib phase', 'arm multicenter study cll leusm hematology']\n",
      "['prognosis assessment', 'early stage chronic lymphocytic leukemia', 'clinical evolution', 'crystal ball', 'ncbi hvhebron hemat']\n",
      "['free drop', 'bones blood cancers virtual support group', 'pm eastern aml multiplemyeloma leukemia lymphoma cll']\n",
      "['health canada approves', 'biosimilar rituximab riximyo', 'rheumatoid arthritis chronic lymphocytic leukemia amp non hodgkin s lymphoma arc acmts']\n",
      "['deep dive', 'leukemic cell metabolism', 'chris fletcher', 'uw2020 award', 'lab s work', 'actual patients', 'cancer sms']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia', 'tait shanafelt', 'drug combo', 'leukemia control', 'standard care cll']\n",
      "[]\n",
      "['early results', 'new treatment', 'refractory cll sll', 'annual virtual meeting', 'promising new data']\n",
      "['cme activity', 'mantlecelllymphoma patient care knowledge', 'virtual patients', 'critical clinical decisions', 'clinical option lymsm']\n",
      "['deborah g kirkland rn bsn mph cn bn', 'nurse navigator', 'hoffberger breast center', 'online article', 'cll chronic lymphocytic leukemia society page deb discusses', 'patient navigator']\n",
      "['trademark law', 'book title', 'trademarks cll']\n",
      "['full panic mode', 'insurance fuckcancer cll leukemiasucks', 's buying kidneys']\n",
      "['chronic lymphocytic leukemia', 'cll specialist', 'treatment options', 'setting patient goals register', 'leukemia leusm']\n",
      "['fda approves imbruvica', 'chronic lymphocytic leukemia']\n",
      "['epigenetic dysregulation', 'chronic lymphocytic leukemia', 'exciting study', 'karsten rippe']\n",
      "['ras braf mapk erk pathway', 'specific subgroup', 'adverse clinical', 'new therapeutic options', 'chronic lymphocytic leukemia asturias publihuca text']\n",
      "['clinical data', 'chronic lymphocytic leukemia cll', 'w drs jennie crews']\n",
      "['prognosis assessment', 'early stage chronic lymphocytic leukemia', 'clinical evolution', 'crystal ball lymphoma lymsm']\n",
      "['new article prognosis assessment', 'early stage chronic lymphocytic leukemia', 'clinical evolution', 'crystal ball mmsm multiplemyeloma hematology']\n",
      "['positive topline results', 'unity cll phase iii study', 'ublituximab u2', 'chronic lymphocytic leukemia lymsm']\n",
      "['thursday eurobloodnet webinar', 'prof dominique bron register', 'rarediseases hematology erneu']\n",
      "['refractory chronic lymphocytic leukemia', 'car t cells', 'complete responses regardless', 'cell dose', 'long term survival leusm']\n",
      "['antitumor effect', 'b cells', 'chronic lymphocytic leukemia patients']\n",
      "['treatment leusm leukemia jnccn360']\n",
      "['ophthopedia update ophthalmic involvement', 'chronic lymphocytic leukemia', 'systematic review', 'cases ophthalmology eye ophthotwitter']\n",
      "['nutrisci assistant professor', 'uw2020 award', 'leukemic cells', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll patients', 'cll experts', 'patient outcomes leusm leukemia chronicillness']\n",
      "['blood commentary car t', 'ibrutinib vs cll sequential', 'simultaneous immnobiology immunotherapy']\n",
      "['car t cells', 'concurrent ibrutinib', 'ibrutinib failure']\n",
      "['new prognostic tool', 'chronic lymphocytic leukemia patients']\n",
      "['video cll', 'disease discontinuation', 'mrd w barbara eichhorst', 'leusm hemeonc oncoalert']\n",
      "['survival rates', 'ibrutinib therapy leusm jnccn360']\n",
      "['chronic lymphocytic leukemia', 'cll specialist', 'treatment options', 'setting patient goals register', 'leukemia leusm']\n",
      "['leukemia therapeutics market', 'marketsandmarkets leukemia therapeutics market categories', 'global market', 'type cll', 'cml aml treatment type chemo']\n",
      "['clinical risks', 'cll leusm coronavirus covid19ncancer jnccn360']\n",
      "['chronic lymphocytic leukemia cll patients', 'cancer diagnosis', 'treatment options', 'cll treatment leusm leukemia cancertreatment carepartners']\n",
      "['radioactive gas', 'lung cancer', 'u s radon', 'chronic lymphocytic leukemia', 'exposure results']\n",
      "['attention onc clinicians', 'cme activities', 'new developments', 'cll mantlecelllymphoma management', 'essential evidence', 'optimal care practices lymsm']\n",
      "['dr woyach discusses', 'adverse events', 'toxicity profiles', 'frontline setting', 'chronic lymphocytic leukemia leukemias']\n",
      "['subcutaneous masses', 'unusual manifestation', 'atypical chronic lymphocytic leukemia', 'prolymphocytoid transformation', 'complex karyotype', 'diagnostic dilemma', 'treatment challenge lymphoma lymsm']\n",
      "['new article subcutaneous masses', 'unusual manifestation', 'atypical chronic lymphocytic leukemia', 'prolymphocytoid transformation', 'complex karyotype', 'diagnostic dilemma', 'treatment challenge cll leusm hematology']\n",
      "['new article covid', 'therapy naive patients', 'b cell chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'protein sp family immunity s chromatin readers cll leusm hematology']\n",
      "['fda approves imbruvica', 'chronic lymphocytic leukemia']\n",
      "['condition chronic lymphocytic leukemia cll mbbs medquiz usmle', 'neetpg medvibes', 'medical motivation fun', 'thuglife sarcasm mcq medicinequotes quotes medicalmnemonics medcomics']\n",
      "['free survival', 'chronic lymphocytic leukemia', 'primary end point', 'global phase iii unity cll trial cllsm']\n",
      "['investigational reversible btk inhibitors', 'preliminary activity', 'chronic lymphocytic leukemia', 'irreversible inhibitors leusm']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['irreversible btk inhibitors']\n",
      "['wan na', 'basketball court', 'backyard cll fieldofdreams']\n",
      "['antitumor effect', 'b cells', 'chronic lymphocytic leukemia patients', 'manouchehri doulabi e abbaspour s rostami s faranoush m ghahramanfard f pak f barati m kokhaei p momtazi borojeni aa']\n",
      "['rna editing alters mirna function', 'chronic lymphocytic leukemia']\n",
      "['new article', 'antitumor effect', 'b cells', 'chronic lymphocytic leukemia patients cll leusm hematology']\n",
      "['new article advances', 'car t therapy', 'hematologic malignancies cll leusm hematology']\n",
      "['new article budget impact', 'treatment duration venetoclax', 'chronic lymphocytic leukemia patients', 'states cll leusm hematology']\n",
      "['new article', 'world evidence rwe', 'chronic lymphocytic leukemia', 'opportunities cll leusm hematology']\n",
      "['new article', 'ighv mutation analysis', 'cll cll leusm hematology']\n",
      "['new article novel pyrrolobenzodiazepine', 'hybrid molecules inhibit nf b activity', 'hematological cancers cll leusm hematology']\n",
      "['new article', 'family coordinates mitochondrial network dynamics', 'stem cell fate cll leusm hematology']\n",
      "['new article rna editing alters mirna function', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['umbralisib ublituximab', 'refractory chronic lymphocytic leukemia cll', 'frontline btk inhibition', 'paul m barr md tgtx']\n",
      "['chronic lymphocytic leukemia', 'new series people', 'cll patient advocates', 'moderate popular online support groups leusm leukemia cancercare cancer']\n",
      "['dr laura michaelis', 'chronic lymphocytic leukemia', 'pandemic hematology leusm covid19 coronavirus']\n",
      "['chronic lymphocytic leukemia treatment pdq health', 'professional version', 'national cancer institute nci']\n",
      "['chronic lymphocytic leukemia']\n",
      "['lo dudes m s p sate por nuestra web y descubre todos nuestros cursosonline y m sterdigitales', 'con los que podr s cambiartuvida y convertirte', 'un profesional', 'xito formaci nonline cll']\n",
      "['imatinib gleevec', 'chronic myelogenous leukemia cml', 'acute lymphocytic leukemia', 'philadelphia chromosome', 'positive ph', 'gastrointestinal stromal tumors gist']\n",
      "['skarbnik describe', 'chronic lymphocytic leukemia', 'btk inhibition', 'current trends', 'impact treatment selection leusm leukemias']\n",
      "[]\n",
      "['phase iii unity cll trial', 'primary endpoint', 'interim analysis', 'superior efficacy']\n",
      "['research report', 'clinical space cll', 'case study authors', 'full article gt gt']\n",
      "['chronic lymphocytic leukemia cll visit', 'patient information support advocacy']\n",
      "['cancer update pandemic edition i m', 'chronic lymphocytic leukemia amp', 'full year cycle', 'bad cell counts', 'amp i ve']\n",
      "['dr ian flinn', 'new coronavirus', 'stem cell transplantations', 'chronic lymphocytic leukemia', 'myeloma clinical trials']\n",
      "['tgtherapeutics announces unitycll phase', 'ublituximab combination demonstrates efficacy', 'chronic lymphocyticleukemia chronic healthcare']\n",
      "['natural killer cells', 'obinutuzumab versus', 'immortal warriors chronic lymphocytic leukemia cells', 'xerxes army']\n",
      "['chronic lymphocytic leukemia', 'covid19 infectious disease specialist dr sydney hester shares expert advice', 'cll patients', 'leusm chronicillness coronavirus']\n",
      "['week s podcast reports', 'new mouse model', 'support human hematopoietic', 'tumor engraftment assess feasibility', 'car t cells', 'concurrent ibrutinib']\n",
      "['national institutes', 'health study links dicamba', 'cancer risks increases risk', 'numerous cancers', 'intrahepatic bile duct cancers', 'chronic lymphocytic leukemia', 'mantle cell lymphoma']\n",
      "['car t cells', 'concurrent ibrutinib', 'small study', 'crs grades', 'high orr mrd neg rate', 'high risk population']\n",
      "['impulsa tu carrera', 'con nuestro bootcamp', 'apachespark profundiza', 'soluci n m s eficiente y', 'popular para procesar enormes cantidades', 'lo dudes comenzamos', 'junio m s informaci n aqu formaci nonline cll']\n",
      "['celg phase', 'open label dose', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma nct02406742', 'primary completion date']\n",
      "['new article car t', 'ibrutinib vs cll sequential', 'simultaneous cll leusm hematology']\n",
      "['new article melanoma incidence', 'myelodysplastic syndrome', 'cohort population', 'study cll leusm hematology']\n",
      "['new article network', 'primary cells reveals drug response landscape', 'acute myeloid leukemia cll leusm hematology']\n",
      "['1st translational research conference', 'cll eshcll2020 november', 'chairs j', 'brown p ghia m hallek abstracts registration information eshconferences']\n",
      "['refractory chronic lymphocytic leukemia leusm']\n",
      "['intensity allogeneic stem cell transplant', 'chronic lymphocytic leukemia view']\n",
      "['eurobloodnet thursday webinar', 'prof dominique bron register', 'rarediseases hematology erneu']\n",
      "['work cll', 'venetoclax btk inhibitor']\n",
      "['muscle pain', 'chronic lymphocytic leukemi']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['line therapy', 'chronic lymphocytic leukemia', 'therapies btk inhibitors', 'nodal disease bcl2 inhibitors', 'bone marrow hematology hemeonc cll leusm lymsm nca notcovid medtwitter']\n",
      "['clinical trial models', 'clinical leader', 'virtual trial technologies cll virtualtrials clinicaltrials']\n",
      "['oncoalert feasibility', 'concurrent ibrutinib', 'ibrutinib failure american society', 'hematology hematology cllsm leusm lymsm']\n",
      "['oncoalert cartcell', 'ibrutinib vs cll sequential', 'simultaneous american society', 'hematology hematology cllsm leusm lymsm']\n",
      "['initial treatment', 'adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['car t cells', 'concurrent ibrutinib', 'ibrutinib failure blood american society', 'hematology leusm']\n",
      "['great work']\n",
      "['canada chronic lymphocytic leukemia cll accounts']\n",
      "['multiple bcl2 mutations co', 'chronic lymphocytic leukemia cll progression', 'venetoclax jan', 'cllsm leusm']\n",
      "['gene expression signature identifies', 'short survival', 'chronic lymphocytic leukemia']\n",
      "['helpful reflections']\n",
      "['chronic lymphocytic leukemia cll experts patients', 'care partners', 'treatment options', 'cll diagnosis', 'coronavirus pandemic']\n",
      "['line therapy', 'chronic lymphocytic leukemia', 'swedish nation', 'wide real world study', 'consecutive patients']\n",
      "['new article hematological malignancies', 'services cll leusm hematology']\n",
      "['gt gt']\n",
      "['expert gt']\n",
      "['thks r4today', 'isolation issues', 'cll leukaemia', 'bloodcancer patients', 'vulnerable letter causes problems']\n",
      "['chronic lymphocytic leukaemia cll', 'food deliveries', 'government cock']\n",
      "['excercise amp cll cc']\n",
      "['trump sprays millions acres', 'dicamba researchers', 'u s', 'national institutes', 'pesticide dicamba', 'numerous cancers', 'liver bile duct cancers chronic lymphocytic leukemia cell lymphoma']\n",
      "['chronic lymphocytic leukemia', 'cancer journey']\n",
      "['tentative steps', 'cll community', 'covid19 crisis']\n",
      "['dyk chronic lymphocytic leukemia cll', 'bone marrow', 'common types']\n",
      "['therapeutic strategies', 'chronic lymphocytic leukemia cll', 'pharmacist s role']\n",
      "['dr woyach discusses', 'adverse events', 'toxicity profiles', 'frontline setting', 'chronic lymphocytic leukemia cllsm leusm']\n",
      "['ublituximab improves progression', 'free survival', 'chronic lymphocytic leukemia raredisease rd360 cll']\n",
      "['free survival', 'chronic lymphocytic leukemia leukemia']\n",
      "['covid19 amp cll webinar', 'dr piers patten kings college london amp marc auckland', 'cll patient pre register']\n",
      "['tg therapeutics inc', 'unity cll phase', 'chronic lymphocytic leukemia', 'primary endpoint']\n",
      "['new article', 'irreversible covalent protacs cll leusm hematology']\n",
      "['new article', 'venetoclax btk inhibitor', 'cll cll leusm hematology']\n",
      "['therapy naive patients', 'b cell chronic lymphocytic leukemia']\n",
      "['market cap x3 peak revenue potential 2b x3 6b vs', 'current tgtx mc', 'u2 inhouse combo opportunities']\n",
      "['pesticide dicamba', 'numerous cancers', 'liver amp intrahepatic bile duct cancers', 'acute amp chronic lymphocytic leukemia amp mantle cell lymphoma']\n",
      "['cure s inaugural webinar series dr farukh awan', 'new coronavirus', 'patient care', 'chronic lymphocytic leukemia']\n",
      "['covid19 amp cll webinar', 'thursday 7th', 'dr piers patten', 'kings college london amp marc auckland', 'cll patient pre register', 'zoom link']\n",
      "['chronic lymphocytic leukemia cll treatment brand', 'educate people']\n",
      "['touts topline ph3 clinicaltrials data', 'umbralisib ublituximab vs', 'amp r r cll trial', 'pfs superiority', 'obinutuzumab chlorambucil comparator immunooncology immunotherapy leukemia']\n",
      "['line ibrutinib treatment']\n",
      "['cationic amino acid transporter', 'arginine uptake', 'chronic lymphocytic leukemia cell proliferation']\n",
      "['abbvie shares', 'health canada approval', 'chronic lymphocytic leukemia abbv']\n",
      "['abbvie shares', 'health canada approval', 'chronic lymphocytic leukemia', 'tickers abbv']\n",
      "['health canada approval', 'venclexta venetoclax', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia experts dr kerry rogers james', 'cll patients', 'separate fact', 'novel coronavirus leusm leukemia covid19']\n",
      "['tg therapeutics announces', 'positive topline results', 'unity cll phase', 'ublituximab u2', 'chronic lymphocytic leukemia']\n",
      "['positive topline results', 'refractory chronic lymphocytic leukemia']\n",
      "['pascal lefevre lab dapk3 participates', 'mrna processing']\n",
      "['medifocus guidebook', 'chronic lymphocytic leukemia format pdf epub mobi txt fb2 kindle djvu audiobook mp3 m4a']\n",
      "['grad day', 'person ceremony', 'graduation day', 'babies umbralisib amp ublituximab u2', 'unity cll trial', 'good hands congrats', 'tg team sites pis patients cll tgtx']\n",
      "['graduation day', 'person ceremony', 'graduation day', 'babies umbralisib', 'ublituximab u2', 'unity cll trial', 'good hands congrats', 'team sites patients cll']\n",
      "['pm tg', 'positive topline results', 'unity cll phase', 'ublituximab u2', 'r r cll', 'primary endpoint', 'pfs p lt', 'superior efficacy']\n",
      "['health canada', 'duration combination regimen', 'chronic lymphocytic leukemia cll']\n",
      "['therapeutic strategies', 'chronic lymphocytic leukemia cll', 'pharmacist s role', 'solutions tune', 'live virtual broadcast']\n",
      "['cll lymphoma key opinion leader']\n",
      "['tg therapeutics shares', 'unity cll phase', 'chronic lymphocytic leukemia', 'primary endpoint tgtx']\n",
      "['tgtx tg therapeutics announces', 'positive topline results', 'unity cll phase', 'ublituximab u2', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll', 'cytotoxic drugs', 'incremental benefit', 'cd20 monoclonal antibodies']\n",
      "['positive ph3 unity results', 'chronic lymphocytic leukemia cll']\n",
      "['amazing news', 'cll cancersucks']\n",
      "['tg therapeutics shares', 'unity cll phase', 'chronic lymphocytic leukemia', 'primary endpoint tgtx']\n",
      "['tg therapeutics shares', 'unity cll phase', 'chronic lymphocytic leukemia', 'primary endpoint', 'tickers tgtx']\n",
      "['health canada approval', 'venclexta venetoclax', 'chronic lymphocytic leukemia abbv']\n",
      "['positive topline results', 'global unity cll phase', 'refractory chronic lymphocytic leukemia']\n",
      "['tg therapeutics announces topline results', 'unity cll phase', 'chronic lymphocytic leukemia trial', 'primary endpoint', 'tickers tgtx']\n",
      "['tgtx tg therapeutics announces', 'positive topline results', 'unity cll phase', 'ublituximab u2', 'chronic lymphocytic leukemia']\n",
      "['tgtx tg therapeutics announces', 'positive topline results', 'unity cll phase', 'ublituximab u2', 'chronic lymphocytic leukemia premarket']\n",
      "['tgtx tg therapeutics announces', 'positive topline results', 'unity cll phase', 'ublituximab u2', 'chronic lymphocytic leukemia premarket']\n",
      "['health canada approval', 'venclexta venetoclax']\n",
      "['tgtx tg therapeutics announces', 'positive topline results', 'unity cll phase', 'ublituximab u2', 'chronic lymphocytic leukemia nasdaq tgtx']\n",
      "['health canada approval', 'chronic lymphocytic leukemia', 'tickers abbv']\n",
      "['tgtx tg therapeutics announces', 'positive topline results', 'unity cll phase', 'ublituximab u2', 'chronic lymphocytic leukemia']\n",
      "['tgtx announces', 'positive topline results', 'unity cll phase', 'ublituximab u2', 'chronic lymphocytic leukemia']\n",
      "['tgtx announces', 'positive topline results', 'unity cll phase', 'ublituximab u2', 'chronic lymphocytic leukemia']\n",
      "['tgtx tg therapeutics announces', 'positive topline results', 'unity cll phase', 'ublituximab u2', 'chronic lymphocytic leukemia']\n",
      "['tgtx tg therapeutics announces', 'positive topline results', 'unity cll phase', 'ublituximab u2', 'chronic lymphocytic leukemia']\n",
      "['grade bladder carcinoma', 'chronic lymphocytic leukemia', 'rare entity', 'indian literature lymphoma lymsm']\n",
      "['new article synchronous', 'grade bladder carcinoma', 'chronic lymphocytic leukemia', 'rare entity', 'indian literature cll leusm hematology']\n",
      "['case series', 'cll patients', 'w amp w', 'lymphocytosis mdsrkto']\n",
      "['therapy naive patients', 'b cell chronic lymphocytic leukemia elsevier', 'btk inhibitors type']\n",
      "['clinical trial', 'refractory chronic lymphocytic leukemia cll', '712k float', 'positive pr', 'stock price']\n",
      "['rns aim cll cello health plc issue']\n",
      "['jci chronic lymphocytic leukemia cells', 'gene expression', 'cd8 t cells']\n",
      "['therapy naive patients', 'b cell chronic lymphocytic leukemia']\n",
      "['supervisor dr michal smida performance', 'car t cells', 'cll atm mut predispose', 'good response', 'car t cell therapy whereas tp53 mut predispose', 'tumor burden', 'therapy failure']\n",
      "['unusual manifestation', 'chronic lymphocytic leukemia']\n",
      "['numerous cancers', 'intrahepatic bile duct cancers', 'chronic lymphocytic leukemia', 'mantle cell lymphoma']\n",
      "['great resource', 'hematologic malignancies data summaries ash research collaborative leusm lymsm mmsm mpnsm cll']\n",
      "['dna methylation', 'chronic lymphocytic leukemia', 'differential response']\n",
      "['refractory chronic lymphocytic leukemia', 'peter hillmen']\n",
      "['immediate treatment', 'chronic lymphocytic leukemia', 'clinical trials', 'future treatment']\n",
      "['chronic lymphocytic leukemia cll patients', 'cll experts', 'tennessee oncology cllsm leusm']\n",
      "['long term outcomes', 'cd19 car t cells', 'chronic lymphocytic leukemia cll leusm immunoonc jco']\n",
      "['duvelisib copiktra pi3k delta gamma inhibitor', 'covid19 sarscov2 coronavirus battle leukemia lymphoma cll sll fl ptcl mzl blood cancer']\n",
      "['small case series', 'treatment naive cll', 'serious covid19 covid', 'therapy naive patients', 'b cell chronic lymphocytic leukemia']\n",
      "['graves disease update hyperthyroidism', 'prostate adenocarcinoma chronic lymphocytic leukemia', 'graves disease']\n",
      "['new article', 'unusual manifestation', 'chronic lymphocytic leukemia', 'hand cll leusm hematology']\n",
      "['new article', 'prostate adenocarcinoma chronic lymphocytic leukemia', 'graves disease cll leusm hematology']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['friend paul', 'wonderful loon', 'top man bloodcancer cll bcuk uk']\n",
      "['jennifer woyach md', 'james discusses', 'chronic lymphocytic leukemia leusm']\n",
      "['dna methylation', 'chronic lymphocytic leukemia', 'differential response']\n",
      "[]\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['i haven t', 'chronic lymphocytic leukemia', 'monterey jazz festival', 'time vote']\n",
      "['blog post']\n",
      "['big thanks', 'dna methylation', 'cytogenetic characteristics tp53', 'ighv mutation status', 'chemotherapy epigenetics chemoresistance']\n",
      "['dna methylation', 'chronic lymphocytic leukemia', 'differential response']\n",
      "['new article dna methylation', 'chronic lymphocytic leukemia', 'differential response', 'chemotherapy cll leusm hematology']\n",
      "['new article genetics', 'high risk chronic lymphocytic leukemia', 'chemoimmunotherapy cll leusm hematology']\n",
      "['phase iii cll14 trial', 'duration treatment', 'chronic lymphocytic leukemia']\n",
      "['wonderful speakers dr jackie broadway', 'btk inhibitors', 'cll skills challenge', 'clinical pearls']\n",
      "['btk inhibitors', 'cll skills challenge', 'clinical pearls', 'oral therapies', 'nurse s role']\n",
      "['btk inhibitors', 'cll skills challenge', 'clinical pearls']\n",
      "['btk inhibitors', 'cll skills challenge', 'clinical pearls']\n",
      "['btk inhibitors', 'cll skills challenge', 'clinical pearls']\n",
      "['btk inhibitors', 'cll skills challenge', 'clinical pearls']\n",
      "['btk inhibitors', 'cll skills challenge', 'clinical pearls', 'atrial fibrillation']\n",
      "['btk inhibitors', 'cll skills challenge', 'clinical pearls']\n",
      "['btk inhibitors', 'cll skills challenge', 'clinical pearls', 'fungal infections']\n",
      "['btk inhibitors', 'cll skills challenge', 'clinical pearls', 'infectious complications']\n",
      "['btk inhibitors', 'cll skills challenge', 'clinical pearls', 'hematologic events']\n",
      "['btk inhibitors', 'cll skills challenge', 'clinical pearls', 'gastrointestinal events']\n",
      "['btk inhibitors', 'cll skills challenge', 'clinical pearls', 'btk inhibitors', 'nccn guidelines']\n",
      "['medscapelive virtual event', 'btk inhibitors', 'cll skills challenge', 'clinical pearls', 'btk inhibitors']\n",
      "['fda approval', 'ibrutinib rituximab combo']\n",
      "['new study', 'chronic lymphocytic leukemia', 'real world performance', 'common amp', 'community settings', 'clinical trial results']\n",
      "['ya queda menos para comenzar', 'nuevo estamos trabajando para asegurar', 'atenci n', 'm xima seguridad centrolaslomas cll guadalajara guadalajaraespa', 'centro las lomas']\n",
      "['unconditional continuation vs', 'agents p lt', 'inpts non icu covid19 experts', 'btkis vs', 'p lt', 'covid19 cll']\n",
      "['new article dicamba use', 'cancer incidence', 'agricultural health study', 'analysis cll leusm hematology']\n",
      "['new article management', 'cll patients', 'international survey', 'cll experts cll leusm hematology']\n",
      "['combination therapies', 'chronic lymphocytic leukemia leusm']\n",
      "['e1912 trial', 'fda approval', 'ibrutinib rituximab combo', 'cll chroniclymphocyticleukemia']\n",
      "['stromal tumor microenvironment', 'chronic lymphocytic leukemia regulation', 'leukemic progression view']\n",
      "['great collaboration', 'ajh survey', 'international experts', 'covid pandemic']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['virtuallectureseries cap neoplasms']\n",
      "['scan results', 'star candlestick', 'rol bbsn fog val vdtk rdt rb cll ntea mmh tan bem']\n",
      "['prognostic score', 'valuable insights', 'chronic lymphocytic leukemia', 'active surveillance']\n",
      "['copyright developments u s', 'supreme court', 'copyright protection', 'official duties cll copyrightdevelopments copyright scotus']\n",
      "['b cell tumors', 'primary human immune cells postdoc position', 'siena postdoc cll']\n",
      "['term growth', 'chronic lymphocytic leukemia market news pharma pharmiweb']\n",
      "['b cell receptor', 'chronic lymphocytic leukemia view']\n",
      "['dnamethylation profiles', 'chroniclymphocyticleukemia patients', 'differential responses']\n",
      "['herbal turmeric', 'natural prevention', 'chronic lymphocytic leukemia']\n",
      "['clinicaltrial e1912 lead', 'fda approval', 'chronic lymphocytic leukemia cll disease']\n",
      "['chronic lymphocytic leukemia analysis']\n",
      "['new cme curriculum', 'cll mantlecelllymphoma patient care', 'interactive activities check']\n",
      "['amp cll', 'place 7th', 'uk cll patients', 'questions resources', 'haematology bloodcancerawareness']\n",
      "['early results', 'phase ia b dose escalation trial', 'refractory cll sll']\n",
      "['lo dudes m s p sate por nuestra web y descubre todos nuestros cursosonline y m sterdigitales', 'con los que podr s cambiartuvida y convertirte', 'un profesional', 'xito formaci nonline cll']\n",
      "['fda approves ibrutinib', 'chronic lymphocytic leukemia']\n",
      "['michael choi md', 'chronic lymphocytic leukemia leusm']\n",
      "['chronic lymphocytic leukemia']\n",
      "['new article', 'chronic lymphocytic leukemia', 'rare morphological', 'review cll leusm hematology']\n",
      "['new article il', 'restrains inflammatory response', 'sirt1 hif', 'pathway cll leusm hematology']\n",
      "['new article oxidation impacts', 'hematological disorders cll leusm hematology']\n",
      "['new article feasibility', 'dose lenalidomide', 'line treatment', 'fcr unfit patients', 'chronic lymphocytic leukemia mmsm multiplemyeloma hematology']\n",
      "['new tool predicts', 'cll patients bjh cll hematology']\n",
      "['asco20 abstract', 'final results', 'genuine phase iii high risk cll trial effect', 'pfs orr', 'mrd negativity', 'high risk chronic lymphocytic leukemia', 'final results', 'genuine phase iii study tgtx']\n",
      "['fda approves imbruvica ibrutinib', 'chronic lymphocytic leukemia cll']\n",
      "['stem cell factor', 'microenvironmental interactions', 'cellular dynamics', 'chronic lymphocytic leukemia haematology thewiderwiserview']\n",
      "['fc riib bcr co ligation inhibits bcr', 'chronic lymphocytic leukemia haematology thewiderwiserview']\n",
      "['easy way', 'distinquish chronic lymphocytic leukemia', 'small cell lymphocytic lymphoma', 'small b cell lymphomas']\n",
      "['chronic lymphocytic leukemia', 'cll treatments', 'new world', 'treatment options', 'leusm leukemia']\n",
      "['new cll therapies lead', 'patient outcomes']\n",
      "['cll diagnosis']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['new article duohexabody cd37', 'novel biparatopic cd37 antibody', 'potential therapy', 'b cell malignancies cll leusm hematology']\n",
      "['kml experten werden vom eha berichten ber cll hodgkin myelom inhl anhl cart cells auf']\n",
      "['old patient', 'chronic lymphocytic leukemia', 'anemic cho anuba lohe s home visit', 'face phek village sc hwc', 'phek district nagaland']\n",
      "['cll lymphoma tweeps', '3l cll', '1l 2l cll lymphoma']\n",
      "['michael choi md', 'front treatment decisions impact', 'refractory setting', 'chronic lymphocytic leukemia leusm']\n",
      "['dr danilov discusses', 'treatment regimen', 'chronic lymphocytic leukemia', 'american society', 'annual meeting cllsm leusm']\n",
      "['great news']\n",
      "['discusses novel approaches', 'refractory chronic lymphocytic leukemia leusm']\n",
      "['initial treatment', 'adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['long term']\n",
      "['cll community', '5pm irish time', 'good friend dr brian koffman', 'diagnoses prognostic tests', 'healthy register']\n",
      "['cll society', 'dr neil kay amp dr brian koffman', 'i need', 'diagnosis prognostic', '00am pdt', '00pm edt']\n",
      "['covid19 icu', 'ventilator leukemia patient mary hernandez', 'excellent strides', 'i m', 'mary s story endcancer']\n",
      "['chronic lymphocytic leukemia', 'new treatment study researchers', 'drug venetoclax', 'treatment regimens']\n",
      "['genmab duohexabody cd37', 'cd37 antibody variants', 'ex vivo cdc assays', 'primary cll patient samples', 'cd20 mabs rituximab ofatumumab', 'obinutuzumab gmab blood cancer journal']\n",
      "['new prognostic model', 'early asymptomatic cll']\n",
      "['immune dysfunction complexity', 'chronic lymphocytic leukemia', 'novel therapeutic strategies lymphoma lymsm']\n",
      "['new article association', 'light chains', 'chronic lymphocytic leukemia', 'monoclonal b cell lymphocytosis mmsm multiplemyeloma hematology']\n",
      "['new article evaluation', 'cd200 expression', 'chronic lymphocytic leukemia', 'mature b cell neoplasms cll leusm hematology']\n",
      "['new article stem cell factor', 'microenvironmental interactions', 'cellular dynamics', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article fc riib bcr co ligation inhibits bcr', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article immune dysfunction complexity', 'chronic lymphocytic leukemia', 'novel therapeutic strategies cll leusm hematology']\n",
      "[]\n",
      "['katy rezvani md phd rezvani discusses', 'natural killer cells', 'non hodgkin s lymphoma', 'medtwitter oncology']\n",
      "['small business owners', 'summary smallbusiness covid19 coronavirus loans grants cll']\n",
      "['pharmacy drug update fda healthcare pharmacist h1n1 flu influenza ncov coronavirus covid19 covid virus pharmacist pemazyre cholangiocarcinoma imbruvica cll sll trodelvy her2 stayathome']\n",
      "['chronic lymphocytic leukemia expert', 'captivate study', 'ibrutinib imbruvica', 'venetoclax venclexta', 'cll leusm leukemia healthjournalism health']\n",
      "['drs joshua brody richard bakst', 'amir steinberg md', 'chronic cll']\n",
      "['long term', 'patients wit']\n",
      "['long term', 'patients leukemia']\n",
      "['cll cll society tuesday april', 'i need', 'dr neil kay amp dr brian koffman']\n",
      "['ibrutinib monotherapy', 'bruton s tyrosine kinase inhibitor', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'settings leusm leukemias']\n",
      "['specific features', 'granulocytic hematopoiesis lineages', 'acute phase', 'chronic myeloid leukemia chronic lymphocytic leukemia', 'multiple myeloma']\n",
      "['specific features', 'granulocytic hematopoiesis lineages', 'acute phase', 'chronic myeloid leukemia chronic lymphocytic leukemia', 'multiple myeloma']\n",
      "['john m burke md amp manuel', 'santiago md', 'therapeutic approaches', 'patient management algorithms', 'cme credits']\n",
      "['chronic lymphocytic leukemia', 'cll patients', 'financial assistance', 'financial navigator alison mulholland', 'nurse navigator amy sheldrick', 'expenses leusm leukemia']\n",
      "[]\n",
      "['new article gene expression workflow', 'analyze residual leukemic cells', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'evolutionary framework', 'lrr rlks', 'stem cll maintenance cll leusm hematology']\n",
      "['new article', 'specific features', 'granulocytic hematopoiesis lineages', 'acute phase', 'chronic myeloid leukemia chronic lymphocytic leukemia', 'multiple mf myelofibrosis hematology']\n",
      "['e1912 trial', 'significant improvement', 'ibrutinib rituximab vs', 'standard fludarabine cyclophosphamide', 'frontline treatment']\n",
      "['line treatment recommendations']\n",
      "['huge ty', 'amp cathykramer', 'gratitude breakout insightful amp', 'patient leaders', 'communities cll']\n",
      "['fda approves imbruvica', 'chronic lymphocytic leukemia']\n",
      "['gratitude babble breakout group healthevoiceslive cll']\n",
      "['hematology meeting', 'recent approval', 'european medicines agency', '1l treatment algorithm', 'cll patients i', 'invaluable input']\n",
      "[]\n",
      "['middle eastern theme night', 'husband lots', 'fresh veggies protein herbs healthevoiceslive cll']\n",
      "['rituximab cll lymsm']\n",
      "[]\n",
      "['refractory chronic lymphocytic leukemia']\n",
      "['new article population pharmacokinetics', 'dihydrodiol metabolite', 'lymphoid malignancies cll leusm hematology']\n",
      "['new article prevalence', 'lymphoid neoplasia', 'retrospective analysis', 'warthin tumor', 'institution experience cll leusm hematology']\n",
      "['new article pregnancy', 'old woman', 'chronic lymphocytic leukemia', 'case report', 'literature cll leusm hematology']\n",
      "['new article p66shc', 'pleiotropic regulator', 'b cell', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['positive quality', 'study leusm leukemia jnccn360']\n",
      "['fda approval', 'btk inhibitor imbruvica ibrutinib', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll cancer therapy leukemia geneonline']\n",
      "['ce credits', 'medscapelive virtual event', 'dr jackie broadway', 'btk inhibitors', 'chronic lymphocytic leukemia cll amp']\n",
      "['cell death differentiation nf b p62 nrf2 survival', 'high ror1 expression', 'chronic lymphocytic leukemia']\n",
      "['i manage cll', 'treatments american society', 'hematology hematology cllsm leusm lymsm']\n",
      "['btk inhibitor covid19 trial', 'positive tgtx']\n",
      "['sawaf md discusses', 'incidence characteristics', 'richter transformation visit medtwitter medicalnews patientcare']\n",
      "['long term outcomes', 'dose optimization study', 'chimeric antigen receptor', 't cells', 'chronic lymphocytic leukemia journal', 'clinical oncology']\n",
      "['drug potency signature links progression', 'chronic lymphocytic leukemia', 'stress responses']\n",
      "['initial treatment', 'adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['annual meeting', 'cll lymsm']\n",
      "['webinar lymphome', 'uhr zu lymphomtherapien und covid19 empfehlungen f r rzte und interessierte u', 'mit einsele m', 'p borchmann', 'engert anmeldung myelom cart zell cll nhl']\n",
      "['new article', 'drug potency signature links progression', 'chronic lymphocytic leukemia', 'stress responses', 'hypoxia cll leusm hematology']\n",
      "['new article composite monoclonal b cell lymphocytosis', 'myd88 l265p', 'positive lymphoplasmacytic lymphoma', 'light chain amyloidosis case report cll leusm hematology']\n",
      "['new article regulation', 'humoral immune responses', 'b cell tolerance', 'igm fc receptor fc r cll leusm hematology']\n",
      "[]\n",
      "['icymi fda', 'frontline treatment', 'adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma leusm lymsm']\n",
      "['elderly man', 'confusion weakness', 'nonproductive cough', 'chronic lymphocytic leukemia jaoaclinicalimage']\n",
      "['optimal therapy treatment', 'chronic lymphocytic leukemia cll', 'clinical data', 'cmecredits click', 'oncology cityofhope paradigmmedcom']\n",
      "['i manage cll', 'treatments blood american society', 'hematology cll leusm']\n",
      "['i manage cll']\n",
      "['j amp j abbvie s imbruvica pads cll lead', 'fda green', 'gold standard', 'cll patient pools']\n",
      "['fda approves ibrutinib', 'chronic lymphocytic leukemia chroniclymphocyticleukemia smalllymphocyticlymphoma cancer leukemia']\n",
      "['chaitra ujjani md', 'captivate study', 'cll seattlecca hematologicmalignanices']\n",
      "['positive results', 'landmark phase', 'e1912 study', 'ecog acrin cancer research group ecog acrin', 'national cancer institute nci', 'great news']\n",
      "['muscle pain', 'chronic lymphocytic leukemia tre']\n",
      "['cll patient care visit lymsm']\n",
      "['new article reaserch', 'b cell receptor pathway', 'chronic lymphocytic leukemia review cll leusm hematology']\n",
      "['new article application', 'cpg oligodeoxynucleotide immunostimulation', 'chromosome study', 'chronic lymphoblastic leukemia cll leusm hematology']\n",
      "['great job', 'cll patients']\n",
      "['great article', 'person experience', 'cll spotleukaemia covid19uk']\n",
      "['muscle pain', 'chronic lymphocytic']\n",
      "['u s fda approves imbruvica ibrutinib', 'chronic lymphocytic leukemia cll']\n",
      "['exciting news', 'sll patients fda approves ibrutinib', 'chronic lymphocytic leukemia']\n",
      "['imbruvica rituximab combo', 'chronic lymphocytic leukemia biospace lifesciences biotechnology pharmaceuticals']\n",
      "['u s fda approves imbruvica ibrutinib', 'chronic lymphocytic']\n",
      "['chronic lymphocytic leukemia cll combinationtherapy']\n",
      "['institutional experience w', 'alternative d1', 'cll pi splits', '100mg d1 amp 900mg d2', 'protocol amendments', 'select pts', '100mg bag']\n",
      "['pleiotropic regulator', 'b cell', 'chronic lymphocytic leukemia', 'laura patrussi nagaja capitani', 'cosima t baldari cll p66shc']\n",
      "['whole i', '1st line treatment', 'cll mx', 'ibrutinib fda approves ibrutinib', 'chronic lymphocytic leukemia']\n",
      "['imbruvica ibrutinib', 'line treatment chronic lymphocytic leukemia', 'small lymphocytic lymphoma projectorbis leusm lymsm cll fda']\n",
      "['imbruvica rituximab combo', 'chronic lymphocytic leukemia']\n",
      "['u s fda', 'new combination regimen', 'chronic lymphocytic leukemia cll']\n",
      "['cll patients', 'vulnerable category']\n",
      "['ibrutinib rituximab combination patients', 'effective non chemoimmunotherapy option']\n",
      "['s approach', 'chroniclymphocyticleukemia cll diagnosis leusm']\n",
      "['re gon na', 'big time', 'lines cll', 'nclh stocks']\n",
      "['raredisease fda approves ibrutinib', 'chronic lymphocytic leukemia hcplive']\n",
      "['chronic lymp leukemia']\n",
      "['fda approves ibrutinib', 'chronic lymphocytic leukemia']\n",
      "['encouraging report', 'cartcell safety efficacy', 'cll shows', 'complete response rate', 'overall response rate', 'median overall survival', 'cr vs', 'cr pfs', 'cr vs']\n",
      "['new clinical trial', 'phase i study', 'refractory b cell lymphoma cll leusm hematology']\n",
      "['webinar lymphome aktuelle therapiekonzepte bei lymphomen hodgkinlymphom myelom cll inhl anhl cart zell', 'covid19 hinweisen mit einsele u']\n",
      "['new article hybrid inhibitors', 'enhance cytotoxicity', 'leukaemia cells cll leusm hematology']\n",
      "['new article', 'manage lymphoid malignancies', 'coronavirus covid', 'brazilian task force recommendation cll leusm hematology']\n",
      "[]\n",
      "['video cll outcomes', 'cd19 car t', 'ibrutinib w', 'leusm tcellrx immunoonc hemeonc oncoalert']\n",
      "['fda approves ibrutinib', 'chronic lymphocytic leukemia']\n",
      "['fda approves ibrutinib', 'frontline treatment chronic lymphocytic leukemia fda cll']\n",
      "['news fda', 'new combination therapy', 'adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'gt gt']\n",
      "['refractory chronic lymphocytic leukem']\n",
      "['imbruvica ibrutinib', 'initial treatment', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll pi']\n",
      "['u s fda approves imbruvica ibrutinib', 'chronic lymphocytic leukemia cll']\n",
      "['u s fda', 'new treatment option', 'chronic lymphocytic leukemia cll', 'common form']\n",
      "['u s fda approves imbruvica ibrutinib', 'chronic lymphocytic leukemia cll', 'delaware county']\n",
      "['phase ib study', 'chronic lymphocytic leukemia']\n",
      "['drug administration', 'ibrutinib imbruvica pharmacyclics llc', 'initial treatment', 'adult patients', 'chronic lymphocytic leukemia cll']\n",
      "['fda update', 'u s food', 'drug administration fda', 'ibrutinib imbruvica pharmacyclics llc', 'initial treatment', 'adult patients']\n",
      "['fda approves ibrutinib rituximab combo', 'frontline cll', 'sudden cardiac death', 'control arm']\n",
      "['fda approval', 'line ibrutinib rituximab', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'ecog e1912', 'tait shanafelt', 'lymsm leusm hematology oncology cancernews']\n",
      "['s approval', 'new treatment', 'u s', 'chronic lymphocytic leukemia']\n",
      "['frontline treatment', 'adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic leukemia leusm']\n",
      "['ibrutinib imbruvica', 'rituximab rituxan', 'frontline therapy', 'chronic lymphocytic leukemia', 'small lymphocytic leukemia']\n",
      "['fda approves ibrutinib', 'chronic lymphocytic leukemia']\n",
      "['certain patients', 'chronic lymphocytic leukemia leukemia cll']\n",
      "['ennio s doctor', 'medical team s', 'chronic lymphocytic leukemia', 'log hours']\n",
      "['fda approves ibrutinib', 'chronic lymphocytic leukemia cll']\n",
      "['fda approves ibrutinib', 'chronic lymphocytic leukemia fda']\n",
      "['chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'patients raredisease fda']\n",
      "['new drug application', 'u s fda', 'chronic lymphocytic leukemia']\n",
      "['new fda approval', 'cll bloodcancer']\n",
      "['ibrutinib imbruvica pharmacyclics llc', 'initial treatment', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma projectorbis leusm lymsm']\n",
      "['fda approves ibrutinib', 'initial treatment', 'adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['clrb douglas', 'chronic lymphocytic leukemia survivor amp lls', 'cancer patients family members caregivers', 'people everywhere llsvolunteer cll tuesdaymotivation inspiration']\n",
      "[]\n",
      "['chronic lymphocytic leukemia mrd updates']\n",
      "['bdfacsmatters webinar', 'chronic lymphocytic leukemia', 'singlecellmultiomics solutions register']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['great sadness', 'senior instructor', 'management brenda eichelberger', 'chronic lymphocytic leukemia']\n",
      "['small business owners', 'summary coronavirus covid19 smallbusiness caresact cll']\n",
      "['impulsa tu carrera', 'con nuestro bootcamp', 'apachespark profundiza', 'soluci n m s eficiente y', 'popular para procesar enormes cantidades', 'lo dudes comenzamos', 'junio m s informaci n aqu formaci nonline cll']\n",
      "['new prognostic tool', 'valuable insights', 'chronic lymphocytic leukemia', 'active surveillance']\n",
      "['new article prevalence', 'immunophenotypic characteristics', 'monoclonal b cell lymphocytosis', 'healthy korean individuals', 'lymphocytosis cll leusm hematology']\n",
      "['new article', 'functional differences', 'specific cd8 t cells', 't cell dysfunction', 'cll cll leusm hematology']\n",
      "['new article', 'chronic lymphocytic leukemia', 'autoimmune hemolytic anemia', 'case report cll leusm hematology']\n",
      "['new article head', 'neck squamous cell cancer', 'lymphoproliferative malignancies', 'aggressive cll leusm hematology']\n",
      "['new article', 't cell functions cll leusm hematology']\n",
      "['cll specialists', 'amp impact', 'cll patients', 'cll amp sll patients', 'uk haematology pagc19']\n",
      "['cll expert']\n",
      "['muscle pain', 'chronic lymphocytic leukemia']\n",
      "['rns aim cll cello health plc', 'annual report']\n",
      "['refractory chronic lymphocytic l leukemia']\n",
      "['international prognostic score', 'useful clinical management tool', 'early stage cll leukemia cll oncology hematology']\n",
      "['dr rod humerickhouse abbvie highlights', 'cll news', 'international workshop', 'chronic lymphocytic leukemia cll chronic lymphocytic leukemia']\n",
      "['nvs phase', 'ofatumumab methylprednisolone', 'ofatumumab lenalidomide', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll nct01497496', 'primary completion date']\n",
      "['new article dapk3 participates', 'mrna processing', 'chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['refractory chronic lymphocytic leukemia', 'long t']\n",
      "['phase iii cll14 trial', 'duration treatment', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['possible hurdles leusm']\n",
      "['star venetoclax', 'useful haemreg haematologyregistrars cll teamhaem']\n",
      "['combination therapies', 'chronic lymphocytic leukemia leusm']\n",
      "['new article', 'warm autoimmune hemolytic anemia clinical profile', 'management cll leusm hematology']\n",
      "['herpes simplex necrotic lymphadenitis', 'richter s transformation', 'treatment naive patients', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['new ibrutinib', 'refractory chronic lymphocytic leukemia l']\n",
      "['cll registry', 'final analysis', 'chronic lymphocytic leukemia', 'sites cll']\n",
      "['novel flow cytometry', 'b cell receptor', 'prognostic factor', 'chronic lymphocytic leukemia']\n",
      "['small molecule inhibitors', 'chronic lymphocytic leukemia']\n",
      "['new article', 'novel flow cytometry', 'b cell receptor', 'prognostic factor', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'unexpected etiology', 'pleural empyema', 'chronic lymphocytic leukemia cll capnocytophaga ochracea cll leusm hematology']\n",
      "['new article herpes simplex necrotic lymphadenitis', 'richter s transformation', 'treatment naive patients', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article efficacy', 'chronic lymphocytic leukemia', 'systematic review cll leusm hematology']\n",
      "['new article', 'a2a adenosine receptor counteracts immunosuppression', 'mouse model', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article transcriptomic analysis', 'sea cucumber holothuria leucospilota coelomocytes', 'echinoderm cytokine response', 'immune challenge cll leusm hematology']\n",
      "['michael choi md', 'chronic lymphocytic leukemia leusm']\n",
      "['cll osuccc']\n",
      "['medscapelive virtual symposium tune', 'identify amp', 'adverse effects', 'btk inhibitors', 'cll register']\n",
      "['optimal therapy treatment', 'chronic lymphocytic leukemia cll', 'clinical data', 'cmecredits oncology cityofhope paradigmmedcom']\n",
      "['cancer stem cells', 'immune inhibitory receptors', 'chronic lymphocytic leukemia cll', 'metastatic cancers', 'pharmaceutical mixture', 'ibrutinib vai']\n",
      "['chemo antibody therapy pcat', 'cancer stem cells', 'immune inhibitory receptors', 'chronic lymphocytic leukemia cll', 'metastatic cancers', 'pharmaceutical mixture']\n",
      "['cancer stem cells', 'immune inhibitory receptors', 'chronic lymphocytic leukemia cll', 'metastatic cancers', 'pharmaceutical mixture']\n",
      "['cancer stem cells', 'immune inhibitory receptors', 'chronic lymphocytic leukemia cll', 'metastatic cancers', 'pharmaceutical mixture', 'ibrutinib vai']\n",
      "['discusses novel approaches', 'refractory chronic lymphocytic leukemia leusm']\n",
      "['muscle pain', 'chronic lymphocytic leukemia treate']\n",
      "['roles amp rules', 'public amp', 'private sectors', 'role companies', 'goods amp services', 'cure disease', 'shares ceo efpvirtual eyeforpharma cll']\n",
      "['drug contenders work ceo', 'master regulator', 'efpvirtual covid19 eyeforpharma cll cytokinestorm']\n",
      "['data cll']\n",
      "['long term outcomes', 'dose optimization study', 'chimeric antigen receptor', 't cells', 'chronic lymphocytic leukemia journal', 'clinical oncology']\n",
      "['excellent study', 'car t']\n",
      "['post doctoral fellow', 'erc consolidator project', 't cells', 'enable car t cell therapy', 'chronic lymphocytic leukemia nl']\n",
      "[]\n",
      "['new article co expression', 'surfactant protein', 'chicken lung lectin', 'chicken respiratory system cll leusm hematology']\n",
      "['new article', 'long term outcomes', 'dose optimization study', 'chimeric antigen receptor', 't cells', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article inhibition', 'enhances cell death', 'selective inhibitor venetoclax', 'preclinical models', 'acute myeloid leukemia cll leusm hematology']\n",
      "['true class environment', 'training solution']\n",
      "['rns aim cll cello health plc total']\n",
      "['bloodcancer patients']\n",
      "['celg phase', 'ofatumumab methylprednisolone', 'ofatumumab lenalidomide', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll nct01497496', 'primary completion date']\n",
      "['cll patients', 'virtual meeting', 'big thanks']\n",
      "['chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['muscle pain', 'chronic lymphocytic leukem']\n",
      "['michael choi md', 'front treatment decisions impact', 'refractory setting', 'chronic lymphocytic leukemia leusm']\n",
      "['long term outcomes', 'dose optimization study', 'chimeric antigen receptor', 't cells', 'chronic lymphocytic leukemia pubs tcellrx celltherapy ctl019 kymriah']\n",
      "['cll patient webinar', 'cancer treatment', 'covid19 pandemic', 'tuesday april', 'p m ct register']\n",
      "['refractory chronic lymphocytic leukemia lo leukemia']\n",
      "['icymi researchers', 'chronic lymphocytic leukemia', 'commercial ibrutinib', 'initial dose', 'dose modification', 'impact event', 'free survival', 'overall survival']\n",
      "['ema approval', 'ruxience bibrands ruxience', 'adult patients', 'non hodgkin s lymphoma chronic lymphocytic leukemia amp granulomatosis', 'polyangiitis amp microscopic polyangiitis']\n",
      "['summary coronavirus covid19 employees caresact cll']\n",
      "['new article prognostic markers', 'chronic lymphocytic leukaemia', 'flow cytometric analysis cll leusm hematology']\n",
      "['new article', 'rare case', 'aggressive merkel cell carcinoma', 'male breast co', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article pathological study', 'novel coronavirus disease covid', 'postmortem core biopsies cll leusm hematology']\n",
      "['new article bcl', 'b cell non hodgkin lymphomas cll leusm hematology']\n",
      "['new article duvelisib', 'chronic lymphocytic leukemia fl lymsm hematology']\n",
      "['new article novel', 'chronic lymphocytic leukemia', 'elderly patients', 'systematic review mmsm multiplemyeloma hematology']\n",
      "['low incidence', 'cll pts', 'mo study doesnot support', 'routine prophylaxis', 'applicable data']\n",
      "['chronic lymphocytic']\n",
      "['chronic lymphocytic leukemia', 'elderly patients', 'systematic review lymphoma lymsm']\n",
      "['webinar epigenetic tools', 'blood cancer research cll webinar scicomm']\n",
      "['chronic lymphocytic leukemia treatment pdq patient version']\n",
      "[]\n",
      "['non covid paper awesome work', 'christine ryan', 'low rates']\n",
      "['cd49d promotes disease progression', 'chronic lymphocytic leukemia', 'new insights', 'cd49d bimodal expression cll']\n",
      "['key role', 'cll patients', 'adverse events', 'adverse events']\n",
      "['leukemia endcancer leusm cll covid19']\n",
      "['cll leukaemia haematology bloodcancer bloodcancerawareness stayathome']\n",
      "['practical tips', 'chronic lymphocytic leukemia cll cancer cancertips']\n",
      "['tumor mutational load predicts time', 'chronic lymphocytic leukemia cll', 'monoclonal b cell lymphocytosis', 'international prognostic index haematology thewiderwiserview']\n",
      "['phenotypic characterization', 'peripheral blood v', 't cells', 'chronic lymphocytic leukemia', 'monoclonal b cell lymphocytosis']\n",
      "['new article utilization', 'subcutaneous immunoglobulins', 'secondary immune deficiency', 'retrospective multicenter study cll leusm hematology']\n",
      "['new article', 'real world use', 'rituximab biosimilars', 'non hodgkin lymphoma', 'oncologist network', 'germany cll leusm hematology']\n",
      "['new article survival risk score', 'real life', 'refractory chronic lymphocytic leukemia patients', 'campus cll study cll leusm hematology']\n",
      "['new article significance', 'flexion range', 'risk factor', 'cervical laminoplasty cll leusm hematology']\n",
      "['phase ib ii pcyc', 'high rates', 'overall survival', 'overall responses', 'long term tolerability', 'treatment na ve', 'refractory settings cll leusm']\n",
      "['non corona academics cll hemepath']\n",
      "['abbv phase', 'refractory chronic lymphocytic leukemia', 'non hodgkin lymphoma nct01328626', 'primary completion date']\n",
      "['abbv phase', 'chronic lymphocytic leukemia', '17p deletion nct01889186', 'primary completion date']\n",
      "['dr mato', 'chronic lymphocytic leukemia cll therapies', 'venetoclax cll society']\n",
      "['cll patients cll society', 'cll questions friday april', 'pm mt', 'pm ct']\n",
      "['ball survival risk score', 'real life', 'refractory cll patients', 'ibrutinib leusm']\n",
      "['cll registry', 'final analysis', 'chronic lymphocytic leukemia', 'sites american society', 'hematology hematology cllsm leusm lymsm']\n",
      "['bioinformatics analyses', 'chronic lymphocytic leukemia cells']\n",
      "['new bendamustine ofatumumab', 'ibrutinib treatment', 'chronic lymphocytic leukemi']\n",
      "['clinical trials', 'non hodgkins lymphoma', 'acute lymphocytic leukemia', 'chronic lymphocytic leukemia avm', 'phase i ii trials cancertreatment leukemia lymphoma']\n",
      "['cll cll cello health group ex dividend date', 'payment date']\n",
      "['rns aim cll cello health plc']\n",
      "['real time data', 'real time information', 'patients journey amp personalization efpvirtual rarediseases cll']\n",
      "['mind blog', 'mark trademark trademarkabandonment internationalregistration cll']\n",
      "['clinical trials', 'non hodgkins lymphoma', 'acute lymphocytic leukemia', 'chronic lymphocytic leukemia', 'phase i ii trials cancertreatment leukemia lymphoma']\n",
      "['treatment naive cll lessons', 'clinical trials', 'important article', 'dramatic changes']\n",
      "['bioinformatics analyses', 'chronic lymphocytic leukemia cells', 'unique circular rna expression pattern']\n",
      "['new article', 'bioinformatics analyses', 'chronic lymphocytic leukemia cells', 'unique circular rna expression pattern cll leusm hematology']\n",
      "['new article pneumocystis jirovecii pneumonia', 'institutional prophylaxis practices', 'cll patients', 'btk inhibitors cll leusm hematology']\n",
      "['new article ibrutinib', 'cardiac tamponade', 'concurrent antiplatelet therapy cll leusm hematology']\n",
      "['new article treatment outcome', 'prognostic factors', 'korean patients', 'chronic lymphocytic leukemia', 'multicenter retrospective study cll leusm hematology']\n",
      "['incubation period']\n",
      "['comparative analysis', 'gene mutations', 'chronic lymphocytic leukemia', 'eric multi center study haematology thewiderwiserview']\n",
      "['cll pt s', 'don t', 'tv doc', 'serious jk', 'patients sense', 'humor covid19']\n",
      "['tumor mutationalload predicts time', 'chronic lymphocytic leukemia cll', 'monoclonal b cell lymphocytosis', 'international prognostic index']\n",
      "['patient leaders', 'cll chroniclymphocyticleukemia leukemia lymphoma']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['new free program', 'manage stress', 'week program', 'hse amp nhs', 'cll community', '2pm amp']\n",
      "['refractory chronic lymphocytic leuke']\n",
      "['system cll hematology oncology leukemia']\n",
      "['ibrutinib treatment', 'patients leukemia']\n",
      "['new prognostic tool uses results', 'available tests', 'chronic lymphocytic leukemia']\n",
      "['international prognostic score', 'stage chronic lymphocytic leukemia blood american society']\n",
      "['refractory chronic lymphocytic leukemia']\n",
      "['new article tumor mutational load predicts time', 'chronic lymphocytic leukemia cll', 'monoclonal b cell lymphocytosis', 'international prognostic index cll leusm hematology']\n",
      "['fellowship project', 'dlbcl preclin models clin trial', 'cll mcl dlbcl', 'mucho gracias hernandezlab', 'coauthors cheers']\n",
      "['pfizer inc', 'non hodgkin s lymphoma chronic lymphocytic leukemia']\n",
      "['appropriate gap', 'chronic lymphocytic leukemia', 'new prognostic tool ips e', 'leukemia leusm']\n",
      "['cll cancer learning']\n",
      "['new article hsa circ', 'hsa mir', '3p bcl', 'regulatory feedback circuit influences', 'cervical cancer hela cells cll leusm hematology']\n",
      "['chronic lymphocytic leukemia']\n",
      "['key statistics', 'chronic lymphocytic leukemia']\n",
      "['dr woyach', 'frontline options', 'chronic lymphocytic leukemia leusm']\n",
      "['icymi researchers', 'chronic lymphocytic leukemia', 'commercial ibrutinib', 'initial dose', 'dose modification', 'impact event', 'free survival', 'overall survival']\n",
      "['cll community']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia sll']\n",
      "['fda approves venetoclax', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia dr michael choi', 'dr jeff sharman talk', 'different genetic mutations', 'treatment leusm']\n",
      "['new coronavirus webinars mpn cll', 'telehealth coronavirus asktheexpert webinars', 'clarify covid19 facts', 'condition mpn mon', 'cancer patients']\n",
      "['bendamustine ofatumumab', 'ibrutinib treatment', 'chronic lymphocytic leukemia wit']\n",
      "['system cll lymsm', 'international prognostic score', 'stage chronic lymphocytic leukemia blood american society']\n",
      "['comparative analysis', 'gene mutations', 'chronic lymphocytic leukemia', 'eric multi center study']\n",
      "['comparative analysis', 'gene mutations', 'chronic lymphocytic leukemia', 'eric multi center study']\n",
      "['evolutionary paths', 'chronic lymphocytic leukemia', 'graft versus leukemia resistance', 'graft versus leukemia gvl effect', 'major barrier', 'successful allogeneic hematopoietic stem cell transplantation']\n",
      "['current prognostic', 'predictive biomarkers', 'chronic lymphocytic leukemia', 'therapy lymphoma lymsm']\n",
      "['new article regulation', 'selective b cell autophagy', 'pro oxidant adaptor p66shc cll leusm hematology']\n",
      "['new article hsv', 'elderly man', 'waldenstrom s macroglobulinemia cll leusm hematology']\n",
      "['new article comparative analysis', 'gene mutations', 'chronic lymphocytic leukemia', 'eric multi center study cll leusm hematology']\n",
      "['new article', 'current prognostic', 'predictive biomarkers', 'chronic lymphocytic leukemia', 'therapy cll leusm hematology']\n",
      "['current perspectives', 'chronic lymphocytic leukemia']\n",
      "['oncoalert cd49d promotes disease progression', 'chronic lymphocytic leukemia cll', 'new insights', 'cd49d bimodal expression american society', 'hematology hematology cllsm leusm lymsm']\n",
      "['new collaborative project', 'group comparative analysis', 'gene mutations', 'chronic lymphocytic leukemia', 'eric multi center study']\n",
      "['observational trial', 'real world treatment utilization', 'pi3k inhibitors', 'cll sll', 'fl status', 'condition summary lymphoma', 'small lymphocytic lymphoma lymphoma non hodgkin chronic lymphocytic leukemia fo']\n",
      "['evolutionary paths', 'chronic lymphocytic leukemia', 'graft versus leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['dr woyach', 'frontline options', 'chronic lymphocytic leukemia cllsm leusm']\n",
      "['bruton tyrosine kinase btk inhibitors', 'new drugs']\n",
      "['bendamustine ofatumumab', 'ibrutinib treatment', 'chronic lymphocytic']\n",
      "['evolutionary paths', 'chronic lymphocytic leukemia', 'graft versus leukemia biorxiv']\n",
      "['international prognostic score', 'stage chronic lymphocytic leukemia haematology thewiderwiserview']\n",
      "['hvis du har brug', 'snak s kontakt lyle dk p lyle dk el tlf', 'ingenskalst alenemedblodkr ft vi er', 'ogs i p sken', 'blodkr ft blodcancer patienter', 'aml cll cml cmml lymfekr ft leuk mi mds']\n",
      "['cll registry', 'final analysis', 'chronic lymphocytic leukemia']\n",
      "['observational trial', 'real world treatment utilization', 'pi3k inhibitors', 'cll sll', 'real duvelisib clinicaltrials difference', 'real world settings vs rct', 'numerous reasons']\n",
      "['covid19 impact cll care expert nicole lamanna hiccc member', 'discusses televisits risk factors', 'treatment changes', 'covid19ncancer leusm']\n",
      "['bendamustine ofatumumab', 'ibrutinib treatment', 'chronic lymphocytic leukemia w']\n",
      "['b cell non hodgkin lymphomas', 'magdalena klanova', 'pavel klener nhl bcellleukemia cll']\n",
      "['prognostic tool', 'chronic lymphocytic leukemia cll cancer treatment researchers study blood']\n",
      "['certain cancers', 'mantle cell lymphoma chronic lymphocytic leukemia', 'small lymphocytic rsp pharmaceuticaldistributor respirator n95 corona covid']\n",
      "['new article', 'cll registry', 'final analysis', 'chronic lymphocytic leukemia', 'sites cll leusm hematology']\n",
      "['new article', 'chronic lymphocytic leukemia', 'm xico', 'treatment cll leusm hematology']\n",
      "['international prognostic score', 'stage chronic lymphocytic leukemia cll ipss']\n",
      "['chronic lymphocytic leukemia changes', 'frontline treatment']\n",
      "['faqs fr covid', 'chronic lymphocytic leukemia version']\n",
      "['jumanji pelicul n cll']\n",
      "['loxo btki trial', 'great credit', 'covid19 era', 'pragmatic sensible flexibility', 'treatment option cll mcl wm lymsm']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['non covid news', 'final analysis', 'cll registry', 'novel agents', 'widespread use', 'collaborative effort']\n",
      "['cll uk guidance', 'covid2019 era']\n",
      "['dr wei', 'discusses changes', 'chroniclymphocyticleukemia cll treatment', 'practice overall leusm']\n",
      "['cll registry', 'final analysis', 'chronic lymphocytic leukemia', 'sites blood']\n",
      "['international prognostic score', 'stage chronic lymphocytic leukemia blood american society']\n",
      "['new prognostic tool', 'ips e predicts', 'chronic lymphocytic leukemia', 'cancer treatment']\n",
      "['bendamustine ofatumumab', 'ibrutinib treatment', 'chronic lymphocyt leukemia']\n",
      "['covid19 incubation period leukemia']\n",
      "['expensive drugs por cll circa', 'mexican patients']\n",
      "['international prognostic score', 'stage chronic lymphocytic leukemia blood american society']\n",
      "['new article progressive multifocal leukoencephalopathy', 'chronic b cell lymphatic leukaemia cll leusm hematology']\n",
      "['new article', 'international prognostic score', 'stage chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article risk factors', 'keratinocyte carcinoma', 'allogeneic hematopoietic cell transplants cll leusm hematology']\n",
      "['new article', 'generation btk inhibitors', 'fungal response', 'cll patients cll leusm hematology']\n",
      "['new article', 'pathological b cells', 'shorter overall survival', 'cll cll leusm hematology']\n",
      "['new article validation', 'chinese eortc chronic lymphocytic leukaemia module application', 'classical test theory', 'item response theory cll leusm hematology']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['pm edt', '1st blood cancers virtual support group', 'free drop', 'info aml multiplemyeloma leukemia lymphoma cll']\n",
      "['combination therapies', 'chronic lymphocytic leukemia leusm']\n",
      "['international prognostic score', 'stage chronic lymphocytic leukemia blood american society']\n",
      "['international prognostic score', 'stage chronic lymphocytic leukemia blood american society']\n",
      "['icymi medicare beneficiaries', 'unfavorable results', 'clinical trial participants', 'follicular lymphoma', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'recent asktheexpert', 'dr nicole lamanna', 'top cll questions', 'small av', 'online bandwidth demands leusm leukemia coronavirus covid19']\n",
      "['illinoissocialwork community learning lab cll', 'community partners', 'current needs']\n",
      "['new study identifies', 'prognostic tool', 'stage leukemia patients plan', 'cancer treatment']\n",
      "['cll webinar', 'facebook leukaemia spotleukaemia']\n",
      "['prof chris fegan']\n",
      "['immunotherapy clinicaltrial', 'nci researchers', 'obinutuzumab contact nih cc office', 'patient recruitment', 'prpl nih gov']\n",
      "['uk amp', 'nhs letter', 'specialist amp haematology centre', 'll collate', 'covid19 coronavirus leukaemia stayhome staysafe']\n",
      "['new article evolution', 'chronic lymphocytic leukemia', 'mrd negativity', 'goal cll leusm hematology']\n",
      "['genetic mutations', 'cd19 cartcells', 'leusm tcellrx immunoonc hemonc']\n",
      "['dr barr', 'umbralisib ublituximab venetoclax', 'refractory cll tgtx u2 combo venetoclax']\n",
      "['large cohort', 'patients w chronic lymphocytic leukemia', 'commercial ibrutinib', 'initial ibrutinib dose', 'dose modification', 'therapy didn t', 'impact event', 'free survival', 'overall survival']\n",
      "['leukemic arthritis', 'chronic lymphocytic leukemia', 'septic arthritis']\n",
      "['chronic lymphocytic leukemia', 'commercial ibrutinib', 'initial dose', 'dose modification', 'impact event', 'free survival', 'overall survival']\n",
      "['oncoalert btk inhibitor therapy', 'venetoclax american society', 'hematology hematology cllsm leusm lymsm']\n",
      "['dividend commitment']\n",
      "['new virtual support group blood cancers april', 'pm edt', 'free drop', 'click link', 'info aml multiplemyeloma leukemia lymphoma cll multiplemyeloma']\n",
      "['cll cello health plc', 'uk cll']\n",
      "['patent amp trademark law', 'alert cares', 'u s patent', 'trademark office', 'fee deadlines', 'trademarks patents uspto cll']\n",
      "['video cll cello health plc']\n",
      "['cll cello health plc', 'uk cll']\n",
      "['ascentage pharma announces approval', 'phase ib ii clinical study', 'inhibitor apg']\n",
      "['ascentage pharma announces cnmpa approval', 'phase ib ii clinical study', 'inhibitor apg', 'r r chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['differential diagnosis', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'indolent lymphomas', 'mantle cell lymphoma lymphoma lymsm']\n",
      "['new article performance', 'color dry antibody reagent', 'minimal residual disease', 'chronic lymphocytic leukemia samples cll leusm hematology']\n",
      "['new article leukemic arthritis', 'chronic lymphocytic leukemia', 'septic arthritis cll leusm hematology']\n",
      "['new article hepatitis b virus reactivation', 'brutinib treatment', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article differential diagnosis', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'indolent lymphomas', 'mantle cell lymphoma fl lymsm hematology']\n",
      "['journals case study shows cll', 'mask covid19 infection', 'mark s lesney']\n",
      "['cll cello health', 'interim dividend', 'uk cll']\n",
      "['rns aim cll cello health plc covid']\n",
      "['chronic lymphocy']\n",
      "['inaugural bloodcancer video support group', 'multiplemyeloma patient leader', 'leukemia lymphoma aml nhl hodgkins cll mpd']\n",
      "['amp cll wednesday', '15pm prof fegan', 'potential changes', 'cll patient care amp advice', 'uk patients registrants', 'full register']\n",
      "['common form', 'acute lymphoblastic leukemia b chronic lymphocytic leukemia c', 'acute myeloid leukemia d chronic myeloid leukemia']\n",
      "['oncoalert theearlierisnotthebetter', 'fcr lacks evidence', 'stage binet', 'high risk cll leusm cllsm']\n",
      "['drg epidemiology report estimates', 'western europe', 'global reports', 'cll leukemia lymphocyticleukemia']\n",
      "['podcast car t', 'cll space', 'tanya siddiqi', 'leusm hemonc immunoonc tcellrx mrd']\n",
      "['ibrutinib treatment i leukemia']\n",
      "['carnk therapy', 'new option', 'non hodgkin lymphoma']\n",
      "['natural killer cells native ability', 'infection carnk therapy', 'new option', 'non hodgkin lymphoma', 'rezvani cancermoonshot endcancer']\n",
      "['i m', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['new bendamustine ofatumumab', 'ibrutinib treatment', 'chronic lymphocytic leukemi']\n",
      "['fate therapeutics shares rise', 'cancer therapy', 'human trial', 'b cell malignancies', 'chronic lymphocytic leukemia fate cancer stocks fate']\n",
      "['fate therapeutics shares rise', 'cancer therapy', 'human trial', 'b cell malignancies', 'chronic lymphocytic leukemia fate cancer stocks fate']\n",
      "['btk inhibition', 'venetoclax discontinuation', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['refractory chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['clinical flow cytometric', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['new ibrutinib', 'salvage treatment', 'chronic lymp']\n",
      "['bendamustine ofatumumab', 'ibrutinib treatment', 'chronic lymphocytic leukemia leukemia']\n",
      "['high risk chronic lymphocytic leukemia', 'recent data', 'current standard', 'watch amp', 'approach leusm']\n",
      "['bruce g raphael md', 'tumor lysis syndrome', 'chronic lymphocytic leukemia leusm']\n",
      "['cross trial comparison', 'agent ibrutinib versus chlorambucil obinutuzumab', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma haematologica cll leusm']\n",
      "['phase i trial', 'disease process']\n",
      "['unfit patients', 'chronic lymphocytic']\n",
      "['european commission', 'rituximab biosimilar ruxience', 'non hodgkin lymphoma chronic lymphocytic leukemia nhl cll ec']\n",
      "['new article btk inhibitor therapy', 'venetoclax cll leusm hematology']\n",
      "['btk inhibitor therapy', 'durable disease control', 'cll patients', 'disease progression', 'median pfs', 'pmcc rmh']\n",
      "['cll chronic lymphocytic leukemia', 'yo son']\n",
      "['lymph nodes']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['cll specialists']\n",
      "['blood cancer folks', 'virtual meeting', 'v apr', 'info amp', 'reminder aml multiplemyeloma leukemia lymphoma cll multiplemyeloma']\n",
      "['bendamustine ofatumumab', 'ibrutinib treatment', 'chronic lymphocytic l']\n",
      "['new study', 'real world setting ibrutinib treatment', 'positive effects', 'patients health', 'treatment satisfaction', 'therapies regardless']\n",
      "['astrid pavlovsky', 'line treatment', 'comprehensive discussion', 'key clinical trials lymsm']\n",
      "['drg epidemiology report estimates', 'western europe', 'global reports', 'cll leukemia lymphocyticleukemia commission']\n",
      "['cd19 car nk cell therapy', 'year post infusion nkcell therapy chronic lymphocytic leukemia']\n",
      "['april newsletter', 'available online cll leukaemia haematology bloodcancerawareness']\n",
      "['coronavirus cll', 'dr lamanna', '9am pst noon est', 'askpatientpower covid19 coronavirus cll leusm leukemia cancer']\n",
      "['company s', 'human phase', 'clinical trial', 'cell therapy product candidate', 'tumor modalities', 'b cell malignancies', 'chronic lymphocytic leukemia']\n",
      "['eu approval', 'mabthera biosimilar approval monoclonal antibody biosimilar nhl cll ra gpa mpa pv data biosimilarity efficacy safety immunogenicity pharmacokinetics pharmacodynamics oncology cancers autoimmune haematology']\n",
      "['new article histopathological', 'tissue alterations', 'human adipose tissue cll leusm hematology']\n",
      "['new article', 'current perspectives', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article hairy cell leukemia', 'ground water contamination', 'industrial solvents', 'case report cll leusm hematology']\n",
      "['new article hif', 'potential treatment target', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'chronic lymphocytic leukaemia', 'final analysis', 'trial cll leusm hematology']\n",
      "['new article germline heterozygous mutations', 'nxf1 perturb rna metabolism', 'trigger thrombocytopenia', 'mice cll leusm hematology']\n",
      "['cll world experts']\n",
      "['don t', 'course online', 'learning whist', 'automotive courses']\n",
      "['chroniclymphocyticleukemia market']\n",
      "['chronic lymphocytic leukemia', 'divergent richter s transformation', 'classical hodgkin s', 'plasmablastic lymphoma', 'case report lymphoma lymsm']\n",
      "['inositol phosphatase contributes', 'chronic lymphocytic leukemia survival']\n",
      "['chronic lymphocyt']\n",
      "['cll covid19']\n",
      "['company s', 'human phase', 'clinical trial', 'cell therapy product candidate', 'tumor modalities', 'b cell malignancies', 'chronic lymphocytic leukemia']\n",
      "['recent research findings', 'safe space advice', 'patients frm irish haematologists amp experiences', 'cll community']\n",
      "['oncoalert prognostic model', 'cll patients', 'binet stage', 'prospective cll1 trial', 'german cll study group cllsm leusm lymsm']\n",
      "['pleasant news', 'great discussion', 'colleagues dr amir steinberg', 'rich bakst', 'cll sll', 'americans cll leukemia lymphoma']\n",
      "['natural prevention', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'bruton tyrosine kinase inhibitor ibrutinib interruptions', 'free survival', 'overall survival']\n",
      "['drs mazyar shadman john byrd michael hallek jennifer', 'brown peter hillmen anthony mato', 'paolo ghia cll covid19 leusm lymsm leukemia']\n",
      "['light cll']\n",
      "['michael choi md', 'discusses frontline treatment considerations', 'chronic lymphocytic leukemia leusm']\n",
      "['new faq']\n",
      "['pandemic s impact', 'cancer community', 'specific impacts', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll', 'line therapy thanks', 'new clinical trial results']\n",
      "['jennifer woyach md', 'james discusses', 'chronic lymphocytic leukemia treatment leusm']\n",
      "['hematology abstracts', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma part', 'refractory disease leusm lymsm hematology']\n",
      "['hematology abstracts', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma part', 'disease hematology leusm lymsm']\n",
      "['great work', 'dr woyach', 'cll resistance mechanisms']\n",
      "['unfit patients', 'chronic lymphocyt']\n",
      "['new article novel bcl2 mutations', 'resistant ibrutinib', 'resistant cll patients', 'btk plcg2 mutations cll leusm hematology']\n",
      "['new article myelodysplastic syndrome', 'transfusion dependence', 'venetoclax cll leusm hematology']\n",
      "['new article btk inhibitors', 'cd20 monoclonal antibodies', 'treatment na ve', 'elderly patients', 'cll cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia', 'divergent richter s transformation', 'classical hodgkin s', 'plasmablastic lymphoma', 'case report cll leusm hematology']\n",
      "['new article sensitivity', 'chronic lymphocytic leukemia cells', 'chemotherapeutic drugs ex vivo', 'expression status', 'cell surface receptors cll leusm hematology']\n",
      "['new article myc copy number', 'mrna expression', 'chronic lymphocytic leukemia patients', 'chornobyl npp accident cll leusm hematology']\n",
      "['new article pharmacists role', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia cll leusm hematology']\n",
      "['important project', 'uk cll forum', 'work cll lymsm covid']\n",
      "['uk cll physicians', 'uk cll forum', 'important data collection', 'covid19uk era covid']\n",
      "['cd19 chimeric antigen receptor t cells', 'chronic lymphocytic leukemia journal']\n",
      "['cll key questions', 'cll management']\n",
      "['chronic lymphocytic leukemia', 'magazine cll']\n",
      "['groups thoughts', 'discussion medtwitter cll']\n",
      "[]\n",
      "['old dad', 'low grade fever', 'immune system', 'cll chronic lymphocytic leukemia']\n",
      "['case study', 'chronic lymphocytic leukemia', 'novel coronavirus covid', 'cll cancer jnccn']\n",
      "['os benefit', '1l cll', 'chronic lymphocytic leukaemia', 'final analysis']\n",
      "['acute pancreatitis', 'chronic lymphocytic leukemia']\n",
      "['chase s', 'week amp', 'virtual celebration', 'w chronic lymphocytic leukemia', 'mom amp blood tests']\n",
      "['couple week', 'lymphoid malignancies', 'chronic lymphocytic leukemia cancer', 'blood bone marrow', 'mature lymphocytes']\n",
      "['hem onc pharm residents', 'important review article pharmacists role', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'negative myeloproliferative neoplasms']\n",
      "[]\n",
      "['dr rod humerickhouse abbvie pharmaceuticals highlights', 'cll news fight cll', 'international workshop', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic']\n",
      "['new article investigation', 'chronic lymphocytic leukemia', 'negative myeloproliferative neoplasms cll leusm hematology']\n",
      "['new article monocytic mdsc', 'immunosuppressive cytokines', 'chronic lymphocytic leukemia cll microenvironment cll leusm hematology']\n",
      "['new article', 'acute pancreatitis', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'tumor microenvironment cell interactions', 'immunotherapy cll leusm hematology']\n",
      "['new article sequential development', 'mantle cell lymphoma', 'chronic lymphocytic leukemia mcl lymsm hematology']\n",
      "['i ll pay', 'full amount', 'credit card', 'health insurance', 'i m', 'chronic lymphocytic leukemia cancelrent']\n",
      "['line treatment', 'high rates', 'undetectable minimal residual disease', 'peripheral blood', 'bone marrow', 'chronic lymphocytic leukemia']\n",
      "['oral drugs copiktra', 'promising results', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma cllmonthlyminutes chroniclymphocyticleukemia']\n",
      "['big thanks', 'cll abstract', 'online april 27th systematic evaluation', 'relevant conditions', 'cll cells ex vivo', 'optimal system', 'therapeutic compounds']\n",
      "['drg epidemiology report estimates', 'western europe', 'global reports', 'cll leukemia lymphocyticleukemia bloodcancer']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['cll society expert panel', 'questions don t', 'cll society covid', 'virtual community meeting friday april', '00a m pt', '00p m mt', '00p m ct', '00p m']\n",
      "['american cancer society chronic lymphocytic leukemia cll', 'common leukemia', 'financial assistance', 'medicare pts', 'prescription medications amp premiums', 'cll treatment']\n",
      "['chronic lymphocytic leukemia', 'cancer dr', 'difficult month']\n",
      "['hi i m', 'way i', 'doctor service', 'podcast webinar i m', 'ritux infusions', 'pandemic wd', 'w venetoclax monotherapy', 'opinions cll']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['information amp guidance', 'cll leukaemia bloodcancer patients', 'website haematology bloodcancerawareness']\n",
      "['bruce g raphael md', 'treatment landscape', 'chronic lymphocytic leukemia leusm']\n",
      "['icymi clinical picture', 'chronic lymphocytic leukaemia', 'potential considerations', 'haematological malignancies cll leusm hemonc']\n",
      "['chronic lymphocytic leukemia']\n",
      "['full length transcript characterization', 'sf3b1 mutation', 'chronic lymphocytic leukemia reveals downregulation']\n",
      "['chronic lymphocytic leuke']\n",
      "['new article', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['invasive aspergillosis', 'ibrutinib therapy', 'chronic lymphocytic leukemia']\n",
      "['rns aim cll cello health plc grant']\n",
      "['chronic lymphocytic leukemia']\n",
      "['data cll leusm lymsm']\n",
      "['chronic lymphocytic leuke']\n",
      "['improvement immunization', 'pts w monoclonal b cell lymphocytosis', 'cll jul', 'leusm cllsm idonc']\n",
      "['japan clinical trials remdesivir', 'duvelisib copiktra covid19 coronavirus leukemia cll sll nfl ptcl cancer leukemia lymphoma t cell hematolgy oncology virology pi3k inhibitor nhl treatment']\n",
      "['cll leukaemia bloodcancer patients', 'hospital clinician', 'march contact']\n",
      "['new article performance', 'cd19 chimeric antigen receptor t cells', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article population genetic study', 'balkan endemic nephropathy', 'serbia cll leusm hematology']\n",
      "['rte news', 'main topic']\n",
      "['ibrutinib treatment']\n",
      "['waves imbruvica janssen johnandjohnsonpharmaceuticalcompany ibrutinib leukemia leukemia aml', 'cml cll makingwaves']\n",
      "['full length transcripts', 'isoforms chronic lymphocytic leukemia cll', 'common form', 'blood cancer', 'biotech biotechnology science']\n",
      "['chronic lymphocytic leu leukemia']\n",
      "['new jitc article performance', 'cd19 chimeric antigen receptor t cells', 'chronic lymphocytic leukemia']\n",
      "['cll patients', 'uk cll forum', 'covid19 era']\n",
      "['unfit patients', 'chronic lymp']\n",
      "['cll patients']\n",
      "['new article', 't cell chronic lymphocytic leukemia', 'richter syndrome', 'central nervous system involvement', 'dog cll leusm hematology']\n",
      "['new article molecular epidemiology', 'epstein barr virus ebv', 'hematologic malignancies cll leusm hematology']\n",
      "['ibrutinib treatment', 'refractory chronic lymphocytic leukemia', 'final analysis', 'pivotal phase 1b', 'study lymphoma lymsm']\n",
      "['ibrutinib treatment']\n",
      "['ibrutinib imbruvica', 'double middle finger weird lymphoma inhibitor treatment t cell bone marrow transplant cll ptcl mzl sll wm mcl leukemia']\n",
      "['i m', 'family boyfriend', 'chronic lymphocytic leukemia']\n",
      "['unfit patients', 'chronic lymphocytic']\n",
      "['cll cll cello health group ex dividend date', 'payment date']\n",
      "['cll society covid', 'virtual community meeting part ii', 'dr anthony mato dr danielle brander dr john pagel lab scientist dr susan leclair covid', 'pharmacist thomas henry drug']\n",
      "['chronic lymphocytic leukaemia', 'interesting article', 'lancet abt patient w', 'blood cancer i', 'suggests immune', 'incubation period']\n",
      "['rare case', 'richter s syndrome localization', 'chronic lymphocytic leukemia cll case report', 'literature lymphoma lymsm']\n",
      "['new article cd30 lymphomatoid skin toxicity', 'ipilimumab cll leusm hematology']\n",
      "['new article association', 'cd49d expression', 'chronic lymphocytic leukemia patients', 'iranian population cll leusm hematology']\n",
      "['new article serum expression', 'chronic lymphocytic leukemia patients cll leusm hematology']\n",
      "['new article vla', 'b cell malignancies', 'clinical aspects cll leusm hematology']\n",
      "['new article ibrutinib treatment', 'refractory chronic lymphocytic leukemia', 'final analysis', 'pivotal phase 1b', 'study cll leusm hematology']\n",
      "['new article', 'novel recombinant expression', 'purification approach', 'full length', 'apoptotic membrane protein bcl', 'cll leusm hematology']\n",
      "['new article', 'rare case', 'richter s syndrome localization', 'chronic lymphocytic leukemia cll case report', 'literature cll leusm hematology']\n",
      "['formydad cancersucks cll gofundme i m raising money', 'john s chemo medication click']\n",
      "['b cell receptor inhibitors', 'novel agents', 'chronic lymphocytic leukemia cll', 'novel agent']\n",
      "['cancer patients need', 'coronavirus covid19 cancer myeloma cll leukemia']\n",
      "['pagc19 covidaus lymphoma cll lime4lymphoma information', 'special edition newsletter']\n",
      "['treatment outcomes', 'idelalisib differs', 'follicular lymphoma amp chronic lymphocytic leukemia', 'clinical setting', 'clinical trial', 'medicare beneficiaries', 'clinical trial counterparts']\n",
      "['minute medscapeedu video', 'data amp recommendations', 'bruton tyrosine kinase btk inhibitors', 'patients w chronic lymphocytic leukemia', 'w drs jeff sharman']\n",
      "['cll specialists', 'amp impact', 'cll patients', 'cll amp sll patients leukaemia bloodcancer bloodcancerawareness haematology']\n",
      "['chronic lymphocytic leukemia']\n",
      "['cllan coronavirus covid', 'extra guidance', 'bloodcancer patient advocates']\n",
      "['t cell chronic lymphocytic leukemia', 'richter syndrome', 'central nervous system involvement']\n",
      "['open access ucl research', 'b cell receptor rearrangement', 'somatic hypermutation', 'b cell class switch fate', 'chronic lymphocytic leukemia ucl discovery']\n",
      "['good morning kapoor', 'journey eyfs cll']\n",
      "['full length transcript characterization', 'sf3b1 mutation', 'chronic lymphocytic leukemia reveals downregulation']\n",
      "['current availability', 'critical cll meds pharmacist tom henry', 'cll society covid', 'virtual community meeting register']\n",
      "['icymi jennifer', 'woyach md', 'frontline treatments', 'chronic lymphocytic leukemia', 'treatments james']\n",
      "['american cancer society', 'people age', 'chronic lymphocytic leukemia cll']\n",
      "['acute lymphocytic leukemia', 'philadelphia chromosome', 'philadelphia translocation ph', 'specific genetic abnormality', 'leukemia cancer cells', 'chronic myeloid leukemia cml cells']\n",
      "['note pt', 'interesting note', 'days covid', 'chronic lymphocytic leukaemia']\n",
      "['cell death differentiation nf b p62 nrf2 survival', 'high ror1 expression', 'chronic lymphocytic leukemia']\n",
      "['t cell chronic lymphocytic leukemia', 'richter syndrome', 'central nervous system involvement']\n",
      "['problems cancer cll patients', 'covid19 restrictions']\n",
      "['fellow wonderworkers', 'sad notice thomas baxter', 'vancouver gen hospital', 'chronic lymphocytic leukemia', 'gentle wise kind soul', 'original delightful mentalist']\n",
      "['unfit patients', 'chronic lymphocyti leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['human medicines european', 'public assessment report epar gazyvaro obinutuzumab leukemia lymphocytic chronic b cell date', 'authorisation revision', 'agenparl cycle cycles reactions treatment']\n",
      "['constantine s tam mbbs md', 'treatment na ve chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['case report', 'young pt', 'progressive cll', 'i ve']\n",
      "['unfit patients', 'chronic lymphocyt']\n",
      "['high risk group']\n",
      "['cll patients']\n",
      "['chronic lymphocytic leukemia', 'long ass lap area', 'cruise ship', 'i m stupid']\n",
      "['alpine zanubrutinib versus ibrutinib', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma lymphoma lymsm']\n",
      "['unfit patients', 'chronic lym']\n",
      "['cancer treatment plan', 'comments info thanks coronavirus covid19 mmsm lcsm bcsm cll']\n",
      "['wagoshag wednesday', 'special message', 'vice chief sam matheny spring conference link', 'bio oa oabsa bsa cll bethere bethere2020 spring conference springconference wildwest service']\n",
      "['question opportunity', 'empower innovate']\n",
      "['fulllength transcripts', 'chronic lymphocytic leukemia cll', 'common form', 'blood cancer']\n",
      "['susan m o brien md', 'stephan stilgenbauer md', 'upfront treatment', 'chronic lymphocytic leukemia cll', 'old standby']\n",
      "['unfit patients', 'chronic leukemia']\n",
      "['constantine s tam md mbbs', 'btk inhibitors', 'cll mcl', 'waldenstr m macroglobulinemia leukemia lymphoma']\n",
      "['tennessee cll infectious disease experts', 'patient questions', 'treatment research family issues worldwide virtual town hall cllsm askpatientpower cll coronavirus covid19']\n",
      "['chronic lymphocytic leukemia treatment pdq health', 'professional version', 'ncbi oncology cll']\n",
      "['undetectable minimal residual disease', 'venetoclax treatment', 'chronic lymphocytic leukemia']\n",
      "['undetectable minimal residual disease', 'venetoclax treatment']\n",
      "[]\n",
      "['unfit patients', 'chronic lymphocytic']\n",
      "['new article alpine zanubrutinib versus ibrutinib', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll leusm hematology']\n",
      "['new article prognostic', 'predictive impact', 'genetic markers', 'venetoclax cll leusm hematology']\n",
      "['new article pdq cancer information summaries cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'risk group', 'self isolate', 'i m']\n",
      "['cll society virtual community meeting q amp', 'cll experts drs anthony mato', 'danielle brander dr susan leclair', 'pharmacist tom henry', 'cll patient dr brian koffman', 'moderate register']\n",
      "['global chronic lymphocytic leukemia therapeutics market premium insight', 'competitive news feed analysis company usability profiles market', 'amp forecasts']\n",
      "['global chronic lymphocytic leukemia therapeutics market premium insight', 'competitive news feed analysis company usability profiles market', 'amp forecasts']\n",
      "['chronic lymphocytic leukemia market size', 'share epidemiology']\n",
      "['ibrutinib treatment', 'refractory chronic lymphocytic leukemia', 'final analysis', 'pivotal phase 1b']\n",
      "['cll community', 'times journalist sean o neill', 'cll patient', 'specific guidelines']\n",
      "['chronic lymphocytic leukemia market size', 'share epidemiology']\n",
      "['chronic lymphocytic leukemia market size', 'share epidemiology']\n",
      "['physical distance', 'cll littleleague coquitlamlittleleague baseball baseballcoach coach']\n",
      "['classify leukemia cases', 'immune system', 'acute lymphocytic leukemia', 'chronic lymphocytic leukemia cll leukemia cancer childhoodcancerawareness']\n",
      "['chronic lymphocytic leukemia market size', 'share epidemiology']\n",
      "['excellent informative', 'new website cll lymsm']\n",
      "['chronic lymphocytic leukemia market size', 'share epidemiology']\n",
      "['chronic lymphocytic leukemia market size', 'share epidemiology']\n",
      "['chronic lymphocytic leukemia market size', 'share epidemiology']\n",
      "['saturday cll town hall', 'online march', 'cll experts', 'patients register']\n",
      "['chronic lymphocytic leukemia', 'manageable disease', 'treatment i', 'ptsd symptoms', 'i waa']\n",
      "['new office yes', 'ergonomic support yes', 'foldable table yes', 'i don t scratch', 'floors yes', 'teleclinic cll', 'whnft james']\n",
      "['cll patients minimize']\n",
      "['adverse events', 'chronic lymphocytic leukemia oral', 'w mollie moran msn cnp aocnp', 'james amp shilpa paul pharmd bcop']\n",
      "['richter transformation', 'chronic lymphocytic leukemia cll', 'german cll study group gcllsg front line treatment trials lymphoma lymsm']\n",
      "['enzyme inhibitor', 'chronic lymphocytic leukemia', 't cells lymphoma lymsm']\n",
      "['new article', 'chronic lymphocytic leukemia', 'clinical case', 'allogeneic stem cell transplantation cll leusm hematology']\n",
      "['new article richter transformation', 'chronic lymphocytic leukemia cll', 'german cll study group gcllsg front line treatment trials cll leusm hematology']\n",
      "['new article immunomodulatory', 'enzyme inhibitor', 'chronic lymphocytic leukemia', 't cells cll leusm hematology']\n",
      "['vulnerable covid', 'coronavirus cll leukaemia patients haematology bloodcancerawareness uk rt']\n",
      "['sean o neill', 'times uk', 'personal thoughts', 'cll uk foreningen']\n",
      "['btk inhibitors transform treatment', 'cll mcl', 'waldenstrom macroglobulinemia constantine s tam md mbbs highlights', 'btk inhibitors', 'chronic lymphocytic leukemia mantle cell lymphoma', 'waldenstr amp ouml m macroglobulinemia']\n",
      "['chronic lymphocytic leukemia oncology learning network']\n",
      "['support cancerresearch physicians', 'clinical trial', 'cll contact patient recruitment', 'prpl nih gov', 'lymphoma lymphomaleukemia']\n",
      "['secondary blood cancers', 'chronic lymphocytic leuk']\n",
      "['monthly newsletter', 'march edition']\n",
      "['don t', 'various cancers organ transplants crohns ms lupus ra amp', 'lives flattenthecurve cll leukemia']\n",
      "['virtual classroom regardless']\n",
      "['great work', 'forgotten weareinthistogether covid19 cll']\n",
      "['stayhome covid19 jointhefightback cll', 'important message', 'northern ireland don t', 'healthcare workers', 'vulnerable people', 'risk research']\n",
      "['whatsapp number', 'enable people', 'covid19ireland cll']\n",
      "['askdrh hi i', 'chronic lymphocytic leukemia', 'lockdown i', 'brilliant job']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['ibrutinib treatment', 'chronic lymphocytic leukemia']\n",
      "['european commission approval', 'venclyxto combination regimen', 'chronic lymphocytic leukemia abbvie news center']\n",
      "['ibrutinib treatment']\n",
      "['bay area rep mark desaulnier', 'critical condition', 'chronic lymphocytic leukemia', 'political work']\n",
      "['ibrutinib treatment']\n",
      "['cll leukaemia bloodcancer patients', 'coronavirus covid', 'bloodcancerawareness haematology rt']\n",
      "['undetectable minimal residual disease', 'venetoclax treatment']\n",
      "['brad s kahl md', 'btk inhibitors', 'therapeutic class', 'cll leukemia']\n",
      "['arthralgias myalgias', 'chronic lymphocytic leukemia incidence', 'clinical outcomes lymphoma lymsm']\n",
      "['new article assessment', 'venetoclax discontinuation', 'cll reveals btk inhibition', 'effective strategy cll leusm hematology']\n",
      "['new article ibrutinib', 'arthralgias myalgias', 'chronic lymphocytic leukemia incidence', 'clinical outcomes mmsm multiplemyeloma hematology']\n",
      "['great piece']\n",
      "['park i don t mind', 'leukemia cll mecfs heart']\n",
      "['refractory chronic lymphocytic leukemia market review epidemiology', 'view insight prices', 'firstview market insight', 'refractory chronic lymphocytic leukemia market review']\n",
      "[]\n",
      "['affects patients', 'minimize risk webinar', 'online leusm']\n",
      "['covid19 crisis', 'blog sends greetings']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['week s', 'expert webinars', 'specific virus issues', 'new programs', 'askpatientpower cll covid19usa']\n",
      "['cll patient carol butler', 'care partner john', 'clinical trials', 'time cll leukemia leusm patientpower']\n",
      "['important decisions counseling', 'possible important questions', 'patients thx']\n",
      "['thoughtful discussion', 'ibrutinib v fcr', 'cll mindful', 'dr o brien s opinion', 'long term progression', 'free survival gt', 'fcr chemoimmunotherapy']\n",
      "['lee greenberger chief', 'scientific officer', 'chronic lymphocytic leukemia']\n",
      "['interesting cllstrong cll patientpower']\n",
      "['cll tgtx', 'generation molecules', 'clinical trials', 'safety profile zanubrutinib umbralisib etc']\n",
      "['ibrutinib treatment', 'patients wi']\n",
      "['new article fbw7', 'hematological tumors cll leusm hematology']\n",
      "['new article', 'line treatment', 'rituximab resistance', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'successful use', 'eosinophilic dermatosis', 'myeloproliferative disease', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'clinical case', 'allogeneic stemcell transplantation']\n",
      "['ibrutinib treatment', 'patients wi']\n",
      "['brad s kahl md', 'btk inhibitors', 'treatment paradigm', 'cll leukemia']\n",
      "['big study']\n",
      "['expert assessment', 'available btk inhibitors', 'cll treatment spectrum leukemia']\n",
      "['expert assessment', 'available btk inhibitors', 'cll treatment spectrum brad s kahl md discusses', 'btk inhibitors', 'treatment paradigm', 'chronic lymphocytic leukemia']\n",
      "['blood cancer mmsm cll leukemia hematology myeloma']\n",
      "['chronic lymphocytic leukemia', 'fda approvals', 'plasma cell malignancies']\n",
      "['i m', 'chronic lymphocytic leukemia rai stage', 'eye opener']\n",
      "['tough questions', 'collegial partnerships worldwide']\n",
      "['btk inhibitors', 'effective therapy', 'venetoclax therapy', 'important data', 'treatment options']\n",
      "['1st time', 'detail n outcomes', 'pts post venetoclax', 'amazing collaboration btki orr post ven reason', 'btki dc influences', 'btki orr pfs post ven']\n",
      "['coronavirus risk', 'blood test show', 'coronavirus covid19 cancer leusm cll']\n",
      "['icymi eviti cmo dr flood co', 'clinical space']\n",
      "['drg epidemiology report estimates', 'western europe', 'global reports', 'cll leukemia lymphocyticleukemia']\n",
      "['car nk cell therapy', 'lymphoma community head', 'phase i ii trial', 'car nk cells', 'r r cd19', 'positive nhl', 'cll lymsm']\n",
      "['couldn t', 'great work benign hematology service james', 'hospital evolve', 'cll team whnft']\n",
      "['biotechniques journal', 'great collaboration']\n",
      "['ibrutinib treatment']\n",
      "['new article', 'full length transcript characterization', 'sf3b1 mutation', 'chronic lymphocytic leukemia reveals downregulation', 'introns cll leusm hematology']\n",
      "['new article methylome', 'methyl coom identifies aberrant expression', 'immune regulatory molecules', 'cll cll leusm hematology']\n",
      "['new article', 'anecdotal case report', 'chronic lymphatic leukemia', 'del 11q', 'artificial nourishment', 'physical activity program cll leusm hematology']\n",
      "['full length transcript characterization', 'sf3b1 mutation', 'chronic lymphocytic leukemia reveals downregulation', 'introns natcommun']\n",
      "['undetectable minimal residual disease', 'venetoclax treatment']\n",
      "['chronic lymphocytic leukemia causes picture symptoms treatment']\n",
      "['medical director', 'infection prevention', 'seattle cancer care alliance', 'blood malignancies', 'non hodgkin lymphoma chronic lymphocytic leukemia', 'acute myeloid leukemia']\n",
      "['cancer patients', 'social support strategies leusm leukemia cll patientpower']\n",
      "['fulllength transcript characterization', 'isf3b1i mutation', 'chronic lymphocytic leukemia null dthstr']\n",
      "['long isoform', 'chronic lymphocytic leukemia', 'cytogenetic groups', 'clinical outcome']\n",
      "['new article', 'dose modification', 'temporary interruption', 'chronic lymphocytic leukemia patients', 'routine clinical practice cll leusm hematology']\n",
      "['new article', 'mangifera indica l', 'juglans regiaaqueous extract', 'human chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article non catalytic bruton s tyrosine kinase activates plc', 'ibrutinib resistance', 'human chronic lymphocytic leukemia cells cll leusm hematology']\n",
      "['new article neat1', 'long isoform', 'chronic lymphocytic leukemia', 'cytogenetic groups', 'clinical outcome cll leusm hematology']\n",
      "['new article tumor suppressors', 'chronic lymphocytic leukemia', 'active targets cll leusm hematology']\n",
      "['new article cd62l expression', 'chronic lymphocytic leukemia patients cll leusm hematology']\n",
      "['motor neuropathy', 'conduction block', 'pan neurofascin antibodies', 'chronic lymphocytic leukemia']\n",
      "['full length transcript characterization', 'sf3b1 mutation', 'chronic lymphocytic leukemia reveals downregulation', 'introns nature communications']\n",
      "['cll diffuseblymphoma', 'lung issues']\n",
      "['new undetectable minimal residual disease', 'venetoclax treatment', 'patients wit']\n",
      "['chronic lymphocytic leukemia', 'leusm hematology']\n",
      "['cll leukemia story']\n",
      "['cell death differentiation nf b p62 nrf2 survival', 'high ror1 expression', 'chronic lymphocytic leukemia']\n",
      "['askpatientpower covid', 'covid19 cll']\n",
      "['chronic lymphocytic leukemia', 'hemorrhagic brain masses']\n",
      "['different lymphoma', 'cll subtypes', 'lymphoma lymsm cll']\n",
      "['expert broadcasts', 'specific hematologic conditions cll', 'myeloma thanks', 'drs justin taylor farrukh awan nina shaw', 'larry anderson covid19 cll myeloma askpatientpower']\n",
      "['life counts', 'great risk', 'leukemia patient i', 'don t', 'highriskcovid19 covid19 cll']\n",
      "['hashtag askpatientpower covid19 cancer leusm cll']\n",
      "['eviti cmo dr flood co', 'clinical space']\n",
      "['coronavirus cll', 'pm pt', 'askpatientpower cll leusm leukemia patientpower coronavirus covid19 cancer']\n",
      "['cll cme', 'prime cll']\n",
      "['full length transcript characterization', 'sf3b1 mutation', 'chronic lymphocytic leukemia reveals downregulation', 'great work', 'amp amp']\n",
      "['full length transcript characterization', 'sf3b1 mutation', 'chronic lymphocytic leukemia reveals downregulation']\n",
      "['cll cello health gains momentum', 'full year profits', 'revenues rise', 'uk cll']\n",
      "['new article', 'new treatment', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['cll cello health hits', 'revenues profits', 'dividend rise', 'uk cll']\n",
      "['alliance a041702', 'triplet regimen s ability', 'ibrutinib discontinuation', 'drug regimen', 'detectable cll', 'year leukemia james']\n",
      "['rns aim cll cello health plc', 'preliminary results']\n",
      "['refractory chronic lymphocytic leukemia market review epidemiology', 'view insight prices', 'firstview market insight', 'refractory chronic lymphocytic leukemia market review']\n",
      "['acute leukemia', 'leukemias increases', 'median age', 'acute myeloid leukemia aml chronic lymphocytic leukemia cll', 'chronic myeloid leukemia cml']\n",
      "['real world study', 'private message', 'contact information', 'global consortium']\n",
      "['rt physrelations rt leukemiamda wwierda', 'mdandersonnews leukemia joins', 'onclive endcancer leusm']\n",
      "['btk inhibitors', 'cll lori leslie md', 'medical oncologist', 'regional cancer care associates discusses', 'btk inhibitors', 'chronic lymphocytic leukemia']\n",
      "['cll sll leukaemia bloodcancer', 'practical advice']\n",
      "['trademark cll']\n",
      "['cll town hall', 'online march', 'cll experts', 'patients register']\n",
      "['leukemia joins', 'endcancer leusm']\n",
      "['current crisis', 'covid19 bloodcancer']\n",
      "['chronic lymphocytic leukemia i']\n",
      "['additional b cell malignancies', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll']\n",
      "['additional b cell malignancies', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll lymphoma lymsm']\n",
      "['new article expression', 'hla dr molecules', 'chronic lymphocytic leukemia patients cll leusm hematology']\n",
      "['new article', 'additional b cell malignancies', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll cll leusm hematology']\n",
      "['new article chronic lymphocytic leukaemia', 'cll leusm hematology']\n",
      "['new article ibrutinib suppresses intracellular mycobacterium tuberculosis growth', 'macrophage autophagy cll leusm hematology']\n",
      "['cll leukaemia', 'severe illness', 'stringent measures', 'safe bloodcancerawareness']\n",
      "['cll blood cancer patient', 'selfisolation ireland']\n",
      "['standard doublet regimen', 'term treatment', 'toxicity leukemia james']\n",
      "['frontline ven obin cll14', 'similar efficacy', 'complex karyotype', 'abnormalities cll cllsm']\n",
      "['undetectable minimal residual disease', 'venetoclax treatment', 'pa leukemia']\n",
      "['investigators pursue lesstoxic treatment', 'frontline cll investigators', 'standard doublet regimen', 'chronic lymphocytic leukemia']\n",
      "['blood high efficacy', 'complex karyotype']\n",
      "['challenge isolate', 'lovely teenage boys', 'cll closeschoolsuk covid19']\n",
      "['investigators pursue', 'toxic treatment', 'frontline cll leukemia']\n",
      "['video arq', 'covalent btki', 'resistant cll w jennifer woyach', 'leusm hemeonc ash19 hematology']\n",
      "['cme activity experts', 'field address clinical advances', 'chronic lymphocytic leukemia', 'multiple myeloma', 'cme credits gt gt']\n",
      "['undetectable minimal residual disease', 'venetoclax treatment']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['human medicines european', 'public assessment report epar mabthera rituximab lymphoma non hodgkin arthritis rheumatoid leukemia lymphocytic chronic b cell date', 'authorisation agenparl chemotherapy combination patients treatment']\n",
      "['undetectable minimal residual disease', 'venetoclax treatment', 'chronic lymphocytic leukemia']\n",
      "['undetectable minimal residual disease', 'venetoclax treatment']\n",
      "['cll covid19 blooducation']\n",
      "['venclyxto gains approval', 'europe europeancommission ec combination treatment adult patients chroniclymphocyticleukaemia cll approval phaseiii cll14 clinicalstudy trial disease', 'fixedduration chemotherapyfree eu']\n",
      "['cll patient', 'uk clinicaltrial', 'feeling human i', 'regular immunoglobulin infusions', 'voicesofthevulnerable stayhome']\n",
      "['chronic lymphocytic leukemia', 'common leukemia', 'adults story', 'janssen oncology']\n",
      "['secondary blood cancers', 'chronic lym leukemia']\n",
      "['new undetectable minimal residual disease', 'venetoclax treatment', 'patients wit']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['coronavirus update andrew schorr', 'dr jeff sharman', 'patients cll questions', 'coronavirus coronavirus patientpower cll leukemia leusm']\n",
      "['cavalier uk authorities', 'highriskcovid19 citizens', 'cll bloodcancer amp', 'northernireland amp rest', 'ireland share', 'urge uk politicians']\n",
      "['mitochondrial respiration correlates', 'prognostic markers', 'chronic lymphocytic leukemia', 'ibrutinib treatment lymphoma lymsm']\n",
      "['new article novel therapies', 'chronic lymphocytic leukemia', 'landscape cll leusm hematology']\n",
      "['new article nfkbie deficiency', 'b cell lymphoproliferative disorders', 'mice cll leusm hematology']\n",
      "['new article mitochondrial respiration correlates', 'prognostic markers', 'chronic lymphocytic leukemia', 'ibrutinib treatment cll leusm hematology']\n",
      "['stocks ftse djia psychology spt hnt cmcx cine gns intu msft aapl aml', 'cll syn dvo indv amp']\n",
      "['pals jan amp', 'cll bloodcancer', 'practice socialdistancingnow']\n",
      "['health conditions', 'aren t', 'hashtag highriskcovid19', 'story amp', 'cll patientvoice']\n",
      "['parents i', 'chronic lymphocytic leukemia', 'hep c', 'home highriskcovid19']\n",
      "['secondary blood cancers', 'chronic lymphoc']\n",
      "['secondary blood cancers', 'chronic lymphocytic']\n",
      "['chronic lymphocytic leukemia', 'day i don t', 't i']\n",
      "['lung disease heart disease kidney disease', 'thyroid disease', 'chronic lymphocytic leukemia i']\n",
      "['secondary blood cancers', 'chronic lymphocy']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['cll covid']\n",
      "['chronic lymphocytic leukemia', 'drs susan o brien amp stephan stilgenbauer', 'early stage treatment options', 'current role']\n",
      "['jennifer woyach md discusses', 'phase iii alliance a041702 trial', 'chronic lymphocytic leukemia james leusm']\n",
      "['secondary blood cancers', 'chronic lymphocytic leuk']\n",
      "['precision medicine management', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['cost savings potential', 'continuous fashion']\n",
      "['new article treatment', 'chronic lymphocytic leukemia', 'pregnancy cll leusm hematology']\n",
      "['new article precision medicine management', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['oncologist stocks', 'blood products', 'blood banks', 'healthy population', 'blood bloodbanks aml bonemarrowtransplant donate stopcoronavirus hemorio multiplemyeloma cll hodgkin lyms']\n",
      "['cll ukcll forum', 'info amp advice', 'cll patients', 'cll patients', 'immune systems amp', 'general population bloodcancer']\n",
      "['secondary blood cancers', 'chronic lymphocytic l']\n",
      "['undetectable minimal residual disease', 'venetoclax treatment']\n",
      "['mrk phase', 'preliminary efficacy', 'chronic lymphocytic leukemia cll', 'mantle cell lymphoma mcl nct03153202', 'primary completion date']\n",
      "['driver mutations', 'chronic lymphocytic leukemia impacts disease outcome']\n",
      "['chroniclymphocyticleukemia market', 'worldwide opportunities market share key players', 'competitive landscape']\n",
      "['early look', 'cart therapy']\n",
      "['european commission approval', 'venclyxto combination regimen', 'chronic lymphocytic leukemia abbvie news center']\n",
      "['new article', 'real word evidence', 'rituximab utilization', 'hospital pharmacy data cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia focus', 'cardiac mass', 'exceptional incidental', 'cll leusm hematology']\n",
      "['new article', 'pi3k inhibitors', 'chronic lymphocytic leukemia', 'non hodgkin lymphoma cll leusm hematology']\n",
      "['new article epstein barr virus', 'positive mucocutaneous ulcer', 'chronic lymphocytic leukemia', 'hypogammaglobulinemia cll leusm hematology']\n",
      "['new article', 'lymphoplasmacytic lymphoma', 'lymphoid population', 'deletion 13q', 'cell culture cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia cll leusm hematology']\n",
      "['chronic myeloid leukemia blast crisis', 'acute lymphocytic leukemia lymphoma lymsm']\n",
      "['pi3k inhibitors', 'chronic lymphocytic leukemia', 'non hodgkin lymphoma lymphoma lymsm']\n",
      "['foreseeable future', 'video session', 'cll haematology consultants', 'near future', 'computer amp', 'questions bloodcancerawareness']\n",
      "['discusses data', 'novel combinations', 'annual meeting', 'effective analyses leukemia']\n",
      "['cll care patient power']\n",
      "['european commission', 'dose combination', 'cll leukemia']\n",
      "['secondary blood cancers', 'chronic lymphocytic l']\n",
      "['new uk cll forum guidance', 'cll patients covid19 foreningen uk']\n",
      "['uk cll experts', 'cll patients']\n",
      "['covid19 pandemic', 'consultant re', 'don t', 'progressive disease', 'causes neutropenia others need', 'continuous treatment']\n",
      "['important advice', 'cll community', 'guidance covid19']\n",
      "['new treatment combination', 'adult patients', 'chronic lymphocytic leukemia', 'european commission offering', 'alternative option']\n",
      "[]\n",
      "['european commission approval', 'venclyxto combination regimen', 'chronic lymphocytic leukemia']\n",
      "['frontline therapy', 'cost savings considerations', 'cll leukemia']\n",
      "['important advice', 'cll patients', 'collective body', 'uk cll experts', 'share cll covid19 covid2019uk']\n",
      "['new uk cll forum guidance', 'cll patients', 'retweet cll lympsom covid']\n",
      "['woyach md', 'frontline treatments', 'chronic lymphocytic leukemia']\n",
      "['frontline therapy', 'costsavings considerations', 'cll matthew s davids md mmsc discusses data', 'novel combinations', 'chronic lymphocytic leukemia', 'annual meeting']\n",
      "['frontline venetoclaxobinutuzumab', 'european commission', 'fixeddose combination', 'chronic lymphocytic leukemia']\n",
      "['vulnerable i m', 'mild asthma', 'chronic lymphocytic leukemia', 'vulnerable vis', 'vis covid']\n",
      "['european commission approval', 'venclyxto combination regimen']\n",
      "['cll cllstrong braveisnow answers', 'cll care']\n",
      "['frontline venetoclax obinutuzumab', 'cll lymphoma']\n",
      "['medical independent sales representatives', 'medical distributors abbvie', 'european commission approval', 'venclyxto r combination regimen', 'chronic lymphocytic leukemia']\n",
      "['abbvie s dual regimen', 'ec s approval', 'chronic lymphocytic leukemia']\n",
      "['leukemia endcancer leusm cll']\n",
      "['european commission', 'novel treatment combination', 'chronic lymphocytic leukemia rhhby rog']\n",
      "['european commission ec', 'venclyxto venetoclax', 'adult patients', 'chronic lymphocytic leukemia cll']\n",
      "['european commission approval', 'venclyxto combination regimen', 'chronic lymphocytic leukemia news pharma pharmiweb']\n",
      "['new combination therapy', 'chronic lymphocytic leukemia']\n",
      "['european commission approval', 'venclyxto combination regimen', 'chronic lymphocytic leukemia']\n",
      "['ec approval', 'venclyxto combination regimen', 'chronic lymphocytic leukemia']\n",
      "['european commission approval', 'venclyxto combination regimen']\n",
      "['secondary blood cancers', 'chronic lymphocytic leukemia']\n",
      "['new article synchronous chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'metastatic squamous cell carcinoma', 'coronary arteries', 'acute myocardial infarction cll leusm hematology']\n",
      "['new article', 'fmc7 negativity', 'chronic lymphocytic leukemia', 'poor prognostic cll leusm hematology']\n",
      "['new article prognostic factors', 'low grade nonhodgkin lymphoma cll leusm hematology']\n",
      "['new article phase 1b study', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'immunoglobulin gene rearrangements', 'normal b cell subsets', 'high throughput immunogenetic approach cll leusm hematology']\n",
      "['new article immune response dysfunction', 'chronic lymphocytic leukemia', 'molecular mechanisms', 'microenvironmental conditions cll leusm hematology']\n",
      "['synchronous chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'metastatic squamous cell carcinoma', 'coronary arteries', 'acute myocardial infarction lymphoma lymsm']\n",
      "['young patient', 'refractory cll', 'jacqueline barrientos', 'ash17 clinicaltrials noveltherapy ctsm leukemia leusm supponc relapse personalisedcare']\n",
      "['line treatment correlates', 'chronic lymphocytic leukemia cll']\n",
      "['didn t', 'oncopharm satellite symposia friday', '7am amp 12pm', 'nsclc her2 breast tnbc', 'days 1hr acpe credit', 'bcsm lcsm cll hopa bcop']\n",
      "['leukemias chronic lymphocytic leukemia healthyradio voiceamerica']\n",
      "['woyach md', 'frontline treatments', 'associate professor', 'frontline treatments', 'chronic lymphocytic leukemia']\n",
      "['cll uk forum']\n",
      "[]\n",
      "['risk pts w blood malignancies non hodgkin lymphoma chronic lymphocytic leukemia', 'acute myeloid leukemia', 'acute lymphoblastic leukemia amp', 'multiple myeloma', 'active treatment', 'cancer amp', 'bone marrow transplants']\n",
      "['phase i trial', 'disease process', 'adult t cell leukemia lymphoma diffuse', 'large b cell lymphoma', 'chronic lymphocytic leukemia']\n",
      "['new publication', 'life cycle', 'intraclonal heterogeneity', 'leukemia cells', 'group unav', 'chiorazzi labs']\n",
      "['precision medicine management', 'chronic lymphocytic leukemia', 'riccardo moia andrea patriarca', 'cll targettherapy precisionmedicine bcellmalignancies']\n",
      "['new article', 'banerji lab', 'oxygen consumption', 'cll cells', 'ibrutinib resets', 'healthy levels suggests mitochondrial respiration', 'effective preclinical tool', 'assess cll cells mdpi']\n",
      "['tp53 sf3b1', 'notch1 mutations', 'ofatumumab therapy efficacy', 'chronic lymphocytic leukemia cll', 'eugen tausch md department', 'internal medicine iii ulm university germany']\n",
      "['el cnagcrg', 'estudio pancancer entre otras cosas mediante', 'secuenciaci n', 'tumores primarios', 'leucemia linf tica cr nica cll']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['checkpoint blockade improves cd8 t cell function', 'chronic lymphocytic leukemia', 'em tcl1 mice haematology thewiderwiserview']\n",
      "['trial hla', 'cd19 car nk cells', 'cord blood', 'refractory cd19', 'positive cancers non hodgkin s lymphoma', 'chronic lymphocytic leukemia cll']\n",
      "['line treatment correlates', 'chronic lymphocytic leukemia cll']\n",
      "['new article ind', 'phase ii study', 'biomarkers raptor', 'refractory chronic lymphocytic leukemia cll leusm hematology']\n",
      "['phase ii study', 'biomarkers raptor', 'refractory chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['alexey danilov', 'team good job phase 1b study', 'chronic lymphocytic leukemia']\n",
      "['pleural effusion', 'chronic lymphocytic leukemia']\n",
      "['real world frontline treatment', 'chronic lymphocytic leukemia']\n",
      "['blood malignancies', 'non hodgkin lymphoma chronic lymphocytic leukemia', 'acute myeloid leukemia', 'acute leukemia amp', 'multiple myeloma', 'clinics need', 'masks amp', 'ppl odettecancercenter canada']\n",
      "['phase 1b study', 'chronic lymphocytic leukemia']\n",
      "['cellfree iggaggregates', 'chronic lymphocytic leukemia', 'chronic activation', 'classical complement pathway therapy regimens', 'chronic lymphocytic leukemia cll']\n",
      "['composite chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'mantle cell lymphoma', 'small cell variant', 'real diagnostic challenge case presentation']\n",
      "['b cell chronic lymphocytic leukemia', 'old dog', 'high lymphocyte']\n",
      "['dr rod humerickhouse abbvie pharmaceuticals highlights', 'cll news', 'international workshop', 'chronic lymphocytic leukemia']\n",
      "['rounds i', 'free i', 'clinical remission', 'friends family']\n",
      "['reading stay', 'lap engagedcommunity successfulstudents cll shareastoryeveryday']\n",
      "['cognitive function', 'chronic lymphocytic leukemia', 'cross sectional study']\n",
      "['new article cll intraclonal fractions exhibit', 'dna methylation cll leusm hematology']\n",
      "['new article cell', 'free igg aggregates', 'chronic lymphocytic leukemia', 'chronic activation', 'classical complement pathway cll leusm hematology']\n",
      "['new article cognitive function', 'chronic lymphocytic leukemia', 'cross sectional study', 'treatment cll leusm hematology']\n",
      "['new article composite chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'mantle cell lymphoma', 'small cell variant', 'real diagnostic challenge case presentation', 'literature mcl lymsm hematology']\n",
      "['new venetoclax', 'elderly patients', 'unresponsive chronic lymphocytic']\n",
      "['cll medicine', 'expert s perspective chroniclymphocyticleukemia']\n",
      "['chronic lymphocytic leukemia gt', 'mature b lymphocytes', 'cd5 antigen patients', 'asymptomatic blood smear shows smudge cells usmle usmlestep1 usmlestep2 usmlepreparation']\n",
      "['new program', 'chronic lymphocytic leukemia cll journey saturday march', 'site link flascoevents flasco oncology']\n",
      "['patient power cll experts']\n",
      "['cancer pals', 'medical director', 'infection prevention', 'seattle cancer care alliance', 'blood malignancies', 'non hodgkin lymphoma chronic lymphocytic leukemia', 'acute myeloid leukemia', 'acute lymphoblastic leukemia', 'multiple myeloma']\n",
      "['video ibrutinib', 'venetoclax upfront', 'high risk cll w', 'leusm hemeonc ash19 hematology']\n",
      "['cll fractions', 'dominant intraclonal dna methylation hallmark', 'reflects cell', 'ighv mutation']\n",
      "['new provision areas', 'new story book handa s surprise cll handassurprise successfulstudents']\n",
      "['ibrutinib resistent researchers', 'new drug', 'fightbloodcancer researchmatters']\n",
      "['chronic lymphocytic leukemia cll', 'additional chemotherapy', 'free option']\n",
      "['medical director', 'infection prevention', 'seattle cancer care alliance', 'blood malignancies', 'non hodgkin lymphoma chronic lymphocytic leukemia', 'acute myeloid leukemia', 'multiple myeloma', 'risk coronavirus']\n",
      "['salvage treatment']\n",
      "['important new venetoclax study', 'pmcc rmh research']\n",
      "['natural prevention', 'chronic lymphocytic leukemia']\n",
      "['large granular lymphocytic leukemia', 'active epsteinbarr virus infection', 'systemic lupus erythematosus']\n",
      "['own discusses', 'covid19 amp', 'vital medication', 'doubt others', 'cll community', 'similar issues', 'travel restrictions', 'amp overseas']\n",
      "['dr woyach', 'cll leukemia james']\n",
      "['majors dodgers cll majorsdodgers claremont american']\n",
      "['dr danilov', 'important studies', 'chronic lymphocytic leukemia space', 'sequential therapy']\n",
      "['john terry', 'tweet jt26 cll']\n",
      "['blood malignancies', 'non hodgkin lymphoma chronic lymphocytic leukemia', 'acute myeloid leukemia', 'acute lymphoblastic leukemia', 'multiple myeloma']\n",
      "['krazyhorse farmhouse i couldn t', 'cheeky pic', 'indian chieftain', 'belegendary cll chemosucks twofingersuptocancer']\n",
      "['new article aspergillus meningitis', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new data', 'effective therapy', 'combination regimens', 'disease cllsm hematology']\n",
      "['bloodcancer community', 'cancer research agency', 'extra issues cll patients']\n",
      "['clinical activity', 'btk inhibitors', 'standard practice', 'triplet regimens', 'cll leukemia']\n",
      "['chronic lymphocytic leukemia causes picture symptoms treatment']\n",
      "['helpful covid19 info', 'cancer patients patients', 'blood malignancies', 'non hodgkin lymphoma chronic lymphocytic leukemia', 'acute myeloid leukemia', 'acute lymphoblastic leukemia', 'multiple myeloma']\n",
      "['coronavirus patients', 'cll leukaemia', 'website haematology bloodcancerawarenes']\n",
      "['wan na', 'cells morphology', 'chronic lymphocytic leukemia check', 'dr matourian clinical laboratory ash americansocietyofhematology cancer leukemia cll sadaffazeli']\n",
      "['ace cafe', 'krazy horse farmhouse', 'belegendary cll chemosucks twofingersuptocancer freedomdevice indianmotorcycle indian challenger']\n",
      "['new article', 'interaction mechanism', 'human serum albumin', 'comprehensive spectroscopic methods', 'technique cll leusm hematology']\n",
      "['new article curcumin augments therapeutic efficacy', 'leukemia cll leusm hematology']\n",
      "['new article inhibition', 'enhances cell death', 'selective inhibitor venetoclax', 'preclinical models', 'acute myeloid leukemia cll leusm hematology']\n",
      "['new article', 'checkpoint blockade improves cd8 t cell function', 'chronic lymphocytic leukemia', 'em tcl1 mice cll leusm hematology']\n",
      "['new article chromosomal aberrations detection', 'chronic lymphocytic leukemia', 'conventional cytogenetics', 'cll leusm hematology']\n",
      "['salvage treatment', 'chronic lymph leukemia']\n",
      "['uk cll leukaemia patients', 'covid19 coronavirus', 'haematology bloodcancerawareness']\n",
      "['chronic lymphocytic leukemia', 'tp53 sf3b1', 'notch1 mutations', 'efficacy leukemia']\n",
      "['askabc2020 i', 'chronic lymphocytic leukemia', 'mid april']\n",
      "['cll specialist']\n",
      "['pf fund', 'ytd pf share', 'ytd cash', 'fif cll', 'mgns dscv', 'new tw sxs']\n",
      "[]\n",
      "['multiple bcl2 mutations', 'cll progression']\n",
      "['early intervention', 'chronic lymphocytic leukemia chronic lymphocytic leukemia cancer']\n",
      "['new article', 'cll cll leusm hematology']\n",
      "['new article depression anxiety', 'hematological malignancies', 'cross sectional study cll leusm hematology']\n",
      "['new article lumbar erector spine plane block', 'pain management', 'postherpetic neuralgia', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'mitochondrial apoptosis', 'treatment resistance', 'cancer cll leusm hematology']\n",
      "['explores interventions', 'novel strategy', 'generate cart cells', 'surface antigens', 'aml cells', 'review data', 'cll cells']\n",
      "['early stage disease', 'experience symptoms', 'clinical trial data']\n",
      "['cll specialist']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['multiple bcl2 mutations', 'chronic lymphocytic leukemia progression', 'venetoclax blood american society']\n",
      "['travel partner', 'saudi arabia', 'hematology congress', 'cll ssbd']\n",
      "['bruce g raphael md', 'recent pivotal trials', 'triplet regimens', 'patients leukemia']\n",
      "['case report', 'atypical cll']\n",
      "['chronic lymphocytic leukemia patient share', 'cll diagnosis']\n",
      "['cll treatment paradigm expands', 'novel combo regimens leukemia']\n",
      "['multiple bcl2 mutations', 'chronic lymphocytic leukemia progression', 'venetoclax blood american society']\n",
      "['multiple bcl2 mutations', 'chronic lymphocytic leukemia cll progression', 'venetoclax american society', 'hematology hematology lymsm leusm']\n",
      "['cll treatment paradigm expands', 'novel combo regimens bruce g raphael md discusses', 'recent pivotal trials', 'chronic lymphocytic leukemia', 'triplet regimens']\n",
      "['own dinosaur books literacy cll']\n",
      "['icymi medicare beneficiaries', 'unfavorable results', 'clinical trial participants', 'follicular lymphoma', 'chronic lymphocytic leukemia']\n",
      "['additional updates', 'cll leukaemia patients']\n",
      "['appropriate use', 'cll interview', 'drs lamana amp koffman']\n",
      "['drs adrian wiestner', 'chris pleyer', 'chronic lymphocytic leukemia cll', 's dc metro blood cancer conference', 'fightbloodcancer researchmatters']\n",
      "['aqui imitando', 'un antiheroe un gusano por donde quiera que se', 'mire instaclown payasosasesinos instachile', 'luchalibrechilena chileluchalibre cll estoeslucha payasos clown elclan instalike']\n",
      "['i need belegendary cll chemosucks twofingersuptocancer freedomdevice indianmotorcycle indian challenger indianchieftain scoutbobber custom scout ftr1200 travel']\n",
      "['captivate study', 'chronic lymphocytic leukemia patients']\n",
      "['new article motor neuropathy', 'conduction block', 'pan neurofascin antibodies', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia', 'progressive anemia', 'composite lymphoma cll leusm hematology']\n",
      "['new article venetoclax', 'high dose methotrexate', 'central nervous system involvement', 'chronic lymphocytic leukemia', 'case report cll leusm hematology']\n",
      "['reading books', 'circle time tiger', 'listeningandattention books cll']\n",
      "['hemato oncology market download', 'free ebook', 'high level overview hematology oncology mm multiplemyeloma cll dlbcl aml']\n",
      "['cll blood test result anxiety']\n",
      "['biotechniques editor', 'karla plevova', 'genomic background', 'chroniclymphocyticleukemia cll', 'utilizes technology']\n",
      "['ron j keller author', 'illinois legislature', 'concise lincoln library series', 'siu press', 'book siuday siu illinois abrahamlincoln lincoln cll readmore twitterstorians']\n",
      "['karla plevova', 'chronic lymphocytic leukemia']\n",
      "['nitin jain md', 'texas houston discusses results', 'refractory chronic lymphocytic leukemia']\n",
      "['elderly patients', 'unresponsive chronic l leukemia']\n",
      "['bone marrow', 'cll diagnosis', 'treatment leusm']\n",
      "['march 5th', 'cll expert', 'minute q amp', 'program register', 'sharman cll leukemia patientpower']\n",
      "['case stydy', 'chronic lymphocytic leukemia', 'cells mm', 'flank pain']\n",
      "['illness mary', 'own support system', 'chronic lymphocytic leukemia']\n",
      "['tp53 sf3b1', 'notch1 mutations', 'ofatumumab therapy efficacy', 'chronic lymphocytic leukemia cll', 'eugen tausch md department', 'internal medicine iii ulm university germany']\n",
      "['chronic lymphocytic leukemia cll2 bio primary endpoint analysis', 'open label phase ii trial haematology thewiderwiserview']\n",
      "['i wouldn t', 'belegendary cll chemosucks twofingersuptocancer freedomdevice indianmotorcycle indian']\n",
      "['differential expression profile', 'mir 27b mir 29a', 'chronic lymphocytic leukemia', 'breast cancer patients']\n",
      "['new article differential expression profile', 'mir 27b mir 29a', 'chronic lymphocytic leukemia', 'breast cancer patients cll leusm hematology']\n",
      "['phd student rebecka svanberg', 'carsten niemann s group', 'functional protocol', 'cll trial samples']\n",
      "['nk cells activity implication', 'tumor response', 'chronic lymphocytic leukemia', 'hemati m rasouli nejad z shokri mr ghahremanfard f mir mohammadkhani m kokhaei p']\n",
      "['cr uk bcr', 'autophagy regulation', 'chronic lymphocytic leukemia']\n",
      "['early treatment', 'fcr versus', 'stage binet', 'high risk chronic lymphocytic leukemia cll', 'trial leukemia']\n",
      "['new btki indications', 'hr acpe credit']\n",
      "['chronic lymphocytic leukemia cll', 'rare type', 'u s visit', 'valuable resources']\n",
      "['cll cases']\n",
      "['fri hmgr', 'cll care']\n",
      "['cll clinic', 'hands don t touch', 'face touch', 'whnft whnft']\n",
      "['new ibrutinib versus', 'standard treatments', 'chronic lymphocytic']\n",
      "['cll town hall nashville tn', 'online march', 'cll experts', 'patients register']\n",
      "['website coronavirus haematology cll leukaemia bloodcancerawareness patients']\n",
      "['s karina s birthday karina', 'comedy amp fashion amp', 'chronic lymphocytic leukemia diagnosis karina', 'i m', 'happy amp', 'silly teen', 'happy birthday karina']\n",
      "['new chronic lymphocytic leukemia drugs ash', 'new chronic lymphocytic leukemia drugs']\n",
      "['salvage treatment', 'ch leukemia']\n",
      "['nk cells activity implication', 'tumor response', 'chronic lymphocytic leukemia']\n",
      "['ace cafe iconic location', 'brighton burn', 'belegendary cll chemosucks twofingersuptocancer freedomdevice indianmotorcycle']\n",
      "['potent btk degrader', 'protac technology', 'nm mt', 'c481s mutant chronic lymphocyticleukemia cll drugdiscovery']\n",
      "['new article il', 'nk cells activity implication', 'tumor response', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article fc receptor', 'fcrl6 discloses progenitor b cell heterogeneity', 'pre bcr', 'independent pathways', 'natural antibody selection cll leusm hematology']\n",
      "['new article', 'chronic lymphocytic leukemia', 'study cll leusm hematology']\n",
      "['new article comparison', 'real world treatment patterns', 'chronic lymphocytic leukemia management', 'british columbia canada cll leusm hematology']\n",
      "['gastrointestinal involvement', 'chronic lymphocytic leukemia']\n",
      "['cll venetoflax newdrug cllspecialist']\n",
      "['evening michael', 'tireless advocate', 'cll bloodcancer patients']\n",
      "['elderly patients', 'unresponsive chronic lymph']\n",
      "['mohs frozen section', 'day chronic lymphocytic leukemia cll note', 'dense nodules']\n",
      "['recent analysis', 'telemedicine program', 'chronic lymphocytic leukemia', 'cancer experts', 'care management']\n",
      "['gene panels', 'prognostic measurements']\n",
      "['peripheral blood mrd shows']\n",
      "['clinical trial perspective', 'chronic lymphocytic leukemia patient cll']\n",
      "['new venetoclax', 'elderly patients', 'unresponsive chronic lymphocytic']\n",
      "['new clinical trial determination', 'blood tumor cells cll leusm hematology']\n",
      "['chroniclymphocyticleukemia market', 'fortune business insights', 'market size growth', 'chain analysis', 'recent technological developments']\n",
      "['novel mutation hotspots', 'regulatory regions', 'chronic lymphocytic leukemia genome publicasergas chus']\n",
      "['recent data', 'btk inhib itors', 'cll sll', 'certain patient', 'efficacious treatments', 'therapy cllsm']\n",
      "['elderly patients', 'unresponsive chronic lymphocytic leukemia']\n",
      "['elderly patients', 'unresponsive chronic lymphocytic']\n",
      "['cll infection rwd']\n",
      "['hypertrophic cardiomyopathy hocm', 'chronic lymphocytic leukemia cll', 'open heart surgery rarediseaseday']\n",
      "['maintenance therapy', 'chronic lymphocytic leukemia ash', 'maintenance therapy', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['elderly patients', 'unresponsive chronic lymphocytic leuk']\n",
      "['revives nostalgia inspires', 'wan na', 'belegendary cll chemosucks twofingersuptocancer freedomdevice indianmotorcycle indian challenger indianchieftain scoutbobber']\n",
      "['peripheral blood mrd shows', 'venetoclax cancer therapy advisor']\n",
      "['new article expression', 'specific antiserum insights', 'exon isoforms', 'dock10 cll leusm hematology']\n",
      "['massive thanks', 'gareth auckland', 'cll support', 'leukaemia bloodcancerawareness charity haematology thankyou']\n",
      "['elderly patients', 'unresponsive chronic lympho']\n",
      "['icymi patients', 'refractory non hodgkin lymphoma', 'chronic lymphocytic leukemia', 'car nk cells', 'cytokine release syndrome neurotoxicity', 'graft versus host disease']\n",
      "[]\n",
      "['day cll majorsdodgers baseballalldayeveryday claremont american']\n",
      "['patient education event', 'typical seattle day']\n",
      "['early treatment', 'high risk cll patient']\n",
      "['cll cllsm diagnosis prognosis', 'tx options org']\n",
      "['great meeting amp', 'great job', 'co chair lymphoma cll']\n",
      "['salvage treatment']\n",
      "['monthly educational theme', 'fda approval', 'rituximab pvvr', 'cll lymsm']\n",
      "['chronic lymphocytic leukemia', 'final analysis', 'trial lymphoma lymsm']\n",
      "['new article overview', 'current microrna biomarker signatures', 'potential diagnostic tools', 'leukaemic conditions cll leusm hematology']\n",
      "['new article', 'chronic lymphocytic leukemia', 'final analysis', 'trial cll leusm hematology']\n",
      "['new article', 'therapies cll leusm hematology']\n",
      "['new article hdac3 functions', 'positive regulator', 'notch signal transduction cll leusm hematology']\n",
      "['new article bendamustine', 'chronic lymphocytic leukemia cll2 bio primary endpoint analysis', 'open label phase ii trial cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemias', 'distinct dna methylation profile', 'chromatin activation cll leusm hematology']\n",
      "['stomach flu', 'chronic lymphocytic leukemia']\n",
      "['clinical trials', 'chronic lymphocytic leukemia']\n",
      "['cd19 car t cells', 'concurrent ibrutinib', 'low crs severity', 'refractory cll leusm']\n",
      "['sequence therapies', 'venetoclax discontinuation', 'leusm hemeonc ash19 hematology']\n",
      "['whereas others', 'urgent attention', 'cancer specialists']\n",
      "['expert interviews', 'front line treatment']\n",
      "['starwars comparisons i', 'future cll', 'storm troopers clones', 'aren t', 'great work']\n",
      "['common types', 'leukemia cancer cancerdiagnosis']\n",
      "['rt europeancancer rt erneurobloodnet eurobloodnet february newsletter focuses', 'rarediseaseday eucancerplan lymphoma coalition', 'global patient survey', 'new linkedin', 'facebook profiles', 'topics check']\n",
      "['doug olson', 'cart clinicaltrial', 'chronic lymphocytic leukemia', 'rare form', 'cancer rarediseaseday']\n",
      "['long term data', 'treatment regimens', 'standard frontline treatments', 'additional research', 'remissions leukemia']\n",
      "['global chronic lymphocytic leukemia market growth trends']\n",
      "['new article clinico biological implications', 'chronic lymphocytic leukemia', 'possible therapeutic role cll leusm hematology']\n",
      "['new article chimeric antigen receptor t cell therapy', 'b cell hematological malignancies', 'pivotal clinical trial data cll leusm hematology']\n",
      "['leeds conference', 'coronavirus covid19 amp people', 'cll amp sll', 'postpone cll leukaemia cancer bloodcancerawareness charity']\n",
      "['eurobloodnet february newsletter focuses', 'rarediseaseday eucancerplan lymphoma coalition', 'global patient survey', 'new linkedin', 'facebook profiles', 'topics check']\n",
      "['frontline treatment', 'combination obinutuzumab chlorambucil', 'chronic lymphocytic leukemia', 'clinical trials results', 'multinational multicenter study', 'israeli cll study group haematology thewiderwiserview']\n",
      "['elderly patients', 'unresponsive chronic lymphocytic']\n",
      "['lymphoma patients', 'global survey']\n",
      "['school cameras', 'outdoor area adventure island cll literacy ead']\n",
      "['free software community tunisia data cll fst jll']\n",
      "['march cll program']\n",
      "['hematologic malignancy', 'rare event', 'cll leukemia cancer']\n",
      "['shoutout cancersurvivors sex cancer needs', 'questions amp', 'new power segment', 'sex cll breastcancer cancersurvivor']\n",
      "[]\n",
      "['recent advances', 'chroniclymphocyticleukemia diffuselargebcell lymphoma', 'follicularlymphoma authors ian w flinn oncology amp hematology review', 'access article']\n",
      "['immunotherapy approaches', 'chronic lymphocytic leukemia']\n",
      "['new article interaction', 'wnt pathway', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article role', 'immunotherapy approaches', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article bone marrow stromal cells drive key hallmarks', 'b cell malignancies cll leusm hematology']\n",
      "['ishbt eric tweets', 'cll workshop', 'chandigarh leusm cll']\n",
      "['s vigibase', 'global database', 'drug complications cancer researchers', 'clearer picture', 'chronic lymphocytic leukemia patients', 'frontline treatment', 'death rate']\n",
      "['michael choi md', 'sheds light', 'pi3k inhibitors', 'cartcell therapy', 'refractory setting leukemia']\n",
      "['elderly patients', 'unresponsive chronic lymphocytic leukemia']\n",
      "['hey friends i m', 'cll education', 'patients amp non heme folks', 'new youtube channel', '1st attempt', 'short video', 'cll cells accumulate']\n",
      "['salvage treatment', 'chronic lymphoc']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['new milestones', 'cll leukemia']\n",
      "['cll treatment infection model', 'patients w cll', 'diagnosis details', 'model gt gt leukemia oncology riskmanagement']\n",
      "['patient s resilience', 'relapse patient power']\n",
      "['iowa mayo clinic lymphoma spore conducts innovative interactive translational research', 'lymphoma chronic lymphocytic leukemia', 'small lymphocytic lymphoma lymsm']\n",
      "['cll patient advocate jay blatt discusses', 'cancer diagnosis cll leukemia leusm patientpower']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['chronic lymphocytic leukemia cll', 'british columbia']\n",
      "['chronic lymphocytic leukemia cll']\n",
      "['1st translational research conference chronic lymphocytic leukaemia eshcll2020 chairs j', 'brown p ghia m hallek', 'opportunity register', 'information cll hematology haematology eshconferences']\n",
      "['routine practice', 'frequent laboratory draws', 'tumor lysis syndrome tls']\n",
      "['frontline treatment', 'combination obinutuzumab chlorambucil', 'chronic lymphocytic leukemia', 'clinical trials results', 'multinational multicenter study', 'israeli cll study group']\n",
      "['new clinical trial', 'obinutuzumab versus fludarabine cyclophosphamide', 'rituximab fcr bendamustine', 'rituximab br', 'fit patients', 'cll leusm hematology']\n",
      "['don t mind opening', 'birthday belegendary cll chemosucks twofingersuptocancer freedomdevice indianmotorcycle indian challenger indianchieftain scoutbobber custom']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia oncology learning network']\n",
      "['new article frequency', 'clinical relevance', 'notch1 mutations', 'early stage binet', 'chronic lymphocytic leukemia patients cll leusm hematology']\n",
      "['new article frontline treatment', 'combination obinutuzumab chlorambucil', 'chronic lymphocytic leukemia', 'clinical trials results', 'multinational multicenter study', 'israeli cll study group cll leusm hematology']\n",
      "['new article unilateral', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'simultaneous kinase inhibition', 'bcl2 inhibition', 'therapeutic strategy', 'acute myeloid leukemia cll leusm hematology']\n",
      "['new article', 'central nervous system aspergillosis infection', 'chronic lymphocytic leukemia patient', 'case report cll leusm hematology']\n",
      "['new article', 'unavailable igh mutational status', 'settings cll leusm hematology']\n",
      "['salvage treatment', 'chronic lymphocyt']\n",
      "['bruce raphael md', 'hematologic malignancies leukemia']\n",
      "['cme activity experts', 'field address clinical advances', 'chronic lymphocytic leukemia', 'multiple myeloma', 'cme credits gt gt']\n",
      "['nitin jain md discusses results', 'line treatment']\n",
      "['birc3 mutations', 'new biomarker', 'high risk', 'fcr failure', 'tp53 disruption leukemia']\n",
      "['endcancer leusm']\n",
      "['cll town hall nashville tn', 'online march', 'cll experts', 'patients register']\n",
      "['new combination therapies', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia non hodgkin lymphoma', 'hl patients', 'chronic lymphocytic leukemia non hodgkin lymphoma', 'hl patients']\n",
      "['clinical trials', 'cll clinical trials leukemia', 'lymphoma society']\n",
      "['chronic lymphocytic leukemia', 'chronic lymphocytic leukemia cancer']\n",
      "['new combination therapies', 'chronic lymphocytic leukemia pharmacy times']\n",
      "['chronic lymphocytic leukemia', 'ph balance', 'nutritional therapy']\n",
      "['cancers vegf', 'growth factor', 'non blood vessel cells', 'chronic lymphocytic leukemia dr steve martin']\n",
      "['new clinical trial observational study', 'refractory chronic lymphocytic leukemia venetoclax', 'clinical trials', 'cll leusm hematology']\n",
      "['kirkstone pass', 'lake district', 'scotland trips', 'amazing place', 'belegendary cll chemosucks twofingersuptocancer freedomdevice']\n",
      "['new article lipid bicelle', 'lithography cll leusm hematology']\n",
      "['new article', 'date role', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'ebmt handbook hematopoietic stem cell transplantation', 'cellular therapies cll leusm hematology']\n",
      "['salvage treatment', 'chronic lymphoc']\n",
      "['butterflies focus', 'hungry caterpillar', 'own caterpillars', 'eyfs cll literacy utw']\n",
      "['leukemia minimal spatial heterogeneity', 'chronic lymphocytic leukemia']\n",
      "['major fundraiser', 'cll support', 'email coordinator org uk cll leukaemia cancer bloodcancerawareness charitytuesday']\n",
      "['disco application', 'financial outcomes', 'hematologic cancer status', 'condition summary chronic lymphocytic leukemia chronic myelogenous leukemia bcr abl1', 'positive plasma cell myeloma']\n",
      "['comparative efficacy', 'novel agents', 'r r cll', 'prospective rcts']\n",
      "['international workshop', 'chronic lymphocytic leukemia', 'krakow poland iwcll2021 cll']\n",
      "['icymi patients', 'refractory non hodgkin lymphoma', 'chronic lymphocytic leukemia', 'car nk cells', 'cytokine release syndrome neurotoxicity', 'graft versus host disease oncology']\n",
      "['great group cll']\n",
      "['cll expert', 'march 5th', 'pm eastern', 'minute q amp', 'program sharman cll leukemia patientpower']\n",
      "['new clinical trial', 'brief title study', 'tislelizumab cll leusm hematology']\n",
      "['new clinical trial cd34', 'hla compatible patients', 'hematologic malignancies cll leusm hematology']\n",
      "['defensive structure', 'napoleonic wars belegendary cll chemosucks twofingersuptocancer freedomdevice']\n",
      "['stat3 promotes chronic lymphocytic leukemia progression', 'smyd3 expression']\n",
      "['new website', 'therapeutic information', 'lymphoma amp cll lymsm']\n",
      "['isn t', 'chronic lymphocytic leukemia']\n",
      "['gly101val mutation', 'venetoclax resistance', 'chronic lymphocytic leukemia cll lymsm']\n",
      "['salvage treatment', 'chronic lymphocytic leukemia medivizor']\n",
      "['new ibrutinib', 'salvage treatment', 'chronic lymp']\n",
      "['important endpoint', 'cll patients']\n",
      "['new article tcl1 transgenic mice', 'cd49d high chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article venetoclax', 'inhibitor enhances', 'chemotherapeutic agents', 'wild type abcg2 overexpression', 'mdr cancer cells cll leusm hematology']\n",
      "['cll14 trial outcomes lori', 'leslie md hematologist oncologist lymphoma department john theurer cancer center hackensack meridian health shares details', 'cll14 trial', 'chronic lymphocytic leukemia cll']\n",
      "['phase i trial', 'disease process', 'adult t cell leukemia lymphoma diffuse', 'large b cell lymphoma amp chronic lymphocytic leukemia']\n",
      "['cll session', 'miami leukemia symposium', 'jennifer woyach', 'frontline treatments leusm lymsm']\n",
      "['sex cll breastcancer cancersurvivor']\n",
      "['data trial', 'chronic lymphocytic leukemia paul m barr md', 'associate professor', 'wilmot cancer institute discusses', 'recent cll', 'chronic lymphocytic leukemia cll']\n",
      "['treatment landscape', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia risks']\n",
      "['new article cortactin expression', 'hematopoietic cells implications', 'hematological malignancies cll leusm hematology']\n",
      "['new article upregulation', 'rna lnc irf2', 'lnc znf667 as1', 'poor survival', 'b chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article generation', 'canine cd19', 'future therapeutic purposes cll leusm hematology']\n",
      "['new article comparative analysis', 'novel therapies', 'refractory chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['treatment tips', 'side effect profile', 'right treatment', 'clinician biases']\n",
      "['commitment rode', 'video don t', 'ride belegendary cll chemosucks twofingersuptocancer']\n",
      "['im rahmen des deutschen krebs kongresses dkk2020 findet heute der krebsaktionstag f r betroffene angeh rige und interessierte statt auch wir haben umfangreiche informationen f r menschen mit cll gemeinsamgrenzenverschieben']\n",
      "['cll patient champions', 'cll support leaflets', 'haematology clinics', 'email michael oneill org uk leukaemia cancer bloodcancerawareness charity']\n",
      "['monocytic myeloid', 'suppressor cells', 'chronic lymphocytic leukemia patients', 'center experience lymphoma lymsm']\n",
      "['hemato oncology key points', 'hematology oncology mm multiplemyeloma cll dlbcl aml']\n",
      "['foto cortes', 'troublephotos wrestler suplex', 'prowrestler chileanswrestler luchalibre luchalibrechilena elmejorbotazodechile puntadiamante pisoton likeforlikes smartfit cll']\n",
      "['icymi patients', 'refractory non hodgkin lymphoma', 'chronic lymphocytic leukemia', 'car nk cells', 'cytokine release syndrome neurotoxicity', 'graft versus host disease nhl cll cancer']\n",
      "['monocytic myeloid', 'suppressor cells', 'chronic lymphocytic leukemia patients', 'center experience']\n",
      "['new article monocytic myeloid', 'suppressor cells', 'chronic lymphocytic leukemia patients', 'center experience cll leusm hematology']\n",
      "['new article', 'i manage cll', 'treatments cll leusm hematology']\n",
      "['new article feasibility', 'car t cells', 'concurrent ibrutinib', 'ibrutinib failure cll leusm hematology']\n",
      "['new article', 'important role', 'chronic lymphocytic leukaemia biology cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['chronic lymphocytic leukemia cll', 'u s visit', 'common form']\n",
      "['invivoscribe labpmm', 'new laboratory', 'pcr capillary ngs', 'flow mrd', 'year aml mm cll', 'precisionmedicine bioinformatics']\n",
      "['clinical trial combination therapies']\n",
      "['chronic lymphocytic leukemia']\n",
      "['prospective trials', 'active regimens', 'nice study', 'counsel pts', 'ae profile', 'r r cll', 'clinical trial']\n",
      "['tgtx phase', 'ibrutinib versus ibrutinib', 'high risk chronic lymphocytic leukemia cll nct02301156', 'primary completion date']\n",
      "['bsh2020 birmingham immunotherapy cll dlbcl lymphoma myeloma mds']\n",
      "['new clinical trial', 'phase ib study', 'b cell hematologic malignancies cll leusm hematology']\n",
      "['comparative analysis', 'novel therapies', 'refractory chronic lymphocytic leukaemia haematologica cll leusm']\n",
      "['belegendary cll chemosucks twofingersuptocancer freedomdevice indianmotorcycle indian challenger indianchieftain scoutbobber']\n",
      "['new website', 'subtypes section', 'cll subtypes lymsm']\n",
      "['smudge cells cll chronic lymphocytic leukemia smudge', 'basket cells', 'wbcs smudge cells', 'cellular fragments', 'cytoplasmic material']\n",
      "['frei f r meinen letzten tag beim dkk2020 los gehts bei abbvie deutschland und der cll unter dem motto zielgerichtet wirksam endlich neue kombinationen', 'der cll']\n",
      "['treatment tips', 'side effect profile', 'right treatment', 'clinician biases']\n",
      "['potential milestone', 'cll car t cell therapy fda approves ind application', 'switchable car t cell therapy car t fda chroniclymphocyticleukemia']\n",
      "['safer car uses', 'nk cells', 'cll nhl cll car patientpower']\n",
      "['chmp cll']\n",
      "['ibrutinib versus', 'standard treatments', 'chronic lymphocytic']\n",
      "['inflammatory cytokine', 'donor t cells review', 'prospective multicenter study', 'clinical relevance', 'low level mutations']\n",
      "['abnormal lymphoid cells peripheral blood smear', 'marginal zone lymphoma', 'follicular lymphoma', 's zary syndrome', 'reactive lymphocytes', 'chronic lymphocytic leukemia', 'hairy cell leukemia', 'large granular lymphocyte lymphoma']\n",
      "['lee greenberger chief', 'scientific officer', 'chronic lymphocytic leukemia']\n",
      "['man w chronic lymphocytic leukemia cll', 'year goal', 'obinutuzuma ibrutinib', 'important part']\n",
      "['good news', 'nhl patients cd19 car nk cell therapy', 'response rate']\n",
      "['cll cnv analysis', 'ngs panel', 'poster demonstrates', 'sureseq cll cnv panel', 'cll samples cll leukaemia cnv cancer ngs']\n",
      "['free webinar dr carolyn owen', 'research updates', 'chronic lymphocytic leukemia cll', 'annual american society', 'hematology ash conference']\n",
      "['great work', 'important questions']\n",
      "['r r cll pts outcomes', '1st novel', 'slight pfs', 'os diff thanks', 'amp lymsm cll']\n",
      "['dr rod humerickhouse abbvie pharmaceuticals highlights', 'cll lymphoma hub news', 'international workshop', 'chronic lymphocytic leukemia']\n",
      "['new article systemic', 'large vessel vasculitis', 'retroperitoneal fibrosis', 't cell chronic lymphocytic leukemia', 'case report cll leusm hematology']\n",
      "['new article', 'long term', 'frontline therapy', 'fit patients', 'fcr versus br cll10 trial', 'gcllsg cll leusm hematology']\n",
      "['new article', 'fcr versus', 'stage binet', 'high risk chronic lymphocytic leukemia cll', 'trial cll leusm hematology']\n",
      "['ut md anderson cancer center', 'cord blood', 'natural killer cell therapy', 'clinical trial', 'response rate', 'non hodgkin lymphoma', 'chronic lymphocytic leukemia patients']\n",
      "['cll patients', 'immune system', 'immune response', 'normal bloodcancerawareness haematology leukaemia cancer charity']\n",
      "['cll btk inhibitors', 'refractory settings leukemia']\n",
      "['ibrutinib versus', 'standard treatments', 'chronic lymphocytic']\n",
      "['tctm20 don t', 's poster', 'clinical outcomes', 'cll patients', 'refractory disease', 'specific cartcell therapy tcellrx lymphoma']\n",
      "['fantastic hemebench tweetorial', 'albumin smears', 'cll blooducation']\n",
      "['new website', 'trials section', 'new site amp view', 'research information trial data licenses amp expert opinions', 'lymphoma amp cll lymsm']\n",
      "['esther schorr', 'coronavirus outbreak coronavirus patientpower ivig leukemia cll']\n",
      "['classification strategy', 'raman data', 'different clinical conditions application', 'chronic lymphocytic leukemia', 'c gobinet', 'uclouvain hc']\n",
      "['new clinicaltrial', 'new drug', 'fightbloodcancer researchmatters']\n",
      "['cartmeeting20 jennifer specht', 'car t cell therapy']\n",
      "['new article', 'cancer treatment information', 'hospital discharge data', 'non hodgkin lymphoma', 'los angeles county case control study cll leusm hematology']\n",
      "['prowrestler chileanswrestler luchalibre luchalibrechilena elmejorbotazodechile puntadiamante pisoton likeforlikes smartfit cll cmll aaa chileanswrestler']\n",
      "['kite pharma s cart cell therapy kte x19', 'priority review designation', 'phase i ii clinical trials', 'mantle cell lymphoma', 'chronic lymphocytic leukemia']\n",
      "['student m', 'popular science magazines', 'public cz', 'chronic lymphocytic leukemia cll', 'ck1 inhibition congrats cz']\n",
      "['fcr versus', 'stage binet', 'high risk cll', 'significant overall survival benefit', 'high risk patients', 'early fcr therapy lymsm leusm']\n",
      "['early treatment', 'fcr versus', 'stage binet', 'high risk chronic lymphocytic leukemia cll']\n",
      "['alexey v danilov md phd', 'elevate tn trial', 'btk inhibitor combinations', 'cll leukemia']\n",
      "['new data', 'effective therapy', 'combination regimens', 'disease leusm']\n",
      "['new article', 'prognostic likelihood', 'chronic lymphocytic leukaemia patients', 'borderline percentage', 'variable heavy chain region mutations cll leusm hematology']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['new article', 'non hodgkin lymphoma cll leusm hematology']\n",
      "['ibrutinib versus', 'standard treatments', 'chronic lymph']\n",
      "['expert highlights evolution', 'btk inhibitors', 'cll leukemia']\n",
      "['cll town hall nashville tn', 'online march', 'cll experts', 'patients register']\n",
      "['finite treatment duration', 'chronic lymphocytic leukemia cll', 'time rt', 'cll care']\n",
      "[]\n",
      "['select candidates', 'allogeneic hematopoietic cell transplant']\n",
      "['patient power', 'cll town hall meeting']\n",
      "['cll diagnosis', 'chronic cancer']\n",
      "['prolong survival', 'chronic lymphocytic leukemia']\n",
      "['survival trends', 'chronic lymphocytic leukemia']\n",
      "['machine learning identifies', 'cll patients', 'certain outcomes']\n",
      "['cll patients', 'complex karyotype']\n",
      "['ibrutinib versus', 'standard treatments', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll b']\n",
      "['chronic lymphocytic leukemia', 'malignant melanoma', 'merkel cell carcinoma', 'seer population']\n",
      "['chronic lymphocytic leukemia pharmamar oncology leukemia lurbibectedin']\n",
      "['btk inhib itors', 'cll sll', 'efficacious treatments', 'therapy cllsm']\n",
      "['early treatment', 'obinutuzumab versus', 'highrisk chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['cll expert', 'march 5th', 'pm eastern', 'minute q amp', 'program sharman cll leukemia patientpower']\n",
      "['ibrutinib versus', 'standard treatments', 'chronic lymphocytic leuk']\n",
      "['experimental car nk cell therapy', 'chronic lymphocytic leukemia', 'non hodgkin lymphona cancer nonhodgkinlymphoma nhl chroniclymphocyticleukemia cll']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['new clinical trial safety', 'car t therapy', 'refractory cd19 b cell leukemia', 'lymphoma cll leusm hematology']\n",
      "['new clinical trial cd19', 'car t cell therapy', 'refractory cd19 b cell leukemia', 'lymphoma cll leusm hematology']\n",
      "['new clinical trial', 'early treatment', 'obinutuzumab versus', 'high risk chronic lymphocytic leukemia', 'cll leusm hematology']\n",
      "['het amc geloof', 'nooit cll spannend']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['ibrutinib versus', 'standard treatments', 'chronic lympho']\n",
      "['annu rev pathol genomic', 'epigenomic alterations', 'chronic lymphocytic leukemia']\n",
      "['phase iii cll14 trial', 'chronic lymphocytic leukemia']\n",
      "['ibrutinib versus', 'standard treatments', 'chronic l leukemia']\n",
      "['new ibrutinib versus', 'standard treatments', 'chronic lymphocytic']\n",
      "['new drug combination', 'chronic lymphocytic leukemia', 'new standard', 'treatment researchers shows healthcare']\n",
      "['cd81 expression', 'differential diagnosis', 'chronic lymphocytic leukemia']\n",
      "['complete remission', 'cll patients', 'ibrutinib clinical significance', 'predictive factors']\n",
      "['chronic lymphocytic leukemia', 'trial thewiderwiserview']\n",
      "['re immune', 'cll leukemia cancer patients medcram']\n",
      "['noon pt', 'gmt immunotherapy neuroinflammation fibrosis cll lymphoma inflammation cancer']\n",
      "['new favourite bike', 'belegendary mcn motorcycleshow carolenash cll chemo chemosucks twofingersuptocancer freedomdevice indianmotorcycle indian challenger']\n",
      "['new article il', 'tumor microenvironment cll leusm hematology']\n",
      "['dr awan', 'cll leukemia']\n",
      "['excel ftr', 'race bike', 'warmup lap belegendary cll chemo chemosucks livelive twofingersuptocancer freedomdevice']\n",
      "['chronic lymphocytic leukemia']\n",
      "['great event', 'carole nash motorcycle show', 'belegendary cll chemo chemosucks livelive twofingersuptocancer freedomdevice']\n",
      "['new article chronic lymphocytic leukemia', 'secondary hematological malignancies', 'wide cancer registry study cll leusm hematology']\n",
      "['new article interleukin', 'inhibitor interrupts toll', 'sensitizes chronic lymphocytic leukaemia cells', 'apoptosis cll leusm hematology']\n",
      "['new article smartphone', 'chip fluorescence', 'capillary flow velocity measurement', 'ror1 cancer cells', 'buffy coat blood samples', 'dual layer paper microfluidic chip cll leusm hematology']\n",
      "['new article immunoregulatory', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article fulminant acanthamoeba castellanii encephalitis', 'patient cll leusm hematology']\n",
      "['new article lenalidomide dexamethasone', 'high risk chronic lymphocytic leukaemia', 'final results', 'ncri cll210 trial cll leusm hematology']\n",
      "['new article impact', 'chronic lymphocytic leukemia', 'trial cll leusm hematology']\n",
      "['new article bruton s tyrosine kinase inhibitors', 'kidney focus', 'ibrutinib cll leusm hematology']\n",
      "['chronic lymphocytic leukemia market', 'redhill local councillors', 'good news']\n",
      "['chronic lymphocytic leukemia market', 'redhill local councillors']\n",
      "['cardiac myxoma', 'cerebral metastases', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'case report', 'review lymphoma lymsm']\n",
      "['response cll leukemia lymphoma']\n",
      "['leukemia treatment breakthroughs', 'chronic lymphocytic leukemia']\n",
      "['venetoclax shows', 'line treatment', 'chronic lymphocytic leukemia cancer fridaythoughts']\n",
      "['scan results', 'star candlestick', 'ghh ancr reci nwt nxr argo stck av sbry stp invp macf av b i3e smsn cll']\n",
      "['complete remission', 'cll patients', 'ibrutinib clinical significance', 'predictive factors american society', 'hematology hematology leusm']\n",
      "['belegendary cll chemo chemosucks livelive twofingersuptocancer freedomdevice indianmotorcycle indian challenger indianchieftain scoutbobber']\n",
      "['allogeneic haploidentical blood', 'marrow transplantation', 'post transplantation cyclophosphamide', 'chronic lymphocytic leukemia mi amigo el dr javier bola os hemat logo mexicano', 'es coautor']\n",
      "['cll patients', 'complex karyotype']\n",
      "['1st study', 'response correlates w pfs', 'cll i']\n",
      "['full time', 'lisa s story gt']\n",
      "['drg epidemiology report estimates', 'western europe', 'global reports', 'cll leukemia lymphocyticleukemia cancer']\n",
      "['un reciente estudio sobre pacientes', 'con leucemia linfoc tica cr nica', 'pa ses bajos', 'confirmado que', 'los ltimos', 'os el ndice', 'con esta enfermedad se', 'visto incrementado notablemente']\n",
      "['novel mutation hotspots', 'regulatory regions', 'chronic lymphocytic leukemia genome']\n",
      "['new article', 'cardiac myxoma', 'cerebral metastases', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'case report', 'review cll leusm hematology']\n",
      "['new article hepatitis b virus', 'non hodgkin lymphoma', 'clinical practice', 'polish lymphoma research group cll leusm hematology']\n",
      "['new article novel mutation hotspots', 'regulatory regions', 'chronic lymphocytic leukemia genome cll leusm hematology']\n",
      "['follicular lymphoma', 'chronic lymphocytic leukemia']\n",
      "['natural killer cell therapy', 'objective response rate', 'complete responses', 'refractory non hodgkin lymphoma', 'cll leukemia']\n",
      "['investigational btk inhibitors', 'patients w b cell malignancies', 'cll dlbcl', 'others dr john allan', 'drug class']\n",
      "['scan results macd bullish centerline cross', 'swg tbcg kgf ful hfg cll aaf ipo tmks zin']\n",
      "['cool analysis', 'ibr monotherapy', 'bone marrow samples', 'cr vs pr spoiler', 'alert prs', 'residual bm tams', 'ripe target', 'consolidation strategies', 'ibr prs']\n",
      "['cll landscape', 'cll lymsm lenalidomide dexamethasone', 'high risk chronic lymphocytic leukaemia', 'final results', 'ncri cll210 trial']\n",
      "['tigit cd226 cd155 receptors ligand system', 'chronic lymphocytic leukemia blood american society']\n",
      "['chronic lymphocytic leukemia']\n",
      "['car nk cell therapy elicits responses', 'cll lymphoma leukemia']\n",
      "['cll experts dr brian hill dr matthew davids', 'dr nicole lamanna', 'promising clinical trial data', 'treatment amp research news mdphd leukemia ash19 cll']\n",
      "['spreadex account', 'big whack', 'ptec uk regulator', 'online stakes']\n",
      "['great work', 'great collaborative lab', 'blood cancers', 'cell resolution', 'patients leusm cll aml mds mpnsm']\n",
      "['jennifer woyach md', 'james discusses', 'elevate tn trial', 'treatment na ve chronic lymphocytic leukemia leusm']\n",
      "['week calibr', 'ind application', 'clbr001 swi019', 'refractory b cell malignancies', 'non hodgkin lymphoma nhl', 'chronic lymphocytic leukemia cll']\n",
      "['natural killer cell therapy induces response', 'non hodgkin lymphoma', 'chronic lymphocytic leukemia healio']\n",
      "['new article chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article stage iv', 'small lymphocytic lymphoma', 'unilateral vision loss cll leusm hematology']\n",
      "['new article iglv3', 'risk factor', 'point mutation', 'autonomous bcr', 'cll leusm hematology']\n",
      "['small profit', 'earnings upgrade', 'didn t materialise']\n",
      "['paula soler', 'martin subero lab', '3dgenome 4dnucleome', 'human b cell differentiation', 'neoplastic transformation cll amp mcl']\n",
      "['lymphoma coalition', 'global patient survey', 'results eurobloodnet', 'webinar program', 'cutaneouslymphoma patients associations', 'advocates rarediseases erneu']\n",
      "['significant advances', 'research efforts', 'cll treatments', 'recent years']\n",
      "['bien que', 'llc soit', 'incurable les efforts', 'recherche sur les traitements ont consid rablement progress ces derni res ann es apprenez', 'dans notre article portant sur ce sujet']\n",
      "['dr rachel thilssen', 'tumour heterogeneity', 'chronic lymphocytic leukemia cll', 'venetoclax lornecancer2020']\n",
      "['special fellows', 'blood cancers development', 'cell resolution cll singlecell epigenetics']\n",
      "['captivate study shows', 'undetectable mrd', 'cll patients']\n",
      "['cll survivor dr charles berry', 'geriatric clinic', 'clinic staff', 'cancermoonshot endcancer']\n",
      "['cll hematology dr woyach dr rogers', 'dr bhatt', 'womeninscience james']\n",
      "['flappycrypto game', 'google play', 'ios app stores bitcoin cll ethereum ripple tether litecoin bitcoincash eos bnb bsv stellar cardano tron tezos monero chainlink neo cosmos iota dash dogecoin']\n",
      "['retrospective database study', 'ibm marketscan commercial claims', 'full summary gt gt heor oncolytics cll sll multiplemyeloma']\n",
      "['inaugural issue', 'pulse pulse', 'significant news', 'chronic lymphocytic leukemia research access pulse']\n",
      "['manage chronic lymphocytic leukemia', 'bloodcancer care']\n",
      "['line treatment', 'chronic lymphocytic leukemia cll', 'absolute lymphocyte', 'treatment regardless']\n",
      "['interesting paper']\n",
      "['great day', 'beach bit', 'gorgeous belegendary cll chemo chemosucks livelive twofingersuptocancer freedomdevice indianmotorcycle indian challenger indianchieftain scoutbobber']\n",
      "['human medicines european', 'public assessment report epar mabthera rituximab lymphoma non hodgkin arthritis rheumatoid leukemia agenparl combination patients', 'strong treatment agenparlenglish dirittogiustizia salute socialnetwork']\n",
      "['new article tisagenlecleucel cellular kinetics dose', 'clinical factors', 'refractory dlbcl cll leusm hematology']\n",
      "['new article prognostic model', 'cll patients', 'binet stage', 'prospective cll1 trial', 'german cll study group cll leusm hematology']\n",
      "['test leukemia diagnostic panel cll hcl sll', 'basic home collection facility', 'address shop', 'paramount spectrum market crossings republik ghaziabad dr lal path', 'paramount crossings republik ghaziabad cll']\n",
      "[]\n",
      "['drs woyach rogers', 'bhat womeninscience cll james']\n",
      "[]\n",
      "['chronic lymphocytic leukemia']\n",
      "['mdanderson novel cell', 'cll amp nhl patients patients healthcare']\n",
      "['carer survey']\n",
      "[]\n",
      "['james dean md sr', 'medical director', 'pharmacyclics inc', 'term data', 'chronic lymphatic leukemia cll pharmacyclics', 'abbvie company']\n",
      "['cll patient', 'advocate shares', 'personal story', 'treatment cll leukemia patientpower']\n",
      "[]\n",
      "['exciting opportunity', 'phd student', 'lab lrc', 'glasgow foxo cll']\n",
      "['duvelisib cll sll ibrutinib lymphoma verastem lab research treatment relaps refractory leukemia treatment']\n",
      "['tp53 gene mutation impacts', 'treatment effect', 'chronic lymphoid leukemia patients prof rka posp ilov', 'dr jitka mal kov update', 'mutation brno cancer cll womeninscience scicomm']\n",
      "[]\n",
      "['cll experts', 'promising cll research amp updates', 'michelenadeembaker amp nicolelamanna']\n",
      "['cll symptoms cllsm']\n",
      "[]\n",
      "['1st translational research conference chronic lymphocytic leukaemia eshcll2020 register', 'chairs j', 'brown p ghia m hallek', 'information cll hematology haematology eshconferences']\n",
      "['optimal method', 'mrd assessment', 'long term response', 'refractory chronic lymphocytic leukemia cll']\n",
      "['oncology experts reflect', 'chronic lymphocytic leukemia cll']\n",
      "[]\n",
      "['european medicines agency', 'lymphoma drugs', 'treatment options', 'b cell lymphomas childhoodcancer amp adults', 'haven t', 'gt news lymsm']\n",
      "['early results', 'gaia cll13 trial', 'old amp', 'new treatments head', 'new treatments', 'cll fcr br vs v o vs v r vs i v o', 'supplant rituximab', 'cll treatment']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['refractory non hodgkin lymphoma', 'chronic lymphocytic leukemia', 'car nk cells', 'cytokine release syndrome neurotoxicity', 'graft versus host disease']\n",
      "[]\n",
      "['new article cpg stimulation', 'chronic lymphocytic leukemia cells induces', 'cell shape', 'promotes migration', 'vivo cll leusm hematology']\n",
      "['new article expression', 'gene myf6', 'hairy cell leukemia cll leusm hematology']\n",
      "['new article', 'clear coverage', 'cell experiment analysis', 'rna seq cll leusm hematology']\n",
      "['new article', 'molecular basis', 'canine models', 'human leukemia', 'lymphoma cll leusm hematology']\n",
      "[]\n",
      "['super independent story', 'role play', 'bears story', 'continuous provision successfulstudents cll welovebooks']\n",
      "['cll sll', 'primary mediastinal lymphoma', 'march pbac meeting closes', 'feb submit cll sll pmbcl pbs']\n",
      "['research team s discovery', 'dark matter', 'new treatments', 'chronic lymphocytic leukemia cll', 'full article']\n",
      "['chronic lymphocytic leukemia', 'tp53 sf3b1', 'notch1 mutations', 'efficacy cllsm']\n",
      "['important analysis', 'cll integrative analysis', 'spontaneous cll regression highlights genetic', 'microenvironmental interdependency', 'cll blood american society']\n",
      "['integrative analysis', 'spontaneous cll regression highlights genetic', 'microenvironmental interdependency']\n",
      "['chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'current treatment', 'new drug', 'duvelisib cll sll clinicaltrial researchmatters']\n",
      "['icymi addition', 'chronic lymphocytic leukemia combination therapy', 'ibrutinib flare', 'important effort']\n",
      "['new article ultrasensitive detection', 'notch1 delct mutations', 'chronic lymphocytic leukemia', 'ddpcr reveals', 'subclonal mutations', 'predicts clinical outcome', 'cll leusm hematology']\n",
      "['tgtx announces completion', 'target enrollment', 'unity cll phase', 'trial u2', 'reminder gavyza chlorambucil', 'line cll u2 pfs results', 'months gt', 'months front line']\n",
      "['icymi viewpoint', 'tumour lysis syndrome', 'chronic lymphocytic leukaemia', 'francesco paolo tambaro amp cll leusm', 'w reg']\n",
      "['dr woyach', 'alliance a041702 trial', 'cll leukemia james']\n",
      "['pt gooooooooooooool ale caligaris anota el segundo para el rojo cll', 'cdmkj vamosrojo']\n",
      "['dt neo', 'oyaide g spot cable 30cm cll dt neo', 'oyaide g spot cable 30cm cll rakuafl']\n",
      "['pt gooooooooooooool joni casalis pone', 'ventaja cll', 'cdmkj vamosrojo']\n",
      "['chronic lymphocytic leukemia patients', 'non cll', 'long time oncology nurse sheila hoff cll leukemia patientpower']\n",
      "['farm roads', 'roads dirt roads', 'belegendary cll chemo chemosucks livelive twofingersuptocancer']\n",
      "['treatment patterns', 'chronic lymphocytic leukemia', 'therapies results', 'informcll registry lymphoma lymsm']\n",
      "['new article prognostic', 'treatment patterns', 'chronic lymphocytic leukemia', 'therapies results', 'informcll registry cll leusm hematology']\n",
      "['mrd analysis', 'early phase venetoclax pts', 'r r cll', 'umrd parallels', 'pb bm', 'survival differences umrd attainment plateaus', '24m tp53 pts', 'inferior pfs', 'umrd cohort value', 'bm umrd', 'venetoclax use gt 24m unclear']\n",
      "['chronic lymphocytic leukemia', 'breakthrough treatments besides', 'typical chemo']\n",
      "['cumplimos el primer objetivo tenemos el', 'regular resultado', 'muchas semanas', 'trabajo y sacrificio ahora vamos por todo labandasigue cll']\n",
      "['available online expression', 'cathelicidin hcap18 ll', 'chronic lymphocytic leukemia']\n",
      "['tolerable toxicity profile', 'refractory chronic lymphocytic leukemia', 'phase i ii clinical trial leusm bloodcancer']\n",
      "['phase i ii clinical trial', 'md anderson cancer center tx usa', 'response rate', 'non hodgkin s lymphoma', 'chronic lymphocytic leukemia', 'allogenic car nk cells', 'umbilical cord blood cancer']\n",
      "['neil kay', 'mayo clinic', 'cll updates', 'new players obino venetoclax ibrutinib idelalisib acala', 'others measurement', 'ven trial hemonc2020 cll']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['jennifer woyach md', 'james sheds light', 'phase iii alliance a041702 trial', 'chronic lymphocytic leukemia cll leusm']\n",
      "['early findings', 'car nkcell therapy', 'leukemia lymphoma patients', 'refractory nonhodgkin lymphoma', 'chronic lymphocytic leukemia', 'car nk cells', 'cytokine release']\n",
      "['uitstekende informatieve bijeenkomst', 'cll door', 'humorvolle tips voor', 'pati nt door bart van echteld beterwordenisnietvoorwatjes']\n",
      "['chronic lymphocytic leukemia', 'cll expert nicole lamanna md', 'peer exchange discussion']\n",
      "['rgcon2020 endcancer leusm cll']\n",
      "['new article richter s transformation', 'chronic lymphocytic leukaemia', 'nationwide epidemiological study cll leusm hematology']\n",
      "['new article ibrutinib', 'case report cll leusm hematology']\n",
      "['lymphoma coalition', 'global patient survey', 'cll age', 'survey link']\n",
      "['cll leukemia']\n",
      "['venetoclax shows', 'line treatment', 'chronic lymphocytic leukemia cancer fridaythoughts']\n",
      "['hey guys', 'chronic lymphocytic leukemia cll', 'hospital bill', 'emergency visit', 'past november pls']\n",
      "['cll patients chemotherapy', 'free treatment raredisease chroniclymphocyticleukemia cll leukemia']\n",
      "['research project', 'free remission', 'john goldman award', 'deadline march', 'eshjga2020 cml cll aml tfr eshcml2020 ilapagani']\n",
      "['hopa s', 'annual conference', 'expert faculty', 'topics chronic lymphocytic leukemia bruton s tyrosine kinase', 'multiple myeloma']\n",
      "['suppress chronic lymphocytic leukemia cll acts', 'genetic program']\n",
      "['survival trends']\n",
      "['drs matthew davids', 'graeme fraser talk', 'new data', 'chronic lymphocytic leukemia cll whu20']\n",
      "['lymphoma coalition', 'global patient survey', 'lymphomas amp cll', 'word lymsm patientexperience cll']\n",
      "['new clinical trial cd19 cd20 dual car t', 'b cell leukemia patients cll leusm hematology']\n",
      "['qi program']\n",
      "['rns aim cll cello health plc']\n",
      "['new article expression', 'prognostic value', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'scalable fabrication', 'dimensional au nanoribbons', 'cll leusm hematology']\n",
      "['new article revolution', 'chronic lymphocytic leukemia therapy', 'free treatment paradigm cll leusm hematology']\n",
      "['new article ibrutinib treatment inhibits breast cancer progression', 'suppressor cells', 'dendritic cells cll leusm hematology']\n",
      "['new article clinical', 'molecular characterization', 'large b cell lymphomas', 'deletion cll leusm hematology']\n",
      "['new article identification', 'novel recurrent gain', 'chronic lymphocytic leukemia', 'array cgh', 'gene expression', 'cll leusm hematology']\n",
      "['cll cells', 'immune cells', 'ibrutinib manifest distinctive epigenetic', 'transcriptional patterns', 'cll cells cll bcell leukemia cancer immunesystem']\n",
      "['exciting results', 'cd19 chimeric antigen receptors i', 'only natural use', 'natural killer cells', 'positive lymphoid tumours rezvani cll lymphoma nkcells']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['epigenetic changes', 'alu elements', 'methylation hypomethylation']\n",
      "['accc quality improvement workshops address', 'chronic lymphocytic leukemia care']\n",
      "['patient community', 'bluecarpet patientsmatter cll prostatecancer']\n",
      "['cd19 car nk cells', 'similar results', 'bcma car nk']\n",
      "['machine learning identifies', 'cll patients', 'certain outcomes leukemia cancer']\n",
      "['machine learning identifies', 'cll patients', 'certain outcomes cancer', 'ai ml dl']\n",
      "['investigational car nk cell therapy agent tak', 'promising results', 'phase i iia trial', 'non hodgkin lymphoma', 'chronic lymphocytic leukemia hematology oncology cancertreatment']\n",
      "['amp mpac', 'charge bur']\n",
      "['cll migration']\n",
      "['phase i trial', 'disease process', 'adult t cell leukemia lymphoma diffuse', 'large b cell lymphoma', 'chronic lymphocytic leukemia']\n",
      "['hme debate', 'novel agents', 'frequent leukemia', 'western countries']\n",
      "['undetectable minimal residual disease', 'cll14 trial']\n",
      "['venetoclax discontinuation']\n",
      "['r r cll']\n",
      "['practice car', 'natural killer cell therapy induces response', 'non hodgkin lymphoma', 'chronic lymphocytic leukemia healio']\n",
      "['hsa mir', '5p 29a 3p', 'subsequent risk', 'chronic lymphocytic leukemia', 'epic study easpdivulga']\n",
      "['phase i ii clinical trial', 'dr katy rezvani', 'cd19 car nk therapy', 'refractory non hodgkin lymphoma', 'chronic lymphocytic leukemia rezvani cancermoonshot endcancer']\n",
      "['new article chronic lymphocytic leukemia', 'small lymphocytic lymphoma version', 'nccn clinical practice guidelines', 'oncology cll leusm hematology']\n",
      "['new article use', 'natural killer cells', 'positive lymphoid tumors cll leusm hematology']\n",
      "['new article minimal spatial heterogeneity', 'chronic lymphocytic leukemia', 'diagnosis cll leusm hematology']\n",
      "[]\n",
      "['hme debates acala', 'cll leusm']\n",
      "['hme debates cll leusm']\n",
      "['cll cello health', 'acess intelligence', 'uk cll']\n",
      "['rns aim cll cello health plc settlement', 'access intelligence']\n",
      "['ncds sdgs cancer', 'hair concentrations', 'environmental remediation dna methylation', 'implicates exposure', 'b cell chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['news study', 'car nk celltherapy', 'high response rates', 'refractory non hodgkin lymphoma amp chronic lymphocytic leukemia study', 'katy rezvani md phd']\n",
      "['scan results macd bullish centerline cross', 'ark sync gri tigt indv pcgh hils genl pin fcit hotc atst fgp cll dddd teng']\n",
      "['new article clinical significance', 'tp53 birc3 atm', 'mapk erk genes', 'chronic lymphocytic leukaemia data', 'uk lrf cll4 trial cll leusm hematology']\n",
      "['new article serum levels', 'hsa mir', '5p 29a 3p', 'subsequent risk', 'chronic lymphocytic leukemia', 'epic study cll leusm hematology']\n",
      "['new article medication adherence health care utilization', 'oral oncolytics', 'multiple myeloma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll leusm hematology']\n",
      "['new article', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll leusm hematology']\n",
      "['new article trametinib', 'histiocytic sarcoma', 'chronic lymphocytic leukemia', 'k ras', 'unique braf mutation cll leusm hematology']\n",
      "['james beebe ralph williams', 'family legacy', 'medical field', 'chronic lymphocytic leukemia', 'prostate cancer', 'ralph s story netde cancer']\n",
      "['amsspringboard newpi firstgrant cll epigenetics']\n",
      "['low immunoglobulin levels shingrix', 'previous reaction', 'medicare patient', 'ethical practices']\n",
      "['chronic lymphocytic leukemia expert dr philip thompson', 'discusses types', 'oral treatments', 'cll leukemia cll patientpower']\n",
      "['event topic', 'post venetoclax treatment strategies', 'great lecture']\n",
      "['superb day', 'blue strong gains', 'mpac amp sfor cll', 'good day']\n",
      "['cll patients', 'different treatment', 'cll dr allesanda ferrajoli chroniclymphocyticleukemia']\n",
      "['news researchers', 'chronic lymphocytic leukemia rnaseq precisionmedicine']\n",
      "['chronic lymphocytic leukemia google search ray']\n",
      "['human phase', '1b dose escalation study', 'single agent', 'refractory chronic lymphocytic leukemia cll', 'non hodgkin s lymphoma nhl patients']\n",
      "['clonal dynamics', 'chronic lymphocytic leukemia']\n",
      "['new therapeutics', 'generation btk inhibitors leukemia']\n",
      "['whole genome exome', 'wgs wes characterization', 'spatial heterogeneity', 'chronic lymphocytic leukemia cll']\n",
      "['cancer clinical trials', 'clinicaltrials cancerpatients cll']\n",
      "['chronic lymphocytic leukaemia', 'common form', 'adult leukaemia', 'new medicines', 'available cll bloodcancer']\n",
      "['new research autoimmune cytopenias', 'chronic lymphocytic leukemia focus', 'molecular aspects autoimmune cytopenias', 'autoimmune hemolytic anemia aiha', 'immune thrombocytopenia itp complicate', 'chronic oncology']\n",
      "['10x single cell', 'spatial technologies', 'recent research', 'suppress chronic lymphocytic leukemia worldcancerday']\n",
      "['roundup options', 'legal center', 'alabama encourages users', 'non hodgkin s lymphoma', 'chronic lymphocytic leukemia', 'steinberg law group experience resources results']\n",
      "['roundup weedkiller monsanto bayer glyphosate nonhodgkinslymphoma lymphoma chroniclymphocyticleukemia leukemia nhl cll thesteinberglawgroup steinberglawgroup steinberglaw steinberg law lawyer lawfirm legalhelp classaction massaction']\n",
      "['non hodgkin lymphoma nhl', 'extralymphatic sites', 'blood involvement', 'chronic lymphocytic leukemia']\n",
      "['non hodgkin lymphoma', 'large diffuse b cell follicullar lymphoma cutaneous t cell anapalastic t cell chronic lymphocytic leukemia', 'small lymphocytic lymphoma mantle cell lymphoma']\n",
      "['excellent discussion', 'frontline cll options', 'dr brad kahl hematology']\n",
      "['chronic lymphocytic leukemia cll', 'b cells', 'white blood cell', 'immune system', 'cll survivors steve', 'cll diagnoses']\n",
      "['non hodgkin s lymphoma nhl chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma', 'non hodgkin s lymphoma']\n",
      "['chronic lymphocytic leukemia', 'high price', 'healthcare system', 'dr adam olszewski discusses', 'ibrutinib use']\n",
      "['chronic lymphocytic leukemia care', 'common types', 'leukemia cll']\n",
      "['reception children', 'emperor penguins', 'wonderful vocabulary', 'beautiful illustrations', 'new words', 'eyfsculturalcapital cll bishoptonprimreception']\n",
      "['glioblastoma brain cancer husband', 'chronic lymphocytic leukemia blood cancer mother', 'breast cancer', 'honour people', 'cancers worldcancerday']\n",
      "['worldcancerday iamandiwill', 'inspire others', 'mission curecancer awareness', 'bloodcancer lymphoma leukemia mds', 'aml cll apl blodkr ft blodcancer patienter sundpol dksund lyle dk livskvalitet lymfekr ft']\n",
      "['chronic lymphocytic leukemia cll', 'word cancer']\n",
      "['new drugs', 'lrc aim', 'blood cancer cll leukemia worldcancerday2020 iamandiwill thanks uk']\n",
      "['stuart blakemore', 'clinical significance', 'tp53 birc3 atm', 'mapk erk']\n",
      "['super reading stay', 'blossom class', 'ups engagedcommunity successfulstudents']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'ohio state leukemia expert dr john byrd shares', 'discoveries spon james']\n",
      "['significant changes', 'antioxidant defence mechanisms', 'chronic lymphocytic leukaemia blood', 'nutrient status worldcancerday cancer leukemia']\n",
      "['world cancer day', 'cancer patients']\n",
      "['cll support', 'education support', 'empower people', 'cll iamandiwill worldcancerday cll haematology bloodcancerawareness charitytuesday']\n",
      "['effective treatment', 'acute lymphoblastic leukemia', 'chronic lymphocytic leukemia cll', 'efficacy integration matters']\n",
      "['worldcancerday2020 cancerresearch cancerawareness cancerprevention cancercare cancerspecialist conney cwsf qmcidgwgbezf cancer', 'dangerous disease cll lungenkrebs magendarmkrebs brustkrebs whounoio']\n",
      "['early stage asymptomatic cll']\n",
      "['mdanderson s amp']\n",
      "['effective communication amp language', 'effective language', 'languagedevelopment cll']\n",
      "['novel agents approaches', 'cll paradigm leukemia']\n",
      "['chronic lymphocytic leukemia', 'blood cancer', 'white blood cells']\n",
      "[]\n",
      "['drug development arm', 'scripps research', 'fda clearance', 'patient trials', 'switchable cart cancerimmunotherapy', 'non hodgkin lymphoma amp chronic lymphocytic leukemia']\n",
      "['new therapeutics', 'cll treatment oncology']\n",
      "['md anderson chronic lymphocytic leukemia specialist alessandra ferrajoli md joins patient power', 'cll patients leukemia cll patientpower']\n",
      "['abstracts march 1st ncllsg2020 cll']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['cll patients', 'colds flu viruses']\n",
      "['new article tumor stroma interaction increases cd147 expression', 'neoplastic b lymphocytes', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article clonal hematopoiesis', 'hematological disorders cll leusm hematology']\n",
      "['top influencer', 'car t cell meeting', 'lymsm cartmeeting20 cart20']\n",
      "['important data', 'therapeutic efficacy', 'high risk cll leusm leukemia gcllsg']\n",
      "['educational event', 'clinical scientists', 'cll leukemia']\n",
      "['chronic lymphocytic leukemia cll', 'cll chroniclymphocyticleukemia ash2019']\n",
      "['cd49d promotes disease progression', 'chronic lymphocytic leukemia', 'new insights', 'cd49d bimodal expression cd49d', 'remarkable prognostic biomarker', 'chronic lymphocytic leukemia cll', 'positive cll cells cutoff']\n",
      "['study shows', 'cell analysis', 'gauge cll patients response rates']\n",
      "['value analysis', 'ven obinutuzmab v ibrutinib ibrutinib', 'survival data', 'indefinite duration cll']\n",
      "['mutual weekends']\n",
      "['cd49d promotes disease progression', 'chronic lymphocytic leukemia', 'new insights', 'cd49d bimodal expression']\n",
      "['onkologisch das ychromosom ist der teil der erbinformation den nur m nner haben von einer chronischen lymphatischen leuk mie cll sind m nner berproportional h ufig betroffen mehr fakten zur cll weltkrebstag worldcancerday']\n",
      "['positive chmp opinion', 'free combination regimen', 'chronic lymphocytic leukemia', 'small molecules news channels abbvie', 'positive chmp']\n",
      "['phase iii cll14 trial', 'disease progression', 'patient population cll leukemia']\n",
      "['new article cd49d promotes disease progression', 'chronic lymphocytic leukemia', 'new insights', 'cd49d bimodal expression cll leusm hematology']\n",
      "['new article birc3 mutations', 'chronic lymphocytic leukemia', 'unfavorable cll leusm hematology']\n",
      "['new article myopathies', 'head drop clinical spectrum', 'treatment outcomes cll leusm hematology']\n",
      "['venex 100mg venetoclax venetoclax', 'trade name venex', 'chronic lymphocytic leukemia cll']\n",
      "['cll leusm', 'cll ipi']\n",
      "['clinical implications', 'amp lt i amp gt birc3 amp lt i amp gt mutations', 'chronic lymphocytic leukemia haematologica cancer epidemiology']\n",
      "['obinutuzumab treatment', 'patients wit']\n",
      "['cll diagnosis', 'cll leukemia patientpower']\n",
      "['line drug', 'chronic lymphocytic leukemia cll', 'oral drug', 'frontline treatment', 'traditional iv chemotherapy']\n",
      "['new drug combination', 'chronic lymphocytic leukemia', 'new standard', 'treatment researchers shows healthcare']\n",
      "['abbvie announces anvisa approval', 'venclexta venetoclax', 'duration treatment', 'chroniclymphocyticleukemia llc', 'previous treatment abbv']\n",
      "['hsp70 hsf1 axis', 'pi3k akt pathway', 'druggable target', 'chronic lymphocytic leukemia']\n",
      "['risk stratification', 'cll patients', 'venetoclax leusm hematology hemeonc cll']\n",
      "['new article high rate', 'mrd responses', 'fit patients', 'chronic lymphocytic leukemia', 'front line fludarabine cyclophosphamide', 'ofatumumab fco2 cll leusm hematology']\n",
      "['european medicines agency s committee', 'medicinal products', 'human use', 'positive opinion', 'dose combination', 'cll leukemia']\n",
      "['study shows', 'cell analysis', 'gauge cll patients response rates']\n",
      "['high rate', 'mrd responses', 'fit patients', 'chronic lymphocytic leukemia', 'front line fludarabine cyclophosphamide', 'ofatumumab fco2']\n",
      "['kollegerna som jobbar', 'och skola har producerat denna inspirerande film fr n educa2020 boakademi kontinuerligtl rande cll snyggt']\n",
      "['positive chmp opinion', 'free combination regimen', 'chronic lymphocytic leukemia']\n",
      "['positive chmp opinion', 'free combination regimen']\n",
      "['eu panel', 'frontline venetoclax obinutuzumab', 'cll leukemia']\n",
      "['time researchers', 'immunotherapy drug ibrutinib', 'chronic lymphocytic leukemia induces', 'consistent chain', 'cancer cells', 'patients news']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['study shows', 'cell analysis', 'gauge cll patients response rates']\n",
      "['recent b cell malignancies centre', 'multiple myeloma cll saudiblood']\n",
      "['venetoclax obinutuzumab', 'important option', 'intensive tx', 'quicker regulatory approvals', 'practice cllsm fda news']\n",
      "['chronic lymphocytic leukemia', 'promising report', 'ash ash2019 leukemia']\n",
      "['section chief', 'cll group', 'grand rounds resistance', 'treatment resistance', 'great talk dr woyach']\n",
      "['medical independent sales representatives', 'medical distributors abbvie', 'positive chmp opinion', 'venclyxto r', 'free combination regimen', 'chronic lymphocytic leukemia']\n",
      "['positive chmp opinion', 'free combination regimen', 'chronic lymphocytic leukemia news pharma pharmiweb']\n",
      "['chronic lymphocytic leukemia', 'urinary tract symptoms', 'visible hematuria', 'atypical urology presentation', 'urology leukemia openaccess']\n",
      "['oncology news', 'positive chmp opinion', 'potential treatment', 'chronic lymphocytic leukemia']\n",
      "['abbv abbvie', 'positive chmp opinion', 'free combination regimen']\n",
      "['chronic lymphocytic leukemia', 'disease ecm']\n",
      "['positive chmp opinion', 'free combination regimen']\n",
      "['year analysis confirms', 'venetoclax rituximab', 'refractory chronic lymphocytic leukemia leusm lymsm abstract']\n",
      "['positive chmp opinion', 'free combination regimen']\n",
      "['positive chmp opinion', 'free combination regimen', 'chronic lymphocytic leukemia']\n",
      "['positive chmp opinion', 'free combination regimen']\n",
      "['new article autoimmune cytopenias', 'chronic lymphocytic leukemia focus', 'molecular aspects cll leusm hematology']\n",
      "['new article cutaneous manifestation', 'chronic lymphocytic leukemia', 'case report', 'literature review cll leusm hematology']\n",
      "['new article impact', 'leader primers', 'ighv mutational status assessment', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article chromatin', 'cell immune', 'temporal dynamics', 'ibrutinib response', 'cll cll leusm hematology']\n",
      "['new article', 'bruton tyrosine kinase inhibitors', 'chronic lymphocytic leukaemia', 'ibrutinib cll leusm hematology']\n",
      "['onkologisch nicht alle leuk mien schreiten aggressiv voran', 'drittel der cll patienten werden nie oder erst zu einem sp teren zeitpunkt therapiert', 'nennt man abwartendes beobachten watchandwait mehr infos weltkrebstag worldcancerday']\n",
      "['japan snodgrass bequest panel', 'new phd student', 'lrc cll foxo']\n",
      "['nf b p62 nrf2 survival', 'high ror1 expression', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['c9111 chronic lymphocytic leukemia']\n",
      "['c9110 chronic lymphocytic leukemia']\n",
      "['obinutuzumab treatment', 'patients w leukemia']\n",
      "['obinutuzumab treatment']\n",
      "['chronic lymphocytic leukemia cll', 'common blood cancer', 'u s']\n",
      "['driver mutations', 'chronic lymphocytic leukemia impacts disease outcome']\n",
      "['triplet combination', 'tolerable toxicity profile', 'refractory chronic lymphocytic leukemia', 'phase i ii clinical trial cllsm']\n",
      "['cell immune', 'temporal dynamics', 'ibrutinib response', 'cll fig multi omics analysis', 'ibrutinib time courses reveals', 'broad changes', 'immune cells epigenome singlecell cll multiomics scrnaseq']\n",
      "['lymphoma patient', 'chronic lymphocytic leukemia', 'new confidential survey', 'lymphoma coalition']\n",
      "['chronic lymphocytic leukemia cll changes', 'frontline treatment']\n",
      "['dr michael taylor', 'didn t']\n",
      "['cytotoxic t', 'nk cells', 'chronic lymphocytic leukemia']\n",
      "['obinutuzumab treatment']\n",
      "['s cancer diagnosis cll leukemia patientpower']\n",
      "['own dr', 'new program', 'chronic lymphocytic leukemia cll journey', 'treatment amp', 'survivorship register', 'leukemia cll']\n",
      "['growth factor', 'non blood vessel cells', 'chronic lymphocytic leukemia']\n",
      "['patient engagement', 'cll patient advocate', 'new hires', 'great event mmsm myeloma patientengagement']\n",
      "['cll group', 'new quality improvement initiative', 'btk inihibitors', 'patient population']\n",
      "['1st translational research conference chronic lymphocytic leukaemia don t', 'chairs j', 'brown p ghia m hallek paris france', 'information eshcll2020 eshconferences cll lymphocytic']\n",
      "['common form', 'blood cancer', 'western world chronic lymphocytic leukemia news researchers', 'international colleagues', 'new study', 'patients response', 'leukemia therapy']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['final chance', 'final chance', 'top minds', 'treatment leukemia lymphoma register']\n",
      "['new article', 'network meta analysis', 'maintenance therapy', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article visual dermatology regression', 'atypical cutaneous infiltration', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'year survival', 'phase iii', 'ofatumumab versus physicians choice', 'bulky fludarabine refractory chronic lymphocytic leukaemia', 'short report cll leusm hematology']\n",
      "['new article nf b p62 nrf2 survival', 'high ror1 expression', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'international prognostic index cll lipi', 'time ldt', 'ighv mutation status', 'settings predicts time', 'overall survival cll leusm hematology']\n",
      "['obinutuzumab treatment', 'patients wit']\n",
      "['chronic lymphocytic leukemia']\n",
      "['new viewpoint tumour lysis syndrome', 'chronic lymphocytic leukaemia', 'inhibitors cll leusm', 'w reg']\n",
      "['weedkiller weeds roundup monsanto glyphosate bayer nonhodgkinslymphoma lymphoma chroniclymphocyticleukemia leukemia thesteinberglawgroup steinberglawgroup steinberglaw lawyer', 'legal law lawsuit nhl cll legalhelp classaction massaction']\n",
      "['new premedication', 'obinutuzumab treatment']\n",
      "['finale ergebnisse der prolong studie ofatumumab verbesserte pfs signifikant bei patienten mit cll onkologie h matologie']\n",
      "['dr john byrd', 'leukemia patients', 'previous drugs cll']\n",
      "['treatment health care resource utilization', 'costs betwee']\n",
      "['sad news', 'elena georgieva', 'bulgarian lymphoma association elena', 'cll patient']\n",
      "['treatment health care resource utilization', 'chronic lymphocytic']\n",
      "['chronic lymphocytic leukemia cll', 'common types', 'caregiver duo s experience', 'cll diagnosis']\n",
      "['cll symptoms']\n",
      "['interim clinical data', 'dose escalation trial', 'b cell leukemias', 'american society hematology', 'annual meeting responses', 'dose levels', 'chronic lymphocytic leukemia cll', 'mantle cell']\n",
      "['physician scientists', 'cll contact office', 'patient recruitment', 'prpl nih gov', 'lymphoma lymphomaleukemia fightcll']\n",
      "['feb 1st ncllsg2020 cll']\n",
      "['cll therapy', 'genetic program patient', 'specific execution']\n",
      "['porridge successfulstudents cll']\n",
      "['sitges amp', 'european cartmeeting20', 'sessions amp', 'car t therapy', 'lymphoma amp cll stay', 'expert opinions amp', 'lymsm cart20']\n",
      "['new clinical trial ft596', 'cd20 monoclonal antibodies cll leusm hematology']\n",
      "['prognostic purposes']\n",
      "['chronic lymphocytic leukemia cll', 'u s', 'available options', 'cll management']\n",
      "['chronic lymphocytic leukemia cll therapy', 'genetic program patient', 'specific execution ref singlecell scrnaseq ccl leukemia']\n",
      "['cll amp lymphoma patients', 'local level']\n",
      "['new article', 'oral drug', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article high efficacy', 'complex karyotype', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article application', 'multiple assignment', 'trial smart design', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article pdq cancer information summaries cll leusm hematology']\n",
      "['amp epigenetic analysis cemm researchers', 'christoph bock s group uncover', 'precise molecular program', 'chronic lymphocytic leukemia', 'ibrutinib cll']\n",
      "['amp epigenetic analysis cemm researchers', 'christoph bock s group uncover', 'precise molecular program', 'chronic lymphocytic leukemia', 'ibrutinib cll']\n",
      "['high efficacy', 'complex karyotype', 'chronic lymphocytic leukemia blood']\n",
      "['nejm venetoclax rituximab', 'refractory chronic lymphocytic leukemia interesante estudio un par', 'veo c mo siempre son bienvenidas las opiniones']\n",
      "['seguir vivo que es lo bueno que tiene el dolor y tambi n', 'ganar y perder cuando todo parece jodido es cuando hay que poner cll']\n",
      "['cll treatment', 'dr alessandra ferrajoli']\n",
      "['good data', 'chronic lymphocytic leukemia cll diffuse', 'large b cell lymphoma dlbcl cutaneous t']\n",
      "['patients gerionc geriheme']\n",
      "['dr alessandra ferrajoli', 'md anderson']\n",
      "['treatment health care resource utilization']\n",
      "['chronic lymphocytic leukemia cll', 'common types', 'leukemia rt', 'cll care']\n",
      "['lifelong learning program', 'professor dr delia heck phoebeneedlescenterinc phoebeneedles phoebeneedlescenter', 'cll seniorprograms seniorcitizens envrionmentalscience']\n",
      "['patient recruitment']\n",
      "['high efficacy', 'complex karyotype', 'chronic lymphocytic leukemia blood american society']\n",
      "['chronic lymphocytic leukemia']\n",
      "['treatment health care resource utilization']\n",
      "['cytotoxic t', 'nk cells', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['new article', 'cytotoxic t', 'nk cells', 'chronic lymphocytic leukemia mmsm multiplemyeloma hematology']\n",
      "['new article bcl w', 'select burkitt lymphoma', 'large b cell lymphoma cell lines cll leusm hematology']\n",
      "['porridge successfulstudents cll goldilocks talktime']\n",
      "['global survey gt', 'lymphoma diagnosis', 'shape amp', 'world charitytuesday cll makebloodcancervisible']\n",
      "['treatment health care resource utilization', 'costs betwee']\n",
      "['natural prevention', 'chronic lymphocytic leukemia']\n",
      "['treatment health care resource utilization', 'chronic lymphocytic']\n",
      "['treatment health care resource utilization', 'costs betw leukemia']\n",
      "['entrenando hasta', 'poder mas', 'se supera el l mite', 'taylorwolfgymoficial wrestler', 'prowrestler chileanswrestler luchalibre luchalibrechilena ngen nomasshowfamiliar xnl cll']\n",
      "['epigenome changes', 'patient response amp prognosis epigenetics 450k']\n",
      "['chronic lymphocytic leukemia treatment', 'stage cll', 'white cell', 'lymph nodes']\n",
      "['chronic lymphocytic leukemia', 'cancer watchful', 'safest approach', 'care check', 'cll survivor steve s experience']\n",
      "['chronic lymphocytic leukemia', 'leukemic lymphocytes cd19']\n",
      "['chronic lymphocytic leukemia', 'white cell', 'lymphocytic predominance']\n",
      "['chronic lymphocytic leukemia infiltration', 'reticuloendothelial system', 'spleen liver', 'bone marrow', 'occurs infection', 'unusual presentations']\n",
      "['chronic lymphocytic leukemia patients', 'age gt', 'nonspecific fatigue lethargy', 'uncomfortable enlargement', 'lymph nodes']\n",
      "['new clinical trial safety', 'preliminary efficacy', 'jbh492 monotherapy', 'chronic lymphocytic leukemia cll', 'non hodgkin s lymphoma nhl cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'asymptomatic elevation', 'white cells', 'routine evaluation']\n",
      "['chronic lymphocytic leukemia cll', 'massive overproduction', 'leukemic lymphocytes', 'monoclonal production', 'b lymphocytes etiology']\n",
      "['cll expert banerji practice', 'treatment naive cll updates', 'ash2019 feb 5th', '11am 1pm est register']\n",
      "['chronic lymphocytic leukemia', 'chronic lymphocytic leukemia cancer']\n",
      "['expert outlines key steps']\n",
      "['chronic lymphocytic leukemia cll', 'common form', 'u s', 'active role', 'treatment discussions']\n",
      "['treatment options']\n",
      "['chronic lymphocytic leukemia', 'chronic lymphocytic leukemia cancer']\n",
      "['treatment health care resource utilization']\n",
      "['educational theme idelalisib', 'na ve patients', 'chronic lymphocytic leukemia lymphoma lymsm cll']\n",
      "['new article', 'prognostic index', 'chronic lymphocytic leukemia', 'ibrutinib results', 'multicenter retrospective cohort study cll leusm hematology']\n",
      "['great excitement', 'crime scene', 'bears cottage cll successfulstudents minidetectives goldilocks']\n",
      "['chronic lymphocytic leukemia treatment pdq patient version']\n",
      "['clinical data', 'chronic lymphocytic leukemia cll', 'w drs jennie crews']\n",
      "['new article autoimmune complications', 'chronic lymphocytic leukemia', 'drugs cll leusm hematology']\n",
      "['double whammy immunotherapy', 'duobody cd3xcd20 induces', 'potent t cell', 'malignant bcells', 'preclinical models amp', 'lymphoma cll dlbcl tcells']\n",
      "['natural killer cell hypo responsiveness', 'chronic lymphocytic leukemia', 'lymphoma lymsm']\n",
      "['early years', 'partner amp medium', 'eef research', 'basis amp', 'essential tools', 'children need', 'literacy cll language talk']\n",
      "['todasparami diadelamujerhondurena cll']\n",
      "['natural killer cell hypo responsiveness', 'chronic lymphocytic leukemia']\n",
      "['don t', 'exciting new updates', 'sll treatment', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma register']\n",
      "['deborah sims cll patient interviews', 'doctors prof john gribben', 'great overview']\n",
      "['chronic lymphocytic leukemia', 'bone marrow', 'white blood cell']\n",
      "['oncoalert survival', 'chronic lymphocytic leukaemia cll', 'lymsm leusm cllsm']\n",
      "['natural killer cell hypo responsiveness', 'chronic lymphocytic leukemia', 'hofland t endstra s gomes ckp', 'boer r', 'weerdt i bobkov v riedl ja heukers r smit mj', 'e levin']\n",
      "['new article genomic', 'epigenomic alterations', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'tissue damage', 'myeloid c type lectin receptors cll leusm hematology']\n",
      "['new article crispr cas9', 'models uncover therapeutic vulnerabilities', 'del 11q cll cells', 'dual bcr', 'parp inhibition cll leusm hematology']\n",
      "['new article novel genes', 'dna methylation alterations', 'korean patients', 'chronic lymphocytic leukaemia', 'methyl cpg', 'study cll leusm hematology']\n",
      "['new article genomic arrays identify high risk chronic lymphocytic leukemia', 'genomic complexity', 'multi center study cll leusm hematology']\n",
      "['new article', '18f fdg pet', 'richter s transformation', 'chronic lymphocytic leukemia', 'b cell receptor inhibitor cll leusm hematology']\n",
      "['new article therapeutic efficacy', 'nyctanthes arbor tristis flowers', 'inhibit proliferation', 'chronic primary human leukemia cells', 'adipocyte differentiation', 'silico analysis', 'cll leusm hematology']\n",
      "['new article', 'natural killer cell hypo responsiveness', 'chronic lymphocytic leukemia', 'mmsm multiplemyeloma hematology']\n",
      "['good news', 'cll hematology oncology']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['genomic arrays identify high risk chronic lymphocytic leukemia', 'genomic complexity', 'multi center study haematologica cancer epidemiology']\n",
      "[]\n",
      "['role play', 'amazing language amp immersion', 'story world', 'magical thegreatexplorer cll vocabulary reading rocks']\n",
      "['2gether event', 'new treatment option', 'r r cll patients', 'spain moreoptionsmorechances innovation']\n",
      "['high incidence', 'atrial fibrillation', 'recent study', 'suggests incidence', 'cll medicine cancer leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['dr fakhri', 'pi3k inhibitors', 'refractory cll leukemia']\n",
      "['cll treatment advances benefit']\n",
      "['prof chris fegan janice rees john perkins sarah draper', 'royal gwent hospital', 'cll bloodcancerawareness haematology leukaemia cancer charity']\n",
      "['new article histologic findings', 'vitreoretinal lymphoma learning', 'enucleation specimens cll leusm hematology']\n",
      "['new article risks', 'primary malignancy', 'cutaneous malignant melanoma survivors', 'surveillance epidemiology', 'results seer program cll leusm hematology']\n",
      "['new article imputation', 'gene expression data', 'blood cancer', 'biological pathways cll leusm hematology']\n",
      "['new article', 'hodgkin s lymphoma', 'case report cll leusm hematology']\n",
      "['new article', 'mll rearrangement', 'unknown clinical significance cll leusm hematology']\n",
      "['b cell chronic lymphocytic leukemia treatment market trends analysis statistics']\n",
      "['herbicide roundup glyphosate nonhodgkinslymphoma lymphoma nonhodgkins chroniclymphocyticleukemia leukemia thesteinberglawgroup steinberglawgroup steinberglaw law', 'legal lawfirm legalhelp legalassistance classaction nhl cll surgeon nurse']\n",
      "['fake s t', 'prosper russ 5luchas mlw cll ngen lwa wwa4 luchalibre luchador prowrestler wrestler champion mascara mask santiago chile']\n",
      "['18f fdg pet', 'richter s transformation', 'b cell receptor inhibitor leusm']\n",
      "['incredible advancements', 'car t therapy', 'value considerations']\n",
      "['important summary', 'post venetoclax data', 'r r cll']\n",
      "[]\n",
      "['global patient survey', 'lymphoma patient', 'shape advocacy work leukaemia']\n",
      "['i m', 'chronic lymphocytic leukemia specialist', 'columbus ohio']\n",
      "['long term results', 'good news venetoclax', 'drug i', 'i m', 'new data ibrutinib']\n",
      "['radioactive elements', 'radioactive gas', 'lung cancer', 'u s radon', 'chronic lymphocytic leukemia']\n",
      "['genomic arrays identify high risk chronic lymphocytic leukemia', 'genomic complexity', 'multi center study']\n",
      "['cll paradigm', 'combination strategies', 'selective btk inhibitors', 'duration approaches leukemia']\n",
      "['new article efficacy', 'disease progression', 'refractory cll', 'duo crossover', 'study cll leusm hematology']\n",
      "['rice bran arabinoxylan', 'curcumin therapy', 'early stage b cell lymphoid malignancies monoclonal gammopathy', 'undetermined significance', 'multiple myeloma', 'chronic lymphocytic leukemia']\n",
      "['herbal turmeric', 'natural prevention', 'chronic lymphocytic leukemia']\n",
      "['prognostic index', 'ibrutinib age', 'r r disease']\n",
      "['bearish list', 'nfc tung cll gog spo tern crh utlf']\n",
      "['school day', 'fabmentor cll placement lovingmyplacement']\n",
      "['cll patients', 'individuals cll leukemia patientpower']\n",
      "['dr sharman', 'elevate tn trial', 'cll leukemia sharman']\n",
      "['rns aim cll cello health plc block', 'interim review']\n",
      "['id cll patients', 'high risk', 'cll treatment', 'clinical data', 'project lead', 'cool aspects']\n",
      "['follicular lymphoma', 'clinical trials vs', 'clinical setting', 'favorable outcomes', 'clinical setting lymsm']\n",
      "['acute myeloid leukemia chronic myeloid leukemia', 'chronic lymphocytic leukemia', 'chemotherapeutic drugs', 'f u c k']\n",
      "['cardiff conference', 'prof chris fegan consultant haematologist', 'patients bloodcancerawareness haematology leukaemia cancer charity']\n",
      "['cd20 antibodies', 'increase profits', 'roche cll']\n",
      "['erweiterung f r imbruvica janssen', 'anwendung f r ibrutinib', 'kombination mit rituximab durch', 'beh rden erhalten kombitherapie cll']\n",
      "['cll creativity']\n",
      "['bita fakhri md', 'discusses data', 'recent trials', 'pipeline leukemia']\n",
      "['chronic lymphocytic leukemia', 'progressive anemia', 'composite lymphoma']\n",
      "['cll kanduri group', 'global 5hmc loss', 'regulatory regions', 'classic cancer 5mc patterns epitwitter cll epigenetics 5hmc']\n",
      "['purposeful talk']\n",
      "['ema nod', 'imbruvica rituximab combo']\n",
      "['cll sll patients', 'international experrience survey data', 'support access discussions', 'new treatments', 'countries uk']\n",
      "['rapid pace', 'cll paradigm leukemia']\n",
      "['chronic lymphocytic leukemia cll', 'common type', 'u s', 'white blood cell', 'b cell']\n",
      "['chronic lymphocytic leukemia cll', 'blood cancer', 'white blood cell', 'b cell', 'available treatment options']\n",
      "['new article ibrutinib', 'initial therapy', 'chronic lymphocytic leukaemia', 'systematic review', 'meta analysis cll leusm hematology']\n",
      "['super story maps', 'group time', 'children s oral', 'story maps', 'continuous provision successfulstudents cll']\n",
      "['fwfopenaccess b cell', 'specific irf4 deletion accelerates chronic lymphocytic leukemia development', 'tumor immune evasion']\n",
      "['extensive lymphadenopathy', 'multiple lymph node stations', 'cll discussion chronic lymphocytic leukemia cll']\n",
      "['month checkup', 'oncologist hematologist', 'intact i', 'i m', 'cures i', 'cancer bloodcancer leukemia cancercure immune discovery', 'cancer bbc news']\n",
      "['dr adam olszewski discusses', 'line therapy']\n",
      "['chronic lymphocytic leukaemia', 'cll leusm']\n",
      "['multiple bcl2 mutations co', 'chronic lymphocytic leukemia cll progression', 'venetoclax jan', 'cllsm leusm']\n",
      "['prolong survival']\n",
      "['great summary', 'cll treatment trials', 'triplet therapies']\n",
      "['functional precision medicine', 'chronic lymphocytic leukemia', 'share uh cell']\n",
      "['andr rendeiro', 'christoph bock s group', 'phd thesis stratification amp', 'chronic lymphocytic leukemia', 'high dimensional molecular data amp computational methods', 'phdlife phdhat']\n",
      "['disturbing findings', 'pmcc rmh research', 'multiple bcl2 mutations co', 'chronic lymphocytic leukemia progression']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['lymphoma cll hematon']\n",
      "['prof john seymour amp', 'royal melbourne hospital', 'year analysis', 'murano study', 'venetoclax amp rituximab', 'refractory cll']\n",
      "['good foods', 'fatigue i', 'cll chronic lymphocytic leukemia', 'don t', 'doesn t', 'colds amp flus', 'haven t']\n",
      "['house nwac nwathleticcenter cascadelittleleague cll indoorbaseballfacility indoorbaseball vancouverwa nw', 'athletic center']\n",
      "['dr woyach', 'btk inhibitors', 'cll leukemia james']\n",
      "['language development', 'medium amp partner schools languagedevelopment cll']\n",
      "['bruton s tyrosine kinase btk inhibitor cll oncology']\n",
      "['medicare beneficiaries', 'unfavorable results', 'clinical trial participants', 'follicular lymphoma', 'chronic lymphocytic leukemia']\n",
      "['multiple bcl2 mutations co', 'chronic lymphocytic leukemia progression', 'venetoclax blood']\n",
      "['cll progression', 'subclone diversity', 'study supports', 'comprehensive genomic', 'novel putative driver mutations', 'evolution cll']\n",
      "['refractory cll', 'undetectable mrd', 'venetoclax therapy', 'months clinicaltrials observations lymphoidneoplasia']\n",
      "['sll leukemia lymphoma reserve']\n",
      "['neutrophilic dermatosis', 'chronic lymphocytic leukemia', 'ncbi ndh sweetssyndrome cll']\n",
      "['multiple bcl2 mutations co', 'chronic lymphocytic leukemia progression', 'venetoclax blood american society']\n",
      "['new article bcl6 modulates', 'innate immunity', 'macrophage activity', 'critical role', 'experimental autoimmune encephalomyelitis cll leusm hematology']\n",
      "['new article immunohistochemical expression', 'lymphoid enhancer', 'positive marginal zone lymphoplasmacytic', 'follicular lymphomas cll leusm hematology']\n",
      "['new article machine learning', 'high risk', 'infection cll leusm hematology']\n",
      "['multiple bcl2 mutations co', 'chronic lymphocytic leukemia cll progression', 'venetoclax american society', 'hematology hematology lymsm cllsm leusm']\n",
      "['video tirabrutinib', 'entospletinib obinutuzumab', 'r r cll w barbara eichhorst', 'leusm immunoonc hemeonc ash19 hematology']\n",
      "['unusual presentation', 'richter s transformation', 'chronic lymphocytic leukemia', 'deoxyglucose positron emission tomography', 'tomography lymphoma lymsm']\n",
      "['ogt launches ngs panel', 'chronic lymphocytic leukemia']\n",
      "['experimental car t therapies', 'high overall response rates', 'mantle cell lymphoma', 'chronic lymphocytic leukemia', 'recent ash2019', 'annual meeting']\n",
      "['multiple bcl2 mutations', 'resistant cll pts', 'early phase trials cll lymsm', 'multiple bcl2 mutations co', 'cll progression']\n",
      "[]\n",
      "['medical care', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll', 'indolent lymphomas', 'marc hoffman md kuashreview kubloodcancer']\n",
      "['teresa retweet', 'medical care', 'chronic lymphocytic leukemia']\n",
      "[]\n",
      "['new clinical trial', 't315i mutation', 't315i mutation cll leusm hematology']\n",
      "['great thing', 'educate cll patients leusm leukemia']\n",
      "['cll expert dr justin taylor discusses', 'genetic mutations', 'md cll leukemia patientpower']\n",
      "['educational theme', 'front line treatment', 'wojciech jurczak', 'topic lymsm lymphoma cll']\n",
      "['cll research', 'dr mato']\n",
      "['new article', 'multiple bcl2 mutations co', 'chronic lymphocytic leukemia progression', 'venetoclax cll leusm hematology']\n",
      "['new article cd16 pre ligation', 'mab sensitizes human nk cells', 'c cytokine stimulation', 'pi3k mtor axis cll leusm hematology']\n",
      "['new article', 'unusual presentation', 'richter s transformation', 'chronic lymphocytic leukemia', 'deoxyglucose positron emission tomography', 'tomography cll leusm hematology']\n",
      "['new article high throughput analysis', 't cell receptor gene repertoire', 'monoclonal b cell lymphocytosis reveals', 'distinct profile', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article expression', 'cathelicidin hcap18 ll', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['genentech partner', 'clonoseq assay', 'minimal residual disease', 'primary endpoint', 'phase iii study', 'chronic lymphocytic leukemia patients']\n",
      "['clinic staff', 'old cll survivor dr charles berry', 'geriatric clinic cancermoonshot endcancer']\n",
      "['small molecule treatments', 'chronic lymphocytic leukemia', 'standard chemotherapies uni cll']\n",
      "['pf fund', 'ytd ath', 'days pf share', 'ytd ath', 'total pf ath', 'days cash', 'blin cll', 'new cpg top', '1st csp ba vty rnwh']\n",
      "['great phd speakers', 'peter napper', 't cells', 'ug16 hwb', 'greatscience research seminar network collaborate']\n",
      "['cll facts thanks', 'provocative yes', 'new cases', 'doesn t', 'year raredisease leukemia chroniclymphocyticleukemia']\n",
      "['chronic lymphocytic leukemia cll', 'deaths cll', 'common leukemia', 'cll patients', 'years memorial sloan', 'cancer center zusia']\n",
      "['new article', 'educational theme', 'front line treatment', 'chronic lymphocytic leukemia cll', 'introduction article lymsm lymphoma']\n",
      "['idelalisib treatment outcomes fridayfact dyk follicularlymphoma rituximab chroniclymphocyticleukemia cll fl clinicaltrial']\n",
      "['car t therapy', 'value considerations cancer therapy advisor']\n",
      "['medtech precisionmedicine scientists', 'chronic lymphocytic leukemia', 'complex model', 'therapeutic strategies']\n",
      "['new article minimal residual disease assessment', 'routine cll leusm hematology']\n",
      "['onkologisch ighv steht f r einen genabschnitt der bei cll mutiert sein kann der ighv status ist ein wichtiger prognosefaktor patienten mit unmutiertem status haben im vergleich zu denen mit mutation eine ung nstigere prognose noch', 'tage bis worldcancerday weltkrebstag']\n",
      "['cll immunotherapy l', 'nice work', 'mds ub', 'long term ibrutinib therapy', 'substantial reversal', 't cell exhaustion', 'b cll']\n",
      "['ringshausen s', 'lymphoma leukemia cll']\n",
      "['beta batters b cells stromal protein kinase c inhibition enhances chemosensitivity', 'b cell malignancies amp overcomes drug resistance', 'cool study', 'ringshausen lymphoma cll']\n",
      "['key genes', 'chromosomal regions', 'chronic lymphocytic leukemia cll']\n",
      "['cancer patients', 'great report', 'comprehensive analysis', 'clinical immuno oncology landscape cll askpatients']\n",
      "['cll diagnostics', 'tp53 chroniclymphocyticleukemia']\n",
      "['btk cll btk']\n",
      "['spring cme conference', 'non hematology colleagues makebloodcancervisible chooselifeoverleukemia']\n",
      "['chronic lymphocytic leukemia memorial sloan', 'cancer center appreciative']\n",
      "['helpful advice', 'chronic lymphocytic leukemia survivor']\n",
      "['chronic lymphocytic leukemia affects', 'jenn s tips']\n",
      "['cll expert dr jennifer woyach', 'cll remission duration trial data', 'different regimens cll leukemia patientpower james']\n",
      "['jennifer woyach md discusses', 'btk inhibitors', 'chronic lymphocytic leukemia leusm']\n",
      "['car t therapy', 'chemotherapy studies', 'survival rates', 'traditional chemotherapy', 'b cell', 'acute lymphoblastic leukemia', 'large b cell lymphoma', 'article gt']\n",
      "['new videos', 'cancer diet', 'chronic lymphocytic leukemia']\n",
      "['tgtx jpm20 mzl fl prevalence']\n",
      "['support group amp i', 'valuable face', 'lymphoma support group thursdaythoughts', 'local group', 'gt cancersupport bloodcancer cll']\n",
      "['new video lindsey roeker md', 'chronic lymphocytic leukemia cll', 'shares advice', 'refractory cll patients click']\n",
      "['exciting news', 'nearby normal cells', 'survival rates', 'lymphoma leukemia cll']\n",
      "['s feast ppix dbox cll eme msys aura mysl thr tek ecr aim smallcaps']\n",
      "['new trial daratumumab', 'refractory chronic lymphocytic leukemia cll genmab gmab jnj']\n",
      "['ogt s', 'new cll cnv panel', 'complete understanding', 'genetic makeup', 'cll research samples', 'ngs assay', 'snvs indels', 'large cnvs', 'trisomies cll leukaemia cnv cancer ngs sureseq']\n",
      "['new article amg', 'antagonist shows preclinical efficacy', 'chronic lymphocytic leukemia cll leusm hematology']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['new article guidance document validation', 'high performance liquid chromatography tandem mass spectrometry immunopeptidomics assay', 'hla class i ligands', 'pharmaceutical therapies cll leusm hematology']\n",
      "['colleagues lymsm research', 'tumour microenvironment skews bh3 proteins', 'lymphoma leukemia cll', 'therapies clinical trials']\n",
      "['strong reaction', 'line update', 'great business', 'right sector i don t hold']\n",
      "['lymphoma coalition', 'global patient survey', 'confidential survey', 'support services amp advocacy efforts lymphomamatters cll']\n",
      "['cash position', 'divi increase']\n",
      "['cll signal', 'cello health', 'eponymous part', 'uk cll brighterir andrewscotttv']\n",
      "['cll cello health', 'healthy cash position announces', 'cello signal', 'uk cll brighterir andrewscotttv']\n",
      "['rns aim cll cello health plc pre']\n",
      "['dr raphael pollock', 'chronic lymphocytic leukemia']\n",
      "['new clinical trial daratumumab', 'refractory chronic lymphocytic leukemia', 'direct study cll leusm hematology']\n",
      "['michele nadeem baker', 'cll patient advocate perspective', 'american society', 'hematology ash', 'annual meeting cll leukemia ash2019 ash19 patientpower']\n",
      "['experimental car t therapies', 'high overall response rates', 'mantle cell lymphoma', 'chronic lymphocytic leukemia cll lymphoma']\n",
      "['genentech partner', 'clonoseq assay', 'minimal residual disease', 'primary endpoint', 'phase iii study', 'chronic lymphocytic leukemia patients']\n",
      "['global survey', 'cll diagnosis']\n",
      "['chronic lymphocytic leukemia']\n",
      "['new article', 'undetectable peripheral blood mrd', 'attainment plateaus', 'months cll leusm hematology']\n",
      "['new article characteristics', 'chronic lymphocytic leukemia', 'togo cll leusm hematology']\n",
      "['new article rna seq', 'clinical outcome cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['natural prevention', 'chronic lymphocytic leukemia']\n",
      "['antagonist shows preclinical efficacy', 'chronic lymphocytic leukemia']\n",
      "['lymphoma coalition', 'global patient survey', 'lymphoma amp cll', 'patients amp caregivers', 'lymsm patientempowerment patientexperience hematology hematology']\n",
      "['lymphoma coalition', 'global patient survey', 'lymphoma amp cll', 'patients amp caregivers', 'lymsm patientempowerment patientexperience patientengagement ffpaciente cyl']\n",
      "['roundup glyphosate nonhodgkinslymphoma nonhodgkins lymphoma weedkiller weeds herbicide chroniclymphocyticleukemia leukemia nhl cll thesteinberglawgroup steinberglawgroup steinberglaw lawyer law', 'legal lawfirm classaction']\n",
      "['cll symptoms']\n",
      "['open dialogue', 'chronic lymphocytic leukemia cll rt', 'empower others']\n",
      "['warthin tumor', 'lymphocytes involvement', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'phyllodal pattern atypical lymphs cd5 cd23 weak', 'confirmation entpath hemepath surgpath']\n",
      "['don t', 'exciting new updates', 'sll treatment', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma register']\n",
      "['great things', 're progress', 'adaptive s blood test', 'fda approval jpmhc20 jpmorgan2020']\n",
      "['cll progression', 'subclone diversity']\n",
      "['clinical data', 'chronic lymphocytic leukemia cll', 'w drs jennie crews']\n",
      "['sureseq cll cnv panel', 'company s', 'high quality', 'ngs offering', 'chronic lymphocytic leukaemia cll cll leukaemia cnv ngs']\n",
      "['multiple b cell malignancies', 'chronic lymphocytic leukemia epidemiology pathology', 'clinical implications lymphoma lymsm']\n",
      "['new article neutrophilic dermatosis', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'b cell lymphoma', 'cancer implications', 'colorectal carcinogenesis cll leusm hematology']\n",
      "['new article', 'multiple b cell malignancies', 'chronic lymphocytic leukemia epidemiology pathology', 'clinical implications cll leusm hematology']\n",
      "['chronic lymphocytic leukemia cells', 'mitochondrial fitness', 'cd8 t cells', 'impede car t cell efficacy blood american society']\n",
      "['clonoseq assay indications', 'cll palmettogba']\n",
      "['re time', 'cme credit', 'hematologic malignancies', 'san diego', 'drs stephen m ansell jennifer r', 'brown amp nitin jain']\n",
      "['assess minimal residual disease', 'ph3 clinicaltrials', 'venetoclax vs cll', 'multiple myeloma amp', 'test vs cll oncology ngs mrd diagnostics']\n",
      "['adpt adaptive genentech partner', 'clonoseq assay', 'chronic lymphocytic leukemia patients']\n",
      "['cll fuckyoucancer bloodcancerawareness']\n",
      "['cll genetic']\n",
      "['sfbn feed adaptive', 'genentech partner', 'clonoseq assay', 'minimal residual disease', 'primary endpoint', 'phase iii study', 'chronic lymphocytic leukemia patients seattle jan', 'bayarea biotech']\n",
      "['own immune system', 'chronic lymphocytic leukemia russell powell credits car t cell therapy', 'battle cancer', 'health nexus']\n",
      "['chronic lymphocytic leukemia']\n",
      "['adpt adaptive', 'genentech partner', 'clonoseq assay', 'minimal residual disease']\n",
      "['genentech partner', 'clonoseq assay', 'minimal residual disease', 'primary endpoint', 'phase iii study', 'chronic lymphocytic leukemia patients seattle jan', 'globe newswire adaptive biotechnologies corporation']\n",
      "['adpt adaptive', 'genentech partner', 'clonoseq assay', 'minimal residual disease', 'primary endpoint', 'phase iii study', 'chronic lymphocytic leukemia patients']\n",
      "['adpt adaptive', 'genentech partner', 'clonoseq assay', 'minimal residual disease', 'primary endpoint', 'phase iii study', 'chronic lymphocytic leukemia patients multi year partnership', 'support venetoclax']\n",
      "['genentech partner', 'clonoseq assay', 'minimal residual disease', 'primary endpoint']\n",
      "['human medicines european', 'public assessment report epar blitzima rituximab lymphoma non hodgkin leukemia lymphocytic chronic b cell date agenparl glossary patients treatment agenparlenglish dirittogiustizia salute socialnetwork']\n",
      "['adaptive biotechnologies', 'medicare coverage', 'chronic lymphocytic leukemia']\n",
      "['dr tanya siddiqi', 'sims cll patient amp patient advocate', 'ash meeting dr siddiqi discusses', 'phase i study', 'refractory patients', 'car t cell therapy lymphoma']\n",
      "['cardiac amyloid', 'experts tweet', 'plasma cell dyscrasia rule', 'cll lymphoma mmsm myeloma endcancer hasan arc']\n",
      "['dr kahl', 'frontline btk inhibitor selection', 'cll leukemia']\n",
      "['exciting data', 'philadelphia lymphoma rounds']\n",
      "['chronic lymphocytic leukemia', 'vitamin d mayo nov', 'new study', '1st evidence', 'vitamin d insufficiency', 'risk factor', 'disease progression', 'cll amp', 'outcome health']\n",
      "['new article prima 1met cytotoxic effect correlates', 'p53 protein reduction', 'chronic lymphocytic leukemia cells cll leusm hematology']\n",
      "['onkologisch ein fehlen eines teils des chromosom', 'deletion 17p stellt einen risikofaktor f r aggressiveres fortschreiten einer cll dar da dieser h ufig mit funktionsverlust des eiwei es p53 einhergeht welches zellteilung reguliert und tumorwachstum hemmt worldcancerday']\n",
      "['fun amp delicious lunch', 'incredible year', 'cll amp']\n",
      "['i didn t', 'cll amp genentech amp abbvie s', 'chemotherapy drugs', 'yr anniversary']\n",
      "['new treatments', 'chronic lymphocytic leukemia mayo clinic']\n",
      "['appreciation luncheon', 'super amazing cll team', 'great year']\n",
      "['follicular lymphoma', 'chronic lymphocytic leukemia', 'clinical setting', 'favorable outcomes', 'clinical trial']\n",
      "['dr tam', 'chronic lymphocytic leukemia', 'phase ii captivate trial leusm']\n",
      "['initial medication']\n",
      "['predictive role', 'gene mutations', 'chronic lymphocytic leukemia results', 'pivotal phase iii study complement1']\n",
      "['clonal evolution', 'chronic lymphocytic leukemia']\n",
      "['new article', 'long term ibrutinib therapy reverses cd8 t cell exhaustion', 'b cell chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['new article', 'driver mutations', 'chronic lymphocytic leukemia impacts disease outcome cll leusm hematology']\n",
      "['new article analysis', 'dna methylation reveals novel', 'epigenetic changes', 'chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['new article prognostic', 'predictive role', 'gene mutations', 'chronic lymphocytic leukemia results', 'pivotal phase iii study complement1 cll leusm hematology']\n",
      "['chronic lymphocytic leukemia cells', 'mitochondrial fitness', 'cd8 t cells']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['refractory chronic lymphocytic leukemia', 'clarity study']\n",
      "['ofatumumab maintenance', 'chronic lymphocytic leukemia leukemia']\n",
      "['review snapshot', 'date overview', 'adrian krainer', 'sciencetwitter medtwitter cll leusm lymsm']\n",
      "['cll specialist dr brian hill outlines', 'cll expert']\n",
      "['new ofatumumab maintenance', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll patients', 'early stage', 'treatment mayo clinic hematologist m b b s discusses', 'disease management']\n",
      "['chronic lymphocytic leukemia cll']\n",
      "['phase iii alpine trial', 'btk inhibitor ibrutinib', 'refractory cll', 'sll leukemia lymphoma']\n",
      "['chronic lymphocytic leukemia', 'pocket costs', 'pan grants']\n",
      "['ofatumumab maintenance', 'chronic lymphocytic leuke']\n",
      "['ofatumumab maintenance', 'chronic lymphocytic leukemia']\n",
      "['sll leukemia lymphoma reserve']\n",
      "['ofatumumab maintenance', 'chronic lymphocytic leukemia']\n",
      "['therapeutic additions', 'treatment paradigm', 'frontline setting leukemia james']\n",
      "['new article chronic lymphocytic leukemia', 'unusual cytoplasmic anomalies cll leusm hematology']\n",
      "['onkologisch b lymphozyten sind antik rper produzierende wei e blutzellen aus dem knochenmark bei bestimmten leuk mieformen wie der cll entstehen zu viele unreife und funktionslose lymphozyten worldcancerday gemeinsamgrenzenverschieben weltkrebstag']\n",
      "['ofatumumab maintenance', 'chronic lymphocytic leukemia']\n",
      "['small lymphocytic lymphoma chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['new cancer therapies', 'global imbruvica market cll chronic lymphocytic leukemia', 'tgtx abbv jnj umbralisib ibrutinib']\n",
      "['dr fakhri', 'optimal treatment', 'cll leukemia']\n",
      "['driver mutations', 'chronic lymphocytic leukemia impacts disease outcome']\n",
      "['association btwn notch1 mut response', 'complement trial mech', 'novel agents', 'cd20 cll lymsm']\n",
      "['driver mutations', 'chronic lymphocytic leukemia impacts disease outcome']\n",
      "['new holdings mpac']\n",
      "['clonoseq sales']\n",
      "['oncoalert idelalisib', 'follicular lymphoma', 'chronic lymphocytic leukemia cll', 'treatment outcomes', 'clinical trial participants vs medicare beneficiaries geriatrics jama oncology lymsm leusm geriheme']\n",
      "['sandra e kurtin phd anp c aocn discusses', 'retrospective study', 'line ibrutinib', 'agent use', 'early discontinuation', 'decision support tools', 'care approaches', 'video aps ash19']\n",
      "['recent advances', 'cll field', 'monthly newsletter', 'ash19 highlights hematology']\n",
      "['leukemia therapeutics market']\n",
      "['dr tam', 'captivate trial', 'chronic lymphocytic leukemia leusm']\n",
      "['manage treatment', 'adverse effects', 'refractory chronic lymphocytic leukemia cll review cases w dr jennifer woyach']\n",
      "['new article hypercalcemia', 'small lymphocytic lymphoma chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article richter s syndrome', 't cell lineage t rex lymphoma cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'manageable disease cll']\n",
      "[]\n",
      "['initial medication']\n",
      "['cll medicine', 'expert s perspective', 'dr alexeydanilov']\n",
      "['adaptive biotechnologies', 'medicare coverage', 'chronic lymphocytic leukemia adpt']\n",
      "['woyach md', 'james discusses', 'treatment paradigm', 'cll leukemia']\n",
      "['advertisement platform', 'current reward', 'cryptoliveleaktoken cll cll']\n",
      "['uk cll forum meeting', 'amp ulm', 'great opportunity', 'network registration']\n",
      "['scan results stochastic', 'pblt rdsb bats cll hcm capc polx rdsa brei mmx skmd cch ctec csn ddv1 phi']\n",
      "['don t', 'additional gains', 'rbd agfx teg', 'bitter sweet gain']\n",
      "['different forms cll aml cml', 'unique treatment']\n",
      "['cll trial leukemia']\n",
      "['car t', 'experimental option', 'patient story', 'mike boston', 'early car t trial']\n",
      "['woyach highlights progress', 'cll paradigm leukemia james']\n",
      "[]\n",
      "['cello health cll', 'new 12y high net cash', 'margins outlook board', 'full year result', 'market expectations', 'good chance', 'defensive sector fwd pe 15x']\n",
      "['adaptive biotechnologies', 'medicare coverage']\n",
      "['adpt adaptive biotechnologies', 'medicare coverage']\n",
      "['chronic lymphocytic leukemia cll']\n",
      "['initial medication']\n",
      "['chronic lymphocytic leukemia cll']\n",
      "['new article sortilin', 'novel diagnostic', 'therapeutic biomarker', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['doc mentions chronic lymphocytic leukemia', 'isn t', 'common bizarre']\n",
      "['clinical setting', 'clinical trials']\n",
      "['don t', 'exciting new updates', 'sll treatment', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma register']\n",
      "['scan results cup', 'expn fen ibt pgit maje idox brna dph mct aie cll ewi arc thrl carr genl']\n",
      "['cll treatment information', 'separate fact', 'fiction cll expert dr javier pinilla ibarz tackles', 'common questions']\n",
      "['cll expert dr javier pinilla ibarz', 'treatment regimen', 'important role', 'patient preference plays']\n",
      "['trabectedin targets leukemic cells', 'restores immune cell function', 'chronic lymphocytic leukemia', 'discovery interests', 'health medicine science marine leukemia']\n",
      "['frontline cll', 'ian w flinn', 'top articles', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukaemia cll eqas', 'ighv mutation status', 'survey cll ighv p53 eqa genomics']\n",
      "['dr woyach', 'elevate tn trial', 'cll leukemia james']\n",
      "['new article amplification', 'post translational modifications', 'urinary bladder urothelial carcinoma cll leusm hematology']\n",
      "['new article autoimmune hemolytic anemia', 'chronic myeloid leukemia', 'case report cll leusm hematology']\n",
      "['new article', 'residential exposure', 'industrial complexes', 'systematic review', 'exposure response meta analysis cll leusm hematology']\n",
      "['video tribute', 'friend bob azopardi']\n",
      "['final infusion i ll', 'oral chemo meds', 'i m', 'i ll', 'oncology nurses', 'wonderful professionals']\n",
      "['natural prevention', 'chronic lymphocytic leukemia']\n",
      "['scan results expansion breakout', 'mno avap ung cgnr spr arc ggp trin als demg inpp jsg vanl cll atym']\n",
      "['interesting story', 'car t patient', 'life cll clinicaltrials patientpoweredjournalism']\n",
      "['dr danielle brander', 'cll patients', 'treatment news']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['ash19 ryan jacobs md', 'javier pinilla ibarz md phd', 'chronic lymphocytic leukemia', 'captivate trial cll leuksm hematology']\n",
      "['1st translational research conference', 'cll march', 'paris eshcll2020 chairs j', 'brown p ghia m hallek submit', 'abstract scholarships']\n",
      "['amy pierre anp bc discusses', 'phase iii trial', 'new strategy', 'exposure time', 'cll video aps ash19']\n",
      "['mess blossom class', 'guess storyhook cll succesfulstudents welovebooks']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['initial medication']\n",
      "['promising cll research', 'clecliniccancer mdphd', 'ash19 leusm']\n",
      "['promising cll research', 'clecliniccancer mdphd', 'ash19 leusm']\n",
      "['chronic lymphocytic leukemia cll patient amp', 's journey', 'stem cell transplant']\n",
      "['line treatment', 'high rates', 'undetectable minimal residual disease', 'peripheral blood', 'bone marrow', 'chronic lymphocytic leukemia']\n",
      "['ibr r vs ibr rct cr predicts pfs', 'nice analysis', 'sure i ll', 'normal fbcs 12m', 'cll lymsm']\n",
      "['cll patients', 'social worker', 'cancer diagnosis cll patientpower']\n",
      "['initial medication']\n",
      "['chronic lymphocytic leukemia']\n",
      "['initial medication']\n",
      "['initial medication']\n",
      "['trabectedin targets leukemic cells', 'restores immune cell function', 'chronic lymphocytic leukemia']\n",
      "['cll panel', 'family members', 'future cll patientpower']\n",
      "['chronic lymphocytic leukemia', 'chronic lymphocytic leukemia cancer']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['study i', 'human clinical trial', 'chronic lymphocytic leukemia']\n",
      "['post ash review', 'important data', 'lymphoma myeloid cancers myeloma cart cll etc register']\n",
      "['international advisory board', 'opportunity i', 'hematology lymsm cll gerionc geriheme cardioonc immunoonc prom hrqol ehealth']\n",
      "['allogeneic transplant', 'chronic lymphocytic leukemia', 'historical experience peri transplant rituximab', 'relapse rates regardless', 'high risk cytogenetics']\n",
      "['clinical trial', 'cll treatment option', 'discusses clinical trial participation leusm cll cllsm bloodcancer']\n",
      "['cll causes', 'james expert dr kerry rogers leusm cllsm bloodcancer']\n",
      "['top stories', 'chronic lymphocytic leukemia', 'inhye e ahn md nhlbi william j archibald md nicole lamanna md ian w flinn md phd']\n",
      "['jeff p sharman md', 'elevate tn trial', 'annual meeting', 'exposition sharman']\n",
      "['dr woyach', 'frontline treatment options', 'cll leukemia james']\n",
      "['protumoral tam m2', 'non cr patients', 'possible new prognostic factor', 'ibrutinib response']\n",
      "['new article', 'complete remission', 'cll patients', 'ibrutinib clinical significance', 'predictive factors cll leusm hematology']\n",
      "['new article bruton tyrosine kinase deficiency augments nlrp3 inflammasome activation', 'causes il', 'colitis cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['yondelis leucemia trabectedin targets leukemic cells', 'restores immune cell function', 'chronic lymphocytic leukemia leukemia pharmamar yondelis trabectedin']\n",
      "['ash19 nicole lamanna md', 'term data', 'murano trial', 'hematology leukemia leuksm cll']\n",
      "['woyach md', 'alliance a041702 trial', 'annual meeting']\n",
      "['ash19 news car t therapy shows', 'mantle cell lymphoma amp chronic lymphocytic leukemia']\n",
      "['woyach md', 'alliance a041702 trial', 'chronic lymphocytic leukemia', 'ohio state university', 'comprehensive cancer center expert', 'alliance a041702 trial', 'annual meeting']\n",
      "['antiviral treatment', 'resistant influenza virus', 'h1n1 pdm09', 'chronic b lymphocytic leukemia']\n",
      "['new clinical trial dietary intervention', 'high phenolic evoo', 'cll cll leusm hematology']\n",
      "['new clinical trial study', 'therapeutic agents', 'cll sll cll leusm hematology']\n",
      "['dyk people', 'chronic lymphocytic leukemia cll', 'additional chemotherapy', 'free option']\n",
      "['trabectedin targets leukemic cells', 'restores immune cell function', 'chronic lymphocytic leukemia']\n",
      "['clinical setting', 'clinical trials']\n",
      "['frontline ibrutinib venetoclax combo', 'high rates', 'undetectable mrd', 'cll leukemia']\n",
      "['ibrutinib rituximab combo', 'pfs advantage', 'cll leukemia']\n",
      "['chronic lymphocytic leukemia', 'common leukemia', 'new cases', 'chroniclymphocyticleukemia cll', 'new cases']\n",
      "['novel triplet shows', 'cll leukemia']\n",
      "['happy new year', 'amazing time', 'recap crypto blockchain cryptonews cryptomedia', 'bitcoin tezos cll cll']\n",
      "['chronic lymphocytic leukemia', 'chronic lymphocytic leukemia cancer']\n",
      "['benefit cll patients', 'expert segment dr susan leclair', 'immune health', 'ivig infusion cll']\n",
      "['chronic lymphocytic leukemia', 'chronic lymphocytic leukemia cancer']\n",
      "['chronic lymphocytic leukemia']\n",
      "['btk inhibition', 'cll leukemia']\n",
      "['new article diagnosis', 'monoclonal b cell lymphocytosis mbl', 'transurethral resection', 'urinary tract symptoms cll leusm hematology']\n",
      "['new article multi fungal sepsis', 'central nervous system', 'case report', 'literature cll leusm hematology']\n",
      "['b cell chronic lymphocytic leukemia', 'cyclin d2', 'dna damage response proteins']\n",
      "['chronic lymphocytic leukemia cancer', 'treatment options']\n",
      "['happy new year', 'cll community']\n",
      "['ny lymphoma rounds', 'interesting case']\n",
      "['chronic lymphocytic leukemia', 'i m', 'polynesian samoan b i d', 'c i', 'birth mother d', 'amp meeting', 'samoan siblings e', 'new family']\n",
      "['chronic lymphocytic leukemia', 'chronic lymphocytic leukemia cancer']\n",
      "['cll experts dr michael', 'dr william wierda', 'cll care', 'global research foundation']\n",
      "['chronic lymphocytic leukemia', 'chronic lymphocytic leukemia cancer']\n",
      "['chronic lymphocytic leukemia', 'future rise', 'nationwide population', 'study hematolog']\n",
      "['btk inhibitors', 'chronic lymphocytic leukemia cll onclivecountsdown2019']\n",
      "['chronic lymphocytic leukemia']\n",
      "['cll community', 'health options', 'great things']\n",
      "['chronic lymphocytic leukemia', 'chronic lymphocytic leukemia cancer']\n",
      "['lyle nsker alle rigtig godt nyt r alt det bedste', 'fremtiden vi arbejder og er p', 'blodkr ft blodcancer patienter og', 'vi er den patientn r', 'som f lger alle', 'lymfekr ft leuk mi mds aml', 'cml cll cmml apl sundpol dksund']\n",
      "['new article pyoderma gangrenosum', 'chest tube placement', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article antecedent chronic lymphocytic leukemia', 'aggressive mycosis fungoides cll leusm hematology']\n",
      "['great year']\n",
      "['cns aspergillosis', 'chronic lymphocytic leukemia', 'line ibrutinib therapy', 'case reports', 'case series', 'invasive aspergillosis', 'invasive aspergillosis']\n",
      "['scan results cup', 'gvp dmgt ung aie eman bgs acc lsrg ttg cll cnc crwn brna ntbr jmat bpet']\n",
      "['original research papers radiation', 'high prevalence', 'chronic lymphocytic leukemia', 'b cell lymphomas', 'nuclear workers', 'alpha emitters case report']\n",
      "['dr richard furman', 'prognostic markers', 'chronic lymphocytic leukemia cll treatment', 'q amp']\n",
      "['dr anthony f daniyan', 'young investigator award', 'chronic lymphocytic leukemia leusm']\n",
      "['dr brander', 'ibrutinib venetoclax', 'cll leukemia onclivecountsdown2019']\n",
      "['don t', 'opportunity scholarships', 'available eshcll2020 eshscholarshipfund eshconferences cll haematology hematology']\n",
      "['susan o brien', 'phase iii multicenter elevate tn study', 'elderly patients', 'chronic lymphocytic leukemia lymsm cll ash19']\n",
      "['cns aspergillosis', 'chronic lymphocytic leukemia', 'line ibrutinib therapy', 'case reports', 'case series', 'invasive aspergillosis']\n",
      "['new year', 'lymsm breakthroughs i', 'therapies combos', 'negative responses']\n",
      "['proteomics insights', 'chronic lymphocytic leukemia']\n",
      "['emergent literacy', 'cache eye units', 'eytwittertagteam books readingforpleasure stories cll communication language']\n",
      "['cll leuk mie onkologie h matologie']\n",
      "['pml mabs cll', 'world s', 'dangerous viruses', 'anna deveaux msc']\n",
      "['clinical trial opportunities', 'open trial']\n",
      "['article reports', 'fantastic news', 'ventures bloodwise cll hope research clinicaltrials beatingbloodcancer']\n",
      "['cll story']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['mutational profile', 'classical prognosis factors lymsm cll']\n",
      "['prognostic value', 'baseline total metabolic tumor volume', 'fdg pet', 'richter syndrome cll leusm lymphoma']\n",
      "['dr seymour', 'year update', 'murano trial', 'cll leukemia ash2019 ash19']\n",
      "['herbal turmeric', 'natural prevention', 'chronic lymphocytic leukemia']\n",
      "['astrid pavlovsky', 'genetic characterization', 'patient treatment pathway', 'elevate trial lymsm ash19']\n",
      "['dr tam', 'captivate trial', 'cll leukemia ash2019 ash19']\n",
      "['promising treatments', 'cll patients w geroge', 'nhs cancertreatment patientcare bloodcancer']\n",
      "['new article', 'cns aspergillosis', 'chronic lymphocytic leukemia', 'line ibrutinib therapy cll leusm hematology']\n",
      "['new article prognostic impact', 'prevalent chronic lymphocytic leukemia', 'subsets analysis', 'prospective clinical trials', 'german cll study group gcllsg cll leusm hematology']\n",
      "['new article', 'dietary inflammatory index', 'chronic lymphocytic leukaemia', 'mcc spain study cll leusm hematology']\n",
      "['scan results cup', 'dmgt lsrg sepl pph genl csh aie cll rel', 'hsbk acc thrl mct ashm cpg']\n",
      "['scan results stochastic', 'bhi igr smj lsrg phsc att cll caml ful bp', 'brwm prtc synt fgt bvt']\n",
      "['telehealth platform', 'chronic lymphocytic leukemia', 'care management']\n",
      "['diagnosis i', 'lymphoma cancer', 'chronic lymphocytic leukemia need', 'blood test', 'treatment plan']\n",
      "['family proteins', 'critical role', 'chronic lymphocytic leukemia cll cells', 'new agents', 'pro survival protein members', 'leukemia amp lymphoma']\n",
      "['prognostic impact', 'prevalent chronic lymphocytic leukemia', 'subsets analysis', 'prospective clinical trials', 'german cll study group gcllsg']\n",
      "['herbal turmeric', 'natural prevention', 'chronic lymphocytic leukemia']\n",
      "['tanya siddiqi', 'transcend cll', 'phase i ii study', 'car t cell therapy lisocabtagene maraleucel', 'refractory chronic lymphocytic leukemia cll lymsm ash19']\n",
      "['s vigibase', 'global database', 'drug complications cancer researchers', 'clearer picture', 'chronic lymphocytic leukemia patients', 'frontline treatment', 'death rate']\n",
      "['new article prognostic value', 'baseline total metabolic tumor volume', 'fdg pet', 'richter syndrome cll leusm hematology']\n",
      "['risk assessment', 'cll leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['zanubrutinib induces platelet receptor', 'gpib ix v', 'integrin iib', 'humans blood advances american society', 'hematology lymsm cll lymphoma']\n",
      "['health care team', 'chronic cancer cancersupport chronic ncds cll chroniccancer']\n",
      "[]\n",
      "['cll amp blood tests experts dr farrukh awan', 'dr nicole lamanna', 'cll patients cll patientpower']\n",
      "['nuclear ribonucleoproteins', 'chronic lymphocytic leukemia', 'potential biomarkers', 'disease aggressiveness']\n",
      "['young patient', 'refractory cll', 'jacqueline barrientos', 'ash17 clinicaltrials noveltherapy ctsm leukemia leusm supponc relapse personalisedcare']\n",
      "['global chronic lymphocytic leukemia treatment market', 'players chronic lymphocyticleukemia treatment lymphoma leucemia']\n",
      "['science news b cell chronic lymphocytic leukemia treatment market', 'top players']\n",
      "['dr mato', 'cll14 trial results', 'cll leukemia']\n",
      "['hand access', 'patient progression', 'thay tgtx s u2 approval', 'foregone conclusion', 'full presentation ibrutinib', 'problem cll lymphoma lymsm']\n",
      "['nuclear ribonucleoproteins', 'chronic lymphocytic leukemia', 'potential biomarkers', 'disease aggressiveness']\n",
      "['cancer diagnosis cll patients', 'christian life coach', 'faith cll patientpower']\n",
      "['phase iii resonate pcyc', 'chronic lymphocytic leukemia', 'small lymphocytic ppt video online download']\n",
      "['btk elevate tn', 'cll sll']\n",
      "['chronic lymphocytic leukemia', 'non hodgkins lymphoma']\n",
      "['phase iii elevate tn trial', 'treatment na ve cll leusm lymsm']\n",
      "['chronic lymphocytic leukemia', 'horizon hope']\n",
      "['new clinical trial duvelisib', 'resistant chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll leusm hematology']\n",
      "['new clinical trial', 'non hodgkin lymphoma', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['phase i study', 'japanese patients', 'treatment na ve chronic lymphocytic leukemia', 'small lymphocytic lymphoma lymphoma lymsm']\n",
      "['new article ibrutinib', 'zanubrutinib induces platelet receptor', 'gpib ix v', 'integrin iib', 'humans cll leusm hematology']\n",
      "['new article', 'total organic carbon', 'soil carbon pools', 'different land management systems', 'garo hills meghalaya cll leusm hematology']\n",
      "['new article phase i study', 'japanese patients', 'treatment na ve chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll leusm hematology']\n",
      "['new article parameter noise', 'tree topology', 'tumor phylogeny inference cll leusm hematology']\n",
      "['fungal infections', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia therapeutics market analysis', 'recent market developments industry']\n",
      "['medical care', 'chronic lymphocytic leukemia', 'teresa smrecansky']\n",
      "['cll patient dave kasanicky', 'caregiver lynnda talk', 'cancer cll patientpower']\n",
      "['frontline ibrutinib venetoclax combo', 'high rates', 'undetectable mrd', 'cll leukemia']\n",
      "['happy holidays', 'faculty staff', 'winter recess', 'thursday jan', 'escnj cll']\n",
      "['own dr brian koffman', 'forces podcast', 'demetri kofinas', 'cll cllsm letscurethis']\n",
      "['valuable information', 'cll patients', 'caregivers novel', 'bispecific t cell engager immunotherapy', 'hematologic malignancies']\n",
      "['ibrutinib rituximab combo', 'pfs advantage', 'cll leukemia']\n",
      "['dr davids', 'cost effectiveness', 'venetoclax obinutuzumab', 'cll leukemia']\n",
      "['btk inhibitor', 'similar efficacy', 'bottom line', 'reasonable competitive price points', 'oncopharm twitterx hemoncrx']\n",
      "['thoracic aortic dissection', 'small lymphocytic lymphoma chronic lymphocytic leukemia', 'risk factor lymphoma lymsm']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['new article thoracic aortic dissection', 'small lymphocytic lymphoma chronic lymphocytic leukemia', 'risk factor cll leusm hematology']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['new article angioedema', 'systemic disease cll leusm hematology']\n",
      "['van oers', 'blood cancer journal', 'final analysis', 'ofatumumab maintenance', 'large pfs advantage', 'os advantage', 'hasn t', 'follicular lymphoma lymsm']\n",
      "['interesting review', 'major series', 'tls post ven', 'review articles cll lymsm']\n",
      "['novel triplet shows', 'cll leukemia']\n",
      "['common leukemia', 'new cases', 'new cases', 'details visit']\n",
      "[]\n",
      "[]\n",
      "['btk inhibition', 'cll leukemia']\n",
      "['response rate', 'treatment naive 17p deletion cll']\n",
      "['renowned cll amp mcl experts', 'patient power', 'treatment research', 'disease management strategies ash19 ash2019 cll mcl patientpower']\n",
      "['cll immunology review', 'btk inhibitors work t lymphocytes rx resistance', 'effective immunotherapy', 'cll cll apoptosis immunology nhlbi']\n",
      "['new article', 'inhibitor gs', 'targets chronic lymphocytic leukemia cells', 'supportive microenvironment cll leusm hematology']\n",
      "['new article', 'aptamer sirna', 'chronic lymphocytic leukaemia cells cll leusm hematology']\n",
      "['new article', 't cells', 'effective immunotherapy', 'cll cll leusm hematology']\n",
      "['oncoalert idelalisib', 'follicular lymphoma', 'chronic lymphocytic leukemia cll', 'treatment outcomes', 'clinical trial participants vs medicare beneficiaries lymsm']\n",
      "['chronic lymphocytic leukemia medication', 'couldn t', 'shouldn t', 'healthcare system', 'medication treatment']\n",
      "['cll cll']\n",
      "['medicare beneficiaries gt', 'w follicular lymphoma fl amp chronic lymphocytic lymphoma cll', 'w idelalisib rituximab', 'unfavorable imbalances vs pts', 'clin trials amp show', 'clinical outcomes hemecsm']\n",
      "['haploidentical allo bmt', 'donor allo bmt', 'chronic lymphocytic leukemia cll post transplantation cyclophosphamide prophylaxis', 'low rates', 'chronic gvhd']\n",
      "['follicular lymphoma', 'cll leusm lymphoma']\n",
      "['response rate', 'treatment naive 17p deletion cll']\n",
      "['new article', 'practical management', 'tumour lysis syndrome', 'chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['new article hepatitis c virus', 'extrahepatic malignancies', 'case control study cll leusm hematology']\n",
      "['new article mechanism', 'neuroprotective effect', 'brain cells', 'animal model', 'parkinson s disease cll leusm hematology']\n",
      "['follicular lymphoma', 'chronic lymphocytic leukemia', 'treatment outcomes', 'clinical trial participants vs medicare beneficiaries lymphoma lymsm']\n",
      "['regular blood transfusions', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll']\n",
      "['new chronic lymphocytic leukemia drugs ash', 'new chronic lymphocytic leukemia drugs']\n",
      "['holiday fun check', 'nuview academy', 'special visit', 'snowman escnj nuview cll']\n",
      "['transcend cll', 'study lymphoma hub leusm']\n",
      "['healthy cells', 'targetedtherapies work', 'cancer cells', 'cell growth']\n",
      "['response rate', 'treatment naive 17p deletion cll']\n",
      "['por siempre tu alegr', 'tambi n y si lloras tambi n estar ah hermanito vivan los payasos perez instaclown cll chileluchalibre luchalibrechilena instachile payasos estoeslucha']\n",
      "['cll dr kerry rogers', 'james reviews', 'common theories', 'cll causes leusm cll cllsm bloodcancer']\n",
      "['i highlight patientstories i', 'doug s story', 'chronic lymphocytic leukemia cll cartcell celltherapy']\n",
      "['monsanto roundup cancer lawsuits charge', 'glyphosate causes cancer non hodgkin lymphoma nhl chronic lymphocytic leukemia cll', 'sub types']\n",
      "['chronic lymphocytic leukemia']\n",
      "['cancer non hodgkin lymphoma', 'large diffuse b cell follicullar lymphoma cutaneous t cell anapalastic t cell chronic lymphocytic leukemia', 'small lymphocytic lymphoma mantle cell lymphoma primary', 'central nervous system cns lymphoma']\n",
      "['non hodgkin s lymphoma nhl chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma', 'non hodgkin s lymphoma']\n",
      "['efficacy results', 'line idelalisib', 'chronic lymphocytic leukemia']\n",
      "['scholar award', 'lineage transformation', 'aggressive large b cell lymphoma ashawards cll singlecell epigenetics']\n",
      "['breakout level', 'p e', 'small net cash health']\n",
      "['practical management', 'tumour lysis syndrome', 'cll leusm']\n",
      "['chromatin accessibility', 'transcription profiles cll use case']\n",
      "['real world', 'idel trial study', 'follicular lymphoma', 'chronic lymphocytic leukemia cll lymphoma rcts rwe fda']\n",
      "['btk inhibitors', 'refractory settings leukemia']\n",
      "['vi nsker alle', 'rigtig gl delig jul og lykkebringende godt nyt r f lg os og vi er', 'dig mange hilsner fra lyle dk bestyrelse d lymfekr ft leuk mi mds cml cll', 'aml cmml dk blodcancer blodkr ft']\n",
      "['new article implementation', 'classification strategy', 'raman data', 'different clinical conditions application', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'human phase i study', 'dual mtor kinase', 'dna pk inhibitor cc', 'malignancy cll leusm hematology']\n",
      "['new article idelalisib', 'follicular lymphoma', 'chronic lymphocytic leukemia', 'treatment outcomes', 'clinical trial participants vs medicare beneficiaries fl lymsm hematology']\n",
      "['registration fee', 'available 1st translational research conference chronic lymphocytic leukaemia march', 'information haematology hematology cll']\n",
      "['gastrointestinal involvement', 'chronic lymphocytic leukemia']\n",
      "['response rate', 'treatment naive 17p deletion cll']\n",
      "['follicular lymphoma', 'chronic lymphocytic leukemia thewiderwiserview']\n",
      "['congrats lab amp cll exerciseoncology hematology']\n",
      "['interim clinical data', 'dose escalation trial', 'b cell leukemias', 'american society hematology', 'annual meeting responses', 'dose levels', 'chronic lymphocytic leukemia cll', 'mantle cell']\n",
      "['scholar award', 'chronic lymphocytic leukemia ashawards cll exerciseoncology']\n",
      "['cll symptoms']\n",
      "['chronic lymphocytic leukemia watchful', 'safest approach', 'care check', 'survivor s story']\n",
      "['new clinical trial nivolumab', 'refractory hematologic malignancies cll leusm hematology']\n",
      "['new article', 'ighv gene identity', 'optimal cutoff', 'chinese patients', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'new treatment', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article investigation', 'conformational dynamics', 'tyr89cys mutation', 'familial melanoma cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['tenalisib rp6530', 'refractory chronic lymphocytic leukemia cll status', 'condition summary leukemia lymphocytic chronic b cell']\n",
      "['chimeric antigen receptor t cell therapy', 'refractory chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'molica hematological oncology wiley online library']\n",
      "['btk inhibition', 'cll anthony r mato md msce discusses', 'recent treatment advances', 'relapsedrefractory settings', 'chronic lymphocytic leukemia']\n",
      "['video discussions']\n",
      "['renowned experts', 'important takeaways', 'cll patients dr brian hill dr matthew davids', 'dr nicole lamanna', 'promising clinical trial data', 'research news cll']\n",
      "['chronic lymphocytic leukemia people']\n",
      "['clinicaltrial efficacy', 'tenalisib rp6530', 'refractory chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukemia cll']\n",
      "['btk inhibition', 'cll leukemia']\n",
      "['pan canadian pharmaceutical alliance pcpa', 'combination venclexta', 'chronic lymphocytic leukemia cll']\n",
      "['dr kanti rai']\n",
      "['top stories', 'treatment discontinuation', 'dr isabel cunningham']\n",
      "['loxo305 clinical trial', 'oral reversible inhibitor', 'cll amp lymphoma', 'center amp']\n",
      "['cytogenetic landscape', 'chronic lymphocytic leukemia abstract']\n",
      "['con quien te mire como tony pogo mira', 'chaky cll clown kajjsjaj perez instaclown payasosasesinos instachile', 'luchalibrechilena chileluchalibre cll estoeslucha payasos clown elclan']\n",
      "['dr neha godiwala goyal', 'emotional ups', 'downs cll patients']\n",
      "['new clinical trial efficacy', 'tenalisib rp6530', 'refractory chronic lymphocytic leukemia cll cll leusm hematology']\n",
      "['didn t', 'autophagy leukaemiaresearch paper', 'andrew steele s lab', 'work bcr', 'autophagy regulation', 'chronic lymphocytic leukemia']\n",
      "['new article cd19', 'car t cell immunotherapy outcomes correlate', 'genomic modification', 'vector integration cll leusm hematology']\n",
      "['new article', 'methylprednisolone premedication', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article mantle cell lymphoma', 'radical prostatectomy', 'prostate adenocarcinoma', 'case report cll leusm hematology']\n",
      "['new article', 'xenograft protocol', 'chronic lymphocytic leukemia results', 'high engraftment efficiency', 'cll subgroups cll leusm hematology']\n",
      "['chronic lymphocytic leukemia cll medlineplus']\n",
      "['dr charles berry', 'geriatric clinic cancermoonshot endcancer']\n",
      "['diagnosis amp treatment', 'chronic lymphocytic leukemia cll']\n",
      "['new research cationic amino acid transporter', 'arginine uptake', 'chronic lymphocytic leukemia cell proliferation', 'tumor metabolism']\n",
      "['scan results', 'star candlestick', 'ppc usfp bmv vin fsta grid cldn mcl aug hlcl iksa hlma iom epic sim cll']\n",
      "['term minimal residual disease mrd', 'cll patients', 'leusm cll cllsm bloodcancer']\n",
      "['chronic lymphocytic leukemia', 'cll genetics', 'signs amp symptoms']\n",
      "['cll symptoms', 'dr kerry rogers', 'james leusm cll cllsm bloodcancer']\n",
      "['cll expert dr william wierda', 'md anderson cancer center', 'patient power', 'treatment side effect management']\n",
      "['wouldn t mind', 'face masks', 'right leukaemia cll bloodcancer spotleukaemia leavingonajetplane airtransat canadaherewecome']\n",
      "['sigo testigo', 'transforac n del arbol qie est detr s', 'mi ventana ya casi', 'tiene hojas chemotherapy cll texas oncology plano presby']\n",
      "['lifelong learning s', 'annual winter concert', 'winter dreams check', 'faces escnj cll']\n",
      "['new article interferon gamma inducible protein', 'ifi16 expression', 'mantle cell lymphoma cll leusm hematology']\n",
      "['new article', 'treatment options', 'p53 pathway deficient cll cll leusm hematology']\n",
      "['new article alexia', 'initial manifestation', 'progressive multifocal leukoencephalopathy', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia', 'hemorrhagic brain masses', 'sepsis cll leusm hematology']\n",
      "['rare cancer', 'middle age']\n",
      "['retweet certhellas rt vjhemonc video bcr receptor sterotypes', 'cll w kostas stamatopoulos', 'certhellas vjhemonc iwcll iwcll2019 cllsm leusm']\n",
      "['y que van hacer enanos cuando regrese wrestler', 'prowrestler chileanswrestler luchalibre luchalibrechilena cll chileanswrestler aaa likeforlikes luchalibre luchalibrechilena']\n",
      "['cll patients', 'severe leukocytosis wbc', 'k cu mm', 'sepsis i', 'hematology cll lymphoma leukostasis leukocytosis']\n",
      "['web site', 'chronic lymphocytic leukemia']\n",
      "['royal marsden', 'regular tests amp consultation', 'good news', 'wasn t', 'bad news i m', 'holidays leukaemia cll bloodcancer spotleukaemia']\n",
      "['informative review', 'non chemotherapeutic treatment', 'cll cllsm', 'dr catherine coombs', '3d demonstration']\n",
      "['jonathan ferland', 't nomm entra neur chef', 'l quipe', 'hockey masculin d2 des faucons du c gep', 'l vis lauzon cll faucons rseq hockey']\n",
      "['dr danilov', 'rituximab biosimilars', 'cll biosimilar leukemia']\n",
      "['new therapy', 'adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'subsequent therapy']\n",
      "['legendary dr kanti rai', 'recent advances', 'cll dr rai', 'lifetime achievement']\n",
      "['dream team', 'cll patients ty']\n",
      "['press release', 'tox profile', 'cll trial']\n",
      "['chronic lymphocytic leukemia cll', 'common types', 'lynn s story']\n",
      "['sara tinsley phd aprn aocn discusses btk inhibitors', 'allogeneic hematopoietic sct', 'venetoclax video aps ash19']\n",
      "['new article comparison', 'oral selenium compounds', 'cancer patients evaluation', 'differential pharmacodynamic', 'malignant cells cll leusm hematology']\n",
      "['new article', 'genetic polymorphisms', 'b cell cll lymphoma', 'confer susceptibility', 'antituberculous therapy', 'liver injury cll leusm hematology']\n",
      "['venetoclax chemotherapy', 'free combination regimen', 'chronic lymphocytic leukemia']\n",
      "['foam fun', 'mark making skills successfulstudents concentration cll ead']\n",
      "['s marsden day', 'leukaemia cll bloodcancer royalmarsden nhs']\n",
      "['leukemia amp lymphoma', 'new article induction', 'chronic lymphocytic leukemia cells']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['dr eradat', 'rituximab biosimilar', 'cd20 b cell non hodgkin lymphoma', 'cll leukemia']\n",
      "['dr smith', 'duration trial', 'ibrutinib venetoclax', 'cll leukemia']\n",
      "['complete resolution', 'chronic lymphocytic leukemia']\n",
      "['marrow transplantation', 'post transplant cyclophosp']\n",
      "['inositol phosphatase contributes', 'chronic lymphocytic leukemia survival', 'b cell differentiation']\n",
      "['web site', 'chronic lymphocytic leukemia']\n",
      "['marrow transplantation', 'post transplant cyclophosphamide', 'chronic lymphocytic leukemia medivizor']\n",
      "['marrow transplantation', 'post transplant cyclophosphamide']\n",
      "['refractory chronic lymphocytic leukemia cll clinical trials', 'companies drugs phases subjects', 'current status', 'global clinical trial report', 'refractory chronic lymphocytic']\n",
      "['marrow transplantation', 'post transplant cyclophosphamide']\n",
      "['top story', 'marrow transplantation', 'post transplant cyclophosphamide', 'chronic lymphocytic leukemia medivizor']\n",
      "['recomendamos el material', 'con kari vega vega una deportista total defiende los colores del guma', 'basquet y f tbol campeona', 'con cll y m xima artillera del']\n",
      "['marrow transplantation', 'post transplant cyclophosphamide leukemia']\n",
      "['elderly onset crohns', 'malignancy cll part']\n",
      "['elderly onset crohns', 'malignancy cll part']\n",
      "['new article myelin uncompaction', 'axo glial detachment', 'chronic ataxic neuropathy', 'monospecific igm antibody', 'ganglioside gd1b cll leusm hematology']\n",
      "['new article correction bidirectional linkage', 'b cell receptor', 'chronic lymphocytic leukemia', 'richter s syndrome therapeutic implications cll leusm hematology']\n",
      "['new article overexpression', 'inositol phosphatase contributes', 'chronic lymphocytic leukemia survival cll leusm hematology']\n",
      "['top story', 'marrow transplantation', 'post transplant cyclophosphamide', 'chronic lymphocytic leukemia medivizor']\n",
      "['marrow transplantation', 'post transplant cyclophosphamide']\n",
      "[]\n",
      "['marrow transplantation', 'post transplant cyclophosphamide']\n",
      "['double blow', 'chronic lymphocytic leukemia ash19']\n",
      "['oncoalert ibrutinib', 'salvage therapy', 'allogeneic hct', 'chronic lymphocytic leukemia cll bone marrow transplantation lymsm cllsm leusm bmtsm']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['mis redes sociales facebook o instagram y estar s participando por una', 'dos entradas individuales para el ltimo e vento del', 'o cll chileluchalibre']\n",
      "['b cell chronic lymphocytic leukemia clinical trials', 'companies drugs phases subjects', 'current status', 'global clinical trial report', 'b cell chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'ph balance', 'nutritional therapy']\n",
      "['year analysis', 'murano study confirms', 'venetoclax rituximab venr', 'refractory r r chronic lymphocytic leukemia cll blood american society']\n",
      "['emotional toll']\n",
      "['salvage therapy', 'allogeneic hct', 'chronic lymphocytic leukemia']\n",
      "['new article preclinical evaluation', 'novel ship1 phosphatase activator', 'malignant b cells cll leusm hematology']\n",
      "['adv ref cll', 'novel drugs', 'advancements shouldn t', 'access issue', 'countries sharman']\n",
      "['chronic lymphocytic leukemia cll mayo clinic']\n",
      "['blood cancer', 'rick simpson oil', 'hey ur', 'remission tho']\n",
      "['i summarise', 'select abstracts', 'dlbcl lymsm', 'rare opportunity i']\n",
      "['drug combination benefits patients']\n",
      "['real world data research shows', 'economic adverse effects burden', 'chronic lymphocytic leukemia cll research', 'james kaye', 'ash2019 hematology']\n",
      "['double blow', 'chronic lymphocytic leukemia ash19']\n",
      "['bone marrow cancer chronic lymphocytic leukemia cll', 'drug combination', 'current standard', 'recent study']\n",
      "['cationic amino acid transporter', 'arginine uptake', 'chronic lymphocytic leukemia cell proliferation']\n",
      "['sara tinsley phd aprn aocn discusses study findings', 'responsive patients', 'allogeneic hsct', 'effective strategies', 'durable responses ash19']\n",
      "['global education platform', 'clinical updates', 'lymphoma subtypes amp chronic lymphocytic leukemia cll', 'weren t', 'days lymsm']\n",
      "['ash19 data', 'clinical practice okosun', 'alexey danilov summarise', 'highlights incl', 'phoenix transcend nhl', 'elevate tn', 'murano trials', 'download slides']\n",
      "['new clinical trial', 'japanese participants', 'refractory chronic lymphocytic leukemia', 'small lymphocytic leukemia cll leusm hematology']\n",
      "['mbl trisomy', 'green dots', 'il2 dsp30 nuclei', 'normal flow citometry', 'clonal b cells cll fish karyotypesstillalive']\n",
      "['natural killer cells', 'obinutuzumab versus', 'immortal warriors chronic lymphocytic leukemia cells', 'xerxes army lymphoma lymsm']\n",
      "['natural killer cells', 'obinutuzumab versus', 'immortal warriors chronic lymphocytic leukemia cells', 'xerxes army', 'mu oz r n jera mj feliu j ant n rem rez j ramalle g mara e', 'n gorricho r p']\n",
      "['new article oxidative stress', 'cll patients', 'th9 cells', 'comprehensive survey cll leusm hematology']\n",
      "['new article', 'active antiretroviral therapy', 'human immunodeficiency virus type', 'cll leusm hematology']\n",
      "['new article', 'chronic lymphocytic leukemia', 'pancreatic involvement cll leusm hematology']\n",
      "['new article', 'central nervous system involvement', 'small lymphocytic lymphoma', 'embolic event cll leusm hematology']\n",
      "['new article battle', 'natural killer cells', 'obinutuzumab versus', 'immortal warriors chronic lymphocytic leukemia cells', 'xerxes army cll leusm hematology']\n",
      "['new article', 'gene expression signature identifies', 'short survival', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'bone marrow', 'white blood cell book', 'drmanojkumarsharma oncologist cancerspecialist chroniclymphocyticleukemia bonemarrow']\n",
      "['notch1 activation correlates', 'chronic lymphocytic leukemia']\n",
      "['uk cll forum ibrutinib data w george', 'nhs iwcll2019 cllsm leusm leukemia']\n",
      "['carol amp', 's story chronic lymphocytic leukemia']\n",
      "['impact treatment', 'care dr kerry rogers', 'leusm cll cllsm bloodcancer']\n",
      "['scan results macd bearish centerline cross', 'rbg zioc reci nah svt uanc att mrl sspg meri xtr boo bor cll pdl rec']\n",
      "['b cell chronic lymphocytic leukemia', 'miniature american eskimo dog']\n",
      "['twodrug combination benefits patients', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll', 'common leukemia', 'adults visit', 'cll fund', 'medicare patients', 'eligibility amp']\n",
      "['apsho member sandra e kurtin phd anp c aocn examines', 'retrospective study', 'line ibrutinib', 'states ash19']\n",
      "['ash19 data', 'kay shows', 'substantial economic burden', 'medicare patients', 'chronic lymphocytic leukemia']\n",
      "['great meeting book', 'lymsm cll']\n",
      "['complaint otis chapman', 'chronic lymphocytic leukemia', 'herbicide roundup']\n",
      "['new clinical trial donor stem cell transplant', 'treosulfan fludarabine', 'body irradiation', 'hematological malignancies cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'common types', 'new cases', 'survivor talk', 'cll diagnosis']\n",
      "['double blow', 'chronic lymphocytic leukemia ash19']\n",
      "['early symptoms', 'chronic lymphocytic leukemia', 'cll rt', 'disease progresses']\n",
      "['drug combination benefits patients', 'chronic lymphocytic leukemia cll combinationtherapy']\n",
      "['i m', 'common play', 'patient amp care partner patients', 'negative feelings', 'ways care partners', 'medical team']\n",
      "['dr pipa n', 'fanca expression', 'bad prognosis indicator', 'chronic lymphocytic leukemia ciemat']\n",
      "['vet j b cell chronic lymphocytic leukemia', 'miniature american eskimo dog', 'submandibular prescapular', 'popliteal lymph nodes', 'blood analysis', 'regenerative anemia amp']\n",
      "['new article', 'drug combination benefits patients', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article cationic amino acid transporter', 'arginine uptake', 'chronic lymphocytic leukemia cell proliferation', 'viability cll leusm hematology']\n",
      "['new article association', 'grp78 hif', 'bag3 expression', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article adult peripheral blood', 'umbilical cord blood nk cells', 'good sources', 'effective car therapy', 'positive leukemic cells cll leusm hematology']\n",
      "['don t', 'opportunity submit', 'eshcll2020 1st translational research conference chronic lymphocytic leukaemia march', 'cll chairs j', 'brown p ghia m hallek submit']\n",
      "['top hashtags', 'ash19 american society', 'hematology orlando u s', 'users amp', 'tweets myeloma mmsm aml lymphoma sicklecell hematology lymsm leusm cartcell cll cart leukemia bloodcancer multiplemyeloma mds bmtsm cancer mpnsm hemophilia']\n",
      "['lifelong learning cll', 'mrei introduces', 'necessary skills', 'personal income expenditure', 'optimum utilization register']\n",
      "['las gumarelas se consagran campeonas tambi n del clausura', 'huerta festejaron un nuevo t tulo donde lo ganaron', 'punta felicitaciones chicas cll']\n",
      "['chronic lymphocytic leukemia epigenetics cancer immunology leukemia']\n",
      "['team cll']\n",
      "['superior progression', 'free survival', 'chronic lymphocytic leukemia']\n",
      "['drug combination', 'refractory chronic lymphocytic leukemia cll ash19']\n",
      "['chronic lymphocytic leukemia affects', 's story', 'video testimonial']\n",
      "['texas cities', 'departure dates', 'lrd aus cll grk', 'maf connections']\n",
      "['video captivate ibrutinib venetoclax delivers', 'cll w constantine tam', 'leusm hemeonc ash19 hematology']\n",
      "['i ve', 'i m', 'oncology appointment i m', 'chronic lymphocytic leukemia condition']\n",
      "['cll symptoms', 's fact', 's fiction dr kerry rogers', 'james shares', 'truth leusm cll cllsm bloodcancer']\n",
      "['novel comorbidity score', 'chronic lymphocytic leukemia oncology times']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['dr pamela crilley chair', 'ctca department', 'medical oncology', 'leukemia research', 'ash19 cll']\n",
      "['jeff folloder', 'cll expert dr edward faber', 'treatment strategies']\n",
      "['communiqu intersyndical', 'national des organisations syndicales snu fsu cgt fo', 'sud solidaires', 'l che rien o sont', 'snap l unsa cll avec']\n",
      "['chronic lymphocytic leukemia cll amp', 'small cell lymphoma scl', 'research team', 'dr john byrd', 'faculty appt']\n",
      "['line treatment', 'high rates', 'undetectable minimal residual disease', 'peripheral blood', 'bone marrow', 'chronic lymphocytic leukemia']\n",
      "['arm c', 'phase iii sequoia trial', 'treatment naive patients', 'del 17p cll sll leukemia lymphoma cll sll ash2019 ash19']\n",
      "['tp53 gene promoter methylation', 'chronic lymphocytic leukemia pathogenesis']\n",
      "['amazing talk', 'cll evolution post transplant', 'agent era']\n",
      "['cardiff conference', '23rd january', 'psychological support amp', 'amp meet others', 'cll amp', 'developments amp resources', 'leukaemia bloodcancer haematology wales']\n",
      "['current therapies', 'immune cell defects', 'immune system', 'cancer immunemodulation macrophages trail tnf tams mdscs']\n",
      "['dana farber s commitment', 'oncologists catherine gutierrez', 'current md phd student', 'dr cathy wu s lab']\n",
      "['cardiff conference 23rd january', 'professor chris fegan consultant haematologist school', 'medicine cardiff university', 'cll haematology bloodcancer wales']\n",
      "['tp53 gene promoter methylation impacts chronic lymphocytic leukemia chronic lymphocytic leukemia cll']\n",
      "['mrd er meget omtalt p ash19 og kemofri behandlinger', 'cll patienter sundpol dksund blodkr ft blodcancer lyle dk']\n",
      "['chronic lymphocytic leukemia ibrutinib', 'risk factor', 'atrial fibrillation wonder', 'severe htn']\n",
      "['phase ii study', 'vitamin d', 'early stage chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll blood american society']\n",
      "['new article inhibition', 'extra terminal proteins increases sensitivity', 'chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['new article impact', 'tp53 gene promoter methylation', 'chronic lymphocytic leukemia pathogenesis', 'progression cll leusm hematology']\n",
      "['new article', 'chronic lymphocytic leukemia', 'jak2 stat3 pathway', 'cll cell death', 'protective bone marrow microenvironment cll leusm hematology']\n",
      "['new article', 'effective quantification', 'tyrosine kinase inhibitors', 'human plasma', 'lc ms ms method', 'potent phospholipids', 'procedure application', 'therapeutic drug', 'cll leusm hematology']\n",
      "['incomplete blood', 'overall response cll sll lymphoma leukemia ash19 ash2019']\n",
      "['effective therapy', 'annual meeting']\n",
      "['full length transcript characterization', 'sf3b1 mutation', 'chronic lymphocytic leukemia reveals downregulation']\n",
      "['long term cll data', 'murano trial']\n",
      "['alpha37 212pb nnv003', 'alpha therapy', 'positive b cell chronic lymphocytic leukemia cll', 'non hodgkin lymphoma nhl', 'amal saidi phd plano texas usa']\n",
      "['tumor suppressor gene tp53', 'chronic lymphocytic leukemia', '17p genetic mutation memorial sloan', 'cancer center disabilityinfo zusia']\n",
      "['lymsm influencer']\n",
      "['cll leusm']\n",
      "['incident cardiovascular events', 'ibrutinib initiation', 'lymphoid malignancy patients cll hemetwitter']\n",
      "['health monitor magazine', 'chronic lymphocytic leukemia']\n",
      "['scan results cup', 'zoo bowl macf idox upgs fif ukcm shb amer cll eqn pshd scin ebox vct mnks']\n",
      "['scan results', 'zoo idox aht aas rhim fcrm ovb cll bvc uog jlp obd ark dotd mrw gvc']\n",
      "[]\n",
      "['vor wenigen minuten endete', 'orlando der ash2019 erstmals berichtet das lymphome', 'der reihe lymphomkompetenz kompakt mit kurzen videoberichten von diesem kongress lymphome cll myelom cartcells gru wort']\n",
      "['mrs foley', 'proud quartet thinkofabetterway']\n",
      "['dr seymour', 'year update', 'murano trial', 'cll leukemia ash2019 ash19']\n",
      "['effective therapy', 'annual meeting']\n",
      "['resistant clones', 'chronic lymphocytic leukemia patients', 'cll research ash19']\n",
      "['chronic lymphocytic leukemia cll']\n",
      "['combination data', 'cll patients', 'captivate study']\n",
      "['ash19 highlights amy pierre anp bc discusses cll', 'alliance trial', 'ibrutinib obinutuzumab']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['dr tam', 'captivate trial', 'cll leukemia ash2019 ash19']\n",
      "['marie benz md faad murano study confirms', 'venetoclax rituximab', 'refractory chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll visit', 'helpful tools', 'resources ash19']\n",
      "['cll ash19']\n",
      "['ash2019 ash19 cll pml lymphoma monoclonal antibodies', 'anna deveaux msc']\n",
      "['interesting abstract', 'gene expression', 'progresi n', 'gonzalo blanco poster3027 ash2019 lymphoidmalignancies imim cll translationalhematology pau hospitaldelmar vhebron']\n",
      "['chronic lymphocytic leukemia market', 'robust pace', 'news pharma pharmiweb']\n",
      "['objective response rate', 'complete rate', 'cll leukemia ash2019 ash19']\n",
      "['gene expression', 'cytokine analyses identify markers', 'monoclonal b cell lymphocytosis', 'chronic lymphocytic leukemia blood american society']\n",
      "['b cell chronic lymphocytic leukemia', 'miniature american eskimo dog lymphoma lymsm']\n",
      "['objective response rate', 'leukemia ash2019 ash19']\n",
      "['new article b cell chronic lymphocytic leukemia', 'miniature american eskimo dog cll leusm hematology']\n",
      "['s god', 'kommer sj ldent til cll leuk mi patienter blodcancer blodkr ft lyle dk']\n",
      "['new cases', 'new cases', 'details visit']\n",
      "['genentech announces', 'venclexta clinical trials', 'genentech clinicaltrial venclexta murano cll rituxan abbvie']\n",
      "['precision medicine pipeline', '7b arqule', 'merck access', 'arqule s lead pipeline product arq', 'targets b cell cancers', 'non hodgkin lymphoma', 'chronic lymphocytic leukemia']\n",
      "['cartcell therapy liso cel', 'promising clinical activity', 'manageable toxicity', 'high risk cll', 'ibrutinib leukemia lymphoma ash2019 ash19']\n",
      "['great time', 'rwe cartcell', 'cll session', 'hematology ash2019']\n",
      "['hall b level', 'poster presentation', 'blanca espinet', 'analysis versus genomic microarrays', 'chronic lymphocytic leukemia cll patients']\n",
      "['btk inhibitor zanubrutinib', 'overall response rates', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma regardless', 'high risk cytogenetics cll sll ash2019 ash19']\n",
      "['cll ash2019']\n",
      "['ash2019 cll cllsm']\n",
      "['aurora research institute', 'new clinical trials', 'potential therapies', 'chronic lymphocytic leukemia', 'huge potential']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['t cell function', 'chronic lymphocytic leukemia', 'hall b']\n",
      "['richter syndrome', 'clare gould', 'piers blombery', 'present poster', 'wilson grant', 'lymsm ash19']\n",
      "['ash19 posters', 'combination trials', 'j exp']\n",
      "['ash19 attendees', 'hall b', 'poster presentation', 'analysis versus genomic microarrays', 'chronic lymphocytic leukemia cll patients', 'blanca espinet']\n",
      "['own dr', 'chronic lymphocytic leukemia cll video', 'view dr shadman s', 'ash19 activity', 'cll leukemia']\n",
      "['new approaches', 'manage treatment side', 'cll leukemia hematology bloodcancers']\n",
      "['interesting session', 'chemo immunotherapy', 'point counterpoint format']\n",
      "['chronic lymphocytic leukemia', 'blood cancer', 'bone marrow', 'adults ash19 leusm']\n",
      "['bloodcancer research', 'hasn t', 'chronic lymphocytic leukemia', 'wife kids grandkids', 'great grandkids']\n",
      "['innovative work', 'blood cancers', 'aml ash19']\n",
      "['cll prognosis', 'treatment options']\n",
      "['mrk s acquisition', 'great news', 'great news', 'blood cancer patients', 'great biopharma ash19 story', 'gen inhibitors', 'outsmart tumors', '1st gen inhibs', 'cll loxo apto snss']\n",
      "['chronic lymphocytic leukemia', 'bone marrow click', 'cll ash19']\n",
      "['liso cel', 'refractory cll sll cll sll leukemia lymphoma ash2019 ash19']\n",
      "['s time', 'ash19 msk round', 'car t', 'stem cell transplants advances', 'blood clots', 'year s meeting']\n",
      "['bcl2 inhibitor', 'refractory r r', 'acute myeloid leukemia aml', 'myelodysplastic syndromes mds', 'chronic lymphocytic leukemia cll']\n",
      "['sequoia trial', 'ash19 zanubrutinib', 'bruton s tyrosine kinase inhibitor', 'high overall response rates', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma regardless', 'deletion 17p status lymsm leusm']\n",
      "['cll sll', 'potent monotherapy', 'powerful drug classes', 'btk inhibitors', 'pi3k delta inhibitor', 'significant unmet needs', 'b cell malignancies']\n",
      "['term data', 'free survival', 'overall survival benefits', 'venclexta venclyxto venetoclax combination', 'refractory chronic lymphocytic leukemia cll abbvie news center']\n",
      "['captivate study', 'new combination regimen', 'line treatment', 'chronic lymphocytic leukemia cll']\n",
      "['bien que', 'llc soit', 'incurable les efforts', 'recherche sur les traitements ont consid rablement progress ces derni res ann es apprenez', 'dans notre article portant sur ce sujet']\n",
      "['data underscore', 'imbruvica ibrutinib', 'chronic lymphocytic leukemia cll businessnews']\n",
      "['hazard ratio', 'phase iii e1912 study', 'annual meeting cll leukemia ash2019 ash19']\n",
      "['regression analysis', 'fantastic work', 'tanja amp co mds mdsrkto integrative analysis', 'spontaneous cll regression highlights genetic', 'microenvironmental interdependency uk']\n",
      "['positive ph1', 'clinical trial', 'ublituximab umbralisib', 'refractory chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukemia', 'common leukemia', 'years medicalsecrets']\n",
      "['car tcell function', 'extracellular vesicles', 'great work ash19 ash2019 ss']\n",
      "['ash19 murano update', 'venr amp biomarkers', 'cll w arnon kater', 'leusm cllsm hemeonc hematology']\n",
      "['ash19 video newsletter', 'alexey danilov', 'jessica okosun', 'clinical practice register', 'lymsm oncology']\n",
      "['international multicohort phase ii captivate trial investigators', 'treatment na ve patients', 'international workshop', 'chronic lymphocytic leukemia criteria ash2019 ash19']\n",
      "['multidisciplinary health sciences research', 'chronic lymphocytic leukemia cll', 'small cell lymphoma scl', 'lay w']\n",
      "['james kaye', 'adverse events amp', 'economic burden', 'chronic lymphocytic leukemia']\n",
      "['johnson amp johnsons imbruvica sales', 'roches rituxan', 'chronic lymphocytic leukemia market']\n",
      "['own advocate', 'chronic lymphocytic leukemia journey']\n",
      "['epigenetics cll', 'research field beyong doubt']\n",
      "['cll ash2019']\n",
      "['imbruvica ibrutinib combination therapy data', 'long term', 'line treatment', 'chronic lymphocytic leukemia']\n",
      "['jnj rhhby', 'new article', 'johnson amp johnson s imbruvica sales', 'roche s rituxan', 'chronic lymphocytic leukemia market']\n",
      "['good morning', 'room w415', 'hacken oral presentation', 'interrogate loss', 'function lesions', 'info singlecell cll']\n",
      "['frontline ibrutinib venetoclax', 'high rates', 'undetectable mrd']\n",
      "['cll sll benefits', 'zanubritinib treatment', 'constantine tam', 'sequioa trial hematology lymsm']\n",
      "['study shows', 'bruton s tyrosine kinase inhibitor', 'superior progression', 'overall survival', 'standard chemoimmunotherapy', 'chronic lymphocytic leukemia']\n",
      "['enable clinicians', 'novel agents', 'chronic lymphocytic leukemia cll', 'ash19 leusm']\n",
      "['refractory cll', 'sll dana farber s jennifer crombie md', 'therapy ash19 leusm lymsm abstract link']\n",
      "['i m', 'man i m', 'man i m', 'super story role play', 'cll roleplay stickman juliadonaldson']\n",
      "['new clinical trial', 'intensity flu mel tbi', 'haplo hct patients', 'hematologic malignancies cll leusm hematology']\n",
      "['chronic lymphopenia amp neutropenia', 'large granular lymphocytic leukemia aleukemic', 'subleukemic leukemia', 'rare variation', 'humans amp dogs', 'bone marrow proliferation', 'peripheral blood']\n",
      "['impossible cllsm']\n",
      "['nursery rhyme area', 'blossom class cll phase1phonics successfulstudents welovenurseryrhymes']\n",
      "['apto cg', 'class pan flt3 pan btk inhibitor exhibits', 'chronic lymphocytic leukemia cells']\n",
      "['yue lynn wang', 'team s work', 'distinct chroniclymphocyticleukaemia cell populations', 'combination treatment']\n",
      "['abbvie s releases', 'new data', 'chronic lymphocytic leukemia treatment korea biomedical review']\n",
      "['term data', 'free survival', 'overall survival benefits', 'venclexta venclyxto venetoclax combination', 'refractory chroniclymphocyticleukemia cll abbv']\n",
      "['tgtherapeutics announces oral presentation', 'umbralisib ublituximab', 'venetoclax triple combination phase i ii data', 'refractory cll', 'ash19 tgtx']\n",
      "['data underscore', 'imbruvica ibrutinib', 'chroniclymphocyticleukemia cll abbv']\n",
      "['video frontline therapies', 'treatment naive cll patients w danielle brander', 'iwcll2019 cllsm leusm']\n",
      "['innovative telemedicine platform', 'expert access', 'chronic lymphocytic leukemia cll']\n",
      "['dinner meeting', 'nordic cll group', 'translational projects', 'artist ash19 creativity collaboration']\n",
      "['ash meetings poster sessions time', 'friends discovery', 'oral sessions', 'danielle brander', 'long term remissions', 'venetoclax cll ash19 leukemia']\n",
      "['danielle brander md']\n",
      "['trials findings', 'clinical activity', 'bgne s brukinsa', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma leukemia lymphoma cll sll beigene']\n",
      "['good times', 'cll review']\n",
      "['allo sct post novel agents']\n",
      "['ash19 ash2019 cll']\n",
      "['ash19 lots', 'video interviews', 'seth karol e karol', 'high dose chemotherapy', 'young aml patients', 'yue lynn wang', 'distinct cll cell populations', 'combination therapy']\n",
      "['umbralisib ublituximab', 'complete remission rate', 'refractory cll leukemia ash2019 ash19']\n",
      "['torneoclausura soldeamerica vs cll finaaal', 'unidasporelobjetivo cllpy']\n",
      "['kitchen tip non', 'chronic lymphocytic leukemia', 'treatable form', 'blood cancer']\n",
      "['torneoclausura soldeamerica vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'liza larrea por karina vega unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'gooooooool stephanie lacoste unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'unidasporelobjetivo cllpy']\n",
      "['high rates', 'high rates', 'cll refractory', 'dr siddiqi', 'phase i transcend trial', 'cd19 car t', 'cll ash19']\n",
      "['orr responses', 'dose levels', 'chronic lymphocytic leukemia cll', 'mantle cell lymphoma mcl', 'btk resistance btk intolerance', 'bcl2 arql']\n",
      "['torneoclausura soldeamerica vs cll', 'unidasporelobjetivo cllpy']\n",
      "['ibrutinib venetoclax combo', 'undetectable mrd', 'captivate imbruvica jnj janssen ash19 hematology']\n",
      "['therapy post venetoclax discontinuation', 'great data']\n",
      "['torneoclausura soldeamerica vs cll', 'unidasporelobjetivo cllpy']\n",
      "['great data ash19', 'noncovalent selective btki', 'human phase', 'btkc481s resistance', 'high orr', 'resistant patients', 'tox cll leusm']\n",
      "['torneoclausura soldeamerica vs cll inici el st', 'griselda garay por yanina l pez unidasporelobjetivo cllpy']\n",
      "['lovely presentation', 'ash19 cll']\n",
      "['cll ash19']\n",
      "['beigene announces clinical data', 'brukinsa zanubrutinib', 'american society', 'hematology ash', 'annual meeting oral presentations', 'clinical trials', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma poster presentation']\n",
      "['research cll lymsm ash19']\n",
      "['non covalent btk inhibitor', 'demonstrates efficacy', 'multiple novel agents orr', 'sd responses deepen', 'crs w median tx duration', '7mos ash19']\n",
      "['great presentation', 'dr anthony mato loxo', 'triple novel therapy failure ash19 cll']\n",
      "['beigene announces clinical data', 'brukinsa zanubrutinib', 'american society', 'hematology ash', 'annual meeting oral presentations', 'clinical trials', 'chronic lymphocytic leukemia stockmarketnews']\n",
      "['torneoclausura soldeamerica vs cll entretiempo', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'unidasporelobjetivo cllpy']\n",
      "['pivotal studies cll14 amp murano', 'clinical benefit', 'duration chemotherapy', 'free venetoclax', 'cll oncopharm leusm gerionc']\n",
      "['zanubrutinib presentation', 'yrs f u', 'cr rate', 'neutropenia ash19 cll leusm']\n",
      "['btk inhibitor zanubrutinib', 'own prof tam']\n",
      "['btk inhibitors', 'frontline setting', 'exceptional response rates zanubrutinib cll ash19']\n",
      "['beigene announces clinical results', 'btk inhibitor', 'chronic lymphocytic leukemia cll amp', 'b cell malignancies', 's ash19 leusm lymsm']\n",
      "['torneoclausura soldeamerica vs cll', 'unidasporelobjetivo cllpy']\n",
      "['dr tam', 'sequoia cohort', 'orr w zanubrutinib', 'del17p cll', 'main grade', 'htn ash19']\n",
      "['frontline 17p del cll', 'neutropenia ash19 leusm']\n",
      "['torneoclausura soldeamerica vs cll', 'unidasporelobjetivo cllpy']\n",
      "['impressive orr', 'dr c tam ash19 cll']\n",
      "['torneoclausura soldeamerica vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'nairelis gutierrez por laurie cristaldo unidasporelobjetivo cllpy']\n",
      "['ash19 session', 'cll btk inhibitors', 'car t cells']\n",
      "['torneoclausura soldeamerica vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll arranc el partido', 'unidasporelobjetivo cllpy']\n",
      "['benjamin lampson md phd', 'germline atm variance', 'chronic lymphocytic leukemia', 'disease results conclude', 'cll patients', 'geramline variance ash19 abstract link']\n",
      "['duration treatment', 'combo venetoclax', 'obinutuzumab results', 'superior pfs amp high rates', 'undetectable minimal residual disease', 'chronic lymphocytic leukemia', 'obinutuzumab ash19']\n",
      "['rituximab vs fludarabine cyclophosphamide', 'cll leukemia ash2019 ash19']\n",
      "['term data', 'free survival', 'overall survival benefits', 'venclexta venclyxto venetoclax combination', 'refractory chronic lymphocytic leukemia cll prnewswire']\n",
      "['line combination', 'undetectable minimal residual disease rate', 'peripheral blood', 'bone marrow', 'cll lt', 'old leukemia ash2019 ash19']\n",
      "['novel treatment combinations', 'chronic lymphocytic leukemia']\n",
      "['tgtx reveals findings', 'early stage study', 'triple combo ublituximab umbralisib venetoclax', 'refractory chronic lymphocytic leukemia cll rrcll leukemia tgtherapeutics']\n",
      "['new btk indications amp', 'guidelines register', 'hrs acpe credit']\n",
      "['novel triplet shows', 'cll leukemia ash2019 ash19']\n",
      "['cll expert edward faber discusses treatment options', 'traditional chemotherapy immunotherapy', 'novel inhibitors']\n",
      "[]\n",
      "[]\n",
      "['ash19 wow', 'cll mechanisms', 'response amp resistance', 'agents targetedtherapy combinationtherapy btk blc2 leukemia']\n",
      "['ash19 jennifer woyach md', 'associate professor', 'current clinical trials', 'cll space', 'treatment landscape']\n",
      "['eloquent review', 'cllsm cll treatments', 'therapies vs chemotherapy', 'dr jennifer woyach', 'therapy head', 'lymsm ash19 ash2019']\n",
      "['cll distinct growth patterns', 'certain subclones growth advantage clonality', 'post allosct relapse btki', 'ighvmut anticd20', 'safer don t', 'daily practice education ash19']\n",
      "['novel agents', 'r r cll', 'dr barbara eichhorst', 'gcllsg leusm']\n",
      "['disease discontinuation', 'minimal residual disease', 'barbara eichhorst']\n",
      "['interesting questions', 'cll barbara eichhorst highlights', 'ash19 hematology leusm cllsm']\n",
      "['cll ash19 hematology leusm cllsm']\n",
      "['mrd matters cll ash19']\n",
      "['term data', 'free survival', 'overall survival benefits']\n",
      "['treatment options', 'rr cll', 'trials barbara eichhorst summarizes', 'ash19 leusm cllsm ctsm']\n",
      "['cll14 trial outcomes lori', 'leslie md hematologist oncologist lymphoma department john theurer cancer center hackensack meridian health shares details', 'cll14 trial', 'chronic lymphocytic leukemia cll']\n",
      "['nice summary', 'dr eichorst', 'response rates', 'novel agents cll ash19']\n",
      "['new data', 'clinical benefit', 'duration chemotherapy', 'free venclexta', 'chronic lymphocytic leukemia']\n",
      "['new data', 'clinical benefit', 'duration chemotherapy', 'free venclexta', 'chronic lymphocytic leukemia']\n",
      "['treatment naive cll', 'jennifer woyach']\n",
      "['cll trials', 'dr jennifer woyach james', 'ash19 hematology ctsm leusm cllsm']\n",
      "['ash19 cll 1stline dr woyach']\n",
      "['great info', 'novel therapies', 'ash19 dr woyach', 'person i']\n",
      "['major cll trials', 'dr jennifer woyach james', 'ash19 hematology ctsm leusm cllsm']\n",
      "['hall d', 'clinical results', 'refractory chronic lymphocytic leukemia', 'cll leusm lymsm']\n",
      "['clonal dynamics', 'catherine j wu']\n",
      "['impressive data', 'allosct post novel agents', 'ash19 cll lymsm']\n",
      "['others ash19 hematology oncoalert']\n",
      "['refractory cll poster', 'il15 avelumab', 'r r', 'mature t cell malignancies poster', 'ash19 poster hall']\n",
      "['dr wu', 'clonal evolution', 'distinct patterns', 'genetic changes']\n",
      "['ash19 poster hall', 'phase i trial', 'refractory cll leusm lymsm']\n",
      "['excellent pfs', 'detectable mrd', 'chemoimmunotherapy ash19 cll']\n",
      "['women lead cll', 'educational session', 'ash19 womeninscience womeninmedicine']\n",
      "['cll ash2019']\n",
      "['endcancer ash19 leusm cll']\n",
      "['umbralisib ublituximab venetoclax', 'refractory cll', 'paul m barr']\n",
      "['umbralisib ublituximab', 'btk refractory cll high response rates', 'manageable toxicities', 'infusion reactions cytopenias', 'gi side', 'cll ash19']\n",
      "['dna damage response', 'refractory b cell non hodgkin lymphoma cll multiplemyeloma', 'solid tumors']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['ibrutinib venetoclax', 'refractory cll', 'nitin jain']\n",
      "['dr rai', 'wt alexa', 'future ash19 cll']\n",
      "['term data', 'free survival', 'overall survival benefits', 'venclexta venclyxto venetoclax combination', 'refractory chronic lymphocytic leukemia cll stocktwits stockmarketnews']\n",
      "['new data', 'clinical benefit', 'duration chemotherapy', 'free venclexta']\n",
      "['term data', 'free survival', 'overall survival benefits', 'venclexta venclyxto venetoclax combination', 'refractory chronic lymphocytic leukemia cll']\n",
      "['frontline ifcg', 'table shows', 'ifcr i wonder', 'ven g', 'ven r', 'cll population ash19']\n",
      "['term data', 'free survival', 'overall survival benefits', 'venclexta venclyxto venetoclax combination', 'refractory chronic lymphocytic leukemia cll']\n",
      "['term data', 'free survival', 'overall survival benefits', 'venclexta venclyxto venetoclax combination', 'refractory chronic lymphocytic leukemia cll']\n",
      "['new data', 'clinical benefit', 'duration chemotherapy', 'free venclexta', 'chronic lymphocytic leukemia business wire']\n",
      "['long term cll data', 'murano trial']\n",
      "['term data', 'free survival', 'overall survival benefits', 'venclexta venclyxto venetoclax combination', 'refractory chronic lymphocytic leukemia cll news pharma pharmiweb']\n",
      "['term data', 'free survival', 'overall survival benefits', 'venclexta venclyxto venetoclax combination', 'refractory chronic lymphocytic leukemia cll news pharma pharmiweb']\n",
      "['roche announces', 'novel chronic lymphocytic leukemia treatment combinations', 'ash19 rhhby rog']\n",
      "['term data', 'free survival', 'overall survival benefits', 'venclexta venclyxto venetoclax combination', 'refractory chronic lymphocytic leukemia cll']\n",
      "['new data', 'clinical benefit', 'duration chemotherapy', 'free venclexta', 'chronic lymphocytic leukemia stocktwits stockmarketnews']\n",
      "['press release', 'new data', 'clinical benefit', 'duration chemotherapy', 'free venclexta', 'chronic lymphocytic leukemia']\n",
      "['new data', 'clinical benefit', 'duration chemotherapy', 'free venclexta', 'chronic lymphocytic leukemia']\n",
      "['year analysis', 'duration chemo', 'free treatment combination', 'refractory chronic lymphocytic leukemia cll', 'hall e1 abstract']\n",
      "['important data', 'btki efficacy', 'post venetoclax setting ash19 cll lymsm']\n",
      "['data underscore', 'imbruvica ibrutinib']\n",
      "['data underscore', 'imbruvica ibrutinib', 'chronic lymphocytic leukemia cll prnewswire']\n",
      "['imbruvica ibrutinib', 'venclexta venclyxto venetoclax combination data show high rates', 'disease clearance', 'chronic lymphocytic leukemia cll prnewswire']\n",
      "['imbruvica ibrutinib', 'venclexta venclyxto venetoclax combination data show high rates', 'disease cl']\n",
      "['ash19 endcancer cll']\n",
      "['ibrutinib rituximab combo', 'pfs advantage', 'cll leukemia ash2019 ash19']\n",
      "['ibrutinib nitin jain']\n",
      "['s ash19 oral sessions', 'btk inhibitor', 'chronic lymphocytic leukemia', 'cll leusm lymsm']\n",
      "['ash19 chemotherapy', 'free treatment combo', 'high rates', 'mrd negativity']\n",
      "['rt physrelations rt mdandersonnews', 'wwierda discusses chemoimmunotherapy', 'cll patients onclive ash19 endcancer']\n",
      "['cll ash19']\n",
      "['people w cll', 'venetoclax discontinuation', 'cll focus', 'b cell receptor signal transduction inhibitors amp cellular therapies ash19']\n",
      "['new analysis', 'treatment patterns outcomes', 'medicare beneficiaries', 'ibrutinib era', 'shows meteoric rise', 'sociodemographics leusm ash19']\n",
      "['dr fischer']\n",
      "['rt physrelations rt ksondermann', 'study dr jain s study', 'i manage', 'pi i', 'nitinjainmd teamcll gotvenetoclax cll combinationtherapy']\n",
      "['new exciting clinical data', 'chronic lymphocytic leukemia cll', 'common form', 'adults ash19']\n",
      "['cll community']\n",
      "[]\n",
      "['i m', 'line chlorambucil', 'br cll leukemia']\n",
      "['own shares perspectives', 'chronic lymphocytic leukemia', 'cellular immunotherapy', 'provider profile']\n",
      "['pm est', 'patient power s facebook', 'cll ash19 ash2019']\n",
      "['interesting article', 'treatment cll', 'blood pressure', 'chronic lymphocytic leukemia']\n",
      "['abbv reveals findings', 'mid stage study', 'combo imbruvica venclexta venclyxto', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll abbvie leukemia lymphoma']\n",
      "['imbruvica ibrutinib combination therapy data', 'long term', 'line treatment', 'chronic lymphocytic leukemia prnewswire']\n",
      "['chronic lymphocytic leukemia care cll ash19']\n",
      "['nhlbi post doc fellow dr deyi zhang', 'new therapeutic strategy', 'chronic lymphocytic leukemia cll', 'room w414ab ash19']\n",
      "['slide sum', 'cll nhl', 'aml mds']\n",
      "['new options', 'cll patients']\n",
      "['study dr jain s study', 'i manage', 'pi i', 'teamcll gotvenetoclax cll combinationtherapy']\n",
      "['apto key findings', 'dose levels', 'r r cll patients btk']\n",
      "['cll ash2019']\n",
      "['e1912 cll trial shows', 'significant pfs benefit', 'ibrutinib rituximab', 'ibrutinib patients', 'months ash19 cll']\n",
      "['mcl ash19']\n",
      "['clinical data', 'refractory peripheral t cell lymphoma cll sll', 'inhl ptcl']\n",
      "['cll question', 'hour ash2019']\n",
      "['data underscore', 'imbruvica ibrutinib']\n",
      "['imbruvica ibrutinib', 'venclexta venclyxto venetoclax combination data show high rates', 'disease cleara']\n",
      "['tolerable therapies', 'chronic lymphocytic leukemia cll', 'patients ash19']\n",
      "['combination data', 'cll patients', 'captivate study']\n",
      "['great morning session', 'front line cll treatment era', 'upfront btk', 'financial toxicity ash19 cll sharman']\n",
      "['data underscore', 'imbruvica ibrutinib', 'chronic lymphocytic leukemia cll']\n",
      "['imbruvica ibrutinib', 'venclexta venclyxto venetoclax combination data show high rates', 'disease clearance', 'chronic lymphocytic leukemia cll']\n",
      "['ash2019 cll bottom line mrd', 'novel agent therapy']\n",
      "['kirsten fisher update', 'cll14 frail', 'cll patients', 'w frontline', 'duration venetoclax obinutuzumab', 'sustainable rates', 'undetectable mrd', 'os diff', 'data confirms prognostic value', 'bm assessments']\n",
      "['dr fischer suggests', 'future cll trials', 'chlorambucil control arm ash19 hematology oncoalert']\n",
      "['dr fischer', 'colleagues ash19 hematology oncoalert']\n",
      "['tp53 disruption', '1l cll ash19']\n",
      "['german group ash19 oncoalert']\n",
      "['mrd news', 'cll patients ibrutinib venetoclax combo', 'captivate trial ash19 ash2019']\n",
      "['combination btk', 'dr lampson', 'btk bcl', 'combination ash19 cll']\n",
      "['imbruvica ibrutinib', 'venclexta venclyxto venetoclax combination data show high rates', 'disease clearance', 'chronic lymphocytic leukemia cll']\n",
      "['dr fischer', 'german cll group', 'slide ash19']\n",
      "['captivate study', 'ibrutinib venetoclax', 'line treatment', 'constantine s tam']\n",
      "['constantine tam', 'captivate trial', 'randomisation ibrutinib', 'venetoclax oral combo activity', 'high risk frontline cll ash19 leusm']\n",
      "['cll patients captivate trial summary']\n",
      "['captivate study high rate', 'undetectable mrd', 'ibru ven cll ash19']\n",
      "['captivate mrd', 's frontline i v study pts', 'curious cll ash19']\n",
      "['toxicity profile', 'clinical trial patients time', 'ash19 lymsm cll']\n",
      "['dr tam', 'colleagues conclusions', 'captivate mrd cohort study', 'cll ash19 oncoalert']\n",
      "['mrd negativity rate', 'captivate cll trial ash19 oncoalert']\n",
      "['great presentation', 'frontline cll']\n",
      "['median age', 'median age', 'cll patients ash19 hematology oncoalert']\n",
      "['interesting front line q', 'cd20 mab', '1l cll', 'genuine clinical benefit', 'possible likely extra tox', 'ash19 lymsm']\n",
      "['data underscore', 'imbruvica ibrutinib', 'chronic lymphocytic leukemia cll abbvie news center']\n",
      "['high rates', 'bm umrd', 'frontline combo', 'i v responses increase w', 'therapy neutropenia', 'pts req gcsf', 'iga improvement', 'ibrutinib monotherapy', 'cd4 w tx cll ash19']\n",
      "['shows ibrutinib', 'cll patients leusm clinres nctn ash19']\n",
      "['shows ibrutinib', 'cll patients leusm clinres nctn ash19']\n",
      "['con tam', 'pmcc rmh', 'captivate data', 'ibrutinib venetoclax', 'cll shows', 'ibrutinib reduces tls risk mrd', 'negative rates', 'p53 mut cll', 'treatment lymsm ash19']\n",
      "['superior outcomes', 'btk inhibition', 'dead q amp', 'dr cheson ash19 cll']\n",
      "['pfs curve', 'fcr vs', 'long term oral ibrutinib r ash19 cll']\n",
      "['venetoclax study', 'cll ash19 hematology oncoalert']\n",
      "['data underscore', 'imbruvica ibrutinib']\n",
      "['tait shanafel', 'long term', 'e1912 trial', 'cll leusm ash19']\n",
      "['frontline cll', 'morning ash19 hematology investigator', 'patients wout high risk']\n",
      "['morning s cll oral presentation session', 'landmark phase', 'e1912 study', 'chronic lymphocytic leukemia', 'news release']\n",
      "['victoriesovercancer amp', 'impossible cllsm lymsm']\n",
      "['ecog1912 update ibrutinib benefit', 'cll patients ash19']\n",
      "['dr shanafelt', 'dead ash19 i don t']\n",
      "['dr shanafelt', 'co authors', 'e1912 frontline cll trial', 'ash19 oncoalert hematology']\n",
      "['tgtx abbv', 'cll ash19']\n",
      "['e1912 trail cll']\n",
      "['long term', 'ir versus fcr', 'front line cll', 'ighv ash19 hematology oncoalert']\n",
      "['interesting data', 'dr lampson', 'front triplet acal ven obi', 'tn cll', 'non heme tox', 'active acala', 'combo approaches', 'non heme tolerability ash19 cll']\n",
      "['imbruvica ibrutinib', 'venclexta venclyxto venetoclax combination data show high rates', 'disease clearance', 'chronic lymphocytic leukemia cll']\n",
      "['data underscore', 'imbruvica ibrutinib', 'chronic lymphocytic leukemia cll']\n",
      "['imbruvica ibrutinib combination therapy data', 'long term', 'line treatment', 'chronic lymphocytic leukemia']\n",
      "['ash19 researchers', 'new data', 'captivate clinical trial', 'line treatment', 'chronic lymphocytic leukemia cll', 'cll oral presentation session click']\n",
      "['abbvie announces', 'chronic lymphocytic leukemia study', 'financial news', 'market intelligence', 'fly s', 'real time']\n",
      "['interesting data', 'free triplet', 'tn cll btk cd20 bcl2']\n",
      "['ir arm', 'tp53 mutation', 'chance cll ash19 hematology oncoalert']\n",
      "['important update', 'tait shanafelt ash19 oncoalert']\n",
      "['benjamin lampson', 'btk bcl2 amp cd20 inhibitor', 'frontline cll', 'acceptable toxicity profile', 'adverse events response primary endpoint', 'undetectable mrd', 'therapy leusm ash19']\n",
      "['discusses chemoimmunotherapy', 'cll patients ash19 endcancer']\n",
      "['avo regimen', 'line cll ash19']\n",
      "['future directions', 'avo trial', 'r r cll', 'ash19 meeting oncoalert']\n",
      "['chronic lymphocytic leukemia click']\n",
      "['undetectable minimal residual disease mrd', 'chronic lymphocytic leukemia cll', 'hall d abstract']\n",
      "['serious aes', 'dr lampson', 'avo regimen', 'r r cll ash19 oncoalert']\n",
      "['study schema', 'r r cll incorporates mrd', 'treatment decision ash19 hematology oncoalert']\n",
      "['avo combination', 'cll ash19 investigator', 'trial oncoalert']\n",
      "['data underscore', 'imbruvica ibrutinib', 'chronic lymphocytic leukemia cll']\n",
      "['imbruvica ibrutinib', 'venclexta venclyxto venetoclax combination data show high rates', 'disease clearance', 'chronic lymphocytic leukemia cll']\n",
      "['dr lampson', 'interesting triple combo', 'cll ash19 oncoalert']\n",
      "['novel novel combinations', 'pretty promising signals', 'therapy cllsm ash19 lymsm']\n",
      "['perfect dr cheson', 'cll ash19']\n",
      "['early ash19', 'elevate tn results']\n",
      "['elevate cll ash19 hematology oncoalert']\n",
      "['adverse events elevate cll', 'morning ash19 oncoalert']\n",
      "['significant hr', 'o acala vs acala monotherapy cll ash19', 'time benefit', 'cd20 mab', 'novel agent', 'r r', '1l cll']\n",
      "['overall survival data', 'elevate cll', 'os ash19 hematology oncoalert']\n",
      "['independent review committee assessment', 'cll elevate study ash19 hematology oncoalert']\n",
      "['study design', 'ash19 oncoalert']\n",
      "['elevate trial cll', 'morning hematology ash19']\n",
      "['cll session ash19', 'actual session']\n",
      "['cll morning session', 'interesting data hematology ash19 oncoalert']\n",
      "['new article treatment naive cll lessons', 'clinical trials cll leusm hematology']\n",
      "['new article clonal dynamics', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'undetectable mrd', 'treatment discontinuation cll leusm hematology']\n",
      "['new article chronic lymphopenia', 'large granular lymphocytic leukemia cll leusm hematology']\n",
      "['new article epilepsia partialis continua', 'pml iris clinical', 'cll leusm hematology']\n",
      "['new article cancer biomarkers', 'therapy cll leusm hematology']\n",
      "['new article prognosis factors', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article etiopathogenesis', 'prognostic implications', 'autoimmune hemolytic anemia association', 'chronic lymphocytic leukemia b cll leusm hematology']\n",
      "['new article chronic lymphocytic leukemia', 'myelodysplastic syndrome', 'erythroleukemia cll leusm hematology']\n",
      "['rt physrelations rt cancerfrontline venetoclax', 'undetectable minimal residual disease', 'dr philip thompson', 'phase ii study', 'high risk cll ash19 endc']\n",
      "['undetectable minimal residual disease', 'dr philip thompson', 'phase ii study', 'high risk cll ash19 endcancer']\n",
      "['ash19 don t', 'oral presentations', 'blood diseases', 'aml cll nhl']\n",
      "['ash19 poster session', 'refractory cll', 'sll poster']\n",
      "['chronic lymphocytic leukemia', 'human b1 cell development']\n",
      "['phase iii clinical trials']\n",
      "['treatment algorithm', 'del 17p', 'tp53 mutation december', 'leusm cll']\n",
      "['treatment algorithm', 'del 17p', 'tp53 mutation december', 'cll leusm']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['wonderful speakers drs danielle brander amp philip thompson', 'medscapelive expert perspectives', 'btk inhibitors', 'cll tweet', 'stream ash19']\n",
      "['expert perspectives', 'btk inhibitors', 'btk inhibitors', 'refractory cll w']\n",
      "['expert perspectives', 'btk inhibitors', 'line studies', 'novel agents w prof philip thompson']\n",
      "['chronic lymphopenia', 'large granular lymphocytic leukemia']\n",
      "['expert perspectives', 'btk inhibitors', 'btk inhibitors', 'development partial cont w prof danielle brander']\n",
      "['expert perspectives', 'btk inhibitors', 'btk inhibitors', 'development partial cont w prof danielle brander']\n",
      "['expert perspectives', 'btk inhibitors', 'development partial w prof danielle brander']\n",
      "['cll shoutout i m', 'cll news', 'pm est']\n",
      "['expert perspectives', 'btk inhibitors']\n",
      "['s choice', 'year s myyearinmedicine', 'year uk']\n",
      "['new exciting clinical data', 'chronic lymphocytic leukemia cll', 'common form', 'adults ash19']\n",
      "['chronic lymphocytic leukemia mantle cell lymphoma']\n",
      "['chronic lymphocytic leukemia mantle cell lymphoma']\n",
      "['hr countdown stay', 'stream amp', 'exclusive slides', 'medscapelive expert perspectives', 'btk inhibitors', 'cll w prof philip thompson', 'experts details']\n",
      "['year s hematology', 'annual meeting visit', 'hematological malignancies', 'chronic lymphocytic leukemia ash19']\n",
      "['treatment sequence']\n",
      "['ofatumumab maintenance', 'chronic lymphocytic leukemia', 'final analysis', 'prolong study blood cancer journal bcj']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['cll guideline updates', 'btk inhibitors ash19 peerview']\n",
      "['future directions', 'b cell cancers']\n",
      "['ash19 richard furman md', 'future directions', 'b cell cancers']\n",
      "['dr richard furman', 'cll guideline updates', 'btk inhibitors ash19 peerview']\n",
      "['free strategies', 'novel drug combinations', 'hall d']\n",
      "['new article resistance', 'btk inhibition', 'pi3k akt activation', 'b cell lymphoid malignancies cll leusm hematology']\n",
      "['new article ofatumumab maintenance prolongs progression', 'free survival', 'chronic lymphocytic leukemia', 'final analysis', 'prolong study cll leusm hematology']\n",
      "['free strategies', 'novel drug combinations', 'hall d']\n",
      "['chronic lymphocytic leukaemia', 'bone marrow', 'white blood cell clinical trials', 's choice', 'myyearinmedicine uk']\n",
      "['ultimate cll fighter']\n",
      "['mrd assessment', 'cll w arnon kater', 'nl iwcll2019 cllsm leusm leukemia']\n",
      "['cll nhl projects', 'team work']\n",
      "['rt physrelations rt leukemiamda dr william wierda wwierda', 'mdandersonnews discusses', 'onclive endcancer leusm']\n",
      "['monoclonal antibodies', 'disease cll pml cancer lymphoma']\n",
      "['rt physrelations rt leukemiamda ash19', 'high risk cll', 'high rate', 'undetectable minimal residual disease rts1 philip', 'thompson m b b s', 'mdandersonnews leukemiamda']\n",
      "['rt physrelations rt leukemiamda ash19', 'refractory r r chronic lymphocytic leukemia cll nitinjainmd', 'mdandersonnews leukemiamda leusm end']\n",
      "['dr william wierda', 'endcancer leusm']\n",
      "['prowrestler chileanswrestler luchalibre luchalibrechilena', 'prowrestler chileanswrestler elmejorbotazodechile ngen cll xnl chileanswrestler pisoton']\n",
      "['new article quantification', 'differential transcription factor activity', 'repressors difftf cll leusm hematology']\n",
      "['new article', 'model interpretability', 'disease progression prediction', 'patient similarity learning cll leusm hematology']\n",
      "['new article pathophysiology', 'chronic lymphocytic leukemia', 'human b1 cell development cll leusm hematology']\n",
      "['don t', 'cll updates', 'advances lymsm']\n",
      "['refractory r r chronic lymphocytic leukemia cll', 'leusm endcancer']\n",
      "['high risk cll', 'high rate', 'undetectable minimal residual disease rts1 philip', 'thompson m b b s', 'leusm endcancer']\n",
      "['ibrutinib fludarabine cyclophosphamide', 'obinutuzumab ifcg', 'line treatment', 'del 17p', 'leusm endcancer cll']\n",
      "['patient recruitment']\n",
      "['frontline treatment', 'chronic lymphocytic leukemia nov', 'stephens cllsm']\n",
      "['monoclonal antibodies', 'anna deveaux msc', 'audio visit pml cll rituximab mabs nhl lymphoma']\n",
      "['expert access', 'expert cll physician', 'cost gain', 'treatment enroll', 'myexpertaccess cll cllsm']\n",
      "['view e learning webcasts', 'car t cell therapy', 'key experts', 'lymphoma multiplemyeloma', 'aml cll gt gt lt lt carttherapy cellulartherapy immunoonc']\n",
      "['chronic lymphocytic leukemia', 'significant updates s ryan w jacobs md previews']\n",
      "['chronic lymphocytic leukemia', 'common types', 'new cases', 'cll video series']\n",
      "['leukemia amp lymphoma community', 'btk inhibitor', 'chronic lymphocytic leukemia', 'meaningful treatment options', 'patients ash19 leusm lymsm']\n",
      "['v fib arrest pt', 'cll i', 'cardiovascular complications', 'real thing']\n",
      "['chronic lymphocytic leukemia allergy', 'clinical immunology jama network', 'open jama network ibrutinib vs kdmn kd025', 'treatment cgvhd', 'rate htn af', 'ibrutinib kd025 benign se profile']\n",
      "['common adverse event', 'hypertension cll lymsm']\n",
      "['excellent work', 'important ae']\n",
      "['lindsey roeker', 'chronic lymphocytic leukemia allergy', 'clinical immunology jama network', 'open jama network']\n",
      "['dna methylation profiles', 'chronic lymphocytic leukemia patients']\n",
      "['torneoclausura cll vs cdc', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs cdc', 'gooooooool liza larrea unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs cdc', 'unidasporelobjetivo cllpy']\n",
      "['ighv cll']\n",
      "['torneoclausura cll vs cdc', 'liza larrea por karina vega unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs cdc', 'unidasporelobjetivo cllpy']\n",
      "['line chronic lymphocytic leukemia', 'national comprehensive cancer network volume']\n",
      "['torneoclausura cll vs cdc', 'gooool liz pe', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs cdc', 'carrasquel unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs cdc empez el segundo tiempo', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs cdc', 'final del primer tiempo', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs cdc', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs cdc', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs cdc', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs cdc', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs cdc', 'unidasporelobjetivo cllpy']\n",
      "['surprising link', 'ibrutinib hypertension spurs', 'study cll leusm']\n",
      "['torneoclausura cll vs cdc inicia el partido', 'unidasporelobjetivo cllpy']\n",
      "['scan results stochastic', 'swef cct ovb php mnzs mtc tpt look spr ddv1 ocn igas cll mhn utlf eai']\n",
      "['high prognostic value', 'measurable residual disease detection', 'flow cytometry', 'chronic lymphocytic leukemia patients', 'front line f', 'ncbi publicasergas chuac']\n",
      "['cll patients w danielle brander', 'iwcll2019 cllsm leusm']\n",
      "['common type', 'u s', 'year share']\n",
      "['important event', 'b cell malignancies cll', 'resistant c481s mutant intolerant', 'ibrutinib arql apto amp', 's aml drug', 'interesting week']\n",
      "['cll amp aml', 'i manage']\n",
      "['line treatment', 'chronic lymphocytic leukemia cll', 'leusm endcancer']\n",
      "['rare cancers', 'chronic lymphocytic leukemia cll', 'poor prognosis']\n",
      "['chronic lymphocytic leukemia cll']\n",
      "['new article integrative analysis', 'spontaneous cll regression highlights genetic', 'microenvironmental interdependency', 'cll cll leusm hematology']\n",
      "['new article dna methylation profiles', 'chronic lymphocytic leukemia patients', 'chemoimmunotherapy cll leusm hematology']\n",
      "['new article hypertension', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article addition', 'chronic lymphocytic leukemia combination therapy', 'ibrutinib flare cll leusm hematology']\n",
      "['new article merkel cell carcinoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll leusm hematology']\n",
      "['new article', 'p53 functions', 'leukemic cells', 'new strategy', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article risk', 'b cell malignancies', 'systematic review', 'meta analysis', 'trials cll leusm hematology']\n",
      "['dr o brien', 'data lymsm leusm cll']\n",
      "['chronic lymphocytic leukemia']\n",
      "['long term safety', 'chronic lymphocyti']\n",
      "['clive james', 'intern term']\n",
      "['term safety', 'chronic lymphoc']\n",
      "['initial treatment', 'chronic lymphocytic leukemia cll', 'dr richard furman']\n",
      "['excellent overview', 'clonal dynamics', 'therapeutic implications cll']\n",
      "['clonal dynamics', 'chronic lymphocytic leukemia blood advances american society']\n",
      "['chronic lymphocytic leukemia cll survivor', 'caregiver share']\n",
      "['000x magnification', 'em banerji', 'cll vs healthy cells givingtuesdayca researchmatters']\n",
      "['long way', 'expert dr farrukh awan', 'international workshop', 'cll iwcll tune', 'dr awan', 'exciting advances', 'cll care cll patientpower']\n",
      "['verastem oncology s commitment', 'cancer care', 'research visit', 'cll lymsm leusm']\n",
      "['dr kerry rogers', 'james discusses signs', 'treatment leusm cll cllsm bloodcancer']\n",
      "['dr andrew roberts', 'grandrounds venetoclax cll']\n",
      "['rns aim cll cello health plc total']\n",
      "['cool dual stain', 'cll sll', 'common incidental lymphoma diagnosis', 'general surgical pathologist']\n",
      "['munchkins cll']\n",
      "['polar animals frozen', 'observational skills', 'melts successfulstudents']\n",
      "['comprehensive coverage', 'committee members', 'meeting insights', 'lymsm cll']\n",
      "['james kaye', 'adverse events amp', 'economic burden', 'chronic lymphocytic leukemia']\n",
      "['overtime analysis', 'dnamethylation profiles']\n",
      "['video innovations', 'clinical assessment', 'cll w carol moreno', 'iwcll2019 cllsm leusm']\n",
      "['ash19 meeting ash', 'important abstracts', 'lymphoma myeloma aml mds cll', 'car t cells']\n",
      "['long term safety', 'chronic lymphocy leukemia']\n",
      "['cycc title', 'phase i study', 'inhibitor cyc065', 'bcl2 inhibitor', 'refractory chronic lymphocytic leukemia cll presenter dr william g wierda session name', 'cll t']\n",
      "['chronic lymphocytic leukemia', 'silent killer']\n",
      "['guest commentary', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'silent killer']\n",
      "['chronic lymphocytic leukemia cll clinical trials', 'companies drugs phases subjects', 'current status', 'global clinical trial report', 'chronic lymphocytic leukemia cll clinical']\n",
      "['long term safety', 'chronic lymphocytic']\n",
      "['chronic lymphocytic leukemia combination therapy', 'ibrutinib flare cll leusm']\n",
      "['chronic lymphocytic leukemia', 'silent killer']\n",
      "['cll14 trial', 'duration chemotherapy', 'free regimen', 'frail patients', 'treatment na ve cll']\n",
      "['cll14 trial', 'duration chemotherapy', 'free regimen', 'frail patients', 'treatment na ve cll']\n",
      "['clinical trial', 'cll treatment option discusses clinical trial participation leusm cll cllsm bloodcancer']\n",
      "['cll causes', 'james expert dr kerry rogers leusm cllsm bloodcancer']\n",
      "['florida woman s bloodcancer journey', 'chronic lymphocytic leukemia cll', 'common type', 'u s']\n",
      "['chronic lymphocytic leukemia cll', 'white blood cell', 'b cells', 'florida woman', 'treatment options']\n",
      "['man shows amazes', 'chronic lymphocytic leukemia', 'top navy seal']\n",
      "['blood commentary cll', 'residual cells', 'ngs matters']\n",
      "['ancient greece', 'chronic lymphocytic leukemia cll']\n",
      "['minimal residual disease']\n",
      "['eye opening', 'year journey', 'chroniclymphocyticleukemia cll bloodcancer']\n",
      "['drg epidemiology report estimates', 'western europe', 'global reports', 'cll leukemia chronic lymphocyticleukemia']\n",
      "['pm est']\n",
      "['david rip clive james bloodcancer cll ibrutinib']\n",
      "['cll pml rituximab', 'white matter', 'anna deveaux msc']\n",
      "['bioanalytical methods', 'chronic lymphocytic leukemia drugs', 'biological matrices massspecpub biomedchrom']\n",
      "['long term safety', 'chronic lymphocyti']\n",
      "['long term safety', 'chronic l']\n",
      "['chronic lymphocytic leukemia']\n",
      "['important week', 'blood cancer patients', 'hematology conference', 'cll updates', 'fellow advocates']\n",
      "['fup median 45m e1912 ibrutinib r vs fcr 1l cll i don t', 'argues re', 'cll fcr', 'long term benefit pfs plateau', 'pts ash19 lymsm']\n",
      "['ash19 oncoalert ash19rc top10 abstracts ibrutinib', 'superior clinical outcome', 'chronic lymphocytic leukemia cll', 'e1912 trial lymsm']\n",
      "['cll society', 'tuesday givingtuesday givingtuesday2019 cll cllsm']\n",
      "['ibrutinib monotherapy', 'total health care costs']\n",
      "['new clinical trial', 'shingles serologic response', 'new recombinant', 'herpes zoster vaccine', 'chronic lymphocytic leukemia', 'waldenstr m macroglobulinemia', 'line btk inhibitors']\n",
      "['dr rai', 'chronic lymphocytic leukemia', 'elderly patient population leusm leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['torneoclausura dvocapiata vs cll finaaal', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'st gooooooool liz pe', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cdc vs cll', 'carrasquel por damia cortaza unidasporelobjetivo cllpy']\n",
      "['torneoclausura cdc vs cll', 'ngeles portillo por karina vega unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'st gooooooool fabiola sandoval unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'nairelis guti rrez por laurie cristaldo unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'st gooooooool karina vega unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll arranc el segundo tiempo', 'unidasporelobjetivo cllpy']\n",
      "['ash19 publication', 'unrecognizable structuralvariants', 'chronic lymphocytic leukemia don t']\n",
      "['torneoclausura dvocapiata vs cll', 'final del primer tiempo', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'pt gooooooool stephanie lacoste unidasporelobjetivo cllpy']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['torneoclausura dvocapiata vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'pt gooooooool stephanie lacoste unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll inici el partido', 'unidasporelobjetivo cllpy']\n",
      "['new article multidisciplinary diagnostics', 'chronic lymphocytic leukemia european research initiative', 'cll eric recommendations cll leusm hematology']\n",
      "['video cll ighv mutational status w nicolas martinez calle', 'iwcll2019 cllsm leusm']\n",
      "['ighv amp', 'shorter time', 'tp53 mutn del17p', 'klhl6 mutations', 'deleterious effect', 'multivariate analysis lymsm']\n",
      "['ibrutinib monotherapy', 'total health care costs']\n",
      "['new article tumor lysis syndrome', 'chronic lymphocytic leukemia', 'rare case report', 'nephrology cll leusm hematology']\n",
      "['new article coexistence', 'lymphoid neoplasms', 'center experience cll leusm hematology']\n",
      "['new article circasxl1', 'regulates bap1 deubiquitinase activity', 'leukemia cll leusm hematology']\n",
      "['chronic lymphocytic leukemia cll ain t', 'fun time', 'quick appeal', 's hasn t', 'good week i', 'election don t squander', 'family amp']\n",
      "['new article cll', 'residual cells', 'ngs matters cll leusm hematology']\n",
      "['new article', 'chloroadenosine alters', 'metabolic profile', 'downregulates antioxidant', 'dna damage repair pathways', 'macrophages cll leusm hematology']\n",
      "['new article', 'neutron radiation therapy potentiate', 'immune response', 'merkel cell carcinoma cll leusm hematology']\n",
      "['occupational exposure', 'u s canada', 'sweden show', 'non hodgkin lymphoma nhl', 'chronic lymphocytic leukemia cll']\n",
      "['literature review', 'large cell lymphoma', 'chronic lymphocytic leukemia']\n",
      "['video bcr receptor sterotypes', 'cll w kostas stamatopoulos', 'iwcll2019 cllsm leusm']\n",
      "['cll expert dr william wierda', 'md anderson cancer center discusses', 'promising research', 'international workshop', 'cll iwcll cll iwcll patientpower']\n",
      "['new exchange', 'cryptoliveleaktoken cll cll', 'mcafeedex check', 'pairs cll eth cll dai cll wbtc cll busd cll tusd']\n",
      "['new clinical trial', 'shingles response', 'shingrix varicella zoster virus vzv vaccine', 'chronic lymphocytic leukemia cll', 'bruton s tyrosine kinase inhibitor btk i']\n",
      "['ash19 presentation', 'trial cll leusm']\n",
      "['risk stratifications', 'natural history', 'subgroup analyses', 'murano trial']\n",
      "['cancer stem cells', 'immune inhibitory receptors', 'chronic lymphocytic leukemia cll', 'metastatic cancers', 'genome discovery']\n",
      "['s4 dvd', 'cancer centre', 'chronic lymphocytic leukemia', 'daily basis', 'outlander cast']\n",
      "['slam dunk', 'cll bone marrow dendritic cells support', 'chronic lymphocytic leukemia cells', 'slam family member', 'dependent manner']\n",
      "['cll chronic lymphocytic leukemia market size', 'key players f hoffman', 'roche abbvie teva pharmaceuticals gilead sciences johnson amp johnson']\n",
      "['interesting day renee beekman', 'genetic predisposition', 'chronic lymphocytic leukemia advcompbio advcompbio2019 womeninstem']\n",
      "['keine m glichkeit zum ash19 zu reisen kml experten informieren', 'k rze ber relevante news zu lymphomen cll multiplesmyelom hodgkin nonhodgkin cartcells unter']\n",
      "['human medicines european', 'public assessment report epar rixathon rituximab lymphoma non hodgkin arthritis rheumatoid leukemia agenparl combination patients', 'strong treatment agenparlenglish dirittogiustizia salute socialnetwork']\n",
      "['irene lopez', 'chronic lymphocytic leukemia cll', 'phd project', 'crgphdsymp2019 ph']\n",
      "['new article cutaneous nocardiosis', 'patient cll leusm hematology']\n",
      "['new article', 'molecular genetics', 'high risk chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article bone marrow dendritic cells support', 'chronic lymphocytic leukemia cells', 'dependent manner cll leusm hematology']\n",
      "['video genomic', 'cll patients', 'wgs w', 'iwcll2019 cllsm leusm']\n",
      "['family vibes', 'familia family cll rootstock amp vine']\n",
      "['natural prevention', 'chronic lymphocytic leukemia']\n",
      "['clinicalupdates review', 'treatment options', 'aml cll amp multiplemyeloma explore w drs delgado']\n",
      "['fludarabine po', 'iv formulation', 'small dose variation 30mg iv 45mg po obs iv', 'insurance bmt']\n",
      "['cll treatment', 'new options', 'webcast dr banerji', 'cll management', 'treatment decisions thanks']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['chronic lymphocytic leukemia', 'future rise', 'nationwide population']\n",
      "['review article treatment naive cll lessons', 'clinical trials']\n",
      "['real world evidence', 'chronic lymphocytic leukemia']\n",
      "['interesting research article novel agents', 'cll treatment', 'recent years', 'curative role']\n",
      "['sad news', 'clive james', 'wouldn t']\n",
      "['yrs condolences', 'family amp heres', 'gettin ibrutinib']\n",
      "['clive james rip cll leukaemia bloodcancer']\n",
      "['monthly newsletter delivers highlights', 'recent developments', 'cll field', 'email box', 'november s issue lmsm']\n",
      "['fda approves', 'new treatment', 'chronic lymphocytic leukemia', 'international program cancer bloodcancer leukemia chroniclymphocyticleukemia cll']\n",
      "['fda approval', 'sll healthcare']\n",
      "['jennifer r', 'brown md phd', 'primary resistance', 'pi3k inhibition', 'patients cll']\n",
      "['new gene signature', 'chronic lymphocytic leukaemia', 'traditional chemotherapy', 'alternative treatment gt lymphomaresearch cll lymsm bloodcancer']\n",
      "['new article clonal dynamics', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article cll14 trial', 'duration chemotherapy', 'free regimen', 'frail patients', 'treatment na ve cll cll leusm hematology']\n",
      "['new article', 'ibrutinib resistance', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['chatterboxes language development', 'fantastic speaking amp', 'resources shop', 'gt eyfs earlyliteracy communication earlyyears']\n",
      "['good news', 's haematologist appointment', 'bad news']\n",
      "['todos duelen pero', 'puedo sacar', 'mente verdad y justicia laluchacontinua instachile', 'luchalibrechilena chileluchalibre cll estoeslucha payasos clown elclan instalike']\n",
      "['torneoclausura cll vs graldiaz', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs graldiaz', 'unidasporelobjetivo cllpy']\n",
      "['beautiful cd19 lef1 immunostain', 'core biopsy', 'cll sll', 'neoplastic b cells']\n",
      "['torneoclausura cll vs graldiaz segundo tiempo', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs graldiaz entretiempo', 'karina vega x2 griselda garay y ang lica v zquez unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs graldiaz', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs graldiaz empieza el partido', 'unidasporelobjetivo cllpy']\n",
      "['international collaboration approves', 'new treatment option', 'chronic lymphocytic leukemia']\n",
      "['refractory b cell non hodgkin lymphoma', 'chronic lymphocytic leukemia cll']\n",
      "['cll diagnosis', 'shares key advice leusm cll cllsm bloodcancer']\n",
      "['friends amp family', 's cancer diagnosis husband', 'wife team jay', 'ruth schorr', 'cll share', 'friends reactions', 'cancer cll cancersupport']\n",
      "['hematology research', 'annual meeting visit', 'cll lymsm ash19']\n",
      "['critical questions', 'hematology ash19 hope']\n",
      "['recent advances', 'important questions ash19 hematology']\n",
      "['bendamustine treatment', 'chronic lymphocytic leukemia clinicaltrials homeopathy healthresearch']\n",
      "['new clinical trial', 'chronic lymphocytic leukemia cll', 'routine clinical practice cll leusm hematology']\n",
      "['chronic lymphocytic leukemia', 'lymphoma lymsm']\n",
      "['chimeric antigen receptor t cells', 'chronic lymphocytic leukemia', 'cure lymphoma lymsm']\n",
      "['resistance mechanisms', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['new article', 'line chronic lymphocytic leukemia', 'chemoimmunotherapy cll leusm hematology']\n",
      "['new article', 'coumarate coenzyme', 'ligase isoform', 'piper nigrum pn4cl3 catalyzes', 'coa thioester formation', 'piperic acids cll leusm hematology']\n",
      "['new article', 'chronic lymphocytic leukemia', 'cll leusm hematology']\n",
      "['new article', 'real world evidence', 'chronic lymphocytic leukemia', 'therapies cll leusm hematology']\n",
      "['new article chimeric antigen receptor t cells', 'chronic lymphocytic leukemia', 'cure cll leusm hematology']\n",
      "['new article resistance mechanisms', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article cost effectiveness', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article relevance', 'minimal residual disease', 'agents cll leusm hematology']\n",
      "['new article bcl', 'future cll leusm hematology']\n",
      "['new article phosphatidylinositol', 'kinase inhibitors', 'future cll leusm hematology']\n",
      "['international collaboration approves', 'new treatment option']\n",
      "['fda approves', 'new treatment', 'chronic lymphocytic leukemia ash19']\n",
      "['sad financial reality', 'cancer patients', 'chronic cancers', 'financial challenge']\n",
      "['phd nightmare', 'lumilab cll']\n",
      "['chronic lymphocytic leukemia', 'hematological malignancies', 'family history']\n",
      "['clinical evaluation', 'novel agents', 'new combinations', 'therapies amp', 'new indications', 'current therapeutics', 'clinical outcomes', 'hematological malignancies']\n",
      "['cll s twist', 'meal students parents', 'pie day', 'various pies', 'local establishments escnj cll']\n",
      "['statistical analysis', 'cll cryptoliveleaktoken cll', 'reward users', 'campaigns impressions', 'views clicks']\n",
      "['chronic lymphocytic leukemia cll', 'white blood cell', 'b cells', 'treatment options']\n",
      "['international collaboration approves', 'new treatment option', 'chronic lymphocytic leukemia healthinnovations pharma health stocks']\n",
      "['newmonographmonday truxima', 'positive b cell non hodgkin lymphoma cd20', 'positive b cell non hodgkin lymphoma cd20', 'positive b cell non hodgkin lymphoma cd20', 'positive chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['good thing', 'cll lymphoma ublituximab amp umbralisib', 'refractory b cell non hodgkin lymphoma amp cll', 'nice work']\n",
      "['gene signature', 'identify treatment naive patients', 'fcr chemoimmunotherapy leusm']\n",
      "['recent cll treatment advances dr kerry rogers', 'james discusses', 'research leusm cll cllsm bloodcancer']\n",
      "['florida woman', 'positive spirit', 'bloodcancer diagnosis', 'betty s journey', 'chronic lymphocytic leukemia cll', 'common type', 'u s']\n",
      "['oral agents duvelisib', 'dr jennifer crombie explore', 'refractory cll sll cll']\n",
      "['thanks jasonk', 'cll lt 5g l', '1g l igg', 'normal increases risk']\n",
      "['new clinical trial study', 'lucar 20s', 'r r nhl cll leusm hematology']\n",
      "['malignancy risk', 'leukemia survivors chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukemia epidemiology', 'chronic lymphocytic leukemia epidemiology', '2027summarychronic lymphocytic leukemia cll', 'international statistical classification']\n",
      "['stat3 promotes chronic lymphocytic leukemia progression', 'smyd3 expression']\n",
      "['fda approves', 'new treatment', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'oncologist appointment']\n",
      "['astrazeneca leverages rtor amp', 'fast track', 'cll drug healthcare']\n",
      "['chronic lymphocytic leukemia']\n",
      "['hello guys jamie', 'chronic lymphocytic leukemia plz donate']\n",
      "['artificial neural network', 'chronic lymphocytic leukemia']\n",
      "['day s events', 'hematology experts', 'pm est', 'sunday december', 'mantle cell lymphoma ash2019 cll']\n",
      "['rapid umrd responses', 'r r cll sll', 'lisocabtagene maraleucel', 'car t cell product', 'high risk disease']\n",
      "['wcrf aicr cancer prevention guidelines', 'chronic lymphocytic leukemia', 'mcc spain study']\n",
      "['natural prevention', 'chronic lymphocytic leukemia']\n",
      "['monthly theme', 'alessandra ferrajoli', 'novel prognostic factors', 'cll lymsm']\n",
      "['torneoclausura soldeamerica vs cll finaaaaaaaaaaaal', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'gooooool liz pe', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'gooooool stephanie lacoste unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'claudia romero por griselda garay unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'nairelis guti rrez por laurie cristaldo unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'yanina l pez por karina vega unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'gooooool liz pe', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'gooooool joana galeano unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll segundo tiempo', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'final del primer tiempo', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'gooooool karina vega unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura soldeamerica vs cll inici el partido', 'unidasporelobjetivo cllpy']\n",
      "['cll treatments', 'real world evidence']\n",
      "['natural prevention', 'chronic lymphocytic leukemia']\n",
      "['new article adherence', 'wcrf aicr cancer prevention guidelines', 'chronic lymphocytic leukemia', 'mcc spain study cll leusm hematology']\n",
      "['new article', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['wcrf aicr cancer prevention guidelines', 'chronic lymphocytic leukemia', 'mcc spain study lymphoma lymsm']\n",
      "['chronic lymphocytic leukaemia cll leusm']\n",
      "['bone marrow', 'acute lymphoblastic leukemia', 'acute myeloid leukemia', 'chronic lymphocytic leukemia fluke']\n",
      "['sao paolo', 'exciting educational event', 'cll mcl']\n",
      "['chemotherapy foundation symposium dr richard furman', 'prognostic markers', 'chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukemia cll', 'b cells']\n",
      "['video biosimilars', 'pharmacy practice trastuzumab rituximab', 'isopp2019 bopa19 oncopharm pharmacist cancertreatment lymphoma cll']\n",
      "['cll patient jay', 'care partner maureen', 'blood tests', 'active lifestyle', 'chronic cancer cll patientpower']\n",
      "['chronic lymphocytic leukemia cll', 'betty s story']\n",
      "['rns aim cll cello health plc']\n",
      "['cancer non hodgkin lymphoma', 'large diffuse b cell follicullar lymphoma cutaneous t cell anapalastic t cell chronic lymphocytic leukemia', 'small lymphocytic lymphoma mantle cell lymphoma primary', 'central nervous system cns lymphoma']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['spanish club', 'new article', 'academic journal estudios sobre el mensaje period stico']\n",
      "['cll patients', 'annual cll patient education forum', 'fantastic partnership']\n",
      "['non hodgkin s lymphoma nhl chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma', 'non hodgkin s lymphoma']\n",
      "['international collaboration approves', 'new treatment option', 'cll projectorbis hemonc oncology']\n",
      "['natural prevention', 'chronic lymphocytic leukemia']\n",
      "['white matter fda biotech pml mab monoclonal drugs cancer cll neurology']\n",
      "['new article treatment naive cll lessons', 'clinical trials cll leusm hematology']\n",
      "['new article', 'fatal legionella pneumophila serogroup', 'pleural empyema', 'case report cll leusm hematology']\n",
      "['new article', 'bioanalytical methods', 'chronic lymphocytic leukemia drugs', 'biological matrices cll leusm hematology']\n",
      "['new article', 'chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['new article bcl2', 'gene discovery', 'treatment cll leusm hematology']\n",
      "['new treatment option', 'chronic lymphocytic leukemia']\n",
      "['richter s syndrome', 'richter s transformation', 'sudden transformation', 'aggressive form', 'large cell lymphoma morphologymonday cll leukaemia underthescope']\n",
      "['international collaboration approves', 'new treatment option', 'chronic lymphocytic leukemia']\n",
      "['new cases', 'new cases', 'leukemia delveinsight', 'details visit']\n",
      "[]\n",
      "['new treatment option', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['dr furman', 'prognostic markers', 'chronic lymphocytic leukemia leusm']\n",
      "['international collaboration approves', 'new treatment option', 'chronic lymphocytic leukemia cll sll']\n",
      "['brain cancer pml cll mabs']\n",
      "['terrific news', 'cll patients', 'treatment option alcalabrutinib']\n",
      "['international collaboration approves', 'new treatment option', 'chronic lymphocytic leukemia fda']\n",
      "['new therapy', 'adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'subsequent therapy', 'advancement gt gt']\n",
      "['idea links', 'eye unit', 'emergent literacy', 'parents carers literacy readingforpleasure stories cll eytwittertagteam']\n",
      "['international collaboration approves', 'new treatment option', 'chronic l']\n",
      "['international collaboration approves', 'new treatment option', 'chronic lymphocytic leukemia']\n",
      "['dr justin taylor amp dr susan leclair', 'cll prognostic markers chromosomal deletion 17p amp', 'current clinical trials', 'negative state cll patientpower']\n",
      "['international collaboration approves', 'new treatment option', 'chronic lymphocytic leukemia']\n",
      "['international collaboration approves', 'new treatment option', 'chronic lymphocytic leukemia']\n",
      "['fda approves', 'new treatment option', 'chronic lymphocytic leukemia cll']\n",
      "['project orbis', 'new treatment option', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['international collaboration approves', 'new treatment option', 'chronic lymphocytic leukemia']\n",
      "['international collaboration approves', 'new treatment option', 'chronic lymphocytic leukemia']\n",
      "['international collaboration approves', 'new treatment option', 'chronic lymphocytic leukemia']\n",
      "['active role', 'bloodcancer journey', 'chronic lymphocytic leukemia cll']\n",
      "['international collaboration approves', 'new treatment option', 'chronic lymphocytic leukemia pharma regulatory']\n",
      "['international collaboration approves', 'new treatment option', 'chronic lymphocytic leukemia']\n",
      "['diagnosis gp learning modules', 'acute leukaemia aml', 'bloodcancer modules', 'cll cml lymphoma amp myeloma']\n",
      "['fda fda', 'international collaboration approves', 'new treatment option', 'chronic lymphocytic leukemia']\n",
      "['new health article', 'herbal turmeric', 'natural prevention', 'chronic lymphocytic leukemia']\n",
      "['bpth bio path holdings announces clearance', 'new drug application', 'bp1002 phase', 'clinical trial', 'chronic lymphocytic leukemia patients']\n",
      "['bpth bio path holdings announces clearance', 'new drug application', 'bp1002 phase', 'clinical trial', 'chronic lymphocytic leukemia patients']\n",
      "['new clinical trial study', 'japanese participants', 'b cell malignancies cll leusm hematology']\n",
      "['new clinical trial quality assurance', 'secondary immunodeficiencies sid', 'cll mm patients cll leusm hematology']\n",
      "['new article single agent ibrutinib', 'resonate versus treatments', 'real world phedra databases', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article genetic dynamics', 'cll patients', 'progressive disease', 'longitudinal study cll leusm hematology']\n",
      "['systematic synthetic phonics links', 'cache eye unit', 'emergent literacy criteria b1 eytwittertagteam literacy reading', 'communication cll']\n",
      "['bioanalytical methods', 'chronic lymphocytic leukemia drugs', 'biological matrices biomedchrom massspec']\n",
      "['immune cells', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['dr rai', 'chronic lymphocytic leukemia', 'elderly patient population cllsm leusm']\n",
      "['torneoclausura cll vs olimpia', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs olimpia', 'gooooool yanina l pez unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs olimpia', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs olimpia', 'gooooool karina vega unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs olimpia', 'gooooool griselda l pez unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs olimpia', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs olimpia', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs olimpia', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs olimpia', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs olimpia ya se juega el segundo tiempo', 'unidasporelobjetivo cllpy']\n",
      "['phase i', 'mcl patients', 'imbruvica healthcare']\n",
      "['torneoclausura cll vs olimpia', 'final del primer tiempo', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs olimpia', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs olimpia', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs olimpia', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs olimpia', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs olimpia partido', 'unidasporelobjetivo cllpy']\n",
      "['scan results cup', 'cll sur rcn esp stx oap3 pin fif thrl lxi kgh apgn scin cpg pac ntbr']\n",
      "['week eyfs eyfstwitterpals rhyme']\n",
      "['clinical studies', 'geniune trial nct02301156', 'high risk cytogenetic', 'positive results oncology']\n",
      "['cll studies', 'ecog bellow', 'preceptorship gerihemo lecture', 'dr goede data']\n",
      "['ibrutinib monotherapy', 'total health care costs']\n",
      "['ibrutinib monotherapy', 'total health care costs']\n",
      "['important part', 'chronic lymphocytic leukemia treatment', 'excellent therapies', 'cancer patients', 'weight gain', 'progress cll bloodcancer wellness anticancer']\n",
      "['chronic lymphocytic leukemia']\n",
      "['tumor immune evasion', 'disease progression', 'chronic lymphocytic leukemia', 'impressive study', 'mouse cll model', 'strong translational aspect']\n",
      "['don t look', 'chronic illness cll chroniclymphocyticleukemia']\n",
      "['b cell', 'specific irf4 deletion accelerates chronic lymphocytic leukemia development', 'tumor immune evasion']\n",
      "['camino cll sll texas oncology plano presby']\n",
      "['upper bollinger band']\n",
      "['complex karyotype', 'overall survival', 'chronic lymphocytic leukemia']\n",
      "['monthly theme', 'gene expression signature', 'distinguish patients', 'term remissions', 'front line fcr chemoimmunotherapy', 'alternative regimens lymsm']\n",
      "['esse ano tem denovo meu respeito ao rap', 'blumenau cll palavradehonra racioc niohumano homic dioverbal rapnocruzeiro vg magnotex']\n",
      "['review paper', 'hem lymsm oncology']\n",
      "['immune cells', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'zou yx zhu hy li xt xia y miao kr zhao ss wu yj wang l xu w li jy']\n",
      "['new article pneumocystis pneumonia', 'multiple sclerosis cll leusm hematology']\n",
      "['new article intraepidermal nerve fiber density', 'postmortem skin', 'novel approach cll leusm hematology']\n",
      "['new article', 'metabolic profiles', 'hematological malignancies cll leusm hematology']\n",
      "['new article holistic approach', 'millenium cll leusm hematology']\n",
      "['new article atypical primary cutaneous cryptococcosis', 'ibrutinib therapy', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['immune cells', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma lymphoma lymsm']\n",
      "['chronic lymphocytic leukemia cll', 'molica hematological oncology wiley online library']\n",
      "['personal stories', 'good science work', 'course stay stylish immunology cll']\n",
      "['cll leuk mie onkologie']\n",
      "['cll cll cryptoliveleaktoken erc20 tokens', 'wordpress dm']\n",
      "['clinical evaluation', 'novel agents', 'new combinations', 'therapies amp', 'new indications', 'current therapeutics', 'clinical outcomes', 'hematological malignancies']\n",
      "['old patients gt 80y w cll', 'key point', 'pathways bellow', 'excellent lecture', 'dr goede preceptorship cll gerihemo']\n",
      "['tumour activity', 'glycodendrimer nanoparticles', 'subcutaneous mec', 'xenograft model', 'human chronic lymphocytic leukemia']\n",
      "['new clinical trial muscle dysfunction', 'hematological diseases', 'stem cell transplant cll leusm hematology']\n",
      "['light chain iglv3', 'new poor prognostic subgroup', 'chronic lymphocytic leukemia results', 'multicenter study']\n",
      "[]\n",
      "[]\n",
      "['new article', 'tumour activity', 'glycodendrimer nanoparticles', 'subcutaneous mec', 'xenograft model', 'human chronic lymphocytic leukemia cll leusm hematology']\n",
      "['allo sct', 'cll high risk patients', 'therapy sequence', 'car t', 'new target drugs']\n",
      "['role play', 'weeks story', 'cll imaginations whatevernext']\n",
      "['cancer stem cells', 'immune inhibitory receptors', 'chronic lymphocytic leukemia cll', 'metastatic cancers', 'pm genome discovery']\n",
      "['care partners', 'regular blood tests', 'monitordisease progress', 'couple manages', 'routine ups', 'downs bloodtests anxiety']\n",
      "['paolo ghia', 'optimize patient stratification', 'cll hematology meeting', 'janssen cilag']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['year olds', 'whole afternoon nurseryrhymes humptydumpty stem cll eyfs literacy', 'favourite rhyme']\n",
      "['eshcll2020 translational research conference', 'chronic lymphocytic leukaemia cll abstract submission', 'open march', 'paris france chairs p ghia submit']\n",
      "['susan o brien md', 'risk patients']\n",
      "['final results', 'phase iii study', 'open label idelalisib', 'chronic lymphocytic leukemia']\n",
      "['cll wizyta u hematologa prosz pana jedena cie lat po chemii nie widzia em jeszcze tak dobrych wynik w tu nie ma si', 'czego przyczepi tu nic nie ma niechaj ju tak zostanie']\n",
      "['ibtihel rayen waaaaw malla google pixel', 'mayetkassrouch jemla key cll']\n",
      "['chronic lymphocytic leukemia cll', 'cll leusm']\n",
      "['torneoclausura dvocapiata vs cll finaaaaal', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'st yanina l pez por liz pe', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll 2do tiempo', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'final del primer tiempo', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'karina vega unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura dvocapiata vs cll ya se juega', 'unidasporelobjetivo cllpy']\n",
      "['dr concannon', 'cancrr care', 'excellent tips', 'cancer diagnosis cll cancer ccw']\n",
      "['new article ibrutinib', 'chronic lymphocytic leukemia cll', 'cll leusm hematology']\n",
      "['new article efficacy', 'cancer immunotherapy', 'umbrella review', 'meta analyses', 'trials cll leusm hematology']\n",
      "['dr kanti rai', 'lifetime achievement award', 'giant congratulations cll raicriteria']\n",
      "['vit d insufficiency amp prognosis', 'chronic lymphocytic leukemia cll nov', 'shanafelt drake', 'cllsm leusm supponc geriheme']\n",
      "['allogeneic haploidentical blood', 'marrow transplantation', 'posttransplant cyclophosphamide', 'chronic lymphocytic leukemia allogeneic blood', 'marrow transplantation allobmt', 'chronic lymphocytic leukemia cll']\n",
      "['dr louise concannon', 'own stress bottle']\n",
      "['descriptive analysis', 'refractory chronic lymphocytic leukemia', 'canadian centre']\n",
      "['dr amjat hayat', 'galway university hospital', 'incredible insights', 'cll treatments', 'individual journey']\n",
      "['ibtk immunesystem immunosurveillance cll hi19', 'interesting talk', 'jos terol']\n",
      "['frontline therapy', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['new article allogeneic haploidentical blood', 'marrow transplantation', 'post transplant cyclophosphamide', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article idelalisib addition', 'bendamustine rituximab', 'patients results', 'trial cll leusm hematology']\n",
      "['new article', 'frontline therapy', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'treatment outcomes', 'chronic lymphocytic leukemia cll', 'chemoimmunotherapy cll leusm hematology']\n",
      "['new article high frequency', 'chronic lymphocytic leukemia', 'monoclonal b cell lymphocytosis', 'japanese descendants', 'brazil cll leusm hematology']\n",
      "['new article idelalisib', 'refractory chronic lymphocytic leukemia cll leusm hematology']\n",
      "['torneoclausura cll vs independiente', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs independiente inici el segundo tiempo', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura cll vs independiente', 'final del primer tiempo', 'unidasporelobjetivo cllpy']\n",
      "['chronic lymphocytic leukemia', 'diagnosis risk stratification', 'treatment american journal']\n",
      "['torneoclausura cll vs independiente partido', 'unidasporelobjetivo cllpy']\n",
      "['dr brian koffman', 'good friend', 'ireland s cll community shares', 'new video']\n",
      "['lifelong learning s rummage sale', 'school s greenhouse way', 'cll escnj cll']\n",
      "['blood spotlight venetoclax', 'frontline treatment', 'chronic lymphocytic leukemia cll']\n",
      "['flashback friday', 'corporate counsel', 'bitter end rock amp roll club', 'musical trademark cle program fbf acc bitterend cowanliebowitzlatman cle4good teachrock cle cll']\n",
      "['frontline treatment', 'chronic lymphocytic leukemia deborah m stephens blood']\n",
      "['roundup monsanto bayer glyphosate weedkiller weeds herbicide nonhodgkinslymphoma nonhodgkins lymphoma chroniclymphocyticleukemia leukemia nhl cll thesteinberglawgroup steinberglawgroup steinberglaw lawyer law', 'legal lawfirm classaction']\n",
      "['bright future', 'cll therapy', 'encouraging research', 'treatment w', 'new drugs amp combinations', 'chronic lymphocytic leukemia patients']\n",
      "['full day', 'cco education', 'aml betathalassemia btkinhibitors cart cell cll hemophilia mpn myeloma']\n",
      "['social media', 'cll society cllsm cll']\n",
      "['new clinical trial tgr', 'treatment na ve patients', 'chronic lymphocytic leukemia cll cll leusm hematology']\n",
      "['new article destabilization', 'ror1 enhances activity', 'chronic lymphocytic leukemia', 'vivo cll leusm hematology']\n",
      "['new article', 'chronic lymphocytic leukemia', 'future rise', 'nationwide population', 'study cll leusm hematology']\n",
      "['new article comparison', 'b cell receptor inhibitors', 'refractory chronic lymphocytic leukemia', 'systematic review', 'network meta analysis cll leusm hematology']\n",
      "['new article selective inhibition', 'pi3k affects survival', 'chronic lymphocytic leukemia b cells cll leusm hematology']\n",
      "['new article tbet', 'th1 cd4 t cells accumulate', 'chronic lymphocytic leukaemia', 'disease progression', 'e tcl1 mice cll leusm hematology']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['new article ibrutinib ibr', 'venetoclax ven', 'line treatment', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll results', 'mrd cohort', 'captivate study cll leusm hematology']\n",
      "['new article ibrutinib', 'superior clinical outcome', 'chronic lymphocytic leukemia cll', 'e1912 trial cll leusm hematology']\n",
      "['new article', 'line treatment', 'chronic lymphocytic leukemia cll mmsm multiplemyeloma hematology']\n",
      "['chatterboxes language development', 'fantastic speaking amp', 'resources shop', 'gt eyfs earlyliteracy communication earlyyears']\n",
      "['new2trip venclexta', 'combo rituximab', 'chronic lymphocytic leukemia details']\n",
      "['chronic lymphocytic leukemia cll']\n",
      "['frontline treatment', 'chronic lymphocytic leukemia blood american society']\n",
      "['council s', 'intellectual property committee', 'nfl s', 'intellectual property counsel federalbarcouncil nationalfootballleague nfl cowanliebowitzlatman cll trademarks investigations']\n",
      "['frontline treatment', 'chronic lymphocytic leukemia nov', 'stephens cllsm ht']\n",
      "['ibrutinib venetoclax obinutuzumab', 'chemo immunotherapy', 'pragmatic review', 'cllsm lymsm']\n",
      "['incurable cancer fatigue', 'principal symptoms']\n",
      "['scan results cup', 'kgh tymn cll slpe sdl wpc bme trig pgit stx kgp esp arr bba aie brge']\n",
      "['cellular therapy', 'iwcll2019 cllsm celltherapy cll leusm']\n",
      "['overseas drugs', 'otc fda issues warning letter', 'dollar tree stores', 'unsafe drugs cll']\n",
      "['cll venetoclax amp obinutuzumab', 'frontline treatment', 'chronic lymphocytic leukemia spotlight', 'great overview']\n",
      "['green tea extract', 'initial clinical trials', 'chronic lymphocytic leukemia laboratory research', 'green tea extract', 'chronic lymphocytic leukemia cells cshealthservices leukemia greentea']\n",
      "['new article molecular', 'neoplastic b lymphocytes', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article', 'novel target', 'chronic lymphocytic leukaemia cll leusm hematology']\n",
      "['s visit', 'hot topics', 'cll ighv mutation status combinations', 'tx amp optimal duration umrd', 'pts lots', 'great work']\n",
      "['open nordic', 'educational meeting', 'cll oslo april', 'barbara eichhorst carol moreno adrian wiestner nicholas chiorazzi maryam sarraf yazdy ncllsg2020']\n",
      "['chronic lymphocytic leukemia treatment market', 'global growth insights trends size share']\n",
      "['rns aim cll cello health plc']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['allogeneic haploidentical blood', 'marrow transplantation', 'post transplant cyclophosphamide', 'chronic lymphocytic leukemia']\n",
      "['600k grant aims', 'research models', 'chronic lymphocytic leukemia cells', 'new therapies']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['cll cll cryptoliveleaktoken check', 'redirect users']\n",
      "['scan results cup', 'cll bme ekf iom ung', 'slpe brge stx epg polr wpc apgn kgh crei itv']\n",
      "['chronic lymphocytic leukemia', 'treatment options', 'teva pharmaceuticals']\n",
      "['chronic lymphocytic leukemia doctor appointments', 'doctor discussion', 'teva pharmaceuticals']\n",
      "['chronic lymphocytic leukemia cll', 'teva pharmaceuticals']\n",
      "['chronic lymphocytic leukemia doctor s appointment feeling', 'doctor discussion', 'teva pharmaceuticals']\n",
      "['io wallet', 'native cryptocurrency cll cll cryptoliveleaktoken']\n",
      "['erc20 cll cll cryptoliveleaktoken']\n",
      "['cll cll cryptoliveleaktoken']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['bendamustine monotherapy', 'line treatment', 'chronic lymphocytic leukemia polish lymphoma research group', 'real life analysis lymphoma lymsm']\n",
      "['new article safety', 'bendamustine monotherapy', 'line treatment', 'chronic lymphocytic leukemia polish lymphoma research group', 'real life analysis cll leusm hematology']\n",
      "['new article pdq cancer information summaries cll leusm hematology']\n",
      "['new article pdq cancer information summaries cll leusm hematology']\n",
      "['rns aim cll cello health plc total']\n",
      "['dr brian hill', 'definition leusm cllsm bloodcancer sll']\n",
      "['chris stevick', 'chronic lymphocytic leukemia cll', 'non hodgkin lymphoma groundwardoc glyphosate herbicides pesticides cancer monsanto']\n",
      "['cll amp fl']\n",
      "['s dr hossein khiabanian', '600k translational award', 'cancer research', 'molecular evolution', 'treatment impact', 'chronic lymphocytic leukemia']\n",
      "['jennifer r', 'brown md phd', 'del 11q cll']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['cll es alegr']\n",
      "['janssen announces health canada approval', 'imbruvica ibrutinib', 'treatment na ve patients', 'chronic lymphocytic leukemia']\n",
      "['combination treatments', 'novel agents', 'chronic lymphocytic leukemia haematologica']\n",
      "['chronic lymphocytic leukemia', 'diagnosis risk stratification', 'treatment hallek', 'american journal', 'hematology wiley online library']\n",
      "['hemato oncology market download', 'free ebook', 'hematology oncology mm multiplemyeloma cll dlbcl aml']\n",
      "['besoin d un rappel', 'connaissance sur', 'l h matologie oncologie t l chargez notre ebook mm myeloma cll leuc mie dlbcl lymphome aml']\n",
      "['human medicines european', 'public assessment report epar imbruvica ibrutinib lymphoma mantle cell leukemia lymphocytic chronic b cell date', 'authorisation revision agenparl agenparlenglish dirittogiustizia salute socialnetwork']\n",
      "['dr karmali', 'chair dr shammo stateofscience', 'line cll', 'waldenstroms chicago hematology']\n",
      "['blood tests', 'alphabet soup', 'prognostic indicators', 'cll treatment decisions', 'great video', 'clltreatment ighv fish chroniclymphocyticleukemi']\n",
      "['new drug application', 'line treatment', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma leusm leukemia']\n",
      "['tgtx phase', 'ibrutinib versus ibrutinib', 'high risk chronic lymphocytic leukemia cll nct02301156', 'primary completion date']\n",
      "['exceptional alsawah', 'intrathecal alemtuzumab', 'refractory leptomeningeal tpll', 'clear evidence', 'campath 1g', 'cns cll', 'interesting case report']\n",
      "['genetic events', 'chronic lymphocytic leukemia', 'word cloud']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['abbvie submits snda', 'imbruvica rituximab combo', 'br ibrutinib cll sll abbv']\n",
      "['week trna fragment signature', 'chronic lymphocytic leukemia genomic sites', 'ultraviolet radiation']\n",
      "['cll patients', 'dr brian hill', 'leusm cllsm bloodcancer']\n",
      "['wide association study', 'igm antibody', 'phenotypic relationship', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll', 'additional chemotherapy', 'free option']\n",
      "['prognostic factors', 'soc evolution', 'frontline setting', 'cll updates', 'soh02019 lymsm']\n",
      "['subcellular fractionation', 'primary chronic lymphocytic leukemia cells', 'nuclear cytoplasmic protein']\n",
      "['hey fellow', 'curious types', 'cll fnce session adler7 amp', 'don t']\n",
      "['new clinical trial t cells', 'cd20 chimeric antigen receptors', 'b cell malignancies', 'hodgkin lymphoma cll leusm hematology']\n",
      "['new clinical trial', 'clinical outcomes', 'relapse refractory chronic lymphocytic leukemia cll patients', 'greece cll leusm hematology']\n",
      "['new article', 'diagnostic chronic lymphocytic leukemia', 'flow cytometry cll leusm hematology']\n",
      "['new article subcellular fractionation', 'primary chronic lymphocytic leukemia cells', 'nuclear cytoplasmic protein', 'cll leusm hematology']\n",
      "['new article', 'complete resolution', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article descriptive analysis', 'refractory chronic lymphocytic leukemia', 'canadian centre cll leusm hematology']\n",
      "['complete resolution', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['descriptive analysis', 'refractory chronic lymphocytic leukemia', 'canadian centre lymphoma lymsm']\n",
      "['new treatment options']\n",
      "['real tonic', 'info entrechem asturias', 'mithralog ec', 'induces chronic lymphocytic leukemia cell death', 'tonic b cell receptor', 'bcells leukemia bcr']\n",
      "['new options', 'line treatment', 'chroniclymphocyticleukemia dana farber cancer institute']\n",
      "['rutgers researcher', 'chronic lymphocytic leukemia']\n",
      "['expert access', 'expert cll physician', 'advice enroll', 'myexpertaccess cll cllsm']\n",
      "['scan results cup', 'cll sur pin edin polr pli epg ascl itv qtx mrch eqn ung kay hstg arr']\n",
      "['cll genetic test results lead', 'effective treatment options', 'explanatory video', 'care leusm cllsm bloodcancer', 'del11q del17p ighv']\n",
      "['new drug application', 'ibrutinib rituximab combo', 'line treatment']\n",
      "['cll specialist dr brian hill', 'leusm cllsm bloodcancer']\n",
      "['patients voice', 'positive impact', 'cll community']\n",
      "['dual btk', 'mdm2 inhibition', 'chronic lymphocytic leukemia cells']\n",
      "['jennifer r', 'brown md phd', 'novel therapy']\n",
      "['monthly theme', 'cll lymsm leusm']\n",
      "['don t', 'apto s cg', 'flt3 aml', 'btk driver kinase cll nhl amp', 'flt3 driver kinase', 'aml precision spares safety targets amp pathways']\n",
      "['new article chemoimmunotherapy practice patterns', 'chronic lymphocytic leukemia impact', 'baseline characteristics', 'treatment choices cll leusm hematology']\n",
      "['new article car t', 'drugs immune checkpoint inhibitors', 'precision medicine', 'new era', 'cancer therapy cll leusm hematology']\n",
      "['line treatment', 'chronic lymphocytic leukemia cll leusm']\n",
      "['final results', 'open label phase ii gibb study', 'obinutuzumab bendamustine', 'cll leusm']\n",
      "['year analysis', 'murano study confirms', 'venetoclax rituximab venr', 'refractory r r cll leusm']\n",
      "['rapid dose escalation', 'refractory chronic lymphocytic leukemia', 'b cell receptor inhibitor therapy leusm cll']\n",
      "['paper ibrutinib', 'superior clinical outcome', 'chronic lymphocytic leukemia cll', 'e1912 trial leusm cll']\n",
      "['uk ibrutinib non trial data', '1st relapse mcl n', 'median 72y', 'sct 1l mpfs 1l', '4m orr', '5m pod24 1l gt pfs', 'tox v diff', 'great wk dr mcculloch simon ash19']\n",
      "['torneoclausura sp vs cll', 'final del partido', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura sp vs cll empieza el st', 'unidasporelobjetivo cllpy']\n",
      "['cll events', 'good way', 'treatment options', 'galway lookin']\n",
      "['torneoclausura sp vs cll', 'final del primer tiempo', 'paola genes griselda garay damia cortaza fabiola sandoval karina vega x3 y liz pe', 'unidasporelobjetivo cllpy']\n",
      "['salvage therapy', 'allogeneic hct', 'chronic lymphocytic leukemia cll']\n",
      "['information amp support', 'cll community', 'clinical psychologist', 'cll expert dr amjad hayat', 'galway s ardilaun hotel']\n",
      "['torneoclausura sp vs cll partido', 'unidasporelobjetivo cllpy']\n",
      "['nvs phase', 'ofatumumab methylprednisolone', 'ofatumumab lenalidomide', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll nct01497496', 'primary completion date']\n",
      "['chronic lymphocytic leukemia', 'richter transformation']\n",
      "['salvage therapy', 'allogeneic hct', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['new article', 'cd4 pd', 'hla dr t cells', 'disease progression', 'cll cll leusm hematology']\n",
      "['new article safety', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article b cell prolymphocytic leukemia case report', 'therapeutic forefront cll leusm hematology']\n",
      "['new article ibrutinib', 'salvage therapy', 'allogeneic hct', 'chronic lymphocytic leukemia cll leusm hematology']\n",
      "['new article immunomodulatory effect', 'fungal infections cll leusm hematology']\n",
      "['ibrutinib fludarabine cyclophosphamide', 'chronic lymphocyt']\n",
      "['series allosct post novel agents', 'r r cll allo', 'viable curative option', 'impact outcome cll status allo hct ci', 'important predictors gt pfs', 'important international collaboration', 'others ash19']\n",
      "['computational prediction', 'chronic lymphocytic leukemia gi2019']\n",
      "['chronic lymphocytic leukemia cll genomics england pilot data wgs', 'variants filter annotate gt identify driver', 'genes non', 'promoters enhancers gi2019']\n",
      "['chronic lymphocytic leukemia', 'women patients', 'tp53 mutation', 'refractory cll', 'marker gi2019']\n",
      "['chronic lymphocytic leukemia cll hypogammaglobulinemia']\n",
      "['r sultats lections cse emploi occitanie 1er snu avec', 'cfdt avec', 'fo avec', 'cgc avec', 'snap avec', 'cgt avec', 'sud avec', 'cftc avec', 'unsa avec', 'cll avec']\n",
      "['con tam pmcc rmh', 'present data', 'arm c', 'sequoia study zanubrutinib', 'treatment naive del 17p chronic lymphocytic leukemia', '3mo orr', 'progressions w cll sll', 'richters amp', 'g5 pneumonia ash19 cllsm']\n",
      "['llor y llor hasta que', 'lucha sigue aguante lxs que luchan sobre todo', 'primera l nea instaclown cll chileluchalibre luchalibrechilena instachile payasos estoeslucha']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['new drug application', 'line treatment', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma lymphoma']\n",
      "['notch1 activation correlates', 'chronic lymphocytic leukemia']\n",
      "['congratulations dr ferrajoli', 'cll expert', 'incredible physician', 'endcancer leusm']\n",
      "['pathways case study', 'chronic lymphocytic leukemia', 'subnephrotic range proteinuria core needle biopsy']\n",
      "['chronic lymphocytic leukemia', 'complete responses crs', 'cllsm leusm']\n",
      "['new drug application', 'u s fda', 'imbruvica ibrutinib']\n",
      "['pr ximo desaf o pr ximo partido para enfrentarlo juntas vamos cll unidasporelobjetivo cllpy']\n",
      "['ash2019 dr koffman', 'exciting results', 'expert access program cll cllsm']\n",
      "['janssen submits', 'new drug application', 'u s fda', 'chronic lymphocytic leukemia cll', 'common form']\n",
      "['cll dr koffman', 'confident self advocate cllsm']\n",
      "['biosimilar truxima', 'non hodgkin lymphoma chronic lymphocytic leukemia oncology cancer']\n",
      "['hsmn janssen announces submission', 'new drug application', 'u s fda', 'imbruvica r ibrutinib', 'chronic lymphocytic leukemia']\n",
      "['pfs hr', 'p value', 'acala monotherapy vs acala obinutuzimab', 'couldn t', 'abstract cll']\n",
      "['abbv submits snda', 'chronic lymphocytic leukemia']\n",
      "['new article', 'weerdt i hofland t lameris r', 'cll v 9v', 't cell fitness', 'cellular therapy', 'ex vivo activation', 'ibrutinib blood', 'cll leusm hematology']\n",
      "['new2trip rituximab', 'non hodgkin s lymphoma amp chronic lymphocytic leukemia details']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['salvage therapy', 'allogeneic hct', 'chronic lymphocytic leukemia']\n",
      "['hematology ash19', 'btk i', 'front line cll', 'proper choice']\n",
      "['good results i m', 'chronic lymphocytic leukemia i', 'cancer chemo medicine', 'remission cancersucks']\n",
      "['new ibrutinib fludarabine cyclophosphamide', 'chronic lymp']\n",
      "['ibrutinib fludarabine cyclophosphamide', 'chronic lymphoc']\n",
      "['salvage therapy', 'allogeneic hct', 'cll bone marrow transplantation leusm']\n",
      "['oral presentations', 'ibrutinib venetoclax', 'line treatment', 'refractory cll hematology hematology bloodcancer leukemia']\n",
      "['cll patient community', 'new data', 'treatment comparisons']\n",
      "['scan results cup', 'biln mmx aefs mnl tymn song ekf qtx pgit cll wpc dig epg cyn tune ascl']\n",
      "['scan results macd bullish centerline cross', 'cll sdry rr skin s32 phc bmpi sqn coa svst bnzl ule abdp tung ajb rdsa']\n",
      "['scan results macd bullish signal line cross', 'aefs sumo fipp g4m crl sro cll omi lre fog sdry tfw ygen geec bby rat']\n",
      "['richter s transformation', 'patients thanks', 'great information booklet', 'cll community']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['dr brian koffman co founder', 'undetectable minimal residual disease umrd', 'cll care']\n",
      "['new article gastrointestinal involvement', 'chronic lymphocytic leukemia cll leukemia hematology']\n",
      "['new article gemtuzumab ozogamicin', 'novel antibody drug conjugates', 'clinical trials', 'acute myeloid leukemia cll leukemia hematology']\n",
      "['new article richter syndrome', 'ibrutinib monotherapy', 'case reports cll leukemia hematology']\n",
      "['new article improvement', 'autoimmune cytopenia', 'chronic lymphocytic leukemia patient', 'monoclonal immunoglobulin deposition disease cll leukemia hematology']\n",
      "['new article clinical application', 'chronic lymphocytic leukemia cll leukemia hematology']\n",
      "['new article', 'positive predictive value', 'cd200 positivity', 'differential diagnosis', 'chronic lymphocytic leukemia cll leukemia hematology']\n",
      "['new article machine learning', 'discriminative gate locations', 'clinical diagnosis cll leukemia hematology']\n",
      "['new article pot1 tpp1', 'regulates telomerase', 'pot1 his266', 'telomere dna length cll leukemia hematology']\n",
      "['chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'trial studies', 'copanlisib work']\n",
      "['cll treatments', 'expert dr javier pinilla ibarz leusm cll cllsm bloodcancer del11q del17p ighv']\n",
      "['cell rna', 'characterizes t cell impairment', 'car t cells']\n",
      "['cell rna', 'characterizes t cell impairment', 'car t cells', 'cll oncology cancer']\n",
      "['medtweetorial tweetorial author boy type physiology', 'specialties nephrology renal neph oncology onc hemeonc topics pseudohyperkalemia hyperkalemia cll']\n",
      "['mimetic peptides', 'leukemic cd5 b cells', 'precursor nontumor cells lymphoidneoplasia']\n",
      "['new oncologist', 'years i m', 'good hands', 'miles vs', 'huge bonus', 'sci cll leukemia']\n",
      "['early stages', 'enhance cancer treatment response cll cancerpatients cancerdiet']\n",
      "['new cll combination treatment findings', 'month ash19', 'i m', 'cll news amp']\n",
      "['experts jennifer r', 'brown md phd bruce d cheson md facp faaas fasco susan o brien md', 'appropriate clinical end points', 'assess response', 'cll cll']\n",
      "['new btk sheriff', 'cll sharman']\n",
      "['new clinical trial bendamustine', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll leukemia hematology']\n",
      "['new clinical trial study', 'autologous peripheral blood lymphocytes', 'sll cll leukemia hematology']\n",
      "['new clinical trial cd20 cd19 compound car ccar t cells', 'refractory b cell malignancies cll leukemia hematology']\n",
      "['new clinical trial cd19 carvac t cells', 'refractory b cell malignancies cll leukemia hematology']\n",
      "['real world setting']\n",
      "['rap name', 'awkward chronic lymphocytic leukemia']\n",
      "['obinutizumab combo', 'potent option', 'cll patients']\n",
      "['ddpcr webinar', 'plcg2 resistance mutations', 'chronic lymphocytic leukemia', 'droplet digital pcr webinar cancer oncology detection register']\n",
      "['principal life insurance company', 'long term disability benefits', 'chronic lymphocytic leukemia', 'disability claim contact']\n",
      "['escnj cll halloween']\n",
      "['great summary', 'practice points', 'sunday fnce session', 'cll rdchat']\n",
      "['current problems', 'cancer journal', 'chronic lymphocytic leukemia', 'study gad md turkk']\n",
      "['apto cg', 'peripheral blood lymphocytes amp', 'tumor burden', 'multiple lesions pet scan', 'dose level cll patient', 'days treatment', 'positive imo']\n",
      "['useful information', 'causes symptoms', 'cll richters']\n",
      "['important real world collaboration', 'cll pts', 'line therapy btkis', 'btki naive pts', 'answers ash19 cll']\n",
      "['cll treatment', 'dr javier pinilla ibarz', 'outlines key factors', 'leusm cll cllsm bloodcancer']\n",
      "['disease chronic lymphocytic leukemia cll dr']\n",
      "['minimal residual disease mrd negativity', 'undetectable disease', 'important measure']\n",
      "['refractory peripheral t cell lymphoma cll sll']\n",
      "['btki activity post venetoclax n', 'series orr', 'btki naive post ven mpfs 32m i e', 'clear btki activity', 'post ven space 24m pfs2', 'intol gt', 'great team work cll ash2019']\n",
      "['apto ash19 abstract cg', 'class pan flt3 pan btk inhibitor exhibits', 'chronic lymphocytic leukemia cells']\n",
      "['dr jennifer', 'pi3k inhibitors', 'grand rounds']\n",
      "['chronic lymphocytic leukemia memory tool alem alemtuzumab lymphocytic chronic leukemia']\n",
      "['mithralog ec', 'induces chronic lymphocytic leukemia cell death', 'tonic b cell receptor', 'asturias publihuca', 'full text']\n",
      "['prof sebastian kobold muenchen uniklinikum reviews rr', 'cd19 car', 'cll dlbcl amp mech', 'resistance shows', 'car t cell improves therapeutic effect', 'xenografts models lesch', 'wic2019 sitc2019']\n",
      "['forgotten aspect', 'dr rai', 'cfs nyc']\n",
      "['high risk disease', 'rai design', 'prognostic marker', 'experience life', 'cfs nyc']\n",
      "['i ve', 'chemotherapy blues', 'cll i', 'different chemo drugs', 'side fx', 'chemo drugs i', 'different meds', 'side fx', 'side fx']\n",
      "['lymphoma t cells cash', 'atm atm activity', 't cells', 'immune surveillance', 'elegant study', 'ataxiatelangiectasia cll leukemia']\n",
      "['new drug', 'chronic lymphocytic leukaemia cll robert weinkove inst']\n",
      "['new2trip venclexta', 'combo rituximab', 'chronic lymphocytic leukemia details']\n",
      "['eddie robinson assistant fire chief', 'cherokee county', 'chronic lymphocytic leukemia', 'cherokee campus', 'northside staff']\n",
      "['early evidence', 'clinical responce', 'cll amp', 'dose escalations', 'interesting fact apto 122m mcap amp arql', '16b mcap']\n",
      "['apto cg', 'early evidence', 'clinical response', 'cll patient', 'dose level']\n",
      "['ibrutinib fludarabine cyclophosphamide', 'chronic lymphoc']\n",
      "['mithralog ec', 'induces chronic lymphocytic leukemia cell death', 'tonic b ce']\n",
      "['scan results cup', 'pog cll thrl sli wpc ibst arr lxi mrch pgit crwn smt brna cyn apgn stx']\n",
      "['scan results hammer candlestick', 'aty hyns cll dxrx agm hdd ntn wmh aatg air bab peb bmv arb ptec crwn']\n",
      "['data trial', 'chronic lymphocytic leukemia paul m barr md', 'associate professor', 'wilmot cancer institute discusses', 'recent cll', 'chronic lymphocytic leukemia cll']\n",
      "['severe shortage hits', 'cancer immune disorders epilepsy', 'cll cancerpatients epilepsy immunedisorders']\n",
      "['new campaign', 'fathers battle', 'chronic lymphocytic leukemia dallas']\n",
      "['primary malignancy', 'cll survivors']\n",
      "['flu shot', 'wasn t', 'immune systems', 'fightflu flushot cll']\n",
      "['cll patients', 'research dr danielle brander', 'advice leusm cllsm']\n",
      "['celg phase', 'ofatumumab methylprednisolone', 'ofatumumab lenalidomide', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll nct01497496', 'primary completion date']\n",
      "['postgraduate cll conference kicking', 'con tam', 'great interactions', 'expert faculty', 'updates cll bologna zinzani ercongressi']\n",
      "['celg phase', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll nct01446133', 'primary completion date']\n",
      "['green tea extract', 'initial clinical trials', 'chronic lymphocytic leukemia laboratory research', 'green tea extract', 'chronic lymphocytic leukemia cells csstaffingllc leukemia greentea']\n",
      "['jill clayburgh u s actress', 'chronic lymphocytic leukemia', 'devin patrick kelley kills', 'amp injures', 'sutherland springs texas']\n",
      "['cll leukaemia']\n",
      "['exciting amp', 'challenging times', 'patients amp', 'cll leukaemia', 'cll support', 'mission haematology bloodcancer charity']\n",
      "['cll leukaemia', 'cll support', 'memorable haematology charitytuesday']\n",
      "['charity rebrand', 'cll support', 'navigate website', 'new booklet leaflet amp logo cll leukaemia bloodcancer bloodcancerawareness haematology charitytuesday']\n",
      "['uk charity', 'education support amp advocacy', 'cll patients amp', 'cll support leukaemia bloodcancer charitytuesday']\n",
      "['exciting day', 'big step', 'members amp', 'online forum cll leukaemia charitytuesday']\n",
      "['ascentage pharma collaborate', 'combination therapy', 'chronic lymphocytic leukemia']\n",
      "['chemotherapy pct', 'cancer stem cells', 'immune inhibitory receptors', 'chronic lymphocytic leukemia cll', 'metastatic cancers genome discovery']\n",
      "['cancer stem cells', 'immune inhibitory receptors', 'chronic lymphocytic leukemia cll', 'metastatic cancer', 'pm genome discovery']\n",
      "['mithralog ec', 'induces chronic lymphocytic leukemia cell death', 'tonic b cell receptor', 'lorenzo herrero s sordo bahamonde c bretones g payer r gonz lez rodr guez ap gonz lez garc', 'e p rez escuredo j villa lvarez']\n",
      "['new article survival improvement', 'chronic lymphocytic leukemia cll', 'routine care', 'cll leukemia hematology']\n",
      "['new article', 'venetoclax therapy', 'elderly patients', 'refractory chronic lymphocytic leukaemia cll leukemia hematology']\n",
      "['new article', 'mithralog ec', 'induces chronic lymphocytic leukemia cell death', 'tonic b cell receptor', 'cll leukemia hematology']\n",
      "['new article cytochrome p450', 'physiological conditions cll leukemia hematology']\n",
      "['survival improvement', 'chronic lymphocytic leukemia cll', 'routine care', 'lymphoma lymsm']\n",
      "[]\n",
      "['new clinical trial', 'tgtx umbralisib', 'ublituximab u2', 'progressive cll', 'novel therapy']\n",
      "['droplet digital pcr webinar series', 'plcg2 resistance mutations', 'chronic lymphocytic leukemia', 'droplet digital pcr webinar cancer oncology detection register']\n",
      "['postgraduate cll conference', 'con tam', 'great interactions', 'expert faculty', 'updates cll bologna zinzani ercongressi']\n",
      "['ibrutinib fludarabine cyclophosphamide', 'chronic lymph leukemia']\n",
      "['michael j', 'chronic lymphocytic leukemia cllsm leukemia']\n",
      "['new data', 'dr cohen', 'chair stateofscience elevate update benefit', 'naive patient arm']\n",
      "['fun time', 'nuggets i ve', 'health monitor magazine stay', 'kate s awesome work healthmonitornetwork cll']\n",
      "['hematologists amp oncologists', 'medscapelive event', 'orlando fl', 'chronic lymphocytic leukemia w prof danielle brander', 'experts register']\n",
      "['similar safety', 'elderly patients', 'r r cll']\n",
      "['equivalent efficacy', 'elderly patients', 'rel ref cll']\n",
      "['open house', 'district representatives', 'amazing schools', 'independence cafe', 'delicious refreshments escnj cll']\n",
      "['treatment health care resource utilization', 'chronic lymphocytic leukemia', 'front line ibrutinib', 'chemoimmunotherapy lymphoma lymsm']\n",
      "['new article comparison', 'treatment health care resource utilization', 'chronic lymphocytic leukemia', 'front line ibrutinib', 'chemoimmunotherapy cll leukemia hematology']\n",
      "['cll diagnosis cll advocate dr brian koffman outlines key steps', 'cllsm bcsm']\n",
      "['elderly cll pts', 'venetoclax n', 'similar pfs os tls aes reasons', 'dc corroborates', 'trial venetoclax data', 'great uk', 'lymsm cll gerionc']\n",
      "['novel cll therapy', 'cll therapy']\n",
      "['practical talk', 'cll drug toxicity', 'bologna cll conference']\n",
      "['chronic form', 'bloodcancer mark credits', 'health care team']\n",
      "['connaissez vous', 'marc avec', 'leuc mielympho dechronique lisez son r cit', 'anglais au cll cancerdusang']\n",
      "['mark s journey', 'chroniclymphocyticleukemia cll bloodcancer']\n",
      "['postgraduate cll conference', 'bologna john seymour melbourne', 'excellent overview', 'cll leukemia leusm']\n",
      "['angela brooks ucsc', 'chronic lymphocytic leukemia emblcangen']\n",
      "['excellent overview', 'treatment regimens']\n",
      "['new clinical trial umbralisib', 'ublituximab u2', 'progressive cll', 'novel therapy cll leukemia hematology']\n",
      "['great talk', 'machine learning ai', 'complex genomic data', 'meaningful risk stratification personalisedmedicine gerc2019']\n",
      "['postgraduate cll conference', 'davide rossi s', 'excellent overview', 'predictive biomarkers leukemia leusm']\n",
      "['ibrutinib fludarabine cyclophosphamide']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['u cll']\n",
      "['cll community fatigue', 'common symptom', 'blood cancer', 'cure magazine']\n",
      "['primary cancers', 'chronic lymphocytic leukemia leukemia']\n",
      "['cll therapies', 'community michael j', 'chronic lymphocytic leukemia']\n",
      "['torneoclausura rp vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura rp vs cll gol', 'ang lica v zquez unidasporelobjetivo cllpy']\n",
      "['torneoclausura rp vs cll gol', 'angeles portillo unidasporelobjetivo cllpy']\n",
      "['torneoclausura rp vs cll gol', 'paola genes unidasporelobjetivo cllpy']\n",
      "['torneoclausura rp vs cll gol', 'carrasquel unidasporelobjetivo cllpy']\n",
      "['torneoclausura rp vs cll gol', 'karina vega unidasporelobjetivo cllpy']\n",
      "['torneoclausura rp vs cll gol', 'yanina l pez unidasporelobjetivo cllpy']\n",
      "['torneoclausura rp vs cll gol', 'yanina l pez unidasporelobjetivo cllpy']\n",
      "['torneoclausura rp vs cll gol', 'ang lica v zquez unidasporelobjetivo cllpy']\n",
      "['torneoclausura rp vs cll gol', 'karina vega unidasporelobjetivo cllpy']\n",
      "['torneoclausura rp vs cll inici el segundo tiempo', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura rp vs cll', 'primera etapa', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura rp vs cll gol', 'paola genes unidasporelobjetivo cllpy']\n",
      "['torneoclausura rp vs cll gol', 'fabiola sandoval unidasporelobjetivo cllpy']\n",
      "['torneoclausura rp vs cll gol', 'fabiola sandoval unidasporelobjetivo cllpy']\n",
      "['torneoclausura rp vs cll gol', 'paola genes unidasporelobjetivo cllpy']\n",
      "['torneoclausura rp vs cll gol', 'karina vega unidasporelobjetivo cllpy']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['torneoclausura rp vs cll gol', 'liza larrea unidasporelobjetivo cllpy']\n",
      "['torneoclausura rp vs cll gol', 'fabiola sandoval unidasporelobjetivo cllpy']\n",
      "['torneoclausura rp vs cll gol', 'karina vega y liz pe', 'unidasporelobjetivo cllpy']\n",
      "['torneoclausura rp vs cll partido', 'unidasporelobjetivo cllpy']\n",
      "['cll patients', 'trial car t', 's potential', 'increase consultant numbers', 'irish patient', 'new treatments']\n",
      "['high prognostic value', 'measurable residual disease detection', 'flow cytometry', 'chronic lymphocytic leukemia patients', 'front line fludarabine cyclophosphamide', 'rituximab maintenance']\n",
      "['chronic lymphocytic leukemia', 'political work']\n",
      "['new article', 'phase i ib studies', 'promising efficacy', 'r r b cell nhl', 'cll orr', 'total cohort', 'mzl patients lymsm lymphoma']\n",
      "['hazel thomas', 'chronic lymphocytic leukemia', 'select people', 'similar situation', 'hazel s story']\n",
      "['saturdaymotivation colorado bullet follome findjoy loveyourlife coloradomountains baileyco cll nevergiveup']\n",
      "['nutrition science wayne campbell thanks', 'fnce r t', 'foods cll']\n",
      "['cll pethema es hematology hematology']\n",
      "['ebv mir bhrf1', 'targets p53 gene potential role', 'epstein barr virus', 'chronic lymphocytic leukemia']\n",
      "['invasive genitourinary aspergillosis', 'chronic lymphocytic leukemia', 'venetoclax case report']\n",
      "[]\n",
      "['novel internal trna', 'rna fragment', 'new prognostic', 'chronic lymphocytic leukemia', 'innovative quantitative', 'real time pcr assay']\n",
      "['novel internal trna', 'rna fragment', 'new prognostic', 'chronic lymphocytic leukemia', 'innovative quantitative', 'real time pcr assay']\n",
      "['cll causes', 'james expert dr kerry rogers leusm cllsm bloodcancer']\n",
      "['high prognostic value', 'measurable residual disease detection', 'flow cytometry', 'chronic lymphocytic leukemia patients', 'front line fludarabine cyclophosphamide', 'rituximab maintenance']\n",
      "['uncommon neurological manifestation', 'chronic lymphocytic leukemia', 'extensive transverse myelitis']\n",
      "['novel internal trna', 'rna fragment', 'new prognostic', 'chronic lymphocytic leukemia', 'innovative quantitative', 'real time pcr assay']\n",
      "['recurrent gly101val mutation', 'bcl2 confers resistance', 'progressive chronic lymphocytic leukemia comment']\n",
      "['llscaregiver mark', 'amazing caregiver i', 'sick issues', 'low immunity']\n",
      "['different phases', 'clinical trials clinical research coordinator jeanne schaffer', 'phase i ii', 'trial process cll clinicaltrials']\n",
      "['cancer non hodgkin lymphoma', 'large diffuse b cell follicullar lymphoma cutaneous t cell anapalastic t cell chronic lymphocytic leukemia', 'small lymphocytic lymphoma mantle cell lymphoma primary', 'central nervous system cns lymphoma']\n",
      "['primary malignancy', 'cll survivors']\n",
      "['non hodgkin s lymphoma chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma', 'non hodgkin s lymphoma']\n",
      "['chronic lymphocytic leukemia cll patients', 'market research study', 'telephone interview', '11th november']\n",
      "['patienter taber og kan vi g re', 'forskel vores opgave er', 's rge', 'patienterne f r bedste', 'og kan vi g re', 'mere blodkr ft blodcancer rettigheder adgangtilmedicin', 'lymfekr ft leuk mi aml', 'cml cll mds cmml']\n",
      "['vi ser i den grad stor sociale uligheder i', 'og viden om blodkr ft blodcancer er meget lav hos patienter der har brug', 'hj lp p kr ftomr det rettigheder', 'qol lyle dk aml', 'cml cll lymfekr ft mds livskvalitet']\n",
      "['stem cells leukemia', 'lymphocytic leukemia differs', 'stem cells', 'chronic leukemia']\n",
      "['cll group', 'spirit happyhalloween', 'leukemia team endcancer leusm']\n",
      "['great costumes', 'school s halloween party', 'year escnj cll happyhalloween']\n",
      "['high prognostic value', 'measurable residual disease detection', 'flow cytometry', 'cll patients', 'front line fludarabine cyclophosphamide', 'rituximab maintenance leusm']\n",
      "['primary cancers', 'chronic lymphocytic leukemia']\n",
      "['impressive work', 'patient empowerment', 'cll certh eric']\n",
      "['daniel addison md', 'james discusses ibrutinib', 'bcellmalignancies cardiooncology oncology mantlecelllymphoma cll waldenstrom']\n",
      "['video iwcll', 'cll regimens', 'mrd w john seymour', 'iwcll19 cllsm hemonc btk']\n",
      "['ibrutinib discontinuation', 'refractory chronic lymphocytic leukemia', 'compassionate use program', 'polish adult leukemia study group palg lymphoma lymsm']\n",
      "['van rebre', 'lamarat tv3', 'cll gr cies', 'tots els donants', 'possible aquest projecte i']\n",
      "['november issue', 'cll oralcancer prostatecancer radonc rhabdomyosarcoma breastcancer coloncancer amp']\n",
      "['allogeneic transplant', 'chronic lymphocytic leukemia', 'historical experience bmtsm cllsm']\n",
      "['droplet digital pcr webinar series', 'plcg2 resistance mutations', 'chronic lymphocytic leukemia', 'droplet digital pcr webinar cancer oncology detection']\n",
      "['oncoalert ibrutinib', 'line treatment', 'cll lymsm leusm']\n",
      "['cll chronic lymphocytic leukemia', 'dna test', 'health risks', 'eastern european ashkenazi jewish bloodline']\n",
      "['stat3 promotes chronic lymphocytic leukemia progression', 'smyd3 expression']\n",
      "['scan results macd bearish centerline cross', 'mnl hsd mtr edr bp cne pin ika n4p mks omu cll evrh star']\n",
      "['stops don t squeeze', 'charmin cancer chemo colon sideeffects leukemia cll oncology probiotics scope bidet sundon tshine survivor cancersucks celiac gluten bloodtest']\n",
      "['full day', 'cco education', 'aml betathalassemia btkinhibitors cart cell cll hemophilia mpn myeloma']\n",
      "['expert dr farrukh awan', 'international workshop', 'cll iwcll', 'cll treatment', 'exciting advances', 'cll care cll cllsm']\n",
      "['renowned expert dr nicole lamanna', 'patient power', 'international workshop', 'cll iwcll', 'share treatment', 'research developments cll cllsm leukemia']\n",
      "['clinical trial', 'trial process', 'start clinicaltrials']\n",
      "['francesc bosch']\n",
      "['cll expert dr nicole lamanna', 'patient power', 'international workshop', 'cll iwcll', 'research developments', 'conference cll iwcll']\n",
      "['clluster banerji reports', 'full dose']\n",
      "['solid breastcancer ovariancancer amp', 'hematologic malignancies cll myeloma infectious diseases', 'hiv tbc fungal amp multiresistant bacteria amp', 'disorders resources']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['great turnout cllsm cll']\n",
      "['own dr brian koffman', 'cll society', 'retweet cll cllsm']\n",
      "['refractory chronic lymphocytic leukemia', 'clarity study']\n",
      "['ibrutinib venetoclax', 'clarity study', 'high rate', 'mrd eradiation', 'encouraging pfs', 'os rates', 'refractory cll']\n",
      "[]\n",
      "['leukemia experts', 's meaningful', 'cll patients', 'perspective cll iwcll19 leukemia']\n",
      "['such excellent questions', 'conversations cll']\n",
      "['dna methylation', 'implicates exposure', 'b cell chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['cll expert dr philip thompson shares', 'important takeaways', 'edinburgh scotland', 'dr thompson discusses novel cll combination therapies', 'new drug approval underway', 'car t cell therapy']\n",
      "['favorite slides', 'visual representation', 'agriculture fnce cll']\n",
      "['greenhouse gas inventory fnce cll']\n",
      "['nutrition education conversations fnce cll']\n",
      "['identity nutrition profile', 'shoppers navigate', 'nutrient perspective', 'important fnce cll']\n",
      "['meat products', 'packages implications', 'regulatory pov', 'food fnce cll']\n",
      "['proteins fnce cll']\n",
      "['nutrition professionals', 'foodsafety components', 'audiences navigate', 'choices fnce cll']\n",
      "['different cuts', 'fnce cll']\n",
      "['oh i', 'food groups', 'nutrient absorption', 'omelet boom fnce cll']\n",
      "['novedades llc tratamiento 1l cll dra baltasar']\n",
      "['nutrition package shifts', 'great variety', 'choices fnce cll']\n",
      "['protein choices', 'full package', 'protein dyk', 'top protein sources nhanes fnce cll']\n",
      "['protein power underway', 'protein options', 'choices fnce cll']\n",
      "['powerful package', 'future room', 'fnce cll moderators']\n",
      "['chronic lymphocytic leukemia cll patients', 'market research study', 'telephone interview', '11th november']\n",
      "['primary cancers', 'chronic lymphocytic leukemia medivizor']\n",
      "['barbara eichhorst highlights', 'cll data', 'ash19 incl novel novel combos phase ii trial updates amp car t', 'hematology cllsm leusm ctsm hemonc']\n",
      "['morning patart hemepath cll pathologists']\n",
      "['trial update clarity shows', 'good toxicity profile', 'r r cll', 'poor prognosis', 'cit orr', 'cr lt mrd4', 'lymsm cll lymphoma']\n",
      "['new2trip rituximab', 'non hodgkin s lymphoma amp chronic lymphocytic leukemia details']\n",
      "['chairpersons j', 'brown p ghia amp m hallek', 'edge esh translational research conference', 'chronic lymphocytic leukaemia eshcll2020', 'registration register', 'information cll haematology']\n",
      "['patienten mit cll haben ein h heres risiko f r eine zweite prim re krebserkrankung liegt das', 'der cll selber oder', 'der therapie eine aktuelle deutsche registerstudienanalyse hilft bei der aufkl rung dgho19']\n",
      "['favorite label thing', 'fnce myopinion superhelpful cll']\n",
      "['chronic lymphocytic leukemia', 'peter hillmen md phd', 'leeds institute', 'medical research', 'st james s', 'leusm venclexta cll']\n",
      "['excellent session', 'fnce cll']\n",
      "['expo hall', 'fda fnce cll']\n",
      "['consumers people', 'fnce cll']\n",
      "['label reboot session', 'practical updates', 'user consumer', 'friendly fnce cll']\n",
      "['massive figures', 'defender cll jt26']\n",
      "['personal feeling', 'venn diagrams kind', 'fnce cll fan ps foodsafetyrocks']\n",
      "['michael hallek chairman', 'scientific committee', 'lymphoid malignancies lymphoma cll eshcll2020']\n",
      "['breast cancer awareness month', 'lifelong learning', 'awful disease', 'cll staff', 'part escnj cll breastcancerawarenessmonth']\n",
      "['primary cancers', 'chronic lymphocytic leu']\n",
      "['dr john allan s interview', 'magazine membermondays']\n",
      "['john terry s', 'chelsea moments', 'blues debut cfc utc jt26 cll johnterry']\n",
      "['experts jennifer r', 'brown md phd bruce d cheson md facp faaas fasco', 'susan o brien md', 'consolidation maintenance therapy', 'era novel therapies cll']\n",
      "['chronic lymphocytic leukemia cll']\n",
      "['jeff neurman', 'chronic lymphocytic leukemia survivor shares', 'personal experiences', 'journey bloodcancer cancer cancersurvivor']\n",
      "['pim kinase inhibitor azd1208 inhibits protein translation', 'induces autophagy', 'primary chronic lymphocytic leukemia cells']\n",
      "['primary cancers', 'chronic lymphocytic leukemia']\n",
      "['primary cancers', 'chronic lymphocytic leukemia']\n",
      "['plcg2 resistance mutations', 'chronic lymphocytic leukemia', 'droplet digital pcr', 'chance webinar cancer oncology detection']\n",
      "['top story', 'primary cancers', 'chronic lymphocytic leukemia medivizor']\n",
      "['primary cancers', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll patients']\n",
      "['important things', 'delivery fnce cll']\n",
      "['beautiful work', 'food security', 'support people s needs', 'positive results', 'planet fnce cll']\n",
      "['precision medicine kind', 'crispr session w fnce cll']\n",
      "['adaptive immune system', 'bacteria fnce cll']\n",
      "['don t', 'fnce cll']\n",
      "['copy paste level', 'crispr fnce cll']\n",
      "['s time', 'fnce cll']\n",
      "['self care needs', 'self care', 'fnce cll']\n",
      "['don t', 'social media talk', 'consistent don t mimic', 'fnce cll']\n",
      "['different things fnce cll']\n",
      "['time fnce cll']\n",
      "['soft skills', 'matters fnce cll']\n",
      "['sound advice', 'fnce cll']\n",
      "['willkommen im team als', 'junior cloud security engineer m w x', 'industrial engineering jobs stellenangebote itsicherheit', 'mint bachelor', 'itsecurity itjobs app automation digital cll jobs']\n",
      "['full conversation fnce cll']\n",
      "['meal behavior', 'nutrition respect balance', 'treatment fnce cll']\n",
      "['s time', 'nutritional epidemiology fnce cll']\n",
      "['current session', 'fnce cll']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['drug amp trial updates', 'website lymsm']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['great visual', 'cooking wellness sustainability food agriculture', 'fnce cll']\n",
      "['banana ice cream fnce cll']\n",
      "['chain everywhere', 'nutrition convos', 'cll fnce']\n",
      "['shout outs', 'fnce cll']\n",
      "['agriculture chair', 'morning cll fcpdpgpastchair fnce']\n",
      "['lifelong learning', 'cll fnce']\n",
      "['attention twitter peeps i m', 'fnce i m', 'lifelong learning', 'i share', 'own thoughts', 'sessions i']\n",
      "['new way', 'chronic lymphocytic leukemia', 'peptides overcomes drug resistance novel cell death pathway']\n",
      "['gute besserung k bi kuhn sfl asf bei cll sind solche komplikationen m glich ch innovative therapien schaffen linderung und erm glichen', 'vielen f llen', 'wiedererlangung guter lebensqualit t']\n",
      "['chronic lymphocytic leukemia cll', 'primary malignancy spm', 'general population']\n",
      "['infectious complications', 'chronic lymphocytic leukemia', 'bcr inhibitors', 'retrospective single institution experience']\n",
      "['multiple myeloma cll', 'mantle cell', 'fortaleza road show ne multiplemyeloma cll mantlecelllymphoma lymsm']\n",
      "['monthly theme', 'effective chemotherapy', 'free option', 'line cll sll treatment', 'high risk populations results', 'phase iii illuminate trial lymsm cll']\n",
      "['chronic lymphocytic leukemia treatment', 'clinical trials', 'combination cllsm leukemia']\n",
      "['oncologist appt', 'mid point', 'chemo treatment', 'sheer volume', 'medications i need', 'battle cancer', 'll excuse', 'i need', 'morning pill brulee']\n",
      "['video immunoglobulin receptor', 'cll w stefano casola', 'iwcll2019 cll leukemia cancer']\n",
      "['b cell classification differentiation chronic lymphocytic leukemia b cell', 'normal cellular counterpart clues', 'functional perspective']\n",
      "['target therapies', 'different studies lecture', 'dr javier pinilla']\n",
      "['chronic lymphocytic leukemia ibrutinib', 'refractory chronic lymphocytic leukemia', 'clarity study jco', 'open access article']\n",
      "['long term ublituximab', 'ibrutinib results', 'pfs benefit', 'high risk cll leusm']\n",
      "['white blood cells', 'chronic lymphocytic leukaemia', 'elderly credit steve gschmeissner science photo library anatomy biology cancer leukemia oncology science microscopy']\n",
      "['offering people', 'cll experience', 'manchester register', 'gt lymphoma research']\n",
      "['term results', 'genuine study', 'free survival', 'high risk r r cll', 'ibrutinib monotherapy tgtx']\n",
      "['eosinophilic dermatosis', 'hematologic malignancy', 'chronic lymphocytic leukemia']\n",
      "[]\n",
      "['important data', 'important work', 'informcll registry']\n",
      "['great talk', 'cart vs allohct', 'cll sehhseth2019']\n",
      "['informcll registry highlight', 'cll treatment lymsm sharman']\n",
      "['key differences btn lymphocytic', 'myloid leukemia', 'cll aml cml haemoncology haematopathology']\n",
      "['free survival', 'independent review committee', 'refractory high risk chronic lymphocytic leukemia cllsm leukemia']\n",
      "['b cell', 'persistent lymphocytic']\n",
      "['piece i', 'current edition', 'cancer cancer cancer', 'cancerhumor leukemia cll findinghumorwithcancer']\n",
      "['b cell', 'widespread lymphocytic']\n",
      "['b cell vitality lymphocytic']\n",
      "['cll treatment', 'combo approaches', 'car tcell therapy william g wierda md phd discusses', 'treatment paradigm', 'chronic lymphocytic leukemia', 'novel approaches']\n",
      "['b cell chronic lymphocytic leukemia clinical trials', 'companies drugs phases subjects', 'current status', 'global clinical trial report', 'b cell chronic lymphocytic leukemia']\n",
      "['minor clone mutations', 'cll patients', 'line treatment w jitka mal kov', 'iwcll2019 cll leukemia cancer']\n",
      "['hemato oncology key points', 'hematology oncology mm multiplemyeloma cll dlbcl aml']\n",
      "['community oncologists', 'treatment landscape', 'chronic lymphocytic leukemia cllsm leusm']\n",
      "['exciting things', 'long impatient', 'labs journal', 'experiments video']\n",
      "['ecr europe rdaplenary14 grant winner maria tsagiopoulou', 'phd studies', 'topic epigenetic mechanisms', 'chronic lymphocytic leukemia meet']\n",
      "['tgtx announces', 'term results', 'genuine study', 'high risk', 'refractory chronic lymphocytic leukemia']\n",
      "['tg therapeutics announces', 'term results', 'genuine study']\n",
      "['recent cll video publication', 'jen cassels talent filmstars check', 'video article']\n",
      "['video geographic diversity', 'african patients w norah akinola', 'iwcll2019 cll leukemia cancer']\n",
      "['white blood cells', 'lymphoid cells', 'cll aml cml haematology leukemia']\n",
      "['primary malignancy']\n",
      "['jove subcellular fractionation', 'primary chronic lymphocytic leukemia cells', 'nuclear cytoplasmic protein']\n",
      "['cd47 peptide', 'resistant cll cells', 'original form', 'cell death', 'g proteins lymphoidneoplasia']\n",
      "['chronic lymphocytic leukemia non hodgkin lymphoma', 'hl patients', 'chronic lymphocytic leukemia non hodgkin lymphoma', 'hl patients']\n",
      "['cll cells ror', 'constitutive stat3', 'immunol stat3', 'chronic lymphocytic leukemia cells', 'survival advantage', 'nice work leukemia bcells ror1']\n",
      "['news verastem oncology', 'clinical data', 'cll sll', 'refractory marginalzonelymphoma']\n",
      "['thompson m b b s', 'leukemia endcancer leusm blood2019 cll']\n",
      "['qotw wie plant ihr eure offseason wir stellen euch', 'erste question', 'week und freuen uns auf eure antworten coacheslifelive cll americanfootballcoaches']\n",
      "['chronic lymphocytic leukemia expresses', 'unique set', 'targetable pathways']\n",
      "['nursery children', 'pumpkin i', 'seeds slime', 'super sticky', 'cold successfulstudents cll']\n",
      "['video ifcg', 'line treatment', 'cll w nitin jain', 'iwcll2019 cll leukemia cancer']\n",
      "['i m', 'car t cell therapy', 'cll cart endcancer']\n",
      "['chronic lymphocytic leukemia', 'hematologic malignancies cll']\n",
      "['scan results hammer candlestick', 'ghe jara sigt fjet farn cll duke bglp ela ful vlg hlma amyt mini aavc pcip']\n",
      "['refractory chronic lymphocytic leukemia', 'richter s transformation', 'phase i ii trial cllsm leusm']\n",
      "['finite treatment duration', 'chronic lymphocytic leukemia cll', 'time rt', 'cll care']\n",
      "['clinical trial', 'r r cll', 'high risk pfs', 'months orr', 'median os', 'months lymsm lymphoma cll']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['cmc coinmarketcap', 'cll cll']\n",
      "['cll cll cryproliveleaktoken']\n",
      "['tuesday night s', 'cancer chronic lymphocytic leukemia presentation', 'martha garcia s', 'dispatch rock island argus article', 'full scoop']\n",
      "['cme credits', 'medscapelive symposium', 'orlando fl', 'ash19 explore', 'chronic lymphocytic leukemia cll w', 'experts register']\n",
      "['video immunoglobulin receptor', 'cll w stefano casola', 'iwcll2019 cll leukemia bloodcancer']\n",
      "['potent stimulator', 'cll cells', 'proliferation migration', 'potent inhibitors', 'new discoveries']\n",
      "['novel treatment options', 'long term outcomes', 'btk inhibitors lymsm']\n",
      "['new2trip venclexta', 'combo rituximab', 'chronic lymphocytic leukemia details']\n",
      "['post appeals eqa summary report', 'individual laboratory report ilr', 'array eqa', 'results cll mds cnvdetection eqa']\n",
      "['excellent news', 'ibrutinib trial', 'long term efficacy amp safety', 'line ibrutinib treatment', 'cll sll', 'study leukemia']\n",
      "['dr wierda', 'community oncologists', 'treatment landscape', 'chronic lymphocytic leukemia leukemia hematology']\n",
      "['iwcll2019 insights w paolo ghia', 'cll leukemia cancer']\n",
      "['week s askalex', 's precisiononcology expert alex rolland answers', 'cancer amp', 'deep dive', 'lymphoma cll', 'new treatments amp advances cancerawareness knowledgeispower']\n",
      "['nyp amp s dr john allan', 'new treatment', 'chronic lymphocytic leukemia']\n",
      "['significant weight gain', 'cll patients', 'deleterious consequence', 'therapy leusm']\n",
      "['libertadoresfem cll vs corinthians', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs corinthians', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs corinthians', 'st joana galeano por liz pe', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs corinthians', 'st yanina lopez por liz pe', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs corinthians', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs corinthians', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs corinthians', 'st fiorella mart nez por laurie cristaldo unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs corinthians', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs corinthians inici el segundo tiempo', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs corinthians', 'final del primer tiempo', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs corinthians gooooooool', 'griselda garay unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs corinthians', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs corinthians', 'unidasporelobjetivo cllpy']\n",
      "['chronic lymphocytic leukemia']\n",
      "['libertadoresfem cll vs corinthians', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs corinthians gooooooool', 'liz pe', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs corinthians', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs corinthians', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs corinthians inici el partido', 'unidasporelobjetivo cllpy']\n",
      "['minor clone mutations', 'cll patients', 'line treatment w jitka mal kov', 'iwcll2019 cll leukemia bloodcancer']\n",
      "['refractory chronic lymphocytic leukemia', 'clarity study journal', 'clinical oncology']\n",
      "['chronic lymphocytic leukemia journal', 'clinical oncology']\n",
      "['roundup options', 'legal center', 'minnesota encourages users', 'non hodgkin s lymphoma', 'chronic lymphocytic leukemia', 'steinberg law group']\n",
      "['nfat2 expression results', 'clonal evolution', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['combination treatments', 'novel agents', 'chronic lymphocytic leukemia']\n",
      "['month sharon', 'support team', 'cll horizons conference', 'field gt cllhz19 cll lymphomamatters']\n",
      "['dr david maloney', 'potential use', 'car t cell therapies', 'fl mcl', 'website cll lymphoma lymsm']\n",
      "['november cll program', 'dr andrea miller']\n",
      "['car t cell', 'non hodgkin s b cell lymphoma', 'chronic lymphocytic leukemia']\n",
      "['i ll', 'nacada19 cll sdf louisville texpat easterwood airport']\n",
      "['great event', 'chronic lymphocytic leukemia click']\n",
      "['afternoon replay', 'town meeting viewers', 'advocacy supportive resources', 'cll cll patientpower']\n",
      "['askalex episode', 'precisiononcology expert alex rolland answers', 'cancer amp', 'deep dive', 'lymphoma cll', 'new treatments amp advances knowledgeispower']\n",
      "['immune cells cd19 cd20 car t cells', 'refractory b cell lymphoma', 'chronic lymphocytic leukemia']\n",
      "['blood cancers non hodgkin s lymphoma b', 't cell chronic lymphocytic leukemia mantle cell hairy cell', 'multiple myeloma', 'killer victims']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['cll leuk mie onkologie h matologie']\n",
      "['refractory cll conclusive results', 'good leusm']\n",
      "['minimal residual disease negativity', 'cll access', 'ahpra number']\n",
      "['cll access', 'ahpra number']\n",
      "['fda panel thumbs', 'urinary tract infections cll']\n",
      "['termina el partido', 'el atahualpa cll natalia pe', 'griselda pe', 'copalibertadoresfemenina desdelascanchasec']\n",
      "['libertadoresfem cll vs', 'unidasporelobjetivo cllpy']\n",
      "['carrasquel cll', 'copalibertadoresfemenina desdelascanchasec']\n",
      "['se adicionan', 'claudia romero joana galeano cll', 'yanina l pez natalia pe', 'tifanny villamar', 'copalibertadoresfemenina desdelascanchasec']\n",
      "['libertadoresfem cll vs', 'unidasporelobjetivo cllpy']\n",
      "['con una jugadora menos cll juega', 'rival y defiende su ventaja', 'grecia vega kaira houser', 'carina caicedo', 'carrasquel griselda l pez cll copalibertadoresfemenina desdelascanchasec']\n",
      "['se muestra c modo', 'el campo cll aprovecha las desatenciones defensivas', 'rival y defiende', 'el marcador', 'copalibertadoresfemenina desdelascanchasec']\n",
      "['libertadoresfem cll vs', 'unidasporelobjetivo cllpy']\n",
      "['cll griselda l pez remat cruzado abajo para marcar', 'tercera desde el punto penal', 'copalibertadoresfemenina desdelascanchasec']\n",
      "['libertadoresfem cll vs', 'griselda l pez unidasporelobjetivo cllpy']\n",
      "['penal para cll farissa c rdoba se', 'llev por delante', 'fabiola sandoval y', 'rbitra sancion penal', 'farissa c rdoba', 'copalibertadoresfemenina desdelascanchasec']\n",
      "['libertadoresfem cll vs', 'empieza el 2do tiempo', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs', 'final del primer tiempo', 'unidasporelobjetivo cllpy']\n",
      "['termina el primer tiempo', 'el atahualpa cll natalia pe', 'copalibertadoresfemenina desdelascanchasec']\n",
      "['cll natalia pe', 'se encontr', 'con un rebote fuera del rea y defini por encima', 'c rdoba para marcar', 'copalibertadoresfemenina desdelascanchasec']\n",
      "['libertadoresfem cll vs', 'liz pe', 'unidasporelobjetivo cllpy']\n",
      "['cll natalia pe', 'hizo una', 'con galeano y defini por un costado', 'c rdoba para marcar', 'primera del partido', 'copalibertadoresfemenina desdelascanchasec']\n",
      "['libertadoresfem cll vs', 'liz pe', 'unidasporelobjetivo cllpy']\n",
      "['se salv cll houser habilit', 'zambrano que trat', 'definir por arriba', 'bailey y', 'arquera paraguaya estuvo atenta para evitar el tanto ecuatoriano', 'copalibertadoresfemenina desdelascanchasec']\n",
      "['el partido se emparej', 'defiende tan cerca', 'su arco cll', 'costado llegar', 'los ltimos minutos', 'copalibertadoresfemenina desdelascanchasec']\n",
      "['libertadoresfem cll vs', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs', 'unidasporelobjetivo cllpy']\n",
      "['se muestra impreciso y', 'mantiene mucho tiempo', 'su poder cll impone condiciones pero', 'faltado definir', 'copalibertadoresfemenina desdelascanchasec']\n",
      "['libertadoresfem cll vs', 'unidasporelobjetivo cllpy']\n",
      "['se acerc cll ang lica v squez levant un centro', 'zaguera stephanie lacoste', 'pein y', 'arquera c rdoba se lanz', 'su izquierda para evitar', 'ca da', 'su arco', 'copalibertadoresfemenina desdelascanchasec']\n",
      "['libertadoresfem cll vs', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs', 'empieza el partido', 'unidasporelobjetivo cllpy']\n",
      "['lifelong learning', 'open house', 'friday oct', 'p m', 'kathy woods', 'escnj cll openhouse']\n",
      "['regional grand rounds oct', 's cardiology', 'patients w cancer part i breastcancer immune checkpoint inhibitor responsive cancer chronic lymphocytic leukemia braley research institute auditorium n', 'ham gen hospital cardioonc']\n",
      "['1st line cll paul m barr md', 'associate professor', 'wilmot cancer institute', '1st line chronic lymphocytic leukemia cll']\n",
      "['great strides', 'common type', 'adult leukemia chronic lymphocytic leukemia cll', 'doctors medicine']\n",
      "['means lack', 'patient understanding', 'pfs points', 'issues cancerpatients pfs cll']\n",
      "['plasma b cell maturation antigen levels', 'disease activity', 'chronic lymphocytic leukemia bcma cll']\n",
      "['joanne lee', 'chronic lymphocytic leukemia t cells', 'session bmes2019']\n",
      "['mayo cll group', 'weekly meeting', 'exciting developments']\n",
      "['immune cells cd19 cd20 car t cells', 'refractory b cell lymphoma', 'chronic lymphocytic leukemia cll lymsm']\n",
      "['cll diagnosis', 'different emotions', 'patients ways']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['expert access', 'expert cll physician', 'easy accessibility enroll', 'myexpertaccess cll cllsm']\n",
      "['ibrutinib venetoclax', 'r r cll', 'high rates', 'mrd hematology smallmolecules']\n",
      "['important gene']\n",
      "['cellular energy metabolic', 'bcl2 inhibitor venetoclax', 'new insights', 'secondary clinical resistance']\n",
      "['timeline i', 'cold hemo', 'good range']\n",
      "['dr danielle brander', 'shares resources', 'cll patients advocate', 'leusm cllsm']\n",
      "['expert access', 'expert cll physician', 'easy accessibility enroll', 'cll cllsm myexpertaccess']\n",
      "['great leukemia seminar', 'cll leusm lymsm']\n",
      "['cll genetic', 'treatment options dr danielle brander', 'leusm cllsm']\n",
      "['dyk estimates', 'new cases', 'different types']\n",
      "['recent didactics friday nih heme onc fellow alumna', 'cll amp', 'clinical trial', 'trial uses', 'simultaneous b', 't cell', 'ibrutinib targets abnormal b cells', 'pembrolizumab recruits t cells', 'attack cll']\n",
      "['s precisiononcology expert alex rolland answers', 'cancer amp', 'deep dive', 'lymphoma cll', 'new treatments amp advances cancerawareness knowledgeispower']\n",
      "['re making progress', 'chronic lymphocytic leukemia', 'new options', 'line therapy']\n",
      "['william wierda md phd', 'treatment paradigm', 'leusm endcancer leukemia']\n",
      "['free combination therapies', 'chronic lymphocytic leukemia']\n",
      "['hemonc times car t cell therapy', 'chronic lymphocytic leukemia cancer health']\n",
      "['reminder gt research opportunity', 'cll share', 'focus group', 'london amp', 'full details', 'share lymphoma research bloodcancer']\n",
      "['chronic lymphocytic leukemia', 'urinary tract symptoms', 'visible hematuria', 'atypical urology presentation', 'full case report urosome']\n",
      "['joint eqas', 'chronic lymphocytic leukaemia cll tp53 variant detection', 'cll ighv mutation status', 'feb cll tp53 ighv']\n",
      "['invasive aspergillosis', 'chronic lymphocytic leukemia therapy']\n",
      "['brilliant talk salt cll']\n",
      "['ibrutinib treatment', 'elderly patients', 'chronic lymphocytic']\n",
      "['dr wierda shares', 'community oncologists', 'treatment landscape', 'chronic lymphocytic leukemia cllsm leusm']\n",
      "['ibrutinib treatment', 'elderly patients', 'chronic lymphocytic']\n",
      "['r seau coll gial ce partenariat rendra accessibles trois nouvelles plateformes novatrices qui permettront', 'partager les ressources des biblioth ques universitaires cr ant ainsi un v', 'ritable carrefour d acc s', 'connaissance cll recherche']\n",
      "['ce sont toujours les tudiants', 't l enseignement qui obtiennent les moyennes les', 'basses comparativement ceux', 'classe virtuelle synchrone', 'formation individualis e', 'ligne cll p dagogie']\n",
      "['clarity trial', 'ibrutinib venetoclax', 'rel ref cll', 'high rate', 'mrd eradication']\n",
      "['gilda s club quad cities', 'nassif community cancer center', 'chronic lymphocytic leukemia workshop', 'tuesday october 22nd', 'cedar rapids']\n",
      "['car t cell therapy', 'chronic lymphocytic leukemia', 'cancer cll leusm']\n",
      "['william wierda md phd', 'rituximab biosimilar', 'cll treatment paradigm', 'leusm endcancer leukemia']\n",
      "['cll i', 'treatment options', 'chronic lymphocytic leukemia leusm endcancer']\n",
      "['tgtx phase', 'ublituximab tgr', 'obinutuzumab chlorambucil', 'chronic lymphocytic leukemia nct02612311', 'primary completion date']\n",
      "['current issue', 'treatment landscape', 'chronic lymphocytic leukemia']\n",
      "['new side', 'ibrutinib treatment', 'elderly patients', 'chronic lymphocytic']\n",
      "['cellular energy metabolic', 'bcl2 inhibitor venetoclax', 'chronic lymphocytic leukemia', 'new dimension', 'clinical resistance', 'venetoclax guieza cancer cell']\n",
      "['chemo infusion', 'cycle amp blood counts', 'i couldn t', 'hubby family amp friends', 'important relationships', 'wonderful gift']\n",
      "['treatment outcomes', 'relapse refractory chronic lymphocytic leukemia', 'systematic review', 'network meta analysis']\n",
      "['new cancer drugs', 'prostatecancer amp chronic lymphocytic leukaemia cll', 'high innovation cancers', 'braincancer amp bladdercancer', 'low innovation cancers prof lichtenberg pharmaus19 medicinesmatter']\n",
      "['libertadoresfem cll vs americadecali', 'final del partido', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs americadecali', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs americadecali liza larrea por karina vega', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs americadecali', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs americadecali nairelis guti rrez por carmen ben tez', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs americadecali liz pe', 'por yanina l pez', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs americadecali', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs americadecali empieza el 2do tiempo', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs americadecali', 'final del primer tiempo', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs americadecali', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs americadecali', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs americadecali', 'unidasporelobjetivo cllpy']\n",
      "['libertadoresfem cll vs americadecali empieza el partido', 'unidasporelobjetivo cllpy']\n",
      "['chronic lymphocytic leukemia cll', 'line therapy thanks', 'new clinical trial results']\n",
      "['annual meeting daniel persky md', 'recent study', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll cancerresearch']\n",
      "['chronic lymphocytic leukemia cll', 'common type', 'western countries cll pharmacy pharmacist activity']\n",
      "['clinical characteristics', 'richter transformation experience', 'center cll lymsm lymphoma']\n",
      "['kirsty sadler', 'busy job', 'amp e tests', 'chronic lymphocytic leukaemia cll', 'spotleukaemia story gt']\n",
      "['nice cll study', 'research mb mb transcriptional modulation', 'idelalisib synergizes', 'chronic lymphocytic leukemia', 'mdpi cd40 cd154 leukaemia bcells']\n",
      "['idial net project', 'european union', 'interreg poctep program', 'project aims', 'early diagnosis', 'blood cancer chronic lymphocytic leukemia cimago']\n",
      "['treatment landscape', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia smear smudge', 'basket blood film cbc']\n",
      "['ibrutinib treatment', 'elderly patients', 'chronic lymphocytic leuk']\n",
      "['article i', 'grade b cell lymphoma', 'cll lymsm lymphoma']\n",
      "['precisiononcology expert alex rolland answers', 'cancer amp', 'deep dive', 'lymphoma cancerawareness knowledgeispower genomics cll follicular']\n",
      "['preliminary program', 'nordic cll meeting', 'oslo ncllsg2020']\n",
      "['focus group', 'drug treatments interactions', 'healthcare professionals amp', 'support services amp information', 'time gt']\n",
      "['cll leukemia ebmt globallc']\n",
      "['ibrutinib treatment', 'elderly patients', 'chronic lymphocytic leukemia']\n",
      "['refractory chronic lymphocytic leukemia', 'clarity study journal', 'clinical oncology high rate', 'mrd eradication']\n",
      "['car t cell therapy', 'iwcart19 saar gill tanya siddiqi', 'key points', 'sneak peek hemonc immunoonc immunooncology cllsm leusm']\n",
      "['leukemia cll cancer blooddisease bloodcancer findingacure illness hope fighter cure donate cancersucks cancerawareness research']\n",
      "['berlin stuart blakemore', 'great talk', 'annual meeting', 'german society', 'oncology dgho']\n",
      "['approach cll treatment goals expert dr jeffrey menashe discusses indications', 'cll therapy', 'healthcare team', 'care cll patientpower']\n",
      "['bullet nevergiveup', 'coffeelover tenacity growth workhard ideas madeinamerica coffeefiltercollapse stepitup cll bestrong']\n",
      "['refractory chronic lymphocytic leukemia', 'clarity study']\n",
      "['hoy juegalibertad las gumarelas debutan ante las colombianas del', 'cali por', 'libradores femenina cll lasgumarelas']\n",
      "['cll preceptorship', 'pr c leblond paris']\n",
      "['neutrophils microbicidal activity', 'chronic lymphocytic leukemia', 'early phases']\n",
      "['refractory chronic lymphocytic leukemia', 'clarity study journal', 'clinical oncology congratulations p hillman s fox amp tap network', 'such important data', 'practice amp']\n",
      "['ibrutinib treatment', 'elderly patients', 'chronic lymph']\n",
      "['moment teaching', 'mrs htg', 'cache eye unit', 'emergent literacy', 'weekly quiz', 'new words', 'sm bsl communication cll']\n",
      "['new cll biomarkers', 'prognostic value i trf glyccc high expression', 'poor survival foreningen dk']\n",
      "['non hodgkins lymphoma b', 't cell chronic lymphocytic leukemia mantle cell hairy cell', 'multiple myeloma', 'class action lawsuit']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['stem cell transplantation', 'curative potential', 'chronic lymphocytic leukemia', 'treatments memorial sloan', 'cancer center disabilityinfo zusia']\n",
      "['nebula library update', 'nature communications discovers', 'multiple genetic variants', 'chronic lymphocytic leukemia', 'nebula explore']\n",
      "['tg therapeutics announces data presentations', 'international workshop', 'chronic lymphocytic leukemia iwcll douglas']\n",
      "['access articles', 'chronic lymphocytic leukemia', 'esr1 mutations', 'breast cancer', 'colon cancer', 'subsequent malignant neoplasm', 'young adults']\n",
      "['iwcll tcells cll iwcll', 'highlight toekomstige behandelingen voor cll']\n",
      "['ilt2 blockade', 'lenalidomide restore nk cell function', 'chronic lymphocytic leukemia asturias publihuca lymphocytic leukemia hematology lenalidomide fulll text']\n",
      "['haemtologica review article sequential', 'combination treatments', 'novel agents', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia leusm endcancer']\n",
      "['visit booth', 'mrd solutions', 'aml mm cll', 't cell malignancies']\n",
      "['john seymour', 'novel therapy era', 'international workshop', 'chronic lymphocytic leukemia iwcll']\n",
      "['din k', 'bad m sari', 'social app ka use bnd kr rha hu aane wale', 'sal tk k liye', 'whatsapp k shiway agr kisi ko mujhese bt krni ho', 'mujhe whatsapp ya cll', 'nu pr kr skte h lekin mujhe malum h kisi k pass v itta time nhi h agr mn kre']\n",
      "['s cll information night', 'mbstorm stay']\n",
      "['lymphoma dr manali kamdar', 'exciting news chroniclymphocyticleukaemia cll leukemia lymphoma']\n",
      "['years students', 'classroom eytwittertagteam literacy cll stories reading books language communication']\n",
      "['non hematologists', 'lymph nodes', 'peripheral blood']\n",
      "['risk factors', 'invasive fungal infections', 'chronic lymphocytic leukemia', 'padua university']\n",
      "['invasive fungal disease', 'cll ibrutinib cll bloodcancer']\n",
      "['idelalisib rituximab vs ibrutinib rituximab', 'chronic lymphocytic leukemia cll']\n",
      "['scan results cup', 'imi pin av', 'wizz brna trig brsc hicl ng crei hbrn jzcp gri cll mto ocdo']\n",
      "['cancer advances', 'chronic lymphocytic leukemia']\n",
      "['marina mostafizar', 'lab tech', 'co author', 'transcriptional modulation', 'idelalisib synergizes', 'chronic lymphocytic leukemia']\n",
      "['multiple myeloma plasma cell dyscrasias chronic lymphocytic leukemia', 'acute leukemia amp car t updates integration', 'biosimilar benign hematology use', 'auto transplant']\n",
      "['communication engagement education', 'decision making', 'health care providers activity pharmacy pharmacist cll']\n",
      "['gsk phase', 'phase ii eltrombopag', 'chronic lymphocytic leukemia cll nct01168921', 'primary completion date']\n",
      "['eshlymphoid2019 meeting highlights video interview discusses', 'trial design', 'novel concepts', 'lymphoma biomarkers']\n",
      "['bullish list', 'sag ezh amyt cbox rbg cll miri renx']\n",
      "['chronic lymphocytic leukemia', 'urinary tract symptoms', 'visible hematuria', 'atypical urology presentation', 'full case report urosome']\n",
      "['son enseignement accompagne certains tudiants bien apr s', 'leur parcours scolaire mais souvent ce ne sont pas les contenus qui marquent', 'm moire il s agit davantage d', 'phrase d un moment', 'valeurs ou d', 'vision ou d', 'passion cll']\n",
      "['bad news guys', 'chronic lymphocytic leukemia', 'chemo medicine']\n",
      "['cll dr koffman', 'confident self advocate cllsm']\n",
      "['don t', 'friday s lecture', 'paolo ghia m d ph d', 'deputy chair', 'experimental oncology universit vita salute san raffaele antigens', 'fatal attraction', 'chronic lymphocytic leukemia', 'york ave nyc room c']\n",
      "['apto 1st', 'cll patient', 'previous therapy lines', 'stable disease', 'clinical activity']\n",
      "['partner yakult honsha', 'phase 1b japanese', 'copiktra duvelisib', 'refractory chronic lymphocytic leukemia', 'small lymp']\n",
      "['rituximab benefits progression', 'free survival pfs', 'overall survival os', 'standard chemoimmunotherapy', 'chronic lymphocytic leukemia']\n",
      "['bld cancer', 'alert non hodgkin s lymphoma b', 't cell chronic lymphocytic leukemia mantle cell hairy cell', 'multiple myeloma', 'killer victims amp families', 'cost obligation review', 'min roundup']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['cll diagnosis cll advocate dr brian koffman outlines key steps', 'cllsm bcsm']\n",
      "['vstm verastem oncology announces', 'yakult honsha co ltd s japanese', 'copiktra duvelisib', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['eshlymphoid2019 meeting highlights video interview prof andreas strasser discusses', 'lymphoid malignancies', 'mc11 inhibitors click', 'cll lymphoma']\n",
      "['yakult honsha co ltd', 'regulatory submission', 'important step', 'potential treatment options']\n",
      "['dr brian koffman co founder', 'undetectable minimal residual disease umrd', 'cll care']\n",
      "['verastem oncology announces', 'yakult honsha co ltd s japanese', 'copiktra duvelisib', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['eshlymphoid2019 meeting highlights video interview dr barbara eichhorst summarises', 'genomics novel agents', 'traditional approaches', 'treatment concept click']\n",
      "['care soc update', 'chronic lymphocytic leukemia cll soho', 'lymsm lymphoma']\n",
      "['dr manali kamdar', 'lymphoma chroniclymphocyticleukemia cll leukemia lymphoma totalhealthconf']\n",
      "['rns aim cll cello health plc total']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['verastem oncology announces', 'yakult honsha co ltd s japanese', 'copiktra duvelisib', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['verastem oncology announces', 'yakult honsha co ltd s japanese', 'copiktra duvelisib', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['vstm verastem oncology announces', 'yakult honsha co ltd s japanese', 'copiktra duvelisib', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['board hassan', 'lrc cll']\n",
      "['hassan almuhanna', 'phd studies lrc cll']\n",
      "['refractory follicular lymphoma', 'chronic lymphocytic leukemia side', 'pi3k inhibitors']\n",
      "['combination treatments', 'novel agents', 'chronic lymphocytic leukemia']\n",
      "['refractory b cell non hodgkin lymphoma', 'chronic lymphocytic leukemia blood journal']\n",
      "['neutrophils microbicidal activity', 'cll leusm']\n",
      "['combination treatments', 'novel agents', 'chronic lymphocytic leukemia chemoimmunotherapy', 'chronic lymphocytic leukemia', 'long time', 'years novel agents']\n",
      "['interesting danish registry cll data igvh mut status influences treatment', 'free survival', 'immunochemotx rx pts', 'overall survival role', 'novel agents', 'population basis', 'btki bcl2i', 'pi3ki lymsm cll']\n",
      "['chronic lymphocytic leukaemia cll']\n",
      "['autophagy regulation', 'chronic lymphocytic leukemia leukemia leusm cll cllsm']\n",
      "['pi3k p110 contributes', 'antibody responses', 'chronic lymphocytic leukemia leusm cll cllsm']\n",
      "['agents updates', 'clinical news cll ash2019']\n",
      "['deaf school staff member', 'special birthday surprise cll bsl signlanguage literacy communication links', 'cache eye units']\n",
      "['s lab', 'joint project', 'cll extracellularvesicles', 'work steps', 'amazing work', 'dominik leukemia']\n",
      "['cll therapy', 'different venetoclax combinations', 'obinutuzumab ven obi', 'ibrutinib ven ibru', 'peripheral blood mrd values']\n",
      "['chronic lymphocytic leukemia', 'magazine cll chroniclymphocyticleukemia']\n",
      "['ublituximab cd20 mab', 'umbralisib oral pi3k inhibitor', 'refractory b cell non hodgkin lymphoma', 'chronic lymphocytic leukemia lymsm']\n",
      "['high incidence', 'adverse events', 'significant economic burden', 'chronic lymphocytic leukemia cll cancer']\n",
      "['abbv phase', 'refractory chronic lymphocytic leukemia', 'non hodgkin lymphoma nct01328626', 'primary completion date']\n",
      "['refractory b cell non hodgkin lymphoma', 'chronic lymphocytic leukemia']\n",
      "['information amp support', 'cll community', 'dr norma jean murphy', 'dr amjad hayat', 'galway s ardilaun hotel register']\n",
      "['fortbildningsdag uppbyggd', 'programmet efter nio', 'm rten och sonja i publiken', 'rare samlade vid', 'temat l sningg rskillnad v rldensb staskola cll']\n",
      "['excellent rw', 'rx options', 'novel agents', 'therapies key q', 'novel therapy era']\n",
      "['neue studie zu leuk mie chronisch lymphatische leuk mie cll strategien', 'einer neuen ra der krebstherapie lesen sie', 'kompletten forschungsergebnisse forschung medizin gesundheit gesundheitsportal onkologie']\n",
      "['video relevance', 'prognostic factors', 'cll w adam kittai md', 'iwcll2019 cancer']\n",
      "['officialnihr kras nras', 'braf mutations', 'chronic lymphocytic leukemia', 'shorter treatment', 'free survival']\n",
      "['pr paolo ghia', 'informal discussion', 'clinical management', 'international group', 'enthusiastic junior scientists', 'eshlymphoid2019 esh programmes', 'diverse opportunities', 'global experts haematology hematology']\n",
      "['zanubrutinib bgb', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma intolerant']\n",
      "['ali abutalib', 'sonali m smith', 'chronic lymphocytic leukemia hematology leusm']\n",
      "['biosimilar cll drugs', 'patients tune', 'expert dr jeff sharman cll biosimilar patientpower']\n",
      "['eshlymphoid2019 meeting', 'estoril barbara eichhorst', 'elegant overview', 'predictive parameters', 'treatment decisions', 'cll patients', 'novel agents leukemia']\n",
      "['w cfo marc schegerin', 'company s breakout year', 'cll amp', 'mosaic trial', 'proteussyndrome amp pros']\n",
      "['cll valerie', 'multiple sclerosis ms', 'clinical trial', 'father s life amp']\n",
      "['eshlymphoid2019 meeting highlights video interview dr dan landau lab sums', 'genomic landscape', 'cll lymphoma lymsm']\n",
      "['cll mrd negativity', 'obinutuzumab vs chlorambucil', 'obinutuzumab icml19 saudilymphoma saudihematology']\n",
      "['zanubrutinib bgb', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma intolerant', 'ibrutinib status', 'condition summary chronic lymphocytic leukemia smal']\n",
      "['combination treatments', 'novel agents', 'chronic lymphocytic leukemia leusm cll']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['uses ibrutinib', 'targets proteins incancer cells', 'cancer cells', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'marginal zone lymphomawaldenstrom macroglobulinemia', 'chronic graft versus host disease pharmaceuticalmedicine rsp']\n",
      "['molecular interactions', 'adaptive immune cells', 'chronic lymphocytic leukemia', 'therapeutic implications']\n",
      "['cll14 trial outcomes lori', 'leslie md hematologist oncologist lymphoma department john theurer cancer center hackensack meridian health shares details', 'cll14 trial', 'chronic lymphocytic leukemia cll']\n",
      "['ph 1b study', 'refractory follicular lymphoma', 'refractory cll sll', 'data check', 'morning lymsm']\n",
      "['hien nguyen', 'excellent lecture', 'drug targets', 'cll eshlymphoid2019']\n",
      "['dr brian koffman co founder', 'mission goals', 'reviews programs', 'chronic lymphocytic leukemia cll patients']\n",
      "['cll causes symptoms', 'dr kerry rogers', 'james leusm cllsm']\n",
      "['cancers b lymphoblastic leukemia', 'lymphoma chronic lymphocytic leukemia b cell lymphoma', 'mantle cell lymphoma', 'non hodgkins lymphoma']\n",
      "['chronic lymphocytic leukemia', 'anthony mato md']\n",
      "['saturday october', 'cancer care', '15pm gvcc19 grythealth cll']\n",
      "['monthly theme', 'potential impact', 'recent updates lymphoma lymsm']\n",
      "['new putative driver mutations', 'disease evolution', 'chronic lymphocytic leukemia cll']\n",
      "['new research opportunity gt', 'inviting people', 'chronic lymphocytic leukaemia cll amp', 'focus group discussions', 'manchester amp london']\n",
      "['dan landau s key message', 'clonal evolution', 'cll involves', 'epigenetic mechanisms', 'cell level eshlymphoid2019 lymphoid malignancies lab']\n",
      "['dr manali kamdar talk', 'chronic lymphocytic leukemia responses']\n",
      "['date october', 'pm est cancer cancerawareness cancerresearch lymphoma cll sll lymphomaawareness']\n",
      "['human medicines european', 'public assessment report epar rixathon rituximab lymphoma non hodgkin arthritis rheumatoid leukemia lymphocytic chronic b cell wegener granulomatosis microscopic polyangiitis date', 'status authoris']\n",
      "['cache eye unit', 'emergent literacy', 'professional practice portfolio', 'btec cpld unit', 'literacy phonics books reading cll']\n",
      "['good morning', 'rich environments', 'mrs htg', 'new story props', 'eytwittertagteam literacy cll storyprops cache']\n",
      "['pretty blooducation blood morphology chromosome microscope cell cll']\n",
      "['notch1 activation correlates', 'chronic lymphocytic leukemia']\n",
      "['1st year post chemo', 'cancer chemo survivor cancersucks cll leukemia lymphoma bloodcancer anxiety cancertribe ptsd surviorguilg oncology warrior']\n",
      "['ighv mutations', 'brown md', 'danafarber dana farber cancer institute harvard', 'medical school']\n",
      "['uk cll forum ibrutinib data', 'w toby eyre md']\n",
      "['christina fisher discusses', 'cll diagnosis', 'christina shares', 'encourages others', 'cll specialist cll patientpower']\n",
      "['dana farber s', 'p m est']\n",
      "['cirmtuzumab blocks wnt5a ror1 stimulation', 'nf b', 'repress autocrine stat3 activation', 'chronic lymphocytic leukemia cll']\n",
      "['cll cello health', 'social media analytics software business', 'uk cll']\n",
      "['dyk people', 'chronic lymphocytic leukemia cll', 'additional chemotherapy', 'free option']\n",
      "['rituximab benefits progression', 'free survival pfs', 'overall survival os', 'standard chemoimmunotherapy', 'chronic lymphocytic leukemia']\n",
      "['cll cello health', 'social media analytics software business', 'uk cll brighterir andrewscotttv']\n",
      "[]\n",
      "['chronic lymphocytic leukemia']\n",
      "['rns aim cll cello health plc disposal']\n",
      "['common form', 'non hodgkin s lymphomas nhl', 'lymphomas access', 'insight overview', 'hemato onco market', 'hemato oncology ebook dlbcl lymphoma nhl treatment cll mm aml']\n",
      "['chronic lymphocytic leukemia subsets', 't cell dependency']\n",
      "['cll patient advocate shares tips', 'cll chroniclymphocyticleukemia watchandwait']\n",
      "['new chronic lymphocytic leukemia drugs ash', 'new chronic lymphocytic leukemia drugs']\n",
      "['entre r os para jugar otra liga', 'provincial otra vez', 'celeste feliz por este nuevo desafio y est nueva oportunidad', 'luis luciano cll fber']\n",
      "['dr john allan s expert perspective', 'novel treatment options', 'combination therapies', 'durable remissions', 'people w chronic lymphocytic leukemia cll cc magazine']\n",
      "['scan results cup', 'jlg pcgh gkp kap pgit ckn tcs av', 'gbg cll pin kay gri sspg tfw hicl']\n",
      "['scan results stochastic', 'rigd ckn hstg ukw iqe cll kay dln gmr ng sgro thrg mate ddv1 utle rdsa']\n",
      "['chronic lymphocytic leukemia treatment market', 'precise outlook altor bioscience amgen aptevo therapeutics arqule']\n",
      "['ucl goals', 'place don t', 'w amp']\n",
      "['lymph gland', 'chronic lymphocytic leukemia', 'susie s', 'amazing discovery', 'chroniclymphocyticleukemia stemcelltreatment stemcelltherapy']\n",
      "['atm pathway', 'cll w tatjana stankovic md phd']\n",
      "['care partner', 'cll patient discusses', 'reliable sources stays', 'caregivers cll patientpower']\n",
      "['cll treatment approaches dr javier pinilla ibarz', 'separates fact', 'fiction leusm cllsm']\n",
      "['cancer non hodgkin lymphoma', 'large diffuse b cell follicullar lymphoma cutaneous t cell anapalastic t cell chronic lymphocytic leukemia', 'small lymphocytic lymphoma mantle cell lymphoma primary', 'central nervous system cns lymphoma']\n",
      "['non hodgkin s lymphoma chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma', 'non hodgkin s lymphoma']\n",
      "['own words scientists', 'broad s cancer program genetic perturbation platform proteomics platform', 'metabolism program describe', 'key changes', 'resistant leukemia cells cll']\n",
      "['college station share', 'travel shots', 'flylocal airport americanairlines cll photography collegestation texas bryantx']\n",
      "['leukemia research jain', 'mrd negativity', 'survival clinicalresearch leukemia cll']\n",
      "['letter word startilg', 'c cult cll']\n",
      "['lymphoma lymphoma research foundation cll bloodcancer bloodcancerawareness cancertreatment']\n",
      "['clinical trials', 'michele nadeem baker cll patient advocate cll chroniclymphocyticleukemia']\n",
      "['cll research', 'kreftforeningens vitensenter', 'evening symposium']\n",
      "['cd38 expression', 'sudanese patients', 'b cell chronic lymphocytic leukemia']\n",
      "[]\n",
      "['tx doubles response', 'fit cll cll chroniclymphocyticleukemia clinicaltrials']\n",
      "['iwcll2019 edinburgh', 'meeting dan landau', 'excellent lecture', 'clonal evolution', 'novel data', 'cell analytics leukemia leusm']\n",
      "['video epigenetic', 'cll dna methylation w christoph plass phd']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['dr kerry rogers', 'james separates fact', 'cll causes amp symptoms', 'leusm cllsm']\n",
      "['amy pierre msn anp bc', 'nancy m nix pharmd bcps bcop', 'advancedpractitioner perspective', 'novel agents', 'refractory mm cll']\n",
      "['org a041702 ph3 rct ibrutinib obinutuzumab venetoclax', 'patients gt 70yo', 'chronic lymphocytic leukemia cll pi woyach nct03737981 leusm cllsm geriheme']\n",
      "['nvs phase', 'refractory chronic lymphocytic leukemia nct02614508', 'primary completion date']\n",
      "['chronic lymphocytic leukemia cll', 'rare bloodcancer', 'treatment visit', 'time bloodcancerawarenessmonth']\n",
      "['bloodcancerawarenessmonth incidence rates', 'cll chronic lymphocytic leukaemia increases', 'cancerawareness leukaemia bloodcancer']\n",
      "['cello health plc', 'potential upside', 'liberum capital cll']\n",
      "['terrific town hall meeting', 'cll patients', 'texas thanks', 'docs lamanna awan', 'thompson cllsm patientpower cll']\n",
      "['undetectable mrd', 'pts u mrd', 'ngs u mrd ngs', 'vs pbmc', 'vs plasma', 'mut ighv', 'likely u mrd', 'u mrd', 'superior pfs vs mrd cll lymsm']\n",
      "['trooper daniel jenkins mike', 'chronic lymphocytic leukemia ccl', 'manta cell lymphoma mcl']\n",
      "['video entospletinib', 'r r cll w adam kittai md', 'iwcll2019 cll']\n",
      "['positive l re du num rique cll tic']\n",
      "['cycle du secondaire l cart', 'r ussite l avantage des filles oscille entre un', 'cinq points', 'pourcentage au qu bec', 'pourcentage cll r ussite']\n",
      "['makebloodcancervisible bloodcancerawareness haematology cll leukaemia lymphoma myeloma cancer']\n",
      "['torneo clausura 6ta fecha cll vs dvosantani', 'los goles karina vega', 'griselda l pez', 'y liza larrea', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 6ta fecha cll vs dvosantani segundo tiempo', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 6ta fecha cll vs dvosantani entre tiempo', 'karina vega', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 6ta fecha cll vs dvosantani partido', 'unidasporelobjetivo cllpy']\n",
      "['cd200 expression', 'matutes score', 'diagnostic differentiation', 'mantle cell lymphoma', 'chronic lymphocytic leukemia', 'flow cytometry lymphoma lymsm']\n",
      "['refractory b cell non hodgkin lymphoma', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['chronic lymphocytic leukemia', 'hematologic malignancies lymphoma lymsm']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['real world evidence', 'venetoclax vs ibrutinib vs idelalisib w toby eyre md', 'iwcll2019 cll']\n",
      "['cll patients', 'lab results impact care andrew schorr', 'dr susan leclair', 'dr justin taylor', 'blood work cll patientpower']\n",
      "['iwcll2019 edinburgh valentin goede', 'excellent overview', 'cll treatment', 'inhibitors leukemia']\n",
      "['min medscapeedu video', 'novel chemo', 'free combinations', 'chronic lymphocytic leukemia cll', 'w professor jacqueline barrientos']\n",
      "['s vigibase', 'global database', 'drug complications cancer researchers', 'clearer picture', 'chronic lymphocytic leukemia patients', 'frontline treatment', 'death rate']\n",
      "['dr marcos gonz lez jefe del servicio cierra hematoforum2019', 'con un nuevo abordaje', 'llc es spain cll']\n",
      "['makebloodcancervisible bloodcancerawareness haematology cll leukaemia lymphoma myeloma']\n",
      "['cell chronic lymphatic leukemia', 'small lymphocytic leukemia', 'prolymphocytic lymphocytic leukemia']\n",
      "['jack eble', 'new medicine']\n",
      "['final analysis', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['final analysis', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['new research', 'new recurrent structural aberrations', 'chronic lymphocytic leukemia', 'data chronic lymphocytic leukemia cll', 'frequent lymphoproliferative syndrome', 'western countries']\n",
      "['scan results stochastic', 'knm cll nvtk mcs nvt ero1 spsy smtp utle aqx fjet bhib']\n",
      "['leukemia research jain', 'mrd negativity', 'survival clinicalresearch leukemia cll']\n",
      "['cll information night', 'cll ibrutinib', 'relapse refractory setting venetoclax nkotb research update', 'clluster psychosocial oncology']\n",
      "['bloodcancer awareness month', 'promising car t cell therapy', 'chronic lymphocytic leukemia asco19 leusm cancer']\n",
      "['gt gt gt', 'cd200 expression', 'matutes score', 'diagnostic differentiation', 'cll lymsm lymphoma']\n",
      "['dr danielle brander', 'expert advice', 'cll patients leusm cllsm']\n",
      "['cholesterol heartdisease cholesterol heartdisease children', 'balding alopecia skincancer bladdercancer breastcancer anemia cll linfomas oncotype medicine mddigitastv mdtvonline mdtvnews oncology', 'information visit']\n",
      "['minimal residual disease', 'chronic lymphocytic leukemia', 'new goal']\n",
      "['chronic lymphocytic leukemia']\n",
      "['dr paoli ghia eric research initiative', 'cll summarizes', 'new research projects', 'chronic lymphocytic leukemia bigdataforbloodcancer', 'general assembly', 'firenze iis es hematolog ju']\n",
      "['phase ib study', 'u2 ublituximab', 'ck1e inhibitor umbralisib', 'r r b cell lymphoma', 'chronic lymphocytic leukemia cllsm lymsm']\n",
      "['bloodcancer research', 'cll community incl', 'treatment options', 'cllhz19 iwcll2019', 'vital patient perspective', 'w eu research initiative', 'cll eric']\n",
      "[]\n",
      "['bone marrow', 'acute lymphoblastic leukemia', 'acute myeloid leukemia', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['org a041702 ph3 rct ibrutinib obinutuzumab venetoclax', 'patients gt 70yo', 'chronic lymphocytic leukemia cll pi woyach nct03737981 leusm cllsm geriheme']\n",
      "['scan results cup', 'kap teg jlen ntv bats tfw cli hlma cll hicl pgit pcgh iom cvsg gbg gsf']\n",
      "['francesca vittoria sbrana phd', 'san raffaele', 'scientific institute', '3d systems', 'chronic lymphocytic leukemia', 'dr sbrana']\n",
      "['cll healthcare team', 'active cll patient toolkit']\n",
      "['cll microenvironment', '3d systems w francesca vittoria sbrana phd']\n",
      "['expressions oncology team', 'iwcll meeting', 'successful trip guys medcomms iwcll cll edinburgh mynucleus']\n",
      "['chronic lymphocytic leukemia cll', 'routine blood test', 'cll diagnosis']\n",
      "['online cll resources', 'separate fact', 'cll causes', 'dr kerry rogers', 'leusm cllsm register']\n",
      "['plant bl3ll yn sgwrsio yn ffrangeg gyda phlant y meithrin prynhawn ac yn dysgu c n rhannau r corff diwrnodieithoeddrhynglwadol cll']\n",
      "['plant bl3ll yn sgwrsio yn ffrangeg gyda phlant y meithrin prynhawn ac yn dysgu c n rhannau r corff diwrnodieithoeddrhynglwadol cll']\n",
      "['new research', 'cll vhebron']\n",
      "['major limitations', 'valid basis', 'concern oncology hematology gt leukemia ibrutinib cardiotoxicity', 'chemo high rates', 'adverse events', 'therapy cll']\n",
      "['key research questions', 'chronic lymphocytic leukemia research', 'thon bigdataforbloodcancer bloodcancerawarenessmonth']\n",
      "['leukemia research jain', 'mrd negativity', 'survival clinicalresearch leukemia cll']\n",
      "['dr lesley ann surton eric research initiative', 'cll summarizes', 'chronic lymphocytic leukemia bigdataforbloodcancer', 'general assembly', 'firenze iis es hematolog']\n",
      "['iwcll2019 edinburgh dr shenmiao yang', 'interesting informations', 'genetic differences', 'clinical management', 'dynamic development', 'leukemia research', 'impressive leusm']\n",
      "['final 6y resonate pfs hr', 'ibrutinib vs ofatumumab os benefit censor', 'crossover pfs', 'high risk cll htn', 'median onset', '6m af', 'htn af pts', 'discont tox mpfs 44m', 'pre rx pts', 'tp53 dx game', 'trial lymsm']\n",
      "['hs1 function', 'ibrutinib therapy', 'cll w cristina scielzo phd']\n",
      "['s perseverance', 'cll cellreports']\n",
      "['pi3k delta inhibitor umbralisib', 'favorable toxicity profile', 'chronic lymphocytic leukemia', 'kinase inhibitor', 'phase ii study cllsm leusm']\n",
      "['car t therapy', 'triple combination therapy', 'cll universityhospitalcologne']\n",
      "['september journal']\n",
      "['open dialogue', 'chronic lymphocytic leukemia cll rt', 'empower others', 'disease bloodcancerawarenessmonth']\n",
      "['sea squirt compound', 'cll trabectedin reveals', 'chronic lymphocytic leukemia aacr']\n",
      "['minimal residual disease negativity abbvie cll']\n",
      "['cll society support groups shares', 'cure magazine', 'chronic lymphocytic leukemia']\n",
      "['patient characteristics', 'cytogenetics cll cllresearchcenter']\n",
      "['novel revelations', 'cll biology', 'venetoclax ibrutinib cervicalcancer']\n",
      "['good idea', 'lucky carlo croce', 'chronic lymphocytic leukemia']\n",
      "['tg therapeutics announces data presentations', 'international workshop', 'chronic lymphocytic leukemia iwcll']\n",
      "['right sorter', 'enrich purify']\n",
      "['new drugs', 'exciting lymphoma cll treatment therapy']\n",
      "['chronic lymphocytic leukemia cll', 'western canada']\n",
      "['exposure response analysis', 'refractory chronic lymphocytic leukemia', 'phase 1b study', 'murano study lymphoma lymsm']\n",
      "['chronic lymphocytic leukemia skin', 'cancers lymphoma lymsm']\n",
      "['chronic lymphocytic leukemia cll', 'western canada']\n",
      "['chronic lymphocytic leukemia']\n",
      "['international community', 'cll patient groups']\n",
      "['international community', 'cll patient groups']\n",
      "['dr montillo prof stamatopoulos', 'bcell receptor', 'natural history', 'immunoglobulin genes', 'important prognostic', 'predictive information cll']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['management tool', 'dr frey', 'chair dr stadtmauer stateofscience hematology mrdforall']\n",
      "['newbie dr gerson updates', 'chair dr stadtmauer stateofscience hematology', 'exciting data', 'cll14 data']\n",
      "['own dr', 's frontline publication', 'fellow dr nikhil kamat', 'lymphoma rounds meeting', 'chronic lymphocytic leukemia cll case study']\n",
      "['chronic lymphocytic leukemia', 'clinical trial', 'treatment options cll leukemia clinicaltrials']\n",
      "['iwcll2019 head', 'new cll podcast', 'recent trial updates', 'novel therapies check']\n",
      "['nuovo evento chronic lymphocytic leukemia']\n",
      "['cancer chronic lymphocytic leukemia stage']\n",
      "['underlies resistance', 'lymphoid malignancies cell authors', 'venetoclax resistance', 'cll dlbcl involves changes', 'energy metabolism amp describe strategies']\n",
      "['tgtherapeutics announces data presentations', 'international workshop', 'chroniclymphocyticleukemia iwcll tgtx']\n",
      "['chronic lymphocytic leukemia', '60th american society', 'annual meeting commentary']\n",
      "['chronic lymphocytic leukemia', '60th american society', 'annual meeting']\n",
      "['chronic lymphocytic leukemia pathogenesis']\n",
      "['chronic myelogenous leukemia', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma lymphoma lymsm']\n",
      "['shanafelt td', 'n engl j', 'ibrutinib rituximab', 'chronic lymphocytic leukemia']\n",
      "['post amp', 'common form', 'bloodcancerawareness month amp', 'help haematology']\n",
      "['great work', 'cll community', 'africa dr oludola omoyiola', 'worthy winner']\n",
      "['xpo1 mutant mouse models genomics structural biology molecular biology xpo1 inhibitors']\n",
      "['day cll', 'patient advocates conference cllhz19']\n",
      "['balding alopecia skincancer bladdercancer breastcancer anemia cll linfomas oncotype', 'breastcancer lungcancer prostatecancer obesity hypertension strokes ovariancancer pancreaticcancer breastcancerawareness']\n",
      "['relapsedrefractory chronic lymphocytic leukemia venetoclax venclyxto venclexta', 'firstinclass oral selective b cell lymphoma2 bcl2 inhibitor', 'numerous countries']\n",
      "['chronic lymphocytic leukemia', 'urinary tract symptoms', 'visible hematuria', 'atypical urology presentation', 'article online lymphocyticleukemia urology urosome']\n",
      "['wonderful laura carfang s podcast survivor cancer cancerhumor cancersucks cancersurvivor breastcancer bloodcancer cll lymphoma']\n",
      "['tanzania cllhz19 cll']\n",
      "['ce 2e volet vise identifier des facteurs', 'sant mentale des tudiants internationaux cll c gep']\n",
      "['refractory chronic lymphocytic leukemia springerlink cll leusm']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll patients', 'leusm bcam']\n",
      "['iwcll2019 edinburgh congratulations', 'hartmut d hner ulm', 'rai binet medal', 'pivotal studies']\n",
      "['u s', 'chronic lymphocytic leukemia cll']\n",
      "['great moment', 'ethnic diversity', 'cll incidence']\n",
      "['chronic lymphocytic leukemia cll accounts', 'new leukemia cases', 'bloodcancer bloodcancerawarenessmonth']\n",
      "['new updates', 'apto s sep presentation', '1st cg', 'cll patient stay', '300mg dose']\n",
      "['refractory chronic lymphocytic leukemia']\n",
      "[]\n",
      "['tg therapeutics announces data presentations', 'international workshop', 'chronic lymphocytic leukemia iw']\n",
      "['tgtx tg therapeutics announces data presentations', 'international workshop', 'chronic lymphocytic leukemia iwcll']\n",
      "['tg therapeutics announces data presentations', 'international workshop', 'chronic lymphocytic tgtx']\n",
      "['tg therapeutics announces data presentations', 'international workshop', 'chronic lymphocytic leukemia iwcll']\n",
      "['pivotal trail', 'cll leuksm cll17 ibrutinib vs obi ven vs ven ibrutinib']\n",
      "['cellular therapy session', 'iwcll2019 noteworthy', 'cll session', 'case reports', 'allosct post venetoclax', 'series data', 'date look']\n",
      "['danielle brander', 'phase ii data', 'umbralisib efficacy', 'bcri intolerant cll patients', 'tolerable option', 'excellent study iwcll2019']\n",
      "['katy rezvani', 'excellent phase', 'shelf nk cord car cells', 'exciting initial responses', 'responses iwcll2019 cll']\n",
      "['stellar trial', 'john byrd richters transformation needs', 'awful disease cll richters']\n",
      "['uk cll forum clinical sciences meeting', 'cll bloodcancerawarenessmonth']\n",
      "['year data', 'murano study', 'venetoclax rituximab w john seymour', 'full interview', 'iwcll2019 cllsm leusm cll']\n",
      "['cllhz19 ukcllforum edinburgh', 'advocate sessions prof anna schuh', 'optimum care', 'uk cll']\n",
      "['cllhz19 ukcllforum edinburgh', 'advocate sessions', 'optimum care', 'support cll']\n",
      "['matt davids', 'clear way', 'future treatment', 'apopotic bcl', 'family protein inhibitors', 'iwcll2019 cll']\n",
      "['prof fegan', 'cllhz19 ukcllforum edinburgh', 'advocate sessions']\n",
      "['andrew rawstron', 'cll therapy', 'iwcll2019 cllsm']\n",
      "['john seymour', 'murano study pfs post', 'duration therapy', 'mrs status', 'time point iwcll2019 cll']\n",
      "['b cell power lymphocytic leukem']\n",
      "['b cell chronic lymphocytic leukemia clinical trials', 'companies drugs phases subjects', 'current status', 'vpa research prices', 'global clinical trial report', 'b cell chronic lymphocytic leukemia']\n",
      "['lymphoma nurse manager donna gairns', 'cll horizons patient advocates amp', 'iwcll conferences lymphoma advocates bestpractice cll iwcll2019 cllhz19']\n",
      "['maine coast', 'venclexta i', 'doc john pagel', 'small world', 'progress cll']\n",
      "['interest irish cll patients']\n",
      "['chronic lymphocytic leukemia survivornet dude wtf roundup poison monsanto']\n",
      "['irish cll patient community']\n",
      "['congress soho2019', 'prof susan o brien', 'current standard', 'frontline treatment', 'chronic lymphocytic leukemia leusm']\n",
      "['possible cll leuksm leukemia clinicaltrials']\n",
      "['iwcll2019 edinburgh', 'mary ann anderson', 'melbourne group', 'complex mechanisms', 'low frequency bcl2 g101v mutations', 'bclxl overexpression leukemia']\n",
      "['chronic lymphocytic leukemia', 'thanks magazine']\n",
      "['invest trade genmab', 's shares', 'etoro genmab', 'danish biotechnology company', 'florian sch', 'arzerra ofatumumab', 'chronic lymphocytic leukemia indications amp darzalex genmab products']\n",
      "['arnon kater', 'mrd response', 'r r cll cllsm leusm']\n",
      "['congress soho2019', 'dr tanya siddiqi', 'car t cell therapy', 'chronic lymphocytic leukemia lymsm']\n",
      "['good luck', 'natasha malik', 'poster presention', 'cll research lrc iwcll2019']\n",
      "['lively debate', 'mrd assessment', 'cll w', 'lydia scarfo', 'full video', 'iwcll2019 cllsm leusm']\n",
      "['clinical trial e1912 fcr vs ibrutinib', 'cll naive pts lt 70yo iwcll2019']\n",
      "['ig mutation status', 'aes median pfs', 'months iwcll2019 cll']\n",
      "['cll cll cello health group ex dividend date', 'payment date']\n",
      "['petra langerbeins', 'gcllsg cll12 trial', 'early intervention', 'asymptomatic cll']\n",
      "['tls risk', 'venetoclax therapy', 'cll renal function', 'independent predictor', 'tls risk uk', 'iwcll2019 cll']\n",
      "['clinical community', 'new treatments', 'cll patients', 'patient advocates']\n",
      "['s day', 'clinical assessment', 'initial therapy', 'resistance mechanisms', 'full coverage', 'cllsm leusm']\n",
      "['world cml day wcmlday', 'important day', 'awareness amp', 'chronic leukaemia bloodcancer makebloodcancervisible bloodcancerawarenessmonth']\n",
      "['breakfast symposium', 'generation btk inhibitors', 'b cell malignancies outcomes', 'cll patients cll']\n",
      "['generation btkinhibitors', 'bcell malignancies data updates', 'case challenge', 'secondary malignancies w prof barbara eichhorst']\n",
      "['generation btkinhibitors', 'bcell malignancies data updates', 'case challenge', 'secondary malignancies w prof barbara eichhorst']\n",
      "['generation btkinhibitors', 'bcell malignancies data updates', 'case challenge', 'continuous treatment w prof barbara eichhorst']\n",
      "['generation btkinhibitors', 'bcell malignancies data updates', 'case challenge', 'continuous treatment w prof barbara eichhorst']\n",
      "['generation btkinhibitors', 'bcell malignancies data updates', 'case challenge', 'treatment approach w prof jacqueline barrientos']\n",
      "['incurable cancer chronic lymphocytic leukemia scientists']\n",
      "['cll check', 'gt gt cllsm leusm ctsm']\n",
      "['cll ipi', 'clinical trials', 'venetoclax therapy', 'refractory cll iwcll2019 uk', 'collaboration lymsm']\n",
      "['danielle brander', 'cll patients intolerant', 'pi3k delta inhibitor therapy cllsm leusm ctsm']\n",
      "['iwcll2019 edinburgh martina seiffert', 'new mechanisms', 'cll mouse model', 'tcl1 mouse']\n",
      "['refractory chronic lymphocytic leukemia cll clinical trials', 'companies drugs phases subjects', 'current status', 'vpa research prices', 'global clinical trial report', 'refractory chronic']\n",
      "['iwcll2019 adam linley', 'signal omics', 'antigen engagement', 'bcr activation', 'full interview', 'cllsm leusm']\n",
      "['vstm verastem', 'clinical data', 'annual international workshop', 'chronic lymphocytic leukemia tak']\n",
      "['excellent overview', 'kostas stamatopoulos', 'immunoglobulin stereotypy', 'cll check', 'summary slide leusm']\n",
      "['uk cll forum ibrutinib data', 'refractory cll', 'iwcll2019 posters', 'dose attenuation survival', 'subsequent rx', 'data lymsm']\n",
      "['excellent talk', 'dr martin subero', 'different epigenetic marks', 'chromatin changes', 'genetics mutations', 'tf activity iwcll2019']\n",
      "['fantastic talk', 'inaki martin subero iwcll2019 cll epigenetics chromatin']\n",
      "['major non trial comparison', 'venetoclax cd20mab vs ibrutinib vs idelalsib', 'novel agent', 'clear difference', 'os outcomes', 'na cll iwcll2019']\n",
      "['shit gt round', 'lt blood cancer', 'alert non hodgkin s lymphoma b', 't cell chronic lymphocytic leukemia mantle cell hairy cell', 'multiple myeloma', 'killer victims', 'compensation look']\n",
      "['cll knowledge meeting', 'international meeting', 'new phd', 'official student', 'cll science']\n",
      "['co fellows p', 'future leaders', 'guys cll iwcll']\n",
      "['cancer conference', 'familiar faces cll bloodcancerawarenessmonth makebloodcancervisible']\n",
      "['cache eye units', 'btec cpld units', 'eytwittertagteam eymatters cll speech communication language']\n",
      "['verastem oncology announces copiktra duvelisib presentations', 'annual international workshop', 'chronic lymphocytic leukemia']\n",
      "['productive meeting', 'chinese colleagues', 'future cooperation', 'iwcll cll leusm leukemia']\n",
      "['s broadresearchroundup', 'driver mutations', 'passenger ones', 'genetic basis', 'diabetickidneydisease whence', 'venetoclax resistance']\n",
      "['verastem oncology pronounces copiktra duvelisib displays']\n",
      "['vstm verastem oncology announces copiktra duvelisib presentations', 'annual international workshop', 'chronic lymphocytic leukemia']\n",
      "['uk cll forum', 'prof paolo ghia', 'eha esmo treatment guidelines', 'cll 1st line', 'r r cll cllhz2019']\n",
      "['verastem oncology announces copiktra duvelisib presentations', 'annual international workshop']\n",
      "['world s', 'clinical data', 'cll lymsm leusm']\n",
      "['conference coverage', 'edinburgh worcester', 'top medical professionals', 'chronic lymphocytic leukemia cll', 'conference iwcll']\n",
      "['vstm verastem oncology announces copiktra duvelisib presentations', 'annual international workshop', 'chronic lymphocytic leukemia']\n",
      "['verastem oncology announces copiktra duvelisib presentations', 'annual international workshop', 'chronic lymphocytic leukemia verastem inc nasdaqvstm verastem oncology', 'biopharmaceutical company']\n",
      "['tad acronym onious', 'great news', 'cll patients', 'undetectable mrd', 'cll bcells leukemia']\n",
      "['minutes journalist', 'dark corner', 'long struggle', 'chronic lymphocytic leukemia']\n",
      "['cll navigator', 'bcam bloodcancerawarenessmonth']\n",
      "['cll expert', 'cll patients', 'blood work']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['excellent session', 'uk cll forum', 'strong engagement', 'cll clinicians', 'cll patient advocates']\n",
      "['cll lyle dk blodcancer bloodcancerawarenessmonth makebloodcancervisible letstalkaboutbloodcancer']\n",
      "['iwcll cllhz19 cll', 'lyle dk blodcancer makebloodcancervisible bloodcancerawarenessmonth letstalkaboutbloodcancer']\n",
      "['own dr kharfan dabaja cll mayoclinic']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['professor paolo ghia shares news', 'new eha esmo tx guidelines', 'joint audience', 'cll patient advocates amp clinical community cllhz19 iwcll2019']\n",
      "['prof paolo ghia', 'international perspectives', 'project eric', 'great tool', 'uk cll forum science day cllhz19']\n",
      "['prof paolo ghia shares', 'treatment guidelines', 'community cllhz19']\n",
      "['prof chris fegan', 'cll cllhz19']\n",
      "['wonderful prof chris fegan', 'unknown unknowns', 'iwcll cllhz19']\n",
      "['prof fegan', 'cll forum og science day cllhz19']\n",
      "['great talk', 'treatment options', 'cll patients cllhz19']\n",
      "['associate professor', 'haematology university', 'oxford reiterates', 'tp53 amp fish', 'tx options', 'cll patients iwcll2019 cllhz19']\n",
      "['dr anna schuh', 'flue vaccine', 'pneumnokok vaccine', 'cll patients']\n",
      "['uk cll forum clinical sciences day', 'field cll bloodcancerawarenessmonth letstalkaboutbloodcancer makebloodcancervisible blodcancer lyle dk watchandworry']\n",
      "['b cell lymphoproliferative disease leusm cll']\n",
      "[]\n",
      "['therapeutic target', 'chronic lymphocytic leukemia']\n",
      "['edinburgh patient organisations', 'leukaemia leukemia patients', 'world meet', 'hot topics']\n",
      "['exciting weekend', 'cll research']\n",
      "['cll w cristina scielzo', 'francesca sbrana', 'full interviews', 'cllsm hemonc']\n",
      "['jennifer wilson', 'information specialists', 'amp obstacles cll patients', 'cllhz19 iwcll2019']\n",
      "['dr kostas stamatopoulos discusses', 'cllhz19 iwcll2019']\n",
      "['cll patients', 'fish test', 'treatment changes', 'dr lamanna cllhz19 iwcll2019']\n",
      "['new treatment', 'cll patients', 'years cllhz19']\n",
      "['interesting program', 'edinburgh letstalkaboutbloodcancer makebloodcancervisible bloodcancerawarenessmonth']\n",
      "['international workshop', 'chronic lymphocytic leukemia iwcll2019']\n",
      "['dr jain', 'phase iii trials', 'additional modifications', 'treatment landscape', 'chronic lymphocytic leukemia cllsm leusm']\n",
      "['roundup options', 'illinois encourages', 'non hodgkin s lymphoma', 'chronic lymphocytic leukemia', 'steinberg law group']\n",
      "['great news', 'chronic lymphocytic leukemia', 'i need']\n",
      "['cll patient advocates']\n",
      "['chronic lymphocytic leukemia', 'melanoma risk melanoma', 'malignant melanoma']\n",
      "['renforcer les liens entre', 'grand public', 'communaut scientifique bravo les frq cll recherche']\n",
      "['cll treatment path dr danielle brander', 'leusm cllsm']\n",
      "['year christina fisher shares']\n",
      "['dyk genetic markers', 'person s chronic lymphocytic leukemia cll', 'bloodcancerawarenessmonth test']\n",
      "['chronic lymphocytic cll', 'chronic myeloid cml leukaemia consultant oncologist dr adrian bloor', 'symptoms amp treatments', 'chronicleukaemia course', 'sneak peak']\n",
      "['precision s investigational', 'new drug application', 'non hodgkin lymphoma nhl chronic lymphocytic leukemia ccl', 'small lymphocytic lymphoma ssl lymphoma bloodcancerawarenessmonth bcam']\n",
      "['backyard roundup use', 'chronic lymphocytic leukemia lawsuit claims']\n",
      "['person s experience', 'chronic lymphocytic leukemia cll', 'unique visit', 'common form', 'u s bloodcancerawarenessmonth']\n",
      "['cllhz19 brian koffman', 'qol livingwithbloodcancer letstalkaboutbloodcancer makebloodcancervisible bloodcancerawarenessmonth']\n",
      "['trabectedin reveals', 'chronic lymphocytic leukemia']\n",
      "['cllhz19 conference', 'cll community meeting others amp', 'social media presentation']\n",
      "['belle initiative merci cll p dagogie']\n",
      "['jeux d apprentissages immersifs', 'des enfants atteints du tdc', 'troubles s v res d apprentissage cll p dagogie']\n",
      "['t cells', 'cll patients', 'overall t cell dysfunction', 'mechanism plays']\n",
      "['bloodcancerawarenessmonth amp', 'spotleukaemia campaign', 'new chronicleukaemia course', 'cml cll']\n",
      "['days sharon', 'info amp support team', 'cll horizons conference', 'hashtag cllhz19']\n",
      "['important informations']\n",
      "['backyard roundup use', 'chronic lymphocytic leukemia lawsuit claims']\n",
      "['cll mehr als zwei drittel der patienten unter btk inhibitor weiterhin ohne progress']\n",
      "['chronic lymphocytic leukemia cll clinical trials', 'companies drugs phases subjects', 'current status', 'vpa research prices', 'global clinical trial report', 'chronic lymphocytic leukemia cll']\n",
      "['icymi ibrutinib demonstrates', 'long term efficacy', 'refractory cll paul barr md shares', 'resonate study cll sll lymphoma']\n",
      "['secondary cancer risk', 'cll david bond md addresses', 'primary neoplasia', 'chronic lymphocytic leukemia']\n",
      "['scan results cup', 'ihr klr ketl jlg smrt swef spsy cll bats cli', 'sspg itv pin igg gsf']\n",
      "['scan results macd bullish signal line cross', 'char cpx mfx ketl dln omi cll ppc demg php mwg crei ascl uu sge mcl']\n",
      "['backyard roundup use', 'chronic lymphocytic leukemia lawsuit claims cll', 'bone marrow', 'complaint joins', 'roundup lawsuits', 'monsanto amp', 'new parent company bayer']\n",
      "['restore humoural immunity', 'immune replacement therapy']\n",
      "['sentinel major infection', 'quantitative ig deficiency', 'point i', 'speaker tour hypogam infections lead', 'complications eg extrapulmonary dissemination']\n",
      "['mortality benefit', 'year duration cll', 'progressive disease', 'mortality benefit', 'severe infections']\n",
      "['i need cll treatment', 'i don t', 'webinar fact', 'fiction cll causes amp symptoms', 'leusm cllsm register']\n",
      "['u s', 'chronic lymphocytic leukemia cll']\n",
      "['selective btk inhibitor zanubrutinib', 'b cell malignancies', 'efficacy evaluation']\n",
      "['arterial thrombosis', 'haematological malignancy', 'ibrutinib cll lymsm lymphoma']\n",
      "['cll cello health reports', 'good growth', 'strong cash flow cll', 'full interview']\n",
      "['verastem oncology offsite', 'team engagement innovation field', 'medical team supports blood cancer awareness month thx msl nurse educator amp customer engagement team', 'bcam verastemoncology cll nhl']\n",
      "['observational study', 'cll sll treatment', 'ibrutinib treatment', 'cll sll', 'routine clinical practice status', 'condition summary chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['dyk chronic lymphocytic leukemia cll accounts', 'u s rt']\n",
      "['new roundup cancer lawsuit alleges', 'plaintiff s backyard use', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['dr susan o brien', 'grand rounds', 'mdacc board review']\n",
      "['congress soho2019', 'chronic lymphocytic leukemia lymsm']\n",
      "['chronic lymphocytic leukemia cll blood smear', 'frequent smudge cells hemepath cytopath cll']\n",
      "['chronic lymphocytic leukemia cll cancer cells', 'normal cells', 'healthy cells', 'innovative therapies', 'cll bloodcancerawarenessmonth']\n",
      "['patient trial', 'different landscape', 'btk inhibitors', 'chronic lymphocytic leukemia']\n",
      "['hi cll friends', 'scotland s skirt']\n",
      "['full interview cello health reports', 'good growth', 'strong cash flow']\n",
      "['full interview cello health reports', 'good growth', 'strong cash flow', 'uk cll brighterir andrewscotttv']\n",
      "['i m', 'share ideas', 'cll communities cll lymphoma']\n",
      "['cll cello health', 'interim profits', 'uk cll']\n",
      "['cll cello health', 'interim profits', 'uk cll brighterir andrewscotttv']\n",
      "['cll headlines', 'cello signal', 'health bit', 'i don t hold']\n",
      "['b cell receptor rearrangement', 'somatic hypermutation', 'b cell class switch fate', 'chronic lymphocytic leukemia']\n",
      "['rns aim cll cello health plc interim results']\n",
      "['b cell receptor rearrangement', 'somatic hypermutation', 'b cell class switch fate', 'chronic lymphocytic leukemia']\n",
      "['rt physrelations rt mdandersonnews', 'therapy landscape', 'soho19 targetedonc endcancer']\n",
      "['cllhz19 conference', 'important week', 'cll community', 'patient advocates']\n",
      "['cll advocates network horizons conference', 'safe travel', 'important week', 'cll community', 'edinburgh hosts', 'conferences cllan horizons']\n",
      "['scan results cup', 'ccji digs rws hicl gsf cll', 'gama kay apgn tcs bats keys sspg ptec']\n",
      "['cancer awareness calendar', 'cancer cancer awareness leukemia bloodcancer survivor cll lymphoma warrior chemo tumor cancertribe oncology cancersucks calendar toomuchcancer']\n",
      "['disease progression', 'chronic lymphocytic leukemia cll', 'kirsten fischer md']\n",
      "['nice ebv cll study', 'polish labs', 'cell death', 'epstein barr virus infection', 'chronic lymphocytic leukaemia bcells immunotherapy']\n",
      "['cerebral networks', 'dramatic global maturation', '20s cll cerveau']\n",
      "['new lymphoquant b cell', 'internal controls', 'lymphotrack b cell', 'low positive control', 'minimal residual disease mrd', 'treatment strategies']\n",
      "['treatment experts', 'cll disease history', 'treatment strategy differs', 'time cll patientpower']\n",
      "['backyard roundup use', 'chronic lymphocytic leukemia lawsuit claims']\n",
      "['carol moreno md', 'ibrutinib rituximab versus fcr cll']\n",
      "['chronic lymphocytic leukemia cll', 'routine blood test', 'cll diagnosis']\n",
      "['cancer non hodgkin lymphoma', 'large diffuse b cell follicullar lymphoma cutaneous t cell anapalastic t cell chronic lymphocytic leukemia', 'small lymphocytic lymphoma mantle cell lymphoma primary', 'central nervous system cns lymphoma']\n",
      "['este momento el imparte', 'fjd una charla sobre el mecanismo', 'acci n y los resultados', 'con llc cll gracias', 'organizaci n']\n",
      "['non hodgkin s lymphoma chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma', 'non hodgkin s lymphoma']\n",
      "['jitc research phase i study', 'chronic lymphocytic leukemia', 'multiple myeloma blockade', 'immune checkpoint cd200']\n",
      "['l ducation ouverte n est pas un ph nom ne nouveau cependant les sciences ouvertes', 'citoyennes leurs infrastructures leurs pratiques', 'leurs valeurs constituent des vecteurs d opportunit s nouvelles cll p dagogie']\n",
      "['hier gibts das neueste zur behandlung von cll kurz reinschauen lohnt sich bestimmt']\n",
      "['therapy landscape', 'soho19 endcancer']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['arzerra novartis pharmaceuticals corporation chronic lymphocytic leukemia cll arzerra ofatumumab']\n",
      "['chronic lymphocytic leukemia patient juliette', 'blood cancer', 'day life bloodcancerawarenessmonth golime4lymphoma patientvoice']\n",
      "['convenci n anual', 'asociaci n latinoamericana', 'servicios ales', 'segu leyendo aqu ales peru cll norbertocapell n']\n",
      "['chronic lymphocytic leukemia', 'breast cancer', 'state nc s dhhs']\n",
      "['det er nu vi skal v re obs p blodcancer blodkr ft livskvalitet lymfekr ft leuk mi mds aml', 'apl cml cll cmml hodgkins nonhodgkins lymphomaawarenessmonth lymphoma wlad2019 nu makebloodcancervisible letstalkaboutbloodcancer knowaml del budskabet hvor du kan']\n",
      "['drs stephen m ansell jennifer r', 'brown amp nitin jain', 'cme video', 'hematologic malignancies', 'san diego', 'free cme credit gt gt']\n",
      "['chronic lymphocytic leukemia']\n",
      "['kirsty sadler', 'busy job', 'amp e tests', 'chronic lymphocytic leukaemia cll', 'spotleukaemia story gt']\n",
      "['scan results cup', 'cwr hotc rat apgn digs smp cll', 'gsf ihr ats sdrc sls bats scin lxi']\n",
      "['cll patients ensure', 'appropriate genetic', 'leusm cllsm', 'personalizedmedicine bcam']\n",
      "['clinical trials work', 'chronic lymphocytic leukemia cll leusm geriheme gerionc']\n",
      "['common leukemia', 'american adults chronic lymphocytic leukemia', 'new cases', 'states memorial sloan', 'cancer center disabilityinfo zusia']\n",
      "['october 17th', 'details bowerymission cowanliebowitz cll']\n",
      "['cll webinar']\n",
      "['medscapelive event', 'prof eichhorst', 'experts explore', 'refractory mantle cell lymphoma amp chronic lymphocytic leukemia cll register iwcll2019']\n",
      "['cll lab tests', 'essential dr danielle brander', 'overview leusm cllsm bcam']\n",
      "['incurable disease', 'ideas onsite registration', 'available iwcll2019']\n",
      "['free combination therapies', 'chronic lymphocytic leukemia']\n",
      "['clinical flow cytometric', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['rapid clinical progression', 'b cell chronic lymphocytic leukemia', 'horse veterinary']\n",
      "['gps nurses amp haematologists', 'new developments', 'cll amp', 'diagnosis amp']\n",
      "['32th workshop', 'landshut henriette huber', 'simone edenhofer', 'encouraging results', 'obinutuzumab ibrutinib venetoclax combination', 'high risk cll', 'deep remissions', 'good tolerability']\n",
      "['btk inhibitors', 'malignant lymphocytes immunonc cll leusm']\n",
      "['podcast paul barr md shares', 'resonate study cll sll lymphoma']\n",
      "['experts address', 'cll patients', 'clinical trial', 'future treatment options', 'cll clinical trials cll']\n",
      "['haematology clinics', 'direct cll patients', 'members pls', 'free bloodcancerawareness']\n",
      "['worldlymphomaday lymphoma', 'hodgkin lymphoma non hodgkin lymphoma', 'common cancer', 'canada wlad worldlymphomaawarenessday bloodcancerawarenessmonth']\n",
      "['i dag r det', 'international lymfomdag lyle patientforeningen', 'lymfekr ft leuk mi og mds st tter naturligvis alle blodkr ft patienter inkl cll cml cmml aml', 'apl del budskabet sundpol dksund lyle dk']\n",
      "['cll patients']\n",
      "['world lymphoma awareness day wlad2019 cll']\n",
      "['advocate partners', 'support wlad2019', 'cll lymphoma']\n",
      "['btk inhibitor', 'cd4 th1 cell outgrowth gt', 'controversial cll immunedeficiency immunology']\n",
      "['video mrd assessment', 'cll w danielle brander', 'asco19 leukemia bloodcancer hemonc']\n",
      "['rt physrelations rt leukemiamda', 'session xiii cll', 'nitin jain md nitinjainmd', 'mdandersonnews leukemiamda', 'frontline therapy', 'cll cancermedmda physrelations leusm']\n",
      "['rt physrelations rt leukemiamda', 'session xiii cll', 'alessandra ferrajoli md', 'mdandersonnews leukemiamda case presentation cancermedmda physrelations leusm']\n",
      "['rt physrelations rt leukemiamda', 'session xiv', 'william wierda md phd wwierda', 'mdandersonnews leukemiamda', 'questions cll cancermedmda physrelations leusm']\n",
      "['annual meeting', 'houston tx', 'cll updates', 'days lymsm']\n",
      "['wow language', 'communication excellence verbal', 'non verbal', 'old cll bsl communication signlanguage']\n",
      "['soho2019 progress']\n",
      "['soho2019 summary cll']\n",
      "['andrea lenartova', 'present norwegian registry data', 'soho2019 houston texas']\n",
      "['ennio s doctor', 'chronic lymphocytic leukemia', 'log hours']\n",
      "['chc2019 plasma cell dyscrasias non hodgkin s lymphoma hodgkin s lymphoma chronic lymphocytic leukemia myeloid disease immunotherapy thrombosis benign diseases']\n",
      "['early registration', 'cll meeting register onsite', 'meeting sept']\n",
      "['session xiv', 'william wierda md phd', 'questions cll leusm']\n",
      "['prognostic markers', 'dr weistner soho2019']\n",
      "['soho2019 cart', 'r r cll dr tanya siddiqui']\n",
      "['multiple lines', 'treatments soho2019']\n",
      "['challenging cll cases', 'dr ferrajoli', 'immune dysregulation', 'cll soho2019']\n",
      "['soho2019 pipeline therapy']\n",
      "['dr jennifer', 'brown soho2019 cllsm']\n",
      "['cll frontline treatment', 'soho2019 cllsm']\n",
      "['congress soho2019 dr jennifer r', 'chronic lymphocytic leukemia ibrutinib qnd venetoclax', 'art combos', 'pfs mrd', 'cost lymphoma lymsm']\n",
      "['soho2019 dr jennifer', 'brown concise therapy overview', 'cll frontline', 'r r']\n",
      "['final analysis', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['soho2019 cll comb ibrutinib venetoclax moab obinutuzumab frontline r r cll', 'safe amp']\n",
      "['session xiii cll', 'alessandra ferrajoli md', 'case presentation leusm']\n",
      "['chronic lymphocytic leukemia treatment pdq health', 'professional version', 'national cancer institute']\n",
      "['session xiii cll', 'nitin jain md', 'frontline therapy', 'cll leusm']\n",
      "['chronic lymphocytic leukemia', 'bone marrow', 'white blood cell']\n",
      "['32th workshop', 'landshut bavaria lukas frenzel', 'excellent overview', 'venetoclax therapy', 'cll bcl2 mutations', 'subclonal event', 'low allelic frequency leukemia']\n",
      "['new2trip rituximab truxima non hodgkin s lymphoma chronic lymphocytic leukemia', 'rheumatoid arthritis']\n",
      "['website bloodcancerawareness haematology medicine']\n",
      "['manuel fuentes', 'tumoral biology', 'immunoproteogenomics approaches novel therapeutic targets', 'chronic lymphocytic leukemia amp leptomeningeal diseases hupo2019 hupo hipp immunoproteogenomics neoantigens cll']\n",
      "['tanya siddiqi', 'brilliant interview', 'car t cell therapy', 'cll look', 'video lymsm']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['bloodcancerawarenessmonth lymphoma symptoms', 'night sweats', 'weight loss gt', 'fatigue swollen lymph nodes cough i', 'w chronic lymphocytic leukemia ok', 'new non chemo drugs']\n",
      "['alessandra ferrajoli', 'novel prognostic factors', 'cll video']\n",
      "['richard r furman', 'r r high risk cll leukemia weill cornell medicine weilcornell cllresearchcenter']\n",
      "['rod humerickhouse', 'minimal residual disease negativity abbvie leukemia']\n",
      "['flow cytometry', 'overall survival', 'chronic lymphocytic leukemia', 'clinical practice data', 'dr bulian', 'coauthors j clinical oncology twitterhomework pathelective']\n",
      "['1l cll answers', 'medimix livetracker cll marketinsights analytics hematology leukemia livetracker medimix']\n",
      "['chronic lymphocytic leukemia 60th ash', 'annual meeting']\n",
      "['prof corradini', 'car t cells', 'unfavorable prognoses safety', 'efficacy data', 'encouraging register']\n",
      "['ogt s', 'ngs panel', 'sureseq mypanel custom cll panel', 'genes sf3b1 atm notch1 tp53', 'birc3 view', 'gene list', 'exon coverage examples sf3b1 atm notch1 tp53 birc3 cll ngs sureseq']\n",
      "['final analysis', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma lymphoma lymsm']\n",
      "['video update', 'car nk cell therapy work', 'md anderson w prof william wierda', 'eha24 cll']\n",
      "['final analysis', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'j hematol cancer epidemiology']\n",
      "['cd19 chimeric antigen receptor t cells', 'chronic lymphocytic leukemia display', 'ifn production profile']\n",
      "['postdoc positions microenvironmental interactions', 'chronic lymphocytic leukemia', 'b cell lymphomas brno cz jobs sciencejobs vacancies brno czechrepublic europe molecularbiology oncology biochemistry']\n",
      "['uk amp', 'cll experts', 'treatment amp', 'patients amp', 'importance email', 'coordinator org uk bloodcancerawareness haematology']\n",
      "['y ahora que wrestler', 'prowrestler chileanswrestler luchalibre luchalibrechilena elmejorbotazodechile elmejordecll mimomento luchalibrechilena chileanswrestler cll likeforlikes']\n",
      "['obinutuzumab fludarabine']\n",
      "['new paper', 'stephan stilgenbauer gcllsg', 'international investigators genomic alterations', 'high risk chronic lymphocytic leukemia', 'cell cycle key regulators']\n",
      "['september cancer awareness leukemia bloodcancer survivor cll lymphoma warrior chemo tumor cancertribe oncology cancersucks']\n",
      "['chronic lymphocytic leukemia']\n",
      "['refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'compromise outcomes', 'increase toxicity soho19 leusm']\n",
      "['visit booth', 'mrd solutions', 'aml mm cll', 't cell malignancies']\n",
      "['chronic lymphocytic leukemia cll information online', 's credible register', 'sept 17th', 'cll expert']\n",
      "['oncoalert phase', 'selective btk inhibitor zanubrutinib', 'b cell malignancies', 'efficacy evaluation', 'cll lymsm leusm cllsm']\n",
      "['selective btk inhibitor zanubrutinib', 'b cell malignancies', 'efficacy evaluation', 'cll leusm']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['genome architecture', 'chromatin function', 'human bcell differentiation', 'neoplastic transformation cll leukemia development']\n",
      "['roundup options', 'new york encourages', 'non hodgkin s lymphoma', 'chronic lymphocytic leukemia', 'steinberg law group']\n",
      "['roundup glyphosate weedkiller chroniclymphocyticleukemia nonhodgkinslymphoma leukemia lymphoma medicalcare doctor surgeon nhl cll herbicide thesteinberglawgroup steinberglawgroup law attorney lawyer lawfirm legalcare legalhelp lawyers']\n",
      "['august rwd', 'livetracker cll ex', 'illustrates drugs', '1st line treatment rwe', 'hcps eu5', 'brazil sept', 'oncology hematology', 'indications cll']\n",
      "['fish tests', 'chromosomal abnormalities', 'cll patients', 'cll cells', 'cancer cell growth', 'survival haematology bloodcancerawareness']\n",
      "['final analysis', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll lymsm leusm']\n",
      "['great popular article', 'paper dissemination']\n",
      "['oncoalert distinct immune composition', 'lymph node', 'peripheral blood', 'cll patients', 'venetoclax treatment lymsm leusm cllsm']\n",
      "['cells cytokines chemokines', 'cancer stress', 'biobehavioral study', 'chronic lymphocytic leukemia']\n",
      "['oslo university hospital', 'soho2019 andrea lenartova', 'cll houston']\n",
      "['lymphoma hub', 'comprehensive coverage', 'annual meeting', 'interviews cll lymsm']\n",
      "['jitc research phase i study', 'chronic lymphocytic leukemia', 'multiple myeloma blockade', 'immune checkpoint cd200']\n",
      "['young patient', 'refractory cll', 'jacqueline barrientos', 'feinstein institute', 'medical research lymphomahub lymphoma overallsurvival prognosis lymsm leusm cancertherapy gogold']\n",
      "['cryptoliveleaktoken cll cll']\n",
      "[]\n",
      "['dyk chronic lymphocytic leukemia cll']\n",
      "['dr richard r furman', 'r r high risk cll leukemia weill cornell medicine']\n",
      "['great group']\n",
      "['common garden flower', 'chronic lymphocytic leukaemia cll cells', 'birmingham researchers gt bloodcancerawarenessmonth makebloodcancervisible']\n",
      "['drg epidemiology report estimates', 'western europe', 'global reports', 'cll leukemia lymphocyticleukemia bloodcancerawarenessmonth']\n",
      "['obinutuzumab fludarabine', 'pati leukemia']\n",
      "['midlands patient cll chronic lymphocytic leukemia research evening', 'free gt bloodcancerawarenessmonth']\n",
      "['fda approves', 'new drug', 'chronic lymphocytic leukemia', 'specific chromosomal abnormality pharma regulatory']\n",
      "['chronic lymphocytic leukemia']\n",
      "['sci member robert negrin', 'robust prognostic', 'stemcelltransplantation outcomes', 'novel risk stratification system', 'chronic lymphocytic leukemia patients aacr cll']\n",
      "['drug duo', 'common leukemia', 'u s patients', 'chronic lymphocytic leukemia cll', 'patient survival']\n",
      "['cll fda']\n",
      "['month s', 'call eric jacobsen md discusses', 'chronic lymphocytic leukemia', 'warm autoimmune hemolytic anemia']\n",
      "['new lymphoquant b cell', 'internal controls', 'lymphotrack b cell', 'low positive control', 'minimal residual disease mrd', 'treatment strategies']\n",
      "['leslie md', 'cll14 trial outcomes hackensack university', 'medical center lymphoma jtcc cll']\n",
      "['msso physician scientist fellow i', 'extracellular vesicles', 'chronic lymphocytic leukemia fightcancer']\n",
      "['birmingham area', 'friendly talks', 'clinicians register']\n",
      "['dr neha godiwala goyal', 'emotional ups', 'downs cll patients']\n",
      "['complex karyotype', 'refractory chronic lymphocytic leukemia', 'idelalisib rituximab hemeonc article']\n",
      "['postdoc positions microenvironmental interactions', 'chronic lymphocytic leukemia', 'b cell lymphoma science career jobs sciencejobs job brno czechrepublic']\n",
      "['original research shows', 'ikaros expression interferes', 'increases b', 'cell proliferation', 'malignant transformation', 'chronic lymphocytic leukemia']\n",
      "['roundup product', 'users w non hodgkin s lymphoma nhl', 'chronic lymphocytic leukemia cll', 'mass tort']\n",
      "['midlands patient cll research evening', 'free attendance']\n",
      "['enable clonal characterization', 'chemotherapeutic responses', 'chronic lymphocytic leukemia biorxiv']\n",
      "['makebloodcancervisible bloodcancerawareness haematology cll leukaemia charitytuesday']\n",
      "['certain patients', 'cll oncology newswatch oncology research cancer cancertherapy']\n",
      "['enable clonal characterization', 'chemotherapeutic responses', 'chronic lymphocytic leukemia', 'remarkable evolutionary capacity', 'major challenge', 'current therapeutic efforts', 'vast clonal']\n",
      "['cryoglobulinemic vasculitis', 'ibrutinib therapy', 'chronic lymphocytic leukemia cll chronic lymphocytic leukemia cll', 'trigger autoimmune phenomena', 'immune thrombocytopenia itp', 'common presentation']\n",
      "['chronic lymphocytic leukemia brian parkinson', 'clinical trial', 'therapeutic bloodcancerawareness']\n",
      "['chronic lymphocytic leukemia', 'common leukemia']\n",
      "['enable clonal characterization', 'chemotherapeutic responses', 'chronic lymphocytic leukemia']\n",
      "['free combination therapies', 'chronic lymphocytic leukemia']\n",
      "['bone marrow', 'acute lymphoblastic leukemia', 'acute myeloid leukemia', 'chronic lymphocytic leukemia']\n",
      "['enable clonal characterization', 'chemotherapeutic responses', 'chronic lymphocytic leukemia']\n",
      "['amp survival', 'chronic lymphocytic leukemia cll', 'medtwitter mrcp usmle fcps hematology clinicalpearl oncology']\n",
      "['enable clonal characterization', 'chemotherapeutic responses', 'chronic lymphocytic leukemia']\n",
      "['cll talk']\n",
      "['emotional toll']\n",
      "['chronic lymphocytic leukemia', 'clinical review']\n",
      "['drg epidemiology report estimates', 'western europe', 'global reports', 'cll leukemia chronic lymphocyticleukemia bloodcancerawarenessmonth']\n",
      "['makebloodcancervisible bloodcancerawareness haematology cll leukaemia lymphoma myeloma']\n",
      "['enable clonal characterization', 'chemotherapeutic responses', 'chronic lymphocytic leukemia biorxiv']\n",
      "['chronic lymphocytic leukaemia', 'haematologicalcancer bloodcancer']\n",
      "['torneo clausura 5ta fecha ccp vs cll finaaaaaaaaallllll', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 5ta fecha ccp vs cll cambio ang lica v zquez por liz pe', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 5ta fecha ccp vs cll', 'gooooool autogol unidasporelobjetivo cllpy']\n",
      "['torneo clausura 5ta fecha ccp vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 5ta fecha ccp vs cll cambio claudia romero por fabiola sandoval unidasporelobjetivo cllpy']\n",
      "['torneo clausura 5ta fecha ccp vs cll', 'gooooool carmen ben tez unidasporelobjetivo cllpy']\n",
      "['torneo clausura 5ta fecha ccp vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 5ta fecha ccp vs cll', 'gooool karina vega unidasporelobjetivo cllpy']\n",
      "['torneo clausura 5ta fecha ccp vs cll segundo tiempo', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 5ta fecha ccp vs cll', 'primera etapa', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 5ta fecha ccp vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 5ta fecha ccp vs cll', 'gooool unidasporelobjetivo cllpy']\n",
      "['torneo clausura 5ta fecha ccp vs cll', 'unidasporelobjetivo cllpy']\n",
      "['hms professor', 'physician catherine wu s research', 'chronic lymphocytic leukemia', 'immune system', 'battle cancer']\n",
      "['checkpoint inhibitors', 'line cll therapy w alison moskowitz md', 'asco19 bloodcancer leukemia hemeonc']\n",
      "['subgroup analysis', 'green study leusm']\n",
      "['relevant biomarkers', 'hematological oncology times lymsm lymphoma cll dlbcl']\n",
      "['btk inhibitors', 'cll oncology times leusm']\n",
      "['interesting concept', 'mrd status', 'recent paper cll']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['ibrutinib rituximab vs chemoimmunotherapy', 'chronic lymphocytic leukemia']\n",
      "['video mrd assessment', 'cll w danielle brander', 'asco19 leukemia bloodcancer hemonc']\n",
      "['cll treatment', 'blood counts amp prolong survival', 'possible leukaemia haematology medicine bloodcancerawareness']\n",
      "['wonderful speakers professors farrukh awan', 'amp john allan', 'medscapelive btkinhibitors', 'cll clinical pearls', 'future directions tweet', 'symposium ashmhm19']\n",
      "['obinutuzumab fludarabine']\n",
      "['cll clinical pearls', 'future directions', 'identify characteristics', 'btk inhibitors', 'resistance setting w prof farrukh awan']\n",
      "['cll clinical pearls', 'future directions', 'kinase inhibitor types w prof farrukh awan']\n",
      "['cll clinical pearls', 'future directions', 'generation btk inhibitors', 'generation agents amp combination therapies', 'outcomes w prof farrukh awan']\n",
      "['cll clinical pearls', 'future directions', 'appropriate therapy', 'patients w prof john allan']\n",
      "['cll clinical pearls', 'future directions', 'btk inhibitors', 'cll treatment landscape', 'r r disease w prof farrukh awan']\n",
      "['ibrutinib rituximab vs chemoimmunotherapy', 'chronic lymphocytic leukemia']\n",
      "['old friesian', 'month history', 'b cell chronic lymphocytic leukemia']\n",
      "['old friesian', 'month history', 'b cell chronic lymphocytic leukemia']\n",
      "['unity consciousness wow', 'name jhe', 'chaldean numerology', 'letters cll relates', 'locus coeruleus']\n",
      "['mount sinai hospital icahn school', 'mount sinai']\n",
      "['free full text', 'cytotoxic t', 'nk cells', 'chronic lymphocytic leukemia']\n",
      "['cytotoxic t', 'nk cells', 'chronic lymphocytic leukemia']\n",
      "['club whenever', 'team jt26 cll foreverblue']\n",
      "['cll patients', 'great work']\n",
      "['combination trial', 'duvelisib ipi', 'bendamustine rituximab', 'non hodgkin lymphoma', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['new2trip rituximab truxima non hodgkin s lymphoma chronic lymphocytic leukemia', 'rheumatoid arthritis']\n",
      "['cll don t need', 'necessary leukaemia haematology bloodcancerawareness medicine']\n",
      "['obinutuzumab fludarabine']\n",
      "['obinutuzumab fludarabine']\n",
      "['educational opportunities', 'disease states', 'nsclc cll amp myeloma cancer']\n",
      "['ibrutinib rituximab vs chemoimmunotherapy', 'chronic lymphocytic leukem']\n",
      "['non hodgkin s lymphoma nhl chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma anaplastic', 'large cell lymphoma angioimmunoblastic lymphoma blastic nk cell lymphoma']\n",
      "['new lab', 'tumour immunology research', 'generous support']\n",
      "['cytotoxic t', 'nk cells', 'cll leusm immunonc']\n",
      "['minutes journalist', 'dark corner', 'long struggle', 'chronic lymphocytic leukemia', 'private bloodcancerawareness']\n",
      "['pharmacy week', 'review pinterest tackles', 'vaccine movement cll', 'melanoma risk']\n",
      "['review study', 'chronic lymphocytic leukemia', 'melanoma study links tramadol']\n",
      "[]\n",
      "['cll creates need', 'person cohort', 'publication msl medicalaffairs melanoma cll']\n",
      "['favourite children s book books gt', 'nationalreadabookday reading books earlyyears eyfs literacy cll']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['patients don t', 'early stages people', 'cll don t', 'routine blood tests', 'diagnosis bloodcancerawareness']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['year amp learning', 'advances amp', 'new treatment options', 'cll community']\n",
      "['front line treatment', 'chronic lymphocytic leukemia']\n",
      "['international leaders']\n",
      "['combination treatment', 'chronic lymphocytic leu']\n",
      "['study shows', 'rituximab increases survival', 'chroniclymphocytic leukemia', 'costly dr joshua brody shares']\n",
      "['jitc research phase i study', 'chronic lymphocytic leukemia', 'multiple myeloma blockade', 'immune checkpoint cd200']\n",
      "['baby boomers', 'cancer therapy advisor researchers', 'baby boomer generation ages', 'seniors 1960s']\n",
      "['torneo clausura 4ta fecha nacional vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 4ta fecha nacional vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 4ta fecha nacional vs cll', 'gool karina vega unidasporelobjetivo cllpy']\n",
      "['torneo clausura 4ta fecha nacional vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 4ta fecha nacional vs cll cambio yanina l pez por liz pe', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 4ta fecha nacional vs cll cambio nairelis guti rrez por laurie cristaldo unidasporelobjetivo cllpy']\n",
      "['torneo clausura 4ta fecha nacional vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 4ta fecha nacional vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 4ta fecha nacional vs cll segundo tiempo', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 4ta fecha nacional vs cll', 'final del pt', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 4ta fecha nacional vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 4ta fecha nacional vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 4ta fecha nacional vs cll gol', 'griselda garay unidasporelobjetivo cllpy']\n",
      "['torneo clausura 4ta fecha nacional vs cll gol', 'fabiola sandoval unidasporelobjetivo cllpy']\n",
      "['torneo clausura 4ta fecha nacional vs cll', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 4ta fecha nacional vs cll partido', 'unidasporelobjetivo cllpy']\n",
      "['front line treatment', 'chronic lymphocytic leukemia', 'great overview', 'free therapy']\n",
      "['new ibrutinib rituximab vs chemoimmunotherapy', 'chronic lymphocytic leukemia']\n",
      "['current cll treatment landscape']\n",
      "['4ta fecha torneo clausura nacional vs cll equipo confirmado unidasporelobjetivo cllpy']\n",
      "['4ta fecha torneo clausura nacional vs cll es hoy unidasporelobjetivo cllpy']\n",
      "['encouraging survival rates', 'refractory chronic lymphocytic leukemia cll', 'clarity trial cll']\n",
      "['ibrutinib rituximab vs chemoimmunotherapy', 'chronic lymphocytic leukemia leukemia']\n",
      "['cll patients', 'town hall meeting', 'arlington texas', 'renowned cll experts lamanna thompson', 'details cllsm cll']\n",
      "['chronic lymphocytic leukemia cll patients', 'uncover causation', 'surveillance melanoma sunaware']\n",
      "['chronic lymphocytic leukemia cll patients', 'melanoma researchers', 'surveillance melanoma sunaware']\n",
      "['june i', 'week i', 'full rooms', 'patient seminars', 'trondheim thankful thoughtful phdnotmd']\n",
      "['oncology researchers', 'medical director dr hayslip', 'new opportunities', 'treatment options']\n",
      "['roundup options', 'california encourages', 'non hodgkin s lymphoma', 'chronic lymphocytic leukemia', 'steinberg law group']\n",
      "['obinutuzumab fludarabine']\n",
      "['visualabstract ibrutinib rituximab', 'chronic lymphocytic leukemia studygraphics chroniclymphocyticleukemiacll']\n",
      "['stadig f pladser tilbage til temadag i aarhus d', 'sep se', 'kom og m d andre i samme b d som dig blodkr ft blodcancer lymfekr ft leuk mi cll cml aml', 'mds apl lyle dk']\n",
      "['bloodcancerawareness month', 'free e learning module', 'chronic lymphocytic leukaemia cll', 'month leukemia lymphoma']\n",
      "['visualabstract ibrutinibrituximab', 'chronic lymphocytic leukemia', 'chronic lymphocytic leukemia cll patients', 'overall survival']\n",
      "['treatment strategies', 'cll w danielle brander', 'asco19 leukemia hemonc']\n",
      "['cll location', 'number amp size', 'lymph nodes', 'swollen lymph node areas', 'blood cell counts leukaemia haematology medicine bloodcancerawareness']\n",
      "['fb page', 'huge inspiration', 'book nvrqt jonlester cll lymphoma']\n",
      "['zhu malu villafane learnisb chinese english ell cll dual language']\n",
      "['ibrutinib rituximab vs chemoimmunotherapy', 'chronic lymphocytic leukemia medivizor']\n",
      "['ibrutinib rituximab vs chemoimmunotherapy', 'chronic lymphocytic leukemia']\n",
      "['wilmot cancer institute', 'chronic lymphocytic leukemia cll']\n",
      "['blog post', 'brief hiatus disembarkation cancer survivor cancersucks chemo remission leukemia lymphoma cancercommunity cancertribe oncology cancerbreak', 'family endurer cll tumor']\n",
      "['ric regimens', 'survival outcomes', 'allogeneic hematopoietic cell transplantation', 'low intensity non myeloablative', 'leusm bmt doi']\n",
      "['bloodcancerawarenessmonth makebloodcancervisible']\n",
      "['r r high risk cll', 'patient characteristics', 'cytogenetics weill cornell medicine cll']\n",
      "['j bloodcancerawarenessmonth voicesofexperience makebloodcancervisible mystory rt share retweet cll leukaemia']\n",
      "['rod humerickhouse', 'minimal residual disease negativity cll leukemia']\n",
      "['sept 17th', 'dr javier pinilla ibarz', 'credible chronic lymphocytic leukemia cll information online']\n",
      "['active cll patient toolkit video advice', 'experts printer', 'friendly office visit planners', 'resource guides leusm chroniclymphocyticleukemia']\n",
      "['jco editorial', 'osu s dr jennifer woyach', 'chronic lymphocytic leukemia cll']\n",
      "['paul m barr md', 'resonate trial', 'cll wilmot cancer institute leukemia']\n",
      "['dr danielle brander', 'expert advice', 'cll patients leusm cllsm']\n",
      "[]\n",
      "['bloodcancerawarenessmonth cll chroniclymphocyticleukaemia', 'chronic form', 'blood cancer', 'share raiseawareness']\n",
      "['adverse drug events', 'elderly patients', 'chronic lymphocytic leukemia', 'systematic review', 'meta analysis', 'trials lymphoma lymsm']\n",
      "['full blood test', 'peripheral blood film amp', 'lymph node biopsy leukaemia haematology medicine bloodcancerawareness']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['allogeneic transplant', 'chronic lymphocytic leukemia', 'historical experience clinicaltrials']\n",
      "['rapid clinical progression', 'b cell chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['new research minimal residual disease', 'chronic lymphocytic leukemia', 'new goal', 'chronic lymphocytic leukemia cll', 'minimal residual disease mrd', 'drug combinations oncology']\n",
      "['chronic lymphocytic leukemia jul', 'leukemia research leusm cllsm melsm']\n",
      "['medscapelive symposium', 'btk inhibitors', 'chronic lymphocytic leukemia cll w prof john allan', 'experts register']\n",
      "['scan results macd bearish centerline cross', 'adt wil cll otmp joul teg cltv sdl kmk']\n",
      "['cll creates need']\n",
      "['blood cancer awareness month i didn t', 'cll chronic lymphocytic leukemia', 'blood cancer awareness month']\n",
      "['fathers cll', 'dr john pagel']\n",
      "['chemo treatment', 'good news', 'cll treatment i', 'mid september']\n",
      "['new study', 'journal leukemia research patients', 'chronic lymphocytic leukemia cll']\n",
      "['new lymphoquant b cell', 'internal controls', 'lymphotrack b cell', 'low positive control', 'minimal residual disease mrd', 'treatment strategies']\n",
      "['allogeneic transplant', 'chronic lymphocytic leukemia', 'historical experience jr kim ht armand p cutler c fisher dc ho v', 'long term', 'intensity allogeneic stem cell transplantation']\n",
      "['medscapelive event', 'prof barrientos', 'experts explore', 'refractory mantle cell lymphoma amp chronic lymphocytic leukemia cll register iwcll2019']\n",
      "['new cases', 'chronic lymphocytic leukemia cll', 'treatment poses', 'significant challenge', 'financial assistance', 'cll fund']\n",
      "['verastem oncology announces', 'poster presentations', 'clinical data', 'hematologic oncology', 'annual meeting', 'houston cll hemeonc']\n",
      "['leukemia awareness month', 'common forms', 'acute lymphoblastic leukemia', 'acute myeloid leukemia aml chronic lymphocytic leukemia cll chronic myelogenous leukemia cml']\n",
      "['winship hematologist jonathon cohen md', 'chemo immunotherapy', 'sub group', 'chronic lymphocytic leukemia cll leusm']\n",
      "['non hodgkin lymphoma', 'large diffuse b cell follicullar lymphoma cutaneous t cell anapalastic t cell chronic lymphocytic leukemia', 'small lymphocytic lymphoma mantle cell lymphoma primary', 'central nervous system lymphoma']\n",
      "['free survival', 'chronic lymphocytic leukemia', 'costly option']\n",
      "['piece i', 'life post chemo', 'tea magazine', 'chemo cancersurvivor effectsofchemo remission cancer cll bloodcancer cancerneverends ptsd anxiety']\n",
      "['non hodgkin s lymphoma chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma', 'non hodgkin s lymphoma']\n",
      "['mature approach', 'cll plasma b cell maturation antigen levels', 'disease activity', 'chronic lymphocytic leukemia bcells']\n",
      "['impressive new study', 'vitro assay', 'biomarker discovery', 'dose prediction', 'venetoclax treatment', 'cll leukemia']\n",
      "['chronic lymphocytic leukemia', 'tp53 gene alterations', 'clinicopathologic analysis']\n",
      "['statin use', 'chronic lymphocytic leukemia incidence', 'case control study', 'manitoba canada']\n",
      "['uk raising awareness', 'makebloodcancervisible blood cancer']\n",
      "['common form', 'cll increases', 'age men', 'cll haematology bloodcancerawareness charitytuesday']\n",
      "['somatic sf3b1 mutations', 'myelodysplastic syndrome', 'ring sideroblasts', 'chronic lymphocytic leukaemia cll', 'ncbi oncology']\n",
      "['eosinophilic dermatosis', 'eosinophilic dermatosis', 'chronic lymphocytic leukemia']\n",
      "['dr bond discusses', 'key findings', 'recent study', 'chronic lymphocytic leukemia cll', 'btk inhibitor cllsm leusm']\n",
      "['blood cancer patient', 'blood test day', 's blog', 'test anxiety', 'cll journey']\n",
      "['plasma b cell maturation antigen levels', 'disease activity', 'cll leusm']\n",
      "[]\n",
      "['recent advances', 'chronic lymphocytic leukemia diffuse', 'large b cell lymphoma', 'follicular lymphoma authors ian w flinn oncology amp hematology review', 'chroniclymphocyticleukemia bcelllymphoma follicularlymphoma']\n",
      "['test results']\n",
      "['cll cll', 'white blood cells', 'bone marrow', 'white blood cells', 'aren t', 'don t work', 'haematology leukaemia bloodcancerawareness medicine']\n",
      "['bloodcancer awareness month', 'busy month']\n",
      "['young patient', 'refractory cll', 'jacqueline barrientos', 'feinstein institute', 'medical research lymphomahub lymphoma lymsm overallsurvival prognosis cancertherapy patienteducation']\n",
      "['blood cancer awareness month', 'chronic lymphocytic leukemia', 'night walk']\n",
      "['bloodcancerawarenessmonth fightbloodcancer cll leukemia lymphoma']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['bloodcancerawareness month', 'consultant amp haematology nurse', 'rt leukaemia cancer charity']\n",
      "['torneo clausura 3ra fecha cll vs sanlorenzo', 'final cll', 'san lorenzo unidasporelobjetivo cllpy']\n",
      "['vitro assay', 'biomarker discovery', 'dose prediction', 'venetoclax treatment', 'cll leusm cll']\n",
      "['torneo clausura 3ra fecha cll vs sanlorenzo cambio ang lica v zquez por stephenie lacoste unidasporelobjetivo cllpy']\n",
      "['torneo clausura 3ra fecha cll vs sanlorenzo', 'goool yanina l pez unidasporelobjetivo cllpy']\n",
      "['torneo clausura 3ra fecha cll vs sanlorenzo', 'goool paola genes unidasporelobjetivo cllpy']\n",
      "['torneo clausura 3ra fecha cll vs sanlorenzo cambio claudia romero por griselda l pez unidasporelobjetivo cllpy']\n",
      "['torneo clausura 3ra fecha cll vs sanlorenzo', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 3ra fecha cll vs sanlorenzo', 'goool karina vega unidasporelobjetivo cllpy']\n",
      "['torneo clausura 3ra fecha cll vs sanlorenzo inici', 'segunda etapa', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 3ra fecha cll vs sanlorenzo entre tiempo', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 3ra fecha cll vs sanlorenzo', 'goool karina vega unidasporelobjetivo cllpy']\n",
      "['torneo clausura 3ra fecha cll vs sanlorenzo', 'karina vega y', 'paola genes unidasporelobjetivo cllpy']\n",
      "['torneo clausura 3ra fecha cll vs sanlorenzo partido', 'unidasporelobjetivo cllpy']\n",
      "['video cll treatment', 'young w', 'hcc leusm leukemia icml2019']\n",
      "['treatment healthcare resource utilization', 'chronic lymphocytic leukemia', 'front line ibrutinib', 'chemoimmunotherapy sciencedirect', 'new paper']\n",
      "['prognostic significance', 'fc receptor', 'chronic lymphocytic leukemia hairy cell leukemia', 'various b cell non hodgkin s lymphoma lymphoma lymsm']\n",
      "['standom s tait shanafelt', 'new drug combination', 'chronic lymphocytic leukemia']\n",
      "['paul m barr md', '1st line cll wilmotcancerinstitute leukemia']\n",
      "['decipher fact', 'cll treatment', 'september 17th', 'cll expert']\n",
      "['curiosity table', 'clear plastic fish bowls', 'baby shower section i ve', 'acorns eytwittertagteam eyfs nature curiosity language cll']\n",
      "['biomarker discovery', 'dose prediction', 'cll thanks', 'fantastic collaboration']\n",
      "['roundup options', 'texas encourages', 'non hodgkin s lymphoma', 'chronic lymphocytic leukemia', 'steinberg law group']\n",
      "['good guidance', 'dose reductions', 'severe hepatic impairment', 'manage dose', 'adverse effects cll venetoclax']\n",
      "['califolink logistics office', 'storage containers', 'cll solutions lka icontactlanka']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['chronic lymphocytic leukemia precision medicine clinic']\n",
      "['alliance a041702 ph3 rct ibrutinib obinutuzumab venetoclax', 'patients gt 70yo', 'chronic lymphocytic leukemia cll nct03737981 leusm cllsm geriheme']\n",
      "['diagnostic chronic lymphocytic leukaemia genome', 'comprehensive rapid low cost']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['pi3k p110 contributes', 'antibody responses', 'chronic lymphocytic leukemia ja o brien s evolution', 'cll treatment', 'therapy nat rev clin oncol', 'hallek m ches']\n",
      "['chronic lymphocytic leukemia cll leusm']\n",
      "['news pi3k p110 contributes', 'antibody responses', 'chronic lymphocytic leukemia']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['medscapelive symposium', 'chicago il', 'ashmhm19 explore', 'btk inhibitors', 'chronic lymphocytic leukemia cll w prof john allan', 'experts register']\n",
      "['new jitc research phase i study', 'chronic lymphocytic leukemia', 'multiple myeloma blockade', 'immune checkpoint cd200']\n",
      "['autophagy regulation', 'cll doi']\n",
      "['video brian koffman', 'professional w', 'leusm leukemia hematology eha24']\n",
      "['chronic lymphocytic leukemia non hodgkin lymphoma', 'hl patients', 'cll lymphoma']\n",
      "['current cll treatment landscape']\n",
      "['blood cancers', 'treatment options', 'special considerations']\n",
      "['human medicines european', 'public assessment report epar gazyvaro obinutuzumab leukemia lymphocytic chronic b cell date', 'pharma regulatory']\n",
      "['september issue', 'hemonc research articles', 'multiple myeloma mmsm cll amp aml leusm']\n",
      "['chlorambucil rituximab', 'lenalidomide combination treatment', 'chronic lymphocytic leukemia medivizor']\n",
      "['fludarabine amp cyclophosphamide', 'chronic lymphocytic leukaemia cll leukaemia immunotherapy']\n",
      "['medicom conference report', 'full report online', 'medicom conference portal', 'medical publishers conference hematology aml cll cart eha24 hematology']\n",
      "['chronic lymphocytic leukemia', 'subgroup analysis', 'green study']\n",
      "['chronic lymphocytic leukemia', 'subgroup analysis', 'green study b robak t montserrat e ghia p hillmen p hallek m', 'chronic lymphocytic leukae']\n",
      "['bcell chronic lymphocytic leukemia pipeline review h1', 'global markets', 'direct prices']\n",
      "['oncoalert obinutuzumab', 'chronic lymphocytic leukemia', 'subgroup analysis', 'green study cll']\n",
      "['immunoglobulin levels', 'chronic lymphocy leukemia']\n",
      "['final results', 'btki pre bcl2i', 'short 1st remission', 'novel agent', 'interesting debate pros', 'approaches thanks', 'cll lymsm']\n",
      "['developmental subtypes', 'dna methylation iplex', 'natural history', 'chronic lymphocytic leukemia cll']\n",
      "['bcl2 inhibitor', 'chronic lymphocytic leukemia']\n",
      "['light chains', 'chronic lymphocytic leukemia', 'monoclonal b cell lymphocytosis']\n",
      "['chronic lymphocytic leukemia cll information online', 's credible register', 'sept 17th', 'cll expert']\n",
      "['oncoalert clinical significance', 'dna methylation', 'chronic lymphocytic leukemia cll patients results', 'uk clinical trials lymsm cllsm leusm']\n",
      "['chronic lymphocytic leukemia']\n",
      "['dr danielle brander', 'expert advice', 'cll patients leusm cllsm']\n",
      "['human medicines european', 'public assessment report epar imbruvica ibrutinib lymphoma mantle cell leukemia lymphocytic chronic b cell date', 'pharma regulatory']\n",
      "['phase i study', 'professor mahadevan', 'therapeutic efficacy', 'cd200 immune checkpoint', 'chronic lymphocytic leukemia', 'multiple myeloma']\n",
      "['difference cll cllsm testbeforetreat']\n",
      "['uses daunosin 20mg tablets', 'chemotherapy medication', 'acute myeloid leukemia', 'acute lymphocytic leukemia chronic myelogenous leukemia', 'kaposi s sarcoma', 'vein rsp']\n",
      "['long term studies', 'ibrutinib therapy', 'del 11q chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['active cll patient toolkit video advice', 'experts printer', 'friendly office visit planners', 'resource guides leusm cllsm']\n",
      "['video venetoclax', 'cll w eha24 hematology hemeonc bloodcancer leukemia lymphoma leusm cancer oncology']\n",
      "['chronic lymphocytic leukemia case series', 'literature lymsm']\n",
      "['genetic predisposition', 'chronic lymphocytic leukemia', 'integrative epigenomics']\n",
      "['video alpine results zanubrutinib vs ibrutinib', 'cll w constantine tam']\n",
      "['pivotal idelalisib r r r cll', 'trial subset comparison', 'complex karyotype ck vs non ck pts', 'i r', 'orr pfs', 'pts tp53 wt', 'small n']\n",
      "['chronic lymphocytic leukemia']\n",
      "['online cll']\n",
      "['tuesday i', 'chronic lymphocytic leukemia', 'socks sea sea', 'perfect size', 'head check', 'cute dose']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['mazyar shadman md mph', 'venetoclax venclexta', 'chronic lymphocytic leukemia lylsm']\n",
      "['liver dysfunction', 'chronic lymphocytic leukemia', 'new findings', 'spleen involvement']\n",
      "['torneo clausura 2da fecha cll vs gralcaballero', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 2ra fecha cll vs gralcaballero cambio ngeles portillo por liza larrea unidasporelobjetivo cllpy']\n",
      "['torneo clausura 2da fecha cll vs gralcaballero', 'gool griselda garay unidasporelobjetivo cllpy']\n",
      "['torneo clausura 2da fecha cll vs gralcaballero', 'gool claudia romero unidasporelobjetivo cllpy']\n",
      "['torneo clausura 2da fecha cll vs gralcaballero', 'gool liz pe', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 2da fecha cll vs gralcaballero', 'gool fabiola sandoval unidasporelobjetivo cllpy']\n",
      "['torneo clausura 2ra fecha cll vs gralcaballero cambio claudia romero por damia cortaza unidasporelobjetivo cllpy']\n",
      "['torneo clausura 2da fecha cll vs gralcaballero', 'gool unidasporelobjetivo cllpy']\n",
      "['torneo clausura 2da fecha cll vs gralcaballero', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 2da fecha cll vs gralcaballero segundo tiempo', 'marcha unidasporelobjetivo cllpy']\n",
      "['torneo clausura 2da fecha cll vs gralcaballero', 'final del primer tiempo', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 2da fecha cll vs gralcaballero', 'pt gool', 'liza larrea unidasporelobjetivo cllpy']\n",
      "['torneo clausura 2da fecha cll vs gralcaballero', 'pt gool', 'liza larrea unidasporelobjetivo cllpy']\n",
      "['torneo clausura 2da fecha cll vs gralcaballero pt gool', 'liza larrea unidasporelobjetivo cllpy']\n",
      "['torneo clausura 2da fecha cll vs gralcaballero pt gool', 'liza larrea unidasporelobjetivo cllpy']\n",
      "['torneo clausura 2da fecha cll vs gralcaballero pt gool', 'fabiola sandoval unidasporelobjetivo cllpy']\n",
      "['torneo clausura 2da fecha cll vs gralcaballero', 'pt gool', 'fabiola sandoval unidasporelobjetivo cllpy']\n",
      "['torneo clausura 2da fecha cll vs gralcaballero', 'pt gool', 'liza larrea unidasporelobjetivo cllpy']\n",
      "['torneo clausura 2da fecha cll vs gralcaballero', 'pt gool', 'ang lica v zquez unidasporelobjetivo cllpy']\n",
      "['torneo clausura 2da fecha cll vs gralcaballero', 'pt gool', 'autogol unidasporelobjetivo cllpy']\n",
      "['non hodgkin s lymphoma b', 't cell chronic lymphocytic leukemia mantle cell hairy cell', 'multiple myeloma', 'killer victims']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['month s', 'hot topic dr curt hanson', 'prognostic markers', 'chronic lymphocytic leukemia cll', 'molecular analyses']\n",
      "['overall survival', 'chronic lymphocytic leukemia cll']\n",
      "['cll patients', 'florence cymbalista', 'hematology leukemia mrd patientcare knowledgeispower patienteducation']\n",
      "['old female', 'chronic lymphocytic leukemia', 'mayo clinic pathways case study clinicalchem mayoclinic path2path']\n",
      "['concurrent cutaneous localization', 'langerhans cell sarcoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['chlorambucil rituximab', 'lenalidomide combination treatment', 'chronic lymphocytic leukemia medivizor']\n",
      "['concurrent cutaneous localization', 'langerhans cell sarcoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['monthly theme', 'car t cell therapy', 'high rates', 'durable responses', 'reasonable choice', 'r r cll lymsm']\n",
      "['intense uptake', 'liposomal curcumin', 'multiple myeloma cell lines comparison', 'normal lymphocytes', 'red blood cells', 'chronic lymphocytic leukemia cells']\n",
      "['concurrent cutaneous localization', 'langerhans cell sarcoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma lymphoma lymsm']\n",
      "['high grade b cell lymphoma', 'bcl6 rearrangements', 'richter transformation', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['dr bond', 'key findings', 'recent study', 'chronic lymphocytic leukemia', 'btk inhibitor leusm leukemia']\n",
      "['refractory setting', 'cll w dr barbara eichhorst', 'eha24 hematology hemeonc leukemia lymphoma']\n",
      "['cancer incidence', 'chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukemia', 'current treatment', 'standard chemoimmunotherapy']\n",
      "['chicago il', 'medscapelive event', 'generation bruton s tyrosine kinase btk inhibitors', 'chronic lymphocytic leukemia cll register']\n",
      "['scan results cup', 'tfw biff stvg jlg pcgh smwh bgs gkp bkg dplm cll gbg whr byg inch pnn']\n",
      "['scan results', 'star candlestick', 'pshd hmlh baf casp pdg blp weir', 'psn mmh itv land rat cll gfrd fin']\n",
      "['chronic lymphocytic leukemia']\n",
      "['hl patients', 'pmcf cll lymphoma']\n",
      "['care perspectives', 'key news', 'plasma cell dyscrasias pcds chronic lymphocytic leukemia cll non hodgkin lymphomas nhl']\n",
      "['month s', 'hot topic dr curt hanson', 'prognostic markers', 'chronic lymphocytic leukemia cll']\n",
      "['combination treatment', 'chronic lymphocytic leukemia', 'scotland raredisease leukemia bloodcancer chroniclymphocyticleukemia cll']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['human medicines european', 'public assessment report epar venclyxto venetoclax leukemia lymphocytic chronic bcell date', 'human medicines european', 'public assessment report epar venclyxto venetoclax']\n",
      "['human medicines european', 'public assessment report epar venclyxto venetoclax leukemia lymphocytic chronic b cell date', 'pharma regulatory']\n",
      "['rns aim cll cello health plc']\n",
      "['roundup options', 'center encourages', 'non hodgkin s lymphoma', 'chronic lymphocytic leukemia', 'steinberg law group']\n",
      "['roundup roundupweedkiller monsanto bayer weedkiller weedkillers glyphosate weeds nonhodgkinslymphoma nhl chroniclymphocyticleukemia cll cancer lawsuit classaction law lawyer lawyers lawsuits', 'legal massaction verdict trial jury']\n",
      "['clinical trial', 'chronic lymphocytic leukemia']\n",
      "['new program', 'cll navigator']\n",
      "['current cll treatment landscape']\n",
      "['jitc review state', 'car t cell therapy', 'chronic lymphocytic leukemia']\n",
      "['drug regimen']\n",
      "['cll lab tests', 'essential dr danielle brander', 'overview leusm cllsm']\n",
      "['year anniversary', 'chronic lymphocytic leukemia', 'i m thankful', 'i m', 'leukemiawarrior leukemiaawareness']\n",
      "['immune cells', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll hematological oncology lymsm cllsm leusm']\n",
      "['peripheral t cell lymphoma', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['full disclosure i m', 'planning committee cll committee', 'lifelong learning']\n",
      "['drg epidemiology report estimates', 'western europe', 'global reports', 'cll leukemia chronic lymphocyticleukemia']\n",
      "['important step', 'cll patients amp others', 'incurable chronic cancer diagnosis need', 'address unmet needs', 'leukaemia amp']\n",
      "['canadian evidence', 'line treatment', 'chronic lymphocytic leukemia']\n",
      "['cancer cancer party', 'cancer remission', 'cll lymphoma cancersucks cancertribe']\n",
      "['dr bond', 'key findings', 'recent study', 'chronic lymphocytic leukemia', 'btk inhibitor cllsm leusm']\n",
      "['great relief', 'chemo session', 'vast improvement week', 'f u cancer']\n",
      "['clinical trial shows', 'chronic lymphocytic leukemia patients s dr sravanti teegavarapu', 'good marker', 'long term remission cll cancer']\n",
      "['sept 17th webinar fact', 'fiction cll treatment']\n",
      "['cll experts', 'cll patients', 'cllsm leusm']\n",
      "['video primary endpoint results', 'cll12 trial w dr barbara eichhorst', 'cll leukemia leusm eha24 hematology']\n",
      "['chronic lymphocytic leukemia']\n",
      "['blood test', 'i m', 'stage iii chronic lymphocytic leukemia']\n",
      "['common type', 'u s', 'year share']\n",
      "['chronic lymphocytic leukemia']\n",
      "['mrd negativity', 'clarity trial', 'measurable residual disease negativity', 'refractory chronic lymphocytic leukemia']\n",
      "['cello health plc', 'potential upside', 'finncap cll']\n",
      "['library tours', 'early childhood student maura', '10am 2pm', 'librarytours cll yourwarwick']\n",
      "['chronic lymphocytic leukemia non hodgkin lymphoma', 'hl patients']\n",
      "['cll komplette remission bei', 'mit kombination ibrutinib und venetoclax cll onkologie h matologie']\n",
      "['complex karyotype', 'overall survival', 'chronic lymphocytic leukemia', 'rituximab cll fightcancer']\n",
      "['mazyar shadman md mph', 'chronic lymphocytic leukemia']\n",
      "['mir 34a', 'mir 29b', 'free survival', 'chronic lymphocytic leukemia patients', 'chinese uygur', 'han populations']\n",
      "['survival outcomes', 'chronic lymphocytic leukemia']\n",
      "['high prevalence', 'chronic lymphocytic leukemia', 'b cell lymphomas', 'nuclear workers', 'alpha emitters case report', 'literature roland wolff']\n",
      "['i m thankful', 'dr susan leclair', 'great fun', 'i hope', 'cll video']\n",
      "['important patients', 'wrong care', 'dr koffman s interview', 'dr nabhan cll cllsm letscurethis']\n",
      "['immune cells', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma zou hematological oncology']\n",
      "['chronic lymphocytic leukemia cll patients', 'overall survival', 'ibrutinib rituximab', 'current standard chemoimmunotherapy rates', 'high grade', 'medical medicine']\n",
      "['hi cll tweeps', 'old binet c tp53 wt cll relapses', '5y post 1l b r', 'clear ci', 'bcl2i btki', 'pathway blooducation cll lymsm pls rt yazdy']\n",
      "['physical distress', 'treatment phases illness perceptions', 'chronic lymphocytic leukemia', 'leventhal s self regulatory model']\n",
      "['global b cell chronic lymphocytic leukemia treatment market analysis size share outlook study']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['topic hematologic cancers', 'sub tracks hodgkin', 'non hodgkin lymphoma myelogenous leukemia', 'acute lymphocytic chronic lymphocytic', 'multiple myeloma']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['human medicines european', 'public assessment report epar zydelig idelalisib lymphoma non hodgkin leukemia lymphocytic chronic b cell date', 'pharma regulatory']\n",
      "['immune cells', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma lymphoma lymsm']\n",
      "['complex karyotype', 'overall survival', 'chronic lymphocytic leukemia', 'rituximab leukemia cll lymsm']\n",
      "['i rant', 'cancer s ass leukemia cll', 'fuckcancer btw america s healthcare sucks i ve', 'cancer center']\n",
      "['duration venetoclax', 'obinutuzumab veng', 'free survival pfs', 'minimal residual disease negativity mrd', 'patients pts', 'chronic lymphocytic leukemia cll']\n",
      "['cancerous cells', 'cancerresearch cll leukemia']\n",
      "['year christina fisher shares']\n",
      "['chronic leukaemias', 'cll don t show symptoms', 'years chronic leukaemia cells', 'normal cells', 'bone marrow chronic leukaemias', 'acute leukaemias']\n",
      "['uses conimab 500mg', 'certain types', 'non hodgkin s lymphoma chronic lymphocytic leukemia', 'cancer cells rituximab', 'rheumatoid arthritis', 'joint pain', 'swelling rsp']\n",
      "['uses conimab 100ml', 'certain types', 'non hodgkin s lymphoma chronic lymphocytic leukemia', 'cancer cells rituximab', 'rheumatoid arthritis', 'joint pain', 'swelling rsp']\n",
      "['non hodgkin s lymphoma b', 't cell chronic lymphocytic leukemia mantle cell hairy cell', 'multiple myeloma', 'killer victims', 'obligation review']\n",
      "['expert faculty dr matthew davids', 'dr anthony mato', 'management considerations', 'cll patient cases', 'novel therapeutics', 'prime cme']\n",
      "['shanafelt td', 'n engl j', 'ibrutinib rituximab', 'chronic lymphocytic leukemia']\n",
      "['nice chart']\n",
      "['s 1am amp', 'fall asleep', 'morning i', 'cll amp i m feeling', 'certain point i', 'anxiety amp i ll sleep']\n",
      "['oncoalert leusm cll']\n",
      "['frontline therapies', 'chronic lymphoid leukemia springerlink cll lymsm']\n",
      "['dr brian koffman', 'committee shares']\n",
      "['druggable target', 'pi3k inhibitor resistance', 'murine model', 'chronic lymphocytic leukemia leusm']\n",
      "['cll w hematology eha24 leukemia leusm cancer oncology']\n",
      "['torneo clausura 1ra fecha cll vs guarani doblete', 'liza larrea', 'del segundo tiempo', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 1ra fecha cll vs guarani', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 1ra fecha cll vs guarani cambio ngeles portillo por liz pe', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 1ra fecha cll vs guarani cambio natalia barros por ang lica v zquez unidasporelobjetivo cllpy']\n",
      "['torneo clausura 1ra fecha cll vs guarani cambio liza larrea por fabiola sandoval unidasporelobjetivo cllpy']\n",
      "['torneo clausura 1ra fecha cll vs guarani goool', 'st fabiola sandoval', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 1ra fecha cll vs guarani goool desde el punto penal por obra', 'griselda garay', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 1ra fecha cll vs guarani', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 1ra fecha cll vs guarani', 'primera etapa unidasporelobjetivo cllpy']\n",
      "['torneo clausura 1ra fecha cll vs guarani goool', 'pt liz pe', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 1ra fecha cll vs guarani goool', 'pt liz pe', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 1ra fecha cll vs guarani', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 1ra fecha cll vs guarani goool', 'pt carmen ben tez', 'unidasporelobjetivo cllpy']\n",
      "['torneo clausura 1ra fecha cll vs guarani partido', 'marcha unidasporelobjetivo cllpy']\n",
      "['torneo clausura 1ra fecha cll vs guarani equipo confirmado natasha mart nez carmen ben tez laurie cristaldo y paola genes stephenie lacoste joana galeano griselda garay y damia cortaza fabiola sandoval karina vega y liz pe']\n",
      "['duration venetoclax', 'obinutuzumab veng', 'free survival pfs', 'minimal residual disease negativity mrd', 'patients pts', 'chronic lymphocytic leukemia cll']\n",
      "['lymphocytic leukemia cll']\n",
      "['oncoalert prognostic score', 'cytogenetic risk classification', 'chronic lymphocytic leukemia cll patients', 'disease status comorbidity index lymphocyte', 'white blood cell', 'hct bmtsm leusm lymsm cllsm']\n",
      "['complex karyotype', 'high risk cll']\n",
      "['data trial', 'chronic lymphocytic leukemia']\n",
      "['prognostic score', 'cytogenetic risk classification', 'chronic lymphocytic leukemia patients center', 'international blood', 'marrow transplant research report cll lymsm']\n",
      "['current treatment options', 'cll w dr john gribben', 'cll leukemia leusm cancer oncology videos']\n",
      "['new chronic lymphocytic leukemia drugs']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['jitc review state', 'car t cell therapy', 'chronic lymphocytic leukemia']\n",
      "['alert non hodgkin s lymphoma b', 't cell chronic lymphocytic leukemia mantle cell hairy cell', 'multiple myeloma', 'killer roundup']\n",
      "['immune cells', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['chronic lymphocytic leukemia']\n",
      "['immune cells', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma zou hematological oncology wiley online library cll lymsm lymphoma']\n",
      "['meld dig til vores temadag d', 'sep det handler om blodcancer blodkr ft lymfekr ft leuk mi cml cll aml', 'mds apl cmml lyle dk']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['immunoglobulin levels', 'chronic lymphocyti']\n",
      "['demand cme web spotlight', 'oncology videowebinars', 'activity click', 'melanoma immuno oncology cll multiplemyeloma cityofhope paradigmmedcom']\n",
      "['treatment naive patients', 'chronic lymphocytic leukemia oncology']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['cross trial comparison', 'agent ibrutinib versus chlorambucil obinutuzumab', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll lymsm lymphoma']\n",
      "['scan results cup', 'lre bbh ror nxr fgp phnx pcgh lms cpc slpe aatg carr mrch eto']\n",
      "['dr danielle brander', 'shares resources', 'cll patients advocate', 'leusm cllsm']\n",
      "['imbruvica use', 'combo treatments', 'chronic lymphocytic leukemia', 'waldenstr m s macroglobulinemia']\n",
      "['current cll treatment landscape']\n",
      "['key things', 'time hotel cost', 'potential benefits', 'company cll']\n",
      "['gerionc geriheme cll cllsm leusm']\n",
      "['new therapies', 'cll cll specialist', 'researcher dr nicole lamanna shares insight', 'treatment developments', 'clinical trials']\n",
      "['sci member steve coutre', 'chronic lymphocytic leukemia cll leusm']\n",
      "['s episode', 'cll cello health s acquisition']\n",
      "['cool review', 'ca2 channels', 'bcells cll lymphoma allergy autoimmunity']\n",
      "[]\n",
      "['adverse drug events', 'elderly patients', 'systematic review', 'meta analysis', 'trials gerionc geriheme lymsm lymphoma']\n",
      "['adverse drug events', 'elderly patients', 'chronic lymphocytic leukemia', 'systematic review', 'meta analysis', 'trials lymphoma lymsm']\n",
      "['cross trial comparison', 'agent ibrutinib versus chlorambucil obinutuzumab', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma lymphoma lymsm']\n",
      "['adverse drug events', 'elderly patients', 'chronic lymphocytic leukemia', 'systematic review', 'meta analysis']\n",
      "['eqls cll aca']\n",
      "['cll cello health expands', '5mln acquisition', 'uk cll brighterir andrewscotttv']\n",
      "['abbvie s venetoclax', 'tecentriq s breast cancer use', 'agenda abbvie s chronic lymphocytic leukemia cll treatment venetoclax']\n",
      "['innovative science solutions', 'regulatory work', 'healthcare doesn t look', 'payment structure', 'i don t hold']\n",
      "['quantium cast episode', 'qrt cll solg']\n",
      "['quantium cast episode', 'qrt cll solg']\n",
      "['cello health cll', '4m acquisition', 'scientific consultancy innovative science solutions']\n",
      "['chemotherapy pct', 'cancer stem cells', 'immune inhibitory receptors', 'chronic lymphocytic leukemia cll', 'metastatic cancers', 'pm genome discovery']\n",
      "['rns aim cll cello health plc acquisition']\n",
      "['maintenance therapy', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['great team cll cheflife']\n",
      "['great team cll cheflife']\n",
      "['great team cll cheflife']\n",
      "['long term safety', 'ibrutinib treatment', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia non hodgkin lymphoma', 'hl patients']\n",
      "['classy gogreengo cll teamcanada']\n",
      "['plcg2 mutations', 'real life cll cohort', 'group study']\n",
      "['scan results cup', 'cbox nxr ats srei', 'phnx mmit bhgg bgs ng cll cpc vod smrt lre eut']\n",
      "['cll lab tests', 'essential dr danielle brander', 'overview leusm cllsm']\n",
      "['oncoalert recommendations', 'ibrutinib treatment', 'atrial fibrillation', 'cardiovascular risk gerionc geriheme cardioonc afib lymsm leusm cll cllsm']\n",
      "['term safety', 'ibrutinib treatment', 'chronic lymphocytic leukemia']\n",
      "['oncoalert prevalence', 'plcg2 mutations', 'real life cll cohort', 'filo group study lymsm cllsm leusm']\n",
      "['chronic lymphocytic leukemia non hodgkin lymphoma', 'hl patients', 'cll leukemia lymphoma']\n",
      "['chronic lymphocytic leukemia cll', 'aggressive lymphoma richter syndrome', 'large b cell lymphoma', 'cll patient blood journal', 'disabilityinfo zusia']\n",
      "['cll patients', 'right provider', 'specialist tune', 'cll survivors patientpower cll']\n",
      "['real i', 'cll chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'cll specialist', 'researcher dr nicole lamanna', 'shares insight', 'treatment developments', 'clinical trials']\n",
      "['trademark law', 'alert immoral', 'scandalous marks', 'u s trademarks supremecourt scotus cll']\n",
      "['ibrutinib treatment', 'atrial fibrillation', 'cardiovascular risk springerlink cll lymsm lymphoma']\n",
      "['low t cd4 depletion post fcr', 'reduces relapses lymsm']\n",
      "['petra langerbeins md', 'eha24 patients', 'early stage chronic lymphocytic leukemia cll', 'agent ibrutinib']\n",
      "['combination treatment', 'chronic lymphocytic leukemia']\n",
      "['new treatment option', 'leukaemia chronic lymphocytic leukaemia cll patients treatment option combination', 'drugs venetoclax venclyxto amp rituximab mabthera rixathon truxima scotland leukaemia cll treatmentoption']\n",
      "['immunoglobulin levels', 'chronic l']\n",
      "['prognostic score', 'cytogenetic risk classification', 'chronic lymphocytic leukemia patients center', 'international blood', 'marrow transplant research report']\n",
      "['car t cell therapy', 'chronic lymphocytic leukemia']\n",
      "['shanafelt td', 'n engl j', 'ibrutinib rituximab', 'chronic lymphocytic leukemia']\n",
      "['great great results', 'cll ibrutinib rituximab', 'chronic lymphocytic leukemia']\n",
      "['new immunoglobulin levels', 'chronic lymphoc']\n",
      "['cross trial comparison ibrutinib mono vs obin chloramb', '1l cll', 'ibr vs o chl', 'cohorts pfs hr', '30m pfs', 'pfs hr high risk', '30m pfs', 'cll lymsm']\n",
      "['cll genetic', 'treatment options dr danielle brander', 'leusm cllsm']\n",
      "['study researchers', 'treatment naive chronic lymphocytic leukemia tn cll patients']\n",
      "['tiny homes', 'alert denise', 'ic bus', 'amazing living space', 'chronic lymphocytic leukemia way']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "[]\n",
      "['european c omission', 'adult patients', 'chronic lymphocytic leukemia', 'adult patients', 'waldenstr m s macroglobulinemia']\n",
      "['severe chronic lymphocytic leukemia b cells', 'hyperactive mode biotechnology lifesciences medicalscience leukemia bcells inflammation cancer startups venturecapital eduardalbertspartners edua']\n",
      "['ibrutinib rituximab', 'cll wednesdaywisdom leukemia chroniclymphocyticleukemia hematology heme oncology research cancer cancerresearch']\n",
      "['pharmafile janssen chalks', 'imbruvica combo therapies ibrutinib', 'chronic lymphocytic leukaemia cll amp', 'waldenstr m s macroglobulinemia']\n",
      "['rooftops cirmtuzumab blocks wnt5a ror1 stimulation', 'nf b', 'repress autocrine stat3 activation', 'chronic lymphocytic leukemia cll']\n",
      "['growth factor', 'receptor igf1r', 'resistance mechanism', 'kinase delta pi3k inhibitor', 'chronic lymphocytic leukemia cll animal model']\n",
      "['shanafelt td', 'n engl j', 'ibrutinib rituximab', 'chronic lymphocytic leukemia']\n",
      "['constitutive activation', 'b cell receptor underlies dysfunctional', 'chronic lymphocytic leukemia']\n",
      "['genetic predisposition', 'chronic lymphocytic leukemia', 'integrative epigenomics']\n",
      "['immunoglobulin levels', 'chronic lymphocytic']\n",
      "['murano trial results lead', 'nhs scotland acceptance', 'site news clinicaltrial healthcare']\n",
      "['chronic lymphocytic leukemia']\n",
      "['willima wierda', 'haematological malignancies venclexta']\n",
      "['standom researchers', 'large multicenter clinical trial', 'chronic lymphocytic leukemia']\n",
      "['immunoglobulin levels', 'chronic lymphocyti']\n",
      "['treatment naive patients', 'chronic lymphocytic leukemia']\n",
      "['anne boev', 'loyal massey supporters', 'chronic lymphocytic leukemia', 'inspire others']\n",
      "['combination ibrutinib venetoclax shows', 'encouraging overall survival rates', 'refractory cll ascodailynews leusm cll targetedtherapy']\n",
      "['key things', 'time hotel cost', 'potential benefits', 'company cll']\n",
      "['car t therapy article']\n",
      "['friends i m', 'chronic lymphocytic leukemia', 'i ll', 'i need', 'pawcircle amp i m', 'hip replacement surgery']\n",
      "['ibrutinib rituximab', 'cll comment', 'dr isabel cunningham']\n",
      "['medical student linda karlsen', 'year research project', 'cll forskerlinje']\n",
      "['kosei lab cll']\n",
      "['lab cll']\n",
      "['nice pitch', 'hubs research', 'cll feverfew']\n",
      "['chemo antibody therapy pcat', 'cancer stem cells', 'immune inhibitory receptors', 'chronic lymphocytic leukemia cll', 'metastatic cancers', 'genome discovery']\n",
      "['treatment naive patients', 'chronic lymphocytic leukemia']\n",
      "['oncology appt draws', 'remission leukemia cancer cll lymphoma bloodcancer oncology cancersucks cancerhumor fightcancer']\n",
      "['covaris m series', 'shear gdna', 'clinical implications', 'birc3 mutations', 'chronic lymphocytic leukemia f diop']\n",
      "['data trial', 'chronic lymphocytic leukemia']\n",
      "['shanafelt td', 'n engl j', 'ibrutinib rituximab', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['gon na', 'long tedious']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['oncoalert chemo immunotherapy', 'chronic lymphocytic leukemia cll time', 'hemasphere geriheme cllsm leusm lymsm']\n",
      "['novel insights', 'regulatory chromatin landscape', 'epigenetics leukemia chroniclymphocyticleukemia']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['genetic predisposition', 'chronic lymphocytic leukemia', 'integrative epigenomics nature communications seom es clleukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chemo immunotherapy', 'chronic lymphocy hemasphere gerionc geriheme cll']\n",
      "['genetic predisposition', 'chronic lymphocytic leukemia', 'integrative epigenomics']\n",
      "['statin use', 'chronic lymphocytic leukemia incidence', 'case control study', 'manitoba canada', 'data suggests', 'doesn t']\n",
      "['substantial insight', 'genetic predisposition', 'chronic lymphocytic leukemia']\n",
      "['harry potter', 'pi3k pathway clinical inhibition', 'chronic lymphocytic leukemia']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia nejm']\n",
      "['helios study', 'ibrutinib bendamustine', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma lymphoma lymsm']\n",
      "['uses chloramax 5mg tablet', 'chronic lymphocytic leukemia malignant lymphomas lymphosarcoma', 'giant follicular lymphoma hodgkin s lymphoma', 'conditions pharmaceuticalmedicine rsp']\n",
      "['uses chloramax tablet', 'chronic lymphocytic leukemia malignant lymphomas lymphosarcoma', 'giant follicular lymphoma hodgkin s lymphoma', 'conditions pharmaceuticalmedicine rsp']\n",
      "['s funny', 'extreme fatigue night sweats', 'fun symptoms']\n",
      "['chronic lymphocytic leukemia']\n",
      "['key insights', 'chronic lymphocytic leukemia', 'lymphoma amp myeloma']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia nejm jacque barrientos']\n",
      "['expert access program', 'top cll physician', 'compassionate care', 'expert advice enroll', 'myexpertaccess cll cllsm']\n",
      "['current chronic lymphocytic leukemia treatment landscape', 'effective practices', 'cll care']\n",
      "['susahnya hati tengok keadaan mama pada umur', 'mama disahkan menhidapi penyakit chronic lymphocytic leukemia c l l semoga allah mempermudahkan urusan kami sekeluarga amin']\n",
      "['blood cancers', 'treatment options', 'special considerations']\n",
      "['long term safety', 'ibrutinib treatment', 'chronic lymphocytic leukemia leukemia']\n",
      "['new leukemia treatment', 'common wild flower chroniclymphocyticleukemia cll drugdiscovery feverfew']\n",
      "['chronic lymphocytic leukemia cll patients', 'overall survival', 'ibrutinib rituximab', 'current standard chemoimmunotherapy summary', 'medical leukemia']\n",
      "['drug combo heralds', 'chronic lymphocytic leukemia treatment']\n",
      "['genetic predisposition', 'chronic lymphocytic leukemia', 'integrative epigenomics']\n",
      "['don t', 'nice cll study london']\n",
      "['tanja jo amp', 'outstanding cancer researchers cll leukaemia cancer']\n",
      "['new paper', 'cll genetics', 'epigenetic information', 'eu uk']\n",
      "['chroniclymphocyticleukemia cll tak', 'potent selective reversible', 'available inhibitor', 'flt3 drugdiscovery leukemia']\n",
      "['chronic immune thrombocytopenia non hodgkin lymphoma chronic lymphocytic leukemia nonmetastatic castration', 'resistant prostate cancer amp', 'select patients', 'esophageal squamous cell carcinoma']\n",
      "[]\n",
      "['oncoalert igf1r', 'druggable target', 'pi3k inhibitor resistance', 'murine model', 'chronic lymphocytic leukemia cll lymsm leusm']\n",
      "['pi3k inhibitor resistance', 'cll lymsm cllsm leusm']\n",
      "['new jitc review state', 'car t cell therapy', 'chronic lymphocytic leukemia']\n",
      "['blood commentary', 'pi3k inhibitor resistance']\n",
      "['druggable target', 'pi3k inhibitor resistance', 'murine model', 'chronic lymphocytic leukemia cll']\n",
      "['maintenance therapy', 'chronic lymphocytic leukemia']\n",
      "['hla b27 positivity', 'cll sll outcomes']\n",
      "['morning i', 'early stage', 'chronic lymphocytic leukemia i']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['pharmavoice100 dr angela howes vp head', 'leukemia development janssen r amp d', 'key role', 'chronic lymphocytic leukemia']\n",
      "['moment 1st lymphoma hub satellite symposium', 'social media coverage', 'convenience click', 'slides expert interviews', 'lymphoma cll lymsm']\n",
      "['chronic lymphocytic leukemia healio']\n",
      "['chronic lymphocytic leukemia']\n",
      "['ibrutinib versus rituximab', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'open label phase', 'study lymphoma lymsm']\n",
      "['reading areas', 'support emergent literacy', 'huge hand', 'giant s library fe fi fo thumb eytwittertagteam literacy books strories readingforpleasure cll']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['oncology appointment', 'chronic lymphocytic leukemia', 'great news', 'cll front i m good', 'months i']\n",
      "['hl patients', 'john kuruvilla md', 'cll lymphoma leukemia']\n",
      "['cll fcr vs br', 'brown md', 'dana farber cancer institute cll harvard', 'medical school']\n",
      "['chronic lymphocytic leukemia progress', 'uncertainty lymsm']\n",
      "['hla b27 positivity', 'cll sll outcomes oncology cancer']\n",
      "['drug combo heralds', 'chronic lymphocytic leukemia treatment']\n",
      "[]\n",
      "['new combination therapy', 'chronic lymphocytic leukemia', 'care chemotherapy dr nicole lamanna']\n",
      "['feverfew plant contains parthenolide', 'new treatment', 'chronic lymphocytic leukemia']\n",
      "['fellowship journalclub', 'exciting practice', 'cll14 trial', 'front line setting figure', 'gcllsg cll']\n",
      "['free books', 'emergent literacy links', 'cache eye units', 'readingforpleasure stories books literacy books cll storyteller reading bookstart bookworms eytwittertagteam eymatters']\n",
      "['clinical trial', 'target b cells', 'novel approach', 'standard treatment']\n",
      "['chronic lymphocytic leukemia']\n",
      "['refractory chronic lymphocytic leukemia', 'clarity study']\n",
      "['th1 immunity', 'tumor microenvironment', 'clinical response', 'chronic lymphocytic leukemia']\n",
      "['drug combo heralds', 'chronic lymphocytic leukemia treatment']\n",
      "['apto 1st cg', 'cll patient', 'ibrutinib venetoclax rituximab', 'days amp', 'pk data']\n",
      "['interesting paper', 'e montserrat lymsm']\n",
      "['chronic lymphocytic leukemia']\n",
      "['high incidence', 'adverse events', 'significant economic burden', 'chronic lymphocytic leukemia cll healthcarecosts cancertreatment financialtoxicity']\n",
      "['joshua brody md', 'icahn school', 'mount sinai', 'mount sinai hospital']\n",
      "['cll experts', 'cll patients', 'blood work']\n",
      "['identify patients', 'high risk', 'poor outcomes']\n",
      "['cll expert']\n",
      "['cll expert webinar', '11am pt', 'special guests']\n",
      "['cancer cells', 'stress signals', 'clinicians assess', 'chronic lymphocytic leukemia', 'new data']\n",
      "['tait shanafelt sci member steven coutre', 'chronic lymphocytic leukemia', 'tx cll']\n",
      "['chronic lymphocytic leukemia cll', 'additional chemotherapy', 'free option']\n",
      "['chronic lymphocytic leukemia treatment market', 'growth factors details trend analysis size share', 'competitors overview']\n",
      "['chronic lymphocytic leukemia treatment market', 'growth factors details trend analysis size share', 'competitors overview', 'reuters chronic lymphocytic leukemia tr']\n",
      "['rns aim cll cello health plc total']\n",
      "['tuesdaynewsday researchers', 'rituximab shows', 'chronic lymphocytic leukemia']\n",
      "['pm eastern', 'minute q amp', 'renowned chronic lymphocytic leukemia cll experts', 'voice questions', 'expert webinar']\n",
      "['feverfew plant', 'alternative treatment', 'chroniclymphocyticleukemia cll']\n",
      "['combination treatment', 'chronic lymp']\n",
      "['ibrutinib rituximab treatment', 'cll chronic lymphocytic leukemia', 'sll dr jo']\n",
      "['ibrutinib rituximab treatment', 'cll chronic lymphocytic leukemia', 'sll dr john sangwon lees pediatric updates']\n",
      "['professors clinical investigator perspectives', 'lymphoma chronic lymphocytic leukemia', 'multiple myeloma cme', 'abim moc', 'video programs', 's symposium']\n",
      "['human medicines european', 'public assessment report epar blitzima rituximab lymphoma non hodgkin leukemia lymphocytic chronic b cell date', 'pharma regulatory']\n",
      "['light chains', 'chronic lymphocytic leukemia', 'monoclonal b cell lymphocytosis participantsall participants', 'institutional review board']\n",
      "['significant advances', 'research efforts', 'cll treatments', 'recent years']\n",
      "['bien que', 'llc soit', 'incurable les efforts', 'recherche sur les traitements ont consid rablement progress ces derni res ann es apprenez', 'dans notre article portant sur ce sujet']\n",
      "['hospital setting i m', 'monoclonal antibodies', 'cancer i m']\n",
      "['sister debbie appelwick', 'metastatic chronic lymphocytic leukemia']\n",
      "['long term safety', 'ibrutinib treatment', 'chronic lymphocytic leukemia']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia n engl j', 'shanafelt td', 'science research']\n",
      "['key mutation therapy', 'ibrutinib rituximab', 'free survival', 'standard chemoimmunotherapy leusm']\n",
      "['george duke', 'grammy award', 'chronic lymphocytic leukemia', 'prolific keyboard player bandleader solo artist music producer', 'musical director']\n",
      "['original article ibrutinib rituximab', 'chronic lymphocytic leukemia']\n",
      "['don t', 'cll expert webinar', 'guests dr susan leclair', 'dr justin taylor']\n",
      "['new jcocci article', 'learning algorithm', 'patient groups', 'cancers diffuse dlbcl follicular lymphoma']\n",
      "['cll treatment', 'ibrutinib rituximab', 'line treatment']\n",
      "['chronic lymphocytic leukemia', 'twimh music history musichistory onthisday thisdayinhistory 10s']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia nejm']\n",
      "['george duke', 'chronic lymphocytic leukemia']\n",
      "['drug combination shows', 'chronic lymphocytic leukemia', 'cancer news']\n",
      "['feverfew compound', 'disease progression v', 'nice work workers']\n",
      "['bruce d cheson md facp faaas fasco', 'conventional prognostic indicators']\n",
      "['t cells', 'effective car t cell treatment', 'chronic lymphocytic leukemia']\n",
      "['rituximab shows', 'chronic lymphocytic leukemia']\n",
      "['george duke american musician composer singer', 'chronic lymphocytic leukemia', 'solo albums']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia', 'ibrutinib rituximab']\n",
      "[]\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia n engl j', 'shanafelt td', 'science research']\n",
      "['chronic lymphocytic leukemia', 'detectable leukemia']\n",
      "['sports analytics', 'cancer patient outcomes dlbcl cll breastcancer']\n",
      "['chronic lymphocytic leukemia']\n",
      "['long term safety', 'ibrutinib treatment', 'chronic lymphocytic leukemia']\n",
      "['key mutation therapy', 'ibrutinib rituximab', 'free survival', 'standard chemoimmunotherapy leusm']\n",
      "['clonal evolution', 'chronic lymphocytic leukemia springerlink cll oncoalert']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia cllsm']\n",
      "['non canonical nfkb pathway', 'birc3 mut cll birc3 mut', 'w resistance', 'fludarabine mpfs', 'tp53 mut', 'pt series adj uva birc mut', 'w pfs hr', 'mva ighv tp53 mut del 17p', 'high risk biomarker', 'fcr resistance lymsm']\n",
      "['chronic lymphocytic leukemia']\n",
      "['drug combo heralds', 'chronic lymphocytic leukemia treatment']\n",
      "['leukemia anemia cll linfomas oncotype', 'breastcancer lungcancer prostatecancer obesity hypertension strokes ovariancancer pancreaticcancer breastcancerawareness digitaltv ny bestmedicalnews dermatolgy oncology']\n",
      "['long term safety', 'ibrutinib treatment', 'chronic lymphocytic leukemia']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia n engl j', 'shanafelt td', 'science research']\n",
      "['car t cell therapy', 'chronic lymphocytic leukemia cll lymsm lymphoma']\n",
      "['drug duo', 'chronic lymphocyticleukemia disease', 'current standard', 'clinical trial', 'relegate chemotherapy', 'fallback plan', 'lead author tait shanafelt']\n",
      "['chronic lymphocytic leukemia', 'medicine goog']\n",
      "['car t cell therapy', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['chronic lymphocytic leukemia patients', 'chronic lymphocytic leukemia cll patients', 'overall survival']\n",
      "['chronic lymphocytic leukemia patients', 'rituximab chronicdisease oncology']\n",
      "['patient advocate', 'cll survivor michele nadeem baker shares tips', 'summer vacations', 'cancer patientpower cll']\n",
      "['drug combo heralds', 'chronic lymphocytic leukemia treatment']\n",
      "['clinical implications', 'birc3 mutations', 'chronic lymphocytic leukemia']\n",
      "['predictive effect', 'ighv mutational status', 'chronic lymphocytic leukemia focus', 'br treatments lymphoma lymsm']\n",
      "['professor patrick thornton s interview', 'cll patients', 'ireland carecantwait']\n",
      "['important update', 'new novel therapies']\n",
      "['clinical implications', 'birc3 mutations', 'chronic lymphocytic leukemia haematologica cancer epidemiology']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['cll patients', 'florence cymbalista', 'hematology mrd mrdnegativity mrdpositivity leusm patientcare knowledgeispower leukemia patienteducation']\n",
      "['chronic lymphocytic leukemia', 'diagnosis risk stratification', 'treatment cll']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia n engl j', 'shanafelt td', 'science research']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia nejm']\n",
      "['cancer stem cells', 'immune inhibitory receptors', 'chronic lymphocytic leukemia cll', 'metastatic cancers', 'pm genome discovery']\n",
      "['dr william wierda', 'world s', 'cll chroniclymphocyticleukemia b cell experts endcancer standuptocancer patientpower cllsociety fighters']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia n engl j', 'shanafelt td', 'science research']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia nejm']\n",
      "['ibrutinib rituximab']\n",
      "['t cells', 'effective car t cell treatment', 'chronic lymphocytic leukemia']\n",
      "['important update']\n",
      "['great update']\n",
      "['cancer news patients', 'chronic lymphocytic leukemia', 'new combination', 'fda approves drugs', 'prostate cancer']\n",
      "['scan results', 'ad4 usg tgp wine acp migo gatc spsy joul scs vlx bbgi nxr merc cll ehg']\n",
      "['chronic lymphocytic leukemia disease', 'current standard', 'clinical trial', 'participants lymphocyticleukemia']\n",
      "['active regimen', 'high risk', 'chronic lymphocytic leukemia leusm hematology']\n",
      "['drug combo heralds', 'chronic lymphocytic leukemia treatment']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia nejm']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia nejm']\n",
      "['feverfew flowers', 'chronic lymphocytic leukemia cll cells', 'laboratory leukemia lymphoma cancer']\n",
      "['drug combo heralds', 'chronic lymphocytic leukemia treatment']\n",
      "['drug combo heralds', 'chronic lymphocytic leukemia treatment']\n",
      "['cancer diagnosis affects', 'family members children', 'patientpower cll']\n",
      "['resistant bcell malignancies', 'study drug ly3214996', 'chronic lymphocytic leukemia cll waldenstrom s macroglobulinemia wm mantle renalcell kidneycancer']\n",
      "['player profile name josh winfield age', 'row player sponsor studio', 'nickname winners job landscaper cll interests', 'previous clubs tst blues caps', 'representative hons']\n",
      "['chronic lymphocytic leukemia', 'new standard']\n",
      "['resistant b cell malignancies status', 'condition summary chronic lymphocytic leukemia waldenstrom macroglobulinemia mantle cell lymphoma', 'marginal zone lymphoma']\n",
      "['distinctive ighv gene usage', 'american patients', 'chronic lymphocytic leukemia stanganelli hematological oncology wiley online library cll']\n",
      "['leukemia endcancer leusm cll']\n",
      "['shanafelt td', 'n engl j', 'ibrutinib rituximab', 'chronic lymphocytic leukemia']\n",
      "['drug combo heralds', 'chronic lymphocytic leukemia treatment']\n",
      "['cll cells radiation therapy', 'salivary gland malt lymphoma ultra', 'low dose treatment', 'spares salivary function lymsm cll']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia nejm']\n",
      "['news zanubrutinib', 'bcell malignancies cll', 'small lymphocytic lymphoma']\n",
      "['cll cll kombination ohne zytostatikum verbessert therapieergebnisse']\n",
      "['cll kombination ohne zytostatikum verbessert therapieergebnisse palo alto eine kombination cll']\n",
      "['oncoalert chronic lymphocytic leukemia cll', 'diagnosis risk stratification', 'treatment leusm cllsm']\n",
      "['cll management chronic lymphocytic leukemia', 'diagnosis risk stratification', 'treatment hallek american journal', 'hematology wiley online library']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia n engl j', 'shanafelt td', 'science research']\n",
      "['new shanafelt td', 'n engl j', 'ibrutinib rituximab', 'chronic lymphocytic leukemia']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['cnag crg', 'bioinformatics analyst', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['combination treatment', 'chronic lymphocytic l']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia']\n",
      "['drug combo heralds', 'chronic lymphocytic leukemia treatment']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chemistry biotech researchers', 'cancer properties', 'garden plant', 'chemoresistant chronic lymphocytic leukemia']\n",
      "['novel parthenolide derivative exhibits activity', 'cll cells article']\n",
      "['drug combo', 'chronic lymphocytic leukemia treatment', 'new era']\n",
      "['data e1912', 'chronic lymphocytic leukemia cll']\n",
      "['frontline cll', 'dependent median age e1912', 'yrs vs', 'alliance trial br vs ir vs i trm', 'e1912 vs', 'alliance trial atrial fibrillation', 'e1912 vs', 'alliance trial cll lymsm blooducation']\n",
      "['recent article', 'ricardo dalla favera explores', 'new insights', 'chronic lymphocytic leukemia', 'genetic lesions', 'future therapies']\n",
      "['results pfs', 'p lt', 'p lt', 'rituximab vs fcr', 'frontline setting', 'chronic lympocytic leukemia ibrutinib cll']\n",
      "['ibrutinib rituximab', 'vs chemoimmunotherapy', 'pfs os advantage overall', 'i r mrd isn t', 'specific lymsm blooducation']\n",
      "['drug duo', 'common leukemia', 'u s patients', 'chronic lymphocytic leukemia cll', 'patient survival']\n",
      "['ibrutinib r vs fcr 1l lt 70y tp53', 'intact cll 3y pfs', 'os adv unmut', 'p n s g3 tox', 'similar time', 'diff dx mut vs unmut', 'cll14 e1912 immunochemo', 'mut cll']\n",
      "['logistical process', 'oral oncolytics']\n",
      "['drug duo', 'common leukemia', 'u s patients', 'chronic lymphocytic leukemia cll', 'patient survival']\n",
      "['chronic lymphocytic leukemia', 'new standard']\n",
      "['car t cell therapy', 'chronic lymphocytic leukemia leusm bloodcancer']\n",
      "['cll question', 'sure register', 'expert session', 'dr susan leclair', 'dr justin taylor']\n",
      "['drug combo heralds', 'chronic lymphocytic leukemia treatment stanford', 'medical center report']\n",
      "['drug combo', 'chronic lymphocytic leukemia treatment', 'new era']\n",
      "['frontline treatment predicts clinical outcomes']\n",
      "['leukemia trial e1912', 'dr shanafelt', 'treatment w ibrutinib rituximab', 'standard treatment', 'w chronic lympocytic leukemia cll']\n",
      "['ruxience rituximab pvvr', 'rituxan rituximab', 'adult patients', 'non hodgkin s lymphoma chronic lymphocytic leukemia granulomatosis', 'microscopic polyangiitis']\n",
      "['new clinical trial', 'chronic lymphocytic leukemia patients', 'treatment cancercare']\n",
      "['new clinical trial', 'chronic lymphocytic leukemia patients', 'treatment clinicaltrials']\n",
      "['drug combo heralds', 'chronic lymphocytic leukemia treatment oncology haem']\n",
      "['current chronic lymphocytic leukemia treatment landscape', 'effective practices', 'cll care']\n",
      "['drug combo heralds', 'chronic lymphocytic leukemia treatment']\n",
      "['appropriate treatment', 'therapy tune', 'dr jain', 'patientpower cll']\n",
      "['game changer', 'chronic lymphocytic leukemia ibrutinib rituximab', 'standard chemoimmunotherapy regimen']\n",
      "['ibrutinib rituximab improves survival', 'current treatment', 'chronic lymphocytic leukemia']\n",
      "['sept edinburg scotland press registration']\n",
      "['ibrutinib rituxan', 'chronic lymphocytic leukemia']\n",
      "['practice ibrutinib', 'chronic lymphocytic leukemia healio']\n",
      "['chronic lymphocytic leukaemia treatment', 'online contributions', 'mds icgs unibham unibham amp', 'authors openaccess cll']\n",
      "['cll lesions', 'trunk extremities biopsy perivascular eosinophil', 'rich lymphohistiocytic infiltrate ve dif', 'drug eruption', 'eosinophilic dermatosis', 'haem malignancy']\n",
      "['uses campath injection', 'b cell chronic lymphocytic leukemia alemtuzumab', 'monoclonal antibodies pharmaceuticalmedicine rsp']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia']\n",
      "['drug combo heralds', 'chronic lymphocytic leukemia treatment']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia', 'vigorbot medicine']\n",
      "['oncoalert ibrutinib rituximab', 'chronic lymphocytic leukemia lymsm cll cllsm leusm chemofree']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia nejm']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia nejm']\n",
      "['combo treatment']\n",
      "['drug combo heralds', 'chronic lymphocytic leukemia treatment']\n",
      "['drug combo heralds', 'chronic lymphocytic leukemia treatment']\n",
      "['drug combo heralds', 'chronic lymphocytic leukemia treatment']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia nejm', '1st line cll']\n",
      "['drug combo heralds', 'chronic lymphocytic leukemia treatment']\n",
      "['data e1912', 'chronic lymphocytic leukemia cll']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia nejm cll lymsm']\n",
      "['drug combo heralds', 'chronic lymphocytic leukemia treatment']\n",
      "['ibrutinib rituximab', 'chronic lymphocytic leukemia']\n",
      "['drug combo heralds', 'chronic lymphocytic leukemia treatment', 'chronic lymphocytic leukemia disease', 'current standard']\n",
      "['nice paper', 'mayo past', 'present cll team ibrutinib rituximab', 'chronic lymphocytic leukemia nejm']\n",
      "['hem onc appe', 'journal club', 'month ibrutinib rituximab', 'chronic lymphocytic leukemia nejm']\n",
      "['drug combo heralds', 'chronic lymphocytic leukemia treatment']\n",
      "['chronic lymphocytic leukemia']\n",
      "['drug combo heralds', 'chronic lymphocytic leukemia treatment']\n",
      "['cll patients', 'b cell receptor inhibitor treatment', 'retrospective multi centre italian experience innocenti british journal', 'haematology wiley online library']\n",
      "['brown md', 'cll chemotherapy leukemia']\n",
      "['yes rcts', 'detect os benefit']\n",
      "['italian venetoclax experience', 'bcri ibrutinib', 'bcri median', 'lines 12m pfs', 'data reason', 'discont bcri influences pfs', 'ven cll lymsm']\n",
      "['chronic lymphocytic leukemia']\n",
      "['minimal residual disease mrd negativity', 'undetectable disease', 'important measure']\n",
      "['molecular pathogenesis', 'chronic lymphocytic leukaemia crassini british journal', 'haematology wiley online library leukemia cll']\n",
      "['chronic lymphocytic leukemia', 'diagnosis risk stratification', 'treatment hallek american journal', 'hematology wiley online library leukemia cll']\n",
      "['synchronous diagnosis', 'primary myelofibrosis', 'chronic lymphocytic leukemia', 'case report', 'literature review', 'rodrigue mintsa nguema', 'bjstrjournal biomedicalopenaccessjournals']\n",
      "['chronic lymphocytic leukemia']\n",
      "['new treatments', 'chronic lymphocytic leukemia']\n",
      "['mohs surgery', 'chronic lymphocytic leukemia cll', 'frozen sections nodules', 'adipose layer cll', 'paraffin sections']\n",
      "['paul m barr md', 'data trial', 'chronic lymphocytic leukemia cll asco19 wilmot cancer institute']\n",
      "['chronic lymphocytic leukemia leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['high response rates', 'mrd negativity', 'chronic lymphocytic leukemia cll patients']\n",
      "['chronic lymphocytic leukemia cll', 'heterogeneous mutational landscape', 'disease dr braggio', 'mayo clinic', 'low frequency variants', 'cll cases']\n",
      "['encouraging phase i data', 'oral btk inhibitor zanubrutinib', 'r r cll']\n",
      "['dr richard furman', 'r r high risk cll', 'patient characteristics', 'c ytogenetics leukemia hematologicmalignancies weill cornell medicine']\n",
      "['chronic lymphocytic leukemia rituxan', 'pharmacy benefit', 'step therapy']\n",
      "['chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll radres', 'neurorad hnrad radiology dwiforthewin', 'cotd site iucotd youtube']\n",
      "['pm eastern', 'minute q amp', 'renowned chronic lymphocytic leukemia cll experts', 'voice questions', 'expert webinar']\n",
      "['trialtuesday alliance investigator jennifer woyach md james', 'alliance a041702', 'immunotherapy trial', 'chronic lymphocytic leukemia']\n",
      "['car t therapy', 'promising cllsm letscurethis']\n",
      "['induces remission', 'refractory chronic lymphocytic leukemia']\n",
      "['induces remission', 'refractory chronic lymphocytic leukemia']\n",
      "['nice work', 'selective btk inhibitor zanubrutinib shows', 'good safety profile amp', 'promising efficacy']\n",
      "['phd students', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['video cll amp car t', 'potential w david maloney', 'hematology eha24']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['acute lymphocytic', 'lymphoblastic leukemia', 'chronic lymphocytic leukemia cll', 'acute myeloid leukemia aml', 'chronic myeloid leukemia cml']\n",
      "['cll patients', 'blood work', '11am pt leusm']\n",
      "['own dr ryan jacobs', 'clinical trials head', 'chronic lymphocytic leukemia', 'breakthroughs potential roles', 't cell therapy advice', 'disease amp']\n",
      "[]\n",
      "['chronic lymphocytic leukemia', 'therapy combinations', 'car t cell therapy']\n",
      "['chronic lymphocytic']\n",
      "['time treatment', 'chronic lymphocyt']\n",
      "['van bruggen jac', 'blood chronic lymphocytic leukemia cells', 'mitochondrial fitness', 'cd8 lt sup gt lt sup gt t cells', 'impede car t cell efficacy']\n",
      "['federal register notification', 'pending exclusive license', 'kite gild', 'allogeneic car t', 'cd20 gene', 'sgmo zf', 'tumor antigen', 'celltherapy relapse kymriah yescarta bcell', 'cll nhl']\n",
      "['international workshop', 'cll meeting chroniclymphocyticleukemia leukemia']\n",
      "['van bruggen jac', 'blood chronic lymphocytic leukemia cells', 'mitochondrial fitness', 'cd8 lt sup gt lt sup gt t cells', 'impede car t cell efficacy']\n",
      "['symptoms nicola', 'night sweats', 'common leukaemia symptom', 'story gt']\n",
      "['top story', 'hemonc times car t cell therapy', 'chronic lymphocytic leukemia leusm bloodcancer']\n",
      "['super res microscopy', 'specific bcr', 'chronic lymphocytic leukemia']\n",
      "['recent results', 'stage trial', 'venetoclax improves progression', 'free survival', 'website gt cll lymphomanews clinicaltrials trialslink lymsm']\n",
      "['cll patients', 'care partners', 'town meeting leusm']\n",
      "['cll event']\n",
      "['multicenter phase', 'chronic lymphocytic leukemia']\n",
      "['combination treatment', 'chronic lymphocytic l']\n",
      "['cllsm letscurethis']\n",
      "['icymi fda', 'rituximab pvvr', 'rituximab biosimilar', 'positive b cell non hodgkin lymphoma', 'microscopic polyangiitis lymphoma cll']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['don t', 'new issue', 'hemonc times', 'jak inhibitor therapy car t cell therapy', 'chronic lymphocytic leukemia', 'cancertreatment endcancer']\n",
      "['new combination treatment', 'chronic lymphocyti']\n",
      "['scan results macd bullish centerline cross', 'fdbk stx kmk stvg cll mer inch csp weir smp adig rat adt xpd bids bab']\n",
      "['leslie md', 'cll14 trial outcomes lymphoma jtcc john theurer cancer center', 'hackensack university', 'medical center hackensack university', 'medical center cll cart celltherapy']\n",
      "['scan results hammer candlestick', 'trt stm rol cll rmv dev aavc ppc nccl hsd aau hgm grc tymn ulvr nxr']\n",
      "['dr jacqueline c barrientos', 'monotherapy vs combination therapy therapy monotherapy cll patients northwellhealth hematologicmalignancies']\n",
      "['final recommendation', 'venetoclax venclexta', 'rituximab v r', 'adult patients', 'chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukemia cll patients benefit', 'chemo immunotherapy winship hematologist jonathon cohen md shares']\n",
      "['august issue ibrutinib', 'fludarabine cyclophosphamide amp rituximab', 'line treatment', 'arm multicentre phase', 'trial leusm']\n",
      "['global b cell chronic lymphocytic leukemia treatment market', 'ab science sa amgen inc celgene corporation dynavax technologies corporation eisai']\n",
      "['musique quand je l coute je', 'd chire les tympans tellement elle est v n re', 'je pende tellement fort s vous cll que que kikroll sourie', 'langue comme vous mdr']\n",
      "['great morning', 'collaboration celebrations', 'sdms leadership advisory team onetribe cll']\n",
      "['fda approves s biosimilar ruxience', 'certain cancers', 'immune conditions', 'non hodgkin s lymphoma cll']\n",
      "['familiar things', 'different angle', 'perspective lovethisplace cll']\n",
      "['double rainbow', 'work cll lakelouise']\n",
      "['john kuruvilla md', 'new drugs', 'exciting cll lymphoma leukemia treatment therapy']\n",
      "['verastem oncology', 'cis turkey', 'africa lymsm leusm cll vstm']\n",
      "['re phase', 'beigene s investigational btk inhibitor', 'chronic lymphocytic leukemia', 'leusm lymsm']\n",
      "['joshua brody md', 'cll icahn school', 'mount sinai']\n",
      "['non hodgkin s lymphoma b', 't cell lymphoma chronic lymphocytic leukemia hairy cell lymphoma', 'mantel cell lymphoma', 'valuable information']\n",
      "['point i need treatment', 'chemo pill', 'bad big pharma', 'medicare4all m4a']\n",
      "['chronic lymphocytic leukemia', 'btk inhibitors', 'secondary cancers', 'general population']\n",
      "['young investigator travel scholarship award', 'cll community']\n",
      "['bruton s tyrosine kinase', 'chronic lymphocytic leukemia']\n",
      "['neuer therapeutischer ansatz f r chronisch lymphatische leuk mie cll forschende wollen krebszellen', 'zellul re unterst tzung entziehen stg abb pd dr mertens uulm leukemia leuk mie cll']\n",
      "['pml progressive multifocal leukoencephalopathy cll leusm']\n",
      "['phd students', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['constitutive activation', 'b cell receptor underlies dysfunctional', 'chronic lymphocytic leukemia', 'ziegler cgk kim j piersanti k oyler yaniv', 'argyropoulos kv van den brink mrm palomba ml altan bonnet n altan bonnet g']\n",
      "['ideal candidate', 'courses applications', 'information yourwarwick cll']\n",
      "['refractory chronic lymphocytic leukemia', 'clarity study']\n",
      "['refractory chronic lymphocytic leukemia', 'clarity study']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['cancer sufferer', 'advice cancer fightcancer survivor cll leukemia lymphoma bloodcancer survivor cancerhumor chronic lls chemo cancersucks remission advice diet']\n",
      "['cancer sufferer', 'advice cancer fightcancer survivor cll leukemia lymphoma bloodcancer survivor cancerhumor chronic lls chemo cancersucks remission advice diet']\n",
      "['non hodgkin lymphoma chronic lymphocytic leukemia', 'microscopic polyangiitis']\n",
      "['fda greenlights', 'new rituxan biosimilar cancer']\n",
      "['pentostatin cyclophosphamide', 'refractory chronic lymphocytic leukemia', 'ecogacrin cancer research group e2903 patients', 'relapsedrefractory rr chronic lymphocytic leukemia cll']\n",
      "['fda update fda approves biosimilar rituximab pvvr ruxience', 'positive non hodgkin b cell lymphomas', 'chronic lymphocytic leukemia']\n",
      "['innovaci n', 'd cada del', 'los primeros reg menes', 'inmunoterapia fueron aprobados', 'combinaci n', 'con quimioterapia para el tratamiento', 'leucemia linfoc tica cr nica']\n",
      "['cousin s brother', 'law way']\n",
      "['pfizer s rituximab biosimilar ruxience rituximab pvvr', 'non hodgkin lymphoma chronic lymphocytic leukemia', 'microscopic polyangiitis']\n",
      "['cll patients', 'blood work']\n",
      "['new clluster paper', 'abnormal iga', 'infections time', 'treatment amp survival igg predicts need', 'immunoglobulin replacement', 'cll mb research']\n",
      "['current state', 'oral oncolytics', 'chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukemia growth', 'wbw bloodcancer cancerresearch']\n",
      "['chronic lymphocytic leukemia cll']\n",
      "['atrial fibrillation', 'chronic lymphocytic leukemia visentin hematological oncology wiley online library']\n",
      "['recognition endcancer leusm cll']\n",
      "['important new article', 'car t history progress', 'price cll cllsm letscurethis']\n",
      "['target cancer', 'great discussion', 'dr yucai wang', 'dr brian koffman cll cllsm letscurethis']\n",
      "['peter hillmen mbchb phd discusses', 'study s results', 'refractory chronic lymphocytic leukemia cll']\n",
      "['constitutive activation', 'b cell receptor underlies dysfunctional', 'chronic lymphocytic leukemia']\n",
      "['cll vibrant', 'cello health', 'ceo scott', 'uk cll']\n",
      "['current chronic lymphocytic leukemia treatment landscape', 'effective practices', 'cll care']\n",
      "['phase ii clarity study results', 'clinical study', 'chronic lymphocytic leukemia', 'complete remission']\n",
      "['alert rituximab pvvr', 'non hodgkin s lymphoma chronic lymphocytic leukemia oncology hemonc biosimilars']\n",
      "['dr william wierda', 'leukemia lymphocytic chronic b cell', 'experts endcancer leusm']\n",
      "['video cll vibrant', 'cello health', 'ceo scott']\n",
      "['cll vibrant', 'cello health', 'ceo scott', 'uk cll brighterir andrewscotttv capitalnetwork1']\n",
      "['cd200 expression improves differential diagnosis', 'chronic lymphocytic leukemia', 'mantle cell lymphoma']\n",
      "['van bruggen jac', 'blood chronic lymphocytic leukemia cells', 'mitochondrial fitness', 'cd8 lt sup gt lt sup gt t cells', 'impede car t cell efficacy']\n",
      "['exciting news', 'stellartrial stellar', 'trialsaccelerationprogramme tap uk']\n",
      "['new issue', 'art inspiration sirolimus', 'gvhd prophylaxis ibrutinib', 'cll amp obinutuzumab', 'follicular b cell lymphoma leusm lymsm']\n",
      "['chronic lymphocytic leukemia therapeutics market identifies', 'key drivers', 'key industry players']\n",
      "['fda approves pfizer s rituximab biosimilar ruxience', 'non hodgkin lymphoma chronic lymphocytic leukemia', 'microscopic polyangiitis cancer']\n",
      "['iga levels', 'potent outcome biomarker']\n",
      "['exciting cll news']\n",
      "['rt physrelations study reports ibrutinib', 'venetoclax combo', 'front line therapy', 'select chronic lymphocytic leukemia patients endcancer leukemia']\n",
      "['pentostatin cyclophosphamide', 'refractory chronic lymphocytic leukemia', 'ecog acrin cancer research group e2903 abstract acta haematologica karger publishers']\n",
      "['constitutive activation', 'b cell receptor underlies dysfunctional', 'chronic lymphocytic leukemia']\n",
      "['fda approves ruxience rituximab pvvr', 'u s', 'adult patients', 'positive b cell non hodgkin s lymphoma', 'positive chronic lymphocytic leukemia']\n",
      "['gastriccancer breastcancer anemia cll linfomas oncotype', 'breastcancer orthopedics medicine mddigitastv mdtvonline mdtvnews oncology', 'information visit']\n",
      "['gastriccancer breastcancer anemia cll linfomas oncotype', 'breastcancer lungcancer prostatecancer obesity hypertension strokes ovariancancer pancreaticcancer breastcancerawareness digitaltv ny', 'information visit']\n",
      "['art cll care', 'great wolf lodge', 'great wolf dr mason', 'ohc cancer experts', 'chronic lymphocytic leukemia']\n",
      "['ruxience rituximab pvvr', 'rituxan rituximab', 'adult patients', 'positive b cell nhl', 'positive cll ruxience']\n",
      "['constitutive activation', 'b cell receptor underlies dysfunctional', 'chronic lymphocytic leukemia']\n",
      "['high disease eradication rate', 'ibrutinib venetoclax combination', 'refractory cll leukemia cancer']\n",
      "['fda approves pfizer s rituximab biosimilar ruxience', 'non hodgkin lymphoma chronic lymphocytic leukemia amp', 'select granulomatoses celltherapy advances savelives']\n",
      "['rituxan biosimilar', 'certain types', 'non hodgkin lymphoma', 'chronic lymphocytic leukemia']\n",
      "['drug administration', 'certain adult patients', 'positive b cell non hodgkin s lymphoma', 'chronic lymphocytic leukemia']\n",
      "['pfizer announces fda', 'ruxience rituximab pvvr', 'adult patients', 'non hodgkin s lymphoma chronic lymphocytic leukemia', 'microscopic polyangiitis pfe']\n",
      "['expert panel discusses', 'available therapies cll cll']\n",
      "['clarity ibrutinib', 'refractory chronic lymphocytic leukemia leusm hematology']\n",
      "['peter hillmen mbchb phd', 'study s results', 'refractory chronic lymphocytic leukemia cll mrdnegativity oncology hematology cancernews']\n",
      "['pm eastern', 'minute q amp', 'renowned chronic lymphocytic leukemia cll experts', 'voice questions', 'expert webinar']\n",
      "['appropriate dose', 'optimize safety', 'clinical activity', 'refractory r r non hodgkin lymphoma nhl', 'r r chronic lymphocytic leukemia cll']\n",
      "['clinical presentation', 'hematological profile', 'old chronic lymphocytic leukemia patients', 'sudan lymphoma lymsm']\n",
      "['new graduates', 'summer graduation ceremony', 'warwickstory doesn t', 'phd warwickgrad']\n",
      "['familiar things', 'different angle', 'perspective lovethisplace cll']\n",
      "['oncoalert iga levels', 'infections time', 'chronic lymphocytic leukemia cll lymsm']\n",
      "['familiar things', 'different angle', 'perspective lovethisplace cll']\n",
      "['cll patients', 'medical screenings mammograms', 'necessary great experience', 'mgh fighters']\n",
      "['don t', 'cancer diagnosis lead', 'financial ruin check', 'financial toxicity cll cllsm letscurethis']\n",
      "['understanding chronic lymphocytic leukemia status', 'condition summary chronic lymphocytic leukemia']\n",
      "['vitro assay', 'biomarker discovery', 'dose prediction', 'venetoclax treatment', 'iwcll edinburgh']\n",
      "['available right', 'treatment options', 'chronic lymphocytic leukemia endcancer']\n",
      "['chronic lymphocytic leukemia cll patients']\n",
      "['phd students', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['clinicaltrial understanding chronic lymphocytic leukemia']\n",
      "['jobs chronic lymphocytic leukemia treatment market', 'global industry analysis']\n",
      "['iga levels', 'infections time', 'chronic lymphocytic leukemia', 'iga levels gut microbiota']\n",
      "['chronic lymphocytic leukemia treatment market', 'global industry analysis amp', 'regional outlook']\n",
      "['chronic lymphocytic leukemia', 'new treatment options']\n",
      "['chronic lymphocytic leukemia', 'new treatment options']\n",
      "['chronic lymphocytic leukemia', 'new treatment options lymphoma lymsm']\n",
      "['location location location v', 'nice review', 'susan pierce amp colleagues', 'b cell', 'context bcells lymphoma cll autoimmunity allergy']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['excellent resource cll cllsm']\n",
      "['infectious complications', 'chronic lymphocytic leukemia pathogenesis spectrum']\n",
      "['kharfan dabaja mayo clinic javier pinilla moffitt cancer center', 'sajil kumar mayo clinic', 'car t cell therapy front line therapy', 'chronic lymphocytic leukemia', 'multiple myeloma', 'hematology session ii', 'noscm congress']\n",
      "['pneumatic tube', 'reverse pseudohyperkalemia', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia patients', 'hla b27', 'allogeneic hematopoietic stem cell transplantation', 'outcomes results', 'case series analysis', 'british columbia canada lymphoma lymsm']\n",
      "['iga levels', 'infections time', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['jeg lever', 'det blodkr ft blodcancer sundpol dksund knoglemarvstransplantation stamcelletransplantation aml cml cll', 'mds cmml']\n",
      "['president duterte', 'nation address', 'clinical picture', 'philippine society', 'chronic lymphocytic leukemia', 'autoimmune disease manifestations']\n",
      "['chronic lymphocytic leukemia']\n",
      "['patient s', 'chronic lymphocytic leukemia', 'new treatments', 'cancer cancer leukemia']\n",
      "['oncology newswatch ibrutinib', 'high risk', 'chronic lymphocytic leukemia leukemia']\n",
      "['new issue', 'hemonc times', 'jak inhibitor therapy car t cell therapy', 'chronic lymphocytic leukemia', 'cancertreatment endcancer']\n",
      "['trial reports minimal residual disease mrd', 'negative responses', 'ibrutinib venetoclax', 'refractory chronic lymphocytic leukemia cll']\n",
      "['work onetribe cll']\n",
      "['chronic lymphocytic leukemia symptoms']\n",
      "['bearish list', 'xpd bwng ctp tta cll saa itm ztf']\n",
      "['young patient', 'refractory cll', 'jacqueline barrientos', 'feinstein institute', 'medical research lymphomahub lymphoma overallsurvival prognosis cancertherapy gogold']\n",
      "['chronic lymphocytic leukemia oncology nurse advisor']\n",
      "['mind blog', 'licensor s ip rights cll iprights']\n",
      "['cll program']\n",
      "['nice article', 'recent interesting research', 'area i', 'commentary cll venetoclax resistance lymsm']\n",
      "['phd students', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['refractory chronic lymphocytic leukemia', 'clarity study cancer']\n",
      "['clonal evolution', 'chronic lymphocytic leukemia', 'langerhans cell histiocytosis', 'case report lymphoma lymsm']\n",
      "['lymphoma fridayfact', 'different types', 'different treatment', 'website gt hodgkin nonhodgkin cll bloodcancer']\n",
      "['counts i', 'proud way', 's playoff ball rmll', 'cll 40man']\n",
      "['dynamic risk', 'cancer biomarkers', 'risk model', 'risk index', 'cll dlbcl', 'numerous cancer types']\n",
      "['complete cambridge tower', 'region s', 'marrow transplant', 'cellular therapeutics', 'kubloodcancer bmt cll']\n",
      "['preclinical research suggests role', 'itk inhibition', 'monocytic mdscs', 'cll monocytic', 'suppressor cells', 'ibrutinib treatment', 'preclinical model', 'chronic lymphocytic leukemia', 'itk inhibition']\n",
      "['tenemos m s conexi n', 'que creemos o coincidencias que acercan cll']\n",
      "['video car t data', 'w david maloney', 'hematology eha24 lymphoma lymsm cll cart']\n",
      "['aptose biosciences inc', 'pan flt3 pan bt', 'phase i study', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'non hodgkin lymphomas']\n",
      "['study reports ibrutinib', 'venetoclax combo', 'front line therapy', 'select chronic lymphocytic leukemia patients']\n",
      "['chronic lymphocytic leukemia cll', 'joanna m rhodes amp anthony r mato']\n",
      "['chronic lymphocytic leukemia cll hypogammaglobulinemia']\n",
      "['cll pendant les vacs pendant vos jours', 'repos je veux qu', 'soir e chez oim avec du']\n",
      "['chronic lymphocytic leukemia', 'hematologic malignancies lymphoma lymsm']\n",
      "['briefedup uk stock market news', 'morning boku i hold cll mmx phtm sdi i hold ketl amp srt']\n",
      "['studies trace', 'cell resolution', 'cll lineages', 'healthy b cell populations', 'epigenomic level epimutation']\n",
      "['confident update', 'expectations quality business', 'divvy i m', 'prize pillock']\n",
      "['cll cello health trumpets', 'uk cll']\n",
      "['cll mmx opti']\n",
      "['video iwcart', 'car ters w david maloney', 'hematology eha24 lymphoma lymsm cll cart']\n",
      "['cll cello health trumpets', 'uk cll brighterir andrewscotttv capitalnetwork1']\n",
      "['clarity trial', 'r r cll delivers', 'mrd negativity']\n",
      "['untold story', 'car t cells', 'cll celltherapy genetherapy immunotherapy tcell']\n",
      "['finite treatment duration', 'chronic lymphocytic leukemia cll', 'time rt', 'cll care']\n",
      "['phosphoflow analyses', 'drug synergy', 'dose venetoclax ibrutinib cll functionalprecisionmedicine']\n",
      "['current chronic lymphocytic leukemia treatment landscape', 'effective practices', 'cll care']\n",
      "['short list', 'practical advice cancer fightcancer survivor cll leukemia lymphoma bloodcancer survivor cancerhumor chronic lls chemo']\n",
      "['untold story', 'car t cells']\n",
      "['cancer chronic lymphocytic leukemia cll', 'bone marrow', 'spongy tissue', 'blood cells']\n",
      "['j ai pas toujours bien r agis avec mes r ponses mais dans mon c ur vous tes l cll']\n",
      "['cancer chronic lymphocytic leukemia cll', 'bone marrow', 'spongy tissue', 'blood cells']\n",
      "['refractory chronic lymphocytic leukemia', 'clarity study']\n",
      "['new research uses exome', 'disease growth', 'chronic lymphocytic leukemia']\n",
      "['time treatment', 'chronic lymphocytic']\n",
      "['new research obinutuzumab amp ibrutinib induction therapy', 'treatment strategy', 'line therapy', 'cll results', 'icll07 filo trial leusm']\n",
      "['wings burnt', 'brazilian sun', 'nice study', 'b1 cells leukaemia bcells']\n",
      "['hoy cumple', 'os nuestro experto', 'oral e implantolog', 'el dr mikel urizar gorosarri feliz cumplea os', 'todo el equipo cll lacasalitner cienciaentusonrisa']\n",
      "['aptose doses', 'cll patient', 'apto253 aps']\n",
      "['vous voir les filles vous tes importantes', 'moi cll']\n",
      "['recent studies', 'btk inhibitors', 'refractory settings leukemia']\n",
      "['teamdavao cll davao davao', 'real estate market research santosknightfrank capitalmarkets advisory consultancy research cli teamdavao davao realestate']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['group s', 'new report plesiomonas shigelloides gastroenteritis', 'chronic lymphocytic leukemia leukemia amp lymphoma', 'superstar fellow dr mansour alfayez leusm']\n",
      "['health care team', 'chronic cancer cancercare chronic ncds cll chroniccancer']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['peter hillmen mbchb phd', 'reports minimal residual disease mrd', 'negative responses', 'ibrutinib venetoclax', 'refractory chronic lymphocytic leukemia cll mrdnegativity oncology cancernews']\n",
      "['cll patients', 'blood work tuesday', '11ampt 2pm', 'leusm chroniclymphocyticleukemia']\n",
      "['zielgerichtete krebstherapie bei chronisch lymphatischer leuk mie cll langfristig wirksam btk hemmer besser als', 'chemotherapie nach', 'jahren waren noch', 'der patienten', 'leben chemotherapie gruppe', 'gefunden auf portal']\n",
      "['recent studies', 'btk inhibitors', 'chronic lymphocytic leukemia', 'refractory settings cll']\n",
      "['pm eastern', 'minute q amp', 'renowned chronic lymphocytic leukemia cll experts', 'voice questions', 'expert webinar']\n",
      "['therapeutic options', 'hematologic malignancies', 'clinical advantages', 'cll mm aml amp lymphoma', 'cme activity']\n",
      "['humans apto', 'days cycle', 'treatment amp', '66mg m2 dose cg', '1st cll patient 150mg', 'q2 earnings']\n",
      "['apto 1st', 'cll patient', 'trial show good pk amp', 'response apto', 'fda amp', 'aml flt3 amp idh1']\n",
      "['hoy cumple', 'os una persona esencial', 'nuestro equipo cll carmen meno', 'atenci n', 'paciente adem s tambi n es su santo muchas felicidades carmen']\n",
      "['important milestone', 'apto s cg', 'clinic amp', '1st cll patient c481s btk amp need', 'days cycle', '1st patient dsmb evaluation things']\n",
      "['chronic lymphocytic leukemia patient samples', 'quantitative reverse transcription pcr']\n",
      "['car t trials', 'david maloney', 'lymphoma lymsm cll cart']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['phd students', 'research synergy project bcllatlas', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['brian t hill md phd', 'btk inhibitors', 'cll leukemia']\n",
      "['sever skin toxicity', 'skin lesions', 'old male patient', 'chronic lymphocytic leukemia case report', 'literature review']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['dose reductions', 'ibrutinib therapy', 'inferior outcomes', 'chronic lymphocytic leukemia cll']\n",
      "['btk inhibitors', 'cll leukemia']\n",
      "['tgtx phase', 'chronic lymphocytic leukemia', 'therapy nct02742090', 'primary completion date']\n",
      "['doesn t']\n",
      "['lymphomamanagement course', 'cll amp hodgkin lymphoma', 'helen dr george', 'amp dr rifca ledieu lymsm haematology oncology bloodcancer']\n",
      "['prof richard rosenquist brandell', 'research focuses', 'chronic lymphocytic leukemia', 'genomic medicine sweden']\n",
      "['lymphomamanagement course', 'seminars amp case study discussions', 'diagnostics pet', 'elderly patients cll', 'hodgkin lymphoma', 'medical speakers haematology oncology bloodcancer']\n",
      "['global b cell chronic lymphocytic leukemia treatment market', 'ab science sa amgen inc celgene corporation dynavax technologies corporation eisai']\n",
      "['refractory chronic lymphocytic leukemia', 'clarity study']\n",
      "['district championship intermediate', 'provincial championship', 'junior provincial championship good luck', 'cll teams', 'postseason journeys cc']\n",
      "['clarity trial', 'grant application', 'small role', 'tap trialsacclerationprogramme cll jco']\n",
      "['new article oxidative stress', 'candidate therapeutic target', 'microenvironmental protection']\n",
      "['happy sunday', 'chronic lymphocytic leukemia cll', 'good overview', 'genetic landscape']\n",
      "['lianne palmer cll specialist nurse', 'co morbidities', 'cll amp day', 'lymphomamasterclass haematology oncology comorbidities livingwithandbeyondcancer cns']\n",
      "['plcg2 mutations', 'real life cll cohort', 'filo group study', 'great publication', 'dr quinquenel']\n",
      "['refractory chronic lymphocytic leukemia', 'clarity study readbyqxmd asco cll ibrutinib venetoclax']\n",
      "['pretty night', 'new digs cll']\n",
      "['undetectable mrd', 'b ven obi', 'cll cramer', 'leukemia leusm obinutuzumab venetoclax']\n",
      "['experts tackles', 'cll patients', 'dr jabbour gotomxh']\n",
      "['video patients', 'chronic lymphocytic leukemia', 'btk inhibitors', 'secondary cancers', 'general population']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['nice article', 'new therapeutic agent', 'cll tp0903', 'combo arm']\n",
      "['line therapies', 'arnon kater', 'amsterdam hematology eha19 leusm']\n",
      "['key insights', 'chronic lymphocytic leukemia', 'lymphoma amp myeloma']\n",
      "['clarity trial', 'r r cll venetoclax ibrutinib 8wk run', 'pre ven primary endpt mrd', '12m i v mrd ve', 'pb bm', 'mrd outcome gt', 'length rx orr', 'fup 21months i v', '1l flair trial uk lymsm blooducation']\n",
      "['new clinicaltrial', 'cll patients']\n",
      "['new venetoclax obinutuzumab combination treatment', 'chronic lympho']\n",
      "['final results', 'phase iii study', 'rituximab w', 'open label idelalisib', 'patients w', 'chronic lymphocytic leukemia']\n",
      "['treatment options', 'chronic lymphocytic leukemia cll', 'chemoimmunotherapy regimens']\n",
      "['chronic lymphocytic leukemia cll', 'genetic mutation', 'recent advances']\n",
      "['refractory chronic lymphocytic leukemia', 'clarity study journal', 'clinical oncology']\n",
      "['blood commentary quest']\n",
      "['oral therapy', 'way oncologists practice', 'care team s experience', 'cne cme activity lymphoma']\n",
      "['chronic lymphocytic leukemia', 'response variables cll']\n",
      "['cll indian green building council igbc', 'environment standards', 'sustainable building design']\n",
      "['chronic lymphocytic leukemia', 'response variables blood journal']\n",
      "['cll ceremony', 'big day', 'graduation faq s']\n",
      "['human medicines european', 'public assessment report epar mabthera rituximab lymphoma non hodgkin arthritis rheumatoid leukemia lymphocytic chronic b cell date', 'pharma regulatory']\n",
      "['cortactin expression', 'non hodgkin b cell lymphomas', 'new marker', 'differential diagnosis', 'chronic lymphocytic leukemia', 'mantle cell lymphoma']\n",
      "['common type', 'uk fridayfact', 'webpage gt lymphomamatters bloodcancer hodgkin nonhodgkin cll image', 'cell division', 'friends uk']\n",
      "['double rainbow', 'work cll lakelouise']\n",
      "['double rainbow', 'work cll lakelouise']\n",
      "['clinicaltrial study', 'chronic lymphocytic leukemia cll']\n",
      "['life qol', 'chronic lymphocytic leukemia']\n",
      "['cancer terminology', 'cancer language cancer fightcancer survivor cll leukemia lymphoma bloodcancer survivor cancerhumor chronic lls chemo cancersucks remission oncology warrior']\n",
      "['important data', 'department efficacy', 'chronic lymphocytic leukemia cll', 'response variables lymsm']\n",
      "['chronic lymphocytic leukemia', 'response variables blood journal patients', 'bulky lymphadenopathy bcri refractory cll', 'adverse mutation profile', 'durable benefit']\n",
      "['chronic lymphocytic leukemia cll', 'response variables']\n",
      "['cll lymsm']\n",
      "['non trial cohort', 'ibrutinib cll pts', 'pd ngs', 'small cll clone', 'present btk mut', 'plcg2 mut', 'btk mut predicts gt shorter pfs', 'data raises q', 'knowledge pre relapse lymsm blooducation']\n",
      "['current chronic lymphocytic leukemia treatment landscape', 'effective practices', 'cll care']\n",
      "['chronic lymphocytic leukemia', 'response variables']\n",
      "['chronic lymphocytic leukemia cll', 'venetoclax status', 'condition summary chronic lymphocytic leukemia']\n",
      "['life qol', 'chronic lymphocytic leukemia status', 'condition summary cll']\n",
      "['phd students', 'research synergy project bcll', 'multi omic single cell characterisation', 'b cells', 'chronic lymphocytic leukaemia cll']\n",
      "['governor science', 'extra virgin olive oil', 'recent trial', 'chronic lymphocytic leukemia', 'monoclonal gammopathy', 'unspecified significance']\n",
      "['newsletter n', 'di ematoinfo focus sulla 15esima edizione dell', 'international conference', 'malignant lymphoma cartcell cll lymsm leusm']\n",
      "['international conference', 'malignant lymphoma sono stati presentati diversi dati relativi', 'trattamento della leucemia linfatica cronica alessandra tedeschi e marco montillo li hanno commentati', 'noi cll leusm']\n",
      "['functionalprecisionmedicine cll boston']\n",
      "['prognostic score', 'cytogenetic risk classification', 'chronic lymphocytic leukemia patients center', 'international blood', 'marrow transplant research report']\n",
      "['prognostic score', 'cytogenetic risk classification', 'chronic lymphocytic leukemia patients center', 'international blood', 'marrow transplant research report']\n",
      "['ibrutinib reprograms', 'glucocorticoid receptor', 'chronic lymphocytic leukemia cells']\n",
      "['venclexta venetoclax abbvie roche drug report', 'chronic lymphocytic leukemia', 'multiple myeloma', 'acute myeloid leukemia']\n",
      "['new clinical trial', 'open letscurethis']\n",
      "['progress progress progress cll cllsm nhl']\n",
      "['cll society s', 'free webinar', 'cll emotional roller coaster', 'pm edt cll cllsm']\n",
      "['chronic lymphocytic leukemia cells', 'mitochondrial fitness', 'cd8 t cells', 'impede car t cell efficacy cll']\n",
      "['long term ibrutinib therapy', 'cll btk mutations', 'signal progression leukemia cancer']\n",
      "['cll patients', 'blood work', '11am pt 2pm']\n",
      "['similar genomic landscapes', 'monoclonal b cell lymphocytosis', 'stable chronic lymphocytic leukemia', 'low frequency', 'driver mutations']\n",
      "['zanubrutinib beigene', 'global drug report', 'chronic lymphocytic leukemia', 'follicular lymphoma']\n",
      "['venclexta venetoclax abbvie roche drug report', 'chronic lymphocytic leukemia', 'multiple myeloma', 'acute myeloid leukemia']\n",
      "['treatment algorithms']\n",
      "['cll diagnosis', 'different emotions', 'patients ways']\n",
      "['kpti phase', 'refractory chronic lymphocytic leukemia', 'aggressive non hodgkin lymphoma nct02303392', 'primary completion date']\n",
      "['gild phase', 'refractory chronic lymphocytic leukemia cll nct02968563', 'primary completion date']\n",
      "['insurance companies', 't pay', 'stops cancer fightcancer survivor cll leukemia lymphoma bloodcancer survivor cancerhumor chronic lls chemo']\n",
      "['excellent review', 'dr francesc bosch', 'dr riccardo dalla favera chronic lymphocytic leukemia', 'treatment vhebron']\n",
      "['scan results', 'retracement bearish', 'bon kwg av', 'usg ebox jel stcm bbgi fipp hvo bse sun dis anp cll mgr']\n",
      "['scan results bearish', 'ltg iom orm shoe brby cll dom']\n",
      "['treatment algorithms', 'cll rafic farah md', 'indepth look', 'relapsedrefractory chronic lymphocytic leukemia']\n",
      "['adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['leukemic cells', 'promising therapeutic target', 'chronic lymphocytic leukemia cll']\n",
      "['pm eastern', 'minute q amp', 'renowned chronic lymphocytic leukemia cll experts', 'voice questions', 'expert webinar']\n",
      "['cll cello health launches', 'new berlin office appoints', 'regional directors', 'uk cll']\n",
      "['cll cello health launches', 'new berlin office appoints', 'new regional directors', 'uk cll brighterir andrewscotttv capitalnetwork1']\n",
      "['blood disorders suck leukaemia cll blood lowplatelets']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['initial treatment', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['chronic lymphocytic leukemia cll', 'genetic mutation', 'treatment plan']\n",
      "['chronic lymphocytic leukemia treatment market size analysis share growth trends', 'regional overview segmentations']\n",
      "['josh brody md', 'new pi3k delta inhibitor umbralisib icahn school', 'mount sinai', 'mount sinai hospital cll leukemia']\n",
      "['moon shots', 'cll targetedtherapy immunotherapy genomics', 'leusm cancermoonshot endcancer']\n",
      "[]\n",
      "['active cll clinical collaborator', 'translational studies', 'future ones']\n",
      "['org a041702 ph3 rct ibrutinib obinutuzumab venetoclax', 'patients gt 70yo', 'chronic lymphocytic leukemia cll pi woyach nct03737981 leusm cllsm geriheme']\n",
      "['susan o brien md discusses', 'cll treatment', 'comorbidities cll']\n",
      "['kansas society', 'clinical oncology', 'dr koffman']\n",
      "['human medicines european', 'public assessment report epar rituzena', 'tuxella rituximab lymphoma non hodgkin microscopic polyangiitis leukemia lymphocytic chronic b cell wegener granulomatosis date']\n",
      "['early disease progression', 'chronic lymphocytic leukemia leusm']\n",
      "['hematopoietic transplantation', 'high levels', 'fanca gene', 'chroniclymphaticleukemia cll']\n",
      "['video venetoclax resistance', 'arnon kater', 'amsterdam hematology eha19 hemeonc leusm chroniclymphocyticleukemia']\n",
      "['cll 4moretogo']\n",
      "['prognostic score', 'cytogenetic risk classification', 'chronic lymphocytic leukemia patients center', 'international blood', 'marrow transplan']\n",
      "['cd19 cartcells', 'concurrent ibrutinib', 'high response rates w o', 'severe crs', 'ibrutinib refractory cll', 'dr gauthier concurrent administration', 'patients amp', 'high rates', 'negative responses']\n",
      "['time treatment', 'chronic lymphocytic']\n",
      "['new risk model', 'chronic lymphocytic leukemia', 'heavy chain immunoparesis', 'free light chain chronic lymphocytic leukemia cll', 'immune dysregulation']\n",
      "['dynamic risk', 'serial tumor biomarkers', 'outcome prediction', 'cll lymsm']\n",
      "['gordonsville day', 'broadway community', 'i ll post link', 'cll states nokesville roadtotennessee']\n",
      "['chronic lymphocytic leukemia cells', 'mitochondrial fitness', 'cd8 t cells', 'impede car t cell efficacy cll']\n",
      "['chronic lymphocytic leukemia cells', 'mitochondrial fitness', 'cd8 t cells', 'impede car t cell efficacy slc2a1 glut1']\n",
      "['early stage asymptomatic', 'chronic lymphocytic leukemia', 'survival outcomes', 'ibrutinib monotherapy', 'phase iii cll12 study', 'eha congress cllsm leusm']\n",
      "['venclexta improves outcomes', 'chronic lymphocytic leukemia asco19']\n",
      "['saanich i hope', 'green wave', 'good luck', 'players coaches', 'fun cll intermediate allstars']\n",
      "['video time', 'barbara eichhorst', 'icml19 hemeonc leusm']\n",
      "['adrian wiestner s lab', 'science bethesda cll']\n",
      "['venetoclax obinutuzumab combination treatment', 'chronic lymphocyt']\n",
      "['venetoclax obinutuzumab combination treatment', 'chronic lymphocytic']\n",
      "['immune cells cd19cd20 cart cells', 'refractory bcell lymphoma', 'chronic lymphocytic leukemia', 'phase i trial studies', 'cd19cd20 chimeric antigen renalcell kidneycancer']\n",
      "['mutational signature analysis', 'multiplemyeloma chroniclymphocyticleukemia cll']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['blood journal chronic lymphocytic leukemia cells', 'mitochondrial fitness', 'cd8 t cells', 'impede car t cell efficacy jaco', 'c van bruggen']\n",
      "['comprehensive review cll form']\n",
      "['scan results', 'retracement bearish', 'sfe epic kwg arr aph bbgi som w7l mgr bltg ebox fch nait hcm igas cll']\n",
      "['venclexta improves outcomes', 'chronic lymphocytic leukemia asco19']\n",
      "['subcutaneous rituximab', 'follicular lymphoma chronic lymphocytic leukemia', 'large b cell lymphoma']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['prognostic score', 'cytogenetic risk classification', 'chronic lymphocytic leukemia patients cll']\n",
      "['own dr brian koffman', 'key aspects', 'short videos cll cllsm letscurethis']\n",
      "['new work', 'high fanca expression', 'bad prognosis factor', 'chronic lymphocytic leukemia']\n",
      "['allogeneic transplantation', 'high risk chronic lymphocytic leukemia', 'center intent']\n",
      "['disease amp', 'different things', 'negative emotions', 'self pity anger remorse guilt despair', 'w mortality fridaythoughts cll']\n",
      "['chronic lymphocytic leukaemia cancer leukemia cll francesc bosch vhebron review']\n",
      "['lab meeting dept i', 'internal medicine maximilian koch', 'excellent talk', 'phd project', 'lyn kinase', 'high risk cll cells leukemia tme leusm']\n",
      "['new research inactivation', 'prostaglandin e2', 'adverse effects', 'chronic lymphocytic leukemia high expression', 'metabolic enzyme udp glucuronosyltransferase ugt2b17', 'chronic lymphocytic leukemia oncology']\n",
      "['chronic lymphocytic leukemia cll cells', 'mitochondrial fitness', 'cd8 t cells', 'impede cartcells efficacy cllsm leusm tcellrx']\n",
      "['scan results', 'retracement bearish', 'pgit wrks acc alb cost lwb nait ams jwng wtan cll geo sfe', 'asc solo']\n",
      "['d cada del', 'los primeros reg menes', 'inmunoterapia fueron aprobados', 'combinaci n', 'con quimioterapia para el tratamiento', 'leucemia linfoc tica cr nica']\n",
      "['c mo', 'evolucionado el tratamiento', 'leucemia linfoc tica cr nica d cadas', 'investigaci n han brindado', 'los cient ficos y m dicos una mejor comprensi n', 'enfermedad y nuevas alternativas terap uticas nos lo muestra']\n",
      "['chronic lymphocytic leukemia cells', 'mitochondrial fitness', 'cd8 t cells', 'impede car t cell efficacy']\n",
      "['venclexta improves outcomes', 'chronic lymphocytic leukemia asco19']\n",
      "['chronic lymphocytic leukemia cll', 'lymsm lymphoma']\n",
      "['independence independence day cancer fightcancer survivor cll leukemia lymphoma bloodcancer survivor cancerhumor chronic lls chemo cancersucks remission oncology']\n",
      "['systematic review', 'chronic lymphocytic leukemia']\n",
      "['time treatment', 'chronic lymphocyti leukemia']\n",
      "['chronische lymphatische leuk mie kurz cll ist', 'unseren breitengraden', 'h ufigsten vorkommende blutkrebsart', 'behandlungsm glichkeiten der erkrankung haben sich', 'den vergangenen jahren stark verbessert']\n",
      "['bien que', 'llc soit', 'incurable les efforts', 'recherche sur les traitements ont consid rablement progress ces derni res ann es apprenez', 'dans notre article portant sur ce sujet']\n",
      "['significant advances', 'research efforts', 'cll treatments', 'recent years']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['phase 1b study']\n",
      "['prognostic score', 'cytogenetic risk classification', 'chronic lymphocytic leukemia patients center', 'international blood', 'marrow transplant research report']\n",
      "['clinicalupdates review', 'treatment options', 'aml cll amp multiplemyeloma explore w drs delgado']\n",
      "['dr ian flinn discusses findings', 'duo trial', 'dose modifications', 'duvelisib cll sll']\n",
      "['environmental scan', 'acute lymphocytic leukemia care education project', 'magazine s article', 'cll care']\n",
      "['blood commentary', 'vo kos cll']\n",
      "['abdominal pain knocks', 'unusual presentation', 'chronic lymphocytic leukemia']\n",
      "['clonal evolution', 'refractory versus', 'chronic lymphocytic leukemia', 'samples samples', 'whole exome']\n",
      "['durable responses', 'cd19 car t', 'alexandre hirayama', 'icml19 hemeonc']\n",
      "['leslie md', 'cll14 trial outcomes hackensack university', 'medical center asco19 lymphoma cll']\n",
      "['fanca expression determines', 'chronic lymphocytic leukemia', 'p53 function']\n",
      "['phase 1b study', 'venetoclax obinutuzumab', 'refractory chronic lymphocytic leukemia cll']\n",
      "['new social media platform', 'westwood squirrels instagram warwickuni cll yourwarwick']\n",
      "['chronic lymphocytic leukemia treatment market size', 'global industry report']\n",
      "['dyk people', 'chronic lymphocytic leukemia cll', 'additional chemotherapy', 'free option']\n",
      "['cancer occurrence', 'leukemia therapeutics market', 'full report chronic lymphocytic leukemia biotech stemcells lifescience chemotherapy drug molecule biologics pharma', 'medical biotechnology opportunities cancer']\n",
      "['molecular evidence', 'azithromycin resistance', 'babesia microti infection', 'chronic lymphocytic leukemia']\n",
      "['hemato oncology market download', 'free ebook', 'hematology oncology mm multiplemyeloma cll dlbcl aml']\n",
      "['besoin d un rappel', 'connaissance sur', 'l h matologie oncologie t l chargez notre ebook mm myeloma cll leuc mie dlbcl lymphome aml']\n",
      "['prognostic risk score', 'refractory chronic lymphocytic leukaemia', 'cohort study', 'external validations cll']\n",
      "['cancer chronic lymphocytic leukemia']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['cll patients', 'effect relation', 'prescription moment lymphoma']\n",
      "['expert access', 'expert cll physician', 'confident enroll', 'myexpertaccess cll cllsm letscurethis']\n",
      "['new cme', 'expert insights', 'therapeutic approaches']\n",
      "['scan results', 'retracement bearish', 'acso sgm hgt asei nait ghh prsm rbg wtan cll ams dtg gcs rps eto imb']\n",
      "['multiplemyeloma breastcancer anemia cll linfomas oncotype', 'dermatolgy oncology painmedicine spinesurgery orthopedics medicine mddigitastv mdtvonline mdtvnews oncology', 'information visit']\n",
      "['favorable results', 'line treatments', 'patients w chronic lymphocyticleukemia', 'small lymphocytic leukemia mylci']\n",
      "['video cll trial highlights', 'kuwait cancer control center icml19 hemeonc']\n",
      "['track post chemo', 'land cancer leukemia oncology cll lymphoma fightcancer cancersucks chronic chemo survivor remission lls cancerhumor recovery']\n",
      "['ruthin library', 'year s summer reading challenge cll']\n",
      "['nice summary', 'dr coutre', 're combination therapies', 'ibrutinib venetoclax']\n",
      "['cll points', 'cll points', 'cll tokens cll cll cryptoliveleak']\n",
      "['art cll care', 'great wolf lodge', 'great wolf dr mason', 'online register', 'ohc cancer experts re chronic lymphocytic leukemia']\n",
      "['foundation phase', 'afternoon cll']\n",
      "['cll patients', 'general health', 'patient share', 'healthier lifestyle', 'diagnosis cll patientpower']\n",
      "['ibrutinib cll cllsm letscurethis']\n",
      "['cll society tribune', 'cll cllsm letscurethis']\n",
      "['chronic lymphocytic leukemia growth', 'leusm bloodcancer cancerresearch']\n",
      "['sept edinburg scotland press registration']\n",
      "['undetectable minimal residual disease status', 'durable responses', 'chronic lymphocytic leukemia']\n",
      "['condition chronic lymphocytic leukaemia', 'positive power i hold outweighs', 'cancer fightingback beatingcancer cll positivementalattitude pma']\n",
      "['drug administration', 'venetoclax venclexta', 'obinutuzumab gazyva', 'initial treatment', 'chronic lymphocytic leukemia']\n",
      "['undetectable mrd status', 'chronic lymphocytic leukemia']\n",
      "['hemonc fellow', 'cll exerciseoncology survivorship amp financialtoxicity lymsm']\n",
      "['chronic lymphocytic leukemia']\n",
      "['leukemia cells', 'critical step', 'chronic lymphocytic leukemia', 'common leukemia']\n",
      "['old human cells self destruct', 'new ones', 'certain cancer cells', 'basic science research', 'natural process']\n",
      "['therapeutic spectrum', 'chronic lymphocytic leukemia']\n",
      "['pretreatment factors response variables', 'venetoclax efficacy', 'chronic lymphocytic leukemia oncology leukemia']\n",
      "['final results', 'phase iii study', 'rituximab w', 'open label idelalisib', 'patients w', 'chronic lymphocytic leukemia']\n",
      "['leukaemia fatigue', 'cll leukaemia fatigue']\n",
      "['significant number', 'cases chemotherapy', 'chronic leukemia myelogenous leukemia cml', 'lymphocytic leukemia cll']\n",
      "['graduation month', 'day cll', 'pre graduation celebration book', 'warwickgrad graduation2019 classof2019 cll']\n",
      "['lpl gene expression', 'chronic lymphocytic leukemia']\n",
      "['cd38 enhances', 'antileukemic activity', 'chronic lymphocytic leukemia']\n",
      "['venetoclax obinutuzumab combination treatment', 'chronic lymphoc leukemia']\n",
      "['conditions venetoclax obinutuzumab', 'free survival', 'chlorambucil obinutuzumab']\n",
      "['proteomics insights', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['scouts bsa summer camp', 'long lake', 'wild week', 'laughter fun camaraderie', 'sore feet', 'bug bites humility strength', 'happy cll scoutsbsa']\n",
      "['time treatment', 'chronic lymphocytic']\n",
      "['fludarabine cyclophosphamide', 'initial treatment', 'chronic lymphocytic leukaemia cll', 'arm multicentre phase', 'trial lymsm leusm']\n",
      "['gene mutations', 'treatment naive chronic lymphocytic leukaemia cll patients lymsm leusm']\n",
      "['mut atm p lt', 'notch1 p lt', 'sf3b1 p', 'ighv p lt', 'del 11q p lt', 'rai p', 'amp binet p lt', 'w shorter ttft del 17p mut tp53 amp ck', 'w shorter ttft mva mut atm p lt', 'amp unmut ighv p lt', 'sig cll blooducation']\n",
      "['forscher des haben herausgefunden dass f r', 'entstehung der cll einer h ufigen form von blutkrebs neben dna mutationen auch fehlerhafte epigenetische signale verantwortlich sind krebsforschung']\n",
      "['prognostic score', 'cytogenetic risk classification', 'chronic lymphocytic leukemia patients center', 'international blood', 'marrow transplant research report']\n",
      "['chronic lymphocytic leukemia cll hypogammaglobulinemia']\n",
      "['new chronic lymphocytic leukemia drugs']\n",
      "['maintenance therapy', 'chronic lymphocytic leukemia']\n",
      "['new chronic lymphocytic leukemia drugs']\n",
      "['piece i', 'cancer nurses survivor oncology lymphoma leukemia cll chemotherapy']\n",
      "['phase 1b study', 'venetoclax obinutuzumab', 'refractory chronic lymphocytic leukemia mab antibody']\n",
      "['smart researchers', 'likelihood timing']\n",
      "['chemofree regimens', 'cll fl mcl dlbcl', 'lugano stay']\n",
      "['line treatment correlates', 'chronic lymphocytic leukemia cll', 'sawaf american journal', 'hematology wiley online library']\n",
      "['need phase', 'interesting concept', 'young fit patients cll']\n",
      "['line treatment correlates', 'chronic lymphocytic leukemia cll patients', 'progressive lymphadenopathy', 'shorter ttnt os', 'favorable qol c w progression']\n",
      "['video venetoclax', 'r r cll analysis', 'vision ho141 trial', 'arnon kater', 'amsterdam hematology eha24 leukemia leusm']\n",
      "['cathy skinner', 'tight muscles increases flexibility balance', 'joints cll myeloma livewell patientpower']\n",
      "['language difficulties', 'feelings cll speech literacy eytwittertagteam eymatters']\n",
      "['scan results expansion breakdown', 'xps aiea cll tnd snr pdg byg mmh macf air ship']\n",
      "['absolute insanity', 'insurance incompetence', 'design cancer cll leukemia lymphoma survivor chronic fightcancer cancersucks cancerhumor insurance oncology']\n",
      "['phase 1b study', 'venetoclax obinutuzumab', 'refractory chronic lymphocytic leukemia cll cllsm']\n",
      "['mobile apps', 'treatment adherence systematic review p rez jover journal', 'medical internet research hematology geriheme gerionc lymsm leusm cll cllsm mmsm']\n",
      "['venetoclax obinutuzumab combination treatment', 'chronic lymphocyt']\n",
      "['cll treatment', 'combination therapies', 'hot i m', 'following trial fcr ibrutinib amp']\n",
      "['expert panelists michael reff', 'kirollos hanna reflect', 'complex paradigm', 'comorbid conditions', 'prescription control']\n",
      "['final results', 'phase iii study', 'rituximab w', 'open label idelalisib', 'patients w', 'chronic lymphocytic leukemia']\n",
      "['medical bills', 'available options cll medicalbills livewell patientpower']\n",
      "['heroic decades', 'long multi centre cll study', 'clonal dynamics amp', 'growth patterns amp', 'individual gene alterations bcells patients leukaemia chromosomes']\n",
      "['estrogen receptors', 'chronic lymphocytic leukemia']\n",
      "['1st iwcll', 'learnings news', 'new treatment options amp', 'incalculable benefit', 'cll community']\n",
      "['venetoclax obinutuzumab combination treatment']\n",
      "['venclexta gazyva reduces disease progression', 'chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['chronic lymphocytic leukemia non hodgkin lymphoma', 'hl patients']\n",
      "['time treatment', 'chronic lym']\n",
      "['nuggetsofjoy cll cancersucks makingmemories']\n",
      "['filo study', 'flaky high incidence', 'btk mutations', 'cll patients']\n",
      "[]\n",
      "['chronic lymphocytic leukemia growth', 'oncology times']\n",
      "['nordic cll study group welcomes', 'educational meeting', 'oslo april', 'cure ncllsg2020']\n",
      "['chronic lymphocytic leukemia growth', 'leusm bloodcancer wednesdaywisdom']\n",
      "['exerts synergistic antitumor', 'chronic lymphocytic leukemia stimulusreport lymphoidneoplasia']\n",
      "['gait speed', 'bloodcancers cll']\n",
      "['early chronic lymphocytic leukemia', 'observation amp', 'cll oncology']\n",
      "['drg epidemiology report estimates', 'western europe', 'global reports', 'cll leukemia chronic lymphocyticleukemia eha24']\n",
      "['immunological changes', 'kinase inhibitor therapy', 'chronic lymphocytic leukemia']\n",
      "['transfusion amp haemovigilance anticoagulants', 'amp obesity', 'new risk score', 'r r cll amp', 'cml leusm']\n",
      "['ibrutinib induces', 'multiple functional defects', 'neutrophil response', 'aspergillus fumigatus lymsm cll cllsm']\n",
      "['family continentallittleleauge cll buenaparkamericanlittleleague crescentlittleleague santa fe']\n",
      "['chronic lymphocytic leukemia', 'health insurance', 'needs support']\n",
      "['international meeting', 'sept iwcll2019']\n",
      "['chronic lymphocytic leukemia']\n",
      "['blog post', 'humor e mc', 'cll leukemia cancer lymphoma survivor fightcancer bloodcancer cancerhumor oncology scanxiety chemo']\n",
      "['renal involvement', 'chronic lymphocytic leukemia nephrology']\n",
      "['data trial', 'chronic lymphocytic leukemia']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['chronic lymphocytic leukemia patterns', 'treatment costs', 'adverse events raredisease chroniclymphocyticleukemia cll']\n",
      "['richter transformation', 'rx naive cll rx naive c w uk phase ii trial n ldh tp53 wt os mos 12m overall age', 'rx ldh', 'w os', 'sct pt lymsm', 'great work']\n",
      "['demand cme webinar series', 'oncology videowebinars', 'activity click', 'melanoma immuno oncology cll multiplemyeloma cityofhope paradigmmedcom']\n",
      "['arql institutional investors', 'potential amp', 'building position', 'cll patients amp']\n",
      "['long term safety', 'agent ibrutinib', 'chronic lymphocytic leukemia cll', 'pivotal studies']\n",
      "['video cll12 ibrutinib monotherapy upfront', 'potential competitor', 'cologne cologne germany icml19 cll leusm']\n",
      "['rod humerickhouse', 'minimal residual disease negativity abbvie leukemia cll']\n",
      "['gm talk', 'rackoonmix cll chocolate lady lover rackooncity producer music hiphop beats rap trap dj soundcloud artist rapper studio musicproducer beatmaker']\n",
      "['trialtuesday org investigator dr jennifer woyach james', 'immunotherapy trial alliance a041702', 'chronic lymphocytic leukemia', 'nci nctn immunotherapy cllsm']\n",
      "['small phase 1b study', 'exciting preliminary results', 'cll patients', 'new pi3k delta inhibitor', 'full article', 'cll cllsm letscurethis']\n",
      "['challenging treatments', 'cancer patients', 'new irsc', 'mb clinician scientists drs dawe', 'banerji cll']\n",
      "['positive recommendation', 'national d excellence', 'services sociaux']\n",
      "['org a041702 ph3 rct ibrutinib obinutuzumab venetoclax', 'patients gt 70yo', 'chronic lymphocytic leukemia cll pi woyach nct03737981 leusm cllsm geriheme']\n",
      "['video ulrich j ger', 'wien discusses', 'chemofree regimens offering hope', 'fl mcl amp dlbcl stay', 'satellite symposium lymhubss']\n",
      "['cll patients', 'non chemo prof thornton']\n",
      "['important feedback motivates', 'maximal energy gcllsg sharman cll leusm leukemia']\n",
      "['nordic nanovector', 'encouraging preclinical data', '212pb nnv', 'drug candidate', 'alpha therapy', 'positive b cell chronic lymphocytic leukemia', 'non hodgkin lymphoma snmmi19']\n",
      "['cancer researchers', 'treatment options', 'chroniclymphocyticleukemia cll']\n",
      "['prof patrick thornton', 'recent national information day', 'good amp', 'cll patients', 'amp overseas']\n",
      "['wan na', 'cll brian koffman', 'cll patient']\n",
      "['national patientadvocacy survey', 'disease burden', 'multiple hematologic malignancies', 'study findings gt oncology cll dlbcl fl']\n",
      "['cll care', 'education project', 'dr john pagel']\n",
      "['big moves']\n",
      "['chronic lymphocytic leukemia cll', 's understanding']\n",
      "['cll management experts review', 'such management organizations', 'oral oncolytics']\n",
      "['cll society', 'blog post', 'cll society cll leusm lymsm ash19']\n",
      "['initial treatment', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['susan o brien md discusses', 'clinical significance', 'subclonal tp53 mutations', 'chronic lymphocytic leukemia cll']\n",
      "['dr davids', 'transcend cll', 'phase i ii trial', 'car t cell therapy lisocabtagene maraleucel', 'refractory chronic lymphocytic leukemia cllsm leukemia']\n",
      "['kml videoberichte lymphome von der', 'icml aus lugano sind nun online es gibt f nf videoberichte zu den themen cll hodgkinlymphom dlbcl indolentelymphome und znsl von der 15icml alle videos und informationen unter']\n",
      "['das kompetenznetz maligne lymphome lymphome berichtet mit f nf videoberichten zu den themen cll hodgkinlymphom dlbcl indolentelymphome und znsl von der', 'icml alle videos und informationen unter']\n",
      "['new study shows', 'large proportion', 'early disease progression amp', 'gli1 bcells']\n",
      "['unilateral granuloma annulare', 'pyoderma gangrenosum', 'chronic lymphocytic leukemia']\n",
      "['meip reveals findings', 'early stage study', 'refractory follicular lymphoma', 'r r chronic lymphocytic leukemia', 'small lymphocytic lymphoma fl cll sll']\n",
      "['early disease progression', 'chronic lymphocytic leukemia ll']\n",
      "['s cure', 'cll cllsm ibrutinib cart']\n",
      "['esther schorr', 'friend jeff folloder cll clltreatment livewell patientpower']\n",
      "['os differs', 'placebo group', 'progression cll eha2019 ibrutinib']\n",
      "['ich habe gerade michael hallek step', 'chronic lymphocytic leukemia treatment auf vimeo hochgel']\n",
      "['blood cancer', 'alert non hodgkin s lymphoma b', 't cell chronic lymphocytic leukemia mantle cell hairy cell', 'multiple myeloma', 'multiple massive settlements']\n",
      "['proper diet', 'cll fuckcancer']\n",
      "['cll project', 'post approval', 'long lugano']\n",
      "['cryptoliveleak cll erc20', 're brand', 'network share', 'new token issuance cll']\n",
      "['renal involvement', 'chronic lymphocytic leukemia clinical kidney journal oxford']\n",
      "['ohio state', 'leukemia research']\n",
      "['combination therapy']\n",
      "['infection control', 'chronic lymphocytic leukemia', 'idelalisib recommendations', 'italian society']\n",
      "['blood commentary hedgehog activation']\n",
      "['cll patients', 'healthcare team', 'financial distress tune']\n",
      "['outcome assessment', 'chronic lymphocytic leukemia poster presentation', 'mascc19 june', 'digital health']\n",
      "['success story', 'patient credits ourhealth physician dr eric wallisa', 'life ohpatientsuccess']\n",
      "['early disease progression', 'chronic lymphocytic leukemia cll']\n",
      "['statin use', 'chronic lymphocytic leukemia incidence', 'case control study', 'manitoba canada onlinefirst']\n",
      "['15icml lugano lymsm lymphoma cll ibtk cart inib', 'big debate']\n",
      "['low potency lipophilic statins fluvastatin', 'chronic lymphocytic leukemia cll']\n",
      "['insightful presentation', 'new prognostic score', 'early binet stage', 'cll i', 'couldn t', 'nice slide', 'different groups', 'early stage patients leukemia']\n",
      "['tcell ibrutinib cartcells', 'promising results', 'cll icml2019']\n",
      "['interesting combination cll imcl19']\n",
      "['congress 15icml discusses', 'durable response', 'car t cell immunotherapy', 'concurrent ibrutinib', 'ibrutinib failure lymsm lymphoma icml19']\n",
      "['interesting responses', 'richters syndrome', 'small numbers', 'such clear areas', 'unmet need', 'active investigation post ibrutinib', 'venetoclax icml2019 15icml']\n",
      "['headline news i', 'car t treatment lymphoma', 'cll icml15']\n",
      "['potential association', 'regular low dose statin use']\n",
      "['intermediate risk cll patients', 'ibrutinib versus observation', 'session amp', 'great thoughts']\n",
      "['delgado j ebmt', 'cibmtr recommendations', 'refractory cll', 'allo imcl19']\n",
      "['cll classes', 'cll 15icml lugano']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['cll patients', 'treatment quicker']\n",
      "['chronic lymphocytic leukemia cll care', 'patients work', 'suitable treatment', 'expert dr wierda']\n",
      "['new combination', 'chronic lymphocytic leukemia']\n",
      "['final results', 'phase iii study', 'rituximab w', 'open label idelalisib', 'patients w', 'chronic lymphocytic leukemia']\n",
      "['end cll leukemia cancer lymphoma lls survivor cancerhumor cancersucks fightcancer chronicillness separation']\n",
      "['medical bills', 'available options cll medicalbills livewell patientpower']\n",
      "['scan results hammer candlestick', 'cll ftc itx', 'red bxp hlcl scs asiz dwf iit web nicl amo hsd spa tate']\n",
      "['sever skin toxicity', 'skin lesions', '68yearold male patient', 'chronic lymphocytic leukemia case report', 'literature review ibrutinib', 'oral inhibitor', 'bruton s tyrosine']\n",
      "['venclexta venetoclax', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['genetic tp53', 'ckt abnormalities', 'cll therapy need', 'efficient treatments cart cells']\n",
      "['characterizes symptomatic bronchial involvement', 'cll leukemia cancer']\n",
      "['kol endorsement', 'tgtx umbralisib', '15icml cll']\n",
      "['rns aim cll cello health plc director pdmr']\n",
      "['oral oncolytics', 'chronic lymphocytic leukemia cll spt experts', 'treatment paradigm']\n",
      "['icml15 beigene announces clinical results', 'investigational btk inhibitor', 'r r chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'r r follicular lymphoma']\n",
      "['beigene announces phase 1b clinical results', 'gazyva obinutuzumab', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'follicular lymphoma', 'international conference', 'malignant l']\n",
      "['pretreatment growth patterns', 'early stage cll', 'disease course leukemia cancer']\n",
      "['chronic lymphocytic leukemia methods', 'protocols methods', 'molecular biology 1st', 'edition ebook']\n",
      "['tgtx umbralisib 15icml cll']\n",
      "['tgtx 15icml umbralisib cll']\n",
      "['tgtx umbralisib 15icml cll']\n",
      "['15icml lymsm umbralisib', 'ki intolerant cll patients definition', 'ki intolerance']\n",
      "['cll imho', 'good reason', 'idelalisib r']\n",
      "['cll patients', 'frontline treatment wonder']\n",
      "['cll session', '15icml kirsten fischer', 'cll14 trial', 'michael hallek', 'john seymour 15icml cll']\n",
      "['icml15 beigene announces', 'pivotal ph ii clinical results', 'investigational btk inhibitor', 'pts w', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['pivotal phase', 'clinical results', 'refractory chronic lymph']\n",
      "['free regimens', 'icml19 cllsm']\n",
      "['das kml ist beim icml15', 'lugano und berichtet ab samstag mit f nf videobeitr gen ber neue ergebnisse zur cll zum hodgkinlymphom znsl sowie zu verschiedenen nhl alle videos', 'gru wort von auf']\n",
      "['dept dissection', 'subclonal evolution', 'temporal mutation', 'chronic lymphocytic leukemia patients']\n",
      "['ezh2 upregulates', 'pi3k akt pathway', 'aggressive chronic lymphocytic leukemia']\n",
      "['dr richard r furman md', 'patient characteristics', 'cytogenetics gduhema2019iss3 weill cornell medicine cll leukemia therapy']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['great 15icml interview', 'sc member', 'cll lymsm']\n",
      "['darwin eha24 cll jose carreras']\n",
      "['geographic tongue', 'chronic lymphocytic leukemia']\n",
      "['untold story', 'car t cells']\n",
      "['recent research supports consideration', 'intensive cancer', 'chronic lymphocytic leukemia cll', 'btk inhibitors']\n",
      "['cll blooducation']\n",
      "['siempre es un gusto escuchar esa voz cll']\n",
      "['excellent presentation', 'petra langerbeins', 'plenary session', 'cll12 trial cll leusm gcllsg clinicaltrials']\n",
      "['genetic markers', 'oral presentation', 'cest icml19']\n",
      "['jos melenhorst s research', 'untold story', 'car t cells']\n",
      "['important study', 'ibrutinib therapy vs placebo', 'high risk cll pts cll12', 'petra langerbeins']\n",
      "['chronic lymphocytic leukemia brian parkinson', 'clinical trial']\n",
      "['front line mcl', 'elderly low risk patients orr', 'active ritux', 'equivalent cll setting 15icml']\n",
      "['15icml video', 'committee member', 'lugano lymsm']\n",
      "['case report', 'long survival', 'chronic lymphocytic leukemia', 'integrative methods matter']\n",
      "['15icml lymphoma lymsm', 'plenary s o brien discusses cll12 trial', 'ibrutinib vs placebo', 'asymptomatic high risk cll']\n",
      "['ibrutinib vs placebo', 'asymptomatic cll overall survival', 'long term', 'notable aes', 'placebo arm 15icml']\n",
      "['congress 15icml petra langerbeins', 'primary endpoint results', 'phase iii double', 'cll12 trial ibrutinib vs placebo', 'asymptomatic treatment na ve', 'stage cll lymsm lymphoma icml19']\n",
      "['eha24 reveals ibrutinib', 'fludarabine cyclophosphamide', 'initial treatment']\n",
      "['new master', 'science henrik bendiksen congratulations', 'bergen cll']\n",
      "['dr carl june', 'optimize car t cell therapy', 'dlbcl patients lymsm 15icml']\n",
      "['combination therapies', 'chronic lymphocytic leukemia cll jadproce']\n",
      "['bayesian population model', 'refractory chronic lymphocytic leukemia results', 'phase iii murano study lymphoma lymsm']\n",
      "['stage cll patients', 'beneficial ibrutinib', 'btk inhibitor', 'impressive clinical efficacy', 'treatment na ve', 'stage cll leukemia']\n",
      "['congress 15icml discusses', 'refectory disease', 'multiple new immune therapies', 'promising activity lymsm lymphoma icml19']\n",
      "['fantastic research publication', 'nicr researchers', 'collaborators non genotoxic mdm2 inhibition', 'pro apoptotic p53 gene signature', 'chronic lymphocytic leukemia cells cancer research science']\n",
      "[]\n",
      "['congress 15icml discusses', 'clinical practice amp', 'line amp', 'line cll treatments lymsm icml2019']\n",
      "['car t cell therapy', 'r r cll']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['rod humerickhouse', 'minimal residual disease negativity check', 'abbvie asco19 cll leukemia chroniclymphocyticleukemia']\n",
      "['early stage asymptomatic', 'chronic lymphocytic leukemia', 'survival outcomes', 'ibrutinib monotherapy', 'phase iii cll12 study cllsm leusm']\n",
      "['cll chronic lymphocytic leukemia']\n",
      "['org a041702 ph3 rct ibrutinib obinutuzumab venetoclax', 'patients gt 70yo', 'chronic lymphocytic leukemia cll nct03737981 leusm cllsm geriheme']\n",
      "['i m', 'incurable cancer cll lymphoma leukemia cancersucks fightcancer survivor cancerlaughs cancerhumor cancer chemo lls chronicillness disease']\n",
      "['brucent ibrutinib genericimbruvica', 'prescription medicine', 'mantle cell lymphoma chronic lymphocytic leukemia', 'marginal zone lymphoma mfg', 'inceptapharma ltd', 'bangladesh contact net genericibrutinib ovariancancer leukemia cancerdrugs']\n",
      "['scan results macd bearish centerline cross', 'lvcg nlb glo upl pin wen ccpg clig panr mbh stb flo cay cll rmm vgas']\n",
      "['team cllsa', 'virgin london 10km run', 'fantastic fundraiser', 'email sarah', 'membership org uk cll leukaemia', 'charity haematology bloodcancer']\n",
      "['alpha therapy', '212pb nnv003', 'positive b cell chronic lymphocytic leukemia cll', 'non hodgkin lymphoma nhl icml15 eha24 lymsm radioimmunotherapy radonc']\n",
      "[]\n",
      "['clinical characteristics', 'richter transformation experience', 'center lymsm cll cllsm']\n",
      "['congress lymhubss', 'final talk', 'chemofree regimens', 'chronic lymphocytic leukemia cll lymsm']\n",
      "['novel therapies', 'fair fee', 'cll update', '15icml symposium']\n",
      "['don t look', 'chronic illness', 'cll patients']\n",
      "['vit d insuff amp prognosis', 'chronic lymphocytic leukemia cll', 'leusm cllsm supponc']\n",
      "['blood flashback', 'chronic lymphocytic leukemia leusm cllsm']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['chronic lymphocytic leukemia', 'leusm cllsm']\n",
      "['combination therapy']\n",
      "['blood cancers']\n",
      "['new paper', 'cll conclusions overall outcome', 'poor rt', 'cll demonstrates', 'select patients', 'excellent work']\n",
      "['venetoclax veneclexta ibrutinib imbruvica', 'effective initial treatment', 'cll chroniclymphocyticleukemia results', 'full article leukemia']\n",
      "['week s futureproof', 'extra podcast car t', 'cll check']\n",
      "['sunesispharma pharmaceutical healthcare clinicaltrial clinicaltrials cll leukemia vecabrutinib eha mcl inhibitor']\n",
      "['eha2019 insights gt gt gt', 'michael hallek', 'twitter eha24', 'cll12 trial', 'ibrutinib versus placebo', 'early stage high risk cll results', 'eha24 lucidquest followthepatient mmsm lymphoma myeloma leusm bloodcancers']\n",
      "['treatment approaches', 'chronic lymphocytic leukemia leusm']\n",
      "['venetoclax venclexta', 'ibrutinib imbruvica', 'effective initial treatment', 'chronic lymphocytic leukemia']\n",
      "['drug administration', 'venetoclax venclexta', 'obinutuzumab gazyva', 'initial treatment', 'chronic lymphocytic leukemia']\n",
      "['jo s cancer', 'test subjects pleaseeeeee amandavscancer cll']\n",
      "['cll12 trial', 'ibrutinib versus placebo', 'early stage high risk cll results', 'petra langerbeins', 'key points', 'efs amp time', 'overall survival leusm']\n",
      "['investigatorprofile dr jennifer woyach', 'chroniclymphocytic leukemia cll clinical trials', 'site news']\n",
      "['medscapelive symposium', 'recent clinicaldata amp', 'future directions', 'small molecule therapies', 'cll w', 'experts register']\n",
      "['jul creole', 'chronic lymphocytic leukemia', 'cancer treatment', 'peter jaret chemotherapy radiation', 'cancer treatments']\n",
      "['bearish list', 'trg cll ctp ehg', 'num fsta pson']\n",
      "['treatment approaches', 'chronic lymphocytic leukemia']\n",
      "['busy scheduling interviews', 'cll experts', 'coverage lymsm']\n",
      "['combination therapy', 'chronic lymphocytic leukemia cancernews']\n",
      "['safety ax r r cll diarrheoa fatigue infection', 'neutropenia trend', 'time prevalence htn inc aes grt dose', 'permanent discont', 'similar msg', 'recent resonate update', 'non trial data blooducation']\n",
      "['chronic lymphocytic leukemia updates']\n",
      "['bone marrow', 'acute lymphoblastic leukemia', 'acute myeloid leukemia', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia updates']\n",
      "['presse detail', 'kml videoberichte vom eha24 sind jetzt online darin aktuelle informationen zu cll multiplesmyelom car t zellen inhl anhl sowie ein gru wort von']\n",
      "['dr jennifer', 'brown dr bruce d cheson', 'dr susan o brien', 'refractory cll cll']\n",
      "['prof dr michael hallek wurde der jos carreras', 'f r seine beeindruckende arbeit im bereich der cll berreicht gute news f r', 'patienten durch seine forschung k nnen neue erfolgsversprechende behandlungsmethoden entwickelt werden herzlichen gl ckwunsch']\n",
      "['video venetoclax obinutuzumab combination improves outcomes', 'treatment naive chronic lymphocytic leukemia asco2019 leukemia oncology']\n",
      "['arql s arq', 'phase i data', 'competitor snss sns', 'benefit differentiations', 'b cell cancer patients', 'imbruvica eha19']\n",
      "['protoporphyrin ix', 'dual inhibitor', 'p53 mdm2', 'p53 mdm4 interactions', 'induces apoptosis', 'b cell chronic lymphocytic leukemia cells']\n",
      "['manager e5 venclexta chronic lymphocytic leukemia cll genentech', 'san francisco ca experience', 'care pharmaceutical', 'biotech bayarea biotech']\n",
      "['gt gt cllsm leusm hematology']\n",
      "['full room', 'healthy debate', 'treatment approaches', 'cll share', 'salles simon', 'ulrich yager tuesday']\n",
      "['eha24 cll ibrutinib phase iii study cll12', 'interesting results']\n",
      "['b cell chronic lymphocytic leukemia pipeline review h1']\n",
      "['trial results', 'asco19 show', 'free combination', 'chronic lymphocytic leukemia']\n",
      "['clinicaltrial data', 'minimal residual disease', 'w philip', 'medscapeedu hemonc medtwitter']\n",
      "['gerionc geriheme cll cllsm ibrutinib venetoclax chemofree']\n",
      "['line oral regimen', 'high risk', 'chronic lymphocytic leukemia', 'open label phase ii trial leukemia bloodcancer']\n",
      "['time i', 'work anxiety', 's blood anxiety', 'matt s leukaemia tests', 'royal marsden', 'leukaemia cll bloodcancer']\n",
      "['early intervention', 'new agents', 'hot topic', 'ibrutinib group os data']\n",
      "['lung cancer', 'chronic lymphocytic leukemia i', 'happy father s day dad']\n",
      "['duration venetoclax', 'obinutuzumab veng', 'free survival pfs', 'minimal residual disease negativity mrd', 'patients pts', 'chronic lymphocytic leukemia cll']\n",
      "['cll treatment', 'times tweet', 'symposium eha24 leusm prof john seymour', 'prof stephan stilgenbauer', 'uni prof']\n",
      "['cll treatment', 'cll14 venetoclax obinutuzumab', 'cll w prof stephan stilgenbauer']\n",
      "['cll treatment', 'cll w prof john seymour']\n",
      "['cll treatment', 'resonate ibrutinib vs ofatumumab', 'notable aes w prof john seymour']\n",
      "['cll treatment', 'resonate ibrutinib vs ofatumumab', 'cll sll w prof john seymour']\n",
      "['cll treatment', 'alliance a041202 itt population response rates', 'mrd w dr']\n",
      "['cll treatment', 'e1912 ibrutinib rituximab vs fcr study design w dr']\n",
      "['cll treatment', 'cll10 fcr vs br', 'front line w dr']\n",
      "['fantastic metaphor', 'cll lymph node', 'educational session eha24 eha2019 f1', 'cll biology']\n",
      "['eha24 ibrutinib', 'asymptomatic cll']\n",
      "['perfekt presentation', 'dear colleague petra langerbeins', 'early stage asymptomatic cll', 'efs pfs amp ttnt', 'similar rates', 'fib amp hypertension']\n",
      "['immunosuppressive treg cells', 'effector t cells', 'chronic lymphocytic leukemia patients']\n",
      "['phase iii murano trial', 'new treatment option', 'refractory chronic lymphocytic leukemia bloodcancer hematology']\n",
      "['las mejores', 'lo largo del desarrollo del torneo hoy lo coronaron', 'tuyucua felicitaciones', 'las chicas', 'libertad limpe o por este logro que sea el primero', 'muchos vamosguma lasgumarelas cll']\n",
      "['own chief resident intracytoplasmic crystalline inclusions', 'chronic lymphocytic leukemia ramlal clinical case reports wiley online library']\n",
      "['final vuelta cll vs cdc fiiinaaaaalll somos campeonas del torneo apertura', 'unidasporelobjetivo cllpy']\n",
      "['final vuelta cll vs cdc', 'ingresa noelia barros por fabiola sandoval unidasporelobjetivo cllpy']\n",
      "['final vuelta cll vs cdc', 'unidasporelobjetivo cllpy']\n",
      "['final vuelta cll vs cdc', 'unidasporelobjetivo cllpy']\n",
      "['final vuelta cll vs cdc', 'unidasporelobjetivo cllpy']\n",
      "['final vuelta cll vs cdc', 'ingresa ang lica v zquez por liz pe', 'unidasporelobjetivo cllpy']\n",
      "['final vuelta cll vs cdc', 'unidasporelobjetivo cllpy']\n",
      "['final vuelta cll vs cdc inici', 'segunda etapa', 'unidasporelobjetivo cllpy']\n",
      "['final vuelta cll vs cdc', 'primera etapa', 'unidasporelobjetivo cllpy']\n",
      "['final vuelta cll vs cdc', 'unidasporelobjetivo cllpy']\n",
      "['final vuelta cll vs cdc', 'unidasporelobjetivo cllpy']\n",
      "['final vuelta cll vs cdc partido', 'unidasporelobjetivo cllpy']\n",
      "['final vuelta cll vs cdc equipo confirmado alicia bobadilla carmen ben tez laurie cristaldo paola genes stephenie lacoste joana galeano griselda garay damia cortaza fabiola sandoval karina vega liz pe', 'unidasporelobjetivo cllpy']\n",
      "['past year', 'father son duo', 'darryl s diagnosis', 'chronic lymphocytic leukemia', 'darryl s story']\n",
      "['eha24 lymsm', 'cancer incidence', 'cll patients', 'btk inhibitors']\n",
      "['eha24 lymsm infections', 'cll patients']\n",
      "['cll abbvie', 'active post venetoclax r']\n",
      "['cll updates', 'cll registration', 'iwcll19 sept', 'edinburgh scotland']\n",
      "['line treatment', 'chronic lymphocytic leukemia', 'novel agents', 'poster sessions', 'afternoon cllsm nkrdata leusm eha24']\n",
      "['eha24 lymsm efficacy', 'cll patients', 'r venetoclax', 'murano trial', 'mdor 15m']\n",
      "['new directions', 'chronic lymphocytic leukemia care', 'treatment guideline updates']\n",
      "['advocacy sessions', 'hematology emotional impact', 'financial impact', 'acute leukaemia aml']\n",
      "['eha24 lymsm', 'emotional impact', 'cll leusm']\n",
      "['eha24 di rilievo', 'chi si occupa di cll il commento di francesca mauro fama83 amadori g']\n",
      "['fantastic work', 'miguel quijada lamo', 'cll dual btk', 'parp inhibition eha24']\n",
      "['saskia rudat', 'cll eha24', 'new biological', 'translational insights session']\n",
      "['free survival time', 'chronic lymphocytic leukemia', 'chlorambucil asco19 bloodcancers']\n",
      "['topps cactus league legends cll', 'insert rockies noreserve baseballcards mlb topps toppsbaseball baseball sports cardcollection cardcollector']\n",
      "['cll clinical trial ifcr updates btw', 'trial i m', 'alive amp']\n",
      "['interesting analysis', 'cll patient s immunocompetence']\n",
      "['ready eha24 eha2019 infectious complications']\n",
      "['cll genetics', 'amp cll']\n",
      "['hematology eha24', 'amazing work', 'cll science', 'young investigators', 'youngeha kudos']\n",
      "['new research', 'bloodcancers rt', 'cll aml']\n",
      "['irak4 disrupts inflammatory pathways', 'delays tumor development', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia amp', 'exciting developments', 'cancer treatment', 'decade car t ntfm believeinscience sfi']\n",
      "['ibrutinib activity', 'cll patients', 'rituximab eha24 hematology']\n",
      "['fire study rwd', 'french cll patients', 'ibrutinib eha24 hematology']\n",
      "['long term safety', 'agent ibrutinib', 'chronic lymphocytic leukemia', 'pivotal studies']\n",
      "['ibrutinib discontinuation', 'refractory chronic lymphocytic leukemia', 'compassionate use program', 'polish adult leukemia study group palg lymphoma lymsm']\n",
      "['agents aes', 'c481s amp plcg2 mutants etc arql']\n",
      "['dutch population', 'line treatment', 'novel agents', 'poster sessions', 'afternoon cllsm nkrdata leusm']\n",
      "['great day', 'kirsten fischer', 'cll14 trial', 'protocol clinicaltrials leukemia leusm cll']\n",
      "['rai amsterdam visit', 'world s', 'academic drone experience', 'new heights', 'cll victoriesovercancer']\n",
      "['major attractives']\n",
      "['education session', 'speakers r houlston', 't robak']\n",
      "['epa senators reps']\n",
      "['dr davids discusses', 'transcend cll', 'phase i ii trial', 'car t cell therapy liso cel', 'refractory chronic lymphocytic leukemia cllsm leukemia']\n",
      "['dr jacqueline c barrientos', 'monotherapy vs combination therapy northwell health hematologicmalignancies cll leukemia']\n",
      "['investigator s perspective', 'chronic lymphocytic leukemia research front']\n",
      "['esther schorr', 'friend jeff folloder cll clltreatment livewell patientpower']\n",
      "['investigator s perspective', 'chronic lymphocytic leukemia research front']\n",
      "['therapeutic spectrum', 'chronic lymphocytic leukemia']\n",
      "['obinutuzumab use', 'eha24 hematology oncology']\n",
      "['monsanto roundup cancer lawsuits charge', 'glyphosate causes cancer non hodgkin lymphoma nhl chronic lymphocytic leukemia cll', 'sub types']\n",
      "['real time online training', 'world class learning', 'interactive experience', 'new convenient ways', 'regulatory training']\n",
      "['cathy skinner', 'tight muscles increases flexibility balance', 'joints cll myeloma livewell patientpower']\n",
      "['eha2019 amsterdam', 'trial updates', 'new novel treatments', 'car t']\n",
      "['new directions', 'chronic lymphocytic leukemia care', 'treatment guideline updates']\n",
      "['clemens martin wendtner', 'fludarabine cyclophosphamide amp rituximab', 'drugs leusm']\n",
      "['new research online', 'eha24 ibrutinib', 'fludarabine cyclophosphamide amp rituximab', 'line treatment', 'fit patients w chronic lymphocytic leukaemia', 'multicentre phase', 'trial cll leusm']\n",
      "['plenary session kirsten fischer', 'duration venetoclax obinutuzumab', 'chronic lymphocytic leukemia lymsm']\n",
      "['tcell exhaustion disfunctional immuesynapsis cll eha24 eha19']\n",
      "['neues im newsletterepignetik f r alle', 'sich f r', 'epigenetik von krebs interessierern leuk mie cll das abo ist kostenlos']\n",
      "['eha24 cll cartcell maloney ibrutinib', 'robust expansion']\n",
      "['eradicate disease', 'cll peter hillmen', 'rapid developments', 'cll treatment landscape', 'full video', 'gt gt lt lt eha24 hematology cllsm leusm mrd']\n",
      "['cll eha24 maloney', 'car t cell therapy decreases crs', 'improves responses']\n",
      "['brilliant presentation', 'car nk cells', 'dr karadimitris', 'uk eha24 bench', 'shelf cars']\n",
      "['interesting data', 'specific car t cells', 'concurrent ibrutinib', 'r r cll', 'dr maloney', 'crs grade', 'ibrutinib cohort cc']\n",
      "['fda approves venetoclax', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['final cll presentation', 'car t trial', 'patients response', 'good deep mrd negativity', 'new drug developments', 'average patient age']\n",
      "['eha24 lymsm gimema llc1114 study ibrutinib', 'front line treatment', 'unfit cll patients gerionc geriheme']\n",
      "['new study identifies patterns', 'chronic lymphocytic leukemia science amp technology research news']\n",
      "['u s', 'frontline cll', 'duration therapy', 'oral therapy ibrutinib patient comorbidities', 'side effect profiles']\n",
      "['lr arql update', 'partial responses prs', 'chronic lymphocytic leukemia cll patients', 'c481s mutation c481sm', '65mg qd', 'medacorp kols']\n",
      "['jos carreras awardee', 'current state', 'cll chronic lymphocytic leukaemia hematology', 'amsterdam eha24 eha2019 hematology']\n",
      "['prof hallek outlines', 'optimal cll therapy', 'eha24 eha2019']\n",
      "['nice compliment', 'project caseload', 'fact i ve', 'w leukemia']\n",
      "['penultimate presentation', 'cll session argues', 'mrd negativity', 'only need']\n",
      "['vision ho141 trial', 'initial data', 'arnon kater', 'eha24 cll', 'rr cll', 'short fup curve wt high response', 'vision wt i v', '1st line']\n",
      "['ibrutinib patients', 'years shows', 'patients eha24 cll']\n",
      "['congress eha24 alessandra tedeschi asst grande ospedale metropolitano niguarda', 'front line cll lymsm']\n",
      "['t cell bispecific antibody combination immunotherapy', 'chronic lymphocytic leukemia', 'kings college london lectures publiclectures lectureslondon']\n",
      "['congress eha24 othman', 'prospective analysis', 'cll14 trial frontline treatment', 'adverse prognosis', 'complex karyotpye', 'chronic lymphocytic leukemia lymsm cll']\n",
      "['pts behave', 'different genetic markers cristof scneider', 'german cll group', 'eha24 cll']\n",
      "['poster pf360', 'drug sensitivity screens', 'afternoon eha24 eha2019 precisionmedicine']\n",
      "['fischer introduction', 'duration chemo', 'free therapy', 'comorbidities s149 eha24 cll14 md']\n",
      "['nuclear power cancer cancersucks survivor cancersurvivor cancerhumor cll leukemia lls lymphoma fightcancer chronicillness disease']\n",
      "['new study identifies patterns', 'chronic lymphocytic leukemia science amp technology research news']\n",
      "['amp ireland s cll community', 'eha2019 eha24', 'news amp', 'new learnings', 'community frm amsterdam', 'days thanks hematology', 'bloodcancer advocate voices']\n",
      "['chronic lymphocytic leukemia']\n",
      "['cll patients survivors', 'care partners', 'informative meeting registration', 'free knowledge', 'power wisdom cll cancer patientpower']\n",
      "['dr john m pagel', 'cll project', 'appropriate treatment selection']\n",
      "['cll chemotherapy', 'free regimen']\n",
      "['simple blood tests', '1st lt eric anderson sr', 'donate blood anderson', 'blood tests amp', 'diagnose chronic lymphocytic leukemia', 'story amp', 'lab tests']\n",
      "['cll susan o brien']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['bloodcancer check', 'focus areas eha24 cll aml']\n",
      "['decision making', 'cll w paolo ghia', 'biomarkers eha24 hematology']\n",
      "['carol moreno', 'del17p tp53 cll eha24 eha2019 cll']\n",
      "['line therapy', 'cll wojciech jurczak', 'expert opinion', 'eha24 lymsm']\n",
      "['paolo ghia', 'prognostic markers', 'therapy decisions eha24 eha2019']\n",
      "['medio paso', 'consagraci n tremendo triunfo', 'las gumarelas', 'libertad limpe o', 'final femenina kari liza y griselda marcaron para dejar', 'definici n falta poco pero todav', 'falta vamos por todo cll lasgumarelas']\n",
      "['cll experts', 'friends peter hillmen amp paolo ghia hematology leusm cllsm hemonc']\n",
      "['busy s', 'morning ulrich j ger wien amp david maloney', 'car t insights', 'lymphoma hematology hemonc cllsm leusm lymsm immunoonc']\n",
      "['early data', 'car t', 'preliminary hints', 'concurrent ibrutinib', 'mix cll clls letscurethis']\n",
      "['toleropharmaceuticals announces', 'investigational agent tp0903']\n",
      "['human medicines european', 'public assessment report epar truxima rituximab lymphoma non hodgkin arthritis rheumatoid wegener granulomatosis leukemia lymphocytic chronic b cell microscopic polyangiitis date']\n",
      "['great speaking', 'cll cart updates don t', 'year s hematology meeting bookmark eha24 eha2019 cllsm leusm leukemia']\n",
      "['secondary b cell lymphoma', 'epstein barr virus', 'chronic lymphocytic leukemia patients lymphoma lymsm']\n",
      "['s time', 'rai amsterdam visit', 'world s', 'academic drone experience', 'new heights', 'cll victoriesovercancer']\n",
      "['chronic lymphocytic leukemia idiots', 'immune system', 'stupid box']\n",
      "['tolero pharmaceuticals announces', 'investigational agent tp', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['medical bills', 'available options cll medicalbills livewell patientpower']\n",
      "['cll community']\n",
      "['final ida cdc vs cll', 'st gooooooooooooolllll griselda garay', 'cllpy unidasporelobjetivo']\n",
      "['final ida cdc vs cll', 'st gooooooooooooolllll liza larrea marca el segundo', 'cllpy unidasporelobjetivo']\n",
      "['final ida cdc vs cll', 'cllpy unidasporelobjetivo']\n",
      "['final ida cdc vs cll', 'cllpy unidasporelobjetivo']\n",
      "['final ida cdc vs cll', 'cllpy unidasporelobjetivo']\n",
      "['final ida cdc vs cll goooool karina vega', 'cllpy unidasporelobjetivo']\n",
      "['final ida cdc vs cll', 'cllpy unidasporelobjetivo']\n",
      "['final ida cdc vs cll', 'cllpy unidasporelobjetivo']\n",
      "['transcend cll', 'trial treatment', 'liso cel', 'encouraging results', 'refractory chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'liso cel', 'car t therapies']\n",
      "['final ida cdc vs cll', 'cllpy unidasporelobjetivo']\n",
      "['final ida cdc vs cll', 'cllpy unidasporelobjetivo']\n",
      "['final ida cdc vs cll', 'cllpy unidasporelobjetivo']\n",
      "['final ida cdc vs cll partido', 'cllpy unidasporelobjetivo']\n",
      "['new data', 'dose modifications', 'refractory cll sll', 'saturday june', 'cll pi3k leusm']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['dr paul m barr', 'asco19 asco2019 chroniclymphocyticleukemia cll lymphoma lymsm']\n",
      "['new study identifies patterns', 'chronic lymphocytic leukemia']\n",
      "['medscapelive symposium', 'experts explore', 'treatment options']\n",
      "['cll treatment news car t cell therapy liso cel']\n",
      "['research projects', 'cll mm mds nhl ju h2020 bigdata hematology']\n",
      "['new research', 'final results', 'destiny trial', 'tki therapy', 'complete treatment discontinuation', 'free remission', 'chronic myeloid leukaemia cll leusm']\n",
      "['uses conimab 500mg injection', 'certain types', 'non hodgkin s lymphoma chronic lymphocytic leukemia', 'cancer cells pharmaceuticalmedicine rsp']\n",
      "['uses conimab 100mg injection', 'certain types', 'non hodgkin s lymphoma chronic lymphocytic leukemia', 'cancer cells pharmaceuticalmedicine rsp']\n",
      "['verastem team', 'eha24 congress', 'clinical trials cll lymsm leusm']\n",
      "['excellent article cll cllsm ibrutinib']\n",
      "['dr davids', 'transcend cll', 'phase i ii trial', 'car t cell therapy liso cel', 'refractory chronic lymphocytic leukemia cllsm leusm']\n",
      "['real world treatment patterns', 'adverse events', 'health care costs', 'cll leukemia cancer']\n",
      "[]\n",
      "['rod humerickhouse md', 'duration venetoclax', 'obinutuzumab veng', 'free survival check', 'cll asco19 chroniclymphocyticleukemia patients']\n",
      "['post chemo', 'don t', 'cancer survivor leukemia cll lymphoma cancersucks fightcancer cancer humor humorfightscancer lls chronicillness chronic']\n",
      "['video duo trial duvelisib', 'cll sll', 'ian flinn', 'tenessee oncology nashville asco19 chroniclymphoidleukemia smalllymphocyticlymphoma leukemia immunoonc hemeonc leusm']\n",
      "['geographic tongue', 'chronic lymphocytic leukemia']\n",
      "['great work', 'cancer relate', 'growth dynamics', 'chronic lymphocytic leukemia cll']\n",
      "['philip baldwin', 'prof paul moss', 'new treatments', 'chronic lymphocytic leukemia wearebrumalum mds']\n",
      "['drg epidemiology report estimates', 'western europe', 'global reports', 'cll leukemia chronic lymphocyticleukemia asco19']\n",
      "['while i', 'amandavscancer kickcancerinthedick cancer cancersurvivor cancerawareness leukemia leukemiaandlymphomasociety chroniclymphocyticleukemia cll smalllymphocyticlymphoma sll']\n",
      "['molecular analysis', 'novel btk mutations', 'plcg2 variants']\n",
      "['video updates', 'trial kte x19', 'r r cll', 'ian flinn', 'tennessee oncology nashville asco19 chroniclymphocyticleukemia immunoonc hemeonc leusm']\n",
      "['multidisciplinary project aims', 'educate physicians patients', 'cll care', 'community cancer centers', 'multidisciplinary chronic lymphocytic leukemia care education project cll cllsm']\n",
      "['cll folks patterns', 'chronic lymphocytic leukemia growth', 'broad institute']\n",
      "['sept edinburg scotland press registration']\n",
      "['cll patients', 'care partner', 'leusm cllsm']\n",
      "['cll community', 'effort nick brian']\n",
      "['treatment algorithm', 'cll14 trial', 'kirsten fischer', 'colleagues lymsm']\n",
      "['chronic lymphocytic leukemia', '17p deletion', 'short report']\n",
      "['rns aim cll cello health plc total']\n",
      "['uses mercaptopurine', 'autoimmune diseases', 'acute lymphocytic leukemia', 'chronic myeloid leukemia cml crohn s disease', 'ulcerative colitis pharmaceuticalmedicine rsp']\n",
      "['prognostic significance', 'microrna 34a', 'han patients', 'chronic lymphocytic leukemia', 'xinjiang uygur autonomous region']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['treatment decisions', 'chronic lymphocytic leukemia']\n",
      "['libertad limpe o est', 'final enorme torneo', 'las gumarelas que las deja', 'un paso m s', 'con el premio', 'campe n ahora vamos por todo vamosguma cll']\n",
      "['chronic lymphocytic leukemia']\n",
      "['semifinal vuelta cll vs ccp', 'unidasporelobjetivo cllpy']\n",
      "['semifinal vuelta cll vs ccp', 'unidasporelobjetivo cllpy']\n",
      "['semifinal vuelta ccp vs cll', 'unidasporelobjetivo cllpy']\n",
      "['semifinal vuelta ccp vs cll', 'unidasporelobjetivo cllpy']\n",
      "['semifinal vuelta ccp vs cll', 'unidasporelobjetivo cllpy']\n",
      "['semifinal vuelta ccp vs cll segundo tiempo', 'unidasporelobjetivo cllpy']\n",
      "['semifinal vuelta ccp vs cll', 'primera etapa', 'unidasporelobjetivo cllpy']\n",
      "['semifinal vuelta ccp vs cll', 'unidasporelobjetivo cllpy']\n",
      "['semifinal vuelta ccp vs cll', 'unidasporelobjetivo cllpy']\n",
      "['semifinal vuelta ccp vs cll', 'unidasporelobjetivo cllpy']\n",
      "['semifinal vuelta ccp vs cll', 'unidasporelobjetivo cllpy']\n",
      "['semifinal vuelta ccp vs cll', 'unidasporelobjetivo cllpy']\n",
      "['semifinal vuelta ccp vs cll partido', 'unidasporelobjetivo cllpy']\n",
      "['semifinal vuelta ccp vs cll equipo confirmado alicia bobadilla carmen ben tez laurie cristaldo paola genes stephenie lacoste joana galeano griselda garay damia cortaza fabiola sandoval karina vega liz pe', 'unidasporelobjetivo cllpy']\n",
      "['line treatment', 'chronic lymphocytic leukemia cll ibrutinib mechanism', 'acton venetoclax mechanism']\n",
      "['emergent literacy links', 'eye units', 'cll stories storytime literacy eytwittertagteam eymatters']\n",
      "['making sense', 'treatment genetic research', 'available support town meeting', 'cll experts', 'important car t cell therapy', 'cll click']\n",
      "['german group', 'cll guidelines cll']\n",
      "['brief interview dr weirda', 'phase iii murano trial', 'new treatment option', 'refractory chronic lymphocytic leukemia leusm leukemias']\n",
      "['cll14 trial fischer', '1l treatment algorithm', 'cll patients i', 'hovon nordic cll group amp gcllsg', 'invaluable input']\n",
      "['great summary', 'things cll insightful thread']\n",
      "['chronic lymphocytic leukemia', 'fludarabine treatment medivizor']\n",
      "['excellent presentation', 'floyd hasenr ck', 'friday lab meeting', 'dept i', 'internal medicine', 'performs chemico genetic investigations', 'pi3k inhibitors', 'hematopoietic cells leukemia k ln cll']\n",
      "['nice visual summary', 'recent report', 'cll14 study cll leukemia gcllsg stunde asco19']\n",
      "['cll treatment', 'prof john seymour', 'patient cases', 'novel therapeutic options']\n",
      "['leukemia drug info fda cll car t leusm medtwitter', 'medstudent asco19']\n",
      "['chronic lymphocytic leukemia', 'ibrut leukemia']\n",
      "['chronic lymphocytic leukemia', 'ighv mutation']\n",
      "['chronic lymphocytic leukemia cll care', 'patients work', 'suitable treatment', 'expert dr wierda']\n",
      "['chronic lymphocytic leukemia']\n",
      "['dr barrientos', 'chronic lymphocytic leukemia cancertreatment bloodcancer']\n",
      "['full house']\n",
      "['chronic lymphocytic leukemia', 'zanubrutinib compa']\n",
      "['cll patients', 'healthcare team', 'financial distress tune']\n",
      "['clinicaltrial data', 'minimal residual disease', 'w philip', 'medscapeedu hemonc medtwitter']\n",
      "['bcl2 inhibitor venetoclax', 'chronic lymphocytic leukemia']\n",
      "['cll expert dr david maloney', 'long cll treatments']\n",
      "['great work eps i ll', 'blood cancers', 'chronic lymphocytic leukemia', 'little guy', 'cancer leukemia police']\n",
      "['dna bindin', 'stat3 kat p300 oncotarget', 'human stat3 stat3', 'chronic lymphocytic leukemia cells']\n",
      "['rod humerickhouse md', 'minimal residual disease negativity check', 'cll asco19 leukemia']\n",
      "['young patient', 'refractory cll w jacqueline barrientos', 'feinstein institute', 'medical research lymphoma prognosis cancertherapy overallsurvival']\n",
      "['friends huh', 'vtes terms cll', 'malkavian sneak amp', 'friends damn', 's bullshit oh hey', 'yea good idea']\n",
      "['discussion dr burke', 'treatment options', 'chronic lymphocytic leukemia', 'clinical decisions bloodcancer hematology']\n",
      "['duration venetoclax', 'obinutuzumab veng', 'free survival pfs', 'minimal residual disease negativity mrd', 'patients pts', 'chronic lymphocytic leukemia cll']\n",
      "['mayo clinic labs curtis hanson m d', 'prognostic markers', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['forscher des haben herausgefunden dass f r', 'entstehung der cll einer h ufigen form von blutkrebs neben dna mutationen auch fehlerhafte epigenetische signale verantwortlich sind krebsforschung']\n",
      "['refractory cll']\n",
      "['study reports ibrutinib', 'venetoclax combo', 'front line therapy', 'select chronic lymphocytic leukemia patients']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['cancer cancer', 'hobby cancer survivor leukemia lymphoma cancersucks fightcancer cancerhumor cll lls laughterasmedicine chronic illness']\n",
      "['80th birthday', 'cll s copyright guru', 'counsel richard dannay', 'offices services manager francisco gonzalez', 'happy birthday richard', 'happy birthday cisco happylawyers happypeople cll 80years 50years']\n",
      "['mir 15a', 'chronic lymphocytic leukemia']\n",
      "['heme malignancies faculty promotion', 'full professor', 'cll expert jennifer']\n",
      "['severe fatigue', 'cancer patients', 'exhaustion tune', 'michele nadeem baker shares triggers', 'fatigue cancerfatigue cll fatigue patientpower']\n",
      "['new data', 'cll therapy', 'exciting times']\n",
      "['k lner krebsforscher stellt wegweisende ergebnisse zur leuk mie behandlung vor cll twankenhaus']\n",
      "['new visualabstract', 'chronic lymphocytic leukemia']\n",
      "['catherine j wu md', 'growth patterns', 'chronic lymphocytic leukemia']\n",
      "['global chronic lymphocytic leukemia clinical trial pipeline highlights', 'market report']\n",
      "['chronic lymphocytic leukemia']\n",
      "['abbv abbvie reports recommendation', 'pan canadian oncology drug review expert review committee', 'combo venclexta', 'chronic lymphocytic leukemia']\n",
      "['exciting times']\n",
      "['cll community', 'sage advice']\n",
      "['chlorambucil chop f cvp etc', 'survival benefit', 'chlorambucil amp obinutuzumab illumina trial summary', 'cll leukemia leusm']\n",
      "['academic group', 'chlorambucil amp obinutuzumab', 'active regimen', 'cll patients', 'goede nejm', 'general practice']\n",
      "['video mrd decision making', 'susan o brien', 'asco19 leukemia chroniclymphocyticleukemia cllsm leusm hemeonc']\n",
      "['different eras', 'new era', 'chemofree era', 'stateofscience hematology']\n",
      "['particular dreams', 'goals goals', 'actions actions', 'achievements worldjuniors cll teamcanada raidernation rmll ala', 'alwaysanaxemen rollpride gomocs']\n",
      "['infinite c b d oil i hope', 'chronic lymphocytic leukemia', 'mellow amp']\n",
      "['dr rokeer', 'real world data']\n",
      "['retweet expert access', 'expert cll physician', 'new enroll', 'myexpertaccess cll cllsm letscurethis']\n",
      "['chronic lymphocytic leukemia', 'induction chemoimmu']\n",
      "['semifinal ida ccp vs cll finaaaaal', 'unidasporelobjetivo cllpy']\n",
      "['semifinal ida ccp vs cll', 'unidasporelobjetivo cllpy']\n",
      "['semifinal ida ccp vs cll', 'unidasporelobjetivo cllpy']\n",
      "['semifinal ida ccp vs cll', 'unidasporelobjetivo cllpy']\n",
      "['semifinal ida ccp vs cll', 'unidasporelobjetivo cllpy']\n",
      "['semifinal ida ccp vs cll', 'unidasporelobjetivo cllpy']\n",
      "['semifinal ida ccp vs cll', 'unidasporelobjetivo cllpy']\n",
      "['semifinal ida ccp vs cll inici el st', 'unidasporelobjetivo cllpy']\n",
      "['semifinal ida ccp vs cll', 'final del pt', 'unidasporelobjetivo cllpy']\n",
      "['semifinal ida ccp vs cll', 'unidasporelobjetivo cllpy']\n",
      "['semifinal ida ccp vs cll', 'liz pe', 'unidasporelobjetivo cllpy']\n",
      "['semifinal ida ccp vs cll', 'unidasporelobjetivo cllpy']\n",
      "['sharman feeling', 'collaborative group']\n",
      "['semifinal ida ccp vs cll', 'unidasporelobjetivo cllpy']\n",
      "['ibrutinib dose interruptions', 'long term outcomes']\n",
      "['semifinal ida ccp vs cll equipo confirmado alicia bobadilla carmen ben tez laurie cristaldo paola genes stephenie lacoste joana galeano griselda garay damia cortaza fabiola sandoval karina vega liz pe', 'unidasporelobjetivo cllpy']\n",
      "['cll nejm']\n",
      "['health professionals', 'treatment amp care', 'lymphomamanagement gt lymsm cll']\n",
      "['new research', 'line treatment', 'chronic lymphocytic leukemia cll']\n",
      "['moment asco', 'lymphoma hub coverage', 'convenience click', 'slides expert interviews', 'lymphoma cll lymsm']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['combination therapy', 'cll research', 'leukemia medtwitter']\n",
      "['r sultats', 'l tude cll14 valuant un traitement sans chimioth rapie base', 'venetoclax abbvie', 'premi re ligne', 'llc pr', 's l asco2019', 'publi s dans', 'new england journal']\n",
      "['lion s', 'lab cll epigenetics cancerevolution']\n",
      "['cll spanish guidelines']\n",
      "['pivotal phase iii cll14 results', 'new england journal', 'medicine ro']\n",
      "['chronic lymphocytic leukemia cells lymphoma lymsm']\n",
      "['roche reports results', 'venclexta venclyxto venetoclax', 'p iii cll14 study', 'chronic lymphocytic leukemia asco2019 rhhby']\n",
      "['pivotal phase iii cll14 results', 'chronic lymphocytic leukemia', 'new england journal']\n",
      "['cll medtwitter']\n",
      "['cll congratulations dr pinilla ibarz', 'landmark trail']\n",
      "['cll abstract']\n",
      "['parab ns e dem', 'chus por esta publicaci n', 'germline variants', 'chronic lymphocytic leukemia outcome suggests', 'novel genes', 'clinical evolution']\n",
      "['gtxi interim data', 'oncternal therapeutics study', 'chronic lymphocytic leukemia', 'blood cancer', 'overall response rate']\n",
      "['chronic lymphocytic leukemia', 'important advances']\n",
      "['line treatment option', 'cll genetech abbvie venclexta gazyva obinutuzumab earlyline cll', 'promising combination chemofree']\n",
      "['neue chemotherapiefreie kombinationstherapie erfolgreich bei unbehandelter cll neue wissenschaftliche ver ffentlichung zu cll14 studie uniklinik k ln krebs asco19 cgcllsg']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['wonderful team', 'important step', 'cll patients gcllsg']\n",
      "['kirsten fischer', 'excellent amp', 'elegant presentation', 'cll14 trial', 'asco19 conference', 'cll gcllsg']\n",
      "['cancer victims optical illusions cancer cancerhumor survivor leukemia lymphoma cancersucks fightcancer chemo cll cancersurvivor']\n",
      "['important trial', 'cll patient population', 'innovative therapies asco19']\n",
      "['dr kanti rai', 'veteran oncologist', 'chronic lymphocytic leukemias ascodailynews asco2019 asco conference chicago conference meetingofminds iaca dinner gaylords']\n",
      "['vast majority', 'post therapy', 'typical medical incidents', 'elderly patient population', 'relevant comorbidity', 'narratives cll']\n",
      "['excellent article cll cllsm']\n",
      "['ven obi', 'prospective multicenter clinicaltrial', 'cll patients']\n",
      "['clinical trial shows', 'encouraging results', 'chronic lymphocytic leukemia amp mantle cell lymphoma']\n",
      "['asco19 cll cll']\n",
      "['chronic lymphocytic leukemia cll', 'news asco19 cll']\n",
      "['venetoclax obinutuzumab', 'venetoclax ibrutinib', '1l cll', 'haematologists version', 'messi vs ronaldo debate', 'amazing times', 'cll blooducation cll14 cllsm']\n",
      "['duration venetoclax obinutuzumab vs chl o', 'pts median age 72y median cirs g', 'pfs hr', 'high risk cll', 'os benefit', 'short 3m post rx mrd ve pb', 'congrats colleagues blooducation']\n",
      "['chronic lymphocytic lymphoma leukemia', 'colon note', 'aberrant cd5 expression', 'b cells']\n",
      "['new study identifies', 'genetic changes', 'chroniclymphaticleukemia development', 'growth pattern', 'cll cells']\n",
      "['congress asco19', 'full morning', 'oral sessions', 'opinion round']\n",
      "['dr richard r furman md discusses novel treatment options', 'cll check', 'weill cornell medicine leukemia cll hematologic malignancies treatment chroniclymphocyticleukemia']\n",
      "['asco19 cognitive function', 'chronic lymphocytic leukemia bloodcancer brainhealth']\n",
      "['risk score predicts atrial fibrillation', 'ibrutinib therapy', 'chronic lymphocytic leukemia']\n",
      "['frontline cll unfit patients time', '2y high mrd negativity', 'venetoclax ibrutinib asco19']\n",
      "['venetoclax obinutuzumab combo frontline cll']\n",
      "['pivotal data', 'treatment combination', 'chronic lymphocytic leukemia', 'nejm rog rhhby']\n",
      "['venetoclax chemotherapy', 'free combination regimen', 'chronic lymphocytic leukemia']\n",
      "['pivotal phase iii cll14 results', 'chronic lymphocytic leukemia', 'new england journal']\n",
      "['asco19 davies', 'lymsm amp cllsm session', 'prognostic risk score', 'r r cll']\n",
      "['venetoclax chemotherapy', 'free combination regimen']\n",
      "['pivotal phase iii cll14 results', 'chronic lymphocytic leukemia']\n",
      "['cll asco2019 cll']\n",
      "['celg bmy asco19 lymsm leusm cll']\n",
      "['venetoclax chemotherapy', 'free combination regimen', 'chronic lymphocytic leukemia abbv abbv']\n",
      "['chronic lymphocytic leukemia cll venetoclax', 'remarkable efficacy', 'cll asco19']\n",
      "['abbv genentech', 'venetoclax chemotherapy', 'free combination regimen', 'chronic lymphocytic leukemia']\n",
      "['free combination', 'chronic lymphocytic leukemia cll', 'common type', 'adult leukemia']\n",
      "['abbv abbvie', 'venetoclax chemotherapy', 'free combination regimen', 'chronic lymphocytic leukemia']\n",
      "['rhhby press release', 'pivotal phase iii cll14 results', 'chronic lymphocytic leukemia', 'new england journal']\n",
      "['hematologic malignancies lymphoma amp chronic lymphocytic leukemia co', 'nancy bartlett md', 'room e451 abstract asco19']\n",
      "['duration vs', 'continuous treatment', 'drs danielle m brander amp jacqueline c barrientos', 'fit patients', 'btki therapy']\n",
      "['congress asco19 jacqueline claudia barrientos', 'mornings lymphoma session', 'duration frontline chemoimmunotherapy', 'chronic lymphocytic leukemia lymsm lymphoma']\n",
      "['anxiety anger fatigue depression', 'emotions symptoms', 'cll patients', 'emotional roller coaster register', 'cll cllsm letscurethis']\n",
      "['own self advocate', 'insurance basics', 'financial toxicity register', 'cll letscurethis']\n",
      "['hope s tanya siddiqi m d', 'e451 cll asco19']\n",
      "['asco19 danielle brander md', 'frontline cll treatment leukemia cll']\n",
      "['risk score predicts atrial fibrillation', 'ibrutinib therapy', 'chronic lymphocytic leukemia oncology leukemia']\n",
      "['cll ibrutinib afib cardioonc asco19']\n",
      "['imbruvica ibrutinib', 'long term data', 'pivotal phase', 'chroniclymphocyticleukaemia cll jnj']\n",
      "['plasma membrane', 'new target', 'progressive chronic lymphocytic leukemia leukemiaresearch cll jirsecondaryantibodies flowcytometry']\n",
      "['chronic lymphocytic leukemia cll growth']\n",
      "['david bond', 'cll patients', 'btk inhibitors asco2019 asco19']\n",
      "['paul barr', 'rel ref cll sll asco2019 asco19']\n",
      "['hr breast cancer', 'cll breastcancer asco19']\n",
      "['cll diagnosis', 'different emotions', 'patients ways']\n",
      "['bcl2 mutation', 'drug venetoclax', 'cll cancer patients', 'new bcl2 structures', 'patients research postdocs']\n",
      "['topical subject', 'cll check', 'focus zone mrd leusm']\n",
      "['ian flinn', 'tennessee oncology discusses economics', 'r r cll', 'full interview', 'gt gt asco19 cllsm leusm']\n",
      "['important work', 'cognitive dysfunction']\n",
      "['long term data', 'asco2019 asco19 asco janssennews cancer bloodcancer leukemia chicagobooth chicagoevents chicago']\n",
      "['chronic lymphocytic leukemia cll', 'common bloodcancer asco19']\n",
      "['cll ibrutinib imbruvica', 'durable responses', 'high risk patients asco2019 chroniclymphocyticleukemia cll janssenglobal wilmotcancer']\n",
      "['excellent abstracts', 'room s103', 'medical student nicholas moore asco19 clonalhematopoiesis cll dfci']\n",
      "['15am pt', 'esther schorr', 'guest jim harlan', 'fb page']\n",
      "['ali mcbride pharmd', 'educational opportunities', 'disease states', 'nsclc cll amp myeloma check', 'asco19 patients immunotherapy accc nsclc cll myeloma cancer lungcancer']\n",
      "['long term chronic lymphocytic leukemia cll data', 'resonate study asco19']\n",
      "['highlights research', 'nyp s dr daniel helbig', 'genetic mutations', 'chronic lymphocytic leukemia visit dr helbig s poster presentation', 'asco19 cll']\n",
      "['retrospective analysis dr john allan amp team', 'early time', 'potential impact', 'patients asco19']\n",
      "['imbruvica ibrutinib', 'long term data', 'pivotal phase', 'chronic lymphocytic leukemia cll']\n",
      "['oral presentations', 'cancer student natalia couto francisco', 'chronic lymphocytic leukemia remodels', 'fibroblast reticular network', 'tumor microenvironment']\n",
      "['chronic lymphocytic leukemia cll asco19']\n",
      "['chronic lymphocytic leukemia cll', 'common leukemia', 'patient journey']\n",
      "['new post study reports ibrutinib', 'venetoclax combo', 'front line therapy', 'select chronic lymphocytic leukemia patients', 'oncology news australia']\n",
      "['ct scans', 'early stage chronic lymphocytic leukemia']\n",
      "['new standard', 'chronic lymphocytic leukemia cll cancerpatients cancertreatment']\n",
      "['treatment strategies', 'chronic lymphocytic leukemia', 'era american society', 'clinical oncology', 'educational book']\n",
      "['amazing cll mantlecelllymphoma walldenstromdisease']\n",
      "['asco19 view', 'new data', 'dose modifications', 'refractory cll sll poster', 'hematologic malignancies lymphoma', 'chronic lymphocytic leukemia cll lymsm leusm']\n",
      "['paso firme libertad limpe o sigue comandando', 'el f tbol femenino lasgumarelas cll']\n",
      "['independiente vs cll', 'unidasporelobjetivo cllpy']\n",
      "['independiente vs cll', 'unidasporelobjetivo cllpy']\n",
      "['independiente vs cll', 'unidasporelobjetivo cllpy']\n",
      "['independiente vs cll', 'liza larrea unidasporelobjetivo cllpy']\n",
      "['independiente vs cll', 'damia cortaza unidasporelobjetivo cllpy']\n",
      "['independiente vs cll st', 'unidasporelobjetivo cllpy']\n",
      "['independiente vs cll', 'final del pt', 'unidasporelobjetivo cllpy']\n",
      "['independiente vs cll', 'liza larrea unidasporelobjetivo cllpy']\n",
      "['independiente vs cll', 'karina vega unidasporelobjetivo cllpy']\n",
      "['independiente vs cll', 'fabiola sandoval unidasporelobjetivo cllpy']\n",
      "['independiente vs cll', 'karina vega unidasporelobjetivo cllpy']\n",
      "['independiente vs cll', 'karina vega unidasporelobjetivo cllpy']\n",
      "['independiente vs cll', 'unidasporelobjetivo cllpy']\n",
      "['survivor i', 'chronic lymphocytic leukemia', 'partial remission', 'day salute', 'fellow survivors']\n",
      "['study reports ibrutinib', 'venetoclax combo', 'front line therapy', 'select chronic lymphocytic leukemia patients']\n",
      "['chronic lymphocytic leukemia cll', 'genetic mutations mutations', '11q deletion', 'way cll']\n",
      "['hepatitis pancreatitis', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll', 'quicker disease progression', 'genetic mutation asco19']\n",
      "['chronic lymphocytic leukemia nationalcancersurvivorsday', 'personal significance']\n",
      "['chronic lymphocytic leukemia ncsd2019 nationalcancersurvivorsday']\n",
      "['year battle', 'chronic lymphocytic leukemia', 'faith hope']\n",
      "['leukemia drug info fda cll car t leusm medtwitter']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['hematologic malignancies lymphoma', 'chronic lymphocytic leukemia', 'dr flinn s posters', 'chronic lymphocytic leukemia cll', '8am asco19']\n",
      "['study reports ibrutinib', 'venetoclax combo', 'front line therapy', 'select chronic lymphocytic leukemia patients']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['kombination aus ibrutinib und venetoclax beseitigt krebszellen aus dem knochenmark wow endcsncer']\n",
      "['good work', 'flora s efforts', 'lobular breast cancer', 'blood cancer cll nhl fl mzl mcl myeloma asco uofm rigel']\n",
      "['chronic lymphocytic leukemia']\n",
      "['ibrutinib cll', 'upfront ibrutinib', 'sequential cit', 'good quality', 'life upfront ibrutinib shows', 'pfs vs br']\n",
      "['ibrutinib venetoclax', 'impressive results', 'front line treatment', 'cll leusm']\n",
      "['long pfs', 'low toxicity inclusion', 'important question', 'partners ibrutinib', 'obinutuzumab lymphoma']\n",
      "['classical features', 'chronic lymphocytic leukaemia', 'small lymphocytic lymphoma dr birgitta sander cll sll hemepath solahp2019 bogota']\n",
      "['dr john pagel cancer institute discusses', 'advisory committee member', 'accc s multidisciplinary chronic lymphocytic leukemia care project', 'patientcare cll bloodcancer lymphocyticleukemia asc019']\n",
      "['cll information day', 'registration list email', 'info ie']\n",
      "['chronic lymphocytic leukemia cll progresses asco19']\n",
      "['year s asco19 theme', 'patient learning', 'u s', 'chronic lymphocytic leukemia cll', 's journey']\n",
      "['chronic lymphocytic leukemia cll', 'genetic mutation']\n",
      "['chronic lymphocytic leukemia', 'therapy combinations', 'car t cell therapy']\n",
      "['oncoalert asco19', 'dramatic changes', 'standard upfront option', 'novel non chemo combos']\n",
      "['upfront venetoclax obinutuzumab data', 'asco19 abstract', 'promising deep remissions', 'impressive mrd negativity rates', 'duration non chemotherapeutic option']\n",
      "['dramatic changes', 'standard upfront option', 'novel non chemo combos', 'recent study shows ibru ven combo', 'cr cri rate', 'mrd neg upfront ven obinutuzumab data', 'asco19 leusm']\n",
      "['original article ibrutinib', 'line treatment', 'chronic lymphocytic leukemia cll editorial ibrutinib']\n",
      "['cll treatments register', 'edinburgh scotland']\n",
      "['chronic lymphocytic leukemia', 'common leukemia', 'u s ibrutinib', 'venetoclax monotherapies', 'favorable response rates', 'preclinical models']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['amp i m kind', 'cll patients']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['s journey', 'chronic lymphocytic leukemia cll', 'disease asco19']\n",
      "['leukemia drug info fda cll car t leusm medtwitter']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['undetectable mrd', 'bone marrow', 'cr rate', 'negative rate', 'ssbmt leusm']\n",
      "['chronic lymphocytic leukemia cll asco19']\n",
      "['chronic lymphocytic leukemia cll', 'common bloodcancer asco19']\n",
      "['chronic lymphocytic leukemia cll', 'genetic mutations mutations', '11q deletion', 'way cll']\n",
      "['chronic lymphocytic leukemia cll progresses asco19']\n",
      "['chronic lymphocytic leukemia cll asco19']\n",
      "['treatment patterns', 'adverse events', 'economic burden', 'chronic lymphocytic leukemia', 'states kabadi cancer medicine wiley online library']\n",
      "['chronic lymphocytic leukemia cll', 'common leukemia', 'patient journey']\n",
      "['chronic lymphocytic leukemia cll', 'quicker disease progression', 'genetic mutation asco19']\n",
      "['year s asco19 theme', 'patient learning', 'u s', 'chronic lymphocytic leukemia cll', 's journey']\n",
      "['s journey', 'chronic lymphocytic leukemia cll', 'disease asco19']\n",
      "['geographic tongue', 'chronic lymphocytic leukemia']\n",
      "['acute tubular injury', 'case series', 'literature american journal', 'denver nephrology onconephrology cll']\n",
      "['study reports ibrutinib', 'venetoclax combo', 'front line therapy', 'select chronic lymphocytic leukemia patients']\n",
      "['trainees keen', 'haematology amp', 'medical oncology', 'place lymsm cll blooducation']\n",
      "['chronic lymphocytic leukemia diagnosis ncsd2019 nationalcancersurvivorsday']\n",
      "['cll journey', 'great information', 'town meeting', 'portland loads', 'cll empower']\n",
      "['effective oral regimen', 'high risk', 'cll leukemia']\n",
      "['ibrutinib amp venetoclax', 'high risk', 'gt 65y cll', '24m rx', 'mrdneg cr cri', 'response inc', 'cll revolution', 're tolerability esp', 'pts optimum dose']\n",
      "['expert panelists reflect', 'complex paradigm', 'chronic lymphocytic leukemia', 'comorbid conditions', 'prescription control']\n",
      "['present new cll sll data', 'monday june', 'verastem oncology booth', 'cll lymsm leusm']\n",
      "['cll treatment updates']\n",
      "['phase ii study', 'complete remission', 'chronic lymphocytic leukemia patients', 'new combination therapy leusm endcancer']\n",
      "['chronic lymphocytic leukemia cll growth']\n",
      "['study reports ibrutinib', 'venetoclax combo', 'front line therapy', 'select chronic lymphocytic leukemia patients']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['s post']\n",
      "['good friends', 'good talks cll friendships']\n",
      "['wu labs', 'recent work', 'cll growth dynamics', 'cathy wu']\n",
      "['phase ii study', 'efficacy results', 'leusm cancermoonshot endcancer']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['growth dynamics', 'chronic lymphocytic leukaemia meduni wien cancer cll lymsm']\n",
      "['endcancer cll']\n",
      "['chronic lymphocytic leukemia growth', 'org dthstr']\n",
      "['bloodcancer affects patients']\n",
      "['excellent study', 'llsscholar catherine wu', 'cll growth patterns']\n",
      "[]\n",
      "['study reports ibrutinib', 'venetoclax combo', 'front line therapy', 'select chronic lymphocytic leukemia patients']\n",
      "['broad institute ri amp report patterns', 'chronic lymphocytic leukemia growth']\n",
      "['morgane i m', 'corresponding author', 'cll patient', 'persistent bronchial symptoms', 'hesitate gt cll bronchus']\n",
      "['phase iii clinicaltrial co', 'shuo ma md', 'effective treatment option', 'frail patients', 'chronic lymphocytic leukemia', 'tolerate chemotherapy asco cll leusm']\n",
      "['chronic lymphocytic leukemia cells', 'mitochondrial fitness', 'cd8 t cells', 'impede car t cell efficacy']\n",
      "['chronic lymphocytic leukemia', 'common leukemia', 'u s ibrutinib', 'venetoclax monotherapies', 'favorable response rates', 'preclinical models']\n",
      "['line treatment', 'ncbi oncology']\n",
      "['ibrutinib dose interruptions', 'long term outcomes']\n",
      "['new article', 'nature exponential', 'logistic growth dynamics', 'chronic lymphocytic leukemia ivana bozic cathy wu']\n",
      "['cll research']\n",
      "['leusm cll']\n",
      "['chronic lymphocytic leukemia', 'bone marrow', 'white blood cell', 'overview leukemia']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['bcl2 inhibitor venetoclax', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['study reports ibrutinib', 'venetoclax combo', 'front line therapy', 'select chronic lymphocytic leukemia patients cll endcancer']\n",
      "['covaris buffer amp', 'ultrasonicator technologies', 'aberrant chromatin', 'chronic lymphocytic leukemia', 'transcription factor networks', 'j mallm']\n",
      "['study reports ibrutinib', 'venetoclax combo', 'front line therapy', 'select chronic lymphocytic leukemia patients']\n",
      "['novel chemofree treatment approaches']\n",
      "['new study', 'high risk chronic lymphocytic leukemia patients leusm cancermoonshot endcancer']\n",
      "['venetoclax combo', 'front line therapy', 'select chronic lymphocytic leukemia patients']\n",
      "['chronic lymphocytic leukemia leukemia']\n",
      "['research teams', 'hovon nordic cll study group', 'amsterdam harbor', 'scientific studies', 'cll13 gaia trial', 'wonderful team', 'creative spirit cll leukemia clinicaltrial']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['ibrutinib ventoclax combo cll', 'promising combination']\n",
      "['combination treatment', 'front line therapy', 'select chronic lymphocytic leukemia patients']\n",
      "['combination treatment', 'front line therapy', 'select chronic lymphocytic leukemia patients']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['publicado hoy ibrutinib', 'line treatment', 'cll nejm cll llc ibrutinib venetoclax']\n",
      "['incredible work ibrutinib venetoclax cll']\n",
      "['study reports ibrutinib', 'venetoclax combo', 'front line therapy', 'select chronic lymphocytic leukemia patients']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['venetoclax combo', 'front line therapy', 'select chronic lymphocytic leukemia patients ibrutinib', 'chronic lymphocytic leukemia cll']\n",
      "['study reports ibrutinib', 'venetoclax combo', 'front line therapy', 'select chronic lymphocytic leukemia patients']\n",
      "['aberrant chromatin', 'chronic lymphocytic leukemia', 'transcription factor networks']\n",
      "['study identifies patterns', 'chronic lymphocytic leukemia growth']\n",
      "['town meeting', 'don t', 'great info', 'leusm leukemia']\n",
      "['liliane paquette', 'damages canadian lawsuit', 'chronic lymphocytic leukemia', 'non hodgkin s lymphoma nhl', 'lawsuits target glyphosate roundup']\n",
      "['high rates', 'mrd negativity']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['drug frontline combination impresses', 'high risk chronic lymphocytic leukemia reports']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['study reports ibrutinib', 'venetoclax combo', 'front line therapy', 'select chronic lymphocytic leukemia patients']\n",
      "['study reports ibrutinib', 'venetoclax combo', 'front line therapy', 'select chronic lymphocytic leukemia patients']\n",
      "['venetoclax combo', 'front line therapy', 'select chronic lymphocytic leukemia patients']\n",
      "['texas md anderson cancer center reports ibrutinib', 'venetoclax combo', 'front line therapy', 'select chronic lymphocytic leukemia patients']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['venetoclax combo', 'front line therapy', 'select chronic lymphocytic leukemia patients']\n",
      "['chronic lymphocytic leukemia growth', 'dana farber cancer institute', 'broad institute', 'harvard massachusetts', 'general hospital']\n",
      "['chronic lymphocytic leukemia cll', 'clonal expansion', 'mature b cells', 'blood bone marrow', 'lymphoid tissues', 'high lymphocyte']\n",
      "['venetoclax ibrutinib combination', 'certain patients', 'chronic lymphocytic leukemia oncology leukemia']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['cll vs sluque o', 'ang lica v zquez unidasporelobjetivo cllpy']\n",
      "['cll vs sluque o', 'karina vega unidasporelobjetivo cllpy']\n",
      "['cll vs sluque o', 'karina vega unidasporelobjetivo cllpy']\n",
      "['cll vs sluque o', 'laurie cristaldo unidasporelobjetivo cllpy']\n",
      "['cll vs sluque o', 'liz pe', 'unidasporelobjetivo cllpy']\n",
      "['cll vs sluque o', 'carmen ben tez unidasporelobjetivo cllpy']\n",
      "['cll vs sluque o', 'angeles portillo unidasporelobjetivo cllpy']\n",
      "['oral oncolytic therapies', 'chronic lymphocytic leukemia', 'full clip']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['chronic lymphocytic leukemia growth', 'chronic lymphocytic leukemia', 'disease growth']\n",
      "['cll vs sluque o', 'final del pt', 'unidasporelobjetivo cllpy']\n",
      "['cll vs sluque o', 'karina vega unidasporelobjetivo cllpy']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['cll vs sluque o', 'paola genes unidasporelobjetivo cllpy']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['cll vs sluque o', 'karina vega unidasporelobjetivo cllpy']\n",
      "['cll vs sluque o', 'griselda garay unidasporelobjetivo cllpy']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['chroniclymphocyticleukemia growth']\n",
      "['cll vs sluque o', 'karina vega unidasporelobjetivo cllpy']\n",
      "['cll vs sluque o', 'karina vega unidasporelobjetivo cllpy']\n",
      "['cll vs sluque o', 'karina vega unidasporelobjetivo cllpy']\n",
      "['cll vs sluque o', 'inicial alicia bobadilla laurie cristaldo carmen ben tez damia cortaza joana galeano fabiola sandoval griselda garay liz pe', 'ang lica v zquez paola genes karina vega unidasporelobjetivo cllpy']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['chronic lymphocytic leukemia growth']\n",
      "['new study identifies patterns', 'chronic lymphocytic leukemia']\n",
      "['dana farber study identifies patterns', 'chronic lymphocytic leukemia growth']\n",
      "['verastem oncology s commitment', 'cancer care', 'hematological malignancies research drop', 'cll lymsm leusm hemeonc']\n",
      "['wednesdaywisdom cll sll chroniclymphocyticleukemia smalllymphocyticlymphoma leukemia lymphoma hematology venetoclax doctorpatient']\n",
      "['great work', 'cell epigenetics epimutation dna methylation', 'b cells', 'chronic lymphocytic leukemia cll']\n",
      "['rt dkfz epigenetische signale f rdern entstehung von leuk mie dkfz wissenschaftler haben herausgefunden dass f r', 'entstehung der cll einer h ufigen form von blutkrebs neben dna mutationen auch fehlerhafte epigenetische signale verantwortl']\n",
      "['epigenetische signale f rdern entstehung von leuk mie dkfz wissenschaftler haben herausgefunden dass f r', 'entstehung der cll einer h ufigen form von blutkrebs neben dna mutationen auch fehlerhafte epigenetische signale verantwortlich sind']\n",
      "['leukemia therapeutics market', 'full report chronic lymphocytic leukemia biotech stemcells lifescience chemotherapy drug molecule biologics pharma', 'medical biotechnology opportunities']\n",
      "['making sense', 'treatment genetic research', 'available support town meeting', 'cll experts', 'important car t cell therapy', 'cll click']\n",
      "['key insights', 'chronic lymphocytic leukemia', 'lymphoma amp myeloma']\n",
      "['dr burke', 'treatment options', 'chronic lymphocytic leukemia', 'clinical decisions immunoonc cllsm']\n",
      "['exciting lecture', 'dr lindsey roeker']\n",
      "['long term fup', 'complement1 trial', 'g chl vs chl cll11', 'os benefit', 'chl vs chl', 'ofa chl arm', 'chl arm cllsm blooducation asco2019 cll']\n",
      "['clb g vs', 'duration veng', 'tn cll comorb', 'fup 29m pfs hr', 'mrd ve pb', 'p lt', 'p lt', '3m mrd', 'pfs mrd', 'veng cll14 asco2019 venetoclax', 'exciting times']\n",
      "['mayo study af', 'ibrutinib cll pts', 'pts gt af', 'medical rx', 'rhythm control', 'variable mx', 'w shorter efs os blooducation asco19']\n",
      "['cll pt', 'ibrutinib trials', 'new htn', 'htn rx', 'htn rx', 'pts increase', 'new htn', 'obesity ckd osa p gt', 'cllsm asco19', 'bp blooducation']\n",
      "['len ritux', 'rr cll', 'bcri bcl2i exposure', 'rr pts', 'effective combination', 'tn pt', 'reasons pd', 'pts tox', 'pt choice', 'park blooducation']\n",
      "['cll support meetings check', 'information cllsm letscurethis']\n",
      "['great experience sysmex user meeting', 'quality hotel olavsgaard kll']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['mother s diagnoses', 's chronic lymphocytic leukemia cll', 'drug subscription']\n",
      "['heute ist weltblutkrebstag f r viele patientinnen hei t es nach der diagnose cll erst einmal abwarten amp beobachten erfahren sie', 'unserem online kurs wie sie mit der belastung umgehen und selbst aktiv werden k nnen cll selpers']\n",
      "['technical alerts', 'week high bollinger band squeeze', 'upper bollinger band walk re']\n",
      "['chronic lymphocytic']\n",
      "['dr brian koffman interviews dr william wierda', 'critical importance', 'cll cllsm letscurethis']\n",
      "['dearest friend', 'challenging disease unfit cll patients cll clubedosangue ibtk']\n",
      "['combination therapy']\n",
      "['memorial day', 'chronic lymphocytic leukemia', 'pointless war']\n",
      "['fwd p e', '3m cash', 'year chart investors chronicle suggests', 'possible takeover target']\n",
      "['astute np', 'phenomenon plasma k', 'serum level', 'chronic lymphocytic leukemia', 'apparent hyperkalemia cleveland clinic journal']\n",
      "['groups paper', 'prognostic implications', 'chronic lymphocytic leukemia cll endcancer']\n",
      "['mondaymotivation fda venetoclax cll sll chroniclymphocyticleukemia smalllymphocyticlymphoma leukemia lymphoma hematology heme']\n",
      "['aberrant chromatin', 'chronic lymphocytic leukemia', 'transcription factor networks']\n",
      "['santani vs cll', 'unidasporelobjetivo cllpy']\n",
      "['santani vs cll', 'karina vega unidasporelobjetivo cllpy']\n",
      "['santani vs cll', 'liza larrea unidasporelobjetivo cllpy']\n",
      "['santani vs cll', 'griselda garay unidasporelobjetivo cllpy']\n",
      "['santani vs cll', 'unidasporelobjetivo cllpy']\n",
      "['santani vs cll', 'unidasporelobjetivo cllpy']\n",
      "['santani vs cll', 'bel n ben tez unidasporelobjetivo cllpy']\n",
      "['santani vs cll', 'unidasporelobjetivo cllpy']\n",
      "['santani vs cll st', 'unidasporelobjetivo cllpy']\n",
      "['santani vs cll', 'final del primer tiempo', 'unidasporelobjetivo cllpy']\n",
      "['santani vs cll', 'laurie cristaldo unidasporelobjetivo cllpy']\n",
      "['santani vs cll', 'damia cortaza unidasporelobjetivo cllpy']\n",
      "['santani vs cll', 'unidasporelobjetivo cllpy']\n",
      "['santani vs cll', 'unidasporelobjetivo cllpy']\n",
      "['santani vs cll', 'liz pe', 'unidasporelobjetivo cllpy']\n",
      "['new rituximab', 'chronic lymphocytic leukemia']\n",
      "['santani vs cll', 'karina vega unidasporelobjetivo cllpy']\n",
      "['santani vs cll', 'unidasporelobjetivo cllpy']\n",
      "['santani vs cll partido', 'unidasporelobjetivo cllpy']\n",
      "['santani vs cll', 'inicial alicia bobadilla laurie cristaldo carmen ben tez damia cortaza joana galeano fabiola sandoval griselda garay liz pe', 'ang lica v zquez paola genes karina vega unidasporelobjetivo cllpy']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['long term resonate data', 'common reasons', 'ibrutinib monotherapy', 'non trial populations', 'cll blooducation']\n",
      "['long term fup', 'btki usage', 'r r cll blooducation']\n",
      "['post ibrutinib options', 'cll oncology']\n",
      "['chronic lymphocytic leukemia']\n",
      "['untold story', 'car t cells']\n",
      "['cll expert dr david maloney', 'long cll treatments']\n",
      "['front line treatment', 'chronic lymphocytic leukemia', 'severe co morbidities', 'malignancies leusm vitale ferrajoli']\n",
      "['big news', 'canadian cll patients venetoclax', 'available option', 'therapies cllsm letscurethis']\n",
      "['waardevolle bijdrage aan', 'hematondag samenbeslissen cll hematon']\n",
      "['hematondag een werksessie', 'samenbeslissen gegeven veel geleerd van lotgenoten', 'naasten meer weten bekijk ook', 'cll keuzehulp lymfatische leukemie']\n",
      "['congrats raptors raptorsnation cll']\n",
      "['autoimmune hemolytic anemia', 'phase iii resonatetm study', 'ibrutinib vs ofatumumab', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'case report']\n",
      "['dr john c byrd', 'btk inhibitors', 'cll ibrutinib pus', 'new kids', 'cll james osuccc james cancer hospital', 'solove research institute btk inhibitors chroniclymphocyticleukemia']\n",
      "['i3 health dr davids', 'shares insights', 'recent fda approval', 'chronic lymphocytic leukemia']\n",
      "['interesting algorithm lots', 'note immunochemotherapy', 'low risk', 'ven r cll treatment algorithms', 'interesting times', 'lymsm blooducation']\n",
      "['high affinity', 'small molecule', 'clinical treatment', 'chronic lymphocytic leukemia cll eurekamag']\n",
      "['chronic lymphocytic leukemia', 'global trends market size share status swot analysis']\n",
      "['aberrant chromatin', 'chronic lymphocytic leukemia', 'transcription factor n']\n",
      "['scan results expansion breakout', 'dx head pets cto mmx sec cll bc12']\n",
      "['important results', 'high grade transformation', 'previous richters transformation', 'cll trial', 'great work', 'jenny k']\n",
      "['rare case', 'central nervous system involvement', 'chronic lymphocytic leukemia']\n",
      "['t cell lymphoma', 't cell malignancies lymsm']\n",
      "['report cll fighters']\n",
      "['severe fatigue', 'cancer patients', 'exhaustion tune', 'michele nadeem baker shares triggers', 'fatigue cancerfatigue cll fatigue patientpower']\n",
      "['old human cells self destruct', 'new ones', 'certain cancer cells', 'basic science research', 'natural process']\n",
      "['bloodcancer patients', 'dr sangmin lee research nurse manager june greenberg', 'cll survivor bob azopardi', 'cancer clinical trials']\n",
      "['ibrutinib vs ibrutinib', 'patients w chronic lymphocytic leukemia']\n",
      "['rns aim cll cello health plc block', 'interim review']\n",
      "['chronic lymphocytic leukemia', 'global trends market size share status swot analysis']\n",
      "['aberrant chromatin', 'chronic lymphocytic leukemia', 'transcription factor networks']\n",
      "['risk score', 'overall survival', 'r r chronic lymphocytic leukaemia', 'therapy ibrutinib idelalisib venetoclax amp chemoimmunotherapy', 'retrospective cohort study cll leusm']\n",
      "['drg epidemiology report estimates', 'western europe', 'global reports', 'leukemia cll lymphocyticleukemia']\n",
      "['chronic lymphocytic leukemia cll hypogammaglobulinemia']\n",
      "['venetoclax venclexta', 'adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma', 'okchem disease unitedstates']\n",
      "['immunoglobulin m cryoglobulinemic vasculitis', 'chronic lymphocytic leukemia', 'hepatitis c virus', 'naveen raj']\n",
      "['dr richard furman', 'cll research', 'caregiver education forum']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['intermittent duvelisib', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'phase ii trial studies', 'intermittent irregular']\n",
      "['chronic lymphocytic leukemia', 'cell death', 'natural process', 'dr vishva dixit']\n",
      "['cancer patients', 'severe fatigue', 'exhaustion tune', 'michele nadeem baker shares triggers', 'fatigue cancerfatigue cll fatigue patientpower']\n",
      "['monsanto roundup cancer lawsuits charge', 'glyphosate causes cancer non hodgkin lymphoma nhl chronic lymphocytic leukemia cll', 'sub types']\n",
      "['great update', 'cll hematology', 'new spanish cll guidelines', 'ibru venetoclax', 'future combos']\n",
      "['bcell lymphoma management', 'cme masterclass', 'hyatt regency chicago', 'wacker reserve', 'peerview cll']\n",
      "['pan canadian pharmaceutical alliance pcpa']\n",
      "['info event leukaemia cll dublin education amp support', 'families amp carers']\n",
      "['cll flares']\n",
      "['drug administration s green', 'obinutuzumab gazyva', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['key insights', 'chronic lymphocytic leukemia', 'lymphoma amp myeloma']\n",
      "['upenn monitors patients', 'cd19 car t', 'chronic lymphocytic leukemia cll', 'interesting data', 'cd8 cells', 'time lt', 'biotechnology celltherapy']\n",
      "['cll vs nacional', 'unidasporelobjetivo cllpy']\n",
      "['cll vs nacional', 'fiorela mart nez unidasporelobjetivo cllpy']\n",
      "['cll vs nacional', 'karina vega unidasporelobjetivo cllpy']\n",
      "['cll vs nacional', 'karina vega unidasporelobjetivo cllpy']\n",
      "['cll vs nacional st', 'unidasporelobjetivo cllpy']\n",
      "['tgtx phase', 'ibrutinib versus ibrutinib', 'high risk chronic lymphocytic leukemia cll', 'primary completion date']\n",
      "['cll vs nacional', 'final del pt', 'unidasporelobjetivo cllpy']\n",
      "['cll vs nacional', 'liz pe', 'unidasporelobjetivo cllpy']\n",
      "['cll vs nacional', 'griselda garay unidasporelobjetivo cllpy']\n",
      "['cll vs nacional', 'unidasporelobjetivo cllpy']\n",
      "['cll vs nacional', 'laurie cristaldo unidasporelobjetivo cllpy']\n",
      "['cll vs nacional partido', 'unidasporelobjetivo cllpy']\n",
      "['cll vs nacional alicia bobadilla laurie cristaldo carmen ben tez damia cortaza joana galeano fabiola sandoval griselda garay liz pe', 'ang lica v zquez paola genes karina vega unidasporelobjetivo cllpy']\n",
      "['abbvie announces', 'fda approval', 'venclexta venetoclax', 'free combination regimen', 'chronic lymphocytic leukemia patients']\n",
      "['joel schmidt bill borchard mary kevlin', 'bob english', 'international trademark association', 'annual meeting', 'boston mass inta cll trademark boston']\n",
      "['great blog cll cllsm letscurethis']\n",
      "['adult patients', 'chronic lymphocytic leukaemia cll', 'small lymphocytic lymphoma sll']\n",
      "['datos y conceptos', 'cll nueva actividad', 'el vhio', 'con el dr bosch gran grupo y excelente nivel cll vhio acindes formaciondelprofesionalsanitario']\n",
      "['aberrant chromatin', 'chronic lymphocytic leukemia', 'transcription factor networks']\n",
      "['aberrant chromatin', 'chronic lymphocytic leukemia', 'transcription factor networks', 'cll papers']\n",
      "['aberrant chromatin', 'chronic lymphocytic leukemia', 'transcription factor networks']\n",
      "['machine learning model', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['pharmacologic inhibition', 'enzyme induces er stress', 'chronic lymphocytic leukemia', 'resistant mantle cell lymphoma cells lymphoma lymsm']\n",
      "['aberrant chromatin', 'chronic lymphocytic leukemia', 'transcription factor networks dna genetics dnatest']\n",
      "['deep dives', 'car t cells', 'car t cell amp', 'persist amp', 'antitumor activity dr david maloney']\n",
      "['fda approves venetoclax', 'chronic lymphocytic leukemia']\n",
      "['chlorambucil rituximab', 'lenalidomide combination treatment', 'chronic lymphocytic leukemia medivizor']\n",
      "['puntadiamante se convirtieron', 'los campeones', 'xnl cll y ngen iwc luchalibrechilena nagero5taregi n pepex']\n",
      "['geographic tongue', 'chronic lymphocytic leukemia']\n",
      "['annual meeting experts dr susan o brien uc irvine amp dr javier pinilla moffitt cancer center', 'exciting developments', 'treatment research', 'new class', 'chronic lymphocytic leukemia cll']\n",
      "['chronic cancer', 'cancer survivor cancersurvivor humorfightscancer lymphoma leukemia cll cancersucks hatecancer chronic']\n",
      "['new fda approval', 'big question', 'frontline treatment', 'chronic lymphocytic leukemia patients leusm endcancer']\n",
      "['geographic tongue', 'chronic lymphocytic leukemia']\n",
      "['cll expert', 'leukemia center director endcancer leusm']\n",
      "['chronic lymphocytic leukemia cll', 'treatment journey', 'cll advocates', 'cll expert']\n",
      "['i3 health shares insights', 'recent fda approval', 'chronic lymphocytic leukemia']\n",
      "['main reasons', 'ibrutinib discontinuation', 'richter transformation', 'india i', 'main reason cll btk oncology hemonc']\n",
      "['venetoclax obinutuzumab combo', 'frontline chronic lymphocytic leukemia cll']\n",
      "['whole genome', 'rna expression', 'genomic aberrations', 'richter s syndrome', 'chronic lymphocytic leukemia joint work', 'jenny klintman jenny taylor']\n",
      "['full agenda', 'successful meeting', 'cll field', 'initiate worldwide collaborations']\n",
      "['differential genomic', 'transcriptomic events', 'high grade transformation', 'chronic lymphocytic leukemia']\n",
      "['new data', 'verastem oncology', 'asco19 effect', 'dose modification', 'refractory cll sll', 'duo study']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll tuesdaynewsday tuesdaythoughts']\n",
      "['interesting poster pf360', 'vitro drug sensitivity', 'chronic lymphocytic leukemia cll patient samples identifies drug candidates', 'precision cancer therapy']\n",
      "['cll society email alerts', 'cll news', 'week cll cllsm letscurethis']\n",
      "['successful meeting', 'cll field', 'initiate worldwide collaborations', 'full agenda']\n",
      "['wnt5a causes ror1', 'activate cortactin', 'enhance migration', 'chronic lymphocytic leukemia cells', 'articles wnt5a causes ror1', 'activate cortactin', 'enhance migration', 'chronic lymphocytic leukemia cells leukemia']\n",
      "['differential genomic', 'transcriptomic events', 'high grade transformation', 'chronic lymphocytic leukemia']\n",
      "['drg epidemiology report estimates', 'western europe', 'updates cll leukemia chronic lymphocyticleukemia fda']\n",
      "['differential genomic', 'transcriptomic events', 'high grade transformation', 'chronic lymphocytic leukemia biorxiv genomic']\n",
      "['differential genomic', 'transcriptomic events', 'high grade transformation', 'chronic lymphocytic leukemia biorxiv']\n",
      "['stellar trial 1st', 'cll opening', 'others blooducation lymsm']\n",
      "['dr brian koffman comments', 'venetoclax obinutuzumab', 'frontline setting', 'cll sll cll sll letscurethis venetoclax']\n",
      "['untold story', 'car t cells']\n",
      "['abbvie announces', 'fda approval', 'venclexta venetoclax', 'free combination regimen', 'chronic lymphocytic leukemia patients']\n",
      "['clinical trial', 'patient advocate', 'clinicaltrials cll cancerresearch']\n",
      "['line regimen', 'chronic lymphocytic leukemia w', 'jennifer r', 'brown md']\n",
      "['chronic lymphocytic leukemia', 'health issues']\n",
      "['rns aim cll cello health plc issue']\n",
      "['untold story', 'car t cells']\n",
      "['vector integration site observations', 'car t cell potency', 'particular vector integration site', 'jan joseph melenhorst phd cartcells leusm']\n",
      "['fda approves venetoclax', 'chronic lymphocytic leukemia']\n",
      "['fda approves venclexta', 'chronic lymphocytic leukemia']\n",
      "['cll news fda approves venetoclax obinutuzumab combo']\n",
      "['combination therapy', 'fda approval', 'chronic lymphocytic leukemia times ecm']\n",
      "['chronic lymphocytic leukemia diagnosis', 'treatment mayo clinic']\n",
      "['arnon kater', 'excellent lecture', 'vi eafo hematology forum', 'moscow key point', 't cell metabolism', 'cart cells leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['fda approves venetoclax', 'small lymphocytic leukemia']\n",
      "['term results', 'r r cll', 'front line']\n",
      "[]\n",
      "['fda approves venetoclax obinutuzumab combo', 'frontline cll oncology']\n",
      "['bellechasse cll']\n",
      "['combination therapy', 'fda approval', 'chronic lymphocytic leukemia']\n",
      "['genetic alterations', 'gene regulation', 'chronic lymphocytic leukemia']\n",
      "['epigenetic deregulation', 'chronic lymphocytic leukemia clinical']\n",
      "['fda approves venetoclax', 'small lymphocytic leukemia']\n",
      "['sharman dr jeff sharman cll medicine']\n",
      "['graldiaz vs cll', 'unidasporelobjetivo cllpy']\n",
      "['5mg kg d', 'high occupancy', 'abrogate kinase function', 'similar clinical outcomes', 'cll patients lymsm', 'cost effectiveness']\n",
      "['graldiaz vs cll', 'fabiola sandoval unidasporelobjetivo cllpy']\n",
      "['graldiaz vs cll', 'unidasporelobjetivo cllpy']\n",
      "['graldiaz vs cll', 'fabiola sandoval unidasporelobjetivo cllpy']\n",
      "['graldiaz vs cll', 'unidasporelobjetivo cllpy']\n",
      "['great discussions', 'patient power making sense', 'cll program sharman jeffreymenashe michaelchoi cll davidmaloney']\n",
      "['nvs phase', 'refractory chronic lymphocytic leukemia', 'primary completion date']\n",
      "['graldiaz vs cll', 'stephenie lacoste unidasporelobjetivo cllpy']\n",
      "['graldiaz vs cll', 'griselda l pez unidasporelobjetivo cllpy']\n",
      "['graldiaz vs cll', 'paola genes unidasporelobjetivo cllpy']\n",
      "['graldiaz vs cll', 'fabiola sandoval unidasporelobjetivo cllpy']\n",
      "['graldiaz vs cll st', 'unidasporelobjetivo cllpy']\n",
      "['graldiaz vs cll', 'karina vega unidasporelobjetivo cllpy']\n",
      "['graldiaz vs cll', 'karina vega unidasporelobjetivo cllpy']\n",
      "['graldiaz vs cll', 'liz pe', 'unidasporelobjetivo cllpy']\n",
      "['graldiaz vs cll', 'karina vega unidasporelobjetivo cllpy']\n",
      "['graldiaz vs cll', 'unidasporelobjetivo cllpy']\n",
      "['minute review', 'chronic lymphocytic leukemia cll matters']\n",
      "['graldiaz vs cll', 'liz pe', 'unidasporelobjetivo cllpy']\n",
      "['graldiaz vs cll partido', 'el nido unidasporelobjetivo cllpy']\n",
      "['cll town meeting powerfulpatients', 'stories tune']\n",
      "['graldiaz vs cll equipo confirmado alicia bobadilla paola genes carmen ben tez stephenie lacoste ang lica v zquez joana galeano griselda l pez damia cortaza fabiola sandoval karina vega y liz pe']\n",
      "['stock ratings biotech bullish biotechnology']\n",
      "['stock ratings biotechnology bullish biotech']\n",
      "['oncology nurse jeanne schaffer', 'clinicaltrial phases', 'busts cll myths tune']\n",
      "['guest expert opinion dr maloney', 'cll town meeting']\n",
      "['stock ratings biotech bullish biotechnology']\n",
      "['cll event']\n",
      "['chronic lymphocytic leukemia', 'cell death', 'natural process', 'dr vishva dixit']\n",
      "['fda approves venetoclax', 'small lymphocytic leukemia']\n",
      "['target price', 'vetr gt biotechnology biotech stock cycc']\n",
      "['high yield', 'practical points', 'superb cll slides', 'hematology malignancy update salim']\n",
      "['informative work', 'prognostic risk score', 'r r cll', 'rapid development']\n",
      "['fda approves venetoclax', 'small lymphocytic leukemia']\n",
      "['new cme event fda approves venetoclax', 'chronic lymphocytic leukemia']\n",
      "['venetoclas indication', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['fda approves venetoclax', 'small lymphocytic leukemia mednews']\n",
      "['non hematology apps need']\n",
      "['novel combination regimens', 'cll danielle m brander md discusses', 'investigational combination treatments', 'chronic lymphocytic leukemia']\n",
      "['fda approves venetoclax', 'small lymphocytic leukemia']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['abbvie roche snag', 'cll nod', 'venclexta gazyva', 'gazyva oncology pharma abbv rog']\n",
      "['cell integration', 'genetic epigenetic', 'transcriptional information', 'lineage history', 'nk amp leukemia cll genomics oncology']\n",
      "['fda approves venetoclax abbvie inc', 'genentech inc', 'adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['fda approves venclexta gazyva regimen', 'chronic lymphocytic leukemia']\n",
      "['free pocket', 'nccn guidelines', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll cancer']\n",
      "['breakthrough nips', 'cll captainmarvel']\n",
      "['cll diagnosis', 'different emotions', 'patients ways']\n",
      "['abbvie roche snag', 'cll nod', 'venclexta gazyva']\n",
      "['small lymphocytic lymphoma analysis', 'clinical trials', 'german chronic lymphocytic leukemia study group gcllsg', 'real life', 'clinical trials lymphoma lymsm']\n",
      "['cll patients', 'skin cancer', 'patient community thanks']\n",
      "['congratulations pavlina janovska', 'rector s', 'outstanding scientists', 'pavlina s research', 'ck1 inhibitors', 'chronic lymphocytic leukemia cll']\n",
      "['i manage ibrutinib intolerance', 'chronic lymphocytic leukemia']\n",
      "['ibrutinib vs ibrutinib', 'patients w chronic lymphocytic leukemia']\n",
      "['roche fda approves drug combo venclexta', 'chronic lymphocytic leukemia']\n",
      "['ra pharma update fda', 's drug venclexta', 's drug gazyva', 'approval click']\n",
      "['abbvie s venclexta', 'fda approval', 'free treatment', 'chronic lymphocytic leukemia', 'oncology priority review program']\n",
      "['excellent news cll cllsm venetoclax letscurethis']\n",
      "['fda approves venetoclax', 'small lymphocytic leukemia']\n",
      "['genentech venclexta amp gazyva combination', 'fda s', 'real time oncology review', 'assessment aid pilot programs cancer fdaapproval cll sll leukemia lymphoma dna']\n",
      "['initial treatment option', 'common form', 'adult leukemia cll']\n",
      "['chronic lymphocytic leukemia undergoes', 'predictable genetic evolution', 'new ways', 'dr dan landau', 'sharp awardee leusm landau lab']\n",
      "['fda approves combo therapy', 'chronic lymphocytic leukemia']\n",
      "['venetoclax venclexta', 'adult individuals', 'chroniclymphocyticleukemia cll', 'smalllymphocyticlymphoma sll leukemia lymphoma bloodcancer lylcl leusm lymsm peripheraltcelllymphoma']\n",
      "['chronic lymphocytic leukemia patients']\n",
      "['common day', 'life cancer leukemia lymphoma cancerhumor fightcancer cancersucks cll cancersurvivor hatecancer']\n",
      "['u s food', 'drug administration', 'new chemotherapy', 'free combination regimen', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['roche fda approves drug combo venclexta', 'chronic lymphocytic leukemia cll reuters']\n",
      "['fda grants approval', 'new treatment combination', 'chronic lymphocytic leukemia media']\n",
      "['combination therapy', 'fda approval', 'chronic lymphocytic leukemia cll']\n",
      "['adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['great work', 'cll community advocacy']\n",
      "['roche fda approves drug combo', 'chronic lymphocytic leukemia']\n",
      "['roche fda approves drug combo venclexta']\n",
      "['fda approves chemo', 'free front line treatment', 'adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll']\n",
      "['u s food', 'drug administration', 'new chemotherapy', 'free combination regimen', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['good news', 'cll drug info']\n",
      "['gazyva venclexta combo', 'chronic lymphocytic leukemia']\n",
      "['genentech announces fda approval', 'chronic lymphocytic leukemia']\n",
      "['autorisation par', 'venetoclax venclexta abbvie associ obinutuzumab gazyva roche', 'leuc mie lympho', 'chronique petit lymphome lymphocytaire']\n",
      "['roche fda approves drug combo venclexta', 'chronic lymphocytic leukemia']\n",
      "['abbvie announces', 'fda approval', 'venclexta venetoclax', 'chemotherapyfree combination regimen', 'chroniclymphocyticleukemia patients']\n",
      "['abbvie announces', 'fda approval', 'venclexta venetoclax', 'free combination regimen', 'chronic lymphocytic leukemia patients']\n",
      "['fda approval', 'bavencio combo', 'rcc merck kgaa', 'pfizer experts', 'breast cancer', 'reservations fda approves combo therapy', 'chronic lymphocytic leukemia']\n",
      "['great achievement', 'cll patients cll14 cll']\n",
      "['1l cll', 'elderly unfit pfs overlay cllsm asco19 cll cll', 'similar pfs', '17p del']\n",
      "['giant cell hepatitis', 'chronic lymphocytic leukemia', 'case series', 'literature lymphoma lymsm']\n",
      "['subcutaneous rituximab', 'follicular lymphoma chronic lymphocytic leukemia', 'large b cell lymphoma lymphoma lymsm']\n",
      "['novel chronic lymphocytic leukemia treatment combination rhhby rog']\n",
      "['roche fda approves drug combo venclexta', 'chronic lymphocytic leukemia']\n",
      "['roche fda approves drug combo venclexta', 'chronic lymphocytic leukemia']\n",
      "['fda approuve', 'venclexta venetoclax', 'combinaison avec', 'gazyva obinutuzumab', 'traiter les patients atteints', 'leuc mie lympho', 'chronique cll', 'ce traitement qualifi', 'perc e th rapeutique sant']\n",
      "['roche fda approves drug combo venclexta', 'chronic lymphocytic leukemia healthnews']\n",
      "['roche s treatment', 'venclexta gazyva', 'chronic lymphocytic leukaemia']\n",
      "['roche fda approves drug combo venclexta']\n",
      "['roche fda approves drug combo venclexta', 'chronic lymphocytic leukemia']\n",
      "['i manage ibrutinib intolerance', 'chronic lymphocytic leukemia']\n",
      "['abbvie s venclexta venetoclax gazyva obinutuzumab', 'fda s approval', 'chronic lymphocytic leukemia']\n",
      "[]\n",
      "['i manage ibrutinib intolerance', 'chronic lymphocytic leukemia cll cllsm leusm']\n",
      "['roche fda approves drug combo venclexta', 'chronic lymphocytic leukemia']\n",
      "['roche fda approves drug combo venclexta', 'chronic lymphocytic leukemia']\n",
      "['roche fda approves drug combo venclexta', 'chronic lymphocytic leukemia']\n",
      "['roche fda approves drug combo venclexta', 'chronic lymphocytic leukemia latestcomments']\n",
      "['specific chimeric antigen receptor', 'car t cell therapy', 'chronic lymphocytic leukemia', 'ibrutinib era']\n",
      "['roche fda approves drug combo venclexta', 'chronic lymphocytic leukemia']\n",
      "['roche fda approves drug combo venclexta', 'chronic lymphocytic leukemia']\n",
      "['roche fda approves drug combo venclexta', 'chronic lymphocytic leukemia']\n",
      "['roche fda approves drug combo venclexta', 'chronic lymphocytic leukemia']\n",
      "['venetoclax obinutuzumab combo', 'frontline cll haszn lat val']\n",
      "[]\n",
      "['prof andrew roberts', 'cll patients', 'venetoclax research cll leukaemia']\n",
      "['fda approves', 'combination use', 'frontline treatment', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['asco19 cll']\n",
      "['oral oncolytic access']\n",
      "['cll14 data', 'press release abbv high mrd rates gt 2x ibr gazyva', 'ibr gazyva']\n",
      "['new chemotherapy', 'free combination regimen', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['news fda approves venetoclax', 'frontline therapy']\n",
      "['huge cll']\n",
      "[]\n",
      "['abbv fda', 'venclexta drug candidate', 'obinutuzumab monoclonal antibody', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['venetoclax venclexta abbvie inc', 'genentech inc', 'adult patients', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['news fda approves venetoclax obinutuzumab combo', 'frontline cll', 'frontline treatment', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['jacqueline barrientos m d', 'drug sequence', 'cll check', 'chroniclymphocyticleukemia cll lymphoma myeloma']\n",
      "['approval marks', 'important step']\n",
      "['combination therapy', 'fda approval', 'chronic lymphocytic leukemia cll']\n",
      "['combination use', 'frontline treatment', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['fda approves venclexta', 'chronic lymphocytic leukemia cll']\n",
      "['genentech announces fda approval', 'chronic lymphocytic leukemia']\n",
      "['genentech announces fda approval', 'chronic lymphocytic leukemia']\n",
      "['epigenetics evolution', 'cll leukemia', 'lab publication', 'hongcang gu trp link']\n",
      "['combination venetoclax', 'frontline treatment', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cllsm bloodcancer']\n",
      "['chronic lymphocytic leukemia', 'small lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukemia cells', 'mitochondrial fitness', 'cd8 t cells', 'impede car t cell efficacy']\n",
      "['fda approves combo therapy', 'chronic lymphocytic leukemia cll']\n",
      "['venetoclax venclexta', 'obinutuzumab gazyva', 'frontline treatment', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['abbvie announces', 'fda approval', 'venclexta venetoclax', 'free combination regimen', 'chronic lymphocytic leukemia patients']\n",
      "['abbv press release', 'abbvie announces', 'fda approval', 'venclexta venetoclax', 'free combination regimen', 'chronic lymphocytic leukemia patients']\n",
      "['abbvie announces', 'fda approval', 'venclexta venetoclax', 'free combination regimen', 'chronic lymphocytic leukemia patients']\n",
      "['genentech announces fda approval', 'chronic lymphocytic leukemia']\n",
      "['roche genentech announces fda approval', 'chronic lymphocytic leukemia']\n",
      "['genentech announces fda approval', 'chronic lymphocytic']\n",
      "['cll combination therapy', 'real time oncology review rtor pilot program']\n",
      "['abbvie announces', 'fda approval', 'venclexta venetoclax', 'free combination regimen']\n",
      "['genentech announces fda approval', 'chronic lymphocytic leukemia business wire']\n",
      "['venclexta gazyva combo', 'line cll sll treatment', 'time oncology review pilot program', 'fda ok']\n",
      "['abbvie announces', 'fda approval', 'venclexta venetoclax', 'free combination regimen', 'chronic lymphocytic leukemia patients abbv abbv']\n",
      "['rhhby press release', 'genentech announces fda approval', 'chronic lymphocytic leukemia']\n",
      "['fda approves', 'medicine combo', 'free treatment option', 'chronic lymphocytic leukemia']\n",
      "['abbvie reports fda approval ov venclexta', 'free combination regimen', 'chronic lymphocytic leukemia patients abbv']\n",
      "['ibrutinib therapy downregulates', 'proliferative fractions', 'chronic lymphocytic leukemia cll']\n",
      "['cd38 enhances', 'antileukemic activity', 'chronic lymphocytic leukemia cll']\n",
      "['great sadness', 'k9 barrett s retirement trust', 'ofc jon cleveland', 'chronic lymphocytic leukemia']\n",
      "['busy month', 'cll society', 'cll cllsm leukemia bloodcancer']\n",
      "['tpecs training', 'live online format', 'busy schedules', 'tight training budgets cll']\n",
      "['chronic lymphocytic leukemia', 'b cell type']\n",
      "['hello london']\n",
      "['kabouter funds whoever', 'zero i don t hold']\n",
      "['rns aim cll cello health plc']\n",
      "['leukemia cancer survivor mug leukemia cancer survivor mug chemotherapy leukaemia', 'acute myeloid leukemia lymphoma blood chronic lymphocytic tumor pneumonia lymphoblastic anemia therapy infection hemorrhage liver', 'courtesy gift']\n",
      "['cd38 enhances', 'antileukemic activity', 'chronic lymphocytic leukemia']\n",
      "['jitc research stim1', 'plasma membrane', 'new target', 'progressive chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'response variables']\n",
      "['minimal residual disease', 'cll rod', 'humerickhouse md cll chroniclymphocyticleukemia residual disease']\n",
      "['key findings', 'phase iii murano trial', 'chronic lymphocytic leukemia cllsm bloodcancer']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['annual dr lyonel g israels memorial lecture', 'dr tait shanafelt', 'diagnosis management', 'new research']\n",
      "['great interview', 'dr hillmen', 'cll cllsm letscurethis']\n",
      "['human trial', 'cd37 antibody bi', 'refractory chronic lymphocytic leukemia clinicaltrials']\n",
      "['pm edt', 'recordings cme cll']\n",
      "['cll chronic lymphocytic leukemia', 'white blood cells', 'don t work', 'normal wbcs', 'bone marrow', 'lymphatic system']\n",
      "['lmw ptp', 'chronic lymphocytic leukemia therapy sibbmpub firenze']\n",
      "['illumintate trial carol moreno md therapy cll chroniclymphocyticleukemia illumintate immunotherapy unibarcelona']\n",
      "['cll patients sharman cll chroniclymphocyticleukemia ibrutinib']\n",
      "['big words cancer bloodcancer cll leukemia lymphoma cancersurvivor cancerhumor cancerfighter cancersucks']\n",
      "['cytogenetic complexity', 'chronic lymphocytic leukemia definitions associations', 'clinical impact']\n",
      "['young patient', 'refractory cll w jacqueline barrientos', 'feinstein institute', 'medical research lymphoma prognosis cancertherapy overallsurvival']\n",
      "['format bsi', 'cll format']\n",
      "['continuous lifecycle london', 'great construction', 'cll continuouslifecycle']\n",
      "['s t', 'chronic lymphocytic leukemia cll hubbyspitty']\n",
      "['cytogenetic complexity', 'chronic lymphocytic leukemia definitions associations', 'clinical impact cll cllsm leusm']\n",
      "['new preprint', 'mimic human cancer mutations', 'celegans sf3b1', 'phd thesis leukemia cll']\n",
      "['chronic lymphocytic leukemia i ain t', 'bell mickey']\n",
      "['chronic lymphocytic leukemia cells', 'mitochondrial fitness', 'cd8 t cells', 'impede car t cell efficacy']\n",
      "['cll vs riverplate']\n",
      "['cll vs riverplate', 'kari vega y ang lica v zquez unidasporelobjetivo cllpy']\n",
      "['cll vs riverplate', 'liza larrea unidasporelobjetivo cllpy']\n",
      "['cll vs riverplate', 'unidasporelobjetivo cllpy']\n",
      "['cll vs riverplate segundo tiempo', 'unidasporelobjetivo cllpy']\n",
      "['cll vs riverplate fin del primer tiempo', 'unidasporelobjetivo cllpy']\n",
      "['cll vs riverplate', 'liza larrea unidasporelobjetivo cllpy']\n",
      "['cll vs riverplate', 'kari vega unidasporelobjetivo cllpy']\n",
      "['cll vs riverplate', 'griselda l pez unidasporelobjetivo cllpy']\n",
      "['cll vs riverplate', 'liza larrea unidasporelobjetivo cllpy']\n",
      "['cll vs riverplate', 'griselda l pez unidasporelobjetivo cllpy']\n",
      "['cll vs riverplate', 'unidasporelobjetivo cllpy']\n",
      "['cll vs riverplate', 'unidasporelobjetivo cllpy']\n",
      "['cll vs riverplate', 'kari vega unidasporelobjetivo cllpy']\n",
      "['cll vs riverplate', 'kari vega unidasporelobjetivo cllpy']\n",
      "['cll vs riverplate', 'bel n ben tez unidasporelobjetivo cllpy']\n",
      "['cll vs riverplate', 'claudia romero unidasporelobjetivo cllpy']\n",
      "['cll vs riverplate', 'liza larrea unidasporelobjetivo cllpy']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['cll vs riverplate', 'karina vega unidasporelobjetivo cllpy']\n",
      "['cll vs riverplate', 'carmen ben tez']\n",
      "['cll vs riverplate', 'unidasporelobjetivo cllpy']\n",
      "['cll vs riverplate', 'kari vega']\n",
      "['cll vs riverplate inici el partido']\n",
      "['cll vs riverplate', 'inicial alicia bobadilla laurie cristaldo carmen ben tez stephenie lacoste anglica v zquez bel n ben tez griselda l pez claudia romero liza larrea m nica vega natalia barros unidasporelobjetivo cllpy']\n",
      "['chronic lymphocytic leukemia cells', 'mitochondrial fitness', 'cd8 t cells', 'impede car t cell efficacy lymphoma lymsm']\n",
      "['big news']\n",
      "['phase iii murano trial', 'new treatment option', 'refractory chronic lymphocytic leukemia bloodcancer hematology']\n",
      "['license agreement amendment increases royalty', 'u s sales', 'chronic lymphocytic leukemia', 'indolent b cell non hodgkin lymphoma treatment']\n",
      "['license agreement amendment increases royalty', 'u s sales', 'chronic lymphocytic leukemia', 'indolent b cell non hodgkin lymphoma treatment']\n",
      "['license agreement amendment increases royalty', 'u s sales', 'chronic lymphocytic leukemia', 'indolent b cell non hodgkin lymphoma treatment']\n",
      "['astrazeneca phase', 'clinical trial', 'positive results', 'cll drug treatment', 'site news healthcare']\n",
      "['lenalidomide bendamustine', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['treatment paradigm', 'chronic lymphocytic leukemia', 'novel agents', 'generation btk', 'pi3k inhibitors', 'dr barrientos cllsm leukemia']\n",
      "['ibrutinib vs ibrutinib', 'patients w chronic lymphocytic leukemia']\n",
      "['results highlight', 'exciting time', 'hematologic malignancies', 'leusm leukemia']\n",
      "['blood jouornal ibrutinib therapy downregulates', 'proliferative fractions', 'chronic lymphocytic leukemia pablo el']\n",
      "['chronic lymphocytic leukemia cll patients', 'cll experts', 'cll progression']\n",
      "['health insurance coverage denial health insurance expert stacey worthy', 'appeal process', 'chronic lymphocytic leukemia cll patients amp', 'social media']\n",
      "['tumor lysis syndrome']\n",
      "['blood commentary ibrutinib']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['michele nadeem baker cll patient advocate']\n",
      "['incurable chronic leukemia', 'll meet', 'great therapist']\n",
      "['cll chronic lymphocytic leukemia']\n",
      "['christoph bock s', 'option crispr', 'model cll', 'atac seq', 'machine learning', 'open chromatin gt 43k sc transcriptomes lead']\n",
      "['human medicines european', 'public assessment report epar arzerra ofatumumab leukemia lymphocytic chronic bcell date', 'human medicines european', 'public assessment report epar arzerra ofatumumab leukemia']\n",
      "['cll drug', 'future therapy', 'c myc translocation non hodgkin lymphomas', 'bad prognosis lymphoma nhl hematology blood']\n",
      "['ibrutinib therapy downregulates', 'proliferative fractions', 'chronic lymphocytic leukemia']\n",
      "['imbruvica market', 'trends size share price growth drivers', 'business opportunities adroit market research cll marketresearch']\n",
      "['immunomodulatory drugs', 'active immunotherapy', 'chronic lymphocytic leukemia']\n",
      "['teacherappreciation gift', 'grateful shout']\n",
      "['ibrutinib cll society ibrutinib tomhenry cllsociety cll']\n",
      "['high incidence', 'adverse events', 'significant economic burden', 'chronic lymphocytic leukemia cll cancer']\n",
      "['cll patients', 'care partner']\n",
      "['mrd response rates', 'ibrutinib exposure w talha munir', 'bsh leusm cllsm leukemia']\n",
      "['successful meeting', 'cll field', 'initiate worldwide collaborations iwcll2019']\n",
      "['chronic lymphocytic leukemia', 'ibrutinib resistance', 'phase ii trial studies', 'chronic lymphocytic leukemia']\n",
      "['oncoalert lymsm ibrutinib therapy downregulates', 'proliferative fractions', 'chronic lymphocytic leukemia cll']\n",
      "['oncoalert lymsm ibrutinib']\n",
      "['gsk phase', 'alemtuzumab ofatumumab', 'symptomatic chronic lymphocytic leukemia estimate primary completion date']\n",
      "['laboratory prognostic indicators', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia treatment industry research report', 'key market insights', 'overall industry ricercaalfa marketresearch research leukemia']\n",
      "['chronic lymphocytic leukaemia', 'cd5 b cells', 'b cell receptor', 'genetic alterations', 'cll pathogenesis']\n",
      "['abbv phase', 'phase 1b study', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma estimate primary completion date']\n",
      "['abbv phase', 'phase 1b study', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma estimate primary completion date']\n",
      "['vit d insufficiency amp prognosis', 'chronic lymphocytic leukemia cll nov', 'shanafelt drake', 'cllsm leusm supponc geriheme']\n",
      "['prognostic factors', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['cll doors', 'devops containers ci cd', 'kubernetes workshops']\n",
      "['elderly patients', 'chronic lymphocytic leukemia']\n",
      "['s webinar key takeaways', 'dr donnellan don t', 'edge research', 'hematology meeting', 'cancer oncology cll']\n",
      "['9na fecha gc vs cll', 'unidasporelobjetivo cllpy']\n",
      "['9na fecha gc vs cll', 'unidasporelobjetivo cllpy']\n",
      "['9na fecha gc vs cll', 'unidasporelobjetivo cllpy']\n",
      "['9na fecha gc vs cll', 'liz pe', 'unidasporelobjetivo cllpy']\n",
      "['9na fecha gc vs cll', 'unidasporelobjetivo cllpy']\n",
      "['9na fecha gc vs cll', 'damia cortaza unidasporelobjetivo cllpy']\n",
      "['9na fecha gc vs cll st', 'unidasporelobjetivo cllpy']\n",
      "['9na fecha gc vs cll', 'fabiola sandoval unidasporelobjetivo cllpy']\n",
      "['9na fecha gc vs cll', 'unidasporelobjetivo cllpy']\n",
      "['9na fecha gc vs cll', 'damia cortaza unidasporelobjetivo cllpy']\n",
      "['9na fecha gc vs cll', 'unidasporelobjetivo cllpy']\n",
      "['9na fecha gc vs cll', 'unidasporelobjetivo cllpy']\n",
      "['9na fecha gc vs cll', 'liz pe', 'unidasporelobjetivo cllpy']\n",
      "['9na fecha gc vs cll', 'unidasporelobjetivo cllpy']\n",
      "['9na fecha gc vs cll partido', 'unidasporelobjetivo cllpy']\n",
      "['new paper', 'nuclear ribonucleoproteins', 'chronic lymphocytic leukemia', 'potential biomarkers', 'disease aggressiveness usereactome']\n",
      "['9na fecha gc vs cll equipo confirmado diana salinas laurie cristaldo paola genes stephenie lacoste anglica v zquez damia cortaza joana galeano fabiola sandoval liza larrea liz pe', 'y natalia barros unidasporelobjetivo cllpy']\n",
      "['chronic lymphocytic leukemia cll patients', 'cll experts', 'cll progression']\n",
      "['car t cell therapy', 'big wave', 'chronic lymphocytic leukemia cll expert dr david maloney shares findings', 'recent clinical trials', 'depth research update', 'car t cell therapy']\n",
      "['chronic lymphocytic leukemia']\n",
      "['health insurance coverage denial health insurance expert stacey worthy', 'appeal process', 'chronic lymphocytic leukemia cll patients amp', 'social media']\n",
      "['pm edt', 'monthly virtual', 'challenging case clinic webinar', 'recordings cme cll']\n",
      "['prognostic value', 'systemic inflammation markers', 'non hodgkin lymphoma', 'chronic lymphocytic leukemia']\n",
      "['issue mechanism', 'b cell chronic lymphocytic leukemia', 'gene expression lead']\n",
      "['rns aim cll cello health plc result']\n",
      "['confident update', 'cello signal', 'line cash conversion', 'decent business', 'i don t hold']\n",
      "['cll cello health', 'robust profits growth', 'uk cll brighterir andrewscotttv capitalnetwork1']\n",
      "['cll cello health', 'robust profits growth', 'uk cll']\n",
      "['cll cello health', 'robust profits growth', 'uk cll brighterir andrewscotttv capitalnetwork1']\n",
      "['briefedup uk stock market news', 'morning cll ehg jsg keys amp vtu']\n",
      "['rns aim cll cello health plc agm statement']\n",
      "['good day', 'app fellow']\n",
      "['noon dr nadia khan', 'elena gitelson memorial lectureship', 'novel chronic lymphocytic leukemia therapies', 'annual lectureship', 'dr gitelson', 'lymphoma specialist']\n",
      "['hits study goal']\n",
      "['amazing hem onc', 'grand rounds', 'novel agents', 'clinical trial', 'real world experience data']\n",
      "['amazing cll team', 'university awards', 'elaine moore jim judges steve gascoigne dean howes emma craddock', 'natalie purnell staffawards cll yourteam']\n",
      "['nice update', 'talha munir', 'clarity trial making', 'bit impact', 'cll thanks']\n",
      "['group katrine melvold', 'master s thesis', 'cll phosphoflow']\n",
      "['video lessons', 'cll clarity study', 'w talha munir', 'bsh leusm cllsm']\n",
      "['chronic lymphocytic leukemia', 'approach cll geriatrics']\n",
      "['peptide vaccination', 'chronic lymphocytic leukemia status', 'condition summary chronic lymphocytic leukemia']\n",
      "['clinicaltrial peptide vaccination', 'chronic lymphocytic leukemia']\n",
      "['wake baptist', 'share cancersucks cll sll leukemia wakebaptist']\n",
      "['amp cll treatment updates', 'patient cll chroniclymphocyticleukemia']\n",
      "['drug sensitivity', 'eha2019 congress', 'amsterdam june']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['jitc research stim1', 'plasma membrane', 'new target', 'progressive chronic lymphocytic leukemia']\n",
      "[]\n",
      "['chronic lymphocytic leukemia cells increase neutrophils survival', 'cd16high cd62ldim immunosuppressive subset']\n",
      "['geriheme gerionc cll cllsm leusm']\n",
      "['national cll patient amp carer information day', 'dublin s spencer hotel ifsc', '4pm register', 'patient advocates amp deborah sims', 'cll patients']\n",
      "['i don t', 'agent ibrutinib', 'chlorambucil obinutuzumab', 'line treatments', 'ibrutinib obinutuzumab vs chlorambucil obinutuzumab cll']\n",
      "['weekly alerts', 'cll news letscurethis']\n",
      "['chemo treatment', 'c l l chronic lymphocytic leukemia stay', 'strong i fight', 'others strength', 'fight cancersuck orangeforleukemia']\n",
      "['cll patients']\n",
      "['prenant toutes les lignes', 'compte pr s', 'des patients llc trait s sont trait s par bcri', 're oivent un traitement fcr', 'sur cette maladie volutive leuc mie traitementllc oncologie h matologie']\n",
      "['i m', 'woohoo cancersucks cll']\n",
      "['chronic lymphocytic leukemia']\n",
      "['ibrutinib reduces obinutuzumab infusion', 'chronic lymphocytic leukemia', 'plasma cytokine levels haematologica']\n",
      "['disease progression', 'chronic lymphocytic leukemia', 'gene somatic hypermutation plays', 'disease course']\n",
      "['b cell malignancies', 'chronic lymphocytic leukemia', 'small lymphocytic leukemia mantle cell lymphoma', 'plasma cell disorders ptce']\n",
      "['great opportunity', 'blood cancer research', 'treatment options register', 'leukemia lymphoma multiplemyeloma mds cll aml nhl immunotherapy cartcell']\n",
      "['treatment strategies', 'cll patients leukemiaupdate']\n",
      "['webcast amp telecast', 'chronic lymphocytic leukemia', 'dr jan']\n",
      "['crummy straw man control arm', 'new drug vs chlorambucil', 'years trials', 'new systematic review']\n",
      "['cll verstehen da chronische lymphatische leuk mie cll sowohl zu den lymphomen als auch zu den leuk mien z hlt sorgt', 'erkrankung oft f r verwirrung cll leuk mie selpers hier geht es zum online kurs']\n",
      "['b cell chronic lymphocytic leukemia treatment adoption', 'drug therapy high dose chemotherapy']\n",
      "['global chronic lymphocytic leukemia market', 'f hoffman', 'roche abbvie teva pharmaceuticals gilead sciences business insights news']\n",
      "['possible additional benefit', 'r r cll', 'interesting reading']\n",
      "['besoin d un rappel', 'h matologie oncologie t l chargez notre ebook mm myeloma cll leuc mie dlbcl lymphome']\n",
      "['long term', 'chronic lymphocytic leukemia leusm hematology']\n",
      "['cart therapy cll']\n",
      "['roberts seymour', 'r r chronic lymphocytic leukemia venetoclax dor', 'cr mrd neg tp53', 'bulky nodal disease btw', 'resistant cllsm research pmcc rmh']\n",
      "['hemato oncology market download', 'free ebook', 'hematology oncology mm multiplemyeloma cll dlbcl']\n",
      "['precision medicine', 'akershus university hospital', 'hoa tran']\n",
      "['chronic lymphocytic leukemia', 'response variables blood journal', 'durable responses ig', 'bulky adenopathy tp53 aberrations notch1 mutations', 'bcr inhibitors']\n",
      "['chimeric antigen receptor therapy', 'chronic lymphocytic leukemia', 'chimeric antigen receptor t cell therapy', 'chronic lymphocytic leukemia bair', 'american journal']\n",
      "['90central feliz d', 'del trabajador ibt cll vmt']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['native kidney biopsy', 'fibrosis pt', 'cll renalpath']\n",
      "['ibrutinib vs ibrutinib', 'patients w chronic lymphocytic leukemia']\n",
      "['follicular lymphoma update', 'american society', 'hematology meeting w stanford university s dr neel gupta gt leukemia cll']\n",
      "['infectious complications', 'chronic lymphocytic leukemia', 'bcr inhibitors', 'retrospective single institution experience autore hematological oncology wiley online library']\n",
      "['common adult leukemia i', 'non chemo drugs ibrutinib', 'amazing advances']\n",
      "['informative thread', 'insights amp comments thanks']\n",
      "['drugs amp treatment regimes options', 'cll fighters']\n",
      "['lymphoma research foundation announces', 'chronic lymphocytic leukemia research grants investment supports', 'young investigators', 'patient therapies', 'lymphoma curesnew york prweb']\n",
      "['chronic lymphocytic leukemia p', 'protein apoptosis zap', 'cd38 receptor']\n",
      "['cll chronic lymphocytic leukemia proliferate', 'expert panel', 'treatment leusm']\n",
      "['12pm pathmicro clinical', 'grand rounds', 'pi3k inhibitors efficacy toxicity', 'dr jennifer', 'brown dir center', 'chronic lymphocytic leukemia institute physician professor esh']\n",
      "['rns aim cll cello health plc total']\n",
      "['chronic lymphocytic leukemia']\n",
      "['vit d insuff amp prognosis', 'chronic lymphocytic leukemia cll']\n",
      "['cousin miyita', 'chronic lymphocytic leukemia', 'i m']\n",
      "['bullish list', 'cll digs sge seit gnc hlma zol nvtk']\n",
      "['leawood ks', 'cll brian koffman cmo', 'annual meeting findings', 'recent patient survey', 'disease management']\n",
      "['f klarar id n', 'livsl ngtl rande det tackar jag f r ppnauniversitetet cll boakademi', 'ak rlek']\n",
      "['perth patients', 'chronic lymphocytic leukemia', 'b cell lymphoma', 'new phase i trial', 'new btk inhibitor loxo', 'c481s mutation', 'info cllsm lymsm']\n",
      "['unexpected visitors', 'good morning wow', 'baa baa', 'black sheep', 'baby sheep readingskills understandingtheworld cll outdoornursery ndnatalk']\n",
      "['huge difference', 'alternatives eyfsresources eyfs earlyyears children language cll positivelanguage']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['postdoc positions microenvironmental interactions', 'chronic lymphocytic leukemia', 'b cell lymphomas brno cz jobs sciencejobs vacancies brno czechrepublic europe eu biochemistry molecularbiology oncology']\n",
      "['peripheral blood mononuclear cells pbmc s samples', 'whole blood', 'unique patients', 'chronic lymphocytic leukemia cll meeting donor exclusion criteria', 'viral infections']\n",
      "['chronic lymphocytic leukemia treatment market', 'cagr till', 'top profilers analysis', 'new technologies size']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['weight practice yoga', 'clinical trial', 'happy birthday', 'years cll mom']\n",
      "['jitc research stim1', 'plasma membrane', 'new target', 'progressive chronic lymphocytic leukemia']\n",
      "['new online cme', 'optimal therapy treatment', 'chronic lymphocytic leukemia cll', 'clinical data', 'cmecredits oncology cityofhope paradigmmedcom']\n",
      "['geoff grubbs', 'georgetown lombardi s', 'medical oncologist bruce cheson md', 'chronic lymphocytic leukemia', 'rare complication']\n",
      "['imbruvica ibrutinib', 'orphan drug worldwide orphandrugs rarediseases chroniclymphocyticleukemia cll']\n",
      "['excellent interview', 'dr adrian wiestner', 'nih cll cllsm letscurethis']\n",
      "['alison duffy pharmd bcop', 'treatment paradigm', 'chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukemia cll', 'bloodcancer affects patients']\n",
      "['chronic lymphocytic leukemia cll', 'immune system', 'white blood cells', 'bone marrow', 't fight infection']\n",
      "['forestschool environment cll']\n",
      "['chronic lymphocytic leukemia', 'bone marrow', 'white blood cell']\n",
      "['immune system', 'cancer treatments']\n",
      "['olimpia vs cll', 'unidasporelobjetivo cllpy']\n",
      "['olimpia vs cll comenz el st', 'unidasporelobjetivo cllpy']\n",
      "['leukemia blood cancer', 'acute myelogenous leukemia', 'common leukemia type', 'chronic myelogenous leukemia', 'chronic lymphocytic leukemia', 'acute lymphocytic leukemia', 'young children']\n",
      "['olimpia vs cll', 'unidasporelobjetivo cllpy']\n",
      "['olimpia vs cll inici el primer tiempo alicia bobadilla stephenie lacoste bel n ben tez damia cortaza johana galeano fabiola sandoval liza larrea griselda l pez ang lica v zquez paola genes karina vega unidasporelobjetivo cllpy']\n",
      "['ji ctla', 'chronic lymphocytic leukemia explores', 'new role', 'drive development', 'cancer therapies readtheji']\n",
      "['von willebrand syndrome', 'allogeneic stem cell transplant', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['minimal residual disease', 'survival outcomes', 'chronic lymphocytic leukemia', 'systematic review', 'meta analysis lymphoma lymsm']\n",
      "['systematic rw meta analysis bendamustine', 'inhl cll bendamustine', 'os hr', 'vs comparator', 'incl comparators dx subtypes blooducation lymsm']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['hodgkin lymphoma transformation', 'chronic lymphocytic leukemia', 'real life data', 'polish lymphoma research group richter transformation rt', 'chronic lymphocytic leukemiasmall lymphocytic lymphoma cllsll', 'hodgkin lymphoma hl']\n",
      "['oncologynews rituximab', 'open label idelalisib']\n",
      "['dr brian koffman', 'dr neil kay', 'mayo cll society', 'educational forum', 'excellent day cll cllsm letscurethis']\n",
      "['full cll patients', 'education seminar', 'morning ss']\n",
      "['patients cll']\n",
      "['cll minneapolis symposium c']\n",
      "['cll patient symposium', 'minneapolis diagnosis treatment novel therapies', 'cll c']\n",
      "['hodgkin lymphoma transformation', 'chronic lymphocytic leukemia', 'real life data', 'polish lymphoma research group lymphoma lymsm']\n",
      "['chronic lymphocytic leukemia', 'response variables lymphoma lymsm']\n",
      "['final results', 'rituximab w idelalisib', 'chronic lymphocytic leukaemia cll', 'long term amp', 'safety profile']\n",
      "['nickiminaj remyma drake tekashi69 boosie cll lilpump cardib lilbaby lilwayne haitian pompano broward miami blueface 50cent kevingates iheartradio youtubemusic rapmusic hiphopmusic lit juicewrld artist music songwriter']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['illumintate trial carol moreno md chroniclymphocyticleukemia cll']\n",
      "['dr catriona jamieson', 'edge hematology research', 'blood cancer specialists', 'lymphoma society event', 'uc san diego', 'real hope mpnsm cll']\n",
      "['dominic leblanc s', 'chronic lymphocytic leukemia', 'complete remission']\n",
      "['cancer 5th', 'annual scientific symposium', 'nice experience playr cll']\n",
      "['pathmicro clinical', 'grand rounds', 'pi3k inhibitors efficacy toxicity', 'dr jennifer', 'brown dir center', 'chronic lymphocytic leukemia institute physician professor', '12pm esh']\n",
      "['chronic lymphocytic leukemia epigenetic deregulation', 'co ordination', 'transcriptomic state cancerresearch']\n",
      "['tnt event', 'tnt events', '90k catch', '26th event']\n",
      "['perfect inspiration note', 'universe fighters cll']\n",
      "['double diagnosis', 'dr sharman', 'disease behavior']\n",
      "['novel chemofree treatment approaches', 'lymphoid malignancies', 'lymsm lymphoma dlbcl fl mcl cll']\n",
      "['q13 q32 ccnd1 igh translocation', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll', 'unusual genetic aberration', 'natural clinical course lymphoma lymsm']\n",
      "['final results rituximab', 'open label idelalisib', 'chronic lymphocytic leukemia leukemia cancer']\n",
      "['q13 q32 ccnd1 igh translocation', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll', 'unusual genetic aberration', 'natural clinical course']\n",
      "['oncoalert lymsm leusm cllsm efficacy', 'chronic lymphocytic leukemia', 'response variables']\n",
      "['chronic lymphocytic leukemia', 'response variables']\n",
      "['manage 17p patients neil e kay m d cll chroniclymphocyticleukemia']\n",
      "['bulk tp53 disruption notch1 mutations', 'bcr i refractoriness', 'venetoclax efficacy', 'chronic lymphocytic leukemia', 'response variables']\n",
      "['small lymphocytic lymphoma', 'proliferation centers', 'high proliferation rate aka', 'small lymphocytic lymphoma chronic lymphocytic leukemia', '17p deletion hemepath pathology lymphoma']\n",
      "['infectious complications', 'chronic lymphocytic leukemia', 'bcr inhibitors', 'retrospective single institution experience']\n",
      "['treatment options', 'young cll patient', 'deletion 17p', 'different approach dr neil e kay cll']\n",
      "['successful conference']\n",
      "['cll jacqueline barrientos m d cll chroniclymphocyticleukemia']\n",
      "['cll carsten niemann', 'clinical trials', 'studies lymphoma lymsm']\n",
      "['christian poulsen', 'knowyournodes lymphoma']\n",
      "['patient story', 'cll conference thanx']\n",
      "['lymphoma hub satellite symposium lymhubss', 'icml lymphoid malignancies', 'chemofree lymsm lymphoma dlbcl fl mcl cll']\n",
      "['genetic mutations', 'cll care', 'expert dr', 'prognostic factors', 'optimal timing', 'frequency leusm']\n",
      "['dr tamar tadmor', 'haifa israel', 'treatment options', 'joint foreningen conference', 'free era', 'cll patients']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['national meeting', 'washington dc', 'immune characteristics', 'aerobic fitness', 'physical function', 'treatment naive cll']\n",
      "['plasma membrane', 'new target', 'progressive chronic lymphocytic leukemia ionchannels j immunother cancer']\n",
      "['exciting conference', 'tamar tadmor']\n",
      "['joint lce lyle foreningen cll lymphoma conference', 'exciting day']\n",
      "['p vej til cll fokusdag m i kbh afholdes i samarbejde m leusm lce handler om blodkr ft lyle dk']\n",
      "['aspin ridge tenderloin cipolinni onions', 'bone marrow crumb horseradish gel cll tastingmenu fnb2020']\n",
      "['dr mato', 'diagnostic workup', 'treatment considerations', 'chronic lymphocytic leukemia', 'clinic cllsm leukemia leusm']\n",
      "['cll jennifer', 'brown m d chroniclymphocyticleukemia cll']\n",
      "['cancer cancersucks humorfightscancer leukemia cll']\n",
      "['victoria por', 'm nima', 'libertad limpe o ante cerro por el f tbol femenino tanto anotado por liza larrea vamosguma cll']\n",
      "['progressive multifocal leukoencephalopathy pml', 'chronic lymphocytic leukemia hiv infection lymphoma', 'idiopathic lymphopenia']\n",
      "['cll vs ccp', 'unidasporelobjetivo cllpy']\n",
      "['cll vs ccp', 'unidasporelobjetivo cllpy']\n",
      "['cll vs ccp', 'unidasporelobjetivo cllpy']\n",
      "['cll vs ccp', 'cambio liz pe', 'ngeles portillo unidasporelobjetivo cllpy']\n",
      "['cll vs ccp', 'cambio kari vega paola genes unidasporelobjetivo cllpy']\n",
      "['cll vs ccp', 'unidasporelobjetivo cllpy']\n",
      "['cll vs ccp', 'unidasporelobjetivo cllpy']\n",
      "['cll vs ccp', 'liza larrea unidasporelobjetivo cllpy']\n",
      "['chronic lymphocytic leukemia']\n",
      "['cll vs ccp', 'unidasporelobjetivo cllpy']\n",
      "['cll vs ccp', 'unidasporelobjetivo cllpy']\n",
      "['cll vs ccp', 'unidasporelobjetivo cllpy']\n",
      "['cll vs ccp', 'unidasporelobjetivo cllpy']\n",
      "['cll vs ccp', 'unidasporelobjetivo cllpy']\n",
      "['cll vs ccp', 'unidasporelobjetivo cllpy']\n",
      "['cll vs ccp', 'unidasporelobjetivo cllpy']\n",
      "['cll vs ccp comenz el partido alicia bobadilla ang lica v zquez laurie cristaldo stephenie lacoste carmen ben tez damia cortaza joana galeano fabiola sandoval griselda l pez natalia pe', 'karina vega']\n",
      "['chronic lymphocytic leukemia']\n",
      "['cll patient seminar']\n",
      "['final results', 'phase iii study', 'open label idelalisib', 'chronic lymphocytic leukemia oncoalert']\n",
      "['chip seq amp singlecell transcriptomics researchers analyze epigenomics', 'cll amp healthy b lymphocytes', 'coordination betw cll epigenome layers links epigenetics amp cancer evolution openaccess oncology']\n",
      "['cll patients', 'patients download', 'free ebook', 'hematology oncology']\n",
      "['des patients cll trait s', 'sont avec bcris', 're oivent fcr t l chargez notre ebook gratuit', 'sur l h matologie oncologie']\n",
      "['s joint lce lyle foreningen', 'national conference', 'chronic lymphocytic leukaemia lymphoma cll']\n",
      "['cancer look', 'healthinsurance plan tune', 'amp eliot finkelstein', 'insurance cll leusm livingwell']\n",
      "['final results', 'chronic lymphocytic leukemia cll leusm']\n",
      "['hematological malignancies', 'cme activity', 'pertinent studies', 'stephen ansell md phd jennifer', 'brown md phd amp nitin jain md mbbs']\n",
      "['hugh growth', 'chronic lymphocytic leukemia market', 'good revenue status till']\n",
      "['lymhubss questions', 'lymsm lymphoma dlbcl fl mcl cll']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['cll patients', 'clinical trials', 'routine clinical practice', 'yazdy amp']\n",
      "['recent work', 'epigenetic diversification', 'chronic lymphocytic leukaemia', 'cll leukemia epigenetics']\n",
      "['exciting work', 'colleague dan landau chronic lymphocytic leukemia epigenetic diversification', 'epigenetic information', 'cellular identities', 'evolution congrats']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['leukemia patients dr jennifer woyach']\n",
      "['chronic lymphocytic leukemia']\n",
      "['mi momento wrestler', 'prowrestler chileanswrestler luchalibre luchalibrechilena elmejorbotazodechile cll xnl ngen pisoton lenkoday elmejordecll taylorwolfgym likeforlikes']\n",
      "['s stateofscience']\n",
      "['key clinical trials', 'chronic lymphocytic leukemia', 'cll leukemia']\n",
      "['alessandro pastore', 'great collaboration cll leukemia epigenetics']\n",
      "['oncoalert lymsm', 'venetoclax rituximab', 'refractory chronic lymphocytic leukemia cll eradicates minimal residual disease mrd', 'prolongs survival post treatment', 'murano phase iii study asco']\n",
      "['new jitc research stim1', 'plasma membrane', 'new target', 'progressive chronic lymphocytic leukemia']\n",
      "['pertinent studies', 'chronic lymphocytic leukemia diffuse', 'large b cell lymphoma', 'waldenstrom macroglobulinemia', 'free cme']\n",
      "['leawood ks', 'cll brian koffman cmo', 'annual meeting findings', 'recent patient survey', 'disease management']\n",
      "['cll patients', 'rbc transfusions', 'hemoglobin transfusion trigger', 'rbc transfusion', 'isbtscience voxsanguinis cll']\n",
      "['high incidence', 'adverse events', 'significant economic burden', 'chronic lymphocytic leukemia cll cancer']\n",
      "['cll doors', 'devops containers ci cd', 'kubernetes workshops']\n",
      "['video limitations', 'car t cell therapy', 'lymphoma w tanya siddiqi', 'immunoonc ebmt19 cll cllsm lymsm']\n",
      "['minutes survey', 'chronic lymphocytic leukemia cll', 'current therapies', 'biosimilar rituximab tbd link']\n",
      "['new combination therapy', 'leukemia patients cll']\n",
      "['don t', 'post ash cll patient', 'educational forum', 'weill cornell medicine', 'nyc cll cllsm leukemia letscurethis']\n",
      "['healthevoices19 i', 'amp ken cll']\n",
      "['globallc un nuevo modelo', 'abordaje integral del paciente', 'con leucemia linfoc tica cr nica cll']\n",
      "['gduhem2019 jacqueline c barrientos md ms']\n",
      "['great meeting', 'cll patientpower lupus suicideprevention']\n",
      "['advocates gps guts purpose strategy cll']\n",
      "['indolent lymphoma dr marc hoffmann', 'clinical trials', 'treatment options click']\n",
      "['news abscience du']\n",
      "['sept edinburg scotland press registration']\n",
      "['chronic lymphocytic leukemia therapeutics market epidemiology analysis therapy development growth demand', 'new technology', 'top key player', 'download sample copy']\n",
      "['chileluchalibre luchalibrechilena cll']\n",
      "['hoy cll chileluchalibre presenta vivalabotch iwc luchalibrechilena nagero5taregi n pepex']\n",
      "['hoy cll chileluchalibre presenta vivalabotch iwc luchalibrechilena nagero5taregi n pepex']\n",
      "['hoy cll chileluchalibre presenta vivalabotch iwc luchalibrechilena nagero5taregi n pepex']\n",
      "['hoy cll chileluchalibre presenta vivalabotch iwc luchalibrechilena nagero5taregi n pepex']\n",
      "['hoy cll chileluchalibre presenta vivalabotch iwc luchalibrechilena nagero5taregi n pepex']\n",
      "['frontline ibrutinib', 'standard fcr', 'chronic lymphocytic leukemia patients', 's tait shanafelt']\n",
      "['duelo suspendido entre libertad limpe o y cerro por el f tbol femenino', 'reprogramaci n vamosguma cll']\n",
      "[]\n",
      "['i ve', 'dragon egg', 'moment eyfstwitterpals', 'eyfs earlyyears edutwitter cll kuw dragons']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['gnocchi sends', 'ain t', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['tragic loss', 'cll community']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['final results', 'phase iii study', 'open label idelalisib', 'chronic lymphocytic leukemia']\n",
      "['myeloma lymphoma', 'aml cll', 'mrd focus', 'residual disease']\n",
      "['dr wierda', 'treatment option', 'chronic lymphocytic leukemia', 'disease leukemia leusm']\n",
      "['cll signup amp', 'treatment options', 'cancer center s dr burger']\n",
      "['patients james s jennifer woyach discusses results', 'chronic lymphocytic leukemia patients']\n",
      "[]\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['independent demonstration', 'bcl2 mutation g101v', 'bcl2 mutation d103y', 'venetoclax resistance']\n",
      "['cll lakelouise thinice']\n",
      "['new ground', 'leukemia care', 'free world podcast']\n",
      "['important paper']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['afternoon s entertainment', 'boxes rainyday juanemakerspace housesforstuffies']\n",
      "['rwe venetoclax tls cll', 'interesting conclusions']\n",
      "['tls risk assessment', 'non trial setting', 'renal function cll']\n",
      "['important work', 'great uk', 'pre ven tls risk group creatinine clearance', 'ven pts', 'r r cll renal function', 'critical element', 'assessment blooducation']\n",
      "['important paper', 'conclusion risk', 'tls exists', 'real world setting', 'cll patients', 'intermediate risk patient', 'high risk patient cllsm']\n",
      "['cll patients', '17p deletion', 'cll expert dr richard furman', 'prognostic markers', 'clinical behavior leusm']\n",
      "['tgif cll thepatient healthevoices19']\n",
      "['chronic lymphocytic leukemia', 'richter transformation']\n",
      "['minimal residual disease mrd negativity', 'undetectable disease', 'important measure']\n",
      "['onze nieuwste keuzehulp', 'kh chronische lymfatische leukemie cll kwam tot stand', 'ons ervaren team hematologie sdm leukemie ehealth samenbeslissen']\n",
      "['rgpd ce que', 'r glement g n ral sur', 'protection des donn es', 'consommateur les volutions', 'rendre notre solution', 'fid lisation des clients clinkloyalty conforme gdpr cll d cryptage']\n",
      "['chronic lymphocytic leukemia market', 'f hoffman', 'roche abbvie teva pharmaceuticals gilead sciences johnson johnson market trends']\n",
      "['annie fitzgerald', 'medicare advantage plan', 'blue shield', 'premium yes', 'chronic lymphocytic leukemia donate']\n",
      "['humor oncological', 'cancer humorfightscancer cll leukemia cancerstinks']\n",
      "['chronic lymphocytic leukemia']\n",
      "['trial results', 'free future treatment hospital leukaemia chemotherapy venetoclax obinutuzumab cll']\n",
      "['day cll cllsm letscurethis']\n",
      "['available register', 'bloodcancer aml immunotherapy transplant multiplemyeloma mds cll nhl lymphoma leukemia']\n",
      "['health canada s rigorous process', 'new biosimilar', 'non hodgkin lymphoma chronic lymphocytic leukemia', 'rheumatoid arthritis']\n",
      "['dr wierda', 'combination therapy', 'refractory chronic lymphocytic leukemia bloodcancers leusm leukemia']\n",
      "['dr anil awesti senior teaching fellow', 'jim judges', 'senior academic technologist', 'cll outreach activities', 'academic outreach', 'annual conference']\n",
      "['interesting cases', 'autoimmune cytopenia aitp aiha', 'bcl2 inhibitor venetoclax openaccess hemasphere']\n",
      "['idela ofatumumab', '1l cll', 'tox esp immune others', 'trial s', 'dx pd', '9m high rates', 'hepatitis mpfs 23m', 'v watchful', 'idela r 1l', 'tp53 del mut cll blooducation']\n",
      "['important data presentation', 'hem onc', 'cll14 venetoclax gazyva', '1l cll', 'deseat btki', '1l comorbid setting cll']\n",
      "['cancer patients', 'caregivers cll cllsm letscurethis']\n",
      "['idelalisib cll usoncology']\n",
      "['chronic lymphocytic leukemia', 'don t', 'ibrutinib experts']\n",
      "['kansas society', 'clinical oncology', 'special cll presentation', 'brian koffman', 'annual meeting register']\n",
      "['final idela r vs r placebo', 'r r cll lt pfs benefit', 'os benefit', 'cll idela r equiv efficacy tp53 dx vs non dx ritux monotx', 'soc option', 'r r cll idela r', 'useful option', 'pts blooducation lymsm']\n",
      "['alison duffy pharmd bcop', 'practice guidelines', 'chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['recent data', 'small molecule combinations', 'duration treatments', 'strong activity', 'salvage settings', 'chronic lymphocytic leukemia bloodcancers leukemia']\n",
      "['cll chronic lymphocytic leukemia proliferate', 'expert panel', 'treatment leusm']\n",
      "['uaa vs cll', 'final del primer tiempo', 'unidasporelobjetivo cllpy']\n",
      "['uaa vs cll', 'damia cortaza unidasporelobjetivo cllpy']\n",
      "['uaa vs cll', 'liz pe', 'unidasporelobjetivo cllpy']\n",
      "['uaa vs cll', 'carmen ben tez unidasporelobjetivo cllpy']\n",
      "['uaa vs cll', 'karina vega unidasporelobjetivo cllpy']\n",
      "['uaa vs cll', 'fabiola sandoval unidasporelobjetivo cllpy']\n",
      "['uaa vs cll', 'karina vega unidasporelobjetivo cllpy']\n",
      "['uaa vs cll', 'fiorella mart nez unidasporelobjetivo cllpy']\n",
      "['uaa vs cll', 'karina vega unidasporelobjetivo cllpy']\n",
      "['uaa vs cll', 'griselda garay y karina vega unidasporelobjetivo cllpy']\n",
      "['uaa vs cll', 'karina vega unidasporelobjetivo cllpy']\n",
      "['uaa vs cll', 'fabiola sandoval unidasporelobjetivo cllpy']\n",
      "['uaa vs cll', 'griselda garay unidasporelobjetivo cllpy']\n",
      "['uaa vs cll', 'liz pe', 'griselda garay y karina vega unidasporelobjetivo cllpy']\n",
      "['uaa vs cll', 'karina vega y fabiola sandoval unidasporelobjetivo cllpy']\n",
      "['uaa vs cll inici el partido', 'unidasporelobjetivo cllpy']\n",
      "['uaa vs cll equipo confirmado diana salinas carmen ben tez ang lica v zquez paola genes stephanie lacoste fiorela mart nez damia cortaza fabiola sandoval griselda l pez liz pe', 'karina vega unidasporelobjetivo cllpy']\n",
      "['cll luekemia leusm']\n",
      "['follicular lymphoma', 'ibrutinib imbruvica idelalisib zydelig venetoclax venclexta share feedback']\n",
      "['cancer diagnosis', 'cll chronic lymphocytic leukemia patients', 'way leusm powerfulpatients']\n",
      "['dr kipps', 'cll cllsm leukemia letscurethis']\n",
      "['cll healthevoices19']\n",
      "['chronic lymphocytic leukemia', 'patients gt', 'white cell']\n",
      "['han sigut', 'amb tots els castors i ll drigues del cms hem fet molts amics i', 'hem parat', 'jugar i gaudir riu amunt koat cms riuamunt cll elscontes', 'carral solsona', 'carral solsona']\n",
      "['scan results bearish', 'bby xsg smds cwr jlg tpou apf cll hlcl stb']\n",
      "['high complete remission rates cll endcancer']\n",
      "['video ublituximab umbralisib', 'nhl w loretta nastoupil', 'bsh2019 cllsm']\n",
      "['video amp', 'genetic mutation amp recommendations']\n",
      "['possible hurdles leusm']\n",
      "[]\n",
      "['different data', 'chronic lymphocytic leukemia bloodcancer hematology']\n",
      "['chronic lymphocytic leukemia']\n",
      "['richter syndrome epidemiology', 'large population', 'chronic lymphocytic leukemia cohort', 'norway lymphoma lymsm']\n",
      "['skola i v rldsklass seminarium', 'lars svedberg i tammerfors skolaiv rldsklass', 'utbildningsdirekt rer', 'cll tammerfors']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['lisa henley durcan', 'full time', 'lisa gt']\n",
      "['chronic lymphocytic leukemia oral oncolytic complexities']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['leawood ks', 'cll brian koffman cmo', 'annual meeting findings', 'recent patient survey', 'disease management']\n",
      "['cll cells cycle', 'cyclin d2 immunol', 'new study', 'shows pi3k amp stat5', 'cpg il', 'vitro leukemia bcells']\n",
      "['young investigators']\n",
      "['cll expert dr richard furman', 'clinical research', 'leusm asktheexpert leukemia']\n",
      "['rns aim cll cello health plc', 'annual report']\n",
      "['ibrutinib therapy releases leukemic surface igm', 'antigen drive', 'chronic lymphocytic leukemia patients']\n",
      "['global chronic lymphocytic leukemia market outlook', 'f hoffman', 'roche abbvie teva pharmaceuticals']\n",
      "['ibrutinib therapy releases leukemic surface igm', 'antigen drive', 'chronic lymphocytic leukemia patients']\n",
      "['chronic lymphoid leukemia', 'fatal disease', 'diagnostic guideline', 'effective treatments', 'individual patients', 'prof rka posp ilov']\n",
      "['oral oncolytic access']\n",
      "['app shopper chronic lymphocytic leukemia']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['medicine chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia clinical impact']\n",
      "['video leukaemia care', 'unmet needs', 'patients w', 'bsh2019 leusm cll cllsm']\n",
      "['chronic lymphocytic leukemia cll clinical impact', 'treatment cllsm leusm']\n",
      "['oncoalert lymsm bendamustine', 'indolent b cell lymphoproliferative malignancies nhl', 'chronic lymphocytic leukaemia cll', 'meta analysis']\n",
      "['leukemia leukaemia cll patients']\n",
      "['video communication', 'cll patients', 'w ben kennedy', 'hospital bsh2019 cllsm']\n",
      "['chronic lymphocytic leukemia cancer', 'bone marrow hammer', 'facebook page', 'amy s', 'healthcare costs', 't shirts wtf']\n",
      "['ultmann chicago lymphoma symposium', 'real world data', 'cll ultmannsymposium cll mskcc chicagolymphoma2019']\n",
      "['patient adherence', 'chronic lymphocytic leukemia', 'oral oncolytics']\n",
      "['ibrutinib doses', 'chronic lymphocytic leukemia']\n",
      "['scientific updates', 'stellar faculty nhl cll fl mzl ptcl', 'chicago team', 'drs sonali smith leo gordon']\n",
      "['cll experts dr sharman dr choi', 'amp dr menashe', 'town meeting', 'online leusm']\n",
      "['teva canada announces', 'non hodgkin s lymphoma chronic lymphocytic leukemia', 'rheumatoid arthritis rhhby']\n",
      "['academic talk', 'prof richard rosenquist brandell', 'genomic medicine sweden', 'research focuses', 'chronic lymphocytic leukemia']\n",
      "['novel chk1 inhibitor mu380 exhibits', 'significant single agent activity', 'chronic lymphocytic leukemia cells lymphoma lymsm']\n",
      "['gift healthevoices19 cll thepatientreporter']\n",
      "['recent trials', 'novel treatment strategies', 'chronic lymphocytic leukemia', 'car t cell therapy']\n",
      "['video infectious complications', 'cll prevention', 'treatment w ben kennedy', 'hospital bsh2019 cllsm ibrutinib rituximab']\n",
      "['high incidence', 'adverse events', 'significant economic burden', 'chronic lymphocytic leukemia cll healthcarecosts cancertreatment financialtoxicity']\n",
      "['pain fatigue night sweats sinus infections', 'cll chronic lymphocytic leukemia', 'uncomfortable symptoms tune']\n",
      "['csd board', 'school directors president julie haywood', 'week s times chronicle glenside news', 'past saturday s cheltenham', 'league opening day playball openingday cll']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['safety pk', 'hematologic malignancies status', 'condition summary chronic lymphocytic leukemia non hodgkin lymphoma']\n",
      "['patients inspirational cll']\n",
      "[]\n",
      "['minutes survey', 'chronic lymphocytic leukemia cll', 'current therapies', 'biosimilar rituximab tbd link']\n",
      "['chronic lymphocytic leukemia cll']\n",
      "['clinicaltrials i', 'clinical trial coordinator', 'tap cll']\n",
      "['key updates', 'chronic lymphocytic leukemia', 'interview stateofscience']\n",
      "['pcrowd participants', 'young cll patients', 'igh mutations', 'long term survival', 'ibrutinib monotherapy', 'ecog study promisestudy cllsm mmsm']\n",
      "['minutes whew dr davids', 'chair dr richardson stateofscience hematology hematology', 'ibrutinib trials data']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['fugitive gas emissions chronic lymphocytic leukemia clinical communication portals']\n",
      "['recent developments', 'fda hematology leukemia ashighlights cll aml hcl']\n",
      "['conex o lado leste est na atividade em breve muito rap', 'bem pra nois cll']\n",
      "['chronic lymphocytic leukemia', 'new research']\n",
      "['video update', 'cll research', 'memorial sloan', 'bsh2019 cllsm']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['world data']\n",
      "['gduhem2019 discusses ibrutinib', 'standard chemoimmunotherapeutic regimen', 'intravenous fludarabine cyclophosphamide']\n",
      "['cll cello health plc elevator pitch', 'uk cll']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['cll cello health plc elevator pitch', 'uk cll brighterir andrewscotttv capitalnetwork1']\n",
      "['cll cello health plc elevator pitch', 'uk cll brighterir andrewscotttv capitalnetwork1']\n",
      "['follicular lymphoma share', 'bloodcancer follicularlymphoma']\n",
      "['marketwatch teva canada announces', 'canada biologics medicine rheumatoidarthritis biosimilar teva truxima thepmi19']\n",
      "['chronic lymphocytic leukemia']\n",
      "['efficacy results', 'line idelalisib', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['teva canada announces', 'non hodgkin s lymphoma chronic lymphocytic leukemia', 'rheumatoid arthritis']\n",
      "['chronic lymphocytic leukemia part']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['cll vs sol', 'final del partido', 'unidasporelobjetivo cllpy']\n",
      "['cll vs sol', 'ingresa liz pe', 'sale karina vega unidasporelobjetivo cllpy']\n",
      "['cll vs sol', 'unidasporelobjetivo cllpy']\n",
      "['cll vs sol', 'karina vega unidasporelobjetivo cllpy']\n",
      "['cll vs sol', 'unidasporelobjetivo cllpy']\n",
      "['cll vs sol', 'ingresa fabiola sandoval sale liza larrea unidasporelobjetivo cllpy']\n",
      "['cll vs sol segundo tiempo', 'unidasporelobjetivo cllpy']\n",
      "['cll vs sol', 'unidasporelobjetivo cllpy']\n",
      "['cll vs sol', 'unidasporelobjetivo cllpy']\n",
      "['cll vs sol', 'unidasporelobjetivo cllpy']\n",
      "['cll vs sol', 'karina vega unidasporelobjetivo cllpy']\n",
      "[]\n",
      "['cll vs sol', 'unidasporelobjetivo cllpy']\n",
      "['clinicalupdates review', 'treatment options', 'aml cll amp multiplemyeloma explore w drs delgado']\n",
      "['cll chroniclymphocyticleukemia rarediseases']\n",
      "[]\n",
      "['double diagnosis', 'dr sharman', 'disease behavior']\n",
      "['chronic lymphocytic leukaemia', 't cells', 'b cell disease cll cllsm leusm']\n",
      "['high orr', 'treatment na ve cll']\n",
      "['b cell disease', 'excellent review']\n",
      "['cll capital markets event']\n",
      "['rns aim cll cello health plc capital markets event']\n",
      "['efficacy results', 'line idelalisib', 'chronic lymphocytic leukemia cll cllsm leusm']\n",
      "['cll society', 'support group meetings visit', 'information cll cllsm leukemia letscurethis']\n",
      "['cancer look', 'healthinsurance plan tune', 'amp eliot finkelstein', 'insurance cll leusm livingwell']\n",
      "['cll patients', 'care partner']\n",
      "['science leusm leuksm']\n",
      "['new research article', 'cd38 enhances', 'antileukemic activity', 'chronic lymphocytic leukemia cll']\n",
      "['leukemia patients', 'dr jennifer woyach', 'free world podcast']\n",
      "['genetic mutations', 'cll care', 'expert dr', 'prognostic factors', 'optimal timing', 'frequency leusm']\n",
      "['chronic lymphocytic leukemia']\n",
      "['outspokenoncology podcast series i host amp', 'experience journey', 'experience u don t', 'new episode']\n",
      "['new short courses', 'cll book']\n",
      "['i manage ibrutinib intolerance', 'chronic lymphocytic leukemia blood journal']\n",
      "['video enhancer landscape', 'btk inhibition w', 'bsh2019 cllsm leusm leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['warrior language', 'interview cll chroniclymphocyticleukemia']\n",
      "['own dr brian koffman', 'car t therapy', 'life cll cllsm letscurethis']\n",
      "['i manage ibrutinib intolerance', 'chronic lymphocytic leukemia']\n",
      "['hashtag activemonitoringtip', 'treatment option', 'info amp advice', 'watchandwait cll nonhodgkin tips livingwithlymphoma']\n",
      "['cll patient', 'treatment resistance', 'cll expert dr richard furman', 'shares research', 'clinical relapse leusm']\n",
      "[]\n",
      "['good luck chef cll']\n",
      "['telomer length', 'cll congrats', 'gcllsg cooperation partners', 'michael chelliah jebaraj', 'stephan stilgenbauer', 'ulm germany cllsm']\n",
      "['btk inhibitors', 'chronic lymphocytic leukemia leusm']\n",
      "['ibrutinib vs ibrutinib', 'chronic lymphocytic leukemia', 'na ve del17p tp53mut']\n",
      "['chroniclymphocyticleukemia patients amp caregivers', 'dr jan berger', 'cll chroniclymphocyticleukemia healthevoices2019 thepatientreporter']\n",
      "[]\n",
      "['cll vs sanlorenzo', 'final del partido', 'unidasporelobjetivo cllpy']\n",
      "['cll vs sanlorenzo cabezazo y gool', 'laurie cristaldo unidasporelobjetivo cllpy']\n",
      "['cll vs sanlorenzo', 'unidasporelobjetivo cllpy']\n",
      "['cll vs sanlorenzo', 'unidasporelobjetivo cllpy']\n",
      "['cll vs sanlorenzo', 'unidasporelobjetivo cllpy']\n",
      "['cll vs sanlorenzo', 'unidasporelobjetivo cllpy']\n",
      "['cll vs sanlorenzo gooool', 'laurie cristaldo unidasporelobjetivo cllpy']\n",
      "['cll vs sanlorenzo', 'unidasporelobjetivo cllpy']\n",
      "['cll vs sanlorenzo arranc el segundo tiempo', 'unidasporelobjetivo cllpy']\n",
      "['cll vs sanlorenzo', 'final del primer tiempo', 'unidasporelobjetivo cllpy']\n",
      "['cll vs sanlorenzo', 'unidasporelobjetivo cllpy']\n",
      "['cll vs sanlorenzo', 'unidasporelobjetivo cllpy']\n",
      "['cll vs sanlorenzo', 'unidasporelobjetivo cllpy']\n",
      "['cll vs sanlorenzo', 'unidasporelobjetivo cllpy']\n",
      "['cll vs sanlorenzo', 'unidasporelobjetivo cllpy']\n",
      "['cll vs sanlorenzo', 'unidasporelobjetivo cllpy']\n",
      "['equipo confirmado cll vs sanlorenzo diana salinas laurie cristaldo stephanie lacoste carmen ben tez paola genes damia cortaza joana galeano griselda l pez claudia romero liza larrea m nica vega unidasporelobjetivo cllpy']\n",
      "['great advice']\n",
      "[]\n",
      "['educate patients', 'cll cllsm']\n",
      "['cll patients', '17p deletion', 'cll expert dr richard furman', 'prognostic markers', 'clinical behavior leusm']\n",
      "['early studies', 'car t cell combination', 'chronic lymphocytic leukemia', 'asco post']\n",
      "['support amp information', 'chronic lymphocytic leukaemia cll', 'follicular lymphoma', 'work lymphomamatters bloodcancer livingwithlymphoma']\n",
      "['s cure', 'cll cllsm letscurethis']\n",
      "['chronic lymphocytic leukemia', 'novo mds', 'institution experience lymphoma lymsm']\n",
      "['great interview', 'cll patients', 'different therapy options thanks']\n",
      "['novel trna', 'rna fragment', 'high prognostic potential', 'chronic lymphocytic leukemia']\n",
      "['lce lymphoma cll community advisory board meeting']\n",
      "['cll patients', 'clear pic', 'care decisions', 'town mtg', 'wath online', 'replay leusm']\n",
      "['weeks cll cab', 'cll patients', 'big thanks']\n",
      "['lymphoma coalition europe lce lymphoma', 'cll community advisory board cab lymphomamatters']\n",
      "['formidable force', 'week s lce lymphoma', 'cll cab', 'big thanks', 'inc sk']\n",
      "['formidable force', 'week s lce lymphoma', 'cll cab', 'big thanks', 'foreningen camp']\n",
      "['expert discusses', 'new treatment options']\n",
      "['hard work', 'lymphoma coalition europe lymphoma', 'cll community advisory board', 'long week', 'meetings key developments', 'patient perspective re', 'new treatments access', 'proms quality', 'life issues']\n",
      "['novel trna', 'rna fragment', 'high prognostic potential', 'chronic lymphocytic leukemia hematol oncol cancer epidemiology']\n",
      "['mrs seddon', 'bearhunt cll r pd ead']\n",
      "['u s fda approves imbruvica ibrutinib', 'non chemotherapy combination regimen', 'treatment naive patients', 'chronic lymphocytic leukemia']\n",
      "['leukemia imbruvica', 'free regimen', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia david gambone', 'health journey']\n",
      "['pharmaceutical product winners', 'chronic lymphocytic leukemia cll', '17p deletion']\n",
      "['smudge cell smudge cells', 'identifiable cytoplasmic membrane', 'nuclear structure smudge cells', 'basket cells', 'fragile lymphocytes', 'chronic lymphocytic leukemia cll']\n",
      "['cll news cllsm letscurethis']\n",
      "['cd38 enhances', 'antileukemic activity', 'chronic lymphocytic leukemia cll']\n",
      "[]\n",
      "['right doctor contribute', 'patient s confidence', 'patientcaf segment', 'right healthcare team', 'difference cll leusm']\n",
      "['refractory chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['rns aim cll cello health plc total']\n",
      "['bioscience chromatin', 'cell immune', 'temporal dynamics', 'ibrutinib drug response', 'chronic lymphocytic leukemia biorxiv']\n",
      "['cell immune', 'temporal dynamics', 'ibrutinib drug response', 'chronic lymphocytic leukemia']\n",
      "['cll patients', 'ibrutinib treatment', 'monitor response', 'biorxiv preprints']\n",
      "['treatment options', 'chronic lymphocytic leukemia cll f leukemia executive', 'medical director', 'cll section chief william g wierda m d ph d', 'magazine endcancer leusm']\n",
      "['cancer diagnosis', 'cll chronic lymphocytic leukemia patients', 'way leusm powerfulpatients']\n",
      "['cell immune', 'temporal dynamics', 'ibrutinib drug response', 'chronic lymphocytic leukemia biorxiv']\n",
      "['cll patients access', 'new treatments']\n",
      "['b cell chronic lymphocytic leukemia pipeline review h1', 'researchbymarkets pharma pharmaceuticals therapeutics drugdiscovery preclinical molecules therapeutic drugtarget chemotherapy oncology']\n",
      "['new advances', 'cart treatment', 'leukemia patients magazine cll endcancer']\n",
      "['novel agents', 'treatment landscape', 'chronic lymphocytic leukemia', 'front line setting']\n",
      "['leukemia2019 leukemia cancer lymphoma oncology aml', 'cml cll mpal bonemarrowtransplant aplasticanemia stemcelltransplant hematology bloodcancer stemcells transplant']\n",
      "['chronic lymphocytic leukemia', 'bone marrow', 'white blood cell']\n",
      "['front line combinations', 'new agents evolve chronic lymphocytic leukemia landscape']\n",
      "['dustin participates', 'chronic lymphocytic leukemia', 'march dustin', 'cll warrior husband register']\n",
      "['cd38 enhances', 'antileukemic activity', 'chronic lymphocytic leukemia cll']\n",
      "['genentech submits supplemental', 'new drug application', 'chronic lymphocytic leukemia', 'medical conditions']\n",
      "['cll society nih patient', 'educational forum cll cllsm leukemia bloodcancer']\n",
      "['cartcell therapy', 'cll experts', 'treatment research', 'landmark immunotherapy leusm']\n",
      "['place lymphoid malignancy meeting conf centre', 'day course', 'haematology colleagues', 'lymphoma myeloma cll view']\n",
      "['meget vigtigt m', 'som kan skabe bedre forhold', 'lymfekr ft cll patienter i europa vi snakker om blodcancer s f lg', 'blodkr ft lyle dk']\n",
      "['notch1 sf3b1 mdm2', 'myd88 mutations', 'chronic lymphocytic leukemia']\n",
      "['lce lymphoma cll community advisory board meetings', 'expert group', 'patient carer advocates', 'european lymphoma cll community', 'lymphoma outcomes lymsm']\n",
      "['lymphoma coalition europe s lymphoma cll community advisory board meeting', 'brussels lymphomacab']\n",
      "['pubsaludmurcia high prognostic value', 'measurable residual disease detection', 'flow cytometry', 'chronic lymphocytic leukemia patients', 'front line fludarabine cyclophosphamide', 'year rituximab maintenance']\n",
      "['cutaneous viral infections', 'incident cutaneous squamous cell carcinoma', 'chronic lymphocytic leukemia', 'hematopoietic stem cell transplant patients']\n",
      "['oral formulation', 'synthetic purine analog', 'hairy cell leukemia', 'b cell chronic lymphocytic leukemia']\n",
      "[]\n",
      "[]\n",
      "['dr esteban braggio', 'dr koichi takahashi', 'novel single cell dna applications', 'spotlight theater b', 'aacr19 aacr2019 cancerresearch singlecell dnaseq']\n",
      "['novel agents', 'relevant standards', 'bsh2019 cllsm leusm hemonc']\n",
      "['early registration rates', 'iwcll2019 cll cancerresearch']\n",
      "['early registration ends', 'biennial iwcll2019 cll cancerresearch']\n",
      "['review series', 'high dimensional single cell technologies']\n",
      "['cll treatment', 'javier pinilla ibarz']\n",
      "['ben kennedy', 'polysaccharide pneumococcal vaccine', 'cll bsh2019 blooducation']\n",
      "['b cell chronic lymphocytic leukemia treatment market', 'ab science sa amgen inc celgene corporation dynavax technologies corporation eisai']\n",
      "['q1 edition', 'cll society tribune', 'cll cllsm leukemia letscurethis']\n",
      "['cll town meeting']\n",
      "['cancergenetics paper', 'establishes pot1', 'melanoma susceptibility gene', 'angiosarcoma variants', 't cell lymphoma', 'chronic lymphocytic leukemia']\n",
      "['libertadlimpe o arranc', 'mejor manera el torneo', 'f tbol femenino', 'super por', 'su estreno del s bado', 'nacional estaremos atentos', 'su andar', 'temporada lasgumarelas cll']\n",
      "['daily current affairs update india bolivia bolivia latinamericaregional diplomat presidentofindia diplomat deputychairman jayavarthan cll exambazaar eb']\n",
      "['leukemia survey amp campaigbsh2019ns hemonc leusm cll', 'cml aml']\n",
      "['lce s', 'lymphoma cll community advisory board meetings', 'expert group', 'patient carer advocates', 'european lymphoma cll community', 'lymphoma outcomes']\n",
      "['bruton s tyrosine kinase', 'b cell malignancies btk']\n",
      "['chronic lymphocytic leukemia']\n",
      "['carl s story', 'lymphoma supportgroup helpful', 'gt sundayread lymphomamatters']\n",
      "['i need', 'i m', 'time i', 'i m', 'logic nevermind']\n",
      "['bruton s tyrosine kinase btk', 'b cell malignancies', 'ncbi oncology']\n",
      "['new open access feasibility', 'dose lenalidomide', 'line treatment', 'fcr unfit patients', 'chronic lymphocytic leukemia']\n",
      "['high prognostic value', 'measurable residual disease detection', 'flow cytometry', 'chronic lymphocytic leukemia patients', 'front line fludarabine cyclophosphamide', 'year rituximab maintenance']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['cll immunotherapy', 'rituximab amp', 'cd20 monoclonal antibodies', 'hbv infection', 'leukemia cancer hepatitis immunotherapy bigdata health cmv cll ai']\n",
      "['important precaution', 'cll patients', 'fluoroquinolone antibiotics', 'immunity cll cllsm']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['phase ii trial', 'ibrutinib monotherapy dose reduction', 'common elective procedure', 'effect survival outcome c w uk cll forum data', 'blooducation cll lymsm']\n",
      "['1l cll signs', 'treatment approach', 'mrd depth mrd prognostic overall', 'fcr gt r maint', 'mrd neg', 'similar outcomes', 'fcr gt r maint', 'small nos', 'blooducation cll lymsm']\n",
      "['cll society exists', 'cll patients', 's cure', 'cllsm letscurethis']\n",
      "['important article', 'nature cll cllsm leukemia letscurethis']\n",
      "['chronic lymphocytic leukemia cll', 'constitutional symptoms', 'fever weight loss night sweats', 'fatigue awesome infographic leukemia cll fever fatigue cancer healthcare disease nationaldoctorsday']\n",
      "['cutaneous squamous cell carcinoma', 'chronic lymphocytic leukemia']\n",
      "['effective treatment', 'unresponsive chronic lympho']\n",
      "['florida blood cancer conference']\n",
      "['cll expert dr richard furman', 'clinical research', 'leusm asktheexpert leukemia']\n",
      "['cll nurses', 'clinicalnursespecialists cns haematology nurses']\n",
      "['cll morning woke', '5am anxiety amp abdominal issues', 'weekend b c i d']\n",
      "['event cll cllsm leukemia letscurethis']\n",
      "['pet ct', 'chronic lymphocytic leukemia', 'b cell receptor pathway inhibitor therapy']\n",
      "['venetoclax studies ash2018 hematology ash cll leukemia cancer cancerfree oncology cancerresearch endcancer beatcancer standuptocancer fightcancer venetoclax healthtalk']\n",
      "['interesting video', 'chronic lymphocytic leukaemia cll', 'helpful tips']\n",
      "['annual meeting', 'cll updates', 'days lymsm']\n",
      "['primary cancers', 'chronic lymphocytic', 'hairy cell leukemia patients amchelsinki tutkimus']\n",
      "['protoporphyrin ix', 'dual inhibitor', 'p53 mdm2', 'p53 mdm4 interactions', 'induces apoptosis', 'b cell chronic lymphocytic leukemia cells']\n",
      "['sweet glycobiology lectins galectins cll']\n",
      "['hemeonc hcps', 'important qol survey', 'patients alqol leusm leukemia globonc hemonc']\n",
      "['baseline pet ct suv', 'richter s transformation', 'cll pts', 'bcr inhibitors tissue']\n",
      "['conventional fluorescence', 'situ hybridization fish fish', 'suspension fish', 'cytometry lsc', 'chronic lymphocytic leukemia openaccess research viafac leukemia cytometry']\n",
      "['murano trial ash2018 hematology ash cll leukemia cancer cancerfree oncology cancerresearch endcancer beatcancer standuptocancer fightcancer research4acure solvecancer healthcare healthtalk']\n",
      "['town mtg', 'cll amp family members', 'portland oregon', 'top specialists']\n",
      "['main tips', 'aml nog', 'boot cll fund tip newton', 'real return unit trust dyor']\n",
      "['venetoclax amp carfilzomib dose escalation study ash2018 hematology ash cll leukemia cancer cancerfree oncology cancerresearch endcancer beatcancer standuptocancer fightcancer venetoclax carfilzomib']\n",
      "['subject tom kipps amp colleagues', 'early disease progression', 'chronic lymphocytic leukaemia', 'new paradigm', 'cll bcells leukemia']\n",
      "['negative status', 'cll patients tune', 'cll expert dr sharman', 'patient perspectives', 'treatment goals', 'treatment response', 'value leusm']\n",
      "['chronic lymphocytic leukemia affects', 'adults researchers', 'new leukemia treatment']\n",
      "['don t', 'cll society patient', 'caregiver forum', 'friday april', 'bethesda details', 'cll cllsm leukemia letscurethis']\n",
      "['ebmt19 expert opinion marie jos kersten', 'car t cells vs autologous sct vs allogeneic sct', 'r r dlbcl lymsm cll lymphoma']\n",
      "['excellent talk', 'text world theory', 'cognitive grammar', 'resistant critical readings', 'political discourse', 'good discussion afterwards']\n",
      "['cancer progression', 'psychological status', 'chronic lymphocytic leukemia patients calgb', 'alliance lymphoma lymsm']\n",
      "['chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['new cancer regiments ash2018 hematology ash cll leukemia cancer cancerfree oncology cancerresearch endcancer beatcancer standuptocancer fightcancer research4acure solvecancer healthcare']\n",
      "['open access ucl research protoporphyrin ix', 'dual inhibitor', 'p53 mdm2', 'p53 mdm4 interactions', 'induces apoptosis', 'b cell chronic lymphocytic leukemia cells']\n",
      "['open access ucl research protoporphyrin ix', 'dual inhibitor', 'p53 mdm2', 'p53 mdm4 interactions', 'induces apoptosis', 'b cell chronic lymphocytic leukemia cells']\n",
      "['cll finncap', '145p price target', 'cello health shares', 'recent good full year', 'uk cll brighterir andrewscotttv capitalnetwork1']\n",
      "['future directions', 'cart therapy']\n",
      "['dr tanya siddiqi', 'duarte ca', 'great overview', 'treatment landscape', 'video cllsm leukemia letscurethis']\n",
      "['amazing year', 'dr brian koffman', 'cll society', 'cll cllsm leukemia letscurethis']\n",
      "['own home', 'travel time', 'bsi s', 'courses cll']\n",
      "['tanya siddiqi', 'transcend cll', 'cll gt gt lt lt ebmt19 immunoonc']\n",
      "['crucial role', 'pre b', 'immature b cell stages', 'b1a cell generation b1a arid3a lin28b b1development cll lymphoma mice']\n",
      "['rns aim cll cello health plc']\n",
      "['children work', 'building campfires', 'morning relationships kuw cll fs fs lsa shirley']\n",
      "['corporate research', 'ptro amo', 'amp register', 'free research portal disclaimer']\n",
      "['chronic lymphocytic leukemia cll therapeutics market size share segment analysis growth drivers']\n",
      "['venetoclax eu venclyxto u s venclexta', 'chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['long term journey', 'right care team', 'huge difference', 'amp treatment']\n",
      "['igh translocations', 'chronic lymphocytic leukemia clinicopathologic', 'clinical outcomes hematolog']\n",
      "['leukaemia treatment test cll']\n",
      "['combination therapies', 'frontline cll cllsm leukemia letscurethis']\n",
      "['trialtuesday alliance researcher jennifer woyach md james', 'alliance a041702', 'immunotherapy trial', 'chronic lymphocytic leukemia', 'cllsm nci nctn cancerresearch']\n",
      "['shelf car nk cells', 'months future clinicaltrials', 'aml dr rezvani ebmt19']\n",
      "['venetoclax obinutuzumab high response rates', 'cll cr', 'r r cll', 'pb r r cll']\n",
      "['chronic lymphocytic leukemia']\n",
      "['nccn guidelines insights chronic lymphocytic leukemia', 'small lymphocytic lymphoma version']\n",
      "['emergent literacy literacy reading cll stories']\n",
      "['tanya siddiqi', 'cll transcend', 'full interview', 'bmtsm cllsm leusm ctsm']\n",
      "['dr siddiqi', 'transcend cll study', 'expansion infusion', 'cartcell cll ebmt19']\n",
      "[]\n",
      "['ltimos pedidos entregados trusa cintur n especial y mu equeras', 'charol rojo y dorado', 'medida para raizor espartano wrestler cll mascarasluchalibreraison luchalibrechilena']\n",
      "['rct compares drugs', 'class compares patient', 'outcomes zanubrutinib bgb', 'versus ibrutinib', 'refractory chronic lymphocytic leukemia lymsm']\n",
      "['cll cll cello health group ex dividend date', 'payment date']\n",
      "['christian gisselbrecht s interview', 'autologous stem cell transplant versus car t', 'r r dlbcl', 'cll lymsm lymphoma']\n",
      "['researchers hope', 'bone marrow function', 'bone marrow function', 'alternate treatments', 'modify marrow function']\n",
      "['wonder drug', 'treats allergies sciatica gout eczema', 'intractable headaches arthritis inflammatory bowel disease asthma', 'copd exacerbations chronic lymphocytic leukemia hypercalcemia']\n",
      "['chronic lymphocytic leukemia leusm']\n",
      "['chronic lymphocytic leukemia']\n",
      "['cll patient', 'treatment resistance', 'cll expert dr richard furman', 'shares research', 'clinical relapse leusm']\n",
      "['khalid asghar', 'controller station director radio pakistan lahore', 'chronic lymphocytic leukemia', 'pbc radio pakistan', 'cancer hospital', 'dg pbc', 'email amp']\n",
      "['new advances', 'chronic lymphocytic leukemia cll', 'dr paraneswaran venugopal', 'treatment options', 'blood cancer patients conference register']\n",
      "['cll patients', 'novel agents cll cllsm leukemia letscurethis']\n",
      "['venetoclax issue', 'week cll clls leukemia']\n",
      "['richard maziarz', 'car t trials', 'ebmt19 interview', 'lymsm lymphoma cll']\n",
      "['high prognostic value', 'measurable residual disease detection', 'flow cytometry', 'chronic lymphocytic leukemia imas12']\n",
      "['ibrutinib doses', 'chronic lymphocytic leukemia']\n",
      "['ibrutinib doses', 'chronic lymphocytic leukemia']\n",
      "['comprehensive coverage', 'annual meeting', 'sessions lymsm']\n",
      "['chronic lymphocytic leukemia']\n",
      "['los investigadores esperan que', 'comprender c mo se deteriora', 'funci n', 'm dula sea', 'leucemia linfocitica cr nica puedan mejorar', 'funci n', 'm dula sea o encontrar tratamientos que', 'afecten lea m s']\n",
      "['researchers hope', 'bone marrow function', 'bone marrow function', 'alternate treatments', 'modify marrow function']\n",
      "['bloodstream infections', 'chronic lymphocytic leukemia cll', 'longitudinal nation', 'wide cohort study cllsm leusm']\n",
      "['venetoclax obintuzumab', 'r r cll', 'effective combination pb mrd ve rate', 'r r', 'pts bcri', '1l g3', 'r r est 24m pfs', 'congrats others blooducation lymsm']\n",
      "['video key population', 'registry studies', 'hematological oncology w magnus bj rkholm', 'isal2019 leusm cll multiplemyeloma mmsm mpnsm']\n",
      "['cll treatment', 'javier pinilla ibarz']\n",
      "['cartcell therapy', 'cll experts', 'treatment research', 'landmark immunotherapy leusm']\n",
      "['i manage ibrutinib intolerance', 'chronic lymphocytic leukemia cll']\n",
      "['new combination therapies', 'expert dr richard furman', 'cll treatment updates', 'novel agent']\n",
      "['sick w cll', 'car t cell therapy', 'durable remission', 'combo w', 'cll specialists leusm']\n",
      "['rgl rka posp ilov brno', 'imi harmony', 'czech cll study group', 'annual meeting', 'chronic lymphocytic leukemia']\n",
      "['cll experts dr susan o brien', 'dr javier pinilla', 'exciting developments', 'treatment research', 'new class', 'cll inhibitors', 'news leusm']\n",
      "['new hope', 'chronic lymphocytic leukemia cancermoonshot leusm endcancer']\n",
      "['international chronic lymphocytic leukemia treatment market']\n",
      "['brain invasion', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['new era chronic lymphocytic leukemia cll', 'bone marrow', 'new clinicaltrial', 'body s', 'natural immune cells', 'leukemia cells']\n",
      "['i manage ibrutinib intolerance', 'chronic lymphocytic leukemia']\n",
      "['i manage ibrutinib intolerance', 'chronic lymphocytic leukemia blood journal']\n",
      "['i manage ibrutinib intolerance', 'chronic lymphocytic leukemia']\n",
      "['cytogenetic complexity', 'chronic lymphocytic leukemia definitions associations', 'clinical impact']\n",
      "['right doctor contribute', 'patient s confidence', 'patientcaf segment', 'right healthcare team', 'difference cll leusm']\n",
      "['i manage ibrutinib intolerance', 'chronic lymphocytic leukemia']\n",
      "['beginning catalan students', 'catalan reading', 'wild cll']\n",
      "['intense uptake', 'liposomal curcumin', 'multiple myeloma cell lines comparison', 'normal lymphocytes', 'red blood cells', 'chronic lymphocytic leukemia cells']\n",
      "['chronic lymphocytic leukemia research grants']\n",
      "['i manage ibrutinib intolerance', 'chronic lymphocytic leukemia cll cllsm']\n",
      "['hey medtwitter', 'cll oncology hematology smudgecellsfordays']\n",
      "['real world data show high rate', 'cll presentation', 'jennifer woyach', 'sintoma19 cll']\n",
      "['i manage ibrutinib intolerance', 'chronic lymphocytic leukemia blood journal']\n",
      "['prospective students', 'student ambassador roles']\n",
      "['ian w flinn m d ph d discusses', 'refractory chronic lymphocytic leukemia']\n",
      "['cll horizons', 'endinburgh scotland', 'international confererence', 'cll registration', 'april pre registration enquiries amp information email info net']\n",
      "['cll cello health plc', 'strong start', 'good order book', 'uk cll brighterir andrewscotttv capitalnetwork1']\n",
      "['min medscapeedu video', 'novel chemo', 'free combinations', 'chronic lymphocytic leukemia cll', 'w professor jacqueline barrientos']\n",
      "['s researchhighlight', 'amp register', 'free research portal disclaimer']\n",
      "['cll results', 'decent unusual cos', 'top good company i don t hold', 'cos i']\n",
      "['leukemia2019 leukemia cancer lymphoma oncology aml', 'cml cll mpal bonemarrowtransplant aplasticanemia stemcelltransplant hematology bloodcancer stemcells transplant']\n",
      "['cll cello', 'strong performance', 'uk cll brighterir andrewscotttv capitalnetwork1']\n",
      "['musical pun', 'cello piece', 'uk cll brighterir andrewscotttv capitalnetwork1']\n",
      "['rns aim cll cello health plc', 'preliminary results']\n",
      "['briefedup uk stock market news', 'morning cll loop pmp spe amp ketl']\n",
      "['mirtazapine pml cll miracle']\n",
      "['cll patients ash2018 hematology ash cll leukemia cancer cancerfree oncology cancerresearch endcancer beatcancer standuptocancer fightcancer research4acure solvecancer healthcare']\n",
      "['old african american female', 'case study focuses', 'cardiovascular care', 'aml leusm leukemia cll']\n",
      "['march bulletin', 'cllsa member', 'free amp', 'inbox amp', 'free access', 'cll leukaemia bloodcancer haematology']\n",
      "['scan results', 'pullback bullish', 'shre nsf sbiz kape vnh ogn boom cll tpk agl cpt saa php skin bdev hri']\n",
      "['mayocll amp dr neil kay kras nras', 'braf mutations', 'chronic lymphocytic leukemia', 'shorter treatment', 'free survival']\n",
      "['cambridge members conference report video amp', 'brilliant presentation', 'dr george', 'enormous thanks', 'brilliant speakers', 'amp nhs haematology cll leukaemia bloodcancer psychology']\n",
      "['novel cd19', 'trike restores nk cell function', 'proliferative capacity']\n",
      "['cll diagnosis', 'don t look', 'brief video clip leusm']\n",
      "['icliniq q', 'blood reports hematology chroniclymphocyticleukemia']\n",
      "['cll patient david lauder s blog']\n",
      "['healthevoices19 amp', 'integral patientreporter patientexperience cll']\n",
      "['early registration', 'biennial iwcll2019 cll cancerresearch']\n",
      "['blood reports bloodtests']\n",
      "['disease progression', 'hematologic malignancies']\n",
      "['press release', 'venetoclax news', 'multiple myeloma', 'link cll cllsm leukemia']\n",
      "['real world data study', 'chronic lymphocytic leukemia cll patient treatment options']\n",
      "['chronic lymphocytic leukemia i']\n",
      "['convenient solutions fly', 'american airlines flylocal iflyeasterwood collegestation tamu bryan airport planes takeoff', 'cll brazosvalley brazos']\n",
      "[]\n",
      "['w cll', 'current therapy', 'gen inhibitors', 'experts drs o brien amp pinilla ibarz']\n",
      "['new clinicaltrial recruits', 'immune system', 'attack chronic lymphocytic leukemia']\n",
      "['cautious news', 'cll cllsm leukemia']\n",
      "['recent protocol', 'ibrutinib amp venetoclax', 'cll patients', 'complete remission', 'year mark', 'chronic lymphocytic leukemia cancermoonshot endcancer']\n",
      "['real world data study', 'chronic lymphocytic leukemia cll patient treatment options', 'effectiveness status', 'condition summary chronic lymphocytic leukemia']\n",
      "['12pm 1pm pst 3pm 4pm est nationalbroadcast', 'grand rounds', 'cmecredits register', 'cityofhope cancercare cll leukemia paradigmmedcom']\n",
      "['intense uptake', 'liposomal curcumin', 'multiple myeloma cell lines comparison', 'normal lymphocytes', 'red blood cells', 'chronic lymphocytic leukemia cells']\n",
      "['cll lymsm']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['long term', 'resonate study', 'vs gt', 'independent pfs predictors', 'cll pts median pfs', 'months fup', 'fit young trial population']\n",
      "['new treatment', 'relapse refractory cll cll leusm leukemia imedex idelalisib duvelisib copanlisib cancer cancerfree oncology cancerresearch endcancer']\n",
      "['iwcll abstract submission', 'open young investigators', 'yim youngeha cll']\n",
      "['blood commentary intricacies', 'cll cytogenetic complexity']\n",
      "['drs luedke', 'distinct pathways', 'plasmablastic lymphoma', 'chronic lymphocytic leukemia poster', '30pm exhibition hall']\n",
      "['body cramps', 'side effect', 'cll treatment', 'cll expert dr sharman discusses pains', 'manage side']\n",
      "['chronic lymphocytic leukemia cll hypogammaglobulinemia']\n",
      "['mitochondrial apoptotic', 'underlies stroma', 'treatment resistance', 'chronic lymphocytic leukemia blood journal']\n",
      "['cytogenetic complexity', 'chronic lymphocytic leukemia definitions associations', 'clinical impact']\n",
      "['genetic mutations', 'cll patients', 'cll experts dr jennifer', 'treatment path leusm']\n",
      "['current issue pd', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll', 'large b cell richter transformation dlbcl rt', 'dlbcl rt', 'potential surrogate marker', 'clonal relatedness']\n",
      "['car t cell revolution cll aml sicklecelldisease', 'haematology allsm amlsm cllsm mmsm lymsm leusm sicklecell cart']\n",
      "['cll nurses', 'clinicalnursespecialists haematology nurses']\n",
      "['cll chileluchalibre presenta inicio', 'iwc luchalibrechilena nagero5taregi n pepex']\n",
      "[]\n",
      "['effective treatment', 'chr leukemia']\n",
      "['ibrutinib doses', 'chronic lymphocytic']\n",
      "['young patient', 'refractory cll w jacqueline barrientos', 'feinstein institute', 'medical research lymphoma cancertherapy overallsurvival']\n",
      "['s time', 'new motto', 'cll society', 's cure', 'cll cllsm leukemia letscurethis']\n",
      "['great day', 'cll community']\n",
      "['genetic background', 'chronic lymphocytic leukemia patients', 'chromosomal gains']\n",
      "['blood work hairy cell leukemia coexistent', 'chronic lymphocytic leukemia cll']\n",
      "['pml cll survivor']\n",
      "['cytogenetic complexity', 'chronic lymphocytic leukemia definitions associations', 'clinical impact']\n",
      "['excellent discussion', 'new data', 'dr moreno dr mulligan', 'dr pavlovsky']\n",
      "['chronic lymphocytic leukemia cll hypogammaglobulinemia']\n",
      "['s game', 'great game', 'cll majorsangels']\n",
      "['interesting slide i', 'b cell differentiation', 'malignancies ibb xbi cll mcl dlbcl']\n",
      "['chronic lymphocytic leukemia']\n",
      "['unresponsive chronic lymphocytic leukemia']\n",
      "['career tune', 'cll patients', 'work life balance', 'cll diagnosis']\n",
      "['video playlist', 'practical tips', 'watchandwait bloodcancer cll']\n",
      "['chronic lymphocytic leukemia']\n",
      "['uk stocks news w c', 'week m', 'gmaa mai mgr rst fan t', 'bgo elco jdg kape ltg mer nah tm17 trb ztf scs w', 'cau sdl teg t', 'cll loop pmp spe spo xar f']\n",
      "['novel regimens', 'cll oncology']\n",
      "['cytogenetic complexity', 'chronic lymphocytic leukemia definitions mbl associations', 'clinical impact blood journal']\n",
      "['chronic lymphocytic leukemia', 'new challenge', 'different emotions', 'active role', 'free fact sheet']\n",
      "['unresponsive chronic lymphocytic leukemia']\n",
      "[]\n",
      "['ibrutinib doses', 'chronic lymphocytic leukemia leukemia']\n",
      "['new leukemia treatment shows', 'chronic lymphocytic leukemia', 'new hope', 'cancer survivors', 'enters phase', 'clinical trial']\n",
      "['young patient', 'refractory cll w jacqueline barrientos', 'feinstein institute', 'medical research lymphoma prognosis cancertherapy overallsurvival lymsm']\n",
      "['effective treatment', 'unresponsive chron']\n",
      "['unresponsive chronic lymphocytic leukemia', 'real world setting cll']\n",
      "['ibrutinib doses', 'chronic lymphocytic leukemia']\n",
      "['igh translocations', 'chronic lymphocytic leukemia clinicopathologic', 'clinical outcomes hematolog']\n",
      "['new clinicaltrial recruits', 'immune system', 'attack cll lymphoma']\n",
      "['effective treatment', 'unresponsive chronic lymp leukemia']\n",
      "['favourite troll character', 'r2 i', 'mixingcolours cll']\n",
      "['novel agents', 'severe cll experts', 'dr javier pinilla ibarz', 'potential complications', 'generation cll treatments leusm']\n",
      "['brief report', 'transcription factors', 'chronic lymphocytic leukemia cll', 'nfat2 precipitates selection', 'certain vdj recombinations']\n",
      "['venetoclax obinutuzumab regimen', 'chronic lymphocytic leukemia']\n",
      "['risk chronic lymphocytic leukemia']\n",
      "['cytogenetic complexity', 'chronic lymphocytic leukemia definitions associations', 'clinical impact blood journal']\n",
      "['nkp30 receptors', 'nk cells', 'chronic lymphocytic leukemia', 'hadadi l hafezi m amirzargar aa sharifian ra abediankenari s asgarian omran h']\n",
      "['nkp30 receptors', 'nk cells', 'chronic lymphocytic leukemia', 'expression pattern', 't cell immunoglobulin', 'molecule3 tim3']\n",
      "['effective treatment', 'unresponsive chronic lym']\n",
      "['non hodgkin lymphoma nhl blood cancer chronic lymphocytic leukemia', 'rheumatoid arthritis', 'tumor cells', 'cancer cells', 'information maball leukemia bloodcancer']\n",
      "['risk chronic lymphocytic leukemia']\n",
      "['shows venetoclax', 'obinutuzumab regimen', 'chronic lymphocytic leukemia cll']\n",
      "['cytogenetic complexity', 'chronic lymphocytic leukemia definitions associations', 'clinical impact']\n",
      "['new outcomes', 'chronic lymphocytic leukemia']\n",
      "['scan results stochastic', 'sch cll gns vls aewu bsif som goco pmg lsai mto mmx fdp sens']\n",
      "['cancer patients', 'cll patient', 'day letscurethis', 'interesting article']\n",
      "['excellent summary', 'own dr brian koffman', 'car t therapy', 'cll cllsm leukemia letscurethis']\n",
      "['cytogenetic complexity', 'chronic lymphocytic leukemia cll definitions associations', 'clinical impact cllsm leusm']\n",
      "['risk chronic lymphocytic leukemia']\n",
      "['dr kamala maddali review', 'chronic lymphocytic leukemia', 'cll cllsm leukemia letscurethis']\n",
      "['world experts', 'blood cancer research', 'boston cll nhl globalsummitonhemmalignancies']\n",
      "['cytogenetic complexity', 'chronic lymphocytic leukemia definitions associations', 'clinical impact blood journal high cytogenetic complexity', 'chromosomal aberrations']\n",
      "['dr john byrd', 'chronic lymphocytic leukemia diagnosis', 'death sentence thanks']\n",
      "['recent paper', 'dr christina westmose yde', 'chronic lymphocytic leukemia clinical impact']\n",
      "['fda grants breakthrough therapy designation', 'venclexta gazyva combination', 'chronic lymphocytic leukemia healio fda grants breakthrough therapy designation', 'venclexta gazyva combination', 'chronic lymphocytic leukemia']\n",
      "['cll frontline tune', 'ash18 coverage', 'experts dr nicole lamanna', 'amp dr sharman', 're treatment research', 'treatment leusm']\n",
      "['ibrutinib imbruvica', 'free survival', 'chronic lymphocytic leukemia cll fda']\n",
      "['cd20 monoclonal antibodies', 'chronic lymphocytic leukemia']\n",
      "['edinburgh scotland press registration']\n",
      "['cll gly101val mutation', 'progressive cll', 'venetoclax ven', 'ven naive patients', 'evade therapy doi']\n",
      "['dr anil awesti', 'free brexit seminars', 'staff students', 'seminar teaching', 'brexit socsci']\n",
      "['risk chroniclymphocyticleukemia']\n",
      "['recurrent gly101val mutation', 'bcl2 confers resistance', 'progressive cll']\n",
      "['new videos', 'cll diagnosis']\n",
      "['new videos', 'cll diagnosis']\n",
      "['chronic lymphocytic leukemi']\n",
      "['cllsa members', 'cllsa support group', 'haematology consultants amp', 'clinical nurse specialist', 'email cllsaiow com cll leukaemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['recurrent gly101val mutation', 'bcl2 confers resistance', 'progressive chronic lymphocytic leukemia cll cancer discovery cllsm']\n",
      "['cancer amp', 'nfl kc', 'free agent', 'great run', 'hodgkin s lymphoma', 'recent seasons', 'injury patientpower cll']\n",
      "['great work', 'cll diagnosis', 'cll specialists']\n",
      "['elegant research paper', 'plenary session', 'new bcl2 inhibitors', 'works cll blooducation']\n",
      "['march issue acquisition', 'recurrent gly101val mutation', 'bcl2 confers resistance', 'progressive chronic lymphocytic leukemia research']\n",
      "['m seiffert', 'overcomes t cell exhaustion', 'improves outcome', 'cll kscancerimm supports ap1 pathway findings il10 high patients', 'biomarker immunecheckpoint']\n",
      "['gene expression patterns identify high risk chronic lymphocytic leukemia clinicalgenomics rnaseq']\n",
      "['cll friend', 'regular reporter', 'clinicaltrial participant', 's medicines']\n",
      "['cll chronic lymphocytic leukemia']\n",
      "['gene expression patterns identify high risk chronic lymphocytic leukemia']\n",
      "['s mid week', 'rainy week', 'cll students', 'wednesdaywisdom believeinyourself yourwarwick socsci']\n",
      "['earlybird tix', 'ci devops containers serverless']\n",
      "['patients incl shock', 'support access', 'specialist amp benefits', 'appointments leukaemia']\n",
      "['cll nurses', 'clinicalnursespecialists haematology nurses']\n",
      "['fresh impact', 'human fc r gene polymorphisms', 'cytokine release', 'critical importance', 'cell assay format', 'medicine uos news immunotherapy bcells lymphoma cll immunoassay']\n",
      "['bcl2 mutation', 'cll patients acquisition', 'recurrent gly101val mutation', 'bcl2 confers resistance', 'progressive chronic lymphocytic leukemia cancer discovery']\n",
      "['effective treatment', 'unresponsive chronic lymphocy']\n",
      "['effective treatment', 'unresponsive chronic lympho']\n",
      "['unresponsive chronic lymphocytic leu leukemia']\n",
      "['unresponsive chronic lympho']\n",
      "['chronic lymphocytic leukemia', 'patients gt', 'white cell']\n",
      "['co chair', 'dr joseph rosenblatt']\n",
      "['cochair dr rosenblatt stateofscience org hematologicmalignancies']\n",
      "['scan results stochastic', 'mto jkx mtc cll tstl piri goco oxb isat obt bur sse sepl ehg rfx rws']\n",
      "['chemo experience', 'resources lymphoma cll']\n",
      "['grand rounds', 'cmecredits tuesday march', 'pm pst', 'pm est register cityofhope cancercare cll leukemia paradigmmedcom']\n",
      "['new treatment', 'relapse refractory cll cll leusm leukemia imedex idelalisib duvelisib copanlisib cancer cancerfree oncology cancerresearch endcancer']\n",
      "['international meeting', 'sept iwcll2019']\n",
      "['head mind thereforce cll me2929']\n",
      "['right cll treatment approach', 'experts dr', 'dr kerry rogers', 'cll treatment classes', 'lifestyle factors']\n",
      "['chris fegan', 'chris pepper', 'instructive editorial', 'uk venetoclax experience', 'refractory cll', 'blooducation lymsm']\n",
      "['recent research imbruvica', 'elderly patients', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['cll patients', 'treatment tune', 'dr william wierda', 'cll patients', 'care team', 'cancertreatment decisions leusm']\n",
      "['das leitlinienprogramm onkologie hat', 'neue patientenleitlinie chronische lymphatische leuk mie herausgegeben sie basiert auf der entsprechenden rztlichen s3 leitlinie', 'erschienen ist und ist allgemeinverst ndlich formuliert cll']\n",
      "['cd38 expression', 'sudanese patients', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['chronic lymphocytic leukemia opportunity analysis experiments evolution fermentation research']\n",
      "['drg epidemiology report estimates', 'prevalent cases', 'western europe', 'updates leukemia cll']\n",
      "['unresponsive chronic lymphocy']\n",
      "['celg celgene', 'phase i ii trial nct03331198', 'refractory chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'primary completion date']\n",
      "['drug sequence', 'cll cll leusm leukemia imedex ibrutinib rituximab cancer cancerfree oncology cancerresearch endcancer beatcancer standuptocancer fightcancer']\n",
      "['pi3 kinase inhibitors autoimmune toxicity cll leusm leukemia imedex idelalisib duvelisib copanlisib cancer cancerfree oncology cancerresearch endcancer beatcancer']\n",
      "['new effectiveness', 'unresponsive chronic lymphocytic']\n",
      "['novel regimens', 'cll matthew s davids md mmsc discusses methods', 'frontline therapies', 'chronic lymphocytic leukemia']\n",
      "['blood commentary']\n",
      "['cll patient advocate lee swanson interviews dr adrian wiestner', 'exciting news']\n",
      "['rituximab cll leusm leukemia ibrutinib rituximab cancer cancerfree oncology cancerresearch endcancer beatcancer standuptocancer fightcancer']\n",
      "['genentech submits supplemental', 'new drug application', 'chronic lymphocytic leukemia', 'medical conditions']\n",
      "['pi3 kinase inhibitors idelalisib duvelisib amp copanlisib cll leusm leukemia idelalisib duvelisib copanlisib cancer cancerfree oncology cancerresearch endcancer beatcancer']\n",
      "['cll patient relapses', 'expert dr richard furman', 'potential progression factors', 'treatment options leusm']\n",
      "['plenary paper', 'ibrutinib vs ibrutinib', 'chronic lymphocytic leukemia cll']\n",
      "['exciting news', 'cll care faculty members', 'certain storylines']\n",
      "['new wave', 'chronic lymphocytic leukemia']\n",
      "['excellent story', 'patient s journey', 'complex world', 'cll deborah', 'good friend', 'cll society', 'amazing woman cllsm leukemia letscurethis']\n",
      "['disease progression', 'hematologic malignancies']\n",
      "['effective treatment']\n",
      "['happy monday', 'student community', 'student engagement coordinator lauren elmore shares', 'mature student']\n",
      "['perc e th rapeutique', 'venetoclax obinutuzumab venclexta venclyxto abbvie roche', 'gazyvaro gazyva roche', 'leuc mie lympho', 'chronique soumission simultan e d', 'demande d', 'd indication']\n",
      "['chronic lymphocytic leukemia']\n",
      "['abbvie announces', 'multiple milestones', 'cll14 venetoclax study', 'duration treatment', 'chroniclymphocyticleukemia patients abbv']\n",
      "['ra pharma update fda', 'adult patients', 'chronic lymphocytic leukemia']\n",
      "['ibrutinib doses', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'tough i', 'family thanks mayor', 'big sister', 'firefighter durkan']\n",
      "['dr jennifer woyach', 'leukemia drug', 'new ground']\n",
      "['hope venetoclax cll']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['young patient', 'refractory cll', 'jacqueline barrientos', 'feinstein institute', 'medical research lymphomahub lymphoma overallsurvival prognosis cancertherapy gogold']\n",
      "['enormous thanks', 'fantastic attendance', 'enthusiastic discussions amp', 'brilliant speakers', 'amp nhs thankyou', 'time amp support haematology cll leukaemia bloodcancer psychology']\n",
      "['ny presbyterian columbia univ', 'medical center investigator', 'shorter treatment time', 'site news healthcare']\n",
      "['long term considerations', 'fertility preservation', 'survivorship care plan']\n",
      "['friend deborah sims', 'cll patients', 'normal prescription', 'low cost', 'irish patients']\n",
      "['hematological diseases', 'particular chronic lymphocytic leukemia', 'technology test fish deletion chromosome i', 'fish molecular technique', 'new breakthrough']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'ibrutinib leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['weekly cll society alerts', 'cancer cll cllsm leukemia letscurethis']\n",
      "['australia cll cllsm venetoclax']\n",
      "['shorter treatment', 'cll cll cllsm venetoclax bloodcancer']\n",
      "['educational forum', 'saturday march', 'cllsm leukemia bloodcancer letscurethis']\n",
      "['hematologic malignancies', 'adult focus', 'acute myeloid leukemia chronic lymphocytic leukemia', 'multiple myeloma']\n",
      "['cll cll']\n",
      "['jacqueline barrientos md ms discusses', 'survival amp', 'chronic lymphocytic leukemia cll clinicalresearch clinicaltrials']\n",
      "['unresponsive chronic lymphocytic leukemia']\n",
      "['disease progression', 'hematologic malignancies cancer therapy advisor']\n",
      "['scary news fiona', 'cll chronic lymphocytic leukemia', 'slow treatable cancer', 'natural lifespan']\n",
      "['chronic lymphocytic leukemia', 'new challenge', 'new booklet']\n",
      "['new combination therapies', 'expert dr richard furman', 'cll treatment updates', 'novel agent']\n",
      "['cll experts dr susan o brien', 'dr javier pinilla', 'exciting developments', 'treatment research', 'new class', 'cll inhibitors', 'news leusm']\n",
      "['fda approval', 'venetoclax obinutuzumab combo', 'frontline cll oncology']\n",
      "['year s night', 'heroes event funds', 'accommodations employment', 'respite services', 'ldnont communitylivinglondon cll']\n",
      "['chronic lymphocytic leukemia', 'common type', 'navigate treatment']\n",
      "['igh translocations', 'chronic lymphocytic leukemia clinicopathologic', 'clinical outcomes hematolog']\n",
      "['cll oncology']\n",
      "['minor role', 'future cll treatment oncology']\n",
      "['student ambassador emma', 'busy afternoon', 'new flyers', 'local area earlychildhood gatewaytohe 2plus2 yourwarwick cll']\n",
      "['cll diagnosis', 'don t look', 'brief video clip leusm']\n",
      "['cll fl mzl dlbcl ms lymphoma follicular sclerosis']\n",
      "['persistent janus kinase', 'chronic lymphocytic leukemia patients', 'ibrutinib results', 'phase i trial lymphoma lymsm']\n",
      "['leptomeningeal carcinomatosis', 'chronic lymphocytic leukemia', 'case report', 'literature lymphoma lymsm']\n",
      "['cll leukaemia amp', 'cambridge conference', 'behalf amp', 'day bloodcancer']\n",
      "['team members', 'psycho oncology service', 'dr george', 'nhs amp', 'cambridge conference', 'cll leukaemia bloodcancer bloodcancerawareness haematology']\n",
      "['ibr vs ibr mono', 'ven data', 'ibrutinib vs ibrutinib', 'chronic lymphocytic leukemia']\n",
      "[]\n",
      "['roche s veclexta', 'breakthrough designation', 'chronic lymphocytic leukemia roche health drugs newsalert clinicaltrials healthcare oncology medicine', 'medical cancer biotechnology']\n",
      "['roche s veclexta', 'breakthrough designation', 'chronic lymphocytic leukemia roche', 'new drug application', 'gazyva combin']\n",
      "['fda grants breakthrough therapy designation', 'new chronic lymphocytic leukemia treatment combination', 'review snda', 'review programme media']\n",
      "['ibrutinib vs ibrutinib', 'chronic lymphocytic leukemia', 'na ve del17p tp53mut']\n",
      "[]\n",
      "['ibrutinib vs ibrutinib', 'chronic lymphocytic leukemia blood journal']\n",
      "['adult patients', 'chronic lymphocytic leukemia fda venetoclax teampharmacy health cll cancer healthcare']\n",
      "['cryptocurrency check', 'video tutorial', 'attention mine cryptoliveleak', 'token cll', 'cll cryptoliveleak attentionmine crypto erc20 utilitytoken freecrypto earncrypto cryptocurrency howto']\n",
      "['tutorial video i', 'attention mine cryptoliveleak', 'token cll', 'cll cryptoliveleak attentionmine crypto erc20 utilitytoken freecrypto earncrypto cryptocurrency howto']\n",
      "['bloodcancer medicines', 'approval consideration']\n",
      "['ibrutinib vs ibrutinib', 'chronic lymphocytic leukemia cll blood journal cllsm leusm']\n",
      "['cll blood journal cllsm leusm']\n",
      "['fda approval', 'chronic lymphocytic leukemia', 'medical conditions cllsm leukemia leusm']\n",
      "['drug bp1002', 'recent fda approval', 'combination treatment', 'chronic lymphocytic leukemia venetoclax', 'ltd rog eb subsidiary genentech']\n",
      "['fda grants breakthrough therapy designation', 'gazyva regimen', 'chronic lymphocytic leukemia cll']\n",
      "['plain language', 'training org', 'clearlanguagelab cll literacyworks']\n",
      "['wouldn t', 'powerful cll drugs', 'ppl meet', 'tough side', 'generation btk inhibitor', 'cll experts']\n",
      "['golden anniversary seminar series prof gibson', 'chronic lymphocytic leukemia radyfhs research']\n",
      "['abbvie announces', 'multiple milestones', 'cll14 venetoclax study', 'duration treatment', 'chronic lymphocytic leukemia patients abbvie news center']\n",
      "['cll patient tune', 'expert dr javier pinilla ibarz', 'classify patients', 'treatment leusm']\n",
      "['basic amp translational research', 'clinicaltrials debates', 'current standard', 'care value', 'cartcell therapy', 'leukemia amp', 'typical friendly atmosphere', 'cll community']\n",
      "['genentech submits supplemental', 'new drug application', 'chronic lymphocytic leukemia', 'medical conditions']\n",
      "['lt cdata test', 'patients treatment response', 'chronic lymphocytic leukemia', 'day gt']\n",
      "['chronic lymphocytic leukemia', 'fighter amp', 'alex trebek amp', 'pancreatic cancer', 'watches alex']\n",
      "['genentech submits snda', 'gazyva combo', 'chronic lymphocytic leukemia genentech', 'roche group', 'ro rog otcqx rhhby', 'new drug application', 'u s food']\n",
      "['abbv abbvie announces', 'multiple milestones', 'cll14 venetoclax study', 'duration treatment', 'chronic lymphocytic leukemia patients']\n",
      "['spotlight gly101val bcl2 mutation', 'venetoclax resistance', 'chronic lymphocytic leukemia', 'shanmugapriya thangavadivel', 'john byrd james']\n",
      "['ibrutinib therapy releases leukemic surface igm', 'antigen drive', 'chronic lymphocytic leukemia patients cll']\n",
      "['abbvie announces', 'multiple milestones', 'cll14 venetoclax study', 'duration treatment', 'chronic lymphocytic leukemia patients']\n",
      "['abbvie announces', 'multiple milestones', 'cll14 venetoclax study', 'duration treatment', 'chronic lymphocytic leukemia patients pharma news']\n",
      "['new cme video', 'clinical advances', 'hematologic malignancies', 'cll mm aml']\n",
      "['press release', 'abbvie announces', 'multiple milestones', 'cll14 venetoclax study', 'duration treatment', 'chronic lymphocytic leukemia patients']\n",
      "['clinical trial data', 'breakthrough therapy designation', 'real time oncology review']\n",
      "['abbv announces', 'multiple milestones', 'cll14 venetoclax study', 'duration treatment', 'chronic lymphocytic leukemia patients']\n",
      "['abbvie announces', 'multiple milestones', 'cll14 venetoclax study', 'duration treatment']\n",
      "['genentech submits supplemental', 'new drug application']\n",
      "['abbv abbvie announces', 'multiple milestones', 'cll14 venetoclax study', 'duration treatment', 'chronic lymphocytic leukemia patients']\n",
      "['bloodcancer medicines', 'fda initiatives', 'expedite reviews']\n",
      "['press release', 'genentech submits supplemental', 'new drug application', 'chronic lymphocytic leukemia', 'medical conditions']\n",
      "['genentech submits supplemental', 'new drug application', 'chronic lymphocytic leukemia', 'medical conditions']\n",
      "['multiple assignment', 'trial smart design', 'chronic lymphocytic leukemia']\n",
      "['chemokine receptor', 'chronic lymphocytic leukemia sibbmpub nagajacapitani cosimabaldari']\n",
      "['p66shc deficiency', 'e tcl1 mouse model', 'chronic lymphocytic leukemia enhances leukemogenesis', 'chemokine receptor landscape sibbmpub']\n",
      "['cll nurses', 'clinicalnursespecialists haematology cns nurses']\n",
      "['dean howes workshop heartmath', 'mental health techniques dean', 'teaching fellow', 'mindfulness psychology', 'modules unimentalhealthday']\n",
      "['cll patients wonder', 'family amp friends', 'family amp friends']\n",
      "['body cramps', 'side effect', 'cll treatment', 'cll expert dr sharman discusses pains', 'manage side']\n",
      "['cll patient david lauder s blog']\n",
      "[]\n",
      "['scan results expansion breakout', 'mpac luce rmp tymn iwg panr smds emis capd ule cll boot sir eto mto kgh']\n",
      "['scan results macd bullish signal line cross', 'rmp drx xpp idea panr smds bats csh emis pcft', 'dom cll spx algw sir']\n",
      "['pilot study', 'chronic lymphocytic leukemia blood journal']\n",
      "['study findings', 'new combination treatment', 'car t cells', 'chronic lymphocytic leukemia patients']\n",
      "['recent advances']\n",
      "[]\n",
      "['ibrutinib bests chemo drug combo', 'cll patients chronic lymphocytic leukemia', 'glad i', 'ibrutinib amp', 'chemo package altogether']\n",
      "['clinical trial', 'multistage treatment approaches', 'cll leukemia oncology']\n",
      "['prime education', 'leukemia amp lymphoma society lls', 'cll society', 'webinars cll cllsm leukemia smartpatients']\n",
      "['brief caregiver survey', 'professional community', 'caregivers thanks', 'advance cll cllsm smartpatients']\n",
      "['expert access', 'free online', 'opinion program', 'cll cllsm leukemia bloodcancer smartpatients']\n",
      "['new interview', 'combination therapies', 'cllsm bloodcancer leukemia']\n",
      "['cathy wu', 'growth patterns', 'cll subclones', 'vivo consequences', 'genetic drivers', 'statistics tumour19']\n",
      "['cll treatment', 'dr philip thompson', 'cll differs', 'cancers leusm']\n",
      "['insightful research seminar', 'barbara merrill', 'scott revers', 'traditional students', 'employment cll yourwarwick research socsci']\n",
      "['old woman', 'chronic lymphocytic leukemia', 'right inguinal lymphadenopathy fever', 'night sweats results', 'core biopsy', 'dominant lymph node', 'large cell transformation']\n",
      "['clear picture', 'cll chronic lymphocytic leukemia patient s diagnosis', 'disease traits cll expert dr jennifer', 'treatment decisions leusm']\n",
      "['lymsm lymphoma hematology']\n",
      "['sharma s', 'cancer chronic lymphocytic leukemia cll treatment', 'such great options']\n",
      "['free light chain ratio', 'high risk chronic lymphocytic leukemia pedigrees']\n",
      "['unresponsive chronic lymphoc leukemia']\n",
      "['chronic lymphocytic leukemia', 'small l']\n",
      "['jacquelinebarrientos discusses', 'survival amp', 'site news toxicity healthcare oncology']\n",
      "['therapy changes', '17p deletion cll leusm leukemia cancer cancerfree oncology cancerresearch endcancer beatcancer standuptocancer fightcancer research4acure']\n",
      "['ibrutinib therapy releases leukemic surface igm', 'antigen drive', 'chronic lymphocytic leukemia patients']\n",
      "['pi3 kinase inhibitors cll leusm leukemia cancer cancerfree oncology cancerresearch endcancer beatcancer standuptocancer fightcancer research4acure solvecancer']\n",
      "['lisa henley durcan', 'full time', 'lisa gt']\n",
      "['new agents', 'cll amp wm cll leusm leukemia cancer cancerfree oncology cancerresearch endcancer beatcancer standuptocancer fightcancer research4acure solvecancer']\n",
      "['bearish list', 'icgt cll park afx nccl uai']\n",
      "['cll cll leusm leukemia cancer cancerfree oncology cancerresearch endcancer beatcancer standuptocancer fightcancer research4acure solvecancer']\n",
      "['international workshop', 'chronic lymphocytic leukemia sept', 'edinburgh scotland', 'details iwcll2019 cll']\n",
      "['unresponsive chronic lymphocytic leukemia', 'real world setting']\n",
      "['chronic lymphocytic leukemia', 'nonmelanoma skin cancer dermatology']\n",
      "['treatment prediction', 'chronic lymphocytic leukemia', 'new transcriptional patterns', 'rna seq time', 'treatment prediction', 'chronic lymphocytic leukemia', 'new tra']\n",
      "['effective treatment']\n",
      "['richter s transformation', 'large b cell lymphoma dlbcl', 'rare cases', 'classic hodgkin s lymphoma', 'chronic lymphocytic leukemia cll']\n",
      "['ovariancancer chronic lymphocytic leukemia cll renalcellcancer colorectalcancer', 'cancer tnbc', 'african american women']\n",
      "['chemotherapy leukemia bloodcancer cll hematology chemotherapy chemo cancer cancerfree oncology cancerresearch endcancer beatcancer standuptocancer fightcancer research4acure']\n",
      "['treatment options', 'ighv chronic lymphocytic leukemia', 'cll moon shot', 'leukcsm cancermoonshot endcancer']\n",
      "['verastem oncology', 'duo data', 'cll sll', 'annual international congress', 'hematologic malignancies cll leusm leukemia hemeonc']\n",
      "['great video overview', 'cll patients treatment advances', 'focus look', 'edinburgh september']\n",
      "['new cme video', 'clinical advances', 'hematologic malignancies', 'cll mm aml']\n",
      "['chronic lymphocytic leukemia', 'new immunotherapy approaches', 'therapies cancermoonshot endcancer']\n",
      "['chronic lymphocytic leukemia cll therapeutics market share growth statistics', 'application production revenue']\n",
      "['new agents arzerra gazyva', 'chronic lymphocytic leukemia cll']\n",
      "['cll cll leusm leukemia cancer cancerfree oncology cancerresearch endcancer beatcancer standuptocancer fightcancer research4acure solvecancer']\n",
      "['upfront management amp immunotherapy', 'immunotherapy imt cll leusm leukemia cancer cancerfree oncology cancerresearch endcancer beatcancer standuptocancer']\n",
      "['manage 17p patients cll leusm leukemia cancer cancerfree oncology cancerresearch endcancer beatcancer standuptocancer fightcancer research4acure solvecancer']\n",
      "['cll cll leusm leukemia cancer cancerfree oncology cancerresearch endcancer beatcancer standuptocancer fightcancer research4acure solvecancer']\n",
      "['cllsm cll leukemia']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['chronic lymphocytic leukemia', 'new agents', 'generation btk', 'pi3k inhibitors cllsm leukemia leusm']\n",
      "['cll cll cancer cancerfree oncology cancerresearch endcancer beatcancer standuptocancer fightcancer research4acure solvecancer healthcare healthtalk']\n",
      "['bone marrow', 'cll diagnosis', 'treatment leusm']\n",
      "['cll society', 'educational forums', 'houston tx', 'smartpatientsgetsmartcare letscurethis cll cllsm']\n",
      "['bat bat', 'basic attention', 'token holder addresses', 'similar utility', 'token cll cll', 'airdrop cll', 'bat holders', 'users basicattentiontoken', 'airdrop brave erc20 ethereum']\n",
      "['cll cllsm leukemia']\n",
      "['cll nurses', 'cns masterclass', 'clinicalnursespecialists haematology nurses']\n",
      "['cll expert dr sharman', 'car t cell therapy research', 's fda', 'cll treatment landscape']\n",
      "['recent progress chronic lymphocytic leukemia', 'challenging disease', 'review highlights', 'novel therapies', 'new test options', 'manage patients w cll']\n",
      "['chemo immunotherapy approach', 'dr susan o brien', 'recent american society', 'hematology mtg leusm']\n",
      "['por fin una media', 'sub 1s 2x2x2 corona cll']\n",
      "['overall response rate', 'blood cancer patients', 'response rate', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma patients']\n",
      "['own dr brian koffman highlights', 'incredible responses', 'new cll treatments cll cllsm leukemia']\n",
      "['non hodgkin s lymphoma chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma amp', 'non hodgkin s lymphoma']\n",
      "['couple tune', 'cll patients', 'different relationship stages leusm']\n",
      "['free light chain ratio', 'high risk chronic lymphocytic leukemia pedigrees bcj blood cancer journal']\n",
      "['unresponsive chronic lymphocyt']\n",
      "['chronic lymphocytic leukemia market', 'level benchmark', 'period gt gt gt strategy competitiveintelligence', 'healthcare pharmaceutical ci pharma biotech']\n",
      "['chronic lymphocytic leukemia diagnosis']\n",
      "['affiliate program check', 'cll points', 'referral signup', 'cll points', 'referral visitor', 'clltoken cll blockchain erc20 cll']\n",
      "['chronic lymphocytic leukemia cll treatment', 'such great options cancer sharma s', 'science research']\n",
      "['cll tokens', 'utility cycle', 'internal wallet', 'gas costs']\n",
      "['genetic mutations', 'cll patients', 'cll experts dr jennifer', 'treatment path leusm']\n",
      "['chronic lymphocytic leukemia cll treatment', 'such great options cancer sharma s', 'science research']\n",
      "['effective treatment']\n",
      "['chronic lymphocytic leukemia', 'small l']\n",
      "['masood azhar', 'jem leader', 'chronic lymphocytic leukemia cll amp', 'islamabad azhar', 'months masoodazhar masoodazhardead jem']\n",
      "['cork event', 'cll patients value meeting amp hearing', 'others cll journeys', 'video shares', 'cll diagnosis', 'good friend nick york']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['fda approves ibrutinib combo regimen']\n",
      "['career tune', 'cll patients', 'work life balance', 'cll diagnosis']\n",
      "['car t therapy shows', 'chronic lymphocytic leukemia']\n",
      "['nccn updates clinical practice guideline', 'cll cllsm cll leukemia']\n",
      "['interesting article cllsm cll leukemia']\n",
      "['cll chronic lymphocytic leukemia case', 'patient s slide', 'medical lab scientist']\n",
      "['expert panel tackles questions', 'faculty drs davids wierda', 'barrientos miamihematology']\n",
      "['potential curative treatments', 'allo sct', 'dr wierda', 'dr davids miamihematology']\n",
      "['dr davids', 'cochair miamihematology']\n",
      "['unresponsive chronic lymphocyt']\n",
      "['great information event', 'cll community', 'wonderful speakers prof mary cahill emma lane hns cork amp fiona moriarty', 'rainy day']\n",
      "['chronic lymphocytic leukemia cll treatment', 'such great options article', 'cancer wiley online library']\n",
      "['short report 17p deletion', 'influences rituximab elimination', 'chronic lymphocytic leukemia']\n",
      "['novel agents', 'severe cll experts', 'dr javier pinilla ibarz', 'potential complications', 'generation cll treatments leusm']\n",
      "['unresponsive chronic']\n",
      "['effective treatment']\n",
      "['michael kneba', 'major contributions', 'response assessment', 'lymphoid cancers', 'successful cooperation lymsm leusm cll gcllsg']\n",
      "['co chair', 'nyc ft cll updates', 'dr richard furman cancer care professionals']\n",
      "['cll nurses', 'clinicalnursespecialists cns haematology nurses']\n",
      "['new test shows', 'leukemia patients', 'chemotherapy researchers', 'future role']\n",
      "['unresponsive chronic lymphocytic']\n",
      "['research seminar series', 'dr spencer gibson phd section head cell biology mb march', '8am ah greenberg lecture theatre']\n",
      "['chronic lymphocytic leukemia cll treatment', 'such great options cancer sharma s', 'science research']\n",
      "['chronic lymphocytic leukemia cll pipeline insight']\n",
      "['i m', 'sure i m', 'article roller coasters', 'different metaphor']\n",
      "['derni re journ e du 1e tour', 's inscrire', 'gestion agricole cll', 'ao t']\n",
      "['cll patient event', '30pm cork chroniclymphocyticleukaemia']\n",
      "['i m', 'sure people wonder', 'gamer nerd tweets', 'offensive i', 'b c i need', 'important i', 'stage b cll', 'amp i ve']\n",
      "['cctg clc2', 'phase iii trial', 'ibrutinib monotherapy', 'valuable treatment option', 'chronic lymphocytic leukemia cll patients trialsthatmatter']\n",
      "['postdoc positions microenvironmental interactions', 'chronic lymphocytic leukemia', 'b cell lymphoma deadline', 'science career jobs sciencejobs job oncology cancerresearch cancer']\n",
      "['anterior chamber fibrinoid syndrome', 'cataract extraction', 'b cell chronic lymphocytic leukemia', 'case report']\n",
      "['attention mine cll', 'attentionmine cll cryptoliveleak cll']\n",
      "['rare disease day', 'previous post', 'chronic lymphocytic leukemia', 'abnormal labs', 'real side effect']\n",
      "['chronic lymphocytic leukemia', 'small lymphocytic lymphoma high doses', 'vitamin d']\n",
      "['march 1st', 'croydon hospital', 'isn t', 'leukaemia cll bloodcancer diagnosisday']\n",
      "['cll frontline tune', 'ash18 coverage', 'experts dr nicole lamanna', 'amp dr sharman', 're treatment research', 'treatment leusm']\n",
      "['interesting article', 'durability fcr response', 'cll patients cllsm cll leukemia bloodcancer']\n",
      "['new study details hereditary component', 'chronic lymphocytic leukemia cll health science medicine cancer']\n",
      "['free clear language lab training', 'clear inclusive communication', 'plainlanguage clearlanguagelab cll adulteducation communication inclusivecommunication']\n",
      "['effective treatment']\n",
      "['u s', 'chronic lymphocytic leukemia cll', 'rare blood cancer', 'adults rarediseaseday showyourrare']\n",
      "['critical patients voice shoutout', 'rare disease fdapatientrepresentatives', 'raredisease cll patientdriven']\n",
      "['cll patients', 'amp check', 'cll cllreport chroniclymphocyticleukemia patientreporter']\n",
      "['cll gvhd']\n",
      "['exciting data', 'significant impact', 'front line cll', 'canada ecog', 'alliance a041202', 'illuminate pcyc']\n",
      "['cancer team', 'cll society', 'potential access', 'opinion bloodcancer letscurethis cll cllsm']\n",
      "['murano study', 'reading room collaboration leukemia cll']\n",
      "['dr neha godiwala goyal', 'emotional ups', 'downs cll patients']\n",
      "['nucleotide polymorphism rs11614913', 'egyptian patients', 'chronic lymphocytic leukemia hematologytransfusioninternationaljournal medcraveonline']\n",
      "['common leukaemia', 'rare disease', 'decision makers', 'public awareness amp support clinicalresearch ie']\n",
      "['prenant toutes les lignes', 'compte pr s', 'des patients llc trait s sont trait s par bcri', 're oivent un traitement fcr', 'sur cette maladie volutive leuc mie traitementllc']\n",
      "['cll patients']\n",
      "['sharma s', 'cancer chronic lymphocytic leukemia cll treatment', 'such great options']\n",
      "['chronic lymphocytic leukemia cll market']\n",
      "['chronic lymphocytic leukemia cll market']\n",
      "['new sharma s', 'cancer chronic lymphocytic leukemia cll treatment', 'such great options']\n",
      "['new guidelines', 'chronic lymphocytic leukemia smal']\n",
      "['fda approval ibrutinib', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma lymsm cancertreatment']\n",
      "['por favor una ayuda para el hijo del querido amigo juan carlos landa carpio']\n",
      "['new test', 'game changer', 'chronic lymphocytic leukemia']\n",
      "['cll leukemia bloodcancer cll hematology chemotherapy chemo cancer cancerfree oncology cancerresearch endcancer beatcancer standuptocancer fightcancer research4acure']\n",
      "['new review article', 'chronic lymphocytic leukemia cll treatment', 'such great options']\n",
      "['17p deletion play', 'treatment tune', 'cll expert dr sharman']\n",
      "['chronic lymphocytic leukemia', 'small leukemia']\n",
      "['free light chain ratio', 'high risk chronic lymphocytic leukemia pedigrees']\n",
      "['cancer research wales', 'month congratulations', 'phd work', 'valuable insights', 'genetic changes', 'impact chronic lymphocytic leukemia']\n",
      "['new test', 'game changer', 'chronic lymphocytic leukemia']\n",
      "['new test', 'game changer', 'chronic lymphocytic leukemia']\n",
      "['dr el', 'campos talks', 'carlos l pez otin s scandal', 'scientific career dr campos', 'scientific heads', 'chronic lymphocytic leukemia', 'international cancer genome consortium']\n",
      "['dna damage response', 'genetic background', 'chronic lymphocytic leukemia patients', 'chromosomal gains']\n",
      "['chronic lymphocytic leukemia gt', 'mature b lymphocytes', 'cd5 antigen patients', 'asymptomatic blood smear shows smudge cells']\n",
      "['chronic lymphocytic leukemia', 'small lym']\n",
      "['cll ibrutinib und chlorambucil kombinationen im direktvergleich']\n",
      "['free access advances', 'chronic lymphocytic leukemia', 'future prospects jennifer l crombie jennifer r']\n",
      "['venetoclax penetrates', 'cerebrospinal fluid', 'central nervous system involvement']\n",
      "['canadian evidence', 'line treatment', 'chronic lymphocytic leukemia']\n",
      "['medical journalist', 'chronic lymphocytic leukemia andrew schorr shares', 'leukemia patients']\n",
      "['patients gain', 'healthcare system', 'patientreporter cll']\n",
      "['cll treatment', 'necessary considerations cllpatients patientreporter chroniclymphocyticleukemia']\n",
      "['right cll treatment approach', 'experts dr', 'dr kerry rogers', 'cll treatment classes', 'lifestyle factors']\n",
      "[]\n",
      "['full list', 'cll society', 'support group meetings', 'cll bloodcancer leukemia']\n",
      "['portland oregon', 'cll society patient', 'caregiver education forum']\n",
      "['early stage', 'fight cll', 'leukemia bloodcancer']\n",
      "['brilliant work', 'measures telomere length', 'cll uk']\n",
      "['iowa mayo clinic lymphoma spore conducts innovative interactive translational research', 'lymphoma chronic lymphocytic leukemia', 'small lymphocytic lymphoma lymsm']\n",
      "['reception superstars', 'didn t', 'word sentence', 'progress eyfs cll']\n",
      "['cll frontline treatment', 'cll expert']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['cll ecp ecp2019 chemistry']\n",
      "['cll nurses', 'cns masterclass', 'clinicalnursespecialists haematology nurses']\n",
      "['cll patient relapses', 'expert dr richard furman', 'potential progression factors', 'treatment options leusm']\n",
      "['sci member steven coutre', 'cll treatment', 'standard treatment', 'free survival leukemia']\n",
      "['cll patients', 'treatment tune', 'dr william wierda', 'cll patients', 'care team', 'cancertreatment decisions leusm']\n",
      "['cme cne', 'chronic lymphocytic leukemia leusm']\n",
      "['mb cart19', 'r r cd19 b cell malignancies bcm status', 'condition summary', 'acute lymphoblastic leukemia recurrent b cell lymphoma recurrent b cell lymphoma refractory chronic lymphocytic leukemia recurrent chronic lymphocytic leukemia r']\n",
      "['cortactin expression', 'non hodgkin b cell lymphomas', 'new marker', 'differential diagnosis', 'chronic lymphocytic leukemia', 'mantle cell lymphoma']\n",
      "['apto aptose biosciences submits ind application', 'non covalent pan flt3 pan btk inhibitor', 'chronic lymphocytic leukemia', 'b cell malignancies', 'acute myeloid leukemia']\n",
      "['obvious signs', 'viral bacterial infection', 'home leukaemia cll bloodcancer']\n",
      "['cll nurses', 'cns masterclass', 'clinicalnursespecialists haematology nurses']\n",
      "['leukemia2019 leukemia cancer lymphoma oncology aml', 'cml cll mpal bonemarrowtransplant aplasticanemia stemcelltransplant hematology bloodcancer stemcells transplant']\n",
      "['great news', 'cll community', 'cll patients', 'pharmaceutical benefits scheme', 'gov support']\n",
      "['cll society exists', 'smart patients', 'smart care', 'open cancersucks bloodcancer leukemia letscurethis']\n",
      "['exciting cll data', 'perfect weather', 'ashfoundationrun spring']\n",
      "['longtime collaborator dr lili wang', 'corresponding author publication', 'new lab', 'mouse model', 'chronic lymphocytic leukemia cancerresearch paper womeninstem womeninscience academictwitter']\n",
      "['instructive commentary', 'davide rossi', 'functional role', 'leusm leukemia']\n",
      "['energy metabolism', 'genetic variants', 'chronic lymphocytic leukemia']\n",
      "['car t cell therapy boosts response', 'cll oncology']\n",
      "['fantastic patient centric symposium']\n",
      "['cll society', 's cure', 'cll cancersurvivor bloodcancer leukemia']\n",
      "['novel cll regimens', 'promising efficacy oncology']\n",
      "['top cll doc s insights', 'treatment cllpatient chroniclymphocyticleukemia patientreporter']\n",
      "['excellent interview', 'nicole lamanna md columbia', 'cll patients courtesy', 'bloodcancer letscurethis leukemia']\n",
      "['excellent resource cll ash2018 letscurethis']\n",
      "['post ash2018 cll society', 'educational forum', 'medical center', 'seattle register', 'link cll bloodcancer letscurethis leukemia']\n",
      "['weekly cll alerts', 'great summary', 'critical developments', 'patients need', 'bloodcancer leukemia']\n",
      "['cll patients', 'joint pain', 'cll treatments', 'patient s joints', 'painful discomfort', 'side effect', 'joint pain']\n",
      "['alemtuzumab campath 1h', 'cd52 panlymphocytic', 't cells monoclonal antibody', 'chronic lymphocytic leukemia alemtuzumab induction therapy', 'kidney transplant recipients']\n",
      "['great update']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['chimeric antigen receptor t cell therapy', 'refractory chronic lymphocytic leukemia']\n",
      "['chimeric antigen receptor t cell therapy', 'refractory chronic lymphocytic leukemia tctm19 cllsm bloodcancer']\n",
      "['cll patient tune', 'expert dr javier pinilla ibarz', 'classify patients', 'treatment leusm']\n",
      "['excellent cll']\n",
      "['new job', 'strategic engagement', 'new year', 'new experiences', 'opportunities makeadifference cll fl']\n",
      "['mrd test', 'cll patients', 'treatment response', 'expert dr susan leclair']\n",
      "['downloadable resource', 'committee members', 'cll lymsm lymphoma']\n",
      "['cancer driver gene']\n",
      "['fbxw7 mutations', 'notch1 accumulation', 'target gene activation']\n",
      "['erc20 compatible ethereum wallet address', 'cll tokens', 'cll cll cryptoliveleak crypto cryptocurrency freecrypto blockchain erc20 giveaway']\n",
      "['cll society patient playbook smart patients', 'smart care', 's cure', 'cll leukemia cancer cancersurvivor bloodcancer']\n",
      "['emotional toll']\n",
      "['cll expert dr sharman', 'car t cell therapy research', 's fda', 'cll treatment landscape']\n",
      "['car t cell therapy', 'experimental treatment', 'pts w', 'cll dr sharman', 'influential community oncologist', 'perspective leusm']\n",
      "['cll nurses', 'cns masterclass', 'clinicalnursespecialists haematology nurses']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['jeff sharman md', 'informcll realworld registry analysis', 'cll novel treatment patterns', 'practice oncology clinicalpathways']\n",
      "['case series', 'clear activity', 'r r cll post allosct', 'nice data', 'cll blooducation lymsm']\n",
      "['short report 17p deletion', 'influences rituximab elimination', 'chronic lymphocytic leukemia']\n",
      "['cart cells', 'cll patients']\n",
      "['hello i', 'cll team i look', 'insightful tweets goldtigers2019 genpactgold socialgenpacter']\n",
      "['chronic lymphocytic leukemia']\n",
      "['car t therapy shows', 'chronic lymphocytic leukemia']\n",
      "['ibrutinib cartcells', 'r r cll', 'complete mrd responses', 'low toxicity', 'right companion', 'cll tctm19']\n",
      "['tctm19 cartcells']\n",
      "['interesting slide', 'cartcells ibrutinib', 'robust expansion tctm2019']\n",
      "['dr jordan gauthier', 'refractory chronic lymphocytic leukemia', 'cartcell therapy', 'remission rates tctm2019', 'p m cst']\n",
      "['solids tumors', 'blood cancer', 'cll dr phil thompson', 'cll specialist']\n",
      "['chronic lymp']\n",
      "['fda approval ibrutinib', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma lymsm cancertreatment']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['cll society', 'scientific conferences', 'conclusions accessible', 'conference coverage videos', 'cancer cll bloodcancer cancersurvivor']\n",
      "['btk inhibitor', 'regimens car t cell therapy', 'novel therapeutic strategies', 'efficacious outcomes', 'chronic lymphocytic leukemia cll']\n",
      "['own amp', 'cll expert professor john seymour', 'associate director', 'clinical research', 'australia s', 'bloodcancer community', 'clinicians amp researchers']\n",
      "['lymphoma cll stemcell transplant apheresis', 'blooducation oxford']\n",
      "['lymphoma amp cll nurses', 'cns masterclass', 'oxford 14jul book', 'clinicalnursespecialists haematology nurses']\n",
      "['final cai', 'tfc cll']\n",
      "['cll society', 'cll patient', 'future cancersurvivor', 'empowerment smart patients', 'smart care endcancer']\n",
      "['novel cll regimens', 'promising efficacy suman kambhampati md reflects', 'chronic lymphocytic leukemia', 'annual meeting']\n",
      "['great stuff cll leukemia bloodcancer']\n",
      "['recent advances', 'cll therapies', 'new combinatorial novel btk amp pi3k inhibitors spleen tyrosine kinase inhibitors immunomodulatory drugs amp immunotherapy']\n",
      "['dr philip thomson', 'risks amp benefits', 'early tx cll']\n",
      "['i didn t', 'growth cll']\n",
      "['cll treatment', 'dr philip thompson', 'cll differs', 'cancers leusm']\n",
      "['video venetoclax resistance', 'piers blombery', 'hematology ash18 leukemia cllsm hemeonc leusm cagenome bcl2']\n",
      "['barbara andersen asc', 'professor highlights', 'research study']\n",
      "['chemo immunotherapy approach', 'dr susan o brien', 'recent american society', 'hematology mtg leusm']\n",
      "['charlotte seattle portland houston bethesda minneapolis boston', 'new york', 'san diego', 'cll society', 'educational forums', 'webpage cll bloodcancer leukemia']\n",
      "['doesn t', 'young children', 'active retirement']\n",
      "['excellent video', 'venetoclax occurs', 'cll bloodcancer leukemia']\n",
      "['tiptuesday download chapters', 'chronic lymphocytic leukemia', 'non hodgkin lymphomas', 'resource center lymsm']\n",
      "['trialtuesday alliance researcher jennifer woyach md james', 'alliance a041702', 'immunotherapy trial', 'chronic lymphocytic leukemia']\n",
      "['excellent review cll form biology', 'therapy hemasphere hematology']\n",
      "['review summarizes', 'success story', 'recent advances', 'chronic lymphocytic leukemia hemasphere']\n",
      "['chronic lymphocytic leukemia therapeutics market epidemiology analysis therapy development growth demand', 'new technology', 'top key player', 'glaxosmithkline roche teva pharmaceuticals gilead sciences novartis johnson amp']\n",
      "['dna methylation', 'implicates exposure', 'b cell chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['complex karyotype', 'chronic lymphocytic leukemia cll', 'comprehensive review', 'literature lymphoma lymsm']\n",
      "['novel contributor', 'chronic lymphocytic leukemia progression', 'dr angeles garcia pardo']\n",
      "['blood tests', 'mum chemo cll remission nhs']\n",
      "['berlebens und', 'heilungschancen bei cll haben sich dank neuer behandlungsm glichkeiten enorm erh ht krebs chronischelymphatischeleuk mie']\n",
      "['neue forschungserfolge bei chronischer lymphatischer leuk mie cll neue']\n",
      "['dr moreno', 'efficacy results', 'illuminate trial', 'promising treatment option', 'chronic lymphocytic leukemia leukemia leusm']\n",
      "['chronic lymphocytic leukemia cll', 'new immunotherapy approaches', 'cll genetics', 'therapies cancermoonshot endcancer']\n",
      "['video car t cells', 'cll jcar014', 'r r setting w', 'hematology ash18 leukemia cllsm hemeonc leusm cartcells immunoonc cellulartherapy']\n",
      "['clear picture', 'cll chronic lymphocytic leukemia patient s diagnosis', 'disease traits cll expert dr jennifer', 'treatment decisions leusm']\n",
      "['cll society expert access program', 'bloodcancer leukemia']\n",
      "['peter hillman', 'ash2018 bloodcancer leukemia']\n",
      "['clinical trial', 'cll visit', 'clinical trial portal', 'cll society webpage', 'bloodcancer leukemia']\n",
      "['doubt taiwo', 'course pregnant', 'full time degree', 'newborn baby']\n",
      "['cll nurses', 'cns masterclass', 'clinicalnursespecialists haematology nurses']\n",
      "['traditional combinations', 'chemotherapy combinations w ibrutinib', 'response rates', 'chronic lymphocytic leukemia cll patients', 'oncology pharmacology']\n",
      "['cll bei lteren', 'der patienten mit ibrutinib nach', 'jahren noch ohne erneute progression onkologie cll']\n",
      "['busy end', 'various cll society patient support groups', 'details cll bloodcancer leukemia']\n",
      "['athina manakas', 'fulbright scholarship', 'christoph rader', 'scripps research institute', 'antibody derivatives', 'chronic lymphocytic leukemia cll matthews']\n",
      "['suman kambhampati md discusses', 'recent fda approval', 'ibrutinib imbruvica', 'obinutuzumab gazyva', 'frontline treatment', 'chronic lymphocytic leukemia cll cll bloodcancer leukemia']\n",
      "['cll society tribune', 'cll patients', 'edition cll bloodcancer leukemia']\n",
      "['clinical trials', 'treatment landscape']\n",
      "['dr furman', 'critical role', 'clinical trials', 'ash2018 bloodcancer leukemia']\n",
      "['couple tune', 'cll patients', 'different relationship stages leusm']\n",
      "['support juan sebastian fights', 'acute lymphocytic leukemia', 'liselotte ponce']\n",
      "['endorphin release', 'positive news', 'dr koffman', 'car t therapy cll bloodcancer leukemia']\n",
      "['video updates', 'cll time', 'venr amp', 'mrd w john seymour', 'hematology ash18 leukemia cllsm hemeonc leusm venetoclax hemonc']\n",
      "['car t therapy visit', 'resource page resource library cll bloodcancer leukemia']\n",
      "['cll iciclle amp clarity w peter hillmen', 'hematology ash18 leukemia cllsm hemeonc leusm']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['cll society patient playbook', 'blood cancer', 's cure', 'cll bloodcancer leukemia cancer testbeforetreat']\n",
      "['guest blogs', 'cll team doagrouchafavorday']\n",
      "['amazing drug dr byrd reflects', 'ash2018 cll bloodcancer testbeforetreat leukemia']\n",
      "['dr brian koffman', 'cll society comments', 'recent cms decision', 'car t', 'cll cart bloodcancer leukemia']\n",
      "['venetoclax cll leukemia testbeforetreat cancer']\n",
      "['excellent article', 'minimal residual disease mrd', 'blood cancers test', 'cll bloodcancer leukemia testbeforetreat']\n",
      "['car t therapy progress', 'major centers', 'years cll bloodcancer leukemia']\n",
      "['dr john pagel describe', 'pik3 inhibitors', 'cll video', 'ash2018 bloodcancer testbeforetreat leukemia']\n",
      "['cll bloodcancer leukemia']\n",
      "['cll expert dr jeff sharman', '17p deletion', 'genetic mutations', 'frontline therapy']\n",
      "['small numbers', 'ibrutinib dose', 'cll patients']\n",
      "['dose reductions', 'ibrutinib therapy', 'inferior outcomes', 'chronic lymphocytic leukemia cll leukemia amp lymphoma lymsm cllsm leusm']\n",
      "['ibrutinib jcar014 combo shows potential', 'refractory cll oncology']\n",
      "['high occupancy', 'abrogate kinase function', 'similar clinical outcomes', 'cll patients lymsm']\n",
      "['shares news', 'cll patients', 'bcr inhibitors', 'word venetoclax cll chroniclymphocyticleukemia patientreporter cllreports fighters']\n",
      "['treatment prediction', 'chronic lymphocytic leukemia', 'new transcriptional patterns adri n mosquera orgueira beatriz antelo rodr guez natalia alonso vence ngeles benda', 'l pez jos ngel d az arias nicol s d az varela marta sonia']\n",
      "['chronic lymphocytic leukemia', 'current research amp', 'future implications', 'leusm fridayreads']\n",
      "['cll amp', 'patient caf', 'panel discussion', 'virtual group discussion pls email cll info']\n",
      "['shirt amp', 'chronic cancer', 'cll nhl', 'superintendentlife publiceducation']\n",
      "['biology mechanism', 'healthy individuals', 'chronic lymphocytic leukemia patients', 'asso website']\n",
      "['great day', 'interactive sessions', 'cart cll']\n",
      "['dr susan leclair', 'dr philip thompson', 'cll characteristics', 'treatment decisions']\n",
      "['nice review', 'cll treatment', '60th hematology congress']\n",
      "['ibrutinib carts', 'negative remission', 'months cll', 'new potential', 'cartable disease', 'great data', 'carl june update hematology 1st carts meeting']\n",
      "['mdpijcm psoas abscess', 'mycobacterium avium', 'chronic lymphocytic leukemia case report']\n",
      "['dr davids', 'clinical implications', 'chronic lymphocytic leukemia leukemia bloodcancer hematology']\n",
      "['positive feedback', 'grub umbralisib', 'eventual approval cll lymsm lymphoma']\n",
      "['acute myelogenous myeloid leukemia aml chronic myelogenous myeloid leukemia cml', 'acute lymphoid leukemia', 'chronic lymphocytic leukemia cll']\n",
      "['insightful video dr william g wierda explores', 'new strategies', 'chronic lymphocytic leukemia leusm']\n",
      "['joint initiatives', 'conventional cll therapy', 'functional medicine approach', 'great podcast mark', 'farmacy series leukaemia']\n",
      "['manage patients', 'lymphoma tune', 'minimize treatment', 'adverse effects', 'cll amp mantlecell lymphoma', 'medscapeedu w mollie moran msn']\n",
      "['rt physrelations rt ca mdanderson william wierda md phd', 'chronic lymphocytic leukemia mohc19 mdanderson endcancer physrelations']\n",
      "['william wierda md phd', 'chronic lymphocytic leukemia mohc19 mdanderson endcancer']\n",
      "['rt physrelations dr william wierda', 'chronic lymphocytic leukemia cll', 'medical oncology amp hematology', 'conference mohc19 wwierda leukemia cll leukemiamda cancermedmda']\n",
      "['rt physrelations', 'chronic lymphocytic leukemia cll', 'dr william wierda', 'medical oncology amp hematology', 'conference mohc19 leukemia cll endcancer wwierda c']\n",
      "['video car t', 'promising treatment', 'cll w lydia scarf', 'hematology ash18 leukemia cllsm hemeonc leusm cartcells immunoonc']\n",
      "['patients matter', 'huge news tv ada', 'drug price transparency', 'cll chroniclymphocyticleukemia patientreporter']\n",
      "['improvement immunization', 'pts w monoclonal b cell lymphocytosis', 'cll whitaker', 'leusm cllsm idonc']\n",
      "['typical treatment', 'chronic lymphocytic leukemia']\n",
      "['partner colleges', 'official college education partnercolleges cll']\n",
      "['cll success story hemasphere hematology cllsm leusm']\n",
      "['failure part', 'cll treatment research cancerpatient cancersurvivor powerfulpatient']\n",
      "['case report', 'chimeric antigen receptor t cells', 'chronic lymphocytic leukemia']\n",
      "['retrospective results', 'concurrent ibrutinib', 'chimeric antigen receptor t cell research', 'chronic lymphocytic leukemia cll cancerdrugs']\n",
      "['education book', 'open door', 'fallinlovewitheducation valentinesday2019']\n",
      "['central nervous system lymphoma', 'chronic lymphocytic leukemia', 'case report', 'literature review lymphoma lymsm']\n",
      "['obinutuzumab combination']\n",
      "['beautiful friend kathleen', 'chronic lymphocytic leukemia', 'mpc2019 shirt', 'reasons i', 'support uk']\n",
      "['update zu chronisch lymphatischer leuk mie cll vom amerikanischen h matologen kongress video interviews mit prof dr georg hess uniklinik mainz und prof dr stephan stilgenbauer uniklinik ulm cll patienteninformation ash2018']\n",
      "['saludos hermano seria', 'gran ayuda difundir esto un', 'familiar neceista', 'ayuda agradecido']\n",
      "['saludos hermano seria', 'gran ayuda difundir esto un', 'familiar neceista', 'ayuda agradecido']\n",
      "['17p deletion', 'bad prognosis']\n",
      "['saludos hermano seria', 'gran ayuda difundir esto un', 'familiar neceista ayuda agradecido']\n",
      "['saludos hermano seria', 'gran ayuda difundir esto un', 'familiar neceista', 'ayuda agradecido']\n",
      "['saludos hermano seria', 'gran ayuda difundir esto un', 'familiar neceista', 'ayuda agradecido']\n",
      "['17p deletion play', 'treatment tune', 'cll expert dr sharman']\n",
      "['scan results macd bullish centerline cross', 'clin oct', 'brfi bab pca pmo mpm bgfd fch gcm rec gemd cru cll kgp']\n",
      "['cienciasmedicasnews chronic lymphocytic leukemia treatment pdq heal']\n",
      "['short report 17p deletion', 'influences rituximab elimination', 'chronic lymphocytic leukemia']\n",
      "['favourable survival outcomes', 'comorbidities versus', 'cll burger british journal', 'haematology geriheme gerionc cllsm leusm']\n",
      "['mise jour temp te', 'c gep est ferm', 'journ e', 'soir e toutes les activit s sont annul es cll tempete']\n",
      "['akademiforums tema ikv ll r', 'viktigt tema', 'representanter fr n hos folkh lsan ubs polisen l', 'rare professorer och elevrepresentanter i panelen cll vbl']\n",
      "['hashtags l r vara ute bland ungdomar viktigt mne sowieso', 'vbl cll']\n",
      "['cll experts dr jonathan cohen', 'dr kerry rogers', 'patient response', 'treatment leusm']\n",
      "['newnprot duckworth', 'proximityligation assay', 'rna playr', 'detect rna']\n",
      "['blood transfusions', 'red blood cells', 'chronic lymphocytic leukemia']\n",
      "['60th ash', 'annual meeting amp exposition', 'chronic lymphocytic leukemia', 'poster sessions cll leukemia leusm']\n",
      "['important cll interview experts', 'regional cancer care associates', 'cll chronic lymphocytic leukemia treatments']\n",
      "['pakistan s patients', 'leukemia treatment', 'blog leukemia cml cll']\n",
      "['leukemia2019 leukemia cancer lymphoma oncology aml', 'cml cll mpal bonemarrowtransplant aplasticanemia stemcelltransplant hematology bloodcancer stemcells transplant']\n",
      "['chronic lymphocytic leukemia treatment', 'global trends market size share status swot analysis']\n",
      "['exciting news', 'week cll', 'own mascot meet brian', 'fellow l81', 'brian s', 'new role campusdog']\n",
      "['c gep est ferm consultez', 'site internet partir', 'les activit s', 'soir e bonne journ e tempete cll']\n",
      "['video cosmos key updates', 'r r cll w jennifer woyach', 'hematology ash18 leukemia cllsm hemeonc leusm']\n",
      "[]\n",
      "['vitamind treatment', 'stabilize disease']\n",
      "['cll amp', 'patient caf', 'panel discussion', 'virtual group discussion pls email cll info']\n",
      "['elderly patients', 'chronic lymphocytic leukemia']\n",
      "['debulk cll patients', 'tls risk', 'pre ven setting', 'question cll blooducation']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['emf paper', 'hardell group', 'power lines', 'chronic lymphocytic leukemia breast cancer melanoma nervous system tumors leukemia non hodgkin lymphoma']\n",
      "['emotional distress increase cll symptom burden', 'cll expert opinions']\n",
      "['education sector']\n",
      "['european leukemianet symposium', 'current projects', 'acute lymphoblastic leukemia', 'acute myeloid leukemia chronic lymphocytic leukemia research patients hematology ju h2020']\n",
      "['leukemia2019 leukemia cancer lymphoma oncology aml', 'cml cll mpal bonemarrowtransplant aplasticanemia stemcelltransplant hematology bloodcancer stemcells transplant']\n",
      "['effective treatment', 'elderly patients', 'chronic lymphocytic leukemia cll']\n",
      "['hola gente disculpen por molestar pero si pueden ayudar o difundirlo ayudar']\n",
      "['por favor ay denos', 'nuestro amigo', 'nuestro hermano gracias difundir esto boys']\n",
      "['womeninscience day', 'important work', 'dr banerji', 'cll dr israels', 'disorders dr murphy']\n",
      "['dr seymour', 'chronic lymphocytic leukemia cllsm leukemia leusm']\n",
      "['scan results', 'polr tmmg kcom oct prsm fjet opti rdt asai lvcg cru bpcr ctec pcft cll rcp']\n",
      "['cll frontline treatment', 'cll expert dr cohen']\n",
      "['cll patient advocate lee swanson interviews dr adrian wiestner', 'exciting news']\n",
      "['drug resistance', 'chronic lymphocytic leukemia', 'new therapeutic strategies']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['cll practice']\n",
      "['cll frontline treatment', 'cll expert']\n",
      "['blog post', 'treatment options', 'cll patients']\n",
      "['specific chimeric antigen receptor t cells', 'chronic lymphocytic leukemia patients']\n",
      "['young patient', 'refractory cll w jacqueline barrientos', 'feinstein institute', 'medical research lymphoma prognosis cancertherapy overallsurvival']\n",
      "['current hurdles', 'cll w lindsey roeker', 'hematology ash18 leukemia cllsm hemeonc leusm']\n",
      "['abbvie announces u s fda approval', 'imbruvica ibrutinib', 'obinutuzumab gazyva', 'cd20 combination regimen', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll']\n",
      "['rare pitfall', 'molecular interpretation', 'braf v600e status', 'settin ingentium melanoma']\n",
      "['psoas abscess', 'mycobacterium avium', 'chronic lymphocytic leukemia case report', 'review lymphoma lymsm']\n",
      "['psoas abscess', 'mycobacterium avium', 'chronic lymphocytic leukemia case report']\n",
      "['con todo el pawaaaa cll chileluchalibre']\n",
      "['video ibrutinib combinations', 'cll illuminate results amp', 'w carol moreno', 'hematology ash18 leukemia cllsm hemeonc leusm']\n",
      "['chronic lymphocytic leukemia cll hypogammaglobulinemia']\n",
      "['undetectable mrd', 'prime time']\n",
      "['chronic lymphocytic leukemia']\n",
      "['rare pitfall', 'molecular interpretation', 'braf v600e status', 'braf v600e', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma lymphoma lymsm']\n",
      "['venetoclax rituximab combination improves survival']\n",
      "['john terry', 'fans jt26 cfc utc cll']\n",
      "['l selectin expression', 'phosphatase activity', 'chronic lymphocytic leukemia']\n",
      "['l selectin expression', 'phosphatase activity', 'chronic lymphocytic leukemia']\n",
      "['month ibrutinib', 'cll tx', 'high risk dz', 'precious time', 'effective therapies']\n",
      "['genpact cll']\n",
      "['scan results macd bullish signal line cross', 'mwg sav blvn stvg vrp ntv pol igp cll ekf bez kyga isat jlen cpc aam']\n",
      "['great debate', 'asymptomatic myeloma', 'haematology summit fightclub glovesoff']\n",
      "['i m', 'protein expression signatures', 'individual cells', 'mass cytometry playr cytof']\n",
      "['new agents', 'refractory chronic lymphocytic leukemia cll']\n",
      "['education group', 'chroniclymphocyticleukemia cll']\n",
      "['reference epigenome', 'regulatory chromatin landscape', 'chronic lymphocytic leukemia europe pmc article europe pmc']\n",
      "['reference epigenome', 'regulatory chromatin landscape', 'chronic lymphocytic leukemia europe pmc article europe pmc']\n",
      "['msk s cll program']\n",
      "['cll patient advocate lee swanson interviews dr anthony mato', 'tools cllpatients', 'cll research']\n",
      "['b cell chronic lymphocytic leukemia cll', 'white blood cell', 'b cells', 'details contact']\n",
      "['nonchemothetapy combo', 'frontline treatment', 'impressive progression', 'free survival', 'response rate']\n",
      "['happy friday', 'exciting news', 'trainee teachers']\n",
      "['reference epigenome', 'regulatory chromatin landscape', 'chronic lymphocytic leukemia']\n",
      "['shows cll disease', 'fat uptake vs glucose lauren thurgood', 'investigates nutrient uptake', 'chronic lymphocytic leukaemia', 'proteomics amp lipidomics comparative data', 'healthy amp', 'b cells lorneproteomics']\n",
      "['cll mascot brian']\n",
      "['chronic l']\n",
      "['chronic lymphocytic leukemia', 'chimeric antigen receptor car t cell therapy blood clinicalresearch award leukemia']\n",
      "['video cll updates', 'choice w john gribben', 'hematology ash18 leukemia cllsm hemeonc leusm']\n",
      "['superior progression', 'free survival', 'line chemotherapy', 'therapy albeit', 'significant toxicity ash18']\n",
      "['dr moreno', 's questions', 'combination ibrutinib', 'chronic lymphocytic leukemia cllsm leukemia bloodcancer']\n",
      "['cll mascot brian']\n",
      "['mrd test', 'cll patients', 'treatment response', 'expert dr susan leclair']\n",
      "['competition time', 'gill principal teaching fellow', 'cll shares']\n",
      "['ibrutinib dose', 'clinical outcome', 'chronic lymphocytic leukemia learning', 'real world lymphoma lymsm']\n",
      "['chronic lymphocytic leukaemia cll', 'learning zone', 'chronic lymphocytic leukaemia care']\n",
      "['good morning', 'department mascot brian', 'busy day', 'students l81 mascot warwickstory wellbeingpets']\n",
      "['rns aim cll cello health plc notice', 'full year results']\n",
      "['ibrutinib amp rituximab', 'free survival amp overall survival', 'years amp', 'chronic lymphocytic leukemia', 'care chemoimmunotherapy ash18 leukemia']\n",
      "['chronic lymphocytic leukemia clinical trials', 'md anderson s paolo strati md wbw leusm fightbloodcancer']\n",
      "['thanks amber', 'useful navigation tool', 'cll patients']\n",
      "['time leukemia bcells immunotherapy']\n",
      "['compounds curcumin', 'active ingredient', 'turmeric amp', 'green tea extract egcg', 'cancer cell death', 'chronic lymphocytic leukemia']\n",
      "['new combination treatment gains approval', 'chronic lymphocytic leukemia']\n",
      "['fda approves imbruvica gazyva combo', 'line treatment', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll']\n",
      "['cll patients', 'hospitable microenvonment']\n",
      "['dose escalation', 'cohort expansion', 'hematologic malignancies status', 'condition summary chronic lymphocytic leukemia mantle cell lymphoma follicular lymphoma', 'marginal zone lymphoma diffuse', 'large b cell lymphoma']\n",
      "['cll patients', 'patient advocate carol preston share', 'encouraging advice', 'cll patients']\n",
      "['chronic lymphocytic leukemia i', 'cry smile', 'life grief', 'i ve']\n",
      "['significant highlights', 'morning sessions', 'acute amp chronic leukaemia treatments cll', 'venetoclax rituximab']\n",
      "['friday s anniversary lecture', 'dr el', 'clinical impact', 'genomic epigenomic perspective', 'chronic lymphocytic leukemia', 'friday february', '00h cicbiogune science research']\n",
      "['chronic lymphocytic leukemia', 'cll treatment']\n",
      "['unresponsive chronic lymphocytic leukemia', 'real world setting leukemia']\n",
      "['nccn guidelines insights chronic lymphocytic leukemia', 'small lymphocytic lymphoma version']\n",
      "['fda approves imbruvica', 'firstline cll treatment ibrutinib obinutuzumab']\n",
      "['concurrent cerebral aspergillosis', 'abdominal mucormycosis', 'ibrutinib therapy', 'chronic lymphocytic leukemia']\n",
      "['blood commentary highs', 'minimal residual disease']\n",
      "['patient engagement opportunities', 'venetoclax venclaxa', 'theor treatment', 'potential opportunities email cindy info cll mmsm aml leukemia myeloma']\n",
      "['cll patient advocate lee swanson interviews dr kerry rogers', 'ohio state university', 'medical center', 'exciting cll news']\n",
      "['prognostic value', 'cll patients']\n",
      "['lisa henley durcan', 'full time', 'lisa gt']\n",
      "['new rituximab', 'unresponsive chronic lymphocytic leukemia', 'real world']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['ai artificiell intelligens', 'teemu roos stort seminarium f r ledare inom finlandssvensk', 'framtidsdalen cll hanaholmen hanasaari', 'cultural centre']\n",
      "['long non', 'disease progression', 'early stage', 'chronic lymphocytic leukemia']\n",
      "['minichromosome maintenance', 'expression sensitizes chronic lymphocytic leukemia cells', 'fludarabine lymphoma lymsm']\n",
      "['chronic lymphocytic leukemia treatment']\n",
      "['car t', 'cll outcomes cll cllpatient cllpatients ibrutinib cart']\n",
      "['hey guys', 'dog s cancer bills', 'ada s', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll mayo clinic']\n",
      "['lenalidomide fludarabine']\n",
      "['em picture', 'cll cell', 'new drug i', 'tunnel digs', 'nucleus iamandiwill worldcancerday banerji']\n",
      "['video updates', 'cll therapy', 'big trials', 'big results w peter hillmen', 'hematology ash18 leukemia cllsm hemeonc leusm']\n",
      "['benzene exposure', 'acute lymphocytic leukemia', 'chronic lymphocytic leukemia cll', 'multiple myeloma', 'non hodgkin lymphoma']\n",
      "['janssen s imbruvica', 'treatment naive patients withcll sll janssen imbruvica cll cancer']\n",
      "['fda approves ibrutinib obinutuzumab', '1st nonchemotherapy combination regimen', 'treatment na ve patients', 'chronic lymphocytic leukemia janssen']\n",
      "['banerji banerji labs i', 'new drugs', 'cell s powerhouse', 'lab coat iamandiwill worldcancerday']\n",
      "['important point', 'new therapies', 'collaborative care', 'routine health maintenance screenings', 'catch spcs']\n",
      "['abstracts iwcll2019', 'cll hematology oncology cancerresearch']\n",
      "['iamandiwill i', 'patient advocate', 'cll lymsm']\n",
      "['uk neqas li', 'worldcancerday worldcancerday2019 aml cml cll aml cml mds']\n",
      "['rt amp', 'blood cancer mondaymotivation worldcancerday worldcancerday2019 iamandiwill cll leukaemia haematology']\n",
      "['b cell chronic lymphocytic leukemia treatment revenue', 'market share']\n",
      "['ii class y', 'b cell malignancies mhc class ii cell', 'regulates self renewal', 'malignant b cells bcells cll leukemia lymphoma myeloma']\n",
      "['free triplet combination', 'chronic lymphocytic leukaemia', 'b cell non hodgkin lymphoma cll tgtx umbralisib ibrutinib abbv']\n",
      "['avui s un dia molt especial diamundialcontraelcancer', 'aix estic molt content d estar', 'l intentant aportar el meu granet']\n",
      "['melbourne aus', 'social media', 'peter maccallum cancer center cancer cll']\n",
      "['cll community', 'cancer community', 'collective voice', 'personal action']\n",
      "['uae s patients', 'cll treatment', 'blog cml cll bmt']\n",
      "['gopats patriots superbowl cryptocurrency crypto blockchain']\n",
      "[]\n",
      "['unresponsive chronic lymphocytic leukemia', 'real world setting']\n",
      "['chronic lymphocytic leu']\n",
      "['fda approves ibrutinib combo regimen']\n",
      "['educational case chronic lymphocytic leukemia']\n",
      "['murine model', 'chronic lymphocytic leukemia', 'b cell', 'sf3b1 mutation', 'atm deletion']\n",
      "['hematologists oncologists amp nurses tune', 'pi3k inhibitors', 'refractory cll', 'follicularlymphoma amp', 'adverse effects', 'medscapeedu author']\n",
      "['week s broadresearchroundup', 'developmental biology', 'century math', 'novel chronic lymphocytic leukemia model morning lark', 'night owl genes', 'immune cells']\n",
      "[]\n",
      "['trip blwyddyn', 'i ganolfan d r cilfynydd yfory cofiwch wisgo yn gynnes gwisgwch esgidiau glaw os yn bosib', 'dewch phecyn bwyd sy n ysgafn ar sbwriel', 'dim bin yn y ganolfan cll']\n",
      "[]\n",
      "['useful article', 'cll patient', 'isn t']\n",
      "['chronic lympho']\n",
      "['murine model', 'chronic lymphocytic leukemia cll', 'b cell', 'sf3b1 mutation', 'atm deletion']\n",
      "['venetoclax rituximab', 'refractory chronic lymphocytic leukemia eradicates minimal residual disease', 'prolongs survival post treatment', 'murano phase iii study journal', 'clinical oncology']\n",
      "['dr marc hoffmann', 'ash18 update', 'cll practice', 'pearls kubloodcancer']\n",
      "['superior progression', 'free survival', 'line chemotherapy', 'therapy albeit', 'significant toxicity ash18']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['cancer news chronic lymphocytic leukemia', 'head neck cancers', 'robert preidt']\n",
      "['fda approves ibrutinib', 'frontline cll sll oncology']\n",
      "['illuminate study findings', 'cll show', 'frontline cll', 'recent fda approval']\n",
      "['cll experts dr jonathan cohen', 'dr kerry rogers', 'patient response', 'treatment leusm']\n",
      "['saturday march', 'cll chroniclymphocyticleukaemia bloodcancer patientsupport patientengagement']\n",
      "['free afternoon event', 'cll patients amp cll community', 'cork clayton hotel silver springs inc', 'haematology expert prof mary cahill emma lane hcns cork amp']\n",
      "['leukemia patients', 'game changer']\n",
      "['cll patients', 'treatment option', 'cll combination therapy', 'chemo cll chroniclymphocyticleukemia cllpatients ibrutinib imbruvica']\n",
      "['unresponsive chronic lymphocytic leukemia', 'real wor']\n",
      "['unresponsive chronic lymphocytic leukemia', 'real world setting']\n",
      "['teleconference update', 'chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukemia', 'current research amp', 'future implications', 'leusm fridayreads']\n",
      "['ibrutinib amp rituximab', 'free survival amp overall survival', 'years amp', 'chronic lymphocytic leukemia', 'care chemoimmunotherapy ash18 leukemia']\n",
      "['community story', 'affable man', 'low key demeanor', 'cll i']\n",
      "['point leukemia cells', 'bone marrow amp', 'blood leukemia cells']\n",
      "['major findings', 'annual meeting cancer ash18 aml cll mds']\n",
      "['hematologists oncologists amp nurses', 'pi3k inhibitors', 'refractory cll', 'adverse effects', 'medscapeedu authors']\n",
      "['dr susan leclair', 'dr philip thompson', 'cll characteristics', 'treatment decisions']\n",
      "['aerobic respiratory chain complexes', 't cell antigen receptor tcr cells', 'chronic lymphocytic leukemia']\n",
      "['expert guidance', 'nsclc cll aml']\n",
      "['regimens yield', 'durable remissions']\n",
      "['dr nasta', 'cll case study scenario', 'hemonc penncme ibrutinib']\n",
      "['illinoissocialwork community learning lab', 'local community']\n",
      "['therapeutic area', 'great place', 'oncology hematology cll dlbcl mm aml hemato oncology key information']\n",
      "['chronic lymphocytic leukemia', 'bone marrow', 'white blood cell']\n",
      "['novel bcl2 mutation', 'venetoclax resistance', 'progressive cll patients', 'secondary venetoclax resistance', 'cll patients']\n",
      "['educational case chronic lymphocytic leukemia']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['ibrutinib prolongs progression', 'free survival', 'elderly patients', 'chronic lymphocytic leukemia cll', 'youtube channel']\n",
      "['search mdedgechats']\n",
      "['great way', 'cll knowledge', 'thoughtful questions mdedgechats']\n",
      "['final questions amp thoughts']\n",
      "[]\n",
      "[]\n",
      "['dr andrew brunner', 'general hospital discusses', 'top takeaways', 'annual meeting cancer ash18 aml cll mds']\n",
      "['mdphd i m mary ellen schneider editor', 'hematology news', 'i ll']\n",
      "[]\n",
      "['mdedgechats hashtag']\n",
      "['current llsscholar catherine wu', 'lili wang', 'atm deletion cooperates', 'sf3b1 mutation', 'cll mouse model', 'current llssfellow']\n",
      "['main difference', 'lymphocytic leukemias', 'cancer cells', 'bone marrow', 'lymph nodes']\n",
      "['prognostic value', 'cll patients', 'rituximab gerionc geriheme cllsm']\n",
      "['minimal residual disease', 'cll mrd cllsm']\n",
      "['mdedgechats twitter', 'evening schedule', 'mdphd medtwitter cll cllsm leusm ash18']\n",
      "['resource center', 'chronic lymphocytic leukemia leusm bloodcancer']\n",
      "['treatment algorithms', 'front line']\n",
      "['failure part', 'cll treatment research cancerpatient cancersurvivor powerfulpatient']\n",
      "['novel translation inhibitors', 'pro survival proteins', 'chronic lymphocytic leukemia', 'mrna translation collaboration cancerresearch compchem leukemia']\n",
      "['front immunol ig', 'ilt2 blockade', 'lenalidomide restore nk cell function', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukaemia', 'cellular pathways cll']\n",
      "['fantastic specialist interview', 'consultant haematologist dr adrian bloor', 'chronic myeloid leukaemia cml', 'chronic lymphocytic leukaemia cll', 'leukaemia course']\n",
      "['cll fish', 'brightest p53', 'liketakingyoursunglassesoff highintensitysignals minimalbackground ogt sysmexbnl']\n",
      "['ohio state', 'chronic lymphocytic leukemia', 'worldwide spon james']\n",
      "['ibrucent ibrutinib 140mg generic imbruvica', 'prescription drug', 'mantle cell lymphoma chronic lymphocytic leukemia treatment mfg', 'incepta pharma', 'bangladesh emails contact net medicineforworld com cancerdrugs curecancer']\n",
      "['nursery s book eyfs', 'cll talestoolkit']\n",
      "['eric consortium conference', 'ighv ighv unmutatedighv cll']\n",
      "['cll patients caregivers family', 'friends cll chroniclymphocyticleukemia cllpatients']\n",
      "['important advice', 'cancerpatients cancersurvivor i', 'drug interactions amp ensure', 'cll cllpatients']\n",
      "['lymphocytic leukemias', 'lymphocytes lymphomas']\n",
      "['scan results hammer candlestick', 'lms pin rmmc piri k3c mate amer ukog mer ehg bbgi sos cll tpk fccn bmpi']\n",
      "['danielle brander', 'elegant data', 'beta mrna isoforms', 'chronic lymphocytic leukemia']\n",
      "['cd20 combination regimen', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll']\n",
      "['hemonc times ibrutinib', 'standard cll treatment']\n",
      "['fda approves ibrutinib obinutuzumab', 'treatment naive patients', 'chronic lymphocytic leukemia']\n",
      "['p m est mdedgechats medtwitter']\n",
      "['playlist chronic lymphocytic leukemia cancer']\n",
      "['car t cell therapy', 'chronic lymphocytic leukemia t cell fatigue']\n",
      "['regional cancer care associates', 'cll chronic lymphocytic leukemia treatments']\n",
      "['exciting news', 'cll patients']\n",
      "['u s food', 'drug administration', 'cd20 combination regimen', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['cll expert dr philip thompson', 'time symptoms']\n",
      "['anna schuh', 'hospitals shows data', 'ibrutinib amp ritux', 'cll lots', 'free treatments']\n",
      "['fda approves imbruvica ibrutinib', 'non chemotherapy combination regimen', 'treatment na ve patients', 'chronic lymphocytic leukemia']\n",
      "['median overall survival', 'chronic lymphocytic leukemia', '1970s cll']\n",
      "['young patient', 'refractory cll', 'jacqueline barrientos', 'feinstein institute', 'medical research lymphomahub lymphoma overallsurvival prognosis cancertherapy gogold']\n",
      "['standard therapy', 'elderly patients', 'chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['blog post', 'cll oncology treatmentoptions leukemia']\n",
      "['bone marrow transplant', 'cll treatment', 'blog bonemarrowtransplant pakistanpatients']\n",
      "['educational case chronic lymphocytic leukemia']\n",
      "['venetoclax mantle cell lymphoma', 'chronic lymphocytic leukemia']\n",
      "['birc3 expression predicts cll progression', 'defines treatment sensitivity', 'nf b', 'nuclear translocation cll birc3']\n",
      "['drug combination', 'adult chronic lymphocytic leukemia patients amp', 'rare childhood bloodcancer', 'lineage leukemia scott weir pharmd phd']\n",
      "['fda approval']\n",
      "['abbv fda', 'imbruvica ibrutinib', 'obinutuzumab gazyva', 'adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll']\n",
      "['del17p cll patients cllsm leusm']\n",
      "['new jitc', 'short report 17p deletion', 'influences rituximab elimination', 'chronic lymphocytic leukemia']\n",
      "['chronic lymp']\n",
      "['johnson amp johnson abbvie shore', 'imbruvica s cll lead', 'gazyva combo', 'entire spectrum', 'line cll patients', 'indications jnj abbv']\n",
      "['video venetoclax', 'clinical trial setting w lindsey roeker', 'hematology ash18 leukemia cllsm hemeonc leusm']\n",
      "['u s fda', 'cd20 combination regimen', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll']\n",
      "['dyk chronic lymphocytic leukemia cll', 'leukemias beatcancer']\n",
      "['cd20 combination regimen', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll']\n",
      "['chronic lymphocytic leukemia']\n",
      "['webinar replay', 'cll chronic lymphocytic leukemia patients', 'stage experts', 'strategy amp patient cathy hamilton shares']\n",
      "['bloodcancer dennis shares', 'chronic lymphocytic leukemia']\n",
      "['cll treatment questions', 'ready dr brian hill', 'dr anthony mato', 'key takeaways', 'ash18 studies']\n",
      "['program director', 'sll diagnosis', 'patients feeling', 'healthcare team tune']\n",
      "['fda approves', 'non chemo combination therapy', 'leukemia cancer therapy treatment leukemia nonchemo ibrutinib obinutuzumab cll sll pfs fda']\n",
      "['monthly newsletter', 'lymsm lymphoma cll']\n",
      "['warm places lots', 'lovely language', 'small world area eyfs smallworld cll']\n",
      "['good news', 'cll patients', 'frontline approvel']\n",
      "['cll optimal proliferation ex vivo', 'sigm cd40 tlr9 il4 il21 bcr', 'chronic lymphocytic leukemia cells proliferation ex vivo bcells leukemia']\n",
      "['similar path', 'experts dr byrd', 'good friend dr brian koffman talk', 'cll hero']\n",
      "['beste krebs kombinationstherapie finden wissenschaftler', 'wiener news haben eine methode entwickelt', 'individuell optimale kombinationstherapie bei chronisch lymphatischer leuk mie cll findet']\n",
      "['imbruvica ok', 'treatment naive cll', 'spare patients', 'chemotherapy leukaemia']\n",
      "['fda approves ibrutinib', 'treatment naive cll sll', 'asco post oncology']\n",
      "['fda approves imbruvica ibrutinib', 'non chemotherapy combination regimen', 'treatment na ve patients', 'chronic lymphocytic leukemia']\n",
      "['fda approves', 'non chemo combination therapy', 'leukemia adult chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll']\n",
      "['non chemotherapy combination', 'certain cll sll patients']\n",
      "['johnson amp johnson abbvie shore', 'imbruvica s cll lead', 'gazyva combo']\n",
      "['ibrutinib combination', 'frontline treatment', 'chronic lymphocytic leukemia cll']\n",
      "['cll fatigue nausea constipation minimal', 'body iwillin chroniclymphoceticleukemia cll chemotherapy lymphoma bloodcancer']\n",
      "['cd20 combination therapeutic option', 'chronic lymphocytic leukemia cll']\n",
      "['icymi dr imran khan discusses', 'chronic lymphocytic leukemia cll', 'front line', 'treatment landscape']\n",
      "['fda approves', 'non chemo combinatorial therapy', 'cll sll imbruvica gazyva', 'adult chronic lymphocytic leukemia amp', 'small lymphocytic lymphoma researchmatters lymphoma leukemia']\n",
      "['preprint mds unibham amp', 'natural product amp', 'resistant leukaemia cll thx mrc']\n",
      "['treatment landscape', 'new treatments', 'high response rates', 'life bcl']\n",
      "['cll studies', 'ecog acrin cancer research group e1912 trial mdphd mdedgechats']\n",
      "['fda approves ibrutinib imbruvica', 'obinutuzumab gazyva', 'adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll']\n",
      "['imbruvica cancer medication', 'genentech s gazyva monoclonal antibody', 'adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['ibrutinib imbruvica abbvie', 'obinutuzumab gazyva', 'adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll']\n",
      "['chronic lymphocytic leukemia cll', 'common type']\n",
      "['fda approves ibrutinib', 'cll sll imbruvica gazyva lymsm']\n",
      "[]\n",
      "['superior progression', 'free survival', 'line chemotherapy', 'therapy albeit', 'significant toxicity ash18']\n",
      "['non chemotherapy combination regimen', 'ibrutinib s efficacy']\n",
      "['fda approves ibrutinib combo regimen']\n",
      "['abbvie s imbruvica', 'time imbruvica', 'roche s gazyva', 'free treatment', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['dipl m e du cll gagne', 'concours sur les traces', 'louis h bert']\n",
      "['non chemo cll use', 'leukemia lymphoma cancer obinutuzumab']\n",
      "['abbvie announces fda approval', 'imbruvica ibrutinib', 'obinutuzumab gazyva', 'cd20 combination regimen', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll']\n",
      "['xsr362 cll college station tx', 'sna santa ana ca', 'frm hrzn', '8mi h', 'abovetustin raspberrypi adsb dump1090']\n",
      "['fda approves ibrutinib', 'cll sll imbruvica gazyva lymsm']\n",
      "['breakthrough year', 'chronic lymphocytic leukemia cll', 'future discoveries', 'new treatments historyofbloodcancer']\n",
      "['s ibrutinib', 'treatment na ve patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll']\n",
      "['emotional distress increase cll symptom burden', 'cll expert opinions']\n",
      "['fda approves abbvie s imbruvica ibrutinib', 'roche s gazyva obinutuzumab', 'adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma abbv']\n",
      "['chronic lymphocytic leukemia cll', 'common types']\n",
      "['chronic lymphocytic leukemia leukemia']\n",
      "['severe autoimmune', 'adverse effects', 'line therapy', 'suppressive function']\n",
      "['treg function', 'exciting new findings', 'pi3k p110 isoform inhibitor idelalisib', 'inhibits human regulatory t cell function tregs autoimmunity cll']\n",
      "['news fda approves frontline tx', 'exciting time']\n",
      "['u s food', 'drug administration', 'ibrutinib imbruvica', 'obinutuzumab gazyva', 'line treatment', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['fda approves imbruvica', 'treatment naive chronic lymphocytic leukemia cll']\n",
      "['combination ibrutinib', 'line treatment', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'cllsm leusm leukemia']\n",
      "['combination regimen', 'treatment na ve chronic lymphocytic leukemia cll']\n",
      "['medical independent sales representatives', 'medical distributors u s fda approves imbruvica r ibrutinib', 'non chemotherapy combination regimen', 'treatment na ve patients', 'chronic lymphocytic leukemia']\n",
      "['abbv s imbruvica obinutuzumab', 'adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll']\n",
      "['chile lucha libre cll luchalibre luchalibrechilena', 'santiago chile']\n",
      "['1st line cll', 'free regimen', '1st line check', 'drgoncology s expectations', 'cll market']\n",
      "['abbvie announces u s fda approval', 'imbruvica ibrutinib', 'obinutuzumab gazyva', 'cd20 combination regimen', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['u s fda approves imbruvica ibrutinib', 'non chemotherapy combination regimen', 'treatment na ve patients', 'chronic lymphocytic leukemia']\n",
      "['long term outcomes', 'murano phase iii trial venetoclax', 'r r cll lymsm leukemia cll']\n",
      "['horsham pa jan']\n",
      "['u s fda approves imbruvica ibrutinib', 'non chemotherapy combination regimen', 'treatment na ve patients', 'chronic lymphocytic leukemia']\n",
      "['cd20 combination regimen', 'line chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll']\n",
      "['abbvie announces u s fda approval', 'imbruvica ibrutinib', 'obinutuzumab gazyva', 'cd20 combination regimen', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll']\n",
      "['cll amp sll', 'sub type', 'youtube film', 'dr george', 'gt bloodcancer makebloodcancervisible']\n",
      "['jnj fda approves imbruvica', '1st non chemo combo regimen', 'treatment na ve patients', 'chronic lymphocytic leukemia']\n",
      "['word story challenge', 'westwood campus', 'creative imaginations']\n",
      "['activity levels', 'team cllsa', 'asics london 10k run', 'email coordinator org uk charity cll leukaemia bloodcancer']\n",
      "['cll patients', 'therapy cll']\n",
      "['ibrutinib amp rituximab', 'free survival amp overall survival', 'years amp', 'chronic lymphocytic leukemia', 'care chemoimmunotherapy ash18 leukemia']\n",
      "['ya nos encontramos', 'con el ambiente veraniego', 'proyectoluchalibre cll']\n",
      "['major findings', 'annual meeting cancer ash18 aml cll mds']\n",
      "['mike fradley', 'great case', 'atrial fibrillation', 'ibrutinib technology']\n",
      "['chronic lymphocytic leukemia']\n",
      "['hoy cll chileluchalibre presenta summerfest iwc luchalibrechilena nagero5taregi n pepex']\n",
      "['hoy cll chileluchalibre presenta summerfest iwc luchalibrechilena nagero5taregi n pepex']\n",
      "['hoy cll chileluchalibre presenta summerfest iwc luchalibrechilena nagero5taregi n pepex']\n",
      "['chronic lymphocytic leukemia cells proliferation ex vivo']\n",
      "['ibrutinib opdivo combination shows', 'richter s transformation', 'overall response', 'richter s transformation', 'disease progression cll']\n",
      "['cll patients', 'therapy oncology']\n",
      "['obinutuzumab combination', 'chronic l']\n",
      "['video ibrutinib rituximab prolongs pfs os', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['amazing advocacy work', 'dr brian koffman', 'cll community']\n",
      "['cll therapy increases risk', 'platelet inhibition amp risk', 'afib warrants', 'cautious use', 'blood thinners acccardioonc use']\n",
      "['free survival', 'cll patients']\n",
      "['sinus infections ivig', 'insurance sucks murica']\n",
      "['things cll', 'annual meeting']\n",
      "['dr andrew brunner', 'general hospital discusses', 'top takeaways', 'annual meeting cancer ash18 aml cll mds']\n",
      "['special guests mdphd', 'murano trial mdedgechats medtwitter']\n",
      "['lymphoma coalition europe s', 'new lymphoma community advisory board', 'cll gt lymphomaaware']\n",
      "['immune system', 'experts dr jean koff', 'dr jonathan cohen', 'disease burden', 'immunity vaccine recommendations']\n",
      "['chemotherapy immunotherapy', 'targetedtherapy options', 'cll patients oncology']\n",
      "['american intergroup study a041202', 'cll patients ash18 mdphd']\n",
      "['davide rossi', 'valeria spina review', 'non protein', 'chronic lymphocytic leukemia', 'special issue']\n",
      "['chronic lymphocytic leukemia survival rates', 'chronic lymphocytic leukemia']\n",
      "['cll patients', 'good luck']\n",
      "['big sequential treatment', 'bendamustine ibrutinib', 'obinutuzumab ga101', 'chronic lymphocytic leukemia clinicaltrials']\n",
      "['week s episode', 'recent cll heroes event', 'chronic lymphocytic leukemia']\n",
      "['f licitations anne sophie paquet dipl m e', 'tgea du cll qui', 'remport avec sa s ur catherine', '2e dition du concours', 'entrepreneuriat agricole sur les traces', 'louis h bert tous les d tails ici']\n",
      "['great session', 'newcastle s', 'own dr helen marr', 'line treatments', 'interesting results cll haematology']\n",
      "['cll patients', 'patient advocate carol preston share', 'encouraging advice', 'cll patients']\n",
      "['illuminate data chl ob vs i ob', 'comorbid cll patients front line', 'pfs curve', 'control arm', 'cll11 data']\n",
      "['dr helen marr', 'br v i v ir', 'elderly cll', 'rituximab cll']\n",
      "['things cll']\n",
      "['cancer immunotherapy response', 'akkermansia muciniphila', 'cll treatments']\n",
      "['landmark study', 'standard therapy', 'elderly patients', 'chronic lymphocytic leukemia cll leukemia']\n",
      "['notch1 variants', 'acute lymphoblastic leukemia lymphoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'jordanian patients', 'diagnostic pathology']\n",
      "['december organiseren', 'een informatiebijeenkomst', 'chronische lymfatische leukemie meer informatie vind je hier cll']\n",
      "['april 27th', 'cll patients']\n",
      "['venetoclax rituximab combination improves survival']\n",
      "['calendars thursday january', 'ash18 mdedgechats']\n",
      "['axl inhibition', 'cll patients pre clinical', 'axl inhibitor', 'clinical trials bemcentinib bgb324 bgbio']\n",
      "['journ e', 'l intelligence artificielle se termine avec', 'discussion sur les aspects philosophiques', 'l ia belle journ e avec un beau tour d horizon sur l ia', 'ses enjeux cll ia']\n",
      "['cll rewards', 'kanga exchange', 'cll cryptoliveleak', 'token tradingcompetition']\n",
      "['calendars thursday january', 'mdedge hematology amp oncology']\n",
      "['murano trial mdedgechats']\n",
      "['mayocll group', 'cll patient', 'educational forum', 'april 27th', 'minneapolis airport marriott cll patientempowerment']\n",
      "['superior progression', 'free survival', 'line chemotherapy', 'therapy albeit', 'significant toxicity ash18']\n",
      "['duo trial duvelisib', 'rel ref chronic lymphocytic leukemia']\n",
      "['premi re journ e sur l intelligence artificielle organis e par', 'c gep', 'l vis lauzon', 'crvi cll ia']\n",
      "['cll expert dr susan leclair', 'strategy amp']\n",
      "['info email cindy info lymsm fl leukemia cll']\n",
      "['obinutuzumab combination', 'chronic lympho']\n",
      "['nursery playground', 'lots changes', 'eyfs ice understanding', 'world cll slippery']\n",
      "['promising treatments', 'cll patients', 'uni leusm lymsm patientcare hematology hodgkin drugaccess noveltherapy lymphoma']\n",
      "['mental manipulation', 'toxicity copper deficiency nfl eyesight exams', 'vaccine hesitancy chronic lymphocytic leukemia child anxiety depression immunesystem cancer']\n",
      "['great work high rates', 'invasive fungal disease', 'ibrutinib monotherapy', 'refractory chronic lymphocytic leukemia']\n",
      "['rituximab treatment', 'unre leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['ibrutinib resistance', 'chronic lymphocytic leukemia cll']\n",
      "['treatment options', 'cll patients']\n",
      "['positive news', 'uk patients']\n",
      "['ibrutinib amp rituximab', 'free survival amp overall survival', 'years amp', 'chronic lymphocytic leukemia', 'care chemoimmunotherapy ash18 leukemia']\n",
      "['scan results macd bearish centerline cross', 'epic dis sdrc rdsb sec cll agk bhp vrs spe pson anii rdsa ifp pca mer']\n",
      "['ash18 presentation', 'adverse events patterns', 'tumor lysis syndrome prophylaxis', 'cll clinicalpathways']\n",
      "['experts sharman', 'interim analysis', 'prospective informcll', 'real world registry', 'optimize cll treatment', 'real world practice']\n",
      "['cll chronic lymphocytic leukemia', 'ground dozens', 'children contract cancer', 'indiana suburb']\n",
      "['webinar replay', 'cll chronic lymphocytic leukemia patients', 'stage experts', 'strategy amp patient cathy hamilton shares']\n",
      "['rituximab treatment']\n",
      "['chronic lymphocytic leukemia']\n",
      "['primary endpoint', 'zanubrutinib versus ibrutinib', 'refractory chronic lymphocytic leukemia', 'full text view cll lymsm']\n",
      "['tumor lysis syndrome tls prophylaxis amp management', 'r r cll', 'trial setting', 'ash18 w amp colleagues podcast w', 'discussions podcasts']\n",
      "['cll est fier', 'faire d sormais partie', 'grande famille', 'l e il s agit d', 'excellente nouvelle', 'nos tudiants athl tes suivez ce lien', 'les d tails']\n",
      "['major findings', 'annual meeting cancer ash18 aml cll mds']\n",
      "['metabolic pathways', 'quantitative mass spectrometry analysis proteomics leukemia metabolomics']\n",
      "['chronic lymphocytic leukemia cll therapeutics market assesses', 'future impact']\n",
      "['beautiful complex karyotype', 'i 17q 12p rearrangement tp53 deletion', 'chronic lymphocytic leukemia cll', 'rare yayyyy']\n",
      "['btk inhibitors', 'cll review safety amp efficacy data', 'btk inhibitors', 'manage patients', 'btk inhibitor therapy w jennifer', 'woyach md', 'activity medscapeedu']\n",
      "['blood cancers cll', 'medical care', 'medical innovation i', 'day bike tour', 'new zealand', 'pedal i', 'cancer mpnsm cll']\n",
      "['cd20 antibodies lymphoma cll leusm']\n",
      "['mental manipulation stealth liver', 'toxicity copper deficiency nfl eyesight', 'vaccine hesitancy chronic lymphocytic leukemia child anxiety depression immunesystem cancer']\n",
      "['scan results', 'dis thrl wtg emh', 'dx stvg kape blnd cnks rnwh ncc cll apps csn amc']\n",
      "['nice article', 'richter s', 'cll key takeaways', 'fna biopsy incisional excisional', 'accessible node', 'issue suvmax gt', 'sens amp spec']\n",
      "['nice approval', 'chronic lymphocytic leukaemia cll']\n",
      "['postdoc position microenvironmental interactions', 'chronic lymphocytic leukemia', 'b cell lymphoma', 'masaryk university czech republic']\n",
      "['share breakthroughs', 'treatment research', 'therapy leusm cll']\n",
      "['free survival', 'cll patients']\n",
      "['veronika bachanova', 'article donor killer cell immunoglobulin', 'receptor kir genotype', 'graft versus leukemia responses', 'chronic lymphocytic leukemia cll', 'donor transplant', 'cibmtr analysis']\n",
      "['nccn guidelines insights chronic lymphocytic leukemia', 'small lymphocytic lymphoma version', 'leukemia lymphoma cll richters clinicalguidelines']\n",
      "['high doses', 'vitamin d', 'stabilize chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'patients cll sll']\n",
      "['cll cello health plc', 'excellent year', 'uk cll brighterir andrewscotttv capitalnetwork1']\n",
      "['cll cello health plc', 'excellent year']\n",
      "['dichotomous toll', 'receptor responses', 'chronic lymphocytic leukemia patients', 'ibrutinib treatment']\n",
      "['b cell receptor isotypes', 'chronic lymphocytic leukemia']\n",
      "['transcriptomic analysis reveals tp63', 'novel player', 'aggressive chronic lymphocytic leukemia']\n",
      "['similar genomic landscapes', 'monoclonal b cell lymphocytosis', 'stable chronic lymphocytic leukemia', 'low frequency', 'driver mutations']\n",
      "['hardest day i ve', 'cll chronic lymphocytic leukemia fuck cancer']\n",
      "['dr andrew brunner', 'general hospital discusses', 'top takeaways', 'annual meeting cancer ash18 aml cll mds']\n",
      "['osso bucco', 'lago restaurant', 'great job', 'entire f amp b team cll fnb2020']\n",
      "['osso bucco', 'lago restaurant', 'great job', 'entire f amp b team cll fnb2020']\n",
      "['chronic lymphocytic leukemia', 'patients gt', 'white cell']\n",
      "['helpful overview', 'adverse effect management', 'cll clinic', 'mechanism blooducation cll lymsm']\n",
      "['premium placement adspace', 'cll cryptoliveleaktoken erc20 utilitytoken']\n",
      "['chronic lymphocytic leukemia patients']\n",
      "['video trials explore optimal treatments resistance', 'chronic lymphocytic leukemia healio video trials explore optimal treatments resistance', 'chronic lymphocytic leukemia healio san diego', 'video hemonc', 'editorial board member']\n",
      "['chronic lymphocytic leukaemia cll', 'previous course', 'treatment good news antibodytherapy']\n",
      "['nccn guidelines insights chronic lymphocytic leukemia', 'small lymphocytic lymphoma version', 'lymphoma lymsm']\n",
      "['chronic lymphocytic leukaemia', 'nutshell check', 'primeview cll']\n",
      "['rituximab treatment']\n",
      "['systemic therapy', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll hypogammaglobulinemia']\n",
      "['matt isn t feeling', 'flat time', 'cll bloodcancer leukaemia']\n",
      "['chronic lymphocytic leukemia cll', 'washington d c area', 'washington d c area cll patient support group', 'pm est']\n",
      "['serum levels', 'chronic lymphocytic leukemia']\n",
      "['big sequential treatment', 'bendamustine ibrutinib', 'obinutuzumab ga101', 'chronic lymphocytic leukemia clinicaltrials']\n",
      "['own jan rynne', 'excellent programme', 'cll community', 'patient advocacy arena']\n",
      "['lo que tweeteaba ayer el grupo alem n tambi n lo tiene claro cll llc']\n",
      "['dr william g wierda', 'md anderson cancer center explores', 'exciting strategies', 'chronic lymphocytic leukemia leusm fbf']\n",
      "['chronic lymphocytic leukaemia cll', 'new treatment']\n",
      "['ash cme symposia', 'entire video program', 'key issues', 'clinical practice lymphoma amp cll multiplemyeloma']\n",
      "['allogeneic hematopoietic cell transplantation', 'chronic lymphocytic leukemia cll', 'mantle cell lymphoma', 'chronic malignancies', 'parties lymsm bmtsm']\n",
      "['cll patients', 'florence cymbalista', 'hematology mrd mrdnegativity mrdpositivity leusm patientcare knowledgeispower leukemia patienteducation']\n",
      "['significant news thousands', 'chronic lymphocytic leukaemia cll', 'new treatment option']\n",
      "['landmark study co', 'loyola oncologist scott smith md phd', 'standard therapy', 'elderly patients', 'chronic lymphocytic leukemia cancerresearch']\n",
      "['guest facebook', 'cll patient', 'shares tips', 'skin side', 'ibrutinib leusm']\n",
      "['key things', 'time hotel cost']\n",
      "['december organiseren', 'een informatiebijeenkomst', 'chronische lymfatische leukemie meer informatie vind je hier cll']\n",
      "['cutaneous composite lymphoma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'follicular lymphoma', 'unique entity', 'putative pathological mechanism', 'cutaneous composite lymphomas lymphoma lymsm']\n",
      "['chronic lymphocytic leukemia cll', 'washington d c area', 'washington d c area cll patient support group', 'saturday jan']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['international phase iii trial demonstrates', 'superior pfs', 'standard chemoimmunotherapy cit', 'chronic lymphocytic leukemia amp justifies', 'care treatment', 'cctg clc2 trialsthatmatter']\n",
      "['chronic lymphocytic leukemia']\n",
      "['major findings', 'annual meeting cancer ash18 aml cll mds']\n",
      "['chronic lymphocytic leuke']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['cll cll cryptoliveleak crypto erc20 cryptocurrency blockchain utilitytoken advertise']\n",
      "['dr davids discusses', 'therapy decisions', 'ash18 results', 'therapy decisions journal', 'clinical pathways']\n",
      "['month sex differences', 'chronic lymphocytic leukemia', 'gt gt gt']\n",
      "['median overall survival', 'chronic lymphocytic leukemia', '1970s cll']\n",
      "['chronic lymphocytic leukemia cells', 'axl receptor tyrosine kinase inhibitor therapy']\n",
      "['dna methylation differences', 'b cell chronic lymphocytic leukemia openaccess']\n",
      "['dual inhibition', 'mk2206 induces apoptosis', 'chronic lymphocytic leukemia cells', 'tumor microenvironment lymphoma lymsm']\n",
      "['cll expert dr philip thompson', 'time symptoms']\n",
      "['s research', 'cll aso iof kwg sng tap', 'amp register', 'research portal disclaimer']\n",
      "['health bit', 'weak opening', 'berlin office', 'europe health bit net cash', 'great business', 'health focus', 'recent years', 'shrewd i don t hold', 'shouldn t']\n",
      "['abbv cycc cyc065', 'cll field', 'neuroblastoma prv', 'unlock 125m']\n",
      "['wetenschap doelgerichte therapie voor cll effectiever', 'gebruik lees het artikel', 'medzine app', 'ibrutinib leukemie therapie geneeskunde']\n",
      "['cll cello health', 'pharma consultancy', 'uk cll brighterir andrewscotttv capitalnetwork1']\n",
      "['venetoclax rituximab combination improves survival']\n",
      "['rns aim cll cello health plc pre']\n",
      "['medical trainee', 'summer hematology lymsm cll mmsm']\n",
      "['judith i', 'new agents i', 'cll patient', 'need world']\n",
      "['chronic lymphocytic leukemia']\n",
      "['dr andrew brunner', 'general hospital discusses', 'top takeaways', 'annual meeting cancer ash18 aml cll mds']\n",
      "['chronic lymphocytic leukemia cll', 'combo w', 'disease amp', 'practice amp', 'care oncology ascoreadingroom']\n",
      "['rituximab improves survival', 'chronic lymphocytic leukemia patients leusm bloodcancer']\n",
      "['video factors', 'treatment decision making', 'cll patients w founder', 'ash18 hematology leusm leukemia cllsm hemeonc clinicaltrials ctsm']\n",
      "['online training courses', 'custom training quote cll']\n",
      "['dr brian hill', 'dr anthony mato', 'key studies', 'ash18 mdedgechats']\n",
      "['venetoclax rituximab combination improves survival', 'unresponsive leukemia']\n",
      "['patient power community member', 'line treatment', 'couple years tune', 'renowned cll expert dr sharman']\n",
      "['infectious diseases amp primary healthcare updates oncologists', 'standard therapy', 'elderly patients', 'chronic lymphocytic leukemia cong humanrights']\n",
      "['ibrutinib amp', 'short video', 'cll patient', 'frontline ibrutinib', 'various mono amp combination treatment options']\n",
      "['current treatments', 'therapeutic area bloodcancer dlbcl cll multiplemyeloma oncology']\n",
      "['such great feedback', 'don t', 'lymphomamatters lymphoma hodgkin nonhodgkin cll bloodcancer cancersupport lymphomastory']\n",
      "['lyme disease', 'chronic lymphocytic leukemia mimics leukemic meningeosis schweighofer cd1 f tkenheuer g staib p hallek m reiser m']\n",
      "['leukemia bloodcancertreatment cml cll']\n",
      "['tiptuesday download chapters', 'chronic lymphocytic leukemia', 'non hodgkin lymphomas', 'resource center lymsm']\n",
      "['new treatment combinations', 'chronic lymphocytic leukemia']\n",
      "['obinutuzumab combination']\n",
      "['commercial study chronic lymphocytic leukemia']\n",
      "['sex differences', 'chronic lymphocytic leukemia', 'important information', 'men vs women']\n",
      "['btk phase', 'explores efficacy', 'oral syk inhibitor']\n",
      "['current treatment algorithm', '2l therapy', 'ash2018 result', 'long discussions', 'nordic group cllsm leusm']\n",
      "['drg epidemiology report estimates', 'chronic lymphocytic leukemia', 'global reports']\n",
      "['manage ibrutinib intolerance', 'chronic lymphocytic leukemia cllsm']\n",
      "['manage ibrutinib intolerance', 'chronic lymphocytic leukemia']\n",
      "['ash18 results', 'ibrutinib vs fcr trial', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['past month accc', 'chronic lymphocytic leukemia', 'identify key barriers', 'cancer care team s support', 'blood cancers page']\n",
      "['new copay assistance program', 'chronic lymphocytic leukemia', 'assistance fund', 'assistance fund', 'independent charitable patient assistance foundation prostatecancer research braincancer cancer oncology']\n",
      "['non hodgkin lymphoma nhl', 'chronic lymphocytic leukaemia cll', '2a study lymsm']\n",
      "['chronic lymphocytic leukemia', 'white link', 'intranet homepage']\n",
      "['interesting amp', 'important treatise re cll']\n",
      "['standard therapy', 'elderly patients', 'chronic lymphocytic leukemia']\n",
      "['dr jeff sharman summarises results', 'recent studies', 'ash18 amp', 'line management', 'chronic lymphocytic leukemia cll']\n",
      "['venetoclax rituximab combination improves survival']\n",
      "['video telomere length', 'prognostic tool', 'fcr chemoimmunotherapy', 'right treatment w christopher fegan', 'hematology ash18 hemonc immunoonc riskfactors leukemia cllsm immunotherapy prognosis']\n",
      "['chronic lymphocytic leukemia']\n",
      "['immunotherapy drug', 'dramatic effect', 'chronic lymphocytic leukemia cll']\n",
      "['word cure', 'chronic lymphocytic leukemia cll']\n",
      "['don t', 'donate cll leukemia lymphoma cart drugtrial immunotherapy gofundme']\n",
      "['ebmt study ibrutinib', 'allogeneic hematopoietic cell transplantation', 'chronic lymphocytic leukemia', 'mantle cell lymphoma ibrutinib', 'subsequent allohct']\n",
      "['dna methylation', 'chronic lymphocytic leukemia', 'women dna cancerresearch']\n",
      "['video monoallelic tp53', 'cll patients', 'durable response', 'ibrutinib monotherapy w carsten niemann', 'hematology hemonc trialupdates leusm leukemia cllsm ctsm clinicaltrials']\n",
      "['landmark study co', 'loyola medicine oncologist', 'standard therapy', 'elderly patients', 'chronic lymphocytic leukemia medicaldiscovery']\n",
      "['exciting results', 'r r patients', 'negative response', 'blood amp bone marrow']\n",
      "['smart people', 'evidence men', 'different dna lets', 'effective treatments sexmatters sexandgender sex', 'dna methylation differences', 'b cell chronic lymphocytic leukemia']\n",
      "['duration therapies cll leusm cllsm']\n",
      "['cll patients', 'ie amp', 'new treatment options']\n",
      "['new leukemia drug ibrutinib', 'use results', 'landmark study', 'new england journal', 'medicine ibrutinib cll sll']\n",
      "['obinutuzumab combination', 'chronic lymp']\n",
      "['entospletinib monotherapy', 'refractory chronic lymphocytic leukemia', 'bcell receptor inhibitors results', 'study entospletinib gs9973', 'oral selective inhibitor', 'spleen tyrosine kinase syk']\n",
      "['chronic lymphocytic leukemia cll', 'antibody therapy', 'possible 3000researchers roc bloodcancer']\n",
      "['important strategy meeting', 'intergroup trial', 'line therapy', 'unfit patients', 'cll partners', 'hovon nordic cll study group sakk cancer trials ireland israel cll study group amp gcllsg']\n",
      "['chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll', 'skin express cd31 dermpath hemepath']\n",
      "['cll amp sll', 'kate talk', 'low grade lymphoma', 'world lymphomastory bloodcancer']\n",
      "['drug ibrutinib attacks cancer cells', 'normal cells', 'chronic lymphocytic leukemia']\n",
      "['cll oncology']\n",
      "['drug cessation', 'cll oncology']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['rituximab treatment']\n",
      "['chronic lymphocytic leukemia']\n",
      "['cll status', 'condition summary chronic lymphocytic leukemia']\n",
      "['landmark study', 'targeteddrug ibrutinib', 'standard therapy', 'chroniclymphocyticleukemia cll leukemia clinicaltrial']\n",
      "['new venetoclax rituximab combination improves survival']\n",
      "['prithviraj bose md', 'treatment options']\n",
      "['cll research', 'treatment news', 'ash18 experts dr nicole lamanna', 'dr jeff sharman']\n",
      "['cll patient advocate lee swanson interviews dr adrian wiestner', 'exciting news']\n",
      "['igh translocations', 'chronic lymphocytic leukemia cll clinicopathologic', 'clinical outcomes']\n",
      "['perspective combinations', 'parts aristotle']\n",
      "['immune system', 'experts dr jean koff', 'dr jonathan cohen', 'disease burden', 'immunity vaccine recommendations']\n",
      "['nctn leukemia trial a041702 ibrutinib', 'chronic lymphocytic leukemia']\n",
      "['cll program', 'effective practices', 'cll patients', 'community cll bloodcancer cancer']\n",
      "['prof john gribben', 'key updates', 'ecog murano', 'illuminate studies', 'ibrutinib vs fcr', 'standard chemoimmunotherapy']\n",
      "['chronic lymphocytic leu leukemia']\n",
      "['chronic lymphocytic leukemia', 'white link', 'intranet homepage']\n",
      "['dose approach investigators', 'lessen toxicity', 'agent lenalidomide', 'cll cll cllsm leukemia']\n",
      "['renowned chronic lymphocytic leukemia cll expert dr susan leclair', 'strategy leusm']\n",
      "['chronic lymphocytic leukemia', 'patients gt', 'white cell']\n",
      "['telomere length', 'fcr chemoimmunotherapy', 'research collaboration']\n",
      "['chronic lymphocytic leukemia']\n",
      "['btk inhibitor', 'car t cells', 'chronic lymphocytic leukemia leukemia bloodcancer hematology']\n",
      "['vitamind treatment', 'stabilize disease', 'cll leukemia']\n",
      "['chronic lymphocytic leukemia cll', 'b lymphocytes', 'b cells', 'white blood cell b lymphocytes', 'immune system amp', 'attack bacteria viruses amp toxins', 'cll page']\n",
      "['obinutuzumab combination', 'chronic lymp']\n",
      "['professor dr jennifer woyach s', 'new study', 'effective way', 'chronic lymphocytic leukemia', 'common form']\n",
      "['rituximab improves survival', 'chronic lymphocytic leukemia patients', 'leusm bloodcancer']\n",
      "['prof chris fegan', 'prof anna schuh', 'key cll information', 'ash18 conference', 're thankful', 'useful synopsis']\n",
      "['cll specialist dr richard furman director', 'cll research center']\n",
      "['dr gauthier', 'overall response rate', 'refractory chronic lymphocytic leukemia', 'clinical trial cll lesum leukemia']\n",
      "['chronic lymphocytic leukemia cll', 'new study', 'dna methylation differences', 'cll risk', 'outcome sexdifferences']\n",
      "['refractory chronic lymphocytic leukemia', 'daily practice', 'final results', 'perle study lymphoma lymsm']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['hematoclinicbcn tcellrx cartcells leusm lymsm cll']\n",
      "['treatment options', 'chronic lymphocytic leukemia leusm']\n",
      "['lancet haematology jan', 'therapy phase', 'sintilimab trial', 'hodgkin lymphoma umbralisib ibrutinib', 'r r chronic lymphocytic leukemia', 'pd l1 immunotherapy hem', 'adverse effects']\n",
      "['old kitty', 'lbs dr johnson', 'chronic lymphocytic leukemia']\n",
      "['cll expert dr susan leclair', 'strategy amp']\n",
      "['telomere length predictive', 'disease progression', 'fcr treatment']\n",
      "['practical implications', 'chronic lymphocytic leukemia', 'q amp', 'alexey v danilov md phd']\n",
      "['ilt2 blockade', 'lenalidomide restore nk cell function', 'chronic lymphocytic leukemia']\n",
      "['good regimen', 'deep remissions', 'phase ii clinical trial', 'new combination ash18 leusm endcancer']\n",
      "['car t cell therapy', 'clinical trials', 'chronic lymphocytic leukemia bloodcancer hematology leukemia']\n",
      "['dna methylation differences', 'b cell chronic lymphocytic leukemia']\n",
      "['ilt2 blockade', 'lenalidomide restore nk cell function', 'chronic lymphocytic leukemia', 'villa lvarez m sordo bahamonde c lorenzo herrero s gonzalez rodriguez ap payer ar gonzalez garcia e villa lvarez mc l pez soto']\n",
      "['treatment options', 'common blood cancers cll dlbcl aml']\n",
      "['video telomere length', 'fcr chemoimmunotherapy', 'cll w christopher fegan', 'hematology ash18 hemonc immunoonc riskfactors ctsm immunotherapy prognosis cllsm']\n",
      "['dr gauthier discusses', 'ibrutinib imbruvica', 'car t cells', 'chronic lymphocytic leukemia cll lesum leukemia']\n",
      "['effective oral', 'cd20 monoclonal antibody', 'drugs cll leusm leukemia']\n",
      "['cytogenetic complexity', 'chronic lymphocytic leukemia definitions associations', 'clinical impact']\n",
      "['cll cll drugdevelopment cancerdrugs']\n",
      "['commencez l ann e du bon', 'vous inscrivant', 'activit s', 'du cll']\n",
      "['leukemia news', 'interesting cll sll oncology vitamind curcumin']\n",
      "['past month accc', 'chronic lymphocytic leukemia', 'identify key barriers', 'cancer care team s support', 'blood cancers page']\n",
      "['cll patient advocate lee swanson interviews dr anthony mato', 'tools cllpatients', 'cll research']\n",
      "['recent research high doses', 'vitamin d', 'stabilize chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'patients cll sll']\n",
      "['springer nature', 'shortest link', 'global distribution', 'dna hydroxymethylation', 'dna methylation', 'chronic lymphocytic leukemia', 'epigenetics amp chromatin', 'open access']\n",
      "['duvelisib monotherapy', 'durable responses', 'refractory chronic lymphocytic leukemia leusm']\n",
      "['combination regimens', 'effective strategy', 'chemoimmunotherapy cll leusm leukemia']\n",
      "['new trial', 'trialtuesday alliance researcher jennifer woyach md james', 'alliance a041702', 'immunotherapy trial', 'chronic lymphocytic leukemia']\n",
      "['video ifcg', 'frontline treatment', 'cll trialupdate', 'hematology ash18 hemonc immunoonc leusm leukemia cllsm ctsm clinicaltrials']\n",
      "['dr rogers', 'phase ii findings', 'cll cllsm cll leusm']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['video cll trial updates alliance amp illuminate w barbara eichhorst', 'hematology ash18 immunotherapy immunoonc trialupdates leusm leukemia cllsm ctsm clinicaltrials']\n",
      "['darlington area', 'patient family member partner friend', 'carer cancersupport bloodcancer']\n",
      "['catch optum heor poster', 'oral presentations monday', 'research projects focus', 'immune thrombocytopenia', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll']\n",
      "['recent study single agent copiktra', 'durable responses', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['nctn leukemia trial ea9161 ibrutinib', 'chronic lymphocytic leukemia']\n",
      "['congratulations sara amp team', 'global distribution', 'dna hydroxymethylation', 'dna methylation', 'chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['couldn t', 'complex refractory patients', 'mayocll cll richters']\n",
      "['excellent informative', 'art review', 'richter s syndrome', 'cll richters blooducation']\n",
      "['drug resistance', 'cll researchers', 'dr john byrd', 'hurdles experts', 'chronic lymphocytic leukemia']\n",
      "[]\n",
      "['hot topic', 'geriatric assessment', 'hematology gah scale', 'fjd hematology ash18 hemonc mmsm multiplemyeloma hemonc immunoonc lymsm cllsm cll gerionc']\n",
      "['line therapy', 'cll onclive', 'line therapy', 'cll onclive panelists review data', 'chronic lymphocytic leukemia', 'minus rituximab']\n",
      "['allogeneic hematopoietic cell transplantation', 'chronic lymphocytic leukemia cll', 'mantle cell lymphoma', 'chronic malignancies', 'parties lymsm cllsm bmtsm']\n",
      "['risks loci', 'immunoglobulin genes igl', 'immunoglobulin gene translocations', 'ex myc']\n",
      "['cll looms', 'denial doesn t', 'lymphocyte counts', 'mountain sharman']\n",
      "['drug cessation', 'cll oncology']\n",
      "['duration venetoclax triplet', 'cll oncology']\n",
      "['allogeneic hematopoietic cell transplantation', 'chronic lymphocytic leukemia', 'mantle cell lymphoma', 'ebmt chronic malignancies', 'parties bone marrow trans']\n",
      "['great work', 'cll lymsm']\n",
      "['5mg kg d', 'high occupancy', 'abrogate kinase function', 'similar clinical outcomes', 'cll patients lymsm lessismore']\n",
      "['complex karyotype', 'eric grp c', 'tp53 status matters', 'chrom abns', 'abn v', 'poor os indep', 'tp53 v', 'interesting t12 t19 ck', 'v indolent cll blooducation bigdata']\n",
      "['medical journalist andrew schorr', 'chronic lymphocytic leukemia', 'patient empowerment']\n",
      "['genetic correlation', 'multiple myeloma', 'chronic lymphocytic leukaemia cll', 'aetiology blood cancer journal cllsm leusm mmsm']\n",
      "['similar origin', 'naive b cells']\n",
      "['germline genetic correlation', 'multiple myeloma amp chronic lymphocytic leukemia evidence', 'genetic etiology mmsm']\n",
      "['great update', 'cll patients', 'cll expert ash']\n",
      "['ash18 check', 'mcl cll', 'multiple myeloma lymsm lylmm cll']\n",
      "['good summary', 'specific car t cells', 'refractory cll tcellrx immunoonc immunotherapy']\n",
      "['early studies', 'car t cell combination', 'chronic lymphocytic leukemia leusm hematology']\n",
      "['cll program', 'new york s', 'new drugs supersede chemo', 'cll patients', 'ash page', 'new videos']\n",
      "['patient power community member', 'line treatment', 'couple years tune', 'renowned cll expert dr sharman']\n",
      "['health care team', 'chronic cancer cancer chronic ncds cll chroniccancer']\n",
      "['cll patient advocate lee swanson interviews dr kerry rogers', 'ohio state university', 'medical center', 'exciting cll news']\n",
      "['past month accc', 'chronic lymphocytic leukemia', 'identify key barriers', 'cancer care team s support', 'blood cancers page']\n",
      "['clinicalupdates trial', 'overall survival', 'ibrutinib rituximab vs fludarabine cyclophosphamide rituximab', 'fit patients lt', 'chronic lymphocytic leukemia cll']\n",
      "['genetic correlation', 'multiple myeloma', 'chronic lymphocytic leukemia']\n",
      "['genetic correlation', 'multiple myeloma', 'chronic lymphocytic leukaemia', 'aetiology blood cancer journal bcj cll openaccess']\n",
      "['cytogenetic complexity', 'chronic lymphocytic leukemia definitions associations', 'clinical impact lymphoma lymsm']\n",
      "['drg epidemiology report estimates', 'chronic lymphocytic leukemia worldwide', 'global reports']\n",
      "['new zealanders', 'chronic lymphocytic leukaemia cll', 'uncommon type', 'common type', 'nz factfriday']\n",
      "['free regimens', 'new non chemo treatment options', 'clinical trials', 'computer simulation']\n",
      "['nile encephalitis', 'unusual infection', 'chronic lymphocytic leukemia patient eurekamag']\n",
      "['retrospective cohort study', 'commercial claims database', 'treatment trends', 'chronic lymphocytic leukemia cll']\n",
      "['personal news', 'husband 52yo', 'cll treatment lymsm leusm']\n",
      "['jci pi3k p110 inactivation antagonizes chronic lymphocytic leukemia', 'reverses t cell immune suppression']\n",
      "['dose reductions', 'ibrutinib therapy', 'inferior outcomes', 'chronic lymphocytic leukemia cll lymphoma lymsm']\n",
      "['cytogenetic complexity', 'chronic lymphocytic leukemia definitions associations', 'clinical impact']\n",
      "['dr kerry rogers shares', 'promising findings', 'cll treatment trial']\n",
      "['paradigms r chl len', 'fit 1st line pts gd orr pfs', 'cll nhl']\n",
      "['free workshop', 'immunoglobulin gene analysis', 'chronic lymphocytic leukemia cll', 'international meeting', 'nih clinical center', 'bethesda md register', 'science training']\n",
      "['free workshop', 'immunoglobulin gene analysis', 'chronic lymphocytic leukemia cll', 'international meeting', 'nih clinical center', 'bethesda md register', 'science training']\n",
      "['dr kerry rogers cll specialist', 'state echoes news', 'non chemo approaches', 'non chemo approaches amp', 'new oral']\n",
      "['dr kerry rogers cll specialist', 'state echoes news', 'non chemo approaches', 'non chemo approaches amp', 'new oral']\n",
      "['cll aml', 'clinical trial participants']\n",
      "['potent drugs ibrutinib', 'captivate study explores', 'patient outcomes', 'dr jeff sharman leadingtogether']\n",
      "['chronic lymphocytic leukemia cll', 'cancer cancerawareness cancertreatment chroniclymphocyticleukemia cll thedaythatchangedmylife truthbetoldseries']\n",
      "['plasma cell disorders chronic lymphocytic leukemia aml', 'mpn mds', 'spring oncology hematology']\n",
      "['phase ii findings', 'obinutuzumab ibrutinib', 'tolerable safety profile', 'promising response rates', 'treatment na ve', 'refractory patients', 'chronic lymphocytic leukemia james leusm']\n",
      "['cll program', 'new york s', 'new drugs supercede chemo', 'cll patients']\n",
      "['velocity vlog', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['chronic lymphocytic leukaemia', 'swollen lymph nodes', 'fatigue health treatment cancer']\n",
      "['chronic lymphocytic leukaemia', 'swollen lymph nodes', 'fatigue cll cancer treatment']\n",
      "['novel therapies', 'cll drburger drbrown']\n",
      "['chronic lymphocytic leukemia methods']\n",
      "[]\n",
      "['fixedduration venetoclax triplet', 'cll kerry', 'rogers md discusses phase ii findings', 'obinutuzumab ibrutinib', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll analysis', 'primary cases', 'normal b cell differentiation cll reference epigenome jose martin subero']\n",
      "['show stress', 'poor outcomes', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'common leukemia', 'years medicalsecrets']\n",
      "['cll community', 'good wishes']\n",
      "['current treatment options', 'john gribben', 'cancertreatment patientcare bloodcancer']\n",
      "['video ecog e192', 'alliance studies ibrutinib therapy', 'cll w taitshanafelt', 'hematology ash18 immunotherapy immunoonc trialupdates leusm leukemia cllsm']\n",
      "['article experts', 'mrd negativity', 's era', 'novel therapies cll drbrown drburger']\n",
      "['donor killer cell immunoglobulin', 'receptor kir genotype', 'graft versus leukemia responses', 'chronic lymphocytic leukemia cll', 'donor transplant', 'cibmtr analysis', 'bachanova v weisdorf dj wang t marsh sge cer']\n",
      "['year s', 'therapeutic areas', 'ebook oncology bloodcancer cll myeloma dlbcl']\n",
      "['chronic lymphocytic leukemia', 'common lymphoid malignancies', 'lymphoid neoplasms']\n",
      "['safecancertx genomics', 'chronic lymphocytic leukemia', 'current research amp', 'future implications']\n",
      "['chronic lymphocytic leukemia', 'current research amp', 'future implications']\n",
      "['chronic lymphocytic leukemia', 'current research amp', 'future implications']\n",
      "['chronic lymphocytic leukemia', 'current research amp', 'future implications bestof2018 leusm']\n",
      "['survivor s outlook', 'propel past cll leukemia', 'b cell lymphoma cancermoonshot endcancer']\n",
      "['chronic lymphocytic leukemia research']\n",
      "['cartcells response', 'chronic lymphocytic leukemia transcriptional profiles joseph melenhorst']\n",
      "['standard approval', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', '17p deletion', 'therapy leusm']\n",
      "['new drug application', 'full approval', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma lymsm']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['orange blue water navy veterans', 'multiple myeloma prostate cancer b cell leukemias', 'hairy cell parkinson s ischemic heart disease hodgkin s disease chronic lymphocytic leukemia non hodgkin s lymphoma']\n",
      "['cll patients wonder', 'aren t', 'experts amp leusm']\n",
      "['dr kay', 'mayocll discusses', 'novel agents', 'cll treatment', 'patient seminar', 'april 27th', 'joint effort']\n",
      "['high rates', 'undetectable minimal residual disease', 'refractory chronic lymphoblastic leukemia cll leusm hematology']\n",
      "['chronic lymphocytic leukaemia cll', 'new video', 'dr george']\n",
      "['chronic lymphocytic leukemia cll chronic lymphocytic leukemia cll', 'white blood cells', 'bone marrow cll']\n",
      "['dr paolo strati asco', 'young investigator awardee describe', 'chronic lymphocytic leukemia clinical trials underway', 'leusm fbf']\n",
      "['illness perceptions', 'chronic lymphocytic leukemia', 'leventhal s selfregulatory model leventhal s selfregulatory model', 'somatic characteristics', 'health threat e g symptom severity', 'threat e g']\n",
      "['ac les dejamos', '2da parte del', 'harry potter', 'cll cll', 'harrypotter kithp navidad', 'buenos aires argentina']\n",
      "['diagnosis i']\n",
      "['new cll video', 'dr kerry rogers', 'research developments', 'dr rogers']\n",
      "['past month accc', 'chronic lymphocytic leukemia', 'identify key barriers', 'cancer care team s support', 'blood cancers page']\n",
      "['malat1 lncrna', 'chronic lymphocytic leukemia patients correlation', 'cytogenetic findings']\n",
      "['chronic lymphocytic leukemia']\n",
      "['expert panelists', 'patient age', 'treatment selection', 'cll cll drburger drbrown']\n",
      "['prime meeting', 'essential preclinical science', 'clinical progress', 'disease abstract deadline', 'cllsm leusm']\n",
      "['chronic lymphocytic leukemia', 'major treatment update']\n",
      "['chronic lymphocytic leukemia', 'didn t']\n",
      "['cancer network brad s kahl md', 'top cll research', 'san diego ash18']\n",
      "['scan results', 'pullback bullish', 'nak sn sgi jlt tstl n4p opg ptsg manx mmh peb cll web aqx pph avct']\n",
      "['new meaning', 'don t', 'amazing job']\n",
      "['front line therapies', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'major treatment update']\n",
      "['cll community member', 'side effect', 'health issues tune', 'dr sharman s expert perspective', 'cll patients w fatigue']\n",
      "['chronic lymphocytic leukemia', 'major treatment update']\n",
      "['chronic lymphocytic leukemia', 'major treatment update']\n",
      "['chronic lymphocytic leukemia', 'major treatment update']\n",
      "['burger md phd', 'b cell receptor', 'potential role', 'solid tumors cll drburger']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'major treatment update']\n",
      "['lenalidomide fludarabine']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['clinical results', 'james shows ibrutinib', 'elderly cll patients compares', 'previous llsscor', 'clinical development']\n",
      "['international physician s', 'cpd credit', 'key learnings', 'new data', 'clinical practice', 'cll w dr john gribben', 'review activity medscapeedu']\n",
      "['article anthony mato md msce reviews', 'novel agents', 'distinct toxicity', 'tolerability profiles', 'cll onconotes']\n",
      "['chinese herbal medicine therapy improves survival', 'chronic lymphocytic leukemia', 'nationwide population', 'cohort study']\n",
      "['cll obinutuzumab pretreatment abrogates tumor lysis risk', 'undetectable mrd', 'venetoclax obinutuzumab', 'cll blood advances']\n",
      "['patient s cll genetics', 'dr thompson', 'cll care prognostic factors', 'treatment amp', 'patient subset', 'novel agents']\n",
      "['obinutuzumab pretreatment abrogates tumor lysis risk', 'undetectable mrd', 'venetoclax obinutuzumab']\n",
      "['car t therapy shows', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['chromatin immunoprecipitation assay', 'identify novel nfat2 target genes', 'chronic lymphocytic leukemia']\n",
      "['dr jennifer r', 'brown s commentary', 'novel therapy cll']\n",
      "['superior progression', 'free survival']\n",
      "['scientists link mutation', 'venetoclax resistance', 'chronic lymphocytic leukemia healio']\n",
      "['chronic lymphocytic leukemia cll hypogammaglobulinemia']\n",
      "['merry christmas', 'cll banff lakelouise']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['merry christmas', 'cll banff lakelouise']\n",
      "['chronic lymphocytic leukemia cll', 'bone marrow', 'new diagnosis', 'test results', 'treatments options']\n",
      "['promising treatments', 'cll patients w geroge', 'nhs cancertreatment patientcare bloodcancer']\n",
      "['successful treatment', 'chronic hepatitis e', 'chronic lymphocytic leukemia']\n",
      "['brown md phd jan burger md phd', 'novel cll agents', 'intrinsic immune dysfunction', 'infection cll drbrown drburger']\n",
      "['ibrutinib regimens versus chemoimmunotherapy', 'cll ecm']\n",
      "['pathology report', 'blood tests', 'immune system', 'bad snuck']\n",
      "['big sequential treatment', 'bendamustine ibrutinib', 'obinutuzumab ga101', 'chronic lymphocytic leukemia leukemia']\n",
      "['identifies induction', 'chronic lymphocytic leukemia cells', 'bone marrow stromal cells']\n",
      "['cll community', 'peaceful holiday']\n",
      "['new lenalidomide', 'chronic lymphocytic leukemia']\n",
      "['free option w', 'treatment duration', 'free survival pfs amp minimal residual disease negativity mrd neg', 'patients w r r cll high proportion', 'w venetoclax rituximab', 'pfs amp mrd neg']\n",
      "['l ann e', 'vers sa fin', 'plupart d entre nous filles ou gar ons voulons des habits neufs mais cela n est pas aussi mauvais', 'question est', 'suivante est ce que vous aviez eu', 'bilan annuel', 'votre vie merrychristmas']\n",
      "['cheap bookkeeping services payroll', 'free resources', 'survival chronic lymphocytic leukemia']\n",
      "['cll patients', 'florence cymbalista', 'hematology mrd mrdnegativity mrdpositivity patienteducation leusm patientcare knowledgeispower']\n",
      "['venetoclax rituximab', 'refractory chronic lymphocytic leukemia eradicates minimal residual disease', 'prolongs survival post treatment', 'murano phase iii study journal', 'clinical oncology vol']\n",
      "['ash18 reversible btk inhibitor arq', 'nhl w jennifer woyach', 'james hematology trialupdate hemonc leusm leukemia lymsm nonhodgkin']\n",
      "['chronic lymphocytic leukemia', 'multiple myelom']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['igh translocations', 'chronic lymphocytic leukemia cll clinicopathologic', 'clinical outcomes fang american journal', 'hematology wiley online library']\n",
      "['lenalidomide fludarabine']\n",
      "['atrial fibrillation jacc clinical electrophysiology cardioonc lymsm leusm cll cllsm cc']\n",
      "['chronic lymphocytic leukemia', 'graft versus host disease', 'skin cancer', 'allogeneic hematopoietic stem cell transplantation']\n",
      "['scan results', 'pullback bullish', 'peb ddv1 tstl amer pyc hrn crwn hum avct bqe enet aym cll nak lsai web']\n",
      "['phase ii study', 'combination therapy', 'bendamustine ibrutinib', 'cll cllsm leusm clinicaltrials']\n",
      "['chronic lymphocytic leukemia']\n",
      "['postdoc positions microenvironmental interactions', 'chronic lymphocytic leukemia', 'b cell lymphoma science career jobs sciencejob job oncology medicine cancer']\n",
      "['dr jan burger shares', 'important prognostic factors', 'possible treatments', 'clinical practice cll drburger']\n",
      "['top discoveries', 'chronic lymphocytic leukemia cll']\n",
      "['care planning']\n",
      "['medicine drugs', 'chemotherapy medication', 'chronic lymphocytic leukemia hodgkin lymphoma', 'non hodgkin lymphoma']\n",
      "['helpful articles i ve', 'cll thanks', 'mind amp', 'specialist s strategies']\n",
      "['car t', 'treatment option', 'such wonderful news', 'cll amp', 'bloodcancer patients', 'ireland someday']\n",
      "['cll souhaite un fabuleux anniversaire', 'intelligent yahya qui termine', 'ans pendant ces', 'ton nouvel ge tu rencontreras', 'joie tu flirteras avec', 'bonheur tu trinqueras avec', 'chance tu']\n",
      "['chronic lymphocytic leukemia epidemiology', 'chronic lymphocytic leukemia epidemiology', '2027summarychronic lymphocytic leukemia cll', 'international statistical classification']\n",
      "['rituximab treatment']\n",
      "['enero xplosionoficial presenta desastre total', 'se lo pierda wrestler', 'prowrestler chileanswrestler cll luchalibre luchalibrechilena']\n",
      "['different treatment options', 'chronic lymphocytic leukaemia cll', 'new targeteddrugs', 'new film', 'dr george']\n",
      "['scan results bearish', 'mwg caml wgb lam cll cyan hnt trcs']\n",
      "['s debate', 'cll expert sharman s', 'recent asktheexpert programs']\n",
      "['cll program', 'new york s', 'new drugs supercede chemo', 'cll patients']\n",
      "['long term', 'real world results', 'ibrutinib therapy', 'refractory chronic lymphocytic leukemia', 'compassionate use cohort']\n",
      "['obinutuzumab pretreatment abrogates tumor lysis risk', 'undetectable mrd', 'venetoclax obinutuzumab']\n",
      "['big sequential treatment', 'bendamustine ibrutinib', 'obinutuzumab ga101', 'chronic lymphocytic leukemia clinicaltrials']\n",
      "['potential combination therapy', 'chronic lymphocytic leukaemia cll di']\n",
      "['kaposi s sarcoma', 'negative chronic lymphocytic leukemia patient', 'immunosuppressive therapy', 'case report openaccess']\n",
      "['cll patients', 'geneticmutations impact prognosis disease behavior', 'treatment decisions', 'experts leusm']\n",
      "['kaposi s sarcoma', 'negative chronic lymphocytic leukemia patient', 'immunosuppressive therapy', 'case report openaccess']\n",
      "['dr lamanna amp dr sharman', 'pt advocate lee swanson', 'cll clinical trial data amp research highlights']\n",
      "['protein p', 'immune therapeutic success', 'chronic lymphocytic leukemia']\n",
      "['pathologic findings', 'bronchopulmonary leukemic infiltrates', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['chronic lymphocytic']\n",
      "['bcl2 mutation confers resistance', 'cll patients amp', 'amp evidence', 'venetoclax treatment', 'amp alternatives']\n",
      "['cll market ehrindustry emrindustry chronic lymphocytic leukemia market industry analysis trend']\n",
      "['chronic lymphocy']\n",
      "['dr hallek', 'outstanding ham wasserman lecture', 'ash18 congratulations', 'happy holidays']\n",
      "['dr jennifer', 'dr jan burger share', 'novel therapy combinations', 'aggressive cll cll onconotes']\n",
      "['scan results macd bullish centerline cross', 'hrn pgr hum aph ffwd rav web', 'mlc cll']\n",
      "['top discoveries', 'chronic lymphocytic leukemia', 'evident ibrutinib drug i m', 'side fx']\n",
      "['cancer network brad s kahl md', 'top cll research', 'san diego ash18']\n",
      "['gcllsg team', 'holiday season', 'ham wasserman lecture award', 'great honor', 'cll patients']\n",
      "['top discoveries', 'chronic lymphocytic leukemia', 'cancer network brad s kahl md', 'top cll research', 'san diego lungcancer prostatecancer breastcancer research oncology']\n",
      "['tiptuesday download chapters', 'chronic lymphocytic leukemia', 'non hodgkin lymphomas', 'bethesda handbook', 'clinical hematology', 'new resource center lymsm']\n",
      "['ash18 cartcells', 'cll jcar014', 'r r setting w', 'hematology hemonc leusm leukemia']\n",
      "['small children', 'patient caf', 'patient panel shares', 'full life']\n",
      "['chronic lymphocytic leukemia cll view']\n",
      "['cll amp', 'dr philip thompson', 'dr susan leclair leusm']\n",
      "['research news scientists link mutation', 'venetoclax resistance', 'chronic lymphocytic leukemia healio']\n",
      "['nfat2 expression results', 'clonal evolution', 'chronic lymphocytic leukemia']\n",
      "['nfat2 expression results', 'clonal evolution', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['scan results', 'kefi evg talk pyc anto lre', 'red rio hotc hum kyga qfi ffwd sdl sbre cll']\n",
      "['cll patients', 'joins experts phil thompson', 'jackie broadway']\n",
      "['michie lab lrc', 'massive team effort', 'great job guys cll academictwitter']\n",
      "['roundtable interview', 'cll experts', 'share breakthroughs', 'treatment research']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['past month accc', 'chronic lymphocytic leukemia', 'identify key barriers', 'cancer care team s support', 'blood cancers page']\n",
      "['video murano updates', 'ash18 time', 'venr amp impact', 'cll w john seymour hematology trialupdate hemonc leusm leukemia mrdfocus']\n",
      "['fda approval', 'new treatment option', 'refractory cll']\n",
      "['bsi s', 'incredible flexibility', 'day courses participants', 'bsi s cll format']\n",
      "['icymi acquisition', 'recurrent gly101val mutation', 'bcl2 confers resistance', 'progressive chronic lymphocytic leukemia piers blombery']\n",
      "['nctn org study a041202', 'superior progression', 'free survival', 'standard chemoimmunotherapy']\n",
      "['recent developments', 'blood cancer treatments', 'chronic lymphocytic leukemia', 'acute myeloid leukemia dlbcl', 'multiple myeloma', 'blog post explores']\n",
      "['cll mcl lancet']\n",
      "['lancet umbralisib', 'refractory chronic lymphocytic leukaemia', 'mantle cell lymphoma', 'multicentre phase', '1b study cll tgtx']\n",
      "['o callaghan', 'oxford s churchill hospital', 'chronic lymphocytic leukemia', 'blood clot']\n",
      "['chronic lymphocytic leukemia']\n",
      "['postdoc amp phd positions microenvironmental interactions', 'rna s', 'chronic lymphocytic leukemia', 'b cell lymphomas brno cz career sciencejobs vacancies brno czechrepublic molecularbiology oncology biochemistry']\n",
      "['pi3k p110 inactivation antagonizes chronic lymphocytic leukemia', 'reverses t cell immune suppression', 'cll cllsm leusm pi3ki']\n",
      "['congrats shuai cll jci pi3k p110 inactivation antagonises chronic lymphocytic leukemia', 'reverses t cell immune suppression cc']\n",
      "['cll patients wonder', 'aren t', 'experts amp leusm']\n",
      "['good news', 'bad news', 'cll medscape s', 'top clinicaltrend']\n",
      "['elderly cll', 'agent ibrutinib w jennifer woyach', 'james hematology trialupdate hemonc leusm leukemia']\n",
      "['canadian evidence', 'line treatment', 'chronic lymphocytic leukemia consensus recommendations', 'available evidence', 'line treatment']\n",
      "['good news amp', 'bad news', 'cll medscape s', 'top clinical trend']\n",
      "['own copy', 'new booklet', 'chronic lymphocytic leukaemia cll', 'new youtube playlist']\n",
      "['ash18 updates ibrutinib obinutuzumab', 'superior results', 'cll w ian flinn', 'oncology hematology immunotherapy immunoonc hemonc hemonc']\n",
      "['clear indicator', 'broad institute', 'researchers pull', 'link micrornas']\n",
      "['enhancer architecture', 'essential core regulatory circuitry', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'insurance i', 'health issues']\n",
      "['clinical resistance', 'recurrent mutation', 'chronic lymphocytic leukemia leukemia cancer']\n",
      "['chronic lymphocytic leukemia', 'personal health']\n",
      "['jennifer woyach s ash2018', 'cll 1l treatment br versus ibrutinib']\n",
      "['plenary session', 'broad recommendation', '1l therapy needs', 'cll cllsm']\n",
      "['lymphomatoid papulosis', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma case report', 'literature review lymphoma lymsm']\n",
      "['clinicaltrial results', '1st line cll treatment amp', 'results ibrutinib', 'cll jennifer', 'woyach md']\n",
      "['new cll video', 'dr kerry rogers', 'research developments', 'dr rogers']\n",
      "['government cll expert', 'patient lee swanson']\n",
      "['venetoclax rituximab', 'refractory chronic lymphocytic leukemia eradicates minimal residual disease', 'prolongs survival post treatment', 'murano phase iii study j clin oncol cancer epidemiology']\n",
      "['bloodstream infections', 'chronic lymphocytic leukemia', 'longitudinal nation', 'wide cohort study']\n",
      "['recent patient cafe', 'chronic lymphocytic leukemia cll patients', 'mid life diagnosis', 'professional life']\n",
      "['training delivery type', 'training options', 'demand courses', 'perfect fit cll']\n",
      "['mmsm hematology']\n",
      "['good news', 'bad news', 'cll medscape s', 'top clinical trend']\n",
      "['senior editor', 'clinical cancer research aacr cll ash18']\n",
      "['ash18 recaps']\n",
      "['good news', 'bad news', 'cll medscape s', 'top clinical trend']\n",
      "['rituximab treatment']\n",
      "['cll community member', 'side effect', 'health issues tune', 'dr sharman s expert perspective', 'cll patients w fatigue']\n",
      "['natalie grover md', 'car t therapy', 'mmsm mbtsm aml myeloma hematology multiplemyeloma cll bmtsm leukemia leukaemia haematology hematology lymphoma lymphoiddiseases celltherapy']\n",
      "['good news', 'bad news', 'medscape s', 'top clinical trend']\n",
      "['chronic lymphocytic leukemia', 'social security disability']\n",
      "['chronic lymphocytic leukemia', 'social security disability']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['mcl cll', 'mcl cll']\n",
      "['rns aim cll cello health plc block']\n",
      "['complex leukemia', 'timely immunotherapy', 'cll leusm']\n",
      "['dr lamanna discusses', 'murano trial', 'refractory chronic lymphocytic leukemia cllsm leukemia leusm']\n",
      "['recent town meeting']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['active management', 'psychological anxiety']\n",
      "['chronic lymphocytic leukemia journal', 'clinical oncology vol']\n",
      "['chronic lymphocytic leukemia cll patients wonder', 'aren t']\n",
      "['ibrutinib resistance', 'chronic lymphocytic leukemia leusm']\n",
      "['new oral therapies', 'iv therapies', 'patients need', 'leukemia doctor', 'cll cll']\n",
      "['bcl2 mutation confers resistance', 'chronic lymphocytic leukemia cll ash18']\n",
      "['ibrutinib outperforms chemoimmunotherapy', 'chronic lymphocytic leukemia']\n",
      "['phase iii data showcase pfs benefit', 'frontline ibrutinib obinutuzumab combo', 'high risk chronic lymphocytic leukemia']\n",
      "['antibody deficiency', 'chronic lymphocytic leukemia', 'prophylactic replacement immunoglobulin cll cllsm leusm']\n",
      "['free tx', 'cll patients', 'overall survival', 'therapy leukemia cll ischemoextinct ash18']\n",
      "['infection pathogenesis', 'prophylaxis recommendations', 'chronic lymphocytic leukemia cll cllsm leusm']\n",
      "['lat temu sko czy em chemi cll przewlek', 'bia aczka limfotyczna gnida dosta', 'chemi po limfocytach wiem e siedzi tam gdzie przyczajona ale mam j w dupie nie rozmy lam nie zamartwiam nie przejmuj si tylko kontroluj b dzie ok zobaczysz']\n",
      "['chemoimmunotherapy treatments', 'elderly patients', 'chronic lymphocytic leukemia', 'long term treatments']\n",
      "['cll tokens', 'cll cll', 'blog crypto socialblog cryptoliveleak']\n",
      "['bj haem ven', 'dual bcri', 'pts orr', 'shorter mpfs', 'analysis i', 'lymsm blooducation cll venetoclax']\n",
      "['recent advances', 'chroniclymphocyticleukemia diffuse largebcelllymphoma']\n",
      "['new guides gt', 'cll sll thanks', 'reader panel', 'medical advisers amp case studies', 'input 12daysofla 12daysofchristmas lymphomamatters']\n",
      "['high level expression', 't cell chemokines ccl3', 'chronic lymphocytic leukemia b cells', 'nurselike cell cocultures', 'bcr stimulation']\n",
      "['critical component', 'b cell leukemogenesis', 'mouse model', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leuke']\n",
      "['roundup lawsuit blames glyphosate exposure', 'b cell chronic lymphocytic leukemia']\n",
      "['roundup lawsuit blames glyphosate exposure', 'b cell chronic lymphocytic leukemia']\n",
      "['combo bests', 'standard care', 'cll patients ibrutinib rituximab ash18 ash2018']\n",
      "['symptoms leukemia health']\n",
      "['cll case studies', 'leusm endcancer']\n",
      "[]\n",
      "['ibrutinib ritux quicker', 'remissions vs ibrutinib monotherapy', 'meaningful survival benefit cll ibrutinib lymsm']\n",
      "['ash18 updates monoallelic tp53', 'cll patients', 'durable response', 'ibrutinib monotherapy w carsten niemann', 'hematology hemonc leusm leukemia trialupdates']\n",
      "['patient s cll genetics', 'dr thompson', 'cll care prognostic factors', 'treatment amp', 'patient subset', 'novel agents']\n",
      "['ibrutinib vs', 'front line treatment', 'chronic lymphocytic leukemia ash18 leusm hematology']\n",
      "['venetoclax rituximab', 'refractory chronic lymphocytic leukemia eradicates minimal residual disease', 'prolongs survival post treatment', 'murano phase iii study']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia combination therapy venetoclax rituximab shows', 'disease progression']\n",
      "['cll chronic lymphocytic leukemia increases', 'flu season', 'sharman vaccines leusm']\n",
      "['standard chemoimmunotherapy', 'chronic lymphocytic leukemia healio']\n",
      "['cancer leukemia cll']\n",
      "['retrospective cohort study', 'commercial claims database', 'treatment trends', 'chronic lymphocytic leukemia leuk mie']\n",
      "['prof kater', 'obinutuzumab venetoclax clinicaltrial combination', 'venetoclax restores t cell function', 'cll cells amp', 'future combinations']\n",
      "['mazyar shadman md mph discusses', 'cll therapeutics cll']\n",
      "['influential voices', 'chronic lymphocytic leukemia ash18 credit auden utengen cll leukemia']\n",
      "['cll basics', 'body dr thompson', 'lab science expert dr susan leclair']\n",
      "['jennifer r', 'brown md phd comments', 'high risk patients', 'chronic lymphocytic leukemia']\n",
      "['treatment patterns', 'chronic lymphocytic leukemia']\n",
      "['nice thing', 'humanity cll']\n",
      "['cll specialist dr richard furman director', 'cll research center']\n",
      "['duo trial duvelisib vs ofatumumab', 'refractory cll sll']\n",
      "['amazing side benefits', 'combination therapies']\n",
      "['chronic lymphocytic leukemia', 'small lymphocytic lymphoma high doses', 'vitamin d', 'new research cll sll']\n",
      "['ash18 updates', 't cell function', 'venetoclax w arnon kater', 'amsterdam hematology hemonc leusm trialupdates']\n",
      "['great news', 'view counter', 'cll cryptoliveleak blockchain altcoin']\n",
      "['patientadvocate carol preston', 'cll specialist', 'specialist s perspective']\n",
      "['cll leukemia hematology oncology blood cancers cancers worldhematology2019 cancerscience2019']\n",
      "['dr blombery', 'research group', 'heterozygous nucleotide variant', 'patient leukemia cells', 'cll cell lines']\n",
      "['ash18 tait shanafelt', 'delivers key updates', 'ecog e192', 'alliance studies', 'ibrutinib therapy', 'cll hematology hemonc trialupdates leusm leukemia']\n",
      "['ash18 update', 'current treatment landscape', 'cll w john gribben', 'hematology hemonc leusm leukemia trialupdates']\n",
      "['leukemia cll lymphoma breastcancer patients']\n",
      "['tp53 aberrations', 'chronic lymphocytic leukemia', 'clinical implications']\n",
      "['line treatment', 'imbruvica treatment', 'chroniclymphocyticleukemia cll jnj']\n",
      "['subglottic stenosis', 'chronic lymphocytic leukemia']\n",
      "['september11 2018stress', 'leukemia patientsfirst study', 'chronic lymphocytic leukemia']\n",
      "['serologic response', 'new recombinant', 'herpes zoster vaccine', 'chronic lymphocytic leukemia', 'waldenstr m macroglobulinemia', 'line btk inhibitors status', 'condition summary chronic lymp']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['global super enhancer architecture', 'heterogeneous disease', 'super enhancers', 'effective therapeutic approach', 'cll llscdp llsscr llsfellow cll']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['chemoimmunotherapy treatments', 'elderly patients', 'chronic lymphocytic leukemia', 'long term treatments']\n",
      "['ash18 insights gt gt gt', 'federal practitioner', 'cll patients', 'ibrutinib avaho ash18 ash18 lucidquest followthepatient']\n",
      "['clinicaltrial serologic response', 'new recombinant', 'herpes zoster vaccine', 'chronic lymphocytic leukemia', 'waldenstr m macroglobulinemia', 'line btk inhibitors']\n",
      "['cll patients', 'ibrutinib avaho ash18']\n",
      "['december s', 'article ott', 'brown bradner amp co', 'enhancer architecture', 'essential core regulatory circuitry', 'chronic lymphocytic leukemia']\n",
      "['great discussion', 'key developments', 'front line therapies']\n",
      "['brad kahl md', 'highlights combinations']\n",
      "['ash18 insights gt gt gt', 'twitter patienten mit chronischer lymphatischer leuk mie cll im', 'von maximal', 'jahren berleben unter einer erstli ash18 lucidquest followthepatient']\n",
      "['patienten mit chronischer lymphatischer leuk mie cll im', 'von maximal', 'jahren berleben unter einer erstlinienbehandlung mit ibrutinib', 'rituximab vergleichen mit dem therapiestandard fcr l nger', 'das ergebnis einer studie ash2018']\n",
      "['genes prognosis', 'treatment decisions', 'genetics101 replay', 'cll experts dr', 'amp dr jennifer']\n",
      "['article panelists', 'chronic lymphocytic leukemia prognostic markers', 'novel treatment era drbrown drburger']\n",
      "['eradicates minimal residual disease', 'refractory chronic lymphocytic leukemia ash18 leusm']\n",
      "['agent ibrutinib', 'strong results', 'refractory setting', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma ash18 leusm']\n",
      "['ash18 show', 'line treatment', 'imbruvica hybridutinib therapy', 'cll patient populations jnj']\n",
      "['press release', 'illuminate trial', 'primary endpoint', 'frontline treatment', 'ibrutinib obinutuzumab versus chemoimmunotherapy check', 'full story']\n",
      "['lisocabtagene maraleucel', 'overall response rate', 'complete response rate', 'high risk patients', 'chronic lymphocytic leukemia ash18 leusm']\n",
      "['multiplemyeloma cll', 'meeting ash18']\n",
      "['pharmacyclics miracle cure', 'cancer drug', 'biotech company', 'riches story', 'cancer drug imbruvica', 'moment w', 'cll chronic lymphocytic leukemia']\n",
      "['ash18 insights gt gt gt', 'jeff sharman', 'twitter nicole lamana', 'things cll', 'fun time laugh', 'way ash18 lucidquest followthepatient']\n",
      "['triplet regimen', 'response rate', 'refractory chronic lymphocytic leukemia ash18 leusm']\n",
      "['nicole lamana', 'things cll', 'fun time laugh']\n",
      "[]\n",
      "['cancer increases', 'cll patients']\n",
      "['video genomic discoveries', 'richard rosenquist', 'eric18 leusm leukemia hemonc genomics cancergenetics cagenome camoldx caxtx endcancer rna dna cancermutations']\n",
      "['dr kahl', 'promising research', 'chronic lymphocytic leukemia']\n",
      "['low level', 'leukemia cll bloodcancer']\n",
      "['trials ibrutinib', 'low grade', 'crude rate', 'similar incidence', 'comparator arms', 'mcl pts', 'risk mcl cll ibrutinib lymsm']\n",
      "['overall survival', 'free survival', 'standard fludarabine cyclophosphamide', 'chronic lymphocytic leukemia ash18 leusm']\n",
      "['top abstracts', 'dr davids', 'ash18top10 cll leusm']\n",
      "['signal inhibitors', 'chronic lymphocytic leukemia eurekamag']\n",
      "['ash2018 lots', 'interesting debates', 'new standard', 'agent btk inhibitors versus combinations']\n",
      "['recurrent mutation', 'b cell leukemia lymphoma', 'protein mediates clinical resistance', 'chronic lymphocytic leukemia ash18 leusm']\n",
      "['ibrutinib outperforms chemoimmunotherapy']\n",
      "['ibrutinib versus ibrutinib', 'relapse cll addition', 'mrd negativity cll']\n",
      "['cll duvelisib vstm aes grade']\n",
      "['chronic lymphocytic leukemia', 'long term condition', 'new ways']\n",
      "['ash2018 blog', 'aml clinical trial results', 'medicine hematology uk']\n",
      "['ash2018 highlights blog', 'car t therapy news cll', 'dlbcl hematology']\n",
      "['eric initiatives', 'paolo ghia', 'eric18 leusm leukemia', 'cagenome camoldx genetics genomics cll']\n",
      "['ibrutinib versus ibrutinib', 'chronic lymphocytic leukemia']\n",
      "['cll chloresteral', 'lipid chronic lymphocytic leukemia']\n",
      "['case s p ash18', 'pfs curves', 'close wonder', 'disease factors', 'aid decision making cll']\n",
      "['ash18 alliance br vs ibrutinib vs ibrutinib rituximab', 'high interest']\n",
      "['experts drbrown drburger address', 'novel agents versus chemoimmunotherapy', 'front line setting']\n",
      "['ash18 insights gt gt gt', 'ash18 coverage', 'wrap check', 'dlbcl sicklecell myeloma', 'big t ash18 lucidquest followthepatient']\n",
      "['ash18 coverage', 'wrap check', 'dlbcl sicklecell myeloma', 'big thanks', 'top meeting', 'complete coverage poster rounds']\n",
      "['good friend cll patient amp advocate deborah simms interviews', 'expert prof peter hillmen', 'shares insights', 'combination therapies murano clinicaltrial minimal residual disease mrd amp']\n",
      "['recent clinical trials highlight potential', 'multiple myeloma', 'chronic lymphocytic leukemia']\n",
      "['venetoclax rituximab', 'refractory chronic lymphocytic leukemia eradicates minimal residual disease', 'prolongs survival post treatment', 'murano phase iii study journal', 'clinical oncology cllsm leusm']\n",
      "['chronic lymphocytic leukemia']\n",
      "['ash18 insights gt gt gt', 'twitter mutation confers resistance', 'cll lymphoma lymsm ash18 ash2018 ash18 lucidquest followthepatient']\n",
      "['video cll treatment duration', 'peter hillmen', 'eric18 leusm leukemia cancertreatment cancerprognosis camoldx caxtx leukemiatreatment mrdfocus']\n",
      "['bruton tyrosine kinase inhibitor', 'resistant chronic lymphocytic leukemia', 'disease progression', 'richter transformation']\n",
      "['cll patients', 'geneticmutations impact prognosis disease behavior', 'treatment decisions', 'experts leusm']\n",
      "['mutation confers resistance', 'cll lymphoma lymsm ash18 ash2018']\n",
      "['happy birthday jt cll']\n",
      "['standard treatment', 'cll leukaemia oncology pharma']\n",
      "['didn t', 'good idea', 'cll leusm ash18']\n",
      "['dr lamanna amp dr sharman', 'pt advocate lee swanson', 'cll clinical trial data amp research highlights']\n",
      "['favourable results', 'chronic lymphocytic leukemia', 'btk inhibitor', 'rituximab outplays chemoimmunotherapy wrt pfs study', 'jennifer woyach james']\n",
      "['news chronic lymphocytic leukemia pfs', 'obinutuzumab illuminate findings', 'ash18 amp']\n",
      "['free survival', 'refractory chronic lymphocytic leukemia', 'prognostic risk category', 'systematic review', 'meta analysis']\n",
      "['positive data', 'commercial boon', 'j amp j s drug', 'high expectations', 'investor disappointment']\n",
      "['chronic lymphocytic leukemia clinical impact']\n",
      "['dr jan burger', 'cellular therapies', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia journal', 'clinical oncology vol']\n",
      "['cll treatments', 'top specialists', 'new options ash18 cll cllsm']\n",
      "['ash18 insights gt gt gt', 'robert z orlowski', 'twitter rt physrelations rt leukemiamda ash18 patientpower video', 'nitinjainmd endcancer leusm cll physre ash18 lucidquest followthepatient']\n",
      "['cll ash18']\n",
      "['positive data', 'commercial boon', 'jnj s medicine', 'high expectations', 'investor disappointment']\n",
      "['cll biopharma dive']\n",
      "['rt physrelations rt leukemiamda ash18 patientpower video', 'nitinjainmd endcancer leusm cll physrelations']\n",
      "['ash18 video', 'endcancer leusm cll']\n",
      "['early dose escalation data', 'potential treatment', 'chronic lymphocytic leukemia']\n",
      "['ash18 cll ptcl']\n",
      "[]\n",
      "['ash18 insights gt gt gt', 'medscape oncology', 'cll patients', 'gly101v ash18 lucidquest followthepatient']\n",
      "['chronic lymphocytic leukaemia cll', 'new video', 'dr george']\n",
      "['year cancerversary cll', 'i ll']\n",
      "['top abstracts', 'week check', 'abstracts multiplemyeloma cll bloodcancer']\n",
      "['cll patients', 'gly101val mutation', 'mechanisms ash18']\n",
      "['abstract presentations', 'hematology hemonc cll cllsm leusm mmsm myeloma sicklecell thrombosis hematology caxtx ctsm trialupdates clinicaltrials']\n",
      "['roundtable interview', 'cll experts', 'share breakthroughs', 'treatment research']\n",
      "['ash18 video', 'cll treatment updates']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['frontline cll', 'shows superiority', 'standard chemoimmunotherapy fcr pfs', 'impressive results', 'ash18 ash2108']\n",
      "['rt physrelations rt leukemiamda single agent venetoclax', 'high mrd rates', 'refractory cll results', 'lead investigator wwierda', 'mdandersonnews leukemiamda', 'targetedonc endcancer ash18 leusm physrelat']\n",
      "['small children', 'patient caf', 'patient panel shares', 'full life']\n",
      "['agent venetoclax', 'high mrd rates', 'refractory cll results', 'lead investigator', 'endcancer ash18 leusm']\n",
      "['video opinion', 'routine use', 'kanti rai', 'eric18 leusm medonc hemonc leukemia immunoonc medonc caxtx camoldx ctsm mrdfocus']\n",
      "['ash18 drs porter', 'complete remission', 'chronic lymphocytic leukemia', 'celltherapy ctl119']\n",
      "['awareforall event', 'clinicaltrials awareness', 'trials amp', 'excellent speakers', 'cll patient patrick kivlehan', 'positive trial story']\n",
      "['great video', 'current cll treatment advances ln', 'undetectable disease levels']\n",
      "['free survival', 'refractory chronic lymphocytic leukemia', 'prognostic risk category', 'systematic review', 'meta analysis lymphoma lymsm']\n",
      "['europe s']\n",
      "['terrific expert summary analysis', 'exciting developments', 'cll treatment', 'sustainable remissions', 'long term complications']\n",
      "['lenalidomide fludarabine']\n",
      "['targetedtreatment s', 'front line therapies', 'chronic lymphocytic leukemia']\n",
      "['big thanks', 'drs lamanna amp sharman', 'dedication ash18 cll']\n",
      "['unusual relapse', 'chronic lymphocytic leukemia', 'remission eurekamag']\n",
      "['dataset peripheral blood', 'bone marrow mrd levels', 'ash18 cll bloodcancer']\n",
      "['rt physrelations rt leukemiamda mdandersonnews clinicaltrial', 'leukemiamda endcancer leusm ash18 cll']\n",
      "['car t therapy shows', 'chronic lymphocytic leukemia']\n",
      "[]\n",
      "['kanga exchange', 'cll btc bitcoin btc btc kanga kangaexchange crypto cllnews cll cryptoliveleak cryptoexchange video']\n",
      "['free treatment', 'cll patients']\n",
      "['ash2018 lots', 'interesting debates', 'new standard', 'agent btk inhibitors versus combinations']\n",
      "['experience amp', 'reliable agent', 'exceptional service look', 'consistent record']\n",
      "['cll amp', 'dr philip thompson', 'dr susan leclair leusm']\n",
      "['dr jennifer', 'resonate study']\n",
      "['ash18 rod humerickhouse md phd', 'venetoclax rituximab therapy', 'refractory chronic lymphocytic leukemia cll']\n",
      "['illuminate trial', 'superior pfs', 'ibrutinib obinutuzumab', 'high risk', 'chronic lymphocytic leukemia', 'small lymphocytic leukemia ash18']\n",
      "['johnson amp johnson abbvie s imbruvica steals', 'cll spotlight', 'market imbruvica front line', 'cll patients']\n",
      "['new treatment options', 'such organizations', 'social media', 'date cll']\n",
      "['cll patients', 'w jacqueline barrientos', 'hematology ash17 leukemia leusm bloodcancer cllsm hcsm chroniclymphocyticleukemia hemonc cancer hemeonc hemonc']\n",
      "['venetoclax monotherapy', 'high rates', 'minimal residual disease mrd', 'peripheral blood', 'bone marrow', 'refractory cll', 'ash18 cll leusm']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['ph3 rct', 'ibrutinib rituximab vs fcr', 'chronic lymphocytic leukemia cll e1912 shanafelt', 'ash18 tue', '15a leusm cllsm eaonc nct02048813']\n",
      "['ibrutinib cll', 'new study', 'effective treatment', 'chronic lymphocytic leukemia cll']\n",
      "['influential voices', 'chronic lymphocytic leukemia ash']\n",
      "['chronic lymphocytic leukemia conversations']\n",
      "['reception class pitching', 'enterprise designs', 'christmas fayre cll']\n",
      "['car t cell therapy', 'refractory chronic lymphocytic leukemia']\n",
      "['ash18 insights gt gt gt', 'michele nadeem baker', 'twitter shares', 'encouraging cll news', 'ash18 lucidquest followthepatient']\n",
      "['cll dream team docs', 'md rm ss']\n",
      "['cll patients', 'watchandwait shares']\n",
      "['encouraging cll news']\n",
      "['practice ibrutinib', 'standard chemoimmunotherapy', 'chronic lymphocytic leukemia healio']\n",
      "['new results']\n",
      "['ibrutinib outperforms chemoimmunotherapy', 'chronic lymphocytic leukemia']\n",
      "['venetoclax rituximab', 'refractory chronic lymphocytic leukemia eradicates minimal residual disease', 'prolongs survival post treatment', 'murano phase iii study journal', 'clinical oncology vol']\n",
      "['cll jest jednym z najcz stszych rodzaj w bia aczki u doros ych wi kszo chorych', 'osoby w starszym wieku bia aczka onkologia']\n",
      "['ultimate cll fighter']\n",
      "['tp53 aberrations', 'chronic lymphocytic leukemia', 'clinical implications', 'diagnostics haematologica review']\n",
      "['cellular therapy']\n",
      "['video considerations', 'new treatments', 'florence cymbalista', 'eric18 leusm cancerprognosis camoldx caxtx cagenome leukemia prognosis medonc hemonc mrdfocus measurableresidualdisease']\n",
      "['cll ground', 'new frontline treatment options']\n",
      "['imbruvica ibrutinib combination regimen', 'survival versus', 'chemoimmunotherapy fcr f']\n",
      "['ibrutinib outperforms chemoimmunotherapy', 'chronic lymphocytic leukemia']\n",
      "['ibrutinib rituximab combo tops', 'cll patients reports tait shanafelt md', 'ash18 article']\n",
      "['cll ibrutinib beats', 'standard chemoimmunotherapy']\n",
      "['ash johnson amp johnson abbvie s imbruvica steals', 'cll spotlight']\n",
      "['influential voices', 'chronic lymphocytic leukemia conversations', 'ash18 cll hcsm']\n",
      "['efficacy tolerability', 'car t cell therapies', 'shannon maude md phd', 'ash18 article']\n",
      "['ash18 rod humerickhouse md phd', 'free treatment', 'refractory chronic lymphocytic leukemia cll venetoclax rituximab']\n",
      "['ash18 insights gt gt gt', 'data presentations', 'chronic lymphocytic leukemia', 'hematology ash18 lucidquest followthepatient']\n",
      "['old female', 'superstar congrats dr shanafelt cll ps i', 'list allo mud sct']\n",
      "['rituximab bij onbehandelde cll ash18 oncologie nu']\n",
      "['sidste ny viden fra ash18 om cll sundlivsstil nyestudierp cll biosimil r medicin opf lgningsprogram mutation telemedicin', 'til lyle dk blodkr ft blodcancer kronisklymfatiskleuk mi patienter p']\n",
      "['new treatment', 'chronic lymphocytic leukemia', 'chemoimmunotherapy share']\n",
      "['scene prep', 'stellar team', 'new insights', 'cll ash18 cll']\n",
      "['car t therapy shows', 'chronic lymphocytic leukemia']\n",
      "['new cancer', 'nordic nanovector', 'alpha therapy', '212pb nnv003', 'positive b cell chronic lymphocytic leukemia', 'non hodgkin lymphoma']\n",
      "['scan results', 'retracement bearish', 'arb bmd sis rse pres divi swef blv cll gdp jsg gkp look cyn']\n",
      "['link prof seymour', 'clinical path', 'venetoclax blombery', 'molecular reasons', 'abstracts ash18 lymsm cll venetoclax']\n",
      "['sensational ash18', 'myeloma sicklecell cll thrombosis vte hematology']\n",
      "['old woman', 'rai stage', 'chronic lymphocytic leukemia cll', 'day history', 'test results', 'current paces finals finalyearmedics']\n",
      "['blood commentary', 'translation rps15 mutations']\n",
      "['tait shanafelt', 'excellent presentation', 'e1912 trial', 'cll patients', 'trial reshapes', 'patient care', 'ea mission ash18 cll nctn']\n",
      "['late breaker', 'adult patients', 'chronic lymphocytic leukemia cll', 'significant improvement', 'free survival', 'free combination regimen']\n",
      "['chronic lymphocytic leukemia patient dennis', 'bloodcancer ash18']\n",
      "['terrific ash18 lba presentation', 'ecog acrin', 'intergroup trial', 'ibrutinib rituximab', 'dr tait shanafelt', 'great work', 'resilience burnout']\n",
      "['ibrutinib outperforms chemoimmunotherapy', 'chronic lymphocytic leukemia']\n",
      "['mutational evolution', 'chronic lymphocytic leukemia']\n",
      "['ig gene', 'look check', 'video article']\n",
      "['cll patients', 'ash18 lymsm']\n",
      "['goodbye ash18', 'new amp', 'old colleagues', 'collaborate amp', 'new ideas', 'new collaborations', 'research pursuits', 'ash lymsm cll lovemyjob']\n",
      "['mass general cancer center s dr jacob soumerai', 'team share', 'risk model', 'overall survival', 'r r chronic lymphocytic leukemia ash18 hematology']\n",
      "['global protein synthesis', 'translational fidelity', 'chronic lymphocytic leukemia cll']\n",
      "['folks cll']\n",
      "['don t', 'ash18 cll']\n",
      "['ash18 insights gt gt gt', 'twitter ibrutinib', 'rituximab improves pfs', 'chronic lymphocytic leuke mia ash18 cll ash18 lucidquest followthepatient']\n",
      "['new phase', 'study findings', 'imbruvica ibrutinib', 'fludarabine cyclophosphamide', 'rituximab fcr', 'chronic lymphocytic leukemia']\n",
      "['rituximab improves pfs', 'chronic lymphocytic leuke mia ash18 cll']\n",
      "['imbruvica ibrutinib combination regimen', 'survival versus', 'chemoimmunotherapy fcr fludarabine cyclophosphamide', 'chronic lymphocytic leukemia cll patients']\n",
      "[]\n",
      "['piers blombery', 'pmcc rmh', 'subclonal mutational resistance']\n",
      "['ash18 lba acquisition', 'recurrent gly101val mutation', 'bcl2 confers resistance', 'progressive chronic lymphocytic leukemia cll cancer discovery aacr leusm']\n",
      "['ash18 abstract acquisition', 'recurrent gly101val mutation', 'bcl2 confers resistance', 'progressive chronic lymphocytic leukemia piers blombery']\n",
      "['new mutation', 'heme exams', 'bcl2 g101v mutation confers resistance', 'venetoclax ash18 cll', 'great work']\n",
      "['compassionate care', 'thejames john byrd', 'cll hero', 'magazine congrats dr byrd details']\n",
      "['ash18 piers blombery', 'bcl2 gly101val mutations', 'clonal growth', 'mutant cells', 'cll leukemia leusm']\n",
      "['late breaker', 'adult patients', 'chronic lymphocytic leukemia cll', 'significant improvement', 'free survival pfs', 'free combination regimen']\n",
      "['imbruvica ibrutinib combination regimen', 'survival versus', 'chemoimmunotherapy fcr fluda']\n",
      "['abbv imbruvica ibrutinib combination regimen', 'survival versus', 'chemoimmunotherapy fcr fludarabine cyclophosphamide', 'chronic lymphocytic leukemia cll patients']\n",
      "['e1912 trial shows ibrutinib rituximab']\n",
      "['years ibrutinib', 'refractory cll patients', 'dr richard furman']\n",
      "['dead os benefit', 'old cll patients ash18', 'assess durability']\n",
      "['dr shanafelt phase iii ibrutinib ritux vs r fc', 'youngsr patients', 'amazing results rituximab', 'ash18 cll']\n",
      "['ash18 shanafelt', 'ecog intergroup study', 'rituximab vs fcr', 'cll patients']\n",
      "['imbruvica ibrutinib data', 'chroniclymphocyticleukemia cll show', 'free survival pfs', 'bruton s tyrosinekinaseinhibitor', 'date ash18 abbv']\n",
      "['ash18 tait shanafelt', 'e1912 results ibrutinib rituximab', 'population leukemia leusm']\n",
      "['e1912 results', 'cll patients age', 'standard care ash18 tait shanafelt md stanford u lead investigator']\n",
      "['interesting results', 'dr kater re mrd status', 'peripheral blood', 'murano trial venr cll']\n",
      "['car t cell therapy combination shows', 'refractory leukemia ash18 cll cartcells']\n",
      "['roche announces', 'chronic lymphocytic leukemia', 'acute myeloid leukemia studies']\n",
      "['free combination', 'free survival vs', 'current standard', 'patients w chronic lymphocytic leukemia cll', '15am pst']\n",
      "['tp53 aberrations']\n",
      "['safe treatment', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'mantle cell lymphoma', 'clinical trials']\n",
      "['trial evolve amp', 'dave maloney', 'fhcrc liso cel', 'refractory chronic lymphocytic leukemia']\n",
      "['cll hematology oncology blood cancers worldhematology2019']\n",
      "['article panelists', 'chronic lymphocytic leukemia prognostic markers', 'novel treatment era drbrown drburger']\n",
      "['interesting poster', 'usa nordic nanovector collaboration ash18', 'alpha therapy', '212pb nnv003', 'positive b cell chronic lymphocytic leukemia cll', 'non hodgkin lymphoma nhl']\n",
      "['liso cel', 'refractory chronic lymphocytic leukemia']\n",
      "['dependent jagged1 expression processing', 'chronic lymphocytic leukemia cells', 'notch activation']\n",
      "['cll patients', 'uk experts']\n",
      "['imbruvica ibrutinib phase', 'combination data', 'significant improvement']\n",
      "['impressive data', 'cll patient experience', 'ash18 hematology']\n",
      "['researcher scientist doctor s doctor', 'famous kanti rai', 'left cll md']\n",
      "['dr lamanna', 'patient advocate leusm']\n",
      "['hematology ash18 poster', 'cost comparisons', 'ibrutinib cit', 'front line cll', 'claims data']\n",
      "['ash18 press mayocll', 'treatment algorithm', 'cll patients', 'richters transformation ss']\n",
      "['trialwatch abbvie s imbruvica data', 'cll show', 'site news imbruvica healthcare']\n",
      "['phase iii', 'combination ir vs br vs i', 'shows superiority pfs', 'classical chemoimmunotherapy br obi clb differences', 'high risk cll patients ighv um del11q del17p ash18 ash']\n",
      "['news network']\n",
      "['mrd assessment', 'cll mm multiplemyeloma']\n",
      "['important paper', 'dose ibrutinib', 'corroborates retrospective findings', 'amp others']\n",
      "['recent treatment advances', 'year survival rate', 'chronic lymphocytic leukemia']\n",
      "['venetoclax improves quality', 'refractory cll', 'important poster ash18', 'tara cochrane', 'maryann anderson', 'lymsm ash18 cllsm bmtsm bloodcancer']\n",
      "['long term', 'dr byrd cll ash18 ashsm']\n",
      "['ash18 don t', 'new data', 'chronic lymphocytic leukemia']\n",
      "['combination cart celltherapy', 'success rates', 'refractory chronic lymphocytic leukemia cll', 'combo treatment', 'phase i ii clinical trial']\n",
      "['chronic lymphocytic leukemia', 'disease progression di']\n",
      "['ash18 interview speaks', 'cll research lymsm']\n",
      "['car t therapy celgene', 'chronic lymphocytic leukemia ash18']\n",
      "['ash18 video', 'italian predittori dei risultati', 'watch lymphoma cll lymsm']\n",
      "['expert spotlight jennifer r', 'brown md phd', 'cll center', 'hematologic malignancies', 'dana farber cancer institute', 'associate professor', 'medical school view articles']\n",
      "['ash18 updates mrd', 'cll results', 'murano w arnon kater', 'amsterdam hematology hemonc leusm trialupdates']\n",
      "['chronic lymphocytic leukemia cll', 'front line', 'treatment model', 'imran khan md phd', 'medical affairs team ash18']\n",
      "['chronic lymphocytic leukemia', 'white blood cells', 'lymphocytes cancer forms', 'normal cells', 'bone marrow', 'bloodstream ash18']\n",
      "['cll research developments', 'dr anthony mato', 'cll program', 'promising information']\n",
      "['imbruvica ibrutinib', 'significant improvement', 'free survival', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['ash18 inhye ahn', 'clinical prognostic models', 'genetic biomarkers', 'drug resistance', 'cll patients', 'ibrutinib lymsm lymphoma']\n",
      "['cll data']\n",
      "['imbruvica ibrutinib', 'significant improvement', 'free survival', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['murano high proportion', 'long term f u', 'lymsm ash18 cll']\n",
      "['arnon kater', 'phase iii murano trial', 'long term clinical outcomes', 'treatment cll lymsm lymphoma']\n",
      "['imbruvica ibrutinib', 'significant improvement', 'free survival', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma realestate cre']\n",
      "['ash18 discussion', 'cll focus', 'geriheme gerionc']\n",
      "['paula cramer', 'durable remissions', 'high risk genetic lesion cll lymsm lymphoma']\n",
      "['ash18 gerionc geriheme']\n",
      "['press release', 'priority review', 'cd20 combination', '1l cll']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['ash18 kerry rogers', 'phase ii trial', 'obinutuzumab ibrutinib', 'treatment na ve', 'refractory cll patients', 'tolerable safety profile lymsm lymphoma']\n",
      "['curative allohct', 'good idea ash18']\n",
      "['ballroom 20a', 'prof seymour', 'murano patients', 'venetoclax ritux', 'excellent outcomes lymsm ash18 cllsm haemoz']\n",
      "['triplet obin ibrutinib ven x 14cycles', 'r r cll', 'interesting blood amp marrow mrd neg cr rate', 'small study n', 'balance tox', 'drug ash18 lymsm cll']\n",
      "['trainees thomas lew', 'long term outcomes', 'venetoclax therapy', 'complex karyotype', 'refractory cll lymsm ash18 lymphoma']\n",
      "['cll profiteren van ibrutinib', 'frontlijn ash18 oncologie nu']\n",
      "['massive thanks', 'tait shanafelt', 'ibrutinib rituximab ir', 'line cll catch', 'full interview', 'hematology leusm hemonc trialupdates']\n",
      "['ash18 cll update cll']\n",
      "['don t', 'wrap ups', 'pm pt', 'news research', 'clinical trials']\n",
      "['ash18 carol moreno', 'phase iii illuminate data', 'ibrutinib obinutuzumab combination', 'superior pfs regardless', 'high risk genomic', 'cll patients lymsm lymphoma']\n",
      "['treatment naive cll', 'risks ibrutinib', 'risks ibrutinib r', 'pts igvh', 'cll ibrutinib']\n",
      "['treatment algorithms', 'ash18 education book']\n",
      "['mrd results', 'free treatment combination', 'r r cll', 'ash18 ballroom 20a', '30am pt abstract']\n",
      "['precision medicine', 'cancer drug sensitivity', 'multiple myeloma cll myeloma bloodcancer']\n",
      "['cll patients', 'line therapy', 'hematology ash18']\n",
      "['s lots', 'patient advocates', 'cll patient', 'patient power host lee swanson', 'story amp news', 'conference leusm']\n",
      "['high prevalence', 'btk mutations', 'ibrutinib therapy rwe high risk cll patients gt gt', 'ighv um', 'population btk mutations', 'tp53 ash18 ash2018']\n",
      "['nhlbi s dr adrian weistner', 'cll developments', 'ash18 leusm']\n",
      "['high risk cll', 'interesting session clonal evolution', 'high risk prognostic markers', 'high risk cll patients ash2018 ash18']\n",
      "['night s cllheroes event', 'chronic lymphocytic leukemia', 'full event recap']\n",
      "['car t therapy shows', 'chronic lymphocytic leukemia']\n",
      "['old woman', 'rai stage', 'chronic lymphocytic leukemia cll', 'day history', 'test results']\n",
      "['ash18 car t immunotherapy shows', 'adult cll leukemia']\n",
      "['br vs ibrutinib r vs ibrutinib', 'cll patients gt', 'years practice', 'ighv cit', 'tx vs', 'ash18 hematology']\n",
      "['ibrutinib outperforms chemoimmunotherapy', 'chronic lymphocytic leukemia']\n",
      "['rod humerickhouse md phd', 'ash18 venetoclax rituximab therapy', 'free remissions', 'refractory chronic lymphocytic leukemia cll']\n",
      "['anthony mato md msce relates', 'key points', 'kinase inhibitor intolerance', 'adverse events', 'novel agents']\n",
      "['tgtx t announces oral presentation', 'triple combination', 'ublituximab umbralisib', 'refractory cll', 'richter s transformation']\n",
      "['ibrutinib outperforms chemoimmunotherapy', 'chronic lymphocytic leukemia science']\n",
      "['pfs vs']\n",
      "['fatigue level correspond', 'patient s cll', 'fatigues leusm']\n",
      "['health care utilization', 'chronic lymphocytic leukemia optum heor shares', 'new findings', 'monday s oral presentation']\n",
      "['busy weekend oncall i m', 'emails updates', 'exciting time']\n",
      "['trial ibrutinib', 'superior progression', 'free survival', 'standard chemoimmunotherapy', 'chronic lymphocytic leukemia', 'ibrutinib response']\n",
      "['dependent jagged1 expression processing', 'chronic lymphocytic leukemia cells', 'notch activation']\n",
      "['novel regimen', 'high risk cll patients', 'link cancer cancercongress cancerconference cancerconferences worldcancermeet cancerevent paris france feb']\n",
      "['att skilja vetenskap fr n trams f rel', 'emma frans skolaiv rldsklass cll solo sokos hotel torni tampere']\n",
      "['drug target', 'chronic lymphocytic leukemia', 'link cancer cancercongress cancerconference cancerconferences worldcancermeet cancerevent paris france feb']\n",
      "['enhancer architecture', 'essential core regulatory circuitry', 'chronic lymphocytic leukemia cell']\n",
      "['new data', 'murano trial', 'venclexta venclyxto venetoclax', 'refractory chroniclymphocyticleukemia', 'treatment course abbv']\n",
      "['ash18 car t shows', 'early cll test', 'car t cell therapy', 'chronic lymphocytic leukemia cll', 'initial signs', 'small group']\n",
      "['ash18 cll fl mzl lymphoma tgtx investor amp analyst event link', 'audio link']\n",
      "['rets sista', 'mycket sorl i f rel sningssalen d deltagarna f rs ker klura ut hur mitt h nga gubbe program fungerar python microbit cll l']\n",
      "['suivi m dian', 'ans dans l tude phase', 'murano valuant', 'venetoclax venclexta venclyxto abbvie roche associ au rituximab mabthera roche dans', 'leuc mie lympho', 'chronique ash18 ash2018']\n",
      "['r sultats', 'suivi jusqu', 'ans dans', 'leuc mie lympho', 'chronique lymphome lymphocytique trait s avec ibrutinib imbruvica abbvie', 'monoth rapie ash18 ash2018']\n",
      "['pretty incredible individuals', 'cll community', 'couldn t', 'amp gratitude', 'lisa r i p']\n",
      "['neoantigens load', 'immunotherapy ash18 ash2018']\n",
      "['ibrutinib outperforms chemoimmunotherapy', 'cll ash clinical news ibrutinib vs ibrutinib rituximab vs br']\n",
      "['imbruvica ibrutinib data', 'chronic lymphocytic leukemia cll show', 'free su']\n",
      "['new data', 'murano trial', 'venclexta venclyxto venetoclax']\n",
      "['nice picture cll ash18 ash2018']\n",
      "['chair salles', 'video interviews', 'french ash18 lymsm lymphoma cll']\n",
      "['chris fegan cardiff', 'anna schuh oxford', 'hematology ash18']\n",
      "['ash18 ibrutinib', 'new standard', 'elderly cll alliance results w jennifer woyach', 'hematology trialupdates leusm leukemia btk chemoimmunotherapy']\n",
      "['ash18 updates cd19 cart', 'r r cll', 'response amp', 'crs w jordan', 'trialupdates cellulartherapy hematology']\n",
      "['snss reveals', 'preliminary findings', 'early stage study', 'refractory chronic lymphocytic leukemia', 'b cell malignancies leukemia cancer']\n",
      "['congratulations jennifer woyach fellow ash', 'crti participant', 'wonderful work ibrutinib', 'superior pfs']\n",
      "['superior pfs', 'cll results', 'org a041202 ash18 ash2018']\n",
      "['plenary abstract', 'own dr woyach', 'elderly cll pts i']\n",
      "['influential voices', 'chronic lymphocytic leukemia', 'ash18 cll']\n",
      "['rod humerickhouse md phd', 'interesting insights', 'cll therapy']\n",
      "['prof seymour', 'roberts mrd negativity predicts pfs', 'cll lymsm lymphoma cllsm haemoz']\n",
      "['ash18 jennifer woyach', 'american intergroup study a041202 cll lymsm lymphoma']\n",
      "['cll management', 'patients ibrutinib', 'hematology heme geriatrics ash18']\n",
      "['ph3 rct', 'ibrutinib rituximab vs fcr', 'chronic lymphocytic leukemia cll e1912 shanafelt', 'ash18 tue', '15am leusm cllsm eaonc nct02048813']\n",
      "['cll patients ibrutinib', 'superior pfs', 'bendmustine rituximab', 'cr rates results', 'american trial a041202 ash18 ashsm cll']\n",
      "['full results', 'murano trial', 'disease progression', 'overall survival', 'refractory chronic lymphocytic leukemia cll patients', 'venetoclax rituximab']\n",
      "['ph3 rct alliance a041202 br vs br ibrutinib vs ritux ibrutinib gt 65y w', 'symptomatic cll', 'pts ibrutinib regimens gt cit', 'different os p', 'ash18 plenarysession james']\n",
      "['important results', 'plenary ibrutinib', 'rituximab improves pfs', 'chronic lymphocytic leukemia org leusm']\n",
      "['ash18 cll ibrutinib bendaka']\n",
      "['org study', 'rituximab improves pfs', 'chronic lymphocytic leukemia ash18 leusm']\n",
      "['ash18 cll ibrutinib bendaka']\n",
      "['ash18 cll ibrutinib bendaka']\n",
      "['ash18 cll ibrutinib bendaka']\n",
      "['ash18 jennifer woyach', 'alliance trial results', 'ibrutinib rituximab vs br', 'frontline use', 'cll ashplenarysession']\n",
      "['chronic lymphocytic leukemia']\n",
      "['ash18 cll ibrutinib bendaka']\n",
      "['rituximab improves pfs', 'chronic lymphocytic leukemia ash18 org leusm']\n",
      "['t cellen belangrijk voor succes car t celtherapie bij cll ash2018 amc armando van bruggen oncologie nu']\n",
      "['rituximab substitute fcr', 'cll age', '17p deletion']\n",
      "['drs flinn', 'long term efficacy', 'new oral monotherapy', 'r r cll', 'sll poster session', 'hall gh']\n",
      "['hot topics', 'hematology confererence', 'san diego ash18 combinations car t therapy survivorship']\n",
      "['david lesoway senior director', 'chronic lymphocytic leukemia', 'american society hematology conference', 's press release']\n",
      "['supplementary figures', 'nejm article', 'plenary session', 'differentiate pfs outcomes', 'ibr vs br os']\n",
      "['dr kerry rogers', 'cll news', 'ash18 leusm']\n",
      "['ighv mutation', 'treatment decisions', 'chronic lymphocytic leukemia stay', 'cll research ash18']\n",
      "['treatment options']\n",
      "['ash18 video', 'interesting interview', 'committee member', 'outcome predictors', 'mzl lymphoma cll lymsm']\n",
      "['leukemia ibrutinib regimens versus chemoimmunotherapy', 'cll nejm']\n",
      "['chronic lymphocytic leukemia', 'common types']\n",
      "['ash18 update', 'new frontline', 'chronic lymphocytic leukemia']\n",
      "['ash18 coverage venetoxlax', 'cll w stephan stilgenbauer', 'ulm hematology leusm leukemia immunoonc']\n",
      "['imbruvica ibrutinib data', 'chronic lymphocytic leukemia cll show', 'free surviv']\n",
      "['breakthrough year', 'chronic lymphocytic leukemia cll dr kanti rai', 'cll patient s prognosis historyofbloodcancer ash18']\n",
      "['dyk chronic lymphocytic leukemia']\n",
      "['committee member', 'outcome predictors', 'mzl stay', 'video interview', 'lymphoma cll lymsm']\n",
      "['aanhoudend profijt van venetoclax', 'rituximab bij r r cll murano ash2018 oncologie nu']\n",
      "['rt physrelations rt leukemiamda ash18 paolo strati md combination', 'lenalidomide amp rituximab', 'pts w treatment na ve', 'cll treatment results', 'predictive factors']\n",
      "[]\n",
      "[]\n",
      "['treatment options', 'cll patients', 'richterstransformation cc']\n",
      "['clinical trials', 'frontline high risk cll patients', 'great work']\n",
      "['ash18 concurrent treatment', 'ibrutinib amp cd19 cartcell therapy jcar014', 'response rate', 'refractory chronic lymphocytic leukemia cll', 'dr jordan gauthier shares']\n",
      "['imbruvica ibrutinib data', 'chronic lymphocytic leukemia cll show', 'free survival pfs', 'bruton s tyrosine kinase inhibitor']\n",
      "['abbv imbruvica data', 'cll show']\n",
      "['imbruvica ibrutinib data', 'chronic lymphocytic leukemia cll show', 'free survival pfs', 'bruton s tyrosine kinase inhibitor']\n",
      "['ash18 tanya siddiqi', 'phase i ii transcend cll', 'trial lymsm lymphoma']\n",
      "['inspirational figure', 'critical questions', 'car t', 'kanti rai']\n",
      "['young patient', 'refractory cll w jacqueline barrientos', 'feinstein institute', 'medical research lymphoma prognosis cancertherapy overallsurvival']\n",
      "['remarkable speech cartcells cll ibrutinib ash18 ash2018']\n",
      "['jordan gauthier', 'refractory cll lymsm lymphoma']\n",
      "['cll tcellrx']\n",
      "[]\n",
      "['specific cartcell therapy', 'refractory cll']\n",
      "['ash18 saar gill', 'prospective clinical trial', 'cd19 car t cells', 'cll shows', 'high response rate lymsm lymphoma']\n",
      "['cartcells ibrutinib', 'impressive results ash18 ash2018']\n",
      "['prospective clinical trial', 'cd19 car t cells', 'chronic lymphocytic leukemia shows', 'high response rate ash18']\n",
      "['anthony mato', 'triplet combination', 'umbralisib ublituximab', 'refractory cll', 'rt patients lymsm lymphoma']\n",
      "['car t', 'ibrutinib shows', 'high response rate', 'chronic lymphocytic leukemia abstract']\n",
      "['dr susan o brien discusses novel therapy']\n",
      "['ash18 paolo strati md combination', 'lenalidomide amp rituximab', 'pts w treatment na ve', 'cll treatment results', 'predictive factors']\n",
      "['rt physrelations rt leukemiamda ash18', '45a oral pres', 'phase ii trial', 'w ibrutinib', 'pts w richter transformation marriottmarina pacific br', 'endcancer leusm cll physrela']\n",
      "['dr brian koffman shares', 'cll patients ash18']\n",
      "['dr jennifer', 'cll ash18']\n",
      "['ash18 paolo strati', 'safe regimen', 'treatment na ve', 'cll patients lymsm lymphoma']\n",
      "['real world data i note', 'cll patients', 'clinical trial data', 'r r median']\n",
      "['recurrent gly101val mutation', 'bcl2 confers resistance', 'progressive chronic lymphocytic leukemia cll blombery', 'ash18 tue', '15a leusm cllsm']\n",
      "['ph3 rct', 'ibrutinib rituximab vs fcr', 'chronic lymphocytic leukemia cll e1912 shanafelt', 'ash18 tue', '15a leusm cllsm eaonc nct02048813']\n",
      "['dr jordan gauthier', 'refractory chronic lymphocytic leukemia', 'cartcell therapy', 'remission rates ash18', '30am pt']\n",
      "['45a oral pres', 'phase ii trial', 'w ibrutinib', 'pts w richter transformation pacific br', 'endcancer leusm cll']\n",
      "['rt physrelations rt leukemiamda ash18', '30a oral pres', 'paolo strati md combination', 'lenalidomide amp rituximab', 'pts w treatment na ve', 'cll treatment results', 'predictive factors', 'response marriottmarina pacific br']\n",
      "['30a oral pres', 'paolo strati md combination', 'lenalidomide amp rituximab', 'pts w treatment na ve', 'cll treatment results', 'predictive factors', 'response pacific br', 'endcancer leusm']\n",
      "['cll moments ash18 ash2018']\n",
      "['enhancer architecture', 'essential core regulatory circuitry', 'chronic lymphocytic leukemia']\n",
      "['ash18 update']\n",
      "['ash18 update']\n",
      "['s sessions', 'mds daniel deangelo', 'aml jennifer', 'scott armstrong', 'dana farber experts ash18']\n",
      "['ash18 day', 'elegant conceptual lecture', 'architectural landscape', 'michael hallek']\n",
      "['ash18 insights gt gt gt', 'twitter cll overall treatment savings', 'ibrutinib imbruvica', 'prescription costs ash18 cll janssen ash18 lucidquest followthepatient']\n",
      "[]\n",
      "['enhancer architecture', 'essential core regulatory circuitry', 'chronic lymphocytic leukemia']\n",
      "['s ash18 sessions', 'mds daniel deangelo', 'full schedule']\n",
      "[]\n",
      "['cll overall treatment savings', 'ibrutinib imbruvica', 'prescription costs ash18 cll janssen lymphoma']\n",
      "['ash18 catch', 'cll results', 'promising agents', 'lymphoma trials amp', 'hematology leusm lymsm hemonc mmsm ctsm trialupdates']\n",
      "['chronic lymphocytic leukaemia', 'small lymphocytic lymphoma', 'new youtube playlist', 'personal experience films', 'sub type', 'sll cll bloodcancer lymphomamatters']\n",
      "[]\n",
      "['new data', 'murano trial', 'venclexta venclyxto venetoclax', 'refractory chronic lymphocytic leukemia', 'treatment course']\n",
      "['landscape frontline cll ash18 ash2018']\n",
      "['regimens yield', 'cll hematology']\n",
      "['ami solutions news abbvie', 'new data', 'murano trial']\n",
      "['abbv abbvie', 'new data', 'murano trial', 'venclexta venclyxto venetoclax', 'refractory chronic lymphocytic leukemia', 'treatment course']\n",
      "['treatment decisions', 'young patients cll']\n",
      "['ibrutinib increase', 'tcr clonality', 'cll patients ash18 ash2018']\n",
      "[]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['ash18 insights gt gt gt', 'f haroun md', 'twitter cll ibrutinib ash2018 hematology nejm ash18 lucidquest followthepatient']\n",
      "['ash18 jae park', 'phase i', 'human clinical trial', '1928z 41bbl', 'car t cells', 'refractory nhl', 'cll lymsm lymphoma']\n",
      "['checkpoint inhibition ash18 immunoonc']\n",
      "['depth look', 'ibrutinib improves', 'cll t cell', 'exhaustion enhancement', 'immune synapses', 'explore ash18 cll immunoonc']\n",
      "['nhlbi dr maria joao baptista', 'tcr repertoire', 'chronic lymphocytic leukemia', 'p m', 'san diego ballroom ash18']\n",
      "['cll bloodcancer']\n",
      "['patient cafes virtual meet ups', 'multiplemyeloma patients', 'care partners ash18']\n",
      "['dr jennifer woyach', 'breakthrough cll treatment research', 'hematology s ahs18 meeting', 'team s']\n",
      "['new data', 'murano trial', 'venclexta venclyxto venetoclax', 'refractory chronic lymphocytic leukemia', 'treatment course']\n",
      "['ash18 nitin jain', 'free oral regimen', 'high risk treatment na ve cll lymsm lymphoma']\n",
      "['new data', 'murano trial', 'venclexta venclyxto venetoclax']\n",
      "['ash18 cll updates', 'ash excitement', 'minne snow ta', 'se mn']\n",
      "['ash18 john seymour', 'murano trial', 'establishes feasibility', 'venetoclax rituximab combination therapy', 'refractory cll lymsm lymphoma']\n",
      "['danielle brander', 'ash18 venetoclax', 'rituximab induces', 'durable responses', 'cll lymsm lymphoma']\n",
      "['pivotal ph3 murano trial', 'r r cll ash18']\n",
      "['john seymour', 'pmcc rmh concludes presentation', 'murano trial', 'refractory r r chronic lymphocytic leukemia cll ash18']\n",
      "['murano trial']\n",
      "['new data', 'murano trial', 'venclexta venclyxto venetoclax', 'refractory chronic lymphocytic leukemia', 'treatment course realestate cre']\n",
      "['new data', 'murano trial', 'venclexta venclyxto venetoclax', 'refractory chronic lymphocytic leukemia', 'treatment course']\n",
      "['john seymour', 'pmcc rmh', 'murano trial', 'venetoclax rituximab venr combination therapy', 'refractory r r chronic lymphocytic leukemia cll ash18']\n",
      "['exciting analyses', 'prof seymour', 'cll lymsm lymphoma amlsm cllsm bmtsm haemoz']\n",
      "['ash18 peter hillmen', 'refractory cll', 'high rate', 'mrd eradication lymsm lymphoma']\n",
      "['dyk chronic lymphocytic leukemia']\n",
      "['cll patients', 'help reports jennifer woyach md', 'ash18 article']\n",
      "['ash18 andy rawstron', 'substantial improvement', 'cll cells', 'peripheral blood', 'bone marrow', 'ibrutinib na ve patients lymsm lymphoma']\n",
      "['inconvenient truths']\n",
      "['microenvironment cll ham wasserman lecture ash18 ash2018']\n",
      "['contemporary approach', 'cll ash18 hamwasserman michaelhallek', '33rd year', 'outstanding presentation']\n",
      "['summary slide', 'michael hallek speaker', 'ham wasserman lecture ash18 cll ssbmt luesm']\n",
      "['future trial strategies', 'clonal evulation', 'treatments novel agents', 'negative disease response ash18']\n",
      "['optimal cll cllsm therapy ash18']\n",
      "['ash18 cllsm leusm ham wasserman lecture', 'translational research', 'chronic lymphocytic leukemia cll gesamtkunstwerk']\n",
      "['ash18 cllsm leusm ham wasserman lecture', 'translational research', 'chronic lymphocytic leukemia cll ven amp ibrutinib']\n",
      "['dr hallek', 'ham wasserman lecture', 'historic developments', 'cll ash18']\n",
      "['ash18 cllsm leusm ham wasserman lecture', 'translational research', 'chronic lymphocytic leukemia cll']\n",
      "['ash18 cllsm leusm ham wasserman lecture', 'translational research', 'chronic lymphocytic leukemia cll chlorambucil']\n",
      "['ash18 cllsm leusm ham wasserman lecture', 'translational research', 'chronic lymphocytic leukemia cll cll ipi']\n",
      "['ash18 cllsm leusm ham wasserman lecture', 'translational research', 'chronic lymphocytic leukemia cll', 'prognostic markers']\n",
      "['ash18 cllsm leusm ham wasserman lecture', 'translational research', 'chronic lymphocytic leukemia cll']\n",
      "['ash18 cllsm leusm ham wasserman lecture', 'translational research', 'chronic lymphocytic leukemia cll']\n",
      "['ash18 cllsm leusm ham wasserman lecture', 'translational research', 'chronic lymphocytic leukemia cll lymphocytosis']\n",
      "['ash18 cllsm leusm ham wasserman lecture', 'translational research', 'chronic lymphocytic leukemia cll']\n",
      "['full house', 'ham wasserman lecture cll', 'dr micheal hallek ash18 hematology']\n",
      "['lymsm lymphoma cll']\n",
      "['speaker uses architecture', 'cll milesvanderrohe godisintbedetails hamwasserman michaelhallek ash18']\n",
      "['dr michael hallek', 'chronic lymphocytic leukemia', 'p m', 'hall ab ash18']\n",
      "['nice update', 'con tam', 'bgbg3111 zunubrutinib', 'lymsm ash2018 lymphoma amlsm cllsm bmtsm bloodcancer haemoz']\n",
      "['expert series', 'renowned cll', 'mpn experts', 'care partners check']\n",
      "['favourite part', 'exhibition hall', 'company pipelines', 'new therapies', 'cll cml leukaemia ash18 hematology']\n",
      "['chronic lymphocytic leukemia cll', 'common adult blood cancer', 'expresses cd19 antigen', 'ash18 car t cell media']\n",
      "['wonderful researchers', 'big trial results', 'ash18 jennifer woyach amp maria domenica cappellini cll', 'thalassemia cllsm hemonc trialupdate ctsm hematology']\n",
      "['frontline cll ash18']\n",
      "['new standard ash2018 cll']\n",
      "['ash18 richters cll treatment flowchart']\n",
      "['ash18 richters cll treatment mayo approach']\n",
      "['sunny san diego janssenoncology', 'new data', 'multiple myeloma chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll', 'front line', 'treatment model', 'imran khan md phd', 'medical affairs team ash18']\n",
      "['ash18 richters cll treatment']\n",
      "['ash18 richters cll treatment']\n",
      "['ash18 richters cll treatment']\n",
      "['morning meetings', 's time', 'great data', 'particular leukaemia ash18 hematology']\n",
      "['ash18 richters cll treatment']\n",
      "['ash18 richters cll treatment']\n",
      "['ash18 richters cll']\n",
      "['mmm alexa', 'cll ash18']\n",
      "['ash18 richters cll presentation']\n",
      "['educational session', 'brown cartcells ash18 ssbmt leusm']\n",
      "['ash18 cll richters prevalence']\n",
      "['term analysis', 'duration treatment combination', '30am pt pacific ballroom']\n",
      "['ash18 richters']\n",
      "['legendary neil kay', 'recent cll amp', 'pro research', 'hematology ash18', 'great discussion amp']\n",
      "['ash18 state']\n",
      "['ash18 novel agents']\n",
      "['ash18 novel combinations', 'cost esp w macra']\n",
      "['ash18 cars vs bmt', 'cll post ibrutinib']\n",
      "['ash18 nuts n bolts']\n",
      "['ash18 ibrutinib mutations']\n",
      "['breakthrough year', 'chronic lymphocytic leukemia cll dr kanti rai', 'cll patient s prognosis historyofbloodcancer ash18']\n",
      "['ash18 dr jen', 'brown director', 'cll center', 'efficacy data', 'duo study', 'exploratory analysis', 'clinical amp biological indicators', 'identify patients']\n",
      "['new landscape', 'frontline cll ash18']\n",
      "['exciting news', 'cll cll leukaemia']\n",
      "['chronic lymphocytic leukemia treatment', 'bendamustine rituximab', 'free survival ash18']\n",
      "['chronic lymphocytic leukemia treatment', 'bendamustine rituximab', 'free survival ash18']\n",
      "['chronic lymphocytic leukemia cll therapy ash18']\n",
      "['chronic lymphocytic leukemia treatment', 'bendamustine rituximab', 'free survival ash18']\n",
      "['refractory chronic lymphocytic leukemia']\n",
      "['3d immunoglobulin protein structures', 'chronic lymphocytic leukemia']\n",
      "['possible ash18 hematology']\n",
      "['dyk chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia patient dennis', 'bloodcancer ash18']\n",
      "['chronic lymphocytic leukemia', 'white blood cells', 'lymphocytes cancer forms', 'normal cells', 'bone marrow', 'bloodstream ash18']\n",
      "['chronic lymphocytic leukemia', 'ash18 cll']\n",
      "['chronic lymphocytic leukemia', 'common types']\n",
      "['communicate results', 'medical algorithm amp', 'human making', 'cll watchandwait ash18']\n",
      "['great work', 'ash18 leusm cll']\n",
      "['lenalidomide fludarabine']\n",
      "['video wherein dr john pagel discusses', 'tgtx umbralisib']\n",
      "['san diego', 'couldn t', 'cll community']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['brad kahl md', 'promising research']\n",
      "['don t', 'br vs ir vs i', 'dr woyach', 'plenary session ash18']\n",
      "['impressive data', 'superior pfs', 'cll results', 'american intergroup study a041202 ash18 leusm']\n",
      "['prof chris fegan', 'hot cll topics', 'hematology ash18 lots', 'new data', 'clinical trials', 'real world evidence']\n",
      "['big cll topics', 'chris fegan', 'hematology ash18', 'year quality', 'huge importance', 'patients cll']\n",
      "['jennifer woyach', 'ash18 stage', 'team s breakthrough cll research', 'event s', 'plenary scientific session']\n",
      "['cll ash18']\n",
      "['cll ash18']\n",
      "['fdaoncology poster ash18', 'follicular lymphoma', 'chronic lymphocytic leukemia', 'clin trials vs', 'real world treatment duration amp survival', 'w pretreatment', 'charlson score dec', '6pm hall gh']\n",
      "['cll chronic lymphocytic leukemia increases', 'flu season', 'sharman vaccines leusm']\n",
      "['live lymphoma', 'cll updates']\n",
      "['case reports', 'hyperprogression flare', 'immune checkpoint inhibition', 'beneficial btk inhibitor', 'antibody results', 'hyperprogressor phenotype', 'mice ash18 immunoonc immunotherapy']\n",
      "['murine data', 't cell responses', 'dysfunctional antigen', 'specific t cell responses', 'experimental cll', 'autologous t cell', 'therapies ash18']\n",
      "['enhancer architecture', 'essential core regulatory circuitry', 'chronic lymphocytic leukemia cancer cell']\n",
      "['15p oral', 'pts w treatment na ve high risk cll pacific br', 'endcancer leusm']\n",
      "['enhancer architecture', 'essential core regulatory circuitry', 'chronic lymphocytic leukemia']\n",
      "['promising results phase ii clinical trial', 'line therapy']\n",
      "['rare colonic manifestation', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['dr jan burger', 'btk inhibition', 'novel agents']\n",
      "['rt physrelations rt leukemiamda ash18', '00p oral', 'nitinjainmd ibrutinib fludarabine cyclophosphamide', 'obinutuzumab ifcg', 'firstline treatment', 'pts w cll w', 'ighv amp w o tp53 aberrations marriottmarina pacific br']\n",
      "['00p oral', 'ibrutinib fludarabine cyclophosphamide', 'obinutuzumab ifcg', 'firstline treatment', 'pts w cll w', 'ighv amp w o tp53 aberrations pacific br', 'endcancer leusm']\n",
      "[]\n",
      "['cll isn t', 'fatigue plagues', 'cll specialists']\n",
      "['resistant chronic lymphocytic leukemia', 'treatment armamentarium lymsm hematology leusm']\n",
      "['chronic lymphocytic leukemia cll view', 'video leuc mie hematology']\n",
      "['brad kahl md', 'exciting data']\n",
      "['asktheexpert segment', 'patient power community member', 'drug duvelisib', 'cll treatment landscape', 'expert dr sharman']\n",
      "['treatment na ve high risk chronic lymphocytic leukemia cll ash18']\n",
      "['video uk', 'cll trials', 'peter hillmen', 'eric18 leusm oncopharm globonc medonc immunoonc hemonc prognosis']\n",
      "['chronic lymphocytic leukaemia cll', 'small lymphocytic lymphoma sll', 'new booklet', 'sll cll sll bloodcancer factfriday']\n",
      "['bone marrow', 'chronic lymphocytic leukemia', 'common types', 'hematology amp oncology program caregivers diagnose', 'cancer cancerawarenessuae']\n",
      "['post 1d', 'ash18 cll meetings i', 'ibrutinib beats chemo immunotherapy', 'frontline cll', 'r r disease']\n",
      "['patient advocacy director zack', 'hematology conference', 'san diego', 'leukaemia aml', 'cml cll']\n",
      "['frontline cll chemofree', 'phase iii study', 'therapy vs fcr chemoimmunotherapy', 'ecog acrin cancer research group e1912']\n",
      "['human il15 rhil15', 'refractory chronic lymphocyte leukemia background chronic lymphocytic leukemia cll', 'blood cancer recombinant human interleukin', 'manmade protein obinutuzumab']\n",
      "['interesting epigenetic regulatory elements', 'excellent drug targets', 'chronic lymphocytic leukemia']\n",
      "['human il', 'refractory chronic lymphocyte leukemia status', 'condition summary leukemia lymphocytic chronic b cell']\n",
      "['patients dream team', 'hematology ash18 sharman drmichaelhallek drstephanstilgenbauer ulm']\n",
      "['s facebook', 'patient journalist lee swanson', 'ash18 coverage', 'patients cancerresearch cll mmsm mpnsm']\n",
      "['recent fda', 'black box warning', 'popular multiplesclerosis ms', 'b cell chronic lymphocytic leukemia b cll drugs']\n",
      "['part video series', 'dr richard furman discusses']\n",
      "['vous trouverez ci joint', 'd claration pr', 'alable lue ce jour par les lu es snu fo cfdt cgt snap unsa soutenus par les organisations syndicales cll', 'sud non pr sentes au ce au ce p', 'emploi occitanie', 'suite du mouvement', 'gr ve p', 'emploi du']\n",
      "['week november', 'full case amp', 'old man', 'chronic lymphocytic leukemia', 'ophthalmic herpes zoster', 'cognitive changes', 'right extensor plantar reflex']\n",
      "['cll patients', 'survivorship december', 'pikesville md event', 'email tracy orwig org patient caregiver bloodcancers']\n",
      "['combo car t ibrutinib treatment', 'chronic lymphocytic leukemia ash18 press']\n",
      "['dr kahl', 'promising research', 'chronic lymphocytic leukemia']\n",
      "['experts jennifer r', 'brown md phd jan', 'burger md phd', 'anthony mato md msce', 'mrd negativity', 'different perspectives drbrown drburger']\n",
      "['dr jordan gauthier', 'refractory chronic lymphocytic leukemia', 'cartcell therapy', 'remission rates ash18', '30am pt']\n",
      "['expert spotlight jan', 'burger m d ph d', 'md anderson cancer center', 'houston usa view articles', 'dr burger']\n",
      "['dr kahl', 'promising research', 'chronic lymphocytic leukemia leusm']\n",
      "['name leukeran', 'chemotherapy medication', 'chronic lymphocytic leukemia cll hodgkin lymphoma', 'non hodgkin lymphoma']\n",
      "['trial data', 'stephan stilgenbauer', 'ulm eric18 leusm ctsm medonc camoldx trialupdate leukemia hemonc immunoonc immunotherapy clinicaltrials']\n",
      "['chronic lymphocytic leukemia']\n",
      "['ash18 insights gt gt gt', 'web check', 'cll images videos', 'popular posts', 'cll ash18 lucidquest followthepatient']\n",
      "['refractory chronic lymphocytic leukemia cll', 'global clinical trials review h1', 'refractory chronic lymphocytic leukemia cll', 'global clinical trials review h1 2018summaryglobaldata s clinical trial report']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['dr richard furman discusses', 'combo w']\n",
      "['sunny san diego janssenoncology', 'new data', 'multiple myeloma chronic lymphocytic leukemia']\n",
      "['multiple myeloma chronic lymphocytic leukemia']\n",
      "['teva s biosimilar truxima', 'low grade lymphoma', 'ref product rituxan s indications', 'dlbcl chronic lymphocytic leukemia', 'autoimmune diseases', 'truxima s label']\n",
      "['recurrent gly101val mutation', 'bcl2 confers resistance', 'progressive chronic lymphocytic leukemia ash2018']\n",
      "['patient advocate tune']\n",
      "['patientadvocate carol preston', 'cll specialist', 'specialist s perspective']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['combination therapies', 'patient perspective deb sims cll patient', 'young children shares', 'cll horizons']\n",
      "['life time management', 'sll explore', 'personal stories online lymphomamatters livingwithlymphoma lymphomastory']\n",
      "['current knowledge', 'tp53 mutation', 'jitka malcikova', 'eric18 leusm leukemia cancermutation cancerresearch biomarker cancertarget drugtarget cancertreatment medonc hemonc']\n",
      "['cll ssc nguvumoja']\n",
      "['cll v 9v', 't cell fitness', 'cellular therapy', 'ex vivo activation']\n",
      "['snss cll dinner event', 'san diego ca', 'slide webcast']\n",
      "['deborah sims cll patient', 'passionate advocate', 'community discusses', 'young family']\n",
      "['global chronic lymphocytic leukemia market']\n",
      "['imbruvicacapsules exporter chronic lymphocytic leukemia', 'treatment chronic lymphocytic leukemia', '17p deletion waldenstr m s macroglobulinemia mantle cell lymphoma']\n",
      "['venous thromboembolism', 'chronic lymphocytic leukemia', 'nationwide cohort study']\n",
      "['storm ash', 'blood cancer conf', 'year 1st work mtgs', 'precious catchup w dear dg amp flower girl friend janie licosati', 'embrace goodness', 'life ash2018 bestworstweek importantwork cll nhl']\n",
      "['pi3k p110 inactivation antagonizes chronic lymphocytic leukemia amp reverses t cell immune suppression']\n",
      "['treatment naive patients']\n",
      "['expert spotlight anthony r mato md msce', 'associate member', 'memorial sloan', 'cancer center', 'chronic lymphocytic leukemia cll program view articles', 'dr mato']\n",
      "['car t cell therapy', 'chronic lymphocytic leukemia leukemia cancer stemcells']\n",
      "['car t cell therapy', 'chronic lymphocytic leukemia leukemia cancer stemcells']\n",
      "['genes prognosis', 'treatment decisions', 'genetics101 replay', 'cll experts dr', 'amp dr jennifer']\n",
      "['nice preview', 'immunotherapy combination trial', 'chronic lymphocytic leukemia']\n",
      "['patient advocacy journalism journalism cll cancer']\n",
      "['human medicine expertise', 'rare disease chronic lymphocytic leukemia', 'didn t']\n",
      "['car t cell therapy', 'chronic lymphocytic leukemia t cell fatigue']\n",
      "['walter styer', 'car t cell therapy patient', 'david porter']\n",
      "['myeloma isn t', 'old person s disease', 'mid life cll']\n",
      "['pi3k p110 inactivation antagonizes chronic lymphocytic leukemia', 'reverses t cell immune suppression james hematology oncology']\n",
      "['chronic lymphocytic leukemia cll market', 'combination therapies', 'chemoimmunotherapy regimens']\n",
      "['u k s', 'national institute', 'care excellence', 'chronic lymphocytic leukemia', 'cost effectiveness estimates']\n",
      "['ash18 cll']\n",
      "['dr jan burger discusses', 'ighv gene mutational status', 'chronic lymphocytic leukemia']\n",
      "['open access ucl research', 'refractory chronic lymphocytic leukemia']\n",
      "['yn mwynhau dysgu', 'addurniadau nadolig fictorianaidd yn y pwll mawr cll']\n",
      "['brain invasion', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['i aki mart n subero', 'eric18 leusm cagenome cancergenetics cancerresearch epigenetics leukemia']\n",
      "['dr john byrd chris dwyer amp lisa minkove r i p', 'new cll heroes awards ceremony', 'recognise individuals', 'cll community magazine']\n",
      "['approves novel b cell receptor bcr kinase inhibitor duvelisib', 'targets phosphoinositide', 'kinase pi3k', 'big ty doc']\n",
      "['ash18 abstract', 'cll tcellrx cartcells turtlelab']\n",
      "['new twitter', 'original circuit']\n",
      "['expert interview', 'cll specialist dr sharman', 'willamette valley cancer institute', 'research center thanks', 'things cll']\n",
      "['een zelfs', 'tegelijk echt pistool letterlijk tegen je hoofd helaas maken toch', 'cll heftiger vanwege', 'jaar nu zo', 'gebleven dus ben', 'angst vergeten maar vraag', 'waarde van', 'diagnose af']\n",
      "['expert session', 'cll specialist dr jeff sharman', 'willamette valley cancer institute', 'research center']\n",
      "['kanti rai', 'cll diagnosis', 'treatment eric18 leusm remission immunotherapy hemonc immunoonc cancertreatment drugtherapies chemotherapy radiotherapy']\n",
      "['director buying', 'fwd p e', 'type stuff']\n",
      "['chronic lymphocytic leukemia', 'cll doesnt']\n",
      "['cll sessions']\n",
      "['pilot study', 'chronic lymphocytic leukemia']\n",
      "['playlist chronic lymphocytic leukemia', 'bruce d cheson md']\n",
      "['playlist chronic lymphocytic leukemia cll mayo clinic']\n",
      "['expert panelists drbrown drburger', 'optimal duration', 'novel agents', 'chronic lymphocytic leukemia']\n",
      "['nordic nanovector', 'usa collaboration', 'present poster', 'alpha therapy', '212pb nnv', 'positive b cell chronic lymphocytic leukemia cll', 'non hodgkin lymphoma nhl biotech rit']\n",
      "['retrospective cohort study', 'commercial claims database', 'treatment trends', 'chronic lymphocytic leukemia leucemia']\n",
      "['therapeutic targets', 'chronic lymphocytic leukemia leukemia signalingpathways sangdun choi review']\n",
      "['aprendan enanos', 'se hace wrestler', 'prowrestler chileanswrestler luchalibre luchalibrechilena elmejorbotazodechile cll xnl ngen pisoton']\n",
      "['mir 125a', 'mir 34a expression predicts richter syndrome', 'chronic lymphocytic leukemia patients']\n",
      "['new new treatment recommendations', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukaemia cll', 'small lymphocytic lymphoma sll', 'similar forms', 'new film', 'dr george', 'consultant haematologist nhs']\n",
      "['fast facts chronic lymphocytic leukemia', 'common type']\n",
      "['leukaemia patients leukemia bloodcancer cll chroniclymphocyticleukaemia']\n",
      "['robin fo md', 'sapienza university', 'rome rome', 'key prognostic markers', 'measurable residual disease']\n",
      "['ibrutinib binds', 't cells', 'vitro treatment', 'ibrutinib enhances markers', 'th1 tc1', 't cells cll']\n",
      "[]\n",
      "['llc series resonant converter box powertips cll']\n",
      "['pilot study', 'chronic lymphocytic leukemia blood journal cll cllsm leusm']\n",
      "['t cells', 'immunotherapy blood journal cll cllsm leusm']\n",
      "['ibrutinib dose blood journal cll cllsm leusm']\n",
      "['top story pi3k p110 inactivation antagonizes chronic lymphocytic leukemia amp reverses t cell immune suppression']\n",
      "['barbara eichhorst', 'soho18 mrdfocus leukemia leusm immunoonc medonc globonc caxtx camoldx ctsm mrdfocus']\n",
      "['cllcancer topics', 'chronic lymphocytic leukemia cll key questions']\n",
      "['therapy combo', 'chronic lymphocytic leukemia']\n",
      "['ash18 insights gt gt gt', 'lymphoma hub', 'official ash18 countdown', 'cll update ash18 lucidquest followthepatient']\n",
      "['dr susan o brien', 'hematologist oncologist', 'california irvine health discusses', 'chimeric antigen receptor car t cell therapy', 'chronic lymphocytic leukemia cll']\n",
      "['official ash18 countdown', 'cll updates', 'lymsm scientificeducationsupport']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['video novel venetoclax combinations', 'eric18 leusm combinationtherapy leukemia biomarkers ctsm cancertreatment mrd remission chemotherapy']\n",
      "['bright amp', 'rainham london', 's liveyourlife conference', 'lymphoma hodgkin nhl', 'cll livingwithandbeyondcancer']\n",
      "['new combinations', 'lenalidomide fludarabine']\n",
      "['phase iii study', 'ibrutinib pci', 'therapy vs', 'standard fludarabine cyclophosphamide', 'rituximab fcr chemoimmunotherapy', 'chronic lymphocytic leukemia cll ash18rf lba tue']\n",
      "['terrific example', 'research science', 'cll wow']\n",
      "['chronic lymphocytic leukemia', 'acute myeloid leukemia']\n",
      "['dr anthony mato discusses prevention', 'chronic lymphocytic leukemia']\n",
      "['tp53 aberrations', 'chronic lymphocytic leukemia overview', 'clinical implications', 'diagnostics haematologica']\n",
      "['complete epigenome', 'cll reveals', 'important areas', 'i aki mart n subero', 'eric18 leusm epigenetics genome genetics camoldx caxtx oncopath globonc medonc drugtargets cancertargets']\n",
      "['good overview']\n",
      "['pilot study', 'chronic lymphocytic leukemia', 'excellent news', 'prospective simon']\n",
      "['pilot study', 'chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukemia cll']\n",
      "['cryptoliveleak online', 'social blog attention mine cll', 'blockchain companies', 'foundations press coverage', 'blockchain cryptocurrency news', 'social influencer event planning']\n",
      "['car t cell therapy', 'car t cell therapy', 'treatment option', 'cll landscape']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['rns aim cll cello health plc']\n",
      "['physical activity', 'increase quality', 'cll patient beatrice', 'practical advice']\n",
      "['framtidsdalen forts tter nu i joki cll joki turku']\n",
      "['canadian evidence', 'line treatment', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['current landscape', 'cll treatment', 'eric18 leusm leukemia medonc hemonc immunoonc immunotherapy']\n",
      "['new booklet', 'cll patients', 'useful advice']\n",
      "['i ve', 'walk round', 'garden worldnurseryrhymeweek roundandround cll']\n",
      "['ash18 insights gt gt gt', 'web mmsm ash18 cll', 'free symplur account', 'access custom influencer', 'tweet transcripts 3x hashtag search results ash18 lucidquest followthepatient']\n",
      "['low blood cell counts', 'chronic lymphocytic leukemia leukemia']\n",
      "['impressive pilot study', 'ibrutinib doses', 'btk saturation inhibition clinical studies', 'non inferiority', 'significant cost savings hpeonc']\n",
      "['cll v 9v', 't cell fitness', 'cellular therapy', 'ex vivo activation', 'ibrutinib blood journal heme leukemia']\n",
      "['video uk', 'cll clinical trials', 'daniel catovsky', 'london eric18 leusm cllsm leukemia ctsm hemeonc medonc caxtx immunoonc globonc supponc cancertreatment clinicaltrials oncopath drugtargets']\n",
      "['dr jennifer', 'high risk patients', 'chronic lymphocytic leukemia']\n",
      "['president trump spat', 'rare form', 'cancer rarecancer cll leukemia']\n",
      "['ibrutinib dose blood journal cll']\n",
      "['ibrutinib dose blood journal cll']\n",
      "['fatigue level correspond', 'patient s cll', 'fatigue leusm']\n",
      "['cryptoliveleak cll gobble']\n",
      "['mir 125a', 'mir 34a expression predicts richter syndrome', 'chronic lymphocytic leukemia patients cll']\n",
      "['human pathology cortactin expression', 'non hodgkin b cell lymphomas', 'new marker', 'differential diagnosis', 'chronic lymphocytic leukemia', 'mantle cell lymphoma']\n",
      "['video cll progress', 'brief history', 'emili montserrat', 'eric18 cllsm leusm leukemia immunoonc ctsm hemonc medonc caxtx']\n",
      "['framtidsdalen unga', 'delaktighet och v lf rd', 'georg henrik wrede cll biocity turku']\n",
      "['rt karolinskainst rt 2017kaw100', 'leukemia wallenberg clinical scholar richard rosenquist brandell', 'new technologies', 'genetic knowledge', 'cancer type chronic lymphocytic leukemia cll kaw100']\n",
      "['leukemia wallenberg clinical scholar richard rosenquist brandell', 'new technologies', 'genetic knowledge', 'cancer type chronic lymphocytic leukemia cll kaw100 cancer leukemia']\n",
      "['cll ibrutinib rituximab shows', 'impressive advantage', 'line rx', 'large rct']\n",
      "['new treatment recommendations', 'chronic lymphocytic leukemia']\n",
      "['video immune exhaustion', 'cll w adrian wiestner', 'eric2018 immunotherapy immunoonc leusm leukemia cllsm ctsm hemonc']\n",
      "['scan results', 'sens csrt sur trak wey sln indv cll scpa vlty dest alm mtph aeg dish']\n",
      "['cll patient caf tools', 'mid life cll diagnosis']\n",
      "['car t cell therapy', 'chronic lymphocytic leukemia cll', 'toxicity profile']\n",
      "['big ideas', 'health award team lyl', 'innovative way', 'support self management', 'lymphoma treatment', 'hodgkin nhl', 'cll livingwithandbeyondcancer']\n",
      "['nice rejects venetoclax rituximab combo', 'line therapy', 'price pa jma']\n",
      "['cll patients', 'watchandwait shares', 's webinar']\n",
      "['cd200 expression', 'cd20 antibody', 'chronic lymphocytic leukemia', 'chronic lymphoproliferative disorders eurekamag']\n",
      "['current treatment options', 'john gribben', 'cancertreatment patientcare bloodcancer']\n",
      "['ash18 insights gt gt gt', 'o jaksic', 'twitter ash18 cll', 'phase iii study', 'ibrutinib pci', 'therapy vs', 'standard fludarabine cyclophos ash18 lucidquest followthepatient']\n",
      "['video cell extrinsic biomarkers', 'cll immunogenetic data', 'andreas agathangelidis', 'eric18 leusm leukemia cllsm ctsm hemonc medonc immunoonc oncopath']\n",
      "['recurrent gly101val mutation', 'bcl2 confers resistance', 'progressive chronic lymphocytic leukemia cll blombery', 'ash18 tue', '15a leusm cllsm']\n",
      "['ash18 cll', 'phase iii study', 'ibrutinib pci', 'therapy vs', 'standard fludarabine cyclophosphamide', 'rituximab fcr chemoimmunotherapy', 'ecog acrin group e1912']\n",
      "['ph3 rct', 'ibrutinib rituximab vs fcr', 'chronic lymphocytic leukemia cll e1912 shanafelt', 'ash18 tue', '15a leusm cllsm eaonc nct02048813']\n",
      "['topic immune dysfunction', 'infection risk', 'chronic lymphocytic leukemia drburger drbrown']\n",
      "['cllr ralph s medicinal cannabis blog', 'leukemia cells', 'cannabinoids work', 'patient uses chemo']\n",
      "['cortactin expression', 'non hodgkin b cell lymphomas', 'new marker', 'differential diagnosis', 'chronic lymphocytic leukemia', 'mantle cell lymphoma lymphoma lymsm']\n",
      "[]\n",
      "['ibrutinib pci', 'therapy vs fcr', 'chronic lymphocytic leukemia cll', 'ecog acrin cancer research group e1912 ash2018 cll']\n",
      "['hematology abstract', 'cll frontline ibrutinib', 'y o', 'leukemia leusm']\n",
      "['ash18 cll', 'patients ibrutinib', 'superior pfs', 'standard cit lba', 'ibrr vs fcr', 'plenary session ibr vs ibrr vs br']\n",
      "['abstract hematology ash18', 'ibrutinib rituximab combination', 'superior pfs amp os', 'non 17p', 'imo cc']\n",
      "['dr jennifer', 'brown addresses', 'chronic lymphocytic leukemia']\n",
      "['ash18 insights gt gt gt', 'milton aranha', 'twitter pratice', '1st line mm', 'cll ash18 myeloma cll ash18 lucidquest followthepatient']\n",
      "['new data', 'frontline cll i ir gt br ir gt fcr ibr gazyva gt clb gazyva ven gazyva gt clb gazyva', 'choices chemoimmunotherapy', 'ibr gazyva gazyva venetoclax', 'markers matter']\n",
      "['interesting results', 'phase iii study', 'ibrutinib rituxumab vs', 'standard fcr', 'ecog acrin cancer research group e1912 ash18 cll']\n",
      "['1st line mm', 'cll ash18 myeloma cll']\n",
      "['llc series resonant converter box powertips cll']\n",
      "['primary endpoint', 'free survival pfs', 'disease progression', 'treatment venetoclax fcr']\n",
      "['didn t', 'ash presentation', 'cll study', 'new data']\n",
      "['nccn pharmacy updates webinar', 'new therapies', 'chronic lymphocytic leukemia']\n",
      "[]\n",
      "['generation medicines', 'duvelisib dr sharman', 'fda approval', 'patients leusm']\n",
      "['video projections', 'realworld evidence', 'cll management', 'robin fo', 'eric18 leusm cancermanagement diseasemanagement globonc survivorship healtheconomics drugcosts heor']\n",
      "['front line therapies', 'chronic lymphocytic leukemia', 'oncology hematology']\n",
      "['ash18 lba', 'phase iii study', 'ibrutinib pci', 'therapy vs', 'standard fludarabine cyclophosphamide', 'rituximab fcr chemoimmunotherapy', 'chronic lymphocytic leukemia cll leusm']\n",
      "['asci member john c byrd', 'tpi3k p110 inactivation antagonizes chronic lymphocytic leukemia', 'reverses t cell immune suppression']\n",
      "['phase iii study', 'ibrutinib pci', 'therapy vs', 'standard fludarabine cyclophosphamide', 'rituximab fcr chemoimmunotherapy', 'chronic lymphocytic leukemia cll', 'ecog acrin']\n",
      "['new support group', 'lymphoma inc cll']\n",
      "['cancer stories cancer cancerawareness cancertreatment chroniclymphocyticleukemia cll tuesdaymotivation tuesdaythoughts']\n",
      "['great work', 'great team research acquisition', 'recurrent gly101val mutation', 'bcl2 confers resistance', 'progressive chronic lymphocytic leukemia ash18']\n",
      "['chronic lymphocytic leukemia treatment', 'resource center leusm tuesdaymotivation']\n",
      "['ibrutinib amp rituximab', 'superior pfs', 'cll age']\n",
      "['phase iii study', 'ibrutinib pci', 'therapy vs', 'standard fludarabine cyclophosphamide', 'rituximab fcr chemoimmunotherapy', 'chronic lymphocytic leukemia cll', 'ecog acrin cancer research']\n",
      "['phase iii study', 'ibrutinib pci', 'therapy vs fcr chemoimmunotherapy', 'chronic lymphocytic leukemia cll', 'ecog acrin cancer research group e1912']\n",
      "['therapeutic target', 'chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukaemia cll', 'new video', 'dr george', 'type bloodcancer']\n",
      "['hematology abstract', 'cll ecog trial', 'frontline therapy']\n",
      "['abstract session', 'ash18 ibrutinib', 'cll patients', 'yr jma']\n",
      "['cll students amp staff local forum', 'great way']\n",
      "['venetoclax resistance', 'ash18 cll']\n",
      "['ash18 cll ash18', 'superior pfs', 'cll age']\n",
      "['cll p3 qlifepro cll pfs']\n",
      "['cll sll', 'chronic cancer', 'new resources']\n",
      "['nursery rhyme number', 'worldnurseryrhymeweek rhymes cll']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['y o male chronic lymphocytic leukemia x', 'new chemo', 'progression icu x', 'respiratory failure amp multisystem organ failure', 'new baseline cap ct caseoftheweek radiology cardsrads']\n",
      "['beigene initiates', 'global head', 'phase iii clinical trial', 'patients w', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['chronic lymphocytic leukemia wtg ut system chancellor bill mcraven']\n",
      "['war hero', 'chronic lymphocytic leukemia', 'political threat']\n",
      "['jci pi3k p110 inactivation antagonizes chronic lymphocytic leukemia', 'reverses t cell immune suppression']\n",
      "['low blood cell counts', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['cll asktheexpert session', 'dr furman']\n",
      "['cll program', 'phoebe needles christmas', 'b sharps', 'christmas holiday cheer']\n",
      "['ut position', 'chronic lymphocytic leukemia']\n",
      "['serious illness pilot study status', 'condition summary malignant neoplasm leukemia lymphocytic chronic b cell lung disease chronic congestive heart failure liver failures chronic renal insuf']\n",
      "['video resistance mechanisms', 'eric18 leusm drugresistance oncopath cagenome', 'genomics bioinformatics hemonc cancerbiology']\n",
      "['update tcellrx', 'ibrutinib tcellrx', 'mrd ibrutinib venetocalx allo', 'ibrutinib venetocalx tcellrx']\n",
      "['adm william h mcraven', 'chronic lymphocytic leukemia', 'bin laden']\n",
      "[]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['pr ximas fechas', 'su campeonabsoluto', 'cll y pr ximo retador n mero', 't tulo', 'noviembre ngen', 'diciembre xnl', 'diciembre cll', 'diciembre ngen']\n",
      "['brief jennifer woyach', 'ibrutinib refractory chronic lymphocytic leukemia']\n",
      "['expert panel discusses', 'chronic lymphocytic leukemia drbrown drburger']\n",
      "['rns aim cll cello health plc']\n",
      "['manageable safety profile', 'date arql ash18 arq531 cll']\n",
      "['promising treatments', 'cll patients', 'nhs cancertreatment patientcare bloodcancer']\n",
      "['lymphoma conference', 'hodgkin nhl non hodgkin']\n",
      "['comprehensive overview', 'tp53 aberrations', 'chronic lymphocytic leukemia']\n",
      "['marc auckland trustee', 'cll leukaemia', 'marc supports', 'charity membership committee', 'conferences cllsa literature cll champions amp supports', 'strategy amp governance team thankyou']\n",
      "['frank mercer trustee', 'complete remission', 'frank s background', 'cllsa treasurer']\n",
      "['chronic lymphocytic leukemia market cll insights epidemiology']\n",
      "['rupert beazley', 'cllsa trustee', 'cll bloodcancer amp nephrotic syndrome', 'remission thankyou rupert', 'strategy amp general business youmadeithappen']\n",
      "['john moore', 'cll bloodcancer', 'john contributes', 'cllsa s', 'amp governance work thankyou john']\n",
      "['david innes', 'chair plays', 'pivotal role', 'advocacy amp policy activities amp', 'cllsa ship', 'br treatment', 'remission thankyou david']\n",
      "['uk charity', 'education support amp advocacy', 'empower people', 'cll leukaemia bloodcancer youmadeithappen rt']\n",
      "['leukaemia patients leukemia bloodcancer cll chroniclymphocyticleukaemia']\n",
      "['cllsa charity members', 'free access', 'frequent regional meetings', 'expert cll consultant speakers', 'support amp', 'wouldn t', 'possible youmadeithappen thankyou mondaymotivation leukaemia']\n",
      "['video cartcell therapy', 'triple combinationtherapy', 'cll w barbara eichhorst', 'soho18 immunotherapy immunoonc leusm ctsm cancerresearch caxtx hemonc medonc cancertreatment cartcells']\n",
      "['hillary clinton fan amp obama backer', 'star admiral', 'texas u', 'chronic lymphocytic leukemia', 'bin laden']\n",
      "['leukaemia patients leukemia bloodcancer cll chroniclymphocyticleukaemia']\n",
      "['chronic lymphocytic leukemia', 'blood cancer']\n",
      "['cool dude', 'cll chronic lymphocytic leukemia', 'couple bucks']\n",
      "['cll combinations', 'parts aristotle']\n",
      "['world nursery rhyme week', 'different nursery rhyme', 'nursery rhyme', 'nursery rhymes', 'class nurseryrhymes cll']\n",
      "['cll patients']\n",
      "['cll expert session', 'dr richard furman']\n",
      "['chronic lymphocytic leukemia']\n",
      "['leukaemia patients leukemia bloodcancer cll chroniclymphocyticleukaemia']\n",
      "['chronic lymphocytic leukemia', 'long term condition', 'new ways']\n",
      "['cd38 expression', 'sudanese patients', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['fda approval', 'significant addition', 'physicians treatment armamentarium', 'unmet need']\n",
      "['florence cymbalista', 'eric18 leusm cancerprognosis camoldx caxtx cagenome leukemia medonc hemonc mrdfocus measurableresidualdisease prognosis']\n",
      "['new treatment recommendations', 'chronic lymphocytic leukemia']\n",
      "['video cll cell dynamics', 'nicholas chiorazzi', 'eric18 leusm lymsm leukemia camoldx cametab cagenome medonc oncopath']\n",
      "['chronic lymphocytic leukema', 'melanoma i', 'effect years', 'seer database', 'personal bibliography recall']\n",
      "['cll treatment advances ssbmt leusm']\n",
      "['eu approval', 'cll ssbmt leusm lymsm']\n",
      "['video eric s', 'paolo ghia', 'eric18 leusm leukemia', 'cagenome camoldx genetics genomics cll']\n",
      "['cll workplaceofchoice thankyoulord tyl', 'palms country club']\n",
      "['low blood cell counts', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia moon shot']\n",
      "['ikaw talaga ang para saakin boxfan salamat po ng marame', 'opssupport workplaceofchoice', 'cll thankyoulord tyl', 'palms country club']\n",
      "['leukaemia patients leukemia bloodcancer cll chroniclymphocyticleukaemia']\n",
      "['dr john allan', 'current treatment landscape', 'refractory cll', 'novel agents', 'ibrutinib idelalisib amp venetoclax']\n",
      "['therapeutic target', 'chronic lymphocytic leukemia cll']\n",
      "['dr o brien discusses', 'oral agents', 'chronic lymphocytic leukemia cll leukemia leusm']\n",
      "['cure media group', 'annual gala', 'chronic lymphocytic leukemia heroes']\n",
      "['cure media group', 'annual gala', 'chronic lymphocytic leukemia heroes magazine']\n",
      "['video regulation', 'cll fda', 'peter hillmen', 'eric18 leusm oncopharm globonc medonc immunoonc hemonc mrdfocus prognosis']\n",
      "['panelists disucss novel therapeutic combinations', 'chronic lymphocytic leukemia cll', 'high risk disease drbrown drburger']\n",
      "['asktheexpert segment', 'patient power community member', 'drug duvelisib', 'cll treatment landscape', 'expert dr sharman']\n",
      "['chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'relative survival rates', 'sex age']\n",
      "['new canadian guidelines', 'front line management', 'dr versha banerji']\n",
      "['gigantic turnip', 'sjsb reading cll parenthub nursery']\n",
      "['senp2 exerts', 'tumor effect', 'chronic lymphocytic leukemia cells', 'nf b', 'pathways lymphoma lymsm']\n",
      "['treatment options', 'chronic lymphocytic leukemia cll']\n",
      "['current eric research', 'cll genomics field', 'eric18 leusm leukemia cagenome camoldx hemonc globonc medonc biomarkers']\n",
      "['leukaemia patients leukemia bloodcancer cll chroniclymphocyticleukaemia']\n",
      "['marwan ghosn', 'chronic lymphocytic leukemia', 'treatment paradigm opl26']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['chronic lymphocytic leukemia', 'paradigms november issue leukemia oncology']\n",
      "['ceo amp founder dr ayg n sahin', 'cart cells', 'boston chapter', 'national chronic lymphoblastic leukemia cll support group', 'car t research expert', 'cll patients']\n",
      "['dr paolo strati', 'asco s', 'young investigator award describe', 'chronic lymphocytic leukemia clinical trials underway thursdaythoughts leusm']\n",
      "['dr john hayslip', 'fellow physicians', 'chronic lymphocytic leukemia']\n",
      "['cll algorithm', 'prognostic markers']\n",
      "['safe treatment', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'mantle cell lymphoma', 'clinical trials']\n",
      "['video duo results duvelisib', 'ofatumumab monotherapy', 'r r cll', 'stephan stilgenbauer', 'ulm eric18 leusm ctsm medonc camoldx trialupdate leukemia hemonc immunoonc immunotherapy clinicaltrials']\n",
      "['sales training', 'hematology sales reps', 'dr rick furman', 'cll monday']\n",
      "['dr anthony mato', 'clinical study', 'novel agents', 'chronic lymphocytic leukemia']\n",
      "['hematology ash18 badges', 'lymphoma amp cll research']\n",
      "['video prognostic markers', 'robin fo', 'eric18 leusm cytogenetics cagenome prognosis medonc camoldx globonc mrdfocus']\n",
      "['patient population', 'chroniclymphocyticleukaemia cll', 'waldenstr mmacroglobulinemia patients', 'healthcare pharmaceutical industry']\n",
      "['low blood cell counts', 'chronic lymphocytic leukemia']\n",
      "['ibrutinib refractory chronic lymphocytic leukemia ash clinical news']\n",
      "['review article']\n",
      "['chronic lymphocytic leukemia occurs', 'apoptotic factor bcl', 'xenograft models', 'effective drug treatment strategies', 'a20 cell line', 'lymphoma model']\n",
      "['scan results', 'lahl irv venn sis deb casp gcm cll sia sou boxe iqe srei mais caml town']\n",
      "['new treatment', 'low blood cell counts', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cells', 'p53 degradation chronic lymphocytic leukemia cll']\n",
      "['evening s decodingcancer talk', 'cll patients', 'clinicalresearch scienceweek']\n",
      "['math school classroomlearninglab cll']\n",
      "['muscular atrophy', 'parkinson s', 'chronic lymphocytic leukemia', 'von hippel lindau syndrome']\n",
      "['retrospective cohort study', 'commercial claims database', 'treatment trends', 'chronic lymphocytic leukemia']\n",
      "['muscular atrophy', 'parkinson s', 'chronic lymphocytic leukemia', 'von hippel lindau syndrome']\n",
      "['recent patient cafe', 'chronic lymphocytic leukemia cll patients', 'mid life diagnosis', 'professional life']\n",
      "['video european research initiative', 'cll eric', 'international meetings', 'kostas stamatopoulos', 'eric18 leusm leukemia medonc hemonc collaboration']\n",
      "['chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'general population', 'melanoma sunaware']\n",
      "['chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'general population', 'melanoma sunaware']\n",
      "['experts drbrown drburger address', 'novel agents versus chemoimmunotherapy', 'front line setting']\n",
      "['chronic lymphocytic leukemia cll view', 'video isporbarcelona']\n",
      "['chroniclymphocyticleukemia therapeutics market segmentation', 'key players f hoffmann', 'roche ltd novartisinternational ag glaxosmithkline teva']\n",
      "['time trends', 'frontline systemic therapy utilization', 'chronic lymphocytic leukemia', 'states cancer isporbarcelona']\n",
      "['video treatment', 'cll btk bcl', 'cd20 amp cartcells', 'kanti rai', 'eric18 leusm oncopharm medonc hemonc leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "[]\n",
      "['genetics webinar', 's s dr jennifer', 'brown amp register']\n",
      "['tcellrx lymsm cll']\n",
      "['chronic lymphocytic leukemia', 'phase iii trial studies']\n",
      "['terry needs', 'cll chronic lymphocytic leukemia terry strawn']\n",
      "['dr jennifer woyach s strategy', 'manage patients']\n",
      "['new video dr paolo strati', 'asco s', 'young investigator award', 'chronic lymphocytic leukemia clinical trials underway', 'leusm tuesdaymotivation']\n",
      "['leukaemia patients leukemia bloodcancer cll chroniclymphocyticleukaemia']\n",
      "['dr jan burger', 'cellular therapies', 'chronic lymphocytic leukemia']\n",
      "['parallel session', 'ann hewitson uk amp nikolaos trasanidis ann s', 'social influences', 'cll survival', 'new target', 'myeloma treatments bloodwiseghd18']\n",
      "['afternoon lymphoma session', 'prof tatjana stankovic', 'dna damage response', 'synthetic lethality bloodwiseghd18 uk']\n",
      "['chronic lymphocytic leukemia']\n",
      "['november issue', 'chronic lymphocytic leukemia', 'recent updates', 'field luekemia cll chroniclymphocyticleukemia']\n",
      "['cll patients', 'valuable advice', 'others navigate', 'own journey', 'spiritual strength']\n",
      "['cll increase w', 'hope w cancermoonshot']\n",
      "['refractory chronic lymphocytic leukemia', 'phase iiib green study haematologica']\n",
      "['osteolytic bone lesions', 'major symptoms', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma patient', 'rare case lymphoma lymsm']\n",
      "['cellular therapies', 'emili montserrat', 'eric18 cllsm leusm leukemia immunoonc ctsm hemonc medonc caxtx biomarkers camoldx']\n",
      "['hearing updates', 'phd students', 'future generation', 'blood cancer researchers', 'yohannes gebreselassie', 'new cancer pathways', 'cll bloodwiseghd18']\n",
      "['measurable success', 'crucial issues', 'cll patients', 'relentless commitment']\n",
      "['average age', 'cll diagnosis', 'people age', 'offering hope endcancer']\n",
      "['new way', 'chronic lymphocytic leukemia']\n",
      "['dr richard furman shares potential ways', 'treatment cc']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['current treatment landscape', 'refractory chronic lymphocytic leukemia leusm hematology']\n",
      "['ash18 insights gt gt gt', 'ritux trial', '17p del pts', 'non 17p del subgroup mut igvh subgrps cll ash18 ash18 lucidquest followthepatient']\n",
      "['cd84 regulates pd', 'pd l1 expression', 'chronic lymphocytic leukemia hematology oncology immunotherapy']\n",
      "['bloodcancer research drop', 'present cll leukemia']\n",
      "['chronic lymphocytic leukemia', 'atypical morphology', 'monocytes hemepath']\n",
      "['arnon p kater', 'refractory cll', 'murano trial']\n",
      "['new toxicities', 'daniel catovsky', 'london eric18 leusm cllsm leukemia ctsm hemonc medonc caxtx immunoonc oncopath']\n",
      "['time i', 'i wasn t', 'infusions amp', 'high dose steroid', 's experience']\n",
      "['dr jennifer', 'resonate study']\n",
      "['rns aim cll cello health plc directorate']\n",
      "['cll biology', 'brazilian hematologists vhebron pau']\n",
      "['chemokine receptor', 'chronic lymphocytic leukemia']\n",
      "['dr furman', 'chronic lymphocytic leukemia', 'luekemia leusm chemo2018']\n",
      "['new treatment recommendations', 'chronic lymphocytic leukemia']\n",
      "[]\n",
      "['therapy combo', 'chronic lymphocytic leukemia']\n",
      "['hoy cll chileluchalibre presenta segunda semifinal se orluchalibre', 'iwc luchalibrechilena nagero5taregi n pepex']\n",
      "['hoy cll chileluchalibre presenta segunda semifinal se orluchalibre', 'iwc luchalibrechilena nagero5taregi n pepex']\n",
      "['hoy cll chileluchalibre presenta segunda semifinal se orluchalibre', 'iwc luchalibrechilena nagero5taregi n pepex']\n",
      "['new diffuser', 'bird sounds', 'i m', 'guard amp frankincense', 'gnocchi s chronic lymphocytic leukemia gnocchi']\n",
      "['article panelists', 'chronic lymphocytic leukemia prognostic markers', 'novel treatment era drbrown drburger']\n",
      "['safecancertx download chapters', 'chronic lymphocytic leukemia', 'non hodgkin lymphomas', 'bethesda handbook', 'clinical hematology']\n",
      "['download chapters', 'chronic lymphocytic leukemia', 'non hodgkin lymphomas', 'bethesda handbook', 'clinical hematology']\n",
      "['video cell intrinsic biomarkers', 'blanca espinet', 'eric18 leusm leukemia cllsm ctsm hemonc medonc caxtx immunoonc oncopath karyotype']\n",
      "['croatian lacrosse league finals zagreb patriots', 'season congratulations crolax cll croatianlacrosse growthegame lax laxlife lacrosse']\n",
      "['modern medicine i suffer', 'hemiplegic migraines', 'chronic lymphocytic leukemia', 'clinical depression']\n",
      "['download chapters', 'chronic lymphocytic leukemia', 'non hodgkin lymphomas', 'bethesda handbook', 'clinical hematology']\n",
      "['nice paper', 'richter syndrome', 'george calin']\n",
      "['therapy combo', 'chronic lymphocytic leukemia']\n",
      "['download chapters', 'chronic lymphocytic leukemia', 'non hodgkin lymphomas', 'bethesda handbook', 'clinical hematology', 'new resource center lymsm']\n",
      "['liveyourlife london', 'hodgkin nhl cll', 'free thanks', 'amp lunch refreshments']\n",
      "['chronic lymphocytic leukemia idelalisib']\n",
      "['lymphoma cll sll']\n",
      "['cll creates psychological stress', 'recent talk']\n",
      "['predictive markers', 'alessandra tedeschi', 'onco eric18 cllsm leusm ctsm leukemia biomarkers hemonc medonc caxtx immunoonc']\n",
      "['presentation cll patients', 'emotional sphycological trauma']\n",
      "['chronic lymphocytic leukemia', 'acute myeloid leukemia', 'patients cases', 'concomitant presence', 'different malignant clones authors mehmet yilmaz', 'details contact']\n",
      "['bloodcancer patients', 'car t']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['chemo experience', 'resources lymphoma cll afterchemo']\n",
      "['f physician endcancer cll']\n",
      "['louise o driscoll senior clinical psychologist', 'excellent presentation amp', 'recent evening', 'psychological support', 'cll community']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['cll epigenome', 'elias campo', 'eric18 leusm cllsm genomics cagenome epigenomics oncopath epigenetics hemeonc genetics genome camoldx']\n",
      "['european commission ec', 'venetoclax venclyxto', 'refractory chronic lymphocytic leukemia r r cll']\n",
      "['physical activity', 'increase quality', 'cll patient beatrice', 'practical advice']\n",
      "['therapy combo', 'chronic lymphocytic leukemia']\n",
      "['launch delay', 'btkinhibitor competitor zanubrutinib', 'h2h trial', 'registrational trial', 'cll oncology']\n",
      "['scientific questions', 'significant amp warrant stakeholders', 'cddfworkshop mrd multistakeholders aml cll collaborationiskey joiningforces']\n",
      "['video thoughts', 'daniel catovsky', 'london eric18 cllsm leusm ctsm hemeonc medonc caxtx cancertreatment', 'prognostic hemonc']\n",
      "['cll ipi', 'refractory chronic lymphocytic leukemia', 'idelalisib phase', 'trials lymphoma lymsm']\n",
      "['multi stakeholder discussions', 'mrd progress', 'cll cddfworkshop']\n",
      "['cll vs maxluchalibre']\n",
      "['dc area residents', 'support group', 'chronic lymphocytic leukemia cll', 'saturday november 17th', 'cll doctor s visit discussion tool']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['survival times', 'chronic lymphocytic leukemia', 'past decade thanks', 'novel agents', 'leusm leukemia bloodcancer']\n",
      "['cancer patients amp', 'cll amp bloodcancer patients', 'treatment options', 'consultatant haematologist']\n",
      "['surveiller ce soir au t l journal qu bec', '18h cll nettoyage campusvert']\n",
      "['polite honesty cll']\n",
      "['cll patients wonder', 'global research foundation', 'pm ct', 'hour webinar w experts leusm']\n",
      "['dr dina el sharkawi', 'royal marsden highlights immune', 'cll patients', 's london conference', 'approproate mmunisation strategies', 'response amp']\n",
      "['key insights', 'chronic lymphocytic leukemia', 'lymphoma amp myeloma']\n",
      "['video cellulartherapies', 'cartcells jennifer', 'eric18 cllsm leusm hemeonc medonc immunoonc caxtx bmtsm hemonc']\n",
      "['voice questions', 'dr richard furman', 'asktheexpert session']\n",
      "['aml amp cll', 'multistakeholder discussions', 'current status amp']\n",
      "['year cddfworkshop', 'mrd aml cll', 'london uk eventmanagement healthcare multistakeholder meetings workshops collaborationiskey']\n",
      "['joe park addresses experience', 'cart cells', 'amp cll', 'carts intl symposiumin madrid jma pa']\n",
      "['cll pathogenesis', 'silvia deaglio', 'eric18 oncopath immunoonc hemeonc medonc genetics genomics cllsm leusm cagenome caenv caxtx globonc camoldx lymphoma diseasepathways']\n",
      "['support information', 'cll bloodcancer patients', 'carers members confernce']\n",
      "['les syndicats snu cgt cftc fo snap cll sud unsa cfdt', 'emploi occitanie invitent les salari s cette apr s midi', '14h 17h foix nimes st c saire', 'perpignan san vicens des r unions d information', 'gr ve emploi du']\n",
      "['clinicaltrial evaluation', 'refractory chronic lymphocytic leukemia', 'p53 dysfunction']\n",
      "['zanubrutinib bgb', 'versus ibrutinib', 'refractory chronic lymphocytic leukemia']\n",
      "['great discussion', 'george canellos']\n",
      "['key insights', 'chronic lymphocytic leukemia', 'lymphoma amp myeloma']\n",
      "['beigene announces', 'global head', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['refractory chronic lymphocytic leukemia', 'p53 dysfunction status', 'condition summary', 'refractory chronic lymphocytic leu']\n",
      "['zanubrutinib bgb', 'versus ibrutinib', 'refractory chronic lymphocytic leukemia status', 'condition summary chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['glyphosate roundup', 'non hodgkin s lymphoma chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma anaplastic', 'large cell lymphoma angioimmunoblastic lymphoma blastic nk cell lymphoma burkitt s lymphoma']\n",
      "['international meeting', 'cll field', 'emili montserrat', 'eric18 leusm cllsm lymphoma ctsm globonc immunoonc hemeonc medonc caxtx supponc clinicaltrials oncopath']\n",
      "['tuesday s cll genetics', 'webinar don t', 'experts dr william wierda', 'dr jennifer']\n",
      "['beigene initiates', 'global head', 'clinical trial']\n",
      "['leukaemia patients leukemia bloodcancer cll chroniclymphocyticleukaemia']\n",
      "['bgne initiates phase', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['bgne initiates', 'global head', 'clinical trial', 'r r chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['video bispecific antibody response', 'adrian wiestner', 'eric18 lymsm cllsm antibodies hemeonc immunoonc medonc caxtx cancertreatment oncopath drugtargets immunology']\n",
      "['chronic lymphocytic leukemia cll hypogammaglobulinemia']\n",
      "['melanoma surveillance', 'chronic lymphocytic leukemia']\n",
      "['melanoma surveillance', 'chronic lymphocytic leukemia']\n",
      "['melanoma surveillance', 'chronic lymphocytic leukemia']\n",
      "['year s hematology conference', 'poster presentations', 'authors dr versha banerji', 'cll biology', 'dr ryan zarychanski', 'palooza trainee sessions']\n",
      "['yorkshire liveyourlife lymphoma health amp', 'nhl hodgkin amp cll', 'free thanks', 'book online']\n",
      "['cll treatment mrd', 'therapy alessandra tedeschi', 'onco discusses', 'eric18 drugtherapy leusm cllsm ctsm personalizedmedicine targetedtherapy cancertreatment leukemia caxtx hemeonc medonc']\n",
      "['phase 1b study', 'obinutuzumab ibrutinib', 'refractory chronic lymphocytic leukemia oct', 'cllsm leusm']\n",
      "['years dr pinilla ibarz', 'chronic lymphocytic leukemia leusm leukemia']\n",
      "['great news', 'chronic lymphocytic leukaemia', 'mabthera combination', 'cll roche abbvie']\n",
      "['ash18 insights gt gt gt', 'twitter video uk', 'cll trials', 'peter hillmen', 'ash18 lucidquest followthepatient']\n",
      "['leukaemia patients leukemia bloodcancer cll chroniclymphocyticleukaemia']\n",
      "['cll cll']\n",
      "['video uk', 'cll trials', 'peter hillmen', 'eric18 ctsm leusm lymsm hemeonc medonc immunoonc caxtx radonc globonc supponc cancertreatment clinicaltrials ctsm oncopath drugtargets']\n",
      "['lih phd candidate marina wierz', 'promising research work', 'tumour microenvironment', 'new immunotherapy approach', 'chronic lymphocytic leukemia', 'international workshop', 'german cll study group cancerresearch leukemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['ibrutinib refractory chronic lymphocytic leukemia']\n",
      "['s dr clive zent', 'recent study', 'cll patients', 'population 3000researchers']\n",
      "['skincancer surveillance', 'chronic lymphocytic leukemia']\n",
      "['scan results', 'retracement bearish', 'sys1 bry tgp fjet re b tcn vcp gmaa sce sls dotd pgit amo swg vtu cll']\n",
      "['long term data', 'phase iii helios trial', 'survival outcomes', 'cll patients cancer']\n",
      "['dr catherine wu s lab', 'variable chain plasmid library', 'tumor neoantigens system', 'candidate epitopes', 'cll patients llsscholar']\n",
      "['video venetoclax antibody combinations', 'stephan stilgenbauer', 'ulm eric18 immunoonc hemeonc leusm ctsm globonc medonc drugtherapy cancertreatment caxtx oncopharm antibodytherapy']\n",
      "['expression system', 't cell receptor specificity', 'functional avidity', 'neoantigens tumor neoantigens immunotherapy neoantigen prediction cll melanoma']\n",
      "['cll cello health promotes non exec director chris jones', 'long time chairman steps', 'uk cll brighterir andrewscotttv capitalnetwork1']\n",
      "['rns aim cll cello health plc directorate']\n",
      "['dr flinn', 'dr danilov', 'refractory cll sll', 'panel discussion']\n",
      "['mitochondrial apoptosis', 'alkoxy phenyl', 'propanone derivatives', 'cll congrats', 'brunati s lab mitochondria apoptosis cll pp2a unipd']\n",
      "['video microenvironmental interactions', 'silvia deaglio', 'eric18 leusm medonc immunoonc hemeonc immunology camicroenv cactc oncopath globonc hsronc']\n",
      "['abbvie annonce l autorisation europ enne', 'l association venetoclax venclexta venclyxto abbvie roche', 'rituximab mabthera roche dans', 'leuc mie lympho', 'rechute ou r fractaire tude murano']\n",
      "['nice job team mutations', 'ras braf mapk erk pathway', 'specific subgroup', 'adverse clinical', 'new therapeutic options', 'chronic lymphocytic leukemia']\n",
      "['bioeurope derivates', 'cll leukemia']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['rachet cancer questions cll']\n",
      "['ella lo', 'hecho todo mucho antes que lo varone gt standards m sicadelatarde cll']\n",
      "['priority review', 'leukemia leusm cll']\n",
      "['i aki mart n subero', 'eric18 leusm lymsm epigenetics genome genetics camoldx caxtx oncopath globonc cagenome cametab medonc drugtargets cancertargets']\n",
      "['western dietary pattern', 'chronic lymphocytic leukemia', 'mcc spain study', 'esp cat']\n",
      "['video sequential therapy', 'stephan stilgenbauer', 'ulm eric18 leusm immunoonc medonc hemeonc cartcell bcl2 resistance oncopharm clinicaltrials ctsm']\n",
      "['video pre leukemic state', 'cll show', 'similar genomic landscapes', 'andreas agathangelidis', 'eric18 genetics leusm genomics cagenome hemeonc hemonc medonc leukemia mutations']\n",
      "['treatment na ve high risk chronic lymphocytic leukemia cll dr nitin jain amp dr bill wierda leusm']\n",
      "['ventoclax rituximab', 'refractory chronic lymphocytic leukemia r r cll']\n",
      "['cll treatment algorithm']\n",
      "['clarity study flair trial amp unity', 'new agents', 'venetoclax ibrutinib ublituximab', 'cll cc']\n",
      "['study assesses', 'chronic lymphocytic leukemia', 'past decade']\n",
      "['chronic lymphocytic leukemia', 'doctor s visit']\n",
      "['roche abbvie s chemo', 'free cll treatment combo pharma']\n",
      "['acronym mrd minimal residual disease', 'chronic lymphocytic leukemia cll']\n",
      "['practical manage', 'dr andrew davis']\n",
      "['abbvie roche regimen', 'gazyva hits', 'pharma companies']\n",
      "['venetoclax rituximab combo', 'cll oncology']\n",
      "['obinutuzumab improves pfs', 'frontline cll oncology']\n",
      "['new treatment recommendations', 'chronic lymphocytic leukemia']\n",
      "['line cll treatment']\n",
      "['europeancommission approves venetoclax', 'rituximab venclyxto cll']\n",
      "['chronic lymphocytic leukemia cll', 'substantial changes', 'personalize therapy', 'new agents', 'clinical benefit']\n",
      "['new studies', 'abramson cancer center', 'chronic lymphocytic leukemia cll', 'chimeric antigen receptor car t cell therapy']\n",
      "['cll genetics webinar', 'genetic mutations', 'w cll', 'care amp treatment plan amp']\n",
      "['multistakeholder discussions', 'aml amp cll registration', 'registration onsite cddfworkshop ema guidelines forum discussion academics regulators industry regulation']\n",
      "['cll sector heats', 'abbvie roche upbeat', 'line venetoclax combo', 'positive top line data', 'abbvie genentech s venetoclax combination', 'line chronic lymphocytic leukemia therapy heralds stiffer competition']\n",
      "['new combination treatment', 'refractory chronic lymphocytic leukemia cll']\n",
      "['uk clarity trial ven ibr', 'r r cll', 'mrd negativity', 'undetectable mrd mrd4', 'bm combination', 'flair trial', 'line setting ash18 cll']\n",
      "['news eu', 'cll patients', 'refractory cll', 'eu member states']\n",
      "['plenary pfs advantage', 'ibr vs br 1st line', 'gt 65y median 71y', 'ritux trial', '17p del pts', 'non 17p del subgroup mut igvh subgrps cll ash18']\n",
      "['cll trials guess', 'complex ck', 'bad thing ven cll ash18']\n",
      "['phase iii study', 'combination treatment', 'chronic lymphocytic leukemia', 'primary endpoint']\n",
      "['venetoclax obinutuzumab combo', 'comorbidities es jma pa pethema']\n",
      "['line cll treatment']\n",
      "['chronic lymphocytic leukemia combination therapy fair number', 'hematologic amp non hematologic', 'adverse effects']\n",
      "['icymi duvelisib monotherapy', 'overall response rates', 'ofatumumab monotherapy', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll']\n",
      "['blockbuster mountain roche abbvie team heralds', 'frontline cll phiii']\n",
      "['phase iii data', 'chronic lymphocytic leukemia', 'co morbidities']\n",
      "['abbvie roche regimen', 'gazyva hits', 'cll fiercepharma']\n",
      "['top tips wise', 'cll patients']\n",
      "['scan results bullish', 'ubi arb gri jpj vcp aaz fres fort cll halo']\n",
      "['kahl highlights frontline considerations', 'cll landscape oncology']\n",
      "['ash18 cll tcellrx']\n",
      "['hemo2018 cll', 'date john allan risk', 'frontline ibrutinib', 'complex karyotype tp53']\n",
      "['obinutuzumab venetoclax combination', 'treatment naive chronic lymphocytic leukemia']\n",
      "['cll ash18 tril']\n",
      "['phase iii study', 'combination treatment', 'chronic lymphocytic leukemia', 'primary endpoint']\n",
      "['roche combo drug', 'main goal', 'late stage study', 'chronic lymphocytic leukemia medicine pharma biotech']\n",
      "['u s', 'chronic lymphocytic leukemia', 'year roche', 'abbvie plan', 'phase iii data', 'combination treatment', 'good outcomes']\n",
      "['real world', 'treatment patterns', 'chronic lymphocytic leukemia', 'seer patterns', 'care analysis cll leusm']\n",
      "['ema approves treatment', 'chronic lymphocytic leukemia', 'previous therapy']\n",
      "['ema approves treatment', 'chronic lymphocytic leukemia', 'previous therapy']\n",
      "['european commission approval', 'venclyxto venetoclax']\n",
      "['combo therapy', 'cll delays disease progression']\n",
      "['roche announces phase iii study', 'chronic lymphocytic leukemia', 'primary endpoint rog rhhby']\n",
      "['roche announces phase iii study', 'chronic lymphocytic leukemia', 'primary endpoint rog rhhby']\n",
      "['treatment naive chronic lymphocytic leukemia']\n",
      "['ph3 clinicaltrial vs cll venetoclax obinutuzumab', 'chlorambucil obinutuzumab', 'superior progression', 'free survival w', 'new safety signals oncology cancer leukemia']\n",
      "['phase iii data', 'chronic lymphocyticleukemia', 'co morbidities rog']\n",
      "['abbvie announces', 'positive results', 'phase iii trial', 'venetoclax combination', 'line therapy', 'chronic lymphocyticleukemia abbv']\n",
      "['line cll treatment']\n",
      "['clinical abstracts', 'new data', 'refractory peripheral t cell lymphoma prognostic', 'investigational therapy', 'cll ptcl']\n",
      "['phase iii data', 'chronic lymphocytic leukemia', 'co morbidities']\n",
      "['improvement immuniz', 'pts w monoclonal b cell lymphocytosis', 'cll whitaker', 'leusm cllsm idonc']\n",
      "['hsmn abbvie', 'european commission approval', 'venclyxto r venetoclax', 'chronic lymphocytic leukemia']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['diagnosis prognosis', 'treatment options', 'cll patient catherine walk', 'healthcare providers', 'available leusm']\n",
      "['roche announces eu approval', 'chronic lymphocytic leukemia']\n",
      "['ibrutinib gazyva combo', 'cll sll', 'fda priority review', 'free combination', 'cd20 antibody', 'line treatment', 'cll sll']\n",
      "['new combination treatment', 'refractory chronic lymphocytic leukemia cll']\n",
      "['dna damage', 'dna damage response', 'monoclonal b cell lymphocytosis', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['cmscript focuses', 'chronic lymphocytic leukemia cll', 'common type', 'illness cmscares4u cmscript pmbs']\n",
      "['multistakeholder discussions', 'aml amp cll registration', 'registration onsite cddfworkshop ema guidelines forum discussion academics regulators industry regulation']\n",
      "['haematological malignancies', 'western lifestyle', 'chronic lymphocytic leukemia', 'commonest leukemia']\n",
      "['european commission approval', 'venclyxto venetoclax', 'chronic lymphocytic leukemia']\n",
      "['refractory chronic lymphocytic leukemia', 'phase iiib green study']\n",
      "['fda approval', 'chronic lymphocytic leukemia', 'future treatment landscape leusm']\n",
      "['european commission approval', 'venclyxto venetoclax']\n",
      "['ami solutions news abbvie', 'european commission approval', 'venclyxto venetoclax']\n",
      "['european commission approval', 'venclyxto venetoclax', 'chronic lymphocytic leukemia']\n",
      "['european commission approval', 'venclyxto venetoclax', 'chronic lymphocytic leukemia', 'therapy realestate cre']\n",
      "['european commission approval', 'venclyxto venetoclax', 'chronic lymphocytic leukemia', 'therapy breakingnews']\n",
      "['european commission approval', 'venclyxto venetoclax', 'chronic lymphocytic leukemia']\n",
      "['abbvie announces', 'positive results', 'venetoclax combination']\n",
      "['phase iii data']\n",
      "['tgtx phase iii data', 'chronic lymphocytic leukemia', 'co morbidities']\n",
      "['successful treatment', 'cll years', 'need treatment', 'i share', 'blog leusm']\n",
      "['scan results hammer candlestick', 'cll qxt mtw gfin ukw rdsb aor thrl fres hnr lbow sln augm mnzs matd macf']\n",
      "['clinical trial', 'chronic lymphocytic leukemia cll']\n",
      "['french startup', 'lead candidate', 'dna cancer vaccine', 'chronic lymphocytic leukemia oncology']\n",
      "['phase iii data']\n",
      "['roche genentech phase iii data', 'chronic lymphocytic leukemia', 'co morbidities']\n",
      "['phase iii study', 'medicine combo', 'positive results']\n",
      "['abbv abbvie announces', 'positive results', 'venetoclax combination', 'line therapy', 'chronic lymphocytic leukemia']\n",
      "['cll patients', 'valuable advice', 'others navigate', 'own journey', 'spiritual strength']\n",
      "['chronic lymphocytic leukemia patients', 'lpl promotor display', 'treatment epigenomics']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['cd39 expression', 'cd4 t lymphocytes', '6q deletion', 'chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukemia', 'proliferation centers', 'bone marrow', 'initial presentation', 'complex karyotype', 'tp53 disruption']\n",
      "['rns aim cll cello health plc director pdmr']\n",
      "['genetic switches', 'melanoma cell survival melanoma lymphoma venetoclax cll', 'leukemia navitoclax']\n",
      "['chronic lymphocytic leukemia', 'substantial changes', 'personalize therapy', 'new agents', 'clinical benefit']\n",
      "['chronic lymphocytic leukemia combination therapy fair number', 'hematologic amp non hematologic', 'adverse effects']\n",
      "['low blood cell counts', 'chronic lymphocytic leukemia']\n",
      "['study confirms', 'inhibitory action', 'dynamic adaptability', 'chronic lymphocytic leukemia cells', 'precision monotherapy precisionmedicine']\n",
      "['time i', 'i wasn t', 'infusions amp', 'high dose steroid', 's experience']\n",
      "['cll cll']\n",
      "['que eric significa iniciativa europea para', 'investigaci n', 'llc y que su sede est', 'bcn ent rate', 'sus actividades y proyectos', 'es cll sll']\n",
      "['cll patient mark amp carepartner nelia', 'healthy relationship making treatment decisions']\n",
      "['mayo clinic cll patient seminar', 'cll patientexperience ss']\n",
      "['multistakeholder discussions', 'aml amp cll registration', 'registration onsite cddfworkshop ema guidelines forum discussion academics regulators industry regulation']\n",
      "['excellent ronnie s blood counts', 'doesn t', 'time cll feelinggood']\n",
      "['law kay', 'chronic lymphocytic leukemia', 'rough time', 'leukemia fundraiser']\n",
      "['chronic lymphocytic leukemia']\n",
      "['cll question', 'sure register', 'expert session', 'dr richard furman']\n",
      "['current treatment options', 'john gribben', 'ebmt17 hematology leusm immunotherapy chemotherapy cancertreatment catx immunoonc noveldrugs bonemarrow hemeonc stemcelltransplant transplant']\n",
      "['new treatment recommendations', 'chronic lymphocytic leukemia leukemia']\n",
      "['adverse events', 'idelalisib treatment', 'chronic lymphocytic leukemia', 'follicular lymphoma', 'multidisciplinary position paper cuneo', 'barosi g danesi r', 'hematological oncology']\n",
      "['dr kanti rai', 'medicine mentor cll']\n",
      "['ibrutinib therapy releases leukemic surface igm', 'antigen drive', 'chronic lymphocytic leukemia patients']\n",
      "['stage cll amp lymphoma']\n",
      "['wonderful weekend', 'i m', 'great plan', 'action moffitt cancer']\n",
      "['l ve', 'millions d euros', 'acc l rer', 'phase ii', 'recherche clinique', 'son vaccin anticanc reux invac', 'phase ii', 'cours au houston usa dans', 'leuc mie lympho', 'chronique llc cll']\n",
      "['chronic lymphocytic leukemia treatment', 'new video', 'dr paolo strati', 'texas md anderson cancer center leusm cancertreatment']\n",
      "['chemo experience', 'resources lymphoma cll afterchemo']\n",
      "['current treatment landscape', 'refractory chronic lymphocytic leukemia leusm hematology']\n",
      "['polite honesty cll']\n",
      "['splice variants', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'lymphoma lymsm']\n",
      "['cml patients', 'patients amp pts families']\n",
      "['happy birthday', 'cll classylookinglovers']\n",
      "['malek s eds chronic lymphocytic leukemia methods', 'molecular biology', 'gene disruption', 'crispr cas9 technology hu n malek sn crispr cas9', 'gene dropout screens wu k malek s n']\n",
      "['rachet cancer questions cll']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['chronic lymphocytic leukemia lt', 'important study', 'melanoma leukemia']\n",
      "['prestigious eu grants', 'unravel cll']\n",
      "['important prognostic markers', 'amp check', 'disease progression amp', 'different treatment options']\n",
      "['behavioral insensitivity', 'tgf beta', 'chronic lymphocytic leukemia']\n",
      "['lymphoma cll sll']\n",
      "['old daughter', 'colors i', 'bloodstream cll']\n",
      "['prof patrick thornton discusses cll genetic markers clinicalresearch ie']\n",
      "['cart cell', 'cancer cll', 'remission leukaemia']\n",
      "['chronic lymphocytic leukemia', 'ph balance', 'nutritional therapy']\n",
      "['chronic lymphocytic leukemia']\n",
      "['final day', 'clinical decision making', 'patientcare stay', 'immunogenetics cllsm leusm cll']\n",
      "['direct pulmonary infiltrates', 'initial manifestation', 'chronic lymphocytic leukemia']\n",
      "['blanca espinet florence cymbalista alessandra tedeschi onco amp', 'founder emili montserrat', 'expert s insights', 'international cll meeting eric18 cllsm leusm hemonc']\n",
      "['mutation tests', 'helpful information', 'cll diagnosis', 's dr paul barr', 'approach hematology 3000researchers roc ashmhm18']\n",
      "['kahl highlights frontline considerations', 'cll landscape oncology']\n",
      "['cll paradigm', 'novel agents oncology']\n",
      "['venetoclax venclexta', 'chronic lymphocytic leukemia']\n",
      "['prestigious eu grants', 'unravel cll chronic lymphocytic leukemia scienmag']\n",
      "['tait shanafelt md', 'young investigtor', 'great talk', 'cll monoclonal b cell lymphocytes']\n",
      "['isabel barbosa speaks', 'clinicaltrial patients need', 'transparent information', 'research patients']\n",
      "['isabel barbosa', 'associacao portuguesa', 'leucemias e linfomas apll', 'cll meeting', 'lisbon patients']\n",
      "[]\n",
      "['nice issues', 'abbvie s venclyxto', 'chronic lymphocytic leukaemia leukemia abbvie pharma cancer']\n",
      "['brexit physicians regulators ju news', 'leukemia mds lymphoma myeloma cll amp', 'neoplasia don t deserve', 'hematology europe']\n",
      "['cll test results', 'treatment options', 'experts explore', 'cll care']\n",
      "['president paola ghia', 'international meeting look', 'year s eric meeting', 'initiatives amp aims', 'future cll cllsm leusm hemonc']\n",
      "['cll experts adrian wiestner john seymour peter hillmen amp kostas stamatopoulos', 'eric18 cllsm leusm leukemia hemonc']\n",
      "['cll insights', 'barcelona thanks', 'andreas agathangelidis certh stephan stilgenbauer ulm jikta malcikova amp jennifer', 'brown eric18 cllsm leusm leukemia hemonc']\n",
      "['phenomenal presentations', 'hot topic', 'haven t', 'cllsm leusm cll']\n",
      "[]\n",
      "['cll experts', 'treatment decisions']\n",
      "['nice issues', 'abbvie s venclyxto', 'chronic lymphocytic leukaemia leukemia abbvie pharma']\n",
      "['young patient', 'refractory cll', 'jacqueline barrientos', 'ash17 clinicaltrials noveltherapy ctsm leukemia leusm supponc relapse personalisedcare']\n",
      "['international eric meeting', 'great talks', 'fruitful conversations']\n",
      "['ethealthworld medgenome launches genetic test', 'chronic lymphocytic leukemia']\n",
      "['ethealthworld medgenome launches genetic test', 'chronic lymphocytic leukemia']\n",
      "['eric18 robin foa nicholas chiorazzi elias campo amp inaki martin subero', 'cll cllsm leusm hemonc epigenome caxtx leukemia']\n",
      "['medgenome launches genetic test', 'chronic lymphocytic leukemia']\n",
      "['news medgenome launches genetic test', 'chronic lymphocytic leukemia medgenome genetictestingindia leukemia genomics']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['ibrutinib retention', 'chronic lymphocytic leukemia participants', 'real world setting status', 'condition summary leukemia lymphocytic chronic b cell']\n",
      "['chronic lymphocytic leukemia methods', 'protocols hardcover book', 'free shipping']\n",
      "['ibrutinib retention', 'chronic lymphocytic leukemia participants', 'real world setting']\n",
      "['cll paradigm', 'novel agents brian t hill md phd discusses', 'recent advances', 'regulatory decisions', 'chronic lymphocytic leukemia']\n",
      "['ibrutinib dose adherence', 'therapeutic efficacy', 'non hodgkin lymphoma', 'center experience lymsm cll cllsm leusm']\n",
      "['real world', 'treatment patterns', 'chronic lymphocytic leukemia', 'seer patterns', 'care analysis leusm']\n",
      "['haematologica mutations', 'ras braf mapk erk pathway', 'specific subgroup', 'adverse clinical', 'new therapeutic options', 'chronic lymphocytic leukemia']\n",
      "['novel regimen', 'high risk cll patients', 'transplantation cancer leukemia']\n",
      "['eric2018 conference', 'barcelona lots', 'great talks', 'chronic lymphocytic leukemia eric18 cll leukemia']\n",
      "['expert session', 'cll specialist dr jeff sharman', 'willamette valley cancer institute', 'research center']\n",
      "['month s cll asktheexpert session', 'dr sharman', 'replay leusm']\n",
      "['useful advice', 'cancer patients', 'flu season cll bloodcancer']\n",
      "['celg ash18', 'significant data', 'ash ph iii data', 'luspatercept medalist', 'xlrn data', 'car t liso cel jcar017', 'cll bb21217']\n",
      "['cll coverage', 'daniel catovsky london amp kanti rai', 'scenes cllsm leusm leukemia hemonc caxtx']\n",
      "['chronic lymphocytic leukemia', 'therapies lymphoma mantlecelllymphoma lymsm']\n",
      "['chronic lymphocytic leukemia patient samples', 'quantitative reverse transcription pcr']\n",
      "['final programme', 'mrd aml cll', 'look amp register', 'multistakeholder discussions gt', 'aml amp cll', 'new data amp', 'scientific guidelines']\n",
      "['chronic lymphocytic leukemia', 'unprecedented resolution', 'cell analysis ictsnews', 'eliascampo amp i akimartinsubero']\n",
      "['investigadors del eu i aconsegueixen una ercsyg dotada amb', 'milions d', 'leuc mia limf tica cr nica mitjan ant l', 'c l lules', 'individual cc research m s informaci']\n",
      "['eloquent amp', 'trial endpoint', 'breast ca', 'myeloma follicularnhl cll']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['tcellrx cll']\n",
      "['cd19 car t cell therapy', 'cll tcellrx']\n",
      "['waldenstr m s macroglobulinemia', 'chronic lymphocytic leukemia cll cll', 'common forms', 'blood cancer', 'adults worldwide']\n",
      "['chronic lymphocytic leukemia']\n",
      "['i don t', 'god reality', 'summer check', 'camp camplakelouise']\n",
      "['study shows', 'squamous cell carcinoma', 'common skin cancer', 'chronic lymphocytic leukemia', 'basal cell', 'merkel cell', 'skincancer sunaware']\n",
      "['study shows', 'squamous cell carcinoma', 'common skin cancer', 'chronic lymphocytic leukemia', 'basal cell', 'merkel cell', 'skincancer sunaware']\n",
      "['ercsyg grant', 'huge step', 'chronic lymphocytic leukemia development', 'singlecell resolution']\n",
      "['chronic lymphocytic leukemia', 'car t cell trial']\n",
      "['patient caf', 'unique perspectives', 'different ppl']\n",
      "['pulmonary arterial hypertension', 'chronic lymphocytic leukemia patient']\n",
      "['beigene announces acceptance', 'new drug application', 'pivotal data']\n",
      "['bgne announces acceptance', 'pivotal data', 'refractory cll', 'small lymphocytic lymphoma']\n",
      "['bgne announces acceptance', 'pivotal data', 'r r cll']\n",
      "['promising treatments', 'cll patients', 'uni leusm lymsm patientcare patientcare hematology hemonc hodgkinlymphoma drugaccess noveltherapy clinicaltrials ctsm']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['chronic lymphocytic leukemia patient samples', 'quantitative reverse transcription pcr']\n",
      "['methodsmolbiol high throughput', 't cell receptor beta chain gene repertoire', 'chronic lymphocytic leukemia']\n",
      "['high throughput', 't cell receptor beta chain gene repertoire', 'chronic lymphocytic leukemia']\n",
      "['research synergy grant', 'unravel chronic lymphocytic leukemia']\n",
      "['differential diagnosis', 'chronic lymphocytic leukemia']\n",
      "['differential diagnosis', 'chronic lymphocytic leukemia']\n",
      "['peter mac s prof john seymour', 'prof andrew roberts', 'victoria prize', 'life sciences', 'cancer drug', 'chronic lymphocytic leukemia cll worldwide']\n",
      "['phenotypic discovery', 'therapeutic antibodies', 'chronic lymphocytic leukemia']\n",
      "['cll sll', 'dim cd20', 'significant minority', 'mantlecelllymphoma cases', 'cd23 esp', 'flow cytometry molecular studies']\n",
      "['dates times', 'junior lacrosse championship', 'friday cll wjlc']\n",
      "['icymi fda', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'certain patients', 'follicular lymphoma copiktra cll sll fl']\n",
      "['prestigious european grants', 'unravel chronic lymphocytic leukemia']\n",
      "['antineutrophil cytoplasmic antibody', 'chronic lymphocytic leukemia', 'rare association']\n",
      "['ivogut amp', 'eliascampo amp i akimartinsubero', 'research synergy grant', 'unravel chronic lymphocytic leukemia congrats ercsyg bcllatlas']\n",
      "['ultimate leukaemia fighter cll']\n",
      "['generous eu', 'human singlecell b cell atlas bcllatlas', 'b cell lineage', 'cll onset', 'clinical evolution collaboration w eu w i aki subero martin', 'elias campo']\n",
      "['combination trials signal', 'treatment armoury', 'cll patients', 'irish community', 'treatment options']\n",
      "['amp ivogut', 'chronic lymphocytic leukemia', 'unprecedented resolution', 'cell analysis', 'eliascampo amp i akimartinsubero']\n",
      "['erc synergy grant ercsyg', 'bcllatlas project aims', 'epigenomic hallmarks', 'chronic lymphocytic leukemia', 'cell analysis']\n",
      "['don t', 'cll traders competition', 'competition ends', 'don t', 'chance crypto kangaexchange opportunity']\n",
      "['curable disease', 'treatable disease', 'chronic lymphocytic leukemia roman stay', 'strong man']\n",
      "['world champ roman reign', 'books recure amen leukemia', 'bone marrow', 'acute lymphoblastic leukemia', 'acute myeloid leukemia', 'chronic lymphocytic leukemia']\n",
      "['future directions', 'cll therapy', 'expert perspective', 'john m burke md', 'text module']\n",
      "['real world', 'treatment patterns', 'chronic lymphocytic leukemia', 'seer patterns', 'care analysis leusm']\n",
      "['connie robinson', 'mayo clinic s arizona campus', 'cll leuksm mayoclinicaz']\n",
      "['great article chronic lymphocytic leukemia treatment algorithm']\n",
      "['fantastic cll content', 'biomarkers stemcells cartcell', 'immunotherapy updates']\n",
      "['genetic tests', 'cll patients registration', 'don t', 'cll experts dr william wierda', 'dr jennifer']\n",
      "['chronic lymphocytic leukemia leukemia']\n",
      "['til gavn', 'blodcancer patienter og til gavn', 'lyle dk foreningen og deres medlemmer', 'lymfekr ft leuk mi og mds', 'aml cml cll blodkr ft']\n",
      "['cll benefit', 'additional perspective', 'cll patient', 'treatment leusm']\n",
      "['real world', 'treatment patterns', 'chronic lymphocytic leukemia', 'seer patterns', 'care analysis']\n",
      "['different types', 'acute myeloid leukemia', 'acute lymphoblastic leukemia', 'chronic lymphocytic leukemia', 'nirali n shah md']\n",
      "['new mrna cancer drivers', 'chronic lymphocytic leukemia']\n",
      "['download chapters', 'chronic lymphocytic leukemia', 'non hodgkin lymphomas', 'new resource center cancerresearch']\n",
      "['cancer leukemia lymphoma mds myeloma cll patients care pethema es seom']\n",
      "['leukemia amp', 'different types', 'stemcell transplants cll endcancer']\n",
      "['bcell chronic lymphocytic leukemia pipeline review h2', 'bcell chronic lymphocytic leukemia pipeline review h2 2018summaryglobal markets', 'direct s', 'healthcare disease pipeline']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['cousin david', 'chronic lymphocytic leukemia', 'lymphotic lymphoma']\n",
      "['chronic lymphocytic leukemia']\n",
      "['louise o driscoll', 'incredible talk', 'psychological support', 'cll community', 'time experience']\n",
      "['till eric18 don t', 'exciting updates', 'cll research', 'treatment diagnosis', 'clinicaltrials leusm ctsm caxtx leukemia cancerresearch hemonc immunoonc']\n",
      "['helios study', 'ibrutinib bendamustine', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma leucemia hematologia']\n",
      "['multistakeholder discussions', 'booth hall b2', 'workshops mrd aml cll microbiomes itoc6 conference edicational courses esmo2018 munich']\n",
      "['ngs genomics hematology', 'oncology fellow dr andrew lipsky']\n",
      "['cd39 expression', 'cd4 t lymphocytes', '6q deletion', 'chronic lymphocytic leukemia']\n",
      "['end cancer', 'boston transforms', 'tropical rainforest', 's unmaskcancer gala raising', 'crucial funds', 'cancer research amp care tickets amp hospitality packages', 'available cll']\n",
      "['cd39 expression', 'cd4 t lymphocytes', '6q deletion', 'chronic lymphocytic leukemia', 'mosaad zaki e', 'hafez r hussein s elaiw']\n",
      "['treatment algorithm']\n",
      "['great resources', 'uk s 5th', 'common cancer', 'free information', 'book awards lymphoma nhl cll hodgkin']\n",
      "['cll patient mark amp carepartner nelia', 'healthy relationship making treatment decisions']\n",
      "['great day', 'lymphomamyeloma2018 congress dr furman', 'novel agents']\n",
      "['lymphomamyeloma2018 cll session chair dr richard furman', 'chronic lymphocytic leukemia']\n",
      "['dr andrew lipsky', 'excellent talk', 'cll lymphomamyeloma2018']\n",
      "['oncology fellow dr andrew lipsky']\n",
      "['interesting chart', 'ibrutinib therapy', 'clinical trials quality', 'treatment options lymsm cll']\n",
      "['lenalidomide induces immunity', 'clinical response']\n",
      "['q amp', 'dr flinn', 'dr danilov cll']\n",
      "['mrd positivity', 'hot topic trials underway lymphomamyeloma2018']\n",
      "['th1 immunity', 'tumor microenvironment', 'clinical response', 'chronic lymphocytic leukemia']\n",
      "['inferior outcomes', 'chronic lymphocytic leukemia', 'ibrutinib gordon', 'cancer wiley online library']\n",
      "['chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia treatment algorithm', 'blood cancer journal']\n",
      "['chronic lymphocytic leukemia']\n",
      "[]\n",
      "['fda grants priority review', 'chronic lymphocytic leukemia cll']\n",
      "['eagle pharmaceuticals', 'such illnesses', 'malignant hyperthermia', 'severe reaction', 'chronic lymphocytic leukemia fast50 crainsny']\n",
      "['dual inhibitor', 'pi3k delta', 'pi3k gamma', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['drug duo', 'priority review', 'chronic lymphocytic leukemia treatment']\n",
      "['bearish list', 'stvg sbtx hstn gpor cll slpe ketl']\n",
      "['new drug application', 'priority review', 'new chemotherapy', 'free combination treatment option', 'chronic lymphocytic leukemia cll']\n",
      "['promising data', 'generation pi3k inhibitors umbralisib', 'duvelisib nicole lamanna md shares', 'pi3k inhibitor']\n",
      "['video medication', 'barbara eichhorst', 'soho18 hemeonc caxtx oncopharm ctsm clinicaltrials chemotherapy']\n",
      "['cll sll ibrutinib imbruvica obinutuzumab gazyva']\n",
      "['medgenome launches genetic test', 'chronic lymphocytic leukemia', 'enable prediction', 'clinical course', 'cll medgenome india s premier genomics', 'diagnostics company', 'ighv gene mutation']\n",
      "['j gribben eha president', 'cll patients']\n",
      "['fda va examiner', 'revue prioritaire', 'demande d autorisation', 'l ibrutinib imbruvica abbvie', 'leuc mie lympho', 'chronique lymphome petits lymphocytes associ l obinutuzumab gazyva roche tude illuminate']\n",
      "['information booklet', 'great help']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['fda priority review', 'frontline treatment', 'chronic lymphocytic leukemia leusm']\n",
      "['chronic lymphocytic leukemia treatment algorithm', 'parikh sa blood cancer j', 'es cll leukemia']\n",
      "['fda grants priority review', 'imbruvica gazyva combination', 'chronic lymphocytic leukemia']\n",
      "['diagnosis prognosis', 'treatment options', 'cll patient catherine walk', 'healthcare providers', 'available leusm']\n",
      "['abbv fda', 'new drug application', 'priority review', 'imbruvica ibrutinib', 'obinutuzumab gazyva', 'adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll']\n",
      "['priority review', 'imbruvica gazyva combo', 'cll sll abbvie inc nyse abbv', 'priority review', 'imbruvica ibrutinib', 'gazyva obinutuzumab', 'chronic lymphocytic leukemia', 'small lymphocytic']\n",
      "['priority review', 's combination therapy ibrutinib obinutuzumab', 'adult patients', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['abbvie announces supplemental', 'new drug application', 'priority review', 'u s fda']\n",
      "['impressive update ibrutinib cll', 'ibrutinib monotherapy', 'chemoimmunotherapy results']\n",
      "['cll patient', 'treatment journey', 'cll share']\n",
      "['fantastic line', 'tackle cll diagnosis treatment mrd pathogenesis amp', 'event ctsm leusm cllsm hemonc']\n",
      "['hsmn abbvie announces supplemental', 'new drug application', 'priority review', 'u s fda', 'imbruvica r ibrutinib', 'obinutuzumab gazyva r', 'chronic lymphocytic leukemia cll']\n",
      "['abbv snda', 'priority review', 'combination gazyva']\n",
      "['new drug application', 'new chemotherapy', 'free combination treatment option', 'chronic lymphocytic leukemia cll']\n",
      "['abbvie announces supplemental', 'new drug application', 'priority review', 'u s fda', 'imbruvica ibrutin']\n",
      "['abbvie announces supplemental', 'new drug application', 'priority review', 'u s fda', 'imbruvica ibr']\n",
      "['abbvie announces supplemental', 'new drug application', 'priority review', 'chronic lymphocytic leukemia']\n",
      "['abbv abbvie announces supplemental', 'new drug application', 'priority review', 'u s fda', 'imbruvica ibrutinib', 'obinutuzumab gazyva', 'chronic lymphocytic leukemia cll']\n",
      "['high dose methylprednisolone', 'maximal cytoreduction', 'allogeneic transplantation', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['new genetic test', 'chronic lymphocytic leukemia medgenome india s premier genomics', 'diagnostics company', 'ighv gene mutation', 'genetictest leukemia ighv medgenome genetictestingindia']\n",
      "['main types', 'acute myeloid', 'myelogenous leukemia aml chronic myeloid']\n",
      "['dr brander', 'current treatment options', 'various patients', 'chronic lymphocytic leukemia', 'frontline leukemia leusm']\n",
      "['tanner s smile', 'chronic lymphocytic leukemia cll']\n",
      "['panel discussion', 'experts dr flinn', 'dr danilov register', 'refractory cll sll']\n",
      "['great visit', 'colleagues jen woyach', 'john byrd', 'cll center', 'ohio state james cancer center james']\n",
      "['molecular pathogenesis', 'bcell neoplasms', 'chronic lymphocytic leukemia mantle cell lymphoma diffuse', 'large b cell lymphoma', 'plasmablastic lymphoma']\n",
      "['comprehensive guidelines', 'available openaccess']\n",
      "['birthday wishes', 'cll gatvol pleadingpoverty voetsek']\n",
      "['ibrutinib lead', 'rr cll status', 'condition summary', 'refractory chronic lymphocytic leukemia chronic lymphocytic leukemia leukemia']\n",
      "['ja trafi em lepiej na loterii bia aczek wyci gn em los z nazw cll ale kto wie mo e si zdarzy e i ja kiedy b d potrzebowa pomocy trzymaj si m ody nie daj si tej bia ejsuce', 'z lewa czy z prawa zr bmy dzisiaj co po ytecznego wiecie co']\n",
      "['improvement immuniz', 'pts w monoclonal b cell lymphocytosis', 'cll whitaker', 'leusm cllsm idonc']\n",
      "['chlorambucil rituximab', 'lenalidomide combination treatment']\n",
      "[]\n",
      "['chronic lymphocytic leukemia', 'graft versus host disease', 'skin cancer', 'allogeneic hematopoietic stem cell transplantation']\n",
      "['cll patients']\n",
      "['dr richard furman', 'foremost cll expert', 'dr furman', 'cll question register', 'don t']\n",
      "['newmonographmonday check', 'new epocrates monograph', 'copiktra duvelisib', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'refractory follicular lymphoma']\n",
      "['ras braf mapk erk pathway', 'adverse clinical', 'new therapeutic options']\n",
      "['lymphoblastic leukemia chronic lymphocytic leukemia cll']\n",
      "['cll cllsm']\n",
      "['cll reference epigenome project', 'new insights', 'genetic predisposition', 'chronic lymphocytic leukemia seminar', 'house seminar', 'ren e beekman oct', '30h barcelona']\n",
      "['pilot study supports', 'chronic lymphocytic leukemia']\n",
      "['light chain iglv3', 'new poor prognostic subgroup', 'chronic lymphocytic leukemia results', 'multicenter study']\n",
      "['chlorambucil rituximab', 'lenalidomide combination treatment', 'chronic lymphocytic leukemia']\n",
      "['top notch informative video', 'stem cell transplants', 'cll community']\n",
      "['new chlorambucil rituximab', 'lenalidomide combination treatment']\n",
      "['cll cells cumulate genetic aberrations', 'inactive disease phase leukemia']\n",
      "['chronic lymphocytic leukemia development', 'cd8 t cells', 'functional exhaustion', 'secondary lymphoid tissues leukemia cll cllsm leusm']\n",
      "['bone marrow hematopoietic dysfunction', 'chronic lymphocytic leukemia patients leukemia cll cllsm leusm']\n",
      "['helios study', 'ibrutinib bendamustine', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma leukemia cll cllsm leusm']\n",
      "['chronic lymphocytic leukemia sll']\n",
      "['new triple threat', 'cll blood journal cll cllsm leusm']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['helios study', 'ibrutinib bendamustine', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma lymphoma lymsm']\n",
      "['interesant simo cll', 'ver si nos escapamos y podemos asistir']\n",
      "['new treatments amp clinicaltrials', 'novel agents underpins', 'amp tx options clinicians', 'cll diagnosis', 'jan amp annemarie']\n",
      "['inferior outcomes', 'chronic lymphocytic leukemia', 'ibrutinib gerionc geriheme cll cllsm leusm']\n",
      "['novel agents geriheme', 'cllsm leusm']\n",
      "['combination trials signal', 'cll oncology']\n",
      "['novel agents', 'cll pipeline oncology']\n",
      "['chlorambucil rituximab', 'lenalidomide combination treatment', 'chronic lymphocytic leukemia medivizor']\n",
      "['bm hematopoietic dysfunction', 'cll patients']\n",
      "['research shows', 'novel agents', 'chronic lymphocytic leukemia cll ibrutinib venetoclax', 'standard doses', 'active chemotherapy', 'free triplet regimen', 'refractory disease']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['chronic lymphocytic leukemia treatment algorithm', 'parikh blood cancer journal']\n",
      "['kanga exchange', 'competition cll freecrypto kangaexchange ethereum exchange kanga']\n",
      "['phase iii duo trial duvelisib versus ofatumumab', 'amp refractory cll sll']\n",
      "['token airdrop', 'competition airdrop tradingcompetition', 'cryptonews freecrypto cll cll']\n",
      "['guest author', 'years past diagnosis', 'incurable cll']\n",
      "['treatment access issues', 'canada cll']\n",
      "['fun cll researchers', 'cll drug', 'pokemon character', 'harry potter']\n",
      "['lenalidomide discontinuation', 'chronic lymphocytic leukemia leukemia']\n",
      "['reliable cll information', 'cll programs']\n",
      "['cll experts', 'treatment decisions']\n",
      "['fantastic cll']\n",
      "['blood commentary', 'new triple threat']\n",
      "['oct 17th']\n",
      "['oct 17th']\n",
      "['xun wu', 'manitoba cll research cluster retreat']\n",
      "['month s cll asktheexpert session', 'dr sharman', 'replay leusm']\n",
      "['don t', 'confidence hope']\n",
      "['helios study', 'ibrutinib bendamustine', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['phase 1b study', 'obinutuzumab ibrutinib', 'refractory chronic lymphocytic lymphoma cll']\n",
      "['cll tokens', 'lucky winners', 'announcements competition', 'token crypto cryptocurrency blockchain kangaexchange']\n",
      "['chlorambucil rituximab', 'lenalidomide combination treatment']\n",
      "['chronic lymphocytic leukemia', 'graft versus host disease', 'skin cancer', 'allogeneic hematopoietic stem cell transplantation']\n",
      "['hemonc times thursdaythoughts', 'dr clive zent', 'chronic lymphocytic leukemia leusm cancerawareness']\n",
      "['duvelisib copiktra', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll', 'refractory follicular lymphoma']\n",
      "['hif1 alpha antibody', 'distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['phase 1b study', 'obinutuzumab ibrutinib', 'refractory chronic lymphocytic leukemia']\n",
      "['phase 1b study', 'obinutuzumab ibrutinib', 'refractory chronic lymphocytic leukemia']\n",
      "['guest author', 'years past diagnosis', 'incurable cll']\n",
      "['dr brander', 'treatment options', 'chronic lymphocytic leukemia', 'leusm leukemia']\n",
      "['cll cello health', 'year profits climb', 'uk cll brighterir andrewscotttv capitalnetwork1']\n",
      "['chronic lymphocytic leukemia', 'phase iii trial studies', 'venetoclax work', 'chronic lymphocytic']\n",
      "['national comprehensive cancer network', 'verastem oncology s treatment option', 'clinical practice guidelines', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll lymphoma nccn']\n",
      "['new treatments', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'small cell lung', 'certain patients', 'follicular lymphoma', 'cutaneous squamous cell carcinoma cancerresearch']\n",
      "['distinct activities', 'glycolytic enzymes identify chronic lymphocytic leukemia patients', 'aggressive course', 'chemo immunotherapy']\n",
      "['chronic lymphocytic leukemia sll']\n",
      "['patient caf', 'unique perspectives', 'different ppl']\n",
      "['new agents', 'fda approval', 'chronic lymphocytic leukemia', 'agents cll leukemia lesum']\n",
      "['fda reviewers', 'celltrion s rituxan biosimilar', 'panel vote', 'fda approval', 'roche s rituxan', 'lymsm cll ra']\n",
      "['chronic lymphocytic leukemia combination therapy fair number', 'hematologic amp non hematologic', 'adverse effects']\n",
      "['chlorambucil rituximab', 'lenalidomide combination treatment']\n",
      "['modulation sensitizes chronic lymphocytic leukemia cells', 'mitochondrial apoptotic dependencies hematology therapeutics']\n",
      "['recent cll town meeting', 'treatment decisions']\n",
      "['team supermarrow', 'chronic lymphocytic leukemia dana farber cancer institute boston ma']\n",
      "['improvement immunization', 'pts w monoclonal b cell lymphocytosis', 'cll whitaker', 'leusm cllsm idonc']\n",
      "['guest author', 'years past diagnosis', 'incurable cll']\n",
      "['cll aiha', 'certain patients leuklymph2018']\n",
      "['duvelisib bests ofatumumab', 'cll sll']\n",
      "['chronic lymphocytic leukemia', '23rd congress', 'european hematology association']\n",
      "['rns aim cll cello health plc director pdmr']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['strong woman', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia treatment algorithm', 'blood cancer journal']\n",
      "['rare instance', 'simultaneous infection', 'pulmonary aspergillus', 'chronic lymphocytic leukemia']\n",
      "['interesting article', 'angela brooks', 'full length transcript characterization', 'sf3b1 mutation', 'chronic lymphocytic leukemia reveals downregulation']\n",
      "['tiptuesday download chapters', 'chronic lymphocytic leukemia', 'non hodgkin lymphomas', 'bethesda handbook', 'clinical hematology', 'new resource center cancerresearch']\n",
      "['deep responses', 'detectable disease', 'dr shadman', 'treatment landscape', 'cll cll leusm']\n",
      "['community oncologists', 'community oncologist', 'jeff sharman', 'peers sharman cll leusm cancer']\n",
      "['national comprehensive cancer network', 'verastem oncology s copiktra duvelisib capsules', 'clinical practice guidelines', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['stem cell transplantation', 'chronic lymphocytic leukemia', 'current treatment', 'curative potential memorial sloan', 'cancer center disabilityinfo zusia']\n",
      "['cll specialist', 'doctor tune', 'dr michael', 'amp dr alessandra ferrajoli']\n",
      "['exchange platform', 'token link', 'market cll kangaexchange cryptocurrency', 'token ico market exchange cryptoliveleak']\n",
      "['stlauthorprophetessdallen pl2018', 'life god', 'stage ii', 'iii chronic lymphocytic leukemia', 'god birth', 'fierce god']\n",
      "['national comprehensive cancer network', 'verastem oncology s copiktra duvelisib capsules', 'clinical practice guidelines', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['pilot study supports', 'chronic lymphocytic leukemia', 'details cancer cancercongress cancerconference cancerconferences worldcancermeet cancerevent paris france feb']\n",
      "['bsms phd student emma kennedy', 'catovsky prize', 'annual uk chronic lymphocytic leukaemia cll forum clinical sciences day']\n",
      "['guest author', 'years past diagnosis', 'incurable cll']\n",
      "['great session', 'penn hall school', 'young people', 'exciting chapters', 'class novel cll wolverhampton education']\n",
      "['chronic lymphocytic leukemia moon shot', 'medical research', 'adapt pre clinical findings', 's treatments cancermoonshot leusm endcancer']\n",
      "['pitch jt26 cll cfc utc ktbffh']\n",
      "['years past diagnosis', 'incurable cll', 'cancer show']\n",
      "['dr john allan s thoughts', 'novel agents', 'nccnhem18 cc']\n",
      "['bullish list', 'peys emis ccji cpx merc hvpe src cll']\n",
      "['good control', 'r r cll', 'sll lymsm']\n",
      "['chronic lymphocytic leukemia', 'free download pdf']\n",
      "['chronic lymphocytic leukemia', 'free download pdf']\n",
      "['chronic lymphocytic leukemia', 'free download pdf']\n",
      "['independent research reviews', 'roundup exposure increases', 'non hodgkin s lymphoma nhl hairy cell leukemia hcl', 'multiple myeloma', 'chronic lymphocytic leukemia rmatthews com']\n",
      "['fda approves copiktra', 'refractory chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'blood cancer']\n",
      "['official cll cll']\n",
      "['lymphocyte ratio', 'chronic lymphocytic leukemia', 'research article openaccess cll leukemia']\n",
      "['great article chronic lymphocytic leukemia treatment algorithm']\n",
      "['cll impact', 'experts dr nicole lamanna', 'amp dr alessandra ferrajoli', 'common infections', 'optimal skin protection']\n",
      "['salvage therapy', 'chronic lymphocytic leukemia']\n",
      "['cancerpatients partner', 'treatment decisions', 'mark silverstein', 'shares tips']\n",
      "['support event', 'mullingar park hotel', 'support event', 'cll patients', 'emotional support']\n",
      "['guest author', 'years past diagnosis', 'incurable cll']\n",
      "['chronic lymphocytic leukemia leusm']\n",
      "['cyclacel pharmaceuticals', 'effective therapies', 'cll aml', 'mds leusm leuksm endcancer']\n",
      "['bone marrow hematopoietic dysfunction', 'chronic lymphocytic leukemia patients']\n",
      "['john terry announces retirement', 'aston villa links cfc jt26 cll']\n",
      "['molecular prognostic markers', 'clinical relevance', 'chronic lymphocytic leukemia']\n",
      "['rare germline variants', 'chronic lymphocytic leukemia']\n",
      "['favourite photographs', 'time skipper', 'player captain leader legend jt26 cll johnterry cfc utc ktbffh']\n",
      "['guest author', 'years past diagnosis', 'incurable cll']\n",
      "['dr rezvani', 'natural killer cells', 'chronic lymphocytic leukemia cll']\n",
      "['lenalidomide consolidation therapy']\n",
      "['dad s 65th birthday', 'weren t', 'fuckcancer cll']\n",
      "['ceo slawek zawdzki', 'coo lukas minkiewicz', 'tokenfest conference', 'video kangaexchange cll cryptoliveleak kanga crypto blockchain']\n",
      "['bone marrow hematopoietic dysfunction', 'chronic lymphocytic leukemia patients', 'manso ba zhang h mikkelson mg gwin ka secreto cr', 'w parikh sa kay ne medina kl']\n",
      "['r r chronic lymphocytic leukemia duo', 'positive study', 'interesting discrepancy', 'irc assessment']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "[]\n",
      "['chlorambucil rituximab', 'lenalidomide combination treatment']\n",
      "['beausejour mp dominic leblanc', 'clean bill', 'successful treatments', 'chronic lymphocytic leukemia nbnews cdnpoli']\n",
      "['beausejour mp dominic leblanc', 'clean bill', 'successful treatments', 'chronic lymphocytic leukemia nbnews cdnpoli']\n",
      "['beausejour mp dominic leblanc', 'clean bill', 'successful treatments', 'chronic lymphocytic leukemia nbnews cdnpoli']\n",
      "['cll landscape', 'venetoclax oncology']\n",
      "['stephen remissionman', 'cll journey']\n",
      "['lenalidomide consolidation therapy']\n",
      "['duvelisib copiktra', 'adult patients', 'refractory cll chronic lymphocytic leukemia', 'small lymphocytic lymphoma drug info ecm']\n",
      "['new partnership', 'competition airdrop tradingcompetition kangaexchange cll cll cryptoliveleak']\n",
      "['good news', 'cll patients igvh', 'non 17pdeletion discusses', 'rationale amp results', 'combination therapy', 'minimal residual disease']\n",
      "['nobel prize winner dr jim allison', 'incredible work', 'immunotherapy research amp development', 'treatments cll patients worldwide', 'man s work', 'amp others']\n",
      "['duvelisib copiktra', 'adult patients', 'refractory cll chronic lymphocytic leukemia', 'small lymphocytic lymphoma drug info ecm']\n",
      "['renal involvement', 'chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['amazing idea', 'cml cll leukaemia']\n",
      "['large rct', 'brave soul', 'pilot study', 'chronic lymphocytic leukemia']\n",
      "['real world treatment', 'chronic lymphocytic leukemia', 'novel agents era gerionc geriheme cll cllsm leusm']\n",
      "['non redundant role control', 'chronic lymphocytic leukemia development', 'cd8 t cells', 'functional exhaustion', 'secondary lymphoid tissues']\n",
      "['venetoclx venclexta abbvie genentech', 'new treatment', 'chronic lympocytic leukemia', 'small lymphocytic lymphoma', '17p deletion', 'common adverse reactions']\n",
      "['video ifcg yields', 'unprecedented mrd negativity', 'soho18 mrd mutations chemotherapy immunotherapy leukemia precisionmedicine clinicaltrials trialupdate']\n",
      "['cll chronic lymphocytic leukemia', 'glenn sabin glenn', 'remarkable story', 'bone marrow', 'conventional cancer drugs health cancer lymphoma']\n",
      "['new cancer drug', 'copiktra duvelisib chroniclymphocyticleukemia cll follicularlymphoma smalllymphocyticleukemia sll cancer']\n",
      "['fantastic morning', 'tettenhall wood', 'special school', 'audio book', 'own voices', 'recordings cll edtech wolverhampton stickman']\n",
      "['cll benefit', 'additional perspective', 'cll patient', 'treatment leusm']\n",
      "['chronic lymphocytic leukemia']\n",
      "['pre congress conference program', 'myelomysplastic syndromes lymphoma myeloma chronic myeloid leukemia chronic lymphocytic leukemia transplantation', 'cart t cells sehhseth18 cancer']\n",
      "['cartcell therapy', 'cll leuklymph2018 dubrovnik']\n",
      "['utr region', 'notch1 gene', 'chronic lymphocytic leukemia patients']\n",
      "['modulation sensitizes chronic lymphocytic leukemia cells', 'mitochondrial apoptotic dependencies lymphoma lymsm']\n",
      "['line treatment', 'leuklymph2018 dubrovnik']\n",
      "['young patient', 'refractory cll', 'jacqueline barrientos', 'feinstein institute', 'medical research lymphomahub lymphoma overallsurvival prognosis cancertherapy gogold']\n",
      "['real world treatment', 'chronic lymphocytic leukemia', 'novel agents era ssbmt luesm cll']\n",
      "['dr pinilla ibarz', 'current treatment landscape', 'chronic lymphocytic leukemia', 'future fro chemotherapy', 'patient population']\n",
      "['chronic lymphocytic leukemia cd5 cd23 tumor cells', 'b cell', 'small round', 'low grade', 'soccer ball appearance', 'small lymphocytic leukemia', 'lymph nodes twitterhomework']\n",
      "['stress affects cellular', 'cytokinemarkers assoc', 'chronic lymphocytic leukemia cll cll', 'inflammatory pathways stress inflammation stress']\n",
      "['sequential treatment', 'chronic lymphocytic leukemia']\n",
      "['mantle cell lymphoma', 'dr dean', 'cochair mdphd stateofscience hyper', 'b cell hematology', 'confuse mcl']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['stress cll stress cll']\n",
      "['stateofscience hematology cochair mdphd history', 'major subtypes igvh', 'rare gogo', 'go fcr']\n",
      "['different patients', 'different treatments', 'approach hemonc stateofscience']\n",
      "['dr jakub svoboda', 'hematological malignancies', 'asco18 meeting', 'philadelphia totalhealth hematology cll']\n",
      "['poor prognosis', 'cll cancer network', 'severe stress anxiety', 'depressive symptoms', 'optimize outcomes', 'study mentalhealth cytokineeffect']\n",
      "['duvelisib monotherapy', 'overall response rates', 'ofatumumab monotherapy', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll']\n",
      "['hemepath fellow', 'ascp2018 pathology cll chicago']\n",
      "['cll cells', 'lymphnode mimimicro data', 'clinical combination', 'cll abbv md anderson']\n",
      "['car nkcells', 'cll therapy', 'soho18 leukemia leusm clinicaltrials ctsm immunotherapy immunoonc cellulartherapy cart']\n",
      "['useful work', 'comprehensive safety analysis', 'venetoclax monotherapy', 'refractory chronic lymphocytic leukemia cllsm']\n",
      "['uk cll forum clinical sciences day', 'diagnostics amp treatment', 'experiences lymphomastory']\n",
      "['cyclacel pharmaceuticals', 'effective therapies', 'cll aml', 'mds leusm leuksm endcancer']\n",
      "['dr nicole lamanna', 'dr michael', 'dr alessandra ferrajoli', 'research affects', 'cll treatments amp', 'person leusm']\n",
      "[]\n",
      "['ibrutinib treatment']\n",
      "['study shows stress', 'certain cellular cytokine', 'chemokine markers', 'cll cancerresearch']\n",
      "['cll patient', 'treatment journey', 'cll share']\n",
      "['patient voice magazine']\n",
      "['chronic lymphocytic leukemia', 'silent disease']\n",
      "['bendamustine chronic lymphocytic leukemia cll hodgkin non hodgkin lymphoma', 'multiple myeloma breast ca', 'main dose', 'myelosuppression moa inhibits mitotic checkpoints', 'mitotic arrest']\n",
      "['tag godt imod det', 'lyle nyt som kan l ses', 'kommenter gerne og hvis du vil', 'det fysiske blad kan den bestilles hos lyle dk', 'kr i porto blodkr ft lymfekr ft leuk mi mds lyle dk blodcancer cll aml knowaml dksund sundpol']\n",
      "['chronic lymphocytic leukemia cll']\n",
      "['friend paul keane', 'national headlines']\n",
      "['cll treatment', 'outcomes hematology oncology world hematology']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['green tea', 'chronic lymphocytic leukemia sciencedirect']\n",
      "['study shows treatment', 'chronic treatment naive cll cancerresearch']\n",
      "['gc identification', 'chronic lymphocytic leukemia subsets', 't cell dependency']\n",
      "['chronic lymphocytic leukemia subsets', 't cell dependency']\n",
      "['chronic lymphocytic leukemia subsets', 't cell dependency']\n",
      "['token talks boston', 'social blog platform', 'cll cll cryptoliveleak erc20']\n",
      "['smart importers', 'experience amp', 'depth understanding', 'essential qualities partner', 'professionalism transparency amp competence', 'peak tincanislandport ibadandelivery']\n",
      "['dr ibarz', 'field cll leukemia leusm']\n",
      "['full length transcript characterization', 'sf3b1 mutation', 'chronic lymphocytic leukemia reveals downregulation']\n",
      "['cll cells cumulate genetic aberrations', 'inactive disease phase cllsm leusm']\n",
      "['nordic nanovector', 'present poster', 'alpha therapy', '212pb nnv', 'positive b cell chronic lymphocytic leukemia cll', 'non hodgkin lymphoma nhl lymsm biotech cancer']\n",
      "['research lab s work', 'chronic lymphocytic leukemia']\n",
      "['new lenalidomide consolidation therapy']\n",
      "['clinical nurse specialist', 'nick york leukemia cancersupport cll mycnsmatters clinicalsupport gogold bloodcancerawarenessmonth bloodcancer spotleukaemia leusm']\n",
      "['cd8 tcells', 'secondary lymphoid tissues evidence', 'oligoclonal cd8s', 'cll development amp', 'lymph nodes immunotherapy leukemia']\n",
      "['nu ppnas m jligheten att bli ambassad r f r sk rg rdshavets biosf romr', 'lokala akt rer ska kunna dra nytta av att k nna biosf romr det b ttre cll sk rg rd h']\n",
      "['duvelisib copiktra', 'adult patients', 'refractory cll chronic lymphocytic leukemia', 'small lymphocytic lymphoma drug info ecm']\n",
      "['duvelisib copiktra', 'adult patients', 'refractory cll chronic lymphocytic leukemia', 'small lymphocytic lymphoma drug info ecm']\n",
      "['rns aim cll cello health plc appointment', 'executive director']\n",
      "['sequential treatment', 'chronic lymphocytic leukemia', 'rece leukemia']\n",
      "['dr reddy s', 'imatinib mesylate tablets', 'generic version', 'novartis pharmaceuticals gleevec', 'chronic myelogenous leukemia', 'acute lymphocytic leukemia']\n",
      "['unusual presentation', 'chronic lymphocytic leukemia']\n",
      "['ibrutinib treatment', 'chronic lymph']\n",
      "['survey cll lymsm immunotherapy inesss', 'patients gain access']\n",
      "['adult patients', 'refractory chronic lymphocytic leukemia r r cll', 'small lymphocytic lymphoma r r sll']\n",
      "['free crypto cryptocurrency cll cryptoliveleak']\n",
      "['verastem oncology vstm', 'drug administration', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['chronic lymphocytic leukemia therapeutics market size share outlook', 'opportunity analysis']\n",
      "['cll floor', 'lavender house', 'new york', 'great cooperation', 'rd weis instafloor na']\n",
      "['cure media group announces chuck pagano', 'guest speaker', 'chronic lymphocytic leukemia heroes awards ceremony', 'chronic lymphocytic leukemia']\n",
      "['cure media group announces chuck pagano', 'guest speaker', 'chronic lymphocytic leukemia heroes awards ceremony']\n",
      "['chronic lymphocytic leukemia life expectancy', 'survival rates']\n",
      "['chronic lymphocytic leukemia cll', 'men amp occurs', 'average age', 'early 70s bloodcancermonth']\n",
      "['chroniclymphocyticleukemia cll therapies dr michael', 'discusses leusm']\n",
      "['word hampshire contacts', 'free places', 'thursday s liveyourlife event', 'cosham offering info amp support', 'hodgkin nhl']\n",
      "['medicine nobelprize2018', 'immune check point therapy', 'cancers immunecheckpointtherapy melanoma bladdercancer nsclc cll leukemia lymphoma rcc']\n",
      "['duvelisib copiktra', 'adult patients', 'refractory cll chronic lymphocytic leukemia', 'small lymphocytic lymphoma drug info ecm']\n",
      "['s october', 'makebloodcancervisible campaign', 'september pinchpunch cll leukaemia cancer']\n",
      "['john terry', 'new role cfc utc ktbffh jt26 cll johnterry']\n",
      "['new venetoclax', 'refractory chronic lymphocytic leukemia']\n",
      "['husk vi taler og har fokus p blodcancer hele ret selvom bloodcancerawarenessmonth er slut f lg os p hjemmesiden og fb vi har mange aktivteter i st beskeen letstalkaboutbloodcancer knowaml leuk mi lymfekr ft cml cll mds blodkr ft']\n",
      "['happy sunday', 'cancer survivor i', 'eradicate chronic lymphocytic leukemia', 'bone cancers', 'team peace', 'toretha corley']\n",
      "['chronic lymphocytic leukemia cll', 'men amp occurs', 'average age', 'early 70s bloodcancermonth']\n",
      "['treatment landscape', 'care oncology']\n",
      "['chronic lymphocytic leukemia development', 'cd8 t cells', 'functional exhaustion', 'secondary lymphoid tissues']\n",
      "['pilot study', 'chronic lymphocytic leukemia cll', 'pilot study', 'ibrutinib dosage', 'cll consultant']\n",
      "[]\n",
      "['pik3ca mutations cll', 'pik3cd pik3cg']\n",
      "['succes temadag i blox', 'opl g om lymfekr ft cll cml akutleuk mi mds cmml blodcancer se p f lg s p v r', 'til n ste arrangement om blodkr ft bloodcancerawarenessmonth makebloodcancervisible letstalkaboutbloodcancer']\n",
      "['treatment landscape', 'care oncology']\n",
      "['new medications', 'btk inhibitors pi3k inhibitors bcl2 cd20mabs', 'chair dr martin stateofscience hematology sanfrancisco gt risk cytogenetics']\n",
      "['fda approves duvelisib', 'follicular lymphoma oncology']\n",
      "['university professor barbara andersen', 'link stress', 'biological disease markers', 'chronic lymphocytic leukemia', 'common type', 'adult leukemia']\n",
      "['video ibrutinib', 'powerful combination', 'soho18 leukemia hemeonc clinicaltrials immunoonc combinationtherapy']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['pilot study', 'chronic lymphocytic leukemia lisa chen', 'blood2018 blood', 'interesting small study i', 'elderly patient struggle']\n",
      "['new sequential treatment', 'chronic lymphocytic leukemia']\n",
      "['bullish list', 'ttg oxig rle wtg brna adig cll gph']\n",
      "['past saturday', 'terrific discussions', 'cll experts', 'wise care']\n",
      "['chronic lymphocytic leukemia cll', 'men amp occurs', 'average age', 'early 70s bloodcancermonth']\n",
      "['cll impact', 'experts dr nicole lamanna', 'amp dr alessandra ferrajoli', 'common infections', 'optimal skin protection']\n",
      "['cll illness mortality']\n",
      "['new chemo drug imbruvica ibrutinib cll bloodcancer']\n",
      "['chronic lymphocytic leukemia development', 'cd8 t cells', 'functional exhaustion', 'secondary lymphoid tissues']\n",
      "['massive increase', 'cll drugs ascoqlty18']\n",
      "['fatigue leukemia bloodcancer chemotherapy chronicmyeloidleukemia cml cll chroniclymphocyticleukemia']\n",
      "['prof katyoun rezvani concludes', 'early clinical trial', 'nk cells']\n",
      "['prof katyoun rezvani', 'md anderson', 'car t therapy', 'engineering nk cells', 't cells']\n",
      "['prof hillmen', 'cll treatment', 'adaptive trials']\n",
      "['prof pete hillmen', 'cll trials', 'uk clarity trial']\n",
      "['molecular factors', 'cll treatment', 'clinical trial', 'effective therapy combination', 'new data 3000researchers']\n",
      "['allo stem cell transplant', 'cll uk cll forum debate evidence', 'car t', 'small molecule inhibitor treatments numbers', 'high risk patients']\n",
      "['code des collectivit s locales cll favorise', 'coop ration internationale travers', 'soci t civile des changes fructueux democratie locale soyons actives actifs tunisie bizerte']\n",
      "['ricters transformation', 'cll patients', 'prof francis bosch', 'uk cll forum', 'different types rt rognosis', 'poor new therapies']\n",
      "['professor francesc bosch', 'long way', 'richters syndrome', 'adequate treatments', 'new data', 'ibrutinib amp nivolumab', 'car t cll richters']\n",
      "['professor francesc bosch', 'richters pts', 'tp53 mutations', 'cdkn2a b myc', 'notch1 cll richterssyndrome']\n",
      "['prof francesc bosch', 'biology treatment', 'richters cll']\n",
      "['prof fox', 'unmet need', 'real world', 'triplet therapies', 'uk clarity trial']\n",
      "['real world data', 'good progression', 'free survival', '1yr overall survival']\n",
      "['new uk data', 'aren t', 'clinical trials overall response rate']\n",
      "['prof chris fox', 'wide impact']\n",
      "['uk cll forum clinical sciences day', 'donna munro', 'cll clinicians', 'patient information perspectives', 'nurse iniatives ist session prof anna schuh', 'high risk cll spotleukaemia']\n",
      "['collaborative work', 'initial approval', 'ash18 hematology']\n",
      "['amazing research', 'cll causes progression', 'drug resistance']\n",
      "['chlorambucil cll']\n",
      "['car t cll world hematology']\n",
      "['chlorambucil rituximab', 'lenalidomide combination treatment']\n",
      "['dr rezvani', 'car nk cells', 'chronic lymphocytic leukemia', 'car t cells cll leusm leukemia']\n",
      "['expert perspectives']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['cpd credits', 'future treatment goals', 'chronic lymphocytic leukemia cll', 'drs john seymour', 'amp peter hillmen']\n",
      "['dyk chronic lymphocytic leukemia', 'common type', 'leukemia symptoms', 'swollen lymph nodes', 'spleen talk']\n",
      "['amp sharman', 'live asktheexpert session', 'cll patients']\n",
      "['free activities hand outs', 'information sheets', 'support children s', 'eyfs children kindergarten preschool nursery cll socialandemotional']\n",
      "['dispense copiktra', 'adult patients', 'refractory chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'refractory follicular lymphoma fl']\n",
      "['blood matthew davids', 'jennifer woyach debate', 'chronic lymphocytic leukemia']\n",
      "['chroniclymphoblasticleukemia cll patient s video diary er', 'harley hudson', 'cll patient', 'patient stemcelltherapy stemcelltransplant chemotherapy experience clinicaltrial leukemia bloodcancer']\n",
      "['cll expert webinar', '12pm pt', 'special guest sharman']\n",
      "['tp53 disruptions', 'diagnostic measure', 'anna schuh', 'bsh2018 biomarkers fish', 'tp54mutation chroniclymphocyticleukemia sanger hemeonc relapse']\n",
      "['fda approves duvelisib', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'grants duvelisib', 'r r follicular lymphoma leusm lymsm']\n",
      "['s media digest abbvie', 'health canada']\n",
      "['s media digest', 'health canada', 'chronic lymphocytic leukemia']\n",
      "['icymi fda', 'adult patients w', 'refractory chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['william wierda', 'current data', 'car t cell therapy']\n",
      "['new powerfulpatient story meet mark silverstein', 'cll patient amp advocate', 'cancer journey', 's remission leusm']\n",
      "['chronic lymphocytic leukemia cll', 'online support community', 'cll support association', 'strong lots', 'helpful info', 'treatment options']\n",
      "['chronic lymphocytic leukemia krohem b cll']\n",
      "['global protein synthesis', 'translational fidelity', 'chronic lymphocytic leukemia']\n",
      "['prof robin foa', 'comprehensive overview', 'cll cllsm riyadh']\n",
      "['prof robin foa', 'comprehensive overview', 'cll cllsm riyadh']\n",
      "['saturday s cll town meeting', 'treatment decisions']\n",
      "['leukemia diagnosis springs patient', 'cll bloodcancerawareness']\n",
      "['year sickness', 'chronic lymphocytic leukemia edward w', 'new york city']\n",
      "['duvelisib copiktra verastem inc', 'adult patients', 'refractory chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['weren t', 'cll expert', 'refractory cll', 'aren t']\n",
      "['verastem oncology co', 'ki faculty members piyush gupta eric lander', 'robert weinberg', 'fda approval', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'follicular lymphoma']\n",
      "['cll specialist', 'doctor tune', 'dr michael', 'amp dr alessandra ferrajoli']\n",
      "['don t', 'voice questions', 'cll expert', '12pmpt amp', 'cll info']\n",
      "['new clinical trials', 'chronic lymphocytic leukemia']\n",
      "['dear fellow cll friends', 'great town meeting', 'past saturday', 'll tackle', 'dr jeff sharman', 'expert broadcast']\n",
      "['chronic lymphocytic leukemia lymphoma lymsm']\n",
      "['verastem s copiktra', 'bloodcancers lymphoma oncology leukaemia cll sll duvelisib follicularlymphoma']\n",
      "['chronic lymphocytic leukemia cll expert', 'live event']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['s sept', 'live cll asktheexpert session', 'dr sharman', 'pm register', 'cll info leusm']\n",
      "['s learnt', 'video marc', 'spotleukaemia story gt']\n",
      "['synt001 phase ib iia study', 'warm autoimmune hemolytic anemia waiha', 'pemphigus vulgaris pv', 'pemphigus foliaceus cll']\n",
      "['pilot study', 'chronic lymphocytic leukemia']\n",
      "['abbv announces health canada issues notice', 'combo w rituximab', 'chronic lymphocytic leukemia']\n",
      "['fda approves duvelisib copiktra', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll', 'refractory follicular lymphoma cancerdrugs cll sll lymphoma']\n",
      "['icymi comorbidities', 'poor prognosis', 'chronic lymphocytic leukemia', 'dr max j gordon', 'cll imbruvica']\n",
      "['health canada', 'chronic lymphocytic leukemia']\n",
      "['medicalaffairs oncology teams b c']\n",
      "['verastem oncology s copiktra', 'adult patients w', 'small lymphocytic lymphoma', 'refractory follicular lymphoma', 'chronic lymphocytic leukemia']\n",
      "['fda approves copiktra duvelisib', 'chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'follicular lymphoma fl']\n",
      "['refractory cll sll follicular lymphoma']\n",
      "['cryptoliveleak affiliate program', 'open cryptoliveleak cll cll affiliateprogram socialmedia getpaidtopost blockchain cryptocurrency']\n",
      "['chronic lympytic leukemia']\n",
      "['fda approves copiktra duvelisib capsules', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'follicular lymphoma']\n",
      "['duvelisib copiktra', 'refractory chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['pi3k inhibitor duvelisb', 'fl cll', 'impressive data duvelisib pi3kinase dualinhibitor approval cll sll follicular']\n",
      "['fda approves duvelisib copiktra', 'adult patients w', 'refractory chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll', 'adult patients w', 'refractory follicular lymphoma fl']\n",
      "['european medicines agency s committee', 'medicinal products', 'human use', 'chronic lymphocytic leukemia', 'previous therapy leukemia leusm cll']\n",
      "['drug administration fda', 'regular approval', 'duvelisib copiktra verastem inc', 'adult patients', 'refractory chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['s duvelisib', 'adult patients w', 'refractory chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['mir 125a', 'mir 34aexpression predicts richter syndrome', 'chronic lymphocytic leukemia patients']\n",
      "['cll patient', 'host carol preston', 'cll patients', 'treatment options', 'disease bcam']\n",
      "['fda approves', 'new drug', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'follicular lymphoma']\n",
      "['brilliant discussion', 'cll cartcells', 'hematology leukemia immunoonc leusm hcsm cllsm']\n",
      "['refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'certain patients', 'follicular lymphoma copiktra cll sll fl']\n",
      "['tg stock sinks', 'blood cancer trial tg therapeutics', 'fda approval', 'ublituximab umbralisib combination', 'chronic lymphocytic leukemia']\n",
      "['duvelisib copiktra verastem inc', 'adult patients', 'refractory chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['duvelisib copiktra verastem inc', 'adult patients', 'refractory chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['adult patients', 'refractory chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll copiktra leukemia chroniclymphocyticleukemia smalllymphocyticleukemia']\n",
      "['fda approves duvelisib copiktra verastem inc', 'adult patients', 'refractory chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['new drug', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'follicular lymphoma']\n",
      "['chronic lympytic leukemia']\n",
      "[]\n",
      "['fdaapproves copikra duvelisib', 'chronic lymphocytic leukemia cll', 'small lymphocyte lymphocytic lymphoma', 'generic name', 'vuh liss ib pronunciation pronounce prodatahealth']\n",
      "['chronic lymphocytic leukemia lymphocytic lymphoma', 'follicular lymphoma']\n",
      "['verastem inc vstm', 'fda approval', 'dual inhibitor', 'pi3k delta', 'pi3k gamma', 'line treatment', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll']\n",
      "['cello health cll 140m mkt cap', 'inflection point', 'net cash', 'y e', 'strategic position']\n",
      "['new drugs', 'chronic lymphocytic leukemia', 'years patients', 'blood cancer']\n",
      "['rns aim cll cello health plc director pdmr']\n",
      "['equal relapse', 'doctor dr']\n",
      "['update approval fda', 's copiktra', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma amp', 'follicular lymphoma click']\n",
      "['fda approves venetoclax', 'sll 17pdeletion abbvie cll fda genentech leukaemia lymphoma sll venclexta venetoclax']\n",
      "['duvelisib fda', 'adult patients', 'r r cll', 'sll cll copiktra duvelisib fda leukaemia lymphoma sll verastem']\n",
      "['duvelisib fda', 'adult patients', 'r r cll', 'sll cll copiktra duvelisib fda leukaemia lymphoma sll verastem']\n",
      "['video car t cells', 'current landscape', 'soho18 cartcells immunoonc leusm leukemia hemeonc ctsm trialupdates clinicaltrials ibrutinib']\n",
      "['duvelisib copiktra verastem inc', 'adult patients', 'refractory chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['rns aim cll cello health plc director pdmr']\n",
      "['fda approves copiktra duvelisib capsules', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'follicular lymphoma']\n",
      "['chronic lymphocytic leukemia']\n",
      "['fda approves copiktra duvelisib', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'follicular lymphoma']\n",
      "['fda approves copiktra duvelisib', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'follicular lymphoma']\n",
      "['news fda approves duvelisib', 'chronic lymphocytic leukemia cll', 'follicular lymphoma']\n",
      "['fda approves copiktra duvelisib capsules', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'follicular lymphoma']\n",
      "['fda approves copiktra duvelisib capsules', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'follicular lymphoma']\n",
      "['important advance', 'refractory chronic lymphocytic leukemia', 'small cell lymphoma', 'follicular lymphoma patients', 'fda approval']\n",
      "['refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'refractory follicular lymphoma']\n",
      "['regular approval', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['dynamo trials', 'dual pi3k inhibitor duvelisib', 'refractory chronic lymphocytic leukemia', 'follicular lymphoma']\n",
      "['refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'refractory follicular lymphoma leusm']\n",
      "['minimal residual disease', 'chronic lymphocytic leukemia', 'current issue']\n",
      "['linfocitos b tumorales', 'leucemia linfoide cr nica cll imagen', 'microscopia electr nica', 'barrido coloreada']\n",
      "['duvelisib copiktra verastem inc', 'adult patients', 'refractory chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['audience members worries', 'cll patients', 'slow drs lamanna amp ferrajoli don t', 'urge pts']\n",
      "['fda approves duvelisib', 'refractory chronic lymphocytic leukemia', 'small lymphocytic lymphoma', 'grants duvelisib', 'r r follicular lymphoma leusm lymsm']\n",
      "['thursday sept', 'pm pt', 'live cll asktheexpert session', 'dr sharman', 'pm register', 'cll info leusm']\n",
      "['great time', 'possibilities fund golf tournament', 'year cll cancer golf tournament']\n",
      "['interesting fact chronic lymphocytic leukemia cll', 'blood cancer', 'b cells']\n",
      "['s worldcancerresearchday', 'run education amp support events', 'lymphoma events', 'treatment amp management', 'hodgkin nhl amp cll']\n",
      "[]\n",
      "['disease markers', 'cll leukemia hematology']\n",
      "['refractory chronic lymphocytic leukemia cll', 'global clinical trials review h1', 'ken research']\n",
      "['refractory chronic lymphocytic leukemia cll', 'global clinical trials review h1', 'ken research']\n",
      "['cancerpatients partner', 'treatment decisions', 'mark silverstein', 'shares tips']\n",
      "['s spotleukaemia london workshop', 'bloodcancer leukaemia', 'early diagnosis', 'leukaemia aml', 'cml cll awareness earlydiagnosis']\n",
      "['iranian rituximab biosimilar', 'chronic lymphocytic leukemia']\n",
      "['cll patients', 'jacqueline barrientos', 'hematology ash17 leukemia leusm bloodcancer chroniclymphocyticleukemia cllsm hcsm hemonc cancer hemonc hemeonc']\n",
      "['rns aim cll cello health plc', 'ftse classification']\n",
      "['cll diagnosis', 'powerful video john', 'john s video', 'bloodcancer leukaemia giveblood campaign mondaymotivation scotland rt']\n",
      "['sequential treatment', 'chronic lymphocytic leukemia']\n",
      "['mi instagram nninitaa y participen por entradas para cll dar', 'los ganadores el', 'octubre evento se realiza el', 'octubre suerte concurso luchalibre cll chile luchachilena']\n",
      "['cll cll cello health group ex dividend date', 'payment date']\n",
      "['mir 125a', 'mir 34a expression predicts richter syndrome', 'chronic lymphocytic leukemia patients']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['mir 125a', 'mir 34a expression predicts richter syndrome', 'chronic lymphocytic leukemia patients']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['eu panel backs venetoclax rituximab combo', 'refractory cll oncology']\n",
      "['cll paradigm']\n",
      "['international cll meeting', 'clinical knowledge', 'nicest atmosphere', 'prof hallek', 'colls cll k ln']\n",
      "['cll study', 'refractory patients', 'disease markers alcs tnf il', 'amp ccl3', 'clear evidence', 'cll patients']\n",
      "['lenalidomide consolidation therapy']\n",
      "['chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['cancer cells', 'assess response', 'chronic lymphocytic leukemia']\n",
      "['own wild animals haha thisisleukemia cll nola allkindsoffriends cheerfam workfam audobonzoo']\n",
      "['hey online audience', 'cll info', 'chronic lymphocytic leukemia cll']\n",
      "['promising cll research making treatment decisions', 'expert panel']\n",
      "['care partners', 'cll town meeting']\n",
      "['tolerate kinase inhibitors', 'line treatments', 'toxicity profile bloodcancerawarenessmonth cancer leukemia cll']\n",
      "['main types', 'acute myeloid leukemia aml', 'chronic myeloid leukemia cml', 'acute lymphocytic leukemia', 'chronic lymphocytic leukemia cll cmlday']\n",
      "['new study', 'chronic lymphocytic leukemia', 'common form', 'adults bloodcancerawarenessmonth']\n",
      "['therapeutic efficacy', 'front line treatment', 'overall response', 'negative remissions']\n",
      "['dose immunoglobulin replacement therapy', 'chronic lymphocytic leukemia link cancer cancercongress cancerconference cancerconferences cancerevent paris france feb']\n",
      "['bispecific antibody', 'promising new treatment approach cll link cancer cancercongress cancerconference cancerconferences cancerevent paris france feb']\n",
      "['chronic lymphocytic leukemia link cancer cancercongress cancerconference cancerconferences cancerevent paris france feb']\n",
      "['oxidative stress', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'american society', 'clinical oncology', 'annual meeting']\n",
      "['delicate reptourneworleans taylorswift cll']\n",
      "['nk allo nkcellrx', 'rt leusm lymsm']\n",
      "['cll town mtg', 'atlanta area']\n",
      "['positive chmp opinion', 'novel chemotherapy', 'free combination', 'venclyxto venetoclax tabl']\n",
      "['positive opinion', 'therapeutic option', 'chronic lymphocytic leukemia cll']\n",
      "['abbv abbvie', 'positive chmp opinion', 'novel chemotherapy', 'free combination', 'venclyxto venetoclax tablets', 'chronic lymphocytic leukemia']\n",
      "['positive chmp opinion', 'novel chemotherapy', 'free combination', 'venclyxto venetoclax tablets', 'chronic lymphocytic leukemia']\n",
      "['positive chmp opinion', 'novel chemotherapy', 'free combination', 'venclyxto venetoclax tablets w rituximab', 'treatment w', 'chronic lymphocytic leukemia']\n",
      "['positive eu committee opinion', 'chronic lymphocytic leukemia']\n",
      "['oxidative stress', 'chronic lymphocytic leukemia', 'debate lymphoma lymsm']\n",
      "['rns aim cll cello health plc director pdmr']\n",
      "['cll combinations', 'm hallek']\n",
      "['interesting article education', 'cancer bloodcancerawarenessmonth cll']\n",
      "['laboratory findings', 'chronic lymphocytic leukemia cll', 'show lymphocytosis']\n",
      "['chronic lymphocytic leukemia cll cancerresearch']\n",
      "['types cll']\n",
      "['hairy cell leukemia chronic lymphocytic leukemia', 'multiple myeloma', 'waldenstr m s macroglobulinemia']\n",
      "['rns aim cll cello health plc']\n",
      "['independent learning project', 'wouldn t guess', 'cll cakesoftwitter']\n",
      "['chronic lymphocytic leukemia', 'dr elias campo', 'oncobellsymposium18 cat idibell']\n",
      "['clinical impact', 'genomic studies', 'chronic lymphocytic leukemia oncobellsymposium18']\n",
      "['lenalidomide consolidation therapy']\n",
      "['acute lymphoblastic leukemia cll chronic lymphocytic leukemia', 'nhl non', 'dr manel juan cat oncobellsymposium18']\n",
      "['rns aim cll cello health plc director pdmr']\n",
      "['stress levels', 'disease bloodcancerawarenessmonth']\n",
      "['high risk cll', 'novel agents car t', 'allogeneic hct', 'dr shadmar', 'chair dr radich stateofscience hematology']\n",
      "['recent case', 'granulomatous interstitial nephritis', 'cll renalpath pathology cll']\n",
      "['ceo tokenfest interview video totle', 'dex bancor airswap kybernetwork', 'cryptotradealert blockchain tokenfestboston tokenfest cryptocurrency digitalcurrency cll cryptoliveleak']\n",
      "['organic papaya leaf glycerite 2oz caricapapaya herbal extract alcoholfree', 'papayaleaf cll chroniclymphocyticleukemia']\n",
      "['lenalidomide consolidation therapy']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['dr nicole lamanna', 'dr michael', 'dr alessandra ferrajoli', 'research affects', 'cll treatments amp', 'person leusm']\n",
      "['chronic lymphocytic leukemia cll expert', 'expert session w dr sharman']\n",
      "['transplant status', 'car t therapy outcomes', 'leukemia oncology']\n",
      "['ibrutinib amp w', 'oral therapies', 'amp stay', 'experimental meds']\n",
      "['cll medicine', 'favorite cll reporter']\n",
      "['specific b cell receptors drive chronic lymphocytic leukemia', 'light chain', 'dependent cross reaction', 'autoantigens fightbloodcancer']\n",
      "['cll cello health making good headway', 'decent organic growth', 'uk cll brighterir andrewscotttv capitalnetwork1']\n",
      "['current treatment landscape', 'chronic lymphocytic leukemia', 'short clip', 'bloodcancerawarenessmonth leukemia lesum']\n",
      "['cll tests', 'guest blog', 'larry saltzman executive research director']\n",
      "['acute myeloid leukemia aml chronic myeloid leukemia cml', 'acute lymphocytic leukemia', 'chronic lymphocytic leukemia cll fightingleukaemia bloodcancerawarenessmonth']\n",
      "['oncologynews remission maintenance treatment options', 'chronic lymphocytic leukemia']\n",
      "['cll results', 'new offices', 'etc chairman', 'i m', 'sure mark scott ceo', 'year chart', 'obvious catalyst', 'i don t hold', 'quality play i']\n",
      "['cll cello health', 'year profits climb', 'uk cll brighterir andrewscotttv capitalnetwork1']\n",
      "['briefedup uk stock market news', 'morning idp aph cll ekt qxt tmmg eck', 'amp ketl']\n",
      "['rns aim cll cello health plc interim results']\n",
      "['morning idp aph cll ekt qxt tmmg amp eck']\n",
      "['sequential treatment', 'chronic lymphocytic leukemia']\n",
      "['new study']\n",
      "['post doc research', 'manitoba chronic lymphocytic leukemia research team mb mb']\n",
      "['front line', 'choice pharmacotherapeutics', 'chronic lymphocytic leukemia']\n",
      "['don t', 'live cll asktheexpert session', 'dr sharman', 'pm register', 'cll info leusm']\n",
      "['front line', 'choice pharmacotherapeutics', 'chronic lymphocytic leukemia introduction chronic lymphocytic leukemia cll', 'common hematologic malignancy', 'variable clinical course frontline treatments']\n",
      "['research assoc mb chronic lymphocytic leukemia research university', 'manitoba winnipeg mb primary responsibilities', 'experimental work', 'mouse models', 'co mbtopemployers eluta']\n",
      "['chronic lymphocytic leukemia b cell']\n",
      "['dr kerry rogers online', 'joins colleagues', 'expert info', 'chronic lymphocytic leukemia treatments', 'event cll']\n",
      "['pharmacy times', 'live broadcast', 'chronic lymphocytic leukemia drug biotech laboratory']\n",
      "['sequential treatment', 'chronic lymphocytic leukemia']\n",
      "['cll experts dr jennifer', 'brown dr jan burger amp dr anthony mato', 'cll amp', 'chemoimmunotherapy versus novel therapies', 'front line setting']\n",
      "['prognostic nomogram', 'survival index', 'chronic lymphocytic leukemia', 'center experience']\n",
      "['high dimensional mass cytometry analysis', 'microenvironment complexity', 'chronic lymphocytic leukemia']\n",
      "['absolute lymphocyte', 'cells l', 'lymph nodes']\n",
      "['tyrosine kinase inhibitor', 'chronic lymphocytic leukemia']\n",
      "['durable molecular remission', 'chronic lymphocytic leukemia']\n",
      "['daily oral polyphenon e', 'asymptomatic rai stage', 'ii chronic lymphocytic leukemia']\n",
      "['mark silverstein', 'toronto canada', 'rough journey w cll', 'powerful patient', 'recent convo']\n",
      "['immunoglobulin replacement therapy', 'chronic lymphocytic leukemia']\n",
      "['phase ii trial', 'high risk malignancy status', 'condition summary', 'acute myeloid leukemia', 'acute lymphocytic leukemia biphenotypic', 'leukemia chronic myelogenous leukemia']\n",
      "['chroniclymphocyticleukemia cll therapies dr michael', 'discusses leusm']\n",
      "['cll update tgtx venetoclax ibrutinib combinations']\n",
      "['w qs', 'dr sharman', 'answers amp']\n",
      "['bone marrow', 'treatment options leusm leukemiaawarenessmonth']\n",
      "['promising results', 'mrd ve']\n",
      "['sept issue phase2 trial', 'chronic lymphocytic leukaemia cll', 'cll2 bag study']\n",
      "['part cme series', 'pan pacific lymphoma conference', 'experts drs thomas kipps amp prof john gribben']\n",
      "['improvement immunization', 'pts w monoclonal b cell lymphocytosis', 'cll whitaker', 'leusm cllsm idonc']\n",
      "['saturday s cll town mtg', 'atlanta area']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['vitro resistance', 'poor response', 'cll patients', 'obvious molecular players', 'immunotherapy leukemia bcells']\n",
      "['cll chemoimmunotherapy', 'fit kinase inhibitors', 'different toxicity profile', 'vulnerable patients', 'bloodcancerawareness leukaemia']\n",
      "['chronic lymphocytic leukemia']\n",
      "['comprehensive safety analysis', 'venetoclax monotherapy', 'refractory chronic lymphocytic leukemia']\n",
      "['comprehensive safety analysis', 'venetoclax monotherapy', 'refractory chronic lymphocytic leukemia']\n",
      "['stable cll cases', 'silent somatic mutations', 'stable cases', 'recurrent lesion', 'clonal mutations', 'notch1 birc3 sf3b1']\n",
      "['powerful message', 'great friend', 'cll community']\n",
      "['rt medlypharmacy', 'medical news', 'chronic lymphocytic leukemia']\n",
      "['medical news', 'chronic lymphocytic leukemia']\n",
      "['cll patients', 'florence cymbalista']\n",
      "['cll ibrutinib r sistance']\n",
      "['car nk cells', 'car t cells', 'car t cells', 'patient car nk cells', 'shelf treatments tcellrx lymsm cll nkcellrx']\n",
      "['tp53 disruptions', 'diagnostic measure', 'cll w anna schuh bsh2018 leukemia leusm cllsm hemonc hcsm biomarkers genetics genomics p53', 'venetoclax chroniclymphocyticleukemia']\n",
      "['worldlymphomaawarenessday wlad cll', 'blood sll', 'disease amp', 'affects lymph nodes']\n",
      "['cll patient discussion', 'hematology leukemia immunoonc leusm hcsm cllsm']\n",
      "['ibrutinib treatment', 'chronic lymphoc']\n",
      "['dr florence cymbalista', 'soho18 progress', 'richters transformation', 'huge unmet need']\n",
      "['rt physrelations rt leukemiamda debate cit', 'soho18 audience majority votes', 'preliminary poll dr phillip thompson', 'mdandersonnews gt yes endcancer physrelations leusm cll']\n",
      "['rt physrelations rt leukemiamda nitinjainmd', 'line treatment', 'cll leusm endcancer soho18 physrelations']\n",
      "['debate cit', 'soho18 audience majority votes', 'preliminary poll dr phillip thompson', 'gt yes endcancer leusm cll']\n",
      "['ny fire chief files', 'new lawsuit', 'illnesses utica fire chief russell brooks', 'chronic lymphocytic leukemia', 'fdny recovery effort']\n",
      "['anna schuh md', 'genomic landscape', 'soho18 leusm']\n",
      "['florencia cymbalista md phd', 'h pital avicenne', 'cll state', 'art update', 'soho18 leusm']\n",
      "['anticancer drug development workshop', 'cll endcancer patientpower']\n",
      "['blood cancer awareness month', 'world lymphoma awareness day', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma cll sll', 'big month']\n",
      "['michael amp jan', 'year s survivorship conference']\n",
      "['lille lille', 'invite yakoub agha']\n",
      "['uses vortuxi', 'mg injection', 'non hodgkin lymphoma nhl blood cancer chronic lymphocytic leukemia', 'rheumatoid arthritis pharmaceuticalmedicine rsp']\n",
      "['rt physrelations rt leukemiamda soho18 saturday', 'session ix cll', 'dr phillip thompson', 'mdandersonnews leukemiamda debate cit', 'yes cancermedmda physrelations leusm']\n",
      "['rt physrelations rt leukemiamda soho18 saturday', 'session ix cll', 'mdandersonnews leukemiamda', 'case study', 'del17p tp53 mutation', 'cancermedmda physrelations leusm']\n",
      "['soho18 saturday', 'session ix cll', 'dr phillip thompson', 'debate cit', 'yes leusm']\n",
      "['soho18 saturday', 'session ix cll', 'case study', 'del17p tp53 mutation']\n",
      "['new modules', 'eortc qlq c30', 'hodgkin s disease eortc qlq hl27 high', 'low grade nhl eortc qlq nhl hg29 eortc qlq nhl lg20', 'cll eortc qlq cll17']\n",
      "['kaposi s sarcoma', 'negative chronic lymphocytic leukemia patient', 'immunosuppressive therapy', 'case report']\n",
      "['emotional impact', 'chronic lymphocytic leukemia cll', 'patients feeling', 'roller coaster', 'ways patients', 'regain control']\n",
      "['december bloodcancer sickday cll']\n",
      "['cll barbara eichhorst', 'soho18 hemeonc cllsm immunotherapy']\n",
      "['immunoglobulin igg', 'cll patients', 'sinus respiratory', 'recurrent infection dr alessandra ferrajoli']\n",
      "['chronic lymphocytic leukemia cll', 'cancer cells', 'new study']\n",
      "['health myhusband sickday makebloodcancervisible bloodcancerawarenessmonth cll']\n",
      "['token fest day', 'tokenfest celsiusnetwork', 'crypto digitalcurrency cryptonews blockchain cryptocurrency cll cryptoliveleak boston blockchainnews cyberrepublic peertopeer']\n",
      "['diet impact cll progression', 'watchandwait dr lamanna', 'diet supplements', 'immune system', 'optimal health leusm']\n",
      "['full length transcript characterization', 'sf3b1 mutation', 'chronic lymphocytic leukemia reveals downregulation']\n",
      "['new modules', 'eortc qlq c30', 'hodgkin s disease eortc qlq hl27 high', 'low grade nhl eortc qlq nhl hg29 eortc qlq nhl lg20', 'cll eortc qlq cll17']\n",
      "['didyouknow bloodcancer', 'uk s', 'cancer killer', 'september amp rt', 'cll leukaemia haematology awareness']\n",
      "['comprehensive safety analysis', 'venetoclax monotherapy', 'refractory chronic lymphocytic leukemia']\n",
      "['widespread intronic polyadenylation inactivates tumour suppressor genes', 'leusm leukemia']\n",
      "['cll patients', 'own body', 'track amp', 'cll town mtg']\n",
      "['chronic lymphocytic leukemia', 'common type', 'western countries ptce', 'live video broadcast', 'questions register']\n",
      "['new drug', 'remarkable results', 'cll protein']\n",
      "['cll car nk tcellrx lymsm']\n",
      "['successful day', 'exciting updates', 'energy bitcoinenergy liquidassets tokenfestboston tokenfest cryptocurrency digitalcurrency blockchain cll cryptoliveleak']\n",
      "['mir 15a', 'chronic lymphocytic leukemia']\n",
      "['rt amp', 'september bloodcancerawareness cll leukaemia myeloma haemtology']\n",
      "['great time', 'lucas ceo', 'easy mine video', 'easymine emt tokenfestboston cryptonews blockchainnews blockchain tokenfest cll cryptoliveleak']\n",
      "['venetoclax shows activity', 'chronic lymphocytic leukemia', 'cll fightbloodcancer bloodcancerawarenessmonth']\n",
      "['cartcell work', 'cll w']\n",
      "['tokenfestboston tokenfest elastos cryptonews blockchain cryptocurrency cll cryptoliveleak boston blockchainnews cyberrepublic peertopeer']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['new lymphoma group', 'info amp support', 'nhl hodgkin cll lymphomas', 'common blood cancers bloodcancerawarenessmonth wlad lymphomamatters']\n",
      "['global conference', 'countries tokenfestboston tokenfest blockchain blockchainnews cryptonews crypto decentralize blockchaintechnology cryptocurrencies globalconference seaportworldtradecenter boston cll cryptoliveleak']\n",
      "['accessible trustless', 'cryptotradealert blockchain tokenfestboston tokenfest cryptocurrency digitalcurrency cll cryptoliveleak']\n",
      "['new powerfulpatient story meet mark silverstein', 'cll patient amp advocate', 'cancer journey', 's remission leusm']\n",
      "['minimal residual disease data', 'phase iii murano trial', 'chronic lymphocytic leukemia leusm leukemia']\n",
      "['cll chief compliance officer pat conlin', 'video interview', 'robert pike', 'token tokenfestboston tokenfest blockchain securitytoken blockchainnews cll cryptoliveleak onecointolightupafrica azizacoin aziza']\n",
      "['effective vaccine strategies', 'high risk', 'infection leusm idonc']\n",
      "['improvement immunization', 'pts w monoclonal b cell lymphocytosis', 'cll whitaker', 'leusm cllsm idonc']\n",
      "['video interview', 'joshua suh director', 'telegramapp blockchainnews cryptonews tokenfestboston tokenfest cll cryptoliveleak']\n",
      "['week s sept', 'cll town mtg', 'atlanta area']\n",
      "['multiple ways', 'assess mrd', 'lymphoid neoplasms', 'comparative advantages mrd', 'powerful biomarkers', 'cll myeloma aml', 'cbciii sept']\n",
      "['mir 15a', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia cll patients', 'immune system', 'zent dermatology medicine']\n",
      "['high risk chronic lymphocytic leukemia', 'pathway inhibitors', 'cellular therapies']\n",
      "['clinical trials', 's bloodcancerawareness month', 'leukaemia cancer']\n",
      "['various chemotherapy regimens', 'line setting', 'treatment naive patients', 'chronic lymphocytic leukemia leukemia oncology']\n",
      "['noncovalent inhibition', 'c481s bruton tyrosine kinase', 'new treatment strategy', 'resistant cll']\n",
      "['cartcell therapy', 'soho2018 immunooncology']\n",
      "['venetoclax fda label', 'minimal residual disease negativity data abbvie cll leukaemia mabthera rituximab roche venclexta venetoclax']\n",
      "['venetoclax fda label', 'minimal residual disease negativity data abbvie cll leukaemia mabthera rituximab roche venclexta venetoclax']\n",
      "['cll questions', 'expert session w dr sharman', 'pm pt', 'cll info']\n",
      "['een elfenbankje drie enthousiaste', 'kundige spreeksters deze keer']\n",
      "['rt physrelations rt leukemiamda soho18 wednesday', '8a mtp vii cll session f dr katy rezvani', 'car nk cell therapy', 'cll cartcell cart cancermedmda physrelations']\n",
      "['jaar zuiderzeewet cll']\n",
      "['regions chronic lymphatic leukemia', 'livetracker shows rwe', 'global regions cll awareness']\n",
      "['rt physrelations rt leukemiamda soho18 wednesday', '8a mtp vii cll session f wwierda', 'mdandersonnews leukemiamda', 'car t leusm cartcell leukemia cart cancermedmda physrelations']\n",
      "['soho18 wednesday', '8a mtp vii cll session f dr katy rezvani', 'car nk cell therapy', 'cll cartcell cart']\n",
      "['soho18 wednesday', '8a mtp vii cll session f', 'car t leusm cartcell leukemia cart']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['chronic lymphocytic leukemia cll', 'commonest form', 'new study shows', 'cll patients', 'cancer cells']\n",
      "['various chemotherapy regimens', 'line setting', 'treatment naive patients', 'chronic lymphocytic leukemia cll leukemia']\n",
      "['abbv fda', 'chronic lymphocytic leukemia cll', 'minimal residual disease mrd negativity']\n",
      "['glycolytic blockade', 'genetic chemo therapies', 'chronic lymphocytic leukemia', 'cancer bio amp therapy', 'jax s']\n",
      "['minimal residual disease negativity data cll leukemia']\n",
      "['bloodcancerawareness month', 'interesting documentary', 'hematologists cll leukemia ash hematology escapetothrive bagit']\n",
      "['chronic lymphocytic leukemia cll']\n",
      "['ibrutinib treatment']\n",
      "['equal relapse', 'doctor dr']\n",
      "['time cll hematology']\n",
      "['new study suggests stress', 'chronic lymphocytic leukemia lead author barbara andersen', 'cancer patients']\n",
      "['vaccine therapies', 'treatment strategy work', 'dr michael', 'current progress', 'dna vaccines leusm']\n",
      "['various chemotherapy regimens', 'line setting', 'chronic lymphocytic leukemia', 'recent study']\n",
      "['ibrutinib treatment', 'chronic lym leukemia']\n",
      "['a2 chronic lymphocytic leukemia cll abim usmle hematology']\n",
      "['new mrna cancer drivers', 'chronic lymphocytic leukemia', 'new evidence']\n",
      "['current treatment options', 'john gribben', 'ebmt17 hematology leusm immunotherapy chemotherapy cancertreatment catx immunoonc noveldrugs']\n",
      "['service level agreement', 'egi begrid belnet service provider', 'belspo belgium', 'european research initiative', 'chronic lymphocytic leukemia', 'details servicesforscience']\n",
      "['uses mabtas n', 'mg injection', 'non hodgkin lymphoma nhl blood cancer chronic lymphocytic leukemia', 'rheumatoid arthritis pharmaceuticalmedicine rsp']\n",
      "['cancer biology', 'awesome view', 'windowless lab', 'phdlife cll cancerresearch']\n",
      "['new drugs', 'chronic lymphocytic leukemia', 'years patients', 'blood cancer']\n",
      "['tlr2 expression', 'leukemic b cells', 'chronic lymphocytic leukemia']\n",
      "['javier pinilla ibarz md phd comments', 'chronic lymphocytic leukemia', 'journal cll']\n",
      "['ibrutinib treatment', 'chronic lymph']\n",
      "['chroniclymphocyticleukemia life expectancy', 'survival rates cll leukemia bonemarrow blood']\n",
      "['oncologynews remission maintenance treatment options', 'chronic lymphocytic leukemia']\n",
      "['tlr2 expression', 'leukemic b cells', 'chronic lymphocytic leukemia']\n",
      "[]\n",
      "['professor freda stevenson', 'uk recipient', 'major haematology award', 'b cell malignancies', 'chronic lymphocytic leukemia cll']\n",
      "['trade cello group plc', 'risk reward']\n",
      "['cll treatments review', 'current amp', 'future treatment goals', 'cll w drs peter hillmen', 'jennifer r']\n",
      "['exciting testimony cll tcellrx venetoclax lymsm']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['venetoclax cll', 'quebec inesss qc2018 healthcare equialaccess canada']\n",
      "[]\n",
      "['cll hero', 'cllheroes awards don t']\n",
      "['cll hero', 'cllheroes awards don t']\n",
      "['b cell receptor rearrangement', 'somatic hypermutation', 'b cell class switch fate', 'chronic lymphocytic leukemia cll immunoverse ngs precisionmedicine']\n",
      "['vi lever', 'blodkr ft blodcancer lymfekr ft leuk mi mds dk lyle dk sundpol kr ft dk dksund lymphoma leukemia cml cll aml aml mds']\n",
      "['chronic lymphocytic leukemia cll', 'infection risk']\n",
      "['dr alison michie discusses cll']\n",
      "['large group', 'chronic lymphocytic leukemia cll', 'wilmot cancer institute', 'scientific team']\n",
      "['novel rna cancer drivers', 'chronic lymphocytic leukemia']\n",
      "['lymsm cll bcl china apg', 'selective inhibitor', 'phase i', 'b cell malignancies']\n",
      "['blood cancer awareness month bcam', 'royal marsden', 'regular blood tests consultation', 'spot leukaemia flyers', 'spotleukaemia makebloodcancervisible cll']\n",
      "['old chronic lymphocytic leukemia patients', 'center study']\n",
      "['bilateral cystoid macular edema', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'nomination cll chroniclymphocyticleukemia bloodcancerawarenessmonth bloodcancerawareness']\n",
      "['chronic lymphocytic leukemia honor']\n",
      "['full length transcript characterization', 'sf3b1 mutation', 'chronic lymphocytic leukemia reveals downregulation', 'introns biorxiv']\n",
      "['belle visite hier', 'fin d apr s midi les tudiants', 'l architecture du sont venus minutieusement dessiner langlicane culturel vis cll ducation l vis c gep l anglicane']\n",
      "['i m', 'national blood cancer awareness month', 'cancer survivors amp', 'chronic lymphocytic leukemia healthcare', 'privilege amp', 'finances fightbloodcancer']\n",
      "['new cme', 'cme credits', 'e learning module oncology hematology']\n",
      "['cll patients', 'preventative vaccinations']\n",
      "['treatment options', 'chronic lymphocytic leukemia cll register', 'free workshop', 'cancer support community cll']\n",
      "['old chronic lymphocytic leukemia patients', 'center study', 'turkey lymphoma lymsm']\n",
      "['bilateral cystoid macular edema', 'chronic lymphocytic leukemia', 'ibrutinib lymphoma lymsm']\n",
      "['adverse events', 'idelalisib treatment', 'chronic lymphocytic leukemia', 'follicular lymphoma', 'multidisciplinary position paper lymphoma lymsm']\n",
      "['bilateral cystoid macular edema', 'chronic lymphocytic leukemia', 'ibrutinib ophthalmology hematology ibrutinib macula']\n",
      "['chronic lymphocytic leukemia patients', 'lpl promotor display', 'treatment cancer blood biomarkers treatment']\n",
      "['blood cancer awareness week', 'don t', 'chronic lymphocytic leukemia']\n",
      "['novel rna cancer drivers', 'chronic lymphocytic leukemia']\n",
      "['ultimate test', 'chronic lymphocytic leukemia']\n",
      "['real world outcomes', 'management strategies', 'chronic lymphocytic leukemia patients']\n",
      "['new mrna cancer drivers']\n",
      "['new blog post', 'cll tests', 'guest blog', 'larry saltzman executive research director']\n",
      "['full length transcript characterization', 'sf3b1 mutation', 'chronic lymphocytic leukemia reveals downregulation']\n",
      "['full length transcript characterization', 'sf3b1 mutation', 'chronic lymphocytic leukemia reveals downregulation', 'introns biorxiv genomic']\n",
      "['full length transcript characterization', 'sf3b1 mutation', 'chronic lymphocytic leukemia reveals downregulation', 'introns biorxiv']\n",
      "['cll questions', 'expert session w dr sharman', 'pm pt amp', 'cll info leusm']\n",
      "['phenotypic discovery', 'therapeutic antibodies', 'chronic lymphocytic leukemia oncology']\n",
      "['msk s chronic lymphocytic leukemia expert dr anthony mato bloodcancerawarenessmonth']\n",
      "['promising treatments', 'cll patients', 'uni leusm lymsm patientcare patientcare hematology hemonc hodgkinlymphoma drugaccess noveltherapy']\n",
      "['global protein synthesis', 'translational fidelity', 'chronic lymphocytic leukemia']\n",
      "['icer standards', 'chronic lymphocytic leukemia', 'web cancer cancercongress cancerconference cancerconferences worldcancermeet paris']\n",
      "['lenalidomide chlorambucil amp rituximab', 'web cancer cancercongress cancerconference cancerconferences worldcancermeet paris']\n",
      "['pulmonary arterial hypertension', 'chronic lymphocytic leukemia patient']\n",
      "['b cell receptor rearrangement', 'somatic hypermutation', 'b cell class switch fate', 'chronic lymphocytic leukemia cll immunoverse ngs precisionmedicine']\n",
      "['cancer chronic lymphocytic leukemia']\n",
      "['susan m o brien md', 'clinical practice strategies', 'cll therapeutic landscape']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['novel rna cancer drivers', 'chronic lymphocytic leukemia']\n",
      "['phenotypic discovery', 'therapeutic antibodies', 'chronic lymphocytic leukemia']\n",
      "['free link', 'article cll', 'infection risk']\n",
      "['modern cll care', 'amp share resources', 'minimize costs', 'financial relief livingwell leusm']\n",
      "['study shows bendamustine', 'treatment naive', 'refractory cll']\n",
      "['september issue', 'research misconduct', 'chronic lymphocytic leukemia']\n",
      "['site ibrutinib', 'superior response rates', 'certain cll patients', 'major clinical trials']\n",
      "['blood cancer', 'makebloodcancervisible wednesdaywisdom haematology awareness cll leukaemia myeloma cancer patients']\n",
      "['blood igg', 'tumor necrosis factor alpha', 'clinical course', 'chronic lymphocytic leukemia']\n",
      "['comorbidity assessments', 'full module bloodcancerawareness bloodcancer']\n",
      "['high school students', 'phd student i', 'persevere phdlife cll']\n",
      "['1st site', 'phase i study', 'btk inhibitor tg', 'pts w prev', 'b cell lymphoma', 'chronic lymphocytic leukemia lymsm cllsm']\n",
      "['inferior outcomes', 'chronic lymphocytic leukemia', 'ibrutinib gerionc geriheme leusm cll']\n",
      "['cll leukemia oncology']\n",
      "['online cll leusm']\n",
      "['cll patients', 'clinical trials cancer network']\n",
      "['bullish list', 'dwha mrl emr elco fmpi cll uai ancr']\n",
      "['way home', 'liveyourlife lymphoma workshop', 'people livingwithandbeyondcancer', 'nhl hodgkin cll', 'makebloodcancervisible bcam']\n",
      "[]\n",
      "['bispecific antibody leukemia oncology']\n",
      "['minimal residual disease', 'cll clinical practice']\n",
      "['recent issue', 'old female', 'chronic lymphocytic leukemia']\n",
      "['mrd negativity', 'chronic lymphocytic leukemia expert perspectives']\n",
      "['don t', 'cll hero', 'chronic lymphocytic leukemia']\n",
      "['bioinvent int ab publish platform', 'superior functional activity', 'chronic lymphocytic leukemia']\n",
      "['phase 1b study', 'obinutuzumab ibrutinib', 'refractory cll orr', 'cri lymphoma hemonc']\n",
      "['cll town mtg', 'atlanta area']\n",
      "['paraneoplastic pemphigus', 'chronic lymphocytic leukemia', 'case report casereports jmedicalcasereports']\n",
      "['makebloodcancervisible campaign', 'amp cll']\n",
      "['free survival rates', 'similar regardless', 'age lt', 'cll gerionc geriheme']\n",
      "['high risk chronic lymphocytic leukemia', 'pathway inhibitors', 'cellular therapies', 'leusm cll']\n",
      "['new combination treatment', 'chronic lymphocytic leukemia cll leukemia']\n",
      "['btk bcl cllsm tcellrx update']\n",
      "['prof lars bullinger charite university berlin', 'studies pilot projects hematology', 'acute myeloid leukemia aml', 'chronic lymphocytic leukemia cll ju h2020']\n",
      "['dear haematologists', 'small sum', 'clinician scientist expert', 's bryone', 'blood cancer fundraiser', 'raffle tickets', 'leichhardt oval']\n",
      "['chronic lymphocytic leukemia combination therapy fair number', 'hematologic amp non hematologic', 'adverse effects']\n",
      "['chronic lymphocytic leukaemia cll', 'cell analysis', 'physical examination bloodcancerawareness bloodcancer cancerdiagnosis']\n",
      "['international conference cll horizons', 'lymphoma australia', 'cll patients', 'ones lymphoma cll']\n",
      "['i m', 'lab coat', 'aerodynamic cll chroniclymphocyticleukaemia']\n",
      "['salvage therapy', 'chronic lymphocytic leukemia']\n",
      "['video carsten niemann', 'promising results', 'cll hematology eha23 cllsm leukemia leusm hemonc hemeonc hcsm ibrutinib venetoclax bcl2 clinicaltrials ctsm trialupdates remission']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['fighters cll', 'leukemia mpncll18 mds', 'special uk']\n",
      "['final session mpncll18', 'inovative medicines', 'cll patients', 'non eu balkans']\n",
      "['video cll11 trial shows', 'os rates', 'obinutuzumab barbara eichhorst hematology eha23 leukemia cllsm leusm hcsm hemonc antibodies caxtx ctsm trialupdates rituximab chemoimmunotherapy immunotherapy immunoonc']\n",
      "['car t amp immunotherapy session', 'prof tal', 'leeds uk cll']\n",
      "['don t', 'recent advances', 'chronic lymphocytic leukemia bloodcancerawarenessmonth']\n",
      "[]\n",
      "['complement activation cell membrane hypersialylation', 'chronic lymphocytic leukemia patients']\n",
      "['s bloodcancerawareness month chemoimmunotherapy', 'effective treatment', 'chronic lymphocytic leukaemia cll', 'alternative therapy', 'cancer cancertreatment']\n",
      "['paraneoplastic pemphigus', 'chronic lymphocytic leukemia', 'case report lymphoma lymsm']\n",
      "['real world outcomes', 'management strategies', 'chronic lymphocytic leukemia cll patients', 'states leusm']\n",
      "['free survival rates', 'similar regardless', 'month progression', 'free survival lt', 'cll leusm ibrutinib olderadults gerionc geriheme']\n",
      "['line ibrutinib treatment', 'chronic lymphocytic leukemia cll', 'gerionc geriheme']\n",
      "['full house mpncll18', 'global gathering', 'bloodcancer patient advocates', 'cll amp mpn patients', '1st day']\n",
      "['haematologists mpncll18', 'cll bloodcancer patients']\n",
      "['line ibrutinib treatment', 'chronic lymphocytic leukemia']\n",
      "['cutaneous squamous cell carcinoma', 'chronic lymphocytic leukemia']\n",
      "['new outcomes', 'salvage therapy', 'chronic lymphocytic leukemia']\n",
      "['deletion 17p genetic mutation', 'tumor suppressor gene tp53', 'chronic lymphocytic leukemia memorial sloan', 'cancer center disabilityinfo zusia']\n",
      "['chronic lymphocytic leukemia cll', 'ya dad']\n",
      "['cutaneous squamous cell carcinoma', 'chronic lymphocytic leukemia patients', 'chronic lymphocytic leukemia cll', 'poor outcomes', 'cutaneous squamous cell']\n",
      "['immunoglobulin igg', 'cll patients', 'sinus respiratory', 'recurrent infection dr alessandra ferrajoli']\n",
      "['dr davids', 'cll patient care raredisease chroniclymphocyticleukemia cll']\n",
      "['chronic lymphocytic leukemia treatment', 'global market key players 4sc abbvie acea biosciences adc therapeutics aeglea biotherapeutics analysis']\n",
      "['practical advice', 'dr davids', 'associate director', 'cancer institute', 'assistant professor', 'medical school']\n",
      "['practical tips', 'chronic lymphocytic leukemia copingwithcancer cll']\n",
      "['diet impact cll progression', 'watchandwait dr lamanna', 'diet supplements', 'immune system', 'optimal health leusm']\n",
      "['dana farber s discusses ways']\n",
      "['abbvie announces', 'new undetectable minimal residual disease data', 'refractory chronic lymphocytic leukemia murano trial', '23rd europe']\n",
      "['cll horizons', 'good friends dr brian koffman amp dr talha munir', 'experts amp']\n",
      "['cll ambassador', 'blogger emma', 'degree pathway', 'final year', 'don t']\n",
      "['cutaneous squamous cell carcinoma', 'chronic lymphocytic leukemia']\n",
      "['chronic lymphocytic leukemia', 'myelofibrosis lymphoma lymsm']\n",
      "['cll arc education session', 'chroniclymphocyticleukaemia cll haematology']\n",
      "['september issue', 'braincancer ovariancancer surgery', 'breast cancer cutaneous tcell lymphoma cll childhoodcancer hodgkin lymphoma']\n",
      "['chronic lymphocytic leukemia cll', 'global clinical trials review h1']\n",
      "['refractory chronic lymphocytic leukemia cll', 'global clinical trials review h1']\n",
      "['high risk chronic lymphocytic leukemia', 'pathway inhibitors', 'cellular therapies leusm cllsm']\n",
      "['cart cells', 'cllsm tcellrx cll']\n",
      "['special report', 'new treatment concepts', 'high risk cll']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['paul o gorman leukaemia research centre', 'cll research conference']\n",
      "['summer cll', 'free family', 'musical festivals', 'uk covhour']\n",
      "['richter syndrome', 'rare complication', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['guts diarrhea', 'colonic involvement', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma']\n",
      "['chronic lymphocytic leukemia cll expert', 'expert session w dr sharman', 'pm pt leusm']\n",
      "['video novel cll therapies', 'jennifer woyach', 'bsh2018 leusm cllsm ctsm combinationtherapy tolerability toxicity immunotherapy immunoonc leukemia hemonc clinicaltrials chemotherapy noveltherapy']\n",
      "['research shows risk', 'cll population', 'general population suggests skin care', 'active surveillance amp', 'intervention amp', 'immune checkpoint inhibitor therapy']\n",
      "['active surveillance', 'cll patients']\n",
      "['lymphoblastic leukemia chronic lymphocytic leukemia cll']\n",
      "['amp hemorrhagic meningoencephalitis', 'acanthamoeba sp', 'cll patient', 'dr voshtina', 'similar case', 'open access link']\n",
      "['c est un d part vers expo champs st liboire', 'les tudiants', 'gestion agricole cll expo champs']\n",
      "['amebic encephalitis', 'chronic lymphocytic leukemia', 'ibrutinib therapy']\n",
      "['richter syndrome', 'rare complication', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma lymphoma lymsm']\n",
      "['guts diarrhea', 'colonic involvement', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma lymphoma lymsm']\n",
      "['virtual tumor board', 'chronic lymphocytic leukemia', 'discussion leukemia leusm hematology']\n",
      "['warwick campus', 'cll students', 'student check', 'extra curricular page']\n",
      "['b cell chronic lymphocytic leukemia pipeline review h2']\n",
      "['hematologic malignancies blood cancers', 'acute lymphoblastic leukemia', 'acute myeloid leukemia aml chronic lymphocytic leukemia cll myelodysplastic syndromes non hodgkins lymphoma', 'multiple myeloma pediatric mematologic malignancies']\n",
      "['cllsm cll mrna']\n",
      "['vaccine therapies', 'treatment strategy work', 'dr michael', 'current progress', 'dna vaccines leusm']\n",
      "['genetic tests', 'cll treatment']\n",
      "['western medicine']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['oncologynews remission maintenance treatment options', 'chronic lymphocytic leukemia']\n",
      "['monsanto roundup cancer lawsuits charge', 'glyphosate causes cancer non hodgkin lymphoma nhl', 'multiple myeloma mm hairy cell leukemia hcl chronic lymphocytic leukemia cll rmatthews com']\n",
      "['cll town mtg', 'atlanta area']\n",
      "['chronic lymphocytic leukemia', 'gene expression']\n",
      "['chronic lymphocytic leukemia', 'gene expression']\n",
      "['new mrna cancer drivers', 'chronic lymphocyticleukemia', 'site news healthcare']\n",
      "['special interest', 'adults leusm gerionc geriheme']\n",
      "['poor prognosis', 'chronic lymphocytic leukemia', 'dr max j gordon', 'cll imbruvica']\n",
      "['wilmslow s charity', 'year charity bag pack', 'sept supports people', 'uk s 5th', 'common cancer pls rt bloodcancer hodgkin nhl cll bcam']\n",
      "['cns involvement chronic lymphocytic leukemia cll', 'b cells', 'affects humoral', 'immunity protection', 'cryptococcal infections']\n",
      "['chronic myelogenous leukemia', 'chronic lymphocytic leukemia patient']\n",
      "['lymphoma liveyourlife workshop', 'nhl hodgkin cll treatment', 'free place bcam wlad']\n",
      "['chronic lymphocytic leukemia', 'epigenetic changes', 'gene expression']\n",
      "['chronic lymphocytic leukemia', 'epigenetic changes', 'gene expression']\n",
      "['absolute lymphocyte', 'complete blood', 'mbl monoclonal b cell lymphocytosis cll chronic lymphocytic leukemia mcl mantle cell lymphoma', 'acute lymphoblastic leukemia nhl non hodgkin lymphoma hcl hairy cell leukemia']\n",
      "['obinutuzumab treatment', 'chronic lymphocytic leukemia leukemia']\n",
      "['interesting new paper', 'damon runyon alumni christine', 'dna mutations', 'chronic lymphocytic leukemia cll']\n",
      "['twist scientists', 'cancer drivers', 'hematology cll']\n",
      "['tumorsuppressor genes', 'leukaemia cll', 'widespread intronic polyadenylation', 'tsg mrna', 'cancer pathogenesis christine mayr']\n",
      "['major types', 'acute myeloid leukemia aml chronic myeloid leukemia cml chronic lymphocytic leukemia cll', 'acute lymphoblastic leukemia']\n",
      "['don t', 'grand rounds', 'dr brander', 'cll management']\n",
      "['cll expert prof peter hillmen discusses', 'new therapies', 's treatment amp', 'information day']\n",
      "['b cell receptor rearrangement', 'somatic hypermutation', 'b cell class switch fate', 'chronic lymphocytic leukemia']\n",
      "['b cell receptor rearrangement', 'somatic hypermutation', 'b cell class switch fate', 'chronic lymphocytic leukemia']\n",
      "['dr pinilla ibarz', 'video interview', 'chronic lymphocytic leukemia lie', 'various drugs', 'patients leukemia leusm cll']\n",
      "['new student', 'partner college', 'graduates shuttlebus']\n",
      "['albumin fibrinogen ratio', 'poor outcomes', 'chronic lymphocytic leukemia', 'cancer cancer cancercongress cancerconference cancerconferences worldcancermeet cancerevent paris france feb']\n",
      "['stlauthorprophetessdallen pl2018', 'life god', 'stage ii', 'iii chronic lymphocytic leukemia', 'god birth', 'fierce god']\n",
      "['tumorsuppressor genes', 'leukaemia cll', 'widespread intronic polyadenylation', 'tsg mrna', 'cancer pathogenesis christine mayr']\n",
      "['new mrna cancer drivers', 'chronic lymphocytic leukemia']\n",
      "['tumorsuppressor genes', 'leukaemia cll', 'widespread intronic polyadenylation', 'tsg mrna', 'cancer pathogenesis christine mayr']\n",
      "['cll hero don t', 'magazine s', 'cllheroes awards nominations']\n",
      "['recent interview', 'magazine shares insight']\n",
      "['james s cll specialist dr kerry rogers', 'patient town hall', 'james patients']\n",
      "['expert purva lad amp cll patient wesley bishop share strategies', 'leusm livingwell']\n",
      "['new combination therapy', 'chronic lymphocytic leukemia raredisease cancersucks cll']\n",
      "['chronic lymphocytic leukemia combination therapy fair number', 'hematologic amp non hematologic', 'adverse effects']\n",
      "['friend partner spouse', 'family member', 'cll journey', 'supportive tips', 'cll diagnosis']\n",
      "['new phase i ii trial nct03331198', 'refractory chronic lymphocytic leukemia cll', 'small lymphocytic lymphoma sll']\n",
      "['video christopher fox', 'cll bsh2018 cllsm leukemia leusm hemonc hemeonc hcsm clinicaltrials ctsm p53 resistance genetics standardofcare targetedtherapy prognosis cagenome']\n",
      "['cache eye unit', 'emergent literacy cll literacyskills reading communication', 'cll eyfs keystage1 forecast28']\n",
      "['playlist chronic lymphocytic leukemia cll']\n",
      "['chronic lymphocytic leukemia']\n",
      "['cache eye units', 'language communication earlyyearseducation cll emergentliteracy']\n",
      "['video telomere dysfunction', 'clinical outcomes', 'cll w chris fegan', 'bsh2018 cllsm leusm leukemia hemonc hemeonc hcsm chromosomes biomarkers chemotherapy genetics prognostic clinicalpractice']\n",
      "['chronic lymphocytic leukemia', 'adults amp', 'lymphocytes cll']\n",
      "['lymphomatoid papulosis', 'chronic lymphocytic leukemia', 'small lymphocytic lymphoma case report', 'literature review lymphoma lymsm']\n",
      "['information day', 's cll expert prof patrick thornton irl', 'cll amp', 'treatment options']\n",
      "['diagnosis amp treatment', 'chronic lymphocytic leukemia cll']\n",
      "['playlist diagnosis amp treatment', 'chronic lymphocytic leukemia cll']\n",
      "['sumamos una victoria m s que nos permite seguir', 'con el t tulo vamos chicas u18 limpe o cll']\n",
      "['longlivelow cll 3l']\n",
      "['global b cell chronic lymphocytic leukemia treatment market', 'overview cost structure analysis growth opportunities']\n",
      "['flair trial', 'website cll leukaemia haematology clinicaltrial medicine research bloodcancer treatment patients']\n"
     ]
    },
    {
     "ename": "KeyboardInterrupt",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mKeyboardInterrupt\u001b[0m                         Traceback (most recent call last)",
      "\u001b[1;32m<ipython-input-20-8c928e23da82>\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m      4\u001b[0m \u001b[1;32mfor\u001b[0m \u001b[0msentences\u001b[0m \u001b[1;32min\u001b[0m \u001b[0mdf\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m'tweet_text'\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m      5\u001b[0m     \u001b[0mblob\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mTextBlob\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0msentences\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mnoun_phrases\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m----> 6\u001b[1;33m     \u001b[0mprint\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mblob\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m      7\u001b[0m \u001b[1;31m#assert price.sentiment == absa.Sentiment.negative\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m      8\u001b[0m \u001b[1;31m#assert slack.sentiment == absa.Sentiment.positive\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\ipykernel\\iostream.py\u001b[0m in \u001b[0;36mwrite\u001b[1;34m(self, string)\u001b[0m\n\u001b[0;32m    402\u001b[0m             \u001b[0mis_child\u001b[0m \u001b[1;33m=\u001b[0m \u001b[1;33m(\u001b[0m\u001b[1;32mnot\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m_is_master_process\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    403\u001b[0m             \u001b[1;31m# only touch the buffer in the IO thread to avoid races\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 404\u001b[1;33m             \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpub_thread\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mschedule\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;32mlambda\u001b[0m \u001b[1;33m:\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m_buffer\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mwrite\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mstring\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    405\u001b[0m             \u001b[1;32mif\u001b[0m \u001b[0mis_child\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    406\u001b[0m                 \u001b[1;31m# mp.Pool cannot be trusted to flush promptly (or ever),\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\ipykernel\\iostream.py\u001b[0m in \u001b[0;36mschedule\u001b[1;34m(self, f)\u001b[0m\n\u001b[0;32m    203\u001b[0m             \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m_events\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mappend\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mf\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    204\u001b[0m             \u001b[1;31m# wake event thread (message content is ignored)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 205\u001b[1;33m             \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m_event_pipe\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0msend\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34mb''\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    206\u001b[0m         \u001b[1;32melse\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    207\u001b[0m             \u001b[0mf\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\zmq\\sugar\\socket.py\u001b[0m in \u001b[0;36msend\u001b[1;34m(self, data, flags, copy, track, routing_id, group)\u001b[0m\n\u001b[0;32m    398\u001b[0m                                  copy_threshold=self.copy_threshold)\n\u001b[0;32m    399\u001b[0m             \u001b[0mdata\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mgroup\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mgroup\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 400\u001b[1;33m         \u001b[1;32mreturn\u001b[0m \u001b[0msuper\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mSocket\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0msend\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mdata\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mflags\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mflags\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mcopy\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mcopy\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mtrack\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mtrack\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    401\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    402\u001b[0m     \u001b[1;32mdef\u001b[0m \u001b[0msend_multipart\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mself\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mmsg_parts\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mflags\u001b[0m\u001b[1;33m=\u001b[0m\u001b[1;36m0\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mcopy\u001b[0m\u001b[1;33m=\u001b[0m\u001b[1;32mTrue\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mtrack\u001b[0m\u001b[1;33m=\u001b[0m\u001b[1;32mFalse\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;33m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32mzmq/backend/cython/socket.pyx\u001b[0m in \u001b[0;36mzmq.backend.cython.socket.Socket.send\u001b[1;34m()\u001b[0m\n",
      "\u001b[1;32mzmq/backend/cython/socket.pyx\u001b[0m in \u001b[0;36mzmq.backend.cython.socket.Socket.send\u001b[1;34m()\u001b[0m\n",
      "\u001b[1;32mzmq/backend/cython/socket.pyx\u001b[0m in \u001b[0;36mzmq.backend.cython.socket._send_copy\u001b[1;34m()\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\zmq\\backend\\cython\\checkrc.pxd\u001b[0m in \u001b[0;36mzmq.backend.cython.checkrc._check_rc\u001b[1;34m()\u001b[0m\n",
      "\u001b[1;31mKeyboardInterrupt\u001b[0m: "
     ]
    }
   ],
   "source": [
    "objective1 = pd.DataFrame.from_dict(c.items())\n",
    "objective1 = objective1.rename(columns = {0: 'entity', 1: 'frequency'})\n",
    "objective1 = objective1.sort_values(by=['frequency'], ascending = False)\n",
    "objective1.reset_index(inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "df=df.set_index('tweet_author')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 311,
   "metadata": {},
   "outputs": [],
   "source": [
    "nlp = absa.load()\n",
    "dataframe = pd.DataFrame(columns = [\"Entity\", \"Sentiment\", \"Name\"])\n",
    "for text in list(df['tweet_text']):\n",
    "   # tinydf = pd.DataFrame()\n",
    "    #print(text)\n",
    "    sentiment_list = {}\n",
    "    noun_phrases = list(TextBlob(text).noun_phrases)\n",
    "    #print(noun_phrases)\n",
    "    for noun in noun_phrases:\n",
    "        word = list(nlp(text, aspects = [noun]).subtasks.values())[0].sentiment\n",
    "        if word == absa.Sentiment.positive:\n",
    "            sentiment_list[noun] = 'Positive'\n",
    "        elif word == absa.Sentiment.negative:\n",
    "            sentiment_list[noun] = 'Negative'\n",
    "        else: sentiment_list[noun] = 'Neutral'\n",
    "    tinydf = pd.DataFrame(sentiment_list.items(), columns = [\"Entity\", \"Sentiment\"]) \n",
    "    tinydf[\"Name\"] = list(df.loc[df['tweet_text'] == text, 'tweet_author'])[0]\n",
    "    dataframe = dataframe.append(tinydf)\n",
    "\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 305,
   "metadata": {},
   "outputs": [],
   "source": [
    "sorted_df = dataframe.sort_values(by='Entity', ascending=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 306,
   "metadata": {},
   "outputs": [],
   "source": [
    "sorted_df = sorted_df.reset_index()\n",
    "cols = ['Entity', 'Name', 'Sentiment']\n",
    "sorted_df = sorted_df[cols]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 309,
   "metadata": {},
   "outputs": [],
   "source": [
    "sorted_df.rename(columns = {'Entity':'entity', 'Name': 'author_name', 'Sentiment':'overall_polarity'}, inplace = True)\n",
    "sorted_df.to_csv('objective2.csv', index = False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
